Citrus Sinensis ID: 003254
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 836 | 2.2.26 [Sep-21-2011] | |||||||
| O81832 | 783 | G-type lectin S-receptor- | yes | no | 0.927 | 0.989 | 0.551 | 0.0 | |
| O81833 | 815 | G-type lectin S-receptor- | no | no | 0.931 | 0.955 | 0.524 | 0.0 | |
| O81905 | 850 | Receptor-like serine/thre | no | no | 0.942 | 0.927 | 0.491 | 0.0 | |
| Q39086 | 843 | Receptor-like serine/thre | no | no | 0.919 | 0.912 | 0.485 | 0.0 | |
| Q09092 | 857 | Putative serine/threonine | N/A | no | 0.949 | 0.926 | 0.461 | 0.0 | |
| Q9S972 | 847 | Receptor-like serine/thre | no | no | 0.925 | 0.913 | 0.482 | 0.0 | |
| Q9ZT07 | 833 | G-type lectin S-receptor- | no | no | 0.938 | 0.942 | 0.468 | 0.0 | |
| P0DH86 | 853 | G-type lectin S-receptor- | no | no | 0.933 | 0.914 | 0.470 | 0.0 | |
| Q9LPZ3 | 845 | G-type lectin S-receptor- | no | no | 0.933 | 0.923 | 0.454 | 0.0 | |
| O81906 | 849 | G-type lectin S-receptor- | no | no | 0.929 | 0.915 | 0.453 | 0.0 |
| >sp|O81832|Y4729_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290 OS=Arabidopsis thaliana GN=At4g27290 PE=3 SV=4 | Back alignment and function desciption |
|---|
Score = 895 bits (2314), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 453/822 (55%), Positives = 581/822 (70%), Gaps = 47/822 (5%)
Query: 23 MEGFNLL-IIYSFLFYIISAARTLDTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRY 81
ME N+L ++ LF I A+ D + Q++KDG+T+VS SFE+GFFSPG S++RY
Sbjct: 1 MEATNVLHLLIISLFSTILLAQATDILIANQTLKDGDTIVSQGGSFEVGFFSPGGSRNRY 60
Query: 82 LGIWYKKIAEGTVTWVANRDAPLSDRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQ 141
LGIWYKKI+ TV WVANRD+PL D SG L+++ NG L L N N +WSS+SS S+Q
Sbjct: 61 LGIWYKKISLQTVVWVANRDSPLYDLSGTLKVS--ENGSLCLFNDRNHIIWSSSSSPSSQ 118
Query: 142 K-----PVAALMESGNLVVKDGKDNNPDNILWQSFDYPCDTLLPGMKLGINLGTGLNRFL 196
K P+ ++++GNLVV++ D+ + +WQS DYP D LPGMK G+N TGLNRFL
Sbjct: 119 KASLRNPIVQILDTGNLVVRNSGDDQ--DYIWQSLDYPGDMFLPGMKYGLNFVTGLNRFL 176
Query: 197 SSWKSTDDPARGDFTYGLDPRGIPQLVLRKNSIITFRAGSWNGLHWTGVPQLQLNPVYTF 256
+SW++ DDP+ G++T +DP G+PQ L+KNS++ FR G WNGL +TG+P L+ NP+Y +
Sbjct: 177 TSWRAIDDPSTGNYTNKMDPNGVPQFFLKKNSVVVFRTGPWNGLRFTGMPNLKPNPIYRY 236
Query: 257 EYVSNEKEAFYTYNLSNSSVPSRMVINPAGTVQRYTWMERTKTWTLFSRFSGVTLDQCDS 316
EYV E+E +YTY L N SV +RM +NP G +QRYTW++ ++W + +D CD
Sbjct: 237 EYVFTEEEVYYTYKLENPSVLTRMQLNPNGALQRYTWVDNLQSWNFYL---SAMMDSCDQ 293
Query: 317 YALCGAYASCNINSNSPECECLQGFVPNSQREWDMQYKSGGCVRRTPLDCKHG-DGFLEH 375
Y LCG+Y SCNIN SP C CL+GFV + + W S GCVRR LDC G DGFL+
Sbjct: 294 YTLCGSYGSCNINE-SPACRCLKGFVAKTPQAWVAGDWSEGCVRRVKLDCGKGEDGFLKI 352
Query: 376 KAVKLPDTRFSWVDKNITLWECKELCSKNCSCTAYANADVRGRGSGCLLWFHDLIDIKEL 435
+KLPDTR SW DKN+ L ECK++C +NC+C+AY+ D+R G GC+LWF DLIDI+E
Sbjct: 353 SKLKLPDTRTSWYDKNMDLNECKKVCLRNCTCSAYSPFDIRDGGKGCILWFGDLIDIREY 412
Query: 436 PESGQDLFIRMAASELDNVERRRQSKNKKQVMIIITSISLATAVIFIGGLMYRRKKHSNQ 495
E+GQDL++R+A+SE++ ++R + S++
Sbjct: 413 NENGQDLYVRLASSEIETLQRESS-------------------------------RVSSR 441
Query: 496 GNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQ 555
E+E++ELP DL ++ AT FS NKLG+GGFGPVYKG L GQE+AVKRLS+ S Q
Sbjct: 442 KQEEEDLELPFLDLDTVSEATSGFSAGNKLGQGGFGPVYKGTLACGQEVAVKRLSRTSRQ 501
Query: 556 GMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDW 615
G+EEFKNE+ LIAKLQHRNLVK+LG C +ERMLIYEY PNKSLD FIFD R + LDW
Sbjct: 502 GVEEFKNEIKLIAKLQHRNLVKILGYCVDEEERMLIYEYQPNKSLDSFIFDKERRRELDW 561
Query: 616 SKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE 675
KR II GIARG+LYLH+DSRLRIIHRDLKASNVLLD+ MN KISDFGLAR+ G D+TE
Sbjct: 562 PKRVEIIKGIARGMLYLHEDSRLRIIHRDLKASNVLLDSDMNAKISDFGLARTLGGDETE 621
Query: 676 ANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGH 735
ANT RVVGTYGYMSPEY IDG FS+KSDVFSFGVLVLEI+ G++NRGF + +H NLLGH
Sbjct: 622 ANTTRVVGTYGYMSPEYQIDGYFSLKSDVFSFGVLVLEIVSGRRNRGFRNEEHKLNLLGH 681
Query: 736 AWRLWIEERPLELIDQSLDNSCS-FSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 794
AWR ++E++ E+ID++++ SC+ SE LR I +GLLCVQQ P+DRPNMS VVLMLS E
Sbjct: 682 AWRQFLEDKAYEIIDEAVNESCTDISEVLRVIHIGLLCVQQDPKDRPNMSVVVLMLSSEM 741
Query: 795 SLPQPQQPGFFTGRNLPESESSSSRQYSASTNEITLSVLEAR 836
L P+QPGFF RNL S++ S S N T+SV++ R
Sbjct: 742 LLLDPRQPGFFNERNLLFSDTVSINLEIPSNNFQTMSVIDPR 783
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|O81833|SD11_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD1-1 OS=Arabidopsis thaliana GN=SD11 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 799 bits (2064), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 426/812 (52%), Positives = 553/812 (68%), Gaps = 33/812 (4%)
Query: 41 AARTLDTISLGQSIKDGETLVSAKESFELGFFS---PGNSKSRYLGIWYKKIAEGTVTWV 97
A + I+ + +KDG+TL S + F+LGFFS + R+LG+WY + V WV
Sbjct: 21 VALDYNVITPKEFLKDGDTLSSPDQVFQLGFFSLDQEEQPQHRFLGLWY--MEPFAVVWV 78
Query: 98 ANRDAPLSDRSGVLRINGERNGILVLLNSTNDTVWSSNSSISA-----QKPVAALMESGN 152
ANR+ PL SG L ++ G L L + + +WSS+SS + P+ + SGN
Sbjct: 79 ANRNNPLYGTSGFLNLSSL--GDLQLFDGEHKALWSSSSSSTKASKTANNPLLKISCSGN 136
Query: 153 LVVKDGKDNNPDNILWQSFDYPCDTLLPGMKLGINLGTGLNRFLSSWKSTDDPARGDFTY 212
L+ DG++ +LWQSFDYP +T+L GMKLG N T + LSSWK+ DP+ GDFT
Sbjct: 137 LISSDGEEA----VLWQSFDYPMNTILAGMKLGKNFKTQMEWSLSSWKTLKDPSPGDFTL 192
Query: 213 GLDPRGIPQLVLRKN--SIITFRAGSWNGLHWTGVPQL-QLNPVYTFEYVSNEKEAFYTY 269
LD RG+PQL+LRKN S ++R GSWNGL +TG P + + N ++ +++ S+ +E Y++
Sbjct: 193 SLDTRGLPQLILRKNGDSSYSYRLGSWNGLSFTGAPAMGRENSLFDYKFTSSAQEVNYSW 252
Query: 270 NLSNSSVPSRMVINPAGTVQRYTWMERTKTWTLFSRFSGVTLDQCDSYALCGAYASCNIN 329
+ V SR+V+N G + R+ + W L + D+CD Y++CGAYA C IN
Sbjct: 253 TPRHRIV-SRLVLNNTGKLHRFI-QSKQNQWILANT---APEDECDYYSICGAYAVCGIN 307
Query: 330 S-NSPECECLQGFVPNSQREWDMQYKSGGCVRRTPLDCKHGDGFLEHKAVKLPDTRFSWV 388
S N+P C CLQGF P S R+W++ + GCV P +C+ D F++ +KLPDT +SW
Sbjct: 308 SKNTPSCSCLQGFKPKSGRKWNISRGAYGCVHEIPTNCEKKDAFVKFPGLKLPDTSWSWY 367
Query: 389 D--KNITLWECKELCSKNCSCTAYANADVRGRGSGCLLWFHDLIDIKELPESGQDLFIRM 446
D +TL +CK CS NCSCTAYAN D+R G GCLLWF DL+D++E GQD++IRM
Sbjct: 368 DAKNEMTLEDCKIKCSSNCSCTAYANTDIREGGKGCLLWFGDLVDMREYSSFGQDVYIRM 427
Query: 447 AASELDNVERRRQSKNKKQVMIIITSISLATAVIFIGGLMYR-RKKHSNQGNEKEEMELP 505
++++ + R ++ I + + F +M R R ++ +G E+E+++LP
Sbjct: 428 GFAKIE-FKGREVVGMVVGSVVAIAVVLVVVFACFRKKIMKRYRGENFRKGIEEEDLDLP 486
Query: 506 IFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVL 565
IFD K I+ ATD+FS N LG GGFGPVYKG L +GQEIAVKRLS SGQG+EEFKNEV
Sbjct: 487 IFDRKTISIATDDFSYVNFLGRGGFGPVYKGKLEDGQEIAVKRLSANSGQGVEEFKNEVK 546
Query: 566 LIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGI 625
LIAKLQHRNLV+LLGCC Q +E MLIYEY+PNKSLD+FIFD RS LDW KR +II G+
Sbjct: 547 LIAKLQHRNLVRLLGCCIQGEECMLIYEYMPNKSLDFFIFDERRSTELDWKKRMNIINGV 606
Query: 626 ARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTY 685
ARG+LYLHQDSRLRIIHRDLKA NVLLDN MNPKISDFGLA+SFG DQ+E++T RVVGTY
Sbjct: 607 ARGILYLHQDSRLRIIHRDLKAGNVLLDNDMNPKISDFGLAKSFGGDQSESSTNRVVGTY 666
Query: 686 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERP 745
GYM PEYAIDG FSVKSDVFSFGVLVLEII GK NRGF HADHD NLLGH W++W+E+R
Sbjct: 667 GYMPPEYAIDGHFSVKSDVFSFGVLVLEIITGKTNRGFRHADHDLNLLGHVWKMWVEDRE 726
Query: 746 LELIDQSLDNSCS-FSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPQQPGF 804
+E+ ++ S E LRCI V LLCVQQ+PEDRP M+SVVLM + SLP P QPGF
Sbjct: 727 IEVPEEEWLEETSVIPEVLRCIHVALLCVQQKPEDRPTMASVVLMFGSDSSLPHPTQPGF 786
Query: 805 FTGRNLPESESSSSRQYSASTNEITLSVLEAR 836
FT RN+P+ SS S + S NE+++++L+ R
Sbjct: 787 FTNRNVPDISSSLSLR---SQNEVSITMLQGR 815
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81905|SD18_ARATH Receptor-like serine/threonine-protein kinase SD1-8 OS=Arabidopsis thaliana GN=SD18 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 788 bits (2036), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 412/838 (49%), Positives = 570/838 (68%), Gaps = 50/838 (5%)
Query: 37 YIISAARTLDTISLGQS--IKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTV 94
Y ISA +T+S +S I T+VS FELGFF PG YLGIWYK I++ T
Sbjct: 25 YSISA----NTLSASESLTISSNNTIVSPGNVFELGFFKPGLDSRWYLGIWYKAISKRTY 80
Query: 95 TWVANRDAPLSDRSGVLRINGERNGILVLLNSTNDTVWSSN-SSISAQKP-VAALMESGN 152
WVANRD PLS G L+I+ LV+L+ ++ VWS+N + + P VA L+++GN
Sbjct: 81 VWVANRDTPLSSSIGTLKISDSN---LVVLDQSDTPVWSTNLTGGDVRSPLVAELLDNGN 137
Query: 153 LVVKDGKDNNPDNILWQSFDYPCDTLLPGMKLGINLGTGLNRFLSSWKSTDDPARGDFTY 212
V++D K++ PD +LWQSFD+P DTLLP MKLG + TG NRF+ SWKS DDP+ GDF++
Sbjct: 138 FVLRDSKNSAPDGVLWQSFDFPTDTLLPEMKLGWDAKTGFNRFIRSWKSPDDPSSGDFSF 197
Query: 213 GLDPRGIPQLVLRKNSIITFRAGSWNGLHWTGVPQLQLNPVYTFEYVSNEKEAFYTYNLS 272
L+ G P++ L +R+G WNG+ ++GVP++Q F + ++++E Y++ ++
Sbjct: 198 KLETEGFPEIFLWNRESRMYRSGPWNGIRFSGVPEMQPFEYMVFNFTTSKEEVTYSFRIT 257
Query: 273 NSSVPSRMVINPAGTVQRYTWMERTKTWTLFSRFSGVTLDQCDSYALCGAYASCNINSNS 332
S V SR+ I+ +G +QR+TW+E + W ++F DQCD Y CG Y C+ N+ S
Sbjct: 258 KSDVYSRLSISSSGLLQRFTWIETAQNW---NQFWYAPKDQCDEYKECGVYGYCDSNT-S 313
Query: 333 PECECLQGFVPNSQREWDMQYKSGGCVRRTPLDCKHGDGFLEHKAVKLPDTRFSWVDKNI 392
P C C++GF P + + W ++ S GCVR+T L C GDGF+ K +KLPDT + VD+ I
Sbjct: 314 PVCNCIKGFKPRNPQVWGLRDGSDGCVRKTLLSCGGGDGFVRLKKMKLPDTTTASVDRGI 373
Query: 393 TLWECKELCSKNCSCTAYANADVRGRGSGCLLWFHDLIDIKELPESGQDLFIRMAASELD 452
+ EC++ C ++C+CTA+AN D+RG GSGC+ W +L DI+ + GQDL++R+AA++L+
Sbjct: 374 GVKECEQKCLRDCNCTAFANTDIRGSGSGCVTWTGELFDIRNYAKGGQDLYVRLAATDLE 433
Query: 453 NVERRRQSK------------------------NKKQVMIIITSI---SLATAVIFIGGL 485
+ +R R +K +K+ ++I T I L + + + +
Sbjct: 434 D-KRNRSAKIIGSSIGVSVLLLLSFIIFFLWKRKQKRSILIETPIVDHQLRSRDLLMNEV 492
Query: 486 MYRRKKHSNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIA 545
+ ++H ++ N +++ELP+ + + +A AT+NFS NKLG+GGFG VYKG L++GQE+A
Sbjct: 493 VISSRRHISRENNTDDLELPLMEFEEVAMATNNFSNANKLGQGGFGIVYKGKLLDGQEMA 552
Query: 546 VKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIF 605
VKRLSK S QG +EFKNEV LIA+LQH NLV+LL CC E+MLIYEYL N SLD +F
Sbjct: 553 VKRLSKTSVQGTDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSHLF 612
Query: 606 DTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGL 665
D +R+ L+W R II GIARGLLYLHQDSR RIIHRDLKASN+LLD M PKISDFG+
Sbjct: 613 DKSRNSKLNWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGM 672
Query: 666 ARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725
AR FG D+TEANT++VVGTYGYMSPEYA+DG+FS+KSDVFSFGVL+LEII K+N+GF +
Sbjct: 673 ARIFGRDETEANTRKVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISSKRNKGFYN 732
Query: 726 ADHDHNLLGHAWRLWIEERPLELIDQSL-DNSCSF--SEALRCIQVGLLCVQQRPEDRPN 782
+D D NLLG WR W E + LE+ID + D+S +F E LRCIQ+GLLCVQ+R EDRP
Sbjct: 733 SDRDLNLLGCVWRNWKEGKGLEIIDPIITDSSSTFRQHEILRCIQIGLLCVQERAEDRPT 792
Query: 783 MSSVVLMLSGER-SLPQPQQPGFFTGRNLPESESSSSRQY---SASTNEITLSVLEAR 836
MS V+LML E ++PQP+ PG+ R+L +++SSSS+Q S + N+IT+SVL+AR
Sbjct: 793 MSLVILMLGSESTTIPQPKAPGYCLERSLLDTDSSSSKQRDDESWTVNQITVSVLDAR 850
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39086|SD17_ARATH Receptor-like serine/threonine-protein kinase SD1-7 OS=Arabidopsis thaliana GN=SD17 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 755 bits (1950), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 399/822 (48%), Positives = 554/822 (67%), Gaps = 53/822 (6%)
Query: 53 SIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPLSDRSGVLR 112
+I +T++S + FELGFF+P +S YLGIWYK I T WVANRD PLS +G L+
Sbjct: 37 TISSNKTIISPSQIFELGFFNPASSSRWYLGIWYKIIPIRTYVWVANRDNPLSSSNGTLK 96
Query: 113 INGERNGILVLLNSTNDTVWSSN-SSISAQKPVAA-LMESGNLVVKDGKDNNPDNILWQS 170
I+G LV+ + ++ VWS+N + + PVAA L+++GN +++D + +LWQS
Sbjct: 97 ISGNN---LVIFDQSDRPVWSTNITGGDVRSPVAAELLDNGNFLLRDSNNR----LLWQS 149
Query: 171 FDYPCDTLLPGMKLGINLGTGLNRFLSSWKSTDDPARGDFTYGLDPRGIPQLVLRKNSII 230
FD+P DTLL MKLG + TG NR L SWK+TDDP+ G+F+ L+ P+ + I
Sbjct: 150 FDFPTDTLLAEMKLGWDQKTGFNRILRSWKTTDDPSSGEFSTKLETSEFPEFYICSKESI 209
Query: 231 TFRAGSWNGLHWTGVPQLQLNPVYTFEYVSNEKEAFYTYNLSNSSVPSRMVINPAGTVQR 290
+R+G WNG+ ++ VP + + ++++E Y+Y ++ +++ SR+ +N AG +QR
Sbjct: 210 LYRSGPWNGMRFSSVPGTIQVDYMVYNFTASKEEVTYSYRINKTNLYSRLYLNSAGLLQR 269
Query: 291 YTWMERTKTWTLFSRFSGVTLDQCDSYALCGAYASCNINSNSPECECLQGFVPNSQREWD 350
TW E T++W + D CD+Y +CG + C+ NS P C C++GF P +++ WD
Sbjct: 270 LTWFETTQSW---KQLWYSPKDLCDNYKVCGNFGYCDSNS-LPNCYCIKGFKPVNEQAWD 325
Query: 351 MQYKSGGCVRRTPLDCKHGDGFLEHKAVKLPDTRFSWVDKNITLWECKELCSKNCSCTAY 410
++ S GC+R+T L C DGF K +KLPDT + VD+ I L CKE C ++C+CTA+
Sbjct: 326 LRDGSAGCMRKTRLSCDGRDGFTRLKRMKLPDTTATIVDREIGLKVCKERCLEDCNCTAF 385
Query: 411 ANADVRGRGSGCLLWFHDLIDIKELPESGQDLFIRMAASELDNVERRRQSKNKKQV--MI 468
ANAD+R GSGC++W +++D++ + GQDL++R+AA+EL++ ++ KN+K + I
Sbjct: 386 ANADIRNGGSGCVIWTREILDMRNYAKGGQDLYVRLAAAELED----KRIKNEKIIGSSI 441
Query: 469 IITSISLATAVIF---------------------------IGGLMYRRKKHSNQGNEKEE 501
++ + L + VIF I ++ R+ ++++ + E
Sbjct: 442 GVSILLLLSFVIFHFWKRKQKRSITIQTPNVDQVRSQDSLINDVVVSRRGYTSKEKKSEY 501
Query: 502 MELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFK 561
+ELP+ +L+ +A AT+NFS NKLG+GGFG VYKG L++G+EIAVKRLSK S QG +EF
Sbjct: 502 LELPLLELEALATATNNFSNDNKLGQGGFGIVYKGRLLDGKEIAVKRLSKMSSQGTDEFM 561
Query: 562 NEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHI 621
NEV LIAKLQH NLV+LLGCC + E+MLIYEYL N SLD +FD TRS L+W KR I
Sbjct: 562 NEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKRFDI 621
Query: 622 IAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRV 681
I GIARGLLYLHQDSR RIIHRDLKASNVLLD M PKISDFG+AR FG ++TEANT+RV
Sbjct: 622 INGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANTRRV 681
Query: 682 VGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWI 741
VGTYGYMSPEYA+DG+FS+KSDVFSFGVL+LEII GK+N+GF +++ D NLLG WR W
Sbjct: 682 VGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGFVWRHWK 741
Query: 742 EERPLELID----QSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS-L 796
E LE++D SL + E LRCIQ+GLLCVQ+R EDRP MSSV++ML E + +
Sbjct: 742 EGNELEIVDPINIDSLSSKFPTHEILRCIQIGLLCVQERAEDRPVMSSVMVMLGSETTAI 801
Query: 797 PQPQQPGFFTGRNLPESESSSSRQY--SASTNEITLSVLEAR 836
PQP++PGF GR+ E++SSSS Q + N+ITLSV++AR
Sbjct: 802 PQPKRPGFCIGRSPLEADSSSSTQRDDECTVNQITLSVIDAR 843
|
Involved in the regulation of cellular expansion and differentiation. Mediates subcellular relocalization of PUB9 from nucleus to plasma membrane in a protein-phosphorylation-dependent manner. May be involved in the abscisic acid-mediated signaling pathway, at least during germination. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q09092|SRK6_BRAOE Putative serine/threonine-protein kinase receptor OS=Brassica oleracea var. acephala GN=SRK6 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 755 bits (1949), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 398/862 (46%), Positives = 560/862 (64%), Gaps = 68/862 (7%)
Query: 26 FNLLIIYSFLFYIISAART-LDTISLGQS--IKDGETLVSAKESFELGFFSPGNSKSR-Y 81
+ L+++ + I A ++T+S +S I +TLVS FE+GFF + SR Y
Sbjct: 13 MSFLLVFVVMILIHPALSIYINTLSSTESLTISSNKTLVSPGSIFEVGFF---RTNSRWY 69
Query: 82 LGIWYKKIAEGTVTWVANRDAPLSDRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQ 141
LG+WYKK+++ T WVANRD PLS+ G L+I+G LVLL+ +N VW +N + +
Sbjct: 70 LGMWYKKVSDRTYVWVANRDNPLSNAIGTLKISGNN---LVLLDHSNKPVWWTNLTRGNE 126
Query: 142 KP--VAALMESGNLVVKDGKDNNPDNILWQSFDYPCDTLLPGMKLGINLGTGLNRFLSSW 199
+ VA L+ +GN V++D +N+ LWQSFDYP DTLLP MKLG NL TGLNRFL+SW
Sbjct: 127 RSPVVAELLANGNFVMRDSSNNDASEYLWQSFDYPTDTLLPEMKLGYNLKTGLNRFLTSW 186
Query: 200 KSTDDPARGDFTYGLDPRGIPQLVLRKNSIITFRAGSWNGLHWTGVPQLQLNPVYTFEYV 259
+S+DDP+ G+F+Y L+ + +P+ L + + R+G WNG+ ++G+P+ Q + ++
Sbjct: 187 RSSDDPSSGNFSYKLETQSLPEFYLSRENFPMHRSGPWNGIRFSGIPEDQKLSYMVYNFI 246
Query: 260 SNEKEAFYTYNLSNSSVPSRMVINPAGTVQRYTWMERTKTWTLFSRFSGVTLDQCDSYAL 319
N +E YT+ ++N+S SR+ + G QR TW + W F +S QCD+Y +
Sbjct: 247 ENNEEVAYTFRMTNNSFYSRLTLISEGYFQRLTWYPSIRIWNRF--WSSPVDPQCDTYIM 304
Query: 320 CGAYASCNINSNSPECECLQGFVPNSQREWDMQYKSGGCVRRTPLDCKHGDGFLEHKAVK 379
CG YA C++N+ SP C C+QGF P + ++WD + +GGC+RRT L C GDGF K +K
Sbjct: 305 CGPYAYCDVNT-SPVCNCIQGFNPRNIQQWDQRVWAGGCIRRTQLSCS-GDGFTRMKKMK 362
Query: 380 LPDTRFSWVDKNITLWECKELCSKNCSCTAYANADVRGRGSGCLLWFHDLIDIKELPES- 438
LP+T + VD++I + ECK+ C +C+CTA+ANAD+R GSGC++W L DI+
Sbjct: 363 LPETTMATVDRSIGVKECKKRCISDCNCTAFANADIRNGGSGCVIWTERLEDIRNYATDA 422
Query: 439 --GQDLFIRMAASELDNVERRRQSKNKKQVMIIITSISLATAVIFIGGLMYRRKKH---- 492
GQDL++R+AA++ + ++R + K II ++ ++ ++ I +++RK+
Sbjct: 423 IDGQDLYVRLAAAD---IAKKRNASGK----IISLTVGVSVLLLLIMFCLWKRKQKRAKA 475
Query: 493 ------SNQGNEK--------------------EEMELPIFDLKIIANATDNFSEKNKLG 526
+ Q N+ EE+ELP+ +++ + AT+NFS NKLG
Sbjct: 476 SAISIANTQRNQNLPMNEMVLSSKREFSGEYKFEELELPLIEMETVVKATENFSSCNKLG 535
Query: 527 EGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD 586
+GGFG VYKG L++G+EIAVKRLSK S QG +EF NEV LIA+LQH NLV++LGCC + D
Sbjct: 536 QGGFGIVYKGRLLDGKEIAVKRLSKTSVQGTDEFMNEVTLIARLQHINLVQVLGCCIEGD 595
Query: 587 ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLK 646
E+MLIYEYL N SLD ++F TR L+W++R I G+ARGLLYLHQDSR RIIHRDLK
Sbjct: 596 EKMLIYEYLENLSLDSYLFGKTRRSKLNWNERFDITNGVARGLLYLHQDSRFRIIHRDLK 655
Query: 647 ASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFS 706
SN+LLD M PKISDFG+AR F D+TEANT +VVGTYGYMSPEYA+ G+FS KSDVFS
Sbjct: 656 VSNILLDKNMIPKISDFGMARIFERDETEANTMKVVGTYGYMSPEYAMYGIFSEKSDVFS 715
Query: 707 FGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDNSCSF------- 759
FGV+VLEI+ GKKNRGF + D++++LL + W W E R LE++D + +S S
Sbjct: 716 FGVIVLEIVSGKKNRGFYNLDYENDLLSYVWSRWKEGRALEIVDPVIVDSLSSQPSIFQP 775
Query: 760 SEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS-LPQPQQPGFFTGRNLPESESSSS 818
E L+CIQ+GLLCVQ+ E RP MSSVV M E + +PQP+ PG+ R+ E + SSS
Sbjct: 776 QEVLKCIQIGLLCVQELAEHRPAMSSVVWMFGSEATEIPQPKPPGYCVRRSPYELDPSSS 835
Query: 819 RQ----YSASTNEITLSVLEAR 836
Q S + N+ T SV++AR
Sbjct: 836 WQCDENESWTVNQYTCSVIDAR 857
|
Involved in sporophytic self-incompatibility system (the inability of flowering plants to achieve self-fertilization), probably acting in combination with S-locus-specific glycoproteins. Interaction with a ligand in the extracellular domain triggers the protein kinase activity of the cytoplasmic domain. Brassica oleracea var. acephala (taxid: 3713) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9S972|SD16_ARATH Receptor-like serine/threonine-protein kinase SD1-6 OS=Arabidopsis thaliana GN=SD16 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 749 bits (1934), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 396/821 (48%), Positives = 540/821 (65%), Gaps = 47/821 (5%)
Query: 53 SIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPLSDRSGVLR 112
+I +T++S + FELGFF+P +S YLGIWYK I T WVANRD PLS +G L+
Sbjct: 37 TISSNKTIISPSQIFELGFFNPDSSSRWYLGIWYKIIPIRTYVWVANRDNPLSSSNGTLK 96
Query: 113 INGERNGILVLLNSTNDTVWSSN-SSISAQKPVAA-LMESGNLVVKDGKDNNPDNILWQS 170
I+ LV+ + ++ VWS+N + + PVAA L++ GN V++D K+N P LWQS
Sbjct: 97 ISDNN---LVIFDQSDRPVWSTNITGGDVRSPVAAELLDYGNFVLRDSKNNKPSGFLWQS 153
Query: 171 FDYPCDTLLPGMKLGI-NLGTGLNRFLSSWKSTDDPARGDFTYGLDPRGIPQLVLRKNSI 229
FD+P DTLL MK+G N G NR L SWK+TDDP+ GDF+ L G P+ +
Sbjct: 154 FDFPTDTLLSDMKMGWDNKSGGFNRILRSWKTTDDPSSGDFSTKLRTSGFPEFYIYNKES 213
Query: 230 ITFRAGSWNGLHWTGVPQLQLNPVYTFEYVSNEKEAFYTYNLSNSSVPSRMVINPAGTVQ 289
IT+R+G W G ++ VP ++ + N ++ Y+Y ++ +++ S + ++ G +Q
Sbjct: 214 ITYRSGPWLGNRFSSVPGMKPVDYIDNSFTENNQQVVYSYRVNKTNIYSILSLSSTGLLQ 273
Query: 290 RYTWMERTKTWTLFSRFSGVTLDQCDSYALCGAYASCNINSNSPECECLQGFVPNSQREW 349
R TWME ++W + D CD+Y CG Y C+ N+ SP C C++GF P +++
Sbjct: 274 RLTWMEAAQSW---KQLWYSPKDLCDNYKECGNYGYCDANT-SPICNCIKGFEPMNEQA- 328
Query: 350 DMQYKSGGCVRRTPLDCKHGDGFLEHKAVKLPDTRFSWVDKNITLWECKELCSKNCSCTA 409
++ S GCVR+T L C DGF+ K ++LPDT + VDK I L EC+E C K C+CTA
Sbjct: 329 ALRDDSVGCVRKTKLSCDGRDGFVRLKKMRLPDTTETSVDKGIGLKECEERCLKGCNCTA 388
Query: 410 YANADVRGRGSGCLLWFHDLIDIKELPESGQDLFIRMAASELDNVERRRQSKNKKQVMII 469
+AN D+R GSGC++W L DI+ + GQDL++R+AA +L+ ++R +SK I
Sbjct: 389 FANTDIRNGGSGCVIWSGGLFDIRNYAKGGQDLYVRVAAGDLE--DKRIKSKKIIGSSIG 446
Query: 470 ITSISLATAVIF---------------------------IGGLMYRRKKHSNQGNEKEEM 502
++ + L + +IF + L+ + ++++ N+ + +
Sbjct: 447 VSILLLLSFIIFHFWKRKQKRSITIQTPIVDLVRSQDSLMNELVKASRSYTSKENKTDYL 506
Query: 503 ELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKN 562
ELP+ + K +A AT+NFS NKLG+GGFG VYKGML++G+EIAVKRLSK S QG +EF N
Sbjct: 507 ELPLMEWKALAMATNNFSTDNKLGQGGFGIVYKGMLLDGKEIAVKRLSKMSSQGTDEFMN 566
Query: 563 EVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHII 622
EV LIAKLQH NLV+LLGCC + E+MLIYEYL N SLD +FD TRS L+W KR II
Sbjct: 567 EVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKRFDII 626
Query: 623 AGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVV 682
GIARGLLYLHQDSR RIIHRDLKASNVLLD M PKISDFG+AR FG ++TEANT+RVV
Sbjct: 627 NGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANTRRVV 686
Query: 683 GTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIE 742
GTYGYMSPEYA+DG+FS+KSDVFSFGVL+LEII GK+N+GF +++ D NLLG WR W E
Sbjct: 687 GTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGFVWRHWKE 746
Query: 743 ERPLELID----QSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS-LP 797
+ LE++D +L + E LRCIQ+GLLCVQ+R EDRP MSSV++ML E + +P
Sbjct: 747 GKELEIVDPINIDALSSEFPTHEILRCIQIGLLCVQERAEDRPVMSSVMVMLGSETTAIP 806
Query: 798 QPQQPGFFTGR--NLPESESSSSRQYSASTNEITLSVLEAR 836
QP++PGF GR +S SS+ R + N++TLSV++AR
Sbjct: 807 QPKRPGFCVGRSSLEVDSSSSTQRDDECTVNQVTLSVIDAR 847
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZT07|RKS1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RKS1 OS=Arabidopsis thaliana GN=RKS1 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 736 bits (1900), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 386/824 (46%), Positives = 527/824 (63%), Gaps = 39/824 (4%)
Query: 44 TLDTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAP 103
++DTI QS++DGE ++SA + F GFFS G+S+ RY+GIWY +I++ T+ WVANRD P
Sbjct: 18 SVDTIMRRQSLRDGEVILSAGKRFAFGFFSLGDSELRYVGIWYAQISQQTIVWVANRDHP 77
Query: 104 LSDRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQKP--VAALMESGNLVVKDGKDN 161
++D SG+++ + N + ++ + +WS+N S S +P VA L + GNLV+ D
Sbjct: 78 INDTSGMVKFSNRGNLSVYASDNETELIWSTNVSDSMLEPTLVATLSDLGNLVLFDPVTG 137
Query: 162 NPDNILWQSFDYPCDTLLPGMKLGINLGTGLNRFLSSWKSTDDPARGDFTYGLDPRGIPQ 221
W+SFD+P DT LP M+LG GL+R L+SWKS DP GD ++ RG PQ
Sbjct: 138 RS---FWESFDHPTDTFLPFMRLGFTRKDGLDRSLTSWKSHGDPGSGDLILRMERRGFPQ 194
Query: 222 LVLRKNSIITFRAGSWNGLHWTGVPQLQLNPVYTFEYVSNEKEAFYTYNLSNSSVPSRMV 281
L+L K +R GSW G W+GVP++ + ++ +V+NE E +TY ++++SV +R +
Sbjct: 195 LILYKGVTPWWRMGSWTGHRWSGVPEMPIGYIFNNSFVNNEDEVSFTYGVTDASVITRTM 254
Query: 282 INPAGTVQRYTWMERTKTWTLFSRFSGVTLDQCDSYALCGAYASCNI-NSNSPECECLQG 340
+N GT+ R+TW+ R K W + F V +QCD+YA CG C+ +S + EC CL G
Sbjct: 255 VNETGTMHRFTWIARDKRW---NDFWSVPKEQCDNYAHCGPNGYCDSPSSKTFECTCLPG 311
Query: 341 FVPNSQREWDMQYKSGGCVRRTPLD-CKHGDGFLEHKAVKLPDTRFSWVDKNITLWECKE 399
F P R W ++ SGGC ++ C DGF++ K +K+PDT + VD NITL ECK+
Sbjct: 312 FEPKFPRHWFLRDSSGGCTKKKRASICSEKDGFVKLKRMKIPDTSDASVDMNITLKECKQ 371
Query: 400 LCSKNCSCTAYANA-DVRGRGS-GCLLWFHDLIDIKELPESGQDLFIRMAASELDNVERR 457
C KNCSC AYA+A RG+ GCL W ++D + SGQD +IR+ EL R
Sbjct: 372 RCLKNCSCVAYASAYHESKRGAIGCLKWHGGMLDARTYLNSGQDFYIRVDKEELARWNRN 431
Query: 458 RQSKNKKQVMIIITSISLATAVIFIGGLMYRRKKHSN----------------------Q 495
S ++ ++I+I+ I+ + I + R ++ SN +
Sbjct: 432 GLSGKRRVLLILISLIAAVMLLTVILFCVVRERRKSNRHRSSSANFAPVPFDFDESFRFE 491
Query: 496 GNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQ 555
++ ELP+FDL I AT+NFS +NKLG GGFGPVYKG+L EIAVKRLS+ SGQ
Sbjct: 492 QDKARNRELPLFDLNTIVAATNNFSSQNKLGAGGFGPVYKGVLQNRMEIAVKRLSRNSGQ 551
Query: 556 GMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDW 615
GMEEFKNEV LI+KLQHRNLV++LGCC + +E+ML+YEYLPNKSLDYFIF + LDW
Sbjct: 552 GMEEFKNEVKLISKLQHRNLVRILGCCVELEEKMLVYEYLPNKSLDYFIFHEEQRAELDW 611
Query: 616 SKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE 675
KR I+ GIARG+LYLHQDSRLRIIHRDLKASN+LLD+ M PKISDFG+AR FG +Q E
Sbjct: 612 PKRMEIVRGIARGILYLHQDSRLRIIHRDLKASNILLDSEMIPKISDFGMARIFGGNQME 671
Query: 676 ANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGH 735
T RVVGT+GYM+PEYA++G FS+KSDV+SFGVL+LEII GKKN F+ + NL+GH
Sbjct: 672 GCTSRVVGTFGYMAPEYAMEGQFSIKSDVYSFGVLMLEIITGKKNSAFH--EESSNLVGH 729
Query: 736 AWRLWIEERPLELIDQSLDN-SCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 794
W LW E+ID +D + E ++CIQ+GLLCVQ+ DR +MSSVV+ML
Sbjct: 730 IWDLWENGEATEIIDNLMDQETYDEREVMKCIQIGLLCVQENASDRVDMSSVVIMLGHNA 789
Query: 795 S-LPQPQQPGFFTGRNL-PESESSSSRQYSASTNEITLSVLEAR 836
+ LP P+ P F + R E+ + Q S N++T S ++ R
Sbjct: 790 TNLPNPKHPAFTSARRRGGENGACLKGQTGISVNDVTFSDIQGR 833
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P0DH86|SRK_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SRK OS=Arabidopsis thaliana GN=SRK PE=2 SV=1 | Back alignment and function description |
|---|
Score = 706 bits (1823), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 393/836 (47%), Positives = 540/836 (64%), Gaps = 56/836 (6%)
Query: 44 TLDTISLGQS--IKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRD 101
+++T+S +S I +T+VS FELGFF S YLGIWYKKI++ T WVANRD
Sbjct: 31 SVNTLSATESLTISSNKTIVSPGGVFELGFFRILGD-SWYLGIWYKKISQRTYVWVANRD 89
Query: 102 APLSDRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAA-LMESGNLVVKDGKD 160
PLS+ G+L+I+ N LV+L++++ VWS+N + + + V A L+++GN V++ K
Sbjct: 90 TPLSNPIGILKIS---NANLVILDNSDTHVWSTNLTGAVRSSVVAELLDNGNFVLRGSKI 146
Query: 161 NNPDNILWQSFDYPCDTLLPGMKLGINLGTGLNRFLSSWKSTDDPARGDFTYGLDPRGIP 220
N D LWQSFD+P DTLLP MKLG + GLNRF++SWKS+ DP+ G F + L+ G+P
Sbjct: 147 NESDEFLWQSFDFPTDTLLPQMKLGRDHKRGLNRFVTSWKSSFDPSSGSFMFKLETLGLP 206
Query: 221 QLVLRKNSIITFRAGSWNGLHWTGVPQLQLNPVYTFEYVSNEKEAFYTYNLSNSSVPSRM 280
+ + + +R+G W+GL ++G+ ++Q + + N +E YT+ +++ + SR+
Sbjct: 207 EFFGFTSFLEVYRSGPWDGLRFSGILEMQQWDDIIYNFTENREEVAYTFRVTDHNSYSRL 266
Query: 281 VINPAGTVQRYTWMERTKTWTLFSRFSGVTLDQCDSYALCGAYASCNINSNSPECECLQG 340
IN G ++ + W + W +F D CD Y +CG YA C++ S SP C C++G
Sbjct: 267 TINTVGRLEGFMWEPTQQEWNMFWFMPK---DTCDLYGICGPYAYCDM-STSPTCNCIKG 322
Query: 341 FVPNSQREWDMQYKSGGCVRRTPLDCKHGDGFLEHKAVKLPDTRFSWVDKNITLWECKEL 400
F P S ++W +G C R+T L C D F +K+P T + VDK I L EC+E
Sbjct: 323 FQPLSPQDWASGDVTGRCRRKTQLTCGE-DRFFRLMNMKIPATTAAIVDKRIGLKECEEK 381
Query: 401 CSKNCSCTAYANADVRGRGSGCLLWFHDLIDIKELPESGQDLFIRMAASELDNVERR--- 457
C +C+CTAYAN+D+R GSGC++W + DI+ GQDLF+R+AA+E ERR
Sbjct: 382 CKTHCNCTAYANSDIRNGGSGCIIWIGEFRDIRNYAADGQDLFVRLAAAEFG--ERRTIR 439
Query: 458 ---RQSKNKKQVMIIITSI-----------SLATA-----------VIFIGGLMYRRKKH 492
+M++++ I + ATA +I G++ +
Sbjct: 440 GKIIGLIIGISLMLVLSFIIYCFWKKKQKRARATAAPIGYRDRIQELIITNGVVMSSGRR 499
Query: 493 SNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKG 552
E E+ L F+ ++A T+NFS+ N LG GGFG VYKG L++GQEIAVKRLS+
Sbjct: 500 LLGEEEDLELPLTEFETVVMA--TENFSDSNILGRGGFGIVYKGRLLDGQEIAVKRLSEM 557
Query: 553 SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRS-K 611
S QG EFKNEV LIA+LQH NLV+LL CC DE++LIYEYL N SLD +F+TT+S
Sbjct: 558 SSQGTNEFKNEVRLIARLQHINLVRLLSCCIYADEKILIYEYLENGSLDSHLFETTQSSN 617
Query: 612 LLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671
L+W R II GIARGLLYLHQDSR +IIHRDLKASNVLLD M PKISDFG+AR F
Sbjct: 618 KLNWQTRFSIINGIARGLLYLHQDSRFKIIHRDLKASNVLLDKNMTPKISDFGMARIFER 677
Query: 672 DQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHN 731
D+TEANT++VVGTYGYMSPEYA++G+FSVKSDVFSFGVLVLEI+ GK+NRGF+++ D+N
Sbjct: 678 DETEANTRKVVGTYGYMSPEYAMEGIFSVKSDVFSFGVLVLEIVSGKRNRGFHNSGQDNN 737
Query: 732 LLGHAWRLWIEERPLELIDQSLDNSCSF------SEALRCIQVGLLCVQQRPEDRPNMSS 785
LLG+ W W E + LE++D + +S S E LRCIQ+GLLCVQ+R EDRP MSS
Sbjct: 738 LLGYTWENWKEGKGLEIVDSIIVDSSSSMSLFQPHEVLRCIQIGLLCVQERAEDRPKMSS 797
Query: 786 VVLMLSGER-SLPQPQQPGFFTGR-NLPESESSSSRQY---SASTNEITLSVLEAR 836
VVLML E+ +PQP++PG+ GR +L ++SSSS + S + N+IT+SV+ AR
Sbjct: 798 VVLMLGSEKGEIPQPKRPGYCVGRSSLDTADSSSSTKRDSESLTVNQITVSVINAR 853
|
Female specificity determinant of self-incompatibility. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LPZ3|Y1141_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11410 OS=Arabidopsis thaliana GN=At1g11410 PE=3 SV=3 | Back alignment and function description |
|---|
Score = 700 bits (1806), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 379/834 (45%), Positives = 518/834 (62%), Gaps = 54/834 (6%)
Query: 46 DTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPLS 105
+TI QS+KDG+ + S + F GFFS GNSK RY+GIWY +++E T+ WVANRD P++
Sbjct: 23 NTILRSQSLKDGDVIYSEGKRFAFGFFSLGNSKLRYVGIWYAQVSEQTIVWVANRDHPIN 82
Query: 106 DRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQKP--VAALMESGNLVVKD---GKD 160
D SG+++ + N + + + +WS++ Q+P VA L + GNLV+ D GK
Sbjct: 83 DTSGLIKFSTRGNLCVYASGNGTEPIWSTDVIDMIQEPALVAKLSDLGNLVLLDPVTGKS 142
Query: 161 NNPDNILWQSFDYPCDTLLPGMKLGINLGTGLNRFLSSWKSTDDPARGDFTYGLDPRGIP 220
W+SF++P +TLLP MK G +G++R ++SW+S DP G+ TY ++ RG P
Sbjct: 143 ------FWESFNHPTNTLLPFMKFGFTRQSGVDRIMTSWRSPGDPGSGNITYRIERRGFP 196
Query: 221 QLVLRKNSIITFRAGSWNGLHWTGVPQLQLNPVYTFEYVSNEKEAFYTYNLSNSSVPSRM 280
Q+++ K + +R GSW G W+GVP++ ++ +V+N E TY + ++SV +RM
Sbjct: 197 QMMMYKGLTLWWRTGSWTGQRWSGVPEMTNKFIFNISFVNNPDEVSITYGVLDASVTTRM 256
Query: 281 VINPAGTVQRYTWMERTKTWTLFSRFSGVTLDQCDSYALCGAYASCNINSNSP-ECECLQ 339
V+N GT+QR+ W R K W F D+CD Y CG C+ S EC CL
Sbjct: 257 VLNETGTLQRFRWNGRDKKWI---GFWSAPEDKCDIYNHCGFNGYCDSTSTEKFECSCLP 313
Query: 340 GFVPNSQREWDMQYKSGGCVR-RTPLDCKHGDGFLEHKAVKLPDTRFSWVDKNITLWECK 398
G+ P + R+W ++ S GC R + C +GF + K VK+P+T VD NITL EC+
Sbjct: 314 GYEPKTPRDWFLRDASDGCTRIKADSICNGKEGFAKLKRVKIPNTSAVNVDMNITLKECE 373
Query: 399 ELCSKNCSCTAYANA--DVRGRGSGCLLWFHDLIDIKELPESGQDLFIRMAASELDNVER 456
+ C KNCSC AYA+A + + GCL W +++D + SGQD ++R+ SEL
Sbjct: 374 QRCLKNCSCVAYASAYHESQDGAKGCLTWHGNMLDTRTYLSSGQDFYLRVDKSELARWNG 433
Query: 457 RRQSKNKKQVMIIITSISLATAVIFIGGLMYRRKKHSNQGNEK----------------- 499
S K+ V+I+I+ I++ ++ R+++ Q N
Sbjct: 434 NGASGKKRLVLILISLIAVVMLLLISFHCYLRKRRQRTQSNRLRKAPSSFAPSSFDLEDS 493
Query: 500 ---EEME-------LPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRL 549
EE+E LP+F+L IA AT+NF+ +NKLG GGFGPVYKG+L G EIAVKRL
Sbjct: 494 FILEELEDKSRSRELPLFELSTIATATNNFAFQNKLGAGGFGPVYKGVLQNGMEIAVKRL 553
Query: 550 SKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTR 609
SK SGQGMEEFKNEV LI+KLQHRNLV++LGCC + +E+ML+YEYLPNKSLDYFIF +
Sbjct: 554 SKSSGQGMEEFKNEVKLISKLQHRNLVRILGCCVEFEEKMLVYEYLPNKSLDYFIFHEEQ 613
Query: 610 SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669
LDW KR II GI RG+LYLHQDSRLRIIHRDLKASNVLLDN M PKI+DFGLAR F
Sbjct: 614 RAELDWPKRMGIIRGIGRGILYLHQDSRLRIIHRDLKASNVLLDNEMIPKIADFGLARIF 673
Query: 670 GLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHD 729
G +Q E +T RVVGTYGYMSPEYA+DG FS+KSDV+SFGVL+LEII GK+N F +
Sbjct: 674 GGNQIEGSTNRVVGTYGYMSPEYAMDGQFSIKSDVYSFGVLILEIITGKRNSAF--YEES 731
Query: 730 HNLLGHAWRLWIEERPLELIDQSL-DNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788
NL+ H W W +E+ID+ + + + E ++C+ +GLLCVQ+ DRP+MSSVV
Sbjct: 732 LNLVKHIWDRWENGEAIEIIDKLMGEETYDEGEVMKCLHIGLLCVQENSSDRPDMSSVVF 791
Query: 789 MLSGER-SLPQPQQPGFFTGRNLPESESSSSRQY-----SASTNEITLSVLEAR 836
ML LP P+ P F GR SS + S++ N++TL+ ++ R
Sbjct: 792 MLGHNAIDLPSPKHPAFTAGRRRNTKTGGSSDNWPSGETSSTINDVTLTDVQGR 845
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81906|B120_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase B120 OS=Arabidopsis thaliana GN=B120 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 697 bits (1800), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 394/868 (45%), Positives = 538/868 (61%), Gaps = 91/868 (10%)
Query: 29 LIIYSFLFYIISAARTLDTISLGQSIKDG---ETLVSAKESFELGFFSPGNSKSRYLGIW 85
L +Y FL+ AA +TI G+S++DG + LVS +++FELGFFSPG+S R+LGIW
Sbjct: 13 LFLYFFLYESSMAA---NTIRRGESLRDGINHKPLVSPQKTFELGFFSPGSSTHRFLGIW 69
Query: 86 YKKIAEGTVTWVANRDAPLSDRSGVLRINGERNGILVLLNSTNDTVWSSN---SSISAQK 142
Y I + V WVANR P+SD+SGVL I+ + N LVLL+ N TVWSSN S+ +
Sbjct: 70 YGNIEDKAVVWVANRATPISDQSGVLMISNDGN--LVLLDGKNITVWSSNIESSTTNNNN 127
Query: 143 PVAALMESGNLVVKDGKDNNPDNILWQSFDYPCDTLLPGMKLGINLGTGLNRFLSSWKST 202
V ++ ++GN V+ + + P +W+SF++P DT LP M++ +N TG N SW+S
Sbjct: 128 RVVSIHDTGNFVLSETDTDRP---IWESFNHPTDTFLPQMRVRVNPQTGDNHAFVSWRSE 184
Query: 203 DDPARGDFTYGLDPRGIPQLVL-RKNSIITFRAGSWNGLHWTGVPQLQL--NPVYTFEYV 259
DP+ G+++ G+DP G P++VL N +R+G WN +TG+P + L N +Y F+
Sbjct: 185 TDPSPGNYSLGVDPSGAPEIVLWEGNKTRKWRSGQWNSAIFTGIPNMSLLTNYLYGFKLS 244
Query: 260 SNEKE---AFYTYNLSNSSVPSRMVINPAGTVQRYTWMERTKTWTLFSRFSGVTLDQCDS 316
S E ++TY S+ SV R + GT + W E K WT +F +CD
Sbjct: 245 SPPDETGSVYFTYVPSDPSVLLRFKVLYNGTEEELRWNETLKKWT---KFQSEPDSECDQ 301
Query: 317 YALCGAYASCNINSNSPECECLQGFVPNSQREWDMQYKSGGCVRRTPLDCKHG-----DG 371
Y CG + C++ ++ C C+ G+ S W S GC RRTPL C+ D
Sbjct: 302 YNRCGKFGICDMKGSNGICSCIHGYEQVSVGNW-----SRGCRRRTPLKCERNISVGEDE 356
Query: 372 FLEHKAVKLPDTRFSWVDKNITLWE-CKELCSKNCSCTAYANADVRGRGSGCLLWFHDLI 430
FL K+VKLPD F + N+ E C+E C +NCSC AY+ G GC++W DL+
Sbjct: 357 FLTLKSVKLPD--FEIPEHNLVDPEDCRERCLRNCSCNAYSLVG----GIGCMIWNQDLV 410
Query: 431 DIKELPESGQDLFIRMAASELDNVERRRQSKNKKQVMIIITSISLATAVIFIGGLM---Y 487
D+++ G L IR+A SE+ +N+K + +I ++ + +I I L+ +
Sbjct: 411 DLQQFEAGGSSLHIRLADSEV--------GENRKTKIAVIVAVLVGVILIGIFALLLWRF 462
Query: 488 RRKKHSN-----------------------------------QGNEKEEMELPIFDLKII 512
+RKK + +G ELP+F L I
Sbjct: 463 KRKKDVSGAYCGKNTDTSVVVADLTKSKETTSAFSGSVDIMIEGKAVNTSELPVFSLNAI 522
Query: 513 ANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQH 572
A AT++F ++N+LG GGFGPVYKG+L +G+EIAVKRLS SGQG++EFKNE++LIAKLQH
Sbjct: 523 AIATNDFCKENELGRGGFGPVYKGVLEDGREIAVKRLSGKSGQGVDEFKNEIILIAKLQH 582
Query: 573 RNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYL 632
RNLV+LLGCC + +E+ML+YEY+PNKSLD+F+FD T+ L+DW R II GIARGLLYL
Sbjct: 583 RNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQALIDWKLRFSIIEGIARGLLYL 642
Query: 633 HQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEY 692
H+DSRLRIIHRDLK SNVLLD MNPKISDFG+AR FG +Q EANT RVVGTYGYMSPEY
Sbjct: 643 HRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGGNQNEANTVRVVGTYGYMSPEY 702
Query: 693 AIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQS 752
A++GLFSVKSDV+SFGVL+LEI+ GK+N ++H +L+G+AW L+ R EL+D
Sbjct: 703 AMEGLFSVKSDVYSFGVLLLEIVSGKRNTSLRSSEHG-SLIGYAWYLYTHGRSEELVDPK 761
Query: 753 LDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLML-SGERSLPQPQQPGFF-TGRNL 810
+ +CS EALRCI V +LCVQ +RPNM+SV+LML S +L P+QP F T RN
Sbjct: 762 IRVTCSKREALRCIHVAMLCVQDSAAERPNMASVLLMLESDTATLAAPRQPTFTSTRRNS 821
Query: 811 PESESS--SSRQYSASTNEITLSVLEAR 836
+ + SS+QY S+NEIT +V+ R
Sbjct: 822 IDVNFALDSSQQYIVSSNEITSTVVLGR 849
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 836 | ||||||
| 224122978 | 831 | predicted protein [Populus trichocarpa] | 0.952 | 0.957 | 0.648 | 0.0 | |
| 224122958 | 812 | predicted protein [Populus trichocarpa] | 0.959 | 0.987 | 0.626 | 0.0 | |
| 147799241 | 818 | hypothetical protein VITISV_027305 [Viti | 0.954 | 0.975 | 0.602 | 0.0 | |
| 359493740 | 2422 | PREDICTED: uncharacterized protein LOC10 | 0.961 | 0.331 | 0.582 | 0.0 | |
| 224122858 | 831 | predicted protein [Populus trichocarpa] | 0.962 | 0.968 | 0.583 | 0.0 | |
| 255587572 | 822 | S-locus-specific glycoprotein S6 precurs | 0.937 | 0.953 | 0.595 | 0.0 | |
| 224115102 | 784 | predicted protein [Populus trichocarpa] | 0.931 | 0.993 | 0.614 | 0.0 | |
| 255569631 | 868 | S-locus-specific glycoprotein S13 precur | 0.958 | 0.922 | 0.588 | 0.0 | |
| 359493721 | 804 | PREDICTED: G-type lectin S-receptor-like | 0.918 | 0.955 | 0.599 | 0.0 | |
| 359493715 | 1603 | PREDICTED: uncharacterized protein LOC10 | 0.948 | 0.494 | 0.605 | 0.0 |
| >gi|224122978|ref|XP_002330411.1| predicted protein [Populus trichocarpa] gi|222871796|gb|EEF08927.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1065 bits (2754), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 533/822 (64%), Positives = 638/822 (77%), Gaps = 26/822 (3%)
Query: 23 MEGFNLLIIYSFLFYIISAAR-TLDTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRY 81
+ GF +L +++FL +ISA R + DT++ GQSI+DG+ LVSA SFELGFFSPG SK RY
Sbjct: 5 ISGFIILFVHTFL--LISAIRASTDTLTPGQSIRDGDLLVSADGSFELGFFSPGISKGRY 62
Query: 82 LGIWYKKIAEGTVTWVANRDAPLSDRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQ 141
LGIWY+KI+ GTV WVANR+ PL+D SG L + + GIL+LLNS+ D +WSSN+S +AQ
Sbjct: 63 LGIWYQKISAGTVVWVANRETPLNDSSGALIVTDQ--GILILLNSSKDAIWSSNASRTAQ 120
Query: 142 KPVAALMESGNLVVKDGKDNNPDNILWQSFDYPCDTLLPGMKLGINLGTGLNRFLSSWKS 201
PV L++SGNLVVKD DN+ +N LWQSFDYP DTLLPGMK G N+ TGL+R+LSSWKS
Sbjct: 121 NPVMKLLDSGNLVVKDINDNS-ENFLWQSFDYPGDTLLPGMKWGRNMVTGLDRYLSSWKS 179
Query: 202 TDDPARGDFTYGLDPRGIPQLVLRKNSIITFRAGSWNGLHWTGVPQLQLNPVYTFEYVSN 261
++DPA+G+FT+ +DPRG Q++L + I +R G+WNG WTG PQL+ N +YT+ ++S
Sbjct: 180 SNDPAQGEFTFRIDPRGNTQMLLMRGPKILYRTGTWNGYRWTGTPQLEPNMLYTYGFIST 239
Query: 262 EKEAFYTYNLSNSSVPSRMVINPAGTVQRYTWMERTKTWTLFSRFSGVTLDQCDSYALCG 321
E +Y ++L NSSV SR+V+N +G QR+TW+ RT +W +RFS V LDQCD YALCG
Sbjct: 240 ATEMYYKFDLINSSVASRIVMNSSGAAQRFTWITRTNSW---ARFSAVLLDQCDDYALCG 296
Query: 322 AYASCNINSNSPECECLQGFVPNSQREWDMQYKSGGCVRRTPLDCKHGDGFLEHKAVKLP 381
AY SCN+N P C CL+GF+P S ++W +Q S GCVRRT LDC GD FL+H VKLP
Sbjct: 297 AYGSCNVNKQ-PVCACLEGFIPKSPKDWSIQEWSDGCVRRTKLDCDKGDRFLQHGGVKLP 355
Query: 382 DTRFSWVDKNITLWECKELCSKNCSCTAYANADVRGRGSGCLLWFHDLIDIKELPESGQD 441
D SWVD + L ECK+LC KNCSC AYAN+D+RG GSGCLLWF +LID +EL GQD
Sbjct: 356 DMIKSWVDTSKGLKECKDLCLKNCSCVAYANSDIRGGGSGCLLWFDELIDTRELTTGGQD 415
Query: 442 LFIRMAASELDNVERRRQSKNKKQVMIIITSISLATAVIFIGGLMY-RRKKHSNQGN--- 497
L+IR+AASEL N+E+ R S +KKQ+ II+ +I V+ + ++Y RRKK Q N
Sbjct: 416 LYIRIAASELYNIEKNRSS-DKKQLGIIVGTIITIVGVLVLAFILYARRKKLKKQANMKT 474
Query: 498 -----------EKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAV 546
KE+MELP FDL IANATDNFS +NKLGEGGFG VYKG LIEGQE+AV
Sbjct: 475 SHLQNYEDEDQRKEDMELPTFDLSTIANATDNFSSRNKLGEGGFGSVYKGTLIEGQEVAV 534
Query: 547 KRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFD 606
KRLSK SGQG+ EFKNEV+LIAKLQHRNLVKLLGCC + DER+LIYEY+PNKSLDYFIFD
Sbjct: 535 KRLSKNSGQGLTEFKNEVILIAKLQHRNLVKLLGCCIEGDERILIYEYMPNKSLDYFIFD 594
Query: 607 TTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLA 666
DW +I+ GIARGLLYLHQDSRLRIIHRDLKA+NVLLDN MNPKISDFGLA
Sbjct: 595 KKTRNSSDWRIWINIVGGIARGLLYLHQDSRLRIIHRDLKAANVLLDNGMNPKISDFGLA 654
Query: 667 RSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHA 726
R+FG DQTEANT ++VGTYGYMSPEYA+DG FSVKSDVFSFGVLVLEI+ GKKNRGFNH
Sbjct: 655 RTFGGDQTEANTNKIVGTYGYMSPEYAVDGFFSVKSDVFSFGVLVLEIVSGKKNRGFNHP 714
Query: 727 DHDHNLLGHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSV 786
DH HNLLGHAWRLW E PLELI++ +SC+ SE +RCI VGLLCVQ+RPEDRPNMSSV
Sbjct: 715 DHHHNLLGHAWRLWNEGMPLELINEPEQDSCTLSEIIRCIHVGLLCVQKRPEDRPNMSSV 774
Query: 787 VLMLSGERSLPQPQQPGFFTGRNLPESESSSSRQYSASTNEI 828
++MLS SLPQP+QPGFFT RNLPE ESSSS Q S STNEI
Sbjct: 775 IVMLSSGISLPQPKQPGFFTERNLPERESSSSNQKSFSTNEI 816
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224122958|ref|XP_002330406.1| predicted protein [Populus trichocarpa] gi|222871791|gb|EEF08922.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1053 bits (2724), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 511/816 (62%), Positives = 620/816 (75%), Gaps = 14/816 (1%)
Query: 27 NLLIIYSFLFYIISAARTLDTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWY 86
+++ +YS F I+ + LD ++ QS++DGETLVS SFELGFF+P S SRYLG+WY
Sbjct: 5 DVIFVYSLFFSILKISSALDAMNTTQSLRDGETLVSTGGSFELGFFTPAGSTSRYLGLWY 64
Query: 87 KKIAEGTVTWVANRDAPLSDRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAA 146
KK + TV WVANR P+S++ G L + + GILVLLN TN+ VWSSN+S + Q PVA
Sbjct: 65 KKSPQ-TVVWVANRGIPISNKFGTLNVTSQ--GILVLLNGTNNIVWSSNTSTTVQNPVAQ 121
Query: 147 LMESGNLVVKDGKDNNPDNILWQSFDYPCDTLLPGMKLGINLGTGLNRFLSSWKSTDDPA 206
L++SGNLVV+DG DN DN LWQSFDYPCDTLLPGMKLG NL TGLN FLSSWK ++PA
Sbjct: 122 LLDSGNLVVRDGNDNKADNFLWQSFDYPCDTLLPGMKLGSNLVTGLNSFLSSWKGKENPA 181
Query: 207 RGDFTYGLDPRGIPQLVLRKNSIITFRAGSWNGLHWTGVPQLQLNPVYTFEYVSNEKEAF 266
G FT G+D +G PQL+LRK + I +R GSWNG ++TG P+L+ +P+YTFE+V N E +
Sbjct: 182 PGQFTLGIDVQGYPQLILRKETRIMYRVGSWNGQYFTGFPELKPDPIYTFEFVFNRNEVY 241
Query: 267 YTYNLSNSSVPSRMVINPAGTVQRYTWMERTKTWTLFSRFSGVTLDQCDSYALCGAYASC 326
+ + L NSSV SR+ + P+G VQ +TW +T W +F+ +D+C++YALCGA A C
Sbjct: 242 FKFELQNSSVFSRLTVTPSGLVQLFTWSHQTNDWYVFAT---AVVDRCENYALCGANARC 298
Query: 327 NINSNSPECECLQGFVPNSQREWDMQYKSGGCVRRTPLDCKHGDGFLEHKAVKLPDTRFS 386
+ NS SP C+CL GF+ S EW+ Q +GGC+RRTPLDC DGF + VKLPDT S
Sbjct: 299 DSNS-SPVCDCLDGFIHKSPTEWNSQNWTGGCIRRTPLDCTDKDGFQSYTGVKLPDTSSS 357
Query: 387 WVDKNITLWECKELCSKNCSCTAYANADVRGRGSGCLLWFHDLIDIKELPESGQDLFIRM 446
W D + +L EC+ LC +NCSC AYAN D RGRGSGCL WF DLID + L E GQD++IR+
Sbjct: 358 WYDDSFSLVECEGLCIQNCSCFAYANLDFRGRGSGCLRWFGDLIDTRRLAEGGQDIYIRL 417
Query: 447 AASELDNVERRRQSKNKKQVMIIITSISLATAVIFIGGLM-YRRKKHSNQGN----EKEE 501
AAS+ V ++ K K +I ++ L ++++ +G + RR+KH GN ++EE
Sbjct: 418 AASQ-SGVTGEKKRKKKTHAGVIGGAVILGSSILILGIVFCIRRRKHRKNGNFEDRKEEE 476
Query: 502 MELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFK 561
MELP+ DL I +ATDNFS KLGEGGFG VYKG LIEGQEIAVKRLSK SGQG+ EFK
Sbjct: 477 MELPMLDLTTIEHATDNFSSSKKLGEGGFGAVYKGELIEGQEIAVKRLSKSSGQGLNEFK 536
Query: 562 NEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHI 621
NEVLLIAKLQHRNLVKLLGCC DE+MLIYEY+PN+SLD FIFD TR K LDWSKR+HI
Sbjct: 537 NEVLLIAKLQHRNLVKLLGCCIHEDEKMLIYEYMPNRSLDSFIFDPTRRKFLDWSKRTHI 596
Query: 622 IAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRV 681
I GIARGLLYLHQDSRLRIIHRD+KASN+LLDN +NPKISDFGLAR FG DQTEANTKRV
Sbjct: 597 IDGIARGLLYLHQDSRLRIIHRDIKASNILLDNELNPKISDFGLARMFGGDQTEANTKRV 656
Query: 682 VGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDH-NLLGHAWRLW 740
VGTYGYMSPEYA+DG FSVKSDVFSFGVLVLEI+ GKKNRGF H D++ NLLGHAW LW
Sbjct: 657 VGTYGYMSPEYALDGHFSVKSDVFSFGVLVLEIVSGKKNRGFCHPDYNQKNLLGHAWMLW 716
Query: 741 IEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPQ 800
PLELID+ +SC+ SEALRCI V LLCVQQRPEDRPNMSSVVLML E LPQP+
Sbjct: 717 FNGIPLELIDECFADSCTPSEALRCIHVALLCVQQRPEDRPNMSSVVLMLGSENPLPQPK 776
Query: 801 QPGFFTGRNLPESESSSSRQYSASTNEITLSVLEAR 836
QPGFF G N PE ++SS++ S S NE+T+++L+AR
Sbjct: 777 QPGFFMGSNPPEKDTSSNKHQSHSANEVTVTLLQAR 812
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147799241|emb|CAN77004.1| hypothetical protein VITISV_027305 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1007 bits (2603), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 496/823 (60%), Positives = 625/823 (75%), Gaps = 25/823 (3%)
Query: 28 LLIIYSFLFYIISAARTLDTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYK 87
L+ ++S++ I+ + +D+I+ Q IKDGET++SA +FELGF G SK++YLGIWYK
Sbjct: 7 LVFLFSYVISILRISTAVDSITANQHIKDGETIISAGGNFELGFVHLGTSKNQYLGIWYK 66
Query: 88 KIAEGTVTWVANRDAPLSDRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAAL 147
K+ TV WVANR+ P++D SG L++ + G LV+LN +N +WSSNSS SA+ P A L
Sbjct: 67 KVTPRTVVWVANRELPVTDSSGXLKVTDQ--GSLVILNGSNGLIWSSNSSRSARNPTAQL 124
Query: 148 MESGNLVVKDGKDNNPDNILWQSFDYPCDTLLPGMKLGINLGTGLNRFLSSWKSTDDPAR 207
++SGNLV+K G D++PDN LWQSFDYP DTLLPGMK G N TGL+R+LSSWKS DDP++
Sbjct: 125 LDSGNLVIKSGNDSDPDNFLWQSFDYPGDTLLPGMKHGRNTVTGLDRYLSSWKSNDDPSK 184
Query: 208 GDFTYGLDPRGIPQLVLRKNSIITFRAGSWNGLHWTGVPQLQLNPVYTFEYVSNEKEAFY 267
GDFTYGLDP G PQL LR S + FR+G WNG+ + G P+L+ NPV+ + +V NEKE ++
Sbjct: 185 GDFTYGLDPSGCPQLFLRSGSTVIFRSGPWNGIRFNGFPELRPNPVFNYSFVFNEKEMYF 244
Query: 268 TYNLSNSSVPSRMVINPAGTVQRYTWMERTKTWTLFSRFSGVTLDQCDSYALCGAYASCN 327
TY L NSSV SR+V+NP G VQR W+ RTK+W ++S D CDSYALCGAY++CN
Sbjct: 245 TYKLVNSSVLSRLVLNPNGNVQRLIWIGRTKSWNVYST---AYKDDCDSYALCGAYSTCN 301
Query: 328 INSNSPECECLQGFVPNSQREWDMQYKSGGCVRRTPLDCKHGDGFLEHKAVKLPDTRFSW 387
I+ SP C C++GFVP +WD S GCVR+T LDC+ GDGF ++ VKLPDTR SW
Sbjct: 302 IH-RSPRCGCMKGFVPKFPYQWDTMDWSNGCVRKTSLDCQKGDGFAKYSGVKLPDTRNSW 360
Query: 388 VDKNITLWECKELCSKNCSCTAYANADVRGRGSGCLLWFHDLIDIKELPESGQDLFIRMA 447
++++ L EC LC +NCSC+AY N+D++G GSGCLLWF DLIDIKE E+GQD +IRMA
Sbjct: 361 FNESMNLKECASLCFRNCSCSAYTNSDIKGGGSGCLLWFGDLIDIKEFTENGQDFYIRMA 420
Query: 448 ASELDNVERRRQSKNKKQVMIIITSISLATAVIF-IGGLMYRRKKH---------SNQGN 497
ASELD + SK K+ +I++++S+A ++ + +Y KK +N+G
Sbjct: 421 ASELDAI-----SKVTKRRWVIVSTVSIAGMILLSLVVTLYLLKKRLKRKGTTELNNEGA 475
Query: 498 E----KEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGS 553
E +E++ELP+F L I NAT NFS NKLGEGGFGPVYKGML +G+EIAVKRLSK S
Sbjct: 476 ETNERQEDLELPLFXLDTILNATHNFSRNNKLGEGGFGPVYKGMLQDGKEIAVKRLSKES 535
Query: 554 GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLL 613
QG++EFKNEV+ I+KLQHRNLVKLLGCC +E+MLIYEY+PNKSL++FIFD +S +L
Sbjct: 536 NQGLDEFKNEVIYISKLQHRNLVKLLGCCIHGEEKMLIYEYMPNKSLNFFIFDGIQSMVL 595
Query: 614 DWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673
DW KR II GIARGLLYLHQDSRLRIIHRDLKA NVLLDN MNP+ISDFG+ARSFG ++
Sbjct: 596 DWPKRFVIINGIARGLLYLHQDSRLRIIHRDLKADNVLLDNEMNPRISDFGMARSFGGNE 655
Query: 674 TEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLL 733
T A TKRVVGTYGYMSPEYAIDG++SVKSDVFSFGVL LEII GK+NRGFNH DHD NLL
Sbjct: 656 TIARTKRVVGTYGYMSPEYAIDGVYSVKSDVFSFGVLXLEIISGKRNRGFNHPDHDLNLL 715
Query: 734 GHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 793
GHAW L++E PLELID S+ + + SE LR + VGLLCVQ+ P+DRPNMSSVVLMLS E
Sbjct: 716 GHAWTLYMEGTPLELIDASVGYTYNQSEVLRALNVGLLCVQRHPDDRPNMSSVVLMLSSE 775
Query: 794 RSLPQPQQPGFFTGRNLPESESSSSRQYSASTNEITLSVLEAR 836
+LPQP++PGFFT RN+ E++S + S NE T+++LE R
Sbjct: 776 GALPQPKEPGFFTERNMLEADSLQCKHAVFSGNEHTITILEGR 818
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493740|ref|XP_002280379.2| PREDICTED: uncharacterized protein LOC100262430 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1004 bits (2595), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 500/858 (58%), Positives = 631/858 (73%), Gaps = 54/858 (6%)
Query: 23 MEGFNLLIIYSFLFYIISAARTLDTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYL 82
MEGF L++ +F I+ + +DT+++ Q I DGET+ SA SFELGFFSP +S++RY+
Sbjct: 1 MEGFATLVL---VFSILRVSIAVDTLTVNQIITDGETITSAGGSFELGFFSPDSSRNRYV 57
Query: 83 GIWYKKIAEGTVTWVANRDAPLSDRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQK 142
GIWYKK+A TV WVANR PL+ SG+L++ G LV+LN TN T+WSSNSS AQ
Sbjct: 58 GIWYKKVATRTVVWVANRQIPLTASSGILKVTDR--GTLVILNGTNTTIWSSNSSRPAQN 115
Query: 143 PVAALMESGNLVVKDGKDNNPDNILWQSFDYPCDTLLPGMKLGINLGTGLNRFLSSWKST 202
P A L++SGNLV+K+G D++ +N LWQSFDYPC+TLLPGMK G N TGL+R+LSSWK+T
Sbjct: 116 PNAQLLDSGNLVMKNGNDSDSENFLWQSFDYPCNTLLPGMKFGRNRVTGLDRYLSSWKTT 175
Query: 203 DDPARGDFTYGLDPRGIPQLVLRKNSIITFRAGSWNGLHWTGVPQLQLNPVYTFEYVSNE 262
DDP+ G+FTY LDP G PQL++R S +TFR+G WNGL ++G PQL+ N VY++ ++ N+
Sbjct: 176 DDPSIGNFTYRLDPGGSPQLLVRNGSTVTFRSGPWNGLRFSGFPQLRPNSVYSYAFIFND 235
Query: 263 KEAFYTYNLSNSSVPSRMVINPAGTVQRYTWMERTKTWTLFSRFSGVTLDQCDSYALCGA 322
KE +YT+ L NSSV +R+V++P G QR+TW++RT W L +S D CDSYALCG
Sbjct: 236 KETYYTFELVNSSVITRLVLSPEGYAQRFTWIDRTSDWIL---YSSAQTDDCDSYALCGV 292
Query: 323 YASCNINSNSPECECLQGFVPNSQREWDMQYKSGGCVRRTPLDCKHGDGFLEHKAVKLPD 382
Y C IN SP+CEC++GF P Q WDM S GCVR TP+ C+ +GFL++ VKLPD
Sbjct: 293 YGICEIN-RSPKCECMKGFEPKFQSNWDMADWSDGCVRSTPMVCQKSNGFLKYSGVKLPD 351
Query: 383 TRFSWVDKNITLWECKELCSKNCSCTAYANADVRGRGSGCLLWFHDLIDIKELPESGQDL 442
TR SW ++++ L EC LC NCSCTAY N+D+RG GSGCLLWF DLIDI+E E+GQD
Sbjct: 352 TRNSWFNESMNLKECASLCLGNCSCTAYTNSDIRGGGSGCLLWFGDLIDIREYTENGQDF 411
Query: 443 FIRMAASEL------------DNVE---------------RRRQSKNKKQVMIIITSISL 475
+IRMA SEL ++V+ SK K+ +I++++S+
Sbjct: 412 YIRMAKSELGMSLSVPYLRIINSVQVFNDKYCTCVYAFAMTNSGSKGAKRKWVIVSTVSI 471
Query: 476 ATAVIFIGGLM--------YRRK------KHSNQG---NEKEE-MELPIFDLKIIANATD 517
++ L RRK KH+ +G NE+EE +ELP+FDL I NATD
Sbjct: 472 VGIILLSLVLTLYVLRKKRLRRKGNNLYSKHNCKGAEINEREEDLELPLFDLDTILNATD 531
Query: 518 NFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVK 577
NFS NKLGEGGFGPVYKGML +G+EIAVKRLSK S QG++EFKNEV I+KLQHRNLVK
Sbjct: 532 NFSNDNKLGEGGFGPVYKGMLQDGKEIAVKRLSKESRQGLDEFKNEVTHISKLQHRNLVK 591
Query: 578 LLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSR 637
LLGCC +E+MLIYEY+PNKSLD+FIFD +S +LDW KR II GIARGLLYLHQDSR
Sbjct: 592 LLGCCIHGEEKMLIYEYMPNKSLDFFIFDGMQSLVLDWPKRFVIINGIARGLLYLHQDSR 651
Query: 638 LRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGL 697
LRIIHRDLKA NVLLDN MNP+ISDFG+ARSF +++EA TKRVVGTYGYMSPEYAIDG+
Sbjct: 652 LRIIHRDLKADNVLLDNEMNPRISDFGMARSFRGNESEARTKRVVGTYGYMSPEYAIDGV 711
Query: 698 FSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDNSC 757
+S+KSDVFSFGVLVLEI+ GK+NRGFNH DH NLLGHAW L++E +PLELID S+ +SC
Sbjct: 712 YSIKSDVFSFGVLVLEIVTGKRNRGFNHPDHALNLLGHAWTLYMEGKPLELIDASMGDSC 771
Query: 758 SFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPQQPGFFTGRNLPESESSS 817
+ SE LR + VGLLCVQ+ P+DRP+MSSVVLMLS E +L QP++PGFFT RN+ E SS+
Sbjct: 772 NQSEVLRALNVGLLCVQRSPDDRPSMSSVVLMLSSESALHQPKEPGFFTERNMLEGSSSA 831
Query: 818 SRQYSASTNEITLSVLEA 835
S+ S NE T++++E
Sbjct: 832 SKHAIFSGNEHTITLIEV 849
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224122858|ref|XP_002330381.1| predicted protein [Populus trichocarpa] gi|222871766|gb|EEF08897.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 998 bits (2581), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 486/833 (58%), Positives = 625/833 (75%), Gaps = 28/833 (3%)
Query: 23 MEGFNLLIIYSFLFYIISAARTLDTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYL 82
M G +L + S +F++ + +++I+ QS++DG+TLVS++ FELGFFSPGNS++RY+
Sbjct: 8 MGGQTILFLLSIVFFLSIPSTAIESINATQSLEDGDTLVSSEGHFELGFFSPGNSRNRYM 67
Query: 83 GIWYKKIAEGTVTWVANRDAPLSDRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQK 142
GIWYKKI+ TV WVANR+ PL+D SG+L+ +G L +NSTN T+WSSN S +A
Sbjct: 68 GIWYKKISSFTVVWVANRNTPLNDSSGMLKF--VDHGNLAFINSTNGTIWSSNISRAAIN 125
Query: 143 PVAALMESGNLVVKDGKDNNPDNILWQSFDYPCDTLLPGMKLGINLGTGLNRFLSSWKST 202
PVA L+++GNLVV+ DN+P+N LWQSFDYP D+ LPGMK GI+ TGLNR+L+SWKS
Sbjct: 126 PVAQLLDTGNLVVRAENDNDPENFLWQSFDYPGDSFLPGMKYGISFVTGLNRYLTSWKSP 185
Query: 203 DDPARGDFTYGLDPRGIPQLVLRKNSIITFRAGSWNGLHWTGVPQLQLNPVYTFEYVSNE 262
DP+ G +T LDP G+PQ L + S+ FR+G WNGL ++G+ L+ NP+YTFE+V N+
Sbjct: 186 SDPSTGKYTNKLDPNGLPQYFLSQGSVDQFRSGPWNGLRFSGMINLKPNPIYTFEFVFNQ 245
Query: 263 KEAFYTYNLSNSSVPSRMVINPAGTVQRYTWMERTKTWTLFSRFSGVTLDQCDSYALCGA 322
+E +Y Y ++NSSV SRMV++P G +QR+TW++RT+ WTL+ +D CD +ALCGA
Sbjct: 246 EEIYYKYQIANSSVLSRMVLSPDGVLQRFTWIDRTQDWTLYLT---ANMDNCDRFALCGA 302
Query: 323 YASCNINSNSPECECLQGFVPNSQREWDMQYKSGGCVRRTPLDCKHGDGFLEHKAVKLPD 382
+ CNIN NSP C+CL+ F P S EW S GCVR+ PLDC +G+GF+++ +K+PD
Sbjct: 303 HGVCNIN-NSPACDCLKEFEPKSLEEWTAADWSQGCVRKAPLDCSNGEGFIKYTGIKVPD 361
Query: 383 TRFSWVDKNITLWECKELCSKNCSCTAYANADVRGRGSGCLLWFHDLIDIKELPESGQDL 442
TR SW +K I L EC+E+C KNCSCTAYAN DVR GSGC+LWF DLIDI++ E+GQD+
Sbjct: 362 TRKSWYNKTINLEECEEVCLKNCSCTAYANLDVRDGGSGCVLWFGDLIDIRQYNENGQDI 421
Query: 443 FIRMAASELDNVERRRQSKNKKQVMIIITSISLATAVIFIGGLMYR------RKKHSNQG 496
+IR+AAS +D + +S+ KK+V II+ +SL + L R +++ + +G
Sbjct: 422 YIRIAASVID---KPVKSRGKKRVRIIVIPVSLVAFSLLALCLFLRFLRKNKQQQLTREG 478
Query: 497 N-------------EKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQE 543
N E++ELP+FDL + +AT+ FS NKLG+GGFGPVYKG+L +GQE
Sbjct: 479 NVVTNPEQDRTKESRNEDLELPLFDLATLTDATNCFSINNKLGQGGFGPVYKGILQDGQE 538
Query: 544 IAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYF 603
IAVKRLSK S QG+ EF+NEV+ IAKLQHRNLVKLLGCC + +ERMLIYEY+PNKSLD F
Sbjct: 539 IAVKRLSKRSRQGINEFRNEVVCIAKLQHRNLVKLLGCCIELEERMLIYEYMPNKSLDSF 598
Query: 604 IFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDF 663
IFD R+ LLDW+KR II GIARGLLYLHQDSRLRIIHRDLKASN+LLD MNPKISDF
Sbjct: 599 IFDKRRNMLLDWTKRFPIINGIARGLLYLHQDSRLRIIHRDLKASNILLDYEMNPKISDF 658
Query: 664 GLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGF 723
G+ARSFG D+T ANT R+VGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI+ G+KNRGF
Sbjct: 659 GMARSFGGDETSANTSRIVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGRKNRGF 718
Query: 724 NHADHDHNLLGHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNM 783
HA+H NLLGHAW L E RPL+LID+S+ ++C SE LR I+V LLCVQ+ PEDRP M
Sbjct: 719 RHAEHKLNLLGHAWMLHKEGRPLDLIDESIVDTCIISEVLRSIEVALLCVQKSPEDRPKM 778
Query: 784 SSVVLMLSGERSLPQPQQPGFFTGRNLPESESSSSRQYSASTNEITLSVLEAR 836
S VVLMLS + LPQP++PGFFT R+L SS+ + +S NE+T ++LEAR
Sbjct: 779 SIVVLMLSSDIVLPQPKEPGFFTERDLSNDSSSTIKHEISSVNELTSTLLEAR 831
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255587572|ref|XP_002534316.1| S-locus-specific glycoprotein S6 precursor, putative [Ricinus communis] gi|223525508|gb|EEF28065.1| S-locus-specific glycoprotein S6 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 996 bits (2576), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 496/833 (59%), Positives = 612/833 (73%), Gaps = 49/833 (5%)
Query: 39 ISAARTLDTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVA 98
+SAA+ L+T+ GQS+KDGETL+SA +FELGFFS G+S+SRYLGIWYK+I TV WV
Sbjct: 4 VSAAQ-LETLYPGQSMKDGETLISADGNFELGFFSQGDSRSRYLGIWYKRIPVKTVVWVG 62
Query: 99 NRDAPLSDRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAALMESGNLVVKDG 158
NR+ P D GVL++N G+++L NST +WSSNSS +A+ PV L++SGNL+VKDG
Sbjct: 63 NREVPSFDNLGVLQVN--EQGVIILQNSTKGIIWSSNSSRTAKNPVLQLLDSGNLIVKDG 120
Query: 159 KDNNPDNILWQSFDYPCDTLLPGMKLGINLGTGLNRFLSSWKSTDDPARGDFTYGLDPRG 218
NNPDNI+WQSFD+P +TLLP MKLG NL GLNR+L+SWKS DDPA+G+F+ +D RG
Sbjct: 121 NGNNPDNIVWQSFDFPYNTLLPSMKLGWNLDKGLNRYLTSWKSIDDPAQGNFSCLIDLRG 180
Query: 219 IPQLVLRKNSIITFRAGSWNGLHWTGVPQLQLNPVYTFEYVSNEKEAFYTYNLSNSSVPS 278
PQL ++K + R+G WNGL +TG PQL NPV+ F +VSN+ E +Y+Y L N+SV S
Sbjct: 181 FPQLFMKKGDAVQVRSGPWNGLQFTGSPQLNPNPVFNFSFVSNKHEIYYSYELKNTSVVS 240
Query: 279 RMVINPAGTVQRYTWMERTKTWTLFSRFSGVTLDQCDSYALCGAYASCNINSNSPECECL 338
R++++ G ++R+ W++RT++WTLF FS V DQCD+Y LCGAYASCNINS P C CL
Sbjct: 241 RLIVSEKGALERHNWIDRTQSWTLF--FS-VPTDQCDTYLLCGAYASCNINS-YPVCSCL 296
Query: 339 QGFVPNSQREWDMQYKSGGCVRRTPLDCKHGDGFLEHKAVKLPDTRFSWVDKNITLWECK 398
+GFVP S +W S GCVRRT L C GDGF + K +KLPDT SWVD ++ L EC+
Sbjct: 297 EGFVPKSPTDWSASDWSDGCVRRTELSCHTGDGFRKLKGMKLPDTSSSWVDMSMDLKECE 356
Query: 399 ELCSKNCSCTAYANADVRGRGSGCLLWFHDLIDIKELPESGQDLFIRMAASELDNVERRR 458
+C +NCSC AYAN+D+RG SGCLLWF LID+++ E GQDL+IR+AASEL +
Sbjct: 357 GMCLRNCSCLAYANSDIRG--SGCLLWFDHLIDMRKFTEGGQDLYIRIAASEL-----AK 409
Query: 459 QSKNKKQVMIIITSISLATAVIFIGGLMYRRKKHSN------------------------ 494
+ K+V II++ + + + +G L+Y RK+ N
Sbjct: 410 GKSHGKRVAIIVSCLIIGMGMTALGSLLYTRKRKRNILGQAVPLVLLVSSFAIHFYIISG 469
Query: 495 -----------QGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQE 543
KE+ EL FDL I NAT NFS NKLGEGGFGPVYKG L++GQE
Sbjct: 470 LAKETYIENYGDNGAKEDTELIAFDLITIRNATGNFSNYNKLGEGGFGPVYKGTLLDGQE 529
Query: 544 IAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYF 603
IAVKRLS+ SGQG +EFKNEV+LIA+LQHRNLVKLLGCC DE+MLIYEY+PNKSLD F
Sbjct: 530 IAVKRLSETSGQGGKEFKNEVILIARLQHRNLVKLLGCCIHGDEKMLIYEYMPNKSLDSF 589
Query: 604 IFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDF 663
IFD RS LLDW II GIARGLLYLHQDSRLRIIHRDLKASN+LLD MNPKISDF
Sbjct: 590 IFDKKRSMLLDWHMCFRIIGGIARGLLYLHQDSRLRIIHRDLKASNILLDCDMNPKISDF 649
Query: 664 GLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGF 723
GLAR+FG DQ ANTKRVVGTYGYMSPEYA+DGLFSVKSDVFSFGVLVLEI+ GK+NRGF
Sbjct: 650 GLARTFGKDQNAANTKRVVGTYGYMSPEYAVDGLFSVKSDVFSFGVLVLEIVSGKRNRGF 709
Query: 724 NHADHDHNLLGHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNM 783
+H DH NLLGHAWRLW+EER LEL D+ + S S+ LRCIQVGLLCVQ+ P DRP+M
Sbjct: 710 SHLDHSLNLLGHAWRLWMEERALELFDKFSQDEYSVSQVLRCIQVGLLCVQRLPHDRPDM 769
Query: 784 SSVVLMLSGERSLPQPQQPGFFTGRNLPESESSSSRQYSASTNEITLSVLEAR 836
S+VV+ML E SLPQP+QPGF+T R+ E++SS+S++ S NEI+ +++E R
Sbjct: 770 SAVVVMLGSESSLPQPKQPGFYTERDPFEADSSTSKERVWSRNEISSTLIEPR 822
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224115102|ref|XP_002316940.1| predicted protein [Populus trichocarpa] gi|222860005|gb|EEE97552.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 993 bits (2567), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 503/818 (61%), Positives = 595/818 (72%), Gaps = 39/818 (4%)
Query: 20 MSKMEG-FNLLIIYSFLFYIISAARTLDTISLGQSIKDGETLVSAKESFELGFFSPGNSK 78
M K EG L +YSFL I + D IS GQ I DG+T+VSA ++FELGFFSPG+S
Sbjct: 5 MRKTEGGIRGLFVYSFLLSTIRVSNAPDIISPGQFIGDGDTIVSAGQNFELGFFSPGSST 64
Query: 79 SRYLGIWYKKIAEGTVTWVANRDAPLSDRSGVLRINGERNGILVLLNSTNDTVWSSNSSI 138
RYLGIWYKK + GTV WVANR+ P+ D SGVL + G L+LLN T D VWSSN +
Sbjct: 65 RRYLGIWYKKFSTGTVVWVANRENPIFDHSGVLYFTNQ--GTLLLLNGTKDVVWSSNRTT 122
Query: 139 SAQKPVAALMESGNLVVKDGKDNNPDNILWQSFDYPCDTLLPGMKLGINLGTGLNRFLSS 198
PVA L+ESGNLVVKDG D+NP++ LWQSFDYP DT LP MKLG NL TGL+ +SS
Sbjct: 123 PKNNPVAQLLESGNLVVKDGNDSNPESFLWQSFDYPGDTNLPDMKLGRNLVTGLDWSISS 182
Query: 199 WKSTDDPARGDFTYGLDPRGIPQLVLRKNSIITFRAGSWNGLHWTGVPQLQLNPVYTFEY 258
WKS DDPARG+++ G+DPRG QLV +K I FRAGSWNG+ +TG +L+ NPVY +E+
Sbjct: 183 WKSLDDPARGEYSLGIDPRGYQQLVYKKGRAIQFRAGSWNGIRFTGATRLRPNPVYRYEF 242
Query: 259 VSNEKEAFYTYNLSNSSVPSRMVINPAGTVQRYTWMERTKTWTLFSRFSGVTLDQCDSYA 318
V N+KE ++ + L NSSV SR V+N +G V+R TW+ + WT R+ V DQCD+Y+
Sbjct: 243 VLNDKEVYFNFELLNSSVASRFVVNASGVVERLTWISQMHRWT---RYFAVGEDQCDAYS 299
Query: 319 LCGAYASCNINSNSPECECLQGFVPNSQREWDMQYKSGGCVRRTPLDCKHGDGFLEHKAV 378
CG+ A CNI+ SP C CL GF P S R+W Q SGGCVRRT L C G+GF++H +
Sbjct: 300 FCGSNAKCNID-KSPVCACLDGFEPKSARDWSFQDWSGGCVRRTTLTCNRGEGFVKHTGM 358
Query: 379 KLPDTRFSWVDKNITLWECKELCSKNCSCTAYANADVRGRGSGCLLWFHDLIDIKELPES 438
KLPDT SW + +I+L EC+ELC K CSC AYAN DVRG GSGCLLWF DLID++E +
Sbjct: 359 KLPDTSSSWYNTSISLKECQELCLKKCSCMAYANTDVRGGGSGCLLWFGDLIDMREFVNT 418
Query: 439 GQDLFIRMAASELDNVERRRQSKNKKQVMIIITSISLATAVIFIGGLMYRRKKHSNQGNE 498
GQDL+IRMAAS ++G + + + +
Sbjct: 419 GQDLYIRMAAS-------------------------------YLGKMKNILEMDYDSHSR 447
Query: 499 KEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGME 558
KEE+ELPI DL IA AT NFS KLGEGGFG VYKG L GQ+IAVKRLS SGQG+E
Sbjct: 448 KEELELPIIDLSTIAKATGNFSSNKKLGEGGFGLVYKGTLY-GQDIAVKRLSMYSGQGIE 506
Query: 559 EFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKR 618
EFKNEVLLIAKLQHRNLVKLLGCC + DERMLIYEY+PNKSLDYFIFD +RSKLLDW R
Sbjct: 507 EFKNEVLLIAKLQHRNLVKLLGCCIEGDERMLIYEYMPNKSLDYFIFDQSRSKLLDWPTR 566
Query: 619 SHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANT 678
II GIARGLLYLHQDSRLRIIHRDLKASNVLLD MNPKISDFG+AR FG +QTEANT
Sbjct: 567 ISIIDGIARGLLYLHQDSRLRIIHRDLKASNVLLDTDMNPKISDFGMARIFGGNQTEANT 626
Query: 679 KRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWR 738
KRVVGTYGYM+PEYA++GLFSVKSD+FSFGVLVLEI+ G+KNRGF +H NL+GHAW+
Sbjct: 627 KRVVGTYGYMAPEYAVEGLFSVKSDIFSFGVLVLEIVSGRKNRGFFSHNHHLNLVGHAWK 686
Query: 739 LWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQ 798
LW+EER LEL D +L S + SE +R I VGLLCVQQ+P+DRPNMS+ VLML GE SLPQ
Sbjct: 687 LWMEERSLELTDNTLGASHALSEIIRYIHVGLLCVQQQPDDRPNMSTAVLMLGGESSLPQ 746
Query: 799 PQQPGFFTGRNLPESESSSSRQYSASTNEITLSVLEAR 836
P+QPGFF RN+P +ESSSS S STN IT++ R
Sbjct: 747 PKQPGFFLERNVPRTESSSSNYKSTSTNGITMTAQYPR 784
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255569631|ref|XP_002525781.1| S-locus-specific glycoprotein S13 precursor, putative [Ricinus communis] gi|223534931|gb|EEF36617.1| S-locus-specific glycoprotein S13 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 991 bits (2561), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 493/838 (58%), Positives = 629/838 (75%), Gaps = 37/838 (4%)
Query: 23 MEGFNLLIIY-SFLFYIISAARTLDTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRY 81
M+ ++L+I+ S+L I+ + DTI++ QS+ DGETLVSA ESF+LGFFSPGNS++RY
Sbjct: 44 MDDTSILVIFCSYLLLSITTSTAADTINITQSVTDGETLVSAGESFKLGFFSPGNSRTRY 103
Query: 82 LGIWYKKIAEGTVTWVANRDAPLSDRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQ 141
LGIWY K++ TV WVANR+ PL D SGVL+I R IL LLN +WSSN +++A+
Sbjct: 104 LGIWYNKVSVMTVVWVANRETPLIDSSGVLKITDHR--ILALLNHNGSKIWSSNVTMAAR 161
Query: 142 KPVAALMESGNLVVKDGKDNNPDNILWQSFDYPCDTLLPGMKLGINLGTGLNRFLSSWKS 201
PVA L++SGNL+VKD D+NP+N LWQSFDYPC+TLLPGMKLG N+ TGL+R++SSWK+
Sbjct: 162 NPVAQLLDSGNLIVKDEGDDNPENFLWQSFDYPCNTLLPGMKLGRNIATGLDRYISSWKT 221
Query: 202 TDDPARGDFTYGLDPRGIPQLVLRKNSIITFRAGSWNGLHWTGVPQLQLNPVYTFEYVSN 261
DP+RG+FTYGLDP G P+++LR+NSI FRAG WNG ++G QL +NP++ +E+V N
Sbjct: 222 PSDPSRGNFTYGLDPAGYPEMILRENSIERFRAGPWNGRSYSGTSQLNVNPIFKYEFVIN 281
Query: 262 EKEAFYTYNLSNSSVPSRMVINPAGTVQRYTWMERTKTWTLFSRFSGVTLDQCDSYALCG 321
E E +Y + L NSSV SRMVIN G +QR+ W ER + W L+ F+ + D CD YALCG
Sbjct: 282 ETEIYYDFQLLNSSVLSRMVINENGILQRFIWAERERKWRLY--FT-IQTDDCDQYALCG 338
Query: 322 AYASCNINSNSPECECLQGFVPNSQREWDMQYKSGGCVRRTPLDCKHGDGFLEHKAVKLP 381
A+ASCNI SNS C CL GFVP +EWD SGGCVR+TPL+C DGF ++ A KLP
Sbjct: 339 AFASCNIKSNS-YCSCLNGFVPKFPKEWDQADWSGGCVRKTPLNCS-SDGFQKYLAFKLP 396
Query: 382 DTRFSWVDKNITLWECKELCSKNCSCTAYANADVRGRGSGCLLWFHDLIDIKELPESGQD 441
+TR SW ++++ L +CK +C KNCSCT YAN D+R SGCLLWF D+ID EL GQD
Sbjct: 397 ETRKSWFNRSMNLEDCKNMCVKNCSCTVYANLDIREGESGCLLWFSDVIDTTELDGDGQD 456
Query: 442 LFIRMAASEL-----DNVERRRQSKNKKQVMIIITSI------SLATAVIFIGGLMYRRK 490
++IRM+AS+L D+ + + +S KKQ+ II++S+ SL+ AVI ++R+K
Sbjct: 457 IYIRMSASQLGVAHDDDPKIQSKSNVKKQMRIILSSLLSAGMMSLSLAVIL---YVWRKK 513
Query: 491 KH------------SNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGML 538
+ +N EKEE++LP+FD IA AT NFS+ NKLGEGGFG G L
Sbjct: 514 QKKEGKAIGILEISANDKGEKEELKLPLFDFGTIACATCNFSDANKLGEGGFG---LGNL 570
Query: 539 IEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNK 598
+GQEIAV+RLSK S QG++EF NEVL IAKLQHRNLV+LLGCC Q +E++LIYE++PNK
Sbjct: 571 KDGQEIAVRRLSKNSNQGVDEFMNEVLHIAKLQHRNLVRLLGCCIQSEEKLLIYEFMPNK 630
Query: 599 SLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNP 658
SLD+FIFD T+SKLLDW KR HII GIARGLLYLHQDSRLRIIHRDLKA N+LLD MNP
Sbjct: 631 SLDFFIFDQTKSKLLDWPKRYHIINGIARGLLYLHQDSRLRIIHRDLKAGNILLDYEMNP 690
Query: 659 KISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGK 718
KISDFG AR F ++TEA+T +VVGT+GYMSPEYAIDGL+S+KSDVFSFGV+VLEI+ GK
Sbjct: 691 KISDFGPARCFWGNETEASTDKVVGTHGYMSPEYAIDGLYSMKSDVFSFGVIVLEIVSGK 750
Query: 719 KNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPE 778
+NRGF H +H NLLGHAW+L + R E+ID S+ NSC+ SE LR + VGLLCVQQ E
Sbjct: 751 RNRGFYHPEHQLNLLGHAWKLHKDGRSTEMIDGSMINSCNLSEVLRSVHVGLLCVQQSLE 810
Query: 779 DRPNMSSVVLMLSGERSLPQPQQPGFFTGRNLPESESSSSRQYSASTNEITLSVLEAR 836
DRP+MS+ V MLSGE +LP+P+QPGFFT R+ E+ SSSS + S+N +T+++ +AR
Sbjct: 811 DRPSMSAAVYMLSGESALPEPKQPGFFTERDCTEANSSSSIKNFNSSNGLTITLPDAR 868
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493721|ref|XP_002280717.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 989 bits (2557), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 485/809 (59%), Positives = 607/809 (75%), Gaps = 41/809 (5%)
Query: 28 LLIIYSFLFYIISAARTLDTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYK 87
L+ ++S++ I+ + +D+I+ Q IKDGET++SA +FELGF G SK++YLGIWYK
Sbjct: 37 LVFLFSYVISILRISTAVDSITANQHIKDGETIISAGGNFELGFVHLGTSKNQYLGIWYK 96
Query: 88 KIAEGTVTWVANRDAPLSDRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAAL 147
K+ TV WVANR+ P++D SGVL++ + G LV+LN +N +WSSNSS SA+ P A L
Sbjct: 97 KVTPRTVVWVANRELPVTDSSGVLKVTDQ--GSLVILNGSNGLIWSSNSSRSARNPTAQL 154
Query: 148 MESGNLVVKDGKDNNPDNILWQSFDYPCDTLLPGMKLGINLGTGLNRFLSSWKSTDDPAR 207
++SGNLV+K G D++PDN LWQSFDYP DTLLPGMK G N TGL+R+LSSWKS DDP++
Sbjct: 155 LDSGNLVIKSGNDSDPDNFLWQSFDYPGDTLLPGMKHGRNTVTGLDRYLSSWKSNDDPSK 214
Query: 208 GDFTYGLDPRGIPQLVLRKNSIITFRAGSWNGLHWTGVPQLQLNPVYTFEYVSNEKEAFY 267
GDFTYGLDP G PQL LR S + FR+G WNG+ + G P+L+ NPV+ + +V NEKE ++
Sbjct: 215 GDFTYGLDPSGCPQLFLRSGSTVIFRSGPWNGIRFNGFPELRPNPVFNYSFVFNEKEMYF 274
Query: 268 TYNLSNSSVPSRMVINPAGTVQRYTWMERTKTWTLFSRFSGVTLDQCDSYALCGAYASCN 327
TY L NSSV SR+V+NP G VQR W+ RTK+W ++S D CDSYALCGAY++CN
Sbjct: 275 TYKLVNSSVLSRLVLNPNGNVQRLIWIGRTKSWNVYST---AYKDDCDSYALCGAYSTCN 331
Query: 328 INSNSPECECLQGFVPNSQREWDMQYKSGGCVRRTPLDCKHGDGFLEHKAVKLPDTRFSW 387
I+ SP C C++GFVP +WD S GCVR+T LDC+ GDGF++ VKLPDTR SW
Sbjct: 332 IH-RSPRCGCMKGFVPKFPYQWDTMDWSNGCVRKTSLDCQKGDGFVKCSGVKLPDTRNSW 390
Query: 388 VDKNITLWECKELCSKNCSCTAYANADVRGRGSGCLLWFHDLIDIKELPESGQDLFIRMA 447
++++ L EC LC +NCSC+AY N+D++G GSGCLLWF DLID+KE E+GQD +IRMA
Sbjct: 391 FNESMNLKECASLCLRNCSCSAYTNSDIKGGGSGCLLWFGDLIDVKEFTENGQDFYIRMA 450
Query: 448 ASELDNVERRRQSKNKKQVMIIITSISLATAVIFIGGLMYRRKKHSNQGNEKEEMELPIF 507
ASEL+ + N++Q E++ELP+F
Sbjct: 451 ASELE-LNNEGAETNERQ----------------------------------EDLELPLF 475
Query: 508 DLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLI 567
DL I NAT NFS NKLGEGGFGPVYKGML +G+EIAVKRLSK S QG++EFKNEV+ I
Sbjct: 476 DLDTILNATHNFSRNNKLGEGGFGPVYKGMLQDGKEIAVKRLSKESNQGLDEFKNEVIYI 535
Query: 568 AKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIAR 627
+KLQHRNLVKLLGCC +E+MLIYEY+PNKSL++FIFD +S +LDW KR II GIAR
Sbjct: 536 SKLQHRNLVKLLGCCIHGEEKMLIYEYMPNKSLNFFIFDGIQSMVLDWPKRFVIINGIAR 595
Query: 628 GLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGY 687
GLLYLHQDSRLRIIHRDLKA NVLLDN MNP+ISDFG+ARSFG ++T+A TKRVVGTYGY
Sbjct: 596 GLLYLHQDSRLRIIHRDLKADNVLLDNEMNPRISDFGMARSFGGNETQARTKRVVGTYGY 655
Query: 688 MSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLE 747
MSPEYAIDG++SVKSDVFSFGVL+LEII GK+NRGFNH DHD NLLGHAW L++E PLE
Sbjct: 656 MSPEYAIDGVYSVKSDVFSFGVLLLEIISGKRNRGFNHPDHDLNLLGHAWTLYMERTPLE 715
Query: 748 LIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPQQPGFFTG 807
LID S+ ++ + SE LR + VGLLCVQ+ P+DRPNMSSVVLMLS E +L QP++PGFFT
Sbjct: 716 LIDASVGDTYNQSEVLRALNVGLLCVQRHPDDRPNMSSVVLMLSSEGALRQPKEPGFFTE 775
Query: 808 RNLPESESSSSRQYSASTNEITLSVLEAR 836
RN+ E++S + S NE T+++LE R
Sbjct: 776 RNMLEADSLQCKHAVFSGNEHTITILEGR 804
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493715|ref|XP_002280938.2| PREDICTED: uncharacterized protein LOC100246941 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 984 bits (2544), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 493/814 (60%), Positives = 610/814 (74%), Gaps = 21/814 (2%)
Query: 34 FLFYIISAARTLDTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGT 93
+F I + +DTI+L Q ++DGE L SA SFELGFFSP +S RYLGIWYKK++ T
Sbjct: 9 LVFSIFRISIAVDTIALNQVVRDGEILTSAGGSFELGFFSPDDSNRRYLGIWYKKVSTMT 68
Query: 94 VTWVANRDAPLSDRSGVLRINGERNGILVLLNSTNDTV-WSSNSSISAQKPVAALMESGN 152
V WVANR+ PL+D SGVL++ + G L +LN +N + WSSNSS SA+ P A L++SGN
Sbjct: 69 VVWVANREIPLNDSSGVLKVTDQ--GTLAILNGSNTNILWSSNSSRSARNPTAQLLDSGN 126
Query: 153 LVVKDGKDNNPDNILWQSFDYPCDTLLPGMKLGINLGTGLNRFLSSWKSTDDPARGDFTY 212
LV+KDG D+NP+N LWQSFDYPC+TLLPGMKLG N TGL+R+LS+WKS DDP++G+FTY
Sbjct: 127 LVMKDGNDDNPENFLWQSFDYPCNTLLPGMKLGRNTVTGLDRYLSAWKSVDDPSKGNFTY 186
Query: 213 GLDPRGIPQLVLRKNSIITFRAGSWNGLHWTGVPQLQLNPVYTFEYVSNEKEAFYTYNLS 272
LDP G PQL+LRK S +TFR+G WNGL ++G P+L NPVYT+E+V NEKE ++ Y L
Sbjct: 187 RLDPSGYPQLILRKGSAVTFRSGPWNGLRFSGFPELGSNPVYTYEFVFNEKEMYFRYELV 246
Query: 273 NSSVPSRMVINPAGTVQRYTWMERTKTWTLFSRFSGVTLDQCDSYALCGAYASCNINSNS 332
NSSV SR+V+NP G+ QR W++RT W L+S +D CDSYALCG Y SCNIN S
Sbjct: 247 NSSVVSRLVLNPDGSKQRVNWIDRTHGWILYS---SAPMDSCDSYALCGVYGSCNIN-RS 302
Query: 333 PECECLQGFVPNSQREWDMQYKSGGCVRRTPLDCKHGDGFLEHKAVKLPDTRFSWVDKNI 392
P+CEC++GFVP +WDM S GCVR TPL C++G+GF++ VKLPDTR SW ++++
Sbjct: 303 PKCECMEGFVPKFPNDWDMADWSNGCVRSTPLGCQNGEGFVKFSGVKLPDTRNSWFNRSM 362
Query: 393 TLWECKELCSKNCSCTAYANADVRGRGSGCLLWFHDLIDIKELPESGQDLFIRMAASELD 452
L EC +C NCSCTAY N D+R GSGCLLWF DLIDI+E E+GQ+L++RMAASEL
Sbjct: 363 DLKECAAVCLSNCSCTAYTNLDIRDGGSGCLLWFGDLIDIREFNENGQELYVRMAASELG 422
Query: 453 NVERRRQSKNKKQVMIIITSISLATAVIFIGGLMYRRKK-----------HSNQGNEKEE 501
R K KK+ +I+ S+S ++ L K ++ +G +KE+
Sbjct: 423 MHRRSGNFKGKKREWVIVGSVSSLGIILLCLLLTLYLLKKKKLRKKGTMGYNLEGGQKED 482
Query: 502 MELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFK 561
+ELP+FD ++ AT++FS NKLGEGGFG VYKG L E QEIAVKRLSK SGQG+ EFK
Sbjct: 483 VELPLFDFATVSKATNHFSIHNKLGEGGFGLVYKGTLQEEQEIAVKRLSKNSGQGLNEFK 542
Query: 562 NEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHI 621
NEV+ I+KLQHRNLV+LLG C +E+MLIYEY+PNKSLD FIFD TRS LDW+KR I
Sbjct: 543 NEVIYISKLQHRNLVRLLGGCIHDEEKMLIYEYMPNKSLDSFIFDKTRSMELDWNKRFLI 602
Query: 622 IAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRV 681
I GIARGLLYLHQDSRLRIIHRDLKA NVLLD M PKISDFG+ARSFG ++TEANTKRV
Sbjct: 603 INGIARGLLYLHQDSRLRIIHRDLKADNVLLDEEMTPKISDFGIARSFGGNETEANTKRV 662
Query: 682 VGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWI 741
VGTYGYMSPEYAIDGL+S KSDVFSFGVLVLEI+ GK+NRGF+H DH NLLGHAW L++
Sbjct: 663 VGTYGYMSPEYAIDGLYSTKSDVFSFGVLVLEIVSGKRNRGFSHPDHSLNLLGHAWTLYM 722
Query: 742 EERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPQQ 801
E R +ELID S+ + + S+ LR I VGLLCVQ P++RP+MSSVVLMLS + +LPQP++
Sbjct: 723 EGRSMELIDSSVGDIHNLSQVLRLINVGLLCVQCGPDERPSMSSVVLMLSSDSTLPQPKE 782
Query: 802 PGFFTGRNLPESESSSSRQYSASTNEITLSVLEA 835
PGFFTGR S SSS Q S N IT+++ +
Sbjct: 783 PGFFTGRG---STSSSGNQGPFSGNGITITMFDV 813
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 836 | ||||||
| TAIR|locus:2131684 | 783 | AT4G27290 [Arabidopsis thalian | 0.497 | 0.531 | 0.516 | 4.1e-243 | |
| TAIR|locus:2131694 | 815 | AT4G27300 [Arabidopsis thalian | 0.925 | 0.949 | 0.527 | 9.4e-217 | |
| TAIR|locus:2141181 | 850 | RK3 "receptor kinase 3" [Arabi | 0.449 | 0.442 | 0.566 | 7.2e-213 | |
| TAIR|locus:2018546 | 843 | RK1 "receptor kinase 1" [Arabi | 0.449 | 0.446 | 0.583 | 5.4e-206 | |
| TAIR|locus:2018506 | 847 | RK2 "receptor kinase 2" [Arabi | 0.449 | 0.443 | 0.583 | 4.4e-202 | |
| TAIR|locus:2141176 | 849 | B120 [Arabidopsis thaliana (ta | 0.407 | 0.401 | 0.595 | 1.8e-183 | |
| TAIR|locus:2200908 | 842 | AT1G61610 [Arabidopsis thalian | 0.406 | 0.403 | 0.570 | 3.9e-179 | |
| TAIR|locus:2200151 | 830 | SD1-13 "S-domain-1 13" [Arabid | 0.406 | 0.409 | 0.536 | 3.4e-169 | |
| UNIPROTKB|O49974 | 848 | KIK1 "Serine/threonine-protein | 0.398 | 0.392 | 0.577 | 1.7e-163 | |
| TAIR|locus:2200888 | 804 | AT1G61500 [Arabidopsis thalian | 0.863 | 0.898 | 0.448 | 7.3e-162 |
| TAIR|locus:2131684 AT4G27290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1220 (434.5 bits), Expect = 4.1e-243, Sum P(2) = 4.1e-243
Identities = 223/432 (51%), Positives = 306/432 (70%)
Query: 42 ARTLDTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRD 101
A+ D + Q++KDG+T+VS SFE+GFFSPG S++RYLGIWYKKI+ TV WVANRD
Sbjct: 21 AQATDILIANQTLKDGDTIVSQGGSFEVGFFSPGGSRNRYLGIWYKKISLQTVVWVANRD 80
Query: 102 APLSDRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQK-----PVAALMESGNLVVK 156
+PL D SG L+++ NG L L N N +WSS+SS S+QK P+ ++++GNLVV+
Sbjct: 81 SPLYDLSGTLKVS--ENGSLCLFNDRNHIIWSSSSSPSSQKASLRNPIVQILDTGNLVVR 138
Query: 157 DGKDNNPDNILWQSFDYPCDTLLPGMKLGINLGTGLNRFLSSWKSTDDPARGDFTYGLDP 216
+ D+ + +WQS DYP D LPGMK G+N TGLNRFL+SW++ DDP+ G++T +DP
Sbjct: 139 NSGDDQ--DYIWQSLDYPGDMFLPGMKYGLNFVTGLNRFLTSWRAIDDPSTGNYTNKMDP 196
Query: 217 RGIPQLVLRKNSIITFRAGSWNGLHWTGVPQLQLNPVYTFEYVSNEKEAFYTYNLSNSSV 276
G+PQ L+KNS++ FR G WNGL +TG+P L+ NP+Y +EYV E+E +YTY L N SV
Sbjct: 197 NGVPQFFLKKNSVVVFRTGPWNGLRFTGMPNLKPNPIYRYEYVFTEEEVYYTYKLENPSV 256
Query: 277 PSRMVINPAGTVQRYTWMERTKTWTLFSRFSGVTLDQCDSYALCGAYASCNINSNSPECE 336
+RM +NP G +QRYTW++ ++W + S + +D CD Y LCG+Y SCNIN SP C
Sbjct: 257 LTRMQLNPNGALQRYTWVDNLQSWNFY--LSAM-MDSCDQYTLCGSYGSCNINE-SPACR 312
Query: 337 CLQGFVPNSQREWDMQYKSGGCVRRTPLDCKHG-DGFLEHKAVKLPDTRFSWVDKNITLW 395
CL+GFV + + W S GCVRR LDC G DGFL+ +KLPDTR SW DKN+ L
Sbjct: 313 CLKGFVAKTPQAWVAGDWSEGCVRRVKLDCGKGEDGFLKISKLKLPDTRTSWYDKNMDLN 372
Query: 396 ECKELCSKNCSCTAYANADVRGRGSGCLLWFHDLIDIKELPESGQDLFIRMAASELDNVE 455
ECK++C +NC+C+AY+ D+R G GC+LWF DLIDI+E E+GQDL++R+A+SE++ ++
Sbjct: 373 ECKKVCLRNCTCSAYSPFDIRDGGKGCILWFGDLIDIREYNENGQDLYVRLASSEIETLQ 432
Query: 456 RR--RQSKNKKQ 465
R R S K++
Sbjct: 433 RESSRVSSRKQE 444
|
|
| TAIR|locus:2131694 AT4G27300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2094 (742.2 bits), Expect = 9.4e-217, P = 9.4e-217
Identities = 426/807 (52%), Positives = 554/807 (68%)
Query: 46 DTISLGQSIKDGETLVSAKESFELGFFSPGNSKS---RYLGIWYKKIAEGTVTWVANRDA 102
+ I+ + +KDG+TL S + F+LGFFS + R+LG+WY + V WVANR+
Sbjct: 26 NVITPKEFLKDGDTLSSPDQVFQLGFFSLDQEEQPQHRFLGLWYME--PFAVVWVANRNN 83
Query: 103 PLSDRSGVLRINGERNGILVLLNSTNDTVWSSNSSIS-----AQKPVAALMESGNLVVKD 157
PL SG L ++ G L L + + +WSS+SS + A P+ + SGNL+ D
Sbjct: 84 PLYGTSGFLNLSSL--GDLQLFDGEHKALWSSSSSSTKASKTANNPLLKISCSGNLISSD 141
Query: 158 GKDNNPDNILWQSFDYPCDTLLPGMKLGINLGTGLNRFLSSWKSTDDPARGDFTYGLDPR 217
G++ +LWQSFDYP +T+L GMKLG N T + LSSWK+ DP+ GDFT LD R
Sbjct: 142 GEEA----VLWQSFDYPMNTILAGMKLGKNFKTQMEWSLSSWKTLKDPSPGDFTLSLDTR 197
Query: 218 GIPQLVLRKN--SIITFRAGSWNGLHWTGVPQL-QLNPVYTFEYVSNEKEAFYTYNLSNS 274
G+PQL+LRKN S ++R GSWNGL +TG P + + N ++ +++ S+ +E Y++ +
Sbjct: 198 GLPQLILRKNGDSSYSYRLGSWNGLSFTGAPAMGRENSLFDYKFTSSAQEVNYSWTPRHR 257
Query: 275 SVPSRMVINPAGTVQRYTWMERTKTWTLFSRFSGVTLDQCDSYALCGAYASCNINS-NSP 333
V SR+V+N G + R+ ++ + W L + D+CD Y++CGAYA C INS N+P
Sbjct: 258 IV-SRLVLNNTGKLHRFIQSKQNQ-WILANT---APEDECDYYSICGAYAVCGINSKNTP 312
Query: 334 ECECLQGFVPNSQREWDMQYKSGGCVRRTPLDCKHGDGFLEHKAVKLPDTRFSWVD-KN- 391
C CLQGF P S R+W++ + GCV P +C+ D F++ +KLPDT +SW D KN
Sbjct: 313 SCSCLQGFKPKSGRKWNISRGAYGCVHEIPTNCEKKDAFVKFPGLKLPDTSWSWYDAKNE 372
Query: 392 ITLWECKELCSKNCSCTAYANADVRGRGSGCLLWFHDLIDIKELPESGQDLFIRMAASEL 451
+TL +CK CS NCSCTAYAN D+R G GCLLWF DL+D++E GQD++IRM +++
Sbjct: 373 MTLEDCKIKCSSNCSCTAYANTDIREGGKGCLLWFGDLVDMREYSSFGQDVYIRMGFAKI 432
Query: 452 DNVERRRQSKNKKQVMIIITSISLATAVIFIGGLMYR-RKKHSNQGNEKEEMELPIFDLK 510
+ R V+ I + + A F +M R R ++ +G E+E+++LPIFD K
Sbjct: 433 EFKGREVVGMVVGSVVAIAVVLVVVFAC-FRKKIMKRYRGENFRKGIEEEDLDLPIFDRK 491
Query: 511 IIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKL 570
I+ ATD+FS N LG GGFGPVYKG L +GQEIAVKRLS SGQG+EEFKNEV LIAKL
Sbjct: 492 TISIATDDFSYVNFLGRGGFGPVYKGKLEDGQEIAVKRLSANSGQGVEEFKNEVKLIAKL 551
Query: 571 QHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLL 630
QHRNLV+LLGCC Q +E MLIYEY+PNKSLD+FIFD RS LDW KR +II G+ARG+L
Sbjct: 552 QHRNLVRLLGCCIQGEECMLIYEYMPNKSLDFFIFDERRSTELDWKKRMNIINGVARGIL 611
Query: 631 YLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSP 690
YLHQDSRLRIIHRDLKA NVLLDN MNPKISDFGLA+SFG DQ+E++T RVVGTYGYM P
Sbjct: 612 YLHQDSRLRIIHRDLKAGNVLLDNDMNPKISDFGLAKSFGGDQSESSTNRVVGTYGYMPP 671
Query: 691 EYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELID 750
EYAIDG FSVKSDVFSFGVLVLEII GK NRGF HADHD NLLGH W++W+E+R +E+ +
Sbjct: 672 EYAIDGHFSVKSDVFSFGVLVLEIITGKTNRGFRHADHDLNLLGHVWKMWVEDREIEVPE 731
Query: 751 QS-LDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPQQPGFFTGRN 809
+ L+ + E LRCI V LLCVQQ+PEDRP M+SVVLM + SLP P QPGFFT RN
Sbjct: 732 EEWLEETSVIPEVLRCIHVALLCVQQKPEDRPTMASVVLMFGSDSSLPHPTQPGFFTNRN 791
Query: 810 LPEXXXXXXXXXXXXTNEITLSVLEAR 836
+P+ NE+++++L+ R
Sbjct: 792 VPDISSSLSLRSQ---NEVSITMLQGR 815
|
|
| TAIR|locus:2141181 RK3 "receptor kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1082 (385.9 bits), Expect = 7.2e-213, Sum P(2) = 7.2e-213
Identities = 218/385 (56%), Positives = 281/385 (72%)
Query: 461 KNKKQVMII--ITSISLATAVIFIGGLMYRRKKHSNQGNEKEEMELPIFDLKIIANATDN 518
K K+ ++I I L + + + ++ ++H ++ N +++ELP+ + + +A AT+N
Sbjct: 466 KQKRSILIETPIVDHQLRSRDLLMNEVVISSRRHISRENNTDDLELPLMEFEEVAMATNN 525
Query: 519 FSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKL 578
FS NKLG+GGFG VYKG L++GQE+AVKRLSK S QG +EFKNEV LIA+LQH NLV+L
Sbjct: 526 FSNANKLGQGGFGIVYKGKLLDGQEMAVKRLSKTSVQGTDEFKNEVKLIARLQHINLVRL 585
Query: 579 LGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRL 638
L CC E+MLIYEYL N SLD +FD +R+ L+W R II GIARGLLYLHQDSR
Sbjct: 586 LACCVDAGEKMLIYEYLENLSLDSHLFDKSRNSKLNWQMRFDIINGIARGLLYLHQDSRF 645
Query: 639 RIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLF 698
RIIHRDLKASN+LLD M PKISDFG+AR FG D+TEANT++VVGTYGYMSPEYA+DG+F
Sbjct: 646 RIIHRDLKASNILLDKYMTPKISDFGMARIFGRDETEANTRKVVGTYGYMSPEYAMDGIF 705
Query: 699 SVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSL-DNSC 757
S+KSDVFSFGVL+LEII K+N+GF ++D D NLLG WR W E + LE+ID + D+S
Sbjct: 706 SMKSDVFSFGVLLLEIISSKRNKGFYNSDRDLNLLGCVWRNWKEGKGLEIIDPIITDSSS 765
Query: 758 SFS--EALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS-LPQPQQPGFFTGRNLPEXX 814
+F E LRCIQ+GLLCVQ+R EDRP MS V+LML E + +PQP+ PG+ R+L +
Sbjct: 766 TFRQHEILRCIQIGLLCVQERAEDRPTMSLVILMLGSESTTIPQPKAPGYCLERSLLDTD 825
Query: 815 XXXXXXXXXXT---NEITLSVLEAR 836
+ N+IT+SVL+AR
Sbjct: 826 SSSSKQRDDESWTVNQITVSVLDAR 850
|
|
| TAIR|locus:2018546 RK1 "receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1105 (394.0 bits), Expect = 5.4e-206, Sum P(2) = 5.4e-206
Identities = 224/384 (58%), Positives = 284/384 (73%)
Query: 461 KNKKQVMIIITSIS-LATAVIFIGGLMYRRKKHSNQGNEKEEMELPIFDLKIIANATDNF 519
K K+ + I ++ + + I ++ R+ ++++ + E +ELP+ +L+ +A AT+NF
Sbjct: 460 KQKRSITIQTPNVDQVRSQDSLINDVVVSRRGYTSKEKKSEYLELPLLELEALATATNNF 519
Query: 520 SEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLL 579
S NKLG+GGFG VYKG L++G+EIAVKRLSK S QG +EF NEV LIAKLQH NLV+LL
Sbjct: 520 SNDNKLGQGGFGIVYKGRLLDGKEIAVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLL 579
Query: 580 GCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLR 639
GCC + E+MLIYEYL N SLD +FD TRS L+W KR II GIARGLLYLHQDSR R
Sbjct: 580 GCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCR 639
Query: 640 IIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFS 699
IIHRDLKASNVLLD M PKISDFG+AR FG ++TEANT+RVVGTYGYMSPEYA+DG+FS
Sbjct: 640 IIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANTRRVVGTYGYMSPEYAMDGIFS 699
Query: 700 VKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQ-SLDN-SC 757
+KSDVFSFGVL+LEII GK+N+GF +++ D NLLG WR W E LE++D ++D+ S
Sbjct: 700 MKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGFVWRHWKEGNELEIVDPINIDSLSS 759
Query: 758 SFS--EALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS-LPQPQQPGFFTGRNLPEXX 814
F E LRCIQ+GLLCVQ+R EDRP MSSV++ML E + +PQP++PGF GR+ E
Sbjct: 760 KFPTHEILRCIQIGLLCVQERAEDRPVMSSVMVMLGSETTAIPQPKRPGFCIGRSPLEAD 819
Query: 815 XXXXXXXXX--XTNEITLSVLEAR 836
N+ITLSV++AR
Sbjct: 820 SSSSTQRDDECTVNQITLSVIDAR 843
|
|
| TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1103 (393.3 bits), Expect = 4.4e-202, Sum P(2) = 4.4e-202
Identities = 224/384 (58%), Positives = 283/384 (73%)
Query: 461 KNKKQVMIIITSISLATAV-IFIGGLMYRRKKHSNQGNEKEEMELPIFDLKIIANATDNF 519
K K+ + I + L + + L+ + ++++ N+ + +ELP+ + K +A AT+NF
Sbjct: 464 KQKRSITIQTPIVDLVRSQDSLMNELVKASRSYTSKENKTDYLELPLMEWKALAMATNNF 523
Query: 520 SEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLL 579
S NKLG+GGFG VYKGML++G+EIAVKRLSK S QG +EF NEV LIAKLQH NLV+LL
Sbjct: 524 STDNKLGQGGFGIVYKGMLLDGKEIAVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLL 583
Query: 580 GCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLR 639
GCC + E+MLIYEYL N SLD +FD TRS L+W KR II GIARGLLYLHQDSR R
Sbjct: 584 GCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCR 643
Query: 640 IIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFS 699
IIHRDLKASNVLLD M PKISDFG+AR FG ++TEANT+RVVGTYGYMSPEYA+DG+FS
Sbjct: 644 IIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANTRRVVGTYGYMSPEYAMDGIFS 703
Query: 700 VKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQ-SLDN-SC 757
+KSDVFSFGVL+LEII GK+N+GF +++ D NLLG WR W E + LE++D ++D S
Sbjct: 704 MKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGFVWRHWKEGKELEIVDPINIDALSS 763
Query: 758 SFS--EALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS-LPQPQQPGFFTGRNLPEXX 814
F E LRCIQ+GLLCVQ+R EDRP MSSV++ML E + +PQP++PGF GR+ E
Sbjct: 764 EFPTHEILRCIQIGLLCVQERAEDRPVMSSVMVMLGSETTAIPQPKRPGFCVGRSSLEVD 823
Query: 815 XXXXXXXXX--XTNEITLSVLEAR 836
N++TLSV++AR
Sbjct: 824 SSSSTQRDDECTVNQVTLSVIDAR 847
|
|
| TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1037 (370.1 bits), Expect = 1.8e-183, Sum P(2) = 1.8e-183
Identities = 206/346 (59%), Positives = 259/346 (74%)
Query: 495 QGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSG 554
+G ELP+F L IA AT++F ++N+LG GGFGPVYKG+L +G+EIAVKRLS SG
Sbjct: 505 EGKAVNTSELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLEDGREIAVKRLSGKSG 564
Query: 555 QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLD 614
QG++EFKNE++LIAKLQHRNLV+LLGCC + +E+ML+YEY+PNKSLD+F+FD T+ L+D
Sbjct: 565 QGVDEFKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQALID 624
Query: 615 WSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674
W R II GIARGLLYLH+DSRLRIIHRDLK SNVLLD MNPKISDFG+AR FG +Q
Sbjct: 625 WKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGGNQN 684
Query: 675 EANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLG 734
EANT RVVGTYGYMSPEYA++GLFSVKSDV+SFGVL+LEI+ GK+N ++H +L+G
Sbjct: 685 EANTVRVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNTSLRSSEHG-SLIG 743
Query: 735 HAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 794
+AW L+ R EL+D + +CS EALRCI V +LCVQ +RPNM+SV+LML +
Sbjct: 744 YAWYLYTHGRSEELVDPKIRVTCSKREALRCIHVAMLCVQDSAAERPNMASVLLMLESDT 803
Query: 795 S-LPQPQQPGFF-TGRNLPEXXXXXXXXXXX--XTNEITLSVLEAR 836
+ L P+QP F T RN + +NEIT +V+ R
Sbjct: 804 ATLAAPRQPTFTSTRRNSIDVNFALDSSQQYIVSSNEITSTVVLGR 849
|
|
| TAIR|locus:2200908 AT1G61610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1015 (362.4 bits), Expect = 3.9e-179, Sum P(2) = 3.9e-179
Identities = 195/342 (57%), Positives = 251/342 (73%)
Query: 496 GNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQ 555
G++ + +LPIF +A+AT +F+E+NKLG+GGFG VYKG EG+EIAVKRLS S Q
Sbjct: 502 GDQVDTPDLPIFSFDSVASATGDFAEENKLGQGGFGTVYKGNFSEGREIAVKRLSGKSKQ 561
Query: 556 GMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDW 615
G+EEFKNE+LLIAKLQHRNLV+LLGCC + +E+ML+YEY+PNKSLD F+FD ++ LDW
Sbjct: 562 GLEEFKNEILLIAKLQHRNLVRLLGCCIEDNEKMLLYEYMPNKSLDRFLFDESKQGSLDW 621
Query: 616 SKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE 675
KR +I GIARGLLYLH+DSRL+IIHRDLKASN+LLD MNPKISDFG+AR F Q
Sbjct: 622 RKRWEVIGGIARGLLYLHRDSRLKIIHRDLKASNILLDTEMNPKISDFGMARIFNYRQDH 681
Query: 676 ANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGH 735
ANT RVVGTYGYM+PEYA++G+FS KSDV+SFGVL+LEI+ G+KN F DH +L+G+
Sbjct: 682 ANTIRVVGTYGYMAPEYAMEGIFSEKSDVYSFGVLILEIVSGRKNVSFRGTDHG-SLIGY 740
Query: 736 AWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS 795
AW LW + + E+ID + ++ +EA+RCI VG+LC Q RPNM SV+LML + S
Sbjct: 741 AWHLWSQGKTKEMIDPIVKDTRDVTEAMRCIHVGMLCTQDSVIHRPNMGSVLLMLESQTS 800
Query: 796 -LPQPQQPGFFTGRNLPEXXXXXXXXXXXXTNEITLSVLEAR 836
LP P+QP F + N + N++T + + R
Sbjct: 801 QLPPPRQPTFHSFLNSGDIELNFDGHDVASVNDVTFTTIVGR 842
|
|
| TAIR|locus:2200151 SD1-13 "S-domain-1 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 962 (343.7 bits), Expect = 3.4e-169, Sum P(2) = 3.4e-169
Identities = 183/341 (53%), Positives = 244/341 (71%)
Query: 497 NEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQG 556
N+ + ELP+F+ +++A AT+NFS NKLG+GGFG VYKG L EG +IAVKRLS+ SGQG
Sbjct: 490 NQYKLKELPLFEFQVLAVATNNFSITNKLGQGGFGAVYKGRLQEGLDIAVKRLSRTSGQG 549
Query: 557 MEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWS 616
+EEF NEV++I+KLQHRNLV+LLG C + +ERML+YE++P LD ++FD + +LLDW
Sbjct: 550 VEEFVNEVVVISKLQHRNLVRLLGFCIEGEERMLVYEFMPENCLDAYLFDPVKQRLLDWK 609
Query: 617 KRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEA 676
R +II GI RGL+YLH+DSRL+IIHRDLKASN+LLD +NPKISDFGLAR F ++ E
Sbjct: 610 TRFNIIDGICRGLMYLHRDSRLKIIHRDLKASNILLDENLNPKISDFGLARIFQGNEDEV 669
Query: 677 NTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHA 736
+T RVVGTYGYM+PEYA+ GLFS KSDVFS GV++LEI+ G++N F + + NL +A
Sbjct: 670 STVRVVGTYGYMAPEYAMGGLFSEKSDVFSLGVILLEIVSGRRNSSFYNDGQNPNLSAYA 729
Query: 737 WRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS- 795
W+LW + L+D + C +E RC+ VGLLCVQ DRP++++V+ MLS E S
Sbjct: 730 WKLWNTGEDIALVDPVIFEECFENEIRRCVHVGLLCVQDHANDRPSVATVIWMLSSENSN 789
Query: 796 LPQPQQPGFFTGRNLPEXXXXXXXXXXXXTNEITLSVLEAR 836
LP+P+QP F R E N ++L+ + R
Sbjct: 790 LPEPKQPAFIPRRGTSEVESSGQSDPRASINNVSLTKITGR 830
|
|
| UNIPROTKB|O49974 KIK1 "Serine/threonine-protein kinase" [Zea mays (taxid:4577)] | Back alignment and assigned GO terms |
|---|
Score = 1014 (362.0 bits), Expect = 1.7e-163, Sum P(2) = 1.7e-163
Identities = 194/336 (57%), Positives = 245/336 (72%)
Query: 503 ELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKN 562
EL ++ L I AT NFS+ NKLGEGGFGPVY G L G+E+AVKRL + SGQG+EEFKN
Sbjct: 514 ELKVYSLDRIRTATSNFSDSNKLGEGGFGPVYMGTLPGGEEVAVKRLCRNSGQGLEEFKN 573
Query: 563 EVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHII 622
EV+LIAKLQHRNLV+LLGCC R+E++L+YEY+PNKSLD F+F+ + +LLDW KR II
Sbjct: 574 EVILIAKLQHRNLVRLLGCCIPREEKILVYEYMPNKSLDAFLFNPEKQRLLDWKKRFDII 633
Query: 623 AGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVV 682
GIARGLLYLH+DSRLR++HRDLKASN+LLD M PKISDFG+AR FG DQ + NT RVV
Sbjct: 634 EGIARGLLYLHRDSRLRVVHRDLKASNILLDADMKPKISDFGMARMFGGDQNQFNTNRVV 693
Query: 683 GTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIE 742
GT+GYMSPEYA++G+FSVKSDV+ FGVL+LEII GK+ F+ + N+ G+AWR W E
Sbjct: 694 GTFGYMSPEYAMEGIFSVKSDVYGFGVLILEIITGKRAVSFHCHEDSLNIAGYAWRQWNE 753
Query: 743 ERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS-LPQPQQ 801
+ ELID + SCS + LRCI + LLCVQ ++RP++ +V+LMLS + S LP P+
Sbjct: 754 DNAAELIDPVIRASCSVRQVLRCIHIALLCVQDHADERPDIPTVILMLSNDSSSLPNPRP 813
Query: 802 PGFFT-GRNLPEXXXXXXXXXXXXTNEITLSVLEAR 836
P GR + E +T++ L R
Sbjct: 814 PTLMLRGREI-ESSKSSEKDRSHSIGTVTMTQLHGR 848
|
|
| TAIR|locus:2200888 AT1G61500 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1576 (559.8 bits), Expect = 7.3e-162, P = 7.3e-162
Identities = 344/767 (44%), Positives = 467/767 (60%)
Query: 57 GETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPLSDRSGVLRINGE 116
G+TL SA E +ELGFFSP N++ +Y+GIW+K V WVANR+ P++D + L I+
Sbjct: 36 GQTLSSANEVYELGFFSPNNTQDQYVGIWFKDTIPRVVVWVANREKPVTDSTAYLAISS- 94
Query: 117 RNGILVLLNSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDNILWQSFDYPCD 176
+G L+LLN + TVWSS + S+ A L +SGNL V D N + LWQSFD+ D
Sbjct: 95 -SGSLLLLNGKHGTVWSSGVTFSSSGCRAELSDSGNLKVID---NVSERALWQSFDHLGD 150
Query: 177 TLLPGMKLGINLGTGLNRFLSSWKSTDDPARGDFTYGLDPRGIPQLVLRKNSIITFRAGS 236
TLL L NL T R L+SWKS DP+ GDF + P+ Q + + S +R+G
Sbjct: 151 TLLHTSSLTYNLATAEKRVLTSWKSYTDPSPGDFLGQITPQVPSQGFVMRGSTPYWRSGP 210
Query: 237 WNGLHWTGVPQLQLNPVYTFEYVSNEK---EAFYTYNLSNSSVPSRMVINPAGTVQRYTW 293
W +TG+P + + YT + ++ + TY + + SR+ + G+++ +
Sbjct: 211 WAKTRFTGIPFMDES--YTGPFTLHQDVNGSGYLTYFQRDYKL-SRITLTSEGSIKMFR- 266
Query: 294 MERTKTWTLFSRFSGVTLDQCDSYALCGAYASCNINSNSPECECLQGFVPNSQREWDMQY 353
+ W L+ CD Y CG + C + S SP C+C +GFVP S EW
Sbjct: 267 -DNGMGWELYYE---APKKLCDFYGACGPFGLC-VMSPSPMCKCFRGFVPKSVEEWKRGN 321
Query: 354 KSGGCVRRTPLDC------KHGDGFLEHKAVKLPDTRFSWVDKNITLWECKELCSKNCSC 407
+GGCVR T LDC + D F + +K PD F ++ EC + C NCSC
Sbjct: 322 WTGGCVRHTELDCLGNSTGEDADDFHQIANIKPPD--FYEFASSVNAEECHQRCVHNCSC 379
Query: 408 TAYANADVRGRGSGCLLWFHDLIDIKELPESGQDLFIRMAASELDNVERRRQSKNKKQVM 467
A+A +G GCL+W DL+D + +G+ L IR+A SELD +K KK ++
Sbjct: 380 LAFAYI----KGIGCLVWNQDLMDAVQFSATGELLSIRLARSELDG------NKRKKTIV 429
Query: 468 IIITSISLATAVIFIGGLMYR-RKKH----SNQG--NEKEEMELP---IFDLKIIANATD 517
I S++L + F ++R R +H S N+ + ++P FD+ I NAT+
Sbjct: 430 ASIVSLTLFMILGFTAFGVWRCRVEHIAHISKDAWKNDLKPQDVPGLDFFDMHTIQNATN 489
Query: 518 NFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVK 577
NFS NKLG+GGFG VYKG L +G+EIAVKRLS SGQG EEF NE++LI+KLQHRNLV+
Sbjct: 490 NFSLSNKLGQGGFGSVYKGKLQDGKEIAVKRLSSSSGQGKEEFMNEIVLISKLQHRNLVR 549
Query: 578 LLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSR 637
+LGCC + +E++LIYE++ NKSLD F+FD+ + +DW KR II GIARGLLYLH DSR
Sbjct: 550 VLGCCIEEEEKLLIYEFMVNKSLDTFLFDSRKRLEIDWPKRFDIIQGIARGLLYLHHDSR 609
Query: 638 LRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGL 697
LR+IHRDLK SN+LLD MNPKISDFGLAR + + + NT+RVVGT GYMSPEYA G+
Sbjct: 610 LRVIHRDLKVSNILLDEKMNPKISDFGLARMYQGTEYQDNTRRVVGTLGYMSPEYAWTGM 669
Query: 698 FSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDNSC 757
FS KSD++SFGVL+LEII G+K F++ L+ +AW W E R ++L+DQ L +SC
Sbjct: 670 FSEKSDIYSFGVLMLEIISGEKISRFSYGVEGKTLIAYAWESWSEYRGIDLLDQDLADSC 729
Query: 758 SFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPQQPGF 804
E RCIQ+GLLCVQ +P DRPN ++ ML+ LP P+QP F
Sbjct: 730 HPLEVGRCIQIGLLCVQHQPADRPNTLELLAMLTTTSDLPSPKQPTF 776
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| O81832 | Y4729_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.5510 | 0.9270 | 0.9897 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.946 |
| 3rd Layer | 2.7.11 | 0.963 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 836 | |||
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-53 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-52 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 7e-51 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-48 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-47 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 7e-47 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 6e-46 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-39 | |
| pfam00954 | 110 | pfam00954, S_locus_glycop, S-locus glycoprotein fa | 2e-37 | |
| pfam01453 | 109 | pfam01453, B_lectin, D-mannose binding lectin | 3e-37 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 7e-35 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-34 | |
| cd00028 | 116 | cd00028, B_lectin, Bulb-type mannose-specific lect | 3e-34 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-33 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-33 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 7e-32 | |
| smart00108 | 114 | smart00108, B_lectin, Bulb-type mannose-specific l | 3e-31 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-31 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 9e-31 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-30 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-30 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-30 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-30 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 5e-30 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 9e-30 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-29 | |
| pfam08276 | 66 | pfam08276, PAN_2, PAN-like domain | 8e-29 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-28 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-28 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-27 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 4e-27 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 6e-27 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 6e-27 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-26 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-26 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-26 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-26 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-26 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 5e-26 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 5e-25 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 5e-25 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 6e-25 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 8e-25 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 8e-25 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-24 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-24 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-24 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 7e-24 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 9e-24 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 9e-24 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-23 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-23 | |
| cd01098 | 84 | cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain | 3e-23 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-23 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 5e-23 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 6e-23 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 7e-23 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-22 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-22 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-22 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-22 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-22 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-22 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-22 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-22 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 6e-22 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 6e-22 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 8e-22 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-21 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-21 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-21 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-21 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-21 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-21 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 6e-21 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 6e-21 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 6e-21 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 7e-21 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 8e-21 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 8e-21 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 8e-21 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 9e-21 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-20 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-20 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-20 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-20 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-20 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-20 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-20 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-20 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-20 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-20 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 5e-20 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 5e-20 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 7e-20 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 8e-20 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-19 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-19 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-19 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-19 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-19 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-19 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-19 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-19 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-19 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-19 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-19 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-19 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 5e-19 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 6e-19 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 7e-19 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 8e-19 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 8e-19 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 8e-19 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 9e-19 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-18 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-18 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-18 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-18 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-18 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-18 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-18 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-18 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 4e-18 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 5e-18 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 5e-18 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 6e-18 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 6e-18 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 7e-18 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 7e-18 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 8e-18 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 9e-18 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-17 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-17 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-17 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-17 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-17 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-17 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-17 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-17 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-17 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-17 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-17 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 4e-17 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-17 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 5e-17 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 5e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 6e-17 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 7e-17 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 7e-17 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 9e-17 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-16 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-16 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-16 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-16 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-16 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-16 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-16 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-16 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-16 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 6e-16 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 6e-16 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 6e-16 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 7e-16 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-15 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-15 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-15 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-15 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-15 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-15 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-15 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-15 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-15 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-15 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-15 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 5e-15 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 7e-15 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 8e-15 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 9e-15 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-14 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-14 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-14 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-14 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-14 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-14 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-14 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-14 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 5e-14 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-14 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 8e-14 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 9e-14 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-13 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-13 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-13 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-13 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-13 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-13 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-13 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-13 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-13 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-13 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-13 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-13 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-13 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 6e-13 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 6e-13 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-12 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-12 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-12 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-12 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-12 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-12 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-12 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-12 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-12 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 4e-12 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 5e-12 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 6e-12 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 8e-12 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 9e-12 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-11 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-11 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-11 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-11 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-11 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-11 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-11 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-11 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-11 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-11 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 5e-11 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 5e-11 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 6e-11 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 6e-11 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 6e-11 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 6e-11 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 7e-11 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 8e-11 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 8e-11 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-10 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-10 | |
| pfam11883 | 48 | pfam11883, DUF3403, Domain of unknown function (DU | 1e-10 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-10 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-10 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-10 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-10 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-10 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-10 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-10 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-10 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-10 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-10 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 6e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 6e-10 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 8e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-09 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-09 | |
| smart00473 | 78 | smart00473, PAN_AP, divergent subfamily of APPLE d | 2e-09 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-09 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 5e-09 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 7e-09 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 7e-09 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 8e-09 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-08 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-08 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-08 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-08 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-08 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 5e-08 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 7e-08 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 7e-08 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 8e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-07 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-07 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-07 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-07 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-07 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-07 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 5e-07 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 6e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-06 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-06 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-06 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-06 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-06 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 6e-06 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 6e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 6e-06 | |
| cd00129 | 80 | cd00129, PAN_APPLE, PAN/APPLE-like domain; present | 1e-05 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-05 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-05 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-05 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 5e-05 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 5e-05 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 1e-04 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-04 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-04 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 0.001 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 0.001 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.003 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 185 bits (472), Expect = 3e-53
Identities = 102/279 (36%), Positives = 138/279 (49%), Gaps = 38/279 (13%)
Query: 524 KLGEGGFGPVYKGMLI-----EGQEIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVK 577
KLGEG FG VYKG L + E+AVK L + S Q +EEF E ++ KL H N+VK
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 578 LLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSR 637
LLG CT+ + M++ EY+P L ++ R K L S IARG+ YL
Sbjct: 66 LLGVCTEEEPLMIVMEYMPGGDLLDYLRK-NRPKELSLSDLLSFALQIARGMEYLE---S 121
Query: 638 LRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT---YGYMSPEYAI 694
IHRDL A N L+ + KISDFGL+R D + + +V G +M+PE
Sbjct: 122 KNFIHRDLAARNCLVGENLVVKISDFGLSR----DLYDDDYYKVKGGKLPIRWMAPESLK 177
Query: 695 DGLFSVKSDVFSFGVLVLEII--CGKKNRGFNHADHDHNLLGHAWRLWIEER-PLELIDQ 751
+G F+ KSDV+SFGVL+ EI + G ++A+ L +RL P EL
Sbjct: 178 EGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEV-LEYLKKGYRLPKPPNCPPELYK- 235
Query: 752 SLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLML 790
+ L C + PEDRP S +V +L
Sbjct: 236 ----------------LMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 181 bits (463), Expect = 4e-52
Identities = 98/281 (34%), Positives = 134/281 (47%), Gaps = 39/281 (13%)
Query: 522 KNKLGEGGFGPVYKGMLI-----EGQEIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNL 575
KLGEG FG VYKG L + E+AVK L + S Q +EEF E ++ KL H N+
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 576 VKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQD 635
VKLLG CT+ + ++ EY+ L ++ L S IARG+ YL
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGMEYLE-- 119
Query: 636 SRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT---YGYMSPEY 692
IHRDL A N L+ + KISDFGL+R D + + R G +M+PE
Sbjct: 120 -SKNFIHRDLAARNCLVGENLVVKISDFGLSR----DLYDDDYYRKRGGKLPIRWMAPES 174
Query: 693 AIDGLFSVKSDVFSFGVLVLEII--CGKKNRGFNHADHDHNLLGHAWRLWIEER-PLELI 749
+G F+ KSDV+SFGVL+ EI + G ++ + L + +RL P EL
Sbjct: 175 LKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEV-LEYLKNGYRLPQPPNCPPELY 233
Query: 750 DQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLML 790
D + L C + PEDRP S +V +L
Sbjct: 234 D-----------------LMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 178 bits (455), Expect = 7e-51
Identities = 93/287 (32%), Positives = 130/287 (45%), Gaps = 45/287 (15%)
Query: 523 NKLGEGGFGPVYKGMLIEGQ----EIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVK 577
KLGEG FG VYKG L E+AVK L + S + ++F E ++ KL H N+V+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 578 LLGCCTQRDERMLIYEYLPNKSLDYFI------FDTTRSKLLDWSKRSHIIAGIARGLLY 631
LLG CT+ + L+ EY+ L ++ F + L IA+G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 632 LHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS-FGLDQTEANTKRVVGTYGYMSP 690
L + +HRDL A N L+ + KISDFGL+R + D T + +M+P
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR-WMAP 176
Query: 691 EYAIDGLFSVKSDVFSFGVLVLEIIC-------GKKNRGFNHADHDHNLLGHAWRLWIEE 743
E DG+F+ KSDV+SFGVL+ EI G N L +RL
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEV------LEYLRKGYRL---P 227
Query: 744 RPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLML 790
+P + L ++ L C Q PEDRP S +V L
Sbjct: 228 KPE-----------YCPDELY--ELMLSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 172 bits (438), Expect = 1e-48
Identities = 82/269 (30%), Positives = 120/269 (44%), Gaps = 24/269 (8%)
Query: 524 KLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFK---NEVLLIAKLQHRNLVKLL 579
KLG G FG VYK G+ +AVK L K + ++ + E+ ++ +L H N+V+L+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKK-RSEKSKKDQTARREIRILRRLSHPNIVRLI 64
Query: 580 GCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLR 639
+D L+ EY L ++ +R L + I I RGL YLH
Sbjct: 65 DAFEDKDHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAKKIALQILRGLEYLH---SNG 118
Query: 640 IIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGL-F 698
IIHRDLK N+LLD KI+DFGLA+ + T VGT YM+PE + G +
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT--FVGTPWYMAPEVLLGGNGY 176
Query: 699 SVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDNSCS 758
K DV+S GV++ E++ G K D L I ++ S
Sbjct: 177 GPKVDVWSLGVILYELLTG-KPPFSGENILDQLQL-------IRRILGPPLEFDEPKWSS 228
Query: 759 FSEALRCIQVGLLCVQQRPEDRPNMSSVV 787
SE + + L + P RP ++
Sbjct: 229 GSEEAKDLIKKCLN--KDPSKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 168 bits (428), Expect = 3e-47
Identities = 78/203 (38%), Positives = 108/203 (53%), Gaps = 17/203 (8%)
Query: 524 KLGEGGFGPVYKGMLIE-----GQEIAVKRLSKGSG-QGMEEFKNEVLLIAKLQHRNLVK 577
KLGEG FG VYKG L ++AVK L +G+ + EEF E ++ KL H N+V+
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 578 LLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSR 637
LLG CTQ + ++ EY+P L F+ + L + IA+G+ YL
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFL--RKHGEKLTLKDLLQMALQIAKGMEYLE---S 120
Query: 638 LRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYG---YMSPEYAI 694
+HRDL A N L+ + KISDFGL+R + + + KR G +M+PE
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSRD--IYEDDYYRKR-GGGKLPIKWMAPESLK 177
Query: 695 DGLFSVKSDVFSFGVLVLEIICG 717
DG F+ KSDV+SFGVL+ EI
Sbjct: 178 DGKFTSKSDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 165 bits (421), Expect = 7e-47
Identities = 72/194 (37%), Positives = 104/194 (53%), Gaps = 11/194 (5%)
Query: 525 LGEGGFGPVYKGM-LIEGQEIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLLGCC 582
LGEGGFG VY G+++A+K + K S +EE E+ ++ KL H N+VKL G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 583 TQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIH 642
+ L+ EY SL + + L + I+ I GL YLH IIH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKE--NEGKLSEDEILRILLQILEGLEYLHS---NGIIH 115
Query: 643 RDLKASNVLLDN-TMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAID-GLFSV 700
RDLK N+LLD+ K++DFGL++ D++ T VGT YM+PE + G +S
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTI--VGTPAYMAPEVLLGKGYYSE 173
Query: 701 KSDVFSFGVLVLEI 714
KSD++S GV++ E+
Sbjct: 174 KSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 164 bits (418), Expect = 6e-46
Identities = 63/202 (31%), Positives = 96/202 (47%), Gaps = 11/202 (5%)
Query: 519 FSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEE-FKNEVLLIAKLQHRNLV 576
+ KLGEG FG VY + G+ +A+K + K + E E+ ++ KL+H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 577 KLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDS 636
+L D+ L+ EY L + + L + + I L YLH
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLL---KKRGRLSEDEARFYLRQILSALEYLHS-- 115
Query: 637 RLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDG 696
I+HRDLK N+LLD + K++DFGLAR VGT YM+PE +
Sbjct: 116 -KGIVHRDLKPENILLDEDGHVKLADFGLARQL---DPGEKLTTFVGTPEYMAPEVLLGK 171
Query: 697 LFSVKSDVFSFGVLVLEIICGK 718
+ D++S GV++ E++ GK
Sbjct: 172 GYGKAVDIWSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 1e-39
Identities = 65/208 (31%), Positives = 101/208 (48%), Gaps = 25/208 (12%)
Query: 523 NKLGEGGFGPVYKGMLIE-GQEIAVK--RLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLL 579
LG G FG VY + + G+ +AVK LS S + +E + E+ +++ LQH N+V+
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 580 GCCTQRDERML-IY-EYLPNKSLDYFI--F-----DTTRSKLLDWSKRSHIIAGIARGLL 630
G ++ L I+ EY+ SL + F R I GL
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQ----------ILEGLA 115
Query: 631 YLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSP 690
YLH I+HRD+K +N+L+D+ K++DFG A+ G +T T V GT +M+P
Sbjct: 116 YLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAP 172
Query: 691 EYAIDGLFSVKSDVFSFGVLVLEIICGK 718
E + +D++S G V+E+ GK
Sbjct: 173 EVIRGEEYGRAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|201524 pfam00954, S_locus_glycop, S-locus glycoprotein family | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 2e-37
Identities = 44/114 (38%), Positives = 77/114 (67%), Gaps = 4/114 (3%)
Query: 232 FRAGSWNGLHWTGVPQLQLNPVYTFEYVSNEKEAFYTYNLSNSSVPSRMVINPAGTVQRY 291
+R+G WNG+ ++G+P++Q Y + + N +E +YTY ++N+S+ SR+ ++ G+++R+
Sbjct: 1 WRSGPWNGIRFSGIPEMQKLSYYVYNFTENNEEVYYTYRMTNNSIYSRLTLSSEGSLERF 60
Query: 292 TWMERTKTWTLFSRFSGVTLDQCDSYALCGAYASCNINSNSPECECLQGFVPNS 345
TW+ ++ W LF +S DQCD Y CG Y C++N SP+C C++GFVP +
Sbjct: 61 TWIPNSQDWNLF--WS-APKDQCDVYGRCGPYGYCDVN-TSPKCNCIKGFVPKN 110
|
In Brassicaceae, self-incompatible plants have a self/non-self recognition system. This is sporophytically controlled by multiple alleles at a single locus (S). S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles. Length = 110 |
| >gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 3e-37
Identities = 56/116 (48%), Positives = 69/116 (59%), Gaps = 7/116 (6%)
Query: 91 EGTVTWVANRDAPLSDRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAALMES 150
TV WVANR PL+D S L + +G LVL + VWSSN+S VA L +
Sbjct: 1 NQTVVWVANRLNPLTDSSYTLILQS--DGNLVLYDGNGRVVWSSNTSGKGSGCVAVLQDD 58
Query: 151 GNLVVKDGKDNNPDNILWQSFDYPCDTLLPGMKLGINLGTGLNRFLSSWKSTDDPA 206
GNLV+ D N +LWQSFD+P DTLLPG K G N+ G +R L+SWKS DP+
Sbjct: 59 GNLVLYD----NSGKVLWQSFDHPTDTLLPGQKDG-NVVIGGSRRLTSWKSNTDPS 109
|
These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 7e-35
Identities = 64/201 (31%), Positives = 108/201 (53%), Gaps = 9/201 (4%)
Query: 519 FSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVK 577
F K+G+GGFG VYK G+E+A+K + S + E+ NE+ ++ K +H N+VK
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 578 LLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSR 637
G ++DE ++ E+ SL + + ++ L S+ +++ + +GL YLH
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLL--KSTNQTLTESQIAYVCKELLKGLEYLHS--- 116
Query: 638 LRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGL 697
IIHRD+KA+N+LL + K+ DFGL+ +VGT +M+PE
Sbjct: 117 NGIIHRDIKAANILLTSDGEVKLIDFGLSAQL---SDTKARNTMVGTPYWMAPEVINGKP 173
Query: 698 FSVKSDVFSFGVLVLEIICGK 718
+ K+D++S G+ +E+ GK
Sbjct: 174 YDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 1e-34
Identities = 82/252 (32%), Positives = 121/252 (48%), Gaps = 45/252 (17%)
Query: 524 KLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGM--EEFKNEVLLIAKLQHRNLVKLLGC 581
KLG G FG V+ G ++AVK L G+ M E F E ++ KL+H LV+L
Sbjct: 13 KLGAGQFGEVWMGTWNGTTKVAVKTLKPGT---MSPEAFLQEAQIMKKLRHDKLVQLYAV 69
Query: 582 CTQRDERMLIYEYLPNKSL-DYFIFDTTRS----KLLDWSKRSHIIAGIARGLLYLHQDS 636
C++ + ++ EY+ SL D+ + +L+D + A IA G+ YL
Sbjct: 70 CSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMA------AQIAEGMAYLE--- 120
Query: 637 RLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEA--NTKRVVGTYGYMSPEYAI 694
IHRDL A N+L+ + KI+DFGLAR D+ A K + + +PE A
Sbjct: 121 SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPI---KWTAPEAAN 177
Query: 695 DGLFSVKSDVFSFGVLVLEIIC-------GKKN--------RGF------NHADHDHNLL 733
G F++KSDV+SFG+L+ EI+ G N RG+ N + ++L+
Sbjct: 178 YGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELYDLM 237
Query: 734 GHAWRLWIEERP 745
W EERP
Sbjct: 238 LQCWDKDPEERP 249
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|237995 cd00028, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 3e-34
Identities = 51/123 (41%), Positives = 64/123 (52%), Gaps = 8/123 (6%)
Query: 52 QSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPLSDRSGVL 111
+ G+TLVS+ FELGFF Y I YK TV WVANRD P S S L
Sbjct: 2 NPLSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGS-SRTVVWVANRDNP-SGSSCTL 59
Query: 112 RINGERNGILVLLNSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDNILWQSF 171
+ +G LV+ + + VWSSN++ V L++ GNLV+ D N LWQSF
Sbjct: 60 TLQ--SDGNLVIYDGSGTVVWSSNTTRVNGNYVLVLLDDGNLVLYDSD----GNFLWQSF 113
Query: 172 DYP 174
DYP
Sbjct: 114 DYP 116
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. Length = 116 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 89/297 (29%), Positives = 132/297 (44%), Gaps = 47/297 (15%)
Query: 523 NKLGEGGFGPVYKGMLI-----EGQEIAVKRLSK-GSGQGMEEFKNEVLLIAKLQHRNLV 576
+LGEG FG V G+++AVK L+ G Q +F+ E+ ++ L H N+V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 577 KLLGCCTQRDER--MLIYEYLPNKSLDYFIFDT----TRSKLLDWSKRSHIIAGIARGLL 630
K G C + R LI EYLP+ SL ++ +LL +S + I +G+
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQ------ICKGMD 123
Query: 631 YLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR--SFGLDQTEANTKRVVGTYGYM 688
YL R IHRDL A N+L+++ KISDFGLA+ D + Y
Sbjct: 124 YLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY- 179
Query: 689 SPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHN-------LLGHAWRLWI 741
+PE FS SDV+SFGV + E+ F + D + ++G A I
Sbjct: 180 APECLRTSKFSSASDVWSFGVTLYEL--------FTYGDPSQSPPAEFLRMIGIAQGQMI 231
Query: 742 EERPLELIDQSLDNSCSFSEALRC----IQVGLLCVQQRPEDRPNMSSVVLMLSGER 794
R LEL L C + LC + P+DRP+ + ++L++ R
Sbjct: 232 VTRLLEL----LKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 78/217 (35%), Positives = 111/217 (51%), Gaps = 27/217 (12%)
Query: 519 FSEKNKLGEGGFGPVYKGMLI------EGQEIAVKRLSK-GSGQGMEEFKNEVLLIAKLQ 571
F E+ LGEG FG VYKG L +A+K L + + +EF+ E L++ LQ
Sbjct: 9 FLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQ 66
Query: 572 HRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIF-------------DTTRSKLLDWSKR 618
H N+V LLG CT+ +++EYL + L F+ D T LD S
Sbjct: 67 HPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDF 126
Query: 619 SHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS-FGLDQTEAN 677
HI IA G+ YL S +HRDL A N L+ + KISDFGL+R + D
Sbjct: 127 LHIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQ 183
Query: 678 TKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 714
+K ++ +M PE + G F+ +SD++SFGV++ EI
Sbjct: 184 SKSLLPVR-WMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 7e-32
Identities = 66/204 (32%), Positives = 106/204 (51%), Gaps = 11/204 (5%)
Query: 518 NFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLS--KGSGQGMEEFKNEVLLIAKLQHRN 574
N+ + +G G FG VYKG+ +E G +A+K++S K + ++ E+ L+ L+H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQ 634
+VK +G D +I EY N SL I + S + + + +GL YLH+
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQII---KKFGPFPESLVAVYVYQVLQGLAYLHE 117
Query: 635 DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAI 694
+IHRD+KA+N+L K++DFG+A L+ + VVGT +M+PE
Sbjct: 118 QG---VIHRDIKAANILTTKDGVVKLADFGVATK--LNDVSKDDASVVGTPYWMAPEVIE 172
Query: 695 DGLFSVKSDVFSFGVLVLEIICGK 718
S SD++S G V+E++ G
Sbjct: 173 MSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|214519 smart00108, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 3e-31
Identities = 52/122 (42%), Positives = 67/122 (54%), Gaps = 9/122 (7%)
Query: 52 QSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPLSDRSGVL 111
++ G+TLVS FELGFF+ Y I YK TV WVANRD P+SD S L
Sbjct: 2 NTLSSGQTLVSGNSLFELGFFTLIMQN-DYNLILYKSS-SRTVVWVANRDNPVSD-SCTL 58
Query: 112 RINGERNGILVLLNSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDNILWQSF 171
+ +G LVL + VWSSN++ + V L++ GNLV+ D + N LWQSF
Sbjct: 59 TLQ--SDGNLVLYDGDGRVVWSSNTTGANGNYVLVLLDDGNLVIYD----SDGNFLWQSF 112
Query: 172 DY 173
DY
Sbjct: 113 DY 114
|
Length = 114 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 126 bits (316), Expect = 3e-31
Identities = 80/283 (28%), Positives = 122/283 (43%), Gaps = 21/283 (7%)
Query: 518 NFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQH-R 573
++ KLGEG FG VY + +A+K L+K + +E F E+ ++A L H
Sbjct: 1 SYRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 574 NLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLH 633
N+VKL L+ EY+ SL+ + R L S+ I+A I L YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 634 QDSRLRIIHRDLKASNVLLD-NTMNPKISDFGLARSFGLDQTEAN----TKRVVGTYGYM 688
IIHRD+K N+LLD + K+ DFGLA+ + ++ VGT GYM
Sbjct: 119 ---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 689 SPEYAIDGLF---SVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERP 745
+PE + S SD++S G+ + E++ G + + P
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLK--IILELPTP 233
Query: 746 LELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788
S N S+A + LL P++R + SS +
Sbjct: 234 SLASPLSPSNPELISKAASDLLKKLLAKD--PKNRLSSSSDLS 274
|
Length = 384 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 9e-31
Identities = 79/285 (27%), Positives = 127/285 (44%), Gaps = 49/285 (17%)
Query: 518 NFSEKNKLGEGGFGPVYKGMLIEGQEI-AVKR--LSKGSGQGMEEFKNEVLLIAKLQHRN 574
+ ++G+G FG VY ++ +K LS S + E+ NEV ++ KL H N
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRS-------KLLDWSKRSHIIAGIAR 627
++K ++ + ++ EY L I + ++LDW +
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDW------FVQLCL 114
Query: 628 GLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGY 687
L YLH SR +I+HRD+K N+ L + K+ DFG+++ L T K VVGT Y
Sbjct: 115 ALKYLH--SR-KILHRDIKPQNIFLTSNGLVKLGDFGISKV--LSSTVDLAKTVVGTPYY 169
Query: 688 MSPE------YAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWI 741
+SPE Y + KSD++S G ++ E+ K H NLL A + I
Sbjct: 170 LSPELCQNKPY------NYKSDIWSLGCVLYELCTLK------HPFEGENLLELALK--I 215
Query: 742 EERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSV 786
+ I +S LR + LL Q+ PE+RP+++ +
Sbjct: 216 LKGQYPPI------PSQYSSELRNLVSSLL--QKDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 67/202 (33%), Positives = 114/202 (56%), Gaps = 22/202 (10%)
Query: 525 LGEGGFGPVYKGMLI-EGQ----EIAVKRLSKGSG-QGMEEFKNEVLLIAKLQHRNLVKL 578
LG G FG VYKG+ I EG+ +A+K L + + + +E +E ++A + H ++V+L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 579 LGCC-TQRDERMLIYEYLPNKSLDYFIF---DTTRSK-LLDWSKRSHIIAGIARGLLYLH 633
LG C + + LI + +P L ++ D S+ LL+W + IA+G+ YL
Sbjct: 75 LGICLSSQ--VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSYLE 126
Query: 634 QDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYA 693
+ R++HRDL A NVL+ + KI+DFGLA+ +D+ E + + +M+ E
Sbjct: 127 EK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESI 183
Query: 694 IDGLFSVKSDVFSFGVLVLEII 715
+ +++ KSDV+S+GV V E++
Sbjct: 184 LHRIYTHKSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 3e-30
Identities = 66/228 (28%), Positives = 110/228 (48%), Gaps = 27/228 (11%)
Query: 500 EEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGME 558
EE++ + D+ + + + K+GEG G VYK G+E+A+K++ + Q E
Sbjct: 2 EELKAALKDIVSEGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKM-RLRKQNKE 60
Query: 559 EFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKR 618
NE+L++ +H N+V DE ++ EY+ SL ++ +
Sbjct: 61 LIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTD---------IITQNFV 111
Query: 619 S---HIIAGIAR----GLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671
IA + R GL YLH +IHRD+K+ N+LL + K++DFG A
Sbjct: 112 RMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQL-- 166
Query: 672 DQTEANTKR--VVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICG 717
T+ +KR VVGT +M+PE + K D++S G++ +E+ G
Sbjct: 167 --TKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 3e-30
Identities = 63/196 (32%), Positives = 107/196 (54%), Gaps = 6/196 (3%)
Query: 519 FSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKL 578
F+ + KLG G FG V++G+ +A+K L ++F+ EV + +L+H++L+ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 579 LGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRL 638
C+ + +I E + SL F+ + ++L + + +A G+ YL +
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFL-RSPEGQVLPVASLIDMACQVAEGMAYLEEQ--- 123
Query: 639 RIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLF 698
IHRDL A N+L+ + K++DFGLAR D ++ K++ Y + +PE A G F
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHGTF 181
Query: 699 SVKSDVFSFGVLVLEI 714
S KSDV+SFG+L+ E+
Sbjct: 182 STKSDVWSFGILLYEM 197
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 71/241 (29%), Positives = 112/241 (46%), Gaps = 41/241 (17%)
Query: 517 DNFSEKNKLGEGGFGPVYKG---MLIEGQE---IAVKRLSKGSGQGMEE-FKNEVLLIAK 569
D K +LGEG FG V+ G L + +AVK L + + + F+ E L+
Sbjct: 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTN 64
Query: 570 LQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFI-----------------FDTTRSKL 612
QH N+VK G CT+ D ++++EY+ + L+ F+ + T S+L
Sbjct: 65 FQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQL 124
Query: 613 LDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672
L I IA G++YL + +HRDL N L+ + KI DFG++R D
Sbjct: 125 L------QIAVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR----D 171
Query: 673 QTEANTKRVVGT----YGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADH 728
+ RV G +M PE + F+ +SDV+SFGV++ EI K + ++
Sbjct: 172 VYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE 231
Query: 729 D 729
+
Sbjct: 232 E 232
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 5e-30
Identities = 64/202 (31%), Positives = 101/202 (50%), Gaps = 19/202 (9%)
Query: 524 KLGEGGFGPVYKGMLIE-GQEIAVKRL-SKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGC 581
LG+G G VYK G+ A+K++ G + ++ E+ + + +VK G
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 582 CTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIAR----GLLYLHQDSR 637
+ E ++ EY+ SL + K+ + ++A IAR GL YLH
Sbjct: 68 FYKEGEISIVLEYMDGGSLADLL-----KKVGKIPEP--VLAYIARQILKGLDYLHTK-- 118
Query: 638 LRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDG- 696
IIHRD+K SN+L+++ KI+DFG+++ L+ T VGT YMSPE I G
Sbjct: 119 RHIIHRDIKPSNLLINSKGEVKIADFGISKV--LENTLDQCNTFVGTVTYMSPE-RIQGE 175
Query: 697 LFSVKSDVFSFGVLVLEIICGK 718
+S +D++S G+ +LE GK
Sbjct: 176 SYSYAADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 9e-30
Identities = 86/284 (30%), Positives = 123/284 (43%), Gaps = 46/284 (16%)
Query: 523 NKLGEGGFGPVYKGMLIE--GQEI--AVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVK 577
+LG G FG V KG+ + G+E+ AVK L + G +EF E ++A+L H +V+
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 578 LLGCCTQRDERMLIYEYLPNKSLDYFIFD---TTRSKLLDWSKRSHIIAGIARGLLYLHQ 634
L+G C + + ML+ E P L ++ S L + + + +A G+ YL
Sbjct: 61 LIGVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQ------VAMGMAYLES 113
Query: 635 DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYG-----YMS 689
+HRDL A NVLL N KISDFG++R+ G T G + +
Sbjct: 114 K---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT----TAGRWPLKWYA 166
Query: 690 PEYAIDGLFSVKSDVFSFGVLVLEIIC--GKKNRGFNHADHDHNLLGHAWRLWIEERPLE 747
PE G FS KSDV+S+GV + E K A+ +L RL RP
Sbjct: 167 PECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEV-IAMLESGERL---PRP-- 220
Query: 748 LIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLS 791
C + L C + RPEDRP S +
Sbjct: 221 -------EECPQE----IYSIMLSCWKYRPEDRPTFSELESTFR 253
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 4e-29
Identities = 68/198 (34%), Positives = 102/198 (51%), Gaps = 14/198 (7%)
Query: 522 KNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGC 581
KLG G FG V++G+ +AVK L G+ ++F E ++ KL+H L++L
Sbjct: 11 LRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAV 69
Query: 582 CTQRDERMLIYEYLPNKSL-DYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRI 640
CT + ++ E + SL +Y R+ L + + A +A G+ YL +
Sbjct: 70 CTLEEPIYIVTELMKYGSLLEYLQGGAGRA--LKLPQLIDMAAQVASGMAYLEAQN---Y 124
Query: 641 IHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT---YGYMSPEYAIDGL 697
IHRDL A NVL+ K++DFGLAR D EA G + +PE A+
Sbjct: 125 IHRDLAARNVLVGENNICKVADFGLARVIKEDIYEARE----GAKFPIKWTAPEAALYNR 180
Query: 698 FSVKSDVFSFGVLVLEII 715
FS+KSDV+SFG+L+ EI+
Sbjct: 181 FSIKSDVWSFGILLTEIV 198
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|219774 pfam08276, PAN_2, PAN-like domain | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 8e-29
Identities = 38/67 (56%), Positives = 49/67 (73%), Gaps = 1/67 (1%)
Query: 366 CKHGDGFLEHKAVKLPDTRFSWVDKNITLWECKELCSKNCSCTAYANADVRGRGSGCLLW 425
C GDGFL +KLPDT + VD++I L EC++ C NCSCTAYA AD+RG GSGCL+W
Sbjct: 1 CGGGDGFLRLPNMKLPDTTAAIVDRSIGLKECEQRCLSNCSCTAYAYADIRG-GSGCLIW 59
Query: 426 FHDLIDI 432
+L+D+
Sbjct: 60 TGELVDM 66
|
Length = 66 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 75/212 (35%), Positives = 105/212 (49%), Gaps = 28/212 (13%)
Query: 525 LGEGGFGPVYKGMLI-------EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLV 576
LG G FG VY+G +AVK L KG+ Q +EF E L++ H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 577 KLLGCCTQRDERMLIYEYLPNKSLDYFIFD----TTRSKLLDWSKRSHIIAGIARGLLYL 632
KLLG C + + +I E + L ++ D LL + I +A+G +YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 633 HQDSRLRIIHRDLKASNVLL-----DNTMNPKISDFGLARSFGLDQTEANTKRVVGT--- 684
Q + IHRDL A N L+ D KI DFGLAR D +++ R G
Sbjct: 123 EQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR----DIYKSDYYRKEGEGLL 175
Query: 685 -YGYMSPEYAIDGLFSVKSDVFSFGVLVLEII 715
+M+PE +DG F+ +SDV+SFGVL+ EI+
Sbjct: 176 PVRWMAPESLLDGKFTTQSDVWSFGVLMWEIL 207
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 4e-28
Identities = 86/250 (34%), Positives = 124/250 (49%), Gaps = 42/250 (16%)
Query: 524 KLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCT 583
KLG G FG V+ G ++A+K L +GS E F E L+ +LQH LV+L T
Sbjct: 13 KLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT 71
Query: 584 QRDERMLIYEYLPNKSLDYFI-----FDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRL 638
Q + +I EY+ N SL F+ T +KL+D + A IA G+ ++ R
Sbjct: 72 Q-EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMA------AQIAEGMAFIE---RK 121
Query: 639 RIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTY--GYMSPEYAIDG 696
IHRDL+A+N+L+ T+ KI+DFGLAR L + T R + + +PE G
Sbjct: 122 NYIHRDLRAANILVSETLCCKIADFGLAR---LIEDNEYTAREGAKFPIKWTAPEAINYG 178
Query: 697 LFSVKSDVFSFGVLVLEIIC-------GKKN--------RGFNHADHD------HNLLGH 735
F++KSDV+SFG+L+ EI+ G N RG+ D + L+
Sbjct: 179 TFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYELMRL 238
Query: 736 AWRLWIEERP 745
W+ EERP
Sbjct: 239 CWKEKPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 67/197 (34%), Positives = 100/197 (50%), Gaps = 19/197 (9%)
Query: 522 KNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGC 581
+G+G FG V G GQ++AVK L K + F E ++ L+H NLV+LLG
Sbjct: 11 GATIGKGEFGDVMLGDY-RGQKVAVKCL-KDDSTAAQAFLAEASVMTTLRHPNLVQLLGV 68
Query: 582 CTQRDERMLIYEYLPNKSL-DYFIFDTTRSKLLDWSKRSHIIA-GIARGLLYLHQDSRLR 639
Q + ++ EY+ SL DY +R + + + A + G+ YL +
Sbjct: 69 VLQGNPLYIVTEYMAKGSLVDYL---RSRGRAVITLAQQLGFALDVCEGMEYLEEK---N 122
Query: 640 IIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTY--GYMSPEYAIDGL 697
+HRDL A NVL+ + K+SDFGLA+ EA+ + G + +PE +
Sbjct: 123 FVHRDLAARNVLVSEDLVAKVSDFGLAK-------EASQGQDSGKLPVKWTAPEALREKK 175
Query: 698 FSVKSDVFSFGVLVLEI 714
FS KSDV+SFG+L+ EI
Sbjct: 176 FSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 68/234 (29%), Positives = 100/234 (42%), Gaps = 47/234 (20%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKL-Q 571
D+F +GEG F V E +E A+K L K + ++ K E ++ +L
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 572 HRNLVKLLGCCTQRDERML--IYEYLPNKSLDYFI-------FDTTRSKLLDWSKRSHII 622
H ++KL T +DE L + EY PN L +I TR
Sbjct: 61 HPGIIKLY--YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTR----------FYA 108
Query: 623 AGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRV- 681
A I L YLH IIHRDLK N+LLD M+ KI+DFG A+ + + + K
Sbjct: 109 AEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDA 165
Query: 682 -----------------VGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGK 718
VGT Y+SPE + SD+++ G ++ +++ GK
Sbjct: 166 TNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 6e-27
Identities = 64/204 (31%), Positives = 99/204 (48%), Gaps = 24/204 (11%)
Query: 525 LGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLG 580
LG+G FG V + G+ A+K L K + +E E +++++ H +VKL
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59
Query: 581 CCTQRDERM-LIYEYLPNKSLDYFI-----FDTTRSKLLDWSKRSHIIAGIARGLLYLHQ 634
Q +E++ L+ EY P L + F R++ A I L YLH
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARF--------YAAEIVLALEYLH- 110
Query: 635 DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAI 694
L II+RDLK N+LLD + K++DFGLA+ + + NT GT Y++PE +
Sbjct: 111 --SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGTPEYLAPEVLL 166
Query: 695 DGLFSVKSDVFSFGVLVLEIICGK 718
+ D +S GVL+ E++ GK
Sbjct: 167 GKGYGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 6e-27
Identities = 80/241 (33%), Positives = 122/241 (50%), Gaps = 40/241 (16%)
Query: 512 IANATDNFSEKNKLGEGGFGPVYKGMLI------EGQEIAVKRLS-KGSGQGMEEFKNEV 564
I +T F E+ LGE FG VYKG L + Q +A+K L K G EEFK+E
Sbjct: 2 INLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEA 59
Query: 565 LLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIF-------------DTTRSK 611
++ ++LQH N+V LLG T+ +I+ Y + L F+ D T
Sbjct: 60 MMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKS 119
Query: 612 LLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671
L+ + HI+ IA G+ +L S ++H+DL NVL+ + +N KISD GL R
Sbjct: 120 TLEPADFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFR---- 172
Query: 672 DQTEANTKRVVGT----YGYMSPEYAIDGLFSVKSDVFSFGVLVLEII-------CGKKN 720
+ A+ +++G +MSPE + G FS+ SD++S+GV++ E+ CG N
Sbjct: 173 EVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN 232
Query: 721 R 721
+
Sbjct: 233 Q 233
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 82/274 (29%), Positives = 137/274 (50%), Gaps = 34/274 (12%)
Query: 524 KLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCT 583
++G G FG V+ G +E +++A+K + +G+ E+F E ++ KL H LV+L G CT
Sbjct: 11 EIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 584 QRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRS--HIIAGIARGLLYLHQDSRLRII 641
+R L++E++ + L ++ R++ +S+ + + + G+ YL + +I
Sbjct: 70 ERSPICLVFEFMEHGCLSDYL----RAQRGKFSQETLLGMCLDVCEGMAYLESSN---VI 122
Query: 642 HRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVK 701
HRDL A N L+ K+SDFG+ R F LD ++ + SPE +S K
Sbjct: 123 HRDLAARNCLVGENQVVKVSDFGMTR-FVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSK 181
Query: 702 SDVFSFGVLVLEIICGKK----NRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDNSC 757
SDV+SFGVL+ E+ K NR + N G RL+ +P L QS+
Sbjct: 182 SDVWSFGVLMWEVFSEGKTPYENRSNSEVVETIN-AGF--RLY---KP-RLASQSV---- 230
Query: 758 SFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLS 791
++ C ++RPEDRP+ S ++ L+
Sbjct: 231 --------YELMQHCWKERPEDRPSFSLLLHQLA 256
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 62/196 (31%), Positives = 103/196 (52%), Gaps = 10/196 (5%)
Query: 525 LGEGGFGPVYKGML-IEGQE---IAVKRLSKGSGQGME-EFKNEVLLIAKLQHRNLVKLL 579
+G G FG V +G L + G++ +A+K L GS +F E ++ + H N+++L
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71
Query: 580 GCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLR 639
G T+ M+I EY+ N SLD F+ + ++ GIA G+ YL S +
Sbjct: 72 GVVTKSRPVMIITEYMENGSLDKFL--RENDGKFTVGQLVGMLRGIASGMKYL---SEMN 126
Query: 640 IIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFS 699
+HRDL A N+L+++ + K+SDFGL+R + TK + +PE F+
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFT 186
Query: 700 VKSDVFSFGVLVLEII 715
SDV+SFG+++ E++
Sbjct: 187 SASDVWSFGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 80/296 (27%), Positives = 128/296 (43%), Gaps = 50/296 (16%)
Query: 515 ATDNFSEKNKLGEGGFGPVYKGMLI------EGQEIAVKRL-SKGSGQGMEEFKNEVLLI 567
D+ + LG G FG VY+G+ ++AVK L S Q +F E L++
Sbjct: 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIM 63
Query: 568 AKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDT----TRSKLLDWSKRSHIIA 623
+K H+N+V+L+G +R R ++ E + L F+ + R L
Sbjct: 64 SKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCAR 123
Query: 624 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNP----KISDFGLARS-FGLDQTEANT 678
+A+G YL ++ IHRD+ A N LL P KI+DFG+AR +
Sbjct: 124 DVAKGCKYLEEN---HFIHRDIAARNCLL-TCKGPGRVAKIADFGMARDIYRASYYRKGG 179
Query: 679 KRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-------GKKNRGFNHADHDHN 731
+ ++ +M PE +DG+F+ K+DV+SFGVL+ EI G+ N+
Sbjct: 180 RAML-PIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV------ME 232
Query: 732 LLGHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVV 787
+ RL + P ++ C Q PEDRPN ++++
Sbjct: 233 FVTGGGRL---DPPKGCPG-------------PVYRIMTDCWQHTPEDRPNFATIL 272
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 83/254 (32%), Positives = 124/254 (48%), Gaps = 28/254 (11%)
Query: 524 KLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCT 583
KLG G FG V+ G ++AVK L G+ ++ F E L+ LQH LV+L T
Sbjct: 13 KLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 584 QRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHR 643
+ + +I EY+ SL F+ K+L K A IA G+ Y+ R IHR
Sbjct: 72 KEEPIYIITEYMAKGSLLDFLKSDEGGKVL-LPKLIDFSAQIAEGMAYIE---RKNYIHR 127
Query: 644 DLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSD 703
DL+A+NVL+ ++ KI+DFGLAR ++ A + +PE G F++KSD
Sbjct: 128 DLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAINFGSFTIKSD 186
Query: 704 VFSFGVLVLEIIC-------GKKN--------RGF------NHADHDHNLLGHAWRLWIE 742
V+SFG+L+ EI+ G N RG+ N D ++++ W+ E
Sbjct: 187 VWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDIMKTCWKEKAE 246
Query: 743 ERP-LELIDQSLDN 755
ERP + + LD+
Sbjct: 247 ERPTFDYLQSVLDD 260
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 61/201 (30%), Positives = 104/201 (51%), Gaps = 10/201 (4%)
Query: 519 FSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVK 577
F KLGEG +G VYK + E GQ +A+K + + ++E E+ ++ + +VK
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP--VEEDLQEIIKEISILKQCDSPYIVK 62
Query: 578 LLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSR 637
G + + ++ EY S+ + +K L + + I+ +GL YLH
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSDIM--KITNKTLTEEEIAAILYQTLKGLEYLHS--- 117
Query: 638 LRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGL 697
+ IHRD+KA N+LL+ K++DFG+ S L T A V+GT +M+PE +
Sbjct: 118 NKKIHRDIKAGNILLNEEGQAKLADFGV--SGQLTDTMAKRNTVIGTPFWMAPEVIQEIG 175
Query: 698 FSVKSDVFSFGVLVLEIICGK 718
++ K+D++S G+ +E+ GK
Sbjct: 176 YNNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 5e-26
Identities = 71/201 (35%), Positives = 103/201 (51%), Gaps = 19/201 (9%)
Query: 525 LGEGGFGPV----YKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLL 579
LG+G FG V Y + G+ +AVK+L + + + +F+ E+ ++ LQH N+VK
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 580 GCCTQRDER--MLIYEYLPNKSL-DYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDS 636
G C R L+ EYLP SL DY R LD K + I +G+ YL
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRER---LDHRKLLLYASQICKGMEYL---G 125
Query: 637 RLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVG---TYGYMSPEYA 693
R +HRDL N+L+++ KI DFGL + D+ E R G + Y +PE
Sbjct: 126 SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK-EYYKVREPGESPIFWY-APESL 183
Query: 694 IDGLFSVKSDVFSFGVLVLEI 714
+ FSV SDV+SFGV++ E+
Sbjct: 184 TESKFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 5e-25
Identities = 66/216 (30%), Positives = 104/216 (48%), Gaps = 29/216 (13%)
Query: 518 NFSEKNKLGEGGFGPVY----KGMLIEGQE--IAVKRLSKGSGQGME-EFKNEVLLIAKL 570
N E LG G FG V+ KG+ EG E + VK L K + ++ EF+ E+ + KL
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65
Query: 571 QHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFI------FDTTRSKLLDWSKRSHIIAG 624
H+N+V+LLG C + + +I EY L F+ + + L ++ +
Sbjct: 66 SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125
Query: 625 IARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS------FGLDQTEANT 678
IA G+ +L S R +HRDL A N L+ + K+S L++ + L
Sbjct: 126 IALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPL 182
Query: 679 KRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 714
+ +++PE + FS KSDV+SFGVL+ E+
Sbjct: 183 R-------WLAPEAVQEDDFSTKSDVWSFGVLMWEV 211
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 69/213 (32%), Positives = 110/213 (51%), Gaps = 30/213 (14%)
Query: 525 LGEGGFGPVYKGM-LIEGQEIAVKR--LSKGSGQG-------MEEFKNEVLLIAKLQHRN 574
+G G FG VY GM G+ +AVK+ L S ++ E+ L+ +LQH N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSL-----DYFIFDTTRSKLLDWSKRSHIIAGIARGL 629
+V+ LG D + EY+P S+ +Y F+ T + + + I +GL
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR--------NFVRQILKGL 119
Query: 630 LYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD--QTEANTKR--VVGTY 685
YLH IIHRD+K +N+L+DN KISDFG+++ + T+ N R + G+
Sbjct: 120 NYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSV 176
Query: 686 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGK 718
+M+PE ++ K+D++S G LV+E++ GK
Sbjct: 177 FWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 6e-25
Identities = 66/198 (33%), Positives = 98/198 (49%), Gaps = 14/198 (7%)
Query: 525 LGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQ 584
LG G FG V+ G ++A+K + +G+ ++F E ++ KL H NLV+L G CT+
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 585 RDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRD 644
+ ++ EY+ N L ++ R L + + + + YL + IHRD
Sbjct: 71 QRPIFIVTEYMANGCLLNYL--RERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRD 125
Query: 645 LKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT---YGYMSPEYAIDGLFSVK 701
L A N L+ K+SDFGLAR DQ ++ GT + PE FS K
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ----GTKFPVKWAPPEVFDYSRFSSK 181
Query: 702 SDVFSFGVLVLEII-CGK 718
SDV+SFGVL+ E+ GK
Sbjct: 182 SDVWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 8e-25
Identities = 64/196 (32%), Positives = 105/196 (53%), Gaps = 11/196 (5%)
Query: 522 KNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLG 580
K+KLG G +G VY+G+ + +AVK L K +EEF E ++ +++H NLV+LLG
Sbjct: 11 KHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 69
Query: 581 CCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRI 640
CT+ +I E++ +L ++ + R ++ ++ I+ + YL + +
Sbjct: 70 VCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKKN---F 125
Query: 641 IHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTY--GYMSPEYAIDGLF 698
IHRDL A N L+ K++DFGL+R L + T + + +PE F
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLSR---LMTGDTYTAHAGAKFPIKWTAPESLAYNKF 182
Query: 699 SVKSDVFSFGVLVLEI 714
S+KSDV++FGVL+ EI
Sbjct: 183 SIKSDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 8e-25
Identities = 77/245 (31%), Positives = 120/245 (48%), Gaps = 32/245 (13%)
Query: 524 KLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCT 583
KLG G FG V+ G ++AVK L G+ E F E ++ KL+H LV+L +
Sbjct: 13 KLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAVVS 71
Query: 584 QRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHR 643
+ ++ EY+ SL F+ D + L + A +A G+ Y+ R+ IHR
Sbjct: 72 EE-PIYIVTEYMSKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHR 126
Query: 644 DLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTY--GYMSPEYAIDGLFSVK 701
DL+++N+L+ + + KI+DFGLAR L + T R + + +PE A+ G F++K
Sbjct: 127 DLRSANILVGDGLVCKIADFGLAR---LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 702 SDVFSFGVLVLEIIC-------GKKN--------RGFNHADHD------HNLLGHAWRLW 740
SDV+SFG+L+ E++ G N RG+ H L+ W+
Sbjct: 184 SDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELMLQCWKKD 243
Query: 741 IEERP 745
EERP
Sbjct: 244 PEERP 248
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 69/217 (31%), Positives = 108/217 (49%), Gaps = 38/217 (17%)
Query: 519 FSEKNKLGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQGMEEFKN--------EVLLIAK 569
+ + KLGEG +G VYK + EI A+K++ ++ + E+ L+ +
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIR------LDNEEEGIPSTALREISLLKE 54
Query: 570 LQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKL-LDWSKRSHIIAGIARG 628
L+H N+VKLL + L++EY + L ++ D L + K I+ + RG
Sbjct: 55 LKHPNIVKLLDVIHTERKLYLVFEYC-DMDLKKYL-DKRPGPLSPNLIK--SIMYQLLRG 110
Query: 629 LLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYM 688
L Y H RI+HRDLK N+L++ K++DFGLAR+FG+ T VV T Y
Sbjct: 111 LAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-TYTHEVV-TLWYR 165
Query: 689 SPE-------YAIDGLFSVKSDVFSFGVLVLEIICGK 718
+PE Y+ +V D++S G + E+I GK
Sbjct: 166 APEILLGSKHYST----AV--DIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 81/288 (28%), Positives = 117/288 (40%), Gaps = 53/288 (18%)
Query: 524 KLGEGGFGPVYKG----MLIEGQEIAVKRLSKGSGQG-MEEFKNEVLLIAKLQHRNLVKL 578
KLG+G FG V +G + +AVK L M++F E ++ L H NL++L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 579 LGCCTQRDERMLIYEYLPNKSLDYFIFDTTR---------SKLLDWSKRSHIIAGIARGL 629
G M++ E P SL D R S L D++ + IA G+
Sbjct: 62 YGVVLT-HPLMMVTELAPLGSL----LDRLRKDALGHFLISTLCDYAVQ------IANGM 110
Query: 630 LYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ----TEANTKRVVGTY 685
YL R IHRDL A N+LL + KI DFGL R+ ++ E + K +
Sbjct: 111 RYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV---PF 164
Query: 686 GYMSPEYAIDGLFSVKSDVFSFGVLVLEII--CGKKNRGFNHADHDHNLLGHAWRLWIEE 743
+ +PE FS SDV+ FGV + E+ + G + + + RL E
Sbjct: 165 AWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERL---E 221
Query: 744 RPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLS 791
RP +C V L C P DRP +++ L
Sbjct: 222 RP---------EACP----QDIYNVMLQCWAHNPADRPTFAALREFLP 256
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 4e-24
Identities = 75/245 (30%), Positives = 121/245 (49%), Gaps = 32/245 (13%)
Query: 524 KLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCT 583
KLG+G FG V+ G +A+K L G+ E F E ++ KL+H LV+L +
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 71
Query: 584 QRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHR 643
+ + ++ EY+ SL F+ K L + + A IA G+ Y+ R+ +HR
Sbjct: 72 E-EPIYIVTEYMSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 126
Query: 644 DLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTY--GYMSPEYAIDGLFSVK 701
DL+A+N+L+ + K++DFGLAR L + T R + + +PE A+ G F++K
Sbjct: 127 DLRAANILVGENLVCKVADFGLAR---LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 702 SDVFSFGVLVLEI---------------ICGKKNRGFNH------ADHDHNLLGHAWRLW 740
SDV+SFG+L+ E+ + + RG+ + H+L+ WR
Sbjct: 184 SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKE 243
Query: 741 IEERP 745
EERP
Sbjct: 244 PEERP 248
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 7e-24
Identities = 86/293 (29%), Positives = 137/293 (46%), Gaps = 52/293 (17%)
Query: 525 LGEGGFGPVYKGMLIEGQ------EIAVKRLSKGSGQG-MEEFKNEVLLIAKLQHRNLVK 577
LGEG FG V K + +AVK L + + + + +E L+ ++ H +++K
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 578 LLGCCTQRDERMLIYEYLPNKSLDYFIFDTTR-------------SKLLDWSKRSHIIAG 624
L G C+Q +LI EY SL F+ ++ + S LD + G
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 625 --------IARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEA 676
I+RG+ YL + ++++HRDL A NVL+ KISDFGL+R + + ++
Sbjct: 128 DLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRD--VYEEDS 182
Query: 677 NTKRVVG--TYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHD-HNLL 733
KR G +M+ E D +++ +SDV+SFGVL+ EI+ N A NLL
Sbjct: 183 YVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLL 242
Query: 734 GHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSV 786
+R+ ERP +C SE + + L C +Q P+ RP + +
Sbjct: 243 KTGYRM---ERP---------ENC--SEEMYNLM--LTCWKQEPDKRPTFADI 279
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 9e-24
Identities = 75/265 (28%), Positives = 116/265 (43%), Gaps = 34/265 (12%)
Query: 525 LGEGGFGPVY------KGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKL 578
LG+GGFG V G + +++ KRL K G+ M NE ++ K+ R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMA--LNEKKILEKVSSRFIVSL 58
Query: 579 LGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRL 638
+D+ L+ + L Y I++ ++ A I GL +LHQ
Sbjct: 59 AYAFETKDDLCLVMTLMNGGDLKYHIYNVG-EPGFPEARAIFYAAQIICGLEHLHQ---R 114
Query: 639 RIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLF 698
RI++RDLK NVLLD+ N +ISD GLA + K GT GYM+PE ++
Sbjct: 115 RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---IKGRAGTPGYMAPEVLQGEVY 171
Query: 699 SVKSDVFSFGVLVLEIICGK---KNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDN 755
D F+ G + E+I G+ + R + ++ R LE +++
Sbjct: 172 DFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEE-----------LKRRTLE---MAVEY 217
Query: 756 SCSFSEALRCIQVGLLCVQQRPEDR 780
FS + + LL + PE R
Sbjct: 218 PDKFSPEAKDLCEALLQ--KDPEKR 240
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 9e-24
Identities = 65/207 (31%), Positives = 105/207 (50%), Gaps = 15/207 (7%)
Query: 518 NFSEKNKLGEGGFGPVYKGML-IEGQEIAVKR--LSKGSGQGMEEFKNEVLLIAKLQHRN 574
+F NK+G+G FG V+K + + + A+K+ LSK + + EE +E ++AKL
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLD---WSKRSHIIAGIARGLLY 631
+++ + + ++ EY N L + L + W I GL +
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVW----RFFIQILLGLAH 116
Query: 632 LHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPE 691
LH +I+HRD+K+ N+ LD N KI D G+A+ + ANT +VGT Y+SPE
Sbjct: 117 LHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGTPYYLSPE 171
Query: 692 YAIDGLFSVKSDVFSFGVLVLEIICGK 718
D ++ KSDV++ GV++ E GK
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGK 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-23
Identities = 74/212 (34%), Positives = 104/212 (49%), Gaps = 25/212 (11%)
Query: 524 KLGEGGFGPVYKGMLI-----EGQEIAVKRLSK-GSGQGMEEFKNEVLLIAKLQHRNLVK 577
+LGE FG +YKG L Q +A+K L + Q EF+ E L+A+L H N+V
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 578 LLGCCTQRDERMLIYEYLPNKSLDYFIF--------------DTTRSKLLDWSKRSHIIA 623
LLG TQ +++EYL L F+ D T LD HI
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 624 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS-FGLDQTEANTKRVV 682
IA G+ YL S +H+DL A N+L+ ++ KISD GL+R + D K ++
Sbjct: 132 QIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188
Query: 683 GTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 714
+M PE + G FS SD++SFGV++ EI
Sbjct: 189 PIR-WMPPEAIMYGKFSSDSDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 59/199 (29%), Positives = 99/199 (49%), Gaps = 12/199 (6%)
Query: 524 KLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKN--EVLLIAKLQHRNLVKLLG 580
K+GEG +G VYK + G+ +A+K++ E+ L+ +L H N++KLL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 581 CCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRI 640
+ + L++E++ D + R + L S + + +GL + H I
Sbjct: 66 VFRHKGDLYLVFEFM---DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH---GI 119
Query: 641 IHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAI-DGLFS 699
+HRDLK N+L++ K++DFGLARSFG T VV T Y +PE + D +S
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPYTHYVV-TRWYRAPELLLGDKGYS 177
Query: 700 VKSDVFSFGVLVLEIICGK 718
D++S G + E++ +
Sbjct: 178 TPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 3e-23
Identities = 38/89 (42%), Positives = 50/89 (56%), Gaps = 8/89 (8%)
Query: 362 TPLDCKHG---DGFLEHKAVKLPDTRFSWVDKNITLWECKELCSKNCSCTAYANADVRGR 418
TPL+C DGFL+ VKLPD + I+L EC+E C NCSCTAYA +
Sbjct: 1 TPLNCGGDGSTDGFLKLPDVKLPDN--ASAITAISLEECREACLSNCSCTAYAYNNG--- 55
Query: 419 GSGCLLWFHDLIDIKELPESGQDLFIRMA 447
GCLLW L +++ L G L++R+A
Sbjct: 56 SGGCLLWNGLLNNLRSLSSGGGTLYLRLA 84
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 3e-23
Identities = 60/192 (31%), Positives = 93/192 (48%), Gaps = 6/192 (3%)
Query: 524 KLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGM-EEFKNEVLLIAKLQHRNLVKLLGCC 582
K+G+G FG VYKG+L E+AVK + +F E ++ + H N+VKL+G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 583 TQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIH 642
Q+ ++ E +P SL F+ + L K + A G+ YL + IH
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFL--RKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIH 116
Query: 643 RDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKS 702
RDL A N L+ KISDFG++R + + +PE G ++ +S
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSES 176
Query: 703 DVFSFGVLVLEI 714
DV+S+G+L+ E
Sbjct: 177 DVWSYGILLWET 188
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99 bits (250), Expect = 5e-23
Identities = 62/220 (28%), Positives = 107/220 (48%), Gaps = 41/220 (18%)
Query: 519 FSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKN--------EVLLIAK 569
+ + ++GEG +G VYK G+ +A+K++ ME K E+ L+ K
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIR------MENEKEGFPITAIREIKLLQK 54
Query: 570 LQHRNLVKLLGCCTQRDER--MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIAR 627
L+H N+V+L T + + +++EY+ + L + D+ K + S+ + +
Sbjct: 55 LRHPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLL-DSPEVKFTE-SQIKCYMKQLLE 111
Query: 628 GLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGY 687
GL YLH + I+HRD+K SN+L++N K++DFGLAR + + T RV+ T Y
Sbjct: 112 GLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWY 167
Query: 688 MSPE---------YAIDGLFSVKSDVFSFGVLVLEIICGK 718
PE + D++S G ++ E+ GK
Sbjct: 168 RPPELLLGATRYGPEV--------DMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 6e-23
Identities = 66/215 (30%), Positives = 110/215 (51%), Gaps = 29/215 (13%)
Query: 522 KNKLGEGGFGPVYKG---MLIEGQE---IAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNL 575
K +LGEG FG V+ L+ Q+ +AVK L + S ++F+ E L+ LQH+++
Sbjct: 10 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHI 69
Query: 576 VKLLGCCTQRDERMLIYEYLPNKSLDYFI-FDTTRSKLLDWSKRS-----------HIIA 623
V+ G CT+ ++++EY+ + L+ F+ +K+L + I +
Sbjct: 70 VRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129
Query: 624 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVG 683
IA G++YL + L +HRDL N L+ + KI DFG++R D + RV G
Sbjct: 130 QIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR----DIYSTDYYRVGG 182
Query: 684 ----TYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 714
+M PE + F+ +SD++SFGV++ EI
Sbjct: 183 RTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 7e-23
Identities = 69/208 (33%), Positives = 112/208 (53%), Gaps = 30/208 (14%)
Query: 525 LGEGGFGPVYKGM-LIEGQEIAVKRLS-----KGSGQGMEEFKNEVLLIAKLQHRNLVKL 578
LG G FG VY+G+ L +G AVK +S + + +++ + E+ L++KLQH N+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 579 LGCCTQRDERML-IY-EYLPNKSL-----DYFIFDTTRSKLLDWSKRSHIIAGIARGLLY 631
LG T+R+E L I+ E +P SL Y F +L ++++ I GL Y
Sbjct: 68 LG--TEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRL--YTRQ------ILLGLEY 117
Query: 632 LHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPE 691
LH +HRD+K +N+L+D K++DFG+A+ + K G+ +M+PE
Sbjct: 118 LHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQV---VEFSFAKSFKGSPYWMAPE 171
Query: 692 Y-AIDGLFSVKSDVFSFGVLVLEIICGK 718
A G + + +D++S G VLE+ GK
Sbjct: 172 VIAQQGGYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 56/203 (27%), Positives = 103/203 (50%), Gaps = 13/203 (6%)
Query: 519 FSEKNKLGEGGFGPVYKGMLIE-GQEIAVKR--LSKGSGQGMEEFKNEVLLIAKLQHRNL 575
F+ +G+G FG VYK + Q +A+K L + + +E+ + E+ +++ + +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDE-IEDIQQEIQFLSQCRSPYI 61
Query: 576 VKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQD 635
K G + + +I EY S D + LD + + I+ + GL YLH++
Sbjct: 62 TKYYGSFLKGSKLWIIMEYCGGGS----CLDLLKPGKLDETYIAFILREVLLGLEYLHEE 117
Query: 636 SRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAID 695
IHRD+KA+N+LL + K++DFG++ ++ NT VGT +M+PE
Sbjct: 118 ---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT--FVGTPFWMAPEVIKQ 172
Query: 696 GLFSVKSDVFSFGVLVLEIICGK 718
+ K+D++S G+ +E+ G+
Sbjct: 173 SGYDEKADIWSLGITAIELAKGE 195
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 2e-22
Identities = 80/293 (27%), Positives = 128/293 (43%), Gaps = 55/293 (18%)
Query: 525 LGEGGFGPVYKGMLIEG----QEIAVK--RLSKGSGQGMEEFKNEVLLIAKLQHRNLVKL 578
LGEG FG V +G L + ++AVK +L + +EEF +E + H N++KL
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 579 LGCCTQRDER------MLIYEYLPNKSLDYFIFDT---TRSKLLDWSKRSHIIAGIARGL 629
+G C + M+I ++ + L F+ + + L + IA G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 630 LYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS-FGLD---QTEANTKRVVGTY 685
YL S IHRDL A N +L M ++DFGL++ + D Q V
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV---- 179
Query: 686 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGF-------NHADHDHNLLGHAWR 738
+++ E D +++ KSDV++FGV + EI RG NH +D L H R
Sbjct: 180 KWIAIESLADRVYTSKSDVWAFGVTMWEIA----TRGQTPYPGVENHEIYD--YLRHGNR 233
Query: 739 LWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLS 791
L ++P + +D+ D S C + P+DRP + + +L
Sbjct: 234 L---KQPEDCLDELYDLMYS-------------CWRADPKDRPTFTKLREVLE 270
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 2e-22
Identities = 83/268 (30%), Positives = 133/268 (49%), Gaps = 42/268 (15%)
Query: 524 KLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCT 583
KLG G FG V+ + ++AVK + GS +E F E ++ LQH LVKL T
Sbjct: 13 KLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT 71
Query: 584 QRDERMLIYEYLPNKSL-DYFIFDTTRS----KLLDWSKRSHIIAGIARGLLYLHQDSRL 638
++ +I E++ SL D+ D KL+D+S A IA G+ ++ Q +
Sbjct: 72 -KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFS------AQIAEGMAFIEQRN-- 122
Query: 639 RIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTY--GYMSPEYAIDG 696
IHRDL+A+N+L+ ++ KI+DFGLAR + + T R + + +PE G
Sbjct: 123 -YIHRDLRAANILVSASLVCKIADFGLAR---VIEDNEYTAREGAKFPIKWTAPEAINFG 178
Query: 697 LFSVKSDVFSFGVLVLEIICGKKN--RGFNHADHDHNLLGHAWRLW-IEERPLELIDQSL 753
F++KSDV+SFG+L++EI+ + G ++ + L +R+ E P EL +
Sbjct: 179 SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA-LERGYRMPRPENCPEELYN--- 234
Query: 754 DNSCSFSEALRCIQVGLLCVQQRPEDRP 781
+ + C + RPE+RP
Sbjct: 235 --------------IMMRCWKNRPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 97.3 bits (243), Expect = 2e-22
Identities = 62/207 (29%), Positives = 96/207 (46%), Gaps = 16/207 (7%)
Query: 519 FSEKNKLGEGGFGPVYKGMLIEGQEIAV-KRLSKGSGQGMEEFK-----NEVLLIAKLQH 572
+ +G+G FG V K +I V K + G+ M E + +EV ++ +L+H
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGN---MTEKEKQQLVSEVNILRELKH 58
Query: 573 RNLVKLLGCCTQRD-ERMLIY-EYLPNKSLDYFIFDTTRSKL-LDWSKRSHIIAGIARGL 629
N+V+ R + + I EY L I + + ++ I+ + L
Sbjct: 59 PNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLAL 118
Query: 630 LYLH--QDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGY 687
H D ++HRDLK +N+ LD N K+ DFGLA+ G D + A T VGT Y
Sbjct: 119 YECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT--YVGTPYY 176
Query: 688 MSPEYAIDGLFSVKSDVFSFGVLVLEI 714
MSPE + KSD++S G L+ E+
Sbjct: 177 MSPEQLNHMSYDEKSDIWSLGCLIYEL 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 2e-22
Identities = 68/215 (31%), Positives = 103/215 (47%), Gaps = 25/215 (11%)
Query: 516 TDNFSEKNKLGEGGFGPVYKGMLIEGQ-EIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRN 574
D E+ LG+G +G VY + Q IA+K + + + ++ E+ L + L+HRN
Sbjct: 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRN 66
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDW----SKRSHII---AGIAR 627
+V+ LG ++ + E +P SL RSK W II I
Sbjct: 67 IVQYLGSDSENGFFKIFMEQVPGGSLS----ALLRSK---WGPLKDNEQTIIFYTKQILE 119
Query: 628 GLLYLHQDSRLRIIHRDLKASNVLLDNTMNP--KISDFGLARSFGLDQTEANTKRVVGTY 685
GL YLH +I+HRD+K NVL+ NT + KISDFG ++ L T+ GT
Sbjct: 120 GLKYLHD---NQIVHRDIKGDNVLV-NTYSGVVKISDFGTSKR--LAGINPCTETFTGTL 173
Query: 686 GYMSPEYAIDGL--FSVKSDVFSFGVLVLEIICGK 718
YM+PE G + +D++S G ++E+ GK
Sbjct: 174 QYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 2e-22
Identities = 70/201 (34%), Positives = 115/201 (57%), Gaps = 20/201 (9%)
Query: 525 LGEGGFGPVYKGMLI-EGQEI----AVKRLSKGSG-QGMEEFKNEVLLIAKLQHRNLVKL 578
LG G FG VYKG+ + EG+ + A+K L++ +G + EF +E L++A + H +LV+L
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 579 LGCCTQRDERMLIYEYLPNKSLDYFIF---DTTRSKLL-DWSKRSHIIAGIARGLLYLHQ 634
LG C + L+ + +P+ L ++ D S+LL +W + IA+G++YL +
Sbjct: 75 LGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLEE 127
Query: 635 DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAI 694
R++HRDL A NVL+ + + KI+DFGLAR D+ E N +M+ E
Sbjct: 128 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 184
Query: 695 DGLFSVKSDVFSFGVLVLEII 715
F+ +SDV+S+GV + E++
Sbjct: 185 YRKFTHQSDVWSYGVTIWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 3e-22
Identities = 74/209 (35%), Positives = 104/209 (49%), Gaps = 34/209 (16%)
Query: 525 LGEGGFG--------PVYKGMLIEGQEIAVKRLSKGSGQGMEE-FKNEVLLIAKLQHRNL 575
LGEG FG P G G+ +AVK L + GQ +K E+ ++ L H N+
Sbjct: 12 LGEGHFGKVSLYCYDPANDGT---GEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENI 68
Query: 576 VKLLGCCTQRDER--MLIYEYLPNKSL-DYFI-FDTTRSKLLDWSKRSHIIAGIARGLLY 631
VK GCC+++ + LI EY+P SL DY ++LL ++++ I G+ Y
Sbjct: 69 VKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQ------ICEGMAY 122
Query: 632 LHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYG----- 686
LH IHRDL A NVLLDN KI DFGLA++ E + V G
Sbjct: 123 LHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV----PEGHEYYRVREDGDSPVF 175
Query: 687 YMSPEYAIDGLFSVKSDVFSFGVLVLEII 715
+ + E + FS SDV+SFGV + E++
Sbjct: 176 WYAVECLKENKFSYASDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 3e-22
Identities = 72/224 (32%), Positives = 100/224 (44%), Gaps = 48/224 (21%)
Query: 525 LGEGGFGPVYKGMLI------EGQEIAVKRLSKGSG---------QGMEEFKNEVLLIAK 569
LGEG FG V K + E +AVK L K ME K +I K
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKML-KDDATEKDLSDLVSEMEMMK----MIGK 74
Query: 570 LQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAG----- 624
H+N++ LLG CTQ ++ EY + +L F+ R S
Sbjct: 75 --HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRAR-RPPGEYASPDDPRPPEETLTQ 131
Query: 625 ---------IARGLLYLHQDSRLRIIHRDLKASNVLL--DNTMNPKISDFGLARSFGLDQ 673
+ARG+ +L + IHRDL A NVL+ D+ M KI+DFGLAR +
Sbjct: 132 KDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVM--KIADFGLAR--DIHH 184
Query: 674 TEANTKRVVG--TYGYMSPEYAIDGLFSVKSDVFSFGVLVLEII 715
+ K G +M+PE D +++ +SDV+SFGVL+ EI
Sbjct: 185 IDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIF 228
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 6e-22
Identities = 60/206 (29%), Positives = 102/206 (49%), Gaps = 10/206 (4%)
Query: 516 TDNFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLS---KGSGQGMEEFKNEVLLIAKLQ 571
NF + K+G+G F VYK + L++G+ +A+K++ + ++ E+ L+ +L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 572 HRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSK-LLDWSKRSHIIAGIARGLL 630
H N++K L + +E ++ E L I + K L+ + L
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 631 YLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSP 690
++H RI+HRD+K +NV + T K+ D GL R F T A++ VGT YMSP
Sbjct: 121 HMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL--VGTPYYMSP 175
Query: 691 EYAIDGLFSVKSDVFSFGVLVLEIIC 716
E + ++ KSD++S G L+ E+
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAA 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 6e-22
Identities = 62/200 (31%), Positives = 112/200 (56%), Gaps = 17/200 (8%)
Query: 525 LGEGGFGPVYKGML-IEGQE---IAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLL 579
+G G FG V++G+L + G++ +A+K L G + + ++F +E ++ + H N+++L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 580 GCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWS--KRSHIIAGIARGLLYLHQDSR 637
G T+ M+I EY+ N +LD ++ R ++S + ++ GIA G+ YL S
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYL----RDHDGEFSSYQLVGMLRGIAAGMKYL---SD 125
Query: 638 LRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYG--YMSPEYAID 695
+ +HRDL A N+L+++ + K+SDFGL+R D E G + +PE
Sbjct: 126 MNYVHRDLAARNILVNSNLECKVSDFGLSRVLE-DDPEGTYTTSGGKIPIRWTAPEAIAY 184
Query: 696 GLFSVKSDVFSFGVLVLEII 715
F+ SDV+SFG+++ E++
Sbjct: 185 RKFTSASDVWSFGIVMWEVM 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 8e-22
Identities = 70/262 (26%), Positives = 127/262 (48%), Gaps = 30/262 (11%)
Query: 525 LGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQG-MEEFKNEVLLIAKLQH---RNLVKLL 579
+G G +G VY+G + G+ +A+K ++ + + + + EV L+++L+ N+ K
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 580 GCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLR 639
G + +I EY S+ + ++ + S II + L Y+H+
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSVRTLM----KAGPIAEKYISVIIREVLVALKYIHKVG--- 121
Query: 640 IIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDG-LF 698
+IHRD+KA+N+L+ NT N K+ DFG+A L+Q + VGT +M+PE +G +
Sbjct: 122 VIHRDIKAANILVTNTGNVKLCDFGVAAL--LNQNSSKRSTFVGTPYWMAPEVITEGKYY 179
Query: 699 SVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDNSCS 758
K+D++S G+ + E+ G ++D D A L + +P L D
Sbjct: 180 DTKADIWSLGITIYEMATGNP----PYSDVD---AFRAMMLIPKSKPPRLEDN------G 226
Query: 759 FSEALRCIQVGLLCVQQRPEDR 780
+S+ LR C+ + P++R
Sbjct: 227 YSKLLREFVAA--CLDEEPKER 246
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 2e-21
Identities = 67/207 (32%), Positives = 107/207 (51%), Gaps = 14/207 (6%)
Query: 518 NFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRL---SKGSGQGMEEFKNEVLLIAKLQHR 573
++++ K+GEG +G VYKG GQ +A+K++ S+ G + E+ L+ +LQH
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIR-EISLLKELQHP 59
Query: 574 NLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRS-KLLDWSKRSHIIAGIARGLLYL 632
N+V L Q LI+E+L Y D+ + +D + I +G+L+
Sbjct: 60 NIVCLQDVLMQESRLYLIFEFLSMDLKKYL--DSLPKGQYMDAELVKSYLYQILQGILFC 117
Query: 633 HQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEY 692
H R++HRDLK N+L+DN K++DFGLAR+FG+ T VV T Y +PE
Sbjct: 118 H---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGI-PVRVYTHEVV-TLWYRAPEV 172
Query: 693 AIDG-LFSVKSDVFSFGVLVLEIICGK 718
+ +S D++S G + E+ K
Sbjct: 173 LLGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 59/214 (27%), Positives = 99/214 (46%), Gaps = 37/214 (17%)
Query: 525 LGEGGFGPVYKGMLI------EGQEIAVKRLSKGSGQGME-EFKNEVLLIAKLQHRNLVK 577
LG+G FG VY+G+ +A+K +++ + EF NE ++ + ++V+
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 578 LLGCCTQRDERMLIYEYL-------------PNKSLDYFIFDTTRSKLLDWSKRSHIIAG 624
LLG + +++ E + P + + T K + + A
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMA------AE 127
Query: 625 IARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
IA G+ YL + +HRDL A N ++ + KI DFG+ R D E + R G
Sbjct: 128 IADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTR----DIYETDYYRKGGK 180
Query: 685 ----YGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 714
+M+PE DG+F+ KSDV+SFGV++ E+
Sbjct: 181 GLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEM 214
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 2e-21
Identities = 63/204 (30%), Positives = 101/204 (49%), Gaps = 19/204 (9%)
Query: 525 LGEGGFGPVYKGMLIE-GQEIAVKR-----LSKGSGQGMEEFKNEVLLIAKLQHRNLVKL 578
LG+G FG VY ++ G+E+AVK+ S + + + + E+ L+ LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 579 LGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRL 638
GC + + EY+P S+ + L + R + I G+ YLH +
Sbjct: 70 YGCLRDDETLSIFMEYMPGGSVKDQL--KAYGALTETVTRKYT-RQILEGVEYLHSN--- 123
Query: 639 RIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT----EANTKRVVGTYGYMSPEYAI 694
I+HRD+K +N+L D+ N K+ DFG ++ QT K V GT +MSPE
Sbjct: 124 MIVHRDIKGANILRDSAGNVKLGDFGASKRL---QTICSSGTGMKSVTGTPYWMSPEVIS 180
Query: 695 DGLFSVKSDVFSFGVLVLEIICGK 718
+ K+DV+S G V+E++ K
Sbjct: 181 GEGYGRKADVWSVGCTVVEMLTEK 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 94.0 bits (233), Expect = 3e-21
Identities = 77/256 (30%), Positives = 127/256 (49%), Gaps = 33/256 (12%)
Query: 524 KLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCT 583
KLG+G FG V+ G ++A+K L G+ E F E ++ KL+H LV L +
Sbjct: 13 KLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS 71
Query: 584 QRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHR 643
+ + ++ E++ SL F+ + K L + + A IA G+ Y+ R+ IHR
Sbjct: 72 E-EPIYIVTEFMGKGSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIE---RMNYIHR 126
Query: 644 DLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTY--GYMSPEYAIDGLFSVK 701
DL+A+N+L+ + + KI+DFGLAR L + T R + + +PE A+ G F++K
Sbjct: 127 DLRAANILVGDNLVCKIADFGLAR---LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 702 SDVFSFGVLVLEIICGKK---------------NRGFNH------ADHDHNLLGHAWRLW 740
SDV+SFG+L+ E++ + RG+ + H L+ W+
Sbjct: 184 SDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMKLCWKKD 243
Query: 741 IEERP-LELIDQSLDN 755
+ERP E I L++
Sbjct: 244 PDERPTFEYIQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 4e-21
Identities = 70/272 (25%), Positives = 119/272 (43%), Gaps = 38/272 (13%)
Query: 525 LGEGGFGPVYK------GMLIEGQEIAVKRLSKGSGQG-MEEFKNEVLLIAKLQHRNLVK 577
LG G F Y+ G L+ +++ R + + +E + E+ L+A+L H ++++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 578 LLGCCTQRDERMLIYEYLPNKSL-----DYFIFDTTRSKLLDWSKRSHIIAGIARGLLYL 632
+LG + L E++ S+ Y F + + RGL YL
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVI--------INYTEQLLRGLSYL 119
Query: 633 HQDSRLRIIHRDLKASNVLLDNT-MNPKISDFGLARSFGLDQTEAN--TKRVVGTYGYMS 689
H++ +IIHRD+K +N+L+D+T +I+DFG A T A +++GT +M+
Sbjct: 120 HEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMA 176
Query: 690 PEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELI 749
PE + DV+S G +++E+ K +H L I
Sbjct: 177 PEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWN-AEKHSNHLALIFKIASATTAPS---I 232
Query: 750 DQSLDNSCSFSEALRCIQVGLLCVQQRPEDRP 781
+ L S LR V L C++ +PEDRP
Sbjct: 233 PEHL------SPGLR--DVTLRCLELQPEDRP 256
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 94.6 bits (235), Expect = 4e-21
Identities = 76/225 (33%), Positives = 114/225 (50%), Gaps = 34/225 (15%)
Query: 517 DNFSEKNKLGEGGFGPVYK----GMLIEGQE----IAVKRLS-KGSGQGMEEFKNEVLLI 567
D LGEG FG V + G+ + +AVK L + + + + +E+ L+
Sbjct: 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELM 71
Query: 568 AKL-QHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFI-----------FDTTRS--KLL 613
+ +H+N++ LLG CTQ +I EY +L F+ FD T+ + L
Sbjct: 72 KLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQL 131
Query: 614 DWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLL--DNTMNPKISDFGLARSFGL 671
+ +ARG+ YL +SR R IHRDL A NVL+ DN M KI+DFGLAR G+
Sbjct: 132 SFKDLVSCAYQVARGMEYL--ESR-RCIHRDLAARNVLVTEDNVM--KIADFGLAR--GV 184
Query: 672 DQTEANTKRVVGTY--GYMSPEYAIDGLFSVKSDVFSFGVLVLEI 714
+ K G +M+PE D +++ +SDV+SFG+L+ EI
Sbjct: 185 HDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEI 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 6e-21
Identities = 69/223 (30%), Positives = 107/223 (47%), Gaps = 39/223 (17%)
Query: 518 NFSEKNKLGEGGFGPVYKGM---LIEGQE---IAVKRLSKGSGQGMEEFKNEVLLIAKLQ 571
N K +LGEG FG V+ L Q+ +AVK L S ++F E L+ LQ
Sbjct: 6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ 65
Query: 572 HRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFI----------------FDTTRSKLLDW 615
H ++VK G C + D ++++EY+ + L+ F+ + T+S++L
Sbjct: 66 HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQML-- 123
Query: 616 SKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE 675
HI IA G++YL + +HRDL N L+ + KI DFG++R D
Sbjct: 124 ----HIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR----DVYS 172
Query: 676 ANTKRVVG----TYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 714
+ RV G +M PE + F+ +SDV+S GV++ EI
Sbjct: 173 TDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEI 215
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 6e-21
Identities = 83/292 (28%), Positives = 138/292 (47%), Gaps = 47/292 (16%)
Query: 522 KNKLGEGGFGPVYKGMLIEG---QEIAVKRLSK-GSGQGMEEFKNEVLLIAKL-QHRNLV 576
++ +GEG FG V K + + + A+KR+ + S +F E+ ++ KL H N++
Sbjct: 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71
Query: 577 KLLGCCTQRDERMLIYEYLPNKSL-DY------------FIFDTTRSKLLDWSKRSHIIA 623
LLG C R L EY P+ +L D+ F + + L + H A
Sbjct: 72 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131
Query: 624 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVG 683
+ARG+ YL Q + IHRDL A N+L+ KI+DFGL+R E K+ +G
Sbjct: 132 DVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRG-----QEVYVKKTMG 183
Query: 684 TYG--YMSPEYAIDGLFSVKSDVFSFGVLVLEIIC--GKKNRGFNHADHDHNLLGHAWRL 739
+M+ E +++ SDV+S+GVL+ EI+ G G A+ + L +RL
Sbjct: 184 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL-YEKLPQGYRL 242
Query: 740 WIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLS 791
E+PL D+ D + C +++P +RP+ + +++ L+
Sbjct: 243 ---EKPLNCDDEVYD-------------LMRQCWREKPYERPSFAQILVSLN 278
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 6e-21
Identities = 80/275 (29%), Positives = 128/275 (46%), Gaps = 42/275 (15%)
Query: 524 KLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCT 583
+LG G FG V G ++A+K + +GS +EF E ++ KL H LV+L G CT
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 584 QRDERMLIYEYLPNKSLDYFIFDTTR----SKLLDWSKRSHIIAGIARGLLYLHQDSRLR 639
++ ++ EY+ N L ++ + + S+LL+ K + G+ YL +
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCK------DVCEGMAYLESK---Q 120
Query: 640 IIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT---YGYMSPEYAIDG 696
IHRDL A N L+D+ K+SDFGL+R + LD ++ VG+ + PE +
Sbjct: 121 FIHRDLAARNCLVDDQGCVKVSDFGLSR-YVLDDEYTSS---VGSKFPVRWSPPEVLLYS 176
Query: 697 LFSVKSDVFSFGVLVLEIIC-GKK--NRGFNHADHDHNLLGHAWRLWIEERPLELIDQSL 753
FS KSDV++FGVL+ E+ GK R N + G RL+ RP +
Sbjct: 177 KFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGL--RLY---RPHLASE--- 228
Query: 754 DNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788
+ + C ++ E+RP ++
Sbjct: 229 ----------KVYAIMYSCWHEKAEERPTFQQLLS 253
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 7e-21
Identities = 61/202 (30%), Positives = 97/202 (48%), Gaps = 18/202 (8%)
Query: 523 NKLGEGGFGPVYKGMLI--EGQEIAVKRLSKGSGQGMEEFKN---EVLLIAKLQHRNLVK 577
+LG G G V K +L G+ +AVK + K E+ ++ K +V
Sbjct: 7 GELGAGNSGVVSK-VLHRPTGKIMAVKTIR--LEINEAIQKQILRELDILHKCNSPYIVG 63
Query: 578 LLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSR 637
G + + EY+ SLD + + I + +GL YLH +
Sbjct: 64 FYGAFYNNGDISICMEYMDGGSLDKIL--KEVQGRIPERILGKIAVAVLKGLTYLH--EK 119
Query: 638 LRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGL 697
+IIHRD+K SN+L+++ K+ DFG++ L + A T VGT YM+PE I G
Sbjct: 120 HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQ--LVNSLAKT--FVGTSSYMAPE-RIQGN 174
Query: 698 -FSVKSDVFSFGVLVLEIICGK 718
+SVKSD++S G+ ++E+ G+
Sbjct: 175 DYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 8e-21
Identities = 58/208 (27%), Positives = 111/208 (53%), Gaps = 10/208 (4%)
Query: 512 IANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKL 570
I + ++ K+G+G G V+ + + GQE+A+K+++ E NE+L++ +L
Sbjct: 14 IGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKEL 73
Query: 571 QHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLL 630
++ N+V L DE ++ EYL SL D +D ++ + + + L
Sbjct: 74 KNPNIVNFLDSFLVGDELFVVMEYLAGGSLT----DVVTETCMDEAQIAAVCRECLQALE 129
Query: 631 YLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSP 690
+LH + ++IHRD+K+ NVLL + K++DFG +Q++ +T +VGT +M+P
Sbjct: 130 FLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAP 184
Query: 691 EYAIDGLFSVKSDVFSFGVLVLEIICGK 718
E + K D++S G++ +E++ G+
Sbjct: 185 EVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 8e-21
Identities = 62/230 (26%), Positives = 105/230 (45%), Gaps = 41/230 (17%)
Query: 517 DNFSEKNKLGEGGFGPVYKGM---LIEGQE---IAVKRLSKGSGQGME-EFKNEVLLIAK 569
+N +G+G FG V++ L+ + +AVK L + + M+ +F+ E L+A+
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 64
Query: 570 LQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSH--------- 620
H N+VKLLG C L++EY+ L+ F+ + S +
Sbjct: 65 FDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124
Query: 621 ----------IIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS-- 668
I +A G+ YL S + +HRDL N L+ M KI+DFGL+R+
Sbjct: 125 LPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 181
Query: 669 ----FGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 714
+ + +A R +M PE ++ +SDV+++GV++ EI
Sbjct: 182 SADYYKASENDAIPIR------WMPPESIFYNRYTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 8e-21
Identities = 64/218 (29%), Positives = 106/218 (48%), Gaps = 28/218 (12%)
Query: 522 KNKLGEGGFGPVY----KGML---------IEGQE--IAVKRL-SKGSGQGMEEFKNEVL 565
K KLGEG FG V+ +G+ +GQ +AVK L + + +F E+
Sbjct: 10 KEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIK 69
Query: 566 LIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFD-TTRSKL--------LDWS 616
++++L++ N+++LLG C D +I EY+ N L+ F+ S + +
Sbjct: 70 IMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIA 129
Query: 617 KRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEA 676
++ IA G+ YL + L +HRDL N L+ N KI+DFG++R+
Sbjct: 130 NLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYR 186
Query: 677 NTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 714
R V +M+ E + G F+ SDV++FGV + E+
Sbjct: 187 IQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEM 224
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 9e-21
Identities = 67/225 (29%), Positives = 105/225 (46%), Gaps = 30/225 (13%)
Query: 522 KNKLGEGGFGPVYKGMLI------EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNL 575
K +LGEG FG V+ + +AVK L + ++F+ E L+ LQH ++
Sbjct: 10 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 69
Query: 576 VKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKL-------------LDWSKRSHII 622
VK G C D ++++EY+ + L+ F+ + L S+ HI
Sbjct: 70 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129
Query: 623 AGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVV 682
+ IA G++YL + +HRDL N L+ + KI DFG++R D + RV
Sbjct: 130 SQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR----DVYSTDYYRVG 182
Query: 683 G----TYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGF 723
G +M PE + F+ +SDV+SFGV++ EI K F
Sbjct: 183 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWF 227
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 1e-20
Identities = 66/206 (32%), Positives = 103/206 (50%), Gaps = 16/206 (7%)
Query: 523 NKLGEGGFGPVYKGMLIEGQEIAVKRLS------KGSGQGMEEFKNEVLLIAKLQHRNLV 576
LG+G +G VY G+ +GQ IAVK++ + + E+ + EV L+ L+H N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 577 KLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDS 636
+ LG C + + E++P S+ + R L I G+ YLH +
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSIL---NRFGPLPEPVFCKYTKQILDGVAYLHNNC 122
Query: 637 RLRIIHRDLKASNVLLDNTMNPKISDFGLARSF---GLDQTEANT-KRVVGTYGYMSPEY 692
++HRD+K +NV+L K+ DFG AR GL T +N K + GT +M+PE
Sbjct: 123 ---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179
Query: 693 AIDGLFSVKSDVFSFGVLVLEIICGK 718
+ + KSD++S G V E+ GK
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 1e-20
Identities = 63/193 (32%), Positives = 101/193 (52%), Gaps = 11/193 (5%)
Query: 524 KLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCT 583
+LG G FG V+ G ++A+K +++G+ E+F E ++ KL H LV+L G CT
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 584 QRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRS--HIIAGIARGLLYLHQDSRLRII 641
Q+ ++ E++ N L ++ R + SK + + G+ YL ++S I
Sbjct: 70 QQKPLYIVTEFMENGCLLNYL----RQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FI 122
Query: 642 HRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVK 701
HRDL A N L+ +T K+SDFG+ R + LD ++ + PE +S K
Sbjct: 123 HRDLAARNCLVSSTGVVKVSDFGMTR-YVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSK 181
Query: 702 SDVFSFGVLVLEI 714
SDV+SFGVL+ E+
Sbjct: 182 SDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 1e-20
Identities = 59/211 (27%), Positives = 102/211 (48%), Gaps = 25/211 (11%)
Query: 525 LGEGGFGPVYKGMLIE-GQEIAVKRLS---------KGSGQGM-EEFKNEVLLIAKLQHR 573
+G+G +G VY + + G+ +AVK++ + M + ++E+ + L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 574 NLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLH 633
N+V+ LG T + + EY+P S+ + R + + GL YLH
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGR---FEEQLVRFFTEQVLEGLAYLH 125
Query: 634 QDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG--LDQTEANTKRVVGTYGYMSPE 691
I+HRDLKA N+L+D KISDFG+++ D + + + G+ +M+PE
Sbjct: 126 SKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQ--GSVFWMAPE 180
Query: 692 YAIDGL---FSVKSDVFSFGVLVLEIICGKK 719
I +S K D++S G +VLE+ G++
Sbjct: 181 -VIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 76/267 (28%), Positives = 125/267 (46%), Gaps = 27/267 (10%)
Query: 523 NKLGEGGFGPVYKGM-LIEGQEIAVK--RLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLL 579
NK+G G FG VY + L G+ +AVK R+ + ++E +E+ ++ L+H NLVK
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 580 GCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLR 639
G R++ + EY +L+ + ++LD + GL YLH
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELLEHG---RILDEHVIRVYTLQLLEGLAYLHSH---G 119
Query: 640 IIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANT--KRVVGTYGYMSPEYAIDGL 697
I+HRD+K +N+ LD+ K+ DFG A + T + + GT YM+PE G
Sbjct: 120 IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGK 179
Query: 698 FSVK---SDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLD 754
+D++S G +VLE+ GK R ++ D++ ++ H + +P I SL
Sbjct: 180 GKGHGRAADIWSLGCVVLEMATGK--RPWSELDNEFQIMFH---VGAGHKP--PIPDSLQ 232
Query: 755 NSCSFSEALRCIQVGLLCVQQRPEDRP 781
S E + C++ P+ RP
Sbjct: 233 LS---PEGKDFLD---RCLESDPKKRP 253
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 3e-20
Identities = 66/209 (31%), Positives = 99/209 (47%), Gaps = 18/209 (8%)
Query: 517 DNFSEKNKLGEGGFGPVYKGM---LIEGQ---EIAVKRL-SKGSGQGMEEFKNEVLLIAK 569
+N S LG G FG V + L + ++AVK L E +E+ +++
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 570 L-QHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARG 628
L H N+V LLG CT ++I EY L F+ R L +A+G
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFL-RRKRESFLTLEDLLSFSYQVAKG 153
Query: 629 LLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ---TEANTKRVVGTY 685
+ +L + IHRDL A NVLL + KI DFGLAR D + N + V
Sbjct: 154 MAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPV--- 207
Query: 686 GYMSPEYAIDGLFSVKSDVFSFGVLVLEI 714
+M+PE + +++ +SDV+S+G+L+ EI
Sbjct: 208 KWMAPESIFNCVYTFESDVWSYGILLWEI 236
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 3e-20
Identities = 64/198 (32%), Positives = 97/198 (48%), Gaps = 23/198 (11%)
Query: 525 LGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGME-EFKNEVLLIAKLQHRNLVKLLGCCT 583
LG+G FG V+KG L + +AVK + Q ++ +F +E ++ + H N+VKL+G CT
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 584 QRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHR 643
QR ++ E +P D+ F + L + A G+ YL + IHR
Sbjct: 63 QRQPIYIVMELVPGG--DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHR 117
Query: 644 DLKASNVLLDNTMNPKISDFGLAR--------SFGLDQTEANTKRVVGTYGYMSPEYAID 695
DL A N L+ KISDFG++R S GL Q + +PE
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIK---------WTAPEALNY 168
Query: 696 GLFSVKSDVFSFGVLVLE 713
G +S +SDV+S+G+L+ E
Sbjct: 169 GRYSSESDVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 3e-20
Identities = 59/212 (27%), Positives = 110/212 (51%), Gaps = 18/212 (8%)
Query: 512 IANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKL 570
+ + ++ K+G+G G VY + + GQE+A+K+++ E NE+L++ +
Sbjct: 14 VGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMREN 73
Query: 571 QHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLL 630
+H N+V L DE ++ EYL SL + +T + IA + R L
Sbjct: 74 KHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDE--------GQIAAVCRECL 125
Query: 631 ----YLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYG 686
+LH + ++IHRD+K+ N+LL + K++DFG +Q++ +T +VGT
Sbjct: 126 QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPY 180
Query: 687 YMSPEYAIDGLFSVKSDVFSFGVLVLEIICGK 718
+M+PE + K D++S G++ +E++ G+
Sbjct: 181 WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 3e-20
Identities = 80/266 (30%), Positives = 118/266 (44%), Gaps = 33/266 (12%)
Query: 525 LGEGGFGPVYK-GMLIEGQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLG 580
LG+GGFG V M G+ A K+L+K +G E E ++AK+ R +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 581 CCTQRDERMLIYEYLPNKSLDYFIFDTTRSKL-LDWSKRSHIIAGIARGLLYLHQDSRLR 639
+ + L+ + L Y I++ + A I GL +LHQ R
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---R 117
Query: 640 IIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFS 699
II+RDLK NVLLDN N +ISD GLA Q++ TK GT G+M+PE +
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TKGYAGTPGFMAPELLQGEEYD 175
Query: 700 VKSDVFSFGVLVLEIICGK---KNRGFNHADHDHNLLGHAWRLWIEERPLE--LIDQSLD 754
D F+ GV + E+I + + RG +E + L+ +++ S+
Sbjct: 176 FSVDYFALGVTLYEMIAARGPFRARGEK----------------VENKELKQRILNDSVT 219
Query: 755 NSCSFSEALRCIQVGLLCVQQRPEDR 780
FS A + LL + PE R
Sbjct: 220 YPDKFSPASKSFCEALL--AKDPEKR 243
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 3e-20
Identities = 72/238 (30%), Positives = 108/238 (45%), Gaps = 39/238 (16%)
Query: 518 NFSEKNKLGEGGFGPVY-----------------KGMLIEGQEIAVKRLSKG-SGQGMEE 559
NF EK LGEG FG V+ +AVK L S E+
Sbjct: 8 NFVEK--LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARED 65
Query: 560 FKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFI--------FDTTRSK 611
F EV ++++L N+ +LLG CT +I EY+ N L+ F+ SK
Sbjct: 66 FLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSK 125
Query: 612 LLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671
L +S ++ IA G+ YL L +HRDL N L+ KI+DFG++R+
Sbjct: 126 SLSFSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNL-- 180
Query: 672 DQTEANTKRVVGT----YGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725
++ RV G +M+ E + G F+ KSDV++FGV + EI+ + + + H
Sbjct: 181 --YSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH 236
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 4e-20
Identities = 64/212 (30%), Positives = 107/212 (50%), Gaps = 29/212 (13%)
Query: 518 NFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKN-----EVLLIAKLQ 571
+ + KLGEG + VYK E G+ +A+K++ G + ++ N E+ L+ +L+
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 572 HRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHI---IAGIARG 628
H N++ LL + L++E++ L+ I + K + + + I + RG
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFMET-DLEKVI----KDKSIVLTP-ADIKSYMLMTLRG 114
Query: 629 LLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYM 688
L YLH I+HRDLK +N+L+ + K++DFGLARSFG T +VV T Y
Sbjct: 115 LEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFG-SPNRKMTHQVV-TRWYR 169
Query: 689 SPEYAIDGLFSVKS-----DVFSFGVLVLEII 715
+PE LF + D++S G + E++
Sbjct: 170 APEL----LFGARHYGVGVDMWSVGCIFAELL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 5e-20
Identities = 61/223 (27%), Positives = 99/223 (44%), Gaps = 28/223 (12%)
Query: 514 NATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKL-QH 572
+ T F +GEG +G VYK + ++ ++ EE K E ++ K H
Sbjct: 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNH 62
Query: 573 RNLVKLLGCCTQR------DERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKR------SH 620
N+ G ++ D+ L+ E S + D + L KR ++
Sbjct: 63 PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGS----VTDLVK-GLRKKGKRLKEEWIAY 117
Query: 621 IIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKR 680
I+ RGL YLH++ ++IHRD+K N+LL K+ DFG++ LD T
Sbjct: 118 ILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQ--LDSTLGRRNT 172
Query: 681 VVGTYGYMSPE-----YAIDGLFSVKSDVFSFGVLVLEIICGK 718
+GT +M+PE D + +SDV+S G+ +E+ GK
Sbjct: 173 FIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGK 215
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 5e-20
Identities = 67/207 (32%), Positives = 112/207 (54%), Gaps = 20/207 (9%)
Query: 519 FSEKNKLGEGGFGPVYKGMLI-EGQEI----AVKRLSKG-SGQGMEEFKNEVLLIAKLQH 572
F + LG G FG VYKG+ I EG+++ A+K L + S + +E +E ++A + +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 573 RNLVKLLGCCTQRDERMLIYEYLPNKSL-DYFIFDTTR---SKLLDWSKRSHIIAGIARG 628
++ +LLG C + LI + +P L DY LL+W + IA+G
Sbjct: 69 PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 121
Query: 629 LLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYM 688
+ YL + R++HRDL A NVL+ + KI+DFGLA+ G D+ E + + +M
Sbjct: 122 MNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWM 178
Query: 689 SPEYAIDGLFSVKSDVFSFGVLVLEII 715
+ E + +++ +SDV+S+GV V E++
Sbjct: 179 ALESILHRIYTHQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 7e-20
Identities = 72/274 (26%), Positives = 129/274 (47%), Gaps = 27/274 (9%)
Query: 514 NATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQH 572
N D + +LG+G FG VYK E G A K + S + +E+F E+ ++++ +H
Sbjct: 2 NPNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKH 61
Query: 573 RNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYL 632
N+V L ++ ++ E+ +LD + + R L + ++ + L +L
Sbjct: 62 PNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERG--LTEPQIRYVCRQMLEALNFL 119
Query: 633 HQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEY 692
H ++IHRDLKA N+LL + K++DFG+ S T +GT +M+PE
Sbjct: 120 HSH---KVIHRDLKAGNILLTLDGDVKLADFGV--SAKNKSTLQKRDTFIGTPYWMAPEV 174
Query: 693 AI-----DGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLE 747
D + K+D++S G+ ++E+ + +H + +L L I +
Sbjct: 175 VACETFKDNPYDYKADIWSLGITLIEL---AQMEPPHHELNPMRVL-----LKILKSEPP 226
Query: 748 LIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRP 781
+DQ S SF++ L+ C+ + P+DRP
Sbjct: 227 TLDQPSKWSSSFNDFLK------SCLVKDPDDRP 254
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 8e-20
Identities = 63/202 (31%), Positives = 102/202 (50%), Gaps = 10/202 (4%)
Query: 523 NKLGEGGFGPVYKGMLIEGQE-IAVKR--LSKGSGQGMEEFKNEVLLIAKLQHRNLVKLL 579
+G G VY + + E +A+KR L K ++E + EV +++ H N+VK
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEK-CQTSVDELRKEVQAMSQCNHPNVVKYY 65
Query: 580 GCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLR 639
DE L+ YL SL + + LD + + ++ + +GL YLH + +
Sbjct: 66 TSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ-- 123
Query: 640 IIHRDLKASNVLLDNTMNPKISDFGLARSF--GLDQTEANTKRVVGTYGYMSPEYAIDGL 697
IHRD+KA N+LL + KI+DFG++ S G D+T K VGT +M+PE
Sbjct: 124 -IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVH 182
Query: 698 -FSVKSDVFSFGVLVLEIICGK 718
+ K+D++SFG+ +E+ G
Sbjct: 183 GYDFKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 1e-19
Identities = 68/272 (25%), Positives = 122/272 (44%), Gaps = 31/272 (11%)
Query: 525 LGEGGFGP--VYK----GMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKL 578
LG+G FG +Y+ L+ +E+ + RLS+ + + NE+++++ LQH N++
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE---KERRDALNEIVILSLLQHPNIIAY 64
Query: 579 LGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRL 638
+ ++ EY +L Y + +L + + I + Y+H+
Sbjct: 65 YNHFMDDNTLLIEMEYANGGTL-YDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG-- 121
Query: 639 RIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLF 698
I+HRD+K N+ L K+ DFG+++ G + + A T VVGT YMSPE +
Sbjct: 122 -ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGTPYYMSPELCQGVKY 178
Query: 699 SVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDNSCS 758
+ KSD+++ G ++ E++ K R F+ N L ++ +
Sbjct: 179 NFKSDIWALGCVLYELLTLK--RTFDAT----NPLNLVVKIVQGNYTPVV--------SV 224
Query: 759 FSEALRCIQVGLLCVQQRPEDRPNMSSVVLML 790
+S L I + +QQ PE RP V+
Sbjct: 225 YSSEL--ISLVHSLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 2e-19
Identities = 60/202 (29%), Positives = 108/202 (53%), Gaps = 11/202 (5%)
Query: 519 FSEKNKLGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQG-MEEFKNEVLLIAKLQHRNLV 576
F++ ++G+G FG VYKG+ +E+ A+K + + +E+ + E+ ++++ +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 577 KLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDS 636
+ G + + +I EYL S D + L+ + + I+ I +GL YLH +
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGS----ALDLLKPGPLEETYIATILREILKGLDYLHSE- 120
Query: 637 RLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDG 696
R IHRD+KA+NVLL + K++DFG+A Q + NT VGT +M+PE
Sbjct: 121 --RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQS 176
Query: 697 LFSVKSDVFSFGVLVLEIICGK 718
+ K+D++S G+ +E+ G+
Sbjct: 177 AYDFKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 2e-19
Identities = 66/198 (33%), Positives = 101/198 (51%), Gaps = 27/198 (13%)
Query: 524 KLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCT 583
+GEG FG V +G GQ++AVK + + F E ++ KL H+NLV+LLG
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIK--CDVTAQAFLEETAVMTKLHHKNLVRLLGVIL 69
Query: 584 QRDERMLIYEYLPNKSLDYFIFDTTRS-----KLLDWSKRSHIIAGIARGLLYLHQDSRL 638
++ E + +L F+ R+ +LL +S +A G+ YL
Sbjct: 70 HNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFS------LDVAEGMEYLESK--- 119
Query: 639 RIIHRDLKASNVLLDNTMNPKISDFGLAR--SFGLDQTEANTKRVVGTYGYMSPEYAIDG 696
+++HRDL A N+L+ K+SDFGLAR S G+D ++ K + +PE
Sbjct: 120 KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK-------WTAPEALKHK 172
Query: 697 LFSVKSDVFSFGVLVLEI 714
FS KSDV+S+GVL+ E+
Sbjct: 173 KFSSKSDVWSYGVLLWEV 190
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 89.4 bits (221), Expect = 2e-19
Identities = 57/208 (27%), Positives = 109/208 (52%), Gaps = 10/208 (4%)
Query: 512 IANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKL 570
+ + ++ K+G+G G VY + I GQE+A+K+++ E NE+L++ +
Sbjct: 14 VGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMREN 73
Query: 571 QHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLL 630
++ N+V L DE ++ EYL SL D +D + + + + L
Sbjct: 74 KNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALD 129
Query: 631 YLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSP 690
+LH + ++IHRD+K+ N+LL + K++DFG +Q++ +T +VGT +M+P
Sbjct: 130 FLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAP 184
Query: 691 EYAIDGLFSVKSDVFSFGVLVLEIICGK 718
E + K D++S G++ +E++ G+
Sbjct: 185 EVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 2e-19
Identities = 66/202 (32%), Positives = 108/202 (53%), Gaps = 19/202 (9%)
Query: 525 LGEGGFGPVYKGMLI--EGQEI--AVKRLSKGSG-QGMEEFKNEVLLIAKLQHRNLVKLL 579
+G+G FG VY G LI +GQ+I AVK L++ + + +E+F E +++ H N++ LL
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 580 GCCTQRD-ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAG--IARGLLYLHQDS 636
G C + +++ Y+ + L FI T + + + I G +A+G+ YL
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTV----KDLIGFGLQVAKGMEYLASK- 117
Query: 637 RLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ---TEANTKRVVGTYGYMSPEYA 693
+ +HRDL A N +LD + K++DFGLAR D+ + N +M+ E
Sbjct: 118 --KFVHRDLAARNCMLDESFTVKVADFGLARDI-YDKEYYSVHNHTGAKLPVKWMALESL 174
Query: 694 IDGLFSVKSDVFSFGVLVLEII 715
F+ KSDV+SFGVL+ E++
Sbjct: 175 QTQKFTTKSDVWSFGVLLWELM 196
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 2e-19
Identities = 62/205 (30%), Positives = 102/205 (49%), Gaps = 19/205 (9%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQGMEEFKNEVLLIAKLQHRNL 575
+++ ++G G +G VYK I E+ A+K + G E + E+ ++ + +H N+
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNI 62
Query: 576 VKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIAR----GLLY 631
V G +RD+ ++ EY SL I+ TR L IA + R GL Y
Sbjct: 63 VAYFGSYLRRDKLWIVMEYCGGGSLQD-IYQVTRGPL-----SELQIAYVCRETLKGLAY 116
Query: 632 LHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPE 691
LH+ IHRD+K +N+LL + K++DFG++ L T A K +GT +M+PE
Sbjct: 117 LHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQ--LTATIAKRKSFIGTPYWMAPE 171
Query: 692 YA---IDGLFSVKSDVFSFGVLVLE 713
A G + K D+++ G+ +E
Sbjct: 172 VAAVERKGGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 3e-19
Identities = 81/288 (28%), Positives = 131/288 (45%), Gaps = 38/288 (13%)
Query: 519 FSEKNKLGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQGMEEFKN---EVLLIAKLQHRN 574
FS+ ++G G FG VY + E+ A+K++S Q E++++ EV + KL+H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQ 634
++ GC + L+ EY + D K L + + + G +GL YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 635 DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAI 694
+ +IHRD+KA N+LL K+ DFG A AN VGT +M+PE +
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM----APANX--FVGTPYWMAPEVIL 184
Query: 695 ---DGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQ 751
+G + K DV+S G+ +E + +K FN N + + + E P
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIE-LAERKPPLFN-----MNAMSALYHIAQNESPALQSGH 238
Query: 752 SLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL---MLSGERSL 796
+ +F ++ C+Q+ P+DRP S V+L + ER
Sbjct: 239 WSEYFRNFVDS---------CLQKIPQDRPT-SEVLLKHRFVLRERPP 276
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 3e-19
Identities = 64/206 (31%), Positives = 104/206 (50%), Gaps = 20/206 (9%)
Query: 525 LGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCT 583
+G G +G VYKG ++ ++A ++ +G EE K E+ ++ K HRN+ G
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73
Query: 584 QR------DERMLIYEYLPNKSLDYFIFDTTRSKLL-DWSKRSHIIAGIARGLLYLHQDS 636
++ D+ L+ E+ S+ I +T + L +W ++I I RGL +LHQ
Sbjct: 74 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWI--AYICREILRGLSHLHQH- 130
Query: 637 RLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAI-- 694
++IHRD+K NVLL K+ DFG+ S LD+T +GT +M+PE
Sbjct: 131 --KVIHRDIKGQNVLLTENAEVKLVDFGV--SAQLDRTVGRRNTFIGTPYWMAPEVIACD 186
Query: 695 ---DGLFSVKSDVFSFGVLVLEIICG 717
D + KSD++S G+ +E+ G
Sbjct: 187 ENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 3e-19
Identities = 60/205 (29%), Positives = 105/205 (51%), Gaps = 23/205 (11%)
Query: 524 KLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKN--------EVLLIAKLQHRN 574
K+GEG +G VYK + G+ +A+K++ +E E+ L+ +L H N
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIR------LETEDEGVPSTAIREISLLKELNHPN 59
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQ 634
+V+LL ++ L++E+L + L ++ D++ LD + + +G+ Y H
Sbjct: 60 IVRLLDVVHSENKLYLVFEFL-DLDLKKYM-DSSPLTGLDPPLIKSYLYQLLQGIAYCHS 117
Query: 635 DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAI 694
R++HRDLK N+L+D K++DFGLAR+FG+ T VV T Y +PE +
Sbjct: 118 H---RVLHRDLKPQNLLIDREGALKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEILL 172
Query: 695 DG-LFSVKSDVFSFGVLVLEIICGK 718
+S D++S G + E++ +
Sbjct: 173 GSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 3e-19
Identities = 67/201 (33%), Positives = 108/201 (53%), Gaps = 20/201 (9%)
Query: 525 LGEGGFGPVYKGMLIEGQE-----IAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKL 578
LG G FG VYKG+ I E +A+K L + S + +E +E ++A + + +L
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 579 LGCCTQRDERMLIYEYLPNKSL-DYFIFDTTR---SKLLDWSKRSHIIAGIARGLLYLHQ 634
LG C + L+ + +P L DY + R LL+W + IA+G+ YL +
Sbjct: 75 LGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQ------IAKGMSYLEE 127
Query: 635 DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAI 694
+R++HRDL A NVL+ + + KI+DFGLAR +D+TE + +M+ E +
Sbjct: 128 ---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL 184
Query: 695 DGLFSVKSDVFSFGVLVLEII 715
F+ +SDV+S+GV V E++
Sbjct: 185 HRRFTHQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 4e-19
Identities = 62/213 (29%), Positives = 93/213 (43%), Gaps = 27/213 (12%)
Query: 518 NFSEKNKLGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQGMEEFKN---EVLLIAKLQHR 573
+F +G+G FG V + +++ A+K ++K +N E ++ +L H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 574 NLVKLLGCCT-QRDERM-LIYEYLPNKSLDYFI-----FDTTRSKLLDWSKRSHIIAGIA 626
LV L + Q +E M L+ + L L Y + F + K I I
Sbjct: 61 FLVNL--WYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKF--------WICEIV 110
Query: 627 RGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYG 686
L YLH IIHRD+K N+LLD + I+DF +A + T GT G
Sbjct: 111 LALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKV---TPDTLTTSTSGTPG 164
Query: 687 YMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKK 719
YM+PE +SV D +S GV E + GK+
Sbjct: 165 YMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 4e-19
Identities = 56/208 (26%), Positives = 108/208 (51%), Gaps = 10/208 (4%)
Query: 512 IANATDNFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKL 570
+ + ++ K+G+G G VY M + GQE+A+++++ E NE+L++ +
Sbjct: 15 VGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN 74
Query: 571 QHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLL 630
++ N+V L DE ++ EYL SL D +D + + + + L
Sbjct: 75 KNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALE 130
Query: 631 YLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSP 690
+LH + ++IHRD+K+ N+LL + K++DFG +Q++ + +VGT +M+P
Sbjct: 131 FLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS--TMVGTPYWMAP 185
Query: 691 EYAIDGLFSVKSDVFSFGVLVLEIICGK 718
E + K D++S G++ +E+I G+
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 5e-19
Identities = 58/204 (28%), Positives = 91/204 (44%), Gaps = 14/204 (6%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQG-MEEFKNEVLLIAKLQHRN 574
+ E ++LGEG G V K L I A+K ++ ++ E+ + +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 575 LVKLLGCCTQRDERML--IYEYLPNKSLDYFIFDTTRSKLLDWSKR--SHIIAGIARGLL 630
+VK G + EY SLD I+ + + ++ I + +GL
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLDS-IYKKVKKRGGRIGEKVLGKIAESVLKGLS 119
Query: 631 YLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSP 690
YLH +IIHRD+K SN+LL K+ DFG++ A T GT YM+P
Sbjct: 120 YLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL--AGT--FTGTSFYMAP 172
Query: 691 EYAIDGLFSVKSDVFSFGVLVLEI 714
E +S+ SDV+S G+ +LE+
Sbjct: 173 ERIQGKPYSITSDVWSLGLTLLEV 196
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 6e-19
Identities = 59/202 (29%), Positives = 108/202 (53%), Gaps = 11/202 (5%)
Query: 519 FSEKNKLGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQG-MEEFKNEVLLIAKLQHRNLV 576
F++ ++G+G FG V+KG+ Q++ A+K + + +E+ + E+ ++++ +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 577 KLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDS 636
K G + + +I EYL S D R+ D + + ++ I +GL YLH +
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGS----ALDLLRAGPFDEFQIATMLKEILKGLDYLHSEK 121
Query: 637 RLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDG 696
+ IHRD+KA+NVLL + K++DFG+A Q + NT VGT +M+PE
Sbjct: 122 K---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIQQS 176
Query: 697 LFSVKSDVFSFGVLVLEIICGK 718
+ K+D++S G+ +E+ G+
Sbjct: 177 AYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 7e-19
Identities = 67/216 (31%), Positives = 101/216 (46%), Gaps = 33/216 (15%)
Query: 518 NFSEKNKLGEGGFGPVYK-GMLIEGQEIAVKR--LSKGSGQGMEEFKNEVLLIAKLQHRN 574
+F KLG+G +G VYK L + Q A+K L S + E+ NE+ ++A + H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 575 LVK-----LLGC--CTQRDERMLIYEYLPNKSLDYFIFDTTRSKLL-----DWSKRSHII 622
++ L G C + EY P L I + + L W I
Sbjct: 61 IISYKEAFLDGNKLCI-------VMEYAPFGDLSKAISKRKKKRKLIPEQEIWR----IF 109
Query: 623 AGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVV 682
+ RGL LH+ +I+HRDLK++N+LL KI D G+++ L + A T +
Sbjct: 110 IQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKV--LKKNMAKT--QI 162
Query: 683 GTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGK 718
GT YM+PE +S KSD++S G L+ E+
Sbjct: 163 GTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFA 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 87.1 bits (215), Expect = 8e-19
Identities = 60/202 (29%), Positives = 106/202 (52%), Gaps = 11/202 (5%)
Query: 519 FSEKNKLGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQG-MEEFKNEVLLIAKLQHRNLV 576
F++ K+G+G FG V+KG+ Q++ A+K + + +E+ + E+ ++++ +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 577 KLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDS 636
K G + + +I EYL S D LD ++ + I+ I +GL YLH +
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGS----ALDLLEPGPLDETQIATILREILKGLDYLHSEK 121
Query: 637 RLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDG 696
+ IHRD+KA+NVLL K++DFG+A L T+ VGT +M+PE
Sbjct: 122 K---IHRDIKAANVLLSEHGEVKLADFGVAGQ--LTDTQIKRNTFVGTPFWMAPEVIKQS 176
Query: 697 LFSVKSDVFSFGVLVLEIICGK 718
+ K+D++S G+ +E+ G+
Sbjct: 177 AYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 8e-19
Identities = 81/265 (30%), Positives = 124/265 (46%), Gaps = 55/265 (20%)
Query: 525 LGEGGFGPVYKGMLI-EGQEI--AVKRLSK-GSGQGMEEFKNEVLLIAKL-QHRNLVKLL 579
+GEG FG V + M+ +G ++ A+K L + S +F E+ ++ KL H N++ LL
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69
Query: 580 GCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWS---KRSHIIAG------------ 624
G C R + EY P +L F+ +S++L+ + H A
Sbjct: 70 GACENRGYLYIAIEYAPYGNLLDFL---RKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 625 -IARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVG 683
+A G+ YL S + IHRDL A NVL+ + KI+DFGL+R E K+ +G
Sbjct: 127 DVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSRG-----EEVYVKKTMG 178
Query: 684 TYG--YMSPEYAIDGLFSVKSDVFSFGVLVLEII-------CG--------KKNRGF--- 723
+M+ E +++ KSDV+SFGVL+ EI+ CG K +G+
Sbjct: 179 RLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRME 238
Query: 724 ---NHADHDHNLLGHAWRLWIEERP 745
N D + L+ WR ERP
Sbjct: 239 KPRNCDDEVYELMRQCWRDRPYERP 263
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 8e-19
Identities = 67/216 (31%), Positives = 114/216 (52%), Gaps = 14/216 (6%)
Query: 518 NFSEKNKLGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQGMEEFK-NEVLLIAKLQHRNL 575
NF + KLGEG + VYKG EI A+K + + +G E+ L+ +L+H N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 576 VKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQD 635
V+L ++ ML++EY+ +K L ++ LD + + +G+ + H++
Sbjct: 61 VRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN 119
Query: 636 SRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANT--KRVVGTYGYMSPEYA 693
R++HRDLK N+L++ K++DFGLAR+FG+ NT VV T Y +P+
Sbjct: 120 ---RVLHRDLKPQNLLINKRGELKLADFGLARAFGI---PVNTFSNEVV-TLWYRAPDVL 172
Query: 694 IDG-LFSVKSDVFSFGVLVLEIICGKK-NRGFNHAD 727
+ +S D++S G ++ E+I G+ G N+ D
Sbjct: 173 LGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED 208
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 9e-19
Identities = 77/287 (26%), Positives = 135/287 (47%), Gaps = 34/287 (11%)
Query: 519 FSEKNKLGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQGMEEFKN---EVLLIAKLQHRN 574
F++ ++G G FG VY + E+ A+K++S Q E++++ EV + +++H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQ 634
++ GC + L+ EY + D K L + + I G +GL YLH
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHS 143
Query: 635 DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAI 694
+ +IHRD+KA N+LL K++DFG A + AN+ VGT +M+PE +
Sbjct: 144 HN---MIHRDIKAGNILLTEPGQVKLADFGSASI----ASPANS--FVGTPYWMAPEVIL 194
Query: 695 ---DGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQ 751
+G + K DV+S G+ +E + +K FN N + + + E P ++
Sbjct: 195 AMDEGQYDGKVDVWSLGITCIE-LAERKPPLFN-----MNAMSALYHIAQNESPTLQSNE 248
Query: 752 SLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQ 798
D +F ++ C+Q+ P+DRP ++ + R P+
Sbjct: 249 WSDYFRNFVDS---------CLQKIPQDRPTSEELLKHMFVLRERPE 286
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 1e-18
Identities = 60/202 (29%), Positives = 94/202 (46%), Gaps = 21/202 (10%)
Query: 525 LGEGGFGPVYKGML-IEGQEIAVKRLSKGS--GQGMEE-FKNEVLLIAKLQHRNLVKLLG 580
LG GGFG V + + + A+K + K G +E +E ++ + H +VKL
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLY- 59
Query: 581 CCTQRDER---MLIYEYLPNKSLDYFIFDTTRSK-LLDWSKRSHIIAGIARGLLYLHQDS 636
T +D++ ML+ EY L + R + L D IA + YLH
Sbjct: 60 -RTFKDKKYIYMLM-EYCLGGEL----WTILRDRGLFDEYTARFYIACVVLAFEYLH--- 110
Query: 637 RLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDG 696
II+RDLK N+LLD+ K+ DFG A+ Q T GT Y++PE ++
Sbjct: 111 NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAPEIILNK 167
Query: 697 LFSVKSDVFSFGVLVLEIICGK 718
+ D +S G+L+ E++ G+
Sbjct: 168 GYDFSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 1e-18
Identities = 64/206 (31%), Positives = 100/206 (48%), Gaps = 15/206 (7%)
Query: 519 FSEKNKLGEGGFGPV------YKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQH 572
F + LG+GGFG V G + +++ KR+ K G+ M NE ++ K+
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMA--LNEKQILEKVNS 59
Query: 573 RNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYL 632
R +V L +D L+ + L + I+ + + + A I GL L
Sbjct: 60 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGF-EEGRAVFYAAEICCGLEDL 118
Query: 633 HQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEY 692
HQ+ RI++RDLK N+LLD+ + +ISD GLA QT K VGT GYM+PE
Sbjct: 119 HQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYMAPEV 172
Query: 693 AIDGLFSVKSDVFSFGVLVLEIICGK 718
+ ++ D ++ G L+ E+I G+
Sbjct: 173 VKNERYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 1e-18
Identities = 63/200 (31%), Positives = 100/200 (50%), Gaps = 15/200 (7%)
Query: 525 LGEGGFGPV------YKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKL 578
LG+GGFG V G + +++ KRL K SG+ M + E+L K+ +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEIL--EKVNSPFIVNL 58
Query: 579 LGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRL 638
+ L+ + L Y I++ + L+ + H A I G+L+LH +
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIYNVG-ERGLEMERVIHYSAQITCGILHLHS---M 114
Query: 639 RIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLF 698
I++RD+K NVLLD+ N ++SD GLA L + T+R GT GYM+PE + +
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLAVE--LKDGKTITQR-AGTNGYMAPEILKEEPY 171
Query: 699 SVKSDVFSFGVLVLEIICGK 718
S D F+ G + E++ G+
Sbjct: 172 SYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-18
Identities = 77/274 (28%), Positives = 127/274 (46%), Gaps = 23/274 (8%)
Query: 518 NFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLS---KGSGQGMEEFKNEVLLIAKLQHR 573
NF + K+G G F VY+ L++G +A+K++ + + E+ L+ +L H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 574 NLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRS-HIIAGIARGLLYL 632
N++K + +E ++ E L I + K L K + L ++
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 633 HQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEY 692
H SR R++HRD+K +NV + T K+ D GL R F T A++ +VGT YMSPE
Sbjct: 123 H--SR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPER 177
Query: 693 AIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQS 752
+ ++ KSD++S G L+ E+ A G L+ + +E D
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEM-----------AALQSPFYGDKMNLYSLCKKIEQCDYP 226
Query: 753 LDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSV 786
S +SE LR Q+ +C+ PE RP+++ V
Sbjct: 227 PLPSDHYSEELR--QLVNMCINPDPEKRPDITYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 65/213 (30%), Positives = 108/213 (50%), Gaps = 31/213 (14%)
Query: 519 FSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLS-KGSGQGMEEFK-NEVLLIAKLQ---H 572
+ E ++GEG +G VYK L G+ +A+K++ S +G+ E+ L+ +L+ H
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 573 RNLVKLLGCC-TQRDER----MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIAR 627
N+V+LL C R +R L++E++ ++ L ++ L ++ + R
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYL-SKCPKPGLPPETIKDLMRQLLR 118
Query: 628 GLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGY 687
G+ +LH RI+HRDLK N+L+ + KI+DFGLAR + + A T VV T Y
Sbjct: 119 GVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEM--ALTSVVV-TLWY 172
Query: 688 MSPE------YAIDGLFSVKSDVFSFGVLVLEI 714
+PE YA V D++S G + E+
Sbjct: 173 RAPEVLLQSSYA----TPV--DMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 2e-18
Identities = 70/202 (34%), Positives = 106/202 (52%), Gaps = 18/202 (8%)
Query: 525 LGEGGFGPVY------KGMLIEGQEIAVKRLSKGSGQG-MEEFKNEVLLIAKLQHRNLVK 577
LGEG FG V +G G+++AVK L SG + + K E+ ++ L H N+VK
Sbjct: 12 LGEGHFGKVELCRYDPEGDNT-GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70
Query: 578 LLGCCTQRDER--MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIA-GIARGLLYLHQ 634
G CT+ LI E+LP+ SL ++ R+K K+ A I +G+ YL
Sbjct: 71 YKGICTEDGGNGIKLIMEFLPSGSLKEYL---PRNKNKINLKQQLKYAVQICKGMDYL-- 125
Query: 635 DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT-YGYMSPEYA 693
SR + +HRDL A NVL+++ KI DFGL ++ D+ K + + + +PE
Sbjct: 126 GSR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECL 184
Query: 694 IDGLFSVKSDVFSFGVLVLEII 715
I F + SDV+SFGV + E++
Sbjct: 185 IQSKFYIASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 4e-18
Identities = 63/202 (31%), Positives = 108/202 (53%), Gaps = 11/202 (5%)
Query: 518 NFSEKNKLGEGGFGPVYKGM-LIEGQEIAVK--RLSKGSGQGMEEFKNEVLLIAKLQHRN 574
NF + K+GEG +G VYK + G+ +A+K RL + E+ L+ +L H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQ 634
+VKLL ++ L++E+L ++ L F+ + S + +S++ + +GL + H
Sbjct: 61 IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQ-LLQGLAFCHS 118
Query: 635 DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAI 694
R++HRDLK N+L++ K++DFGLAR+FG+ T VV T Y +PE +
Sbjct: 119 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEILL 173
Query: 695 DG-LFSVKSDVFSFGVLVLEII 715
+S D++S G + E++
Sbjct: 174 GCKYYSTAVDIWSLGCIFAEMV 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 4e-18
Identities = 60/203 (29%), Positives = 108/203 (53%), Gaps = 21/203 (10%)
Query: 525 LGEGGFGPVYKGML-IEGQE---IAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLL 579
+G G FG V +G L + G+ +A+K L G + + +F +E ++ + H N++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 580 GCCTQRDERMLIYEYLPNKSLDYFIFDT----TRSKLLDWSKRSHIIAGIARGLLYLHQD 635
G T+ M+I E++ N +LD F+ T +L+ ++ GIA G+ YL
Sbjct: 72 GVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVG------MLRGIAAGMKYL--- 122
Query: 636 SRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVG---TYGYMSPEY 692
S + +HRDL A N+L+++ + K+SDFGL+R D ++ +G + +PE
Sbjct: 123 SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEA 182
Query: 693 AIDGLFSVKSDVFSFGVLVLEII 715
F+ SDV+S+G+++ E++
Sbjct: 183 IAYRKFTSASDVWSYGIVMWEVM 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 4e-18
Identities = 64/213 (30%), Positives = 105/213 (49%), Gaps = 43/213 (20%)
Query: 525 LGEGGFGPVYKGML-IEGQE---IAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLL 579
+G G FG V G L + G+ +A+K L G + + +F +E ++ + H N++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 580 GCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSH-----------IIAGIARG 628
G T+ M++ EY+ N SLD F+ R H ++ GIA G
Sbjct: 72 GVVTKSKPVMIVTEYMENGSLDAFL-------------RKHDGQFTVIQLVGMLRGIASG 118
Query: 629 LLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYG-- 686
+ YL S + +HRDL A N+L+++ + K+SDFGL+R D A T R G
Sbjct: 119 MKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR-----GGK 170
Query: 687 ----YMSPEYAIDGLFSVKSDVFSFGVLVLEII 715
+ +PE F+ SDV+S+G+++ E++
Sbjct: 171 IPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVM 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 5e-18
Identities = 80/288 (27%), Positives = 138/288 (47%), Gaps = 47/288 (16%)
Query: 525 LGEGGFGPVYKGMLIEG---QEIAVKRLSK-GSGQGMEEFKNEVLLIAKL-QHRNLVKLL 579
+GEG FG V K + + + A+KR+ + S +F E+ ++ KL H N++ LL
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 580 GCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWS---KRSHIIAGI--ARGLLYLHQ 634
G C R L EY P+ +L F+ +S++L+ ++ A ++ LL+
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFL---RKSRVLETDPAFAIANSTASTLSSQQLLHFAA 119
Query: 635 D--------SRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYG 686
D S+ + IHRDL A N+L+ KI+DFGL+R E K+ +G
Sbjct: 120 DVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRG-----QEVYVKKTMGRLP 174
Query: 687 --YMSPEYAIDGLFSVKSDVFSFGVLVLEIIC--GKKNRGFNHADHDHNLLGHAWRLWIE 742
+M+ E +++ SDV+S+GVL+ EI+ G G A+ + L +RL
Sbjct: 175 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL-YEKLPQGYRL--- 230
Query: 743 ERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLML 790
E+PL D+ + +R C +++P +RP+ + +++ L
Sbjct: 231 EKPLNCDDE-------VYDLMR------QCWREKPYERPSFAQILVSL 265
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 5e-18
Identities = 66/209 (31%), Positives = 108/209 (51%), Gaps = 22/209 (10%)
Query: 517 DNFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLS-KGSGQGMEEFK-NEVLLIAKLQHR 573
D + + K+GEG +G VYK + + IA+K++ + +G+ E+ L+ ++QH
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
Query: 574 NLVKLLGCCTQRDERMLIYEYLPNKSLDYFIF-DTTRSKLLDWSKRSHIIAG----IARG 628
N+V+L L++EYL LD D++ D++K +I I RG
Sbjct: 62 NIVRLQDVVHSEKRLYLVFEYL---DLDLKKHMDSSP----DFAKNPRLIKTYLYQILRG 114
Query: 629 LLYLHQDSRLRIIHRDLKASNVLLDNTMNP-KISDFGLARSFGLDQTEANTKRVVGTYGY 687
+ Y H R++HRDLK N+L+D N K++DFGLAR+FG+ T VV T Y
Sbjct: 115 IAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI-PVRTFTHEVV-TLWY 169
Query: 688 MSPEYAIDGL-FSVKSDVFSFGVLVLEII 715
+PE + +S D++S G + E++
Sbjct: 170 RAPEILLGSRHYSTPVDIWSVGCIFAEMV 198
|
Length = 294 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 6e-18
Identities = 81/271 (29%), Positives = 132/271 (48%), Gaps = 36/271 (13%)
Query: 519 FSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKN---EVLLIAKLQHRN 574
F++ ++G G FG VY + + +A+K++S Q E++++ EV + +L+H N
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQ 634
++ GC + L+ EY + D I + + K L + + I G +GL YLH
Sbjct: 77 TIEYKGCYLREHTAWLVMEYCLGSASD--ILEVHK-KPLQEVEIAAICHGALQGLAYLHS 133
Query: 635 DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPE--Y 692
R IHRD+KA N+LL K++DFG A + AN+ VGT +M+PE
Sbjct: 134 HER---IHRDIKAGNILLTEPGTVKLADFGSASL----VSPANS--FVGTPYWMAPEVIL 184
Query: 693 AID-GLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERP-LELID 750
A+D G + K DV+S G+ +E + +K FN N + + + + P L D
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIE-LAERKPPLFN-----MNAMSALYHIAQNDSPTLSSND 238
Query: 751 QSLDNSCSFSEALRCIQVGLLCVQQRPEDRP 781
S D +F + C+Q+ P+DRP
Sbjct: 239 WS-DYFRNFVD---------SCLQKIPQDRP 259
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 6e-18
Identities = 66/231 (28%), Positives = 104/231 (45%), Gaps = 43/231 (18%)
Query: 522 KNKLGEGGFGPVYKGMLIEGQE-----------------IAVKRL-SKGSGQGMEEFKNE 563
K KLGEG FG V+ ++ Q+ +AVK L + +F E
Sbjct: 10 KEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKE 69
Query: 564 VLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRS---- 619
V ++++L+ N+++LLG C D +I EY+ N L+ F+ + L D +
Sbjct: 70 VKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFL---SSHHLDDKEENGNDAV 126
Query: 620 ---------------HIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFG 664
H+ IA G+ YL S L +HRDL N L+ + KI+DFG
Sbjct: 127 PPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFG 183
Query: 665 LARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEII 715
++R+ R V +M+ E + G F+ SDV++FGV + EI+
Sbjct: 184 MSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 84.4 bits (208), Expect = 7e-18
Identities = 63/204 (30%), Positives = 103/204 (50%), Gaps = 17/204 (8%)
Query: 525 LGEGGFGPVYKGMLIE-GQEIAVKRL-----SKGSGQGMEEFKNEVLLIAKLQHRNLVKL 578
LG+G FG VY ++ G+E+A K++ S + + + + E+ L+ LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 579 LGCCTQRDERML--IYEYLPNKSLDYFIFDTTRS-KLLDWSKRSHIIAGIARGLLYLHQD 635
GC R E+ L EY+P S+ D ++ L S I G+ YLH +
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVK----DQLKAYGALTESVTRKYTRQILEGMSYLHSN 125
Query: 636 SRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF-GLDQTEANTKRVVGTYGYMSPEYAI 694
I+HRD+K +N+L D+ N K+ DFG ++ + + + V GT +MSPE
Sbjct: 126 ---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVIS 182
Query: 695 DGLFSVKSDVFSFGVLVLEIICGK 718
+ K+DV+S G V+E++ K
Sbjct: 183 GEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 7e-18
Identities = 64/225 (28%), Positives = 102/225 (45%), Gaps = 29/225 (12%)
Query: 517 DNFSEKNKLGEGGFGPVY----KGMLIEGQE-------------IAVKRL-SKGSGQGME 558
+ K KLGEG FG V+ +GM + +AVK L +
Sbjct: 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARN 64
Query: 559 EFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFI--------FDTTRS 610
+F E+ ++++L+ N+++LL C D +I EY+ N L+ F+ +
Sbjct: 65 DFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADV 124
Query: 611 KLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670
+ +S + IA G+ YL S L +HRDL N L+ KI+DFG++R+
Sbjct: 125 VTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLY 181
Query: 671 LDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEII 715
R V +MS E + G F+ SDV++FGV + EI+
Sbjct: 182 SGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 8e-18
Identities = 58/215 (26%), Positives = 108/215 (50%), Gaps = 15/215 (6%)
Query: 509 LKIIANATD---NFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEV 564
L+++ + D K+GEG G V G+++AVK++ Q E NEV
Sbjct: 8 LQLVVDPGDPRSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEV 67
Query: 565 LLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSL-DYFIFDTTRSKLLDWSKRSHIIA 623
+++ QH N+V++ DE ++ E+L +L D I TR ++ + + +
Sbjct: 68 VIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTD--IVTHTR---MNEEQIATVCL 122
Query: 624 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVG 683
+ + L +LH +IHRD+K+ ++LL + K+SDFG + + K +VG
Sbjct: 123 AVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQ--VSKEVPRRKSLVG 177
Query: 684 TYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGK 718
T +M+PE + + D++S G++V+E++ G+
Sbjct: 178 TPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 9e-18
Identities = 61/191 (31%), Positives = 94/191 (49%), Gaps = 13/191 (6%)
Query: 525 LGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQ 584
+G+G FG V G G ++AVK + + + F E ++ +L+H NLV+LLG +
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 585 RDERMLIY-EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHR 643
+ I EY+ SL ++ RS +L + + YL ++ +HR
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEANN---FVHR 126
Query: 644 DLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSD 703
DL A NVL+ K+SDFGL + T+ K V + +PE + FS KSD
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTKE--ASSTQDTGKLPV---KWTAPEALREKKFSTKSD 181
Query: 704 VFSFGVLVLEI 714
V+SFG+L+ EI
Sbjct: 182 VWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 1e-17
Identities = 60/204 (29%), Positives = 100/204 (49%), Gaps = 17/204 (8%)
Query: 525 LGEGGFGPVYKGMLIEGQEI---AVK--RLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLL 579
LGEG FG V +G L + I AVK +++ + ME+F +E + + + H N+++L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 580 GCCTQRDER------MLIYEYLPNKSLDYFIFDT---TRSKLLDWSKRSHIIAGIARGLL 630
G C Q E ++I ++ + L F+ + + L + IA G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 631 YLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSP 690
YL S IHRDL A N +L+ MN ++DFGL++ + +++
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 691 EYAIDGLFSVKSDVFSFGVLVLEI 714
E D +++ KSDV+SFGV + EI
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEI 207
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-17
Identities = 80/275 (29%), Positives = 129/275 (46%), Gaps = 28/275 (10%)
Query: 518 NFSEKNKLGEGGFGPVY--KGMLIEGQEIAVKR--LSKGSGQGMEEFKNEVLLIAKLQHR 573
+ K+GEG FG +Y K + + +K L+K + E K EV+L+AK++H
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAK-SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHP 59
Query: 574 NLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLH 633
N+V + ++ EY L I + R L + I+ GL ++H
Sbjct: 60 NIVTFFASFQENGRLFIVMEYCDGGDLMKRI-NRQRGVLFSEDQILSWFVQISLGLKHIH 118
Query: 634 QDSRLRIIHRDLKASNVLLD-NTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEY 692
+I+HRD+K+ N+ L N M K+ DFG+AR L+ + VGT Y+SPE
Sbjct: 119 DR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQ--LNDSMELAYTCVGTPYYLSPEI 173
Query: 693 AIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQS 752
+ ++ K+D++S G ++ E +C K H +NL H L I + I
Sbjct: 174 CQNRPYNNKTDIWSLGCVLYE-LCTLK-----HPFEGNNL--HQLVLKICQGYFAPI--- 222
Query: 753 LDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVV 787
S +FS LR + L V P DRP+++S++
Sbjct: 223 ---SPNFSRDLRSLISQLFKVS--PRDRPSITSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 1e-17
Identities = 59/209 (28%), Positives = 90/209 (43%), Gaps = 50/209 (23%)
Query: 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKN--------EVL 565
++ KLGEG FG VYK I+ G+ +A+K++ M K+ E+
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKIL------MHNEKDGFPITALREIK 59
Query: 566 LIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLD----YFIF---DTTRSKLLDWSK- 617
++ KL+H N+V L+ + E Y + D S LL+
Sbjct: 60 ILKKLKHPNVVPLID---------MAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSV 110
Query: 618 ---RSHI---IAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF-- 669
S I + + G+ YLH++ I+HRD+KA+N+L+DN KI+DFGLAR +
Sbjct: 111 KLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDG 167
Query: 670 -------GLDQTEANTKRVVGTYGYMSPE 691
G +V T Y PE
Sbjct: 168 PPPNPKGGGGGGTRKYTNLVVTRWYRPPE 196
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 1e-17
Identities = 64/201 (31%), Positives = 102/201 (50%), Gaps = 20/201 (9%)
Query: 525 LGEGGFGPVYKGMLI-EGQEI----AVKRLSKGSG-QGMEEFKNEVLLIAKLQHRNLVKL 578
LG G FG V+KG+ I EG I A+K + SG Q +E + +L + L H +V+L
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 579 LGCCTQRDERMLIYEYLPNKSLDYFIFDTTRS----KLLDWSKRSHIIAGIARGLLYLHQ 634
LG C L+ + P SL + S +LL+W + IA+G+ YL +
Sbjct: 75 LGICPG-ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQ------IAKGMYYLEE 127
Query: 635 DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAI 694
R++HR+L A N+LL + +I+DFG+A D + +M+ E +
Sbjct: 128 H---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESIL 184
Query: 695 DGLFSVKSDVFSFGVLVLEII 715
G ++ +SDV+S+GV V E++
Sbjct: 185 FGRYTHQSDVWSYGVTVWEMM 205
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-17
Identities = 73/278 (26%), Positives = 127/278 (45%), Gaps = 31/278 (11%)
Query: 518 NFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLS---KGSGQGMEEFKNEVLLIAKLQHR 573
NF + K+G G F VY+ L++ + +A+K++ + ++ E+ L+ +L H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 574 NLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLD-----WSKRSHIIAGIARG 628
N++K L + +E ++ E L I + K L W + + +
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE-- 120
Query: 629 LLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYM 688
H SR R++HRD+K +NV + T K+ D GL R F T A++ +VGT YM
Sbjct: 121 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYM 173
Query: 689 SPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLEL 748
SPE + ++ KSD++S G L+ E+ A G L+ + +E
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEM-----------AALQSPFYGDKMNLFSLCQKIEQ 222
Query: 749 IDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSV 786
D + +SE LR ++ +C+ P+ RP++ V
Sbjct: 223 CDYPPLPTEHYSEKLR--ELVSMCIYPDPDQRPDIGYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 2e-17
Identities = 60/199 (30%), Positives = 102/199 (51%), Gaps = 17/199 (8%)
Query: 524 KLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCC 582
+LG+G FG VYK E G A K + S + +E++ E+ ++A H +VKLLG
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 583 TQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIH 642
+ ++ E+ P ++D + + R L + I + L YLH ++IIH
Sbjct: 79 YWDGKLWIMIEFCPGGAVDAIMLELDRG--LTEPQIQVICRQMLEALQYLHS---MKIIH 133
Query: 643 RDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKR--VVGTYGYMSPEYAI-----D 695
RDLKA NVLL + K++DFG++ + +R +GT +M+PE + D
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVSAK----NVKTLQRRDSFIGTPYWMAPEVVMCETMKD 189
Query: 696 GLFSVKSDVFSFGVLVLEI 714
+ K+D++S G+ ++E+
Sbjct: 190 TPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.0 bits (206), Expect = 2e-17
Identities = 63/200 (31%), Positives = 96/200 (48%), Gaps = 22/200 (11%)
Query: 524 KLGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQGMEEFKN--EVLLIAKLQ-HRNLVKLL 579
+LG+G FG VY E E+ A+K++ K EE N EV + KL H N+VKL
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKM-KKKFYSWEECMNLREVKSLRKLNEHPNIVKLK 64
Query: 580 GCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLR 639
+ DE ++EY+ +L Y + + K S II I +GL ++H +
Sbjct: 65 EVFRENDELYFVFEYM-EGNL-YQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KHG 119
Query: 640 IIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRV----VGTYGYMSPEYAI- 694
HRDLK N+L+ KI+DFGLAR E ++ V T Y +PE +
Sbjct: 120 FFHRDLKPENLLVSGPEVVKIADFGLAR-------EIRSRPPYTDYVSTRWYRAPEILLR 172
Query: 695 DGLFSVKSDVFSFGVLVLEI 714
+S D+++ G ++ E+
Sbjct: 173 STSYSSPVDIWALGCIMAEL 192
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 82.3 bits (204), Expect = 2e-17
Identities = 60/210 (28%), Positives = 94/210 (44%), Gaps = 36/210 (17%)
Query: 528 GGFGPVY---KGMLIEGQEIAVKRLSKGSGQG---MEEFKNEVLLIAKLQHRNLVKLLGC 581
G +G V+ K G A+K + K +++ E ++++ Q +VKL
Sbjct: 4 GAYGRVFLAKKK--STGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY-Y 60
Query: 582 CTQRDERM-LIYEYLPN-------KSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLH 633
Q + + L+ EYLP +++ D R IA I L YLH
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVAR----------IYIAEIVLALEYLH 110
Query: 634 QDSRLRIIHRDLKASNVLLDNTMNPKISDFGLA------RSFGLDQTEANTKRVVGTYGY 687
IIHRDLK N+L+D+ + K++DFGL+ R L+ E KR+VGT Y
Sbjct: 111 S---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDY 167
Query: 688 MSPEYAIDGLFSVKSDVFSFGVLVLEIICG 717
++PE + S D +S G ++ E + G
Sbjct: 168 IAPEVILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 3e-17
Identities = 62/212 (29%), Positives = 104/212 (49%), Gaps = 23/212 (10%)
Query: 525 LGEGGFGPVY--------KGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLV 576
+G G FG V+ K ++I ++I V++++K + NE ++ L H N++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVII--KQIPVEQMTKDERLAAQ---NECQVLKLLSHPNII 62
Query: 577 KLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDS 636
+ + M++ EY P +L +I S LLD H I L ++H
Sbjct: 63 EYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNS-LLDEDTILHFFVQILLALHHVHTKL 121
Query: 637 RLRIIHRDLKASNVLLD-NTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAID 695
I+HRDLK N+LLD + M KI DFG+++ +++ VVGT Y+SPE
Sbjct: 122 ---ILHRDLKTQNILLDKHKMVVKIGDFGISKILS---SKSKAYTVVGTPCYISPELCEG 175
Query: 696 GLFSVKSDVFSFGVLVLEIICGKKNRGFNHAD 727
++ KSD+++ G ++ E+ K R F A+
Sbjct: 176 KPYNQKSDIWALGCVLYELASLK--RAFEAAN 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 3e-17
Identities = 69/216 (31%), Positives = 109/216 (50%), Gaps = 32/216 (14%)
Query: 525 LGEGGFGPVYKGMLI--------EGQEIAVKRLSK-GSGQGMEEFKNEVLLIAKL-QHRN 574
LGEG FG V I + +AVK L + + + + +E+ ++ + +H+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYFI-----------FDTTR--SKLLDWSKRSHI 621
++ LLG CTQ ++ EY +L ++ FDT + + L +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 622 IAGIARGLLYLHQDSRLRIIHRDLKASNVLL--DNTMNPKISDFGLARSF-GLDQTEANT 678
+ARG+ YL + + IHRDL A NVL+ DN M KI+DFGLAR +D + T
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVM--KIADFGLARDVHNIDYYKKTT 194
Query: 679 KRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 714
+ +M+PE D +++ +SDV+SFGVL+ EI
Sbjct: 195 NGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLLWEI 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 3e-17
Identities = 68/219 (31%), Positives = 101/219 (46%), Gaps = 19/219 (8%)
Query: 522 KNKLGEGGFGPVY---KGMLIEGQEIAV-KRLSKGSGQGMEEFKN--EVLLIAKLQHRNL 575
+ +LG+G FG VY + + + V K + G E + E L++KL H +
Sbjct: 5 QQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAI 64
Query: 576 VKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRS-KLLDWSKRSHIIAGIARGLLYLHQ 634
VK +RD +I EY + LD + + + K L ++ + G+ Y+HQ
Sbjct: 65 VKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ 124
Query: 635 DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAI 694
RI+HRDLKA N+ L N + KI DFG++R A T GT YMSPE
Sbjct: 125 R---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT--FTGTPYYMSPEALK 178
Query: 695 DGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLL 733
+ KSD++S G ++ E+ C HA N L
Sbjct: 179 HQGYDSKSDIWSLGCILYEMCC------LAHAFEGQNFL 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 4e-17
Identities = 65/221 (29%), Positives = 103/221 (46%), Gaps = 26/221 (11%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLI--------EGQEIAVKRLS-KGSGQGMEEFKNEVLLI 567
D + LGEG FG V + E +AVK L + + + + +E+ ++
Sbjct: 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 74
Query: 568 AKL-QHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFI-----------FDTTR--SKLL 613
+ +H+N++ LLG CTQ +I EY +L ++ +D R + +
Sbjct: 75 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQM 134
Query: 614 DWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673
+ +ARG+ YL + + IHRDL A NVL+ KI+DFGLAR
Sbjct: 135 TFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNID 191
Query: 674 TEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 714
T +M+PE D +++ +SDV+SFGVL+ EI
Sbjct: 192 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 232
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 5e-17
Identities = 75/270 (27%), Positives = 126/270 (46%), Gaps = 34/270 (12%)
Query: 519 FSEKNKLGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQGMEEFKN---EVLLIAKLQHRN 574
F +++G G FG VY E+ AVK++S Q E++++ EV + +L+H N
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQ 634
++ GC + L+ EY + D K L + + I G +GL YLH
Sbjct: 83 TIEYKGCYLKEHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHS 139
Query: 635 DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAI 694
+ +IHRD+KA N+LL K++DFG A + AN+ VGT +M+PE +
Sbjct: 140 HN---MIHRDIKAGNILLTEPGQVKLADFGSASK----SSPANS--FVGTPYWMAPEVIL 190
Query: 695 ---DGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQ 751
+G + K DV+S G+ +E + +K FN N + + + + P ++
Sbjct: 191 AMDEGQYDGKVDVWSLGITCIE-LAERKPPLFN-----MNAMSALYHIAQNDSPTLQSNE 244
Query: 752 SLDNSCSFSEALRCIQVGLLCVQQRPEDRP 781
D+ F + C+Q+ P++RP
Sbjct: 245 WTDSFRGFVD---------YCLQKIPQERP 265
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 5e-17
Identities = 53/171 (30%), Positives = 87/171 (50%), Gaps = 10/171 (5%)
Query: 524 KLGEGGFGPVYKGMLIE-GQEIAVKR--LSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLG 580
++GEG G V+K E G+ +A+K+ L + G + E+ + QH +VKLL
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66
Query: 581 CCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRI 640
+L+ EY+P+ L + D R L + +S + + +G+ Y+H I
Sbjct: 67 VFPHGSGFVLVMEYMPS-DLSEVLRDEERP-LPEAQVKS-YMRMLLKGVAYMHA---NGI 120
Query: 641 IHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPE 691
+HRDLK +N+L+ KI+DFGLAR F ++ + + V T Y +PE
Sbjct: 121 MHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ-VATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 5e-17
Identities = 64/223 (28%), Positives = 107/223 (47%), Gaps = 20/223 (8%)
Query: 508 DLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLI 567
DL + + F +G G +G VYKG ++ ++A ++ + EE K E+ ++
Sbjct: 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINML 66
Query: 568 AKL-QHRNLVKLLGCCTQR------DERMLIYEYLPNKSLDYFIFDTTRSKLL-DWSKRS 619
K HRN+ G ++ D+ L+ E+ S+ + +T + L DW +
Sbjct: 67 KKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWI--A 124
Query: 620 HIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTK 679
+I I RGL +LH ++IHRD+K NVLL K+ DFG+ S LD+T
Sbjct: 125 YICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGV--SAQLDRTVGRRN 179
Query: 680 RVVGTYGYMSPEYAI-----DGLFSVKSDVFSFGVLVLEIICG 717
+GT +M+PE D + +SD++S G+ +E+ G
Sbjct: 180 TFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 6e-17
Identities = 58/169 (34%), Positives = 88/169 (52%), Gaps = 24/169 (14%)
Query: 620 HIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTK 679
I + GL YL+ + RI+HRD+K SN+L+++ K+ DFG+ S L + A+T
Sbjct: 107 KIAVAVVEGLTYLY--NVHRIMHRDIKPSNILVNSRGQIKLCDFGV--SGELINSIADT- 161
Query: 680 RVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRL 739
VGT YMSPE G ++VKSDV+S G+ ++E+ GK F++ D D G +
Sbjct: 162 -FVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDD----GQDDPM 216
Query: 740 WIEERPLELIDQSLDN------SCSFSEALR-CIQVGLLCVQQRPEDRP 781
I L+L+ Q + S F E LR + C+ + P +RP
Sbjct: 217 GI----LDLLQQIVQEPPPRLPSSDFPEDLRDFVD---ACLLKDPTERP 258
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 7e-17
Identities = 77/299 (25%), Positives = 137/299 (45%), Gaps = 44/299 (14%)
Query: 512 IANATDNFSEKNKLGEGGFGPVYKGMLIEG-----QEIAVKRLSKGSGQ-GMEEFKNEVL 565
IA + D + + L EG FG ++ G+LI+ +E+ VK + + + + E
Sbjct: 1 IAISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESC 60
Query: 566 LIAKLQHRNLVKLLGCCTQRDER-MLIYEYLPNKSLDYF-----IFDTTRSKLLDWSKRS 619
L+ L H+N++ +L C + E ++Y Y+ +L F + + + L +
Sbjct: 61 LLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLV 120
Query: 620 HIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS-FGLDQ--TEA 676
H+ IA G+ YLH + +IH+D+ A N ++D + KI+D L+R F +D
Sbjct: 121 HMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGD 177
Query: 677 NTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHD----HNL 732
N R V +M+ E ++ +S SDV+SFGVL+ E++ + + + D
Sbjct: 178 NENRPV---KWMALESLVNKEYSSASDVWSFGVLLWELMTLGQT---PYVEIDPFEMAAY 231
Query: 733 LGHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLS 791
L +RL +P+ D+ + C C PE+RP+ S +V L+
Sbjct: 232 LKDGYRL---AQPINCPDE-------LFAVMAC------CWALDPEERPSFSQLVQCLT 274
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 7e-17
Identities = 64/205 (31%), Positives = 103/205 (50%), Gaps = 19/205 (9%)
Query: 525 LGEGGFGPVYKGMLIE-GQEIAVKRL-----SKGSGQGMEEFKNEVLLIAKLQHRNLVKL 578
LG+G FG VY + G+E+AVK++ S + + + + E+ L+ L H +V+
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 579 LGCCTQRDERML--IYEYLPNKSLDYFIFDTTRS--KLLDWSKRSHIIAGIARGLLYLHQ 634
GC ER L E++P S I D +S L + R + I G+ YLH
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGS----IKDQLKSYGALTENVTRKYT-RQILEGVSYLHS 124
Query: 635 DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF-GLDQTEANTKRVVGTYGYMSPEYA 693
+ I+HRD+K +N+L D+ N K+ DFG ++ + + K V GT +MSPE
Sbjct: 125 N---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVI 181
Query: 694 IDGLFSVKSDVFSFGVLVLEIICGK 718
+ K+D++S G V+E++ K
Sbjct: 182 SGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 9e-17
Identities = 68/213 (31%), Positives = 107/213 (50%), Gaps = 20/213 (9%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE--GQEIAVKRL-SKGSGQGMEEFKNEVLLIAKLQH- 572
++ + ++G G FG V K ML + G +AVKR+ S + + ++ ++ +
Sbjct: 4 EDLKDLGEIGRGAFGTVNK-MLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDC 62
Query: 573 RNLVKLLGCCTQRDERMLIYEYLPNKSLDYF---IFDTTRSKLLDWSKRSHIIAGIARGL 629
+VK G R+ I L + SLD F +++ +S + I + L
Sbjct: 63 PYIVKFYGA-LFREGDCWICMELMDISLDKFYKYVYEVLKSVI-PEEILGKIAVATVKAL 120
Query: 630 LYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMS 689
YL ++ L+IIHRD+K SN+LLD N K+ DFG+ S L + A T R G YM+
Sbjct: 121 NYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGI--SGQLVDSIAKT-RDAGCRPYMA 175
Query: 690 PE----YAIDGLFSVKSDVFSFGVLVLEIICGK 718
PE A DG + V+SDV+S G+ + E+ GK
Sbjct: 176 PERIDPSARDG-YDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 1e-16
Identities = 68/273 (24%), Positives = 119/273 (43%), Gaps = 28/273 (10%)
Query: 457 RRQSKNKKQVMIIITSISLATAVIFIG-GLMYRRKKHSNQ----GNEKEEMELPIFDLKI 511
+R K I ++ + + G ++ R +++ + NE EL FD K+
Sbjct: 620 KRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKV 679
Query: 512 IANATDN-----FSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVL 565
+ T N E+N + G G YKG I+ G + VK ++ + E +
Sbjct: 680 SKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIAD--- 736
Query: 566 LIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGI 625
+ KLQH N+VKL+G C LI+EY+ K+L + + L W +R I GI
Sbjct: 737 -MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------LSWERRRKIAIGI 789
Query: 626 ARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTY 685
A+ L +LH ++ +L +++D P + L D +
Sbjct: 790 AKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS------ 842
Query: 686 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGK 718
Y++PE + KSD++ FG++++E++ GK
Sbjct: 843 AYVAPETRETKDITEKSDIYGFGLILIELLTGK 875
|
Length = 968 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 1e-16
Identities = 56/205 (27%), Positives = 105/205 (51%), Gaps = 12/205 (5%)
Query: 514 NATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQH 572
N ++F ++G G +G VYK + G+ A+K + G+ + E++++ +H
Sbjct: 6 NPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKH 65
Query: 573 RNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYL 632
N+V G +RD+ + E+ SL I+ T L S+ +++ +GL YL
Sbjct: 66 SNIVAYFGSYLRRDKLWICMEFCGGGSLQD-IYHVTGP--LSESQIAYVSRETLQGLYYL 122
Query: 633 HQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEY 692
H + +HRD+K +N+LL + + K++DFG+ S + T A K +GT +M+PE
Sbjct: 123 HSKGK---MHRDIKGANILLTDNGHVKLADFGV--SAQITATIAKRKSFIGTPYWMAPEV 177
Query: 693 AI---DGLFSVKSDVFSFGVLVLEI 714
A G ++ D+++ G+ +E+
Sbjct: 178 AAVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 1e-16
Identities = 64/210 (30%), Positives = 105/210 (50%), Gaps = 27/210 (12%)
Query: 524 KLGEGGFGPVY----KGMLIEGQE--IAVKRLSK-GSGQGMEEFKNEVLLIAKLQHRNLV 576
+LG+G FG VY KG++ + E +A+K +++ S + EF NE ++ + ++V
Sbjct: 13 ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72
Query: 577 KLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSK--------LLDWSKRSHIIAGIARG 628
+LLG +Q ++I E + L ++ + R + K + IA G
Sbjct: 73 RLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131
Query: 629 LLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT---- 684
+ YL+ + + +HRDL A N ++ KI DFG+ R D E + R G
Sbjct: 132 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRKGGKGLLP 184
Query: 685 YGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 714
+MSPE DG+F+ SDV+SFGV++ EI
Sbjct: 185 VRWMSPESLKDGVFTTYSDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 2e-16
Identities = 58/196 (29%), Positives = 102/196 (52%), Gaps = 13/196 (6%)
Query: 524 KLGEGGFGPVYKG---MLIEGQEIAVKRLSKGSGQGM-EEFKNEVLLIAKLQHRNLVKLL 579
+LG G FG V KG M + ++A+K L + + + +E E ++ +L + +V+++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 580 GCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLR 639
G C + + ML+ E L+ F+ + + + S ++ ++ G+ YL +
Sbjct: 62 GVC-EAEALMLVMEMASGGPLNKFL--SGKKDEITVSNVVELMHQVSMGMKYLEGKN--- 115
Query: 640 IIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTY--GYMSPEYAIDGL 697
+HRDL A NVLL N KISDFGL+++ G D + R G + + +PE
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY-KARSAGKWPLKWYAPECINFRK 174
Query: 698 FSVKSDVFSFGVLVLE 713
FS +SDV+S+G+ + E
Sbjct: 175 FSSRSDVWSYGITMWE 190
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 80.3 bits (199), Expect = 2e-16
Identities = 66/213 (30%), Positives = 113/213 (53%), Gaps = 24/213 (11%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEI-AVKRL---SKGSGQGMEEFKNEVLLIAKLQH 572
D + + N++ EG +G VY+ + EI A+K+L + G + + E+ ++ KLQH
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLR-EINILLKLQH 63
Query: 573 RNLVKL----LGCCTQRDERMLIYEYLPN--KSLDYFIFDTTRSKLLDWSKRSHIIAGIA 626
N+V + +G + D+ ++ EY+ + KSL +T + L S+ ++ +
Sbjct: 64 PNIVTVKEVVVG--SNLDKIYMVMEYVEHDLKSL----METMKQPFLQ-SEVKCLMLQLL 116
Query: 627 RGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYG 686
G+ +LH + I+HRDLK SN+LL+N KI DFGLAR +G + T+ VV T
Sbjct: 117 SGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYG-SPLKPYTQLVV-TLW 171
Query: 687 YMSPEYAID-GLFSVKSDVFSFGVLVLEIICGK 718
Y +PE + +S D++S G + E++ K
Sbjct: 172 YRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 2e-16
Identities = 66/220 (30%), Positives = 103/220 (46%), Gaps = 34/220 (15%)
Query: 515 ATDNFSE---KNKLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKN----EVLL 566
A + SE N++G G G VYK + G+ A+K + G + + E+ +
Sbjct: 69 AAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIY---GNHEDTVRRQICREIEI 125
Query: 567 IAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIA 626
+ + H N+VK E ++ E++ SL+ + + D + + I
Sbjct: 126 LRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLE-------GTHIADEQFLADVARQIL 178
Query: 627 RGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYG 686
G+ YLH R I+HRD+K SN+L+++ N KI+DFG++R L QT VGT
Sbjct: 179 SGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRI--LAQTMDPCNSSVGTIA 233
Query: 687 YMSPEY--------AIDGLFSVKSDVFSFGVLVLEIICGK 718
YMSPE A DG D++S GV +LE G+
Sbjct: 234 YMSPERINTDLNHGAYDGY---AGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 2e-16
Identities = 67/218 (30%), Positives = 104/218 (47%), Gaps = 36/218 (16%)
Query: 525 LGEGGFGPVYKGMLIEG-----------QEIAVKRL-SKGSGQGMEEFKNEVLLIAKL-Q 571
LGEG FG V ++ E ++AVK L S + + + + +E+ ++ + +
Sbjct: 26 LGEGCFGQV---VMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 82
Query: 572 HRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIF-------------DTTRSKLLDWSKR 618
H+N++ LLG CTQ +I EY +L ++ + L +
Sbjct: 83 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142
Query: 619 SHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLL--DNTMNPKISDFGLARSFGLDQTEA 676
+ARG+ YL + + IHRDL A NVL+ DN M KI+DFGLAR
Sbjct: 143 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVM--KIADFGLARDIHHIDYYK 197
Query: 677 NTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 714
T +M+PE D +++ +SDV+SFGVL+ EI
Sbjct: 198 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 235
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 3e-16
Identities = 64/212 (30%), Positives = 107/212 (50%), Gaps = 19/212 (8%)
Query: 518 NFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRL-----SKGSGQGMEEFKNEVLLIAKLQ 571
N+ LG G FG VY + G+E+AVK++ S+ + + + + E+ L+ L+
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 572 HRNLVKLLGCCTQRDERML--IYEYLPNKSLDYFIFDTTRS--KLLDWSKRSHIIAGIAR 627
H +V+ GC +E+ L EY+P S I D ++ L + R + I +
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGS----IKDQLKAYGALTENVTRRYT-RQILQ 117
Query: 628 GLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF-GLDQTEANTKRVVGTYG 686
G+ YLH + I+HRD+K +N+L D+ N K+ DFG ++ + + K V GT
Sbjct: 118 GVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPY 174
Query: 687 YMSPEYAIDGLFSVKSDVFSFGVLVLEIICGK 718
+MSPE + K+DV+S V+E++ K
Sbjct: 175 WMSPEVISGEGYGRKADVWSVACTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 4e-16
Identities = 65/224 (29%), Positives = 105/224 (46%), Gaps = 48/224 (21%)
Query: 518 NFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKN--------EVLLIA 568
F + N++GEG +G VY+ G+ +A+K++ M+ ++ E+ L+
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVR------MDNERDGIPISSLREITLLL 61
Query: 569 KLQHRNLVKLLGCCT--QRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIA 626
L+H N+V+L D L+ EY + + LLD + +
Sbjct: 62 NLRHPNIVELKEVVVGKHLDSIFLVMEYC----------EQDLASLLDNMPTPFSESQVK 111
Query: 627 -------RGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTK 679
RGL YLH++ IIHRDLK SN+LL + KI+DFGLAR++GL T
Sbjct: 112 CLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM-TP 167
Query: 680 RVVGTYGYMSPEYAIDGLFSVKS-----DVFSFGVLVLEIICGK 718
+VV T Y +PE L + D+++ G ++ E++ K
Sbjct: 168 KVV-TLWYRAPEL----LLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 6e-16
Identities = 64/221 (28%), Positives = 112/221 (50%), Gaps = 31/221 (14%)
Query: 517 DNFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFK----NEVLLIAKLQ 571
D F ++GEG +G VYK G+ +A+K++ + + E F E+ ++ +L
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK--EGFPITAIREIKILRQLN 64
Query: 572 HRNLVKLLGCCTQRDERM----------LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHI 621
HRN+V L T + + + L++EY+ D+ + S L+ +S+ HI
Sbjct: 65 HRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYM-----DHDLMGLLESGLVHFSE-DHI 118
Query: 622 ---IAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANT 678
+ + GL Y H+ + L HRD+K SN+LL+N K++DFGLAR + +++ T
Sbjct: 119 KSFMKQLLEGLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYT 175
Query: 679 KRVVGTYGYMSPEYAI-DGLFSVKSDVFSFGVLVLEIICGK 718
+V+ T Y PE + + + DV+S G ++ E+ K
Sbjct: 176 NKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 6e-16
Identities = 75/259 (28%), Positives = 114/259 (44%), Gaps = 36/259 (13%)
Query: 525 LGEGGFGPV------YKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKL 578
LG+GGFG V G + +++ KR+ K G+ M NE ++ K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKQILEKVNSRFVVSL 65
Query: 579 LGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRL 638
+D L+ + L + I++ D + A I GL LH R
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGF-DEERAVFYAAEITCGLEDLH---RE 121
Query: 639 RIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLF 698
RI++RDLK N+LLD+ + +ISD GLA +T + VGT GYM+PE + +
Sbjct: 122 RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET---IRGRVGTVGYMAPEVVKNERY 178
Query: 699 SVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDN--- 755
+ D + G L+ E+I GK +R E+ E +++ +
Sbjct: 179 TFSPDWWGLGCLIYEMIEGKS----------------PFRQRKEKVKREEVERRVKEDQE 222
Query: 756 --SCSFSEALRCIQVGLLC 772
S FSEA R I LL
Sbjct: 223 EYSEKFSEAARSICRQLLT 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 6e-16
Identities = 59/204 (28%), Positives = 98/204 (48%), Gaps = 13/204 (6%)
Query: 522 KNKLGEGGFGPVYKGMLI--EGQEI--AVKRLSKGSGQGM-EEFKNEVLLIAKLQHRNLV 576
+GEG FG VY+G+ + E ++I AVK + + E+F E ++ + H ++V
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70
Query: 577 KLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDS 636
KL+G T+ + ++ E P L ++ LD + ++ L YL
Sbjct: 71 KLIGVITE-NPVWIVMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTALAYLES-- 125
Query: 637 RLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDG 696
R +HRD+ A NVL+ + K+ DFGL+R D++ + +M+PE
Sbjct: 126 -KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE-DESYYKASKGKLPIKWMAPESINFR 183
Query: 697 LFSVKSDVFSFGVLVLEIIC-GKK 719
F+ SDV+ FGV + EI+ G K
Sbjct: 184 RFTSASDVWMFGVCMWEILMLGVK 207
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 7e-16
Identities = 58/195 (29%), Positives = 100/195 (51%), Gaps = 12/195 (6%)
Query: 524 KLGEGGFGPVYKGMLIEGQEI-AVKRLS-KGSGQGMEEFK-NEVLLIAKLQHRNLVKLLG 580
K+GEG +G V+K E EI A+KR+ +G+ E+ L+ +L+H+N+V+L
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 581 CCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRI 640
+ L++EY ++ L + FD+ + D + + +GL + H +
Sbjct: 67 VLHSDKKLTLVFEYC-DQDLKKY-FDSCNGDI-DPEIVKSFMFQLLKGLAFCHSH---NV 120
Query: 641 IHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDG-LFS 699
+HRDLK N+L++ K++DFGLAR+FG+ + VV T Y P+ L+S
Sbjct: 121 LHRDLKPQNLLINKNGELKLADFGLARAFGI-PVRCYSAEVV-TLWYRPPDVLFGAKLYS 178
Query: 700 VKSDVFSFGVLVLEI 714
D++S G + E+
Sbjct: 179 TSIDMWSAGCIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-15
Identities = 57/197 (28%), Positives = 99/197 (50%), Gaps = 13/197 (6%)
Query: 524 KLGEGGFGPVYKGMLIEGQEIAV-KRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCC 582
+LG+G FG VYK E +A K + S + +E++ E+ ++A H N+VKLL
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 583 TQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIH 642
+ ++ E+ ++D + + R L + + L YLH++ +IIH
Sbjct: 72 YYENNLWILIEFCAGGAVDAVMLELERP--LTEPQIRVVCKQTLEALNYLHEN---KIIH 126
Query: 643 RDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAI-----DGL 697
RDLKA N+L + K++DFG+ S +T +GT +M+PE + D
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGV--SAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRP 184
Query: 698 FSVKSDVFSFGVLVLEI 714
+ K+DV+S G+ ++E+
Sbjct: 185 YDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 1e-15
Identities = 66/204 (32%), Positives = 96/204 (47%), Gaps = 23/204 (11%)
Query: 525 LGEGGFGPVYKGMLIE----GQEIAVKRLSKG---SGQGMEEFKNE--VLLIAKLQHRNL 575
LG+G FG V +L E + AVK L K +E E VL +A +H L
Sbjct: 3 LGKGSFGKV---LLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG-KHPFL 58
Query: 576 VKLLGCCTQRDERM-LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQ 634
+L C Q +R+ + EY+ L + I RS D + A I GL +LH+
Sbjct: 59 TQLH-SCFQTKDRLFFVMEYVNGGDLMFHI---QRSGRFDEPRARFYAAEIVLGLQFLHE 114
Query: 635 DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAI 694
II+RDLK NVLLD+ + KI+DFG+ + L T GT Y++PE
Sbjct: 115 RG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG--GVTTSTFCGTPDYIAPEILS 169
Query: 695 DGLFSVKSDVFSFGVLVLEIICGK 718
+ D ++ GVL+ E++ G+
Sbjct: 170 YQPYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 1e-15
Identities = 55/196 (28%), Positives = 98/196 (50%), Gaps = 10/196 (5%)
Query: 524 KLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCC 582
K+GEG G V G+++AVK + Q E NEV+++ QH+N+V++
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 583 TQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIH 642
+E ++ E+L +L D L+ + + + + + L YLH +IH
Sbjct: 88 LVGEELWVLMEFLQGGALT----DIVSQTRLNEEQIATVCESVLQALCYLHSQG---VIH 140
Query: 643 RDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKS 702
RD+K+ ++LL K+SDFG D + K +VGT +M+PE + +
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK--RKSLVGTPYWMAPEVISRTPYGTEV 198
Query: 703 DVFSFGVLVLEIICGK 718
D++S G++V+E++ G+
Sbjct: 199 DIWSLGIMVIEMVDGE 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 2e-15
Identities = 72/282 (25%), Positives = 126/282 (44%), Gaps = 36/282 (12%)
Query: 525 LGEGGFGPVYK-------GMLIEGQEIAVKRLSKGSG-----QGMEEFKNEVLLIAK-LQ 571
LG G FG VYK L+ +EI V + G + + + +EV +I + L+
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 572 HRNLVKLLGCCTQRDERMLIYEYLPNKSL-DYFIFDTTRSKLLDWSKRSHIIAGIARGLL 630
H N+V+ + D ++ + + L ++F + + + +I + L
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127
Query: 631 YLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSP 690
YLH++ R I+HRDL +N++L I+DFGLA+ Q E+ VVGT Y P
Sbjct: 128 YLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQ---KQPESKLTSVVGTILYSCP 182
Query: 691 EYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELID 750
E + + K+DV++FG ++ ++ + N+L A + I E E +
Sbjct: 183 EIVKNEPYGEKADVWAFGCILYQMCT------LQPPFYSTNMLSLATK--IVEAVYEPLP 234
Query: 751 QSLDNSCSFSEALR-CIQVGLLCVQQRPEDRPNMSSVVLMLS 791
+ + +SE + I C+ E RP++ V M+S
Sbjct: 235 EGM-----YSEDVTDVITS---CLTPDAEARPDIIQVSAMIS 268
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 55/206 (26%), Positives = 103/206 (50%), Gaps = 14/206 (6%)
Query: 514 NATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQH 572
N ++ ++G G +G VYK + G+ AVK + G + E+ ++ + +H
Sbjct: 6 NPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKH 65
Query: 573 RNLVKLLGCCTQRDERMLIYEYLPNKSL-DYFIFDTTRSKLLDWSKRSHIIAGIARGLLY 631
N+V G R++ + EY SL D + S+L + +++ +GL Y
Sbjct: 66 CNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSEL----QIAYVCRETLQGLAY 121
Query: 632 LHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPE 691
LH ++ HRD+K +N+LL + + K++DFG+A + T A K +GT +M+PE
Sbjct: 122 LHSKGKM---HRDIKGANILLTDNGDVKLADFGVAAK--ITATIAKRKSFIGTPYWMAPE 176
Query: 692 YAI---DGLFSVKSDVFSFGVLVLEI 714
A +G ++ D+++ G+ +E+
Sbjct: 177 VAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-15
Identities = 55/196 (28%), Positives = 97/196 (49%), Gaps = 10/196 (5%)
Query: 524 KLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCC 582
K+GEG G V G+++AVK++ Q E NEV+++ H N+V +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 583 TQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIH 642
DE ++ E+L +L D ++ + + + + R L YLH +IH
Sbjct: 89 LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIH 141
Query: 643 RDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKS 702
RD+K+ ++LL + K+SDFG + + K +VGT +M+PE + +
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCAQ--VSKEVPKRKSLVGTPYWMAPEVISRLPYGTEV 199
Query: 703 DVFSFGVLVLEIICGK 718
D++S G++V+E+I G+
Sbjct: 200 DIWSLGIMVIEMIDGE 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-15
Identities = 56/203 (27%), Positives = 101/203 (49%), Gaps = 13/203 (6%)
Query: 517 DNFSEKNKLGEGGFGPVYKGML-IEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNL 575
DNF K+GEG G V + G+ +AVK++ Q E NEV+++ QH N+
Sbjct: 23 DNFI---KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 79
Query: 576 VKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQD 635
V++ DE ++ E+L +L D ++ + + + + + L LH
Sbjct: 80 VEMYNSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLKALSVLHAQ 135
Query: 636 SRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAID 695
+IHRD+K+ ++LL + K+SDFG + + K +VGT +M+PE
Sbjct: 136 G---VIHRDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKSLVGTPYWMAPELISR 190
Query: 696 GLFSVKSDVFSFGVLVLEIICGK 718
+ + D++S G++V+E++ G+
Sbjct: 191 LPYGPEVDIWSLGIMVIEMVDGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-15
Identities = 60/206 (29%), Positives = 97/206 (47%), Gaps = 15/206 (7%)
Query: 519 FSEKNKLGEGGFGPV------YKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQH 572
F LG+GGFG V G + +++ KR+ K G+ M NE ++ K+
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKRILEKVNS 59
Query: 573 RNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYL 632
R +V L +D L+ + L + I++ D + A + GL L
Sbjct: 60 RFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGF-DEQRAIFYAAELCCGLEDL 118
Query: 633 HQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEY 692
++ RI++RDLK N+LLD+ + +ISD GLA +T + VGT GYM+PE
Sbjct: 119 QRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET---VRGRVGTVGYMAPEV 172
Query: 693 AIDGLFSVKSDVFSFGVLVLEIICGK 718
+ ++ D + G L+ E+I G+
Sbjct: 173 INNEKYTFSPDWWGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 2e-15
Identities = 58/198 (29%), Positives = 93/198 (46%), Gaps = 15/198 (7%)
Query: 524 KLGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQGMEEFK---NEVLLIAKLQHRNLVKLL 579
++G+GG+G V+ + EI A+KR+ K + E + E ++ + LVKLL
Sbjct: 8 QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL 67
Query: 580 GCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLR 639
+ L EY+P D+ L + R ++ + LH L
Sbjct: 68 YAFQDDEYLYLAMEYVPGG--DFRTLLNNLGVLSEDHARFYMAEMFE-AVDALH---ELG 121
Query: 640 IIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFS 699
IHRDLK N L+D + + K++DFGL++ T AN+ VVG+ YM+PE +
Sbjct: 122 YIHRDLKPENFLIDASGHIKLTDFGLSKGI---VTYANS--VVGSPDYMAPEVLRGKGYD 176
Query: 700 VKSDVFSFGVLVLEIICG 717
D +S G ++ E +CG
Sbjct: 177 FTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-15
Identities = 58/194 (29%), Positives = 97/194 (50%), Gaps = 11/194 (5%)
Query: 524 KLGEGGFGPVYKGML-IEGQEIAVKRLSKGSGQGME-EFKNEVLLIAKLQHRNLVKLLGC 581
++G G FG V+ G L + +AVK + ++ +F E ++ + H N+V+L+G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 582 CTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRII 641
CTQ+ ++ E + + D+ F T L + ++ A G+ YL I
Sbjct: 62 CTQKQPIYIVMELV--QGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CI 116
Query: 642 HRDLKASNVLLDNTMNPKISDFGLAR--SFGLDQTEANTKRVVGTYGYMSPEYAIDGLFS 699
HRDL A N L+ KISDFG++R G+ + K++ + +PE G +S
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI--PVKWTAPEALNYGRYS 174
Query: 700 VKSDVFSFGVLVLE 713
+SDV+SFG+L+ E
Sbjct: 175 SESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 3e-15
Identities = 63/196 (32%), Positives = 94/196 (47%), Gaps = 19/196 (9%)
Query: 528 GGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKN----EVLLIAKLQHRNLVKLLGCC 582
G FG VY G A+K L K + N +++ + + + KL
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF 66
Query: 583 TQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIH 642
+D L+ EYL I T DW+K+ IA + G+ LHQ IIH
Sbjct: 67 QSKDYLYLVMEYLNGGDCASLI-KTLGGLPEDWAKQ--YIAEVVLGVEDLHQRG---IIH 120
Query: 643 RDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVK- 701
RD+K N+L+D T + K++DFGL+R+ GL+ K+ VGT Y++PE I G+ K
Sbjct: 121 RDIKPENLLIDQTGHLKLTDFGLSRN-GLEN-----KKFVGTPDYLAPE-TILGVGDDKM 173
Query: 702 SDVFSFGVLVLEIICG 717
SD +S G ++ E + G
Sbjct: 174 SDWWSLGCVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 5e-15
Identities = 65/202 (32%), Positives = 102/202 (50%), Gaps = 25/202 (12%)
Query: 524 KLGEGGFGPVYKG---MLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAK----LQHRNLV 576
+LG G FG V KG M + +AVK L + K+E+L A L + +V
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNND--PALKDELLREANVMQQLDNPYIV 59
Query: 577 KLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDS 636
+++G C + + ML+ E L+ F+ ++K + + ++ ++ G+ YL + +
Sbjct: 60 RMIGIC-EAESWMLVMELAELGPLNKFL---QKNKHVTEKNITELVHQVSMGMKYLEETN 115
Query: 637 RLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYG-----YMSPE 691
+HRDL A NVLL KISDFGL+++ G D+ K T+G + +PE
Sbjct: 116 ---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK----THGKWPVKWYAPE 168
Query: 692 YAIDGLFSVKSDVFSFGVLVLE 713
FS KSDV+SFGVL+ E
Sbjct: 169 CMNYYKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 7e-15
Identities = 58/202 (28%), Positives = 100/202 (49%), Gaps = 23/202 (11%)
Query: 525 LGEGGFGPVYKGML-IEGQE---IAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLL 579
LG G FG + +G L + + +A+ L G S + F E L + + H N+V+L
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72
Query: 580 GCCTQRDERMLIYEYLPNKSLDYFIF----DTTRSKLLDWSKRSHIIAGIARGLLYLHQD 635
G T+ + M++ EY+ N +LD F+ +L+ ++ G+A G+ YL
Sbjct: 73 GVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMG------MLPGLASGMKYL--- 123
Query: 636 SRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEA--NTKRVVGTYGYMSPEYA 693
S + +H+ L A VL+++ + KIS F + D++EA T + +PE
Sbjct: 124 SEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQE---DKSEAIYTTMSGKSPVLWAAPEAI 180
Query: 694 IDGLFSVKSDVFSFGVLVLEII 715
FS SDV+SFG+++ E++
Sbjct: 181 QYHHFSSASDVWSFGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 8e-15
Identities = 60/209 (28%), Positives = 105/209 (50%), Gaps = 25/209 (11%)
Query: 524 KLGEGGFGPVYKGM---LIEGQ---EIAVKRLSK-GSGQGMEEFKNEVLLIAKLQHRNLV 576
+LG+G FG VY+G +I+G+ +AVK +++ S + EF NE ++ ++V
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72
Query: 577 KLLGCCTQRDERMLIYEYLPNKSLDYFIF-------DTTRSKLLDWSKRSHIIAGIARGL 629
+LLG ++ +++ E + + L ++ + + + A IA G+
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132
Query: 630 LYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT----Y 685
YL+ + +HRDL A N ++ + KI DFG+ R D E + R G
Sbjct: 133 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPV 185
Query: 686 GYMSPEYAIDGLFSVKSDVFSFGVLVLEI 714
+M+PE DG+F+ SD++SFGV++ EI
Sbjct: 186 RWMAPESLKDGVFTTSSDMWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 9e-15
Identities = 57/191 (29%), Positives = 89/191 (46%), Gaps = 37/191 (19%)
Query: 523 NKLGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQGMEEFKN--------EVLLIAKLQHR 573
K+G+G FG V+K + ++I A+K++ ME K E+ ++ L+H
Sbjct: 18 AKIGQGTFGEVFKARHKKTKQIVALKKVL------MENEKEGFPITALREIKILQLLKHE 71
Query: 574 NLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKL----------LDWSKRSHIIA 623
N+V L+ C R Y K Y +F+ L S+ ++
Sbjct: 72 NVVNLIEIC-----RTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMK 126
Query: 624 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEAN---TKR 680
+ GL Y+H R +I+HRD+KA+N+L+ K++DFGLAR+F L + T R
Sbjct: 127 MLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNR 183
Query: 681 VVGTYGYMSPE 691
VV T Y PE
Sbjct: 184 VV-TLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 1e-14
Identities = 54/200 (27%), Positives = 91/200 (45%), Gaps = 15/200 (7%)
Query: 524 KLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKN----EVLLIAKLQHRNLVKL 578
+GEG +G V K G+ +A+K+ K S + E+ K EV ++ +L+H N+V L
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKF-KES-EDDEDVKKTALREVKVLRQLRHENIVNL 65
Query: 579 LGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRL 638
++ L++EY+ L+ L I + + + Y H
Sbjct: 66 KEAFRRKGRLYLVFEYVERTLLELL---EASPGGLPPDAVRSYIWQLLQAIAYCH---SH 119
Query: 639 RIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAI-DGL 697
IIHRD+K N+L+ + K+ DFG AR+ T V T Y +PE + D
Sbjct: 120 NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVA-TRWYRAPELLVGDTN 178
Query: 698 FSVKSDVFSFGVLVLEIICG 717
+ DV++ G ++ E++ G
Sbjct: 179 YGKPVDVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 1e-14
Identities = 59/206 (28%), Positives = 100/206 (48%), Gaps = 15/206 (7%)
Query: 519 FSEKNKLGEGGFGPV------YKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQH 572
F + LG+GGFG V G + + + KR+ K G+ M NE ++ K+
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMA--LNEKQILEKVNS 59
Query: 573 RNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYL 632
+ +V L +D L+ + L + I++ + + A I GL L
Sbjct: 60 QFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGF-EEERALFYAAEILCGLEDL 118
Query: 633 HQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEY 692
H+++ ++RDLK N+LLD+ + +ISD GLA + + E+ R VGT GYM+PE
Sbjct: 119 HREN---TVYRDLKPENILLDDYGHIRISDLGLA--VKIPEGESIRGR-VGTVGYMAPEV 172
Query: 693 AIDGLFSVKSDVFSFGVLVLEIICGK 718
+ +++ D + G L+ E+I G+
Sbjct: 173 LNNQRYTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 1e-14
Identities = 64/200 (32%), Positives = 101/200 (50%), Gaps = 17/200 (8%)
Query: 525 LGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNE--VLLIAKLQHRNLVKL 578
LG+G FG V L E G+ AVK L K +E E +L +A+ H L +L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-NHPFLTQL 61
Query: 579 LGCCTQRDERML-IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSR 637
CC Q +R+ + E++ L +F +S+ D ++ A I L++LH
Sbjct: 62 Y-CCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEARARFYAAEITSALMFLHDKG- 116
Query: 638 LRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGL 697
II+RDLK NVLLD+ + K++DFG+ + + +T GT Y++PE + L
Sbjct: 117 --IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTST--FCGTPDYIAPEILQEML 172
Query: 698 FSVKSDVFSFGVLVLEIICG 717
+ D ++ GVL+ E++CG
Sbjct: 173 YGPSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 59/199 (29%), Positives = 99/199 (49%), Gaps = 14/199 (7%)
Query: 524 KLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEE--FKNEVLLIAKLQHRNLVKLLG 580
+GEG +G V K E GQ +A+K+ + M + E+ ++ +L+H NLV L+
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 581 CCTQRDERMLIYEYLPNKSLDYFIFDTTRSKL-LDWSKRSHIIAGIARGLLYLHQDSRLR 639
++ L++E++ + LD D + LD S+ + I RG+ + H +
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLD----DLEKYPNGLDESRVRKYLFQILRGIEFCHSHN--- 120
Query: 640 IIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAI-DGLF 698
IIHRD+K N+L+ + K+ DFG AR+ E T V T Y +PE + D +
Sbjct: 121 IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EVYTD-YVATRWYRAPELLVGDTKY 178
Query: 699 SVKSDVFSFGVLVLEIICG 717
D+++ G LV E++ G
Sbjct: 179 GRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-14
Identities = 73/282 (25%), Positives = 134/282 (47%), Gaps = 45/282 (15%)
Query: 519 FSEKNKLGEGGFGPVYKGMLI----EGQEIAVKRL--SKGSGQGMEEFKNEVLLIAKLQH 572
+ + K+GEG FG K +L+ +G++ +K + SK S + EE + EV +++ ++H
Sbjct: 2 YVKVKKIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKH 58
Query: 573 RNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRS------KLLDWSKRSHIIAGIA 626
N+V+ + ++ +Y L Y + R ++LDW I
Sbjct: 59 PNIVQYQESFEENGNLYIVMDYCEGGDL-YKKINAQRGVLFPEDQILDW------FVQIC 111
Query: 627 RGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYG 686
L ++H +I+HRD+K+ N+ L K+ DFG+AR L+ T + +GT
Sbjct: 112 LALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARV--LNSTVELARTCIGTPY 166
Query: 687 YMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPL 746
Y+SPE + ++ KSD+++ G ++ E+ K HA N+ + L
Sbjct: 167 YLSPEICENRPYNNKSDIWALGCVLYEMCTLK------HAFEAGNM---------KNLVL 211
Query: 747 ELIDQSLDN-SCSFSEALRCIQVGLLCVQQRPEDRPNMSSVV 787
++I S S +S LR + L ++ P DRP+++S++
Sbjct: 212 KIIRGSYPPVSSHYSYDLRNLVSQLF--KRNPRDRPSVNSIL 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 2e-14
Identities = 59/210 (28%), Positives = 99/210 (47%), Gaps = 16/210 (7%)
Query: 525 LGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKN---EVLLIAKLQHRNLVKLLG 580
+G G +G V + G+++A+K+LS+ Q K E+ L+ + H N++ LL
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSR-PFQSAIHAKRTYRELRLLKHMDHENVIGLLD 81
Query: 581 CCTQRDERMLIYE-YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLR 639
T + YL + + + + + L ++ I RGL Y+H
Sbjct: 82 VFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHS---AG 138
Query: 640 IIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFS 699
IIHRDLK SN+ ++ KI DFGLAR T+ V T Y +PE ++ +
Sbjct: 139 IIHRDLKPSNIAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYRAPEIMLNWMHY 193
Query: 700 VKS-DVFSFGVLVLEIICGKK-NRGFNHAD 727
++ D++S G ++ E++ GK G +H D
Sbjct: 194 NQTVDIWSVGCIMAELLTGKTLFPGSDHID 223
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 3e-14
Identities = 57/203 (28%), Positives = 102/203 (50%), Gaps = 20/203 (9%)
Query: 524 KLGEGGFGPVYKGMLIE--GQEIAVKRLS-KGSGQGME-EFKNEVLLIAKLQ---HRNLV 576
++GEG +G V+K ++ G+ +A+KR+ + +GM EV ++ L+ H N+V
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 577 KLLGCCT-QRDER----MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLY 631
+L CT R +R L++E++ Y D + ++ + RGL +
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYL--DKVPEPGVPTETIKDMMFQLLRGLDF 125
Query: 632 LHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPE 691
LH R++HRDLK N+L+ ++ K++DFGLAR + + VV T Y +PE
Sbjct: 126 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVTLWYRAPE 179
Query: 692 YAIDGLFSVKSDVFSFGVLVLEI 714
+ ++ D++S G + E+
Sbjct: 180 VLLQSSYATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 73.3 bits (181), Expect = 4e-14
Identities = 62/218 (28%), Positives = 97/218 (44%), Gaps = 41/218 (18%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEI-AVKRLSKG----SGQGMEEFKNEVLLIAKLQ 571
D+F LG G FG V + A+K LSK Q +E NE ++ ++
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQ-VEHVLNEKRILQSIR 59
Query: 572 HRNLVKLLGCCTQRDERML--IYEYLPNKSLDYFI-----FDTTRSKLLDWSKRSHIIAG 624
H LV L G + +D+ L + EY+P L + F ++ A
Sbjct: 60 HPFLVNLYG--SFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFY--------AAQ 109
Query: 625 IARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
+ L YLH L I++RDLK N+LLD+ KI+DFG A+ + + T + GT
Sbjct: 110 VVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAK-----RVKGRTYTLCGT 161
Query: 685 YGYMSPEYAIDGLFSVK-----SDVFSFGVLVLEIICG 717
Y++PE + K D ++ G+L+ E++ G
Sbjct: 162 PEYLAPE-----IILSKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 5e-14
Identities = 61/203 (30%), Positives = 99/203 (48%), Gaps = 19/203 (9%)
Query: 523 NKLGEGGFGPVYKGM------LIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLV 576
+KLGEG + VYKG L+ +EI RL G + EV L+ L+H N+V
Sbjct: 12 DKLGEGTYATVYKGRSKLTDNLVALKEI---RLEHEEGAPCTAIR-EVSLLKDLKHANIV 67
Query: 577 KLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDS 636
L L++EYL +K L ++ D ++ + + RGL Y H
Sbjct: 68 TLHDIIHTEKSLTLVFEYL-DKDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCH--- 121
Query: 637 RLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDG 696
R +++HRDLK N+L++ K++DFGLAR+ + T+ + VV T Y P+ +
Sbjct: 122 RRKVLHRDLKPQNLLINERGELKLADFGLARAKSI-PTKTYSNEVV-TLWYRPPDILLGS 179
Query: 697 L-FSVKSDVFSFGVLVLEIICGK 718
+S + D++ G + E+ G+
Sbjct: 180 TDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 5e-14
Identities = 67/229 (29%), Positives = 98/229 (42%), Gaps = 52/229 (22%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE--GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRN 574
D+ +LG G +G V K M G +AVKR+ + + E Q R
Sbjct: 1 DDLEVIEELGRGAYGVVDK-MRHVPTGTIMAVKRI-RATVNSQE------------QKRL 46
Query: 575 LVKL-----LGCCTQ---------RDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKR-- 618
L+ L C R+ + I + + SLD F K+ D
Sbjct: 47 LMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMDTSLDKFY-----KKVYDKGLTIP 101
Query: 619 ----SHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674
I I + L YLH S+L +IHRD+K SNVL++ K+ DFG+ S L +
Sbjct: 102 EDILGKIAVSIVKALEYLH--SKLSVIHRDVKPSNVLINRNGQVKLCDFGI--SGYLVDS 157
Query: 675 EANTKRVVGTYGYMSPEYAIDGL-----FSVKSDVFSFGVLVLEIICGK 718
A T G YM+PE I+ + VKSDV+S G+ ++E+ G+
Sbjct: 158 VAKTID-AGCKPYMAPE-RINPELNQKGYDVKSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 8e-14
Identities = 65/205 (31%), Positives = 99/205 (48%), Gaps = 25/205 (12%)
Query: 525 LGEGGFGPVYKGMLIE----GQEIAVKRLSKGSGQGMEEFKNEVLLIAK------LQHRN 574
LG+G FG V ML E + A+K L K +E+ E ++ + +H
Sbjct: 3 LGKGSFGKV---MLAELKGTNEFFAIKALKKDVV--LEDDDVECTMVERRVLALAWEHPF 57
Query: 575 LVKLLGCCTQRDERML-IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLH 633
L L C Q E + + EYL L + I + R D ++ A I GL +LH
Sbjct: 58 LTHLF-CTFQTKEHLFFVMEYLNGGDLMFHIQSSGR---FDEARARFYAAEIICGLQFLH 113
Query: 634 QDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYA 693
+ II+RDLK NVLLD + KI+DFG+ + + +A+T GT Y++PE
Sbjct: 114 KKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST--FCGTPDYIAPEIL 168
Query: 694 IDGLFSVKSDVFSFGVLVLEIICGK 718
++ D +SFGVL+ E++ G+
Sbjct: 169 KGQKYNESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 9e-14
Identities = 62/206 (30%), Positives = 100/206 (48%), Gaps = 15/206 (7%)
Query: 517 DNFSEKNKLGEGGFGPVYKGML-IEGQEIAVK--RLSKGSGQGMEEFKNEVLLIAKLQHR 573
D++ + KLGEG + VYKG + G+ +A+K RL + G + E L+ L+H
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHA 63
Query: 574 NLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLH 633
N+V L ++ L++EY+ Y L + + RGL Y+H
Sbjct: 64 NIVLLHDIIHTKETLTLVFEYVHTDLCQYM---DKHPGGLHPENVKLFLFQLLRGLSYIH 120
Query: 634 QDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL-DQTEANTKRVVGTYGYMSPEY 692
Q I+HRDLK N+L+ +T K++DFGLAR+ + T +N V T Y P+
Sbjct: 121 QRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNE---VVTLWYRPPDV 174
Query: 693 AIDGL-FSVKSDVFSFGVLVLEIICG 717
+ +S D++ G + +E+I G
Sbjct: 175 LLGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 1e-13
Identities = 61/216 (28%), Positives = 100/216 (46%), Gaps = 38/216 (17%)
Query: 525 LGEGGFGPVYKGMLIE----GQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKL 578
LG+G FG V + L Q++AVK L S +EEF E + + H N++KL
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 579 LGCCTQRDER------MLIYEYLPNKSLDYFI---------FDTTRSKLLDWSKRSHIIA 623
+G + + M+I ++ + L F+ F L+ + +
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRF------MI 120
Query: 624 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS-FGLD---QTEANTK 679
IA G+ YL S IHRDL A N +L+ M ++DFGL++ + D Q A+
Sbjct: 121 DIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177
Query: 680 RVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEII 715
V +++ E D +++ SDV++FGV + EI+
Sbjct: 178 PV----KWLALESLADNVYTTHSDVWAFGVTMWEIM 209
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 1e-13
Identities = 62/208 (29%), Positives = 90/208 (43%), Gaps = 32/208 (15%)
Query: 525 LGEGGFGPVYKGMLIE----GQEIAVKRLSKG---SGQGMEEFKNE--VLLIA-KLQHRN 574
LG G FG V +L E G+ A+K L KG + +E E + A +H
Sbjct: 7 LGRGHFGKV---LLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYFI----FDTTRSKLLDWSKRSHIIAGIARGLL 630
LV L C D + EY L I F R+ A + GL
Sbjct: 64 LVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFY--------AACVVLGLQ 115
Query: 631 YLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS-FGLDQTEANTKRVVGTYGYMS 689
YLH++ +I++RDLK N+LLD KI+DFGL + G T GT +++
Sbjct: 116 YLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR---TSTFCGTPEFLA 169
Query: 690 PEYAIDGLFSVKSDVFSFGVLVLEIICG 717
PE + ++ D + GVL+ E++ G
Sbjct: 170 PEVLTETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 1e-13
Identities = 56/236 (23%), Positives = 107/236 (45%), Gaps = 38/236 (16%)
Query: 513 ANATDNFSEKNK-LGEGGFGPVYKGM-LIEGQEIAVKR--LSKGSGQGMEEFKN------ 562
+ ++ + +K LGEG +G V K + G+ +A+K+ + + S ++ +
Sbjct: 4 FSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGI 63
Query: 563 ------EVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWS 616
E+ ++ +++H N++ L+ + D L+ + + L + R L S
Sbjct: 64 HFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIR---LTES 119
Query: 617 KRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD---- 672
+ I+ I GL LH+ +HRDL +N+ +++ KI+DFGLAR +G
Sbjct: 120 QVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSD 176
Query: 673 ---------QTEANTKRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIICGK 718
+ E T +VV T Y +PE + + D++S G + E++ GK
Sbjct: 177 TLSKDETMQRREEMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 73.0 bits (180), Expect = 1e-13
Identities = 68/228 (29%), Positives = 111/228 (48%), Gaps = 60/228 (26%)
Query: 522 KNKLGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQGMEEFKN---------EVLLIAKL- 570
KLG+G +G V+K + +E+ A+K++ + F+N E++ + +L
Sbjct: 12 LQKLGKGAYGIVWKAIDRRTKEVVALKKI-------FDAFRNATDAQRTFREIMFLQELG 64
Query: 571 QHRNLVKLLGCCTQRDERM----LIYEYLPNKSLDYFIFDT-----TRSKLL-DWSKRSH 620
H N+VKLL + E L++EY+ +T R+ +L D KR +
Sbjct: 65 DHPNIVKLLN--VIKAENDKDIYLVFEYM----------ETDLHAVIRANILEDVHKR-Y 111
Query: 621 IIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKR 680
I+ + + L Y+H S +IHRDLK SN+LL++ K++DFGLARS L + E N +
Sbjct: 112 IMYQLLKALKYIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLARS--LSELEENPEN 166
Query: 681 -----VVGTYGYMSPEYAIDGLFSVKS-----DVFSFGVLVLEIICGK 718
V T Y +PE L D++S G ++ E++ GK
Sbjct: 167 PVLTDYVATRWYRAPEI----LLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-13
Identities = 68/279 (24%), Positives = 121/279 (43%), Gaps = 58/279 (20%)
Query: 522 KNKLGEGGFGPVYKGM-LIEGQEIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLL 579
+ LG G G VYK L+ + +AVK + + + ++ +E+ ++ K ++
Sbjct: 6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFY 65
Query: 580 GCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIA----RGLLYLHQD 635
G + + E++ SLD + H++ IA +GL YL
Sbjct: 66 GAFFVENRISICTEFMDGGSLDVY-----------RKIPEHVLGRIAVAVVKGLTYLWS- 113
Query: 636 SRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAID 695
L+I+HRD+K SN+L++ K+ DFG++ + K VGT YM+PE
Sbjct: 114 --LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQL----VNSIAKTYVGTNAYMAPERISG 167
Query: 696 GLFSVKSDVFSFGVLVLEIICGK-------KNRGFNHADHDHNLLGHAWRLWIEERPLEL 748
+ + SDV+S G+ +E+ G+ KN+G L+ PL+L
Sbjct: 168 EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGS--------LM-----------PLQL 208
Query: 749 IDQSLDNSC------SFSEALRCIQVGLLCVQQRPEDRP 781
+ +D FSE + C++++P++RP
Sbjct: 209 LQCIVDEDPPVLPVGQFSEKF--VHFITQCMRKQPKERP 245
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 72.6 bits (179), Expect = 1e-13
Identities = 60/225 (26%), Positives = 97/225 (43%), Gaps = 59/225 (26%)
Query: 525 LGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKN---------EVLLIAKLQHRN 574
+G G +G V + G+++A+K++S F + E+ L+ L+H N
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISN-------VFDDLIDAKRILREIKLLRHLRHEN 60
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYFIFD----------TTRSKLLDWSKRSHIIAG 624
++ LL +L + + Y + + + L D + +
Sbjct: 61 IIGLL--------DILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTD-DHIQYFLYQ 111
Query: 625 IARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEAN--TKRVV 682
I RGL YLH +IHRDLK SN+L+++ + KI DFGLAR D+ E T+ VV
Sbjct: 112 ILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVV 168
Query: 683 GTYGYMSPE---------YAIDGLFSVKSDVFSFGVLVLEIICGK 718
T Y +PE AI D++S G + E++ K
Sbjct: 169 -TRWYRAPELLLSSSRYTKAI--------DIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 2e-13
Identities = 39/153 (25%), Positives = 72/153 (47%), Gaps = 9/153 (5%)
Query: 563 EVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHII 622
E +L+ + H +++++ ++ LP+ S D + + T RS+ L + I
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIE 163
Query: 623 AGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVV 682
I GL YLH RIIHRD+K N+ +++ I D G A+ +
Sbjct: 164 KQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQ---FPVVAPAFLGLA 217
Query: 683 GTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEII 715
GT +PE ++ K+D++S G+++ E++
Sbjct: 218 GTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 2e-13
Identities = 60/199 (30%), Positives = 101/199 (50%), Gaps = 13/199 (6%)
Query: 524 KLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFK--NEVLLIAKLQHRNLVKLLG 580
KLGEG + VYKG+ I GQ +A+K +S + +G+ F E L+ L+H N+V L
Sbjct: 12 KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVP-FTAIREASLLKGLKHANIVLLHD 70
Query: 581 CCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRI 640
++ ++EY+ Y I L ++ R + + RGL Y+H I
Sbjct: 71 IIHTKETLTFVFEYMHTDLAQYMI--QHPGGLHPYNVRLFMFQ-LLRGLAYIH---GQHI 124
Query: 641 IHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGL-FS 699
+HRDLK N+L+ K++DFGLAR+ + ++ + VV T Y P+ + +S
Sbjct: 125 LHRDLKPQNLLISYLGELKLADFGLARAKSI-PSQTYSSEVV-TLWYRPPDVLLGATDYS 182
Query: 700 VKSDVFSFGVLVLEIICGK 718
D++ G + +E++ G+
Sbjct: 183 SALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 75/269 (27%), Positives = 123/269 (45%), Gaps = 30/269 (11%)
Query: 525 LGEGGFGPVYKGMLI----EGQEIAVKRLS--KGSGQGMEEFKNEVLLIAKLQHRNLVKL 578
+G+G +G V L+ +G++ +K+L+ S + + + E L+++L+H N+V
Sbjct: 8 VGKGSYGEV---SLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64
Query: 579 LGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRL 638
D + I Y + KLL ++ IA L YLH+
Sbjct: 65 RESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK--- 121
Query: 639 RIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLF 698
I+HRDLK NV L T K+ D G+AR A+T ++GT YMSPE + +
Sbjct: 122 HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST--LIGTPYYMSPELFSNKPY 179
Query: 699 SVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDNSCS 758
+ KSDV++ G V E+ K HA + ++ +R+ IE + L D S
Sbjct: 180 NYKSDVWALGCCVYEMATLK------HAFNAKDMNSLVYRI-IEGK---LPPMPKDYSPE 229
Query: 759 FSEALRCIQVGLLCVQQRPEDRPNMSSVV 787
E + +L +RPE RP++ S++
Sbjct: 230 LGELIA----TMLS--KRPEKRPSVKSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 3e-13
Identities = 53/190 (27%), Positives = 83/190 (43%), Gaps = 33/190 (17%)
Query: 524 KLGEGGFGPVYKGMLIE---GQEIAVKRLSKGSGQGMEEFK----NEVLLIAKLQHRNLV 576
+G G +G VYK G+E A+K+ KG + E+ L+ +L+H N+V
Sbjct: 7 CIGRGTYGRVYKAKRKNGKDGKEYAIKKF-KGDKEQYTGISQSACREIALLRELKHENVV 65
Query: 577 KLLGCCTQRDERMLIYEYLPNKSLDYFIFD---------TTRSKLLDWSKRSHIIAGIAR 627
L+ + ++ + YL DY D + + S ++ I
Sbjct: 66 SLVEVFLEHADKSV---YL---LFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILN 119
Query: 628 GLLYLHQDSRLRIIHRDLKASNVLLDNTMNP----KISDFGLARSFG--LDQTEANTKRV 681
G+ YLH + ++HRDLK +N+L+ KI D GLAR F L + A+ V
Sbjct: 120 GVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPL-KPLADLDPV 175
Query: 682 VGTYGYMSPE 691
V T Y +PE
Sbjct: 176 VVTIWYRAPE 185
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 56/202 (27%), Positives = 95/202 (47%), Gaps = 19/202 (9%)
Query: 524 KLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKN--EVLLIAKLQ---HRNLVK 577
++G G +G VYK G +A+K + + + EV L+ +L+ H N+V+
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 578 LLG-CCTQRDER----MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYL 632
L+ C T R +R L++E++ Y D L ++ RGL +L
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHVDQDLRTYL--DKVPPPGLPAETIKDLMRQFLRGLDFL 124
Query: 633 HQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEY 692
H + I+HRDLK N+L+ + K++DFGLAR + + VV T Y +PE
Sbjct: 125 HAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY---SCQMALTPVVVTLWYRAPEV 178
Query: 693 AIDGLFSVKSDVFSFGVLVLEI 714
+ ++ D++S G + E+
Sbjct: 179 LLQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 3e-13
Identities = 64/202 (31%), Positives = 97/202 (48%), Gaps = 19/202 (9%)
Query: 525 LGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEE------FKNEVLLIAKLQHRNLVK 577
LG+G FG V+ L Q A+K L K M++ + VL +A +H L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVL-MDDDVECTMVEKRVLSLA-WEHPFLTH 60
Query: 578 LLGCCTQRDERML-IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDS 636
L C Q E + + EYL L + I + D + + A I GL +LH
Sbjct: 61 LY-CTFQTKENLFFVMEYLNGGDLMFHIQSCHK---FDLPRATFYAAEIICGLQFLHSKG 116
Query: 637 RLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDG 696
I++RDLK N+LLD + KI+DFG+ + L +A T GT Y++PE +
Sbjct: 117 ---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLG--DAKTCTFCGTPDYIAPEILLGQ 171
Query: 697 LFSVKSDVFSFGVLVLEIICGK 718
++ D +SFGVL+ E++ G+
Sbjct: 172 KYNTSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 4e-13
Identities = 61/209 (29%), Positives = 101/209 (48%), Gaps = 19/209 (9%)
Query: 517 DNFSEKNKLGEGGFGPVYKGM------LIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKL 570
+ + + KLGEG + V+KG L+ +EI RL G + EV L+ L
Sbjct: 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEI---RLEHEEGAPCTAIR-EVSLLKDL 61
Query: 571 QHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLL 630
+H N+V L L++EYL +K L ++ D ++ + I RGL
Sbjct: 62 KHANIVTLHDIVHTDKSLTLVFEYL-DKDLKQYMDDC--GNIMSMHNVKIFLYQILRGLA 118
Query: 631 YLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSP 690
Y H R +++HRDLK N+L++ K++DFGLAR+ + T+ + VV T Y P
Sbjct: 119 YCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSV-PTKTYSNEVV-TLWYRPP 173
Query: 691 EYAI-DGLFSVKSDVFSFGVLVLEIICGK 718
+ + +S + D++ G + E+ G+
Sbjct: 174 DVLLGSSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 6e-13
Identities = 68/283 (24%), Positives = 112/283 (39%), Gaps = 29/283 (10%)
Query: 523 NKLGEGGFGPVYKG---MLIEGQEIAVKRL-SKGSGQGMEEFKNEVLLIAKLQHRNLVKL 578
+++G G FG V G + + VK L + + F EV +L H N+++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 579 LGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRS--HIIAGIARGLLYLHQDS 636
LG C + +L+ E+ P L ++ K + +A GLL+LHQ
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ-- 118
Query: 637 RLRIIHRDLKASNVLLDNTMNPKISDFGLARS-FGLDQTEANTKRVVGTYGYMSPEYAI- 694
IH DL N L ++ KI D+GLA + D V +++PE
Sbjct: 119 -ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAV-PLRWLAPELVEI 176
Query: 695 --DGLFSVK----SDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLEL 748
L S+++S GV + E+ + +D +L + E+ ++L
Sbjct: 177 RGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ--VLKQV----VREQDIKL 230
Query: 749 IDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLS 791
LD +S+ R +V C PE RP V +L+
Sbjct: 231 PKPQLD--LKYSD--RWYEVMQFCWLD-PETRPTAEEVHELLT 268
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 6e-13
Identities = 65/201 (32%), Positives = 102/201 (50%), Gaps = 18/201 (8%)
Query: 525 LGEGGFGPVYKGMLI----EGQEIAVKRLSKGSGQGMEEF--KNEVLLIAKLQHRNLVKL 578
LG+G FG V+ I GQ A+K L K + + + K E ++A++ H +VKL
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63
Query: 579 LGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKR--SHIIAGIARGLLYLHQDS 636
+ LI ++L + D F T SK + +++ +A +A L +LH
Sbjct: 64 HYAFQTEGKLYLILDFL--RGGDLF---TRLSKEVMFTEEDVKFYLAELALALDHLH--- 115
Query: 637 RLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDG 696
L II+RDLK N+LLD + K++DFGL++ +D E GT YM+PE
Sbjct: 116 SLGIIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDH-EKKAYSFCGTVEYMAPEVVNRR 173
Query: 697 LFSVKSDVFSFGVLVLEIICG 717
+ +D +SFGVL+ E++ G
Sbjct: 174 GHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 1e-12
Identities = 58/228 (25%), Positives = 102/228 (44%), Gaps = 45/228 (19%)
Query: 514 NATDNFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQ-----GMEEFKNEVLLI 567
+ + + +GEG +G V G ++A+K++S Q + E K ++
Sbjct: 2 DVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIK----IL 57
Query: 568 AKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYF--------IFDTTRSKLLDWSKRS 619
+ +H N++ I + + S + F + +T KL+ S
Sbjct: 58 RRFKHENIIG-------------ILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLS 104
Query: 620 --HI---IAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674
HI + I RGL Y+H + ++HRDLK SN+LL+ + KI DFGLAR D
Sbjct: 105 NDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI--ADPE 159
Query: 675 EANTKRV---VGTYGYMSPEYAIDGLFSVKS-DVFSFGVLVLEIICGK 718
+T + V T Y +PE ++ K+ D++S G ++ E++ +
Sbjct: 160 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 1e-12
Identities = 62/199 (31%), Positives = 93/199 (46%), Gaps = 13/199 (6%)
Query: 525 LGEGGFGPVYKGMLI-EGQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLG 580
LG+G FG V L +G+ AVK L K +E E ++A + L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 581 CCTQ-RDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLR 639
C Q ++ + E+L L + I D R D + + A I GL +LH
Sbjct: 63 CTFQTKEHLFFVMEFLNGGDLMFHIQDKGR---FDLYRATFYAAEIVCGLQFLHSKG--- 116
Query: 640 IIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFS 699
II+RDLK NV+LD + KI+DFG+ + A+T GT Y++PE ++
Sbjct: 117 IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST--FCGTPDYIAPEILQGLKYT 174
Query: 700 VKSDVFSFGVLVLEIICGK 718
D +SFGVL+ E++ G+
Sbjct: 175 FSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 1e-12
Identities = 58/214 (27%), Positives = 95/214 (44%), Gaps = 30/214 (14%)
Query: 516 TDNFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKNEVL--------- 565
T+ + + +G G FG V + GQ +A+K++ M+ F VL
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKI-------MKPFSTPVLAKRTYRELK 61
Query: 566 LIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGI 625
L+ L+H N++ L E + L L + S+ L+ + + I
Sbjct: 62 LLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLL----TSRPLEKQFIQYFLYQI 117
Query: 626 ARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTY 685
RGL Y+H ++HRDLK SN+L++ + KI DFGLAR + V T
Sbjct: 118 LRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI-----QDPQMTGYVSTR 169
Query: 686 GYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGK 718
Y +PE + + V+ D++S G + E++ GK
Sbjct: 170 YYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 65/219 (29%), Positives = 104/219 (47%), Gaps = 19/219 (8%)
Query: 509 LKIIANATDNFSEKNKLGEGGFGPVYK-GMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLI 567
L+ + + TD + +G+G +G VYK +G AVK L S EE + E ++
Sbjct: 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEYNIL 72
Query: 568 AKL-QHRNLVKLLGCCTQRDERM-----LIYEYLPNKSLDYFIFDTTR-SKLLDWSKRSH 620
L H N+VK G + D+ + L+ E S+ + + LD + S+
Sbjct: 73 QSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISY 132
Query: 621 IIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKR 680
I+ G GL +LH + RIIHRD+K +N+LL K+ DFG++ + NT
Sbjct: 133 ILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS- 188
Query: 681 VVGTYGYMSPEY-----AIDGLFSVKSDVFSFGVLVLEI 714
VGT +M+PE D + + DV+S G+ +E+
Sbjct: 189 -VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIEL 226
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 1e-12
Identities = 53/169 (31%), Positives = 72/169 (42%), Gaps = 21/169 (12%)
Query: 625 IARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
+ARG+ +L SR + IHRDL A N+LL KI DFGLAR D
Sbjct: 182 VARGMEFL--ASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238
Query: 685 YGYMSPEYAIDGLFSVKSDVFSFGVLVLEI--ICGKKNRGFNHADHDHNLLGHAWRLWIE 742
+M+PE D +++ +SDV+SFGVL+ EI + G + L R+
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAP 298
Query: 743 ERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLS 791
E I + L C PEDRP S +V +L
Sbjct: 299 EYATPEIYSIM----------------LDCWHNNPEDRPTFSELVEILG 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 1e-12
Identities = 60/203 (29%), Positives = 97/203 (47%), Gaps = 48/203 (23%)
Query: 538 LIEGQEIAVKRLSKGSGQGMEEFKN---------EVLLIAKLQHRNLVKLLGCCTQRDER 588
+ GQ +A+K+LS+ F+N E++L+ + H+N++ LL T
Sbjct: 38 TVTGQNVAIKKLSR-------PFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFT----- 85
Query: 589 MLIYEYLPNKSLD-----YFIFDTTRSKL-------LDWSKRSHIIAGIARGLLYLHQDS 636
P KSL+ Y + + + L LD + S+++ + G+ +LH
Sbjct: 86 -------PQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAG 138
Query: 637 RLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDG 696
IIHRDLK SN+++ + KI DFGLAR+ G T VV Y Y +PE I G
Sbjct: 139 ---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPE-VILG 191
Query: 697 L-FSVKSDVFSFGVLVLEIICGK 718
+ + D++S G ++ E+I G
Sbjct: 192 MGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 1e-12
Identities = 57/189 (30%), Positives = 95/189 (50%), Gaps = 28/189 (14%)
Query: 542 QEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLD 601
+ +A+K+LS+ F+N+ AK +R LV L+ C ++ L+ + P KSL+
Sbjct: 50 RNVAIKKLSR-------PFQNQTH--AKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLE 99
Query: 602 -----YFIFDTTRSKL-------LDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASN 649
Y + + + L LD + S+++ + G+ +LH IIHRDLK SN
Sbjct: 100 EFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSN 156
Query: 650 VLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGV 709
+++ + KI DFGLAR+ G + T VV Y Y +PE + + D++S G
Sbjct: 157 IVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGC 213
Query: 710 LVLEIICGK 718
++ E+I G
Sbjct: 214 IMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-12
Identities = 60/219 (27%), Positives = 94/219 (42%), Gaps = 34/219 (15%)
Query: 525 LGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLL--------------IAKL 570
LG+G FG V I V+ + G M+ K EV++ +
Sbjct: 3 LGKGTFGKV----------ILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNT 52
Query: 571 QHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLL 630
+H L L +D + EY+ L F +R ++ + A I L
Sbjct: 53 RHPFLTSLKYSFQTKDRLCFVMEYVNGGEL---FFHLSRERVFSEDRTRFYGAEIVSALD 109
Query: 631 YLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSP 690
YLH +I++RDLK N++LD + KI+DFGL + D A K GT Y++P
Sbjct: 110 YLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATMKTFCGTPEYLAP 164
Query: 691 EYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHD 729
E D + D + GV++ E++CG+ F + DH+
Sbjct: 165 EVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHE 201
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 36/94 (38%), Positives = 60/94 (63%), Gaps = 6/94 (6%)
Query: 625 IARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
+ RGL YL + + +I+HRD+K SN+L+++ K+ DFG+ S L + AN+ VGT
Sbjct: 108 VLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGV--SGQLIDSMANS--FVGT 161
Query: 685 YGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGK 718
YMSPE ++V+SD++S G+ ++E+ G+
Sbjct: 162 RSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 4e-12
Identities = 65/224 (29%), Positives = 107/224 (47%), Gaps = 30/224 (13%)
Query: 519 FSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVK 577
+ + +G G G V + G +AVK+LS+ F+N+ AK +R LV
Sbjct: 23 YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSR-------PFQNQTH--AKRAYRELV- 72
Query: 578 LLGCCTQRDERMLIYEYLPNKSLD-----YFIFDTTRSKL-------LDWSKRSHIIAGI 625
LL C ++ L+ + P KSL+ Y + + + L LD + S+++ +
Sbjct: 73 LLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQM 132
Query: 626 ARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTY 685
G+ +LH IIHRDLK SN+++ + KI DFGLAR+ + T VV Y
Sbjct: 133 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMM--TPYVVTRY 187
Query: 686 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKK-NRGFNHADH 728
Y +PE + + D++S G ++ E++ G +G +H D
Sbjct: 188 -YRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQ 230
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 5e-12
Identities = 58/213 (27%), Positives = 102/213 (47%), Gaps = 32/213 (15%)
Query: 523 NKLGEGGFGPVYK------GMLIEGQEIAVKRLSKGSGQGMEEFK-NEVLLIAKLQHR-- 573
++LG+G +G VYK G+ + +EI RL ++E K N++++ + H+
Sbjct: 7 DELGKGNYGSVYKVLHRPTGVTMAMKEI---RLE------LDESKFNQIIMELDILHKAV 57
Query: 574 --NLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLY 631
+V G + EY+ SLD ++ + I + +GL +
Sbjct: 58 SPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKF 117
Query: 632 LHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPE 691
L ++ IIHRD+K +NVL++ K+ DFG+ S L + A T +G YM+PE
Sbjct: 118 LKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGV--SGNLVASLAKTN--IGCQSYMAPE 171
Query: 692 Y------AIDGLFSVKSDVFSFGVLVLEIICGK 718
+ ++V+SDV+S G+ +LE+ G+
Sbjct: 172 RIKSGGPNQNPTYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 6e-12
Identities = 54/197 (27%), Positives = 101/197 (51%), Gaps = 10/197 (5%)
Query: 525 LGEGGFGPVYKGMLIEGQEI-AVKRL--SKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGC 581
+GEG +G V K E +EI A+K+ S+ + + E E+ ++ L+ N+V+L
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68
Query: 582 CTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRII 641
+R + L++EY+ L+ + + + + RS+I I + + + H++ I+
Sbjct: 69 FRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPEKVRSYIYQLI-KAIHWCHKND---IV 122
Query: 642 HRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVK 701
HRD+K N+L+ + K+ DFG AR+ + + AN V T Y SPE + +
Sbjct: 123 HRDIKPENLLISHNDVLKLCDFGFARNLS-EGSNANYTEYVATRWYRSPELLLGAPYGKA 181
Query: 702 SDVFSFGVLVLEIICGK 718
D++S G ++ E+ G+
Sbjct: 182 VDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 8e-12
Identities = 62/220 (28%), Positives = 93/220 (42%), Gaps = 36/220 (16%)
Query: 525 LGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAK------------LQ- 571
LG+G FG V I V+ + G M+ + EV+ IAK LQ
Sbjct: 3 LGKGTFGKV----------ILVREKATGRYYAMKILRKEVI-IAKDEVAHTVTESRVLQN 51
Query: 572 --HRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGL 629
H L L D + EY L F +R ++ + A I L
Sbjct: 52 TRHPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSAL 108
Query: 630 LYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMS 689
YLH +++RD+K N++LD + KI+DFGL + D A K GT Y++
Sbjct: 109 EYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLA 163
Query: 690 PEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHD 729
PE D + D + GV++ E++CG+ F + DH+
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHE 201
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 9e-12
Identities = 65/237 (27%), Positives = 109/237 (45%), Gaps = 38/237 (16%)
Query: 510 KIIANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSK--GSGQGMEEFKNEVLL 566
K I D + + ++G G +G V + G ++A+K+L + S + E+ L
Sbjct: 8 KTIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRL 67
Query: 567 IAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYF--------IFDTTRSKLLDWSKR 618
+ ++H N++ LL T P+ SLD F T KL+ K
Sbjct: 68 LKHMKHENVIGLLDVFT------------PDLSLDRFHDFYLVMPFMGTDLGKLMKHEKL 115
Query: 619 S-----HIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673
S ++ + +GL Y+H IIHRDLK N+ ++ KI DFGLAR Q
Sbjct: 116 SEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----Q 167
Query: 674 TEANTKRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIICGKK-NRGFNHADH 728
T++ V T Y +PE ++ + ++ D++S G ++ E++ GK +G +H D
Sbjct: 168 TDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQ 224
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 1e-11
Identities = 50/195 (25%), Positives = 85/195 (43%), Gaps = 28/195 (14%)
Query: 541 GQEIAVKRLSKGSGQGMEE---FKNEVLLIAKLQHRNLVKLLGCCTQRDERML-IYEYLP 596
G E+A+K L + + + F+ E L A+L H N+V LL + ++EY+P
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 597 NKSLDYFIFDTTRSKL-----LDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVL 651
++L R L L + ++ + L H I+HRDLK N++
Sbjct: 63 GRTL--------REVLAADGALPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIM 111
Query: 652 L---DNTMNPKISDFG---LARSFG--LDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSD 703
+ + K+ DFG L T T V+GT Y +PE + SD
Sbjct: 112 VSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSD 171
Query: 704 VFSFGVLVLEIICGK 718
++++G++ LE + G+
Sbjct: 172 LYAWGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 58/200 (29%), Positives = 95/200 (47%), Gaps = 13/200 (6%)
Query: 523 NKLGEGGFGPVYKGML-IEGQEIAVK--RLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLL 579
+KLGEG + V+KG + +A+K RL G + EV L+ L+H N+V L
Sbjct: 11 DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKNLKHANIVTLH 69
Query: 580 GCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLR 639
L++EYL + Y L+ + + RGL Y H + +
Sbjct: 70 DIIHTERCLTLVFEYLDSDLKQYL---DNCGNLMSMHNVKIFMFQLLRGLSYCH---KRK 123
Query: 640 IIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGL-F 698
I+HRDLK N+L++ K++DFGLAR+ + T+ + VV T Y P+ + +
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLARAKSV-PTKTYSNEVV-TLWYRPPDVLLGSTEY 181
Query: 699 SVKSDVFSFGVLVLEIICGK 718
S D++ G ++ E+ G+
Sbjct: 182 STPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 63/205 (30%), Positives = 93/205 (45%), Gaps = 25/205 (12%)
Query: 525 LGEGGFGPVYKGMLIE--GQE--IAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVK 577
LG+G FG V ML E G + A+K L K +E E ++A +
Sbjct: 8 LGKGSFGKV---MLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLT 64
Query: 578 LLGCCTQRDERM-LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHII---AGIARGLLYLH 633
L C Q +R+ + EY+ L Y I + K H + A IA GL +LH
Sbjct: 65 QLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFK------EPHAVFYAAEIAIGLFFLH 118
Query: 634 QDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYA 693
II+RDLK NV+LD + KI+DFG+ + T+ GT Y++PE
Sbjct: 119 SKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG--GKTTRTFCGTPDYIAPEII 173
Query: 694 IDGLFSVKSDVFSFGVLVLEIICGK 718
+ D ++FGVL+ E++ G+
Sbjct: 174 AYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 52/210 (24%), Positives = 96/210 (45%), Gaps = 22/210 (10%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKN-------EVLLIA 568
+ + + +K+GEG +G V+K E GQ +A+K+ + E+ E+ ++
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVES-----EDDPVIKKIALREIRMLK 55
Query: 569 KLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARG 628
+L+H NLV L+ ++ + L++EY + L+ + + II +
Sbjct: 56 QLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNEL---EKNPRGVPEHLIKKIIWQTLQA 112
Query: 629 LLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYM 688
+ + H+ IHRD+K N+L+ K+ DFG AR L + V T Y
Sbjct: 113 VNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARI--LTGPGDDYTDYVATRWYR 167
Query: 689 SPEYAI-DGLFSVKSDVFSFGVLVLEIICG 717
+PE + D + DV++ G + E++ G
Sbjct: 168 APELLVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 49/147 (33%), Positives = 70/147 (47%), Gaps = 14/147 (9%)
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHII---AGIARGLLY 631
L +L C D + EY+ L Y I R K H + A IA GL +
Sbjct: 63 LTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFK------EPHAVFYAAEIAIGLFF 116
Query: 632 LHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPE 691
LH II+RDLK NV+LD+ + KI+DFG+ + D TK GT Y++PE
Sbjct: 117 LHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV--TTKTFCGTPDYIAPE 171
Query: 692 YAIDGLFSVKSDVFSFGVLVLEIICGK 718
+ D ++FGVL+ E++ G+
Sbjct: 172 IIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 2e-11
Identities = 56/199 (28%), Positives = 94/199 (47%), Gaps = 13/199 (6%)
Query: 525 LGEGGFGPVYKGMLIEGQEI-AVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLG 580
LG+G FG V L E+ A+K L K ++ E ++A + L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62
Query: 581 CCTQRDERML-IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLR 639
CC Q +R+ + EY+ L +F RS+ D + A + L++LH+
Sbjct: 63 CCFQTKDRLFFVMEYVNGGDL---MFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG--- 116
Query: 640 IIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFS 699
+I+RDLK N+LLD + K++DFG+ + G+ T GT Y++PE + +
Sbjct: 117 VIYRDLKLDNILLDAEGHCKLADFGMCKE-GILN-GVTTTTFCGTPDYIAPEILQELEYG 174
Query: 700 VKSDVFSFGVLVLEIICGK 718
D ++ GVL+ E++ G+
Sbjct: 175 PSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 57/196 (29%), Positives = 94/196 (47%), Gaps = 16/196 (8%)
Query: 525 LGEGGFGPVYKGMLIE----GQEIAVK--RLSKGSGQGMEEFKNEVLLIAKLQHRNLVKL 578
+GEG FG + +L++ Q+ A+K RL K S +E+ + E +L+AK++H N+V
Sbjct: 8 VGEGSFG---RALLVQHVNSDQKYAMKEIRLPK-SSSAVEDSRKEAVLLAKMKHPNIVAF 63
Query: 579 LGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRL 638
++ EY L I R KL + G+ ++H+
Sbjct: 64 KESFEADGHLYIVMEYCDGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEK--- 119
Query: 639 RIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLF 698
R++HRD+K+ N+ L K+ DFG AR A T VGT Y+ PE + +
Sbjct: 120 RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT--YVGTPYYVPPEIWENMPY 177
Query: 699 SVKSDVFSFGVLVLEI 714
+ KSD++S G ++ E+
Sbjct: 178 NNKSDIWSLGCILYEL 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 65/221 (29%), Positives = 97/221 (43%), Gaps = 55/221 (24%)
Query: 525 LGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCT 583
+G G G VYK + G +AVK++ + + EE K R L+ L
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENK-----------RILMDLDVVLK 69
Query: 584 QRDERMLIYEYLPNKSLDYFIFD-----------TTRSKLLDWSKRS----------HII 622
D ++ K YFI D T KLL KR +
Sbjct: 70 SHDCPYIV------KCYGYFITDSDVFICMELMSTCLDKLL---KRIQGPIPEDILGKMT 120
Query: 623 AGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVV 682
I + L YL + +IHRD+K SN+LLD + N K+ DFG+ S L ++A T R
Sbjct: 121 VAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGI--SGRLVDSKAKT-RSA 175
Query: 683 GTYGYMSPEYAID-----GLFSVKSDVFSFGVLVLEIICGK 718
G YM+PE ID + +++DV+S G+ ++E+ G+
Sbjct: 176 GCAAYMAPE-RIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 51/155 (32%), Positives = 73/155 (47%), Gaps = 24/155 (15%)
Query: 524 KLGEGGFGPVYKGM-LIEGQEIAVK--RLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLG 580
KLGEG + VYKG + GQ +A+K RL G + E L+ L+H N+V L
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR-EASLLKDLKHANIVTLHD 70
Query: 581 CCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSH-------IIAGIARGLLYLH 633
+ L++EYL DT + +D + + RGL Y H
Sbjct: 71 IIHTKKTLTLVFEYL----------DTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCH 120
Query: 634 QDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668
Q R++HRDLK N+L+ K++DFGLAR+
Sbjct: 121 QR---RVLHRDLKPQNLLISERGELKLADFGLARA 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 64/228 (28%), Positives = 103/228 (45%), Gaps = 41/228 (17%)
Query: 510 KIIANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKN---EVL 565
K I + + + +G G +G V + G +AVK+LS+ Q + K E+
Sbjct: 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 68
Query: 566 LIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYF--IFDTTR------------SK 611
L+ ++H N++ LL T P +SL+ F ++ T K
Sbjct: 69 LLKHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQK 116
Query: 612 LLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671
L D +I I RGL Y+H IIHRDLK SN+ ++ KI DFGLAR
Sbjct: 117 LTD-DHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR---- 168
Query: 672 DQTEANTKRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIICGK 718
T+ V T Y +PE ++ + ++ D++S G ++ E++ G+
Sbjct: 169 -HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 60/219 (27%), Positives = 94/219 (42%), Gaps = 33/219 (15%)
Query: 525 LGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLL--------------IAKL 570
LG+G FG V I VK + G M+ K EV++ +
Sbjct: 3 LGKGTFGKV----------ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 52
Query: 571 QHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLL 630
+H L L D + EY L F +R ++ + A I L
Sbjct: 53 RHPFLTALKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSALD 109
Query: 631 YLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSP 690
YLH + +++RDLK N++LD + KI+DFGL + G+ + A K GT Y++P
Sbjct: 110 YLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKE-GI-KDGATMKTFCGTPEYLAP 165
Query: 691 EYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHD 729
E D + D + GV++ E++CG+ F + DH+
Sbjct: 166 EVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHE 202
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 5e-11
Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 21/213 (9%)
Query: 525 LGEGGFGPVYKGMLIE----GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVK 577
LG+G FG V ML E + A+K L K +E E ++A +
Sbjct: 8 LGKGSFGKV---MLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLT 64
Query: 578 LLGCCTQRDERM-LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDS 636
L C Q +R+ + EY+ L Y I + K + A I+ GL +LH+
Sbjct: 65 QLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFK---EPQAVFYAAEISVGLFFLHRRG 121
Query: 637 RLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDG 696
II+RDLK NV+LD+ + KI+DFG+ + +D T+ GT Y++PE
Sbjct: 122 ---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV--TTRTFCGTPDYIAPEIIAYQ 176
Query: 697 LFSVKSDVFSFGVLVLEIICGKKNRGFNHADHD 729
+ D +++GVL+ E++ G+ F+ D D
Sbjct: 177 PYGKSVDWWAYGVLLYEMLAGQPP--FDGEDED 207
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 5e-11
Identities = 34/95 (35%), Positives = 54/95 (56%), Gaps = 5/95 (5%)
Query: 625 IARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
I RGL YLH I+HRD+K N+L+++ KI DFGLAR D+++ T+ VV
Sbjct: 112 ILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQ 168
Query: 685 YGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIICGK 718
Y Y +PE + ++ D++S G + E++ +
Sbjct: 169 Y-YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 6e-11
Identities = 56/214 (26%), Positives = 101/214 (47%), Gaps = 20/214 (9%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE---GQEIAVKRLSK---GSGQGMEEFKNEVLLIAKL 570
+F K+ +G G FG V ++ E G A+K + K + + + F+ E +++
Sbjct: 1 KDFDVKSLVGRGHFGEVQ--VVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS 58
Query: 571 QHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLL 630
+ +L +D L+ EY P L + ++ D +A +L
Sbjct: 59 NSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLL-----NRYEDQFDEDMAQFYLAELVL 113
Query: 631 YLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSP 690
+H ++ +HRD+K NVL+D T + K++DFG A ++ N+K VGT Y++P
Sbjct: 114 AIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM-VNSKLPVGTPDYIAP 172
Query: 691 EY--AIDG----LFSVKSDVFSFGVLVLEIICGK 718
E ++G + V+ D +S GV+ E+I G+
Sbjct: 173 EVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 6e-11
Identities = 59/219 (26%), Positives = 101/219 (46%), Gaps = 33/219 (15%)
Query: 517 DNFSEKNKLGEGGFGPVYKGM-LIEGQEIAVK--RLSKGSGQGMEE------FKNEVLLI 567
D + + K+GEG +G VYK G+ +A+K RL M+E E+ L+
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLE------MDEEGIPPTALREISLL 54
Query: 568 AKLQHRN-LVKLLGCCTQRDERM------LIYEYLPNKSLDYFIFDTTR--SKLLDWSKR 618
L +V+LL +E+ L++EYL + L F+ R + L
Sbjct: 55 QMLSESIYIVRLL-DVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTI 112
Query: 619 SHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNP-KISDFGLARSFGLDQTEAN 677
+ + +G+ + H + ++HRDLK N+L+D KI+D GL R+F + ++
Sbjct: 113 KSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSI-PVKSY 168
Query: 678 TKRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEII 715
T +V T Y +PE + +S D++S G + E+
Sbjct: 169 THEIV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMS 206
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 6e-11
Identities = 38/90 (42%), Positives = 51/90 (56%), Gaps = 3/90 (3%)
Query: 625 IARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
+ARG+ +L SR + IHRDL A N+LL KI DFGLAR D
Sbjct: 183 VARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239
Query: 685 YGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 714
+M+PE D +++ +SDV+SFGVL+ EI
Sbjct: 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEI 269
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 6e-11
Identities = 65/240 (27%), Positives = 112/240 (46%), Gaps = 24/240 (10%)
Query: 490 KKHSNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQE-IAVKR 548
+ H+N E E+ E I D I + ++ N +G G FG VY+ + I+ E +A+K+
Sbjct: 40 RSHNNNAGEDEDEEKMI-DNDINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKK 98
Query: 549 LSKGSGQGMEEFKNEVLLIAK-LQHRNLVKLLGC----CTQRDERML----IYEYLPNKS 599
+ + ++KN LLI K L H N++ L C +++E+ + + E++P
Sbjct: 99 VLQDP-----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTV 153
Query: 600 LDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD-NTMNP 658
Y + L + R L Y+H I HRDLK N+L+D NT
Sbjct: 154 HKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTL 210
Query: 659 KISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIICG 717
K+ DFG A++ Q + + + Y +PE + ++ D++S G ++ E+I G
Sbjct: 211 KLCDFGSAKNLLAGQRSVS---YICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 7e-11
Identities = 53/208 (25%), Positives = 96/208 (46%), Gaps = 19/208 (9%)
Query: 517 DNFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGM---EEFKNEVLLIAKLQH 572
D+ +G G FG V+ I A+K ++ + + NE ++ ++ H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 573 RNLVKLLGCCTQRDERML--IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLL 630
+++L T+ D+R L + EY+P L F + + + + + + I L
Sbjct: 61 PFIIRLF--WTEHDQRFLYMLMEYVPGGEL--FSYLRNSGRFSNSTGLFYA-SEIVCALE 115
Query: 631 YLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSP 690
YLH I++RDLK N+LLD + K++DFG A+ D+T + GT Y++P
Sbjct: 116 YLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKL-RDRTWT----LCGTPEYLAP 167
Query: 691 EYAIDGLFSVKSDVFSFGVLVLEIICGK 718
E + D ++ G+L+ E++ G
Sbjct: 168 EVIQSKGHNKAVDWWALGILIYEMLVGY 195
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 8e-11
Identities = 61/206 (29%), Positives = 102/206 (49%), Gaps = 33/206 (16%)
Query: 525 LGEGGFGPV---YKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGC 581
+G G G V Y +L + +A+K+LS+ F+N+ AK +R LV L+ C
Sbjct: 25 IGSGAQGIVCAAYDAVL--DRNVAIKKLSR-------PFQNQTH--AKRAYRELV-LMKC 72
Query: 582 CTQRDERMLIYEYLPNKSLD-----YFIFDTTRSKL-------LDWSKRSHIIAGIARGL 629
++ L+ + P KSL+ Y + + + L LD + S+++ + G+
Sbjct: 73 VNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 132
Query: 630 LYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMS 689
+LH IIHRDLK SN+++ + KI DFGLAR+ G + T VV Y Y +
Sbjct: 133 KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRY-YRA 186
Query: 690 PEYAIDGLFSVKSDVFSFGVLVLEII 715
PE + + D++S G ++ E++
Sbjct: 187 PEVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 8e-11
Identities = 77/281 (27%), Positives = 129/281 (45%), Gaps = 27/281 (9%)
Query: 524 KLGEGGFGPVYKGMLIEG---QEIAVKRL-SKGSGQGMEEFKNEVLLIAKLQHRNLVKLL 579
++G G FG V G + G ++ VK L S Q +F E LQH NL++ L
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 580 GCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLL--DWSKRSHIIAGIARGLLYLHQDSR 637
G CT+ +L+ E+ P L ++ +++L+ D + + IA GLL+LH+++
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN- 120
Query: 638 LRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYA--ID 695
IH DL N LL + KI D+GL+ + + ++ +++PE +
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVH 178
Query: 696 GLFSV-----KSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELID 750
G V +S+V+S GV + E+ ++ + H D +L + + E+ L+L
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWELF-ELGSQPYRHLS-DEQVLTYT----VREQQLKLPK 232
Query: 751 QSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLS 791
L + R +V C Q PE RP+ V L+LS
Sbjct: 233 PRL----KLPLSDRWYEVMQFCWLQ-PEQRPSAEEVHLLLS 268
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-10
Identities = 37/90 (41%), Positives = 52/90 (57%), Gaps = 3/90 (3%)
Query: 625 IARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
+A+G+ +L SR + IHRDL A N+LL KI DFGLAR D
Sbjct: 188 VAKGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 685 YGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 714
+M+PE D +++++SDV+SFGVL+ EI
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEI 274
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 1e-10
Identities = 41/112 (36%), Positives = 61/112 (54%), Gaps = 9/112 (8%)
Query: 606 DTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGL 665
DT S LD + +A+G+ +L + IHRD+ A NVLL + KI DFGL
Sbjct: 202 DTEDSWPLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGL 258
Query: 666 ARSFGLDQT---EANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 714
AR D + N + V +M+PE D +++V+SDV+S+G+L+ EI
Sbjct: 259 ARDIMNDSNYVVKGNARLPV---KWMAPESIFDCVYTVQSDVWSYGILLWEI 307
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|221289 pfam11883, DUF3403, Domain of unknown function (DUF3403) | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 1e-10
Identities = 22/43 (51%), Positives = 33/43 (76%), Gaps = 2/43 (4%)
Query: 796 LPQPQQPGFFTGRNLPESESSSSRQY--SASTNEITLSVLEAR 836
+PQP+QPGF GR+ E++SSSS Q S + N++T+SV++AR
Sbjct: 6 IPQPKQPGFCVGRSPYETDSSSSTQRDESWTVNQVTVSVIDAR 48
|
This domain is functionally uncharacterized. This domain is found in eukaryotes. This presumed domain is about 50 amino acids in length. This domain is found associated with pfam00069, pfam08276, pfam00954, pfam01453. Length = 48 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 1e-10
Identities = 57/201 (28%), Positives = 94/201 (46%), Gaps = 18/201 (8%)
Query: 525 LGEGGFGPVYKGM-LIEGQEIAVKRLSK--GSGQGMEEFKNEVLLIAKLQHRNLVKLLGC 581
+G G +G V + G+++A+K+LS+ S + E+ L+ +QH N++ LL
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82
Query: 582 CTQR---DERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRL 638
T DE Y +P D L K +++ + GL Y+H
Sbjct: 83 FTSAVSGDEFQDFYLVMPYMQTD---LQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAG-- 137
Query: 639 RIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLF 698
IIHRDLK N+ ++ KI DFGLAR +A V T Y +PE ++ +
Sbjct: 138 -IIHRDLKPGNLAVNEDCELKILDFGLARH-----ADAEMTGYVVTRWYRAPEVILNWMH 191
Query: 699 SVKS-DVFSFGVLVLEIICGK 718
++ D++S G ++ E++ GK
Sbjct: 192 YNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 1e-10
Identities = 59/214 (27%), Positives = 98/214 (45%), Gaps = 31/214 (14%)
Query: 525 LGEGGFGPVYKGMLIE---------GQEIAVKRLSKGSGQGM-EEFKNEVLLIAKLQHRN 574
LG+G F +YKG+L GQE++V GS F L+++L H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQ 634
LVKL G C RDE +++ EY+ LD F+ + L W + + +A L YL
Sbjct: 63 LVKLYGVCV-RDENIMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLED 119
Query: 635 DSRLRIIHRDLKASNVLL----DNTMNP---KISDFGLARSFGLDQTEANTKRVVGTYGY 687
+++H ++ N+L+ N K+SD G+ + E +R+ +
Sbjct: 120 K---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVL--SREERVERI----PW 170
Query: 688 MSPEYAIDGLFSVKS--DVFSFGVLVLEIICGKK 719
++PE +G S+ D +SFG +LEI +
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLEICSNGE 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 56/199 (28%), Positives = 94/199 (47%), Gaps = 13/199 (6%)
Query: 525 LGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKN--EVLLIAKLQHRNLVKLLGC 581
+G G +G V Q++AVK+LS+ + + E+ L+ ++H N++ LL
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82
Query: 582 CTQRDERMLIYE-YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRI 640
T E YL + + + + + L +I + RGL Y+H I
Sbjct: 83 FTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAG---I 139
Query: 641 IHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGL-FS 699
IHRDLK SNV ++ +I DFGLAR Q + V T Y +PE ++ + ++
Sbjct: 140 IHRDLKPSNVAVNEDCELRILDFGLAR-----QADDEMTGYVATRWYRAPEIMLNWMHYN 194
Query: 700 VKSDVFSFGVLVLEIICGK 718
D++S G ++ E++ GK
Sbjct: 195 QTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 37/95 (38%), Positives = 60/95 (63%), Gaps = 6/95 (6%)
Query: 624 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVG 683
+ RGL YL + + +I+HRD+K SN+L+++ K+ DFG+ S L + AN+ VG
Sbjct: 111 AVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGV--SGQLIDSMANS--FVG 164
Query: 684 TYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGK 718
T YMSPE +SV+SD++S G+ ++E+ G+
Sbjct: 165 TRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 52/208 (25%), Positives = 95/208 (45%), Gaps = 34/208 (16%)
Query: 523 NKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKN--EVLLIAKLQ-HRNLVKL 578
K+GEG F V K + G+ A+K + K + +E+ N E+ + +L H N+++L
Sbjct: 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCM-KKHFKSLEQVNNLREIQALRRLSPHPNILRL 63
Query: 579 L--------GCCTQRDE--RMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARG 628
+ G E M +YE + R + L + + + +
Sbjct: 64 IEVLFDRKTGRLALVFELMDMNLYELIKG-----------RKRPLPEKRVKSYMYQLLKS 112
Query: 629 LLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYM 688
L ++H++ I HRD+K N+L+ + K++DFG R G+ T+ + T Y
Sbjct: 113 LDHMHRNG---IFHRDIKPENILIKDD-ILKLADFGSCR--GIYSKPPYTE-YISTRWYR 165
Query: 689 SPEYAI-DGLFSVKSDVFSFGVLVLEII 715
+PE + DG + K D+++ G + EI+
Sbjct: 166 APECLLTDGYYGPKMDIWAVGCVFFEIL 193
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 58/211 (27%), Positives = 98/211 (46%), Gaps = 18/211 (8%)
Query: 518 NFSEKNKLGEGGFGPVYKGMLIEGQE----IAVKRLSKGS----GQGMEEFKNEVLLIAK 569
NF LG G +G V+ + G + A+K L K + + E + E ++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 570 LQHRNLVKLLGCCTQRDERM-LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARG 628
++ + L Q D ++ LI +Y+ L F + R + + + + I
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGEL--FTHLSQRERFKEQEVQIYS-GEIVLA 117
Query: 629 LLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYM 688
L +LH +L II+RD+K N+LLD+ + ++DFGL++ F D+ E GT YM
Sbjct: 118 LEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE-RAYSFCGTIEYM 173
Query: 689 SPEYAI--DGLFSVKSDVFSFGVLVLEIICG 717
+P+ DG D +S GVL+ E++ G
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 65/223 (29%), Positives = 94/223 (42%), Gaps = 42/223 (18%)
Query: 525 LGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAK------------LQ- 571
LG+G FG V I V+ + G M+ K EV+ IAK LQ
Sbjct: 3 LGKGTFGKV----------ILVREKATGKYYAMKILKKEVI-IAKDEVAHTLTESRVLQN 51
Query: 572 --HRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGL 629
H L L D + EY L F +R ++ + A I L
Sbjct: 52 TRHPFLTALKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSAL 108
Query: 630 LYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR---SFGLDQTEANTKRVVGTYG 686
YLH +++RDLK N++LD + KI+DFGL + S G A K GT
Sbjct: 109 GYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-----ATMKTFCGTPE 160
Query: 687 YMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHD 729
Y++PE D + D + GV++ E++CG+ F + DH+
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHE 201
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 3e-10
Identities = 53/231 (22%), Positives = 91/231 (39%), Gaps = 51/231 (22%)
Query: 525 LGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQGMEE---FKNEVLLIAKLQHRNLVKLLG 580
+G G FG V+ + ++ A+K L K + + E ++A +VKL
Sbjct: 9 IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLY- 67
Query: 581 CCTQRDERML--IYEYLPNKSL-----DYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLH 633
+ +DE L + EY+P L +F ++ IA + L +H
Sbjct: 68 -YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFY--------IAELVLALDSVH 118
Query: 634 QDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG----------------------- 670
+ L IHRD+K N+L+D + K++DFGL +
Sbjct: 119 K---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLV 175
Query: 671 ----LDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICG 717
Q VGT Y++PE + ++ D +S GV++ E++ G
Sbjct: 176 RRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 4e-10
Identities = 35/90 (38%), Positives = 49/90 (54%), Gaps = 3/90 (3%)
Query: 625 IARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
+ARG+ +L + +HRDL A NVLL KI DFGLAR D +
Sbjct: 246 VARGMEFLASKN---CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLP 302
Query: 685 YGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 714
+M+PE D L++ SDV+S+G+L+ EI
Sbjct: 303 VKWMAPESIFDNLYTTLSDVWSYGILLWEI 332
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 4e-10
Identities = 57/208 (27%), Positives = 103/208 (49%), Gaps = 19/208 (9%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHR--- 573
D+F + ++LG G G V+K I ++L + +N+++ ++ H
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIK--PAIRNQIIRELQVLHECNS 62
Query: 574 -NLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTR--SKLLDWSKRSHIIAGIARGLL 630
+V G E + E++ SLD + R ++L + + +GL
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQIL-----GKVSIAVIKGLT 117
Query: 631 YLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSP 690
YL + + +I+HRD+K SN+L+++ K+ DFG+ S L + AN+ VGT YMSP
Sbjct: 118 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGV--SGQLIDSMANS--FVGTRSYMSP 171
Query: 691 EYAIDGLFSVKSDVFSFGVLVLEIICGK 718
E +SV+SD++S G+ ++E+ G+
Sbjct: 172 ERLQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 6e-10
Identities = 36/96 (37%), Positives = 58/96 (60%), Gaps = 8/96 (8%)
Query: 623 AGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVV 682
A I GL ++H +R +++RDLK +N+LLD + +ISD GLA F + A+ V
Sbjct: 104 AEIILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----V 156
Query: 683 GTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIICG 717
GT+GYM+PE G+ + +D FS G ++ +++ G
Sbjct: 157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 6e-10
Identities = 58/202 (28%), Positives = 96/202 (47%), Gaps = 20/202 (9%)
Query: 525 LGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLG 580
+G GGFG VY + G+ A+K L K QG NE ++++ L +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS-LVSTGDCPFIV 60
Query: 581 CCT----QRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDS 636
C T D+ I + + L Y + ++ + + I GL ++H +
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHL---SQHGVFSEKEMRFYATEIILGLEHMH--N 115
Query: 637 RLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDG 696
R +++RDLK +N+LLD + +ISD GLA F + A+ VGT+GYM+PE G
Sbjct: 116 RF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPEVLQKG 170
Query: 697 L-FSVKSDVFSFGVLVLEIICG 717
+ +D FS G ++ +++ G
Sbjct: 171 TAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 8e-10
Identities = 38/98 (38%), Positives = 53/98 (54%), Gaps = 6/98 (6%)
Query: 622 IAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRV 681
IA I L +LHQ L II+RD+K N+LLD+ + ++DFGL++ F L + E
Sbjct: 111 IAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEF-LAEEEERAYSF 166
Query: 682 VGTYGYMSPEY--AIDGLFSVKSDVFSFGVLVLEIICG 717
GT YM+PE G D +S GVL E++ G
Sbjct: 167 CGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 62/209 (29%), Positives = 96/209 (45%), Gaps = 32/209 (15%)
Query: 525 LGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCT 583
+G+G FG VY+ + + I A+K LSK +E + + RN++ T
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTI------GERNILV----RT 50
Query: 584 QRDERMLI----YEYLPNKSLDYFIFDTTRSKLLDW---------SKRSHI-IAGIARGL 629
DE I + + + L Y + D L W R+ IA + L
Sbjct: 51 LLDESPFIVGLKFSFQTDSDL-YLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLAL 109
Query: 630 LYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMS 689
+LH+ I++RDLK N+LLD T + + DFGL+++ D NT GT Y++
Sbjct: 110 EHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT--FCGTTEYLA 164
Query: 690 PEYAIDGL-FSVKSDVFSFGVLVLEIICG 717
PE +D ++ D +S GVLV E+ CG
Sbjct: 165 PEVLLDEKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 58/210 (27%), Positives = 98/210 (46%), Gaps = 28/210 (13%)
Query: 525 LGEGGFGPVYKGMLIE----GQ----EIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLV 576
LG+G F ++KG+ E G+ E+ +K L K E F ++++L H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 577 KLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDS 636
G C DE +++ EY+ SLD ++ L++ S + + +A L +L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYL--KKNKNLINISWKLEVAKQLAWALHFLEDKG 120
Query: 637 RLRIIHRDLKASNVLL-----DNTMNP---KISDFGLARSFGLDQTEANTKRVVGTYGYM 688
+ H ++ A NVLL T NP K+SD G+ S + E +R+ ++
Sbjct: 121 ---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI--SITVLPKEILLERI----PWV 171
Query: 689 SPEYAIDGL-FSVKSDVFSFGVLVLEIICG 717
PE + S+ +D +SFG + EI G
Sbjct: 172 PPECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|214680 smart00473, PAN_AP, divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 2e-09
Identities = 25/81 (30%), Positives = 33/81 (40%), Gaps = 6/81 (7%)
Query: 367 KHGDGFLEHKAVKLPDTRFSWVDKNITLWECKELCSK-NCSCTAYANADVRGRGSGCLLW 425
K D F+ KLP + +L EC C NCSC ++ GCLLW
Sbjct: 1 KSDDCFVRLPNTKLPGFSRIVIS-VASLEECASKCLNSNCSCRSFTY---NNGTKGCLLW 56
Query: 426 -FHDLIDIKELPESGQDLFIR 445
L D + P G DL+ +
Sbjct: 57 SESSLGDARLFPSGGVDLYEK 77
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. Length = 78 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 3e-09
Identities = 62/211 (29%), Positives = 96/211 (45%), Gaps = 29/211 (13%)
Query: 518 NFSEKNKLGEGGFGPV----YKGMLIEGQEIAVKRLSKGSGQGMEEFKN---EVLLIAKL 570
+F LG G FG V +KG G+ A+K L K M++ ++ E ++ +L
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKG---TGEYYAIKCLKKREILKMKQVQHVAQEKSILMEL 75
Query: 571 QHRNLVKLLGCCTQRDERM-LIYEYLPNKSLDYFIFDTTRSKLL---DWSKRSHIIAGIA 626
H +V ++ C Q + R+ + E++ L F R D +K H A +
Sbjct: 76 SHPFIVNMM-CSFQDENRVYFLLEFVVGGEL----FTHLRKAGRFPNDVAKFYH--AELV 128
Query: 627 RGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYG 686
YLH II+RDLK N+LLDN + K++DFG A+ + T + GT
Sbjct: 129 LAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK-----KVPDRTFTLCGTPE 180
Query: 687 YMSPEYAIDGLFSVKSDVFSFGVLVLEIICG 717
Y++PE D ++ GVL+ E I G
Sbjct: 181 YLAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 3e-09
Identities = 53/183 (28%), Positives = 85/183 (46%), Gaps = 25/183 (13%)
Query: 629 LLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYM 688
LL +H +IHRD+K++N+LL + K+ DFG ++ + ++ + GT Y+
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212
Query: 689 SPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLEL 748
+PE +S K+D+FS GVL+ E++ K R F+ + +EE +
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLK--RPFDGEN-------------MEEVMHKT 257
Query: 749 IDQSLDN-SCSFSEALRCIQVGLLCVQQRPEDRP------NMSSVVLMLSGERSLPQPQQ 801
+ D S S ++ I LL P+ RP NM L +SG + Q Q
Sbjct: 258 LAGRYDPLPPSISPEMQEIVTALLSSD--PKRRPSSSKLLNMPICKLFISGLLEIVQ-TQ 314
Query: 802 PGF 804
PGF
Sbjct: 315 PGF 317
|
Length = 496 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 4e-09
Identities = 60/232 (25%), Positives = 94/232 (40%), Gaps = 63/232 (27%)
Query: 517 DNFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNL 575
+ +G G +G V + G+++A+K++ +V +AK R L
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAF---------DVPTLAKRTLREL 55
Query: 576 VKLLGCCTQR----DERMLIYEYL-PNKSLD---YFIFDTTRSKLLDWSKRSHIIAG--- 624
K+L R D + I + L P + Y + D S L HII
Sbjct: 56 -KIL-----RHFKHDNIIAIRDILRPPGADFKDVYVVMDLMESDL------HHIIHSDQP 103
Query: 625 ------------IARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672
+ RGL Y+H + +IHRDLK SN+L++ +I DFG+AR GL
Sbjct: 104 LTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMAR--GLS 158
Query: 673 QTEANTKRV----VGTYGYMSPEYAIDGLFSV-----KSDVFSFGVLVLEII 715
+ K V T Y +PE L S+ D++S G + E++
Sbjct: 159 SSPTEHKYFMTEYVATRWYRAPEL----LLSLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 5e-09
Identities = 45/147 (30%), Positives = 69/147 (46%), Gaps = 8/147 (5%)
Query: 572 HRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLY 631
H LV L C + EY+ L +F R + L A I+ L Y
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNY 111
Query: 632 LHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPE 691
LH+ II+RDLK NVLLD+ + K++D+G+ + GL + T GT Y++PE
Sbjct: 112 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGD-TTSTFCGTPNYIAPE 166
Query: 692 YAIDGLFSVKSDVFSFGVLVLEIICGK 718
+ D ++ GVL+ E++ G+
Sbjct: 167 ILRGEDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 7e-09
Identities = 60/222 (27%), Positives = 103/222 (46%), Gaps = 21/222 (9%)
Query: 506 IFDLKIIANATDNFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKNEV 564
IFD + +D + +G+G +G V+K + G + AVK L EE + E
Sbjct: 9 IFD--SFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID-EEIEAEY 65
Query: 565 LLIAKLQ-HRNLVKLLGCCTQRDER-----MLIYEYLPNKSL-DYFIFDTTRSKLLDWSK 617
++ L H N+VK G ++D + L+ E S+ D R + ++
Sbjct: 66 NILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPI 125
Query: 618 RSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEAN 677
++I+ GL +LH + + IHRD+K +N+LL K+ DFG++ + N
Sbjct: 126 IAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRN 182
Query: 678 TKRVVGTYGYMSPEY-----AIDGLFSVKSDVFSFGVLVLEI 714
T VGT +M+PE +D + + DV+S G+ +E+
Sbjct: 183 TS--VGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIEL 222
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 7e-09
Identities = 57/211 (27%), Positives = 101/211 (47%), Gaps = 21/211 (9%)
Query: 521 EKNKLGEGGFGPVYKGMLIEGQ---EIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVK 577
E K+G G +G VYK +G+ E A+K++ +G+G M + E+ L+ +L+H N++
Sbjct: 5 EGCKVGRGTYGHVYKAKRKDGKDEKEYALKQI-EGTGISMSACR-EIALLRELKHPNVIA 62
Query: 578 LLGCCTQRDERM--LIYEYLPNKSLDYFIFD-----TTRSKLLDWSKRSHIIAGIARGLL 630
L +R L+++Y + F + L S ++ I G+
Sbjct: 63 LQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIH 122
Query: 631 YLHQDSRLRIIHRDLKASNVLL----DNTMNPKISDFGLARSFGLD-QTEANTKRVVGTY 685
YLH + ++HRDLK +N+L+ KI+D G AR F + A+ VV T+
Sbjct: 123 YLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179
Query: 686 GYMSPEYAIDGLFSVKS-DVFSFGVLVLEII 715
Y +PE + K+ D+++ G + E++
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 8e-09
Identities = 52/172 (30%), Positives = 81/172 (47%), Gaps = 13/172 (7%)
Query: 525 LGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKNEV----LLIAKLQHRNLVKLL 579
+G+G FG V +G+ AVK L K + +E K+ + +L+ ++H LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 580 GCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLR 639
D+ + +Y+ L F R + + A IA L YLH L
Sbjct: 63 YSFQTADKLYFVLDYVNGGEL---FFHLQRERSFPEPRARFYAAEIASALGYLHS---LN 116
Query: 640 IIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPE 691
II+RDLK N+LLD+ + ++DFGL + G+ + T GT Y++PE
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCKE-GI-EHSKTTSTFCGTPEYLAPE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 1e-08
Identities = 34/93 (36%), Positives = 54/93 (58%), Gaps = 9/93 (9%)
Query: 625 IARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT---EANTKRV 681
+A+G+ +L + IHRDL A N+LL + KI DFGLAR D + N +
Sbjct: 223 VAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLP 279
Query: 682 VGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 714
V +M+PE + +++ +SDV+S+G+L+ EI
Sbjct: 280 V---KWMAPESIFNCVYTFESDVWSYGILLWEI 309
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 56/213 (26%), Positives = 99/213 (46%), Gaps = 38/213 (17%)
Query: 525 LGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKN---------EVLLIAKLQHRN 574
+G G +G V E +++A+K+++ F N E+ L+ L H N
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANA-------FDNRIDAKRTLREIKLLRHLDHEN 65
Query: 575 LVKLLGCC--TQRDERMLIYEYLPNKSLDYFIFDT------TRSKLLDWSKRSHIIAGIA 626
++ + R+ +Y + Y + DT S+ L + + +
Sbjct: 66 VIAIKDIMPPPHREAFNDVY-------IVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLL 118
Query: 627 RGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYG 686
RGL Y+H + ++HRDLK SN+LL+ + KI DFGLAR+ ++ + T+ VV T
Sbjct: 119 RGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLART-TSEKGDFMTEYVV-TRW 173
Query: 687 YMSPEYAID-GLFSVKSDVFSFGVLVLEIICGK 718
Y +PE ++ ++ DV+S G + E++ K
Sbjct: 174 YRAPELLLNCSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-08
Identities = 58/209 (27%), Positives = 92/209 (44%), Gaps = 32/209 (15%)
Query: 525 LGEGGFGPVYKGMLIEGQE----IAVKRLSKG----SGQGMEEFKNEVLLIAKLQHRNLV 576
LG+GG+G V++ + G + A+K L K + + K E ++ ++H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 577 KLLGCCTQRDERMLIYEYLPNKSL-------DYFIFDTTRSKLLDWSKRSHIIAGIARGL 629
L+ + LI EYL L F+ DT ++ I+ L
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTA----------CFYLSEISLAL 113
Query: 630 LYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR-SFGLDQTEANTKRVVGTYGYM 688
+LHQ II+RDLK N+LLD + K++DFGL + S T GT YM
Sbjct: 114 EHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTV---THTFCGTIEYM 167
Query: 689 SPEYAIDGLFSVKSDVFSFGVLVLEIICG 717
+PE + D +S G L+ +++ G
Sbjct: 168 APEILMRSGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-08
Identities = 57/218 (26%), Positives = 99/218 (45%), Gaps = 33/218 (15%)
Query: 518 NFSEKNKLGEGGFGPVYKGMLIEGQE----IAVKRLSKGS----GQGMEEFKNEVLLIAK 569
NF LG G +G V+ + G + A+K L K + + +E + E ++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 570 LQHRNLVKLLGCCTQRDERM-LIYEYLPNKSL-------DYFIFDTTRSKLLDWSKRSHI 621
++ + L Q + ++ LI +Y+ + D F D R
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVR-----------F 109
Query: 622 IAG-IARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKR 680
+G I L +LH +L I++RD+K N+LLD+ + ++DFGL++ F L + + T
Sbjct: 110 YSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEF-LSEEKERTYS 165
Query: 681 VVGTYGYMSPEYAIDGLFSVKS-DVFSFGVLVLEIICG 717
GT YM+PE K+ D +S G+L+ E++ G
Sbjct: 166 FCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-08
Identities = 33/90 (36%), Positives = 48/90 (53%), Gaps = 3/90 (3%)
Query: 625 IARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
+A G+ +L + +HRDL A NVL+ KI DFGLAR D +
Sbjct: 248 VANGMEFLASKN---CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP 304
Query: 685 YGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 714
+M+PE + L++ SDV+SFG+L+ EI
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEI 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-08
Identities = 53/198 (26%), Positives = 93/198 (46%), Gaps = 13/198 (6%)
Query: 525 LGEGGFGPVYKGML-IEGQEIAVKRLSKGSGQGMEEFKNEV----LLIAKLQHRNLVKLL 579
+G+G FG V ++G+ AVK L K +E K+ + +L+ ++H LV L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 580 GCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLR 639
++ + +++ L F R + + A IA L YLH +
Sbjct: 63 YSFQTTEKLYFVLDFVNGGEL---FFHLQRERSFPEPRARFYAAEIASALGYLHS---IN 116
Query: 640 IIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFS 699
I++RDLK N+LLD+ + ++DFGL + G+ Q++ T GT Y++PE +
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLCKE-GIAQSDTTTT-FCGTPEYLAPEVIRKQPYD 174
Query: 700 VKSDVFSFGVLVLEIICG 717
D + G ++ E++ G
Sbjct: 175 NTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 44/144 (30%), Positives = 67/144 (46%), Gaps = 8/144 (5%)
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQ 634
LV L C L+ EY+ L +F R + L A I L +LH+
Sbjct: 58 LVGLHSCFQTTSRLFLVIEYVNGGDL---MFHMQRQRKLPEEHARFYAAEICIALNFLHE 114
Query: 635 DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAI 694
II+RDLK NVLLD + K++D+G+ + GL + T GT Y++PE
Sbjct: 115 RG---IIYRDLKLDNVLLDADGHIKLTDYGMCKE-GLGPGD-TTSTFCGTPNYIAPEILR 169
Query: 695 DGLFSVKSDVFSFGVLVLEIICGK 718
+ D ++ GVL+ E++ G+
Sbjct: 170 GEEYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 4e-08
Identities = 55/217 (25%), Positives = 99/217 (45%), Gaps = 36/217 (16%)
Query: 525 LGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKL---LG 580
LG G G V+ + + + +AVK++ Q ++ E+ +I +L H N+VK+ LG
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 581 CCTQRDERMLIYEYLPNKSLDYF--------IFDTTRSKLLDWSKRS--HI---IAGIAR 627
+ SL +T + +L+ S H + + R
Sbjct: 73 PSGSDLTEDV-------GSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLR 125
Query: 628 GLLYLHQDSRLRIIHRDLKASNVLLD-NTMNPKISDFGLARSFGLDQTEAN----TKRVV 682
GL Y+H + ++HRDLK +NV ++ + KI DFGLAR +D ++ ++ +V
Sbjct: 126 GLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARI--VDPHYSHKGYLSEGLV 180
Query: 683 GTYGYMSPEYAIDGLFSVKS-DVFSFGVLVLEIICGK 718
+ Y SP + K+ D+++ G + E++ GK
Sbjct: 181 TKW-YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 54.9 bits (133), Expect = 5e-08
Identities = 43/149 (28%), Positives = 65/149 (43%), Gaps = 15/149 (10%)
Query: 572 HRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSK-LLDWSKRSHIIAGIARGLL 630
+ N +KL T +LI +Y+ + L FD + + L ++ II + L
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDL----FDLLKKEGKLSEAEVKKIIRQLVEALN 123
Query: 631 YLHQDSRLRIIHRDLKASNVLLDNTMNP-KISDFGLARSFGLDQTEANTKRVVGTYGYMS 689
LH + IIH D+K NVL D + + D+GL + G GT Y S
Sbjct: 124 DLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYD------GTLDYFS 174
Query: 690 PEYAIDGLFSVKSDVFSFGVLVLEIICGK 718
PE + V D ++ GVL E++ GK
Sbjct: 175 PEKIKGHNYDVSFDWWAVGVLTYELLTGK 203
|
Length = 267 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 7e-08
Identities = 56/211 (26%), Positives = 103/211 (48%), Gaps = 21/211 (9%)
Query: 521 EKNKLGEGGFGPVYKGMLIEGQE---IAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVK 577
E K+G G +G VYK +G++ A+K++ +G+G M + E+ L+ +L+H N++
Sbjct: 5 EGCKVGRGTYGHVYKAKRKDGKDDRDYALKQI-EGTGISMSACR-EIALLRELKHPNVIS 62
Query: 578 LLGCCTQRDERM--LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLY---- 631
L +R L+++Y + + I R+ + K + G+ + LLY
Sbjct: 63 LQKVFLSHADRKVWLLFDYAEHDL--WHIIKFHRASKAN-KKPVQLPRGMVKSLLYQILD 119
Query: 632 -LHQDSRLRIIHRDLKASNVLL----DNTMNPKISDFGLARSFGLD-QTEANTKRVVGTY 685
+H ++HRDLK +N+L+ KI+D G AR F + A+ VV T+
Sbjct: 120 GIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179
Query: 686 GYMSPEYAIDGLFSVKS-DVFSFGVLVLEII 715
Y +PE + K+ D+++ G + E++
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 7e-08
Identities = 55/229 (24%), Positives = 98/229 (42%), Gaps = 49/229 (21%)
Query: 524 KLGEGGFGPVYKGM-LIEGQEIAVKRLSKG-SGQGM--EEFKNEVLLIAKLQHRNLVKLL 579
+G+GG G VY + + +A+K++ + S + + F E + A L H +V +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 580 GCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLD--WSKRS---------------HII 622
C+ D +Y +P +I T LL W K S I
Sbjct: 69 SICSDGD---PVYYTMP------YIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIF 119
Query: 623 AGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE-----AN 677
I + Y+H S+ ++HRDLK N+LL I D+G A L++ + +
Sbjct: 120 HKICATIEYVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVD 176
Query: 678 TK-----------RVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEII 715
+ ++VGT YM+PE + S +D+++ GV++ +++
Sbjct: 177 ERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQML 225
|
Length = 932 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 8e-08
Identities = 47/176 (26%), Positives = 85/176 (48%), Gaps = 18/176 (10%)
Query: 547 KRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFD 606
KR+ GS + + +NE+L + +L H N++K+ + R Y+ + D+ ++
Sbjct: 198 KRVKAGS-RAAIQLENEILALGRLNHENILKI-----EEILRSEANTYMITQKYDFDLYS 251
Query: 607 TTRSKLLDWSKR------SHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKI 660
+ DW R I+ + + Y+H ++IHRD+K N+ L+ +
Sbjct: 252 FMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVL 308
Query: 661 SDFGLARSFGLDQTEANTKRVVGTYGYMSPE-YAIDGLFSVKSDVFSFGVLVLEII 715
DFG A F + EA VGT SPE A DG + +D++S G+++L+++
Sbjct: 309 GDFGTAMPFE-KEREAFDYGWVGTVATNSPEILAGDGYCEI-TDIWSCGLILLDML 362
|
Length = 501 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 1e-07
Identities = 45/143 (31%), Positives = 72/143 (50%), Gaps = 13/143 (9%)
Query: 579 LGCCTQRDERM-LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSR 637
L C Q + R+ + E++ L +F R + L A I+ L +LH+
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDL---MFHMQRQRKLPEEHARFYSAEISLALNFLHERG- 116
Query: 638 LRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEY--AID 695
II+RDLK NVLLD + K++D+G+ + G+ + T GT Y++PE D
Sbjct: 117 --IIYRDLKLDNVLLDAEGHIKLTDYGMCKE-GIRPGDT-TSTFCGTPNYIAPEILRGED 172
Query: 696 GLFSVKSDVFSFGVLVLEIICGK 718
FSV D ++ GVL+ E++ G+
Sbjct: 173 YGFSV--DWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 33/113 (29%), Positives = 54/113 (47%), Gaps = 13/113 (11%)
Query: 605 FDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFG 664
FD +R++ A L L + +I+RDLK N+LLD + + DFG
Sbjct: 90 FDLSRARFY-----------TAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFG 138
Query: 665 LARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICG 717
L + D + NT GT Y++PE + ++ D ++ GVL+ E++ G
Sbjct: 139 LCKLNMKDDDKTNT--FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 63/239 (26%), Positives = 103/239 (43%), Gaps = 22/239 (9%)
Query: 490 KKHSNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEI-AVKR 548
+K+ N N E + ++ + +++ +G G FG V Q++ A+K
Sbjct: 16 RKNKNIDNFLNRYEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKL 75
Query: 549 LSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERM-LIYEYLPNKSLDYFI- 604
LSK + F E I + V L C Q D+ + ++ EY+P L +
Sbjct: 76 LSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMS 135
Query: 605 -FDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDF 663
+D W+K A +L L + +IHRD+K N+LLD + K++DF
Sbjct: 136 NYDVPEK----WAKFY-----TAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADF 186
Query: 664 GLARSFGLDQT-EANTKRVVGTYGYMSPEY----AIDGLFSVKSDVFSFGVLVLEIICG 717
G +D+T VGT Y+SPE DG + + D +S GV + E++ G
Sbjct: 187 GTC--MKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 59/245 (24%), Positives = 101/245 (41%), Gaps = 31/245 (12%)
Query: 481 FIGGLMYRRKKHSN---QGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGM 537
F+ L +KK S+ + K +M+ ++F+ LG G FG V
Sbjct: 3 FLKNLQLHKKKDSDSTKEPKRKNKMKY------------EDFNFIRTLGTGSFGRVILAT 50
Query: 538 LIEGQ--EIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592
+A+KR K + ++ +E ++ + H V L G L+
Sbjct: 51 YKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVL 110
Query: 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLL 652
E++ ++F F R+K A I YL L I++RDLK N+LL
Sbjct: 111 EFVIGG--EFFTF-LRRNKRFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLL 164
Query: 653 DNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVL 712
D K++DFG A+ + T + GT Y++PE ++ +D ++ G+ +
Sbjct: 165 DKDGFIKMTDFGFAKV-----VDTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIY 219
Query: 713 EIICG 717
EI+ G
Sbjct: 220 EILVG 224
|
Length = 340 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 33/97 (34%), Positives = 49/97 (50%), Gaps = 6/97 (6%)
Query: 625 IARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF--GLDQTEANTKRVV 682
I GL Y+H + ++HRDLK N+L++ KI DFGLAR F + V
Sbjct: 114 ILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV 170
Query: 683 GTYGYMSPEYAIDGLFSVKS-DVFSFGVLVLEIICGK 718
T Y +PE + K+ DV+S G ++ E++ K
Sbjct: 171 ATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 54/198 (27%), Positives = 90/198 (45%), Gaps = 13/198 (6%)
Query: 525 LGEGGFGPVYKGML-IEGQEIAVKRLSKGSGQGMEEFKNEV----LLIAKLQHRNLVKLL 579
+G+G FG V +G AVK L K + +E + + +L+ L+H LV L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 580 GCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLR 639
++ + +Y+ L F R + + A +A + YLH L
Sbjct: 63 YSFQTAEKLYFVLDYVNGGEL---FFHLQRERCFLEPRARFYAAEVASAIGYLHS---LN 116
Query: 640 IIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFS 699
II+RDLK N+LLD+ + ++DFGL + G++ E T GT Y++PE +
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCKE-GVEP-EETTSTFCGTPEYLAPEVLRKEPYD 174
Query: 700 VKSDVFSFGVLVLEIICG 717
D + G ++ E++ G
Sbjct: 175 RTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 4e-07
Identities = 55/200 (27%), Positives = 91/200 (45%), Gaps = 17/200 (8%)
Query: 525 LGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQGMEEFKNEV----LLIAKLQHRNLVKLL 579
+G+G FG V ++ AVK L K + +E K+ + +L+ ++H LV L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 580 GCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLR 639
D+ + +Y+ L Y + R + + A IA L YLH L
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHL---QRERCFLEPRARFYAAEIASALGYLHS---LN 116
Query: 640 IIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEAN--TKRVVGTYGYMSPEYAIDGL 697
I++RDLK N+LLD+ + ++DFGL + + E N T GT Y++PE
Sbjct: 117 IVYRDLKPENILLDSQGHIVLTDFGLCK----ENIEHNGTTSTFCGTPEYLAPEVLHKQP 172
Query: 698 FSVKSDVFSFGVLVLEIICG 717
+ D + G ++ E++ G
Sbjct: 173 YDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 5e-07
Identities = 38/156 (24%), Positives = 70/156 (44%), Gaps = 8/156 (5%)
Query: 563 EVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHII 622
E ++ + H ++++L G T LI LP D + + + + + I
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNIAICDILA-IE 188
Query: 623 AGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVV 682
+ R + YLH++ RIIHRD+KA N+ +++ + + DFG A F +D
Sbjct: 189 RSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKYYGWA 244
Query: 683 GTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGK 718
GT +PE + D++S G+++ E+
Sbjct: 245 GTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 6e-07
Identities = 57/217 (26%), Positives = 96/217 (44%), Gaps = 32/217 (14%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQGMEE---FKNEVLLIAKLQH 572
++F +G G FG V +++ A+K LSK + F E ++A
Sbjct: 43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANS 102
Query: 573 RNLVKLLGCCTQRDERML--IYEYLPNKSL-----DYFIFDTTRSKLLDWSKRSHIIAGI 625
+V+L +D++ L + EY+P L +Y I + W++ A +
Sbjct: 103 EWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPE-------KWAR--FYTAEV 151
Query: 626 ARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD-QTEANTKRVVGT 684
L +H + IHRD+K N+LLD + + K++DFG + +T VGT
Sbjct: 152 VLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDT--AVGT 206
Query: 685 YGYMSPEY----AIDGLFSVKSDVFSFGVLVLEIICG 717
Y+SPE DG + + D +S GV + E++ G
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 1e-06
Identities = 45/186 (24%), Positives = 76/186 (40%), Gaps = 18/186 (9%)
Query: 546 VKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIF 605
VK ++ G G E+ ++ + HR ++ L+ + ++ +P D F +
Sbjct: 124 VKAVTGGKTPG-----REIDILKTISHRAIINLIHAYRWKSTVCMV---MPKYKCDLFTY 175
Query: 606 DTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGL 665
RS L + I + L YLH IIHRD+K N+ LD N + DFG
Sbjct: 176 -VDRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGA 231
Query: 666 ARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI------ICGKK 719
A GT SPE + K+D++S G+++ E+ + GK+
Sbjct: 232 ACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQ 291
Query: 720 NRGFNH 725
+ +
Sbjct: 292 VKSSSS 297
|
Length = 392 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 34/99 (34%), Positives = 54/99 (54%), Gaps = 6/99 (6%)
Query: 625 IARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
IA +L +H +L +HRD+K NVLLD + +++DFG D T + VGT
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT-VQSSVAVGT 166
Query: 685 YGYMSPEY--AID---GLFSVKSDVFSFGVLVLEIICGK 718
Y+SPE A++ G + + D +S GV + E++ G+
Sbjct: 167 PDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 2e-06
Identities = 66/287 (22%), Positives = 121/287 (42%), Gaps = 40/287 (13%)
Query: 524 KLGEGGFGPVYKGMLIEGQEIA---VKRL-SKGSGQGMEEFKNEVLLIAKLQHRNLVKLL 579
++G G FG V + +A VK L + S + EF + LQH N+++ L
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 580 GCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRS-------HIIAGIARGLLYL 632
G C + +L++EY L ++ W +R+ + IA G+ ++
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQE------QWHRRNSQLLLLQRMACEIAAGVTHM 115
Query: 633 HQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS-FGLDQTEANTKRVVGTYGYMSPE 691
H + +H DL N L + + K+ D+G+ S + D E + V +++PE
Sbjct: 116 H---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCV-PLRWLAPE 171
Query: 692 YAI---DGLFSVK----SDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEER 744
GL + + S+V++ GV + E+ + +D + +L H I+++
Sbjct: 172 LVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE--VLNHV----IKDQ 225
Query: 745 PLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLS 791
++L L+ +SE R +V C PE R V +L+
Sbjct: 226 QVKLFKPQLEL--PYSE--RWYEVLQFC-WLSPEKRATAEEVHRLLT 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 2e-06
Identities = 35/97 (36%), Positives = 47/97 (48%), Gaps = 10/97 (10%)
Query: 627 RGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR-SFGLDQTEANTKRVVGTY 685
R L Y+H + + HRDLK N+L + KI DFGLAR +F T V T
Sbjct: 114 RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 686 GYMSPEYAIDGLFSVKS----DVFSFGVLVLEIICGK 718
Y +PE G F K D++S G + E++ GK
Sbjct: 171 WYRAPELC--GSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 4e-06
Identities = 42/156 (26%), Positives = 75/156 (48%), Gaps = 4/156 (2%)
Query: 561 KNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKL-LDWSKRS 619
++E+ +A H +VK D+ +LI EY L+ I + L +
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVG 172
Query: 620 HIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTK 679
+ I L +H SR +++HRDLK++N+ L T K+ DFG ++ + +
Sbjct: 173 LLFYQIVLALDEVH--SR-KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVAS 229
Query: 680 RVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEII 715
GT Y++PE +S K+D++S GV++ E++
Sbjct: 230 SFCGTPYYLAPELWERKRYSKKADMWSLGVILYELL 265
|
Length = 478 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 6e-06
Identities = 62/229 (27%), Positives = 100/229 (43%), Gaps = 42/229 (18%)
Query: 524 KLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKN-----EVLLIAKLQHRNLVKL 578
K+G G FG V+ QE + S +G++E + EV ++ +L+H+N+V+
Sbjct: 20 KIGNGRFGEVFLVKHKRTQEFFCWKAI--SYRGLKEREKSQLVIEVNVMRELKHKNIVRY 77
Query: 579 LGCCTQRDERML--IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLL----YL 632
+ + + L + E+ L I + + H I I R LL Y
Sbjct: 78 IDRFLNKANQKLYILMEFCDAGDLSRNI---QKCYKMFGKIEEHAIVDITRQLLHALAYC 134
Query: 633 HQ----DSRLRIIHRDLKASNVLLD-------------NTMN----PKISDFGLARSFGL 671
H + R++HRDLK N+ L N +N KI DFGL+++ G+
Sbjct: 135 HNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGI 194
Query: 672 DQTEANTKRVVGTYGYMSPEYAIDGLFSV--KSDVFSFGVLVLEIICGK 718
E+ VGT Y SPE + S KSD+++ G ++ E+ GK
Sbjct: 195 ---ESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240
|
Length = 1021 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 6e-06
Identities = 32/150 (21%), Positives = 54/150 (36%), Gaps = 15/150 (10%)
Query: 520 SEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLV--K 577
S L G VY + + +K S + + + EV ++ L + L K
Sbjct: 1 SSIKLLKGGLTNRVYLLGTKDE-DYVLKI--NPSREKGADREREVAILQLLARKGLPVPK 57
Query: 578 LLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSR 637
+L L+ E++ ++LD + +A L LHQ
Sbjct: 58 VLASGESDGWSYLLMEWIEGETLDEVSEEEKEDIAEQ----------LAELLAKLHQLPL 107
Query: 638 LRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
L + H DL N+L+D+ I D+ A
Sbjct: 108 LVLCHGDLHPGNILVDDGKILGIIDWEYAG 137
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 6e-06
Identities = 60/243 (24%), Positives = 94/243 (38%), Gaps = 66/243 (27%)
Query: 525 LGEGGFGPVYKGMLIEGQEI-AVKRLSKGS----GQGMEEFKNEVLLIAKLQHRNLVKLL 579
+G G FG V + I A+K+L K Q + + E ++A+ + +VKL
Sbjct: 9 IGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQ-VAHVRAERDILAEADNPWVVKLY 67
Query: 580 GCCTQRDER--MLIYEYLPNKSL-------DYFIFDTTRSKLLDWSKRSHIIAGIARGLL 630
+ +DE LI EYLP + D F + TR IA +L
Sbjct: 68 --YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFY-------------IAETIL 112
Query: 631 YLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG----------LDQTEANTKR 680
+ +L IHRD+K N+LLD + K+SDFGL L +
Sbjct: 113 AIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFL 172
Query: 681 --------------------------VVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 714
VGT Y++PE + ++ + D +S GV++ E+
Sbjct: 173 DFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEM 232
Query: 715 ICG 717
+ G
Sbjct: 233 LVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|238074 cd00129, PAN_APPLE, PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 1e-05
Identities = 23/84 (27%), Positives = 34/84 (40%), Gaps = 13/84 (15%)
Query: 366 CKHGDGFLEHKAVKLPDTRFSWVDKNITLWECKELCSKN---CSCTAYANADVRGRGSGC 422
CK L A+K+ T+ T EC C KN SC A+ A R C
Sbjct: 5 CKSAGTTLIKIALKIKTTKA------NTADECANRCEKNGLPFSCKAFVFAKARK---QC 55
Query: 423 LLW-FHDLIDIKELPESGQDLFIR 445
L + F+ + +++ G DL+
Sbjct: 56 LWFPFNSMSGVRKEFSHGFDLYEN 79
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. Length = 80 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 1e-05
Identities = 63/285 (22%), Positives = 105/285 (36%), Gaps = 64/285 (22%)
Query: 544 IAVKRLSKGSGQGMEEFK---NEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSL 600
+AVK+++ S E+ K E++ +LQH N++ + E ++ + S
Sbjct: 28 VAVKKINLDS-CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86
Query: 601 DYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKI 660
+ + T + L + I+ + L Y+H IHR +KAS++LL +
Sbjct: 87 EDLL-KTHFPEGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVL 142
Query: 661 SDFGLARSFGLDQTEANTKRVVGTYG--------YMSPEYAIDGL--FSVKSDVFSFGVL 710
S + S +RVV + ++SPE L ++ KSD++S G+
Sbjct: 143 SGLRYSVSM---IKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGIT 199
Query: 711 VLEIICG--------------KKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDNS 756
E+ G +K RG D + PL S S
Sbjct: 200 ACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTY-----------PLYEDSMSQSRS 248
Query: 757 C----------------SFSEALRCIQVGLLCVQQRPEDRPNMSS 785
+FSE Q LC+Q+ PE RP+ S
Sbjct: 249 SNEHPNNRDSVDHPYTRTFSEHFH--QFVELCLQRDPESRPSASQ 291
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 28/81 (34%), Positives = 42/81 (51%), Gaps = 5/81 (6%)
Query: 641 IHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEY----AIDG 696
IHRD+K N+LLD + + K++DFG + VGT Y+SPE DG
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDG 222
Query: 697 LFSVKSDVFSFGVLVLEIICG 717
+ + D +S GV + E++ G
Sbjct: 223 YYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-05
Identities = 32/99 (32%), Positives = 53/99 (53%), Gaps = 6/99 (6%)
Query: 625 IARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
+A +L + +L +HRD+K NVLLD + +++DFG D T + VGT
Sbjct: 108 LAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT-VQSNVAVGT 166
Query: 685 YGYMSPEY--AID---GLFSVKSDVFSFGVLVLEIICGK 718
Y+SPE A++ G + + D +S GV + E++ G+
Sbjct: 167 PDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 2e-05
Identities = 21/46 (45%), Positives = 31/46 (67%), Gaps = 3/46 (6%)
Query: 622 IAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
I+ +A L YLH+ IIHRDLK N+L+ N + K++DFGL++
Sbjct: 110 ISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 32/103 (31%), Positives = 52/103 (50%), Gaps = 18/103 (17%)
Query: 629 LLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL--------------DQT 674
L YLH I+HRDLK N+L+ + + K++DFGL++ GL D
Sbjct: 114 LEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSK-IGLMSLTTNLYEGHIEKDTR 169
Query: 675 EANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICG 717
E K+V GT Y++PE + + D ++ G+++ E + G
Sbjct: 170 EFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 56/220 (25%), Positives = 88/220 (40%), Gaps = 72/220 (32%)
Query: 621 IIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEA---N 677
I+ G RGL YLHQ+ IHR++KAS++L IS GL GL + N
Sbjct: 106 ILFGALRGLNYLHQNG---YIHRNIKASHIL--------ISGDGLVSLSGLSHLYSLVRN 154
Query: 678 TKRVVGTYGY----------MSPEYAIDGL--FSVKSDVFSFGVLVLEIICG-------- 717
++ Y + +SPE L ++VKSD++S G+ E+ G
Sbjct: 155 GQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDML 214
Query: 718 ------KKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDN---------------- 755
+K +G ++ D EE ++ +D+
Sbjct: 215 RTQMLLQKLKGPPYSPLDITTFPC------EESRMKNSQSGVDSGIGESVVAAGMTQTMT 268
Query: 756 --------SCSFSEALRCIQVGLLCVQQRPEDRPNMSSVV 787
S +FS A + + LC+QQ PE RP+ SS++
Sbjct: 269 SERLRTPSSKTFSPAFQ--NLVELCLQQDPEKRPSASSLL 306
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 3e-05
Identities = 64/265 (24%), Positives = 97/265 (36%), Gaps = 85/265 (32%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE----GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQH 572
++F +G+G FG V L++ G+ A+K L K E FK + L K +
Sbjct: 1 EDFHTVKVIGKGAFGEV---RLVQKKDTGKIYAMKTLLKS-----EMFKKDQLAHVKAER 52
Query: 573 RNL--------VKLLGCCTQRDERMLIYEYLPNKSL-------DYFIFDTTRSKLLDWSK 617
L V L LI E+LP L D F D TR
Sbjct: 53 DVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFY------ 106
Query: 618 RSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF-------- 669
+A +L + +L IHRD+K N+L+D + K+SDFGL+ F
Sbjct: 107 -------MAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAY 159
Query: 670 --GLDQTEANTKRV-----------------------------------VGTYGYMSPEY 692
L Q ++N R+ VGT Y++PE
Sbjct: 160 YQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEI 219
Query: 693 AIDGLFSVKSDVFSFGVLVLEIICG 717
+ + + D +S G ++ E + G
Sbjct: 220 FLQQGYGQECDWWSLGAIMFECLIG 244
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 5e-05
Identities = 60/241 (24%), Positives = 97/241 (40%), Gaps = 49/241 (20%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE----GQEIAVKRLSKGSGQGMEE---FKNEVLLIAK 569
++F +G G FG V L++ G A+K L K E+ + E ++ +
Sbjct: 1 EDFESLKVIGRGAFGEV---RLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVE 57
Query: 570 LQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGL 629
+VK+ + LI E+LP + + + L + IA +
Sbjct: 58 ADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLM---KKDTLTEEETQFYIAETVLAI 114
Query: 630 LYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLA----------------RSFGLDQ 673
+HQ L IHRD+K N+LLD+ + K+SDFGL S D
Sbjct: 115 DSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDF 171
Query: 674 T--EANTKR---------------VVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC 716
T N+KR VGT Y++PE + ++ D +S GV++ E++
Sbjct: 172 TFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI 231
Query: 717 G 717
G
Sbjct: 232 G 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 5e-05
Identities = 60/241 (24%), Positives = 95/241 (39%), Gaps = 49/241 (20%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE----GQEIAVKRLSKGSGQGMEE---FKNEVLLIAK 569
D+F +G G FG V L++ G A+K L K E+ + E ++ +
Sbjct: 1 DDFESLKVIGRGAFGEV---RLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVE 57
Query: 570 LQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGL 629
+VK+ + LI E+LP + + + L IA +
Sbjct: 58 ADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLM---KKDTLSEEATQFYIAETVLAI 114
Query: 630 LYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF-GLDQTE------------- 675
+HQ L IHRD+K N+LLD + K+SDFGL +TE
Sbjct: 115 DAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDF 171
Query: 676 ----ANTKR---------------VVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC 716
N+KR VGT Y++PE + ++ D +S GV++ E++
Sbjct: 172 SFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI 231
Query: 717 G 717
G
Sbjct: 232 G 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 1e-04
Identities = 64/296 (21%), Positives = 109/296 (36%), Gaps = 43/296 (14%)
Query: 452 DNVERRRQSKNKKQVMIIITSISLATAVIFIGGLMYRRKKHSNQGNEKEEMELPIFDLKI 511
+ + K T + T + +KK + E F + +
Sbjct: 61 ETATSTDSGRTKSHEGAATTKQATTTPTTNVEVAPPPKKKKVTYALPNQSREEGHFYVVL 120
Query: 512 ---IANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIA 568
I +T F + LGEG FG V + + +E ++ + + + K E+ +
Sbjct: 121 GEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFME 180
Query: 569 KLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSK-LLDW-------SKR-- 618
K++ + R M I Y N++ I LLDW S R
Sbjct: 181 KVRQADP-------ADRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFSHRHL 233
Query: 619 SHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLL---DNTMNP-------------KISD 662
+ II L Y H + L ++H DLK N+L+ D ++P +I D
Sbjct: 234 AQIIFQTGVALDYFH--TELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICD 291
Query: 663 FGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGK 718
G D+ + T +V T Y SPE + + +D++S G ++ E+ GK
Sbjct: 292 LGGC----CDERHSRTA-IVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK 342
|
Length = 467 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 2e-04
Identities = 39/181 (21%), Positives = 78/181 (43%), Gaps = 22/181 (12%)
Query: 547 KRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLG----CCTQRDERMLIYEYLPNKSLDY 602
K+ KG ++ +NE+ + ++ N++K+ G LI EY L
Sbjct: 52 KKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLRE 111
Query: 603 FIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQ-DSRLRIIHRDLKASNVLLDNTMNPKIS 661
+ + K L + + + +GL L++ ++ +++L + + L+ KI
Sbjct: 112 VL---DKEKDLSFKTKLDMAIDCCKGLYNLYKYTNK---PYKNLTSVSFLVTENYKLKII 165
Query: 662 DFGLARSFGLDQTEANTK-RVVGTYGYMSPEYAIDGLFS---VKSDVFSFGVLVLEIICG 717
GL++ ++ + V Y S + D +FS +K D++S GV++ EI G
Sbjct: 166 ------CHGLEKILSSPPFKNVNFMVYFSYKMLND-IFSEYTIKDDIYSLGVVLWEIFTG 218
Query: 718 K 718
K
Sbjct: 219 K 219
|
Length = 283 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 28/87 (32%), Positives = 48/87 (55%), Gaps = 6/87 (6%)
Query: 637 RLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEY--AI 694
+L +HRD+K N+L+D + +++DFG D T + VGT Y+SPE A+
Sbjct: 120 QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAM 178
Query: 695 D---GLFSVKSDVFSFGVLVLEIICGK 718
+ G + + D +S GV + E++ G+
Sbjct: 179 EDGKGKYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 0.001
Identities = 44/179 (24%), Positives = 73/179 (40%), Gaps = 36/179 (20%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-----GQEIAVKRLSKGSGQGMEEFKNEVLL----- 566
D+F KLGEG FG VYK L+ + +K+ + G +E + NE +
Sbjct: 132 DDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKK-ATEYGA-VEIWMNERVRRACPN 189
Query: 567 -IAKLQHRNLVKLLGCCTQRDERMLIYEY---------LPNKSLDY----FIFDTTRSKL 612
A + L + + DE L++ Y + +K Y ++ +
Sbjct: 190 SCADFVYGFLEPVSS--KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLP 247
Query: 613 LDWSKRSHIIAGIARGLLY----LHQDSRLRIIHRDLKASNVLLDN-TMNPKISDFGLA 666
+ + II I R +L+ LH I+HRD+K N++ + + KI D G A
Sbjct: 248 KGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNIIFSEGSGSFKIIDLGAA 303
|
Length = 566 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.5 bits (98), Expect = 0.001
Identities = 57/236 (24%), Positives = 90/236 (38%), Gaps = 57/236 (24%)
Query: 524 KLGEGGFGPVYKGMLIE----GQEIAVKRLSKGSGQGMEE--------FKNEVLLIAKLQ 571
LG+G G V+ L+ G+ A+K L K M + + E+L A L
Sbjct: 8 LLGKGDVGRVF---LVRLKGTGKLFALKVLDKKE---MIKRNKVKRVLTEQEIL--ATLD 59
Query: 572 HRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLY 631
H L L L+ +Y P L + + K L A + L Y
Sbjct: 60 HPFLPTLYASFQTETYLCLVMDYCPGGEL-FRLLQRQPGKCLSEEVARFYAAEVLLALEY 118
Query: 632 LHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS----------------------- 668
LH L I++RDLK N+LL + + +SDF L++
Sbjct: 119 LHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNS 175
Query: 669 ----FGLDQTEANTKRVVGTYGYMSPEYAIDGL---FSVKSDVFSFGVLVLEIICG 717
++ + VGT Y++PE I G +V D ++ G+L+ E++ G
Sbjct: 176 IPSETFSEEPSFRSNSFVGTEEYIAPE-VISGDGHGSAV--DWWTLGILLYEMLYG 228
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.003
Identities = 32/123 (26%), Positives = 56/123 (45%), Gaps = 11/123 (8%)
Query: 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLL----YLHQDSRLRIIHRDLKASNV 650
LP D + + R + L ++ + +AR LL Y+H + IIHRD+K NV
Sbjct: 239 LPKYRSDLYTYLGARLRPLGLAQ----VTAVARQLLSAIDYIHGEG---IIHRDIKTENV 291
Query: 651 LLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVL 710
L++ + + DFG A + + GT +PE ++ D++S G++
Sbjct: 292 LVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLV 351
Query: 711 VLE 713
+ E
Sbjct: 352 IFE 354
|
Length = 461 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 836 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.98 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.98 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.98 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.98 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.98 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.98 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.98 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.98 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.98 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.98 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.98 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.98 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.97 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.97 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.97 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.96 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.96 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.96 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.95 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 99.95 | |
| PF00954 | 110 | S_locus_glycop: S-locus glycoprotein family; Inter | 99.95 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.94 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.94 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.94 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.93 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.93 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 99.93 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.93 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.92 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.92 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.92 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.91 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.91 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 99.9 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.9 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.89 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.88 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.87 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.85 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.83 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.81 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.81 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.79 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.79 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.77 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.77 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.77 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.75 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.73 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.73 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.71 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.7 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.65 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.65 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.64 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.64 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.63 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.63 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.61 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.58 | |
| PF08276 | 66 | PAN_2: PAN-like domain; InterPro: IPR013227 PAN do | 99.56 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.54 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.53 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.49 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.49 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.48 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.35 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.32 | |
| cd00129 | 80 | PAN_APPLE PAN/APPLE-like domain; present in N-term | 99.29 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.22 | |
| cd01098 | 84 | PAN_AP_plant Plant PAN/APPLE-like domain; present | 99.13 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.11 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.05 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.04 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.04 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.0 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.92 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.91 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.91 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.84 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.73 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.71 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.69 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.54 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.47 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.37 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.35 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 98.24 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.24 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.18 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.17 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 98.15 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.09 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.01 | |
| smart00473 | 78 | PAN_AP divergent subfamily of APPLE domains. Apple | 97.99 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.97 | |
| PF11883 | 48 | DUF3403: Domain of unknown function (DUF3403); Int | 97.92 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.92 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.9 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.89 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.75 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.69 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 97.64 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.63 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.62 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.51 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.48 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.44 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.4 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.33 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.24 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.19 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.12 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.99 | |
| PLN02236 | 344 | choline kinase | 96.57 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.54 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.49 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.24 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.2 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.16 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 95.93 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 95.78 | |
| cd01100 | 73 | APPLE_Factor_XI_like Subfamily of PAN/APPLE-like d | 95.49 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 95.45 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.45 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.33 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.2 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-53 Score=467.67 Aligned_cols=291 Identities=45% Similarity=0.733 Sum_probs=257.1
Q ss_pred ccCcccHHHHHhhcccccccCeecccCceeEEEEEeecCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEE
Q 003254 503 ELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCC 582 (836)
Q Consensus 503 ~~~~~~~~~l~~a~~~f~~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~ 582 (836)
....|++.++..||++|+..+.||+|+||.||+|.+.+|+.||||++.....+..++|.+|+.++.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 56679999999999999999999999999999999999999999998766543156699999999999999999999999
Q ss_pred eeCC-eeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceee
Q 003254 583 TQRD-ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKIS 661 (836)
Q Consensus 583 ~~~~-~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~ 661 (836)
.+.+ +++||||||++|+|+++|+..... +++|..|++||.++|+||+|||+...++||||||||+|||||+++++||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 9999 599999999999999999875544 89999999999999999999999998899999999999999999999999
Q ss_pred ccCcccccCCCccccccccc-cccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhh
Q 003254 662 DFGLARSFGLDQTEANTKRV-VGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLW 740 (836)
Q Consensus 662 DFgla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~ 740 (836)
|||+|+..... ....... .||.+|+|||+...+..++|+|||||||+|+||+||+++.....+.....+..|++..+
T Consensus 220 DFGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~ 297 (361)
T KOG1187|consen 220 DFGLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL 297 (361)
T ss_pred CccCcccCCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence 99999764321 1111112 89999999999999999999999999999999999999877665555556888888888
Q ss_pred hccCchhhcccccc-CCCCh-HHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCCCC
Q 003254 741 IEERPLELIDQSLD-NSCSF-SEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSL 796 (836)
Q Consensus 741 ~~~~~~~~~d~~l~-~~~~~-~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~~ 796 (836)
.+....+++|+.+. ..... +++.++.+++.+|++.+|++||+|.||+++|+.+...
T Consensus 298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 88889999999987 55554 6888999999999999999999999999999766543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=391.95 Aligned_cols=256 Identities=32% Similarity=0.490 Sum_probs=209.4
Q ss_pred cccCeecccCceeEEEEEeecCcEEEEEEecCCCc--hhHHHHHHHHHHHHhhcCCceeeEEeEEeeCC-eeeEEEeecC
Q 003254 520 SEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSG--QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD-ERMLIYEYLP 596 (836)
Q Consensus 520 ~~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-~~~lV~Ey~~ 596 (836)
...+.||+|+||+||+|.+.....||||++..... ...++|.+|+.+|.+++|||||+++|+|.+.. ..++|||||+
T Consensus 44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~ 123 (362)
T KOG0192|consen 44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP 123 (362)
T ss_pred hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence 33456999999999999995444499999976532 22569999999999999999999999999887 7999999999
Q ss_pred CCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCC-CceeeccCcccccCCCccc
Q 003254 597 NKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTM-NPKISDFGLARSFGLDQTE 675 (836)
Q Consensus 597 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~-~~kl~DFgla~~~~~~~~~ 675 (836)
+|+|..+++.. +...+++..+++++.+||+||.|||+++. ||||||||+||||+.++ ++||+|||+++......
T Consensus 124 ~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-- 198 (362)
T KOG0192|consen 124 GGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-- 198 (362)
T ss_pred CCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc--
Confidence 99999999764 46789999999999999999999999874 99999999999999997 99999999998754321
Q ss_pred cccccccccccccCccccc--CCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccccc
Q 003254 676 ANTKRVVGTYGYMSPEYAI--DGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSL 753 (836)
Q Consensus 676 ~~~~~~~gt~~y~aPE~~~--~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 753 (836)
.......||+.|||||++. ...|+.|+|||||||+||||+||+.||..... .+.+...... ..
T Consensus 199 ~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~------~~~~~~v~~~---------~~ 263 (362)
T KOG0192|consen 199 TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP------VQVASAVVVG---------GL 263 (362)
T ss_pred ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhc---------CC
Confidence 2223368999999999999 56999999999999999999999999764332 1111111111 12
Q ss_pred cCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCCC
Q 003254 754 DNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS 795 (836)
Q Consensus 754 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~ 795 (836)
+...+......+..++.+||+.||++||++.|++.+|+.+..
T Consensus 264 Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 264 RPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS 305 (362)
T ss_pred CCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence 222333355678899999999999999999999999997643
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=384.57 Aligned_cols=258 Identities=33% Similarity=0.485 Sum_probs=216.6
Q ss_pred ccccCeecccCceeEEEEEeecCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEeecCCC
Q 003254 519 FSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNK 598 (836)
Q Consensus 519 f~~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 598 (836)
+...+.||+|.||.||.|.++....||+|.++.. ....+.|.+|+.+|++|+|+|||+++|+|..++.++||||||++|
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G 286 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG 286 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence 3446789999999999999977789999999765 345578999999999999999999999999999999999999999
Q ss_pred ChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcccccc
Q 003254 599 SLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANT 678 (836)
Q Consensus 599 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~ 678 (836)
+|.++|.. ..+..+...+.+.++.|||+||+||++++ +|||||.++||||+++..+||+|||||+....+.. ...
T Consensus 287 sLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y-~~~ 361 (468)
T KOG0197|consen 287 SLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEY-TAS 361 (468)
T ss_pred cHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCce-eec
Confidence 99999965 34567899999999999999999999998 99999999999999999999999999995543333 223
Q ss_pred ccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhccCchhhccccccCCC
Q 003254 679 KRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDNSC 757 (836)
Q Consensus 679 ~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 757 (836)
....-+..|.|||.+..+.++.|||||||||+||||+| |+.|+..... .+..+.++...+-..
T Consensus 362 ~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn----------------~ev~~~le~GyRlp~ 425 (468)
T KOG0197|consen 362 EGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN----------------EEVLELLERGYRLPR 425 (468)
T ss_pred CCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH----------------HHHHHHHhccCcCCC
Confidence 33455789999999999999999999999999999999 5555332111 122344444445556
Q ss_pred ChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCCCCCC
Q 003254 758 SFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQ 798 (836)
Q Consensus 758 ~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~~~~ 798 (836)
+..++..+.+|+..||+.+|++|||++.+...|+.+.....
T Consensus 426 P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~~ 466 (468)
T KOG0197|consen 426 PEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTSTE 466 (468)
T ss_pred CCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhccc
Confidence 66788889999999999999999999999999988765433
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-43 Score=362.19 Aligned_cols=248 Identities=27% Similarity=0.357 Sum_probs=205.5
Q ss_pred cccccCeecccCceeEEEEEeec-CcEEEEEEecCC-CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCC-eeeEEEee
Q 003254 518 NFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD-ERMLIYEY 594 (836)
Q Consensus 518 ~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-~~~lV~Ey 594 (836)
+++..+.||+|..|+|||+.++. ++.+|+|.+... .+...+++.+|++++++.+||+||+++|.|.... ...|+|||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 44556789999999999999965 788999999655 3456788999999999999999999999999988 59999999
Q ss_pred cCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhc-CCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCc
Q 003254 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQ-DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (836)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~ 673 (836)
|++|+|+.++.. .+.+++...-+|+.+|++||.|||+ .. ||||||||+||||+..|.+||+|||.+..+.+.
T Consensus 160 MDgGSLd~~~k~---~g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS- 232 (364)
T KOG0581|consen 160 MDGGSLDDILKR---VGRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS- 232 (364)
T ss_pred cCCCCHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence 999999999954 3568999999999999999999996 44 999999999999999999999999999876433
Q ss_pred cccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccccc
Q 003254 674 TEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSL 753 (836)
Q Consensus 674 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 753 (836)
.....+||..|||||.+.+..|+.++||||||+.++|+.+|+.|+...... .. .+.++++...
T Consensus 233 ---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~-~~-------------~~~~Ll~~Iv 295 (364)
T KOG0581|consen 233 ---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPP-YL-------------DIFELLCAIV 295 (364)
T ss_pred ---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCC-CC-------------CHHHHHHHHh
Confidence 345689999999999999999999999999999999999999997543111 11 1122222222
Q ss_pred cC---CCCh-HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 754 DN---SCSF-SEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 754 ~~---~~~~-~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
.+ ..+. ....++.+++..||++||.+||++.|+++.
T Consensus 296 ~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 296 DEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred cCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 21 1122 244678899999999999999999998763
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=376.76 Aligned_cols=247 Identities=27% Similarity=0.402 Sum_probs=210.5
Q ss_pred ccccccCeecccCceeEEEEEe-ecCcEEEEEEecCC---CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEE
Q 003254 517 DNFSEKNKLGEGGFGPVYKGML-IEGQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~-~~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 592 (836)
..|...+.||+|||+.||+++. ..|+.||+|++.+. .....+...+||+|.+.|+|||||+++++|++.+..|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5788999999999999999998 66999999999764 3445677899999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCC
Q 003254 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (836)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~ 672 (836)
|+|++++|..++. +++++++.++..++.||+.||.|||+.+ |+|||||..|++|+++.++||+|||||..+..+
T Consensus 98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence 9999999999883 6788999999999999999999999998 999999999999999999999999999987544
Q ss_pred ccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhcccc
Q 003254 673 QTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQS 752 (836)
Q Consensus 673 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 752 (836)
.. ...+.+|||.|+|||++.....+..+||||+|||||-||.|++||+...-.+ ..+... .-+.
T Consensus 172 ~E--rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vke-------ty~~Ik------~~~Y- 235 (592)
T KOG0575|consen 172 GE--RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKE-------TYNKIK------LNEY- 235 (592)
T ss_pred cc--ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHH-------HHHHHH------hcCc-
Confidence 33 3455899999999999999999999999999999999999999986432211 111111 1111
Q ss_pred ccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 753 LDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 753 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
..+......+.+||..+|+.+|.+|||+++|+.
T Consensus 236 ---~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 236 ---SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred ---ccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 112233445779999999999999999999985
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=357.98 Aligned_cols=253 Identities=25% Similarity=0.361 Sum_probs=200.8
Q ss_pred hcccccccCeecccCceeEEEEEeec-CcEEEEEEecCCCch-------hHHHHHHHHHHHHhhcCCceeeEEeEEeeCC
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQ-------GMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD 586 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~-------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~ 586 (836)
..+.|...+.||+|+||.|-+|.... |+.||||++++.... ......+|+++|++++|||||++++++...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 34667788999999999999998754 999999999765211 1233579999999999999999999999999
Q ss_pred eeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCC---CCceeecc
Q 003254 587 ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNT---MNPKISDF 663 (836)
Q Consensus 587 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~---~~~kl~DF 663 (836)
..||||||+++|.|.+.+.. .+.+.+..-..++.|++.|+.|||++| |+||||||+|||+..+ ..+||+||
T Consensus 250 s~YmVlE~v~GGeLfd~vv~---nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVA---NKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred ceEEEEEEecCccHHHHHHh---ccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEeccc
Confidence 99999999999999999854 455778888899999999999999999 9999999999999755 78999999
Q ss_pred CcccccCCCccccccccccccccccCcccccCCc--c-CccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhh
Q 003254 664 GLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGL--F-SVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLW 740 (836)
Q Consensus 664 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~-t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~ 740 (836)
|+|+..+. .....+.+||+.|.|||++.++. + ..|+|+||+||+||-+++|.+||.....+.. + .++.
T Consensus 324 GlAK~~g~---~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s--l----~eQI 394 (475)
T KOG0615|consen 324 GLAKVSGE---GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS--L----KEQI 394 (475)
T ss_pred chhhcccc---ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc--H----HHHH
Confidence 99998753 23355689999999999998654 3 3488999999999999999999865443310 1 1111
Q ss_pred hccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 741 IEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 741 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
..++.. + ......+-.++..+++.+||..||++|||+.|+++
T Consensus 395 ~~G~y~--f----~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 395 LKGRYA--F----GPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred hcCccc--c----cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 111110 0 00111223456789999999999999999999875
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=356.96 Aligned_cols=200 Identities=31% Similarity=0.531 Sum_probs=180.4
Q ss_pred hcccccccCeecccCceeEEEEEeec-CcEEEEEEecCC--CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEE
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 591 (836)
...+|...++||+|.||+||+|++.. +..||||.+.+. .....+.+..|+.+|+.++|||||++++++...+..+||
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 34678888899999999999999865 899999998766 556677789999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCC------CCceeeccCc
Q 003254 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNT------MNPKISDFGL 665 (836)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~------~~~kl~DFgl 665 (836)
||||.+|+|.+++.. .+.+++.....++.|||.||++||+++ ||||||||+||||+.. -.+||+|||+
T Consensus 88 MEyC~gGDLs~yi~~---~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRR---RGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred EEeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 999999999999953 447999999999999999999999998 9999999999999764 5689999999
Q ss_pred ccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCC
Q 003254 666 ARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGF 723 (836)
Q Consensus 666 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~ 723 (836)
|+.+... ......+|++-|||||++..++|+.|+|+||+|++|||+++|+.||..
T Consensus 162 AR~L~~~---~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a 216 (429)
T KOG0595|consen 162 ARFLQPG---SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA 216 (429)
T ss_pred hhhCCch---hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence 9998633 234458999999999999999999999999999999999999999863
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=390.23 Aligned_cols=262 Identities=31% Similarity=0.462 Sum_probs=215.8
Q ss_pred ccccccCeecccCceeEEEEEeec------CcEEEEEEecCCCch-hHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeee
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE------GQEIAVKRLSKGSGQ-GMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERM 589 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~------g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 589 (836)
.+....+.||+|.||+||+|+..+ ...||||.++..... ..++|++|++++..++|||||+|+|+|.+++..+
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~ 565 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC 565 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence 455667899999999999999643 345999999887665 7889999999999999999999999999999999
Q ss_pred EEEeecCCCChhHHHhhcc-------CC----CcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCc
Q 003254 590 LIYEYLPNKSLDYFIFDTT-------RS----KLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNP 658 (836)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~-------~~----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~ 658 (836)
||+|||..|+|.+||.... .. .+|+..+.+.||.|||.||+||-++. +|||||.++|+||.++..|
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~V 642 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVV 642 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEE
Confidence 9999999999999997432 12 23889999999999999999998887 9999999999999999999
Q ss_pred eeeccCcccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhH
Q 003254 659 KISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAW 737 (836)
Q Consensus 659 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~ 737 (836)
||+||||++.....+.........-+.+|||||.++.++||.+||||||||+|||+++ |+-|......+
T Consensus 643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~---------- 712 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ---------- 712 (774)
T ss_pred EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH----------
Confidence 9999999998765554433333455789999999999999999999999999999999 55554321111
Q ss_pred HhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCCCCC
Q 003254 738 RLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLP 797 (836)
Q Consensus 738 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~~~ 797 (836)
.+.+.+...-.-+.+..++.++..|+..||+.+|++||+++||-..|+......
T Consensus 713 ------EVIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 713 ------EVIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred ------HHHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 111222111113566677888999999999999999999999999998765433
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=339.37 Aligned_cols=258 Identities=25% Similarity=0.380 Sum_probs=207.3
Q ss_pred ccccccCeecccCceeEEEEEe-ecCcEEEEEEecCC--CchhHHHHHHHHHHHHhhcCCceeeEEe-EEeeCCe-eeEE
Q 003254 517 DNFSEKNKLGEGGFGPVYKGML-IEGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLG-CCTQRDE-RMLI 591 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~-~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g-~~~~~~~-~~lV 591 (836)
.+|.+.++||+|.||+|||+.. .+|..+|.|.+... +....+....|+.+|++|+|||||++++ .+.+..+ ++||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 4577888999999999999985 56999999998744 3455677899999999999999999998 5555555 8999
Q ss_pred EeecCCCChhHHHhhccC-CCcCChhhhHHHHHHHHhhhHhhhcCC-CCcEEeccCCCCceEecCCCCceeeccCccccc
Q 003254 592 YEYLPNKSLDYFIFDTTR-SKLLDWSKRSHIIAGIARGLLYLHQDS-RLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (836)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~-~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~ 669 (836)
|||+..|+|..++.+... .+.+++..+++++.|++.||.++|.+- +..|+||||||.||+|+.+|.+||+|||+++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 999999999999987543 457999999999999999999999843 235999999999999999999999999999998
Q ss_pred CCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhc
Q 003254 670 GLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELI 749 (836)
Q Consensus 670 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (836)
...... ....+|||.||+||.+.+.+|+.|+||||+||++|||+.-++||... ++.... +.....+.
T Consensus 179 ~s~~tf--A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~~~L~-~KI~qgd~---- 245 (375)
T KOG0591|consen 179 SSKTTF--AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NLLSLC-KKIEQGDY---- 245 (375)
T ss_pred cchhHH--HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------cHHHHH-HHHHcCCC----
Confidence 654433 34589999999999999999999999999999999999999998643 111111 11111111
Q ss_pred cccccCCCC-hHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcC
Q 003254 750 DQSLDNSCS-FSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 792 (836)
Q Consensus 750 d~~l~~~~~-~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~ 792 (836)
...+ ......+.+|+..|+..||+.||+...++..+..
T Consensus 246 -----~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 246 -----PPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred -----CCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 1112 3455678899999999999999996555554443
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=342.46 Aligned_cols=240 Identities=27% Similarity=0.395 Sum_probs=201.8
Q ss_pred hcccccccCeecccCceeEEEEEeec-CcEEEEEEecCCC---chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeE
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 590 (836)
..++|+..+.||+|+||+||.++..+ ++.+|+|++++.. ....+..++|..++.+++||.||+++..|.+.+.+||
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 34789999999999999999999876 8889999997752 3456778999999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccC
Q 003254 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (836)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~ 670 (836)
|+||+.||.|..+| .+.+.+++..+.-++..|+.||.|||+.+ ||||||||+|||||++|+++|+|||+++...
T Consensus 103 Vld~~~GGeLf~hL---~~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 103 VLDYLNGGELFYHL---QREGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EEeccCCccHHHHH---HhcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 99999999999998 44567899999999999999999999999 9999999999999999999999999998643
Q ss_pred CCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhcc
Q 003254 671 LDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELID 750 (836)
Q Consensus 671 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 750 (836)
.. ...+...+||+.|||||++.+..|+.++|.||+|+++|||++|.+||...... ++++
T Consensus 177 ~~--~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~-------------------~~~~ 235 (357)
T KOG0598|consen 177 KD--GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK-------------------KMYD 235 (357)
T ss_pred cC--CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH-------------------HHHH
Confidence 22 23345589999999999999999999999999999999999999997542221 1222
Q ss_pred ccccCC---CChHHHHHHHHHHHHcccCCCCCCC
Q 003254 751 QSLDNS---CSFSEALRCIQVGLLCVQQRPEDRP 781 (836)
Q Consensus 751 ~~l~~~---~~~~~~~~l~~li~~Cl~~dP~~RP 781 (836)
..+++. .+.-...+..+++...|+.+|++|-
T Consensus 236 ~I~~~k~~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 236 KILKGKLPLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred HHhcCcCCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 222111 1111234567899999999999995
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=328.27 Aligned_cols=264 Identities=19% Similarity=0.314 Sum_probs=202.3
Q ss_pred ccccccCeecccCceeEEEEEeec-CcEEEEEEecCCCc--hhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEe
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSG--QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 593 (836)
++|+...++|+|+||.|||.+.++ |+.||||++....+ .-.+-.++|+++|++++|+|+|.++.+|.....++||||
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 568888899999999999999877 99999999976543 234557899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCc
Q 003254 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (836)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~ 673 (836)
|++..-|+++-. ...-++.+.+.+++.|+++|+.|+|+++ +|||||||+||||+.++.+||+|||+|+.+...
T Consensus 82 ~~dhTvL~eLe~---~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p- 154 (396)
T KOG0593|consen 82 YCDHTVLHELER---YPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAP- 154 (396)
T ss_pred ecchHHHHHHHh---ccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCC-
Confidence 999977755542 2234788899999999999999999998 999999999999999999999999999988632
Q ss_pred cccccccccccccccCcccccC-CccCccccccchhhhhhhhhhCCCCCCCCCCccccchhh--------hhHHhhhccC
Q 003254 674 TEANTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLG--------HAWRLWIEER 744 (836)
Q Consensus 674 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~--------~~~~~~~~~~ 744 (836)
.......+.|..|+|||.+.+ .+|...+||||+||++.||++|.+.+......++...+. .....+....
T Consensus 155 -gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~ 233 (396)
T KOG0593|consen 155 -GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNP 233 (396)
T ss_pred -cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCC
Confidence 223345789999999999987 689999999999999999999998754333222221111 1111122111
Q ss_pred ch-hhccccccCCCC-----hHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 745 PL-ELIDQSLDNSCS-----FSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 745 ~~-~~~d~~l~~~~~-----~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
.. .+.-|......+ .....-+++++..|++.||.+|++-+|++.
T Consensus 234 ~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 234 FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 11 000000000000 111224789999999999999999998764
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=343.60 Aligned_cols=276 Identities=24% Similarity=0.321 Sum_probs=218.6
Q ss_pred hcccccccCeecccCceeEEEEEeec-CcEEEEEEecCCC---chhHHHHHHHHHHHHhh-cCCceeeEEeEEeeCCeee
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDERM 589 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~ 589 (836)
...+|...+.||+|+|++|++++... ++++|||++.+.. +...+....|-.+|.+| .||.|++|+-.|.++..+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 44688899999999999999999765 8999999997652 23345567799999999 7999999999999999999
Q ss_pred EEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCccccc
Q 003254 590 LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (836)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~ 669 (836)
+|+||+++|+|.++|.+. +.+++.....++.+|+.||+|||+.| ||||||||+|||||+|+++||+|||.|+.+
T Consensus 151 FvLe~A~nGdll~~i~K~---Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKY---GSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKIL 224 (604)
T ss_pred EEEEecCCCcHHHHHHHh---CcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccC
Confidence 999999999999999554 56999999999999999999999999 999999999999999999999999999988
Q ss_pred CCCccc---------ccc--ccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHH
Q 003254 670 GLDQTE---------ANT--KRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWR 738 (836)
Q Consensus 670 ~~~~~~---------~~~--~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~ 738 (836)
...... ... ..++||..|.+||++.++..+..+|+|+|||+||+|+.|++||.....- ......
T Consensus 225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney---liFqkI-- 299 (604)
T KOG0592|consen 225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY---LIFQKI-- 299 (604)
T ss_pred ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH---HHHHHH--
Confidence 532221 111 4489999999999999999999999999999999999999998532211 000000
Q ss_pred hhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh-------cCCCCCCCCCCCCccccCCCC
Q 003254 739 LWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLML-------SGERSLPQPQQPGFFTGRNLP 811 (836)
Q Consensus 739 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L-------~~~~~~~~p~~p~~~~~~~~~ 811 (836)
..++-. ++..-...+.+|+.+.|..||.+|+|..||-+.. +.+.....|+.-++.......
T Consensus 300 --------~~l~y~----fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~nlw~~~PP~l~py~p~~~~s 367 (604)
T KOG0592|consen 300 --------QALDYE----FPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWENLWQQTPPKLQPYKPATSIS 367 (604)
T ss_pred --------HHhccc----CCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhhhhhcCCCcccCCCCcccCC
Confidence 011111 1112224567899999999999999999998753 344555666665555444433
Q ss_pred CC
Q 003254 812 ES 813 (836)
Q Consensus 812 ~~ 813 (836)
++
T Consensus 368 ~e 369 (604)
T KOG0592|consen 368 PE 369 (604)
T ss_pred cc
Confidence 33
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=352.69 Aligned_cols=261 Identities=28% Similarity=0.423 Sum_probs=203.1
Q ss_pred cccccccCeecccCceeEEEEEee------cCcEEEEEEecCCC-chhHHHHHHHHHHHHhh-cCCceeeEEeEEeeCC-
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLI------EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRD- 586 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~------~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~- 586 (836)
.++|++.++||+|+||.||+|... .++.||||++.... ....+.+.+|+.++..+ +||||+++++++...+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 467888999999999999999742 25679999987543 23456789999999999 8999999999887644
Q ss_pred eeeEEEeecCCCChhHHHhhccC---------------------------------------------------------
Q 003254 587 ERMLIYEYLPNKSLDYFIFDTTR--------------------------------------------------------- 609 (836)
Q Consensus 587 ~~~lV~Ey~~~gsL~~~l~~~~~--------------------------------------------------------- 609 (836)
..++||||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 57899999999999999864211
Q ss_pred --CCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCccccccccccccccc
Q 003254 610 --SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGY 687 (836)
Q Consensus 610 --~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y 687 (836)
..++++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++...............++..|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 134788889999999999999999988 999999999999999999999999999865433222222234567889
Q ss_pred cCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhccCchhhccccccCCCChHHHHHHH
Q 003254 688 MSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDNSCSFSEALRCI 766 (836)
Q Consensus 688 ~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 766 (836)
+|||++.+..++.++|||||||+||||++ |+.|+....... . ........... ..+......+.
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~--~----~~~~~~~~~~~---------~~~~~~~~~l~ 307 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE--E----FCQRLKDGTRM---------RAPENATPEIY 307 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH--H----HHHHHhcCCCC---------CCCCCCCHHHH
Confidence 99999999999999999999999999997 888875422211 0 11111111110 11112234578
Q ss_pred HHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 003254 767 QVGLLCVQQRPEDRPNMSSVVLMLSGER 794 (836)
Q Consensus 767 ~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 794 (836)
+++.+||+.+|++|||+.||++.|+.+.
T Consensus 308 ~li~~cl~~dp~~RPs~~el~~~l~~~~ 335 (338)
T cd05102 308 RIMLACWQGDPKERPTFSALVEILGDLL 335 (338)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 9999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=377.81 Aligned_cols=261 Identities=31% Similarity=0.471 Sum_probs=212.9
Q ss_pred cccccccCeecccCceeEEEEEeec--Cc----EEEEEEecCC-CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCee
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLIE--GQ----EIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDER 588 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~~--g~----~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 588 (836)
.++.+..+.||+|+||.||+|...+ |. .||||.+.+. +.+...+|.+|..+|++++|||||+++|+|.+....
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 3455667889999999999999755 43 4899999776 456778999999999999999999999999999999
Q ss_pred eEEEeecCCCChhHHHhhccC----CCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccC
Q 003254 589 MLIYEYLPNKSLDYFIFDTTR----SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFG 664 (836)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFg 664 (836)
++++|||++|+|..+|.+... ...|+..+.+.++.|||+|+.|||++. +|||||.++|+||++...|||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence 999999999999999976522 346889999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhcc
Q 003254 665 LARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEE 743 (836)
Q Consensus 665 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 743 (836)
||+.+...+.........-+..|||||.++++.||.|+|||||||+||||+| |..|+......+- ...+.++
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v-------~~~~~~g 920 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEV-------LLDVLEG 920 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHH-------HHHHHhC
Confidence 9997655444333333345679999999999999999999999999999999 5566432222110 0001111
Q ss_pred CchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCCC
Q 003254 744 RPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS 795 (836)
Q Consensus 744 ~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~ 795 (836)
.+| ..+..+...+.+|+..||+.+|++||++..+++.+..+..
T Consensus 921 -------gRL--~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~ 963 (1025)
T KOG1095|consen 921 -------GRL--DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISN 963 (1025)
T ss_pred -------Ccc--CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhh
Confidence 111 3344566778899999999999999999999999987744
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=340.17 Aligned_cols=265 Identities=24% Similarity=0.364 Sum_probs=201.7
Q ss_pred cccccccCeecccCceeEEEEEee-cCcEEEEEEecCCC--chhHHHHHHHHHHHHhhcCCceeeEEeEEeeC--CeeeE
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR--DERML 590 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~l 590 (836)
.+.|+..++||+|.||.|||++.. .|+.||+|+++... +....-..+||.||++|+||||++|.+...+. ..+||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 356788889999999999999975 49999999987654 44556678899999999999999999998876 67999
Q ss_pred EEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccC
Q 003254 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (836)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~ 670 (836)
|||||++ +|.-++. ...-.++..++..++.|++.||.|+|..+ |+|||||.+|||||.+|.+||+|||||+.+.
T Consensus 196 VFeYMdh-DL~GLl~--~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLS--SPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred EEecccc-hhhhhhc--CCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeecc
Confidence 9999988 6666663 23446899999999999999999999999 9999999999999999999999999999876
Q ss_pred CCccccccccccccccccCcccccCC-ccCccccccchhhhhhhhhhCCCCCCCCCCccccchh--------hhhHHh--
Q 003254 671 LDQTEANTKRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLL--------GHAWRL-- 739 (836)
Q Consensus 671 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~--------~~~~~~-- 739 (836)
...... ....+.|..|+|||.+.+. .|+.++|+||.||||.||++|++.+......++...+ ...|..
T Consensus 270 ~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~k 348 (560)
T KOG0600|consen 270 PSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSK 348 (560)
T ss_pred CCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccccc
Confidence 544333 3346779999999999875 6999999999999999999999886543332221111 111110
Q ss_pred hh---ccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 740 WI---EERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 740 ~~---~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
+- .-.+..-....+.+. -..-....++|+..+|..||.+|.|+.++++
T Consensus 349 LP~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 349 LPHATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred CCcccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 00 000000011111110 0011134678999999999999999999875
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=360.92 Aligned_cols=255 Identities=27% Similarity=0.422 Sum_probs=215.4
Q ss_pred ccccCeecccCceeEEEEEeec-C---cEEEEEEecCCC-chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEe
Q 003254 519 FSEKNKLGEGGFGPVYKGMLIE-G---QEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (836)
Q Consensus 519 f~~~~~lG~G~fG~Vykg~~~~-g---~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 593 (836)
..+.++||.|.||.||+|+++- | ..||||.++... +....+|+.|+.||.+++||||++|.|+....+..+||.|
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE 710 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE 710 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence 4567899999999999999864 3 459999998774 4456789999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCc
Q 003254 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (836)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~ 673 (836)
||+||+|+.+|... .+.+.+.+..-++++||.||+||.+.+ +|||||.++||||+.+...|++|||+++.+..+.
T Consensus 711 yMENGsLDsFLR~~--DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~ 785 (996)
T KOG0196|consen 711 YMENGSLDSFLRQN--DGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 785 (996)
T ss_pred hhhCCcHHHHHhhc--CCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccCC
Confidence 99999999999643 456999999999999999999999988 9999999999999999999999999999775443
Q ss_pred cc-cccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhccCchhhccc
Q 003254 674 TE-ANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQ 751 (836)
Q Consensus 674 ~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 751 (836)
.. ..+..-.-+.+|.|||.+...++|.++||||||||+||.++ |.+|+-... ..+....++.
T Consensus 786 ~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmS----------------NQdVIkaIe~ 849 (996)
T KOG0196|consen 786 EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS----------------NQDVIKAIEQ 849 (996)
T ss_pred CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccc----------------hHHHHHHHHh
Confidence 21 11222233679999999999999999999999999999887 677742111 1223344555
Q ss_pred cccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 003254 752 SLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 794 (836)
Q Consensus 752 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 794 (836)
..+-..+++++..|.+|++.|||+|-.+||.+.||+.+|+.+.
T Consensus 850 gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklI 892 (996)
T KOG0196|consen 850 GYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLI 892 (996)
T ss_pred ccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHh
Confidence 5556778888999999999999999999999999999998764
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=334.73 Aligned_cols=258 Identities=28% Similarity=0.395 Sum_probs=202.8
Q ss_pred ccccccCeecccCceeEEEEEeec-CcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCC--eeeEEEe
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD--ERMLIYE 593 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~--~~~lV~E 593 (836)
.++...+.||+|.||.||++...+ |...|||..........+.+.+|+.+|.+++|||||+++|.....+ .++++||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 456677899999999999999866 8999999987664444677899999999999999999999855544 6899999
Q ss_pred ecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecC-CCCceeeccCcccccCCC
Q 003254 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-TMNPKISDFGLARSFGLD 672 (836)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~-~~~~kl~DFgla~~~~~~ 672 (836)
|+++|+|.+++..... .+++..+..++.||++||+|||+++ |+||||||+||||+. ++.+||+|||++......
T Consensus 97 y~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred ccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 9999999999965432 6999999999999999999999998 999999999999999 799999999999876531
Q ss_pred c-cccccccccccccccCcccccCCc-cCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhcc
Q 003254 673 Q-TEANTKRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELID 750 (836)
Q Consensus 673 ~-~~~~~~~~~gt~~y~aPE~~~~~~-~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 750 (836)
. .........||+.|||||++..+. ...++|||||||++.||+||++|+... ................
T Consensus 172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~~~----- 241 (313)
T KOG0198|consen 172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGREDSL----- 241 (313)
T ss_pred cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccCCC-----
Confidence 1 112233478999999999999643 345999999999999999999886432 0011111111111100
Q ss_pred ccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 003254 751 QSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 793 (836)
Q Consensus 751 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 793 (836)
...+......+.+++.+|++.+|++|||+.|+++..--.
T Consensus 242 ----P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~ 280 (313)
T KOG0198|consen 242 ----PEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLK 280 (313)
T ss_pred ----CCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhh
Confidence 122223344577999999999999999999999876443
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=347.67 Aligned_cols=270 Identities=27% Similarity=0.410 Sum_probs=212.2
Q ss_pred cccccccCeecccCceeEEEEEeecCcEEEEEEecCCC--chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEe
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 593 (836)
.+.+.....||+|.||+||+|.+. ..||||.+.... .+..+.|++|+..+++-+|.||+-+.|+|.+... .||..
T Consensus 391 ~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTq 467 (678)
T KOG0193|consen 391 PEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQ 467 (678)
T ss_pred HHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeeh
Confidence 345566789999999999999983 369999997653 4567899999999999999999999999998777 99999
Q ss_pred ecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCc
Q 003254 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (836)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~ 673 (836)
+|++.+|..+++.. ...++......||+|||+||.|||.++ |||||||..||+|.++++|||+|||++..-..-.
T Consensus 468 wCeGsSLY~hlHv~--etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~ 542 (678)
T KOG0193|consen 468 WCEGSSLYTHLHVQ--ETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWS 542 (678)
T ss_pred hccCchhhhhccch--hhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceeeeeeec
Confidence 99999999999653 356888999999999999999999999 9999999999999999999999999987543322
Q ss_pred cccccccccccccccCcccccC---CccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhcc
Q 003254 674 TEANTKRVVGTYGYMSPEYAID---GLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELID 750 (836)
Q Consensus 674 ~~~~~~~~~gt~~y~aPE~~~~---~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 750 (836)
.........|...|||||++.. .+|++++||||||+|+|||++|..|+.....+.....++ +-.-..|
T Consensus 543 g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVG---------rG~l~pd 613 (678)
T KOG0193|consen 543 GEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVG---------RGYLMPD 613 (678)
T ss_pred cccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEec---------ccccCcc
Confidence 2223334567889999999964 469999999999999999999999977333332222211 1111111
Q ss_pred ccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCCCCCCCCCCCccc
Q 003254 751 QSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPQQPGFFT 806 (836)
Q Consensus 751 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~~~~p~~p~~~~ 806 (836)
.. .....+...+.+|+..||..++++||.+.+|+.+|+.+... .|+..++..
T Consensus 614 ~s---~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~-~pki~RS~S 665 (678)
T KOG0193|consen 614 LS---KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS-LPKINRSAS 665 (678)
T ss_pred ch---hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc-ccccccCcC
Confidence 11 11123445678899999999999999999999999887653 445444443
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=341.38 Aligned_cols=262 Identities=24% Similarity=0.333 Sum_probs=204.7
Q ss_pred hcccccccCeecccCceeEEEEEeec-CcEEEEEEecCCCchhHHHH--HHHHHHHHhhc-CCceeeEEeEEeeCC-eee
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEF--KNEVLLIAKLQ-HRNLVKLLGCCTQRD-ERM 589 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~~~~~~--~~Ei~~l~~l~-H~niv~l~g~~~~~~-~~~ 589 (836)
..++|...++||.|.||.||+|+-.. |..||||++++.-.. .++. .+|++.|++++ |||||++.+++.+.+ .++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 34678889999999999999999755 889999999765332 3333 57999999998 999999999998888 899
Q ss_pred EEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCccccc
Q 003254 590 LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (836)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~ 669 (836)
+|||||+. +|.+++.+. .+++++..+..|+.||++||+|+|.+| +.||||||+|||+..+..+||+|||+||.+
T Consensus 87 fVfE~Md~-NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 87 FVFEFMDC-NLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred eeHHhhhh-hHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccc
Confidence 99999976 888888653 778999999999999999999999999 999999999999999999999999999987
Q ss_pred CCCccccccccccccccccCccccc-CCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCch--
Q 003254 670 GLDQTEANTKRVVGTYGYMSPEYAI-DGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPL-- 746 (836)
Q Consensus 670 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-- 746 (836)
.... .....+.|..|+|||++. .+.|+.+.|+||+|||++||.+-++.|......++...+- +.+......
T Consensus 161 ~Skp---PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc---~VLGtP~~~~~ 234 (538)
T KOG0661|consen 161 RSKP---PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKIC---EVLGTPDKDSW 234 (538)
T ss_pred ccCC---CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHH---HHhCCCccccc
Confidence 5332 234478899999999986 5679999999999999999999998765433322211111 011100000
Q ss_pred -------hhccccccC-------CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 747 -------ELIDQSLDN-------SCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 747 -------~~~d~~l~~-------~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
..+.-.+.. ..-.....++++++.+|++.||.+|||+.|.++.
T Consensus 235 ~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 235 PEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred hhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 001101100 1111255678899999999999999999999875
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=328.80 Aligned_cols=263 Identities=22% Similarity=0.336 Sum_probs=206.4
Q ss_pred hcccccccCeecccCceeEEEEEe-ecCcEEEEEEecCCCc-hhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEE
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGML-IEGQEIAVKRLSKGSG-QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~-~~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 592 (836)
..+.|+..+.||.|..+.||+|+. +.+..||||++.-..- ...+.++.|+..|+.++||||++++-.|..+..+++||
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 346788889999999999999996 4589999999975432 33688999999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCC
Q 003254 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (836)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~ 672 (836)
+||.+|++.+++...-..+ +++..+..|++++++||.|||.++ .||||||+.||||+++|.|||+|||.+..+...
T Consensus 104 pfMa~GS~ldIik~~~~~G-l~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYPDG-LEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred hhhcCCcHHHHHHHHcccc-ccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 9999999999997654433 889999999999999999999999 999999999999999999999999987765432
Q ss_pred cccc--ccccccccccccCcccccC--CccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhh
Q 003254 673 QTEA--NTKRVVGTYGYMSPEYAID--GLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLEL 748 (836)
Q Consensus 673 ~~~~--~~~~~~gt~~y~aPE~~~~--~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (836)
..+. .....+||+.|||||+++. ..|+.|+||||||++..||.+|..||....+- ......+ .+.+...
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm------kvLl~tL-qn~pp~~ 252 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM------KVLLLTL-QNDPPTL 252 (516)
T ss_pred CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH------HHHHHHh-cCCCCCc
Confidence 2222 2256789999999999654 35999999999999999999999998643321 0011111 1112111
Q ss_pred ccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 749 IDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 749 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
.-..+...........+.+++..||+.||++|||++++++
T Consensus 253 ~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 253 LTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred ccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 1111111111111235788999999999999999999874
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=347.49 Aligned_cols=261 Identities=30% Similarity=0.400 Sum_probs=206.7
Q ss_pred ccccccCeecccCceeEEEEEeecC----cE-EEEEEecC---CCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCee
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIEG----QE-IAVKRLSK---GSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDER 588 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~g----~~-vavK~l~~---~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 588 (836)
++....++||+|+||.||+|++... .. ||||..+. .......+|++|+++|++++|||||+++|++...+++
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl 236 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL 236 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence 4445558999999999999998652 23 89999874 2356778999999999999999999999999999999
Q ss_pred eEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccc
Q 003254 589 MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (836)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~ 668 (836)
++|||+|.||+|+++|.... +.++..++..++.+.|.||+|||+++ ++||||.++|+|++.++.+||+||||++.
T Consensus 237 ~ivmEl~~gGsL~~~L~k~~--~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~ 311 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLKKNK--KSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSRA 311 (474)
T ss_pred EEEEEecCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccccC
Confidence 99999999999999996533 36899999999999999999999998 99999999999999999999999999875
Q ss_pred cCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhccCchh
Q 003254 669 FGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEERPLE 747 (836)
Q Consensus 669 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (836)
-. ..........-+..|+|||.+..+.|+.++|||||||++||+++ |..|+...... ........
T Consensus 312 ~~--~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~-------~v~~kI~~----- 377 (474)
T KOG0194|consen 312 GS--QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY-------EVKAKIVK----- 377 (474)
T ss_pred Cc--ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH-------HHHHHHHh-----
Confidence 32 11111112245789999999999999999999999999999999 67665322211 11111101
Q ss_pred hccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCCCCCCC
Q 003254 748 LIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQP 799 (836)
Q Consensus 748 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~~~~p 799 (836)
...+...+......+..++.+|+..+|++||+|.+|.+.|+.+.....+
T Consensus 378 ---~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 378 ---NGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred ---cCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 0111122224445667788899999999999999999999987665544
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=311.02 Aligned_cols=277 Identities=26% Similarity=0.392 Sum_probs=210.6
Q ss_pred ccccccCeecccCceeEEEEEeec-CcEEEEEEecCCCch--hHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEe
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQ--GMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 593 (836)
++|...++||+|.||.||+|+... |+.||||+++..... ......+|++.|+.++|+||+.+++++...+...||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 467778899999999999999754 999999999765322 23467899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCc
Q 003254 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (836)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~ 673 (836)
||+. +|+..+.+ +...++...+..++.++++|++|||.+. |+||||||.|+|++++|.+||+|||+|+.++...
T Consensus 82 fm~t-dLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 82 FMPT-DLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred eccc-cHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 9976 89888854 3467899999999999999999999998 9999999999999999999999999999987554
Q ss_pred cccccccccccccccCcccccCC-ccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCch------
Q 003254 674 TEANTKRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPL------ 746 (836)
Q Consensus 674 ~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------ 746 (836)
..... .+.|..|+|||.+.|. .|+..+|+||.|||+.||+.|.+-+.....-++ .....+.+....+.
T Consensus 156 ~~~~~--~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQ---L~~If~~LGTP~~~~WP~~~ 230 (318)
T KOG0659|consen 156 RIQTH--QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQ---LSKIFRALGTPTPDQWPEMT 230 (318)
T ss_pred ccccc--ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHH---HHHHHHHcCCCCcccCcccc
Confidence 43322 3789999999999875 599999999999999999999876543222111 11222222221111
Q ss_pred hhccccc--------cCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCCCCCCCCCCCcc
Q 003254 747 ELIDQSL--------DNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPQQPGFF 805 (836)
Q Consensus 747 ~~~d~~l--------~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~~~~p~~p~~~ 805 (836)
++.|..- ....-..+...+++++..++..||.+|++++|++++=- ....|.|..|.-.
T Consensus 231 ~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~y-f~~~P~pt~~~~l 296 (318)
T KOG0659|consen 231 SLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPY-FKSLPLPTPPSKL 296 (318)
T ss_pred ccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchh-hhcCCCCCChhhC
Confidence 1111100 00111223345689999999999999999999987531 2334555544444
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=336.05 Aligned_cols=264 Identities=27% Similarity=0.405 Sum_probs=202.0
Q ss_pred ccccccCeecccCceeEEEEEeec-----------------CcEEEEEEecCCC-chhHHHHHHHHHHHHhhcCCceeeE
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-----------------GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKL 578 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-----------------g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l 578 (836)
++|...++||+|+||.||++.+.+ +..||+|.+.... .....+|.+|+.++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 567888999999999999998532 3369999987643 3345679999999999999999999
Q ss_pred EeEEeeCCeeeEEEeecCCCChhHHHhhcc----------------CCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEe
Q 003254 579 LGCCTQRDERMLIYEYLPNKSLDYFIFDTT----------------RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIH 642 (836)
Q Consensus 579 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH 642 (836)
++++...+..++||||+++++|.+++.... ....+++..+.+++.||+.||+|||+.+ |+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 999999999999999999999999885421 1134788899999999999999999998 999
Q ss_pred ccCCCCceEecCCCCceeeccCcccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCC--CC
Q 003254 643 RDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGK--KN 720 (836)
Q Consensus 643 ~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~--~p 720 (836)
|||||+|||+++++.+||+|||+++.+.............++..|+|||++.++.++.++||||||+++|||+++. .|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 9999999999999999999999998764332222223345678999999999889999999999999999999754 44
Q ss_pred CCCCCCccccchhhhhHHhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcC
Q 003254 721 RGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 792 (836)
Q Consensus 721 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~ 792 (836)
+..... ..........+..... ... ...+......+.+++.+||+.+|++|||+.||.+.|++
T Consensus 242 ~~~~~~---~~~~~~~~~~~~~~~~-~~~-----~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 242 YGELTD---EQVIENAGEFFRDQGR-QVY-----LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCcCCH---HHHHHHHHHHhhhccc-ccc-----ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 432211 1111111111111100 000 00111233567899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=339.28 Aligned_cols=241 Identities=28% Similarity=0.400 Sum_probs=201.1
Q ss_pred ccCeecccCceeEEEEEeecCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEeecCCCCh
Q 003254 521 EKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSL 600 (836)
Q Consensus 521 ~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 600 (836)
+++-||.|+.|.||+|++ .++.||||+++... ..+|+-|++|+|+||+.+.|+|.....++||||||..|-|
T Consensus 128 ELeWlGSGaQGAVF~Grl-~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL 199 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRL-HNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL 199 (904)
T ss_pred hhhhhccCcccceeeeec-cCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence 346799999999999999 78899999875332 3578899999999999999999999999999999999999
Q ss_pred hHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcccccccc
Q 003254 601 DYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKR 680 (836)
Q Consensus 601 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~ 680 (836)
...|. ...++.......+..+||.||.|||.+. |||||||.-||||..+..+||+|||-++..... .....
T Consensus 200 ~~VLk---a~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMS 270 (904)
T KOG4721|consen 200 YEVLK---AGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMS 270 (904)
T ss_pred HHHHh---ccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh---hhhhh
Confidence 99994 4556888889999999999999999998 999999999999999999999999999876422 33445
Q ss_pred ccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccccccCCCChH
Q 003254 681 VVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDNSCSFS 760 (836)
Q Consensus 681 ~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 760 (836)
++||..|||||++.+.+.++|+|||||||||||||||..|+......... | .+-...|.-..+..
T Consensus 271 FaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAII----w-----------GVGsNsL~LpvPst 335 (904)
T KOG4721|consen 271 FAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAII----W-----------GVGSNSLHLPVPST 335 (904)
T ss_pred hhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeE----E-----------eccCCcccccCccc
Confidence 89999999999999999999999999999999999999996432221110 0 01111222334455
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 003254 761 EALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 793 (836)
Q Consensus 761 ~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 793 (836)
+..-+.-|+.+||+..|..||++++|+..|+-.
T Consensus 336 cP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 336 CPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred CchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 566677899999999999999999999999754
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=341.58 Aligned_cols=250 Identities=26% Similarity=0.396 Sum_probs=207.6
Q ss_pred ccccccCeecccCceeEEEEEee-cCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEeec
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 595 (836)
..|....+||+|..|.||.+... .++.||||++........+-+.+|+.+|+..+|+|||.+++.+...+++++|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 46777789999999999999864 48899999997776666677899999999999999999999999999999999999
Q ss_pred CCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCccc
Q 003254 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE 675 (836)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 675 (836)
++|+|.+.+.. ..+++.++..|+.++++||+|||.++ |+|||||.+|||++.++.+||+|||++..+.....
T Consensus 353 ~ggsLTDvVt~----~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~- 424 (550)
T KOG0578|consen 353 EGGSLTDVVTK----TRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS- 424 (550)
T ss_pred CCCchhhhhhc----ccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC-
Confidence 99999998843 34899999999999999999999999 99999999999999999999999999988765544
Q ss_pred cccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccccccC
Q 003254 676 ANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDN 755 (836)
Q Consensus 676 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 755 (836)
.....+||+.|||||+.....|.+|+||||||++++||+-|.+|+-...+- ...+.....+.+ ++
T Consensus 425 -KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Pl------rAlyLIa~ng~P-~l------- 489 (550)
T KOG0578|consen 425 -KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPL------RALYLIATNGTP-KL------- 489 (550)
T ss_pred -ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChH------HHHHHHhhcCCC-Cc-------
Confidence 233479999999999999999999999999999999999999996542221 111111111111 11
Q ss_pred CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 756 SCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 756 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
.........+.++..+||+.|+++||++.|+|+.
T Consensus 490 k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 490 KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 1112223457799999999999999999999863
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=333.22 Aligned_cols=245 Identities=20% Similarity=0.296 Sum_probs=197.5
Q ss_pred CeecccCceeEEEEEeecCcEEEEEEecCCCchh---HHHHHHHHHHHHhhcCCceeeEEeEEee----CCeeeEEEeec
Q 003254 523 NKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQG---MEEFKNEVLLIAKLQHRNLVKLLGCCTQ----RDERMLIYEYL 595 (836)
Q Consensus 523 ~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~---~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~~lV~Ey~ 595 (836)
..||+|++|.||+|++ +|+.||||++....... .+.|.+|+.++.+++||||++++|++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 5799999999999998 78999999987653322 5678899999999999999999999876 34678999999
Q ss_pred CCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcC-CCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcc
Q 003254 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (836)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~ 674 (836)
++|+|.+++.. .+.+++.....++.+++.||.|||+. + ++||||||+|||+++++.+||+|||+++.+....
T Consensus 105 ~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~- 177 (283)
T PHA02988 105 TRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP- 177 (283)
T ss_pred CCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence 99999999853 34688999999999999999999985 5 7899999999999999999999999998653221
Q ss_pred ccccccccccccccCcccccC--CccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhcccc
Q 003254 675 EANTKRVVGTYGYMSPEYAID--GLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQS 752 (836)
Q Consensus 675 ~~~~~~~~gt~~y~aPE~~~~--~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 752 (836)
....++..|+|||++.+ ..++.++|||||||++|||++|+.||...... .. .........
T Consensus 178 ----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~---~~----~~~i~~~~~------- 239 (283)
T PHA02988 178 ----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK---EI----YDLIINKNN------- 239 (283)
T ss_pred ----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH---HH----HHHHHhcCC-------
Confidence 12467889999999976 68999999999999999999999997632211 11 111111100
Q ss_pred ccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 003254 753 LDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 794 (836)
Q Consensus 753 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 794 (836)
....+......+.+++.+||+.||++|||+.||++.|+...
T Consensus 240 -~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 240 -SLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred -CCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 01112223456889999999999999999999999998764
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=346.18 Aligned_cols=258 Identities=27% Similarity=0.381 Sum_probs=201.9
Q ss_pred ccccccCeecccCceeEEEEEe------ecCcEEEEEEecCCC-chhHHHHHHHHHHHHhh-cCCceeeEEeEEeeCCee
Q 003254 517 DNFSEKNKLGEGGFGPVYKGML------IEGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDER 588 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~------~~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~ 588 (836)
++|+..+.||+|+||.||+++. ..+..||||+++... ....+.+.+|+.++..+ +||||+++++++......
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~ 114 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT 114 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence 4688889999999999999974 235689999986543 33456788999999999 899999999999999999
Q ss_pred eEEEeecCCCChhHHHhhccC-----------------------------------------------------------
Q 003254 589 MLIYEYLPNKSLDYFIFDTTR----------------------------------------------------------- 609 (836)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~----------------------------------------------------------- 609 (836)
++||||+++|+|.+++.....
T Consensus 115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (375)
T cd05104 115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY 194 (375)
T ss_pred eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence 999999999999998864211
Q ss_pred -------------CCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcccc
Q 003254 610 -------------SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEA 676 (836)
Q Consensus 610 -------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~~ 676 (836)
...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.........
T Consensus 195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 271 (375)
T cd05104 195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV 271 (375)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence 125788899999999999999999988 9999999999999999999999999998764332222
Q ss_pred ccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhccCchhhccccccC
Q 003254 677 NTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDN 755 (836)
Q Consensus 677 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 755 (836)
......++..|+|||.+.+..++.++||||||+++|||++ |..|+....... ........... .
T Consensus 272 ~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~------~~~~~~~~~~~---------~ 336 (375)
T cd05104 272 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS------KFYKMIKEGYR---------M 336 (375)
T ss_pred ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH------HHHHHHHhCcc---------C
Confidence 2222345678999999999999999999999999999998 777764322110 11111111100 0
Q ss_pred CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcC
Q 003254 756 SCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 792 (836)
Q Consensus 756 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~ 792 (836)
..+.....++.+|+.+||+.+|++||++.||+++|+.
T Consensus 337 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 337 LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 0011123467899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=338.91 Aligned_cols=249 Identities=23% Similarity=0.364 Sum_probs=203.8
Q ss_pred hhcccccccCeecccCceeEEEEEee-cCcEEEEEEecCC----Cc-hhHHHHHHHHHHHHhhc-CCceeeEEeEEeeCC
Q 003254 514 NATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG----SG-QGMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQRD 586 (836)
Q Consensus 514 ~a~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~----~~-~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~ 586 (836)
...++|...+.||+|.||+|+.|... .+..||+|++.+. .. ...+.+.+|+.++++++ ||||++++.++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 34578999999999999999999875 4899999977653 22 33556778999999999 999999999999999
Q ss_pred eeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCC-CCceeeccCc
Q 003254 587 ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNT-MNPKISDFGL 665 (836)
Q Consensus 587 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~-~~~kl~DFgl 665 (836)
..++||||+.+|.|.+++.+ .+++.+.++.+++.|++.|++|+|+.+ |+||||||+|||++.+ +++||+|||+
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred eEEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccc
Confidence 99999999999999999954 457888999999999999999999998 9999999999999999 9999999999
Q ss_pred ccccCCCccccccccccccccccCcccccCCc-cC-ccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhcc
Q 003254 666 ARSFGLDQTEANTKRVVGTYGYMSPEYAIDGL-FS-VKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEE 743 (836)
Q Consensus 666 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~t-~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 743 (836)
+.... .........+|++.|+|||++.+.. |+ .++||||+||+||-|++|+.||.... .. ...+.....
T Consensus 168 s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~------~~-~l~~ki~~~ 238 (370)
T KOG0583|consen 168 SAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN------VP-NLYRKIRKG 238 (370)
T ss_pred ccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc------HH-HHHHHHhcC
Confidence 99863 2223345589999999999999877 86 67999999999999999999986411 11 111111111
Q ss_pred CchhhccccccCCCChHH-HHHHHHHHHHcccCCCCCCCCHHHHH
Q 003254 744 RPLELIDQSLDNSCSFSE-ALRCIQVGLLCVQQRPEDRPNMSSVV 787 (836)
Q Consensus 744 ~~~~~~d~~l~~~~~~~~-~~~l~~li~~Cl~~dP~~RPt~~eVl 787 (836)
. .. ++... ...+.+++.+|++.+|.+|+|+.+|+
T Consensus 239 ~-~~---------~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 239 E-FK---------IPSYLLSPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred C-cc---------CCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 0 00 11111 45678999999999999999999999
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=345.65 Aligned_cols=259 Identities=29% Similarity=0.425 Sum_probs=202.5
Q ss_pred ccccccCeecccCceeEEEEEee------cCcEEEEEEecCCC-chhHHHHHHHHHHHHhh-cCCceeeEEeEEeeCCee
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLI------EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDER 588 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~------~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~ 588 (836)
++|+..+.||+|+||.||+++.. ++..||||++.... ....+.+.+|+.+++.+ +|+||+++++++......
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~ 117 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV 117 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence 57888899999999999998842 23579999997543 33456788999999999 899999999999999999
Q ss_pred eEEEeecCCCChhHHHhhcc------------------------------------------------------------
Q 003254 589 MLIYEYLPNKSLDYFIFDTT------------------------------------------------------------ 608 (836)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~------------------------------------------------------------ 608 (836)
++||||+++|+|.+++....
T Consensus 118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (374)
T cd05106 118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS 197 (374)
T ss_pred EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence 99999999999999885421
Q ss_pred -------CCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCccccccccc
Q 003254 609 -------RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRV 681 (836)
Q Consensus 609 -------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~~ 681 (836)
...++++..+.+++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++..............
T Consensus 198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 274 (374)
T cd05106 198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA 274 (374)
T ss_pred cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence 1124788889999999999999999988 999999999999999999999999999865433222112223
Q ss_pred cccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhccCchhhccccccCCCChH
Q 003254 682 VGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDNSCSFS 760 (836)
Q Consensus 682 ~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 760 (836)
.++..|+|||++.+..++.++|||||||++|||++ |+.|+....... . ........ .....+..
T Consensus 275 ~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~----~~~~~~~~---------~~~~~~~~ 339 (374)
T cd05106 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--K----FYKMVKRG---------YQMSRPDF 339 (374)
T ss_pred CCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--H----HHHHHHcc---------cCccCCCC
Confidence 45678999999999999999999999999999997 998875322111 0 00111100 00011111
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 003254 761 EALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 793 (836)
Q Consensus 761 ~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 793 (836)
....+.+++.+||+.+|++|||+.+|+++|+++
T Consensus 340 ~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 340 APPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 234678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=327.03 Aligned_cols=250 Identities=33% Similarity=0.498 Sum_probs=192.9
Q ss_pred ccCeecccCceeEEEEEee-----cCcEEEEEEecCCC-chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEee
Q 003254 521 EKNKLGEGGFGPVYKGMLI-----EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (836)
Q Consensus 521 ~~~~lG~G~fG~Vykg~~~-----~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 594 (836)
..+.||.|.||.||+|.+. .+..|+||.+.... ....++|.+|++.+++++||||++++|++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3568999999999999987 26789999996543 33478999999999999999999999999988889999999
Q ss_pred cCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcc
Q 003254 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (836)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~ 674 (836)
+++|+|.+++... ....+++..+..++.||++||.|||+.+ ++|+||+++|||+++++.+||+|||++........
T Consensus 83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred ccccccccccccc-cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 9999999999654 2456899999999999999999999988 99999999999999999999999999987633222
Q ss_pred ccccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhccCchhhccccc
Q 003254 675 EANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSL 753 (836)
Q Consensus 675 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 753 (836)
............|+|||.+.+..++.++||||||+++|||++ |+.|+..... .. ......+...
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~---~~----~~~~~~~~~~-------- 223 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN---EE----IIEKLKQGQR-------- 223 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH---HH----HHHHHHTTEE--------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccc---cc----cccccccccc--------
Confidence 222233456789999999999999999999999999999999 5676432211 11 1111111111
Q ss_pred cCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 003254 754 DNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLML 790 (836)
Q Consensus 754 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L 790 (836)
...+......+.+++..||+.+|++|||+.+|++.|
T Consensus 224 -~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 224 -LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp -TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred -ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 011112345577999999999999999999999987
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=326.79 Aligned_cols=257 Identities=31% Similarity=0.489 Sum_probs=205.6
Q ss_pred ccccccCeecccCceeEEEEEeec-C-----cEEEEEEecCCC-chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeee
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-G-----QEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERM 589 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-g-----~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 589 (836)
++|+..+.||+|+||.||+|.... + ..||+|.+.... ....++|.+|+.++.+++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 467888999999999999998754 2 579999986543 334567899999999999999999999999999999
Q ss_pred EEEeecCCCChhHHHhhccC-------------CCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCC
Q 003254 590 LIYEYLPNKSLDYFIFDTTR-------------SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTM 656 (836)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~ 656 (836)
++|||+++++|.+++..... ...+++..+..++.|+++||.|||+.+ ++|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999999865321 145788899999999999999999998 99999999999999999
Q ss_pred CceeeccCcccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhh
Q 003254 657 NPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGH 735 (836)
Q Consensus 657 ~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~ 735 (836)
.+||+|||+++...............+++.|+|||.+.++.++.++|||||||++|||++ |..|+...... .
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~---~---- 234 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ---E---- 234 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH---H----
Confidence 999999999987643332222333456889999999998999999999999999999998 88886432211 1
Q ss_pred hHHhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcC
Q 003254 736 AWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 792 (836)
Q Consensus 736 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~ 792 (836)
.......... ...+......+.+|+.+||+.+|.+||++.||++.|+.
T Consensus 235 ~~~~i~~~~~---------~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 235 VIEMIRSRQL---------LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHcCCc---------CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 1111111111 11122334668899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=329.71 Aligned_cols=269 Identities=26% Similarity=0.400 Sum_probs=206.2
Q ss_pred ccccccCeecccCceeEEEEEeecCcEEEEEEecCCCchhHHHHHHHHHHHHh--hcCCceeeEEeEEeeCC----eeeE
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAK--LQHRNLVKLLGCCTQRD----ERML 590 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~--l~H~niv~l~g~~~~~~----~~~l 590 (836)
+..+..+.||+|+||.||||.+ +++.||||++.. +..+.|++|-+|++. ++|+||+++++.-.... +++|
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred CchhhHHHhhcCccceeehhhc-cCceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 4455667899999999999999 569999999965 445778889888886 57999999999877666 7999
Q ss_pred EEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCC------CCcEEeccCCCCceEecCCCCceeeccC
Q 003254 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDS------RLRIIHRDLKASNVLLDNTMNPKISDFG 664 (836)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------~~~ivH~DLkp~NILl~~~~~~kl~DFg 664 (836)
|+||.++|+|.++|. ...++|.+..+|+..+++||+|||+.- .++|+|||||++||||.+|++..|+|||
T Consensus 286 Vt~fh~kGsL~dyL~----~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG 361 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYLK----ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG 361 (534)
T ss_pred EeeeccCCcHHHHHH----hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence 999999999999994 456899999999999999999999762 4579999999999999999999999999
Q ss_pred cccccCCCccccccccccccccccCcccccCCc-cC-----ccccccchhhhhhhhhhCCCCCC------CCCCcc---c
Q 003254 665 LARSFGLDQTEANTKRVVGTYGYMSPEYAIDGL-FS-----VKSDVFSFGVLVLEIICGKKNRG------FNHADH---D 729 (836)
Q Consensus 665 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~t-----~ksDVwS~GvvL~elltG~~p~~------~~~~~~---~ 729 (836)
+|..+............+||.+|||||++.+.. +. .+.||||+|.|||||++.-.... +..+.+ .
T Consensus 362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG 441 (534)
T KOG3653|consen 362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG 441 (534)
T ss_pred eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhc
Confidence 999998766666666689999999999997643 22 36899999999999999654321 111110 0
Q ss_pred -cchhhhhHHhhhccCc-hhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCCCCC
Q 003254 730 -HNLLGHAWRLWIEERP-LELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLP 797 (836)
Q Consensus 730 -~~~~~~~~~~~~~~~~-~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~~~ 797 (836)
+--.+..+.....++. ..+.+.-. ....+..+++.+..||+.||+.|-|+.=|-+++.++.-..
T Consensus 442 ~hPt~e~mq~~VV~kK~RP~~p~~W~----~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 442 NHPTLEEMQELVVRKKQRPKIPDAWR----KHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW 507 (534)
T ss_pred CCCCHHHHHHHHHhhccCCCChhhhh----cCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence 0001111111111111 11111111 1144566889999999999999999999999998875543
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=328.92 Aligned_cols=248 Identities=25% Similarity=0.400 Sum_probs=206.7
Q ss_pred ccccccCeecccCceeEEEEEeec-CcEEEEEEecCC-CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEee
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 594 (836)
..|+..+.||+|.||.||||.... ++.||+|++... .....+++++|+.++.+++|+||.+++|.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 456667899999999999999865 888999999755 445678899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcc
Q 003254 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (836)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~ 674 (836)
|.+|++.+.+ .....+++..+.-++.++..||.|||+++ .+|||||+.|||+..+|.+||+|||.+..+.....
T Consensus 93 ~~gGsv~~lL---~~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 93 CGGGSVLDLL---KSGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred hcCcchhhhh---ccCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 9999999988 34455688889999999999999999998 99999999999999999999999999987754443
Q ss_pred ccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhcccccc
Q 003254 675 EANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLD 754 (836)
Q Consensus 675 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 754 (836)
.. ..++||+.|||||++....|+.|+||||||++.+||.+|.+|+...++-.-..++. +-.-|.+.
T Consensus 167 rr--~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIp------------k~~PP~L~ 232 (467)
T KOG0201|consen 167 RR--KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIP------------KSAPPRLD 232 (467)
T ss_pred cc--ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEecc------------CCCCCccc
Confidence 33 56899999999999998899999999999999999999999976544422111111 11111222
Q ss_pred CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 755 NSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 755 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
+ .....+.+++..||+.+|+.||++.++++
T Consensus 233 ~----~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 233 G----DFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred c----ccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 2 22344779999999999999999999875
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=377.18 Aligned_cols=263 Identities=25% Similarity=0.438 Sum_probs=210.5
Q ss_pred hcccccccCeecccCceeEEEEEee-cCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEe
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 593 (836)
..+.+...+.||+|+||.||+|+.. ++..||||++...... ..+|++++++++|||||+++|+|.+.+..++|||
T Consensus 688 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E 763 (968)
T PLN00113 688 ILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE 763 (968)
T ss_pred HHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence 3456777889999999999999974 6899999998654322 2356889999999999999999999999999999
Q ss_pred ecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCc
Q 003254 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (836)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~ 673 (836)
|+++|+|.+++. .++|..+.+++.|||+||+|||+...++|+||||||+||++++++.+++. |+.+.....
T Consensus 764 y~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~-- 834 (968)
T PLN00113 764 YIEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT-- 834 (968)
T ss_pred CCCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc--
Confidence 999999999983 37899999999999999999997755669999999999999999988876 665543211
Q ss_pred cccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccccc
Q 003254 674 TEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSL 753 (836)
Q Consensus 674 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 753 (836)
.....+++.|+|||++.+..++.|+|||||||++|||++|+.|+...... ......+.............+|+.+
T Consensus 835 ----~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (968)
T PLN00113 835 ----DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV-HGSIVEWARYCYSDCHLDMWIDPSI 909 (968)
T ss_pred ----CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCC-CCcHHHHHHHhcCccchhheeCccc
Confidence 11236789999999999999999999999999999999999997432222 2233344433333333445566665
Q ss_pred cC--CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCCC
Q 003254 754 DN--SCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS 795 (836)
Q Consensus 754 ~~--~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~ 795 (836)
.. ....++..++.+++.+||+.+|++||||.||+++|+.+..
T Consensus 910 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 910 RGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred cCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 43 2345667788999999999999999999999999997644
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=331.83 Aligned_cols=264 Identities=27% Similarity=0.421 Sum_probs=212.9
Q ss_pred ccccccCeecccCceeEEEEEeecCcEEEEEEecCCCc-hhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEeec
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSG-QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 595 (836)
+...+.++||+|-||.|.......+..||||+++.... ...++|..|+++|.+++||||++++|+|..++.+++|+|||
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm 617 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM 617 (807)
T ss_pred hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence 45567889999999999999997789999999987654 44589999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCccc
Q 003254 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE 675 (836)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 675 (836)
++|+|.+++..... ..+......+|+.|||.||+||.+.. +|||||.++|+|+|.++++||+|||+++.+......
T Consensus 618 EnGDLnqFl~ahea-pt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy 693 (807)
T KOG1094|consen 618 ENGDLNQFLSAHEL-PTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY 693 (807)
T ss_pred hcCcHHHHHHhccC-cccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCce
Confidence 99999999965422 22566777889999999999999988 999999999999999999999999999987766665
Q ss_pred cccccccccccccCcccccCCccCccccccchhhhhhhhhh--CCCCCCCCCCccccchhhhhHHhhhccCchhhccccc
Q 003254 676 ANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC--GKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSL 753 (836)
Q Consensus 676 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt--G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 753 (836)
....+.+-+.+|||+|.+..+++|.++|||+||++|||+++ ...|++....+ +.+......+ .......+
T Consensus 694 ~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e---~vven~~~~~-~~~~~~~~---- 765 (807)
T KOG1094|consen 694 RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE---QVVENAGEFF-RDQGRQVV---- 765 (807)
T ss_pred eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH---HHHHhhhhhc-CCCCccee----
Confidence 55556777899999999999999999999999999999866 44564432221 1111111111 11111111
Q ss_pred cCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 003254 754 DNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 793 (836)
Q Consensus 754 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 793 (836)
...+.-+...+.+++++||..|.++||+++++...|.+.
T Consensus 766 -l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 766 -LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred -ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 122334456678999999999999999999999998764
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=323.02 Aligned_cols=256 Identities=25% Similarity=0.349 Sum_probs=202.3
Q ss_pred cccccccCeecccCceeEEEEEee----cCcEEEEEEecCCC-chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeE
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLI----EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~----~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 590 (836)
.++|++.+.||+|+||.||+|.+. .+..||+|.++... ....+.|.+|+.++.+++||||+++++++...+..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 356888899999999999999864 25689999987653 2345678999999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccC
Q 003254 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (836)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~ 670 (836)
||||+++|+|++++... ...+++..++.++.||+.||+|||+.+ ++||||||+|||++.++.+|++|||.+....
T Consensus 84 v~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 84 VTEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 99999999999998542 346899999999999999999999988 9999999999999999999999999876532
Q ss_pred CCccccccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhccCchhhc
Q 003254 671 LDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEERPLELI 749 (836)
Q Consensus 671 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (836)
.... .......++..|+|||.+.++.++.++||||||+++||+++ |+.|+....... . ........
T Consensus 159 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~---~----~~~~~~~~----- 225 (266)
T cd05064 159 SEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD---V----IKAVEDGF----- 225 (266)
T ss_pred ccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---H----HHHHHCCC-----
Confidence 1111 11112345678999999999999999999999999999775 998875322110 0 11111110
Q ss_pred cccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 003254 750 DQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 793 (836)
Q Consensus 750 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 793 (836)
....+......+.+++..||+.+|++||++.||++.|+..
T Consensus 226 ----~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 226 ----RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred ----CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 0011222345678999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=322.76 Aligned_cols=258 Identities=28% Similarity=0.459 Sum_probs=211.1
Q ss_pred hhcccccccCeecccCceeEEEEEeecCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEe
Q 003254 514 NATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (836)
Q Consensus 514 ~a~~~f~~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 593 (836)
....+|+..++||.|+||.||+|...+++.+++|.+........+++.+|+.+++.++|+||+++++++...+..++|||
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 34567888999999999999999998899999999987766567789999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCc
Q 003254 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (836)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~ 673 (836)
|+++++|.+++.+. ....+++..+..++.+|+.||.|||+.+ ++|+||||+||++++++.+||+|||++.......
T Consensus 83 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 83 LMEKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDV 158 (261)
T ss_pred ecccCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence 99999999999653 3456899999999999999999999988 9999999999999999999999999998764322
Q ss_pred cccccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhccCchhhcccc
Q 003254 674 TEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQS 752 (836)
Q Consensus 674 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 752 (836)
.. .....++..|+|||.+.+..++.++||||||+++++|++ |+.|+...... ... ..... .
T Consensus 159 ~~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~---~~~----~~~~~---------~ 220 (261)
T cd05148 159 YL--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH---EVY----DQITA---------G 220 (261)
T ss_pred cc--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH---HHH----HHHHh---------C
Confidence 11 112345778999999998899999999999999999998 78886432211 011 11111 0
Q ss_pred ccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 003254 753 LDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 793 (836)
Q Consensus 753 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 793 (836)
.....+......+.+++.+|++.+|++|||+.++++.|+.+
T Consensus 221 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 221 YRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 11112223345678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=307.10 Aligned_cols=234 Identities=27% Similarity=0.362 Sum_probs=197.6
Q ss_pred ccccccCeecccCceeEEEEEeec-CcEEEEEEecCCCc---hhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEE
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSG---QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 592 (836)
++|+..+.||.|+||.|..++.+. |.-+|+|++.+..- ...+...+|..+|+.+.||.++++++.+.+....+|||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 578888999999999999999865 77899999977632 33456788999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCC
Q 003254 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (836)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~ 672 (836)
||+++|.|..++. +.+++++..+.-+|.+|+.||+|||+.+ |++|||||+|||||.+|.+||+|||+|+...
T Consensus 124 eyv~GGElFS~Lr---k~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~-- 195 (355)
T KOG0616|consen 124 EYVPGGELFSYLR---KSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVS-- 195 (355)
T ss_pred eccCCccHHHHHH---hcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEec--
Confidence 9999999999994 4456999999999999999999999998 9999999999999999999999999999753
Q ss_pred ccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhcccc
Q 003254 673 QTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQS 752 (836)
Q Consensus 673 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 752 (836)
..+.+.+|||.|+|||++..+.+..++|-|||||++|||+.|.+||....+ .++.++.
T Consensus 196 ---~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~-------------------~~iY~KI 253 (355)
T KOG0616|consen 196 ---GRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP-------------------IQIYEKI 253 (355)
T ss_pred ---CcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh-------------------HHHHHHH
Confidence 235668999999999999999999999999999999999999999864333 1222222
Q ss_pred ccCC--CChHHHHHHHHHHHHcccCCCCCC
Q 003254 753 LDNS--CSFSEALRCIQVGLLCVQQRPEDR 780 (836)
Q Consensus 753 l~~~--~~~~~~~~l~~li~~Cl~~dP~~R 780 (836)
+.+. ++.--...+.+|+...|+.|-.+|
T Consensus 254 ~~~~v~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 254 LEGKVKFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred HhCcccCCcccCHHHHHHHHHHHhhhhHhh
Confidence 2221 122222346678888888888888
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=334.87 Aligned_cols=253 Identities=22% Similarity=0.344 Sum_probs=202.4
Q ss_pred ccccccCeecccCceeEEEEEeec-CcEEEEEEecCCC---chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEE
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 592 (836)
++|++.+.||+|+||.||+|+..+ ++.||||++.... ....+.+.+|+.++..++||||+++++++...+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 468889999999999999999865 8899999987542 234567889999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCC
Q 003254 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (836)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~ 672 (836)
||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 81 EYVPGGDFRTLLNN---LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 99999999999843 346889999999999999999999998 99999999999999999999999999986532
Q ss_pred ccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhcccc
Q 003254 673 QTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQS 752 (836)
Q Consensus 673 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 752 (836)
......|++.|+|||++.+..++.++|||||||++|||++|+.|+........ ........ ..+...
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-------~~~i~~~~--~~~~~~ 220 (333)
T cd05600 154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET-------WENLKYWK--ETLQRP 220 (333)
T ss_pred ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHH-------HHHHHhcc--ccccCC
Confidence 22346789999999999999999999999999999999999999754322111 00000000 000000
Q ss_pred ccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 753 LDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 753 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
............+.+++.+||+.+|++||++.|+++.
T Consensus 221 ~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 221 VYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 0000001223457789999999999999999999975
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=319.64 Aligned_cols=256 Identities=29% Similarity=0.433 Sum_probs=205.7
Q ss_pred cccccccCeecccCceeEEEEEeecCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEeec
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 595 (836)
.++|+..+.||+|++|.||+|...+++.||+|.++... ...+++.+|+.++++++|+||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 46688889999999999999998778899999986543 34577999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCccc
Q 003254 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE 675 (836)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 675 (836)
++++|.+++.... ...+++..+..++.+++.||.|||+.+ ++||||||+||++++++.+||+|||++.........
T Consensus 84 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 84 KYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred cCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 9999999985432 346899999999999999999999988 999999999999999999999999999876522111
Q ss_pred cccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhccCchhhcccccc
Q 003254 676 ANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLD 754 (836)
Q Consensus 676 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 754 (836)
.......+..|+|||.+.+..++.++||||||++++||++ |+.|+...... .......... .
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-------~~~~~~~~~~---------~ 222 (261)
T cd05068 160 -AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA-------EVLQQVDQGY---------R 222 (261)
T ss_pred -ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH-------HHHHHHHcCC---------C
Confidence 1111233468999999999999999999999999999999 88886432111 0111111110 0
Q ss_pred CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 003254 755 NSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 793 (836)
Q Consensus 755 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 793 (836)
...+......+.+++.+|++.+|++||++.++++.|++.
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 223 MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 011122335678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=339.68 Aligned_cols=261 Identities=27% Similarity=0.369 Sum_probs=204.5
Q ss_pred cccccccCeecccCceeEEEEEeec------CcEEEEEEecCCCc-hhHHHHHHHHHHHHhhc-CCceeeEEeEEeeCCe
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLIE------GQEIAVKRLSKGSG-QGMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQRDE 587 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~~------g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~ 587 (836)
.++|.+.++||+|+||.||+|+... +..||||++..... ...+.+.+|+.+++++. ||||+++++++.+...
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 4678888999999999999998532 34699999975433 34567899999999996 9999999999999999
Q ss_pred eeEEEeecCCCChhHHHhhccC----------------------------------------------------------
Q 003254 588 RMLIYEYLPNKSLDYFIFDTTR---------------------------------------------------------- 609 (836)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~---------------------------------------------------------- 609 (836)
.+|||||+++|+|.+++.....
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 9999999999999998864210
Q ss_pred -----------------------------------CCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecC
Q 003254 610 -----------------------------------SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN 654 (836)
Q Consensus 610 -----------------------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~ 654 (836)
...+++..+..++.||++||+|||+.+ |+||||||+|||+++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeC
Confidence 124778888999999999999999988 999999999999999
Q ss_pred CCCceeeccCcccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchh
Q 003254 655 TMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLL 733 (836)
Q Consensus 655 ~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~ 733 (836)
++.+||+|||+++.+.............++..|+|||.+.+..++.++|||||||++|||++ |..|+....... .
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~--~-- 348 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS--T-- 348 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH--H--
Confidence 99999999999987643322222233456788999999999999999999999999999997 888864321110 0
Q ss_pred hhhHHhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 003254 734 GHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 794 (836)
Q Consensus 734 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 794 (836)
......... ...........+.+++.+||+.+|++||++.+|+++|+.+.
T Consensus 349 --~~~~~~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 349 --FYNKIKSGY---------RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred --HHHHHhcCC---------CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 011111110 00111123356789999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=323.19 Aligned_cols=250 Identities=26% Similarity=0.359 Sum_probs=198.8
Q ss_pred ccccCeecccCceeEEEEEee-cCcEEEEEEecCCC---chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEee
Q 003254 519 FSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (836)
Q Consensus 519 f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 594 (836)
|+..+.||+|+||.||++... +|+.||+|.+.... ......+.+|+.++.+++|+||+++++++.+.+..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 667789999999999999975 58999999986542 22345678999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcc
Q 003254 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (836)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~ 674 (836)
+++|+|..++... ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++.......
T Consensus 82 ~~~g~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05631 82 MNGGDLKFHIYNM-GNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE- 156 (285)
T ss_pred cCCCcHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence 9999998887543 2346889999999999999999999998 9999999999999999999999999998753221
Q ss_pred ccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhcccccc
Q 003254 675 EANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLD 754 (836)
Q Consensus 675 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 754 (836)
......|+..|+|||++.+..++.++|||||||+||||++|+.||......... ........ ...
T Consensus 157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~---~~~~~~~~-~~~--------- 221 (285)
T cd05631 157 --TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR---EEVDRRVK-EDQ--------- 221 (285)
T ss_pred --eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH---HHHHHHhh-ccc---------
Confidence 122357899999999999999999999999999999999999998643321110 00000000 000
Q ss_pred CCCChHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 003254 755 NSCSFSEALRCIQVGLLCVQQRPEDRPN-----MSSVVL 788 (836)
Q Consensus 755 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~eVl~ 788 (836)
...+......+.+|+.+||+.+|++||+ ++++++
T Consensus 222 ~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 222 EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 0111122345778999999999999997 788876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=331.64 Aligned_cols=265 Identities=23% Similarity=0.310 Sum_probs=203.2
Q ss_pred cccccccCeecccCceeEEEEEeec-CcEEEEEEecCCC-chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEe
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 593 (836)
.++|+..+.||+|+||.||+++... +..+|+|.+.... ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 4688999999999999999999864 7889999987543 3345679999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCc
Q 003254 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (836)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~ 673 (836)
|+++++|.+++.. ...+++..+..++.|++.||.|||+.+ .|+||||||+|||+++++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 157 (331)
T cd06649 84 HMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (331)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc-
Confidence 9999999999853 345889999999999999999999853 3999999999999999999999999998765322
Q ss_pred cccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHH-------hhhc----
Q 003254 674 TEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWR-------LWIE---- 742 (836)
Q Consensus 674 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~-------~~~~---- 742 (836)
......|++.|+|||++.+..++.++|||||||++|||++|+.|+................. ....
T Consensus 158 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (331)
T cd06649 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPR 234 (331)
T ss_pred ---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccc
Confidence 12335689999999999999999999999999999999999999753222110000000000 0000
Q ss_pred ------------c----CchhhccccccC----CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 743 ------------E----RPLELIDQSLDN----SCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 743 ------------~----~~~~~~d~~l~~----~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
. ...++.+..... .........+.+++.+||+.||++|||+.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 235 PPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred cccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0 000001100000 0011233568899999999999999999999864
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=332.06 Aligned_cols=245 Identities=23% Similarity=0.267 Sum_probs=199.1
Q ss_pred ccccccCeecccCceeEEEEEeec-CcEEEEEEecCCC---chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEE
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 592 (836)
++|+..+.||+|+||.||+++... ++.||+|.+.... ....+.+.+|+.++++++||||+++++++...+..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 678888999999999999999864 8899999986532 234567889999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCC
Q 003254 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (836)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~ 672 (836)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 98 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 98 EFVVGGELFTHLRK---AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred cCCCCChHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 99999999998853 346788899999999999999999998 999999999999999999999999999865321
Q ss_pred ccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhcccc
Q 003254 673 QTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQS 752 (836)
Q Consensus 673 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 752 (836)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||...... ...........
T Consensus 172 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-------~~~~~i~~~~~------- 232 (329)
T PTZ00263 172 -----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF-------RIYEKILAGRL------- 232 (329)
T ss_pred -----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH-------HHHHHHhcCCc-------
Confidence 12357899999999999999999999999999999999999997532111 01111111110
Q ss_pred ccCCCChHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 003254 753 LDNSCSFSEALRCIQVGLLCVQQRPEDRPN-----MSSVVLM 789 (836)
Q Consensus 753 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~eVl~~ 789 (836)
..+.....++.+++.+||+.||++||+ +.+++..
T Consensus 233 ---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 233 ---KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred ---CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 011112235679999999999999997 6777643
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=331.05 Aligned_cols=257 Identities=26% Similarity=0.421 Sum_probs=202.5
Q ss_pred ccccccCeecccCceeEEEEEeec-Cc----EEEEEEecCCC-chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeE
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQ----EIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-g~----~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 590 (836)
.+|+..+.||+|+||.||+|++.. ++ .||+|.+.... ....+++.+|+.+++.++||||++++|++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 568889999999999999998643 33 38999986543 34567899999999999999999999999764 5779
Q ss_pred EEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccC
Q 003254 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (836)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~ 670 (836)
|+||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 86 v~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 86 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence 99999999999998643 345888999999999999999999998 9999999999999999999999999998765
Q ss_pred CCccccccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhccCchhhc
Q 003254 671 LDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEERPLELI 749 (836)
Q Consensus 671 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (836)
............++..|+|||.+.+..++.++||||||+++|||++ |+.|+....... ........
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~-------~~~~~~~~------ 227 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISSILEKG------ 227 (316)
T ss_pred CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHhCC------
Confidence 4333222222344678999999999999999999999999999998 888864321110 01111110
Q ss_pred cccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCCC
Q 003254 750 DQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS 795 (836)
Q Consensus 750 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~ 795 (836)
.....+......+.+++.+||+.+|++||++.+++..|..+..
T Consensus 228 ---~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 228 ---ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred ---CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 0001111223457889999999999999999999999987644
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=319.48 Aligned_cols=255 Identities=29% Similarity=0.424 Sum_probs=205.5
Q ss_pred cccccccCeecccCceeEEEEEeecCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEeec
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 595 (836)
.++|+..++||+|+||.||+|...+++.||+|.+.... ...+.+.+|+.+++.++|+||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 36788899999999999999998888899999986533 34578999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCccc
Q 003254 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE 675 (836)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 675 (836)
++++|.+++... ....+++..+..++.++++||+|||+.+ ++||||||+||++++++.+||+|||++.........
T Consensus 84 ~~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 84 AKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred CCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 999999998543 3456888999999999999999999988 999999999999999999999999999876432221
Q ss_pred cccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhccCchhhcccccc
Q 003254 676 ANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLD 754 (836)
Q Consensus 676 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 754 (836)
......++..|+|||.+.++.++.++||||||+++|||++ |+.|+...... .. ..........
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~----~~~~~~~~~~-------- 223 (261)
T cd05072 160 -AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS---DV----MSALQRGYRM-------- 223 (261)
T ss_pred -ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH---HH----HHHHHcCCCC--------
Confidence 1122345678999999998899999999999999999998 88886432211 11 1111111000
Q ss_pred CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcC
Q 003254 755 NSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 792 (836)
Q Consensus 755 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~ 792 (836)
.........+.+++.+|++.+|++||+++++.++|+.
T Consensus 224 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 224 -PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred -CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0111223457899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=323.50 Aligned_cols=257 Identities=28% Similarity=0.455 Sum_probs=205.4
Q ss_pred ccccccCeecccCceeEEEEEeec------CcEEEEEEecCCCch-hHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeee
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE------GQEIAVKRLSKGSGQ-GMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERM 589 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~------g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 589 (836)
++|.+.+.||+|+||.||+|+..+ ++.||||.+...... ..+.+.+|+++++.++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 567888999999999999998743 478999998765444 5678999999999999999999999999999999
Q ss_pred EEEeecCCCChhHHHhhcc-----------CCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCc
Q 003254 590 LIYEYLPNKSLDYFIFDTT-----------RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNP 658 (836)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~ 658 (836)
+||||+++++|.+++.... ....+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence 9999999999999986432 1245788999999999999999999998 9999999999999999999
Q ss_pred eeeccCcccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhH
Q 003254 659 KISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAW 737 (836)
Q Consensus 659 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~ 737 (836)
||+|||+++...............+++.|+|||++.++.++.++||||||+++|||++ |+.|+....... ..
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~---~~---- 234 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE---VI---- 234 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HH----
Confidence 9999999986533222222223445788999999999999999999999999999998 998864322211 11
Q ss_pred HhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcC
Q 003254 738 RLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 792 (836)
Q Consensus 738 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~ 792 (836)
......... ..+......+.+++.+||+.+|++||++.||++.|+.
T Consensus 235 ~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 235 ECITQGRLL---------QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred HHHHcCCcC---------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 111111110 1111233567899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=331.42 Aligned_cols=262 Identities=24% Similarity=0.376 Sum_probs=213.5
Q ss_pred ccccccCeecccCceeEEEEEeec-CcEEEEEEecCC--CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEe
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 593 (836)
++|.+.+.||+|.||.||||+.+. .+.||+|.+.+. .+...+.+++|++|+++++|||||.+++.|+...+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 567888899999999999999765 788999998765 34456779999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCc
Q 003254 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (836)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~ 673 (836)
|+.+ +|..++.+ .+.++++.+..++.++..||.|||+.. |+|||+||+|||++.++.+|++|||+|+.+...
T Consensus 82 ~a~g-~L~~il~~---d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~- 153 (808)
T KOG0597|consen 82 YAVG-DLFTILEQ---DGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN- 153 (808)
T ss_pred hhhh-hHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccC-
Confidence 9987 99999944 456999999999999999999999998 999999999999999999999999999987542
Q ss_pred cccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccccc
Q 003254 674 TEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSL 753 (836)
Q Consensus 674 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 753 (836)
......+.|||-|||||...+++|+..+|.||+||+|||+++|++||.. ....+++..++
T Consensus 154 -t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a-------------------~si~~Lv~~I~ 213 (808)
T KOG0597|consen 154 -TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA-------------------RSITQLVKSIL 213 (808)
T ss_pred -ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH-------------------HHHHHHHHHHh
Confidence 2233457899999999999999999999999999999999999999742 11112222222
Q ss_pred cC--CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hcC-CCCCCCCCCCCccc
Q 003254 754 DN--SCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM--LSG-ERSLPQPQQPGFFT 806 (836)
Q Consensus 754 ~~--~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~--L~~-~~~~~~p~~p~~~~ 806 (836)
.+ ..+......+..++...|++||.+|.|-.+++.. .++ +.....|.+|++..
T Consensus 214 ~d~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~~~~~~~~~~a~~s 271 (808)
T KOG0597|consen 214 KDPVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKINIAELPAQVAFDS 271 (808)
T ss_pred cCCCCCcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhhhhhcccccccccC
Confidence 21 1222444567889999999999999999998753 233 23334455555543
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=317.89 Aligned_cols=252 Identities=27% Similarity=0.418 Sum_probs=201.2
Q ss_pred ccccccCeecccCceeEEEEEeecCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEeecC
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLP 596 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 596 (836)
++|+..+.||+|+||.||++...++..+|+|.+... ....+++.+|+.++++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 457778899999999999999988889999988643 2345678999999999999999999999999999999999999
Q ss_pred CCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcccc
Q 003254 597 NKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEA 676 (836)
Q Consensus 597 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~~ 676 (836)
+|+|.+++... ...+++..+..++.+++.||+|||+.+ ++|+||||+||++++++.+||+|||+++.........
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 83 NGCLLNYLRQR--QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 99999988542 235889999999999999999999988 9999999999999999999999999988653222211
Q ss_pred ccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhccCchhhccccccC
Q 003254 677 NTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDN 755 (836)
Q Consensus 677 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 755 (836)
.....++..|+|||++.+..++.++||||||+++|||++ |+.|+...... ... ........ ...
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~---~~~----~~i~~~~~--~~~----- 222 (256)
T cd05114 158 -SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY---EVV----EMISRGFR--LYR----- 222 (256)
T ss_pred -cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHH----HHHHCCCC--CCC-----
Confidence 112345668999999998889999999999999999999 88886432211 111 11111100 000
Q ss_pred CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 003254 756 SCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLS 791 (836)
Q Consensus 756 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~ 791 (836)
+......+.+++.+||+.+|++||++.|+++.|+
T Consensus 223 --~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 223 --PKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred --CCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1112245789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=333.89 Aligned_cols=245 Identities=25% Similarity=0.342 Sum_probs=204.9
Q ss_pred ccccccCeecccCceeEEEEEeec-CcEEEEEEecCCC---chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEE
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 592 (836)
.-|+..+.||+|+-|.|-.|++.. |+.+|||++.+.. ......+.+|+.+|+.+.|||++++++++++.+++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 346677899999999999999855 9999999997652 233456889999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCC
Q 003254 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (836)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~ 672 (836)
||+++|.|.+++. +.+++.+.++.+++.||+.|+.|+|..+ |+||||||+|+|||+.+++||+|||||..-
T Consensus 92 Eyv~gGELFdylv---~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe--- 162 (786)
T KOG0588|consen 92 EYVPGGELFDYLV---RKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLE--- 162 (786)
T ss_pred EecCCchhHHHHH---hhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecc---
Confidence 9999999999994 4577999999999999999999999998 999999999999999999999999999863
Q ss_pred ccccccccccccccccCcccccCCccC-ccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccc
Q 003254 673 QTEANTKRVVGTYGYMSPEYAIDGLFS-VKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQ 751 (836)
Q Consensus 673 ~~~~~~~~~~gt~~y~aPE~~~~~~~t-~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 751 (836)
......++.+|.+.|.|||++.+.+|. .++||||.|||||.||+|+.||+. +++ ..++.+
T Consensus 163 ~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD------dNi-------------r~LLlK 223 (786)
T KOG0588|consen 163 VPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD------DNI-------------RVLLLK 223 (786)
T ss_pred cCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC------ccH-------------HHHHHH
Confidence 233334567999999999999999985 679999999999999999999862 111 111222
Q ss_pred cccCC--CChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 752 SLDNS--CSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 752 ~l~~~--~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
.-++. ++.....++.+|+.+|+..||+.|.|++||++.
T Consensus 224 V~~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 224 VQRGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred HHcCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 11221 222334567799999999999999999999885
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=322.52 Aligned_cols=259 Identities=25% Similarity=0.408 Sum_probs=202.8
Q ss_pred hcccccccCeecccCceeEEEEEee------cCcEEEEEEecCCC-chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCe
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLI------EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDE 587 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~------~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 587 (836)
+.++|+..+.||+|+||.||+|... .+..||+|++.... .....++.+|+.+++.++|+||+++++++.+...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4578999999999999999999853 24679999986543 2345678999999999999999999999999999
Q ss_pred eeEEEeecCCCChhHHHhhccC-------CCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCcee
Q 003254 588 RMLIYEYLPNKSLDYFIFDTTR-------SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKI 660 (836)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl 660 (836)
.++||||+++++|.+++..... ...+++..+..++.|+++||+|||+.+ ++|+||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 9999999999999999864321 234678889999999999999999987 999999999999999999999
Q ss_pred eccCcccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHh
Q 003254 661 SDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRL 739 (836)
Q Consensus 661 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 739 (836)
+|||+++...............++..|+|||.+.++.++.++||||||+++|||++ |..|+...... .....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~-------~~~~~ 233 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE-------QVLRF 233 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHH
Confidence 99999986543322222222345778999999999999999999999999999999 67776432211 11111
Q ss_pred hhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcC
Q 003254 740 WIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 792 (836)
Q Consensus 740 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~ 792 (836)
....... ..+......+.+++.+|++.+|++|||+.|+++.|++
T Consensus 234 ~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 234 VMEGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HHcCCcC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 1111110 1111223467899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=318.48 Aligned_cols=255 Identities=27% Similarity=0.407 Sum_probs=204.3
Q ss_pred ccccccCeecccCceeEEEEEeec-CcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEeec
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 595 (836)
.+|+..+.||+|+||.||+|...+ ++.||+|++... ....+++.+|++++++++|+||+++++++......++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 457788899999999999999865 888999998654 344678999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCccc
Q 003254 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE 675 (836)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 675 (836)
++++|.+++... ....+++..++.++.|+++||+|||+.+ ++||||||+||++++++.+||+|||++.........
T Consensus 85 ~~~~L~~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 85 TYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred CCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 999999988543 2346899999999999999999999988 999999999999999999999999999876432211
Q ss_pred cccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhccCchhhcccccc
Q 003254 676 ANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLD 754 (836)
Q Consensus 676 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 754 (836)
......++..|+|||.+.+..++.++||||||+++|||++ |..|+...... ......... ..
T Consensus 161 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~-------~~~~~~~~~---------~~ 223 (263)
T cd05052 161 -AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-------QVYELLEKG---------YR 223 (263)
T ss_pred -ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHHHHCC---------CC
Confidence 1112234668999999999999999999999999999998 88886432111 111111111 01
Q ss_pred CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 003254 755 NSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 793 (836)
Q Consensus 755 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 793 (836)
...+......+.+++.+||+.+|++||++.+++++|+.+
T Consensus 224 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 224 MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 111112235678999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=325.88 Aligned_cols=265 Identities=21% Similarity=0.276 Sum_probs=200.2
Q ss_pred ccccccCeecccCceeEEEEEeec-CcEEEEEEecCCC--chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEe
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 593 (836)
++|++.+.||+|+||.||+++... ++.||+|++.... ....+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 468889999999999999999864 7889999987542 2345678899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCc
Q 003254 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (836)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~ 673 (836)
|++++.+..+.. ....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 81 YVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 999987765542 2346889999999999999999999988 9999999999999999999999999998764322
Q ss_pred cccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhh--------hHHhhhccC-
Q 003254 674 TEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGH--------AWRLWIEER- 744 (836)
Q Consensus 674 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~--------~~~~~~~~~- 744 (836)
. .......|++.|+|||++.+..++.++|||||||++|||++|+.||.............. ....+....
T Consensus 155 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07848 155 N-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR 233 (287)
T ss_pred c-ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence 1 122235689999999999998999999999999999999999999754322111000000 000000000
Q ss_pred chhhccccccCC------CChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 745 PLELIDQSLDNS------CSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 745 ~~~~~d~~l~~~------~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
......+..... ........+.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000000000000 00112345889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=323.95 Aligned_cols=260 Identities=28% Similarity=0.430 Sum_probs=208.2
Q ss_pred ccccccCeecccCceeEEEEEee------cCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeE
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLI------EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~------~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 590 (836)
++|...+.||+|+||.||+++.. ++..+++|.+........+.+.+|+.++++++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 45777889999999999999853 245689999876666666789999999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhcc-------------CCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCC
Q 003254 591 IYEYLPNKSLDYFIFDTT-------------RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMN 657 (836)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~ 657 (836)
||||+++++|.+++.... ....+++..++.++.||+.||+|||+++ |+||||||+||++++++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999986432 1234889999999999999999999998 999999999999999999
Q ss_pred ceeeccCcccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhh
Q 003254 658 PKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHA 736 (836)
Q Consensus 658 ~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~ 736 (836)
+||+|||++................++..|+|||.+.+..++.++||||||+++|||++ |+.|+....... .
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-------~ 234 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE-------V 234 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------H
Confidence 99999999986543322222223456788999999999999999999999999999999 888864322211 1
Q ss_pred HHhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCCC
Q 003254 737 WRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS 795 (836)
Q Consensus 737 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~ 795 (836)
..........+ ........+.+++.+||+.+|++||++.+|+++|+.+..
T Consensus 235 ~~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 235 IECITQGRVLE---------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred HHHHhCCCCCC---------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 11111111111 111223467899999999999999999999999998744
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=318.36 Aligned_cols=273 Identities=26% Similarity=0.384 Sum_probs=211.7
Q ss_pred hcccccccCeecccCceeEEEEEee-cCcEEEEEEecCCCc--------------hhHHHHHHHHHHHHhhcCCceeeEE
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSG--------------QGMEEFKNEVLLIAKLQHRNLVKLL 579 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~~--------------~~~~~~~~Ei~~l~~l~H~niv~l~ 579 (836)
..++|+..+.||+|.||.|-+|... +++.||||++.+... ...+..++||.+|++++|||||+|+
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 3478999999999999999999975 488999999965421 1235788999999999999999999
Q ss_pred eEEee--CCeeeEEEeecCCCChhHHHhhccCCCc-CChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCC
Q 003254 580 GCCTQ--RDERMLIYEYLPNKSLDYFIFDTTRSKL-LDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTM 656 (836)
Q Consensus 580 g~~~~--~~~~~lV~Ey~~~gsL~~~l~~~~~~~~-l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~ 656 (836)
.+..+ .+..|||+|||..|.+... ...++ ++..++++++.++..||+|||.++ ||||||||+|+||++++
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~----p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g 247 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWC----PPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDG 247 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccC----CCCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCC
Confidence 99865 4568999999999987432 22334 899999999999999999999999 99999999999999999
Q ss_pred CceeeccCcccccCCC---ccccccccccccccccCcccccCCc----cCccccccchhhhhhhhhhCCCCCCCCCCccc
Q 003254 657 NPKISDFGLARSFGLD---QTEANTKRVVGTYGYMSPEYAIDGL----FSVKSDVFSFGVLVLEIICGKKNRGFNHADHD 729 (836)
Q Consensus 657 ~~kl~DFgla~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~----~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~ 729 (836)
++||+|||.+..+... .........+||+.|+|||...++. ...+.||||+||+||-|+.|+.||-...
T Consensus 248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~---- 323 (576)
T KOG0585|consen 248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF---- 323 (576)
T ss_pred cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch----
Confidence 9999999999876322 1122234478999999999998743 3567899999999999999999974211
Q ss_pred cchhhhhHHhhhccCchhhcccccc----CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC--CCCCCCCCC
Q 003254 730 HNLLGHAWRLWIEERPLELIDQSLD----NSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER--SLPQPQQPG 803 (836)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~~~d~~l~----~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~--~~~~p~~p~ 803 (836)
..++.++... -....+...++.+|++++|++||++|.+..+|....--.. ..+.+.+|.
T Consensus 324 ---------------~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~~~~~s~~~ 388 (576)
T KOG0585|consen 324 ---------------ELELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGDSPQSSEPS 388 (576)
T ss_pred ---------------HHHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCCCCCccCCcc
Confidence 1222222222 2222345567889999999999999999999988775443 345566666
Q ss_pred ccccCCCCCC
Q 003254 804 FFTGRNLPES 813 (836)
Q Consensus 804 ~~~~~~~~~~ 813 (836)
....-+..++
T Consensus 389 ~c~~v~v~ee 398 (576)
T KOG0585|consen 389 SCSRVEVTEE 398 (576)
T ss_pred cceeeeeecc
Confidence 6654444444
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=323.77 Aligned_cols=260 Identities=28% Similarity=0.438 Sum_probs=207.2
Q ss_pred ccccccCeecccCceeEEEEEee------cCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeE
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLI------EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~------~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 590 (836)
++|.+.+.||+|+||.||++... ++..+|+|.+........+.+.+|+.++++++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 57888899999999999999852 245689999877666667789999999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhcc----------CCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCcee
Q 003254 591 IYEYLPNKSLDYFIFDTT----------RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKI 660 (836)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl 660 (836)
||||+++++|.+++.... +...+++..+..++.|++.||+|||+++ ++||||||+||++++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence 999999999999986432 1235899999999999999999999988 999999999999999999999
Q ss_pred eccCcccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHh
Q 003254 661 SDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRL 739 (836)
Q Consensus 661 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 739 (836)
+|||+++...............++..|+|||.+.+..++.++||||||++++||++ |+.|+....... ....
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~-------~~~~ 234 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-------VIEC 234 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHH
Confidence 99999986543322222223445778999999998899999999999999999998 888864322110 1111
Q ss_pred hhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCCC
Q 003254 740 WIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS 795 (836)
Q Consensus 740 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~ 795 (836)
........ .+......+.+++.+||+.+|.+|||+.||++.|+.+..
T Consensus 235 i~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 235 ITQGRVLQ---------RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred HHcCCcCC---------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 11111100 011122457899999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=318.43 Aligned_cols=256 Identities=27% Similarity=0.419 Sum_probs=204.4
Q ss_pred ccccccCeecccCceeEEEEEeec----CcEEEEEEecCCC-chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEE
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE----GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~----g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 591 (836)
++|+..+.||+|+||.||+|++.. ...||||.++... .....+|.+|+.++++++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 578889999999999999999753 3579999987543 33456789999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCC
Q 003254 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (836)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~ 671 (836)
|||+++++|.+++... ...+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||+++.+..
T Consensus 84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 84 TEYMENGSLDKFLREN--DGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEcCCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 9999999999998542 346899999999999999999999988 99999999999999999999999999998752
Q ss_pred CccccccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhccCchhhcc
Q 003254 672 DQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEERPLELID 750 (836)
Q Consensus 672 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 750 (836)
...........++..|+|||.+.+..++.++||||||++++||++ |..|+...... . ..........
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~---~----~~~~~~~~~~----- 226 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ---D----VIKAVEDGYR----- 226 (266)
T ss_pred cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH---H----HHHHHHcCCC-----
Confidence 222222222345678999999998899999999999999999998 88886322111 0 1111111100
Q ss_pred ccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 003254 751 QSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 793 (836)
Q Consensus 751 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 793 (836)
...+......+.+++.+|++.+|++||++.||++.|+.+
T Consensus 227 ----~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 227 ----LPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ----CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 011122335678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=320.88 Aligned_cols=257 Identities=31% Similarity=0.452 Sum_probs=202.1
Q ss_pred ccccccCeecccCceeEEEEEee-----cCcEEEEEEecCCC-chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeE
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLI-----EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~-----~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 590 (836)
++|+..+.||+|+||.||+|... .++.+++|.+.... .....++.+|+.++++++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 45777889999999999999852 35789999987543 3445678999999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhccC--------------CCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCC
Q 003254 591 IYEYLPNKSLDYFIFDTTR--------------SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTM 656 (836)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~ 656 (836)
||||+++++|.+++..... ...+++..+..++.+++.||+|||+++ ++||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 9999999999999853211 234788889999999999999999998 99999999999999999
Q ss_pred CceeeccCcccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhh
Q 003254 657 NPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGH 735 (836)
Q Consensus 657 ~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~ 735 (836)
.+||+|||++................++..|+|||++.++.++.++||||||++++||++ |..|+...... .
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~-------~ 234 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ-------E 234 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH-------H
Confidence 999999999987643322222233445778999999998889999999999999999998 88776422111 0
Q ss_pred hHHhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcC
Q 003254 736 AWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 792 (836)
Q Consensus 736 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~ 792 (836)
........... ..+......+.+++.+|++.+|++||++.+|+++|..
T Consensus 235 ~~~~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 235 VIEMVRKRQLL---------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHcCCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 11111111100 1111223467889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=329.05 Aligned_cols=241 Identities=24% Similarity=0.312 Sum_probs=194.3
Q ss_pred CeecccCceeEEEEEee-cCcEEEEEEecCCC---chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEeecCCC
Q 003254 523 NKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNK 598 (836)
Q Consensus 523 ~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 598 (836)
+.||+|+||.||+++.. +|+.||+|++.... ......+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999975 48899999987532 234466788999999999999999999999999999999999999
Q ss_pred ChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcccccc
Q 003254 599 SLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANT 678 (836)
Q Consensus 599 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~ 678 (836)
+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~--~~~~ 152 (323)
T cd05571 81 ELFFHLSR---ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISD--GATM 152 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccC--CCcc
Confidence 99888843 356899999999999999999999998 999999999999999999999999998753211 1122
Q ss_pred ccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccccccCCCC
Q 003254 679 KRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDNSCS 758 (836)
Q Consensus 679 ~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 758 (836)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... . .......... ..+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~---~----~~~~~~~~~~----------~~p 215 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---K----LFELILMEEI----------RFP 215 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH---H----HHHHHHcCCC----------CCC
Confidence 3467999999999999999999999999999999999999997432111 0 0011111100 111
Q ss_pred hHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 003254 759 FSEALRCIQVGLLCVQQRPEDRP-----NMSSVVL 788 (836)
Q Consensus 759 ~~~~~~l~~li~~Cl~~dP~~RP-----t~~eVl~ 788 (836)
......+.+++.+||+.||++|| ++.++++
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 216 RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 12234577999999999999999 7999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=331.13 Aligned_cols=260 Identities=30% Similarity=0.426 Sum_probs=202.3
Q ss_pred ccccccCeecccCceeEEEEEeec------CcEEEEEEecCCCc-hhHHHHHHHHHHHHhh-cCCceeeEEeEEeeC-Ce
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE------GQEIAVKRLSKGSG-QGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQR-DE 587 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~------g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~-~~ 587 (836)
++|++.+.||+|+||.||+|...+ ++.||+|++..... ...+.+..|+.++.++ +|+||+++++++... ..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 578889999999999999997422 47899999875432 3345678899999999 799999999988654 56
Q ss_pred eeEEEeecCCCChhHHHhhccC----------------------------------------------------------
Q 003254 588 RMLIYEYLPNKSLDYFIFDTTR---------------------------------------------------------- 609 (836)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~---------------------------------------------------------- 609 (836)
.+++|||+++++|.+++.....
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 7899999999999998854221
Q ss_pred CCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCccccccccccccccccC
Q 003254 610 SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMS 689 (836)
Q Consensus 610 ~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~a 689 (836)
...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.............++..|+|
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 136889999999999999999999988 99999999999999999999999999987643322222233456778999
Q ss_pred cccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhccCchhhccccccCCCChHHHHHHHHH
Q 003254 690 PEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQV 768 (836)
Q Consensus 690 PE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l 768 (836)
||++.+..++.++|||||||+|+||++ |+.|+......+ . .......... ...+......+.++
T Consensus 244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~--~----~~~~~~~~~~---------~~~~~~~~~~~~~l 308 (337)
T cd05054 244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE--E----FCRRLKEGTR---------MRAPEYATPEIYSI 308 (337)
T ss_pred cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH--H----HHHHHhccCC---------CCCCccCCHHHHHH
Confidence 999999999999999999999999998 888864322111 0 0111111100 01111223467899
Q ss_pred HHHcccCCCCCCCCHHHHHHHhcCCC
Q 003254 769 GLLCVQQRPEDRPNMSSVVLMLSGER 794 (836)
Q Consensus 769 i~~Cl~~dP~~RPt~~eVl~~L~~~~ 794 (836)
+.+||+.+|++||++.||++.|+.+.
T Consensus 309 ~~~cl~~~p~~RPs~~ell~~l~~~~ 334 (337)
T cd05054 309 MLDCWHNNPEDRPTFSELVEILGDLL 334 (337)
T ss_pred HHHHccCChhhCcCHHHHHHHHHHHH
Confidence 99999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=320.75 Aligned_cols=272 Identities=26% Similarity=0.389 Sum_probs=201.8
Q ss_pred ccccccCeecccCceeEEEEEee-----cCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeC--Ceee
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLI-----EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR--DERM 589 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~-----~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~ 589 (836)
++|+..+.||+|+||.||++... +++.||+|++........+.+.+|++++++++||||+++++++... ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 56788899999999999999753 4788999999777666678899999999999999999999987543 4578
Q ss_pred EEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCccccc
Q 003254 590 LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (836)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~ 669 (836)
+||||+++++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++..+
T Consensus 84 lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 999999999999998532 345899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCccccc-cccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhh
Q 003254 670 GLDQTEAN-TKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLEL 748 (836)
Q Consensus 670 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (836)
........ .....++..|+|||.+.+..++.++||||||++++||++|..+..........................+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIEL 238 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHH
Confidence 43222111 11122345699999999889999999999999999999987654321110000000000000000000001
Q ss_pred ccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 003254 749 IDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 793 (836)
Q Consensus 749 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 793 (836)
+...............+.+++.+||+.+|++|||+.||++.|+.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 239 LKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 111001111122335688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=322.38 Aligned_cols=264 Identities=22% Similarity=0.319 Sum_probs=197.2
Q ss_pred ccccccCeecccCceeEEEEEee-cCcEEEEEEecCCC-chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEee
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 594 (836)
++|+..++||+|+||.||+|... +++.||+|+++... ......+.+|+.++++++||||+++++++......++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 56888999999999999999976 48899999986543 23345678999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcc
Q 003254 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (836)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~ 674 (836)
+++ +|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.......
T Consensus 85 ~~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 85 LDS-DLKQYLDNC--GNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK 158 (288)
T ss_pred CCc-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence 985 888877432 345788999999999999999999998 99999999999999999999999999976432211
Q ss_pred ccccccccccccccCcccccC-CccCccccccchhhhhhhhhhCCCCCCCCCCccccchhh--------hhHHhhhcc-C
Q 003254 675 EANTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLG--------HAWRLWIEE-R 744 (836)
Q Consensus 675 ~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~--------~~~~~~~~~-~ 744 (836)
......+++.|+|||.+.+ ..++.++||||+||++|||++|+.||............. ..+...... .
T Consensus 159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07871 159 --TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEE 236 (288)
T ss_pred --cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchh
Confidence 1223567899999999875 568999999999999999999999975433221110000 000000000 0
Q ss_pred chhhccccccCC----CChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 745 PLELIDQSLDNS----CSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 745 ~~~~~d~~l~~~----~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
......+..... ........+.+++.+||+.||.+|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000000000000 00011245779999999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=342.32 Aligned_cols=263 Identities=25% Similarity=0.304 Sum_probs=213.0
Q ss_pred hcccccccCeecccCceeEEEEEeecC-cEEEEEEecCCCchhHHHHHHHHHHHHhhc-CCceeeEEeE-Eee------C
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLIEG-QEIAVKRLSKGSGQGMEEFKNEVLLIAKLQ-HRNLVKLLGC-CTQ------R 585 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~~g-~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~-~~~------~ 585 (836)
...++++.+.|.+|||+.||.+....+ .++|+|++-..++...+..++||.+|++|+ |+|||.+++. ... .
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 345667788999999999999999776 999999998888888999999999999997 9999999993 221 2
Q ss_pred CeeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCc
Q 003254 586 DERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGL 665 (836)
Q Consensus 586 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgl 665 (836)
-+.+|.||||++|.|-+++......+ |++.++++|+.++++|+++||... ++|||||||-+||||+.++..||||||.
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGS 192 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGS 192 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcccc
Confidence 35789999999999999997655544 999999999999999999999986 6799999999999999999999999999
Q ss_pred ccccCCCcccccc-------ccccccccccCcccc---cCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhh
Q 003254 666 ARSFGLDQTEANT-------KRVVGTYGYMSPEYA---IDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGH 735 (836)
Q Consensus 666 a~~~~~~~~~~~~-------~~~~gt~~y~aPE~~---~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~ 735 (836)
|............ -...-|+.|+|||++ .+..+++|+|||+|||+||-|+....||+..-.-
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l-------- 264 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL-------- 264 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce--------
Confidence 8754322211000 012358899999987 4778999999999999999999999998643111
Q ss_pred hHHhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCCCCCC
Q 003254 736 AWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQ 798 (836)
Q Consensus 736 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~~~~ 798 (836)
.+++-...-.....+..++.+||..||+.+|++||++-+|++.+-.+...+.
T Consensus 265 -----------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~ 316 (738)
T KOG1989|consen 265 -----------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPC 316 (738)
T ss_pred -----------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCC
Confidence 1222222222234677889999999999999999999999999987755443
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=322.98 Aligned_cols=270 Identities=24% Similarity=0.332 Sum_probs=211.3
Q ss_pred hcccccccCeecccCceeEEEEEeec-CcEEEEEEecCCC---chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeE
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 590 (836)
..++|+.+..||+|+||.||.++.++ |..+|+|++++.. ....+..++|-.+|...++|.||+|+..|.+.+.+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 56889999999999999999999876 8999999998763 3456778899999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccC
Q 003254 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (836)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~ 670 (836)
||||++||++-.+| .+...|++..+..++.+++-|+.-||+.| +|||||||+|+|||..|++||+||||+.-+.
T Consensus 219 iMEylPGGD~mTLL---~~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLL---MRKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD 292 (550)
T ss_pred EEEecCCccHHHHH---HhcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhh
Confidence 99999999999999 45678999999999999999999999999 9999999999999999999999999985331
Q ss_pred C---------------------Ccccc-----c-------------------cccccccccccCcccccCCccCcccccc
Q 003254 671 L---------------------DQTEA-----N-------------------TKRVVGTYGYMSPEYAIDGLFSVKSDVF 705 (836)
Q Consensus 671 ~---------------------~~~~~-----~-------------------~~~~~gt~~y~aPE~~~~~~~t~ksDVw 705 (836)
. ..... . ....+|||.|+|||++.+..|+..+|.|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW 372 (550)
T KOG0605|consen 293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW 372 (550)
T ss_pred hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence 1 00000 0 0124699999999999999999999999
Q ss_pred chhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCC---
Q 003254 706 SFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPN--- 782 (836)
Q Consensus 706 S~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt--- 782 (836)
|+|||+||||.|.+||....+... ++.+...+. .+..........++.+||.+|+. ||++|--
T Consensus 373 SLG~ImyEmLvGyPPF~s~tp~~T-------~rkI~nwr~------~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G 438 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSETPQET-------YRKIVNWRE------TLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKG 438 (550)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHHHhh------hccCCCcCcccHHHHHHHHHHhc-CHHHhcCccc
Confidence 999999999999999875554322 221111110 01111112222567899999998 9999976
Q ss_pred HHHHHHH-------hcCCCCCCCCCCCCc
Q 003254 783 MSSVVLM-------LSGERSLPQPQQPGF 804 (836)
Q Consensus 783 ~~eVl~~-------L~~~~~~~~p~~p~~ 804 (836)
+.||-+. .+.+.+.++|..|..
T Consensus 439 ~~EIK~HPfF~~v~W~~l~~~~apfvP~v 467 (550)
T KOG0605|consen 439 AEEIKKHPFFKGVDWDHLREMPAPFVPQV 467 (550)
T ss_pred HHHHhcCCccccCCcchhhcCCCCCCCCC
Confidence 5555442 123444455555544
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=326.16 Aligned_cols=245 Identities=21% Similarity=0.246 Sum_probs=199.2
Q ss_pred ccccccCeecccCceeEEEEEee-cCcEEEEEEecCCC---chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEE
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 592 (836)
++|+..+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46888899999999999999986 48899999986432 234567889999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCC
Q 003254 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (836)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~ 672 (836)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 81 EYVPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence 99999999998843 346889999999999999999999998 999999999999999999999999999865321
Q ss_pred ccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhcccc
Q 003254 673 QTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQS 752 (836)
Q Consensus 673 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 752 (836)
.....|++.|+|||++.+..++.++|||||||++|||++|+.|+....... ..........
T Consensus 155 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~-------~~~~i~~~~~------- 215 (291)
T cd05612 155 -----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG-------IYEKILAGKL------- 215 (291)
T ss_pred -----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCc-------
Confidence 223568999999999999889999999999999999999999975322110 0111111100
Q ss_pred ccCCCChHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 003254 753 LDNSCSFSEALRCIQVGLLCVQQRPEDRPN-----MSSVVLM 789 (836)
Q Consensus 753 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~eVl~~ 789 (836)
..+......+.+++.+||+.||.+||+ +.|+++.
T Consensus 216 ---~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 216 ---EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred ---CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 011112345779999999999999995 8887754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=314.08 Aligned_cols=248 Identities=25% Similarity=0.374 Sum_probs=195.5
Q ss_pred CeecccCceeEEEEEee-cCcEEEEEEecCCC-chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEeecCCCCh
Q 003254 523 NKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSL 600 (836)
Q Consensus 523 ~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 600 (836)
+.||+|+||.||+|+.. +++.+|+|.+.... ......+.+|++++++++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 36999999999999985 58899999876543 34456799999999999999999999999999999999999999999
Q ss_pred hHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcccccccc
Q 003254 601 DYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKR 680 (836)
Q Consensus 601 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~ 680 (836)
.+++.. ....+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++..............
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 81 LTFLRT--EGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 998843 2346889999999999999999999988 99999999999999999999999999876432211111111
Q ss_pred ccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhccCchhhccccccCCCCh
Q 003254 681 VVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDNSCSF 759 (836)
Q Consensus 681 ~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 759 (836)
...+..|+|||.+.++.++.++||||||+++|||++ |..|+....... ....... ......+.
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~-------~~~~~~~---------~~~~~~~~ 219 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ-------TREAIEQ---------GVRLPCPE 219 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH-------HHHHHHc---------CCCCCCcc
Confidence 223467999999999999999999999999999998 777764221110 0111111 01111122
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 003254 760 SEALRCIQVGLLCVQQRPEDRPNMSSVVLMLS 791 (836)
Q Consensus 760 ~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~ 791 (836)
.....+.+++.+|++.+|++|||+.||+++|.
T Consensus 220 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 220 LCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 22346789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=327.06 Aligned_cols=241 Identities=22% Similarity=0.275 Sum_probs=191.9
Q ss_pred ecccCceeEEEEEeec-CcEEEEEEecCC---CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEeecCCCCh
Q 003254 525 LGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSL 600 (836)
Q Consensus 525 lG~G~fG~Vykg~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 600 (836)
||+|+||.||+++..+ ++.||+|++... .......+.+|+.++.+++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 7999999999999865 788999998643 234456788999999999999999999999999999999999999999
Q ss_pred hHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcccccccc
Q 003254 601 DYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKR 680 (836)
Q Consensus 601 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~ 680 (836)
.+++.. ...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~ 152 (312)
T cd05585 81 FHHLQR---EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNT 152 (312)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Ccccc
Confidence 998853 346899999999999999999999998 9999999999999999999999999998642221 12234
Q ss_pred ccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccccccCCCChH
Q 003254 681 VVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDNSCSFS 760 (836)
Q Consensus 681 ~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 760 (836)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...... .......... . ..+..
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~-------~~~~~~~~~~-~---------~~~~~ 215 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN-------EMYRKILQEP-L---------RFPDG 215 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH-------HHHHHHHcCC-C---------CCCCc
Confidence 67899999999999999999999999999999999999997532110 1111111110 0 11112
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 003254 761 EALRCIQVGLLCVQQRPEDRPNMSSVVLML 790 (836)
Q Consensus 761 ~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L 790 (836)
....+.+++.+||+.||++||++.++.+.|
T Consensus 216 ~~~~~~~li~~~L~~dp~~R~~~~~~~e~l 245 (312)
T cd05585 216 FDRDAKDLLIGLLSRDPTRRLGYNGAQEIK 245 (312)
T ss_pred CCHHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence 234577999999999999998654443333
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=314.91 Aligned_cols=252 Identities=27% Similarity=0.414 Sum_probs=201.6
Q ss_pred ccccccCeecccCceeEEEEEeecCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEeecC
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLP 596 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 596 (836)
++|...+.||+|+||.||+|...++..+|+|.+.... ...+++.+|+.++.+++||||+++++++.+....++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 4677888999999999999998777789999986443 345679999999999999999999999999899999999999
Q ss_pred CCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcccc
Q 003254 597 NKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEA 676 (836)
Q Consensus 597 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~~ 676 (836)
+++|.+++... ...+++..++.++.||+.||+|||+.+ ++|+||||+||++++++.+||+|||+++........
T Consensus 83 ~~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~- 156 (256)
T cd05113 83 NGCLLNYLREH--GKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT- 156 (256)
T ss_pred CCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCcee-
Confidence 99999988543 236899999999999999999999998 999999999999999999999999998865432211
Q ss_pred ccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhccCchhhccccccC
Q 003254 677 NTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDN 755 (836)
Q Consensus 677 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 755 (836)
......++..|+|||.+.+..++.++||||||+++|||++ |+.|+....... . ..........
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~----~~~~~~~~~~--------- 220 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE---T----VEKVSQGLRL--------- 220 (256)
T ss_pred ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---H----HHHHhcCCCC---------
Confidence 1112345678999999998889999999999999999998 888864322110 1 1111111100
Q ss_pred CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 003254 756 SCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLS 791 (836)
Q Consensus 756 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~ 791 (836)
.........+.+++.+||+.+|++||++.+|++.|+
T Consensus 221 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 221 YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 011112356789999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=319.55 Aligned_cols=257 Identities=26% Similarity=0.369 Sum_probs=200.4
Q ss_pred ccccccCeecccCceeEEEEEeec-Cc----EEEEEEecCCCc-hhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeE
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQ----EIAVKRLSKGSG-QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-g~----~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 590 (836)
++|+..+.||+|+||.||+|+... ++ .+++|.+..... ....++..|+.++++++||||+++++++. ....++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 467788899999999999999743 44 478888754432 34467888999999999999999999885 455789
Q ss_pred EEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccC
Q 003254 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (836)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~ 670 (836)
++||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ ++||||||+|||+++++.+||+|||+++...
T Consensus 86 i~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 86 VTQLSPLGSLLDHVRQH--RDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEeCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 99999999999998542 346899999999999999999999988 9999999999999999999999999998764
Q ss_pred CCccccccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhccCchhhc
Q 003254 671 LDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEERPLELI 749 (836)
Q Consensus 671 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (836)
............++..|+|||.+.++.++.++||||||+++|||++ |+.|+........ ..........
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-------~~~~~~~~~~--- 230 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV-------PDLLEKGERL--- 230 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-------HHHHHCCCcC---
Confidence 3322222333556788999999999999999999999999999998 8888643222110 0111111100
Q ss_pred cccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCCC
Q 003254 750 DQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS 795 (836)
Q Consensus 750 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~ 795 (836)
..+......+.+++.+|++.+|++|||+.|+++.|..+..
T Consensus 231 ------~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 231 ------AQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred ------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 0011122356789999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=297.59 Aligned_cols=267 Identities=21% Similarity=0.236 Sum_probs=212.0
Q ss_pred hhcccccccCeecccCceeEEEEEe-ecCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCe-----
Q 003254 514 NATDNFSEKNKLGEGGFGPVYKGML-IEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDE----- 587 (836)
Q Consensus 514 ~a~~~f~~~~~lG~G~fG~Vykg~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~----- 587 (836)
...++|.+.++||+|||.-||.++. .++..+|+|++.....+..+..++|++..++++|||+++++++...+..
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 3457899999999999999999984 4588899999987777788999999999999999999999998755443
Q ss_pred eeEEEeecCCCChhHHHhhccCC-CcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcc
Q 003254 588 RMLIYEYLPNKSLDYFIFDTTRS-KLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLA 666 (836)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla 666 (836)
.+|+++|...|+|.+.+...... ..+++.++++|+.+|++||++||+.. ++++||||||.|||+.+.+.++|.|||.+
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCc
Confidence 89999999999999998765443 47999999999999999999999987 47999999999999999999999999998
Q ss_pred cccCCCcccc-------ccccccccccccCccccc---CCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhh
Q 003254 667 RSFGLDQTEA-------NTKRVVGTYGYMSPEYAI---DGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHA 736 (836)
Q Consensus 667 ~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~---~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~ 736 (836)
....-..... .......|..|+|||.+. +...++++|||||||+||+|+.|..||+...........
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaL--- 253 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLAL--- 253 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEE---
Confidence 7653211110 011235688999999985 456899999999999999999999998754442221111
Q ss_pred HHhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 003254 737 WRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 794 (836)
Q Consensus 737 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 794 (836)
.+......-.-.....+.+.+++.+|++.||.+||++.+++..++.+.
T Consensus 254 ----------Av~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 254 ----------AVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred ----------eeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 111111111111124456889999999999999999999999987653
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=343.12 Aligned_cols=252 Identities=17% Similarity=0.196 Sum_probs=202.5
Q ss_pred cccccCeecccCceeEEEEEeec--CcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEeec
Q 003254 518 NFSEKNKLGEGGFGPVYKGMLIE--GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (836)
Q Consensus 518 ~f~~~~~lG~G~fG~Vykg~~~~--g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 595 (836)
.|...+.||+|+||.||++.... ++.||+|.+..........+++|+.+++.++||||+++++++...+..+|||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 48888999999999999998643 5678888876555555667889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhc-cCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcc
Q 003254 596 PNKSLDYFIFDT-TRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (836)
Q Consensus 596 ~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~ 674 (836)
++|+|.+++... ....++++.++..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+.....
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999988643 23456889999999999999999999988 99999999999999999999999999987643322
Q ss_pred ccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhcccccc
Q 003254 675 EANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLD 754 (836)
Q Consensus 675 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 754 (836)
........||+.|+|||++.+..++.++|||||||++|||++|+.|+...... .. ..........
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~---~~----~~~~~~~~~~-------- 289 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR---EI----MQQVLYGKYD-------- 289 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH---HH----HHHHHhCCCC--------
Confidence 22234467999999999999999999999999999999999999997432110 00 0111111000
Q ss_pred CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 755 NSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 755 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
..+......+.+++.+||+.+|++||++.+++.
T Consensus 290 -~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 290 -PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred -CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 011122345789999999999999999999864
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=303.40 Aligned_cols=262 Identities=24% Similarity=0.311 Sum_probs=200.0
Q ss_pred hcccccccCeecccCceeEEEEEeec-CcEEEEEEecCCCch--hHHHHHHHHHHHHhhcCCceeeEEeEEee--CCeee
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQ--GMEEFKNEVLLIAKLQHRNLVKLLGCCTQ--RDERM 589 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~ 589 (836)
..++|+.++.|++|.||.||+|+.+. ++.||+|+++...+. -.-.-.+||.+|.+++|||||.+-.+..- -+..|
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy 153 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIY 153 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence 34678889999999999999999865 788999999755321 12235789999999999999999888754 45699
Q ss_pred EEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCccccc
Q 003254 590 LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (836)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~ 669 (836)
||||||++ +|..++... .+++...++..++.|+++|++|||.+. |+|||||++|+|+++.|.+||+|||+|+.+
T Consensus 154 ~VMe~~Eh-DLksl~d~m--~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 154 IVMEYVEH-DLKSLMETM--KQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREY 227 (419)
T ss_pred eeHHHHHh-hHHHHHHhc--cCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhh
Confidence 99999988 788888543 367899999999999999999999998 999999999999999999999999999998
Q ss_pred CCCccccccccccccccccCcccccCC-ccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhh
Q 003254 670 GLDQTEANTKRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLEL 748 (836)
Q Consensus 670 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (836)
+.... .....+-|..|+|||.+.+. .|+.+.|+||+|||+.||+++++.|......++.+. ..+.+ +.+.+.
T Consensus 228 gsp~k--~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~---If~ll--GtPte~ 300 (419)
T KOG0663|consen 228 GSPLK--PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDK---IFKLL--GTPSEA 300 (419)
T ss_pred cCCcc--cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHH---HHHHh--CCCccc
Confidence 75532 23346789999999999876 599999999999999999999987654332222111 11111 111111
Q ss_pred cccc-------------------ccCCCChH-HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 749 IDQS-------------------LDNSCSFS-EALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 749 ~d~~-------------------l~~~~~~~-~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
+.+. ++..+... ....-.+|....+..||.+|-|++|.++.
T Consensus 301 iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 301 IWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred cCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 1111 11111111 22445688889999999999999998753
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=320.46 Aligned_cols=260 Identities=28% Similarity=0.405 Sum_probs=205.4
Q ss_pred hcccccccCeecccCceeEEEEEeec------CcEEEEEEecCCC-chhHHHHHHHHHHHHhh-cCCceeeEEeEEeeCC
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLIE------GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRD 586 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~~------g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~ 586 (836)
..++|+..+.||+|+||.||++.... ...+|+|.+.... .....++.+|+.++.++ +|+||+++++++...+
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 44678888999999999999998743 3579999987542 33456788999999999 7999999999999999
Q ss_pred eeeEEEeecCCCChhHHHhhc-------------cCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEec
Q 003254 587 ERMLIYEYLPNKSLDYFIFDT-------------TRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD 653 (836)
Q Consensus 587 ~~~lV~Ey~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~ 653 (836)
..++||||+++|+|..++... .....+++..++.++.|++.||+|||+.+ |+||||||+||+++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEc
Confidence 999999999999999998542 22356889999999999999999999988 99999999999999
Q ss_pred CCCCceeeccCcccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccch
Q 003254 654 NTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNL 732 (836)
Q Consensus 654 ~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~ 732 (836)
+++.+||+|||+++.+.............++..|+|||.+.+..++.++|||||||++|||++ |..|+......
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~----- 241 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE----- 241 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH-----
Confidence 999999999999987643322222222345678999999998999999999999999999998 87775422111
Q ss_pred hhhhHHhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 003254 733 LGHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 793 (836)
Q Consensus 733 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 793 (836)
.......... ....+......+.+++.+|++.+|++|||+.|+++.|+.+
T Consensus 242 --~~~~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 242 --ELFKLLKEGY---------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred --HHHHHHHcCC---------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 0111111110 0011223345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=314.52 Aligned_cols=256 Identities=25% Similarity=0.391 Sum_probs=200.2
Q ss_pred ccccCeecccCceeEEEEEeec----CcEEEEEEecCCC--chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCe-----
Q 003254 519 FSEKNKLGEGGFGPVYKGMLIE----GQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDE----- 587 (836)
Q Consensus 519 f~~~~~lG~G~fG~Vykg~~~~----g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~----- 587 (836)
|.+.+.||+|+||.||+|++.. +..||+|+++... ....+++.+|+..++.++|+||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4567889999999999999753 3679999987542 3345688999999999999999999999876554
Q ss_pred -eeEEEeecCCCChhHHHhhcc---CCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeecc
Q 003254 588 -RMLIYEYLPNKSLDYFIFDTT---RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDF 663 (836)
Q Consensus 588 -~~lV~Ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DF 663 (836)
.++|+||+++++|..++.... ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 789999999999999886532 2246889999999999999999999988 999999999999999999999999
Q ss_pred CcccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhc
Q 003254 664 GLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIE 742 (836)
Q Consensus 664 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 742 (836)
|+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |..|+...... .. ......
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~---~~----~~~~~~ 230 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH---EI----YDYLRH 230 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH---HH----HHHHHc
Confidence 99987643322222222345678999999988899999999999999999999 77776432111 11 111111
Q ss_pred cCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 003254 743 ERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 793 (836)
Q Consensus 743 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 793 (836)
.... ..+......+.+++.+|++.+|++|||+.||++.|+++
T Consensus 231 ~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 231 GNRL---------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCCC---------CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1111 11122345688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=326.20 Aligned_cols=199 Identities=26% Similarity=0.367 Sum_probs=173.7
Q ss_pred cccccccCeecccCceeEEEEEeec-CcEEEEEEecCCC-chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEe
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 593 (836)
.++|+..++||+|+||.||++.... +..+|+|.+.... ....+.+.+|++++++++|+||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 4789999999999999999999864 7889999886543 3345678999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCc
Q 003254 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (836)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~ 673 (836)
|+++++|.+++.. ...+++..+..++.++++||.|||+.. .|+|+||||+|||+++++.+||+|||++..+...
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~- 157 (333)
T cd06650 84 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (333)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-
Confidence 9999999999853 345888999999999999999999752 3999999999999999999999999998765321
Q ss_pred cccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCC
Q 003254 674 TEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGF 723 (836)
Q Consensus 674 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~ 723 (836)
......|+..|+|||.+.+..++.++|||||||++|||++|+.|+..
T Consensus 158 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred ---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 12235689999999999988999999999999999999999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=317.20 Aligned_cols=259 Identities=29% Similarity=0.445 Sum_probs=202.3
Q ss_pred hcccccccCeecccCceeEEEEEeec------CcEEEEEEecCCC-chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCe
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLIE------GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDE 587 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~~------g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 587 (836)
..++|...+.||+|++|.||+|.+.+ +..||+|.+.... ......|.+|+.++++++|+||+++++++.+...
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 45678889999999999999999864 4678999886543 3345678999999999999999999999999999
Q ss_pred eeEEEeecCCCChhHHHhhccC----CCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCC---Ccee
Q 003254 588 RMLIYEYLPNKSLDYFIFDTTR----SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTM---NPKI 660 (836)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~---~~kl 660 (836)
.++||||+++++|.+++..... ...+++..+.+++.||+.||+|||+.+ ++|+||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence 9999999999999999865421 235889999999999999999999998 99999999999998654 5999
Q ss_pred eccCcccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHh
Q 003254 661 SDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRL 739 (836)
Q Consensus 661 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 739 (836)
+|||+++.+..............+..|+|||++.+..++.++|||||||++|||++ |+.||....... . ...
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~---~----~~~ 233 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE---V----MEF 233 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---H----HHH
Confidence 99999987632222111122234568999999999999999999999999999997 888865322111 1 111
Q ss_pred hhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcC
Q 003254 740 WIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 792 (836)
Q Consensus 740 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~ 792 (836)
..... ....+......+.+++.+|++.+|++||++.+|++.|+.
T Consensus 234 ~~~~~---------~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 234 VTGGG---------RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred HHcCC---------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 11110 011112223567899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=320.24 Aligned_cols=258 Identities=28% Similarity=0.419 Sum_probs=202.6
Q ss_pred cccccCeecccCceeEEEEEeec------CcEEEEEEecCCCc-hhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeE
Q 003254 518 NFSEKNKLGEGGFGPVYKGMLIE------GQEIAVKRLSKGSG-QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (836)
Q Consensus 518 ~f~~~~~lG~G~fG~Vykg~~~~------g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 590 (836)
+|...+.||+|+||.||+|+... ...+++|.+..... ...+++.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 46778899999999999998632 35689998865533 345678999999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhcc---------------------CCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCc
Q 003254 591 IYEYLPNKSLDYFIFDTT---------------------RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASN 649 (836)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~N 649 (836)
|+||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999885421 1235888999999999999999999988 9999999999
Q ss_pred eEecCCCCceeeccCcccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCcc
Q 003254 650 VLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADH 728 (836)
Q Consensus 650 ILl~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~ 728 (836)
||+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||++++||++ |+.|+......
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~- 236 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE- 236 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH-
Confidence 9999999999999999986543322222222345678999999988889999999999999999998 88886432111
Q ss_pred ccchhhhhHHhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 003254 729 DHNLLGHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 794 (836)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 794 (836)
..+...... .....+......+.+++.+|++.+|++||++.|+++.|+++.
T Consensus 237 ------~~~~~~~~~---------~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 237 ------RLFNLLKTG---------YRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred ------HHHHHHhCC---------CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence 111111111 011111222346789999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=319.87 Aligned_cols=257 Identities=29% Similarity=0.433 Sum_probs=202.0
Q ss_pred ccccccCeecccCceeEEEEEeec------CcEEEEEEecCCCc-hhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeee
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE------GQEIAVKRLSKGSG-QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERM 589 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~------g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 589 (836)
.+|...++||+|+||.||+|...+ ++.||+|+++.... ...+.+.+|+.++..++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 346677899999999999998643 47899999975543 23467889999999999999999999999999999
Q ss_pred EEEeecCCCChhHHHhhcc-------------CCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCC
Q 003254 590 LIYEYLPNKSLDYFIFDTT-------------RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTM 656 (836)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~ 656 (836)
+++||+++++|.+++.... ....+++..+..++.|++.||+|||+.+ |+||||||+||++++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCC
Confidence 9999999999999985321 1235788889999999999999999988 99999999999999999
Q ss_pred CceeeccCcccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhh
Q 003254 657 NPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGH 735 (836)
Q Consensus 657 ~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~ 735 (836)
.+||+|||+++...............+++.|+|||.+.++.++.++||||||+++|||++ |..|+...... .
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-------~ 234 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ-------D 234 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH-------H
Confidence 999999999887643322222233456789999999998899999999999999999998 77665421111 1
Q ss_pred hHHhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcC
Q 003254 736 AWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 792 (836)
Q Consensus 736 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~ 792 (836)
.......... ...+......+.+++..|++.+|++||++.||++.|+.
T Consensus 235 ~~~~i~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 235 VIEMIRNRQV---------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHHHcCCc---------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 1111111111 01122334557899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=313.18 Aligned_cols=260 Identities=22% Similarity=0.346 Sum_probs=206.8
Q ss_pred ccccccCeecccCceeEEEEEee-cCcEEEEEEecCC---CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEE
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 592 (836)
++|++.+.||+|+||.||+|+.. +++.||||.+... .......+.+|+.+++.++||||+++++++...+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57888999999999999999975 5899999987542 2334457889999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcc-CCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCC
Q 003254 593 EYLPNKSLDYFIFDTT-RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (836)
Q Consensus 593 Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~ 671 (836)
||+++++|..++.... ....++...+..++.|+++||+|||+.+ ++|+||||+||+++.++.++|+|||++..+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999998885432 2345788999999999999999999988 99999999999999999999999999887643
Q ss_pred CccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccc
Q 003254 672 DQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQ 751 (836)
Q Consensus 672 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 751 (836)
... ......++..|+|||.+.+..++.++||||||+++|||++|+.|+...... ..... ........
T Consensus 159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~----~~~~~-~~~~~~~~------ 225 (267)
T cd08228 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LFSLC-QKIEQCDY------ 225 (267)
T ss_pred hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc----HHHHH-HHHhcCCC------
Confidence 221 112346788999999999888999999999999999999999996432211 00100 01000000
Q ss_pred cccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 003254 752 SLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 794 (836)
Q Consensus 752 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 794 (836)
...........+.+++.+||+.+|++||++.||++.|++++
T Consensus 226 --~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 226 --PPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred --CCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 00111223356789999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=323.12 Aligned_cols=241 Identities=24% Similarity=0.326 Sum_probs=193.5
Q ss_pred CeecccCceeEEEEEee-cCcEEEEEEecCC---CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEeecCCC
Q 003254 523 NKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNK 598 (836)
Q Consensus 523 ~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 598 (836)
+.||+|+||.||+++.. +|+.||+|++... .......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999975 4899999998754 2234556788999999999999999999999999999999999999
Q ss_pred ChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcccccc
Q 003254 599 SLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANT 678 (836)
Q Consensus 599 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~ 678 (836)
+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~ 152 (323)
T cd05595 81 ELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATM 152 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Ccc
Confidence 99888743 346899999999999999999999998 9999999999999999999999999987532211 122
Q ss_pred ccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccccccCCCC
Q 003254 679 KRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDNSCS 758 (836)
Q Consensus 679 ~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 758 (836)
....|++.|+|||++.++.++.++|||||||++|||++|+.|+...... .. ......... ..+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~---~~----~~~~~~~~~----------~~p 215 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---RL----FELILMEEI----------RFP 215 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH---HH----HHHHhcCCC----------CCC
Confidence 3357899999999999999999999999999999999999997532211 00 011110000 011
Q ss_pred hHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 003254 759 FSEALRCIQVGLLCVQQRPEDRP-----NMSSVVL 788 (836)
Q Consensus 759 ~~~~~~l~~li~~Cl~~dP~~RP-----t~~eVl~ 788 (836)
......+.+++.+||+.+|++|| ++.++++
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 216 RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 12234567999999999999998 8888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=317.37 Aligned_cols=257 Identities=26% Similarity=0.409 Sum_probs=203.5
Q ss_pred ccccccCeecccCceeEEEEEee------cCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeE
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLI------EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~------~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 590 (836)
++|...++||+|+||.||++... ++..+++|.+........+.+.+|+++++.++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 46677889999999999999742 256799999877666667889999999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhccC------------CCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCc
Q 003254 591 IYEYLPNKSLDYFIFDTTR------------SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNP 658 (836)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~ 658 (836)
||||+++++|.+++..... ...+++..+..++.||+.||+|||+.+ ++|+||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999999864321 135889999999999999999999988 9999999999999999999
Q ss_pred eeeccCcccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhH
Q 003254 659 KISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAW 737 (836)
Q Consensus 659 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~ 737 (836)
||+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |+.|+....... . .
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~----~ 234 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE---A----I 234 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH---H----H
Confidence 9999999986543222122222345778999999999999999999999999999998 888764221110 0 0
Q ss_pred HhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcC
Q 003254 738 RLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 792 (836)
Q Consensus 738 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~ 792 (836)
......... ..+......+.+++.+||+.+|++||++.||++.|+.
T Consensus 235 ~~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 235 ECITQGREL---------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HHHHcCccC---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 111111110 1111223457799999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=325.34 Aligned_cols=252 Identities=23% Similarity=0.303 Sum_probs=198.7
Q ss_pred ccccccCeecccCceeEEEEEee-cCcEEEEEEecCCC---chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEE
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 592 (836)
++|+..+.||+|+||.||+++.. +|+.||+|+++... ....+.+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46888999999999999999976 48899999987542 234567889999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCC
Q 003254 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (836)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~ 672 (836)
||+++|+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 999999999998543 246899999999999999999999998 999999999999999999999999999876432
Q ss_pred ccccccccccccccccCccccc------CCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCch
Q 003254 673 QTEANTKRVVGTYGYMSPEYAI------DGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPL 746 (836)
Q Consensus 673 ~~~~~~~~~~gt~~y~aPE~~~------~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (836)
... ......||+.|+|||++. ...++.++|||||||++|||++|+.||....... .........
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~-------~~~~i~~~~-- 225 (330)
T cd05601 156 KMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK-------TYNNIMNFQ-- 225 (330)
T ss_pred Cce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH-------HHHHHHcCC--
Confidence 221 222357899999999986 4567899999999999999999999975322110 011111100
Q ss_pred hhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 747 ELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 747 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
. .+.-.........+.+++..|++ +|++|||+.++++
T Consensus 226 ~----~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 226 R----FLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred C----ccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 0 00000111123456788899997 9999999999985
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=328.65 Aligned_cols=248 Identities=25% Similarity=0.362 Sum_probs=192.7
Q ss_pred ccccccCeecccCceeEEEEEee-cCcEEEEEEecCCCc-hhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEee
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSG-QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 594 (836)
++|+..++||+|+||.||+++.. +++.||||++..... ...+.+.+|+++++.++|+||+++++++...+..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 45666789999999999999975 489999999865433 3456789999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcc
Q 003254 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (836)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~ 674 (836)
+++++|.... ..++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.....
T Consensus 154 ~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~ 223 (353)
T PLN00034 154 MDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD 223 (353)
T ss_pred CCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence 9999985432 3456778899999999999999998 99999999999999999999999999987642211
Q ss_pred ccccccccccccccCcccccC-----CccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhc
Q 003254 675 EANTKRVVGTYGYMSPEYAID-----GLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELI 749 (836)
Q Consensus 675 ~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (836)
......|+..|+|||.+.. ...+.++|||||||++|||++|+.||..........+. .......
T Consensus 224 --~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~----~~~~~~~----- 292 (353)
T PLN00034 224 --PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLM----CAICMSQ----- 292 (353)
T ss_pred --cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHH----HHHhccC-----
Confidence 1233578999999998743 23456899999999999999999998632211110000 0000000
Q ss_pred cccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 750 DQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 750 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
...........+.+++.+||+.+|++|||+.||++.
T Consensus 293 ----~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 293 ----PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred ----CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 001111233457899999999999999999999874
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=317.42 Aligned_cols=268 Identities=29% Similarity=0.429 Sum_probs=202.1
Q ss_pred ccccCeecccCceeEEEEEe-----ecCcEEEEEEecCCCc-hhHHHHHHHHHHHHhhcCCceeeEEeEEeeC--CeeeE
Q 003254 519 FSEKNKLGEGGFGPVYKGML-----IEGQEIAVKRLSKGSG-QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR--DERML 590 (836)
Q Consensus 519 f~~~~~lG~G~fG~Vykg~~-----~~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~l 590 (836)
|...+.||+|+||.||++.. .+++.||+|.+..... ...+.+.+|++++++++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 37788999999999988653 3477899999875532 3456788999999999999999999998654 35789
Q ss_pred EEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccC
Q 003254 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (836)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~ 670 (836)
||||+++++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 86 v~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 86 IMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred EecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccC
Confidence 9999999999999843 34899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCccccc-cccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhc
Q 003254 671 LDQTEAN-TKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELI 749 (836)
Q Consensus 671 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (836)
....... .....++..|+|||.+.+..++.++||||||++++||++|+.|+........ ................+.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQGQMTVVRLIELL 237 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhcccccccchhhhhhhh
Confidence 3322111 1123456679999999988999999999999999999999988643221110 0000000000001111122
Q ss_pred cccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 003254 750 DQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 794 (836)
Q Consensus 750 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 794 (836)
+.......+......+.+++.+|++.+|++|||+++|+++|+.+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 238 ERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 221111222334467889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=324.85 Aligned_cols=242 Identities=24% Similarity=0.330 Sum_probs=194.7
Q ss_pred CeecccCceeEEEEEeec-CcEEEEEEecCC---CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEeecCCC
Q 003254 523 NKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNK 598 (836)
Q Consensus 523 ~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 598 (836)
+.||+|+||.||++.... ++.||+|++... .......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 469999999999999754 889999998754 2334567889999999999999999999999999999999999999
Q ss_pred ChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcccccc
Q 003254 599 SLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANT 678 (836)
Q Consensus 599 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~ 678 (836)
+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++..... ....
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~ 152 (328)
T cd05593 81 ELFFHLSR---ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITD--AATM 152 (328)
T ss_pred CHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCc--cccc
Confidence 99888743 346899999999999999999999998 999999999999999999999999998753221 1122
Q ss_pred ccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccccccCCCC
Q 003254 679 KRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDNSCS 758 (836)
Q Consensus 679 ~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 758 (836)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .. ........ . ..+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~---~~----~~~~~~~~------~----~~p 215 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KL----FELILMED------I----KFP 215 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH---HH----HHHhccCC------c----cCC
Confidence 3457899999999999999999999999999999999999997532211 00 00000000 0 111
Q ss_pred hHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 003254 759 FSEALRCIQVGLLCVQQRPEDRP-----NMSSVVLM 789 (836)
Q Consensus 759 ~~~~~~l~~li~~Cl~~dP~~RP-----t~~eVl~~ 789 (836)
......+.+++.+||+.+|++|| ++.|+++.
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 216 RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 12234577899999999999997 89998864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=324.90 Aligned_cols=248 Identities=24% Similarity=0.330 Sum_probs=210.6
Q ss_pred ccccccCeecccCceeEEEEEeec-CcEEEEEEecCC--CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCe-eeEEE
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDE-RMLIY 592 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~-~~lV~ 592 (836)
++|...++||+|+||.++..+++. ++.+|+|.+... .....+...+|+.++++++|||||.+.+.+.+++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 578889999999999999988764 788999987644 34445578999999999999999999999999988 99999
Q ss_pred eecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCC
Q 003254 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (836)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~ 672 (836)
+|++||++.+.+.... ...++++.+..++.|++.|+.|||++. |+|||||+.||+++.+..|||+|||+|+.+..+
T Consensus 84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 9999999999996543 567899999999999999999999776 999999999999999999999999999998755
Q ss_pred ccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhcccc
Q 003254 673 QTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQS 752 (836)
Q Consensus 673 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 752 (836)
.. .....+||+.||.||.+.+.+|..|+|||||||++|||++-+++|...... .++.+.
T Consensus 160 ~~--~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~-------------------~Li~ki 218 (426)
T KOG0589|consen 160 DS--LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS-------------------ELILKI 218 (426)
T ss_pred hh--hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH-------------------HHHHHH
Confidence 42 234479999999999999999999999999999999999999987543322 111111
Q ss_pred c---cCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 753 L---DNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 753 l---~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
. -...+......+..++..|++.+|+.||++.+++.+
T Consensus 219 ~~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 219 NRGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred hhccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 1 123444556678899999999999999999999876
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=329.12 Aligned_cols=259 Identities=17% Similarity=0.183 Sum_probs=194.2
Q ss_pred cccccccCeecccCceeEEEEEeec-CcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEee
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 594 (836)
..+|++.+.||+|+||.||++.... ++.||+|... .+.+.+|+.++++++||||+++++++......++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 3579999999999999999999754 8899999753 24567899999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcc
Q 003254 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (836)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~ 674 (836)
+. ++|..++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 165 ~~-~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~- 236 (391)
T PHA03212 165 YK-TDLYCYLAA---KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN- 236 (391)
T ss_pred CC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccc-
Confidence 86 677777743 345889999999999999999999998 9999999999999999999999999997542211
Q ss_pred ccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCcccc----chhhhhHHhhhcc------C
Q 003254 675 EANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDH----NLLGHAWRLWIEE------R 744 (836)
Q Consensus 675 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~----~~~~~~~~~~~~~------~ 744 (836)
........||+.|+|||++.+..++.++|||||||+||||++|+.|+-........ ............. .
T Consensus 237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~ 316 (391)
T PHA03212 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID 316 (391)
T ss_pred ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence 11223467999999999999999999999999999999999999875322211100 0000000000000 0
Q ss_pred ----chhhc----cc-cc--cCCCC----hHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 745 ----PLELI----DQ-SL--DNSCS----FSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 745 ----~~~~~----d~-~l--~~~~~----~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
..+.. .. .. ..... ......+.+++.+||+.||++|||+.|+++
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000 00 00 00000 112346789999999999999999999985
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=329.47 Aligned_cols=253 Identities=21% Similarity=0.321 Sum_probs=194.9
Q ss_pred cccccCeecccCceeEEEEEeec-CcEEEEEEecCCC---chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEe
Q 003254 518 NFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (836)
Q Consensus 518 ~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 593 (836)
.|+..+.||+|+||.||+|+... ++.||||++.... ....+.+.+|+.++.+++|+||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 57788999999999999998754 7899999996542 2345678999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCc
Q 003254 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (836)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~ 673 (836)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.+....
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 82 YIPGGDMMSLLIR---MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred cCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 9999999999853 346888899999999999999999988 9999999999999999999999999986432100
Q ss_pred c---------------------------------------------ccccccccccccccCcccccCCccCccccccchh
Q 003254 674 T---------------------------------------------EANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFG 708 (836)
Q Consensus 674 ~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~G 708 (836)
. ........||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 0 0001235799999999999998999999999999
Q ss_pred hhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccccccCCCChHHHHHHHHHHHH--cccCCCCCCCCHHHH
Q 003254 709 VLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLL--CVQQRPEDRPNMSSV 786 (836)
Q Consensus 709 vvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~--Cl~~dP~~RPt~~eV 786 (836)
|++|||++|+.||........ .......... +...........+.+++.+ |+..+|..||++.|+
T Consensus 236 ~il~elltG~~Pf~~~~~~~~------~~~i~~~~~~-------~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~ 302 (381)
T cd05626 236 VILFEMLVGQPPFLAPTPTET------QLKVINWENT-------LHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDI 302 (381)
T ss_pred hHHHHHHhCCCCCcCCCHHHH------HHHHHccccc-------cCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHH
Confidence 999999999999754322110 0000000000 0000001112345567765 666777789999999
Q ss_pred HHH
Q 003254 787 VLM 789 (836)
Q Consensus 787 l~~ 789 (836)
+..
T Consensus 303 l~h 305 (381)
T cd05626 303 KAH 305 (381)
T ss_pred hcC
Confidence 874
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=315.42 Aligned_cols=258 Identities=24% Similarity=0.407 Sum_probs=204.8
Q ss_pred cccccccCeecccCceeEEEEEeec------CcEEEEEEecCCC-chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCee
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLIE------GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDER 588 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~~------g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 588 (836)
.++|.+.+.||+|+||.||+|.... +..||+|.+.... ......+.+|+.+++.++|+||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 3578888999999999999998753 3679999986553 23456788999999999999999999999999999
Q ss_pred eEEEeecCCCChhHHHhhccC-------CCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceee
Q 003254 589 MLIYEYLPNKSLDYFIFDTTR-------SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKIS 661 (836)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~ 661 (836)
++||||+++++|.+++..... ...+++..+..++.||+.||.|||+.+ ++||||||+||++++++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 999999999999999865322 234788999999999999999999988 9999999999999999999999
Q ss_pred ccCcccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhh
Q 003254 662 DFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLW 740 (836)
Q Consensus 662 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 740 (836)
|||+++.+.............++..|+|||.+.++.++.++||||||+++|||++ |+.|+....... .....
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-------~~~~~ 234 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE-------VLKFV 234 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH-------HHHHH
Confidence 9999987643322222223456789999999998889999999999999999998 888764322111 11111
Q ss_pred hccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcC
Q 003254 741 IEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 792 (836)
Q Consensus 741 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~ 792 (836)
...... ..+......+.+++.+||+.+|++|||+.++++.|+.
T Consensus 235 ~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 235 IDGGHL---------DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred hcCCCC---------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 111111 1111224567899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=328.95 Aligned_cols=242 Identities=26% Similarity=0.384 Sum_probs=205.8
Q ss_pred hhcccccccCeecccCceeEEEEEeec-CcEEEEEEecCCC---chhHHHHHHHHHHHHhhc-CCceeeEEeEEeeCCee
Q 003254 514 NATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQRDER 588 (836)
Q Consensus 514 ~a~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~ 588 (836)
...++|...++||+|.||+|+++.++. ++.+|||.+++.. .+..+..+.|..|+.... ||.++.++.++...+++
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 345789999999999999999999876 7889999998873 456778888999988875 99999999999999999
Q ss_pred eEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccc
Q 003254 589 MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (836)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~ 668 (836)
++||||+.+|++..+ .+...+++..+.-++..|+.||+|||+++ ||+||||.+|||||.+|.+||+||||++.
T Consensus 445 ~fvmey~~Ggdm~~~----~~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe 517 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHH----IHTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKE 517 (694)
T ss_pred EEEEEecCCCcEEEE----EecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccc
Confidence 999999999994322 34567999999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhh
Q 003254 669 FGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLEL 748 (836)
Q Consensus 669 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (836)
-.. ....+.+++||+.|||||++.+..|+.++|-|||||+|||||.|..||..+.. .++
T Consensus 518 ~m~--~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE-------------------ee~ 576 (694)
T KOG0694|consen 518 GMG--QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDE-------------------EEV 576 (694)
T ss_pred cCC--CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCH-------------------HHH
Confidence 421 23356679999999999999999999999999999999999999999754322 244
Q ss_pred ccccccC--CCChHHHHHHHHHHHHcccCCCCCCCCH
Q 003254 749 IDQSLDN--SCSFSEALRCIQVGLLCVQQRPEDRPNM 783 (836)
Q Consensus 749 ~d~~l~~--~~~~~~~~~l~~li~~Cl~~dP~~RPt~ 783 (836)
.|.++.. .++.-...+.+.++.+.+..+|++|-.+
T Consensus 577 FdsI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 577 FDSIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HHHHhcCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 4444433 2344455678899999999999999877
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=311.53 Aligned_cols=253 Identities=28% Similarity=0.467 Sum_probs=201.7
Q ss_pred ccccccCeecccCceeEEEEEeecCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEeecC
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLP 596 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 596 (836)
++|++.++||+|+||.||++...++..+|+|.+..... ..+.+.+|+.++++++|+|++++++++. ....++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 56888899999999999999988888999999865433 3467999999999999999999999885 456899999999
Q ss_pred CCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcccc
Q 003254 597 NKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEA 676 (836)
Q Consensus 597 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~~ 676 (836)
+++|.+++... ....+++..+..++.+++.||+|||+.+ ++|+||||+||++++++.++|+|||++..+......
T Consensus 84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~- 158 (260)
T cd05070 84 KGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT- 158 (260)
T ss_pred CCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccc-
Confidence 99999998543 2345889999999999999999999988 999999999999999999999999999875432211
Q ss_pred ccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhccCchhhccccccC
Q 003254 677 NTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDN 755 (836)
Q Consensus 677 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 755 (836)
......++..|+|||.+.+..++.++||||||++++||++ |+.|+...... .. ....... ...
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~---~~----~~~~~~~---------~~~ 222 (260)
T cd05070 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR---EV----LEQVERG---------YRM 222 (260)
T ss_pred cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH---HH----HHHHHcC---------CCC
Confidence 1112345668999999988899999999999999999999 78886432111 11 1111110 011
Q ss_pred CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcC
Q 003254 756 SCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 792 (836)
Q Consensus 756 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~ 792 (836)
..+......+.+++.+|++.+|++|||+.++++.|++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 223 PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1122233568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=316.75 Aligned_cols=261 Identities=25% Similarity=0.392 Sum_probs=206.3
Q ss_pred hcccccccCeecccCceeEEEEEeec-----CcEEEEEEecCCC-chhHHHHHHHHHHHHhhcCCceeeEEeEEee-CCe
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-----GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQ-RDE 587 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~~-----g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~ 587 (836)
..++|+..+.||+|+||.||+|...+ +..|++|++.... ....+.+.+|+.++++++|+||+++++++.. ...
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 34688889999999999999999876 6889999986543 3445678899999999999999999998876 467
Q ss_pred eeEEEeecCCCChhHHHhhccCC-----CcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeec
Q 003254 588 RMLIYEYLPNKSLDYFIFDTTRS-----KLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISD 662 (836)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~D 662 (836)
.++++||+++++|.+++...... ..+++..+..++.+++.||+|||+.+ ++|+||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence 89999999999999998654322 46899999999999999999999988 99999999999999999999999
Q ss_pred cCcccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhh
Q 003254 663 FGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWI 741 (836)
Q Consensus 663 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~ 741 (836)
||+++.+.............++..|+|||.+.+..++.++||||||+++||+++ |+.|+....+. ... ....
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~----~~~~ 233 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF---EMA----AYLK 233 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH---HHH----HHHH
Confidence 999986643322221222345678999999998889999999999999999999 89886532211 111 1111
Q ss_pred ccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 003254 742 EERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 794 (836)
Q Consensus 742 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 794 (836)
.... + .........+.+++.+|++.+|++|||+.+|++.|+.+.
T Consensus 234 ~~~~-------~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 234 DGYR-------L--AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred cCCC-------C--CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 1100 0 011112345789999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=312.02 Aligned_cols=252 Identities=28% Similarity=0.397 Sum_probs=200.3
Q ss_pred ccccccCeecccCceeEEEEEeecCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEeecC
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLP 596 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 596 (836)
.+|+..+.||+|+||.||++....+..+|+|.+.... ....++.+|+.++++++|+||+++++++......++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 3577788999999999999998777789999986443 234578899999999999999999999999999999999999
Q ss_pred CCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcccc
Q 003254 597 NKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEA 676 (836)
Q Consensus 597 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~~ 676 (836)
+++|.+++... ...+++..+..++.||+.||+|||+.+ ++||||||+||++++++.+||+|||+++.........
T Consensus 83 ~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 83 NGCLLNYLRER--KGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred CCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 99999998542 236899999999999999999999998 9999999999999999999999999998654221111
Q ss_pred ccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhccCchhhccccccC
Q 003254 677 NTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDN 755 (836)
Q Consensus 677 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 755 (836)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.|+...... .. ....... ...
T Consensus 158 -~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~----~~~~~~~---------~~~ 220 (256)
T cd05059 158 -SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS---EV----VESVSAG---------YRL 220 (256)
T ss_pred -cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH---HH----HHHHHcC---------CcC
Confidence 111234567999999999999999999999999999999 78776432211 01 1111111 000
Q ss_pred CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 003254 756 SCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLS 791 (836)
Q Consensus 756 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~ 791 (836)
..+......+.+++.+||+.+|++|||+.||++.|.
T Consensus 221 ~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 221 YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 111123456889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=341.56 Aligned_cols=260 Identities=21% Similarity=0.287 Sum_probs=205.7
Q ss_pred HHHhhcccccccCeecccCceeEEEEEee-cCcEEEEEEecCC--CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCC-
Q 003254 511 IIANATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD- 586 (836)
Q Consensus 511 ~l~~a~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~- 586 (836)
+.....++|.+.+.||+|+||.||+++.. +|+.||||++... .......+.+|+.++..++|+|++++...+....
T Consensus 26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~ 105 (496)
T PTZ00283 26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP 105 (496)
T ss_pred cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence 33445679999999999999999999865 5899999998654 3345567889999999999999999988775432
Q ss_pred -------eeeEEEeecCCCChhHHHhhcc-CCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCc
Q 003254 587 -------ERMLIYEYLPNKSLDYFIFDTT-RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNP 658 (836)
Q Consensus 587 -------~~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~ 658 (836)
..++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+
T Consensus 106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~v 182 (496)
T PTZ00283 106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLV 182 (496)
T ss_pred cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCE
Confidence 2679999999999999986532 2356889999999999999999999988 9999999999999999999
Q ss_pred eeeccCcccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHH
Q 003254 659 KISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWR 738 (836)
Q Consensus 659 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~ 738 (836)
||+|||+++.+.............||+.|+|||++.+..++.++|||||||+||||++|+.||...... ....
T Consensus 183 kL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~-------~~~~ 255 (496)
T PTZ00283 183 KLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME-------EVMH 255 (496)
T ss_pred EEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH-------HHHH
Confidence 999999998765433333334467999999999999999999999999999999999999997532111 0111
Q ss_pred hhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 739 LWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 739 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
....... + ..+......+.+++.+||+.+|++||++.+++..
T Consensus 256 ~~~~~~~----~-----~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 256 KTLAGRY----D-----PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HHhcCCC----C-----CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 1111100 0 1112233567899999999999999999999864
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=324.25 Aligned_cols=265 Identities=20% Similarity=0.309 Sum_probs=194.5
Q ss_pred cccccCeecccCceeEEEEEee-cCcEEEEEEecCC--CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCC-----eee
Q 003254 518 NFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD-----ERM 589 (836)
Q Consensus 518 ~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-----~~~ 589 (836)
+|+..++||+|+||.||+|+.. +++.||||++... .......+.+|+.++++++||||+++++++.... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4778899999999999999975 4899999998643 2234457889999999999999999999885432 479
Q ss_pred EEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCccccc
Q 003254 590 LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (836)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~ 669 (836)
+||||+. ++|.+++.. ...+++..+..++.||++||.|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIKA---NDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHHh---cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999996 588887743 346899999999999999999999998 999999999999999999999999999865
Q ss_pred CCCccc-cccccccccccccCcccccC--CccCccccccchhhhhhhhhhCCCCCCCCCCccccchh--------hhhHH
Q 003254 670 GLDQTE-ANTKRVVGTYGYMSPEYAID--GLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLL--------GHAWR 738 (836)
Q Consensus 670 ~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~--------~~~~~ 738 (836)
...... .......|++.|+|||++.+ ..++.++|||||||++|||++|+.||............ .....
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS 233 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 322211 11233578999999999876 67899999999999999999999997543221100000 00000
Q ss_pred hhhccCchhhccccccC-CCC-----hHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 739 LWIEERPLELIDQSLDN-SCS-----FSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 739 ~~~~~~~~~~~d~~l~~-~~~-----~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
........+.+...... ... ......+.+++.+||+.+|++|||++|+++.
T Consensus 234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00000000111100000 000 0112356799999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=319.50 Aligned_cols=240 Identities=27% Similarity=0.367 Sum_probs=188.5
Q ss_pred CeecccCceeEEEEEeec-CcEEEEEEecCCC---chhHHHHHHHHHHHHhh-cCCceeeEEeEEeeCCeeeEEEeecCC
Q 003254 523 NKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDERMLIYEYLPN 597 (836)
Q Consensus 523 ~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 597 (836)
+.||+|+||.||+|+... ++.||+|.++... ....+.+..|..++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 369999999999999865 7889999987532 23344556677777654 899999999999999999999999999
Q ss_pred CChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCccccc
Q 003254 598 KSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEAN 677 (836)
Q Consensus 598 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~ 677 (836)
|+|..++.. ...++...+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~ 152 (316)
T cd05592 81 GDLMFHIQS---SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GK 152 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cc
Confidence 999888843 346889999999999999999999988 9999999999999999999999999998643222 22
Q ss_pred cccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccccccCCC
Q 003254 678 TKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDNSC 757 (836)
Q Consensus 678 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 757 (836)
.....||+.|+|||++.+..++.++|||||||++|||++|+.|+...... .. ........ ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~---~~----~~~i~~~~----------~~~ 215 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED---EL----FDSILNDR----------PHF 215 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH---HH----HHHHHcCC----------CCC
Confidence 23467899999999999999999999999999999999999997532211 01 11111110 011
Q ss_pred ChHHHHHHHHHHHHcccCCCCCCCCHH-HHH
Q 003254 758 SFSEALRCIQVGLLCVQQRPEDRPNMS-SVV 787 (836)
Q Consensus 758 ~~~~~~~l~~li~~Cl~~dP~~RPt~~-eVl 787 (836)
+......+.+++.+||+.+|++||++. +++
T Consensus 216 ~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 216 PRWISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 111234567899999999999999976 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=326.74 Aligned_cols=263 Identities=21% Similarity=0.272 Sum_probs=206.9
Q ss_pred cccccccCeecccCceeEEEEEeec--CcEEEEEEecCC---CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeE
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLIE--GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~~--g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 590 (836)
.++|+..+.||+|+||.||+|+... +..||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3578889999999999999998654 368999998643 22345678899999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccC
Q 003254 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (836)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~ 670 (836)
||||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 109 v~Ey~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRR---NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 9999999999999853 346889999999999999999999998 9999999999999999999999999998653
Q ss_pred CCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhcc
Q 003254 671 LDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELID 750 (836)
Q Consensus 671 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 750 (836)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... . ..........
T Consensus 183 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~---~----~~~~i~~~~~----- 245 (340)
T PTZ00426 183 TR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL---L----IYQKILEGII----- 245 (340)
T ss_pred CC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH---H----HHHHHhcCCC-----
Confidence 21 22357899999999999988999999999999999999999997532211 0 0111111100
Q ss_pred ccccCCCChHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH--hcCC-------CCCCCCCCCCccc
Q 003254 751 QSLDNSCSFSEALRCIQVGLLCVQQRPEDRP-----NMSSVVLM--LSGE-------RSLPQPQQPGFFT 806 (836)
Q Consensus 751 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~eVl~~--L~~~-------~~~~~p~~p~~~~ 806 (836)
..+......+.+++.+|++.+|++|+ +++|+++. ++++ .....|..|.+..
T Consensus 246 -----~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~~~~~~~~~~~~~p~~~~ 310 (340)
T PTZ00426 246 -----YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSLLHKNVEVPYKPKYKN 310 (340)
T ss_pred -----CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCC
Confidence 01111123467899999999999995 89998775 2221 2344566666543
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=313.18 Aligned_cols=255 Identities=26% Similarity=0.408 Sum_probs=196.7
Q ss_pred cccCeecccCceeEEEEEeecC-c--EEEEEEecCC--CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeC------Cee
Q 003254 520 SEKNKLGEGGFGPVYKGMLIEG-Q--EIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR------DER 588 (836)
Q Consensus 520 ~~~~~lG~G~fG~Vykg~~~~g-~--~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~~~ 588 (836)
.+.+.||+|+||.||+|+..+. . .+|+|.++.. .....+.+..|+.+++.++|+||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 4567899999999999998653 2 5899988654 334467889999999999999999999987532 246
Q ss_pred eEEEeecCCCChhHHHhhcc---CCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCc
Q 003254 589 MLIYEYLPNKSLDYFIFDTT---RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGL 665 (836)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgl 665 (836)
++||||+++|+|..++.... ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCc
Confidence 89999999999998875322 2345889999999999999999999988 99999999999999999999999999
Q ss_pred ccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhccC
Q 003254 666 ARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEER 744 (836)
Q Consensus 666 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 744 (836)
++.+.............+++.|+|||.+.+..++.++||||||+++|||++ |+.|+...... ..........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-------~~~~~~~~~~ 231 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS-------EIYDYLRQGN 231 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHHHHcCC
Confidence 987643322111222345678999999999999999999999999999999 77776432111 1111111111
Q ss_pred chhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 003254 745 PLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 793 (836)
Q Consensus 745 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 793 (836)
.. .........+.+++.+||+.+|++|||+.+|++.|+.+
T Consensus 232 ~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 232 RL---------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 10 01112234578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=325.68 Aligned_cols=253 Identities=28% Similarity=0.426 Sum_probs=210.3
Q ss_pred cccccCeecccCceeEEEEEeec-CcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEeecC
Q 003254 518 NFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLP 596 (836)
Q Consensus 518 ~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 596 (836)
+....++||.|.||.||.|.++. .-.||||.++.. ....++|+.|..+|+.++|||+|+|+|+|..+...|||.|||.
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~ 346 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMC 346 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEeccc
Confidence 44567899999999999999977 778999999654 4668999999999999999999999999999999999999999
Q ss_pred CCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcccc
Q 003254 597 NKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEA 676 (836)
Q Consensus 597 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~~ 676 (836)
+|+|.++|.+..+ ..++-...+.++.||+.||.||..+. +|||||.++|+|+.++..+||+|||+++++..+....
T Consensus 347 yGNLLdYLRecnr-~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTA 422 (1157)
T KOG4278|consen 347 YGNLLDYLRECNR-SEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTA 422 (1157)
T ss_pred CccHHHHHHHhch-hhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCceec
Confidence 9999999977654 45677788899999999999999988 9999999999999999999999999999985433222
Q ss_pred ccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhccCchhhccccccC
Q 003254 677 NTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDN 755 (836)
Q Consensus 677 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 755 (836)
.....-++.|.|||-+....++.|+|||+|||+||||.| |-.|+.. .++ . .+.++++...+.
T Consensus 423 -HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPG------idl-S---------qVY~LLEkgyRM 485 (1157)
T KOG4278|consen 423 -HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPG------IDL-S---------QVYGLLEKGYRM 485 (1157)
T ss_pred -ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCC------ccH-H---------HHHHHHhccccc
Confidence 222334678999999999999999999999999999998 4444211 111 1 122444444444
Q ss_pred CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcC
Q 003254 756 SCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 792 (836)
Q Consensus 756 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~ 792 (836)
.-+..+...+.+|++.||+..|.+||++.|+-+.+|.
T Consensus 486 ~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEt 522 (1157)
T KOG4278|consen 486 DGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFET 522 (1157)
T ss_pred cCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHH
Confidence 5566677788999999999999999999999888864
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=320.18 Aligned_cols=264 Identities=28% Similarity=0.401 Sum_probs=206.7
Q ss_pred hcccccccCeecccCceeEEEEEee--------cCcEEEEEEecCCC-chhHHHHHHHHHHHHhh-cCCceeeEEeEEee
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLI--------EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQ 584 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~--------~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~ 584 (836)
..++|.+.+.||+|+||.||+++.. ++..||+|.+.... ....+++.+|+.+++.+ +||||+++++++..
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 3467888899999999999999742 24579999986543 34457789999999999 89999999999999
Q ss_pred CCeeeEEEeecCCCChhHHHhhccC-------------CCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceE
Q 003254 585 RDERMLIYEYLPNKSLDYFIFDTTR-------------SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVL 651 (836)
Q Consensus 585 ~~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NIL 651 (836)
....++||||+++++|.+++..... ...+++..+..++.||++||+|||+.+ ++||||||+||+
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nil 169 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVL 169 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEE
Confidence 9999999999999999999865321 235788899999999999999999998 999999999999
Q ss_pred ecCCCCceeeccCcccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCcccc
Q 003254 652 LDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDH 730 (836)
Q Consensus 652 l~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~ 730 (836)
+++++.+||+|||+++.+.............+++.|+|||.+.+..++.++||||||+++|||++ |..|+.....
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---- 245 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV---- 245 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH----
Confidence 99999999999999987643332222223445678999999998889999999999999999998 6666532111
Q ss_pred chhhhhHHhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCCCCC
Q 003254 731 NLLGHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLP 797 (836)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~~~ 797 (836)
............. ..+......+.+++.+||+.+|++||++.||++.|+++....
T Consensus 246 ---~~~~~~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~ 300 (304)
T cd05101 246 ---EELFKLLKEGHRM---------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT 300 (304)
T ss_pred ---HHHHHHHHcCCcC---------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhh
Confidence 1111111111110 111223356778999999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=317.30 Aligned_cols=261 Identities=24% Similarity=0.363 Sum_probs=192.8
Q ss_pred ccccccCeecccCceeEEEEEee--cCcEEEEEEecCCC--chhHHHHHHHHHHHHhh---cCCceeeEEeEEee-----
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLI--EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKL---QHRNLVKLLGCCTQ----- 584 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~--~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~~----- 584 (836)
++|+..+.||+|+||.||+++.. +++.||+|+++... ......+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 46888899999999999999873 36789999986542 22334566788777766 69999999999852
Q ss_pred CCeeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccC
Q 003254 585 RDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFG 664 (836)
Q Consensus 585 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFg 664 (836)
....++||||++ ++|.+++... ....+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence 345899999997 5888887543 2345889999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccC
Q 003254 665 LARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEER 744 (836)
Q Consensus 665 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 744 (836)
+++..... .......|++.|+|||.+.+..++.++|||||||++|||++|++||......+. ............
T Consensus 156 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~---~~~i~~~~~~~~ 229 (290)
T cd07862 156 LARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ---LGKILDVIGLPG 229 (290)
T ss_pred ceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHH---HHHHHHHhCCCC
Confidence 99865432 222345689999999999988999999999999999999999999764332111 111100000000
Q ss_pred ----chh--hcccccc--CCCC-----hHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 745 ----PLE--LIDQSLD--NSCS-----FSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 745 ----~~~--~~d~~l~--~~~~-----~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
+.+ .....+. .... ......+.+++.+|++.+|++|||+.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 230 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 000 0000000 0000 112234679999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=328.85 Aligned_cols=253 Identities=24% Similarity=0.347 Sum_probs=202.2
Q ss_pred ccccccCeecccCceeEEEEEee-cCcEEEEEEecCCC---chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEE
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 592 (836)
++|.+.+.||+|+||.||+++.. +++.||||++.... ....+.+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46888999999999999999986 48999999987542 234567899999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCC
Q 003254 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (836)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~ 672 (836)
||+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 999999999998543 56899999999999999999999988 999999999999999999999999999876433
Q ss_pred c---------------------------cccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCC
Q 003254 673 Q---------------------------TEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (836)
Q Consensus 673 ~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~ 725 (836)
. .........||+.|+|||.+.+..++.++|||||||+||||++|+.|+....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 2 0011233568999999999999999999999999999999999999975432
Q ss_pred CccccchhhhhHHhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCC-HHHHHHH
Q 003254 726 ADHDHNLLGHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPN-MSSVVLM 789 (836)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-~~eVl~~ 789 (836)
... ......... ..+...........+.+++..|++ +|++||+ +.|+++.
T Consensus 235 ~~~-------~~~~i~~~~------~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 235 LQE-------TYNKIINWK------ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHH-------HHHHHhccC------CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 110 111111100 000000011123457789999997 9999999 9999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=314.70 Aligned_cols=265 Identities=28% Similarity=0.400 Sum_probs=204.3
Q ss_pred cccccccCeecccCceeEEEEEeec-----------------CcEEEEEEecCCC-chhHHHHHHHHHHHHhhcCCceee
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLIE-----------------GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVK 577 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~~-----------------g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~ 577 (836)
.++|+..+.||+|+||.||+++..+ +..||+|.+.... ....+++.+|+.++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3578889999999999999988653 2458999987653 345678899999999999999999
Q ss_pred EEeEEeeCCeeeEEEeecCCCChhHHHhhcc--------CCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCc
Q 003254 578 LLGCCTQRDERMLIYEYLPNKSLDYFIFDTT--------RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASN 649 (836)
Q Consensus 578 l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~N 649 (836)
+++++......++|+||+++++|..++.... ....+++..++.++.|++.||+|||+.+ ++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 9999999999999999999999999986533 1236899999999999999999999988 9999999999
Q ss_pred eEecCCCCceeeccCcccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhh--CCCCCCCCCCc
Q 003254 650 VLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC--GKKNRGFNHAD 727 (836)
Q Consensus 650 ILl~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt--G~~p~~~~~~~ 727 (836)
|++++++.++|+|||+++...............++..|+|||.+.++.++.++||||||+++|||++ +..|+.....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~- 239 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD- 239 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh-
Confidence 9999999999999999986543322222233456788999999998899999999999999999998 4555432111
Q ss_pred cccchhhhhHHhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcC
Q 003254 728 HDHNLLGHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 792 (836)
Q Consensus 728 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~ 792 (836)
..........+......... ........++.+++.+|++.+|++|||+.||++.|+.
T Consensus 240 --~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 240 --QQVIENAGHFFRDDGRQIYL------PRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred --HHHHHHHHhccccccccccC------CCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 11111111111111100000 1111223568899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=314.51 Aligned_cols=260 Identities=27% Similarity=0.405 Sum_probs=203.2
Q ss_pred ccccccCeecccCceeEEEEEee-cCc----EEEEEEecCCC-chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeE
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQ----EIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~-~g~----~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 590 (836)
++|+..++||+|+||.||+|+.. +++ .||+|.+.... ....+++.+|+.++..++|+||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence 56788899999999999999864 344 48999986543 3445678999999999999999999999975 45789
Q ss_pred EEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccC
Q 003254 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (836)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~ 670 (836)
++||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 86 ~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 86 VTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred EEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeecc
Confidence 99999999999988542 346899999999999999999999988 9999999999999999999999999998764
Q ss_pred CCccccccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhccCchhhc
Q 003254 671 LDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEERPLELI 749 (836)
Q Consensus 671 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (836)
............++..|+|||.+.+..++.++||||||+++|||++ |..|+....... +. ........
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~----~~~~~~~~---- 229 (279)
T cd05109 161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE---IP----DLLEKGER---- 229 (279)
T ss_pred cccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HH----HHHHCCCc----
Confidence 3322211222344678999999999999999999999999999998 888864322111 10 00111100
Q ss_pred cccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCCCCCC
Q 003254 750 DQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQ 798 (836)
Q Consensus 750 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~~~~ 798 (836)
..........+.+++..||+.+|++||++.++++.|+.....+.
T Consensus 230 -----~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~~ 273 (279)
T cd05109 230 -----LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDPS 273 (279)
T ss_pred -----CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCCc
Confidence 01111223457899999999999999999999999988766553
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=317.35 Aligned_cols=263 Identities=24% Similarity=0.320 Sum_probs=195.8
Q ss_pred cccccccCeecccCceeEEEEEee-cCcEEEEEEecCCCc-hhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEe
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSG-QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 593 (836)
.++|+..+.||+|+||.||+|+.. +++.||||++..... .....+.+|+.+++.++||||+++++++......++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999986 488999999875432 233467889999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCc
Q 003254 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (836)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~ 673 (836)
|++ ++|.+++.. ....++...+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||++.......
T Consensus 84 ~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 84 YVH-TDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred CCC-cCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 996 567666643 2345888999999999999999999998 9999999999999999999999999987543221
Q ss_pred cccccccccccccccCcccccC-CccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCch------
Q 003254 674 TEANTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPL------ 746 (836)
Q Consensus 674 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------ 746 (836)
.......+++.|+|||++.+ ..++.++||||+||++|||++|+.||....... ................
T Consensus 158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 233 (303)
T cd07869 158 --HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ--DQLERIFLVLGTPNEDTWPGVH 233 (303)
T ss_pred --ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHHhCCCChhhccchh
Confidence 12223567899999999875 458899999999999999999999986432110 0000000000000000
Q ss_pred --hhccc-ccc--CCCCh-------HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 747 --ELIDQ-SLD--NSCSF-------SEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 747 --~~~d~-~l~--~~~~~-------~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
...++ ... ..... .....+.+++.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 00000 000 00000 01235678999999999999999999975
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=315.13 Aligned_cols=264 Identities=25% Similarity=0.369 Sum_probs=199.8
Q ss_pred ccccccCeecccCceeEEEEEeec---------------CcEEEEEEecCCC-chhHHHHHHHHHHHHhhcCCceeeEEe
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE---------------GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLG 580 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~---------------g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g 580 (836)
++|++.+.||+|+||.||++...+ ...||+|.++... ....+.|.+|++++++++|+|++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 578888999999999999987643 1248999987542 334567999999999999999999999
Q ss_pred EEeeCCeeeEEEeecCCCChhHHHhhccC---------CCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceE
Q 003254 581 CCTQRDERMLIYEYLPNKSLDYFIFDTTR---------SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVL 651 (836)
Q Consensus 581 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~---------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NIL 651 (836)
++......++||||+++++|.+++..... ...+++..++.++.|++.||+|||+.+ ++|+||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence 99999999999999999999998854321 124688899999999999999999998 999999999999
Q ss_pred ecCCCCceeeccCcccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhC--CCCCCCCCCccc
Q 003254 652 LDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICG--KKNRGFNHADHD 729 (836)
Q Consensus 652 l~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG--~~p~~~~~~~~~ 729 (836)
+++++.+||+|||++..+.............++..|+|||.+.++.++.++||||||++++||+++ ..|+......
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~-- 239 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE-- 239 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH--
Confidence 999999999999999865432222222223457789999999988999999999999999999984 4444321111
Q ss_pred cchhhhhHHhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcC
Q 003254 730 HNLLGHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 792 (836)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~ 792 (836)
.........+..... . .....+......+.+++.+|++.+|++||+|.+|++.|++
T Consensus 240 -~~~~~~~~~~~~~~~-~-----~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 240 -QVIENTGEFFRNQGR-Q-----IYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred -HHHHHHHHhhhhccc-c-----ccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 111111111110000 0 0000111123468899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=330.34 Aligned_cols=259 Identities=26% Similarity=0.377 Sum_probs=202.0
Q ss_pred ccccccCeecccCceeEEEEEee------cCcEEEEEEecCCCc-hhHHHHHHHHHHHHhhc-CCceeeEEeEEeeCCee
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLI------EGQEIAVKRLSKGSG-QGMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQRDER 588 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~------~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~ 588 (836)
++|...++||+|+||.||+|++. .++.||||++..... ...+.+.+|+.++.++. ||||+++++++......
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~ 116 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI 116 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence 46777889999999999999863 246799999976532 33457889999999997 99999999999999999
Q ss_pred eEEEeecCCCChhHHHhhccC-----------------------------------------------------------
Q 003254 589 MLIYEYLPNKSLDYFIFDTTR----------------------------------------------------------- 609 (836)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~----------------------------------------------------------- 609 (836)
++|+||+++|+|.++++....
T Consensus 117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (401)
T cd05107 117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK 196 (401)
T ss_pred EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence 999999999999999864321
Q ss_pred ------------------------------------CCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEec
Q 003254 610 ------------------------------------SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD 653 (836)
Q Consensus 610 ------------------------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~ 653 (836)
...+++..+..++.||+.||+|||+.+ ++||||||+|||++
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl~ 273 (401)
T cd05107 197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLIC 273 (401)
T ss_pred hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEEe
Confidence 124677788999999999999999987 99999999999999
Q ss_pred CCCCceeeccCcccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccch
Q 003254 654 NTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNL 732 (836)
Q Consensus 654 ~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~ 732 (836)
+++.+||+|||+++...............++..|+|||.+.+..++.++||||||++++||++ |+.|+.......
T Consensus 274 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~---- 349 (401)
T cd05107 274 EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE---- 349 (401)
T ss_pred CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH----
Confidence 999999999999986533222122223456788999999998889999999999999999998 787764322110
Q ss_pred hhhhHHhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 003254 733 LGHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 793 (836)
Q Consensus 733 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 793 (836)
.......... ....+......+.+++.+||+.+|++||+++||++.|+.+
T Consensus 350 --~~~~~~~~~~---------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 350 --QFYNAIKRGY---------RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred --HHHHHHHcCC---------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 0011111110 0011112235678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=318.74 Aligned_cols=262 Identities=27% Similarity=0.410 Sum_probs=202.9
Q ss_pred ccccccCeecccCceeEEEEEeec-Cc--EEEEEEecCC-CchhHHHHHHHHHHHHhh-cCCceeeEEeEEeeCCeeeEE
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQ--EIAVKRLSKG-SGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDERMLI 591 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-g~--~vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV 591 (836)
++|++.+.||+|+||.||+|...+ +. .+++|.++.. .....+.+.+|+.++.++ +||||+++++++......++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578888999999999999999854 33 4788888643 334456789999999999 799999999999999999999
Q ss_pred EeecCCCChhHHHhhcc-------------CCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCc
Q 003254 592 YEYLPNKSLDYFIFDTT-------------RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNP 658 (836)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~ 658 (836)
+||+++++|.+++.... ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999999986432 1135888999999999999999999988 9999999999999999999
Q ss_pred eeeccCcccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhH
Q 003254 659 KISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAW 737 (836)
Q Consensus 659 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~ 737 (836)
||+|||++...... ........+..|+|||++.+..++.++|||||||++|||++ |+.|+....... ..
T Consensus 159 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~-------~~ 228 (297)
T cd05089 159 KIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE-------LY 228 (297)
T ss_pred EECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------HH
Confidence 99999998643211 11111223557999999998899999999999999999998 888864322110 11
Q ss_pred HhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCCCCCCCC
Q 003254 738 RLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPQ 800 (836)
Q Consensus 738 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~~~~p~ 800 (836)
...... .....+......+.+++.+|++.+|.+||++.+|++.|+.+.....+.
T Consensus 229 ~~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~~ 282 (297)
T cd05089 229 EKLPQG---------YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKAY 282 (297)
T ss_pred HHHhcC---------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhccc
Confidence 111111 000111122345779999999999999999999999998876544433
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=308.45 Aligned_cols=260 Identities=25% Similarity=0.367 Sum_probs=207.8
Q ss_pred ccccccCeecccCceeEEEEEee-cCcEEEEEEecCC---CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEE
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 592 (836)
++|+..+.||+|+||.||+|... +|+.||+|.++.. .....+.+.+|++++++++|+|++++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57888999999999999999987 6899999988642 2334568899999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcc-CCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCC
Q 003254 593 EYLPNKSLDYFIFDTT-RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (836)
Q Consensus 593 Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~ 671 (836)
||+++++|..++.... ....+++..+..++.++++||+|||+.+ ++|+||+|+||++++++.++|+|||++..+..
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 9999999999886532 2456889999999999999999999988 99999999999999999999999999886543
Q ss_pred CccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccc
Q 003254 672 DQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQ 751 (836)
Q Consensus 672 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 751 (836)
... ......++..|+|||.+.+..++.++||||||+++|+|++|+.|+...... ... ......... .
T Consensus 159 ~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~-~~~~~~~~~----~-- 225 (267)
T cd08224 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYS-LCKKIEKCD----Y-- 225 (267)
T ss_pred CCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc----HHH-HHhhhhcCC----C--
Confidence 221 122346788999999999888999999999999999999999986432211 000 000000000 0
Q ss_pred cccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 003254 752 SLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 794 (836)
Q Consensus 752 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 794 (836)
...........+.+++.+||+.+|++|||+.+|+++|+++.
T Consensus 226 --~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 226 --PPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred --CCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 00011123346789999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=310.12 Aligned_cols=268 Identities=23% Similarity=0.318 Sum_probs=203.3
Q ss_pred hcccccccCeecccCceeEEEEEeec-CcEEEEEEec--CCCchhHHHHHHHHHHHHhhcCCceeeEEeEEee-----CC
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLS--KGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQ-----RD 586 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~--~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-----~~ 586 (836)
....|...+.||+|+||.|.+++... |+.||||++. -......++..+|+++++.++|+||+.+++.+.. -+
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 44566667889999999999999854 8999999997 3345566788999999999999999999998855 35
Q ss_pred eeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcc
Q 003254 587 ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLA 666 (836)
Q Consensus 587 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla 666 (836)
..|+|+|+| ..+|...+. .++.|+......++.||++||+|+|+.+ |+||||||+|+|++.+..+||+|||+|
T Consensus 100 DvYiV~elM-etDL~~iik---~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLA 172 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIK---SQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLA 172 (359)
T ss_pred eeEEehhHH-hhHHHHHHH---cCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccce
Confidence 689999999 558888873 3445999999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCcccccC-CccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhh--------hH
Q 003254 667 RSFGLDQTEANTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGH--------AW 737 (836)
Q Consensus 667 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~--------~~ 737 (836)
+..............+.|..|+|||++.. ..||.+.||||.||||.||++|++-|.....-++..++.. ..
T Consensus 173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l 252 (359)
T KOG0660|consen 173 RYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDL 252 (359)
T ss_pred eeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHH
Confidence 98754422233345788999999999864 5799999999999999999999998765444333222111 11
Q ss_pred HhhhccCchhhccccc-cCCCCh-----HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 738 RLWIEERPLELIDQSL-DNSCSF-----SEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 738 ~~~~~~~~~~~~d~~l-~~~~~~-----~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
...........+...- ....+. ......++|+.+||..||.+|+|++|+++.
T Consensus 253 ~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 253 QKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 1111111111111000 001111 122457899999999999999999999864
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=321.15 Aligned_cols=248 Identities=21% Similarity=0.330 Sum_probs=194.4
Q ss_pred CeecccCceeEEEEEeec-CcEEEEEEecCC---CchhHHHHHHHHHHHHhh-cCCceeeEEeEEeeCCeeeEEEeecCC
Q 003254 523 NKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDERMLIYEYLPN 597 (836)
Q Consensus 523 ~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 597 (836)
+.||+|+||.||+++... ++.||+|+++.. .....+.+..|..++..+ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 369999999999999864 889999999754 223456688899999998 699999999999999999999999999
Q ss_pred CChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCccccc
Q 003254 598 KSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEAN 677 (836)
Q Consensus 598 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~ 677 (836)
|+|..++.. .+.+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~~ 152 (329)
T cd05588 81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--DT 152 (329)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCC--Cc
Confidence 999888743 356899999999999999999999998 9999999999999999999999999987532111 12
Q ss_pred cccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccc--cchhhhhHHhhhccCchhhccccccC
Q 003254 678 TKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHD--HNLLGHAWRLWIEERPLELIDQSLDN 755 (836)
Q Consensus 678 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~d~~l~~ 755 (836)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ............... .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--------~-- 222 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ--------I-- 222 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC--------C--
Confidence 2346789999999999999999999999999999999999999864322111 111111111111111 0
Q ss_pred CCChHHHHHHHHHHHHcccCCCCCCCC------HHHHHH
Q 003254 756 SCSFSEALRCIQVGLLCVQQRPEDRPN------MSSVVL 788 (836)
Q Consensus 756 ~~~~~~~~~l~~li~~Cl~~dP~~RPt------~~eVl~ 788 (836)
..+......+.+++.+||+.||++||+ +.++++
T Consensus 223 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 223 RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 111122345779999999999999997 677764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=309.94 Aligned_cols=246 Identities=28% Similarity=0.433 Sum_probs=194.5
Q ss_pred eecccCceeEEEEEee---cCcEEEEEEecCCC--chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEeecCCC
Q 003254 524 KLGEGGFGPVYKGMLI---EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNK 598 (836)
Q Consensus 524 ~lG~G~fG~Vykg~~~---~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 598 (836)
+||+|+||.||+|.+. +++.+|+|+++... ....+++.+|+.+++.++|+||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 6999999999999753 47889999986543 234578999999999999999999999885 45678999999999
Q ss_pred ChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCccccc-
Q 003254 599 SLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEAN- 677 (836)
Q Consensus 599 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~- 677 (836)
+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++..........
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 81 PLNKFLQK---NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 99999843 346889999999999999999999988 99999999999999999999999999987643322111
Q ss_pred cccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhccCchhhccccccCC
Q 003254 678 TKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDNS 756 (836)
Q Consensus 678 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 756 (836)
.....++..|+|||.+....++.++||||||+++|||++ |+.|+...... .. ........ ...
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~----~~~i~~~~---------~~~ 218 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN---EV----TQMIESGE---------RME 218 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HH----HHHHHCCC---------CCC
Confidence 112234678999999988889999999999999999998 88887532211 11 11111111 111
Q ss_pred CChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcC
Q 003254 757 CSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 792 (836)
Q Consensus 757 ~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~ 792 (836)
.+......+.+++.+|++.+|++||++.+|++.|++
T Consensus 219 ~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 219 CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 122233567899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=326.72 Aligned_cols=253 Identities=23% Similarity=0.320 Sum_probs=197.6
Q ss_pred ccccccCeecccCceeEEEEEeec-CcEEEEEEecCCC---chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEE
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 592 (836)
++|+..+.||+|+||.||+++... ++.||||++.... ....+.+.+|+.++..++||||+++++++......++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 478889999999999999999864 8899999986532 234466889999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCC
Q 003254 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (836)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~ 672 (836)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 E~~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 81 EYLPGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCCcHHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 99999999999854 346899999999999999999999998 999999999999999999999999998765321
Q ss_pred cccc------------------------------------ccccccccccccCcccccCCccCccccccchhhhhhhhhh
Q 003254 673 QTEA------------------------------------NTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC 716 (836)
Q Consensus 673 ~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt 716 (836)
.... .....+||+.|+|||++.+..++.++|||||||++|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 1000 0112468999999999999999999999999999999999
Q ss_pred CCCCCCCCCCccccchhhhhHHhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCC---HHHHHHH
Q 003254 717 GKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPN---MSSVVLM 789 (836)
Q Consensus 717 G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt---~~eVl~~ 789 (836)
|+.||....... .......... .+...........+.+++.+|+. +|.+|++ +.|+++.
T Consensus 235 G~~Pf~~~~~~~-------~~~~i~~~~~------~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 235 GYPPFCSDNPQE-------TYRKIINWKE------TLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCCCCHHH-------HHHHHHcCCC------ccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 999975322110 0011111000 00000000112346688888886 9999998 8888773
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=310.41 Aligned_cols=254 Identities=27% Similarity=0.425 Sum_probs=201.9
Q ss_pred ccccccCeecccCceeEEEEEeecCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEeecC
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLP 596 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 596 (836)
++|++.++||+|+||.||+|+..+...||+|++.... ...+++.+|+.++++++|+||+++++++. ....++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 83 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence 5688899999999999999998777789999987533 33467899999999999999999999875 456799999999
Q ss_pred CCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcccc
Q 003254 597 NKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEA 676 (836)
Q Consensus 597 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~~ 676 (836)
+++|.+++... ....+++..+..++.++++||+|||+.+ ++|+||||+||++++++.+||+|||.++.+......
T Consensus 84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~- 158 (262)
T cd05071 84 KGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT- 158 (262)
T ss_pred CCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccc-
Confidence 99999998543 2346789999999999999999999988 999999999999999999999999999866432211
Q ss_pred ccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhccCchhhccccccC
Q 003254 677 NTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDN 755 (836)
Q Consensus 677 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 755 (836)
......++..|+|||...+..++.++||||||+++|||++ |+.|+....... ......... ..
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~-------~~~~~~~~~---------~~ 222 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQVERGY---------RM 222 (262)
T ss_pred cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH-------HHHHHhcCC---------CC
Confidence 1122346678999999998899999999999999999999 777764322110 111111100 00
Q ss_pred CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 003254 756 SCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 793 (836)
Q Consensus 756 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 793 (836)
.........+.+++.+|++.+|++||++.++++.|+..
T Consensus 223 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 223 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 11223345678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=313.09 Aligned_cols=247 Identities=28% Similarity=0.369 Sum_probs=194.9
Q ss_pred ecccCceeEEEEEee-cCcEEEEEEecCCC---chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEeecCCCCh
Q 003254 525 LGEGGFGPVYKGMLI-EGQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSL 600 (836)
Q Consensus 525 lG~G~fG~Vykg~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 600 (836)
||+|+||+||++... +++.+|+|.+.... ....+.+..|+.+++.++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999875 48899999986542 22345678899999999999999999999999999999999999999
Q ss_pred hHHHhhcc-CCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCccccccc
Q 003254 601 DYFIFDTT-RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTK 679 (836)
Q Consensus 601 ~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~ 679 (836)
..++.... ....+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||++..+..... ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence 88875432 3456899999999999999999999998 99999999999999999999999999986543222 123
Q ss_pred cccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccccccCCCCh
Q 003254 680 RVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDNSCSF 759 (836)
Q Consensus 680 ~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 759 (836)
...|++.|+|||.+.+..++.++||||||+++|||++|+.|+......... ........ .... ..+.
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~---~~~~~~~~--------~~~~--~~~~ 222 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN---KELKQRIL--------NDSV--TYPD 222 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH---HHHHHhhc--------ccCC--CCcc
Confidence 357899999999999999999999999999999999999997542221100 00000000 0000 1112
Q ss_pred HHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 003254 760 SEALRCIQVGLLCVQQRPEDRP-----NMSSVVLM 789 (836)
Q Consensus 760 ~~~~~l~~li~~Cl~~dP~~RP-----t~~eVl~~ 789 (836)
.....+.+++.+||+.+|++|| +++++++.
T Consensus 223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 2334577999999999999999 77888763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=320.47 Aligned_cols=248 Identities=22% Similarity=0.333 Sum_probs=193.4
Q ss_pred CeecccCceeEEEEEeec-CcEEEEEEecCC---CchhHHHHHHHHHHHHhh-cCCceeeEEeEEeeCCeeeEEEeecCC
Q 003254 523 NKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDERMLIYEYLPN 597 (836)
Q Consensus 523 ~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 597 (836)
+.||+|+||.||+++... ++.||+|++.+. .....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 469999999999999765 788999998754 233455678899988877 799999999999999999999999999
Q ss_pred CChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCccccc
Q 003254 598 KSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEAN 677 (836)
Q Consensus 598 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~ 677 (836)
|+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~ 152 (329)
T cd05618 81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DT 152 (329)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--Cc
Confidence 999888743 346899999999999999999999998 9999999999999999999999999987532211 12
Q ss_pred cccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCcccc--chhhhhHHhhhccCchhhccccccC
Q 003254 678 TKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDH--NLLGHAWRLWIEERPLELIDQSLDN 755 (836)
Q Consensus 678 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~d~~l~~ 755 (836)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......... ...............
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~---------- 222 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI---------- 222 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC----------
Confidence 23367899999999999999999999999999999999999998532221111 111111111111110
Q ss_pred CCChHHHHHHHHHHHHcccCCCCCCCC------HHHHHH
Q 003254 756 SCSFSEALRCIQVGLLCVQQRPEDRPN------MSSVVL 788 (836)
Q Consensus 756 ~~~~~~~~~l~~li~~Cl~~dP~~RPt------~~eVl~ 788 (836)
..+......+.+++.+||+.||++||+ +.++++
T Consensus 223 ~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05618 223 RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 261 (329)
T ss_pred CCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhc
Confidence 111222345779999999999999998 466643
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=315.83 Aligned_cols=261 Identities=24% Similarity=0.405 Sum_probs=202.8
Q ss_pred hcccccccCeecccCceeEEEEEeec------CcEEEEEEecCCCc-hhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCe
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLIE------GQEIAVKRLSKGSG-QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDE 587 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~~------g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 587 (836)
..++|++.+.||+|+||.||+|...+ +..||+|.+..... .....+.+|+.+++.++|+||+++++++.....
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 45789999999999999999997542 45799998865432 334568899999999999999999999999999
Q ss_pred eeEEEeecCCCChhHHHhhccC-------CCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCcee
Q 003254 588 RMLIYEYLPNKSLDYFIFDTTR-------SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKI 660 (836)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl 660 (836)
.++||||+++|+|.+++..... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 9999999999999999964321 234567788899999999999999988 999999999999999999999
Q ss_pred eccCcccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHh
Q 003254 661 SDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRL 739 (836)
Q Consensus 661 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 739 (836)
+|||+++...............++..|+|||.+.++.++.++|||||||+++||++ |..|+...... .. ...
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~---~~----~~~ 233 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE---QV----LKF 233 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH---HH----HHH
Confidence 99999986543222222222345678999999999999999999999999999999 67675421111 00 011
Q ss_pred hhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 003254 740 WIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 794 (836)
Q Consensus 740 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 794 (836)
....... ..+......+.+++.+|++.+|++|||+.++++.|+...
T Consensus 234 ~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 234 VMDGGYL---------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred HHcCCCC---------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 1111000 011122356889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=317.76 Aligned_cols=257 Identities=28% Similarity=0.404 Sum_probs=202.7
Q ss_pred ccccccCeecccCceeEEEEEee------cCcEEEEEEecCCC-chhHHHHHHHHHHHHhh-cCCceeeEEeEEeeCCee
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLI------EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDER 588 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~------~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~ 588 (836)
++|...+.||+|+||.||++... .+..||||+++... ....+.+.+|+.+++++ +|+||+++++++...+..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 57888999999999999999752 24579999987553 33456789999999999 799999999999999999
Q ss_pred eEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccc
Q 003254 589 MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (836)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~ 668 (836)
++||||+++|+|.+++.... ...+++.++..++.+++.||+|||+++ |+|+||||+|||+++++.+||+|||+++.
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~~ 190 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARD 190 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCccccc
Confidence 99999999999999985422 234899999999999999999999988 99999999999999999999999999987
Q ss_pred cCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhccCchh
Q 003254 669 FGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEERPLE 747 (836)
Q Consensus 669 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (836)
+.............++..|+|||.+.++.++.++||||||+++|||++ |+.|+....... . .........
T Consensus 191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~--~----~~~~~~~~~--- 261 (302)
T cd05055 191 IMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS--K----FYKLIKEGY--- 261 (302)
T ss_pred ccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH--H----HHHHHHcCC---
Confidence 643322111222345778999999999999999999999999999998 888864322110 0 001111110
Q ss_pred hccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcC
Q 003254 748 LIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 792 (836)
Q Consensus 748 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~ 792 (836)
...........+.+++.+|++.+|++|||+.||++.|+.
T Consensus 262 ------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 262 ------RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred ------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence 000111123467899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=321.15 Aligned_cols=252 Identities=22% Similarity=0.303 Sum_probs=196.6
Q ss_pred cccccCeecccCceeEEEEEee----cCcEEEEEEecCC----CchhHHHHHHHHHHHHhh-cCCceeeEEeEEeeCCee
Q 003254 518 NFSEKNKLGEGGFGPVYKGMLI----EGQEIAVKRLSKG----SGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDER 588 (836)
Q Consensus 518 ~f~~~~~lG~G~fG~Vykg~~~----~g~~vavK~l~~~----~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~ 588 (836)
+|++.+.||+|+||.||+++.. .++.||+|++.+. .....+.+..|+.++..+ +|+||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4778899999999999998863 4788999998643 223345678899999999 599999999999999999
Q ss_pred eEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccc
Q 003254 589 MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (836)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~ 668 (836)
++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 999999999999998853 346889999999999999999999998 99999999999999999999999999986
Q ss_pred cCCCccccccccccccccccCcccccCC-ccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchh
Q 003254 669 FGLDQTEANTKRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLE 747 (836)
Q Consensus 669 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (836)
+..... .......||+.|+|||++.+. .++.++|||||||++|||++|+.|+......... ..........
T Consensus 155 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~---~~~~~~~~~~---- 226 (332)
T cd05614 155 FLSEEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ---SEVSRRILKC---- 226 (332)
T ss_pred ccccCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH---HHHHHHHhcC----
Confidence 533222 122346789999999999865 4789999999999999999999997532221111 1111111111
Q ss_pred hccccccCCCChHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 003254 748 LIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRP-----NMSSVVLM 789 (836)
Q Consensus 748 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~eVl~~ 789 (836)
++ ..+......+.+++.+||+.||++|| +++++++.
T Consensus 227 --~~----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 227 --DP----PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred --CC----CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 11 11112234567899999999999999 77777753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=311.89 Aligned_cols=255 Identities=22% Similarity=0.367 Sum_probs=201.1
Q ss_pred cccccccCeecccCceeEEEEEee-cCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEee
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 594 (836)
.++|++.+.||+|+||.||+|+.. +++.||+|++..........+.+|+.++++++||||+++++++...+..++|+||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 357889999999999999999974 5889999998766555566788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcc
Q 003254 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (836)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~ 674 (836)
+++++|.+++.. ...+++..+..++.|+++||.|||+.+ |+||||||+||++++++.+||+|||++..+.....
T Consensus 88 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06646 88 CGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA 161 (267)
T ss_pred CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence 999999998843 346889999999999999999999988 99999999999999999999999999987632211
Q ss_pred ccccccccccccccCccccc---CCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccc
Q 003254 675 EANTKRVVGTYGYMSPEYAI---DGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQ 751 (836)
Q Consensus 675 ~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 751 (836)
......++..|+|||.+. ...++.++||||||++++||++|+.|+............ ... ....+
T Consensus 162 --~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~-------~~~---~~~~~ 229 (267)
T cd06646 162 --KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM-------SKS---NFQPP 229 (267)
T ss_pred --ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheee-------ecC---CCCCC
Confidence 122356788999999884 445788999999999999999999986432211110000 000 00000
Q ss_pred cccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 003254 752 SLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLML 790 (836)
Q Consensus 752 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L 790 (836)
.... .......+.+++.+||+.+|++|||+++|++.|
T Consensus 230 ~~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 230 KLKD--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCcc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 1110 111234678999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=321.27 Aligned_cols=241 Identities=24% Similarity=0.336 Sum_probs=192.8
Q ss_pred CeecccCceeEEEEEee----cCcEEEEEEecCC----CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEee
Q 003254 523 NKLGEGGFGPVYKGMLI----EGQEIAVKRLSKG----SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (836)
Q Consensus 523 ~~lG~G~fG~Vykg~~~----~g~~vavK~l~~~----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 594 (836)
+.||+|+||.||+++.. .++.||||++... .......+.+|+.+++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 57999999999999863 4788999998653 223345678899999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcc
Q 003254 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (836)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~ 674 (836)
+++++|.+++.. ...+.+..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 82 LSGGELFMHLER---EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred CCCchHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence 999999988843 346788888999999999999999998 99999999999999999999999999875432211
Q ss_pred ccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhcccccc
Q 003254 675 EANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLD 754 (836)
Q Consensus 675 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 754 (836)
......|++.|+|||++.+..++.++||||||+++|||++|+.||...... .......... .
T Consensus 156 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~-------~~~~~~~~~~--------~- 217 (323)
T cd05584 156 --VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK-------KTIDKILKGK--------L- 217 (323)
T ss_pred --cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH-------HHHHHHHcCC--------C-
Confidence 223357899999999999988999999999999999999999997532211 0111111110 0
Q ss_pred CCCChHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 003254 755 NSCSFSEALRCIQVGLLCVQQRPEDRP-----NMSSVVL 788 (836)
Q Consensus 755 ~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~eVl~ 788 (836)
..+......+.+++.+||+.+|++|| ++.++++
T Consensus 218 -~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 218 -NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred -CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 11112234577999999999999999 7888876
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=308.57 Aligned_cols=254 Identities=30% Similarity=0.437 Sum_probs=202.8
Q ss_pred cccccccCeecccCceeEEEEEeecCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEeec
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 595 (836)
.++|+..++||+|+||.||+|...+++.||+|.+.... ...+.+.+|+.++++++|+|++++++++. .+..++||||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence 36788889999999999999998889999999987544 33568899999999999999999999874 46789999999
Q ss_pred CCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCccc
Q 003254 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE 675 (836)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 675 (836)
++++|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++.........
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05067 83 ENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence 999999988543 3456889999999999999999999988 999999999999999999999999999875422211
Q ss_pred cccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhccCchhhcccccc
Q 003254 676 ANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLD 754 (836)
Q Consensus 676 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 754 (836)
......++..|+|||.+....++.++||||||++++||++ |+.|+...... .. .........
T Consensus 159 -~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~----~~~~~~~~~--------- 221 (260)
T cd05067 159 -AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP---EV----IQNLERGYR--------- 221 (260)
T ss_pred -cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH---HH----HHHHHcCCC---------
Confidence 1122345678999999998889999999999999999999 89887532211 11 111111100
Q ss_pred CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcC
Q 003254 755 NSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 792 (836)
Q Consensus 755 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~ 792 (836)
..........+.+++.+|++.+|++||+++++++.|+.
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 222 MPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 01111223468899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=309.67 Aligned_cols=251 Identities=22% Similarity=0.350 Sum_probs=197.8
Q ss_pred ccccccCeecccCceeEEEEEee-cCcEEEEEEecCC-CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEee
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 594 (836)
++|+..+.||+|+||.||+|+.. +++.||+|++... .....+++.+|+.++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 35777889999999999999874 4888999998654 234456789999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcc
Q 003254 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (836)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~ 674 (836)
+++++|..+. .+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||++..+...
T Consensus 81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-- 148 (279)
T cd06619 81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-- 148 (279)
T ss_pred CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc--
Confidence 9999996542 3678888999999999999999998 999999999999999999999999999865322
Q ss_pred ccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhcccccc
Q 003254 675 EANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLD 754 (836)
Q Consensus 675 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 754 (836)
......++..|+|||.+.+..++.++||||||+++|||++|+.|+.......................... +
T Consensus 149 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-----~- 220 (279)
T cd06619 149 --IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPV-----L- 220 (279)
T ss_pred --cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCC-----C-
Confidence 12235789999999999999999999999999999999999999754322211111101111111111100 0
Q ss_pred CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 755 NSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 755 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
........+.+++.+|++.+|++||++.|+++.
T Consensus 221 --~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 221 --PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred --CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 011122457799999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=322.63 Aligned_cols=242 Identities=24% Similarity=0.315 Sum_probs=193.1
Q ss_pred CeecccCceeEEEEEee-cCcEEEEEEecCC---CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEeecCCC
Q 003254 523 NKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNK 598 (836)
Q Consensus 523 ~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 598 (836)
+.||+|+||.||++... .|+.||+|++... .......+.+|++++..++||||+++.+++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999875 4889999998753 2234567788999999999999999999999999999999999999
Q ss_pred ChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhc-CCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCccccc
Q 003254 599 SLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQ-DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEAN 677 (836)
Q Consensus 599 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~ 677 (836)
+|..++.. ...+++..+..++.||+.||+|||+ .+ |+||||||+|||+++++.+||+|||+++...... ..
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~ 152 (325)
T cd05594 81 ELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--AT 152 (325)
T ss_pred cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--cc
Confidence 99888743 3468999999999999999999997 56 9999999999999999999999999987542221 12
Q ss_pred cccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccccccCCC
Q 003254 678 TKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDNSC 757 (836)
Q Consensus 678 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 757 (836)
.....||+.|+|||++.+..++.++|||||||+||||++|+.||....... .......... ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~-------~~~~i~~~~~----------~~ 215 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-------LFELILMEEI----------RF 215 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH-------HHHHHhcCCC----------CC
Confidence 233578999999999999999999999999999999999999975322110 0010000000 01
Q ss_pred ChHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 003254 758 SFSEALRCIQVGLLCVQQRPEDRP-----NMSSVVLM 789 (836)
Q Consensus 758 ~~~~~~~l~~li~~Cl~~dP~~RP-----t~~eVl~~ 789 (836)
+......+.+++.+||+.||++|+ ++.++++.
T Consensus 216 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 216 PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 111234577899999999999996 89998754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=307.43 Aligned_cols=250 Identities=26% Similarity=0.352 Sum_probs=203.0
Q ss_pred cccccCeecccCceeEEEEEeec-CcEEEEEEecCC--CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEee
Q 003254 518 NFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (836)
Q Consensus 518 ~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 594 (836)
+|+..+.||+|++|.||+++... ++.|++|.+... .....+++.+|++++++++|||++++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 46778899999999999999864 889999998643 334567889999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcc
Q 003254 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (836)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~ 674 (836)
+++++|.+++... ....+++..+..++.+++.||.|||+.+ ++|+||||+||++++++.+||+|||++..+.....
T Consensus 81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 9999999998653 2457889999999999999999999987 99999999999999999999999999887643222
Q ss_pred ccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhcccccc
Q 003254 675 EANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLD 754 (836)
Q Consensus 675 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 754 (836)
. .....+++.|+|||++.+..++.++||||||++++||++|+.|+...... . ..........
T Consensus 157 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~----~~~~~~~~~~--------- 218 (256)
T cd08529 157 F--ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG---A----LILKIIRGVF--------- 218 (256)
T ss_pred h--hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH---H----HHHHHHcCCC---------
Confidence 1 22346788999999999999999999999999999999999997533211 1 1111111110
Q ss_pred CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 755 NSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 755 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
..........+.+++.+|++.+|++||++.++++.
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 219 PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 01111233567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=319.01 Aligned_cols=260 Identities=28% Similarity=0.397 Sum_probs=203.3
Q ss_pred cccccccCeecccCceeEEEEEeec--------CcEEEEEEecCCC-chhHHHHHHHHHHHHhh-cCCceeeEEeEEeeC
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLIE--------GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQR 585 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~~--------g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~ 585 (836)
.++|.+.+.||+|+||.||+++... +..+|+|.+.... .....++.+|+.++.++ +|+||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 3678899999999999999998532 3569999987542 34456788999999999 799999999999999
Q ss_pred CeeeEEEeecCCCChhHHHhhccC-------------CCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEe
Q 003254 586 DERMLIYEYLPNKSLDYFIFDTTR-------------SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLL 652 (836)
Q Consensus 586 ~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl 652 (836)
...++||||+++++|.+++..... ...+++.++++++.|++.||+|||+.+ ++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 999999999999999999965321 235889999999999999999999988 9999999999999
Q ss_pred cCCCCceeeccCcccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccc
Q 003254 653 DNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHN 731 (836)
Q Consensus 653 ~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~ 731 (836)
++++.+||+|||++................++..|+|||.+.+..++.++||||||+++|||++ |+.|+......
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~---- 249 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---- 249 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH----
Confidence 9999999999999876543221111112234568999999998889999999999999999998 77776432111
Q ss_pred hhhhhHHhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 003254 732 LLGHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 794 (836)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 794 (836)
............ ..+......+.+++.+|++.+|++||+|.+|++.|+.+.
T Consensus 250 ---~~~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~ 300 (307)
T cd05098 250 ---ELFKLLKEGHRM---------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 300 (307)
T ss_pred ---HHHHHHHcCCCC---------CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 111111111110 111122346778999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=327.41 Aligned_cols=252 Identities=22% Similarity=0.303 Sum_probs=195.2
Q ss_pred ccccccCeecccCceeEEEEEee-cCcEEEEEEecCC---CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEE
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 592 (836)
++|+..++||+|+||.||++... +++.||||++.+. .....+.+.+|++++.+++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 46888899999999999999875 4889999998653 2234567889999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCC
Q 003254 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (836)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~ 672 (836)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 81 EFLPGGDLMTMLIK---YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 99999999998853 356888899999999999999999998 999999999999999999999999999643211
Q ss_pred ccc-----------c----------------------------------ccccccccccccCcccccCCccCccccccch
Q 003254 673 QTE-----------A----------------------------------NTKRVVGTYGYMSPEYAIDGLFSVKSDVFSF 707 (836)
Q Consensus 673 ~~~-----------~----------------------------------~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~ 707 (836)
... . .....+||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 000 0 0012468999999999999999999999999
Q ss_pred hhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhcc-CchhhccccccCCCChHHHHHHHHHHHHcccCCCCCC---CCH
Q 003254 708 GVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEE-RPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDR---PNM 783 (836)
Q Consensus 708 GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~R---Pt~ 783 (836)
||+||||++|+.||....... . ....... ....+.+ .......+.+++.+|++ +|.+| |++
T Consensus 235 Gvil~elltG~~Pf~~~~~~~---~----~~~i~~~~~~~~~p~-------~~~~s~~~~dli~~lL~-~~~~r~~r~~~ 299 (377)
T cd05629 235 GAIMFECLIGWPPFCSENSHE---T----YRKIINWRETLYFPD-------DIHLSVEAEDLIRRLIT-NAENRLGRGGA 299 (377)
T ss_pred chhhhhhhcCCCCCCCCCHHH---H----HHHHHccCCccCCCC-------CCCCCHHHHHHHHHHhc-CHhhcCCCCCH
Confidence 999999999999975322211 0 1111100 0000000 00112356788899997 66665 599
Q ss_pred HHHHHH
Q 003254 784 SSVVLM 789 (836)
Q Consensus 784 ~eVl~~ 789 (836)
.|+++.
T Consensus 300 ~~~l~h 305 (377)
T cd05629 300 HEIKSH 305 (377)
T ss_pred HHHhcC
Confidence 998875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=309.46 Aligned_cols=259 Identities=24% Similarity=0.342 Sum_probs=205.6
Q ss_pred ccccccCeecccCceeEEEEEee-cCcEEEEEEecCC---CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEE
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 592 (836)
++|+..+.||+|+||.||++... +++.+|||.+... .....+++.+|+.+++.++|+||+++++++.+.+..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 46788889999999999999964 6899999987643 2234567889999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcc-CCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCC
Q 003254 593 EYLPNKSLDYFIFDTT-RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (836)
Q Consensus 593 Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~ 671 (836)
||+++++|.+++.... ....+++..+..++.+|++||.|||+.+ ++|+||||+||+++.++.++|+|||++..+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 9999999999886432 2456899999999999999999999988 99999999999999999999999999886543
Q ss_pred CccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccc
Q 003254 672 DQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQ 751 (836)
Q Consensus 672 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 751 (836)
... ......++..|+|||++.+..++.++||||||+++|||++|..|+....... .. ....... ...+
T Consensus 159 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~~-~~~~~~~-----~~~~ 226 (267)
T cd08229 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----YS-LCKKIEQ-----CDYP 226 (267)
T ss_pred CCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchH----HH-Hhhhhhc-----CCCC
Confidence 221 1223568889999999998889999999999999999999999864322110 00 0000000 0000
Q ss_pred cccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 003254 752 SLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 793 (836)
Q Consensus 752 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 793 (836)
. .........+.+++.+|++.+|++||||.+|++++++.
T Consensus 227 ~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 227 P---LPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred C---CCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 0 01112334678999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=305.82 Aligned_cols=247 Identities=28% Similarity=0.393 Sum_probs=197.0
Q ss_pred CeecccCceeEEEEEeecCcEEEEEEecCCCc-hhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEeecCCCChh
Q 003254 523 NKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSG-QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLD 601 (836)
Q Consensus 523 ~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~ 601 (836)
+.||+|+||.||+|...+++.+|+|.+..... .....+.+|+.++++++||||+++++++......++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 36999999999999988889999999876543 33457889999999999999999999999999999999999999999
Q ss_pred HHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCccccccccc
Q 003254 602 YFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRV 681 (836)
Q Consensus 602 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~~ 681 (836)
+++... ...+++..+..++.+++.||.|||+.+ ++|+||||+||++++++.+||+|||++......... .....
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~ 154 (250)
T cd05085 81 SFLRKK--KDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGLK 154 (250)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccc-cCCCC
Confidence 988532 345789999999999999999999988 999999999999999999999999998754322111 11112
Q ss_pred cccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhccCchhhccccccCCCChH
Q 003254 682 VGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDNSCSFS 760 (836)
Q Consensus 682 ~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 760 (836)
.++..|+|||++.++.++.++||||||+++|||++ |..|+....... ......... ....+..
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~-------~~~~~~~~~---------~~~~~~~ 218 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ-------AREQVEKGY---------RMSCPQK 218 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH-------HHHHHHcCC---------CCCCCCC
Confidence 34568999999998899999999999999999998 888864322110 111111110 0111222
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 003254 761 EALRCIQVGLLCVQQRPEDRPNMSSVVLMLS 791 (836)
Q Consensus 761 ~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~ 791 (836)
....+.+++.+|++.+|++||++.|+++.|.
T Consensus 219 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 219 CPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 3456889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=313.93 Aligned_cols=264 Identities=25% Similarity=0.379 Sum_probs=201.2
Q ss_pred ccccccCeecccCceeEEEEEee-----------------cCcEEEEEEecCCC-chhHHHHHHHHHHHHhhcCCceeeE
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLI-----------------EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKL 578 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~-----------------~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l 578 (836)
++|++.++||+|+||.||++... ++..+|+|++.... ....+++.+|+.+++.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 56888999999999999998532 23468999987543 3445789999999999999999999
Q ss_pred EeEEeeCCeeeEEEeecCCCChhHHHhhccC--------CCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCce
Q 003254 579 LGCCTQRDERMLIYEYLPNKSLDYFIFDTTR--------SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNV 650 (836)
Q Consensus 579 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NI 650 (836)
++++...+..++||||+++++|.+++..... ...+++..+..++.|++.||+|||+.+ ++|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence 9999999999999999999999999865321 134778889999999999999999998 99999999999
Q ss_pred EecCCCCceeeccCcccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhh--CCCCCCCCCCcc
Q 003254 651 LLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC--GKKNRGFNHADH 728 (836)
Q Consensus 651 Ll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt--G~~p~~~~~~~~ 728 (836)
|+++++.++|+|||+++.+.............++..|+|||...++.++.++|||||||++|||++ |..|+......
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~- 240 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE- 240 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH-
Confidence 999999999999999987643322222222344678999999888899999999999999999998 55665322111
Q ss_pred ccchhhhhHHhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcC
Q 003254 729 DHNLLGHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 792 (836)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~ 792 (836)
.........+..... .... ..+......+.+++.+||+.+|++||++.||++.|+.
T Consensus 241 --~~~~~~~~~~~~~~~-~~~~-----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 241 --QVIENTGEFFRDQGR-QVYL-----PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred --HHHHHHHHHHhhccc-cccC-----CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 111111111111100 0000 0111223567899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=314.90 Aligned_cols=258 Identities=27% Similarity=0.440 Sum_probs=202.8
Q ss_pred cccccccCeecccCceeEEEEEee------cCcEEEEEEecCCC-chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCee
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLI------EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDER 588 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~------~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 588 (836)
.++|+..+.||+|+||.||++... .+..||+|++.... ....+++.+|+.++++++||||+++++++..+...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467888999999999999999864 36789999987553 34456799999999999999999999999999999
Q ss_pred eEEEeecCCCChhHHHhhcc-------------------CCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCc
Q 003254 589 MLIYEYLPNKSLDYFIFDTT-------------------RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASN 649 (836)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~N 649 (836)
++||||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 99999999999999986421 1134788889999999999999999988 9999999999
Q ss_pred eEecCCCCceeeccCcccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCcc
Q 003254 650 VLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADH 728 (836)
Q Consensus 650 ILl~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~ 728 (836)
|++++++.+||+|||+++.+..............+..|+|||.+.+..++.++|||||||++|||++ |..|+......
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~- 239 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE- 239 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-
Confidence 9999999999999999886543322111222344678999999998899999999999999999998 77675321111
Q ss_pred ccchhhhhHHhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcC
Q 003254 729 DHNLLGHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 792 (836)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~ 792 (836)
............ ..+......+.+++.+|++.+|++|||+.|+++.|+.
T Consensus 240 ------~~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 240 ------EVIYYVRDGNVL---------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred ------HHHHHHhcCCCC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 011111111110 1111233568899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=310.10 Aligned_cols=256 Identities=27% Similarity=0.452 Sum_probs=202.7
Q ss_pred ccccccCeecccCceeEEEEEeec-C---cEEEEEEecCCC-chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEE
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-G---QEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-g---~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 591 (836)
++|+..+.||+|+||.||+|+... + ..+|+|.+.... ....+++.+|++++++++|+|++++.+++...+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 567888999999999999999853 3 369999986553 34456789999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCC
Q 003254 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (836)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~ 671 (836)
|||+++++|..++... ...+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||++.....
T Consensus 85 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 85 TEYMENGALDKYLRDH--DGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 9999999999998542 356899999999999999999999988 99999999999999999999999999986643
Q ss_pred Cccccc-cccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhccCchhhc
Q 003254 672 DQTEAN-TKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEERPLELI 749 (836)
Q Consensus 672 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (836)
...... ......+..|+|||++.+..++.++||||||+++|||++ |+.|+...... .........
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~-------~~~~~i~~~------ 226 (268)
T cd05063 160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH-------EVMKAINDG------ 226 (268)
T ss_pred ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH-------HHHHHHhcC------
Confidence 222111 111223557999999998889999999999999999997 99887432211 011111111
Q ss_pred cccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 003254 750 DQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 793 (836)
Q Consensus 750 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 793 (836)
............+.+++.+|++.+|++||++.+|++.|+++
T Consensus 227 ---~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 227 ---FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ---CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 01111112335678999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=310.94 Aligned_cols=252 Identities=27% Similarity=0.353 Sum_probs=199.3
Q ss_pred cccccCeecccCceeEEEEEee-cCcEEEEEEecCCC---chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEe
Q 003254 518 NFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (836)
Q Consensus 518 ~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 593 (836)
+|+..+.||+|+||.||++... +++.||+|++.... ......+.+|+.++++++||||+++++.+...+..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4777889999999999999975 48899999986532 2233557889999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCc
Q 003254 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (836)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~ 673 (836)
|+++|+|..++... ....+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 99999999887543 2346899999999999999999999998 9999999999999999999999999998653221
Q ss_pred cccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccccc
Q 003254 674 TEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSL 753 (836)
Q Consensus 674 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 753 (836)
. .....|+..|+|||++.+..++.++||||+|+++|||++|+.||......... ........ ..
T Consensus 157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~---~~~~~~~~-~~--------- 220 (285)
T cd05605 157 T---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKR---EEVERRVK-ED--------- 220 (285)
T ss_pred c---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHH---HHHHHHhh-hc---------
Confidence 1 12356899999999999889999999999999999999999998642221100 00000000 00
Q ss_pred cCCCChHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 003254 754 DNSCSFSEALRCIQVGLLCVQQRPEDRP-----NMSSVVLM 789 (836)
Q Consensus 754 ~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~eVl~~ 789 (836)
....+......+.+++..|++.||++|| ++.++++.
T Consensus 221 ~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 221 QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 0111122334578999999999999999 88888553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=326.78 Aligned_cols=252 Identities=21% Similarity=0.311 Sum_probs=194.1
Q ss_pred cccccCeecccCceeEEEEEeec-CcEEEEEEecCCC---chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEe
Q 003254 518 NFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (836)
Q Consensus 518 ~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 593 (836)
+|++.+.||+|+||.||+++... ++.||||++.+.. ....+.+.+|+.++++++|+||+++++.+.+.+..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 68889999999999999999754 8899999986432 2334668899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCc
Q 003254 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (836)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~ 673 (836)
|+++|+|.+++.. ...++...+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 82 YIPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 9999999999853 346888888999999999999999998 9999999999999999999999999985331100
Q ss_pred c-----------------------------------------ccccccccccccccCcccccCCccCccccccchhhhhh
Q 003254 674 T-----------------------------------------EANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVL 712 (836)
Q Consensus 674 ~-----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ 712 (836)
. ........||+.|+|||++.+..++.++|||||||+||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 0 00011347999999999999999999999999999999
Q ss_pred hhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCC---CHHHHHHH
Q 003254 713 EIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRP---NMSSVVLM 789 (836)
Q Consensus 713 elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP---t~~eVl~~ 789 (836)
||++|+.||........ . ........ . +...........+.+++.+|+ .+|++|+ ++.|+++.
T Consensus 236 ell~G~~Pf~~~~~~~~------~-~~i~~~~~-~-----~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 236 EMLVGQPPFLADTPAET------Q-LKVINWET-T-----LHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred ehhhCCCCCCCCCHHHH------H-HHHhccCc-c-----ccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 99999999854322110 0 00000000 0 000001111234556777765 5999999 88888765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=310.22 Aligned_cols=256 Identities=25% Similarity=0.411 Sum_probs=200.8
Q ss_pred ccccccCeecccCceeEEEEEeec-C---cEEEEEEecCC-CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEE
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-G---QEIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-g---~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 591 (836)
..|+..+.||+|+||.||+|.... + ..||||.+... .....++|..|+.++++++||||+++++++..+...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 346778899999999999999764 3 35999998755 344567899999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCC
Q 003254 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (836)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~ 671 (836)
|||+++++|.+++... ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++.....
T Consensus 84 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 84 TEFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence 9999999999988543 346889999999999999999999988 99999999999999999999999999876543
Q ss_pred Ccccccccccc---ccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhccCchh
Q 003254 672 DQTEANTKRVV---GTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEERPLE 747 (836)
Q Consensus 672 ~~~~~~~~~~~---gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (836)
........... .+..|+|||.+.+..++.++||||||+++|||++ |..|+...... .. ........
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---~~----~~~i~~~~--- 228 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DV----INAIEQDY--- 228 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---HH----HHHHHcCC---
Confidence 22211111111 2457999999999999999999999999999886 88886432211 01 11110000
Q ss_pred hccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 003254 748 LIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 793 (836)
Q Consensus 748 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 793 (836)
....+.+....+.+++..||+.+|++||++.+|+++|+.+
T Consensus 229 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 229 ------RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0011112234578999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=306.72 Aligned_cols=251 Identities=27% Similarity=0.389 Sum_probs=203.4
Q ss_pred cccccccCeecccCceeEEEEEeecCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEeec
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 595 (836)
.++|+..+.||.|+||.||++.. .|+.||+|.+..... ..+++.+|+.++++++|+||+++++++......++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 35788889999999999999987 488999999976544 5678999999999999999999999999889999999999
Q ss_pred CCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCccc
Q 003254 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE 675 (836)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 675 (836)
++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||+++.......
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~- 157 (256)
T cd05039 83 AKGSLVDYLRSRG-RAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD- 157 (256)
T ss_pred CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence 9999999985432 236899999999999999999999998 99999999999999999999999999987532211
Q ss_pred cccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhccCchhhcccccc
Q 003254 676 ANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLD 754 (836)
Q Consensus 676 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 754 (836)
....+..|+|||.+.++.++.++||||||++++||++ |+.|+...... .+ .........
T Consensus 158 ----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~----~~~~~~~~~--------- 217 (256)
T cd05039 158 ----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DV----VPHVEKGYR--------- 217 (256)
T ss_pred ----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH---HH----HHHHhcCCC---------
Confidence 2334668999999998899999999999999999997 88886432111 11 111111100
Q ss_pred CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 003254 755 NSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 793 (836)
Q Consensus 755 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 793 (836)
...+......+.+++.+|++.+|++||++.|++++|+.+
T Consensus 218 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 218 MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 011112235678999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=320.35 Aligned_cols=242 Identities=24% Similarity=0.377 Sum_probs=192.9
Q ss_pred CeecccCceeEEEEEeec-CcEEEEEEecCC---CchhHHHHHHHHHHHHhh-cCCceeeEEeEEeeCCeeeEEEeecCC
Q 003254 523 NKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDERMLIYEYLPN 597 (836)
Q Consensus 523 ~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 597 (836)
+.||+|+||.||+|+... ++.||+|++... .....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 369999999999999865 789999998653 233455677899998876 799999999999999999999999999
Q ss_pred CChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCccccc
Q 003254 598 KSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEAN 677 (836)
Q Consensus 598 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~ 677 (836)
++|...+.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||++....... ..
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~ 152 (321)
T cd05591 81 GDLMFQIQR---SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VT 152 (321)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC--cc
Confidence 999888843 346889999999999999999999998 9999999999999999999999999987542221 12
Q ss_pred cccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccccccCCC
Q 003254 678 TKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDNSC 757 (836)
Q Consensus 678 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 757 (836)
.....|++.|+|||++.+..++.++|||||||++|||++|+.|+...... .. ......... ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~---~~----~~~i~~~~~----------~~ 215 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED---DL----FESILHDDV----------LY 215 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH---HH----HHHHHcCCC----------CC
Confidence 23357899999999999999999999999999999999999997533211 11 111111100 01
Q ss_pred ChHHHHHHHHHHHHcccCCCCCCC-------CHHHHHHH
Q 003254 758 SFSEALRCIQVGLLCVQQRPEDRP-------NMSSVVLM 789 (836)
Q Consensus 758 ~~~~~~~l~~li~~Cl~~dP~~RP-------t~~eVl~~ 789 (836)
+......+.+++..||+.+|++|| ++.++++.
T Consensus 216 p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 216 PVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 111224577899999999999999 88888754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=317.99 Aligned_cols=243 Identities=23% Similarity=0.334 Sum_probs=191.6
Q ss_pred CeecccCceeEEEEEeec-CcEEEEEEecCCC---chhHHHHHHHHHHHHhh-cCCceeeEEeEEeeCCeeeEEEeecCC
Q 003254 523 NKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDERMLIYEYLPN 597 (836)
Q Consensus 523 ~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 597 (836)
+.||+|+||.||++.... ++.||+|++.... ....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 469999999999999765 7889999997542 23456688999999888 699999999999999999999999999
Q ss_pred CChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCccccc
Q 003254 598 KSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEAN 677 (836)
Q Consensus 598 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~ 677 (836)
|+|..++.. .+.+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (327)
T cd05617 81 GDLMFHMQR---QRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DT 152 (327)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCC--Cc
Confidence 999888743 346899999999999999999999998 9999999999999999999999999987532111 12
Q ss_pred cccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccccccCCC
Q 003254 678 TKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDNSC 757 (836)
Q Consensus 678 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 757 (836)
.....||+.|+|||++.+..++.++|||||||+||||++|+.||...................... +. ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~---------~~ 222 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK-PI---------RI 222 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC-CC---------CC
Confidence 234678999999999999999999999999999999999999986433222211111122211111 00 11
Q ss_pred ChHHHHHHHHHHHHcccCCCCCCCCH
Q 003254 758 SFSEALRCIQVGLLCVQQRPEDRPNM 783 (836)
Q Consensus 758 ~~~~~~~l~~li~~Cl~~dP~~RPt~ 783 (836)
+......+.+++.+||+.||++||++
T Consensus 223 p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 223 PRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 11122456799999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=317.66 Aligned_cols=245 Identities=25% Similarity=0.369 Sum_probs=192.0
Q ss_pred ccccCeecccCceeEEEEEeec-CcEEEEEEecCCC---chhHHHHHHHHHHH---HhhcCCceeeEEeEEeeCCeeeEE
Q 003254 519 FSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLI---AKLQHRNLVKLLGCCTQRDERMLI 591 (836)
Q Consensus 519 f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~~l---~~l~H~niv~l~g~~~~~~~~~lV 591 (836)
|++.+.||+|+||.||++.... ++.||||+++... ....+.+..|+.++ +.++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 5667899999999999999754 8899999987542 23345666776665 456799999999999999999999
Q ss_pred EeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCC
Q 003254 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (836)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~ 671 (836)
|||+++++|...+. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 81 ~E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 99999999988773 346899999999999999999999998 99999999999999999999999999875322
Q ss_pred CccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccc
Q 003254 672 DQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQ 751 (836)
Q Consensus 672 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 751 (836)
. ........|++.|+|||.+.+..++.++|||||||++|||++|+.|+...... .. .........
T Consensus 154 ~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~---~~----~~~i~~~~~------ 218 (324)
T cd05589 154 F--GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE---EV----FDSIVNDEV------ 218 (324)
T ss_pred C--CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH---HH----HHHHHhCCC------
Confidence 1 11223467899999999999999999999999999999999999997532211 00 011111100
Q ss_pred cccCCCChHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 003254 752 SLDNSCSFSEALRCIQVGLLCVQQRPEDRP-----NMSSVVLM 789 (836)
Q Consensus 752 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~eVl~~ 789 (836)
..+......+.+++.+||+.||++|| ++.++++.
T Consensus 219 ----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 219 ----RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred ----CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 01111234567899999999999999 56666653
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=312.10 Aligned_cols=271 Identities=29% Similarity=0.407 Sum_probs=204.5
Q ss_pred ccccccCeecccCceeEEEEEee-----cCcEEEEEEecCCCch-hHHHHHHHHHHHHhhcCCceeeEEeEEee--CCee
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLI-----EGQEIAVKRLSKGSGQ-GMEEFKNEVLLIAKLQHRNLVKLLGCCTQ--RDER 588 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~-----~g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~ 588 (836)
+.|+..+.||+|+||.||++++. .+..+|||.+...... ..+.|.+|+++++.++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 45677789999999999999864 2678999999765443 56789999999999999999999999877 5578
Q ss_pred eEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccc
Q 003254 589 MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (836)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~ 668 (836)
++||||+++++|.+++... ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++..
T Consensus 84 ~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRH--RDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhC--ccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 9999999999999998543 235899999999999999999999988 99999999999999999999999999987
Q ss_pred cCCCcccc-ccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchh
Q 003254 669 FGLDQTEA-NTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLE 747 (836)
Q Consensus 669 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (836)
........ ......++..|+|||.+.+..++.++||||||++++||++|+.|+........... .............+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~ 237 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMI-GIAQGQMIVTRLLE 237 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccc-ccccccccHHHHHH
Confidence 65322211 11123445679999999988999999999999999999999988643222110000 00000000000001
Q ss_pred hccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 003254 748 LIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 793 (836)
Q Consensus 748 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 793 (836)
.+........+......+.+++.+|++.+|++||||.||+++|+.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 238 LLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 1111111111222335688999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=325.39 Aligned_cols=201 Identities=25% Similarity=0.372 Sum_probs=174.0
Q ss_pred ccccccCeecccCceeEEEEEeec-CcEEEEEEecCCC---chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEE
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 592 (836)
++|+..+.||+|+||.||++.... ++.||+|++.+.. ......+.+|+.++.+++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 478889999999999999998764 8899999986532 233457888999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCC
Q 003254 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (836)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~ 672 (836)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 81 EFLPGGDMMTLLMK---KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred cCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 99999999999853 356899999999999999999999998 999999999999999999999999998764321
Q ss_pred ccc---------------------------------cccccccccccccCcccccCCccCccccccchhhhhhhhhhCCC
Q 003254 673 QTE---------------------------------ANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKK 719 (836)
Q Consensus 673 ~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~ 719 (836)
... ......+||+.|+|||++.+..++.++|||||||+||||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 100 00123579999999999999999999999999999999999999
Q ss_pred CCCC
Q 003254 720 NRGF 723 (836)
Q Consensus 720 p~~~ 723 (836)
||..
T Consensus 235 Pf~~ 238 (363)
T cd05628 235 PFCS 238 (363)
T ss_pred CCCC
Confidence 9853
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=312.53 Aligned_cols=263 Identities=26% Similarity=0.392 Sum_probs=201.8
Q ss_pred ccccccCeecccCceeEEEEEe-----ecCcEEEEEEecCCC-chhHHHHHHHHHHHHhhcCCceeeEEeEEeeC--Cee
Q 003254 517 DNFSEKNKLGEGGFGPVYKGML-----IEGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR--DER 588 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~-----~~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~ 588 (836)
+.|++.+.||+|+||.||+++. ..+..||+|.++... ....+.+.+|+.+++.++|||++++.+++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 4567888999999999999974 247789999986553 34456799999999999999999999998775 568
Q ss_pred eEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccc
Q 003254 589 MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (836)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~ 668 (836)
++||||+++++|.+++... ...+++..+..++.||+.||+|||+.+ ++||||||+||++++++.+||+|||+++.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence 8999999999999998432 235899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCccc-cccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCcc--------ccchhhhhHHh
Q 003254 669 FGLDQTE-ANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADH--------DHNLLGHAWRL 739 (836)
Q Consensus 669 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~--------~~~~~~~~~~~ 739 (836)
+...... .......++..|+|||.+.+..++.++||||||+++|||++++.|........ ...........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV 238 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 6433221 11223456778999999998889999999999999999999876532211100 00000000000
Q ss_pred hhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 003254 740 WIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 793 (836)
Q Consensus 740 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 793 (836)
..... ...........+.+++.+|++.+|++|||+.++++.|+.+
T Consensus 239 ~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 239 LEEGK---------RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHcCc---------cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 00000 0011122345688999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=290.57 Aligned_cols=249 Identities=26% Similarity=0.356 Sum_probs=205.8
Q ss_pred cccccccCeecccCceeEEEEEeec-CcEEEEEEecCCC---chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEE
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 591 (836)
.++|++.+.||+|.||.||.|+.+. +-.||+|++.+.. .+..+++++|+++-+.|+||||+++++++.+....||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 3788999999999999999999865 6789999986542 33456889999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCC
Q 003254 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (836)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~ 671 (836)
+||.++|.|...|.+. +...+++.....++.|+|.||.|+|... |+||||||+|+|++.++..||+|||-+..-.
T Consensus 101 lEya~~gel~k~L~~~-~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p- 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEG-RMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP- 175 (281)
T ss_pred EEecCCchHHHHHHhc-ccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence 9999999999999643 4567889999999999999999999998 9999999999999999999999999987632
Q ss_pred CccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccc
Q 003254 672 DQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQ 751 (836)
Q Consensus 672 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 751 (836)
.......+||..|.|||...+..++..+|+|++|++.||++.|.+||+..... ...+.... .++.+
T Consensus 176 ---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~-------etYkrI~k---~~~~~- 241 (281)
T KOG0580|consen 176 ---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS-------ETYKRIRK---VDLKF- 241 (281)
T ss_pred ---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH-------HHHHHHHH---ccccC-
Confidence 22334589999999999999999999999999999999999999998643311 11111110 11111
Q ss_pred cccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 752 SLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 752 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
+......+.+++.+|+..+|.+|.+..||+..
T Consensus 242 ------p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 242 ------PSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred ------CcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 11223346799999999999999999999753
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=318.20 Aligned_cols=262 Identities=27% Similarity=0.396 Sum_probs=204.2
Q ss_pred ccccccCeecccCceeEEEEEeec--------CcEEEEEEecCCC-chhHHHHHHHHHHHHhh-cCCceeeEEeEEeeCC
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE--------GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRD 586 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~--------g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~ 586 (836)
.+|.+.+.||+|+||.||++.... +..||+|.+.... ....+++.+|+.++.++ +||||+++++++....
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 467888999999999999997532 2368999886543 34467899999999999 7999999999999999
Q ss_pred eeeEEEeecCCCChhHHHhhcc-------------CCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEec
Q 003254 587 ERMLIYEYLPNKSLDYFIFDTT-------------RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD 653 (836)
Q Consensus 587 ~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~ 653 (836)
..++++||+++|+|.+++.... ....+++..+..++.||++||+|||+.+ ++||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence 9999999999999999986432 2235888999999999999999999988 99999999999999
Q ss_pred CCCCceeeccCcccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccch
Q 003254 654 NTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNL 732 (836)
Q Consensus 654 ~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~ 732 (836)
+++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..|+......
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~----- 243 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE----- 243 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH-----
Confidence 999999999999987643222212222334568999999999999999999999999999998 77775322111
Q ss_pred hhhhHHhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCCCCC
Q 003254 733 LGHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLP 797 (836)
Q Consensus 733 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~~~ 797 (836)
............ ..+......+.+++.+|++.+|++||++.|+++.|+.+....
T Consensus 244 --~~~~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 244 --ELFKLLKEGHRM---------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred --HHHHHHHcCCCC---------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 111111111110 111122346779999999999999999999999999876433
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=305.47 Aligned_cols=254 Identities=28% Similarity=0.406 Sum_probs=191.7
Q ss_pred CeecccCceeEEEEEeec---CcEEEEEEecCCCc-hhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEeecCCC
Q 003254 523 NKLGEGGFGPVYKGMLIE---GQEIAVKRLSKGSG-QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNK 598 (836)
Q Consensus 523 ~~lG~G~fG~Vykg~~~~---g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 598 (836)
+.||+|+||.||+|...+ +..+|+|.++.... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 369999999999998644 45799998865542 34457889999999999999999999999999999999999999
Q ss_pred ChhHHHhhccC--CCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcccc
Q 003254 599 SLDYFIFDTTR--SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEA 676 (836)
Q Consensus 599 sL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~~ 676 (836)
+|.+++..... ...+++..+..++.|+++||+|||+.+ ++|+||||+||++++++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999865332 234667788899999999999999988 9999999999999999999999999997643332222
Q ss_pred ccccccccccccCcccccCC-------ccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhccCchhh
Q 003254 677 NTKRVVGTYGYMSPEYAIDG-------LFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEERPLEL 748 (836)
Q Consensus 677 ~~~~~~gt~~y~aPE~~~~~-------~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (836)
......++..|+|||++.+. .++.++||||||+++|||++ |+.|+....... .... .........
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~---~~~~----~~~~~~~~~ 230 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ---VLTY----TVREQQLKL 230 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH---HHHH----HhhcccCCC
Confidence 22334577889999998642 35789999999999999996 998875322211 1000 011111111
Q ss_pred ccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 003254 749 IDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLS 791 (836)
Q Consensus 749 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~ 791 (836)
.++.+. ......+.+++..|+ .+|++|||+.||+..|+
T Consensus 231 ~~~~~~----~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKPRLK----LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCccC----CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 111111 112234667888998 58999999999999885
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=326.15 Aligned_cols=254 Identities=21% Similarity=0.268 Sum_probs=199.1
Q ss_pred hcccccccCeecccCceeEEEEEeec-CcEEEEEEecCC---CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeE
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 590 (836)
..++|+..+.||+|+||.||+++... ++.||+|++.+. .....+.+.+|+.+++.++||||+++++++......++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 45789999999999999999999864 889999998643 22334567889999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccC
Q 003254 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (836)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~ 670 (836)
||||+++|+|..++.. ..++...+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++....
T Consensus 121 v~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 121 VMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 9999999999998843 34778888899999999999999998 9999999999999999999999999998754
Q ss_pred CCccccccccccccccccCcccccCC----ccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCch
Q 003254 671 LDQTEANTKRVVGTYGYMSPEYAIDG----LFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPL 746 (836)
Q Consensus 671 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (836)
.... .......||+.|+|||++.+. .++.++|||||||+||||++|+.||...... . ..........
T Consensus 194 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~-~~~~i~~~~~- 264 (370)
T cd05596 194 ANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------G-TYSKIMDHKN- 264 (370)
T ss_pred CCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH------H-HHHHHHcCCC-
Confidence 3221 112335799999999998653 4789999999999999999999997532211 0 1111111100
Q ss_pred hhccccccCCCChHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 003254 747 ELIDQSLDNSCSFSEALRCIQVGLLCVQQRPED--RPNMSSVVLM 789 (836)
Q Consensus 747 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~--RPt~~eVl~~ 789 (836)
. +.-.........+.+++..||+.+|++ ||++.|++..
T Consensus 265 ~-----~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 265 S-----LTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred c-----CCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 0 000011112345778999999999987 9999999764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=306.53 Aligned_cols=252 Identities=25% Similarity=0.385 Sum_probs=200.2
Q ss_pred ccccccCeecccCceeEEEEEee-cCcEEEEEEecCCCc-----hhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeE
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSG-----QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~~-----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 590 (836)
++|...+.||+|++|.||++... .++.+|+|.+..... ...+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57888999999999999999975 489999999864421 234578899999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccC
Q 003254 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (836)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~ 670 (836)
|+||+++++|.+++.. ...+++..+..++.+++.||.|||+.+ ++|+||+|+||++++++.++|+|||+++...
T Consensus 82 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKA---YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 9999999999998853 346888999999999999999999998 9999999999999999999999999997654
Q ss_pred CCccccc-cccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhc
Q 003254 671 LDQTEAN-TKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELI 749 (836)
Q Consensus 671 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (836)
....... .....++..|+|||.+.+..++.++||||||+++|||++|+.|+...... ...........
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~----- 224 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM------AAIFKIATQPT----- 224 (263)
T ss_pred ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH------HHHHHHhccCC-----
Confidence 3221111 12345788999999999988999999999999999999999986422111 00000000000
Q ss_pred cccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 750 DQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 750 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
....+......+.+++.+||+.+|++|||+.|+++.
T Consensus 225 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 225 ----NPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ----CCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 011122233457789999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=305.88 Aligned_cols=253 Identities=28% Similarity=0.440 Sum_probs=200.4
Q ss_pred ccccccCeecccCceeEEEEEeecCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEeecC
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLP 596 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 596 (836)
++|...++||+|++|.||++....+..+|+|++.... ...+.+.+|+.++++++|+|++++++++. ....++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 5678888999999999999998777789999886443 33567899999999999999999999875 456889999999
Q ss_pred CCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcccc
Q 003254 597 NKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEA 676 (836)
Q Consensus 597 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~~ 676 (836)
+++|.+++... ....+++..+..++.+++.||+|||+.+ ++|+||||+||++++++.++|+|||++.........
T Consensus 84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~- 158 (260)
T cd05069 84 KGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT- 158 (260)
T ss_pred CCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCccc-
Confidence 99999998643 2345889999999999999999999988 999999999999999999999999999865432211
Q ss_pred ccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhccCchhhccccccC
Q 003254 677 NTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDN 755 (836)
Q Consensus 677 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 755 (836)
......++..|+|||...+..++.++||||||+++|||++ |+.|+...... . .......... .
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~----~~~~~~~~~~---------~ 222 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR---E----VLEQVERGYR---------M 222 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH---H----HHHHHHcCCC---------C
Confidence 1122345678999999998899999999999999999999 88886432211 0 1111111100 0
Q ss_pred CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcC
Q 003254 756 SCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 792 (836)
Q Consensus 756 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~ 792 (836)
..+......+.+++.+||+.+|++||++.+|++.|+.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 223 PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1112233567899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=321.45 Aligned_cols=238 Identities=25% Similarity=0.300 Sum_probs=190.0
Q ss_pred CeecccCceeEEEEEee----cCcEEEEEEecCCC--chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEeecC
Q 003254 523 NKLGEGGFGPVYKGMLI----EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLP 596 (836)
Q Consensus 523 ~~lG~G~fG~Vykg~~~----~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 596 (836)
+.||+|+||.||+++.. .|+.||+|++.... ......+.+|++++++++||||+++++++......++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 57999999999998752 47899999987542 2234567789999999999999999999999999999999999
Q ss_pred CCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcccc
Q 003254 597 NKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEA 676 (836)
Q Consensus 597 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~~ 676 (836)
+|+|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++...... .
T Consensus 82 ~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~ 153 (318)
T cd05582 82 GGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--K 153 (318)
T ss_pred CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--C
Confidence 9999988843 346899999999999999999999998 9999999999999999999999999988653221 1
Q ss_pred ccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccccccCC
Q 003254 677 NTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDNS 756 (836)
Q Consensus 677 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 756 (836)
......|++.|+|||.+.+..++.++||||||+++|||++|+.|+...... .. ......... .
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~---~~----~~~i~~~~~----------~ 216 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK---ET----MTMILKAKL----------G 216 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH---HH----HHHHHcCCC----------C
Confidence 223357899999999999888999999999999999999999997532211 00 011111100 1
Q ss_pred CChHHHHHHHHHHHHcccCCCCCCCCHHH
Q 003254 757 CSFSEALRCIQVGLLCVQQRPEDRPNMSS 785 (836)
Q Consensus 757 ~~~~~~~~l~~li~~Cl~~dP~~RPt~~e 785 (836)
.+......+.+++.+||+.||++||++.+
T Consensus 217 ~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 217 MPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 11112345678999999999999999555
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=306.50 Aligned_cols=256 Identities=30% Similarity=0.455 Sum_probs=205.4
Q ss_pred hcccccccCeecccCceeEEEEEeecCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEee
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 594 (836)
..++|.+.+.||+|+||.||++...+++.+|||.+.... ...+++.+|+.++++++|+||+++++++......++||||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 346788899999999999999998888899999987543 3457899999999999999999999999988999999999
Q ss_pred cCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcc
Q 003254 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (836)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~ 674 (836)
+++++|.+++... ....+++..+..++.+++.||.|||+.+ ++|+||||+||++++++.+||+|||++..+.....
T Consensus 83 ~~~~~L~~~i~~~-~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 83 MSKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred cCCCCHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 9999999998543 2346899999999999999999999998 99999999999999999999999999987643211
Q ss_pred ccccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhccCchhhccccc
Q 003254 675 EANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSL 753 (836)
Q Consensus 675 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 753 (836)
........+..|+|||.+.+..++.++||||||++++||++ |+.|+...... ... ...... .
T Consensus 159 -~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~~----~~~~~~---------~ 221 (261)
T cd05034 159 -TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR---EVL----EQVERG---------Y 221 (261)
T ss_pred -hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHH----HHHHcC---------C
Confidence 11112334568999999998899999999999999999999 88886432111 111 111110 0
Q ss_pred cCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcC
Q 003254 754 DNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 792 (836)
Q Consensus 754 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~ 792 (836)
....+......+.+++.+|++.+|++||++.++++.|+.
T Consensus 222 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 222 RMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 001111123467899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=316.92 Aligned_cols=237 Identities=23% Similarity=0.289 Sum_probs=186.3
Q ss_pred CeecccCceeEEEEEee-cCcEEEEEEecCCC---chhHHHHHHHHH-HHHhhcCCceeeEEeEEeeCCeeeEEEeecCC
Q 003254 523 NKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS---GQGMEEFKNEVL-LIAKLQHRNLVKLLGCCTQRDERMLIYEYLPN 597 (836)
Q Consensus 523 ~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~-~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 597 (836)
+.||+|+||.||+++.. +|+.||+|++.... ....+++..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999986 48999999986532 223344555554 56778999999999999999999999999999
Q ss_pred CChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCccccc
Q 003254 598 KSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEAN 677 (836)
Q Consensus 598 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~ 677 (836)
|+|..++.. ...+++..+..++.||++||.|||+.+ |+||||||+|||+++++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (323)
T cd05575 81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--KT 152 (323)
T ss_pred CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--Cc
Confidence 999888843 456889999999999999999999998 9999999999999999999999999987532211 12
Q ss_pred cccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccccccCCC
Q 003254 678 TKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDNSC 757 (836)
Q Consensus 678 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 757 (836)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... . ......... + ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~------~-~~~~i~~~~--------~--~~ 215 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA------E-MYDNILNKP--------L--RL 215 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH------H-HHHHHHcCC--------C--CC
Confidence 23457899999999999999999999999999999999999997532111 0 011111110 0 01
Q ss_pred ChHHHHHHHHHHHHcccCCCCCCCCHH
Q 003254 758 SFSEALRCIQVGLLCVQQRPEDRPNMS 784 (836)
Q Consensus 758 ~~~~~~~l~~li~~Cl~~dP~~RPt~~ 784 (836)
.......+.+++.+||+.+|++||++.
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 216 KPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 111234577999999999999999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=304.90 Aligned_cols=250 Identities=34% Similarity=0.478 Sum_probs=202.6
Q ss_pred CeecccCceeEEEEEeec----CcEEEEEEecCCCch-hHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEeecCC
Q 003254 523 NKLGEGGFGPVYKGMLIE----GQEIAVKRLSKGSGQ-GMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPN 597 (836)
Q Consensus 523 ~~lG~G~fG~Vykg~~~~----g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 597 (836)
+.||+|+||.||++.... +..|++|.+...... ..+.+.+|++++..++|+|++++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999999864 788999998765433 367899999999999999999999999999999999999999
Q ss_pred CChhHHHhhccC------CCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCC
Q 003254 598 KSLDYFIFDTTR------SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (836)
Q Consensus 598 gsL~~~l~~~~~------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~ 671 (836)
++|.+++..... ...+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999865421 367899999999999999999999988 99999999999999999999999999988754
Q ss_pred CccccccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhccCchhhcc
Q 003254 672 DQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEERPLELID 750 (836)
Q Consensus 672 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 750 (836)
...........++..|+|||.+....++.++||||+|++++||++ |+.|+...... ...........
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-------~~~~~~~~~~~----- 225 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE-------EVLEYLRKGYR----- 225 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH-------HHHHHHHcCCC-----
Confidence 332222334567889999999998899999999999999999999 58886543111 11111111100
Q ss_pred ccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 003254 751 QSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLS 791 (836)
Q Consensus 751 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~ 791 (836)
...+......+.+++.+|++.+|++|||+.|+++.|+
T Consensus 226 ----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 226 ----LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ----CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 0111122456789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=306.66 Aligned_cols=247 Identities=23% Similarity=0.374 Sum_probs=205.7
Q ss_pred ccccccCeecccCceeEEEEEe-ecCcEEEEEEecCC---CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEE
Q 003254 517 DNFSEKNKLGEGGFGPVYKGML-IEGQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~-~~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 592 (836)
.+|++.+.||+|.||+|-++.. ..|+.||||.+++. +.+..-.+++|++||+.|+||||+.++.+|+..+.+.|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 4677788999999999999986 56999999999765 4455667899999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCC
Q 003254 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (836)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~ 672 (836)
||..+|.|.+++. +.+.|++.+..+++.||..|+.|+|.+. ++|||||.+|||||.|+++||+|||++-++...
T Consensus 133 EYaS~GeLYDYiS---er~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 133 EYASGGELYDYIS---ERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYADK 206 (668)
T ss_pred EecCCccHHHHHH---HhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhccc
Confidence 9999999999994 4567999999999999999999999998 999999999999999999999999999887533
Q ss_pred ccccccccccccccccCcccccCCccC-ccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccc
Q 003254 673 QTEANTKRVVGTYGYMSPEYAIDGLFS-VKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQ 751 (836)
Q Consensus 673 ~~~~~~~~~~gt~~y~aPE~~~~~~~t-~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 751 (836)
. -...++|++-|.+||+..+.+|. +.+|-|||||+||-|+.|.-||....- ..++ ++...+..
T Consensus 207 k---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh---k~lv----rQIs~GaY------ 270 (668)
T KOG0611|consen 207 K---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH---KRLV----RQISRGAY------ 270 (668)
T ss_pred c---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH---HHHH----HHhhcccc------
Confidence 2 23458999999999999999985 789999999999999999999753111 1111 11111111
Q ss_pred cccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 003254 752 SLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLML 790 (836)
Q Consensus 752 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L 790 (836)
...+......-||+|||-.+|+.|-|+.+|....
T Consensus 271 -----rEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 271 -----REPETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred -----cCCCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 1112234466799999999999999999998764
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=305.32 Aligned_cols=262 Identities=22% Similarity=0.289 Sum_probs=196.2
Q ss_pred ccccccCeecccCceeEEEEEeec-CcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCC-----eeeE
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD-----ERML 590 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-----~~~l 590 (836)
-.|...+++|.|.||.||+|++.. +++||||+...... .-..|+.+|++++|||||+++-++.... ...+
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl 99 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL 99 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence 356677899999999999999866 68999999865432 2246999999999999999999885533 2468
Q ss_pred EEeecCCCChhHHHhhc-cCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCC-CCceeeccCcccc
Q 003254 591 IYEYLPNKSLDYFIFDT-TRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNT-MNPKISDFGLARS 668 (836)
Q Consensus 591 V~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~-~~~kl~DFgla~~ 668 (836)
|||||+. +|...+.+. .....++...+.-+..||.+||+|||+.+ |+||||||.|+|+|.+ +.+||+|||.|+.
T Consensus 100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCccee
Confidence 9999998 787877653 23456888888899999999999999988 9999999999999965 9999999999998
Q ss_pred cCCCccccccccccccccccCcccccCC-ccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhH-----Hhhhc
Q 003254 669 FGLDQTEANTKRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAW-----RLWIE 742 (836)
Q Consensus 669 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~-----~~~~~ 742 (836)
+...... .....|..|+|||.+.+. .|+.+.||||.|||+.||+.|++-|......++...+-... +....
T Consensus 176 L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~ 252 (364)
T KOG0658|consen 176 LVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKS 252 (364)
T ss_pred eccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence 7544333 235678999999999875 69999999999999999999999876544333221111110 00000
Q ss_pred cCc--hhhccccccCC-----CChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 743 ERP--LELIDQSLDNS-----CSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 743 ~~~--~~~~d~~l~~~-----~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
..+ .+.-.+.+... .......++++++.++++.+|.+|.++.|++..
T Consensus 253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 001 11111222111 222344568899999999999999999999853
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=325.49 Aligned_cols=261 Identities=21% Similarity=0.284 Sum_probs=195.9
Q ss_pred cccccCeecccCceeEEEEEee-cCcEEEEEEecCC--CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCC-----eee
Q 003254 518 NFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD-----ERM 589 (836)
Q Consensus 518 ~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-----~~~ 589 (836)
+|+..+.||+|+||.||++... +++.||||++... .....+++.+|+.+++.++|+||+++++++.... ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4677899999999999999975 5899999998653 2234567889999999999999999999998776 789
Q ss_pred EEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCccccc
Q 003254 590 LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (836)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~ 669 (836)
+|+||+. ++|...+. ....+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 lv~e~~~-~~l~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIV---SPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999997 46767663 3456899999999999999999999998 999999999999999999999999999865
Q ss_pred CCCccccccccccccccccCcccccCC-ccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchh-
Q 003254 670 GLDQTEANTKRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLE- 747 (836)
Q Consensus 670 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~- 747 (836)
...... ......+++.|+|||.+.+. .++.++|||||||+++||++|+.||.......... ............+
T Consensus 154 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~---~i~~~~g~~~~~~~ 229 (372)
T cd07853 154 EPDESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLD---LITDLLGTPSLEAM 229 (372)
T ss_pred ccCccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHH---HHHHHcCCCCHHHH
Confidence 322211 12234678899999998875 47999999999999999999999986433221110 0000000000000
Q ss_pred ---------hccccc-c-------CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 748 ---------LIDQSL-D-------NSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 748 ---------~~d~~l-~-------~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
.+.... . ..........+.+++.+||+.||++|||+.|+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 230 RSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 000000 0 00111123457899999999999999999999874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=314.08 Aligned_cols=242 Identities=27% Similarity=0.366 Sum_probs=193.3
Q ss_pred CeecccCceeEEEEEeec-CcEEEEEEecCC---CchhHHHHHHHHHHHHhh-cCCceeeEEeEEeeCCeeeEEEeecCC
Q 003254 523 NKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDERMLIYEYLPN 597 (836)
Q Consensus 523 ~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 597 (836)
+.||+|+||.||++.... ++.||||++.+. .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999999865 789999998754 233456678899999888 699999999999999999999999999
Q ss_pred CChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCccccc
Q 003254 598 KSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEAN 677 (836)
Q Consensus 598 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~ 677 (836)
|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (318)
T cd05570 81 GDLMFHIQR---SGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VT 152 (318)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC--Cc
Confidence 999888843 346899999999999999999999998 9999999999999999999999999987532111 12
Q ss_pred cccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccccccCCC
Q 003254 678 TKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDNSC 757 (836)
Q Consensus 678 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 757 (836)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||...... . .......... ..
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~---~----~~~~i~~~~~----------~~ 215 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED---E----LFQSILEDEV----------RY 215 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH---H----HHHHHHcCCC----------CC
Confidence 23356899999999999999999999999999999999999997532211 0 1111111100 01
Q ss_pred ChHHHHHHHHHHHHcccCCCCCCCCH-----HHHHHH
Q 003254 758 SFSEALRCIQVGLLCVQQRPEDRPNM-----SSVVLM 789 (836)
Q Consensus 758 ~~~~~~~l~~li~~Cl~~dP~~RPt~-----~eVl~~ 789 (836)
+......+.+++.+||+.||++||++ .++++.
T Consensus 216 ~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 216 PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 11123457899999999999999999 888653
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=302.70 Aligned_cols=265 Identities=25% Similarity=0.348 Sum_probs=200.0
Q ss_pred cccccccCeecccCceeEEEEEeec-CcEEEEEEecCCCc--hhHHHHHHHHHHHHhhcCCc-eeeEEeEEeeCC-----
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSG--QGMEEFKNEVLLIAKLQHRN-LVKLLGCCTQRD----- 586 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~n-iv~l~g~~~~~~----- 586 (836)
...|...++||+|.||+||+|+... |+.||+|++..... .......+|+.++++++|+| ||++.+++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 3456677889999999999999754 88999999876543 23456789999999999999 999999998877
Q ss_pred -eeeEEEeecCCCChhHHHhhccCC-CcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccC
Q 003254 587 -ERMLIYEYLPNKSLDYFIFDTTRS-KLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFG 664 (836)
Q Consensus 587 -~~~lV~Ey~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFg 664 (836)
..+|||||++. +|..++...... ..++...+..++.||+.||+|||+++ |+||||||+||||+++|.+||+|||
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccc
Confidence 78899999965 888888654422 34666889999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCccccccccccccccccCcccccCC-ccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhcc
Q 003254 665 LARSFGLDQTEANTKRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEE 743 (836)
Q Consensus 665 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 743 (836)
+|+.+.-+... ....++|..|+|||++.+. .|+...||||+|||+.||++++.-|......++ .....+.....
T Consensus 166 lAra~~ip~~~--yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~q---l~~If~~lGtP 240 (323)
T KOG0594|consen 166 LARAFSIPMRT--YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQ---LFRIFRLLGTP 240 (323)
T ss_pred hHHHhcCCccc--ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHH---HHHHHHHcCCC
Confidence 99976533322 3346789999999999987 699999999999999999998887654333211 11111111110
Q ss_pred C----ch--hhcccc--ccC---C--CChHH---HHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 744 R----PL--ELIDQS--LDN---S--CSFSE---ALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 744 ~----~~--~~~d~~--l~~---~--~~~~~---~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
. +. .+.+.. ... . ..... .....+++.+||+.+|.+|.|++.++++
T Consensus 241 ~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 241 NEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 0 00 011110 000 0 00001 1357899999999999999999999886
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=315.89 Aligned_cols=259 Identities=28% Similarity=0.405 Sum_probs=202.3
Q ss_pred ccccccCeecccCceeEEEEEee--------cCcEEEEEEecCCC-chhHHHHHHHHHHHHhh-cCCceeeEEeEEeeCC
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLI--------EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRD 586 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~--------~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~ 586 (836)
++|.+.++||+|+||.||+++.. ....+|+|.+.... .....++.+|+.+++++ +||||+++++++....
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 57788899999999999999752 24568999987543 34456789999999999 6999999999999989
Q ss_pred eeeEEEeecCCCChhHHHhhcc-------------CCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEec
Q 003254 587 ERMLIYEYLPNKSLDYFIFDTT-------------RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD 653 (836)
Q Consensus 587 ~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~ 653 (836)
..++||||+++|+|.+++.... ....+++..+.+++.||+.||.|||+.+ ++||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEEc
Confidence 9999999999999999986532 1245889999999999999999999988 99999999999999
Q ss_pred CCCCceeeccCcccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccch
Q 003254 654 NTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNL 732 (836)
Q Consensus 654 ~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~ 732 (836)
+++.+||+|||+++...............++..|+|||.+.++.++.++||||||+++|||++ |+.|+......
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~----- 243 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE----- 243 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH-----
Confidence 999999999999987643222111112234567999999999899999999999999999999 77776422111
Q ss_pred hhhhHHhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 003254 733 LGHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 794 (836)
Q Consensus 733 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 794 (836)
............ ..+......+.+++.+|++.+|++|||+.|+++.|+++.
T Consensus 244 --~~~~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 294 (314)
T cd05099 244 --ELFKLLREGHRM---------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294 (314)
T ss_pred --HHHHHHHcCCCC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 111111111110 111222345779999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=305.32 Aligned_cols=248 Identities=26% Similarity=0.403 Sum_probs=194.3
Q ss_pred eecccCceeEEEEEee---cCcEEEEEEecCCCc-hhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEeecCCCC
Q 003254 524 KLGEGGFGPVYKGMLI---EGQEIAVKRLSKGSG-QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKS 599 (836)
Q Consensus 524 ~lG~G~fG~Vykg~~~---~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gs 599 (836)
.||+|+||.||+|++. .+..||+|++..... ...+++.+|+.++++++|+||+++++++. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999864 355799999876533 34567999999999999999999999885 457899999999999
Q ss_pred hhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCccccc-c
Q 003254 600 LDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEAN-T 678 (836)
Q Consensus 600 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~-~ 678 (836)
|.+++.. ....+++..+++++.|++.||+|||+++ ++||||||+|||++.++.+||+|||++..+........ .
T Consensus 81 L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 81 LNKFLSG--KKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 9998853 2346899999999999999999999988 99999999999999999999999999986543322111 1
Q ss_pred ccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhccCchhhccccccCCC
Q 003254 679 KRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDNSC 757 (836)
Q Consensus 679 ~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 757 (836)
....++..|+|||.+.+..++.++||||||+++|||++ |+.|+...... .......... ....
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-------~~~~~~~~~~---------~~~~ 219 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP-------EVMSFIEQGK---------RLDC 219 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH-------HHHHHHHCCC---------CCCC
Confidence 11233578999999988889999999999999999996 88886432211 0111111111 1112
Q ss_pred ChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 003254 758 SFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 793 (836)
Q Consensus 758 ~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 793 (836)
+......+.+++.+||+.+|++||++.+|.+.|+..
T Consensus 220 ~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 220 PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 223345677899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=315.06 Aligned_cols=255 Identities=28% Similarity=0.452 Sum_probs=198.6
Q ss_pred ccccccCeecccCceeEEEEEeec-Cc--EEEEEEecCC-CchhHHHHHHHHHHHHhh-cCCceeeEEeEEeeCCeeeEE
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQ--EIAVKRLSKG-SGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDERMLI 591 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-g~--~vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV 591 (836)
++|++.+.||+|+||.||+|...+ +. .+++|.+... .....+++.+|++++.++ +|+||+++++++...+..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 577888999999999999999754 44 4688877643 234556789999999999 899999999999999999999
Q ss_pred EeecCCCChhHHHhhcc-------------CCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCc
Q 003254 592 YEYLPNKSLDYFIFDTT-------------RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNP 658 (836)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~ 658 (836)
|||+++++|.+++.... ....+++..++.++.||+.||+|||+.+ ++||||||+|||+++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence 99999999999986432 1235789999999999999999999988 9999999999999999999
Q ss_pred eeeccCcccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhH
Q 003254 659 KISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAW 737 (836)
Q Consensus 659 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~ 737 (836)
||+|||+++..... .......++..|+|||++.+..++.++||||||++++||++ |..|+....... . .
T Consensus 164 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~----~ 233 (303)
T cd05088 164 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---L----Y 233 (303)
T ss_pred EeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH---H----H
Confidence 99999998642111 11111234668999999988889999999999999999998 888864322110 0 0
Q ss_pred HhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 003254 738 RLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 793 (836)
Q Consensus 738 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 793 (836)
...... .....+......+.+++.+|++.+|++||++.++++.|+.+
T Consensus 234 ~~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~ 280 (303)
T cd05088 234 EKLPQG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 280 (303)
T ss_pred HHHhcC---------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111000 00001111234578999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=319.06 Aligned_cols=236 Identities=27% Similarity=0.414 Sum_probs=189.1
Q ss_pred CeecccCceeEEEEEeec-CcEEEEEEecCC---CchhHHHHHHHHHHHHhh-cCCceeeEEeEEeeCCeeeEEEeecCC
Q 003254 523 NKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDERMLIYEYLPN 597 (836)
Q Consensus 523 ~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 597 (836)
+.||+|+||.||+++... ++.||||++.+. .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 369999999999999865 789999998653 233456677888888876 699999999999999999999999999
Q ss_pred CChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCccccc
Q 003254 598 KSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEAN 677 (836)
Q Consensus 598 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~ 677 (836)
|+|..++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~~---~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~ 152 (320)
T cd05590 81 GDLMFHIQK---SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KT 152 (320)
T ss_pred chHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--Cc
Confidence 999988843 346889999999999999999999998 9999999999999999999999999987542211 12
Q ss_pred cccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccccccCCC
Q 003254 678 TKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDNSC 757 (836)
Q Consensus 678 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 757 (836)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ........... ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-------~~~~~i~~~~~----------~~ 215 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED-------DLFEAILNDEV----------VY 215 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH-------HHHHHHhcCCC----------CC
Confidence 23457899999999999999999999999999999999999997532211 01111111110 01
Q ss_pred ChHHHHHHHHHHHHcccCCCCCCCCH
Q 003254 758 SFSEALRCIQVGLLCVQQRPEDRPNM 783 (836)
Q Consensus 758 ~~~~~~~l~~li~~Cl~~dP~~RPt~ 783 (836)
+......+.+++.+||+.||++||++
T Consensus 216 ~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 216 PTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 11123457799999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=321.78 Aligned_cols=260 Identities=29% Similarity=0.413 Sum_probs=199.3
Q ss_pred ccccccCeecccCceeEEEEEe------ecCcEEEEEEecCCC-chhHHHHHHHHHHHHhh-cCCceeeEEeEEeeC-Ce
Q 003254 517 DNFSEKNKLGEGGFGPVYKGML------IEGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQR-DE 587 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~------~~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~-~~ 587 (836)
++|+..+.||+|+||.||+|.. ..++.||||+++... ....+.+.+|+.++.++ +|+||+++++++... ..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 5788899999999999999974 246789999997543 23456788999999999 689999999988654 45
Q ss_pred eeEEEeecCCCChhHHHhhccC----------------------------------------------------------
Q 003254 588 RMLIYEYLPNKSLDYFIFDTTR---------------------------------------------------------- 609 (836)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~---------------------------------------------------------- 609 (836)
.++||||+++|+|.+++.....
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 7899999999999999864210
Q ss_pred ------CCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCccccccccccc
Q 003254 610 ------SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVG 683 (836)
Q Consensus 610 ------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~~~g 683 (836)
...+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||++..+.............+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 124678888999999999999999988 99999999999999999999999999987543222222222345
Q ss_pred cccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhccCchhhccccccCCCChHHH
Q 003254 684 TYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDNSCSFSEA 762 (836)
Q Consensus 684 t~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 762 (836)
+..|+|||.+.+..++.++||||||+++|||++ |..|+...... .. ............ .+....
T Consensus 244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~----~~~~~~~~~~~~---------~~~~~~ 308 (343)
T cd05103 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EE----FCRRLKEGTRMR---------APDYTT 308 (343)
T ss_pred CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc--HH----HHHHHhccCCCC---------CCCCCC
Confidence 678999999999899999999999999999997 88775432111 00 111111111000 011112
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 003254 763 LRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 794 (836)
Q Consensus 763 ~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 794 (836)
..+.+++..||+.+|++|||+.||++.|+.+.
T Consensus 309 ~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~ 340 (343)
T cd05103 309 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 340 (343)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 35789999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=315.98 Aligned_cols=240 Identities=25% Similarity=0.350 Sum_probs=189.5
Q ss_pred CeecccCceeEEEEEeec-CcEEEEEEecCCC---chhHHHHHHHHHHHHhh-cCCceeeEEeEEeeCCeeeEEEeecCC
Q 003254 523 NKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDERMLIYEYLPN 597 (836)
Q Consensus 523 ~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 597 (836)
+.||+|+||.||+++... |+.||+|.++... ....+.+..|..++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 469999999999999864 8899999987532 23445667788888765 899999999999999999999999999
Q ss_pred CChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCccccc
Q 003254 598 KSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEAN 677 (836)
Q Consensus 598 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~ 677 (836)
|+|..++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (316)
T cd05620 81 GDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NR 152 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC--Cc
Confidence 999888843 346889999999999999999999998 9999999999999999999999999987532111 12
Q ss_pred cccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccccccCCC
Q 003254 678 TKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDNSC 757 (836)
Q Consensus 678 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 757 (836)
.....|++.|+|||++.+..++.++|||||||++|||++|+.|+...... . ..+...... +. .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~---~----~~~~~~~~~------~~----~ 215 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED---E----LFESIRVDT------PH----Y 215 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---H----HHHHHHhCC------CC----C
Confidence 23467899999999999999999999999999999999999997532211 1 111111110 00 1
Q ss_pred ChHHHHHHHHHHHHcccCCCCCCCCHH-HHH
Q 003254 758 SFSEALRCIQVGLLCVQQRPEDRPNMS-SVV 787 (836)
Q Consensus 758 ~~~~~~~l~~li~~Cl~~dP~~RPt~~-eVl 787 (836)
+......+.+++.+||+.||++||++. +++
T Consensus 216 ~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 216 PRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 111224567899999999999999985 555
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=312.93 Aligned_cols=263 Identities=23% Similarity=0.312 Sum_probs=199.8
Q ss_pred ccccccCeecccCceeEEEEEeec-CcEEEEEEecCCC-chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEee
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 594 (836)
++|++.+.||+|+||.||++.... +..+|+|.+.... ....+++.+|++++.+++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 468889999999999999999754 7889999886542 33456788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcC-CCCcEEeccCCCCceEecCCCCceeeccCcccccCCCc
Q 003254 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (836)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~ 673 (836)
+++++|.+++.. ...+++..+..++.|+++||.|||+. + ++|+||||+|||+++++.+||+|||++......
T Consensus 81 ~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 153 (308)
T cd06615 81 MDGGSLDQVLKK---AGRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 153 (308)
T ss_pred cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccccccc-
Confidence 999999999853 35688999999999999999999974 5 999999999999999999999999998764322
Q ss_pred cccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhcc----------
Q 003254 674 TEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEE---------- 743 (836)
Q Consensus 674 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---------- 743 (836)
......++..|+|||.+.+..++.++||||||++++||++|+.|+......................
T Consensus 154 ---~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (308)
T cd06615 154 ---MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHP 230 (308)
T ss_pred ---ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCC
Confidence 1223568899999999988889999999999999999999999974322111100000000000000
Q ss_pred -------CchhhccccccC---C-CChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 744 -------RPLELIDQSLDN---S-CSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 744 -------~~~~~~d~~l~~---~-~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
...+..+..... . ........+.+++.+||+.+|++|||+.||++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 231 PDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000001100000 0 000123457899999999999999999999875
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=311.70 Aligned_cols=251 Identities=24% Similarity=0.384 Sum_probs=202.7
Q ss_pred hcccccccCeecccCceeEEEEEee-cCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEe
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 593 (836)
...+|+..+.||+|+||.||+|+.. +++.|++|.+........+.+.+|+.+++.++|+|++++++.+......++|||
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e 97 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeec
Confidence 3467888899999999999999864 488999999977665566788999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCc
Q 003254 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (836)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~ 673 (836)
|+++++|.+++.. ..+++.++..++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||++.......
T Consensus 98 ~~~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~ 170 (296)
T cd06654 98 YLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (296)
T ss_pred ccCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence 9999999998842 35789999999999999999999998 9999999999999999999999999988653222
Q ss_pred cccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccccc
Q 003254 674 TEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSL 753 (836)
Q Consensus 674 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 753 (836)
. ......+++.|+|||.+.+..++.++|||||||++|||++|+.||....... .......... .. +
T Consensus 171 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~------~~~~~~~~~~-~~-----~ 236 (296)
T cd06654 171 S--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR------ALYLIATNGT-PE-----L 236 (296)
T ss_pred c--ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH------hHHHHhcCCC-CC-----C
Confidence 1 1122468889999999998889999999999999999999999975322211 0000000000 00 0
Q ss_pred cCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 754 DNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 754 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
..+......+.+++.+||+.+|++||++.||++
T Consensus 237 --~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 237 --QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred --CCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 011122345778999999999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=326.37 Aligned_cols=200 Identities=24% Similarity=0.397 Sum_probs=171.4
Q ss_pred cccccCeecccCceeEEEEEeec-CcEEEEEEecCCC---chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEe
Q 003254 518 NFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (836)
Q Consensus 518 ~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 593 (836)
.|+..++||+|+||.||+|+... ++.||+|++.... ....+.+.+|+.++++++|+||+++++.+.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 57888999999999999999754 7889999986542 2345678899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCc
Q 003254 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (836)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~ 673 (836)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 82 YIPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 9999999998853 346788889999999999999999998 9999999999999999999999999976432100
Q ss_pred c---------------------------------------------ccccccccccccccCcccccCCccCccccccchh
Q 003254 674 T---------------------------------------------EANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFG 708 (836)
Q Consensus 674 ~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~G 708 (836)
. .......+||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 0 0001224689999999999999999999999999
Q ss_pred hhhhhhhhCCCCCCC
Q 003254 709 VLVLEIICGKKNRGF 723 (836)
Q Consensus 709 vvL~elltG~~p~~~ 723 (836)
|+||||++|+.||..
T Consensus 236 vil~elltG~~Pf~~ 250 (382)
T cd05625 236 VILYEMLVGQPPFLA 250 (382)
T ss_pred HHHHHHHhCCCCCCC
Confidence 999999999999854
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=318.65 Aligned_cols=246 Identities=26% Similarity=0.353 Sum_probs=194.5
Q ss_pred cccccCeecccCceeEEEEEeec-CcEEEEEEecCC---CchhHHHHHHHHHHHHhhcCC-ceeeEEeEEeeCCeeeEEE
Q 003254 518 NFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHR-NLVKLLGCCTQRDERMLIY 592 (836)
Q Consensus 518 ~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~-niv~l~g~~~~~~~~~lV~ 592 (836)
+|+..+.||+|+||.||+|+..+ ++.||||++... .....+.+..|+.++..++|+ +|+++++++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 47788999999999999999865 788999998753 233456788899999999765 6888999999999999999
Q ss_pred eecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCC
Q 003254 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (836)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~ 672 (836)
||+++|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQQ---VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 99999999988843 345889999999999999999999998 999999999999999999999999998753221
Q ss_pred ccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhcccc
Q 003254 673 QTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQS 752 (836)
Q Consensus 673 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 752 (836)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.|+...... .. .........
T Consensus 155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---~~----~~~i~~~~~------- 218 (324)
T cd05587 155 G--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED---EL----FQSIMEHNV------- 218 (324)
T ss_pred C--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HH----HHHHHcCCC-------
Confidence 1 1223357899999999999999999999999999999999999997532211 11 111111100
Q ss_pred ccCCCChHHHHHHHHHHHHcccCCCCCCCCH-----HHHHH
Q 003254 753 LDNSCSFSEALRCIQVGLLCVQQRPEDRPNM-----SSVVL 788 (836)
Q Consensus 753 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~-----~eVl~ 788 (836)
..+......+.+++.+||+.+|++||+. .++++
T Consensus 219 ---~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 256 (324)
T cd05587 219 ---SYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIRE 256 (324)
T ss_pred ---CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 1111223457789999999999999976 55554
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=302.89 Aligned_cols=249 Identities=28% Similarity=0.378 Sum_probs=197.8
Q ss_pred CeecccCceeEEEEEeecCcEEEEEEecCCCch-hHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEeecCCCChh
Q 003254 523 NKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQ-GMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLD 601 (836)
Q Consensus 523 ~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~ 601 (836)
++||+|+||.||++...+++.||+|++...... ..+.+.+|++++++++|+||+++++++......++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 369999999999999877999999998765443 5678999999999999999999999999999999999999999999
Q ss_pred HHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCccccccccc
Q 003254 602 YFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRV 681 (836)
Q Consensus 602 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~~ 681 (836)
+++... ...+++..+..++.+++.||+|||+++ ++||||||+||+++.++.+||+|||++...............
T Consensus 81 ~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 81 TFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 988543 235788999999999999999999998 999999999999999999999999999865322211111122
Q ss_pred cccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhccCchhhccccccCCCChH
Q 003254 682 VGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDNSCSFS 760 (836)
Q Consensus 682 ~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 760 (836)
..+..|+|||.+.++.++.++||||||++++||++ |..|+....... ........ .....+..
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~-------~~~~~~~~---------~~~~~~~~ 219 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ-------TRERIESG---------YRMPAPQL 219 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH-------HHHHHhcC---------CCCCCCcc
Confidence 34567999999998899999999999999999999 777753322110 00111000 00011122
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHhcC
Q 003254 761 EALRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 792 (836)
Q Consensus 761 ~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~ 792 (836)
....+.+++.+|++.+|++|||+.||++.|+.
T Consensus 220 ~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 220 CPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 23468899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=313.87 Aligned_cols=241 Identities=26% Similarity=0.384 Sum_probs=190.1
Q ss_pred CeecccCceeEEEEEeec-CcEEEEEEecCCC---chhHHHHHHHHHHHHhh-cCCceeeEEeEEeeCCeeeEEEeecCC
Q 003254 523 NKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDERMLIYEYLPN 597 (836)
Q Consensus 523 ~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 597 (836)
+.||+|+||.||+|+... ++.||||+++... ....+.+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 469999999999999865 7889999987542 23345567788888764 899999999999999999999999999
Q ss_pred CChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCccccc
Q 003254 598 KSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEAN 677 (836)
Q Consensus 598 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~ 677 (836)
|+|..++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (316)
T cd05619 81 GDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AK 152 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--Cc
Confidence 999998843 346889999999999999999999998 9999999999999999999999999987532211 12
Q ss_pred cccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccccccCCC
Q 003254 678 TKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDNSC 757 (836)
Q Consensus 678 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 757 (836)
.....||+.|+|||++.+..++.++|||||||++|||++|+.|+...... .. ........ +..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~---~~----~~~i~~~~------~~~---- 215 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE---EL----FQSIRMDN------PCY---- 215 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH---HH----HHHHHhCC------CCC----
Confidence 23457899999999999999999999999999999999999997532211 11 11111000 001
Q ss_pred ChHHHHHHHHHHHHcccCCCCCCCCHH-HHHH
Q 003254 758 SFSEALRCIQVGLLCVQQRPEDRPNMS-SVVL 788 (836)
Q Consensus 758 ~~~~~~~l~~li~~Cl~~dP~~RPt~~-eVl~ 788 (836)
+......+.+++.+||+.+|++||++. ++.+
T Consensus 216 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 216 PRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred CccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 111223567899999999999999997 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=304.24 Aligned_cols=249 Identities=32% Similarity=0.482 Sum_probs=196.0
Q ss_pred CeecccCceeEEEEEeec-C---cEEEEEEecCCCc-hhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEeecCC
Q 003254 523 NKLGEGGFGPVYKGMLIE-G---QEIAVKRLSKGSG-QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPN 597 (836)
Q Consensus 523 ~~lG~G~fG~Vykg~~~~-g---~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 597 (836)
++||+|+||.||+|+... + ..+|+|.+..... ...+++.+|+.+++.++|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 469999999999998643 2 6899999876543 34567899999999999999999999876 5568999999999
Q ss_pred CChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCccccc
Q 003254 598 KSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEAN 677 (836)
Q Consensus 598 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~ 677 (836)
++|.+++... ..+++..+..++.|++.||+|||..+ ++|+||||+|||+++++.+||+|||+++.+........
T Consensus 80 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 80 GPLLKYLKKR---REIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 9999999543 36899999999999999999999988 99999999999999999999999999987643322111
Q ss_pred -cccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhccCchhhccccccC
Q 003254 678 -TKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDN 755 (836)
Q Consensus 678 -~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 755 (836)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.|+...... ... .........
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~---~~~----~~~~~~~~~--------- 217 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA---EVI----AMLESGERL--------- 217 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH---HHH----HHHHcCCcC---------
Confidence 111223567999999998899999999999999999998 88887532211 111 111111110
Q ss_pred CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 003254 756 SCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 794 (836)
Q Consensus 756 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 794 (836)
..+......+.+++.+|++.+|++||++.+|++.|+++.
T Consensus 218 ~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 218 PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 111122346779999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=305.33 Aligned_cols=258 Identities=24% Similarity=0.359 Sum_probs=200.4
Q ss_pred HhhcccccccCeecccCceeEEEEEeec-CcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEE
Q 003254 513 ANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (836)
Q Consensus 513 ~~a~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 591 (836)
+.+++++.....||+|+||.||+|+..+ +..|++|.+........+.+.+|+.++++++|+||+++++++..++..++|
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 83 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF 83 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence 4456666667799999999999999754 778999998777666778899999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecC-CCCceeeccCcccccC
Q 003254 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-TMNPKISDFGLARSFG 670 (836)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~-~~~~kl~DFgla~~~~ 670 (836)
+||+++++|.+++.........++..+..++.||+.||+|||+.+ |+||||||+||+++. ++.+||+|||++....
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 160 (268)
T cd06624 84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 160 (268)
T ss_pred EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence 999999999999864322112277888899999999999999988 999999999999976 6799999999987653
Q ss_pred CCccccccccccccccccCcccccCCc--cCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhh
Q 003254 671 LDQTEANTKRVVGTYGYMSPEYAIDGL--FSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLEL 748 (836)
Q Consensus 671 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (836)
.... ......++..|+|||++.+.. ++.++||||||+++|||++|+.|+......... .+......
T Consensus 161 ~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~-----~~~~~~~~----- 228 (268)
T cd06624 161 GINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA-----MFKVGMFK----- 228 (268)
T ss_pred cCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh-----Hhhhhhhc-----
Confidence 2211 122345788999999987654 789999999999999999999987432111000 00000000
Q ss_pred ccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 749 IDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 749 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
.....+......+.+++.+||+.+|++|||+.|+++.
T Consensus 229 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 229 ----IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred ----cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 0011122233457789999999999999999999863
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=323.19 Aligned_cols=258 Identities=21% Similarity=0.256 Sum_probs=198.8
Q ss_pred HHHhhcccccccCeecccCceeEEEEEeec-CcEEEEEEecCC---CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCC
Q 003254 511 IIANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD 586 (836)
Q Consensus 511 ~l~~a~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~ 586 (836)
.+....++|+..+.||+|+||.||+++... ++.+|+|.+.+. .....+.+.+|+.+++.++||||+++++++...+
T Consensus 37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (370)
T cd05621 37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK 116 (370)
T ss_pred hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 344456789999999999999999999865 788999998642 2233456889999999999999999999999999
Q ss_pred eeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcc
Q 003254 587 ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLA 666 (836)
Q Consensus 587 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla 666 (836)
..++||||+++|+|.+++.. ..++...+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a 189 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTC 189 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccc
Confidence 99999999999999998843 34788899999999999999999998 999999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCcccccCC----ccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhc
Q 003254 667 RSFGLDQTEANTKRVVGTYGYMSPEYAIDG----LFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIE 742 (836)
Q Consensus 667 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 742 (836)
..+.... ........||+.|+|||++.+. .++.++||||+||+||||++|+.||...... . .......
T Consensus 190 ~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~------~-~~~~i~~ 261 (370)
T cd05621 190 MKMDETG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV------G-TYSKIMD 261 (370)
T ss_pred eecccCC-ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH------H-HHHHHHh
Confidence 8764221 1122346799999999998754 3789999999999999999999998532211 1 1111111
Q ss_pred cCchhhccccccCCCChHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 003254 743 ERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPED--RPNMSSVVLM 789 (836)
Q Consensus 743 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~--RPt~~eVl~~ 789 (836)
... .+...........+.+++..|++.++.. ||++.|+++.
T Consensus 262 ~~~------~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 262 HKN------SLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred CCc------ccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 000 0000011112344668888898755543 8899999886
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=315.95 Aligned_cols=237 Identities=22% Similarity=0.300 Sum_probs=185.7
Q ss_pred CeecccCceeEEEEEeec-CcEEEEEEecCCC---chhHHHHHHHHH-HHHhhcCCceeeEEeEEeeCCeeeEEEeecCC
Q 003254 523 NKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVL-LIAKLQHRNLVKLLGCCTQRDERMLIYEYLPN 597 (836)
Q Consensus 523 ~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~-~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 597 (836)
+.||+|+||.||+++... ++.||+|++.+.. .....++..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999999854 8899999986532 222344555554 57889999999999999999999999999999
Q ss_pred CChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCccccc
Q 003254 598 KSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEAN 677 (836)
Q Consensus 598 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~ 677 (836)
++|...+.. ...++...+..++.||++||.|||+.+ |+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (321)
T cd05603 81 GELFFHLQR---ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ET 152 (321)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--Cc
Confidence 999887743 346788889999999999999999988 9999999999999999999999999987532211 12
Q ss_pred cccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccccccCCC
Q 003254 678 TKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDNSC 757 (836)
Q Consensus 678 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 757 (836)
.....|++.|+|||.+.+..++.++|||||||++|||++|+.||...... . ........ . + ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~-~~~~i~~~-~-------~--~~ 215 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS------Q-MYDNILHK-P-------L--QL 215 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH------H-HHHHHhcC-C-------C--CC
Confidence 23457899999999999989999999999999999999999997532110 0 11111111 0 0 11
Q ss_pred ChHHHHHHHHHHHHcccCCCCCCCCHH
Q 003254 758 SFSEALRCIQVGLLCVQQRPEDRPNMS 784 (836)
Q Consensus 758 ~~~~~~~l~~li~~Cl~~dP~~RPt~~ 784 (836)
+......+.+++.+||+.+|++||+..
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 216 PGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 122334678999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=316.88 Aligned_cols=238 Identities=21% Similarity=0.297 Sum_probs=186.8
Q ss_pred CeecccCceeEEEEEee-cCcEEEEEEecCC---CchhHHHHHHHHH-HHHhhcCCceeeEEeEEeeCCeeeEEEeecCC
Q 003254 523 NKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG---SGQGMEEFKNEVL-LIAKLQHRNLVKLLGCCTQRDERMLIYEYLPN 597 (836)
Q Consensus 523 ~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~-~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 597 (836)
+.||+|+||.||+++.. +|+.+|+|++... ......++..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999975 4889999998654 2233345556655 46778999999999999999999999999999
Q ss_pred CChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCccccc
Q 003254 598 KSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEAN 677 (836)
Q Consensus 598 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~ 677 (836)
|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++..... ...
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~~ 152 (325)
T cd05604 81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--SDT 152 (325)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCC--CCC
Confidence 999888743 456899999999999999999999998 999999999999999999999999998753211 112
Q ss_pred cccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccccccCCC
Q 003254 678 TKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDNSC 757 (836)
Q Consensus 678 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 757 (836)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||...... . ......... + ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~---~----~~~~~~~~~--------~--~~ 215 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA---E----MYDNILHKP--------L--VL 215 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH---H----HHHHHHcCC--------c--cC
Confidence 23467899999999999999999999999999999999999997532211 0 111111110 0 00
Q ss_pred ChHHHHHHHHHHHHcccCCCCCCCCHHH
Q 003254 758 SFSEALRCIQVGLLCVQQRPEDRPNMSS 785 (836)
Q Consensus 758 ~~~~~~~l~~li~~Cl~~dP~~RPt~~e 785 (836)
.......+.+++.+|++.+|++||++.+
T Consensus 216 ~~~~~~~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 216 RPGASLTAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred CCCCCHHHHHHHHHHhccCHHhcCCCCC
Confidence 1112345678999999999999998864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=308.01 Aligned_cols=254 Identities=28% Similarity=0.402 Sum_probs=198.3
Q ss_pred HhhcccccccCeecccCceeEEEEEeec-CcEEEEEEecCCCchhHHHHHHHHHHHHhh-cCCceeeEEeEEeeC-----
Q 003254 513 ANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQR----- 585 (836)
Q Consensus 513 ~~a~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~----- 585 (836)
+.+++.|+..+.||+|+||.||+|...+ ++.||+|++.... ....++.+|+.++.++ +|+||+++++++...
T Consensus 2 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 2 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred CChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 3466788889999999999999999765 7889999986543 3456788999999998 699999999998753
Q ss_pred -CeeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccC
Q 003254 586 -DERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFG 664 (836)
Q Consensus 586 -~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFg 664 (836)
...++||||+++++|.+++... ....+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg 156 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFG 156 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCC
Confidence 3578999999999999988542 3356889999999999999999999988 9999999999999999999999999
Q ss_pred cccccCCCccccccccccccccccCccccc-----CCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHh
Q 003254 665 LARSFGLDQTEANTKRVVGTYGYMSPEYAI-----DGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRL 739 (836)
Q Consensus 665 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~ 739 (836)
++....... .......|+..|+|||++. +..++.++|||||||++|||++|+.|+....... ....
T Consensus 157 ~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~-------~~~~ 227 (272)
T cd06637 157 VSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR-------ALFL 227 (272)
T ss_pred Cceeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH-------HHHH
Confidence 998653221 1223356889999999986 3458889999999999999999999874321110 0000
Q ss_pred hhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 740 WIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 740 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
.......... .......+.+++.+||+.+|.+|||+.||++
T Consensus 228 ~~~~~~~~~~--------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 228 IPRNPAPRLK--------SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred HhcCCCCCCC--------CCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 0000000010 1112235779999999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=305.81 Aligned_cols=240 Identities=20% Similarity=0.333 Sum_probs=187.9
Q ss_pred CeecccCceeEEEEEeec-------------CcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeee
Q 003254 523 NKLGEGGFGPVYKGMLIE-------------GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERM 589 (836)
Q Consensus 523 ~~lG~G~fG~Vykg~~~~-------------g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 589 (836)
+.||+|+||.||+|+... ...|++|.+..........|.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 369999999999998532 2358999886655555668899999999999999999999999999999
Q ss_pred EEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCC-------ceeec
Q 003254 590 LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMN-------PKISD 662 (836)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~-------~kl~D 662 (836)
+||||+++++|+.++.. ....+++..+..++.||++||+|||+.+ |+||||||+|||++.++. +|++|
T Consensus 81 lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHR--KSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 99999999999888743 2346899999999999999999999988 999999999999986654 89999
Q ss_pred cCcccccCCCccccccccccccccccCccccc-CCccCccccccchhhhhhhhh-hCCCCCCCCCCccccchhhhhHHhh
Q 003254 663 FGLARSFGLDQTEANTKRVVGTYGYMSPEYAI-DGLFSVKSDVFSFGVLVLEII-CGKKNRGFNHADHDHNLLGHAWRLW 740 (836)
Q Consensus 663 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~t~ksDVwS~GvvL~ell-tG~~p~~~~~~~~~~~~~~~~~~~~ 740 (836)
||++...... ....++..|+|||.+. +..++.++|||||||++|||+ .|+.|+....... . ..+
T Consensus 156 ~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-------~-~~~ 221 (262)
T cd05077 156 PGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE-------K-ERF 221 (262)
T ss_pred CCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH-------H-HHH
Confidence 9998764321 1245778899999887 466899999999999999998 4776653211110 0 000
Q ss_pred hccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 003254 741 IEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLS 791 (836)
Q Consensus 741 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~ 791 (836)
.... . .........+.+|+.+||+.||++||++.+|++.|+
T Consensus 222 ~~~~--------~--~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 222 YEGQ--------C--MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred HhcC--------c--cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 0000 0 001112345789999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=306.82 Aligned_cols=252 Identities=29% Similarity=0.461 Sum_probs=198.8
Q ss_pred ccccCeecccCceeEEEEEeec-CcEEEEEEecCCCchhHH--HHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEeec
Q 003254 519 FSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGME--EFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (836)
Q Consensus 519 f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~~~~--~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 595 (836)
|+..+.||+|+||.||+++... ++.+|+|++......... ...+|+.++++++||||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 5677899999999999999876 668999999877543322 3456999999999999999999999999999999999
Q ss_pred CCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCccc
Q 003254 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE 675 (836)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 675 (836)
++++|.+++. ....+++..+..++.||++||++||+.+ ++|+||||+||++++++.++|+|||.+.... ...
T Consensus 81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~--~~~ 152 (260)
T PF00069_consen 81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLS--ENN 152 (260)
T ss_dssp TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEEST--STT
T ss_pred cccccccccc---cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc--ccc
Confidence 9999999995 3456899999999999999999999998 9999999999999999999999999998641 122
Q ss_pred cccccccccccccCccccc-CCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhcccccc
Q 003254 676 ANTKRVVGTYGYMSPEYAI-DGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLD 754 (836)
Q Consensus 676 ~~~~~~~gt~~y~aPE~~~-~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 754 (836)
.......++..|+|||++. +..++.++||||+|+++++|++|+.|+................ ........
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~-------~~~~~~~~-- 223 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKIL-------KRPLPSSS-- 223 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHH-------HTHHHHHT--
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcc-------cccccccc--
Confidence 2333467899999999998 8889999999999999999999999875431111110000000 00000000
Q ss_pred CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 755 NSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 755 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
.........+.+++..||+.+|++||++.++++
T Consensus 224 -~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 224 -QQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp -TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred -cccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000011256889999999999999999999985
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=316.82 Aligned_cols=246 Identities=27% Similarity=0.353 Sum_probs=194.5
Q ss_pred cccccCeecccCceeEEEEEeec-CcEEEEEEecCCC---chhHHHHHHHHHHHHhh-cCCceeeEEeEEeeCCeeeEEE
Q 003254 518 NFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDERMLIY 592 (836)
Q Consensus 518 ~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 592 (836)
+|...+.||+|+||.||+++... ++.||+|++.+.. ....+.+..|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 47788899999999999999865 7889999987542 23345567788888877 5899999999999999999999
Q ss_pred eecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCC
Q 003254 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (836)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~ 672 (836)
||+++|+|...+.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQQ---VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 99999999888843 345889999999999999999999988 999999999999999999999999999754321
Q ss_pred ccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhcccc
Q 003254 673 QTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQS 752 (836)
Q Consensus 673 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 752 (836)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.|+...... .+ .........
T Consensus 155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~---~~----~~~i~~~~~------- 218 (323)
T cd05616 155 G--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---EL----FQSIMEHNV------- 218 (323)
T ss_pred C--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH---HH----HHHHHhCCC-------
Confidence 1 1223467899999999999999999999999999999999999997532211 11 111111100
Q ss_pred ccCCCChHHHHHHHHHHHHcccCCCCCCCCH-----HHHHH
Q 003254 753 LDNSCSFSEALRCIQVGLLCVQQRPEDRPNM-----SSVVL 788 (836)
Q Consensus 753 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~-----~eVl~ 788 (836)
..+......+.+++.+|++.+|++|++. .++.+
T Consensus 219 ---~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~ 256 (323)
T cd05616 219 ---AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 256 (323)
T ss_pred ---CCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhc
Confidence 1111223457799999999999999984 56543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=306.55 Aligned_cols=256 Identities=27% Similarity=0.414 Sum_probs=201.6
Q ss_pred ccccccCeecccCceeEEEEEeec----CcEEEEEEecCCC-chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEE
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE----GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~----g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 591 (836)
++|++.+.||+|+||.||+|+... +..+|+|.+.... ....+.+.+|+.++.+++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 567888999999999999998742 3369999986543 23456889999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCC
Q 003254 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (836)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~ 671 (836)
|||+++++|.+++... ...+++.++..++.|++.||+|||+.+ ++||||||+|||+++++.++|+|||++..+..
T Consensus 84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 9999999999998542 346899999999999999999999988 99999999999999999999999999987643
Q ss_pred Cccccc-cccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhccCchhhc
Q 003254 672 DQTEAN-TKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEERPLELI 749 (836)
Q Consensus 672 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (836)
...... .....++..|+|||.+.+..++.++||||||++++|+++ |+.|+......+ .. ....+..
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~~----~~~~~~~----- 226 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---VI----KAIEEGY----- 226 (267)
T ss_pred ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---HH----HHHhCCC-----
Confidence 322111 111223568999999998899999999999999999886 998864322111 11 1111110
Q ss_pred cccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 003254 750 DQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 793 (836)
Q Consensus 750 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 793 (836)
...........+.+++.+|++.+|++||+|.++++.|+.+
T Consensus 227 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 227 ----RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ----cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0011112234577999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=304.49 Aligned_cols=249 Identities=29% Similarity=0.403 Sum_probs=198.6
Q ss_pred CeecccCceeEEEEEeec--C--cEEEEEEecCCCc-hhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEeecCC
Q 003254 523 NKLGEGGFGPVYKGMLIE--G--QEIAVKRLSKGSG-QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPN 597 (836)
Q Consensus 523 ~~lG~G~fG~Vykg~~~~--g--~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 597 (836)
+.||+|++|.||+|.+.+ + ..||+|.+..... ...+.+.+|+.++++++||||+++++.+.. ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999999754 3 3689999987655 567789999999999999999999999988 889999999999
Q ss_pred CChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcccc-
Q 003254 598 KSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEA- 676 (836)
Q Consensus 598 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~~- 676 (836)
++|.+++.+... ..+++..+..++.|+++||+|||+.+ ++|+||||+||+++.++.+||+|||+++.+.......
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 999999865432 56899999999999999999999998 9999999999999999999999999998765422211
Q ss_pred ccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhccCchhhccccccC
Q 003254 677 NTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDN 755 (836)
Q Consensus 677 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 755 (836)
......++..|+|||.+.+..++.++||||||++++||++ |+.|+...... ..... .... ... .
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~----~~~~-~~~-----~-- 220 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS---QILKK----IDKE-GER-----L-- 220 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH----HHhc-CCc-----C--
Confidence 1122456789999999999899999999999999999999 99886422111 01100 0000 000 0
Q ss_pred CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 003254 756 SCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLS 791 (836)
Q Consensus 756 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~ 791 (836)
..+......+.+++.+|++.+|++||++.+|++.|.
T Consensus 221 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 221 ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 011122356789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=303.37 Aligned_cols=249 Identities=25% Similarity=0.337 Sum_probs=197.6
Q ss_pred ccccccCeecccCceeEEEEEeecCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEe-eCCeeeEEEeec
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCT-QRDERMLIYEYL 595 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~-~~~~~~lV~Ey~ 595 (836)
++|...+.||+|+||.||++.. .|..+|+|.+.... ..+.+.+|+.++++++|+|++++++++. ..+..++|+||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 4678889999999999999987 57889999986433 3567899999999999999999999764 455689999999
Q ss_pred CCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCccc
Q 003254 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE 675 (836)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 675 (836)
++++|.+++... ....+++..+..++.+|+.||+|||+++ ++||||||+||++++++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 83 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 999999998543 2345889999999999999999999988 9999999999999999999999999987643221
Q ss_pred cccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhccCchhhcccccc
Q 003254 676 ANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLD 754 (836)
Q Consensus 676 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 754 (836)
.....+..|+|||++.+..++.++||||||+++|||++ |+.|+..... .. ..........
T Consensus 157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~------~~-~~~~~~~~~~--------- 217 (256)
T cd05082 157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL------KD-VVPRVEKGYK--------- 217 (256)
T ss_pred ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH------HH-HHHHHhcCCC---------
Confidence 12334568999999998889999999999999999998 8887642211 00 1111111111
Q ss_pred CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 003254 755 NSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 793 (836)
Q Consensus 755 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 793 (836)
..........+.+++.+|++.+|++|||+.++++.|+.+
T Consensus 218 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 218 MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 011112335678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=307.79 Aligned_cols=247 Identities=26% Similarity=0.365 Sum_probs=191.9
Q ss_pred ecccCceeEEEEEeec-CcEEEEEEecCCC---chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEeecCCCCh
Q 003254 525 LGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSL 600 (836)
Q Consensus 525 lG~G~fG~Vykg~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 600 (836)
||+|+||.||++.... |+.+|+|++.... ....+.+..|++++++++||||+++++++......++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 7999999999999754 8999999986432 12234566799999999999999999999999999999999999999
Q ss_pred hHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcccccccc
Q 003254 601 DYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKR 680 (836)
Q Consensus 601 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~ 680 (836)
..++... ....+++..+..++.||+.||+|||+.+ |+||||||+||++++++.++|+|||++....... ....
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~ 153 (277)
T cd05607 81 KYHIYNV-GERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQ 153 (277)
T ss_pred HHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeec
Confidence 8887543 2345889999999999999999999988 9999999999999999999999999998754321 1223
Q ss_pred ccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccccccCCCChH
Q 003254 681 VVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDNSCSFS 760 (836)
Q Consensus 681 ~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 760 (836)
..|+..|+|||++.+..++.++||||+||++|||++|+.|+........ ....... ..... +. .. ...
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~--~~~~~~~-~~~~~----~~--~~---~~~ 221 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA--KEELKRR-TLEDE----VK--FE---HQN 221 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh--HHHHHHH-hhccc----cc--cc---ccc
Confidence 5688999999999998999999999999999999999999753221111 0000000 00000 00 00 001
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 003254 761 EALRCIQVGLLCVQQRPEDRPNMSSVVLML 790 (836)
Q Consensus 761 ~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L 790 (836)
....+.+++..||+.+|++||+++|+++.+
T Consensus 222 ~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 222 FTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred CCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 233578999999999999999998766433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=303.73 Aligned_cols=253 Identities=24% Similarity=0.360 Sum_probs=188.3
Q ss_pred eecccCceeEEEEEeec---CcEEEEEEecCCC-chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEeecCCCC
Q 003254 524 KLGEGGFGPVYKGMLIE---GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKS 599 (836)
Q Consensus 524 ~lG~G~fG~Vykg~~~~---g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gs 599 (836)
.||+|+||.||+|...+ ...+++|.+.... ......+.+|+.+++.++|+||+++++.+......++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 69999999999998654 3468888876443 3345678899999999999999999999999999999999999999
Q ss_pred hhHHHhhccC--CCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCccccc
Q 003254 600 LDYFIFDTTR--SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEAN 677 (836)
Q Consensus 600 L~~~l~~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~ 677 (836)
|.+++..... ....++.....++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++..........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 9999865432 233567788899999999999999998 99999999999999999999999999875432222122
Q ss_pred cccccccccccCccccc-------CCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhccCchhhc
Q 003254 678 TKRVVGTYGYMSPEYAI-------DGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEERPLELI 749 (836)
Q Consensus 678 ~~~~~gt~~y~aPE~~~-------~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (836)
.....++..|+|||++. ...++.++||||||+++|||++ |..|+...... .. .............
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~---~~----~~~~~~~~~~~~~ 231 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE---QV----LKQVVREQDIKLP 231 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH---HH----HHHHhhccCccCC
Confidence 22345577899999874 2457889999999999999999 66665422111 01 1111111111111
Q ss_pred cccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 003254 750 DQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLS 791 (836)
Q Consensus 750 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~ 791 (836)
.+.+ .......+.+++..|+ .||++|||++||++.|+
T Consensus 232 ~~~~----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 232 KPQL----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCcc----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 2211 1122244567788888 59999999999999884
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=308.51 Aligned_cols=239 Identities=21% Similarity=0.306 Sum_probs=186.6
Q ss_pred eecccCceeEEEEEeec-------------------------CcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeE
Q 003254 524 KLGEGGFGPVYKGMLIE-------------------------GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKL 578 (836)
Q Consensus 524 ~lG~G~fG~Vykg~~~~-------------------------g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l 578 (836)
.||+|+||.||+|.+.. ...|++|++.........+|.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999998521 13589998866555556778999999999999999999
Q ss_pred EeEEeeCCeeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCC--
Q 003254 579 LGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTM-- 656 (836)
Q Consensus 579 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~-- 656 (836)
++++.+....++||||+++|+|+.++.. ....+++..+..++.||++||+|||+.+ |+||||||+|||+++.+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK--EKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence 9999999999999999999999988853 2346889999999999999999999988 99999999999997643
Q ss_pred -----CceeeccCcccccCCCccccccccccccccccCcccccC-CccCccccccchhhhhhhhh-hCCCCCCCCCCccc
Q 003254 657 -----NPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEII-CGKKNRGFNHADHD 729 (836)
Q Consensus 657 -----~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~ell-tG~~p~~~~~~~~~ 729 (836)
.+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.|+........
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 230 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK 230 (274)
T ss_pred cCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH
Confidence 3799999988653211 12346788999998875 56899999999999999995 68887653222110
Q ss_pred cchhhhhHHhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 003254 730 HNLLGHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLS 791 (836)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~ 791 (836)
....... . ..+......+.+++.+||+.+|++|||+.+|++.|+
T Consensus 231 -------~~~~~~~---------~--~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 231 -------ERFYEKK---------H--RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred -------HHHHHhc---------c--CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 0000000 0 001111235789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=302.97 Aligned_cols=254 Identities=29% Similarity=0.434 Sum_probs=202.3
Q ss_pred cccccccCeecccCceeEEEEEeecCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEeec
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 595 (836)
.++|...++||+|+||.||++...++..+|+|.+.... ...+.+.+|+.++++++|+|++++.+++.+ ...+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 36788899999999999999998778889999886543 345678999999999999999999999887 7789999999
Q ss_pred CCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCccc
Q 003254 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE 675 (836)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 675 (836)
++++|.+++... ....+++..+..++.+++.||.|||+.+ ++|+||||+||+++.++.+||+|||++..+......
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 158 (260)
T cd05073 83 AKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 158 (260)
T ss_pred CCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence 999999998543 2346788999999999999999999987 999999999999999999999999999865432211
Q ss_pred cccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhccCchhhcccccc
Q 003254 676 ANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLD 754 (836)
Q Consensus 676 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 754 (836)
......++..|+|||++..+.++.++||||||+++++|++ |+.|+...... .. ..........
T Consensus 159 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~----~~~~~~~~~~-------- 222 (260)
T cd05073 159 -AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EV----IRALERGYRM-------- 222 (260)
T ss_pred -cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH---HH----HHHHhCCCCC--------
Confidence 1122345678999999998889999999999999999999 88886432111 01 1111111110
Q ss_pred CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcC
Q 003254 755 NSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 792 (836)
Q Consensus 755 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~ 792 (836)
.........+.+++.+|++.+|++||++.++++.|+.
T Consensus 223 -~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 223 -PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred -CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1111223457899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=314.32 Aligned_cols=262 Identities=23% Similarity=0.357 Sum_probs=196.3
Q ss_pred ccccccCeecccCceeEEEEEeec-CcEEEEEEecCCCc-hhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEee
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSG-QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 594 (836)
++|...++||+|+||.||+|+... ++.||+|++..... .....+.+|+.++++++||||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 568889999999999999999764 78899999875432 2345678899999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcc
Q 003254 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (836)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~ 674 (836)
+++ +|..++... ...+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||+++.......
T Consensus 86 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 86 LDK-DLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 986 777776432 345788999999999999999999988 99999999999999999999999999976432221
Q ss_pred ccccccccccccccCcccccC-CccCccccccchhhhhhhhhhCCCCCCCCCCccccchhh--------hhHHhhhccCc
Q 003254 675 EANTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLG--------HAWRLWIEERP 745 (836)
Q Consensus 675 ~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~--------~~~~~~~~~~~ 745 (836)
......+++.|+|||.+.+ ..++.++||||||++++||++|+.||......+...... ..+.......
T Consensus 160 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 236 (309)
T cd07872 160 --TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSND- 236 (309)
T ss_pred --ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchh-
Confidence 1223467899999999865 468999999999999999999999975433221111100 0000000000
Q ss_pred hhhccccccC-------CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 746 LELIDQSLDN-------SCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 746 ~~~~d~~l~~-------~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
+..+..... .........+.+++.+||+.||++|||+.|+++
T Consensus 237 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 237 -EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred -hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 000000000 000112235679999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=316.11 Aligned_cols=252 Identities=26% Similarity=0.416 Sum_probs=209.2
Q ss_pred ccccCeecccCceeEEEEEeec---Cc--EEEEEEecCC-CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEE
Q 003254 519 FSEKNKLGEGGFGPVYKGMLIE---GQ--EIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (836)
Q Consensus 519 f~~~~~lG~G~fG~Vykg~~~~---g~--~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 592 (836)
.+..++||.|.||.||+|+..+ |+ .||||..+.+ ..+..+.|++|..+|++++||||++++|+|.+ ...++||
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wivm 469 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIVM 469 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEEE
Confidence 3445789999999999999643 33 4899988764 45567899999999999999999999999985 6789999
Q ss_pred eecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCC
Q 003254 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (836)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~ 672 (836)
|.++-|.|..+|.. +...|+......++.||+.||+|||+.. .|||||..+|||+.....+||+|||+++.+..+
T Consensus 470 EL~~~GELr~yLq~--nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~ 544 (974)
T KOG4257|consen 470 ELAPLGELREYLQQ--NKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLEDD 544 (974)
T ss_pred ecccchhHHHHHHh--ccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhcccc
Confidence 99999999999954 3456888888999999999999999987 999999999999999999999999999988644
Q ss_pred ccccccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhccCchhhccc
Q 003254 673 QTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQ 751 (836)
Q Consensus 673 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 751 (836)
.... .....-+..|||||.+.-..+|.++|||-|||++|||++ |.+||...... +....++.
T Consensus 545 ~yYk-aS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNs----------------DVI~~iEn 607 (974)
T KOG4257|consen 545 AYYK-ASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNS----------------DVIGHIEN 607 (974)
T ss_pred chhh-ccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccccc----------------ceEEEecC
Confidence 3332 223455778999999999999999999999999999987 78887543322 22223333
Q ss_pred cccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 003254 752 SLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 793 (836)
Q Consensus 752 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 793 (836)
.-+..+++.++..+..|+.+||+.+|.+||++.|+...|+.+
T Consensus 608 GeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv 649 (974)
T KOG4257|consen 608 GERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDV 649 (974)
T ss_pred CCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHH
Confidence 334466778888899999999999999999999999888654
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=305.58 Aligned_cols=250 Identities=28% Similarity=0.454 Sum_probs=194.1
Q ss_pred CeecccCceeEEEEEeec-Cc--EEEEEEecCC-CchhHHHHHHHHHHHHhh-cCCceeeEEeEEeeCCeeeEEEeecCC
Q 003254 523 NKLGEGGFGPVYKGMLIE-GQ--EIAVKRLSKG-SGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDERMLIYEYLPN 597 (836)
Q Consensus 523 ~~lG~G~fG~Vykg~~~~-g~--~vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 597 (836)
+.||+|+||.||+|++.+ +. .+++|.+... .....+.+.+|++++.++ +||||+++++++......++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 369999999999999865 43 4688888653 334556889999999999 799999999999999999999999999
Q ss_pred CChhHHHhhcc-------------CCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccC
Q 003254 598 KSLDYFIFDTT-------------RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFG 664 (836)
Q Consensus 598 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFg 664 (836)
++|.+++.... ....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 99999986432 1235789999999999999999999987 9999999999999999999999999
Q ss_pred cccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhcc
Q 003254 665 LARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEE 743 (836)
Q Consensus 665 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 743 (836)
++..... .........+..|+|||++....++.++||||||++++||++ |..|+...... . ........
T Consensus 158 l~~~~~~---~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---~----~~~~~~~~ 227 (270)
T cd05047 158 LSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---E----LYEKLPQG 227 (270)
T ss_pred Cccccch---hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH---H----HHHHHhCC
Confidence 9863211 111111233567999999988889999999999999999997 88886422111 0 11111111
Q ss_pred CchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 003254 744 RPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 794 (836)
Q Consensus 744 ~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 794 (836)
... .........+.+++.+|++.+|.+|||+.++++.|+++.
T Consensus 228 ~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 228 YRL---------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CCC---------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 000 011122345779999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=322.48 Aligned_cols=260 Identities=20% Similarity=0.276 Sum_probs=198.3
Q ss_pred ccccccCeecccCceeEEEEEeec---CcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEe
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE---GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~---g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 593 (836)
.+|++.+.||+|+||.||++...+ ++.||+|.+... +...+|+.++++++||||+++++++......++|||
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMP 166 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEeh
Confidence 578899999999999999997533 578999987543 345689999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCc
Q 003254 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (836)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~ 673 (836)
++. ++|..++ .....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 167 ~~~-~~l~~~l---~~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 167 KYK-CDLFTYV---DRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred hcC-CCHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 986 5777777 23457899999999999999999999998 9999999999999999999999999998765433
Q ss_pred cccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhh-----
Q 003254 674 TEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLEL----- 748 (836)
Q Consensus 674 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 748 (836)
.........||+.|+|||++.+..++.++|||||||++|||++|+.|+................+..... +.+.
T Consensus 240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~-~~~~~~~~~ 318 (392)
T PHA03207 240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVH-PLEFPQNGS 318 (392)
T ss_pred ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccC-ccccCCccc
Confidence 3333334679999999999999999999999999999999999999975433322111111111110000 0000
Q ss_pred ---------ccccccCCCCh-------HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 749 ---------IDQSLDNSCSF-------SEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 749 ---------~d~~l~~~~~~-------~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
+....+..... .....+.+++.+||+.+|++|||+.|++..
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000110110 112356789999999999999999999875
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=329.50 Aligned_cols=261 Identities=20% Similarity=0.306 Sum_probs=191.2
Q ss_pred hcccccccCeecccCceeEEEEEeec-CcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeC--------
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR-------- 585 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-------- 585 (836)
..++|+..+.||+|+||.||+|...+ ++.||||++.... ....+|+.+++.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 44689999999999999999999854 8899999885432 2345799999999999999999886432
Q ss_pred CeeeEEEeecCCCChhHHHhhc-cCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCC-Cceeecc
Q 003254 586 DERMLIYEYLPNKSLDYFIFDT-TRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTM-NPKISDF 663 (836)
Q Consensus 586 ~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~-~~kl~DF 663 (836)
...++||||+++ +|..++... .....+++..+..++.||+.||+|||+.+ |+||||||+||||+.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence 136689999986 566665432 23457899999999999999999999998 99999999999998654 7999999
Q ss_pred CcccccCCCccccccccccccccccCcccccCC-ccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhc
Q 003254 664 GLARSFGLDQTEANTKRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIE 742 (836)
Q Consensus 664 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 742 (836)
|+++.+..... .....||+.|+|||++.+. .++.++|||||||+||||++|++||........ + .........
T Consensus 216 Gla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~--~-~~i~~~~~~ 289 (440)
T PTZ00036 216 GSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ--L-VRIIQVLGT 289 (440)
T ss_pred ccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--H-HHHHHHhCC
Confidence 99987643221 2235689999999998764 689999999999999999999999754322111 0 001111000
Q ss_pred cCchh---------------hccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 743 ERPLE---------------LIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 743 ~~~~~---------------~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
..... .....+....+.....++.+|+.+||+.+|++|||+.|+++.
T Consensus 290 p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 290 PTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred CCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 00000 000001111111223467899999999999999999999843
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=312.95 Aligned_cols=260 Identities=28% Similarity=0.439 Sum_probs=201.2
Q ss_pred ccccccCeecccCceeEEEEEeec-Cc----EEEEEEecCCCc-hhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeE
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQ----EIAVKRLSKGSG-QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-g~----~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 590 (836)
++|+..+.||+|+||.||+|+... |. .+|+|.+..... ....++.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 567778899999999999998743 43 478898865432 3345788999999999999999999998754 5679
Q ss_pred EEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccC
Q 003254 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (836)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~ 670 (836)
++||+++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||+++.+.
T Consensus 86 v~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 86 VTQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred eehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccccc
Confidence 99999999999988532 335788999999999999999999988 9999999999999999999999999998764
Q ss_pred CCccccccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhccCchhhc
Q 003254 671 LDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEERPLELI 749 (836)
Q Consensus 671 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (836)
............++..|+|||.+.+..++.++||||||+++|||++ |+.|+....... ..........
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~-------~~~~~~~~~~---- 229 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE-------IPDLLEKGER---- 229 (303)
T ss_pred CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHCCCC----
Confidence 3322222223445778999999998899999999999999999997 888864321110 0111111100
Q ss_pred cccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCCCCCC
Q 003254 750 DQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQ 798 (836)
Q Consensus 750 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~~~~ 798 (836)
+ .........+.+++..|+..+|++||++.++++.|+.+...+.
T Consensus 230 ---~--~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~~ 273 (303)
T cd05110 230 ---L--PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQ 273 (303)
T ss_pred ---C--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhchh
Confidence 0 0111123457899999999999999999999999998754443
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=302.52 Aligned_cols=252 Identities=28% Similarity=0.464 Sum_probs=200.4
Q ss_pred ccccccCeecccCceeEEEEEeecCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEeecC
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLP 596 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 596 (836)
.+|+..+.||+|+||.||++...++..+|+|.+.... ....+|.+|++++++++|||++++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 4677788999999999999998778899999986543 234678999999999999999999999999999999999999
Q ss_pred CCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcccc
Q 003254 597 NKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEA 676 (836)
Q Consensus 597 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~~ 676 (836)
+++|.+++... ...+++..+..++.+++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.........
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 83 HGCLSDYLRAQ--RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence 99999888532 245789999999999999999999988 9999999999999999999999999998654322111
Q ss_pred ccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhccCchhhccccccC
Q 003254 677 NTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDN 755 (836)
Q Consensus 677 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 755 (836)
.....++.+|+|||.+.++.++.++||||||+++|||++ |+.|+...... ... ...... .....+
T Consensus 158 -~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~~~----~~~~~~--~~~~~~---- 223 (256)
T cd05112 158 -STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS---EVV----ETINAG--FRLYKP---- 223 (256)
T ss_pred -cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH---HHH----HHHhCC--CCCCCC----
Confidence 112335678999999998899999999999999999998 88886432211 010 001000 000011
Q ss_pred CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 003254 756 SCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLS 791 (836)
Q Consensus 756 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~ 791 (836)
......+.+++.+||+.+|++||++.||++.|.
T Consensus 224 ---~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 224 ---RLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred ---CCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 112356889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=301.78 Aligned_cols=250 Identities=22% Similarity=0.291 Sum_probs=200.3
Q ss_pred cccccCeecccCceeEEEEEeec-CcEEEEEEecCC-CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEeec
Q 003254 518 NFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (836)
Q Consensus 518 ~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 595 (836)
+|+..+.||+|+||.||++.... ++.+|+|.+... .....+.+.+|+.+++.++|+||+++++.+......++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 46778899999999999999764 889999998643 3345577889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCccc
Q 003254 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE 675 (836)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 675 (836)
++++|.+++... ....++...+..++.|++.||.|||+.+ |+|+||||+||++++++.++|+|||++..+.....
T Consensus 81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~- 155 (255)
T cd08219 81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA- 155 (255)
T ss_pred CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc-
Confidence 999998887532 3456788999999999999999999998 99999999999999999999999999986543221
Q ss_pred cccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccccccC
Q 003254 676 ANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDN 755 (836)
Q Consensus 676 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 755 (836)
......++..|+|||++.+..++.++||||||+++++|++|+.|+...... ... .........
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~------~~~-~~~~~~~~~--------- 218 (255)
T cd08219 156 -YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK------NLI-LKVCQGSYK--------- 218 (255)
T ss_pred -ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH------HHH-HHHhcCCCC---------
Confidence 122356888999999999888999999999999999999999997532111 000 011111110
Q ss_pred CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 756 SCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 756 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
..+......+.+++.+||+.+|++||++.||+..
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 219 PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 0111222457789999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=314.65 Aligned_cols=258 Identities=26% Similarity=0.440 Sum_probs=208.7
Q ss_pred eecccCceeEEEEEeec-CcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEeecCCCChhH
Q 003254 524 KLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDY 602 (836)
Q Consensus 524 ~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~ 602 (836)
+||+|.||+||-|++.+ ...+|||.+.....+..+-+.+||.+.++++|.|||+++|.+.+++..-+.||-++||+|..
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 69999999999999876 45699999988888888889999999999999999999999999999999999999999999
Q ss_pred HHhhccCCCcC--ChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEec-CCCCceeeccCcccccCCCccccccc
Q 003254 603 FIFDTTRSKLL--DWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD-NTMNPKISDFGLARSFGLDQTEANTK 679 (836)
Q Consensus 603 ~l~~~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~-~~~~~kl~DFgla~~~~~~~~~~~~~ 679 (836)
++... -+++ ++..+-.+.+||++||.|||++. |||||||-+|+||+ -.|.+||+|||-++.+. .-..-+.
T Consensus 662 LLrsk--WGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA--ginP~TE 734 (1226)
T KOG4279|consen 662 LLRSK--WGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA--GINPCTE 734 (1226)
T ss_pred HHHhc--cCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhc--cCCcccc
Confidence 99543 3566 67778889999999999999998 99999999999996 57899999999998763 2233455
Q ss_pred cccccccccCcccccCCc--cCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccccccCCC
Q 003254 680 RVVGTYGYMSPEYAIDGL--FSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDNSC 757 (836)
Q Consensus 680 ~~~gt~~y~aPE~~~~~~--~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 757 (836)
.+.||..|||||++..++ |..++|||||||++.||.||++||-....... + ++.-+ + -......
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA------A--MFkVG----m--yKvHP~i 800 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA------A--MFKVG----M--YKVHPPI 800 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH------h--hhhhc----c--eecCCCC
Confidence 688999999999998764 88999999999999999999999753222110 0 00000 0 0123355
Q ss_pred ChHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HhcCCCCCCCCCCC
Q 003254 758 SFSEALRCIQVGLLCVQQRPEDRPNMSSVVL--MLSGERSLPQPQQP 802 (836)
Q Consensus 758 ~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~--~L~~~~~~~~p~~p 802 (836)
+.+...++..++++|+.++|.+||+++++++ .|.--...+.|+.+
T Consensus 801 Peelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~~kk~r~~ls 847 (1226)
T KOG4279|consen 801 PEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHNNKKPRPKLS 847 (1226)
T ss_pred cHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccCCCCCCCCCC
Confidence 6666778899999999999999999999986 34333333444443
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=324.21 Aligned_cols=194 Identities=21% Similarity=0.277 Sum_probs=167.1
Q ss_pred cccccccCeecccCceeEEEEEeec-CcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEee
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 594 (836)
..+|.+.+.||+|+||.||++.+.. ++.||||... ...+.+|+.++++++|+|||++++++...+..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 4578999999999999999999865 7889999642 23467899999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcc
Q 003254 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (836)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~ 674 (836)
+. ++|..++.. ....+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+.....
T Consensus 242 ~~-~~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 242 YR-SDLYTYLGA--RLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred cC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 95 677777743 2346899999999999999999999998 99999999999999999999999999987643222
Q ss_pred ccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCC
Q 003254 675 EANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNR 721 (836)
Q Consensus 675 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~ 721 (836)
........||..|+|||++.+..++.++|||||||+||||++|..++
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 22223457999999999999999999999999999999999988654
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=306.19 Aligned_cols=265 Identities=25% Similarity=0.338 Sum_probs=196.8
Q ss_pred cccccCeecccCceeEEEEEee-cCcEEEEEEecCCC--chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEee
Q 003254 518 NFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (836)
Q Consensus 518 ~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 594 (836)
+|+..+.||+|++|.||+|+.. +++.||+|++.... ....+.+.+|+.++.+++||||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4778889999999999999986 48899999986542 23346788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcc
Q 003254 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (836)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~ 674 (836)
++ ++|.+++........+++..+..++.||++||+|||+.+ ++|+||||+||++++++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 97 588888755444467899999999999999999999988 99999999999999999999999999986543221
Q ss_pred ccccccccccccccCcccccCC-ccCccccccchhhhhhhhhhCCCCCCCCCCccccchh--------hhhHHhhhcc-C
Q 003254 675 EANTKRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLL--------GHAWRLWIEE-R 744 (836)
Q Consensus 675 ~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~--------~~~~~~~~~~-~ 744 (836)
......+++.|+|||.+.+. .++.++||||||++++||++|+.|+............ ...+...... .
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd07861 157 --VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD 234 (285)
T ss_pred --cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence 11224568899999988754 5789999999999999999999987543221100000 0000000000 0
Q ss_pred chhhccccccC---CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 745 PLELIDQSLDN---SCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 745 ~~~~~d~~l~~---~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
........... ........++.+++.+||+.||++|||+.+|++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000000000 000012245679999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=306.03 Aligned_cols=256 Identities=27% Similarity=0.420 Sum_probs=202.1
Q ss_pred ccccccCeecccCceeEEEEEeec-Cc----EEEEEEecCCCc-hhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeE
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQ----EIAVKRLSKGSG-QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-g~----~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 590 (836)
++|...+.||+|+||.||+|...+ |. .+|+|.+..... ....++.+|+.++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 567788999999999999999754 33 589998866543 345678999999999999999999999987 78899
Q ss_pred EEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccC
Q 003254 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (836)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~ 670 (836)
||||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ ++|+||||+||++++++.+||+|||+++.+.
T Consensus 86 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 86 ITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred EEecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence 99999999999998542 335899999999999999999999987 9999999999999999999999999998765
Q ss_pred CCccccccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhccCchhhc
Q 003254 671 LDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEERPLELI 749 (836)
Q Consensus 671 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (836)
............++..|+|||.+....++.++||||||++++||++ |+.|+......+ + .........
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~----~~~~~~~~~---- 229 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE---I----PDLLEKGER---- 229 (279)
T ss_pred CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH---H----HHHHhCCCC----
Confidence 3322222222234568999999988899999999999999999998 998865322111 1 011111100
Q ss_pred cccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 003254 750 DQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 794 (836)
Q Consensus 750 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 794 (836)
...+......+.+++.+||..+|++||++.++++.|+...
T Consensus 230 -----~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05057 230 -----LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMA 269 (279)
T ss_pred -----CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 0111112345778999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=305.47 Aligned_cols=251 Identities=32% Similarity=0.481 Sum_probs=196.8
Q ss_pred CeecccCceeEEEEEeec-------CcEEEEEEecCCC-chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEee
Q 003254 523 NKLGEGGFGPVYKGMLIE-------GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (836)
Q Consensus 523 ~~lG~G~fG~Vykg~~~~-------g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 594 (836)
+.||+|+||.||+|+..+ ++.+|+|.+.... .....++.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 369999999999998753 2579999886543 24467889999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcc----CCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCC-----CceeeccCc
Q 003254 595 LPNKSLDYFIFDTT----RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTM-----NPKISDFGL 665 (836)
Q Consensus 595 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~-----~~kl~DFgl 665 (836)
+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++ .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999986532 2234788999999999999999999987 99999999999999877 899999999
Q ss_pred ccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhccC
Q 003254 666 ARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEER 744 (836)
Q Consensus 666 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 744 (836)
+................++..|+|||.+.++.++.++||||||+++|||++ |+.|+...... ... .......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~---~~~----~~~~~~~ 230 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ---EVL----QHVTAGG 230 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH---HHH----HHHhcCC
Confidence 986643322222222345678999999999999999999999999999998 88886422111 110 0000000
Q ss_pred chhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcC
Q 003254 745 PLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 792 (836)
Q Consensus 745 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~ 792 (836)
...........+.+++.+||+.+|++||++.+|++.|++
T Consensus 231 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 231 ---------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred ---------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 001111233567899999999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=306.13 Aligned_cols=251 Identities=24% Similarity=0.354 Sum_probs=199.0
Q ss_pred cccccCeecccCceeEEEEEeec-CcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEeecC
Q 003254 518 NFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLP 596 (836)
Q Consensus 518 ~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 596 (836)
.|+..+.||+|+||.||+|.... +..+++|.+........+.+.+|+++++.++|||++++++++...+..++|+||++
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~ 85 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 85 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence 36677889999999999999865 77889999877666667789999999999999999999999999999999999999
Q ss_pred CCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcccc
Q 003254 597 NKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEA 676 (836)
Q Consensus 597 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~~ 676 (836)
+++|..++.. ...++++..+..++.|+++||.|||+.+ ++||||||+||+++.++.+||+|||++....... .
T Consensus 86 ~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~ 158 (282)
T cd06643 86 GGAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--Q 158 (282)
T ss_pred CCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc--c
Confidence 9999888753 2356899999999999999999999988 9999999999999999999999999987653221 1
Q ss_pred ccccccccccccCccccc-----CCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccc
Q 003254 677 NTKRVVGTYGYMSPEYAI-----DGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQ 751 (836)
Q Consensus 677 ~~~~~~gt~~y~aPE~~~-----~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 751 (836)
......++..|+|||++. +..++.++|||||||++|||++|+.|+...... ...... ..........
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~------~~~~~~-~~~~~~~~~~- 230 (282)
T cd06643 159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM------RVLLKI-AKSEPPTLAQ- 230 (282)
T ss_pred ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH------HHHHHH-hhcCCCCCCC-
Confidence 122356889999999984 445788999999999999999999986432211 000010 1111111110
Q ss_pred cccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 752 SLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 752 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
+......+.+++.+||+.+|++||++.++++.
T Consensus 231 ------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 231 ------PSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred ------ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11122457899999999999999999998754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=305.06 Aligned_cols=252 Identities=23% Similarity=0.394 Sum_probs=199.5
Q ss_pred ccccccCeecccCceeEEEEEeec-CcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEeec
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 595 (836)
++|+..+.||+|+||.||+++... ++.||+|.++.........+.+|+.+++.++||||+++++.+...+..++|+||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 578888899999999999998754 8899999987665555667889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCccc
Q 003254 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE 675 (836)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 675 (836)
++++|.+++.. .+.+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++..+....
T Consensus 89 ~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-- 160 (267)
T cd06645 89 GGGSLQDIYHV---TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI-- 160 (267)
T ss_pred CCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc--
Confidence 99999998843 346899999999999999999999998 9999999999999999999999999987654221
Q ss_pred cccccccccccccCccccc---CCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhcccc
Q 003254 676 ANTKRVVGTYGYMSPEYAI---DGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQS 752 (836)
Q Consensus 676 ~~~~~~~gt~~y~aPE~~~---~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 752 (836)
.......|+..|+|||++. .+.++.++|||||||++|||++|+.|+........ . ... .... ...+.
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~--~----~~~-~~~~---~~~~~ 230 (267)
T cd06645 161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA--L----FLM-TKSN---FQPPK 230 (267)
T ss_pred cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh--H----Hhh-hccC---CCCCc
Confidence 1223357899999999974 45688999999999999999999998643221110 0 000 0000 00000
Q ss_pred ccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 753 LDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 753 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
..... .....+.+++.+|++.+|++||++.+|++
T Consensus 231 ~~~~~--~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 231 LKDKM--KWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred ccccC--CCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 10000 11235779999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=301.33 Aligned_cols=250 Identities=26% Similarity=0.403 Sum_probs=202.5
Q ss_pred cccccccCeecccCceeEEEEEeec-CcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEee
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 594 (836)
.++|+..+.||+|+||.||+|+..+ ++.+++|.+..... .+++.+|++++++++|+||+++++++......++++||
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 3678889999999999999999876 78999999865432 67899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcc
Q 003254 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (836)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~ 674 (836)
+++++|.+++.. ....+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 80 ~~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (256)
T cd06612 80 CGAGSVSDIMKI--TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA 154 (256)
T ss_pred CCCCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence 999999999843 2356899999999999999999999988 99999999999999999999999999987643221
Q ss_pred ccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhcccccc
Q 003254 675 EANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLD 754 (836)
Q Consensus 675 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 754 (836)
......++..|+|||.+.+..++.++||||||++++||++|+.|+......... ...... .. +.+
T Consensus 155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~-------~~~~~~-~~----~~~- 219 (256)
T cd06612 155 --KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI-------FMIPNK-PP----PTL- 219 (256)
T ss_pred --ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh-------hhhccC-CC----CCC-
Confidence 122345788999999999889999999999999999999999997542221110 000000 00 000
Q ss_pred CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 755 NSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 755 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
..+......+.+++.+|++.+|++|||+.||++
T Consensus 220 -~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 220 -SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred -CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 011122345789999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=303.92 Aligned_cols=248 Identities=25% Similarity=0.394 Sum_probs=201.2
Q ss_pred ccccccCeecccCceeEEEEEeec-CcEEEEEEecCCC-chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEee
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 594 (836)
++|+..+.||.|++|.||+|+... ++.||+|.+.... ......+.+|+.+++.++|+|++++++++.+....++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 367788899999999999999764 8899999986553 34456788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcc
Q 003254 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (836)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~ 674 (836)
+++++|.+++.. .++++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++..+.....
T Consensus 81 ~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 153 (274)
T cd06609 81 CGGGSCLDLLKP----GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS 153 (274)
T ss_pred eCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence 999999998843 27899999999999999999999988 99999999999999999999999999987653321
Q ss_pred ccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhcccccc
Q 003254 675 EANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLD 754 (836)
Q Consensus 675 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 754 (836)
......++..|+|||.+.+..++.++||||||+++|||++|+.|+...... . ............+.+
T Consensus 154 --~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~---~----~~~~~~~~~~~~~~~---- 220 (274)
T cd06609 154 --KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM---R----VLFLIPKNNPPSLEG---- 220 (274)
T ss_pred --ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH---H----HHHHhhhcCCCCCcc----
Confidence 222356788999999999988999999999999999999999997532211 0 000111111111110
Q ss_pred CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 755 NSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 755 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
. .....+.+++.+||+.+|++|||++++++
T Consensus 221 -~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 221 -N---KFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred -c---ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 0 02345778999999999999999999977
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=302.83 Aligned_cols=254 Identities=23% Similarity=0.341 Sum_probs=199.7
Q ss_pred cccccCeecccCceeEEEEEeec--CcEEEEEEecCC----------CchhHHHHHHHHHHHHh-hcCCceeeEEeEEee
Q 003254 518 NFSEKNKLGEGGFGPVYKGMLIE--GQEIAVKRLSKG----------SGQGMEEFKNEVLLIAK-LQHRNLVKLLGCCTQ 584 (836)
Q Consensus 518 ~f~~~~~lG~G~fG~Vykg~~~~--g~~vavK~l~~~----------~~~~~~~~~~Ei~~l~~-l~H~niv~l~g~~~~ 584 (836)
+|+..+.||+|+||.||+|.... ++.+|+|.+... ......++.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47778899999999999999865 678999987532 22234567788888875 799999999999999
Q ss_pred CCeeeEEEeecCCCChhHHHhhc-cCCCcCChhhhHHHHHHHHhhhHhhhc-CCCCcEEeccCCCCceEecCCCCceeec
Q 003254 585 RDERMLIYEYLPNKSLDYFIFDT-TRSKLLDWSKRSHIIAGIARGLLYLHQ-DSRLRIIHRDLKASNVLLDNTMNPKISD 662 (836)
Q Consensus 585 ~~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~DLkp~NILl~~~~~~kl~D 662 (836)
.+..++||||+++++|.+++... .....+++..+++++.|++.||.|||+ .+ ++|+||+|+||++++++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 99999999999999999887542 234568899999999999999999996 45 99999999999999999999999
Q ss_pred cCcccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhc
Q 003254 663 FGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIE 742 (836)
Q Consensus 663 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 742 (836)
||++....... ......++..|+|||.+.++.++.++||||||+++|||++|+.|+...... . .......
T Consensus 158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~------~-~~~~~~~ 227 (269)
T cd08528 158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML------S-LATKIVE 227 (269)
T ss_pred ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH------H-HHHHHhh
Confidence 99998754322 223456888999999999988999999999999999999999986432111 0 0001111
Q ss_pred cCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcC
Q 003254 743 ERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 792 (836)
Q Consensus 743 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~ 792 (836)
... .+. ........+.+++.+|++.+|++||++.||.++|+.
T Consensus 228 ~~~----~~~----~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 228 AVY----EPL----PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred ccC----CcC----CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 100 000 011122457789999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=307.52 Aligned_cols=252 Identities=24% Similarity=0.395 Sum_probs=203.2
Q ss_pred hhcccccccCeecccCceeEEEEEee-cCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEE
Q 003254 514 NATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (836)
Q Consensus 514 ~a~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 592 (836)
...++|+..+.||+|+||.||++... +++.||+|.+........+.+.+|+.+++.++|+|++++++++......++||
T Consensus 16 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 95 (297)
T cd06656 16 DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 95 (297)
T ss_pred ChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence 34478899999999999999999974 58999999997665556677899999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCC
Q 003254 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (836)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~ 672 (836)
||+++++|.+++.+ ..+++..+..++.+++.||.|||+.+ ++||||||+|||++.++.++|+|||++......
T Consensus 96 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~ 168 (297)
T cd06656 96 EYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (297)
T ss_pred cccCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCC
Confidence 99999999998842 35788999999999999999999988 999999999999999999999999998765432
Q ss_pred ccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhcccc
Q 003254 673 QTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQS 752 (836)
Q Consensus 673 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 752 (836)
.. ......+++.|+|||.+.+..++.++||||||+++|+|++|+.|+........... ......+ .
T Consensus 169 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~------~~~~~~~-~----- 234 (297)
T cd06656 169 QS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IATNGTP-E----- 234 (297)
T ss_pred cc--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee------eccCCCC-C-----
Confidence 21 11234678899999999998899999999999999999999999753222111000 0000000 0
Q ss_pred ccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 753 LDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 753 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
+ ..+......+.+++.+||+.+|++||++.+|++
T Consensus 235 ~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 235 L--QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred C--CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 011122244678999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=338.25 Aligned_cols=260 Identities=21% Similarity=0.299 Sum_probs=201.3
Q ss_pred ccccccCeecccCceeEEEEEeec-CcEEEEEEecCCC---chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEE
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 592 (836)
++|++.++||+|+||.||+|+... |+.||+|++.... ....+++.+|+.++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 578889999999999999999764 8899999987542 233567899999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhccC--------CCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccC
Q 003254 593 EYLPNKSLDYFIFDTTR--------SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFG 664 (836)
Q Consensus 593 Ey~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFg 664 (836)
||+++++|.+++..... ...+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 99999999998864211 234567788999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCcc----------------ccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCcc
Q 003254 665 LARSFGLDQT----------------EANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADH 728 (836)
Q Consensus 665 la~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~ 728 (836)
+++....... ........||+.|+|||.+.+..++.++|||||||+++||++|+.|+.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9987621110 001122568999999999999999999999999999999999999975321110
Q ss_pred ccchhhhhHHhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHhcCC
Q 003254 729 DHNLLGHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRP-NMSSVVLMLSGE 793 (836)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-t~~eVl~~L~~~ 793 (836)
.. ..... ..+.+.. ........+.+++.+|++.+|++|| ++.++++.|+..
T Consensus 239 ---i~---~~~~i-~~P~~~~-------p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~ 290 (932)
T PRK13184 239 ---IS---YRDVI-LSPIEVA-------PYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH 290 (932)
T ss_pred ---hh---hhhhc-cChhhcc-------ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 00 00000 0000000 0011224567899999999999995 677777777654
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=292.54 Aligned_cols=251 Identities=25% Similarity=0.348 Sum_probs=199.1
Q ss_pred hcccccccCeecccCceeEEEEEee-cCcEEEEEEecCC--CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEE
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 591 (836)
.++.|+..+.||+|.|+.||+.... .|+++|+|++... .....+++.+|+.|-+.++||||+++...+.+....+||
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 4567888889999999999998764 5899999987533 334678899999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEec---CCCCceeeccCcccc
Q 003254 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD---NTMNPKISDFGLARS 668 (836)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~---~~~~~kl~DFgla~~ 668 (836)
||+|.++.|..-+.. +...++..+-+.+.||+++|.|+|.++ |||||+||+|+||. ..--+||+|||+|..
T Consensus 89 Fe~m~G~dl~~eIV~---R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVA---REFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred EecccchHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEE
Confidence 999999999776643 245778888999999999999999998 99999999999994 344699999999998
Q ss_pred cCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhh
Q 003254 669 FGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLEL 748 (836)
Q Consensus 669 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (836)
++ ........+|||+|||||++...+|+..+|||+.||+||-|+.|.+||...... .+. +....+.
T Consensus 163 l~---~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~---rly----e~I~~g~---- 228 (355)
T KOG0033|consen 163 VN---DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLY----EQIKAGA---- 228 (355)
T ss_pred eC---CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH---HHH----HHHhccc----
Confidence 76 222334578999999999999999999999999999999999999997532211 111 1111111
Q ss_pred ccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 003254 749 IDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVV 787 (836)
Q Consensus 749 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl 787 (836)
+| .....-........+|+.+||..||.+|.|+.|.+
T Consensus 229 yd--~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL 265 (355)
T KOG0033|consen 229 YD--YPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEAL 265 (355)
T ss_pred cC--CCCcccCcCCHHHHHHHHHHhccChhhhccHHHHh
Confidence 01 00001111223467899999999999999999865
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=301.57 Aligned_cols=238 Identities=23% Similarity=0.414 Sum_probs=188.6
Q ss_pred CeecccCceeEEEEEeecCc-----------EEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEE
Q 003254 523 NKLGEGGFGPVYKGMLIEGQ-----------EIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (836)
Q Consensus 523 ~~lG~G~fG~Vykg~~~~g~-----------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 591 (836)
+.||+|+||.||+|.+.+.. .+++|.+...... ...+.+|+.+++.++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46999999999999986533 5788877654433 6789999999999999999999999988 778999
Q ss_pred EeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCC-------CceeeccC
Q 003254 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTM-------NPKISDFG 664 (836)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~-------~~kl~DFg 664 (836)
|||+++|+|.+++.... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 79 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHREK--NNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence 99999999999986432 26889999999999999999999988 99999999999999887 79999999
Q ss_pred cccccCCCccccccccccccccccCcccccCC--ccCccccccchhhhhhhhhhC-CCCCCCCCCccccchhhhhHHhhh
Q 003254 665 LARSFGLDQTEANTKRVVGTYGYMSPEYAIDG--LFSVKSDVFSFGVLVLEIICG-KKNRGFNHADHDHNLLGHAWRLWI 741 (836)
Q Consensus 665 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~ksDVwS~GvvL~elltG-~~p~~~~~~~~~~~~~~~~~~~~~ 741 (836)
++..... .....++..|+|||++.+. .++.++||||||+++|||++| ..|+........ ...+.
T Consensus 154 ~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~-------~~~~~ 220 (259)
T cd05037 154 IPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK-------ERFYQ 220 (259)
T ss_pred ccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH-------HHHHh
Confidence 9986532 1224566789999999876 789999999999999999995 555433211100 00000
Q ss_pred ccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 003254 742 EERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLS 791 (836)
Q Consensus 742 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~ 791 (836)
... ..+......+.+++.+|++.+|++|||+.+|++.|+
T Consensus 221 ~~~-----------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 221 DQH-----------RLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred cCC-----------CCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 000 001111156789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=306.75 Aligned_cols=247 Identities=25% Similarity=0.384 Sum_probs=199.0
Q ss_pred cccccCeecccCceeEEEEEeec-CcEEEEEEecCCC-chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEeec
Q 003254 518 NFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (836)
Q Consensus 518 ~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 595 (836)
.|+..+.||+|+||.||+|.... ++.||+|.+.... ....+.+.+|+.++++++||||+++++++......++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 46667789999999999998754 7889999986543 344567899999999999999999999999999999999999
Q ss_pred CCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCccc
Q 003254 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE 675 (836)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 675 (836)
++++|.+++. ...+++..+..++.++++||.|||+.+ ++|+||+|+||++++++.++|+|||++..+.....
T Consensus 85 ~~~~L~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06642 85 GGGSALDLLK----PGPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch-
Confidence 9999988873 346889999999999999999999988 99999999999999999999999999986543221
Q ss_pred cccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccccccC
Q 003254 676 ANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDN 755 (836)
Q Consensus 676 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 755 (836)
......++..|+|||.+.+..++.++||||||++++||++|+.|+......... ....... ..
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~-------~~~~~~~---------~~ 219 (277)
T cd06642 157 -KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL-------FLIPKNS---------PP 219 (277)
T ss_pred -hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHH-------hhhhcCC---------CC
Confidence 122246788999999999989999999999999999999999986532211100 0000000 01
Q ss_pred CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 756 SCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 756 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
.........+.+++.+|++.+|++||+|.+|++.
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 220 TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 1112234557899999999999999999999984
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=303.82 Aligned_cols=256 Identities=27% Similarity=0.386 Sum_probs=201.6
Q ss_pred ccccccCeecccCceeEEEEEeec------CcEEEEEEecCCCch-hHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeee
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE------GQEIAVKRLSKGSGQ-GMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERM 589 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~------g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 589 (836)
++|+....||+|+||.||+|+... .+.|++|.+...... ..+++.+|+.++++++|+||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 578888999999999999999642 457999988665443 4678999999999999999999999999989999
Q ss_pred EEEeecCCCChhHHHhhccCC------CcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeecc
Q 003254 590 LIYEYLPNKSLDYFIFDTTRS------KLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDF 663 (836)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DF 663 (836)
+||||+++++|.+++...... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999998654321 26899999999999999999999998 999999999999999999999999
Q ss_pred CcccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhc
Q 003254 664 GLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIE 742 (836)
Q Consensus 664 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 742 (836)
|++....... ........++..|+|||.+.+..++.++||||||+++++|++ |..|+..... ..... ....
T Consensus 162 ~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~---~~~~~----~~~~ 233 (275)
T cd05046 162 SLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD---EEVLN----RLQA 233 (275)
T ss_pred ccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch---HHHHH----HHHc
Confidence 9987543221 112223456778999999988889999999999999999999 6667532111 01111 1110
Q ss_pred cCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 003254 743 ERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLS 791 (836)
Q Consensus 743 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~ 791 (836)
... ...........+.+++.+|++.+|++||++.|++..|+
T Consensus 234 ~~~--------~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 234 GKL--------ELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCc--------CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 000 00111122346789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=305.26 Aligned_cols=252 Identities=25% Similarity=0.372 Sum_probs=201.0
Q ss_pred cccccccCeecccCceeEEEEEeec-CcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEee
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 594 (836)
.++|++.++||+|+||.||+|+... ++.+++|.+........+.+.+|+.+++.++|+|++++++++......++||||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 3678889999999999999999865 889999999877766778899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcc
Q 003254 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (836)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~ 674 (836)
+++++|..++... ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 91 ~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~- 164 (292)
T cd06644 91 CPGGAVDAIMLEL--DRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL- 164 (292)
T ss_pred CCCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccc-
Confidence 9999998877432 346899999999999999999999988 9999999999999999999999999987543221
Q ss_pred ccccccccccccccCccccc-----CCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhc
Q 003254 675 EANTKRVVGTYGYMSPEYAI-----DGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELI 749 (836)
Q Consensus 675 ~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (836)
.......++..|+|||++. ...++.++|||||||++|||++|+.|+...... . ..............
T Consensus 165 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------~-~~~~~~~~~~~~~~ 236 (292)
T cd06644 165 -QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM------R-VLLKIAKSEPPTLS 236 (292)
T ss_pred -cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH------H-HHHHHhcCCCccCC
Confidence 1122356788999999984 345788999999999999999999987532211 0 01111111110000
Q ss_pred cccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 750 DQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 750 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
.+......+.+++.+||+.+|++||++.|+++
T Consensus 237 -------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 237 -------QPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred -------CCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 01122345778999999999999999999976
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=310.97 Aligned_cols=241 Identities=27% Similarity=0.375 Sum_probs=191.0
Q ss_pred cccccCeecccCceeEEEEEeec-CcEEEEEEecCC---CchhHHHHHHHHHHHHhhc-CCceeeEEeEEeeCCeeeEEE
Q 003254 518 NFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQRDERMLIY 592 (836)
Q Consensus 518 ~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~ 592 (836)
+|+..+.||+|+||.||++.... |+.||+|++.+. .....+.+..|..++..+. |++|+++.+++...+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 36677899999999999999754 889999998753 2234466788999998886 577888999999999999999
Q ss_pred eecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCC
Q 003254 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (836)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~ 672 (836)
||+++|+|..++.. ...+++.++..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQQ---VGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 99999999988843 346899999999999999999999988 999999999999999999999999998754322
Q ss_pred ccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhcccc
Q 003254 673 QTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQS 752 (836)
Q Consensus 673 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 752 (836)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.|+...... .. .........
T Consensus 155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---~~----~~~i~~~~~------- 218 (323)
T cd05615 155 G--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED---EL----FQSIMEHNV------- 218 (323)
T ss_pred C--ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH---HH----HHHHHhCCC-------
Confidence 1 1223356899999999999999999999999999999999999997532211 11 111111100
Q ss_pred ccCCCChHHHHHHHHHHHHcccCCCCCCCCH
Q 003254 753 LDNSCSFSEALRCIQVGLLCVQQRPEDRPNM 783 (836)
Q Consensus 753 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~ 783 (836)
..+......+.+++.+|++.+|.+|++.
T Consensus 219 ---~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 219 ---SYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred ---CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 1111223456789999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=315.29 Aligned_cols=240 Identities=23% Similarity=0.290 Sum_probs=186.3
Q ss_pred CeecccCceeEEEEEeec-CcEEEEEEecCCC---chhHHHHHHHH-HHHHhhcCCceeeEEeEEeeCCeeeEEEeecCC
Q 003254 523 NKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEV-LLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPN 597 (836)
Q Consensus 523 ~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei-~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 597 (836)
+.||+|+||.||+++... ++.||+|++.... .....++..|. .+++.++|+||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 369999999999999865 7789999986532 12233444444 456778999999999999999999999999999
Q ss_pred CChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCccccc
Q 003254 598 KSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEAN 677 (836)
Q Consensus 598 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~ 677 (836)
++|..++.. ...+....+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~--~~ 152 (325)
T cd05602 81 GELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--GT 152 (325)
T ss_pred CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCC--CC
Confidence 999988853 345778888899999999999999998 9999999999999999999999999997542211 12
Q ss_pred cccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccccccCCC
Q 003254 678 TKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDNSC 757 (836)
Q Consensus 678 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 757 (836)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .. ....... .. ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~----~~~i~~~-~~---------~~ 215 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA---EM----YDNILNK-PL---------QL 215 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH---HH----HHHHHhC-Cc---------CC
Confidence 23467999999999999999999999999999999999999997532211 00 0111110 00 01
Q ss_pred ChHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 003254 758 SFSEALRCIQVGLLCVQQRPEDRPNMSSVV 787 (836)
Q Consensus 758 ~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl 787 (836)
.......+.+++.+|++.+|.+||++.+.+
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 216 KPNITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred CCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 112234577899999999999999987543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=301.26 Aligned_cols=248 Identities=27% Similarity=0.410 Sum_probs=197.2
Q ss_pred ccccCeecccCceeEEEEEeec-CcEEEEEEecCCCch---------hHHHHHHHHHHHHhhcCCceeeEEeEEeeCCee
Q 003254 519 FSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQ---------GMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDER 588 (836)
Q Consensus 519 f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~---------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 588 (836)
|...+.||+|++|.||+|.... ++.+|+|.+...... ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 5667899999999999998754 789999988654321 235688999999999999999999999999999
Q ss_pred eEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccc
Q 003254 589 MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (836)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~ 668 (836)
++|+||+++++|..++.. ...+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||+++.
T Consensus 82 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 82 NIFLEYVPGGSVAALLNN---YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred EEEEEecCCCCHHHHHHh---ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 999999999999999843 356888999999999999999999988 99999999999999999999999999987
Q ss_pred cCCCcccc----ccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccC
Q 003254 669 FGLDQTEA----NTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEER 744 (836)
Q Consensus 669 ~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 744 (836)
........ ......++..|+|||.+.+..++.++||||||+++|+|++|+.|+...... ... .....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~-~~~~~-- 226 (267)
T cd06628 156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL------QAI-FKIGE-- 226 (267)
T ss_pred cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH------HHH-HHHhc--
Confidence 64221111 111245788999999999989999999999999999999999997532110 000 00000
Q ss_pred chhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 745 PLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 745 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
... ...+......+.+++.+||+.+|++||++.||++
T Consensus 227 ---~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 227 ---NAS----PEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ---cCC----CcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 001 1111223356778999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=319.33 Aligned_cols=201 Identities=26% Similarity=0.380 Sum_probs=173.5
Q ss_pred ccccccCeecccCceeEEEEEeec-CcEEEEEEecCC---CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEE
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 592 (836)
++|+..+.||+|+||.||+++... ++.||+|++... .....+.+.+|+.++..++|+||+++++.+...+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 468888999999999999999865 889999998643 2234567888999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCC
Q 003254 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (836)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~ 672 (836)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 81 EFLPGGDMMTLLMK---KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred eCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 99999999999843 356889999999999999999999998 999999999999999999999999998754211
Q ss_pred cc---------------------------------ccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCC
Q 003254 673 QT---------------------------------EANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKK 719 (836)
Q Consensus 673 ~~---------------------------------~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~ 719 (836)
.. .......+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 10 000113478999999999999999999999999999999999999
Q ss_pred CCCC
Q 003254 720 NRGF 723 (836)
Q Consensus 720 p~~~ 723 (836)
||..
T Consensus 235 Pf~~ 238 (360)
T cd05627 235 PFCS 238 (360)
T ss_pred CCCC
Confidence 9754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=305.36 Aligned_cols=264 Identities=21% Similarity=0.317 Sum_probs=198.7
Q ss_pred ccccccCeecccCceeEEEEEeec-CcEEEEEEecCCC--chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEe
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 593 (836)
++|+..+.||+|+||.||+|+... |+.||+|++.... ....+.+.+|+.++++++|+|++++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 468888999999999999999864 8899999986542 2234568899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCc
Q 003254 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (836)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~ 673 (836)
|+++++|..++. ....+++..+..++.|+++||+|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 81 YCDHTVLNELEK---NPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred ccCccHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 999998887763 2345899999999999999999999988 9999999999999999999999999998764332
Q ss_pred cccccccccccccccCcccccC-CccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhH--------HhhhccC
Q 003254 674 TEANTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAW--------RLWIEER 744 (836)
Q Consensus 674 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~--------~~~~~~~ 744 (836)
. ......++..|+|||.+.+ ..++.++||||||++++||++|+.|+......+......... ..+....
T Consensus 155 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07847 155 D--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ 232 (286)
T ss_pred c--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccc
Confidence 1 1223457889999999876 468899999999999999999999975433211110000000 0000000
Q ss_pred c-hhhccccccCCCCh-----HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 745 P-LELIDQSLDNSCSF-----SEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 745 ~-~~~~d~~l~~~~~~-----~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
. .....+......+. .....+.+++.+||+.+|++||++.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 0 00000000000000 11345789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=315.04 Aligned_cols=263 Identities=24% Similarity=0.321 Sum_probs=194.8
Q ss_pred hcccccccCeecccCceeEEEEEeec-CcEEEEEEecCC--CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCC-----
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD----- 586 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----- 586 (836)
..++|+..+.||+|+||.||++.... |+.||||++... .......+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 34789999999999999999999754 889999998654 2334567889999999999999999999986543
Q ss_pred -eeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCc
Q 003254 587 -ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGL 665 (836)
Q Consensus 587 -~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgl 665 (836)
..++||||++++ |...+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~~-l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 99 QDVYLVMELMDAN-LCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred ceeEEEEeCCCcC-HHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence 469999999764 545542 24788889999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccc------------hh
Q 003254 666 ARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHN------------LL 733 (836)
Q Consensus 666 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~------------~~ 733 (836)
++..... .......+|+.|+|||.+.+..++.++|||||||++|||++|+.||.......... ..
T Consensus 170 a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 246 (359)
T cd07876 170 ARTACTN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFM 246 (359)
T ss_pred ccccccC---ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHH
Confidence 9764321 11223578999999999999999999999999999999999999986432111000 00
Q ss_pred h---hhHHhhhccCc-------hhhccccccC---CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 734 G---HAWRLWIEERP-------LELIDQSLDN---SCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 734 ~---~~~~~~~~~~~-------~~~~d~~l~~---~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
. .....+....+ .+........ .........+.+++.+||+.||++|||+.|+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 247 NRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0 00000000000 0000000000 0011123457899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=301.52 Aligned_cols=251 Identities=28% Similarity=0.402 Sum_probs=190.9
Q ss_pred CeecccCceeEEEEEeec----CcEEEEEEecCC-CchhHHHHHHHHHHHHhhcCCceeeEEeEEee-CCeeeEEEeecC
Q 003254 523 NKLGEGGFGPVYKGMLIE----GQEIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQ-RDERMLIYEYLP 596 (836)
Q Consensus 523 ~~lG~G~fG~Vykg~~~~----g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~~~lV~Ey~~ 596 (836)
+.||+|+||.||+|...+ ...+|+|++... .....+.+.+|+.+++.++|||++++++++.. +...++|+||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 469999999999998643 357999998543 33456788999999999999999999998764 455789999999
Q ss_pred CCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCccc-
Q 003254 597 NKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE- 675 (836)
Q Consensus 597 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~- 675 (836)
+++|.+++... ...+++..+..++.||++||+|||+.+ ++||||||+|||+++++.+||+|||+++.+......
T Consensus 81 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 81 HGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 99999998542 234677888999999999999999987 999999999999999999999999999865322111
Q ss_pred -cccccccccccccCcccccCCccCccccccchhhhhhhhhhCCC-CCCCCCCccccchhhhhHHhhhccCchhhccccc
Q 003254 676 -ANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKK-NRGFNHADHDHNLLGHAWRLWIEERPLELIDQSL 753 (836)
Q Consensus 676 -~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 753 (836)
.......++..|+|||.+.+..++.++||||||+++|||++|.. |+..... .... .........
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---~~~~----~~~~~~~~~------- 221 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS---FDIT----VYLLQGRRL------- 221 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHHH----HHHhcCCCC-------
Confidence 11122345678999999988899999999999999999999654 4322111 0111 111111000
Q ss_pred cCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 003254 754 DNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 794 (836)
Q Consensus 754 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 794 (836)
..+......+.+++..||+.+|++||++.||++.|+.+.
T Consensus 222 --~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 222 --LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred --CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 001111245779999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=301.44 Aligned_cols=251 Identities=26% Similarity=0.393 Sum_probs=198.3
Q ss_pred cccccCeecccCceeEEEEEeecCcEEEEEEecCCC------chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEE
Q 003254 518 NFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGS------GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (836)
Q Consensus 518 ~f~~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~------~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 591 (836)
+|...+.||+|+||.||+|...+++.+|+|.+.... ....+.+.+|+.++++++|+||+++++++.+....++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 367788999999999999998789999999886432 12235688999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCC
Q 003254 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (836)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~ 671 (836)
+||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+|+||+|+||++++++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILNR---FGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 999999999999843 245789999999999999999999988 99999999999999999999999999886532
Q ss_pred Ccc----ccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchh
Q 003254 672 DQT----EANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLE 747 (836)
Q Consensus 672 ~~~----~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (836)
... ........++..|+|||.+.+..++.++||||||++++||++|+.|+....... .. .. .... .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~--~~----~~-~~~~---~ 224 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA--AM----FY-IGAH---R 224 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH--HH----HH-hhhc---c
Confidence 111 111223468889999999998889999999999999999999999975321110 00 00 0000 0
Q ss_pred hccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 748 LIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 748 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
...+ ..+......+.+++.+||+.+|++||++.|+++
T Consensus 225 ~~~~----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 225 GLMP----RLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CCCC----CCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0001 111223345789999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=306.15 Aligned_cols=255 Identities=26% Similarity=0.388 Sum_probs=202.0
Q ss_pred ccccccCeecccCceeEEEEEeec-CcEEEEEEecCCC-chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEee
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 594 (836)
++|+..+.||+|+||.||++.... ++.||+|++.... ....+.+.+|+++++.++||||+++++++......++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 567888999999999999999754 8889999876543 34467889999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcC-CCCcEEeccCCCCceEecCCCCceeeccCcccccCCCc
Q 003254 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (836)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~ 673 (836)
+++++|..++.. .+.+++..+..++.+++.||.|||+. + ++|+||||+||++++++.++|+|||++......
T Consensus 85 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~- 157 (284)
T cd06620 85 MDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINS- 157 (284)
T ss_pred CCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhh-
Confidence 999999988743 34689999999999999999999974 5 999999999999999999999999998754221
Q ss_pred cccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCcccc-----chhhhhHHhhhccCchhh
Q 003254 674 TEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDH-----NLLGHAWRLWIEERPLEL 748 (836)
Q Consensus 674 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~ 748 (836)
......++..|+|||.+.++.++.++|||||||+++||++|+.|+......... ...... ........
T Consensus 158 ---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~--- 230 (284)
T cd06620 158 ---IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLL-QQIVQEPP--- 230 (284)
T ss_pred ---ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHH-HHHhhccC---
Confidence 122357899999999998889999999999999999999999997643322110 001100 00110000
Q ss_pred ccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 003254 749 IDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLML 790 (836)
Q Consensus 749 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L 790 (836)
+.+ ........+.+++.+|++.+|++|||+.||+++.
T Consensus 231 --~~~---~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 231 --PRL---PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred --CCC---CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 000 0111334578999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=311.68 Aligned_cols=254 Identities=20% Similarity=0.246 Sum_probs=194.7
Q ss_pred ccccccCeecccCceeEEEEEeec-CcEEEEEEecCC---CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEE
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 592 (836)
++|+..+.||+|+||.||+++... ++.||+|.+.+. .....+.+.+|+.++..++|+||+++++++...+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 478889999999999999999864 788999998643 2233456888999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCC
Q 003254 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (836)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~ 672 (836)
||+++|+|..++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 999999999998542 346888999999999999999999988 999999999999999999999999999876432
Q ss_pred ccccccccccccccccCcccccC-----CccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccC-ch
Q 003254 673 QTEANTKRVVGTYGYMSPEYAID-----GLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEER-PL 746 (836)
Q Consensus 673 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~ 746 (836)
... ......|++.|+|||++.+ +.++.++||||||++||||++|+.|+...... . ......... ..
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~------~-~~~~i~~~~~~~ 227 (331)
T cd05624 156 GTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV------E-TYGKIMNHEERF 227 (331)
T ss_pred Cce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH------H-HHHHHHcCCCcc
Confidence 221 1223568999999999875 56889999999999999999999997532211 0 011111100 00
Q ss_pred hhccccccCCCChHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 003254 747 ELIDQSLDNSCSFSEALRCIQVGLLCVQQRPED--RPNMSSVVLM 789 (836)
Q Consensus 747 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~--RPt~~eVl~~ 789 (836)
.+ . .........+.+++.+|+..++++ |+++.++++.
T Consensus 228 ~~-p-----~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 228 QF-P-----SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred cC-C-----CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 00 0 000112345778888888765543 5688888764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=313.74 Aligned_cols=192 Identities=22% Similarity=0.322 Sum_probs=164.2
Q ss_pred hcccccccCeecccCceeEEEEEeec-CcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEe
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 593 (836)
...+|++.+.||+|+||.||+|+... ++.||+|..... ....|+.++++++|+||+++++++......++|+|
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 44679999999999999999999865 678999975432 23568999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCc
Q 003254 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (836)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~ 673 (836)
|+. ++|..++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 138 ~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~- 210 (357)
T PHA03209 138 HYS-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA- 210 (357)
T ss_pred ccC-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC-
Confidence 995 577777743 3456899999999999999999999998 999999999999999999999999999753211
Q ss_pred cccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCC
Q 003254 674 TEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNR 721 (836)
Q Consensus 674 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~ 721 (836)
.......||..|+|||++.+..++.++|||||||++|||+++..++
T Consensus 211 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 211 --PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred --cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 1223356899999999999999999999999999999999976553
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=308.60 Aligned_cols=264 Identities=22% Similarity=0.337 Sum_probs=196.6
Q ss_pred ccccccCeecccCceeEEEEEeec-CcEEEEEEecCCC-chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEee
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 594 (836)
++|+..++||+|+||.||+|+... ++.||+|.+.... ......+.+|+.++++++||||+++++++......++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 578889999999999999999764 7889999986543 23345678899999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcc
Q 003254 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (836)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~ 674 (836)
++ ++|..++... ...+++..+..++.||++||+|||+.+ |+|+||||+||++++++.+||+|||++........
T Consensus 86 ~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 86 LD-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 97 5888877542 345788999999999999999999988 99999999999999999999999999976432211
Q ss_pred ccccccccccccccCcccccCC-ccCccccccchhhhhhhhhhCCCCCCCCCCccccchh--------hhhHHhhhccCc
Q 003254 675 EANTKRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLL--------GHAWRLWIEERP 745 (836)
Q Consensus 675 ~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~--------~~~~~~~~~~~~ 745 (836)
......+++.|+|||.+.+. .++.++||||||+++|||++|+.||............ ...+........
T Consensus 160 --~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (301)
T cd07873 160 --TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE 237 (301)
T ss_pred --cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccc
Confidence 12224568899999998754 5788999999999999999999997543321110000 000110000000
Q ss_pred hhhcc-ccccC----CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 746 LELID-QSLDN----SCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 746 ~~~~d-~~l~~----~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
....+ +.... .........+.+++.+|++.||.+|||+.||++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00000 00000 001112235679999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=307.76 Aligned_cols=250 Identities=24% Similarity=0.403 Sum_probs=201.9
Q ss_pred cccccccCeecccCceeEEEEEee-cCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEee
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 594 (836)
.++|+..+.||.|++|.||+|... +++.|++|.+........+.+.+|+.+++.++|+|++++++++...+..++|+||
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 97 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY 97 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence 357899999999999999999864 5899999998766555667889999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcc
Q 003254 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (836)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~ 674 (836)
+++++|..++.. ..+++.++..++.+++.||+|||+.+ ++|+||||+||++++++.+||+|||++........
T Consensus 98 ~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 170 (296)
T cd06655 98 LAGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS 170 (296)
T ss_pred cCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence 999999998842 35899999999999999999999998 99999999999999999999999999886543222
Q ss_pred ccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhcccccc
Q 003254 675 EANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLD 754 (836)
Q Consensus 675 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 754 (836)
......++..|+|||.+.+..++.++|||||||++|+|++|+.|+........ .. ......... +
T Consensus 171 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~------~~-~~~~~~~~~-----~- 235 (296)
T cd06655 171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA------LY-LIATNGTPE-----L- 235 (296)
T ss_pred --cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HH-HHHhcCCcc-----c-
Confidence 12234678899999999988899999999999999999999999753222110 00 000000000 0
Q ss_pred CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 755 NSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 755 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
..+......+.+++.+||+.+|++||++.+|+.
T Consensus 236 -~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 236 -QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred -CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 011112235678999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=302.47 Aligned_cols=256 Identities=25% Similarity=0.377 Sum_probs=197.6
Q ss_pred ccccCeecccCceeEEEEEee----cCcEEEEEEecCC--CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCC------
Q 003254 519 FSEKNKLGEGGFGPVYKGMLI----EGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD------ 586 (836)
Q Consensus 519 f~~~~~lG~G~fG~Vykg~~~----~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------ 586 (836)
|.+.+.||+|+||.||+|.+. .++.||||++... .....+++.+|+.++++++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 456788999999999999864 2678999998654 2344667899999999999999999999886543
Q ss_pred eeeEEEeecCCCChhHHHhhcc---CCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeecc
Q 003254 587 ERMLIYEYLPNKSLDYFIFDTT---RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDF 663 (836)
Q Consensus 587 ~~~lV~Ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DF 663 (836)
..++++||+++|+|..++.... ....+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 2478899999999988875332 1224788899999999999999999988 999999999999999999999999
Q ss_pred CcccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhc
Q 003254 664 GLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIE 742 (836)
Q Consensus 664 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 742 (836)
|+++...............++..|++||.+....++.++||||||+++|||++ |++|+...... .+ ......
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~---~~----~~~~~~ 230 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS---EI----YNYLIK 230 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH---HH----HHHHHc
Confidence 99987643322222222345678999999998889999999999999999999 77776432111 11 111111
Q ss_pred cCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 003254 743 ERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 793 (836)
Q Consensus 743 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 793 (836)
... + .........+.+++.+|++.+|++||++.|+++.|+++
T Consensus 231 ~~~-------~--~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 231 GNR-------L--KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCc-------C--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 110 0 01112335688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=304.66 Aligned_cols=260 Identities=24% Similarity=0.328 Sum_probs=191.2
Q ss_pred cccccCeecccCceeEEEEEeec-CcEEEEEEecCCC--chhHHHHHHHHHHHHhh---cCCceeeEEeEEee-----CC
Q 003254 518 NFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS--GQGMEEFKNEVLLIAKL---QHRNLVKLLGCCTQ-----RD 586 (836)
Q Consensus 518 ~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~~-----~~ 586 (836)
+|+..+.||+|+||.||++...+ ++.||+|.+.... ......+.+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 47788999999999999999864 8899999986542 22234566777777765 69999999998864 23
Q ss_pred eeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcc
Q 003254 587 ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLA 666 (836)
Q Consensus 587 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla 666 (836)
..++||||+++ +|..++... ....+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKV-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEccccc-CHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 47899999985 787777443 2345899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCc-
Q 003254 667 RSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERP- 745 (836)
Q Consensus 667 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 745 (836)
+...... ......++..|+|||++.+..++.++|||||||++|||++|++||........ .............
T Consensus 156 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~---~~~~~~~~~~~~~~ 229 (288)
T cd07863 156 RIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ---LGKIFDLIGLPPED 229 (288)
T ss_pred ccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHH---HHHHHHHhCCCChh
Confidence 8754221 12235678999999999998999999999999999999999998754322111 0000000000000
Q ss_pred ---------hhhcccccc---CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 746 ---------LELIDQSLD---NSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 746 ---------~~~~d~~l~---~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
.....+... ..........+.+++.+||+.||++|||+.|++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 230 DWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred hCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000000000 0011122345789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=301.66 Aligned_cols=248 Identities=25% Similarity=0.385 Sum_probs=201.3
Q ss_pred ccccccCeecccCceeEEEEEeec-CcEEEEEEecCCC-chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEee
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 594 (836)
..|+..+.||.|+||.||+|+... ++.||+|.+.... ....+.+.+|+.++++++|+||+++++++......++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 356777899999999999999754 8899999987543 34567889999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcc
Q 003254 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (836)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~ 674 (836)
+++++|.+++. ..++++..+..++.+++.||+|||+.+ ++|+||+|+||++++++.++|+|||++..+.....
T Consensus 84 ~~~~~L~~~i~----~~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 84 LGGGSALDLLR----AGPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 99999998884 245888899999999999999999988 99999999999999999999999999987643221
Q ss_pred ccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhcccccc
Q 003254 675 EANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLD 754 (836)
Q Consensus 675 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 754 (836)
......++..|+|||.+.+..++.++||||||+++|||++|+.|+......... ..+.....
T Consensus 157 --~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~----------------~~~~~~~~ 218 (277)
T cd06640 157 --KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL----------------FLIPKNNP 218 (277)
T ss_pred --ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh----------------hhhhcCCC
Confidence 122346788999999999889999999999999999999999987532221100 00000011
Q ss_pred CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 755 NSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 755 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
..........+.+++.+||+.+|++||++.++++.
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 219 PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 12222345567899999999999999999999765
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=304.95 Aligned_cols=240 Identities=25% Similarity=0.389 Sum_probs=189.0
Q ss_pred CeecccCceeEEEEEeec--------CcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEee
Q 003254 523 NKLGEGGFGPVYKGMLIE--------GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (836)
Q Consensus 523 ~~lG~G~fG~Vykg~~~~--------g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 594 (836)
+.||+|+||.||+|.... ..++++|.+........+++.+|+.+++.++|||++++++++......++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 369999999999998643 234888888665555567889999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCC--------ceeeccCcc
Q 003254 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMN--------PKISDFGLA 666 (836)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~--------~kl~DFgla 666 (836)
+++|+|..++... ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++. ++++|||++
T Consensus 81 ~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKN--KNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 9999999998543 236889999999999999999999988 999999999999987765 589999988
Q ss_pred cccCCCccccccccccccccccCcccccCC-ccCccccccchhhhhhhhhhCC-CCCCCCCCccccchhhhhHHhhhccC
Q 003254 667 RSFGLDQTEANTKRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIICGK-KNRGFNHADHDHNLLGHAWRLWIEER 744 (836)
Q Consensus 667 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~GvvL~elltG~-~p~~~~~~~~~~~~~~~~~~~~~~~~ 744 (836)
..... .....++..|+|||++.+. .++.++||||||+++|||++|. .|+....... ........
T Consensus 156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~--------~~~~~~~~ 221 (258)
T cd05078 156 ITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK--------KLQFYEDR 221 (258)
T ss_pred cccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH--------HHHHHHcc
Confidence 65432 1224578899999999864 5799999999999999999995 4432211110 00000000
Q ss_pred chhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 003254 745 PLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLS 791 (836)
Q Consensus 745 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~ 791 (836)
...+......+.+++.+||+.+|++|||++++++.|+
T Consensus 222 ----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 222 ----------HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ----------ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0111122345789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=318.00 Aligned_cols=260 Identities=20% Similarity=0.251 Sum_probs=199.7
Q ss_pred HHHHHhhcccccccCeecccCceeEEEEEeec-CcEEEEEEecCC---CchhHHHHHHHHHHHHhhcCCceeeEEeEEee
Q 003254 509 LKIIANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQ 584 (836)
Q Consensus 509 ~~~l~~a~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~ 584 (836)
...+....++|+..+.||+|+||.||+++... ++.+|+|++.+. .....+.+.+|+.+++.++||||+++++.+..
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 33444566899999999999999999999865 788999998642 22334567889999999999999999999999
Q ss_pred CCeeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccC
Q 003254 585 RDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFG 664 (836)
Q Consensus 585 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFg 664 (836)
....++||||+++|+|..++.. ..++...+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG 187 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFG 187 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCC
Confidence 9999999999999999998843 34788888999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCccccccccccccccccCcccccCC----ccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhh
Q 003254 665 LARSFGLDQTEANTKRVVGTYGYMSPEYAIDG----LFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLW 740 (836)
Q Consensus 665 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~ 740 (836)
+++....... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... . .....
T Consensus 188 ~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~-~~~~i 259 (371)
T cd05622 188 TCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------G-TYSKI 259 (371)
T ss_pred ceeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH------H-HHHHH
Confidence 9987642211 122346799999999998753 3789999999999999999999997532211 1 11111
Q ss_pred hcc-CchhhccccccCCCChHHHHHHHHHHHHcccCCCCC--CCCHHHHHHHh
Q 003254 741 IEE-RPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPED--RPNMSSVVLML 790 (836)
Q Consensus 741 ~~~-~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~--RPt~~eVl~~L 790 (836)
... ...... ........+.+++..|++.++.+ ||++.|+++..
T Consensus 260 ~~~~~~~~~~-------~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 260 MNHKNSLTFP-------DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred HcCCCcccCC-------CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 111 001111 11122345678999999844433 78999988753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=303.42 Aligned_cols=250 Identities=27% Similarity=0.366 Sum_probs=197.3
Q ss_pred ccccCeecccCceeEEEEEeec-CcEEEEEEecCCC---chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEee
Q 003254 519 FSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (836)
Q Consensus 519 f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 594 (836)
|+..+.||+|+||.||++.... ++.||||.+.... ....+.+.+|+.++++++|+|++++++.+...+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 6677899999999999999864 8899999986542 22335678899999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcc
Q 003254 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (836)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~ 674 (836)
+++++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 156 (285)
T cd05630 82 MNGGDLKFHIYHM-GEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ- 156 (285)
T ss_pred cCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-
Confidence 9999999888543 2345889999999999999999999988 9999999999999999999999999987643221
Q ss_pred ccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhcccccc
Q 003254 675 EANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLD 754 (836)
Q Consensus 675 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 754 (836)
......|+..|+|||.+.+..++.++||||||+++|||++|+.|+......... . ...........
T Consensus 157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~---~-~~~~~~~~~~~-------- 222 (285)
T cd05630 157 --TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR---E-EVERLVKEVQE-------- 222 (285)
T ss_pred --cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH---H-HHHhhhhhhhh--------
Confidence 112346899999999999999999999999999999999999997543221100 0 00111000000
Q ss_pred CCCChHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 003254 755 NSCSFSEALRCIQVGLLCVQQRPEDRPN-----MSSVVL 788 (836)
Q Consensus 755 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~eVl~ 788 (836)
.........+.+++..||+.+|++||| +.|+++
T Consensus 223 -~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 223 -EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred -hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 011112235679999999999999999 788876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=302.24 Aligned_cols=262 Identities=24% Similarity=0.307 Sum_probs=201.9
Q ss_pred cHHHHHhhcccccccCeecccCceeEEEEEeec-CcEEEEEEecCCCchhHHHHHHHHHHHHhh-cCCceeeEEeEEe--
Q 003254 508 DLKIIANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCT-- 583 (836)
Q Consensus 508 ~~~~l~~a~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~-- 583 (836)
.+..+..+.++|+..+.||+|+||.||+++... ++.+|+|.+.... ....++.+|+.++.++ +|+||+++++++.
T Consensus 9 ~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 87 (286)
T cd06638 9 IFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87 (286)
T ss_pred EeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence 344556788999999999999999999998854 7899999876432 2346788999999999 6999999999884
Q ss_pred ---eCCeeeEEEeecCCCChhHHHhhc-cCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCce
Q 003254 584 ---QRDERMLIYEYLPNKSLDYFIFDT-TRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPK 659 (836)
Q Consensus 584 ---~~~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~k 659 (836)
.+...++||||+++++|.+++... .....+++..+..++.|+++||.|||+.+ ++||||||+||++++++.+|
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~k 164 (286)
T cd06638 88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVK 164 (286)
T ss_pred ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEE
Confidence 345689999999999999887542 23456888999999999999999999988 99999999999999999999
Q ss_pred eeccCcccccCCCccccccccccccccccCcccccC-----CccCccccccchhhhhhhhhhCCCCCCCCCCccccchhh
Q 003254 660 ISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAID-----GLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLG 734 (836)
Q Consensus 660 l~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~ 734 (836)
|+|||+++....... ......|+..|+|||++.. ..++.++|||||||++|||++|+.|+........
T Consensus 165 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~----- 237 (286)
T cd06638 165 LVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA----- 237 (286)
T ss_pred EccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH-----
Confidence 999999886532211 2223568999999999853 4578999999999999999999998753221100
Q ss_pred hhHHhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 735 HAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 735 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
.............++ ......+.+++.+|++.+|++|||+.||++.
T Consensus 238 --~~~~~~~~~~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 238 --LFKIPRNPPPTLHQP-------ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred --HhhccccCCCcccCC-------CCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 000000101111110 1112357899999999999999999999875
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=299.74 Aligned_cols=250 Identities=26% Similarity=0.404 Sum_probs=192.4
Q ss_pred ccccccCeecccCceeEEEEEeec-CcEEEEEEecCCC-----chhHHHHHHHHHHHHhhcCCceeeEEeEEeeC--Cee
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS-----GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR--DER 588 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~-----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~ 588 (836)
.+|+..+.||+|+||.||++.... ++.|++|++.... ....+.+.+|+.++++++||||+++++++... ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 368888999999999999999754 8899999886432 12345688999999999999999999988653 567
Q ss_pred eEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccc
Q 003254 589 MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (836)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~ 668 (836)
++++||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||+++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA---YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 899999999999998843 345889999999999999999999987 99999999999999999999999999986
Q ss_pred cCCCcc-ccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchh
Q 003254 669 FGLDQT-EANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLE 747 (836)
Q Consensus 669 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (836)
...... ........++..|+|||.+.+..++.++||||||+++|||++|+.|+...... ..........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~------~~~~~~~~~~---- 225 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM------AAIFKIATQP---- 225 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH------HHHHHHhcCC----
Confidence 532211 11122345788999999999988999999999999999999999997532110 0000000000
Q ss_pred hccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 748 LIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 748 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
..+ ..+......+.+++ .|+..+|++||+++||++
T Consensus 226 -~~~----~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 226 -TNP----QLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred -CCC----CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 001 11111223344555 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=302.71 Aligned_cols=256 Identities=25% Similarity=0.349 Sum_probs=200.9
Q ss_pred cccccccCeecccCceeEEEEEeecC----cEEEEEEecCCC-chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeE
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLIEG----QEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~~g----~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 590 (836)
.++|...+.||+|+||.||+|...+. ..|+||...... ....+.+.+|+.++++++||||+++++++.. +..++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 35677889999999999999987542 468999887654 4456789999999999999999999999875 56789
Q ss_pred EEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccC
Q 003254 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (836)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~ 670 (836)
||||+++++|.+++... ...+++..+..++.+++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++...
T Consensus 84 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 84 VMELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred EEEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecc
Confidence 99999999999998542 235899999999999999999999988 9999999999999999999999999998654
Q ss_pred CCccccccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhccCchhhc
Q 003254 671 LDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEERPLELI 749 (836)
Q Consensus 671 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (836)
...... .....++..|+|||.+....++.++||||||++++||++ |+.|+....... ... ........
T Consensus 159 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~---~~~----~~~~~~~~--- 227 (270)
T cd05056 159 DESYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND---VIG----RIENGERL--- 227 (270)
T ss_pred ccccee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH---HHH----HHHcCCcC---
Confidence 332111 112334568999999988889999999999999999986 998874322111 110 11111000
Q ss_pred cccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 003254 750 DQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 794 (836)
Q Consensus 750 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 794 (836)
.........+.+++.+|+..+|++|||+.++++.|+++.
T Consensus 228 ------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~ 266 (270)
T cd05056 228 ------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL 266 (270)
T ss_pred ------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 011122346788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=298.70 Aligned_cols=253 Identities=23% Similarity=0.367 Sum_probs=203.1
Q ss_pred ccccccCeecccCceeEEEEEeec-CcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEeec
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 595 (836)
++|+..+.||+|+||.||++.... ++.+++|.+........+.+.+|+.++++++||||+++++++......+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 678889999999999999999854 7889999998766566788999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCccc
Q 003254 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE 675 (836)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 675 (836)
++++|.+++... ...++...+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||++..+.....
T Consensus 83 ~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~- 156 (262)
T cd06613 83 GGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA- 156 (262)
T ss_pred CCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhhh-
Confidence 999999988542 246889999999999999999999988 99999999999999999999999999886543211
Q ss_pred cccccccccccccCcccccCC---ccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhcccc
Q 003254 676 ANTKRVVGTYGYMSPEYAIDG---LFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQS 752 (836)
Q Consensus 676 ~~~~~~~gt~~y~aPE~~~~~---~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 752 (836)
......++..|+|||.+.+. .++.++||||||++++||++|+.|+........ ... .... ......
T Consensus 157 -~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~------~~~-~~~~---~~~~~~ 225 (262)
T cd06613 157 -KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA------LFL-ISKS---NFPPPK 225 (262)
T ss_pred -ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH------HHH-HHhc---cCCCcc
Confidence 12235678899999999876 889999999999999999999998743221110 000 0000 000000
Q ss_pred ccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 753 LDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 753 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
+ .........+.+++.+|++.+|.+|||+.+|+.
T Consensus 226 ~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 226 L--KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred c--cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1 111223456889999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=297.33 Aligned_cols=251 Identities=23% Similarity=0.325 Sum_probs=202.2
Q ss_pred cccccCeecccCceeEEEEEeec-CcEEEEEEecCC--CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEee
Q 003254 518 NFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (836)
Q Consensus 518 ~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 594 (836)
+|+..+.||.|+||.||.++... ++.+++|.+... .....+++.+|+.++++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 47888999999999999988654 888999987654 344567789999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcc
Q 003254 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (836)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~ 674 (836)
+++++|.+++.... ...+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 99999999885432 356889999999999999999999988 99999999999999999999999999987643322
Q ss_pred ccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhcccccc
Q 003254 675 EANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLD 754 (836)
Q Consensus 675 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 754 (836)
......+++.|+|||.+.+..++.++||||||++++||++|+.|+...... ..... ........
T Consensus 157 --~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~------~~~~~-~~~~~~~~------- 220 (256)
T cd08221 157 --MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL------NLVVK-IVQGNYTP------- 220 (256)
T ss_pred --cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH------HHHHH-HHcCCCCC-------
Confidence 223356889999999999888999999999999999999999987432211 11111 11111100
Q ss_pred CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 003254 755 NSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLML 790 (836)
Q Consensus 755 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L 790 (836)
........+.+++.+|++.+|++||++.++++.+
T Consensus 221 --~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 221 --VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred --CccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 1112234577999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=303.03 Aligned_cols=250 Identities=26% Similarity=0.365 Sum_probs=196.1
Q ss_pred ccccCeecccCceeEEEEEee-cCcEEEEEEecCCC---chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEee
Q 003254 519 FSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (836)
Q Consensus 519 f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 594 (836)
|+..+.||+|+||+||++... +++.+|+|.+.... ....+.+.+|+.++++++|+|++++.+++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 566788999999999999975 48899999986542 22345578899999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcc
Q 003254 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (836)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~ 674 (836)
+++++|..++... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05632 82 MNGGDLKFHIYNM-GNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE- 156 (285)
T ss_pred ccCccHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC-
Confidence 9999999888543 2346899999999999999999999988 9999999999999999999999999987643221
Q ss_pred ccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhcccccc
Q 003254 675 EANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLD 754 (836)
Q Consensus 675 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 754 (836)
......|+..|+|||.+.+..++.++||||||+++|||++|+.|+......... ........... .
T Consensus 157 --~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~---~~~~~~~~~~~--~------- 222 (285)
T cd05632 157 --SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKR---EEVDRRVLETE--E------- 222 (285)
T ss_pred --cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHhhhccc--c-------
Confidence 112356899999999999889999999999999999999999997532211100 00000000000 0
Q ss_pred CCCChHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 003254 755 NSCSFSEALRCIQVGLLCVQQRPEDRPN-----MSSVVL 788 (836)
Q Consensus 755 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~eVl~ 788 (836)
.........+.+++..|++.+|++||+ +.+++.
T Consensus 223 -~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 223 -VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred -ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 011112234678999999999999999 666665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=306.95 Aligned_cols=197 Identities=25% Similarity=0.393 Sum_probs=159.9
Q ss_pred cCeecccCceeEEEEEee---cCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEee--CCeeeEEEeecC
Q 003254 522 KNKLGEGGFGPVYKGMLI---EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQ--RDERMLIYEYLP 596 (836)
Q Consensus 522 ~~~lG~G~fG~Vykg~~~---~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~lV~Ey~~ 596 (836)
.++||+|+||.||+|+.. .++.+|+|.+.... ....+.+|+.++++++||||+++++++.. ....++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 358999999999999965 35789999986542 23457889999999999999999998854 455789999987
Q ss_pred CCChhHHHhhcc------CCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEe----cCCCCceeeccCcc
Q 003254 597 NKSLDYFIFDTT------RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLL----DNTMNPKISDFGLA 666 (836)
Q Consensus 597 ~gsL~~~l~~~~------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl----~~~~~~kl~DFgla 666 (836)
+ +|..++.... ....+++..+..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 5 6766664221 1235888899999999999999999998 9999999999999 45678999999999
Q ss_pred cccCCCcc-ccccccccccccccCcccccCC-ccCccccccchhhhhhhhhhCCCCCCCC
Q 003254 667 RSFGLDQT-EANTKRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (836)
Q Consensus 667 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~GvvL~elltG~~p~~~~ 724 (836)
+.+..... ........+|+.|+|||++.+. .++.++||||+||+++||++|++||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 87643322 1222346789999999999874 5899999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=310.39 Aligned_cols=253 Identities=23% Similarity=0.286 Sum_probs=210.1
Q ss_pred hhcccccccCeecccCceeEEEEEeec-CcEEEEEEecCCCch---hHHHHHHHHHHHHhhc-CCceeeEEeEEeeCCee
Q 003254 514 NATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQ---GMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQRDER 588 (836)
Q Consensus 514 ~a~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~---~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~ 588 (836)
...+.|+..+.||+|.||.||+++.+. |+.+|+|.+.+.... ..+...+|+.+|+++. |||||.+.+.++.....
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV 111 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence 345678888999999999999999877 999999999776432 3468899999999998 99999999999999999
Q ss_pred eEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecC----CCCceeeccC
Q 003254 589 MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN----TMNPKISDFG 664 (836)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~----~~~~kl~DFg 664 (836)
++|||++.+|.|.+.+... .+++..+..++.||+.+++|||+.+ |+||||||+|+|+.. ++.+|++|||
T Consensus 112 ~lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred EEEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 9999999999999999655 2899999999999999999999988 999999999999953 3579999999
Q ss_pred cccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccC
Q 003254 665 LARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEER 744 (836)
Q Consensus 665 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 744 (836)
++..... .......+||+.|+|||++....|+.++||||+||++|.|++|.+||.......... ......
T Consensus 185 la~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-------~i~~~~ 254 (382)
T KOG0032|consen 185 LAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-------AILRGD 254 (382)
T ss_pred CceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-------HHHcCC
Confidence 9998754 334556899999999999999999999999999999999999999986544332211 111111
Q ss_pred chhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 745 PLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 745 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
. ......-......+.+++..++..||.+|+|+.++++.
T Consensus 255 ~------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 255 F------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred C------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 1 11112222334557799999999999999999999994
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=298.29 Aligned_cols=253 Identities=21% Similarity=0.329 Sum_probs=188.1
Q ss_pred eecccCceeEEEEEeecC---cEEEEEEecCCC-chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEeecCCCC
Q 003254 524 KLGEGGFGPVYKGMLIEG---QEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKS 599 (836)
Q Consensus 524 ~lG~G~fG~Vykg~~~~g---~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gs 599 (836)
+||+|+||.||+|...++ ..+++|.+.... ....+.+.+|+.+++.++||||+++++.+......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 699999999999986543 346677765443 3456789999999999999999999999999999999999999999
Q ss_pred hhHHHhhccC-CCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcccccc
Q 003254 600 LDYFIFDTTR-SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANT 678 (836)
Q Consensus 600 L~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~ 678 (836)
|.+++..... ...++...+..++.||++||+|||+.+ ++||||||+|||++.++.+||+|||++............
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 9999865322 234666778899999999999999988 999999999999999999999999998643222111122
Q ss_pred ccccccccccCcccccC-------CccCccccccchhhhhhhhhhC-CCCCCCCCCccccchhhhhHHhhhccCchhhcc
Q 003254 679 KRVVGTYGYMSPEYAID-------GLFSVKSDVFSFGVLVLEIICG-KKNRGFNHADHDHNLLGHAWRLWIEERPLELID 750 (836)
Q Consensus 679 ~~~~gt~~y~aPE~~~~-------~~~t~ksDVwS~GvvL~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 750 (836)
....++..|+|||++.. ..++.++||||||+++|||+++ ..|+..... .. ............+.+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~---~~----~~~~~~~~~~~~~~~ 231 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD---RE----VLNHVIKDQQVKLFK 231 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH---HH----HHHHHHhhcccccCC
Confidence 23567889999998753 2457899999999999999975 455432111 11 111111222222333
Q ss_pred ccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 003254 751 QSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLS 791 (836)
Q Consensus 751 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~ 791 (836)
+.+... ....+.+++..|+ .+|++||++.||++.|.
T Consensus 232 ~~~~~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 232 PQLELP----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CccCCC----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 322222 2245677888899 67999999999999885
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=311.05 Aligned_cols=240 Identities=24% Similarity=0.310 Sum_probs=184.7
Q ss_pred ecccCceeEEEEEeec-CcEEEEEEecCCC---chhHHHHHHHHHHHHhh---cCCceeeEEeEEeeCCeeeEEEeecCC
Q 003254 525 LGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKL---QHRNLVKLLGCCTQRDERMLIYEYLPN 597 (836)
Q Consensus 525 lG~G~fG~Vykg~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~~~~~~~lV~Ey~~~ 597 (836)
||+|+||.||+++... ++.||||++.+.. ......+..|..++... +||||+++++++.+....++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 7999999999999764 8899999986432 12233455677777665 699999999999999999999999999
Q ss_pred CChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCccccc
Q 003254 598 KSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEAN 677 (836)
Q Consensus 598 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~ 677 (836)
|+|..++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~ 152 (330)
T cd05586 81 GELFWHLQK---EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KT 152 (330)
T ss_pred ChHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CC
Confidence 999888843 456899999999999999999999998 9999999999999999999999999987543221 12
Q ss_pred cccccccccccCcccccCC-ccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccccccCC
Q 003254 678 TKRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDNS 756 (836)
Q Consensus 678 ~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 756 (836)
.....||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ........... .+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~-------~~~~~i~~~~~-~~~~------ 218 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ-------QMYRNIAFGKV-RFPK------ 218 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH-------HHHHHHHcCCC-CCCC------
Confidence 2346789999999998765 4899999999999999999999997532211 01111111100 0000
Q ss_pred CChHHHHHHHHHHHHcccCCCCCCC----CHHHHHH
Q 003254 757 CSFSEALRCIQVGLLCVQQRPEDRP----NMSSVVL 788 (836)
Q Consensus 757 ~~~~~~~~l~~li~~Cl~~dP~~RP----t~~eVl~ 788 (836)
......+.+++.+||+.+|++|| ++.++++
T Consensus 219 --~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 219 --NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred --ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 01123567899999999999998 5666655
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=298.64 Aligned_cols=247 Identities=26% Similarity=0.393 Sum_probs=196.8
Q ss_pred ccccccCeecccCceeEEEEEeecCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEeecC
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLP 596 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 596 (836)
++|+..+.||+|+||.||++.. .++.+|+|.+.... ..+.+.+|+.++++++|||++++++++.. +..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILH-NGLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcC-CCcEEEEECCC
Confidence 5688889999999999999975 68889999986542 34678999999999999999999999865 45799999999
Q ss_pred CCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcccc
Q 003254 597 NKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEA 676 (836)
Q Consensus 597 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~~ 676 (836)
+++|.+++.... ...+++..+..++.|+++||.|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~---- 153 (254)
T cd05083 82 KGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG---- 153 (254)
T ss_pred CCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc----
Confidence 999999986432 345789999999999999999999988 999999999999999999999999998764321
Q ss_pred ccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhccCchhhccccccC
Q 003254 677 NTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDN 755 (836)
Q Consensus 677 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 755 (836)
......+..|+|||.+.++.++.++||||||++++||++ |+.|+....... ........ ...
T Consensus 154 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~---------~~~ 216 (254)
T cd05083 154 -VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE-------VKECVEKG---------YRM 216 (254)
T ss_pred -CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH-------HHHHHhCC---------CCC
Confidence 112234568999999998899999999999999999998 888864322111 01111111 001
Q ss_pred CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcC
Q 003254 756 SCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 792 (836)
Q Consensus 756 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~ 792 (836)
.........+.+++.+|++.+|++||++.+|++.|+.
T Consensus 217 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 217 EPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 1111223567799999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=316.62 Aligned_cols=252 Identities=29% Similarity=0.374 Sum_probs=205.9
Q ss_pred cccccCeecccCceeEEEEEeec--Cc--EEEEEEecCCCch-hHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEE
Q 003254 518 NFSEKNKLGEGGFGPVYKGMLIE--GQ--EIAVKRLSKGSGQ-GMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (836)
Q Consensus 518 ~f~~~~~lG~G~fG~Vykg~~~~--g~--~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 592 (836)
+....++||+|.||.|++|.+.. |+ .||||.++..... ....|++|+.+|.+|+|+|+++|+|+... ....|||
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ 189 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF 189 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence 33445689999999999999864 54 4899999776543 67899999999999999999999999987 8889999
Q ss_pred eecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCC
Q 003254 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (836)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~ 672 (836)
|.++.|+|.+.|.+ .....+-......++.|||.||.||..+. +|||||.++|+||-..-.+||+||||.+.++..
T Consensus 190 ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 190 ELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGEN 265 (1039)
T ss_pred hhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCC
Confidence 99999999999987 45567888899999999999999999988 999999999999999999999999999988654
Q ss_pred cccccc-ccccccccccCcccccCCccCccccccchhhhhhhhhhCC-CCCCCCCCccccchhhhhHHhhhccCchhhcc
Q 003254 673 QTEANT-KRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGK-KNRGFNHADHDHNLLGHAWRLWIEERPLELID 750 (836)
Q Consensus 673 ~~~~~~-~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 750 (836)
...... ....-...|.|||.+....|+.++|||+|||+||||+|+. .|.-.. ....+.+.+|
T Consensus 266 ed~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~----------------~g~qIL~~iD 329 (1039)
T KOG0199|consen 266 EDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGC----------------RGIQILKNID 329 (1039)
T ss_pred CcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCC----------------CHHHHHHhcc
Confidence 443322 2233467899999999999999999999999999999954 332110 0111223444
Q ss_pred ccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 003254 751 QSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLML 790 (836)
Q Consensus 751 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L 790 (836)
..-+-..+..+.+++++++..||..+|++|||+..|.+.+
T Consensus 330 ~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 330 AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 3333344566788899999999999999999999998544
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=311.49 Aligned_cols=255 Identities=19% Similarity=0.227 Sum_probs=193.5
Q ss_pred ccccccCeecccCceeEEEEEeec-CcEEEEEEecCC---CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEE
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 592 (836)
++|+..++||+|+||.||+++... ++.+|+|++.+. .....+.+.+|+.++..++|+||+++++++......++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 468889999999999999999865 778999998642 2223455888999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCC
Q 003254 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (836)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~ 672 (836)
||+++|+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 ey~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 999999999999542 346888999999999999999999988 999999999999999999999999998765322
Q ss_pred ccccccccccccccccCccccc-----CCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchh
Q 003254 673 QTEANTKRVVGTYGYMSPEYAI-----DGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLE 747 (836)
Q Consensus 673 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (836)
.. .......||+.|+|||++. ...++.++|||||||+||||++|+.||...... ..............
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~------~~~~~i~~~~~~~~ 228 (332)
T cd05623 156 GT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIMNHKERFQ 228 (332)
T ss_pred Cc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH------HHHHHHhCCCcccc
Confidence 21 1222357899999999986 346889999999999999999999997532211 11111100000000
Q ss_pred hccccccCCCChHHHHHHHHHHHHcccCC--CCCCCCHHHHHHH
Q 003254 748 LIDQSLDNSCSFSEALRCIQVGLLCVQQR--PEDRPNMSSVVLM 789 (836)
Q Consensus 748 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~d--P~~RPt~~eVl~~ 789 (836)
.. .........+.+++.+|+..+ +..||++.|+++.
T Consensus 229 ~p------~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 229 FP------AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred CC------CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 00 000112244667788877544 4447899999876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=297.73 Aligned_cols=250 Identities=22% Similarity=0.349 Sum_probs=200.2
Q ss_pred cccccCeecccCceeEEEEEee-cCcEEEEEEecCC--CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEee
Q 003254 518 NFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (836)
Q Consensus 518 ~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 594 (836)
+|+..+.||+|+||.||+++.. +|+.||+|++... .....+++.+|+.++++++||||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4778899999999999999875 4889999998643 234456889999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcc
Q 003254 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (836)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~ 674 (836)
+++++|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 81 CEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 9999999888542 2335788999999999999999999988 99999999999999999999999999987543221
Q ss_pred ccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhcccccc
Q 003254 675 EANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLD 754 (836)
Q Consensus 675 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 754 (836)
......+++.|+|||++.++.++.++||||||+++++|++|+.|+..... ....... .....
T Consensus 157 --~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~------~~~~~~~-~~~~~--------- 218 (256)
T cd08218 157 --LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM------KNLVLKI-IRGSY--------- 218 (256)
T ss_pred --hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH------HHHHHHH-hcCCC---------
Confidence 12234578899999999998999999999999999999999998642211 1111111 11100
Q ss_pred CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 755 NSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 755 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
...+......+.+++.+|++.+|++||+|.+|++.
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 219 PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 01112223457899999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=285.91 Aligned_cols=252 Identities=23% Similarity=0.351 Sum_probs=198.7
Q ss_pred hcccccccCeecccCceeEEEEEeec-CcEEEEEEecCCCc--------hhHHHHHHHHHHHHhh-cCCceeeEEeEEee
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSG--------QGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQ 584 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~--------~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~ 584 (836)
.-.+|...+.||.|..+.|-+..++. |+++|+|++..... ...++-..|+.||+++ .||+|+.+.++++.
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 34577888899999999999888754 88999999854321 1234557899999998 59999999999999
Q ss_pred CCeeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccC
Q 003254 585 RDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFG 664 (836)
Q Consensus 585 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFg 664 (836)
..-.++|+|.|+.|.|.++|.+ .-.+++++..+|+.|+.+|+.|||..+ ||||||||+|||+|++.++||+|||
T Consensus 95 ~sF~FlVFdl~prGELFDyLts---~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFG 168 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTS---KVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFG 168 (411)
T ss_pred cchhhhhhhhcccchHHHHhhh---heeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccc
Confidence 9999999999999999999943 446899999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCccccccccccccccccCcccccC------CccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHH
Q 003254 665 LARSFGLDQTEANTKRVVGTYGYMSPEYAID------GLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWR 738 (836)
Q Consensus 665 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~ 738 (836)
++..+..... ....+|||+|+|||.+.. ..|+..+|+|+.||++|-|+.|.+||-...+ + ...+
T Consensus 169 Fa~~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ-----m--lMLR 238 (411)
T KOG0599|consen 169 FACQLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ-----M--LMLR 238 (411)
T ss_pred eeeccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH-----H--HHHH
Confidence 9998754433 344799999999999853 2478899999999999999999999631100 0 0111
Q ss_pred hhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 739 LWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 739 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
...++.. ++ ..+.-.+......+|+.+||+.||.+|.|++|+++
T Consensus 239 ~ImeGky-qF-----~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 239 MIMEGKY-QF-----RSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred HHHhccc-cc-----CCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 1111110 00 00111122345679999999999999999999875
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=316.58 Aligned_cols=263 Identities=24% Similarity=0.313 Sum_probs=195.4
Q ss_pred hcccccccCeecccCceeEEEEEeec-CcEEEEEEecCC--CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeC------
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR------ 585 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------ 585 (836)
..++|...+.||+|+||.||++.... ++.||||++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 44789999999999999999998754 889999998754 233456788899999999999999999988543
Q ss_pred CeeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCc
Q 003254 586 DERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGL 665 (836)
Q Consensus 586 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgl 665 (836)
...++||||+++ +|...+. ..+++..+..++.|+++||.|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence 346999999976 5555552 24788899999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccc-hhh----------
Q 003254 666 ARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHN-LLG---------- 734 (836)
Q Consensus 666 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~-~~~---------- 734 (836)
++...... ......+|..|+|||++.+..++.++|||||||++|||++|+.||.......... ...
T Consensus 166 ~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (355)
T cd07874 166 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_pred cccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 98653221 1223578999999999999999999999999999999999999975432111000 000
Q ss_pred ----hhHHhhhccCch--hh------cccccc--CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 735 ----HAWRLWIEERPL--EL------IDQSLD--NSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 735 ----~~~~~~~~~~~~--~~------~d~~l~--~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
.....+....+. .. .+.... ..........+.+++.+||+.||++|||+.|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000000000000 00 000000 00111123467899999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=307.11 Aligned_cols=261 Identities=25% Similarity=0.376 Sum_probs=197.9
Q ss_pred ccccccCeecccCceeEEEEEeec-CcEEEEEEecCCCc--hhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEe
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSG--QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 593 (836)
++|+..++||+|+||.||++...+ ++.||+|++..... ...+.+.+|+++++.++||||+++++++......++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 468888999999999999999864 88999999865432 235678899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCc
Q 003254 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (836)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~ 673 (836)
|+++++|..+... ...+++..+..++.||++||+|||+.+ ++|+||+|+||++++++.++|+|||++..+....
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 81 FVDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred cCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 9999999877632 335899999999999999999999988 9999999999999999999999999988754322
Q ss_pred cccccccccccccccCcccccC-CccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhc--cCchhhcc
Q 003254 674 TEANTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIE--ERPLELID 750 (836)
Q Consensus 674 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~d 750 (836)
. ......++..|+|||++.+ ..++.++||||||++++||++|++|+....... ........... ....+..+
T Consensus 155 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07846 155 E--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDID---QLYHIIKCLGNLIPRHQEIFQ 229 (286)
T ss_pred c--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHH---HHHHHHHHhCCCchhhHHHhc
Confidence 1 1223467889999999875 457889999999999999999998875322111 00000000000 00000000
Q ss_pred ----------ccccCC-----CChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 751 ----------QSLDNS-----CSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 751 ----------~~l~~~-----~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
+..... ........+.+++.+||+.+|++||++.+|++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 230 KNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred cchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 000000 01122356889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=302.45 Aligned_cols=252 Identities=23% Similarity=0.390 Sum_probs=199.2
Q ss_pred ccccccCeecccCceeEEEEEee-cCcEEEEEEecCC-CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEee
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 594 (836)
++|+..+.||+|+||.||++... .++.||+|.+... .....+.+.+|+.++++++|+||+++++++...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 46788899999999999999986 5899999988654 334456889999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcC-CCCcEEeccCCCCceEecCCCCceeeccCcccccCCCc
Q 003254 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (836)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~ 673 (836)
+++++|..++........+++..+..++.+++.||.|||++ + |+|+||||+||+++.++.+||+|||++..+...
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 156 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS- 156 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCC-
Confidence 99999998886543344789999999999999999999974 5 999999999999999999999999998765322
Q ss_pred cccccccccccccccCcccccCCc------cCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchh
Q 003254 674 TEANTKRVVGTYGYMSPEYAIDGL------FSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLE 747 (836)
Q Consensus 674 ~~~~~~~~~gt~~y~aPE~~~~~~------~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (836)
......++..|+|||.+.+.. ++.++|||||||++|||++|+.|+...... .... ...........
T Consensus 157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~-~~~~~~~~~~~- 228 (286)
T cd06622 157 ---LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA---NIFA-QLSAIVDGDPP- 228 (286)
T ss_pred ---ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh---hHHH-HHHHHhhcCCC-
Confidence 122345788999999985543 588999999999999999999997432111 1110 01111111111
Q ss_pred hccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 748 LIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 748 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
.........+.+++.+|++.+|++||++.+++.
T Consensus 229 --------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 229 --------TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred --------CCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 112223456779999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=311.06 Aligned_cols=200 Identities=26% Similarity=0.352 Sum_probs=171.7
Q ss_pred ccccccCeecccCceeEEEEEeec-CcEEEEEEecCC---CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEE
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 592 (836)
++|++.+.||+|+||.||+++... ++.||+|++.+. .....+.+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 478889999999999999999765 889999998642 2234566889999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCC
Q 003254 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (836)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~ 672 (836)
||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 999999999998532 346888999999999999999999998 999999999999999999999999998765432
Q ss_pred ccccccccccccccccCcccccC-----CccCccccccchhhhhhhhhhCCCCCC
Q 003254 673 QTEANTKRVVGTYGYMSPEYAID-----GLFSVKSDVFSFGVLVLEIICGKKNRG 722 (836)
Q Consensus 673 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDVwS~GvvL~elltG~~p~~ 722 (836)
.. .......||+.|+|||++.. +.++.++|||||||++|||++|+.||.
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~ 209 (331)
T cd05597 156 GT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFY 209 (331)
T ss_pred CC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCC
Confidence 21 11223468999999999863 457889999999999999999999975
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=297.00 Aligned_cols=257 Identities=26% Similarity=0.400 Sum_probs=204.0
Q ss_pred ccccccCeecccCceeEEEEEee-cCcEEEEEEecCCC-chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEee
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 594 (836)
++|+..+.||.|+||.||+|... ++..+++|++.... ....+.+.+|+++++.++|+|++++++.+...+..++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47888999999999999999975 47889999986543 33567899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcc
Q 003254 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (836)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~ 674 (836)
+++++|.+++........+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999865433356899999999999999999999988 99999999999999999999999999987654322
Q ss_pred cc--ccccccccccccCcccccCC-ccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccc
Q 003254 675 EA--NTKRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQ 751 (836)
Q Consensus 675 ~~--~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 751 (836)
.. ......++..|+|||.+... .++.++||||||++++||++|+.|+....... ....... ... +
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~------~~~~~~~-~~~-----~ 225 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK------VLMLTLQ-NDP-----P 225 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh------hHHHHhc-CCC-----C
Confidence 21 22335688999999998877 78999999999999999999999975322210 0001001 100 0
Q ss_pred cccCCC-ChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 752 SLDNSC-SFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 752 ~l~~~~-~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
.+.... .......+.+++.+|++.+|++||++.+|++
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 226 SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 111100 0122345779999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=296.16 Aligned_cols=250 Identities=24% Similarity=0.334 Sum_probs=198.9
Q ss_pred cccccCeecccCceeEEEEEeec-CcEEEEEEecCCC--chhHHHHHHHHHHHHhhcCCceeeEEeEEeeC-CeeeEEEe
Q 003254 518 NFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR-DERMLIYE 593 (836)
Q Consensus 518 ~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-~~~~lV~E 593 (836)
+|+..+.||+|++|.||+++... ++.+|+|++.... ....+.+.+|++++++++|+|++++++.+... ...++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 47788999999999999999764 7889999986542 34456789999999999999999999987643 45789999
Q ss_pred ecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCc
Q 003254 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (836)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~ 673 (836)
|+++++|.+++... ....+++.++..++.+++.|++|||+.+ ++|+||||+||++++++.++|+|||++..+....
T Consensus 81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 99999999988643 2356899999999999999999999998 9999999999999999999999999998764322
Q ss_pred cccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccccc
Q 003254 674 TEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSL 753 (836)
Q Consensus 674 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 753 (836)
. ......+++.|+|||++.+..++.++||||||++++||++|+.|+...... .... .......
T Consensus 157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~------~~~~-~~~~~~~-------- 219 (257)
T cd08223 157 D--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN------SLVY-RIIEGKL-------- 219 (257)
T ss_pred C--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH------HHHH-HHHhcCC--------
Confidence 1 222356789999999999999999999999999999999999986532111 1000 1111110
Q ss_pred cCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 754 DNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 754 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
...+......+.+++.+|++.+|++||++.++++.
T Consensus 220 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 220 -PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred -CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 01112233567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=302.09 Aligned_cols=263 Identities=26% Similarity=0.337 Sum_probs=203.8
Q ss_pred ccHHHHHhhcccccccCeecccCceeEEEEEee-cCcEEEEEEecCCCchhHHHHHHHHHHHHhh-cCCceeeEEeEEee
Q 003254 507 FDLKIIANATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQ 584 (836)
Q Consensus 507 ~~~~~l~~a~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~ 584 (836)
+.+..+..++++|+..+.||+|+||.||++... +++.+|+|.+.... ....++.+|+.++.++ +|||++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 455666778899999999999999999999985 48899999986543 2346678899999999 79999999999875
Q ss_pred CC-----eeeEEEeecCCCChhHHHhhc-cCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCc
Q 003254 585 RD-----ERMLIYEYLPNKSLDYFIFDT-TRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNP 658 (836)
Q Consensus 585 ~~-----~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~ 658 (836)
.+ ..++|+||+++++|.+++... .....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCE
Confidence 43 579999999999999988542 23456899999999999999999999988 9999999999999999999
Q ss_pred eeeccCcccccCCCccccccccccccccccCcccccCC-----ccCccccccchhhhhhhhhhCCCCCCCCCCccccchh
Q 003254 659 KISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDG-----LFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLL 733 (836)
Q Consensus 659 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~ 733 (836)
||+|||++......... .....++..|+|||.+... .++.++|||||||++|||++|+.|+......
T Consensus 168 kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~------ 239 (291)
T cd06639 168 KLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV------ 239 (291)
T ss_pred EEeecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH------
Confidence 99999998865432211 1234678899999998643 3689999999999999999999997532211
Q ss_pred hhhHHhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 734 GHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 734 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
.... .........+.+ .......+.+++.+|++.+|++||++.|+++.
T Consensus 240 ~~~~-~~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 240 KTLF-KIPRNPPPTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred HHHH-HHhcCCCCCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 0000 111111111111 11223457899999999999999999999863
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=299.73 Aligned_cols=255 Identities=25% Similarity=0.399 Sum_probs=196.8
Q ss_pred cccccCeecccCceeEEEEEee-cCcEEEEEEecCCCc----------hhHHHHHHHHHHHHhhcCCceeeEEeEEeeCC
Q 003254 518 NFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSG----------QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD 586 (836)
Q Consensus 518 ~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~~----------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~ 586 (836)
+|...+.||+|+||.||+|... +|+.+|+|.+..... ...+.+.+|+.+++.++|+|++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4667789999999999999875 488999998753211 12346788999999999999999999999999
Q ss_pred eeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcc
Q 003254 587 ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLA 666 (836)
Q Consensus 587 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla 666 (836)
..++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ ++|+||+|+||++++++.++|+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence 999999999999999998543 56889999999999999999999988 999999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCcccccCCc--cCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccC
Q 003254 667 RSFGLDQTEANTKRVVGTYGYMSPEYAIDGL--FSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEER 744 (836)
Q Consensus 667 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 744 (836)
+...............++..|+|||.+.... ++.++||||||++++|+++|+.|+...... ..........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~- 228 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI------AAMFKLGNKR- 228 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH------HHHHHhhccc-
Confidence 8654322222223356788999999987654 889999999999999999999986421110 0011100000
Q ss_pred chhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 745 PLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 745 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
....+. ..........+.+++.+|++.+|++||++.+|++.
T Consensus 229 ~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 229 SAPPIP----PDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred cCCcCC----ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 000011 11111223567889999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=302.82 Aligned_cols=253 Identities=24% Similarity=0.366 Sum_probs=202.0
Q ss_pred cccccccCeecccCceeEEEEEee-cCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEee
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 594 (836)
.++|++.+.||.|+||.||++... +++.+|+|.+........+.+.+|++++++++|+|++++++.+......++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 467888999999999999999985 4889999999776666677899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcc
Q 003254 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (836)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~ 674 (836)
+++++|..++... ...+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (280)
T cd06611 84 CDGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ 158 (280)
T ss_pred cCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence 9999999988542 346899999999999999999999998 99999999999999999999999999876532211
Q ss_pred ccccccccccccccCccccc-----CCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhc
Q 003254 675 EANTKRVVGTYGYMSPEYAI-----DGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELI 749 (836)
Q Consensus 675 ~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (836)
......+++.|+|||.+. ...++.++||||||+++|||++|+.|+...... .. ..........
T Consensus 159 --~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~------~~-~~~~~~~~~~--- 226 (280)
T cd06611 159 --KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM------RV-LLKILKSEPP--- 226 (280)
T ss_pred --ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH------HH-HHHHhcCCCC---
Confidence 122356889999999975 345788999999999999999999997532211 00 0111111000
Q ss_pred cccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 750 DQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 750 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
.+. .+......+.+++..||+.+|++||++.+|++.
T Consensus 227 --~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 227 --TLD--QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred --CcC--CcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 000 011122457789999999999999999999764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=296.97 Aligned_cols=266 Identities=22% Similarity=0.295 Sum_probs=201.7
Q ss_pred ccccccCeecccCceeEEEEEeecCcEEEEEEecCCCchhHHHHHHHHHHHHh--hcCCceeeEEeEEeeCC----eeeE
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAK--LQHRNLVKLLGCCTQRD----ERML 590 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~--l~H~niv~l~g~~~~~~----~~~l 590 (836)
++....+.||+|.||.||+|.+ .|+.||||++...++ +.+.+|.+|++. |+|+||+.+++.-..++ +++|
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwL 286 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWL 286 (513)
T ss_pred heeEEEEEecCccccceeeccc-cCCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEE
Confidence 5667788999999999999999 899999999976543 456777777775 59999999998765543 4899
Q ss_pred EEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcC-----CCCcEEeccCCCCceEecCCCCceeeccCc
Q 003254 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQD-----SRLRIIHRDLKASNVLLDNTMNPKISDFGL 665 (836)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~ivH~DLkp~NILl~~~~~~kl~DFgl 665 (836)
|.+|.++|+|.++|. +..++....++++..+|.||+|||.+ +.+.|.|||||+.||||..++...|+|+||
T Consensus 287 vTdYHe~GSL~DyL~----r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGL 362 (513)
T KOG2052|consen 287 VTDYHEHGSLYDYLN----RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 362 (513)
T ss_pred eeecccCCcHHHHHh----hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeecee
Confidence 999999999999993 36799999999999999999999954 678899999999999999999999999999
Q ss_pred ccccCCCcc--ccccccccccccccCcccccCCc----c-C-ccccccchhhhhhhhhhCC----------CCCCCCCCc
Q 003254 666 ARSFGLDQT--EANTKRVVGTYGYMSPEYAIDGL----F-S-VKSDVFSFGVLVLEIICGK----------KNRGFNHAD 727 (836)
Q Consensus 666 a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~----~-t-~ksDVwS~GvvL~elltG~----------~p~~~~~~~ 727 (836)
|........ .......+||.+|||||++...- + + ..+||||||.|+||+.-.- .||....+.
T Consensus 363 Av~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~ 442 (513)
T KOG2052|consen 363 AVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPS 442 (513)
T ss_pred eEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCC
Confidence 988754422 33345578999999999996432 2 2 3589999999999996522 233221111
Q ss_pred cccchhhhhHHhhhccCchhhcccccc-CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCCCC
Q 003254 728 HDHNLLGHAWRLWIEERPLELIDQSLD-NSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSL 796 (836)
Q Consensus 728 ~~~~~~~~~~~~~~~~~~~~~~d~~l~-~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~~ 796 (836)
+... +...+-.-.+.+.|... .-.+.+.+..+.+++..||..+|..|-|+--|-+.|.++...
T Consensus 443 DPs~------eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~ 506 (513)
T KOG2052|consen 443 DPSF------EEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNS 506 (513)
T ss_pred CCCH------HHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcC
Confidence 1110 00000000111112221 124557778899999999999999999999999999887643
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=326.74 Aligned_cols=264 Identities=20% Similarity=0.249 Sum_probs=191.2
Q ss_pred HHhhcccccccCeecccCceeEEEEEeec-CcEEEEEEecCCCchhHHHHHHHHHHHHhhcCC------ceeeEEeEEee
Q 003254 512 IANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHR------NLVKLLGCCTQ 584 (836)
Q Consensus 512 l~~a~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~------niv~l~g~~~~ 584 (836)
+...+++|++.++||+|+||.||++.... ++.||||+++... ...+++..|+.++.+++|. +++++++++..
T Consensus 124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 34456889999999999999999999754 7889999986432 2345567788888877654 58889988876
Q ss_pred C-CeeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcC-CCCcEEeccCCCCceEecCCC------
Q 003254 585 R-DERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNTM------ 656 (836)
Q Consensus 585 ~-~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~DLkp~NILl~~~~------ 656 (836)
. ...++|||++ +++|.+++.. ...+++..+..++.||+.||+|||++ + |+||||||+|||++.++
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~ 275 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMK---HGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPV 275 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccccc
Confidence 4 4688999987 6677777743 34689999999999999999999974 6 99999999999998765
Q ss_pred ----------CceeeccCcccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCC
Q 003254 657 ----------NPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHA 726 (836)
Q Consensus 657 ----------~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~ 726 (836)
.+||+|||++.... .......||+.|+|||++.+..++.++|||||||+||||++|+.||.....
T Consensus 276 ~~~~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~ 350 (467)
T PTZ00284 276 TNRALPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDN 350 (467)
T ss_pred cccccCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 49999999876422 112346789999999999999999999999999999999999999864332
Q ss_pred ccccchhhhhH----Hhhhc----cCchhhccc------c---------ccCC--CChHHHHHHHHHHHHcccCCCCCCC
Q 003254 727 DHDHNLLGHAW----RLWIE----ERPLELIDQ------S---------LDNS--CSFSEALRCIQVGLLCVQQRPEDRP 781 (836)
Q Consensus 727 ~~~~~~~~~~~----~~~~~----~~~~~~~d~------~---------l~~~--~~~~~~~~l~~li~~Cl~~dP~~RP 781 (836)
.+....+.... ..+.. ....++.+. . .... ........+++|+.+||+.||++||
T Consensus 351 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ 430 (467)
T PTZ00284 351 LEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRL 430 (467)
T ss_pred HHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCC
Confidence 11111100000 00000 000000000 0 0000 0001124578999999999999999
Q ss_pred CHHHHHH
Q 003254 782 NMSSVVL 788 (836)
Q Consensus 782 t~~eVl~ 788 (836)
|+.|+++
T Consensus 431 ta~e~L~ 437 (467)
T PTZ00284 431 NARQMTT 437 (467)
T ss_pred CHHHHhc
Confidence 9999986
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=296.94 Aligned_cols=247 Identities=26% Similarity=0.415 Sum_probs=198.3
Q ss_pred cccccCeecccCceeEEEEEee-cCcEEEEEEecCCC-----chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEE
Q 003254 518 NFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS-----GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (836)
Q Consensus 518 ~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~-----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 591 (836)
+|+..+.||+|++|.||+|... +++.|++|.+.... .+..+.+.+|+.+++.++|+||+++++++......++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 3667789999999999999986 68999999986543 23456789999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCC
Q 003254 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (836)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~ 671 (836)
+||+++++|.+++.. ...+++..+..++.||++||+|||+.+ ++|+||+|+||++++++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKK---YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 999999999999843 345889999999999999999999988 99999999999999999999999999887543
Q ss_pred CccccccccccccccccCcccccCCc-cCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhcc
Q 003254 672 DQTEANTKRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELID 750 (836)
Q Consensus 672 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 750 (836)
.. ......++..|+|||.+.... ++.++|+||||+++++|++|+.|+...... ............
T Consensus 155 ~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~------~~~~~~~~~~~~----- 220 (258)
T cd06632 155 FS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV------AAVFKIGRSKEL----- 220 (258)
T ss_pred cc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH------HHHHHHHhcccC-----
Confidence 22 223356888999999988776 899999999999999999999997532210 001110000000
Q ss_pred ccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 751 QSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 751 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
...+......+.+++.+|++.+|++||++.++++
T Consensus 221 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 221 ----PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred ----CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 0111122345678999999999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=313.35 Aligned_cols=260 Identities=23% Similarity=0.300 Sum_probs=195.4
Q ss_pred hcccccccCeecccCceeEEEEEeec-CcEEEEEEecCC--CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeC------
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR------ 585 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------ 585 (836)
..++|...+.||+|+||.||++.... ++.||||++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 34789999999999999999999754 888999998654 233456788999999999999999999987543
Q ss_pred CeeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCc
Q 003254 586 DERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGL 665 (836)
Q Consensus 586 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgl 665 (836)
...++||||+++ +|...+. ..+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence 347999999976 5656552 24788899999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHH-------
Q 003254 666 ARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWR------- 738 (836)
Q Consensus 666 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~------- 738 (836)
++...... ......++..|+|||++.+..++.++|||||||++|||++|+.||........ ......
T Consensus 173 a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~---~~~~~~~~~~~~~ 246 (364)
T cd07875 173 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ---WNKVIEQLGTPCP 246 (364)
T ss_pred ccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCCCCH
Confidence 98653221 12235689999999999999999999999999999999999999854321110 000000
Q ss_pred -----------hhhccCch-------hhcccccc---CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 739 -----------LWIEERPL-------ELIDQSLD---NSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 739 -----------~~~~~~~~-------~~~d~~l~---~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
......+. +.....+. ..........+.+++.+|++.||++|||+.|+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 247 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00000000 00000000 00111123457899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=302.17 Aligned_cols=261 Identities=24% Similarity=0.345 Sum_probs=197.1
Q ss_pred cccccCeecccCceeEEEEEee-cCcEEEEEEecCCCch-----hHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEE
Q 003254 518 NFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQ-----GMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (836)
Q Consensus 518 ~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~~~-----~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 591 (836)
+|+..+.||+|+||.||+|... +++.||||++...... ....+..|++++++++|+||+++++++......++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4677789999999999999975 4899999998755322 345677899999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCC
Q 003254 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (836)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~ 671 (836)
|||+ +++|.+++.... ..+++..+..++.||++||.|||+.+ ++|+||||+||+++.++.+||+|||++.....
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 899999885322 36899999999999999999999998 99999999999999999999999999987643
Q ss_pred CccccccccccccccccCcccccC-CccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCc-----
Q 003254 672 DQTEANTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERP----- 745 (836)
Q Consensus 672 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~----- 745 (836)
... ......++..|+|||.+.+ ..++.++||||||++++||++|.+++...... .......+.......
T Consensus 155 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 229 (298)
T cd07841 155 PNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI---DQLGKIFEALGTPTEENWPG 229 (298)
T ss_pred CCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH---HHHHHHHHHcCCCchhhhhh
Confidence 321 1222356788999998865 46789999999999999999997765432211 111111111000000
Q ss_pred ----hhhccccccCCCC-----hHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 746 ----LELIDQSLDNSCS-----FSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 746 ----~~~~d~~l~~~~~-----~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
............+ ......+.+++.+||+.+|++|||+.||++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0000000000111 1223567899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=295.01 Aligned_cols=250 Identities=36% Similarity=0.524 Sum_probs=198.3
Q ss_pred cccCeecccCceeEEEEEeec-----CcEEEEEEecCCCch-hHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEe
Q 003254 520 SEKNKLGEGGFGPVYKGMLIE-----GQEIAVKRLSKGSGQ-GMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (836)
Q Consensus 520 ~~~~~lG~G~fG~Vykg~~~~-----g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 593 (836)
++.+.||.|+||.||+++..+ +..||+|.+...... ..+.+.+|+.++..++|+||+++++++.+.+..+++||
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e 81 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME 81 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence 456789999999999999865 378999999665433 56789999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCc
Q 003254 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (836)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~ 673 (836)
|+++++|.+++..... ..+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++.......
T Consensus 82 ~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 82 YMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred ccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 9999999999854321 22899999999999999999999998 9999999999999999999999999998765432
Q ss_pred cccccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhccCchhhcccc
Q 003254 674 TEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQS 752 (836)
Q Consensus 674 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 752 (836)
..... ...++..|+|||.+.+..++.++||||+|++++||++ |+.|+..... ... ..........
T Consensus 158 ~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~---~~~----~~~~~~~~~~------ 223 (258)
T smart00219 158 YYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN---EEV----LEYLKKGYRL------ 223 (258)
T ss_pred ccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH---HHH----HHHHhcCCCC------
Confidence 21111 2336789999999988889999999999999999998 6776543111 011 1111111110
Q ss_pred ccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 003254 753 LDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLML 790 (836)
Q Consensus 753 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L 790 (836)
.........+.+++.+|++.+|++|||+.|+++.|
T Consensus 224 ---~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 224 ---PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ---CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 11111334678899999999999999999999875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=306.29 Aligned_cols=249 Identities=24% Similarity=0.350 Sum_probs=198.3
Q ss_pred cccccCeecccCceeEEEEEee-cCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEeecC
Q 003254 518 NFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLP 596 (836)
Q Consensus 518 ~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 596 (836)
.|.....||+|+||.||++... ++..||||.+........+.+.+|+.+++.++|+||+++++.+...+..++||||++
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 102 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE 102 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence 3344467999999999999875 488999999876655566778999999999999999999999999999999999999
Q ss_pred CCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcccc
Q 003254 597 NKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEA 676 (836)
Q Consensus 597 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~~ 676 (836)
+++|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||++........
T Consensus 103 ~~~L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-- 173 (292)
T cd06658 103 GGALTDIVTH----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-- 173 (292)
T ss_pred CCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--
Confidence 9999988732 35889999999999999999999998 99999999999999999999999999876532221
Q ss_pred ccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccccccCC
Q 003254 677 NTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDNS 756 (836)
Q Consensus 677 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 756 (836)
......++..|+|||.+.+..++.++||||||++++||++|+.|+....... . ...... .+.+.+...
T Consensus 174 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~---~----~~~~~~-----~~~~~~~~~ 241 (292)
T cd06658 174 KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ---A----MRRIRD-----NLPPRVKDS 241 (292)
T ss_pred cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---H----HHHHHh-----cCCCccccc
Confidence 1223568899999999998889999999999999999999999975322110 0 000100 111111111
Q ss_pred CChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 757 CSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 757 ~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
......+.+++.+|++.+|++|||+.|+++.
T Consensus 242 --~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 242 --HKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred --cccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 1122356789999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=304.36 Aligned_cols=195 Identities=26% Similarity=0.406 Sum_probs=158.6
Q ss_pred CeecccCceeEEEEEeec---CcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEee--CCeeeEEEeecCC
Q 003254 523 NKLGEGGFGPVYKGMLIE---GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQ--RDERMLIYEYLPN 597 (836)
Q Consensus 523 ~~lG~G~fG~Vykg~~~~---g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~lV~Ey~~~ 597 (836)
.+||+|+||.||+|+..+ +..||+|.+.... ....+.+|+.++++++||||+++++++.. ....++||||+++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 579999999999999754 5689999986543 23467889999999999999999999854 4567899999876
Q ss_pred CChhHHHhhc------cCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEe----cCCCCceeeccCccc
Q 003254 598 KSLDYFIFDT------TRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLL----DNTMNPKISDFGLAR 667 (836)
Q Consensus 598 gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl----~~~~~~kl~DFgla~ 667 (836)
+|.+++... .....+++..+..++.||+.||.|||+.+ |+||||||+|||+ ++++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 565655321 12235788899999999999999999998 9999999999999 567799999999998
Q ss_pred ccCCCccc-cccccccccccccCcccccCC-ccCccccccchhhhhhhhhhCCCCCCC
Q 003254 668 SFGLDQTE-ANTKRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIICGKKNRGF 723 (836)
Q Consensus 668 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~GvvL~elltG~~p~~~ 723 (836)
.+...... .......+|+.|+|||++.+. .++.++|||||||++|||++|++||..
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 76433221 122335789999999998764 589999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=296.18 Aligned_cols=250 Identities=24% Similarity=0.357 Sum_probs=194.3
Q ss_pred ccccccCeecccCceeEEEEEeec-CcEEEEEEecCCC-----chhHHHHHHHHHHHHhhcCCceeeEEeEEeeC--Cee
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS-----GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR--DER 588 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~-----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~ 588 (836)
++|+..+.||+|+||.||+|...+ ++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 478888999999999999999755 8899999875321 12346788999999999999999999998764 457
Q ss_pred eEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccc
Q 003254 589 MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (836)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~ 668 (836)
++||||+++++|.+++.. ...+++..+.+++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKS---YGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence 899999999999998853 245788889999999999999999998 99999999999999999999999999986
Q ss_pred cCCCcc-ccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchh
Q 003254 669 FGLDQT-EANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLE 747 (836)
Q Consensus 669 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (836)
...... ........++..|+|||.+.+..++.++||||||+++|||++|+.|+...... ..........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~---- 225 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM------AAIFKIATQP---- 225 (265)
T ss_pred cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH------HHHHHHhcCC----
Confidence 532211 11122346888999999998888999999999999999999999997532111 0000000000
Q ss_pred hccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 748 LIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 748 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
.....+......+.+++..|+. +|++||+++||++
T Consensus 226 -----~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 226 -----TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred -----CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 0111222333456788888884 9999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=307.72 Aligned_cols=198 Identities=19% Similarity=0.243 Sum_probs=164.3
Q ss_pred cCeeccc--CceeEEEEEee-cCcEEEEEEecCCC--chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEeecC
Q 003254 522 KNKLGEG--GFGPVYKGMLI-EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLP 596 (836)
Q Consensus 522 ~~~lG~G--~fG~Vykg~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 596 (836)
.++||+| +|++||+++.. +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++...+..++||||++
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 82 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence 4689999 78999999875 48899999986542 2344567889999999999999999999999999999999999
Q ss_pred CCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcccc
Q 003254 597 NKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEA 676 (836)
Q Consensus 597 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~~ 676 (836)
+|+|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++++||+............
T Consensus 83 ~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 83 YGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 999999985432 345889999999999999999999988 9999999999999999999999998755432111100
Q ss_pred -----ccccccccccccCcccccC--CccCccccccchhhhhhhhhhCCCCCCC
Q 003254 677 -----NTKRVVGTYGYMSPEYAID--GLFSVKSDVFSFGVLVLEIICGKKNRGF 723 (836)
Q Consensus 677 -----~~~~~~gt~~y~aPE~~~~--~~~t~ksDVwS~GvvL~elltG~~p~~~ 723 (836)
......++..|+|||++.+ ..++.++|||||||+++||++|+.|+..
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 1122356778999999976 4589999999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=297.07 Aligned_cols=253 Identities=25% Similarity=0.426 Sum_probs=199.0
Q ss_pred cccccCeecccCceeEEEEEee-cCcEEEEEEecCCC------chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeE
Q 003254 518 NFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS------GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (836)
Q Consensus 518 ~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~------~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 590 (836)
+|+..+.||+|++|.||++... +++.+|+|.+.... ....+.+.+|+.++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 4677889999999999999864 48899999986533 1235678999999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCC-CceeeccCccccc
Q 003254 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTM-NPKISDFGLARSF 669 (836)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~-~~kl~DFgla~~~ 669 (836)
||||+++++|.+++.. ..++++..+..++.||+.||.|||+.+ ++|+||||+||+++.++ .+||+|||++...
T Consensus 81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 9999999999998853 346889999999999999999999998 99999999999998775 5999999999876
Q ss_pred CCCcccc--ccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchh
Q 003254 670 GLDQTEA--NTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLE 747 (836)
Q Consensus 670 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (836)
....... ......++..|+|||.+.+..++.++||||+|+++++|++|+.|+......... ....+....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~---~~~~~~~~~----- 226 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHL---ALIFKIASA----- 226 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchH---HHHHHHhcc-----
Confidence 4331111 112346788999999998888999999999999999999999997532211110 000000000
Q ss_pred hccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 748 LIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 748 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
......+......+.+++.+|++.+|++||++.|+++
T Consensus 227 ----~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 227 ----TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ----CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 0011122233456789999999999999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=303.79 Aligned_cols=253 Identities=22% Similarity=0.295 Sum_probs=200.5
Q ss_pred ccccccCeecccCceeEEEEEeec-CcEEEEEEecCCCc---hhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEE
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSG---QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 592 (836)
++|+..+.||+|++|.||++...+ ++.+|+|.+..... ...+.+.+|+++++.++|+||+++++.+......++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 468888999999999999999865 89999999876532 24567889999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCC
Q 003254 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (836)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~ 672 (836)
||+.+++|.+++.. .....+++..+..++.|+++||+|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~-~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 81 DYCPGGELFRLLQR-QPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EecCCCCHHHHHHh-CCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 99999999998853 23457899999999999999999999988 999999999999999999999999998765321
Q ss_pred ccc---------------------------cccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCC
Q 003254 673 QTE---------------------------ANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (836)
Q Consensus 673 ~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~ 725 (836)
... .......|+..|+|||++.+..++.++||||||+++|+|++|+.|+....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 110 01122467889999999998889999999999999999999999975322
Q ss_pred CccccchhhhhHHhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCC----HHHHHH
Q 003254 726 ADHDHNLLGHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPN----MSSVVL 788 (836)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt----~~eVl~ 788 (836)
... .... ..+..............+.+++.+|++.+|++||+ +.|++.
T Consensus 237 ~~~-------~~~~--------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 237 RDE-------TFSN--------ILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred hHH-------HHHH--------HhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 110 0000 01111110111113456889999999999999999 666665
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=301.98 Aligned_cols=265 Identities=21% Similarity=0.337 Sum_probs=199.8
Q ss_pred ccccccCeecccCceeEEEEEeec-CcEEEEEEecCC--CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEe
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 593 (836)
++|+..+.||+|+||.||+|...+ ++.||+|++... .....+.+.+|++++++++|+||+++++++...+..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 368888999999999999999865 789999988654 23345778999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCc
Q 003254 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (836)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~ 673 (836)
|++++.+..+.. +...+++..+..++.+|+.||.|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 81 YVERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 999877766553 2345889999999999999999999998 9999999999999999999999999998765432
Q ss_pred cccccccccccccccCcccccCC-ccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhh--------HHhhhccC
Q 003254 674 TEANTKRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHA--------WRLWIEER 744 (836)
Q Consensus 674 ~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~--------~~~~~~~~ 744 (836)
. .......++..|+|||++.+. .++.++||||||+++|+|++|+.|+......+........ ...+....
T Consensus 155 ~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07833 155 A-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNP 233 (288)
T ss_pred c-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCc
Confidence 2 122235678899999999888 7899999999999999999999887532211000000000 00000000
Q ss_pred c---hhhcccc----ccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 745 P---LELIDQS----LDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 745 ~---~~~~d~~----l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
. .+..+.. .....+......+.+++.+||+.+|++||+++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 0 0000000 000111122466889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=295.30 Aligned_cols=254 Identities=25% Similarity=0.359 Sum_probs=199.7
Q ss_pred cccccCeecccCceeEEEEEee-cCcEEEEEEecCC--CchhHHHHHHHHHHHHhhcCCceeeEEeEEee--CCeeeEEE
Q 003254 518 NFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQ--RDERMLIY 592 (836)
Q Consensus 518 ~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~lV~ 592 (836)
+|+..+.||.|+||.||++... +++.+|+|++... .....+++.+|+.++++++|+||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4777889999999999999875 4788999998654 23345678899999999999999999998754 44578999
Q ss_pred eecCCCChhHHHhhcc-CCCcCChhhhHHHHHHHHhhhHhhhcCC--CCcEEeccCCCCceEecCCCCceeeccCccccc
Q 003254 593 EYLPNKSLDYFIFDTT-RSKLLDWSKRSHIIAGIARGLLYLHQDS--RLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (836)
Q Consensus 593 Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~ 669 (836)
||+++++|.+++.... ...++++..+..++.+|++||+|||..+ ...++|+||||+||++++++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 9999999999986532 2457899999999999999999999332 233999999999999999999999999999876
Q ss_pred CCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhc
Q 003254 670 GLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELI 749 (836)
Q Consensus 670 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (836)
...... .....++..|+|||.+.+..++.++||||||+++++|++|+.|+...... ... .......
T Consensus 161 ~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~----~~~~~~~----- 226 (265)
T cd08217 161 GHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL---QLA----SKIKEGK----- 226 (265)
T ss_pred cCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH---HHH----HHHhcCC-----
Confidence 433221 22346889999999999888999999999999999999999997542211 111 1111110
Q ss_pred cccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 750 DQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 750 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
....+......+.+++.+|++.+|++||++.+|++.
T Consensus 227 ----~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 227 ----FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ----CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 011222334567899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=296.40 Aligned_cols=260 Identities=24% Similarity=0.306 Sum_probs=200.5
Q ss_pred ccccccCeecccCceeEEEEEeec-CcEEEEEEecCCCc-hhHHHHHHHHHHHHhhcCCceeeEEeEEeeC--CeeeEEE
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSG-QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR--DERMLIY 592 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV~ 592 (836)
++|+..+.||.|++|.||++.... ++.+|+|.+..... ....++.+|++++++++||||+++++++... ...++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 467888999999999999999854 78899999875433 4557789999999999999999999998654 3689999
Q ss_pred eecCCCChhHHHhhcc-CCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCC
Q 003254 593 EYLPNKSLDYFIFDTT-RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (836)
Q Consensus 593 Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~ 671 (836)
||+++++|.+++.... ....++...+..++.||+.||+|||+.+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 9999999998875422 3456888999999999999999999988 99999999999999999999999999876532
Q ss_pred CccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccc
Q 003254 672 DQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQ 751 (836)
Q Consensus 672 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 751 (836)
.. .....++..|+|||.+.+..++.++||||||+++|||++|+.|+......... ... ............+.+.
T Consensus 158 ~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~ 231 (287)
T cd06621 158 SL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLG-PIE-LLSYIVNMPNPELKDE 231 (287)
T ss_pred cc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCC-hHH-HHHHHhcCCchhhccC
Confidence 21 11245788999999999999999999999999999999999997644221111 111 1111111111111110
Q ss_pred cccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 752 SLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 752 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
. .........+.+++.+||+.+|++|||+.||++
T Consensus 232 -~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 232 -P--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred -C--CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 0 001122456789999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=299.29 Aligned_cols=259 Identities=27% Similarity=0.398 Sum_probs=200.4
Q ss_pred cHHHHHhhcccccccCeecccCceeEEEEEeec-CcEEEEEEecCCCchhHHHHHHHHHHHHhh-cCCceeeEEeEEee-
Q 003254 508 DLKIIANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQ- 584 (836)
Q Consensus 508 ~~~~l~~a~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~- 584 (836)
++..+....+.|+..+.||+|+||.||+|.... ++.+|+|.+.... ....++..|+.++.++ +|+||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 455555677889999999999999999999854 7889999986543 3446788999999998 69999999999853
Q ss_pred -----CCeeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCce
Q 003254 585 -----RDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPK 659 (836)
Q Consensus 585 -----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~k 659 (836)
....+++|||+++|+|.+++... ....+++..+..++.||++||.|||+.+ |+|+||||+||++++++.++
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNT-KGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence 45689999999999999988543 3345788889999999999999999988 99999999999999999999
Q ss_pred eeccCcccccCCCccccccccccccccccCccccc-----CCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhh
Q 003254 660 ISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAI-----DGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLG 734 (836)
Q Consensus 660 l~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~ 734 (836)
|+|||++........ ......++..|+|||.+. +..++.++||||||+++|||++|+.|+..........
T Consensus 162 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~--- 236 (282)
T cd06636 162 LVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF--- 236 (282)
T ss_pred EeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh---
Confidence 999999876532211 123356889999999986 3468889999999999999999999974322110000
Q ss_pred hhHHhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 735 HAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 735 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
.......... ........+.+++.+||+.+|.+|||+.|+++
T Consensus 237 ----~~~~~~~~~~--------~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 237 ----LIPRNPPPKL--------KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred ----hHhhCCCCCC--------cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0000000000 01112346789999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-33 Score=296.36 Aligned_cols=247 Identities=26% Similarity=0.404 Sum_probs=198.3
Q ss_pred cccccCeecccCceeEEEEEee-cCcEEEEEEecCCC-chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEeec
Q 003254 518 NFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (836)
Q Consensus 518 ~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 595 (836)
-|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++.+++||||+++++++..+...++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 4667789999999999999875 57899999986543 334567889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCccc
Q 003254 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE 675 (836)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 675 (836)
++++|..++. ...+++..+..++.+++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 85 ~~~~l~~~i~----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06641 85 GGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh-
Confidence 9999998883 246889999999999999999999988 99999999999999999999999999876543211
Q ss_pred cccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccccccC
Q 003254 676 ANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDN 755 (836)
Q Consensus 676 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 755 (836)
......++..|+|||.+.+..++.++||||||+++++|++|..|+....... .......... .
T Consensus 157 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-------~~~~~~~~~~---------~ 219 (277)
T cd06641 157 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK-------VLFLIPKNNP---------P 219 (277)
T ss_pred -hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH-------HHHHHhcCCC---------C
Confidence 1223467889999999998889999999999999999999999864322110 0000000100 0
Q ss_pred CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 756 SCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 756 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
.........+.+++.+|++.+|++||++.++++.
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 220 TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 1111223457789999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-33 Score=293.17 Aligned_cols=252 Identities=25% Similarity=0.348 Sum_probs=205.1
Q ss_pred ccccccCeecccCceeEEEEEeec-CcEEEEEEecCCCc-hhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEee
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSG-QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 594 (836)
++|+..+.||+|++|.||+++... ++.|+||++..... ...+.+.+|+.++.+++|+|++++++++......++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 367888999999999999999875 89999999876644 4567899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhc-CCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCc
Q 003254 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQ-DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (836)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~ 673 (836)
+++++|.+++... ..++...+..++.|+++||+|||+ .+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 81 MDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 9999999998543 568999999999999999999999 87 9999999999999999999999999998764332
Q ss_pred cccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccccc
Q 003254 674 TEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSL 753 (836)
Q Consensus 674 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 753 (836)
... ....++..|+|||.+.+..++.++||||||+++|||++|+.|+........... .........
T Consensus 155 ~~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~----~~~~~~~~~-------- 220 (264)
T cd06623 155 DQC--NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFEL----MQAICDGPP-------- 220 (264)
T ss_pred Ccc--cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHH----HHHHhcCCC--------
Confidence 221 235678899999999999999999999999999999999999754332111111 111111100
Q ss_pred cCCCChH-HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 754 DNSCSFS-EALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 754 ~~~~~~~-~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
...+.. ....+.+++.+|++.+|++||++.|+++.
T Consensus 221 -~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 221 -PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred -CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 011111 33567899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=299.64 Aligned_cols=262 Identities=22% Similarity=0.307 Sum_probs=199.4
Q ss_pred cccccCeecccCceeEEEEEee-cCcEEEEEEecCCC--chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEee
Q 003254 518 NFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (836)
Q Consensus 518 ~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 594 (836)
+|+..+.||+|+||.||+|+.. +|+.||+|++.... ....+.+.+|+.++++++||||+++++++......++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4777889999999999999975 58899999987653 33456899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcc
Q 003254 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (836)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~ 674 (836)
+ +++|.+++.... ..+++..+..++.||++||+|||+.+ ++|+||||+||++++++.++|+|||++........
T Consensus 81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 9 999999885432 56899999999999999999999988 99999999999999999999999999987643321
Q ss_pred ccccccccccccccCcccccCC-ccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCc------hh
Q 003254 675 EANTKRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERP------LE 747 (836)
Q Consensus 675 ~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~------~~ 747 (836)
.......++..|+|||.+.+. .++.++||||+|++++||++|++++...... .........+..... .+
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07832 155 -RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI---EQLAIVFRTLGTPNEETWPGLTS 230 (286)
T ss_pred -CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH---HHHHHHHHHcCCCChHHHhhccC
Confidence 112235688999999998754 4689999999999999999997776432211 111111110000000 00
Q ss_pred hcc------cccc----CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 748 LID------QSLD----NSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 748 ~~d------~~l~----~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
+.+ +... ..........+.+++.+|++.+|++||+++++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 231 LPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred cchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000 0000 00011223678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=312.05 Aligned_cols=258 Identities=24% Similarity=0.335 Sum_probs=193.9
Q ss_pred hhcccccccCeecccCceeEEEEEee-cCcEEEEEEecCCC--chhHHHHHHHHHHHHhhcCCceeeEEeEEeeC-----
Q 003254 514 NATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR----- 585 (836)
Q Consensus 514 ~a~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~----- 585 (836)
...++|...+.||+|+||.||++... .++.||||++.... ....+.+.+|+.++++++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 45578999999999999999999975 47899999986542 23345678899999999999999999987543
Q ss_pred -CeeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccC
Q 003254 586 -DERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFG 664 (836)
Q Consensus 586 -~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFg 664 (836)
...++++|++ +++|..++. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg 163 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFG 163 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCc
Confidence 3468999987 678877763 346899999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCccccccccccccccccCcccccC-CccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhcc
Q 003254 665 LARSFGLDQTEANTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEE 743 (836)
Q Consensus 665 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 743 (836)
+++..... .....|++.|+|||++.+ ..++.++|||||||++|||++|+.||........ ...... ....
T Consensus 164 ~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~~~~-~~~~ 234 (343)
T cd07878 164 LARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQ---LKRIME-VVGT 234 (343)
T ss_pred cceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH---HHHHHH-HhCC
Confidence 99865321 223568999999999877 5689999999999999999999999753221110 000000 0000
Q ss_pred Cchhhccc-----------cccCCCCh--------HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 744 RPLELIDQ-----------SLDNSCSF--------SEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 744 ~~~~~~d~-----------~l~~~~~~--------~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
...+.... .+. ..+. .....+.+++.+|++.||++|||+.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 235 PSPEVLKKISSEHARKYIQSLP-HMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred CCHHHHHhcchhhHHHHhhccc-cccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000 000 0000 011246799999999999999999999854
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=297.12 Aligned_cols=253 Identities=25% Similarity=0.380 Sum_probs=201.3
Q ss_pred ccccccCeecccCceeEEEEEeec-CcEEEEEEecCCC-chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEee
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 594 (836)
++|+..+.||.|++|.||++.... ++.+|+|++.... ....+++.+|++++++++||||+++++.+......++|+||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 357778899999999999999864 8899999987653 34556789999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhc-CCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCc
Q 003254 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQ-DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (836)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~ 673 (836)
+++++|.+++.... ..++...+..++.|+++||+|||+ .+ ++|+||||+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 81 MDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred cCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 99999999985432 578889999999999999999999 77 9999999999999999999999999987653221
Q ss_pred cccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccccc
Q 003254 674 TEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSL 753 (836)
Q Consensus 674 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 753 (836)
. ....++..|+|||.+.+..++.++||||||+++++|++|+.|+........ ..... .+........
T Consensus 156 ~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~-~~~~~~~~~~------- 222 (265)
T cd06605 156 A----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD-GIFEL-LQYIVNEPPP------- 222 (265)
T ss_pred h----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc-cHHHH-HHHHhcCCCC-------
Confidence 1 115678899999999999999999999999999999999999754322111 11111 1111111110
Q ss_pred cCCCChH-HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 754 DNSCSFS-EALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 754 ~~~~~~~-~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
..... ....+.+++.+|+..+|++|||+.|++..
T Consensus 223 --~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 223 --RLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred --CCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 01111 23457799999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=330.67 Aligned_cols=257 Identities=21% Similarity=0.300 Sum_probs=197.6
Q ss_pred HhhcccccccCeecccCceeEEEEEeec-CcEEEEEEecCC--CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeC--Ce
Q 003254 513 ANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR--DE 587 (836)
Q Consensus 513 ~~a~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~ 587 (836)
....++|.+.++||+|+||.||+++... +..+|+|.+... .......|..|+.++.+++|||||++++++... ..
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 3445789999999999999999999865 678899988644 233456789999999999999999999988543 56
Q ss_pred eeEEEeecCCCChhHHHhhcc-CCCcCChhhhHHHHHHHHhhhHhhhcCCC----CcEEeccCCCCceEecC--------
Q 003254 588 RMLIYEYLPNKSLDYFIFDTT-RSKLLDWSKRSHIIAGIARGLLYLHQDSR----LRIIHRDLKASNVLLDN-------- 654 (836)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~----~~ivH~DLkp~NILl~~-------- 654 (836)
.+|||||+++++|..+|.... ....+++..++.|+.||+.||.|||+.+. .+|+||||||+||||+.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 899999999999999986532 23568999999999999999999998542 24999999999999964
Q ss_pred ---------CCCceeeccCcccccCCCccccccccccccccccCcccccC--CccCccccccchhhhhhhhhhCCCCCCC
Q 003254 655 ---------TMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAID--GLFSVKSDVFSFGVLVLEIICGKKNRGF 723 (836)
Q Consensus 655 ---------~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~ksDVwS~GvvL~elltG~~p~~~ 723 (836)
...+||+|||++..+.... ......||+.|+|||++.+ ..++.++||||||||||||++|+.||..
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~ 245 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245 (1021)
T ss_pred cccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 2348999999998754221 1223578999999999864 4589999999999999999999999753
Q ss_pred CCCccccchhhhhHHhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 724 NHADHDHNLLGHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
.... .......... + .+. .......+.+|+..||+.+|.+||++.|++.
T Consensus 246 ~~~~------~qli~~lk~~-p------~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 246 ANNF------SQLISELKRG-P------DLP---IKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CCcH------HHHHHHHhcC-C------CCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 2211 0111111111 0 000 0112345789999999999999999999983
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=303.64 Aligned_cols=257 Identities=20% Similarity=0.273 Sum_probs=200.4
Q ss_pred ccccccCeecccCceeEEEEEeec-CcEEEEEEecCCC---chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEE
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 592 (836)
++|+..+.||+|+||.||++.... ++.|++|.+.... ....+.+.+|+.+++.++||||+++++.+...+..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 368888999999999999999865 7899999987553 233467889999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCC
Q 003254 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (836)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~ 672 (836)
||+++++|.+++.. ...+++..+..++.+++.||+|||+.+ ++||||||+||++++++.+||+|||+++.....
T Consensus 81 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 81 EYVEGGDCATLLKN---IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 99999999999843 346889999999999999999999988 999999999999999999999999998742110
Q ss_pred cc-------------ccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHh
Q 003254 673 QT-------------EANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRL 739 (836)
Q Consensus 673 ~~-------------~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~ 739 (836)
.. ........++..|+|||.+.+..++.++||||||+++|||++|+.|+...... .+ ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~---~~----~~~ 227 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE---EL----FGQ 227 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HH----HHH
Confidence 00 00111245788999999999888999999999999999999999997422111 11 111
Q ss_pred hhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 003254 740 WIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 793 (836)
Q Consensus 740 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 793 (836)
..... ...+... ......+.+++.+||+.+|++||++.++.+.|+..
T Consensus 228 ~~~~~---~~~~~~~----~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~ 274 (305)
T cd05609 228 VISDD---IEWPEGD----EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHR 274 (305)
T ss_pred HHhcc---cCCCCcc----ccCCHHHHHHHHHHhccChhhccCccCHHHHHhCc
Confidence 11000 0000000 01234567999999999999999988888877763
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=292.55 Aligned_cols=249 Identities=24% Similarity=0.361 Sum_probs=198.8
Q ss_pred cccccCeecccCceeEEEEEee-cCcEEEEEEecCC--CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEee
Q 003254 518 NFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (836)
Q Consensus 518 ~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 594 (836)
+|+..+.||+|+||.||++... .++.+|+|++... .....+.+.+|+.++++++|||++++++.+...+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4778899999999999999875 4888999998654 234467889999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCC-CCceeeccCcccccCCCc
Q 003254 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNT-MNPKISDFGLARSFGLDQ 673 (836)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~-~~~kl~DFgla~~~~~~~ 673 (836)
+++++|.+++... ....+++..+..++.++++||+|||+++ ++|+||||+||+++++ ..+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 81 APGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCCHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 9999999998543 2345889999999999999999999988 9999999999999854 468999999998764322
Q ss_pred cccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccccc
Q 003254 674 TEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSL 753 (836)
Q Consensus 674 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 753 (836)
. .....++..|+|||.+.+..++.++||||||+++++|++|+.|+...... ...... ......
T Consensus 157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~------~~~~~~-~~~~~~------- 219 (256)
T cd08220 157 K---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP------ALVLKI-MSGTFA------- 219 (256)
T ss_pred c---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH------HHHHHH-HhcCCC-------
Confidence 1 22356788999999999888999999999999999999999987432211 011110 001000
Q ss_pred cCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 754 DNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 754 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
.........+.+++.+||+.+|++|||+.|+++.
T Consensus 220 --~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 220 --PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred --CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 1111223457799999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=293.41 Aligned_cols=252 Identities=27% Similarity=0.461 Sum_probs=199.7
Q ss_pred cccccCeecccCceeEEEEEee-cCcEEEEEEecCCCc--hhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEee
Q 003254 518 NFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSG--QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (836)
Q Consensus 518 ~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 594 (836)
+|...+.||+|+||.||+|+.. +++.|++|.+..... ...+.+.+|+.++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4677889999999999999975 588999999876644 3677899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcc
Q 003254 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (836)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~ 674 (836)
+++++|.+++.. ...+++..+..++.++++||.|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 81 CSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 999999999853 345789999999999999999999988 99999999999999999999999999987643322
Q ss_pred ccc--cccccccccccCcccccCCc---cCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhc
Q 003254 675 EAN--TKRVVGTYGYMSPEYAIDGL---FSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELI 749 (836)
Q Consensus 675 ~~~--~~~~~gt~~y~aPE~~~~~~---~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (836)
... .....++..|+|||++.+.. ++.++||||||++++||++|+.|+...... ......... ..
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~-----~~~~~~~~~-~~----- 223 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE-----FQIMFHVGA-GH----- 223 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch-----HHHHHHHhc-CC-----
Confidence 111 12356788999999998766 899999999999999999999997532211 000100000 00
Q ss_pred cccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 750 DQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 750 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
.+.+.. .......+.+++.+|++.+|++||++.|++.
T Consensus 224 ~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 224 KPPIPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCCCCc--ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000100 0111345678999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=299.22 Aligned_cols=251 Identities=25% Similarity=0.400 Sum_probs=202.3
Q ss_pred cccccccCeecccCceeEEEEEee-cCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEee
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 594 (836)
.++|...+.||+|+||.||++... +++.|++|.+........+.+.+|+.++++++|||++++++++...+..++|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 367888899999999999999864 4788999998765555567889999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcc
Q 003254 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (836)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~ 674 (836)
+++++|.+++.. ..+++..+..++.+++.||.|||+.+ ++|+||||+||++++++.+||+|||++..+.....
T Consensus 98 ~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 98 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred CCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 999999998843 35788999999999999999999998 99999999999999999999999999876543222
Q ss_pred ccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhcccccc
Q 003254 675 EANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLD 754 (836)
Q Consensus 675 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 754 (836)
......+++.|+|||.+.++.++.++||||||+++||+++|+.||............ .....+ . .
T Consensus 171 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~------~~~~~~-~-----~- 235 (293)
T cd06647 171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI------ATNGTP-E-----L- 235 (293)
T ss_pred --ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh------hcCCCC-C-----C-
Confidence 122346888999999999888999999999999999999999997543221110000 000000 0 0
Q ss_pred CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 755 NSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 755 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
.........+.+++.+||+.+|++||++.+++..
T Consensus 236 -~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 236 -QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred -CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111123457789999999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=303.15 Aligned_cols=267 Identities=22% Similarity=0.295 Sum_probs=196.3
Q ss_pred cccccCeecccCceeEEEEEeec---CcEEEEEEecCCC---chhHHHHHHHHHHHHhhcCCceeeEEeEEeeC--Ceee
Q 003254 518 NFSEKNKLGEGGFGPVYKGMLIE---GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR--DERM 589 (836)
Q Consensus 518 ~f~~~~~lG~G~fG~Vykg~~~~---g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~ 589 (836)
+|+..++||+|+||.||+|.... ++.||+|.+.... ....+.+.+|+.++.+++||||+++++++... ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 46778899999999999999854 7899999997633 34456778899999999999999999999888 7899
Q ss_pred EEEeecCCCChhHHHhhcc-C-CCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecC----CCCceeecc
Q 003254 590 LIYEYLPNKSLDYFIFDTT-R-SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN----TMNPKISDF 663 (836)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~-~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~----~~~~kl~DF 663 (836)
+||||+++ +|..++.... . ...++...+..++.||+.||.|||+.+ |+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999986 5555553322 2 236888999999999999999999998 999999999999999 999999999
Q ss_pred CcccccCCCcc-ccccccccccccccCcccccCC-ccCccccccchhhhhhhhhhCCCCCCCCCCcccc-ch-----hhh
Q 003254 664 GLARSFGLDQT-EANTKRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDH-NL-----LGH 735 (836)
Q Consensus 664 gla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~-~~-----~~~ 735 (836)
|++..+..... ........++..|+|||.+.+. .++.++||||||++++||++|+.|+......... .. ...
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99987643322 1122335678899999988764 5789999999999999999999998654332210 00 000
Q ss_pred hHHhhhccC------------chhhccccccCCCC---h--------HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 736 AWRLWIEER------------PLELIDQSLDNSCS---F--------SEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 736 ~~~~~~~~~------------~~~~~d~~l~~~~~---~--------~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
....+.... .....+.......+ . .....+.+++.+|++.+|++|||+.|+++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000000000 00000000000001 0 22345789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=295.95 Aligned_cols=255 Identities=26% Similarity=0.375 Sum_probs=199.8
Q ss_pred hhcccccccCeecccCceeEEEEEeec-CcEEEEEEecCCCchhHHHHHHHHHHHHhh-cCCceeeEEeEEeeCC-----
Q 003254 514 NATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRD----- 586 (836)
Q Consensus 514 ~a~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~----- 586 (836)
.++++|+..+.||+|++|.||+|.... ++.+++|++..... ..+++.+|+.+++++ +|+||+++++++....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 467899999999999999999999854 78899999865543 456789999999999 6999999999997654
Q ss_pred -eeeEEEeecCCCChhHHHhhcc-CCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccC
Q 003254 587 -ERMLIYEYLPNKSLDYFIFDTT-RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFG 664 (836)
Q Consensus 587 -~~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFg 664 (836)
..++||||+++++|.+++.... ....+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCc
Confidence 4899999999999999885432 2457899999999999999999999988 9999999999999999999999999
Q ss_pred cccccCCCccccccccccccccccCcccccC-----CccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHh
Q 003254 665 LARSFGLDQTEANTKRVVGTYGYMSPEYAID-----GLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRL 739 (836)
Q Consensus 665 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~ 739 (836)
++........ ......++..|+|||.+.. ..++.++||||||+++++|++|+.|+...... . ....
T Consensus 159 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~-----~~~~ 229 (275)
T cd06608 159 VSAQLDSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM--R-----ALFK 229 (275)
T ss_pred cceecccchh--hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH--H-----HHHH
Confidence 9876532221 1223568889999998753 34788999999999999999999997532111 0 0001
Q ss_pred hhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 740 WIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 740 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
........+ .........+.+++.+||..||++|||+.||++
T Consensus 230 ~~~~~~~~~-------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 230 IPRNPPPTL-------KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred hhccCCCCC-------CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 111111111 111123346789999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=303.71 Aligned_cols=246 Identities=24% Similarity=0.357 Sum_probs=196.9
Q ss_pred ccCeecccCceeEEEEEee-cCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEeecCCCC
Q 003254 521 EKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKS 599 (836)
Q Consensus 521 ~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gs 599 (836)
....||+|+||.||++... +++.||+|.+........+.+.+|+.++..++|||++++++++..++..++|+||+++++
T Consensus 25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~ 104 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104 (297)
T ss_pred hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence 3457999999999999875 488999999876555556778899999999999999999999999999999999999999
Q ss_pred hhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCccccccc
Q 003254 600 LDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTK 679 (836)
Q Consensus 600 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~ 679 (836)
|..++.. ..+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||++..+..... ...
T Consensus 105 L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~ 175 (297)
T cd06659 105 LTDIVSQ----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRK 175 (297)
T ss_pred HHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc--ccc
Confidence 9887732 45889999999999999999999988 99999999999999999999999999876543221 122
Q ss_pred cccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccccccCCCCh
Q 003254 680 RVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDNSCSF 759 (836)
Q Consensus 680 ~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 759 (836)
...++..|+|||++.+..++.++||||||++++||++|+.|+....... ........... . .. ...
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-------~~~~~~~~~~~-~----~~--~~~ 241 (297)
T cd06659 176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ-------AMKRLRDSPPP-K----LK--NAH 241 (297)
T ss_pred ceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHhccCCC-C----cc--ccC
Confidence 3568899999999998899999999999999999999999975322110 00111111000 0 00 001
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 760 SEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 760 ~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
.....+.+++.+|++.+|++||++.+|++.
T Consensus 242 ~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 242 KISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 122346789999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=305.57 Aligned_cols=245 Identities=28% Similarity=0.422 Sum_probs=196.7
Q ss_pred ccccccCeecccCceeEEEEEeec-CcEEEEEEecCCC---chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEE
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 592 (836)
+-|+.++.||.|+||.||-++... .+.||||++.... ....+++..|+..|.+++|||++.+.|||..+...+|||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 456777889999999999999754 6789999997654 345677899999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCC
Q 003254 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (836)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~ 672 (836)
|||-| +-.+++. ...+++.+.++..|..+.+.||+|||+.+ .||||||+.||||++.|.|||+|||.|.....
T Consensus 106 EYClG-SAsDlle--VhkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P- 178 (948)
T KOG0577|consen 106 EYCLG-SASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAP- 178 (948)
T ss_pred HHHhc-cHHHHHH--HHhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCc-
Confidence 99965 5556652 23568889999999999999999999998 99999999999999999999999999987532
Q ss_pred ccccccccccccccccCccccc---CCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhc
Q 003254 673 QTEANTKRVVGTYGYMSPEYAI---DGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELI 749 (836)
Q Consensus 673 ~~~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (836)
...++|||.|||||++. .+.|+-|+||||||++..||.-.++|.-.... .. +.-.......
T Consensus 179 -----AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA------MS-ALYHIAQNes---- 242 (948)
T KOG0577|consen 179 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MS-ALYHIAQNES---- 242 (948)
T ss_pred -----hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH------HH-HHHHHHhcCC----
Confidence 33489999999999985 57899999999999999999998887321111 01 1111111111
Q ss_pred cccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 750 DQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 750 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
|.|. ..+-...++.++..||+.-|.+|||..+++.
T Consensus 243 -PtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 243 -PTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred -CCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 1111 2344567889999999999999999988654
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=308.02 Aligned_cols=195 Identities=24% Similarity=0.363 Sum_probs=168.2
Q ss_pred cccccCeecccCceeEEEEEeec-CcEEEEEEecCCCchhHHHHHHHHHHHHhhc-C-----CceeeEEeEEeeCCeeeE
Q 003254 518 NFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQ-H-----RNLVKLLGCCTQRDERML 590 (836)
Q Consensus 518 ~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H-----~niv~l~g~~~~~~~~~l 590 (836)
+|++.+.||+|.||.|.|+.... ++.||||+++.. .....+...|+.+|..++ | -|+|++++++...++.+|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 78889999999999999999765 899999999654 344566788999999997 4 389999999999999999
Q ss_pred EEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecC--CCCceeeccCcccc
Q 003254 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN--TMNPKISDFGLARS 668 (836)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~--~~~~kl~DFgla~~ 668 (836)
|+|.+.. +|.+++... +...++...+..++.||+.||..||+.+ |||+||||+||||.+ ...+||+|||.+..
T Consensus 266 VfELL~~-NLYellK~n-~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 266 VFELLST-NLYELLKNN-KFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eehhhhh-hHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccc
Confidence 9999865 898998654 3456899999999999999999999998 999999999999964 34799999999987
Q ss_pred cCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCC
Q 003254 669 FGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGF 723 (836)
Q Consensus 669 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~ 723 (836)
.... .....-+..|+|||++.+.+|+.+.||||||||+.||++|.+.|..
T Consensus 341 ~~q~-----vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG 390 (586)
T KOG0667|consen 341 ESQR-----VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPG 390 (586)
T ss_pred cCCc-----ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCC
Confidence 4321 1145678899999999999999999999999999999999876543
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=299.52 Aligned_cols=261 Identities=22% Similarity=0.321 Sum_probs=193.7
Q ss_pred cccccCeecccCceeEEEEEee-cCcEEEEEEecCCC--chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEee
Q 003254 518 NFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (836)
Q Consensus 518 ~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 594 (836)
+|+..+.||+|+||.||+++.. +|+.+|+|++.... ......+.+|+.++++++|+||+++++++......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4777889999999999999986 48899999986542 22345678899999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcc
Q 003254 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (836)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~ 674 (836)
+++ +|..++... ...+++..+..++.||++||.|||+.+ ++||||||+||+++.++.+||+|||+++.+.....
T Consensus 81 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 81 CDQ-DLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence 975 676766432 346899999999999999999999998 99999999999999999999999999986543221
Q ss_pred ccccccccccccccCcccccCC-ccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCc------hh
Q 003254 675 EANTKRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERP------LE 747 (836)
Q Consensus 675 ~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~------~~ 747 (836)
......++..|+|||.+.+. .++.++||||||+++|||++|+.|+....... .......+....... .+
T Consensus 155 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07839 155 --CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEESWPGVSK 230 (284)
T ss_pred --CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH--HHHHHHHHHhCCCChHHhHHhhh
Confidence 11224568899999998765 47899999999999999999998853221110 000000000000000 00
Q ss_pred hccc----cccC-----CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 748 LIDQ----SLDN-----SCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 748 ~~d~----~l~~-----~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
..+. .... .........+.+++.+||+.||.+|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred cccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 0000 0000 001112345779999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=298.02 Aligned_cols=254 Identities=25% Similarity=0.385 Sum_probs=204.3
Q ss_pred HhhcccccccCeecccCceeEEEEEee-cCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEE
Q 003254 513 ANATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (836)
Q Consensus 513 ~~a~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 591 (836)
....+.|+..+.||+|++|.||+|... +++.+++|.+..... ..+.+.+|+++++.++|+|++++++++......++|
T Consensus 15 ~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 93 (286)
T cd06614 15 GDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV 93 (286)
T ss_pred CCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence 346678888899999999999999987 488999999976544 567789999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCC
Q 003254 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (836)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~ 671 (836)
+||+++++|.+++.... ..+++..+..++.+++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 94 ~e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 168 (286)
T cd06614 94 MEYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTK 168 (286)
T ss_pred EeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence 99999999999996532 37899999999999999999999988 99999999999999999999999999876532
Q ss_pred CccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccc
Q 003254 672 DQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQ 751 (836)
Q Consensus 672 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 751 (836)
... ......++..|+|||.+.+..++.++||||||+++|+|++|+.|+....... .. ............
T Consensus 169 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~------~~-~~~~~~~~~~~~-- 237 (286)
T cd06614 169 EKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR------AL-FLITTKGIPPLK-- 237 (286)
T ss_pred chh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH------HH-HHHHhcCCCCCc--
Confidence 221 1223457889999999998889999999999999999999999865322110 00 000001000000
Q ss_pred cccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 752 SLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 752 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
........+.+++.+|++.+|.+||++.+|++
T Consensus 238 -----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 238 -----NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred -----chhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 00112345779999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=296.12 Aligned_cols=251 Identities=24% Similarity=0.349 Sum_probs=191.6
Q ss_pred ccccccCeecccCceeEEEEEeec-CcEEEEEEecCCC-chhHHHHHHHHHH-HHhhcCCceeeEEeEEeeCCeeeEEEe
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS-GQGMEEFKNEVLL-IAKLQHRNLVKLLGCCTQRDERMLIYE 593 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~-~~~~~~~~~Ei~~-l~~l~H~niv~l~g~~~~~~~~~lV~E 593 (836)
++|++.+.||+|+||.||+++... |+.||+|++.... .....++..|+.+ ++.++|||++++++++......++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 468888999999999999999864 8999999987543 2334456666665 556689999999999999999999999
Q ss_pred ecCCCChhHHHhhc-cCCCcCChhhhHHHHHHHHhhhHhhhcC-CCCcEEeccCCCCceEecCCCCceeeccCcccccCC
Q 003254 594 YLPNKSLDYFIFDT-TRSKLLDWSKRSHIIAGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (836)
Q Consensus 594 y~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~ 671 (836)
|++ ++|..++... .....+++..+..++.||+.||+|||++ + ++||||||+||++++++.+||+|||++..+..
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 997 6787777543 2345789999999999999999999987 5 99999999999999999999999999986532
Q ss_pred CccccccccccccccccCcccccC----CccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchh
Q 003254 672 DQTEANTKRVVGTYGYMSPEYAID----GLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLE 747 (836)
Q Consensus 672 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (836)
.. ......++..|+|||.+.+ ..++.++|+||||+++|||++|+.|+...... ....... .......
T Consensus 157 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~-~~~~~~~ 227 (283)
T cd06617 157 SV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-----FQQLKQV-VEEPSPQ 227 (283)
T ss_pred cc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-----HHHHHHH-HhcCCCC
Confidence 21 1122467889999998865 45688999999999999999999997421110 0000010 1110101
Q ss_pred hccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 748 LIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 748 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
.. .......+.+++.+||+.+|++||++.+|++
T Consensus 228 ~~--------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 228 LP--------AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred CC--------ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 10 0112245789999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=297.75 Aligned_cols=262 Identities=24% Similarity=0.359 Sum_probs=194.9
Q ss_pred ccccccCeecccCceeEEEEEee-cCcEEEEEEecCCCc-hhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEee
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSG-QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 594 (836)
++|+..+.||+|++|.||+|... +++.||+|.+..... .....+.+|++++++++|+||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 67888899999999999999986 488999999865432 2234577899999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcc
Q 003254 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (836)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~ 674 (836)
+++ +|.+++... ...+++..+..++.|+++||.|||+.+ |+|+||||+||++++++.+||+|||+++.......
T Consensus 85 ~~~-~L~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 85 LDT-DLKQYMDDC--GGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred CCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 985 888887543 236889999999999999999999988 99999999999999999999999999875432111
Q ss_pred ccccccccccccccCcccccC-CccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchh------
Q 003254 675 EANTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLE------ 747 (836)
Q Consensus 675 ~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 747 (836)
......++..|+|||.+.+ ..++.++||||+|+++|||++|+.|+...... ........+.........
T Consensus 159 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07844 159 --TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDV--EDQLHKIFRVLGTPTEETWPGVSS 234 (291)
T ss_pred --cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccH--HHHHHHHHHhcCCCChhhhhhhhh
Confidence 1112346788999999875 45889999999999999999999987533211 000000111000000000
Q ss_pred ---hcc--------ccccCC-CChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 748 ---LID--------QSLDNS-CSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 748 ---~~d--------~~l~~~-~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
... ..+... ........+.+++.+||+.+|++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 235 NPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 000 000000 01111245679999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=294.41 Aligned_cols=247 Identities=25% Similarity=0.440 Sum_probs=197.3
Q ss_pred cccccCeecccCceeEEEEEee-cCcEEEEEEecCC-CchhHHHHHHHHHHHHhhc---CCceeeEEeEEeeCCeeeEEE
Q 003254 518 NFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG-SGQGMEEFKNEVLLIAKLQ---HRNLVKLLGCCTQRDERMLIY 592 (836)
Q Consensus 518 ~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~~~~~lV~ 592 (836)
.|+..+.||+|+||.||+|... +++.+|+|.+... .....+++.+|+.++++++ |||++++++++......++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 4677889999999999999974 5889999998654 3345567889999999997 999999999999999999999
Q ss_pred eecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCC
Q 003254 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (836)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~ 672 (836)
||+++++|.+++.. ..+++..+..++.+++.||.|||+.+ ++|+||+|+||++++++.++|+|||++..+...
T Consensus 82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 99999999988742 36889999999999999999999998 999999999999999999999999999876433
Q ss_pred ccccccccccccccccCcccccCC-ccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccc
Q 003254 673 QTEANTKRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQ 751 (836)
Q Consensus 673 ~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 751 (836)
.. ......|+..|+|||.+.++ .++.++||||||+++|+|++|+.|+......... .......+ +
T Consensus 155 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~-------~~~~~~~~-----~ 220 (277)
T cd06917 155 SS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM-------MLIPKSKP-----P 220 (277)
T ss_pred cc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhh-------hccccCCC-----C
Confidence 21 12234688899999998754 4789999999999999999999997532211100 00000000 0
Q ss_pred cccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 752 SLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 752 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
.+... .....+.+++.+|++.+|++||++.|+++
T Consensus 221 ~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 221 RLEDN---GYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 11110 12345778999999999999999999976
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=290.25 Aligned_cols=273 Identities=23% Similarity=0.290 Sum_probs=212.1
Q ss_pred ccccccCeecccCceeEEEEEeec-CcEEEEEEecCCC---chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEE
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 592 (836)
+.|+..+.||.|.-|+||++.+.+ +..+|+|++.+.. .....+.+.|-+||+.++||.+..|++.++..+..+|||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 456677899999999999999976 5889999997763 344556788999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCC-
Q 003254 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL- 671 (836)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~- 671 (836)
|||+||+|..+.. .+..+.+++..+.-++..|+-||+|||..| ||.|||||+||||-++|++-|+||.|+.....
T Consensus 157 eyCpGGdL~~Lrq-kQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQ-KQPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred ecCCCccHHHHHh-hCCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 9999999987774 455678999999999999999999999999 99999999999999999999999998754310
Q ss_pred --------------------------------Ccc---------------------ccccccccccccccCcccccCCcc
Q 003254 672 --------------------------------DQT---------------------EANTKRVVGTYGYMSPEYAIDGLF 698 (836)
Q Consensus 672 --------------------------------~~~---------------------~~~~~~~~gt~~y~aPE~~~~~~~ 698 (836)
... ......++||-.|+|||++.+...
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 000 011234679999999999999999
Q ss_pred CccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCC
Q 003254 699 SVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPE 778 (836)
Q Consensus 699 t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~ 778 (836)
+.++|-|+|||+||||+.|+.||........ +. .++.+.+.-.........+.+||++.|.+||+
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~T--l~-------------NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~ 377 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKET--LR-------------NIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPS 377 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchhh--HH-------------HHhcCCCcCCCCCcchhHHHHHHHHHhccChh
Confidence 9999999999999999999999865443221 11 11111111111123345678999999999999
Q ss_pred CCCC----HHHHHHH--hcCC-----CCCCCCCCCCccccC
Q 003254 779 DRPN----MSSVVLM--LSGE-----RSLPQPQQPGFFTGR 808 (836)
Q Consensus 779 ~RPt----~~eVl~~--L~~~-----~~~~~p~~p~~~~~~ 808 (836)
+|-. +.||-+. +++. +..-.|..|......
T Consensus 378 kRlg~~rGA~eIK~HpFF~gVnWaLir~~~PP~iP~~~d~~ 418 (459)
T KOG0610|consen 378 KRLGSKRGAAEIKRHPFFEGVNWALIRCARPPEIPKPVDGG 418 (459)
T ss_pred hhhccccchHHhhcCccccCCChhheeccCCCcCCCccccC
Confidence 9998 7777652 3443 222334446655543
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=308.94 Aligned_cols=251 Identities=24% Similarity=0.399 Sum_probs=205.2
Q ss_pred ccccccCeecccCceeEEEEEeec-CcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEeec
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 595 (836)
+.+++...||.|+||.|||+..++ +-..|-|.+...+....+.|+-||+||...+||+||+|++.|...+.++|+.|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 456777889999999999999766 3445788887778888899999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCccc
Q 003254 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE 675 (836)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 675 (836)
.||..+..+... ...|...++..++++++.||.|||++. |||||||+.|||++-+|.++|+|||.+.... ...
T Consensus 112 ~GGAVDaimlEL--~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~--~t~ 184 (1187)
T KOG0579|consen 112 GGGAVDAIMLEL--GRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNK--STR 184 (1187)
T ss_pred CCchHhHHHHHh--ccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccch--hHH
Confidence 999999998654 347999999999999999999999998 9999999999999999999999999986532 222
Q ss_pred cccccccccccccCccccc-----CCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhcc
Q 003254 676 ANTKRVVGTYGYMSPEYAI-----DGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELID 750 (836)
Q Consensus 676 ~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 750 (836)
.....+.|||.|||||+.+ ..+|+.++||||||++|.||..+.+|-. +..+ ....-.+....+..++.
T Consensus 185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHh------elnp-MRVllKiaKSePPTLlq 257 (1187)
T KOG0579|consen 185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHH------ELNP-MRVLLKIAKSEPPTLLQ 257 (1187)
T ss_pred hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcc------ccch-HHHHHHHhhcCCCcccC
Confidence 3334588999999999874 5689999999999999999999998832 1111 12222223333333333
Q ss_pred ccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 751 QSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 751 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
|. .-...+.++..+||..+|..||++.++++
T Consensus 258 PS-------~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 258 PS-------HWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred cc-------hhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 22 22345778999999999999999999875
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=295.60 Aligned_cols=262 Identities=24% Similarity=0.381 Sum_probs=198.1
Q ss_pred cccccCeecccCceeEEEEEeec-CcEEEEEEecCCCc-hhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEeec
Q 003254 518 NFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSG-QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (836)
Q Consensus 518 ~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 595 (836)
+|+..++||.|++|.||+|+... |+.||||++..... ...+.+.+|+.++++++|+||+++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 57888999999999999999864 88999999876533 23467788999999999999999999999999999999999
Q ss_pred CCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCccc
Q 003254 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE 675 (836)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 675 (836)
++ +|.+++........+++..+..++.||+.||.|||+.+ ++|+||||+||++++++.++|+|||++..+.....
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 85 78887755444456899999999999999999999988 99999999999999999999999999976533211
Q ss_pred cccccccccccccCcccccCC-ccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCc---h-----
Q 003254 676 ANTKRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERP---L----- 746 (836)
Q Consensus 676 ~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~----- 746 (836)
......++..|+|||.+.+. .++.++||||||+++|||++|+.|+........ .....+....... .
T Consensus 156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07836 156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQ---LLKIFRIMGTPTESTWPGISQL 231 (284)
T ss_pred -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHH---HHHHHHHhCCCChhhHHHHhcC
Confidence 11224568899999998764 578999999999999999999998754332111 0000000000000 0
Q ss_pred hhcccccc-------CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 747 ELIDQSLD-------NSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 747 ~~~d~~l~-------~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
........ ..........+.+++.+|++.+|.+||++.||++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 232 PEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred chhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000000 0001122345789999999999999999999985
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=287.03 Aligned_cols=251 Identities=25% Similarity=0.404 Sum_probs=203.1
Q ss_pred cccccCeecccCceeEEEEEee-cCcEEEEEEecCCCc--hhHHHHHHHHHHHHhhcCCceeeEEeEEeeC--CeeeEEE
Q 003254 518 NFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSG--QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR--DERMLIY 592 (836)
Q Consensus 518 ~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV~ 592 (836)
+|...+.||+|++|.||+|+.. +++.|++|++..... ...+.+.+|+.++++++|+||+++++.+... ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4667789999999999999987 588999999876542 4567899999999999999999999999988 8899999
Q ss_pred eecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCC
Q 003254 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (836)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~ 672 (836)
||+++++|.+++... ..+++..+..++.++++||+|||+.+ ++|+||+|+||++++++.++|+|||.+......
T Consensus 81 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKKF---GKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 999999999998543 37899999999999999999999988 999999999999999999999999999876543
Q ss_pred ccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhcccc
Q 003254 673 QTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQS 752 (836)
Q Consensus 673 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 752 (836)
..........++..|+|||.+.+...+.++||||||+++++|++|+.|+.... .............
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~--------- 220 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG-----NPMAALYKIGSSG--------- 220 (260)
T ss_pred cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----chHHHHHhccccC---------
Confidence 32111233567889999999998889999999999999999999999975433 1111111110000
Q ss_pred ccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 753 LDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 753 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
.....+......+.+++.+|++.+|++||++.|++.
T Consensus 221 ~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 221 EPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred CCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 011112222456889999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=287.59 Aligned_cols=250 Identities=30% Similarity=0.442 Sum_probs=202.6
Q ss_pred cccccCeecccCceeEEEEEee-cCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEeecC
Q 003254 518 NFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLP 596 (836)
Q Consensus 518 ~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 596 (836)
+|+..+.||+|++|.||++... +++.+++|++........+.+.+|+.++++++|+|++++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4677889999999999999986 588999999977665567889999999999999999999999999999999999999
Q ss_pred CCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcccc
Q 003254 597 NKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEA 676 (836)
Q Consensus 597 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~~ 676 (836)
+++|.+++.... ..+++..+..++.+++.||+|||+.+ ++|+||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 153 (253)
T cd05122 81 GGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-- 153 (253)
T ss_pred CCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence 999999885432 46899999999999999999999987 99999999999999999999999999987643321
Q ss_pred ccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccccccCC
Q 003254 677 NTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDNS 756 (836)
Q Consensus 677 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 756 (836)
.....++..|+|||.+.+..++.++||||||+++++|++|+.|+....... ...............
T Consensus 154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~~~~~------ 219 (253)
T cd05122 154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMK-------ALFKIATNGPPGLRN------ 219 (253)
T ss_pred -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHH-------HHHHHHhcCCCCcCc------
Confidence 234568889999999998889999999999999999999999865322110 000000010111110
Q ss_pred CChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 757 CSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 757 ~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
.......+.+++.+|++.+|++|||+.|+++.
T Consensus 220 -~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 220 -PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred -ccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 01113457899999999999999999999863
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=319.45 Aligned_cols=253 Identities=28% Similarity=0.409 Sum_probs=209.3
Q ss_pred ccccCeecccCceeEEEEEe-ecCc----EEEEEEecCC-CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEE
Q 003254 519 FSEKNKLGEGGFGPVYKGML-IEGQ----EIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (836)
Q Consensus 519 f~~~~~lG~G~fG~Vykg~~-~~g~----~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 592 (836)
....++||+|+||+||||.+ ++|+ +||+|++... ..+..+++.+|+.+|.+++|||++||+|+|.... ..||.
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 34467899999999999996 4444 5899988655 4456789999999999999999999999998766 88999
Q ss_pred eecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCC
Q 003254 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (836)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~ 672 (836)
+||+.|+|.+++.. .+..+.-+..+.|..|||+||.|||++. ++||||.++||||.+-..+||.|||+++.+..+
T Consensus 777 q~mP~G~LlDyvr~--hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVRE--HRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred HhcccchHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 99999999999965 4457888999999999999999999987 999999999999999999999999999998777
Q ss_pred ccccccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhccCchhhccc
Q 003254 673 QTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQ 751 (836)
Q Consensus 673 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 751 (836)
..........-.+.|||-|.+....|+.++|||||||.+||++| |..|.......+.. .+++.
T Consensus 852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~----------------dlle~ 915 (1177)
T KOG1025|consen 852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIP----------------DLLEK 915 (1177)
T ss_pred cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhh----------------HHHhc
Confidence 66666655566789999999999999999999999999999998 66664332222211 22222
Q ss_pred cccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 003254 752 SLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 793 (836)
Q Consensus 752 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 793 (836)
..+-..+..+..++..++.+||..|+..||+++++.+.+++.
T Consensus 916 geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ 957 (1177)
T KOG1025|consen 916 GERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRM 957 (1177)
T ss_pred cccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHH
Confidence 222234556677889999999999999999999998887653
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=295.47 Aligned_cols=264 Identities=24% Similarity=0.345 Sum_probs=195.4
Q ss_pred hcccccccCeecccCceeEEEEEee-cCcEEEEEEecCCCc-hhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEE
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSG-QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 592 (836)
++++|...+.||+|+||.||+|... +++.||+|++..... .....+.+|+.+++.++|+||+++.+++......++|+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 4578999999999999999999875 488999999865432 23346788999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCC
Q 003254 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (836)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~ 672 (836)
||+. ++|..++... ...+.+..+..++.||+.||+|||+.+ |+|+||||+||+++.++.+||+|||+++.....
T Consensus 83 e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 83 EYMH-TDLAQYMIQH--PGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred eccc-CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 9996 5666666432 345778888999999999999999998 999999999999999999999999999764322
Q ss_pred ccccccccccccccccCcccccCC-ccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccC-------
Q 003254 673 QTEANTKRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEER------- 744 (836)
Q Consensus 673 ~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~------- 744 (836)
.. ......++..|+|||++.+. .++.++||||||++++||++|+.|+...... .......+..+....
T Consensus 157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 232 (291)
T cd07870 157 SQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV--FEQLEKIWTVLGVPTEDTWPGV 232 (291)
T ss_pred CC--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH--HHHHHHHHHHcCCCChhhhhhh
Confidence 11 11224568899999998764 5788999999999999999999997533221 011111111000000
Q ss_pred ------chhhccc----cccC-CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 745 ------PLELIDQ----SLDN-SCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 745 ------~~~~~d~----~l~~-~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
..+.... .+.. .........+.+++.+|++.+|++|||+.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 233 SKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0000000 0000 000012345678999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=295.60 Aligned_cols=244 Identities=25% Similarity=0.309 Sum_probs=198.2
Q ss_pred ccccccCeecccCceeEEEEEeec-CcEEEEEEecCCC---chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEE
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 592 (836)
++|+..+.||+|+||.||++.... ++.+|+|.+.... ....+.+.+|++++++++||||+++++++..+...++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 468888999999999999999864 8899999986532 234567889999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCC
Q 003254 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (836)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~ 672 (836)
||+++++|.+++.. ...++...+..++.||++||.|||+.+ ++|+||+|+||++++++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~---~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRK---SGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 99999999999854 356889999999999999999999988 999999999999999999999999999875432
Q ss_pred ccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhcccc
Q 003254 673 QTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQS 752 (836)
Q Consensus 673 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 752 (836)
.....+++.|+|||.+.+...+.++||||||+++++|++|+.|+...... ...........
T Consensus 155 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~------- 215 (290)
T cd05580 155 -----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI-------QIYEKILEGKV------- 215 (290)
T ss_pred -----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHhcCCc-------
Confidence 22356889999999998888999999999999999999999997532210 11111111110
Q ss_pred ccCCCChHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 003254 753 LDNSCSFSEALRCIQVGLLCVQQRPEDRP-----NMSSVVL 788 (836)
Q Consensus 753 l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~eVl~ 788 (836)
..+......+.+++.+||+.+|.+|| +++|+++
T Consensus 216 ---~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 216 ---RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred ---cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 11111235677999999999999999 6677653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=297.54 Aligned_cols=264 Identities=24% Similarity=0.317 Sum_probs=196.8
Q ss_pred ccccccCeecccCceeEEEEEeec-CcEEEEEEecCCCc--hhHHHHHHHHHHHHhhcCCceeeEEeEEeeC--CeeeEE
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSG--QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR--DERMLI 591 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV 591 (836)
++|+..+.||+|+||.||+|+... ++.+|+|.++.... .....+.+|+.++.+++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 578888999999999999999864 88999999865432 2234577899999999999999999998877 789999
Q ss_pred EeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCC
Q 003254 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (836)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~ 671 (836)
|||+++ +|.+++... ...+++..+..++.||+.||+|||+.+ ++|+||||+||++++++.+||+|||++..+..
T Consensus 85 ~e~~~~-~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVEH-DLKSLMETM--KQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcCc-CHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 999985 888877432 236899999999999999999999998 99999999999999999999999999987653
Q ss_pred CccccccccccccccccCcccccCC-ccCccccccchhhhhhhhhhCCCCCCCCCCccccchh--------hhhHHhhhc
Q 003254 672 DQTEANTKRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLL--------GHAWRLWIE 742 (836)
Q Consensus 672 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~--------~~~~~~~~~ 742 (836)
... ......++..|+|||.+.+. .++.++||||||++++||++|+.|+............ ...|..+..
T Consensus 159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (293)
T cd07843 159 PLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE 236 (293)
T ss_pred Ccc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence 321 12234578899999998765 4689999999999999999999987643221110000 000100000
Q ss_pred ------cCchhhccccccCCCChH-HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 743 ------ERPLELIDQSLDNSCSFS-EALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 743 ------~~~~~~~d~~l~~~~~~~-~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
....+.....+....... ....+.+++.+||+.+|++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 000000000111111111 2345779999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=295.41 Aligned_cols=248 Identities=24% Similarity=0.354 Sum_probs=198.9
Q ss_pred cccccCeecccCceeEEEEEee-cCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEeecC
Q 003254 518 NFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLP 596 (836)
Q Consensus 518 ~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 596 (836)
.|...+.||+|++|.||++... +++.+++|++........+.+.+|+.+++.++|+|++++++++...+..++|+||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 3455678999999999999974 588999999876555556778999999999999999999999999999999999999
Q ss_pred CCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcccc
Q 003254 597 NKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEA 676 (836)
Q Consensus 597 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~~ 676 (836)
+++|.+++.. ..+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.++|+|||++........
T Consensus 100 ~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-- 170 (285)
T cd06648 100 GGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-- 170 (285)
T ss_pred CCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc--
Confidence 9999998843 45889999999999999999999998 99999999999999999999999998876532211
Q ss_pred ccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccccccCC
Q 003254 677 NTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDNS 756 (836)
Q Consensus 677 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 756 (836)
......|+..|+|||.+.+..++.++||||||++++||++|+.|+...... . ........... ....
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~------~-~~~~~~~~~~~-----~~~~- 237 (285)
T cd06648 171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL------Q-AMKRIRDNLPP-----KLKN- 237 (285)
T ss_pred ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH------H-HHHHHHhcCCC-----CCcc-
Confidence 122346889999999999888999999999999999999999986432211 0 01111111110 0100
Q ss_pred CChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 757 CSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 757 ~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
.......+.+++.+||+.+|++||++.++++
T Consensus 238 -~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 238 -LHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred -cccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 1112346789999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=294.89 Aligned_cols=260 Identities=23% Similarity=0.355 Sum_probs=194.7
Q ss_pred cccccCeecccCceeEEEEEee-cCcEEEEEEecCCC--chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEee
Q 003254 518 NFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (836)
Q Consensus 518 ~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 594 (836)
+|+..+.||.|++|.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4778899999999999999975 48899999886442 22345788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcc
Q 003254 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (836)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~ 674 (836)
+. ++|..++... ....+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||++..+.....
T Consensus 81 ~~-~~l~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 81 LH-QDLKKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred cc-cCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 96 5788877543 2356899999999999999999999988 99999999999999999999999999886543221
Q ss_pred ccccccccccccccCcccccCCc-cCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCc--------
Q 003254 675 EANTKRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERP-------- 745 (836)
Q Consensus 675 ~~~~~~~~gt~~y~aPE~~~~~~-~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------- 745 (836)
......++..|+|||.+.+.. ++.++||||||+++|||++|+.|+....... .... ..+.......
T Consensus 156 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07860 156 --TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFR-IFRTLGTPDEVVWPGVTS 230 (284)
T ss_pred --ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHH-HHHHhCCCChhhhhhhhH
Confidence 112235678999999887654 6889999999999999999999875322111 0000 0000000000
Q ss_pred --------hhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 746 --------LELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 746 --------~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
.......+. .........+.+++.+|++.||++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 231 LPDYKPSFPKWARQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHHHhhcccccccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 000000000 000011234678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=288.32 Aligned_cols=250 Identities=26% Similarity=0.401 Sum_probs=206.2
Q ss_pred ccccccCeecccCceeEEEEEeec-CcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEeec
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 595 (836)
+-|.++++||+|.||.|||+.++. |+.+|+|++... ...+++..|+.++++.+.|++|+++|.+.....+++|||||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 346677899999999999999876 999999998654 45688999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCccc
Q 003254 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE 675 (836)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 675 (836)
.-|+..+.+. .++++|++.++..++...++||+|||... -+|||||+.||||+.+|.+||+|||.|-.+.. .-
T Consensus 111 GAGSiSDI~R--~R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD--TM 183 (502)
T KOG0574|consen 111 GAGSISDIMR--ARRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTD--TM 183 (502)
T ss_pred CCCcHHHHHH--HhcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhh--hH
Confidence 9999999984 46789999999999999999999999876 79999999999999999999999999976532 22
Q ss_pred cccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccccccC
Q 003254 676 ANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDN 755 (836)
Q Consensus 676 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 755 (836)
.......||+.|||||++..-.|+.++||||||+...||..|++|+..-++-..... +...+. +..
T Consensus 184 AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFM--------IPT~PP----PTF-- 249 (502)
T KOG0574|consen 184 AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFM--------IPTKPP----PTF-- 249 (502)
T ss_pred HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEe--------ccCCCC----CCC--
Confidence 233457899999999999999999999999999999999999999653322111110 001110 001
Q ss_pred CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 756 SCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 756 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
..+..-..++-++++.||-..|++|-|+.++++.
T Consensus 250 ~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 250 KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 1233445678899999999999999999887763
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=298.05 Aligned_cols=248 Identities=27% Similarity=0.401 Sum_probs=194.5
Q ss_pred hcccccccCeecccCceeEEEEEee-cCcEEEEEEecCCC---chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeE
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 590 (836)
..+.|...+.||+|+||.||+|+.. +++.||+|.+.... ....+++.+|+++++.++|||++++.+++......++
T Consensus 13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~l 92 (307)
T cd06607 13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWL 92 (307)
T ss_pred cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEE
Confidence 3456888899999999999999975 48899999986442 2334578899999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccC
Q 003254 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (836)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~ 670 (836)
|+||++ |+|.+++.. ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++....
T Consensus 93 v~e~~~-g~l~~~~~~--~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~ 166 (307)
T cd06607 93 VMEYCL-GSASDILEV--HKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVS 166 (307)
T ss_pred EHHhhC-CCHHHHHHH--cccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecC
Confidence 999997 466666532 2346899999999999999999999988 9999999999999999999999999987643
Q ss_pred CCccccccccccccccccCccccc---CCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchh
Q 003254 671 LDQTEANTKRVVGTYGYMSPEYAI---DGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLE 747 (836)
Q Consensus 671 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (836)
.. ....++..|+|||.+. .+.++.++||||||+++|||++|+.|+...... ..... ........
T Consensus 167 ~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~------~~~~~-~~~~~~~~ 233 (307)
T cd06607 167 PA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYH-IAQNDSPT 233 (307)
T ss_pred CC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH------HHHHH-HhcCCCCC
Confidence 21 2246788999999874 456889999999999999999999986432111 00000 00000000
Q ss_pred hccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 748 LIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 748 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
+ ........+.+++.+||+.+|++||++.+|+..
T Consensus 234 -----~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 234 -----L---SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred -----C---CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0 011223457899999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=295.69 Aligned_cols=260 Identities=24% Similarity=0.358 Sum_probs=196.1
Q ss_pred ccccCeecccCceeEEEEEeec-CcEEEEEEecCCC--chhHHHHHHHHHHHHhhcCCceeeEEeEEeeC--CeeeEEEe
Q 003254 519 FSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR--DERMLIYE 593 (836)
Q Consensus 519 f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV~E 593 (836)
|+..++||.|++|.||+|+..+ ++.+|+|++.... ....+.+.+|+.++++++|+|++++++++... +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 5667899999999999999865 8899999997653 33456788999999999999999999999888 78999999
Q ss_pred ecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCc
Q 003254 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (836)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~ 673 (836)
|+++ +|..++... ...+++..+..++.||++||+|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMDH-DLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred cccc-cHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 9985 787777432 246899999999999999999999988 9999999999999999999999999998765432
Q ss_pred cccccccccccccccCcccccC-CccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccC--------
Q 003254 674 TEANTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEER-------- 744 (836)
Q Consensus 674 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~-------- 744 (836)
. .......++..|+|||.+.+ ..++.++||||||++++||++|+.|+........ ............
T Consensus 155 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07840 155 S-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQ---LEKIFELCGSPTDENWPGVS 230 (287)
T ss_pred c-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCchhhccccc
Confidence 2 11222456788999998765 4578999999999999999999998754332111 010000000000
Q ss_pred ---------chhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 745 ---------PLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 745 ---------~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
........+.......+...+.+++.+|++.+|++||+++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 231 KLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred cchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00000000000011112456789999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=297.34 Aligned_cols=255 Identities=27% Similarity=0.392 Sum_probs=198.0
Q ss_pred cccccCeecccCceeEEEEEee-cCcEEEEEEecCCC---chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEe
Q 003254 518 NFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (836)
Q Consensus 518 ~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 593 (836)
.|...+.||+|+||.||+++.. ++..+|+|++.... ....+.+.+|+.++++++|+|++++++++......++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 4667789999999999999975 48899999986442 2334578899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCc
Q 003254 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (836)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~ 673 (836)
|+++ +|.+.+.. ...++++..+..++.+++.||.|||+.+ ++||||+|+||+++.++.+||+|||++.....
T Consensus 106 ~~~g-~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~-- 177 (317)
T cd06635 106 YCLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP-- 177 (317)
T ss_pred CCCC-CHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC--
Confidence 9975 67666642 2356899999999999999999999998 99999999999999999999999999875432
Q ss_pred cccccccccccccccCccccc---CCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhcc
Q 003254 674 TEANTKRVVGTYGYMSPEYAI---DGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELID 750 (836)
Q Consensus 674 ~~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 750 (836)
.....++..|+|||++. .+.++.++||||||++++||++|+.|+...... . ..........
T Consensus 178 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~---~----~~~~~~~~~~----- 241 (317)
T cd06635 178 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---S----ALYHIAQNES----- 241 (317)
T ss_pred ----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH---H----HHHHHHhccC-----
Confidence 12346788999999974 456899999999999999999999986432110 0 0000110000
Q ss_pred ccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCCCCCCC
Q 003254 751 QSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQP 799 (836)
Q Consensus 751 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~~~~p 799 (836)
...........+.+++.+|++.+|++||++.+|++.+--....+.+
T Consensus 242 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~ 287 (317)
T cd06635 242 ---PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPET 287 (317)
T ss_pred ---CCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCccc
Confidence 0001112234578999999999999999999999876655444443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=293.28 Aligned_cols=261 Identities=22% Similarity=0.336 Sum_probs=210.6
Q ss_pred ccccccCeecccCceeEEEEEee-cCcEEEEEEecCCC--chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEe
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 593 (836)
.-|...+.||+|.|+.|-.+++- .|..||||++.+.. ......+.+|+.-|+.++|||||+|+.+......+|||.|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 44666789999999999999864 59999999998763 3445678999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEec-CCCCceeeccCcccccCCC
Q 003254 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD-NTMNPKISDFGLARSFGLD 672 (836)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~-~~~~~kl~DFgla~~~~~~ 672 (836)
.=++|+|.++|.+. ..-+++....+++.||+.|+.|+|+.. +|||||||+|+.+- .-|-+||.|||++-.+...
T Consensus 98 LGD~GDl~DyImKH--e~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKH--EEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred ecCCchHHHHHHhh--hccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 99999999999654 345899999999999999999999987 99999999999874 6789999999999887654
Q ss_pred ccccccccccccccccCcccccCCccC-ccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccc
Q 003254 673 QTEANTKRVVGTYGYMSPEYAIDGLFS-VKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQ 751 (836)
Q Consensus 673 ~~~~~~~~~~gt~~y~aPE~~~~~~~t-~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 751 (836)
+. ....+|...|-|||++.+..|+ +++||||||||||.|++|++||......+.. ..++|=
T Consensus 173 ~k---L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETL---------------TmImDC 234 (864)
T KOG4717|consen 173 KK---LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETL---------------TMIMDC 234 (864)
T ss_pred ch---hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhh---------------hhhhcc
Confidence 43 3457899999999999999886 6789999999999999999998643322111 111111
Q ss_pred cccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hcCCCCCCCCCCC
Q 003254 752 SLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM--LSGERSLPQPQQP 802 (836)
Q Consensus 752 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~--L~~~~~~~~p~~p 802 (836)
+-..+.....++.+||..||..||++|.+.+||+.. |+.+..-+....|
T Consensus 235 --KYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~sT~iP 285 (864)
T KOG4717|consen 235 --KYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRGLSTAIP 285 (864)
T ss_pred --cccCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCCccccCc
Confidence 112344455678999999999999999999999753 4444333333333
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=295.49 Aligned_cols=262 Identities=22% Similarity=0.309 Sum_probs=193.6
Q ss_pred ccccccCeecccCceeEEEEEee-cCcEEEEEEecCCCc--hhHHHHHHHHHHHHhhc-CCceeeEEeEEeeCCe-----
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSG--QGMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQRDE----- 587 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~----- 587 (836)
++|+..+.||+|+||.||+|... +++.||+|.+..... .....+.+|+.+++.++ |+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888899999999999999976 488999998765432 23467888999999995 6999999999987665
Q ss_pred eeEEEeecCCCChhHHHhhccC--CCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecC-CCCceeeccC
Q 003254 588 RMLIYEYLPNKSLDYFIFDTTR--SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-TMNPKISDFG 664 (836)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~-~~~~kl~DFg 664 (836)
.++||||+++ +|.+++..... ...+++..+..++.||++||.|||+.+ |+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999986 78887754332 346899999999999999999999988 999999999999998 8999999999
Q ss_pred cccccCCCccccccccccccccccCcccccC-CccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhcc
Q 003254 665 LARSFGLDQTEANTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEE 743 (836)
Q Consensus 665 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 743 (836)
+++.+...... .....+++.|+|||++.+ ..++.++||||||+++|||++|..|+........ . ........ .
T Consensus 157 ~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~--~-~~~~~~~~-~ 230 (295)
T cd07837 157 LGRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ--L-LHIFKLLG-T 230 (295)
T ss_pred cceecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH--H-HHHHHHhC-C
Confidence 99865332111 112356788999998865 4579999999999999999999988753221110 0 00000000 0
Q ss_pred Cchhhcc-----------cccc----CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 744 RPLELID-----------QSLD----NSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 744 ~~~~~~d-----------~~l~----~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
...+... +... ..........+.+++.+||+.+|++||++.|++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 231 PTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred CChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0000000 0000 0000112345789999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=289.88 Aligned_cols=250 Identities=24% Similarity=0.347 Sum_probs=198.4
Q ss_pred cccccCeecccCceeEEEEEeec-CcEEEEEEecCCC--chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEee
Q 003254 518 NFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (836)
Q Consensus 518 ~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 594 (836)
+|+..+.||+|+||.||+|.... |..+|+|.+.... ....+.+.+|+.+++.++|+|++++++.+......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 47778899999999999999865 8899999986542 23456788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCC-CceeeccCcccccCCCc
Q 003254 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTM-NPKISDFGLARSFGLDQ 673 (836)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~-~~kl~DFgla~~~~~~~ 673 (836)
+++++|.+++... ....+++..+..++.++++||.|||+.+ ++|+||||+||++++++ .+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 9999999988543 2335789999999999999999999988 99999999999999875 46999999998764322
Q ss_pred cccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccccc
Q 003254 674 TEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSL 753 (836)
Q Consensus 674 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 753 (836)
. ......|++.|+|||++.+..++.++||||||++++||++|+.|+..... ...... ...... .
T Consensus 157 ~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~-~~~~~~----~--- 220 (257)
T cd08225 157 E--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL------HQLVLK-ICQGYF----A--- 220 (257)
T ss_pred c--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHH-HhcccC----C---
Confidence 1 11224578899999999888899999999999999999999998643211 111111 111110 0
Q ss_pred cCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 754 DNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 754 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
.........+.+++.+|++.+|++|||+.||++.
T Consensus 221 --~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 221 --PISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred --CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 0111223457899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-32 Score=301.37 Aligned_cols=263 Identities=27% Similarity=0.341 Sum_probs=196.2
Q ss_pred hcccccccCeecccCceeEEEEEee-cCcEEEEEEecCC--CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeC------
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR------ 585 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------ 585 (836)
..++|+..+.||+|+||.||++... +++.||+|++... .....+++.+|+.++++++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 3478999999999999999999975 4899999998643 233456778899999999999999999988543
Q ss_pred CeeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCc
Q 003254 586 DERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGL 665 (836)
Q Consensus 586 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgl 665 (836)
...++||||+.+ +|.+.+.. .++...+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence 346999999965 77776632 2788899999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccc------------h-
Q 003254 666 ARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHN------------L- 732 (836)
Q Consensus 666 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~------------~- 732 (836)
++....... .....++..|+|||.+.+..++.++|||||||++++|++|+.||.......... .
T Consensus 165 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 241 (353)
T cd07850 165 ARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM 241 (353)
T ss_pred ceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 987543211 223467889999999999999999999999999999999999975432110000 0
Q ss_pred --hhhhHHhhhccCc-------hhhcccccc----CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 733 --LGHAWRLWIEERP-------LELIDQSLD----NSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 733 --~~~~~~~~~~~~~-------~~~~d~~l~----~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
.......+....+ .+.....+. ..........+.+++.+||+.||++|||+.|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000000010000 011111100 00111234567899999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=290.77 Aligned_cols=247 Identities=25% Similarity=0.316 Sum_probs=200.0
Q ss_pred cccccCeecccCceeEEEEEeec-CcEEEEEEecCCC---chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEe
Q 003254 518 NFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (836)
Q Consensus 518 ~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 593 (836)
+|+..+.||.|+||.||++.... ++.+|+|.+.+.. ....+.+.+|++++++++||||+++++++.+....++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 47788999999999999999864 8899999987543 2456789999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCc
Q 003254 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (836)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~ 673 (836)
|+++++|.+++... .++++..+..++.||++||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 99999999988432 47889999999999999999999988 9999999999999999999999999988764332
Q ss_pred cccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccccc
Q 003254 674 TEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSL 753 (836)
Q Consensus 674 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 753 (836)
......++..|+|||.+.+..++.++||||||+++|+|++|+.|+........... ...... .
T Consensus 155 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~----~~~~~~----------~ 217 (258)
T cd05578 155 ---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQI----RAKQET----------A 217 (258)
T ss_pred ---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHH----HHHhcc----------c
Confidence 12235678899999999988899999999999999999999999764333211111 000000 0
Q ss_pred cCCCChHHHHHHHHHHHHcccCCCCCCCCH--HHHH
Q 003254 754 DNSCSFSEALRCIQVGLLCVQQRPEDRPNM--SSVV 787 (836)
Q Consensus 754 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~--~eVl 787 (836)
....+......+.+++.+||+.+|.+||++ +|++
T Consensus 218 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 218 DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 011112223567899999999999999999 6654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=296.82 Aligned_cols=267 Identities=22% Similarity=0.358 Sum_probs=192.6
Q ss_pred cccccccCeecccCceeEEEEEeec-CcEEEEEEecCCC--chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCe-----
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDE----- 587 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~----- 587 (836)
.++|+..++||+|+||.||+++... ++.||||.+.... ......+.+|+.++++++||||+++++++...+.
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 3578999999999999999999754 8899999886542 2223456789999999999999999999876543
Q ss_pred ---eeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccC
Q 003254 588 ---RMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFG 664 (836)
Q Consensus 588 ---~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFg 664 (836)
.++||||+.+ +|...+.. ....+++.++..++.||+.||+|||+.+ ++|+||||+||++++++.+||+|||
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSN--KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCC
Confidence 4999999975 67666632 2336899999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCccc--cccccccccccccCcccccCC-ccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhh
Q 003254 665 LARSFGLDQTE--ANTKRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWI 741 (836)
Q Consensus 665 la~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 741 (836)
++..+...... .......++..|+|||.+.+. .++.++||||||++++||++|+.|+....................
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT 244 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 99876432221 112234578889999988765 478899999999999999999988754322111111000000000
Q ss_pred -----ccCchhhcccc---------ccCC-CChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 742 -----EERPLELIDQS---------LDNS-CSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 742 -----~~~~~~~~d~~---------l~~~-~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
........+.. .... ........+.+++.+||+.+|++|||+.|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 00000000000 0000 00011235678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-32 Score=294.46 Aligned_cols=260 Identities=23% Similarity=0.338 Sum_probs=194.4
Q ss_pred ccccCeecccCceeEEEEEee-cCcEEEEEEecCCC--chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEeec
Q 003254 519 FSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (836)
Q Consensus 519 f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 595 (836)
|+..+.||.|++|.||+|... +|+.||+|++.... ....+.+.+|+.++++++|||++++++++......++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 566789999999999999975 58999999986543 223467889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCccc
Q 003254 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE 675 (836)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 675 (836)
+ ++|.+++.... ...+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.++|+|||++..+.....
T Consensus 81 ~-~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~- 154 (283)
T cd07835 81 D-LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR- 154 (283)
T ss_pred C-cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-
Confidence 5 68888875432 246899999999999999999999987 99999999999999999999999999976532211
Q ss_pred cccccccccccccCcccccCC-ccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccC---------c
Q 003254 676 ANTKRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEER---------P 745 (836)
Q Consensus 676 ~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~---------~ 745 (836)
......++..|+|||++.+. .++.++||||||+++|||++|+.|+........ ... ..+...... .
T Consensus 155 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~-~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd07835 155 -TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ--LFR-IFRTLGTPDEDVWPGVTSL 230 (283)
T ss_pred -ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHH-HHHHhCCCChHHhhhhhhc
Confidence 11223568899999988764 578999999999999999999998754322110 000 000000000 0
Q ss_pred hhhcccccc------CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 746 LELIDQSLD------NSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 746 ~~~~d~~l~------~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
.+....... ..........+.+++.+|++.+|++|||+.||++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 231 PDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000000000 0001112245779999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.7e-32 Score=293.00 Aligned_cols=255 Identities=24% Similarity=0.358 Sum_probs=194.0
Q ss_pred ccccccCeecccCceeEEEEEeec-CcEEEEEEecCCC-chhHHHHHHHHHHHHhhc-CCceeeEEeEEeeCCeeeEEEe
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQRDERMLIYE 593 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~E 593 (836)
++|+..+.||+|+||.||++.... ++.+|+|++.... ......+.+|+.++.++. |+||+++++++......+++||
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 355667789999999999999754 8899999987543 344567889999999996 9999999999999889999999
Q ss_pred ecCCCChhHHHhh--ccCCCcCChhhhHHHHHHHHhhhHhhhcC-CCCcEEeccCCCCceEecCCCCceeeccCcccccC
Q 003254 594 YLPNKSLDYFIFD--TTRSKLLDWSKRSHIIAGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (836)
Q Consensus 594 y~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~ 670 (836)
|+.. ++..+... ......+++..+..++.++++||+|||+. + ++||||||+||+++.++.+||+|||++..+.
T Consensus 84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 9874 55443321 12235689999999999999999999975 5 9999999999999999999999999997654
Q ss_pred CCccccccccccccccccCcccccCC---ccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchh
Q 003254 671 LDQTEANTKRVVGTYGYMSPEYAIDG---LFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLE 747 (836)
Q Consensus 671 ~~~~~~~~~~~~gt~~y~aPE~~~~~---~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (836)
.... .....++..|+|||.+.+. .++.++||||||++++||++|+.|+.... .......+ ......
T Consensus 160 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~-~~~~~~-- 228 (288)
T cd06616 160 DSIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQ-VVKGDP-- 228 (288)
T ss_pred cCCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhh-hcCCCC--
Confidence 2221 1224578899999999776 68999999999999999999999975322 11111111 111111
Q ss_pred hccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 748 LIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 748 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
+.+...........+.+++.+|++.+|++|||+.+|++.
T Consensus 229 ---~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 229 ---PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred ---CcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111111112234567899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-33 Score=307.21 Aligned_cols=244 Identities=24% Similarity=0.355 Sum_probs=193.7
Q ss_pred ccCeecccCceeEEEEEeec-CcEEEEEEecC----CCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCe--eeEEEe
Q 003254 521 EKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSK----GSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDE--RMLIYE 593 (836)
Q Consensus 521 ~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~----~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~--~~lV~E 593 (836)
...+||+|.|-+||||.+.. |.+||--.++. ..+...++|..|+.+|+.|+||||++++.++.+... ..+|.|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 44689999999999999854 77775333221 234556889999999999999999999999987665 778999
Q ss_pred ecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecC-CCCceeeccCcccccCCC
Q 003254 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-TMNPKISDFGLARSFGLD 672 (836)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~-~~~~kl~DFgla~~~~~~ 672 (836)
.|..|+|..++... +.++.+.+..|+.||++||.|||++. +||||||||-+||+|+. .|.|||+|+|||......
T Consensus 124 L~TSGtLr~Y~kk~---~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 124 LFTSGTLREYRKKH---RRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred cccCCcHHHHHHHh---ccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 99999999999544 45788899999999999999999986 68999999999999975 689999999999986432
Q ss_pred ccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhcccc
Q 003254 673 QTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQS 752 (836)
Q Consensus 673 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 752 (836)
......|||.|||||+.. ..|++.+|||||||+++||+|+..|+.. .. -.....+.+..+.....+.+.
T Consensus 200 ----~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsE-----C~-n~AQIYKKV~SGiKP~sl~kV 268 (632)
T KOG0584|consen 200 ----HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSE-----CT-NPAQIYKKVTSGIKPAALSKV 268 (632)
T ss_pred ----ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhh-----hC-CHHHHHHHHHcCCCHHHhhcc
Confidence 223378999999999887 7899999999999999999999998531 11 112233444444333332221
Q ss_pred ccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 753 LDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 753 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
- ..++.++|.+||.. .++|||+.|+|.
T Consensus 269 ~--------dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 269 K--------DPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred C--------CHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 1 23467899999999 999999999986
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.2e-32 Score=295.11 Aligned_cols=263 Identities=25% Similarity=0.364 Sum_probs=194.5
Q ss_pred hcccccccCeecccCceeEEEEEeec-CcEEEEEEecCCCc--hhHHHHHHHHHHHHhhcCCceeeEEeEEeeC--Ceee
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSG--QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR--DERM 589 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~ 589 (836)
..++|+..+.||+|+||.||+|+... |+.||+|+++.... .....+.+|+.++++++|+|++++++++... +..+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 34688999999999999999999854 89999999864432 2234567899999999999999999998755 4589
Q ss_pred EEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCccccc
Q 003254 590 LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (836)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~ 669 (836)
+||||+.+ +|.+++... ...+++..+..++.||++||+|||+.+ ++||||||+||++++++.+||+|||++...
T Consensus 85 lv~e~~~~-~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 85 LVMEYCEQ-DLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEEecCCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeec
Confidence 99999975 787777432 356899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCccccccccccccccccCcccccC-CccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhh
Q 003254 670 GLDQTEANTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLEL 748 (836)
Q Consensus 670 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (836)
..... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+........ ........... ....
T Consensus 159 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~---~~~~~~~~~~~-~~~~ 232 (309)
T cd07845 159 GLPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQ---LDLIIQLLGTP-NESI 232 (309)
T ss_pred CCccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCCC-Chhh
Confidence 43221 1122345778999999875 4578999999999999999999998753322111 11000000000 0000
Q ss_pred ---------ccc-cccC-CC-C-----hHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 749 ---------IDQ-SLDN-SC-S-----FSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 749 ---------~d~-~l~~-~~-~-----~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
... .+.. .. . ......+.+++.+|++.||++|||+.|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 233 WPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred chhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000 0000 00 0 0013456789999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-32 Score=303.23 Aligned_cols=268 Identities=21% Similarity=0.308 Sum_probs=197.3
Q ss_pred hcccccccCeecccCceeEEEEEee-cCcEEEEEEecCCC-chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCC-----e
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD-----E 587 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-----~ 587 (836)
..++|++.++||+|+||.||+|+.. +|+.||+|++.... ......+.+|+.++++++|+||+++++++.... .
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 3578999999999999999999875 48899999986432 334567889999999999999999999875543 4
Q ss_pred eeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCccc
Q 003254 588 RMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667 (836)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~ 667 (836)
.++|+||+++ +|...+. ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++.
T Consensus 83 ~~lv~e~~~~-~l~~~~~----~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~ 154 (336)
T cd07849 83 VYIVQELMET-DLYKLIK----TQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLAR 154 (336)
T ss_pred EEEEehhccc-CHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECccccee
Confidence 7999999975 6766652 346899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCcccc-ccccccccccccCcccccC-CccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCc
Q 003254 668 SFGLDQTEA-NTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERP 745 (836)
Q Consensus 668 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (836)
......... ......++..|+|||.+.+ ..++.++||||||++++||++|+.|+........ .............
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~---~~~~~~~~~~~~~ 231 (336)
T cd07849 155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQ---LNLILGVLGTPSQ 231 (336)
T ss_pred eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCCH
Confidence 754322211 1123567899999998765 4689999999999999999999998753221100 0000000000000
Q ss_pred ---hhhcccc-------c--cCCCC-----hHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hcCC
Q 003254 746 ---LELIDQS-------L--DNSCS-----FSEALRCIQVGLLCVQQRPEDRPNMSSVVLM--LSGE 793 (836)
Q Consensus 746 ---~~~~d~~-------l--~~~~~-----~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~--L~~~ 793 (836)
....+.. . ..... ......+.+++.+||+.+|++|||+.|+++. ++..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~ 298 (336)
T cd07849 232 EDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY 298 (336)
T ss_pred HHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence 0000000 0 00000 0113457899999999999999999999987 6554
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.7e-32 Score=287.22 Aligned_cols=242 Identities=25% Similarity=0.335 Sum_probs=193.4
Q ss_pred ecccCceeEEEEEeec-CcEEEEEEecCCC---chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEeecCCCCh
Q 003254 525 LGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSL 600 (836)
Q Consensus 525 lG~G~fG~Vykg~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 600 (836)
||.|++|.||+++... ++.+|+|.+.... ....+.+.+|+.+++.++||||+++++.+.++...++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 6999999999999865 8899999986543 23456789999999999999999999999999999999999999999
Q ss_pred hHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcccccccc
Q 003254 601 DYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKR 680 (836)
Q Consensus 601 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~ 680 (836)
.+++.. ...+++..+..++.||+.||+|||+.+ ++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~ 151 (262)
T cd05572 81 WTILRD---RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWT 151 (262)
T ss_pred HHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccc
Confidence 999843 345889999999999999999999988 9999999999999999999999999998764322 1223
Q ss_pred ccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccccccCCCChH
Q 003254 681 VVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDNSCSFS 760 (836)
Q Consensus 681 ~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 760 (836)
..++..|+|||.+.+..++.++|+||||+++|||++|+.|+.....+ ... ...... ........+..
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~-~~~~~~--------~~~~~~~~~~~ 218 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED----PME-IYNDIL--------KGNGKLEFPNY 218 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC----HHH-HHHHHh--------ccCCCCCCCcc
Confidence 46788999999998888999999999999999999999997543321 000 001100 00001111222
Q ss_pred HHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 003254 761 EALRCIQVGLLCVQQRPEDRPN-----MSSVVL 788 (836)
Q Consensus 761 ~~~~l~~li~~Cl~~dP~~RPt-----~~eVl~ 788 (836)
....+.+++.+||+.+|++||+ +.|+++
T Consensus 219 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 219 IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred cCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 2456889999999999999999 666654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.3e-32 Score=289.17 Aligned_cols=242 Identities=24% Similarity=0.326 Sum_probs=186.1
Q ss_pred eecccCceeEEEEEeec-CcEEEEEEecCCC---chhHHHHHHHHHHHHh---hcCCceeeEEeEEeeCCeeeEEEeecC
Q 003254 524 KLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAK---LQHRNLVKLLGCCTQRDERMLIYEYLP 596 (836)
Q Consensus 524 ~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~---l~H~niv~l~g~~~~~~~~~lV~Ey~~ 596 (836)
.||+|+||.||++...+ ++.+|+|.+.... ......+.+|..++.. .+|||++.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 48999999999999754 8899999886542 1222334555544444 369999999999999999999999999
Q ss_pred CCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcccc
Q 003254 597 NKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEA 676 (836)
Q Consensus 597 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~~ 676 (836)
+++|.+++.. .+.+++..+..++.|++.||+|||+.+ |+|+||||+|||+++++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--- 151 (279)
T cd05633 81 GGDLHYHLSQ---HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (279)
T ss_pred CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence 9999988843 346899999999999999999999998 9999999999999999999999999987653221
Q ss_pred ccccccccccccCcccccC-CccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccccccC
Q 003254 677 NTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDN 755 (836)
Q Consensus 677 ~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 755 (836)
.....|+..|+|||.+.+ ..++.++|||||||+++||++|+.||........... ... ... . ..
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~----~~~-~~~-----~----~~ 216 (279)
T cd05633 152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----DRM-TLT-----V----NV 216 (279)
T ss_pred -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHH----HHH-hhc-----C----Cc
Confidence 122468999999999864 5689999999999999999999999754332211100 000 000 0 01
Q ss_pred CCChHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 003254 756 SCSFSEALRCIQVGLLCVQQRPEDRP-----NMSSVVLM 789 (836)
Q Consensus 756 ~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~eVl~~ 789 (836)
..+......+.+++.+||+.+|++|| +++|+++.
T Consensus 217 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 217 ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 11222335678999999999999999 69999885
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-32 Score=294.03 Aligned_cols=257 Identities=26% Similarity=0.358 Sum_probs=202.0
Q ss_pred HHhhcccccccCeecccCceeEEEEEeecCcEEEEEEecC--CCchhHHHHHHHHHHHHhhc-CCceeeEEeEEeeCCee
Q 003254 512 IANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSK--GSGQGMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQRDER 588 (836)
Q Consensus 512 l~~a~~~f~~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~--~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~ 588 (836)
+......|++.++||.||.+.|||+.-.+.+.+|+|++.. .+.+...-|.+|+..|.+++ |.+||+|++|-..++.+
T Consensus 356 i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~l 435 (677)
T KOG0596|consen 356 IKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYL 435 (677)
T ss_pred EEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceE
Confidence 3445567899999999999999999987888899887643 35667788999999999996 99999999999999999
Q ss_pred eEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccc
Q 003254 589 MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (836)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~ 668 (836)
||||||= .-+|..+|.+.. .....| .+..+..|++.|+.++|+++ |||.||||.|+|+- .|.+||.|||+|..
T Consensus 436 YmvmE~G-d~DL~kiL~k~~-~~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~a 508 (677)
T KOG0596|consen 436 YMVMECG-DIDLNKILKKKK-SIDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIANA 508 (677)
T ss_pred EEEeecc-cccHHHHHHhcc-CCCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhcc
Confidence 9999984 458888885433 233445 77788999999999999999 99999999999985 46899999999998
Q ss_pred cCCCccccccccccccccccCcccccCC-----------ccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhH
Q 003254 669 FGLDQTEANTKRVVGTYGYMSPEYAIDG-----------LFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAW 737 (836)
Q Consensus 669 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~ 737 (836)
+..+.........+||+.||+||.+... +.+.++||||+|||||+|+-|+.||+.... .++.
T Consensus 509 I~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n-------~~aK 581 (677)
T KOG0596|consen 509 IQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN-------QIAK 581 (677)
T ss_pred cCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH-------HHHH
Confidence 8777666666678999999999998532 256789999999999999999999752111 1111
Q ss_pred HhhhccCchhhccccccCCCC-hHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 738 RLWIEERPLELIDQSLDNSCS-FSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 738 ~~~~~~~~~~~~d~~l~~~~~-~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
...+.|+.-.-+++ ......+++++..||+.||.+||+..|+|+.
T Consensus 582 -------l~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 582 -------LHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred -------HHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 11222221111111 1112238999999999999999999999863
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.9e-32 Score=293.36 Aligned_cols=264 Identities=24% Similarity=0.340 Sum_probs=195.4
Q ss_pred hhcccccccCeecccCceeEEEEEeec-CcEEEEEEecCCC--chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCC----
Q 003254 514 NATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD---- 586 (836)
Q Consensus 514 ~a~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~---- 586 (836)
...++|++.+.||+|+||.||+|+... |+.||+|+++... ......+.+|+.++++++|||++++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 456789999999999999999999864 8899999986543 233456788999999999999999999987655
Q ss_pred ------eeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCcee
Q 003254 587 ------ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKI 660 (836)
Q Consensus 587 ------~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl 660 (836)
..++|+||+++ ++...+.. ....+++..+..++.||+.||+|||+.+ |+|+||||+||++++++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLES--GLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence 78999999987 56566532 2346899999999999999999999998 999999999999999999999
Q ss_pred eccCcccccCCCccccccccccccccccCcccccCC-ccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHh
Q 003254 661 SDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRL 739 (836)
Q Consensus 661 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~ 739 (836)
+|||++........ .......++..|+|||.+.+. .++.++|||||||+++||++|++|+....... ........
T Consensus 158 ~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~---~~~~~~~~ 233 (302)
T cd07864 158 ADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELA---QLELISRL 233 (302)
T ss_pred CcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHH
Confidence 99999987643322 111223457789999988654 57899999999999999999998875322111 00001110
Q ss_pred hhccCch---hh--------cc------ccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 740 WIEERPL---EL--------ID------QSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 740 ~~~~~~~---~~--------~d------~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
.....+. .+ .+ ........ .....+.+++.+||+.+|++||++.+|++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 234 CGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFS-FIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred hCCCChhhcccccccccccccccccccccchhhhcC-CCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0000000 00 00 00000000 11345789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.2e-32 Score=292.72 Aligned_cols=243 Identities=23% Similarity=0.353 Sum_probs=194.9
Q ss_pred CeecccCceeEEEEEee-cCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEeecCCCChh
Q 003254 523 NKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLD 601 (836)
Q Consensus 523 ~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~ 601 (836)
.+||+|+||.||++... +++.||||++........+.+.+|+.+++.++|+|++++++++...+..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 47999999999999885 58899999987655556677899999999999999999999999999999999999999998
Q ss_pred HHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCccccccccc
Q 003254 602 YFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRV 681 (836)
Q Consensus 602 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~~ 681 (836)
+++. ...+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++........ .....
T Consensus 106 ~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~~ 176 (292)
T cd06657 106 DIVT----HTRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSL 176 (292)
T ss_pred HHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc--ccccc
Confidence 8773 235789999999999999999999988 99999999999999999999999999876543221 12235
Q ss_pred cccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccccccCCCChHH
Q 003254 682 VGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDNSCSFSE 761 (836)
Q Consensus 682 ~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 761 (836)
.++..|+|||.+.+..++.++||||||++++||++|+.|+....... . ........+ +.+.. ....
T Consensus 177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~---~----~~~~~~~~~-----~~~~~--~~~~ 242 (292)
T cd06657 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK---A----MKMIRDNLP-----PKLKN--LHKV 242 (292)
T ss_pred ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---H----HHHHHhhCC-----cccCC--cccC
Confidence 67889999999988889999999999999999999999965322110 0 011111101 00100 0112
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 762 ALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 762 ~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
...+.+++.+||+.+|.+||++.+|++
T Consensus 243 ~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 243 SPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred CHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 235678999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-32 Score=288.83 Aligned_cols=247 Identities=25% Similarity=0.362 Sum_probs=196.0
Q ss_pred ecccCceeEEEEEeec-CcEEEEEEecCCCc---hhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEeecCCCCh
Q 003254 525 LGEGGFGPVYKGMLIE-GQEIAVKRLSKGSG---QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSL 600 (836)
Q Consensus 525 lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 600 (836)
||+|+||.||+++... |+.+++|.+..... ...+.+.+|++++++++|+||+++++.+......++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999875 89999999865533 4556789999999999999999999999999999999999999999
Q ss_pred hHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcc------
Q 003254 601 DYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT------ 674 (836)
Q Consensus 601 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~------ 674 (836)
.+++... ..+++..+..++.||++||+|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~---~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLENV---GSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 9988542 36899999999999999999999988 99999999999999999999999999876533211
Q ss_pred ccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhcccccc
Q 003254 675 EANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLD 754 (836)
Q Consensus 675 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 754 (836)
........++..|+|||...+...+.++||||||++++||++|+.|+....... . ......... .
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~---~----~~~~~~~~~--------~ 219 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE---I----FQNILNGKI--------E 219 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH---H----HHHHhcCCc--------C
Confidence 112223567889999999988889999999999999999999999975322110 0 000100000 0
Q ss_pred CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcC
Q 003254 755 NSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 792 (836)
Q Consensus 755 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~ 792 (836)
..........+.+++.+|++.+|++|||+.+|.+.|+.
T Consensus 220 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 220 WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred CCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 00000013567899999999999999999777777764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.8e-32 Score=298.87 Aligned_cols=267 Identities=19% Similarity=0.318 Sum_probs=197.4
Q ss_pred cccccccCeecccCceeEEEEEeec-CcEEEEEEecCCC--chhHHHHHHHHHHHHhhcCCceeeEEeEEee----CCee
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQ----RDER 588 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~ 588 (836)
.++|+..+.||+|+||.||+|+... |+.||+|++.... ....+.+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 3788999999999999999999764 8999999987542 2345677889999999999999999988753 3468
Q ss_pred eEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccc
Q 003254 589 MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (836)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~ 668 (836)
++||||+. ++|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||++..
T Consensus 84 ~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 84 YVVMDLME-SDLHHIIH---SDQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEEehhh-hhHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence 99999996 58888773 3345899999999999999999999988 99999999999999999999999999987
Q ss_pred cCCCcccc--ccccccccccccCcccccC-CccCccccccchhhhhhhhhhCCCCCCCCCCccccchhh--------hhH
Q 003254 669 FGLDQTEA--NTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLG--------HAW 737 (836)
Q Consensus 669 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~--------~~~ 737 (836)
........ ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||............. ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~ 236 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL 236 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence 54322211 1123578889999999865 468999999999999999999999975332211000000 000
Q ss_pred HhhhccCchhhccccc-cCCCC-----hHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 738 RLWIEERPLELIDQSL-DNSCS-----FSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 738 ~~~~~~~~~~~~d~~l-~~~~~-----~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
.........+..+... ..... ......+.+++.+|++.+|++||++.+++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0000000011111000 00011 1124568899999999999999999998874
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=287.67 Aligned_cols=244 Identities=29% Similarity=0.376 Sum_probs=190.9
Q ss_pred ecccCceeEEEEEee-cCcEEEEEEecCCC---chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEeecCCCCh
Q 003254 525 LGEGGFGPVYKGMLI-EGQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSL 600 (836)
Q Consensus 525 lG~G~fG~Vykg~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 600 (836)
||+|+||+||++... +|+.+|+|.+.... ....+.+.+|+++++.++|||++++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999875 48899999986532 22345677899999999999999999999999999999999999999
Q ss_pred hHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcccccccc
Q 003254 601 DYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKR 680 (836)
Q Consensus 601 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~ 680 (836)
.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++...... .....
T Consensus 81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~---~~~~~ 153 (277)
T cd05577 81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG---KKIKG 153 (277)
T ss_pred HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccC---Ccccc
Confidence 998864332 46889999999999999999999998 999999999999999999999999998765321 11223
Q ss_pred ccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccccccCCCChH
Q 003254 681 VVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDNSCSFS 760 (836)
Q Consensus 681 ~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 760 (836)
..++..|+|||.+.++.++.++||||||+++++|++|+.|+............. .... ... ...+..
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~~~~-~~~---------~~~~~~ 220 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELK---RRTL-EMA---------VEYPDK 220 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHH---hccc-ccc---------ccCCcc
Confidence 457889999999988889999999999999999999999975432211110000 0000 000 011112
Q ss_pred HHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 003254 761 EALRCIQVGLLCVQQRPEDRP-----NMSSVVL 788 (836)
Q Consensus 761 ~~~~l~~li~~Cl~~dP~~RP-----t~~eVl~ 788 (836)
....+.+++.+||+.+|++|| ++.+++.
T Consensus 221 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 221 FSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred CCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 234577999999999999999 6666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=282.86 Aligned_cols=247 Identities=28% Similarity=0.437 Sum_probs=200.1
Q ss_pred cccccCeecccCceeEEEEEeec-CcEEEEEEecCCCc--hhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEee
Q 003254 518 NFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSG--QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (836)
Q Consensus 518 ~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 594 (836)
+|+..+.||+|++|.||+++... ++.|++|.+..... ...+.+.+|++++++++|+|++++++++...+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 46778899999999999998764 78999999876643 4567899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcc
Q 003254 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (836)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~ 674 (836)
+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 81 AENGSLRQIIKK---FGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCCcHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 999999998843 357899999999999999999999988 99999999999999999999999999987643222
Q ss_pred ccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhcccccc
Q 003254 675 EANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLD 754 (836)
Q Consensus 675 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 754 (836)
. .....++..|+|||...+..++.++|||++|+++++|++|+.|+..... ....+.. .....
T Consensus 155 ~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~------~~~~~~~-~~~~~--------- 216 (254)
T cd06627 155 D--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP------MAALFRI-VQDDH--------- 216 (254)
T ss_pred c--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHH-hccCC---------
Confidence 1 2235678899999999888889999999999999999999998653211 0001110 00000
Q ss_pred CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 755 NSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 755 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
...+......+.+++.+||+.+|++||++.+++.
T Consensus 217 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 217 PPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 0111122345779999999999999999999974
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.9e-32 Score=299.99 Aligned_cols=268 Identities=23% Similarity=0.330 Sum_probs=197.5
Q ss_pred cccccccCeecccCceeEEEEEeec-CcEEEEEEecCC--CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeC-----Ce
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR-----DE 587 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~ 587 (836)
.++|...+.||+|+||.||+++... ++.||||.+... .......+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 4578889999999999999999754 889999998653 233455678899999999999999999988654 34
Q ss_pred eeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCccc
Q 003254 588 RMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667 (836)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~ 667 (836)
.++|+||+. ++|.+++. ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.
T Consensus 84 ~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIR---SSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 799999996 67877774 2356899999999999999999999988 9999999999999999999999999998
Q ss_pred ccCCCccccccccccccccccCcccccC-CccCccccccchhhhhhhhhhCCCCCCCCCCccccchhh--------hhHH
Q 003254 668 SFGLDQTEANTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLG--------HAWR 738 (836)
Q Consensus 668 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~--------~~~~ 738 (836)
...... .......++..|+|||.+.+ ..++.++||||||+++++|++|+.|+............. ..+.
T Consensus 157 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (337)
T cd07858 157 TTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLG 234 (337)
T ss_pred ccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhh
Confidence 754321 11223467889999998865 468999999999999999999999975332110000000 0000
Q ss_pred hhhccCchhhcc-------ccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hcCC
Q 003254 739 LWIEERPLELID-------QSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM--LSGE 793 (836)
Q Consensus 739 ~~~~~~~~~~~d-------~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~--L~~~ 793 (836)
........+.+. .... .........+.+++.+||+.+|++|||+.|+++. ++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 235 FIRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred hcCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 000000000000 0000 0011223557899999999999999999999987 6554
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.8e-32 Score=290.82 Aligned_cols=259 Identities=24% Similarity=0.354 Sum_probs=196.9
Q ss_pred ccccCeecccCceeEEEEEee-cCcEEEEEEecCCCc--hhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEeec
Q 003254 519 FSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSG--QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (836)
Q Consensus 519 f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 595 (836)
|+..+.||+|++|.||++... +++.+++|++..... .....+.+|+.++++++|+||+++++++......++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 456788999999999999985 488899999865532 24567889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCccc
Q 003254 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE 675 (836)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 675 (836)
++ +|.+++... ...+++..+..++.+|++||.|||+.+ |+|+||||+||++++++.+||+|||.+........
T Consensus 81 ~~-~l~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~- 153 (283)
T cd05118 81 DT-DLYKLIKDR--QRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR- 153 (283)
T ss_pred CC-CHHHHHHhh--cccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc-
Confidence 86 777777442 257899999999999999999999998 99999999999999999999999999987654331
Q ss_pred cccccccccccccCcccccCC-ccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCc---hhhcc-
Q 003254 676 ANTKRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERP---LELID- 750 (836)
Q Consensus 676 ~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~d- 750 (836)
......++..|+|||.+.+. .++.++||||||+++++|++|+.|+......+. .....+....... ....+
T Consensus 154 -~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd05118 154 -PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ---LFKIFRTLGTPDPEVWPKFTSL 229 (283)
T ss_pred -cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCchHhcccchhh
Confidence 11224577889999998876 789999999999999999999988753322111 1000010000000 00000
Q ss_pred --c---cc---c----CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 751 --Q---SL---D----NSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 751 --~---~l---~----~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
. .. . ..........+.+++..||+.+|.+||++++++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0 00 0 0011123456889999999999999999999985
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.3e-32 Score=299.59 Aligned_cols=267 Identities=22% Similarity=0.335 Sum_probs=196.7
Q ss_pred hcccccccCeecccCceeEEEEEeec-CcEEEEEEecCC--CchhHHHHHHHHHHHHhh-cCCceeeEEeEEeeC--Cee
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG--SGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQR--DER 588 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~--~~~ 588 (836)
..++|+..+.||+|+||.||+|.... ++.+|+|++... .......+..|+.+++++ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 45788889999999999999999864 788999988543 233445678899999999 999999999998653 358
Q ss_pred eEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccc
Q 003254 589 MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (836)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~ 668 (836)
++||||++ ++|..++.. ..+++..+..++.||+.||+|||+.+ |+|+||||+||++++++.+||+|||++..
T Consensus 85 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 85 YLVFEYME-TDLHAVIRA----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEEecccc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 99999997 488877732 26889999999999999999999988 99999999999999999999999999987
Q ss_pred cCCCccc---cccccccccccccCcccccC-CccCccccccchhhhhhhhhhCCCCCCCCCCccccchh--------hhh
Q 003254 669 FGLDQTE---ANTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLL--------GHA 736 (836)
Q Consensus 669 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~--------~~~ 736 (836)
+...... .......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+............ ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED 236 (337)
T ss_pred cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 6433221 12233568899999998865 45789999999999999999999987532221100000 000
Q ss_pred HHhhhccCchhhccccccC-C-----CChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 737 WRLWIEERPLELIDQSLDN-S-----CSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 737 ~~~~~~~~~~~~~d~~l~~-~-----~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
+..+.......+++..... . ........+.+++.+|++.+|++|||+.++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0000000011111100000 0 001123467899999999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=282.67 Aligned_cols=251 Identities=23% Similarity=0.338 Sum_probs=203.3
Q ss_pred cccccCeecccCceeEEEEEee-cCcEEEEEEecCCCc--hhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEee
Q 003254 518 NFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSG--QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (836)
Q Consensus 518 ~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 594 (836)
+|+..+.||.|+||.||++... +++.+++|++..... ...+++.+|+++++.++|+|++++++.+......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4777889999999999999986 488999999876533 4567789999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcc-CCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCc
Q 003254 595 LPNKSLDYFIFDTT-RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (836)
Q Consensus 595 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~ 673 (836)
+++++|.+++.... ....+++..+..++.+++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999886532 2367899999999999999999999998 9999999999999999999999999998764432
Q ss_pred cccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccccc
Q 003254 674 TEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSL 753 (836)
Q Consensus 674 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 753 (836)
.......+++.|+|||.+.+..++.++||||+|+++++|++|+.|+...... . ..........
T Consensus 158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~---~----~~~~~~~~~~-------- 220 (258)
T cd08215 158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL---E----LALKILKGQY-------- 220 (258)
T ss_pred --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH---H----HHHHHhcCCC--------
Confidence 1223356888999999999888999999999999999999999986432211 0 1111111111
Q ss_pred cCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 754 DNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 754 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
...+......+.+++.+||+.+|++|||+.|+++.
T Consensus 221 -~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 221 -PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred -CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 01111233567899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.8e-32 Score=285.03 Aligned_cols=249 Identities=27% Similarity=0.364 Sum_probs=201.5
Q ss_pred cccccCeecccCceeEEEEEee-cCcEEEEEEecCCC--chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEee
Q 003254 518 NFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (836)
Q Consensus 518 ~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 594 (836)
+|+..++||+|+||.||+++.. +++.+++|.+.... .....++.+|+.++++++|+||+++++++......++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4777889999999999999865 47899999986542 33456788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcc-CCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCc
Q 003254 595 LPNKSLDYFIFDTT-RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (836)
Q Consensus 595 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~ 673 (836)
+++++|..++.+.. ....+++..+..++.+++.||+|||+.+ ++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 99999999886532 2356889999999999999999999988 999999999999999999999999999876433
Q ss_pred cccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccccc
Q 003254 674 TEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSL 753 (836)
Q Consensus 674 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 753 (836)
......++..|+|||.+.+..++.++|+||||++++||++|+.|+...... .. ........
T Consensus 157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~---~~----~~~~~~~~--------- 217 (256)
T cd08530 157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ---DL----RYKVQRGK--------- 217 (256)
T ss_pred ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HH----HHHHhcCC---------
Confidence 122245788999999999999999999999999999999999997532211 00 00111110
Q ss_pred cCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 754 DNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 754 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
....+......+.+++.+|++.+|++||++.|+++.
T Consensus 218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 218 YPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred CCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 111222344568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=284.44 Aligned_cols=250 Identities=25% Similarity=0.363 Sum_probs=195.2
Q ss_pred ccccccCeecccCceeEEEEEeec-CcEEEEEEecCC-----CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeC--Cee
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG-----SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR--DER 588 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~-----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~ 588 (836)
.+|...+.||+|+||.||+|+... ++.||+|.+... .....+.+.+|++++++++|+||+++++++... ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 468888999999999999999754 889999987532 223456788999999999999999999998664 457
Q ss_pred eEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccc
Q 003254 589 MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (836)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~ 668 (836)
++|+||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ ++|+||||+||++++++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA---YGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence 899999999999998843 345788999999999999999999998 99999999999999999999999999986
Q ss_pred cCCCcc-ccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchh
Q 003254 669 FGLDQT-EANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLE 747 (836)
Q Consensus 669 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (836)
...... ........++..|+|||.+.+..++.++||||||++++||++|+.|+...... ..........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~---- 225 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM------AAIFKIATQP---- 225 (264)
T ss_pred cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH------HHHHHHHcCC----
Confidence 532111 11122356889999999999888999999999999999999999997532111 0011111000
Q ss_pred hccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 748 LIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 748 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
.....+......+.+++.+|++ +|..||+..+++.
T Consensus 226 -----~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 226 -----TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred -----CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 0111222233557899999999 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-32 Score=314.28 Aligned_cols=200 Identities=23% Similarity=0.366 Sum_probs=158.3
Q ss_pred hcccccccCeecccCceeEEEEEeec--CcEEEEE------------------EecCCCchhHHHHHHHHHHHHhhcCCc
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLIE--GQEIAVK------------------RLSKGSGQGMEEFKNEVLLIAKLQHRN 574 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~~--g~~vavK------------------~l~~~~~~~~~~~~~Ei~~l~~l~H~n 574 (836)
..++|++.++||+|+||.||++.... +...++| .+. ........+.+|+.++++++|+|
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence 45789999999999999999987643 2222222 111 12233456889999999999999
Q ss_pred eeeEEeEEeeCCeeeEEEeecCCCChhHHHhhccC--CCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEe
Q 003254 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTR--SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLL 652 (836)
Q Consensus 575 iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl 652 (836)
|+++++++...+..++|+|++.. +|..++..... ........+..++.||+.||+|||+.+ |+||||||+|||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 99999999999999999999865 56566543211 122335567789999999999999998 9999999999999
Q ss_pred cCCCCceeeccCcccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCC
Q 003254 653 DNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKN 720 (836)
Q Consensus 653 ~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p 720 (836)
+.++.+||+|||+++.+..... .......||..|+|||++.+..++.++|||||||+||||++|..+
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~ 367 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFC 367 (501)
T ss_pred CCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 9999999999999987643222 112235789999999999999999999999999999999998754
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-32 Score=288.63 Aligned_cols=257 Identities=20% Similarity=0.278 Sum_probs=190.2
Q ss_pred ccccCeecccCceeEEEEEee-cCcEEEEEEecCCC-chhHHHHHHHHHHHHhhc-CCceeeEEeEEeeC--CeeeEEEe
Q 003254 519 FSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQR--DERMLIYE 593 (836)
Q Consensus 519 f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~--~~~~lV~E 593 (836)
|+..++||+|+||.||+|+.. +++.||+|+++... .........|+.++.++. |+|++++++++.+. +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 556788999999999999975 48899999987542 222334557888898885 99999999999887 88999999
Q ss_pred ecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCc
Q 003254 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (836)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~ 673 (836)
|+++ +|.+.+... ...+++..+..++.|++.||+|||+.+ ++||||||+||++++ +.+||+|||+++......
T Consensus 81 ~~~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 81 LMDM-NLYELIKGR--KRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred cCCc-cHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 9974 777776432 346899999999999999999999998 999999999999999 999999999998764322
Q ss_pred cccccccccccccccCccccc-CCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHh-----------hh
Q 003254 674 TEANTKRVVGTYGYMSPEYAI-DGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRL-----------WI 741 (836)
Q Consensus 674 ~~~~~~~~~gt~~y~aPE~~~-~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~-----------~~ 741 (836)
. .....++..|+|||.+. ++.++.++|||||||++|||++|+.|+......+ ........ ..
T Consensus 154 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 227 (282)
T cd07831 154 P---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD---QIAKIHDVLGTPDAEVLKKFR 227 (282)
T ss_pred C---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH---HHHHHHHHcCCCCHHHHHhhc
Confidence 1 12245788999999765 4567899999999999999999999875432211 11111000 00
Q ss_pred ccCchhhccccccC----CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 742 EERPLELIDQSLDN----SCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 742 ~~~~~~~~d~~l~~----~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
.........+.... .........+.+++.+||+.+|++||++.++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 228 KSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred ccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 00000000000000 001123467889999999999999999999986
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-32 Score=291.04 Aligned_cols=261 Identities=25% Similarity=0.341 Sum_probs=192.9
Q ss_pred ccccccCeecccCceeEEEEEee-cCcEEEEEEecCCC--chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEe
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 593 (836)
++|+..+.||+|++|.||+|+.. +|+.||+|++.... ....+.+.+|++++++++|+||+++++++......++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 56888899999999999999986 48899999986543 2334678899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecC-CCCceeeccCcccccCCC
Q 003254 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-TMNPKISDFGLARSFGLD 672 (836)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~-~~~~kl~DFgla~~~~~~ 672 (836)
|+++ +|..++... ....+++..+..++.||+.||+|||+.+ ++|+||+|+||++++ ++.+||+|||++......
T Consensus 82 ~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLDL-DLKKHMDSS-PDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred cccc-cHHHHHHhC-CCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 9964 777766432 2234577888899999999999999988 999999999999985 567999999999765432
Q ss_pred ccccccccccccccccCcccccCC-ccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhc--
Q 003254 673 QTEANTKRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELI-- 749 (836)
Q Consensus 673 ~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 749 (836)
.. ......+++.|+|||++.+. .++.++||||||+++|+|++|+.|+......+. ........... .....
T Consensus 157 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~---~~~~~~~~~~~-~~~~~~~ 230 (294)
T PLN00009 157 VR--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDE---LFKIFRILGTP-NEETWPG 230 (294)
T ss_pred cc--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCC-Chhhccc
Confidence 11 11224568899999988764 578999999999999999999999754322110 00000000000 00000
Q ss_pred -----c-----ccccC----CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 750 -----D-----QSLDN----SCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 750 -----d-----~~l~~----~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
+ +.... .........+.+++.+|++.+|++||++.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 231 VTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred cccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 00000 001112344789999999999999999999986
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=284.42 Aligned_cols=244 Identities=25% Similarity=0.289 Sum_probs=188.0
Q ss_pred CeecccCceeEEEEEeec-CcEEEEEEecCCCc---hhHHHHHHHHHHH-HhhcCCceeeEEeEEeeCCeeeEEEeecCC
Q 003254 523 NKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSG---QGMEEFKNEVLLI-AKLQHRNLVKLLGCCTQRDERMLIYEYLPN 597 (836)
Q Consensus 523 ~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~---~~~~~~~~Ei~~l-~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 597 (836)
+.||+|+||.||+|+... ++.||+|.+..... .....+..|..++ ...+|+|++++++++...+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 469999999999999854 88999999865432 2223344555444 445899999999999999999999999999
Q ss_pred CChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCccccc
Q 003254 598 KSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEAN 677 (836)
Q Consensus 598 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~ 677 (836)
++|..++.. ...+++..+..++.||+.||.|||+.+ ++|+||+|+||++++++.+||+|||++.....
T Consensus 82 ~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------ 149 (260)
T cd05611 82 GDCASLIKT---LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------ 149 (260)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------
Confidence 999998843 346889999999999999999999988 99999999999999999999999999876432
Q ss_pred cccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccccccCCC
Q 003254 678 TKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDNSC 757 (836)
Q Consensus 678 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 757 (836)
.....++..|+|||.+.+..++.++||||||++++||++|..|+...... . ........... .....
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~----~~~~~~~~~~~------~~~~~ 216 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD---A----VFDNILSRRIN------WPEEV 216 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH---H----HHHHHHhcccC------CCCcc
Confidence 22346788999999998888999999999999999999999997532211 0 11111111000 00011
Q ss_pred ChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 003254 758 SFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLS 791 (836)
Q Consensus 758 ~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~ 791 (836)
.......+.+++.+||+.+|++||++.++.+.|+
T Consensus 217 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 217 KEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred cccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 1122355789999999999999998877766654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=282.66 Aligned_cols=245 Identities=22% Similarity=0.257 Sum_probs=186.9
Q ss_pred hhcccccccCee--cccCceeEEEEEeec-CcEEEEEEecCCCchhHHHHHHHHHHHHhh-cCCceeeEEeEEeeCCeee
Q 003254 514 NATDNFSEKNKL--GEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDERM 589 (836)
Q Consensus 514 ~a~~~f~~~~~l--G~G~fG~Vykg~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~ 589 (836)
...++|++.+.+ |+|+||.||++.... ++.+|+|.+........ |+.....+ +|+|++++++.+...+..+
T Consensus 11 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~ 85 (267)
T PHA03390 11 QFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHV 85 (267)
T ss_pred HHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeE
Confidence 334566666666 999999999999754 78899999865422111 22222222 6999999999999999999
Q ss_pred EEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCC-CceeeccCcccc
Q 003254 590 LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTM-NPKISDFGLARS 668 (836)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~-~~kl~DFgla~~ 668 (836)
+||||+++++|.+++.. ...+++.++..++.||++||.|||+.+ ++||||||+||+++.++ .++|+|||++..
T Consensus 86 iv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~ 159 (267)
T PHA03390 86 LIMDYIKDGDLFDLLKK---EGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKI 159 (267)
T ss_pred EEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCcccee
Confidence 99999999999999843 237899999999999999999999998 99999999999999988 999999999876
Q ss_pred cCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhh
Q 003254 669 FGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLEL 748 (836)
Q Consensus 669 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (836)
.... ....++..|+|||++.+..++.++||||||++++||++|+.|+....... ....... ... ....
T Consensus 160 ~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~-~~~--~~~~-- 227 (267)
T PHA03390 160 IGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLL-KRQ--QKKL-- 227 (267)
T ss_pred cCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHH-Hhh--cccC--
Confidence 5322 12457889999999999899999999999999999999999976322211 1111110 000 0000
Q ss_pred ccccccCCCChHHHHHHHHHHHHcccCCCCCCCC-HHHHHH
Q 003254 749 IDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPN-MSSVVL 788 (836)
Q Consensus 749 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-~~eVl~ 788 (836)
.........+.+++.+||+.+|.+||+ ++|+++
T Consensus 228 -------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 228 -------PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred -------CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 011123345789999999999999996 688874
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=289.45 Aligned_cols=261 Identities=18% Similarity=0.210 Sum_probs=182.9
Q ss_pred hcccccccCeecccCceeEEEEEeecC----cEEEEEEecCCCchhH-----------HHHHHHHHHHHhhcCCceeeEE
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLIEG----QEIAVKRLSKGSGQGM-----------EEFKNEVLLIAKLQHRNLVKLL 579 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~~g----~~vavK~l~~~~~~~~-----------~~~~~Ei~~l~~l~H~niv~l~ 579 (836)
..++|.+.++||+|+||.||+|...++ ..+|+|.......... .....+...+..++|+|+++++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 346899999999999999999997553 4566665432221111 1122333445566899999999
Q ss_pred eEEeeCC----eeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCC
Q 003254 580 GCCTQRD----ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNT 655 (836)
Q Consensus 580 g~~~~~~----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~ 655 (836)
+++.... ..++++|++.. ++.+.+.. ....++..+..++.|+++||+|||+.+ |+||||||+|||++.+
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~ 162 (294)
T PHA02882 90 GCGSFKRCRMYYRFILLEKLVE-NTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGN 162 (294)
T ss_pred EeeeEecCCceEEEEEEehhcc-CHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCC
Confidence 9876544 34677777644 45444422 223567888999999999999999988 9999999999999999
Q ss_pred CCceeeccCcccccCCCccc-----cccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCcccc
Q 003254 656 MNPKISDFGLARSFGLDQTE-----ANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDH 730 (836)
Q Consensus 656 ~~~kl~DFgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~ 730 (836)
+.++|+|||+++.+...... .......||+.|+|||.+.+..++.++|||||||+|+||++|+.|+.......
T Consensus 163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~-- 240 (294)
T PHA02882 163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG-- 240 (294)
T ss_pred CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch--
Confidence 99999999999876422111 11223469999999999999999999999999999999999999986432211
Q ss_pred chhhhhHHhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 003254 731 NLLGHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLS 791 (836)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~ 791 (836)
.........+... +....+. .......+.+++..|++.+|++||++.++++.|+
T Consensus 241 ~~~~~~~~~~~~~----~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 241 NLIHAAKCDFIKR----LHEGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHHHhHHHHHHH----hhhhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 1111111111100 0000000 0112356789999999999999999999999874
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=286.72 Aligned_cols=263 Identities=25% Similarity=0.316 Sum_probs=193.8
Q ss_pred ccccCeecccCceeEEEEEeec-CcEEEEEEecCCCc-hhHHHHHHHHHHHHhhc-CCceeeEEeEEeeCCeeeEEEeec
Q 003254 519 FSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSG-QGMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQRDERMLIYEYL 595 (836)
Q Consensus 519 f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~ 595 (836)
|++.+.||+|++|.||+|+..+ ++.|+||++..... .......+|+..+.+++ |+|++++++++...+..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 5667899999999999999865 78899999865432 22334567999999999 999999999999999999999999
Q ss_pred CCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCccc
Q 003254 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE 675 (836)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 675 (836)
+++|.+++.... ...+++..+..++.|++.+|.|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~- 154 (283)
T cd07830 81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP- 154 (283)
T ss_pred -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC-
Confidence 788888875432 346899999999999999999999988 99999999999999999999999999986542211
Q ss_pred cccccccccccccCcccccC-CccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhh-----hHHhhhccC-chhh
Q 003254 676 ANTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGH-----AWRLWIEER-PLEL 748 (836)
Q Consensus 676 ~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~-----~~~~~~~~~-~~~~ 748 (836)
.....++..|+|||.+.. ..++.++||||||++++||++|+.|+.............. ....+.+.. ....
T Consensus 155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07830 155 --YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK 232 (283)
T ss_pred --cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence 223467889999998854 4579999999999999999999988754322111000000 000000000 0000
Q ss_pred ccccccC-------CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 749 IDQSLDN-------SCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 749 ~d~~l~~-------~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
.+..+.. .........+.+++.+|++.+|++|||+.|++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0000000 0001113568899999999999999999999763
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=288.08 Aligned_cols=251 Identities=22% Similarity=0.362 Sum_probs=192.5
Q ss_pred ccccccCeecccCceeEEEEEeec-CcEEEEEEecCCC-chhHHHHHHHHHHHHhhc-CCceeeEEeEEeeCCeeeEEEe
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQRDERMLIYE 593 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~E 593 (836)
++|+..+.||+|+||.||+|+... ++.||||++.... .....++..|+.++.+.. |+||+++++++......++|||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 678888999999999999999876 8899999987543 234456777887777775 9999999999999999999999
Q ss_pred ecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcC-CCCcEEeccCCCCceEecCCCCceeeccCcccccCCC
Q 003254 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (836)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~ 672 (836)
|+++ +|..++... ...+++..+..++.+|++||+|||+. + |+||||+|+||++++++.+||+|||++..+...
T Consensus 95 ~~~~-~l~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 95 LMST-CLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred ccCc-CHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 9864 676666432 24789999999999999999999974 5 999999999999999999999999998765432
Q ss_pred ccccccccccccccccCcccccCCc----cCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhh
Q 003254 673 QTEANTKRVVGTYGYMSPEYAIDGL----FSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLEL 748 (836)
Q Consensus 673 ~~~~~~~~~~gt~~y~aPE~~~~~~----~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (836)
.. .....++..|+|||.+.+.. ++.++||||||+++|||++|+.|+...... ...... .........
T Consensus 169 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~-~~~~~~~~~ 239 (296)
T cd06618 169 KA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-----FEVLTK-ILQEEPPSL 239 (296)
T ss_pred Cc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-----HHHHHH-HhcCCCCCC
Confidence 21 12235778999999987553 889999999999999999999997432111 000111 111111000
Q ss_pred ccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 749 IDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 749 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
. ........+.+++.+||+.+|++||++.++++.
T Consensus 240 ~-------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 240 P-------PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred C-------CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 000123457899999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=292.56 Aligned_cols=260 Identities=23% Similarity=0.286 Sum_probs=190.9
Q ss_pred Ceeccc--CceeEEEEEee-cCcEEEEEEecCCC--chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEeecCC
Q 003254 523 NKLGEG--GFGPVYKGMLI-EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPN 597 (836)
Q Consensus 523 ~~lG~G--~fG~Vykg~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 597 (836)
..||+| +||+||++++. .|+.||+|++.... ....+.+.+|+.+++.++||||+++++++..++..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 357777 89999999985 58999999986542 23457789999999999999999999999999999999999999
Q ss_pred CChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcccc-
Q 003254 598 KSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEA- 676 (836)
Q Consensus 598 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~~- 676 (836)
++|.+++.... ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 84 GSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 99999885432 235888999999999999999999988 9999999999999999999999998654432111110
Q ss_pred ----ccccccccccccCcccccCC--ccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhh--------------
Q 003254 677 ----NTKRVVGTYGYMSPEYAIDG--LFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHA-------------- 736 (836)
Q Consensus 677 ----~~~~~~gt~~y~aPE~~~~~--~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~-------------- 736 (836)
......++..|+|||++.+. .++.++||||||++++||++|+.|+........ .....
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 237 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM--LLQKLKGPPYSPLDITTFP 237 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH--HHHHhcCCCCCCccccccc
Confidence 01112345679999999764 478999999999999999999999754321100 00000
Q ss_pred --HHhhhc----------------cCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 737 --WRLWIE----------------ERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 737 --~~~~~~----------------~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
...... .....+.+..+...........+.+++.+||+.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 238 CEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred hhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 000000 0000111111111222334456889999999999999999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-32 Score=295.03 Aligned_cols=248 Identities=25% Similarity=0.363 Sum_probs=204.8
Q ss_pred hhcccccccCeecccCceeEEEEEeec-CcEEEEEEecCCCc--hhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeE
Q 003254 514 NATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSG--QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (836)
Q Consensus 514 ~a~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 590 (836)
.....|.+.++||+|.|++|..+++.. +.+||+|.+++... ...+.+.+|+++|..++|||||+++.+.+....+++
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 345678888999999999999999865 99999999987643 334568999999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccC
Q 003254 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (836)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~ 670 (836)
||||+.+|.+.+++.... .+....+..++.|+..|++|||+++ |+|||||++||||+.+.++||+|||++..+.
T Consensus 133 V~eya~~ge~~~yl~~~g---r~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVKHG---RMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred EEEeccCchhHHHHHhcc---cchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeec
Confidence 999999999999996543 3556888899999999999999999 9999999999999999999999999998875
Q ss_pred CCccccccccccccccccCcccccCCcc-CccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhc
Q 003254 671 LDQTEANTKRVVGTYGYMSPEYAIDGLF-SVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELI 749 (836)
Q Consensus 671 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (836)
. .......+|++.|.|||++.+..| .+++|+||+|++||-|++|..||+...-. ++-
T Consensus 207 ~---~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk-------------------~Lr 264 (596)
T KOG0586|consen 207 Y---GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK-------------------ELR 264 (596)
T ss_pred c---cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccc-------------------ccc
Confidence 2 233455899999999999998876 57899999999999999999997532211 111
Q ss_pred cccccC--CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 750 DQSLDN--SCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 750 d~~l~~--~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
++.+.+ ..+.....++-++++++|-.+|.+|+++.++.+.
T Consensus 265 ~rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 265 PRVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred chheeeeecccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 111111 1222223346689999999999999999998753
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=290.74 Aligned_cols=249 Identities=28% Similarity=0.380 Sum_probs=194.0
Q ss_pred ccccccCeecccCceeEEEEEeec-CcEEEEEEecCC---CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEE
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 592 (836)
+.|+..+.||+|+||.||+|+... ++.+|+|.+... .....+++.+|+++++.++|+|++++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 446777889999999999999754 788999998643 2234567889999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCC
Q 003254 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (836)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~ 672 (836)
||+. |+|.+.+.. ....+++..+..++.+++.||.|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 95 e~~~-~~l~~~~~~--~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 95 EYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred EccC-CCHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 9997 577666643 2345889999999999999999999988 999999999999999999999999998765321
Q ss_pred ccccccccccccccccCccccc---CCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhc
Q 003254 673 QTEANTKRVVGTYGYMSPEYAI---DGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELI 749 (836)
Q Consensus 673 ~~~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (836)
....++..|+|||.+. .+.++.++|||||||+++||++|+.|+....... .. .........
T Consensus 169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~----~~~~~~~~~--- 232 (308)
T cd06634 169 ------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS---AL----YHIAQNESP--- 232 (308)
T ss_pred ------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH---HH----HHHhhcCCC---
Confidence 2346788999999974 3567889999999999999999998864321110 00 000000000
Q ss_pred cccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcC
Q 003254 750 DQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 792 (836)
Q Consensus 750 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~ 792 (836)
. .........+.+++.+||+.+|++||++.+|++..--
T Consensus 233 --~---~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~ 270 (308)
T cd06634 233 --A---LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 270 (308)
T ss_pred --C---cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccc
Confidence 0 0111233457789999999999999999999976443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=287.23 Aligned_cols=256 Identities=24% Similarity=0.316 Sum_probs=198.6
Q ss_pred cccccCeecccCceeEEEEEee----cCcEEEEEEecCCC----chhHHHHHHHHHHHHhh-cCCceeeEEeEEeeCCee
Q 003254 518 NFSEKNKLGEGGFGPVYKGMLI----EGQEIAVKRLSKGS----GQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDER 588 (836)
Q Consensus 518 ~f~~~~~lG~G~fG~Vykg~~~----~g~~vavK~l~~~~----~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~ 588 (836)
+|+..+.||+|++|.||+++.. +++.||||.+.+.. ....+.+.+|+.++.++ +|+||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 3677789999999999999853 46789999986432 23345688999999999 599999999999999999
Q ss_pred eEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccc
Q 003254 589 MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (836)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~ 668 (836)
++||||+++++|..++.. ...+++..+..++.|+++||.|||+.+ ++|+||||+||++++++.++|+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence 999999999999988843 346889999999999999999999988 99999999999999999999999999887
Q ss_pred cCCCccccccccccccccccCcccccCCc--cCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCch
Q 003254 669 FGLDQTEANTKRVVGTYGYMSPEYAIDGL--FSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPL 746 (836)
Q Consensus 669 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (836)
+...... ......++..|+|||.+.+.. .+.++||||||++++||++|+.|+....... ........ .....
T Consensus 155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~~~~-~~~~~-- 228 (288)
T cd05583 155 FLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN--SQSEISRR-ILKSK-- 228 (288)
T ss_pred ccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc--hHHHHHHH-HHccC--
Confidence 5433221 122346788999999987665 7889999999999999999999975322111 00111101 00000
Q ss_pred hhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 003254 747 ELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 793 (836)
Q Consensus 747 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 793 (836)
...+......+.+++.+||+.+|++|||+.+|.+.|+-.
T Consensus 229 --------~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 229 --------PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred --------CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 011111224567899999999999999999998888764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=289.94 Aligned_cols=260 Identities=20% Similarity=0.228 Sum_probs=190.0
Q ss_pred CeecccCceeEEEEEeecCcEEEEEEecCC--CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEeecCCCCh
Q 003254 523 NKLGEGGFGPVYKGMLIEGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSL 600 (836)
Q Consensus 523 ~~lG~G~fG~Vykg~~~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 600 (836)
+.+|.|+++.||++.. +++.||||++... .....+.+.+|+.+++.++|+||+++++++.+.+..+++|||+++++|
T Consensus 8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86 (314)
T ss_pred HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence 3455556666666655 6899999998754 344567899999999999999999999999999999999999999999
Q ss_pred hHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcc-----c
Q 003254 601 DYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT-----E 675 (836)
Q Consensus 601 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~-----~ 675 (836)
.+++.... ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||.+..+..... .
T Consensus 87 ~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~ 162 (314)
T cd08216 87 EDLLKTHF-PEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH 162 (314)
T ss_pred HHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccccc
Confidence 99986432 345788899999999999999999998 99999999999999999999999999876532111 1
Q ss_pred cccccccccccccCcccccCC--ccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHH---hhhccC------
Q 003254 676 ANTKRVVGTYGYMSPEYAIDG--LFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWR---LWIEER------ 744 (836)
Q Consensus 676 ~~~~~~~gt~~y~aPE~~~~~--~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~---~~~~~~------ 744 (836)
.......++..|+|||++... .++.++|||||||+++||++|+.||....... ........ ......
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 240 (314)
T cd08216 163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPCLLDKSTYPLYE 240 (314)
T ss_pred cccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCccccccCchhhhc
Confidence 111234567789999998763 58899999999999999999999976432111 00000000 000000
Q ss_pred --chh----hccccc----cCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 745 --PLE----LIDQSL----DNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 745 --~~~----~~d~~l----~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
... ..++.. ...........+.+++.+||+.+|++|||+.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred CCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 000 000000 001111223467899999999999999999999863
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=283.63 Aligned_cols=242 Identities=25% Similarity=0.337 Sum_probs=186.0
Q ss_pred eecccCceeEEEEEeec-CcEEEEEEecCCCc---hhHHHHHHHHHHH---HhhcCCceeeEEeEEeeCCeeeEEEeecC
Q 003254 524 KLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSG---QGMEEFKNEVLLI---AKLQHRNLVKLLGCCTQRDERMLIYEYLP 596 (836)
Q Consensus 524 ~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~---~~~~~~~~Ei~~l---~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 596 (836)
.||+|+||.||++.... ++.||+|.+.+... .....+..|..++ +...||||+++++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 48999999999998754 88999999865421 2222344454443 34579999999999999999999999999
Q ss_pred CCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcccc
Q 003254 597 NKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEA 676 (836)
Q Consensus 597 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~~ 676 (836)
+++|..++. +...+++..+..++.|+++||.|||+.+ |+||||||+||++++++.+||+|||++..+....
T Consensus 81 g~~L~~~l~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--- 151 (278)
T cd05606 81 GGDLHYHLS---QHGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (278)
T ss_pred CCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC---
Confidence 999998884 3456999999999999999999999988 9999999999999999999999999987653221
Q ss_pred ccccccccccccCcccccCC-ccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccccccC
Q 003254 677 NTKRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDN 755 (836)
Q Consensus 677 ~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 755 (836)
.....|+..|+|||.+.++ .++.++||||+|++++||++|+.|+........... ..... . ...
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~----~~~~~-~-----~~~---- 216 (278)
T cd05606 152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----DRMTL-T-----MAV---- 216 (278)
T ss_pred -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH----HHHhh-c-----cCC----
Confidence 1234689999999998754 689999999999999999999999754322211110 00000 0 000
Q ss_pred CCChHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 003254 756 SCSFSEALRCIQVGLLCVQQRPEDRP-----NMSSVVLM 789 (836)
Q Consensus 756 ~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~eVl~~ 789 (836)
..+......+.+++.+|++.+|++|| ++.++++.
T Consensus 217 ~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 217 ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 11111234678999999999999999 99999853
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=314.57 Aligned_cols=261 Identities=29% Similarity=0.382 Sum_probs=204.6
Q ss_pred hcccccccCeecccCceeEEEEEeec--------CcEEEEEEecCCCc-hhHHHHHHHHHHHHhh-cCCceeeEEeEEee
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLIE--------GQEIAVKRLSKGSG-QGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQ 584 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~~--------g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~ 584 (836)
..++....+.||+|.||.|++|.... ...||||.++.... ...+.+..|+++|+.+ +|+|++.++|+|..
T Consensus 294 ~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~ 373 (609)
T KOG0200|consen 294 PRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ 373 (609)
T ss_pred chhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc
Confidence 33445556699999999999998542 34699999976543 4567899999999999 59999999999999
Q ss_pred CCeeeEEEeecCCCChhHHHhhcc------C-----C--CcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceE
Q 003254 585 RDERMLIYEYLPNKSLDYFIFDTT------R-----S--KLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVL 651 (836)
Q Consensus 585 ~~~~~lV~Ey~~~gsL~~~l~~~~------~-----~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NIL 651 (836)
.+..++|.||+..|+|..++.+.. . . ..++..+.+.++.|||.||+||++.. ++||||.++|||
T Consensus 374 ~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVL 450 (609)
T KOG0200|consen 374 DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVL 450 (609)
T ss_pred CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEE
Confidence 999999999999999999997654 0 0 23888999999999999999999987 999999999999
Q ss_pred ecCCCCceeeccCcccccCCCcccccc-ccccccccccCcccccCCccCccccccchhhhhhhhhhC-CCCCCCCCCccc
Q 003254 652 LDNTMNPKISDFGLARSFGLDQTEANT-KRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICG-KKNRGFNHADHD 729 (836)
Q Consensus 652 l~~~~~~kl~DFgla~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG-~~p~~~~~~~~~ 729 (836)
+.++..+||+|||+|+........... ....-+..|||||.+....|+.|+|||||||+||||+|. ..|+......
T Consensus 451 i~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~-- 528 (609)
T KOG0200|consen 451 ITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT-- 528 (609)
T ss_pred ecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH--
Confidence 999999999999999976443332211 111135679999999999999999999999999999994 4553220000
Q ss_pred cchhhhhHHhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 003254 730 HNLLGHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 793 (836)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 793 (836)
....+ .+.+..+...+..+..++.++++.||+.+|++||++.|+++.++..
T Consensus 529 ----~~l~~---------~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 529 ----EELLE---------FLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred ----HHHHH---------HHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 00111 1122222233444566788999999999999999999999999884
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=297.30 Aligned_cols=262 Identities=22% Similarity=0.321 Sum_probs=194.4
Q ss_pred cccccccCeecccCceeEEEEEee-cCcEEEEEEecCCC--chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCC------
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD------ 586 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------ 586 (836)
.++|...+.||+|+||.||+|+.. +|+.||||++.... ......+.+|+.+++.++|+||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 478999999999999999999975 58999999986542 233456889999999999999999999986543
Q ss_pred eeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcc
Q 003254 587 ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLA 666 (836)
Q Consensus 587 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla 666 (836)
..++|+||+.. +|..++ ...+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||++
T Consensus 94 ~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 46899999974 665554 235889999999999999999999988 999999999999999999999999998
Q ss_pred cccCCCccccccccccccccccCcccccC-CccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCc
Q 003254 667 RSFGLDQTEANTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERP 745 (836)
Q Consensus 667 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (836)
+..... .....++..|+|||.+.+ ..++.++|||||||+++||++|+.||....... ......... ....
T Consensus 165 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~---~~~~~~~~~-~~~~ 235 (342)
T cd07879 165 RHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD---QLTQILKVT-GVPG 235 (342)
T ss_pred cCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhc-CCCC
Confidence 764221 123467889999999876 468999999999999999999999986432110 000000000 0000
Q ss_pred hhh------------ccc---cccCCC---ChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hcCCCC
Q 003254 746 LEL------------IDQ---SLDNSC---SFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM--LSGERS 795 (836)
Q Consensus 746 ~~~------------~d~---~l~~~~---~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~--L~~~~~ 795 (836)
.++ +.. ...... .......+.+++.+||+.+|++||++.|++.. +++.+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 236 PEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred HHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 000 000 000000 00122457899999999999999999999954 666544
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-32 Score=273.37 Aligned_cols=284 Identities=22% Similarity=0.275 Sum_probs=202.3
Q ss_pred ccccccCeecccCceeEEEEEeec-----CcEEEEEEecCCCc--hhHHHHHHHHHHHHhhcCCceeeEEeEEee-CCee
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-----GQEIAVKRLSKGSG--QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQ-RDER 588 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-----g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~~ 588 (836)
..|+....||+|.||.|||+.-.+ .+.+|+|+++.... .......+|+.+++.++|||++.+..++.+ +...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 567888899999999999996533 23689999875532 123456789999999999999999999877 7789
Q ss_pred eEEEeecCCCChhHHHhhc--cCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCC----CCceeec
Q 003254 589 MLIYEYLPNKSLDYFIFDT--TRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNT----MNPKISD 662 (836)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~----~~~kl~D 662 (836)
+|++||.+. +|...|+.. .+.+.++...+..|+.||+.|+.|||++- |+||||||.||||..+ |.|||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeec
Confidence 999999988 565665532 23356888899999999999999999987 9999999999999876 9999999
Q ss_pred cCcccccCCCcc-ccccccccccccccCcccccCC-ccCccccccchhhhhhhhhhCCCCCCCCCCcccc---chhhhhH
Q 003254 663 FGLARSFGLDQT-EANTKRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDH---NLLGHAW 737 (836)
Q Consensus 663 Fgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~---~~~~~~~ 737 (836)
||+++.+...-. .......+-|..|+|||.+.+. .||.+.|||+.|||+.||++-.+-|......... .-.+...
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~ 259 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD 259 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence 999999865433 2244557789999999999986 5899999999999999999988776533222111 1111111
Q ss_pred Hhh-hccCchhhccccccC--------------CC-C--hH--------HHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 003254 738 RLW-IEERPLELIDQSLDN--------------SC-S--FS--------EALRCIQVGLLCVQQRPEDRPNMSSVVLMLS 791 (836)
Q Consensus 738 ~~~-~~~~~~~~~d~~l~~--------------~~-~--~~--------~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~ 791 (836)
+.+ .-+.+.+..-+.++. .. + .. ......+|...+|+.||-+|.|+++.++..=
T Consensus 260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~y 339 (438)
T KOG0666|consen 260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPY 339 (438)
T ss_pred HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccc
Confidence 111 001111111111100 00 0 00 0012578999999999999999999876431
Q ss_pred CCCCCCCCCCCCcc
Q 003254 792 GERSLPQPQQPGFF 805 (836)
Q Consensus 792 ~~~~~~~p~~p~~~ 805 (836)
-...+.||+|..-
T Consensus 340 -F~~d~lpp~pt~~ 352 (438)
T KOG0666|consen 340 -FTEDPLPPLPTSD 352 (438)
T ss_pred -cccCCCCCCcccc
Confidence 1233455555543
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-31 Score=282.41 Aligned_cols=259 Identities=22% Similarity=0.329 Sum_probs=192.5
Q ss_pred ccccCeecccCceeEEEEEeec-CcEEEEEEecCCCc--hhHHHHHHHHHHHHhh---cCCceeeEEeEEeeCCe-----
Q 003254 519 FSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSG--QGMEEFKNEVLLIAKL---QHRNLVKLLGCCTQRDE----- 587 (836)
Q Consensus 519 f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~~~~~----- 587 (836)
|++.+.||+|+||.||+|+... ++.+|+|++..... .....+.+|+.++.++ +|+|++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 5667899999999999999875 89999999874422 2234566788877766 59999999999988776
Q ss_pred eeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCccc
Q 003254 588 RMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667 (836)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~ 667 (836)
.+++|||+++ +|.+++.... ...+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||++.
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhccc-CHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 8999999975 7888775432 235899999999999999999999988 9999999999999999999999999998
Q ss_pred ccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCc--
Q 003254 668 SFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERP-- 745 (836)
Q Consensus 668 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~-- 745 (836)
.+..... .....++..|+|||.+.+..++.++||||||++++||++|++|+......+ ..............
T Consensus 156 ~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~ 229 (287)
T cd07838 156 IYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD---QLDKIFDVIGLPSEEE 229 (287)
T ss_pred eccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH---HHHHHHHHcCCCChHh
Confidence 7643321 122357889999999999999999999999999999999988865322111 11111000000000
Q ss_pred --------hhhccccccC---CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 746 --------LELIDQSLDN---SCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 746 --------~~~~d~~l~~---~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
.......... .........+.+++.+||+.+|++||++.|++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred cCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0000000000 001122355779999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-32 Score=320.92 Aligned_cols=255 Identities=25% Similarity=0.354 Sum_probs=200.6
Q ss_pred hhcccccccCeecccCceeEEEEEeec-CcEEEEEEecCC--CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeE
Q 003254 514 NATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (836)
Q Consensus 514 ~a~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 590 (836)
+.+-++....+||.|.||.||.+...+ |.-.|||-+... .......+.+|..++..++|||+|+++|+-.+.+..+|
T Consensus 1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence 344566677899999999999999765 788899977544 33455678899999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccC
Q 003254 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (836)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~ 670 (836)
.||||++|+|.+++.+ +...++.....+..|++.|++|||+++ ||||||||.||+|+.+|.+|++|||.|..+.
T Consensus 1312 FMEyC~~GsLa~ll~~---gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~ 1385 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEH---GRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIK 1385 (1509)
T ss_pred HHHHhccCcHHHHHHh---cchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEec
Confidence 9999999999999944 334566667778899999999999999 9999999999999999999999999999886
Q ss_pred CCcc--ccccccccccccccCcccccCCc---cCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCc
Q 003254 671 LDQT--EANTKRVVGTYGYMSPEYAIDGL---FSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERP 745 (836)
Q Consensus 671 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~---~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (836)
.... ....+...||+.|||||++.+.. ...++||||+|||++||+||++|......+... . + .+..++.
T Consensus 1386 ~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aI--M-y---~V~~gh~ 1459 (1509)
T KOG4645|consen 1386 NNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAI--M-Y---HVAAGHK 1459 (1509)
T ss_pred CchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHH--H-h---HHhccCC
Confidence 5421 12234578999999999997644 567899999999999999999996432222110 0 0 0111111
Q ss_pred hhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 746 LELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 746 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
++.+......-.+++.+||+.||++|-++.|+++.
T Consensus 1460 ---------Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1460 ---------PQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred ---------CCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 12233334456789999999999999888887765
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-31 Score=287.58 Aligned_cols=244 Identities=27% Similarity=0.410 Sum_probs=190.0
Q ss_pred ccccCeecccCceeEEEEEee-cCcEEEEEEecCCC---chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEee
Q 003254 519 FSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (836)
Q Consensus 519 f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 594 (836)
|...++||+|+||.||+|+.. .++.|++|++.... ....+.+.+|+.+++.++|||++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 555678999999999999975 48899999986542 23345788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcc
Q 003254 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (836)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~ 674 (836)
+.+ +|.+++.. ...++++..+..++.||+.||.|||+.+ ++|+||+|+||++++++.+||+|||++.....
T Consensus 103 ~~~-~l~~~l~~--~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--- 173 (313)
T cd06633 103 CLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP--- 173 (313)
T ss_pred CCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence 964 66666632 2346899999999999999999999988 99999999999999999999999999864321
Q ss_pred ccccccccccccccCccccc---CCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccc
Q 003254 675 EANTKRVVGTYGYMSPEYAI---DGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQ 751 (836)
Q Consensus 675 ~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 751 (836)
.....++..|+|||++. .+.++.++||||||++++||++|+.|+...... .......... .....
T Consensus 174 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~------~~~~~~~~~~-~~~~~-- 241 (313)
T cd06633 174 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQND-SPTLQ-- 241 (313)
T ss_pred ---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHHhcC-CCCCC--
Confidence 12356788999999984 456889999999999999999999986432211 0001100001 10000
Q ss_pred cccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 752 SLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 752 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
.......+.+++.+||+.+|++||++.+++..
T Consensus 242 ------~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 242 ------SNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred ------ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11112347789999999999999999999854
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=288.88 Aligned_cols=263 Identities=24% Similarity=0.330 Sum_probs=191.6
Q ss_pred cccccccCeecccCceeEEEEEeec-CcEEEEEEecCCCc--hhHHHHHHHHHHHHhhcCCceeeEEeEEeeCC------
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSG--QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD------ 586 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------ 586 (836)
.++|+..++||+|+||.||+|+... ++.+|+|++..... .....+.+|+++++.++|+||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 4789999999999999999999754 88999999865432 22346788999999999999999999875443
Q ss_pred --eeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccC
Q 003254 587 --ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFG 664 (836)
Q Consensus 587 --~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFg 664 (836)
..++|+||+.. +|...+.. ....+++..+..++.|+++||+|||+.+ |+|+||||+||++++++.+||+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence 36999999976 56555532 2346899999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCcccc---------ccccccccccccCcccccCC-ccCccccccchhhhhhhhhhCCCCCCCCCCccccchhh
Q 003254 665 LARSFGLDQTEA---------NTKRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLG 734 (836)
Q Consensus 665 la~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~ 734 (836)
+++......... ......+++.|+|||.+.+. .++.++||||||++++||++|++|+........ ..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~---~~ 237 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQ---LH 237 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHH---HH
Confidence 998654322111 11223567889999988654 589999999999999999999998753222110 00
Q ss_pred hhHHhhhccCc---------hhhc--------cccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 735 HAWRLWIEERP---------LELI--------DQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 735 ~~~~~~~~~~~---------~~~~--------d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
........... .... .+.+... .......+.+++.+|++.+|++|||+.|++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 238 LIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEER-FGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHH-cccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 00000000000 0000 0000000 0011245789999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=284.87 Aligned_cols=251 Identities=23% Similarity=0.310 Sum_probs=193.8
Q ss_pred cccccCeecccCceeEEEEEee----cCcEEEEEEecCCC----chhHHHHHHHHHHHHhh-cCCceeeEEeEEeeCCee
Q 003254 518 NFSEKNKLGEGGFGPVYKGMLI----EGQEIAVKRLSKGS----GQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDER 588 (836)
Q Consensus 518 ~f~~~~~lG~G~fG~Vykg~~~----~g~~vavK~l~~~~----~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~ 588 (836)
+|+..+.||+|+||.||++... +|+.||+|++.... ....+++.+|+.++.++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4677889999999999999863 58899999986532 22346788999999999 599999999999999999
Q ss_pred eEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccc
Q 003254 589 MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (836)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~ 668 (836)
++||||+++++|.+++.. ...+++..+..++.|+++||.|||+.+ ++||||+|+|||+++++.+||+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 999999999999998853 346888999999999999999999988 99999999999999999999999999987
Q ss_pred cCCCccccccccccccccccCcccccCC--ccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCch
Q 003254 669 FGLDQTEANTKRVVGTYGYMSPEYAIDG--LFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPL 746 (836)
Q Consensus 669 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (836)
...... .......|+..|+|||.+.+. .++.++||||||+++|+|++|+.|+....... .............
T Consensus 155 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~--~~~~~~~~~~~~~--- 228 (290)
T cd05613 155 FHEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN--SQAEISRRILKSE--- 228 (290)
T ss_pred cccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc--cHHHHHHHhhccC---
Confidence 543221 112235688899999998753 46889999999999999999999975322111 1111111100000
Q ss_pred hhccccccCCCChHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 003254 747 ELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRP-----NMSSVVL 788 (836)
Q Consensus 747 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~eVl~ 788 (836)
...+......+.+++.+|++.+|++|| ++.+++.
T Consensus 229 --------~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 229 --------PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred --------CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 011112234567899999999999997 6666655
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=290.48 Aligned_cols=264 Identities=23% Similarity=0.338 Sum_probs=196.3
Q ss_pred HhhcccccccCeecccCceeEEEEEee-cCcEEEEEEecCCC--chhHHHHHHHHHHHHhhcCCceeeEEeEEee-CCee
Q 003254 513 ANATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQ-RDER 588 (836)
Q Consensus 513 ~~a~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~~ 588 (836)
...+++|+..+.||.|+||.||++... +++.||+|++.+.. ....+.+.+|+.++.+++||||+++.+++.. ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 346788999999999999999999875 58999999886432 2345678899999999999999999999865 5578
Q ss_pred eEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccc
Q 003254 589 MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (836)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~ 668 (836)
++|+||+ +++|..++. ..++++..+..++.|+++||+|||+.+ |+|+||+|+||++++++.+||+|||++..
T Consensus 86 ~lv~e~~-~~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 86 YFVTELL-GTDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred EEEeehh-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccc
Confidence 8999998 458877763 345788888899999999999999998 99999999999999999999999999875
Q ss_pred cCCCccccccccccccccccCcccccC-CccCccccccchhhhhhhhhhCCCCCCCCCCccccch--------hhhhHHh
Q 003254 669 FGLDQTEANTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNL--------LGHAWRL 739 (836)
Q Consensus 669 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~--------~~~~~~~ 739 (836)
... ......++..|+|||.+.+ ..++.++||||||++++||++|+.|+........... .....+.
T Consensus 158 ~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd07856 158 QDP-----QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT 232 (328)
T ss_pred cCC-----CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 422 1122456889999998866 5689999999999999999999998753322110000 0000000
Q ss_pred hhccCchhhcccc-ccCCCCh-----HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 740 WIEERPLELIDQS-LDNSCSF-----SEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 740 ~~~~~~~~~~d~~-l~~~~~~-----~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
.......+++... .....+. .....+.+++.+|++.+|++||++.+++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 1111111111100 0011111 123567899999999999999999998765
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=292.31 Aligned_cols=262 Identities=21% Similarity=0.284 Sum_probs=192.8
Q ss_pred ccccc-cCeecccCceeEEEEEee-cCcEEEEEEecCCCchh--------------HHHHHHHHHHHHhhcCCceeeEEe
Q 003254 517 DNFSE-KNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQG--------------MEEFKNEVLLIAKLQHRNLVKLLG 580 (836)
Q Consensus 517 ~~f~~-~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~~~~--------------~~~~~~Ei~~l~~l~H~niv~l~g 580 (836)
++|.. .+.||.|+||.||+|... .++.||||.+....... ...+.+|+++++.++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 45553 467999999999999975 48999999986542211 124778999999999999999999
Q ss_pred EEeeCCeeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCcee
Q 003254 581 CCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKI 660 (836)
Q Consensus 581 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl 660 (836)
++...+..++||||++ ++|.+++.. ...+++.....++.|++.||.|||+.+ ++|+||+|+||+++.++.+||
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDR---KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEE
Confidence 9999999999999997 588888743 345889999999999999999999988 999999999999999999999
Q ss_pred eccCcccccCCCc------------cccccccccccccccCcccccCC-ccCccccccchhhhhhhhhhCCCCCCCCCCc
Q 003254 661 SDFGLARSFGLDQ------------TEANTKRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIICGKKNRGFNHAD 727 (836)
Q Consensus 661 ~DFgla~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~GvvL~elltG~~p~~~~~~~ 727 (836)
+|||++....... .........++..|+|||.+.+. .++.++||||||++++||++|+.|+......
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~ 240 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI 240 (335)
T ss_pred CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999998764111 01111123467889999998765 4689999999999999999999987543321
Q ss_pred cccchhhhhHHhhhccCch-----------hhccccccC---CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 728 HDHNLLGHAWRLWIEERPL-----------ELIDQSLDN---SCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 728 ~~~~~~~~~~~~~~~~~~~-----------~~~d~~l~~---~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
+ ............... ......... .........+.+++.+||+.+|++||++.|++.
T Consensus 241 ~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 241 D---QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred H---HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 1 111111100000000 000000000 000112345789999999999999999999986
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=286.68 Aligned_cols=249 Identities=27% Similarity=0.362 Sum_probs=200.2
Q ss_pred ccccccCeecccCceeEEEEEee-cCcEEEEEEecCC---CchhHHHHHHHHHHHHhhc-CCceeeEEeEEeeCCeeeEE
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQRDERMLI 591 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV 591 (836)
++|...+.||+|+||.||+++.. +++.||+|++... .....+.+.+|+.++++++ |+||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46888899999999999999986 5899999998653 2234567889999999998 99999999999999999999
Q ss_pred EeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCC
Q 003254 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (836)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~ 671 (836)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~---~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRK---YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 999999999999853 346999999999999999999999988 99999999999999999999999999987643
Q ss_pred Cccc------------------cccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchh
Q 003254 672 DQTE------------------ANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLL 733 (836)
Q Consensus 672 ~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~ 733 (836)
.... .......++..|+|||.+.+..++.++||||||++++++++|+.|+...... ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~- 230 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY---LT- 230 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH---HH-
Confidence 2211 1122346788999999999888999999999999999999999997532210 00
Q ss_pred hhhHHhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCH----HHHHH
Q 003254 734 GHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNM----SSVVL 788 (836)
Q Consensus 734 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~----~eVl~ 788 (836)
...... .....+......+.+++.+||+.+|++||++ +++++
T Consensus 231 ---~~~~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 231 ---FQKILK----------LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred ---HHHHHh----------cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 000000 0011112224557899999999999999999 77764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-32 Score=285.24 Aligned_cols=244 Identities=27% Similarity=0.373 Sum_probs=198.2
Q ss_pred cccccccCeecccCceeEEEEEeec-CcEEEEEEecCC---CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEE
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 591 (836)
.+.|...++||+|+||.||-.+... |+.+|.|++.+. ..++..-.++|-.|+.+++.+.||.+-..++..+.++||
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 3567888999999999999988765 999999988654 234455678999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCC
Q 003254 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (836)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~ 671 (836)
+..|.+|+|..+|..... .-+++..+.-++.+|+-||++||... ||.|||||+|||||+.|+++|+|+|+|..+..
T Consensus 264 LtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred EEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 999999999999876543 56899999999999999999999998 99999999999999999999999999998754
Q ss_pred CccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccc
Q 003254 672 DQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQ 751 (836)
Q Consensus 672 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 751 (836)
.+.. ...+||.+|||||++.++.|+...|-||+||+||||+.|+.||....... ..+-+|.
T Consensus 340 g~~~---~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKv----------------k~eEvdr 400 (591)
T KOG0986|consen 340 GKPI---RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKV----------------KREEVDR 400 (591)
T ss_pred CCcc---ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhh----------------hHHHHHH
Confidence 4332 22489999999999999999999999999999999999999975322211 1111222
Q ss_pred ccc---CCCChHHHHHHHHHHHHcccCCCCCCCC
Q 003254 752 SLD---NSCSFSEALRCIQVGLLCVQQRPEDRPN 782 (836)
Q Consensus 752 ~l~---~~~~~~~~~~l~~li~~Cl~~dP~~RPt 782 (836)
+.. ..++..-..++.++....|+.||++|-.
T Consensus 401 r~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLG 434 (591)
T KOG0986|consen 401 RTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLG 434 (591)
T ss_pred HHhcchhhcccccCHHHHHHHHHHHccCHHHhcc
Confidence 111 1222223345667888888999999954
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-32 Score=272.14 Aligned_cols=256 Identities=22% Similarity=0.294 Sum_probs=195.6
Q ss_pred CeecccCceeEEEEE-eecCcEEEEEEecCCCchhHHHHHHHHHHHHhhc-CCceeeEEeEEeeCCeeeEEEeecCCCCh
Q 003254 523 NKLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQRDERMLIYEYLPNKSL 600 (836)
Q Consensus 523 ~~lG~G~fG~Vykg~-~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 600 (836)
+.||+|+|+.|--.+ +..|.++|||++.+.......+..+|++++.+.+ |+||++|+++|+++...|||||-|.+|.|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 579999999998876 4569999999999988888899999999999986 99999999999999999999999999999
Q ss_pred hHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCC---CceeeccCcccccC--CCcc-
Q 003254 601 DYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTM---NPKISDFGLARSFG--LDQT- 674 (836)
Q Consensus 601 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~---~~kl~DFgla~~~~--~~~~- 674 (836)
..+|.+ .+.+++.++.++.++|+.||.+||.++ |.||||||+|||-.+-. -+||+||.+..-+. .+..
T Consensus 164 LshI~~---~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp 237 (463)
T KOG0607|consen 164 LSHIQK---RKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP 237 (463)
T ss_pred HHHHHH---hhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence 999854 456899999999999999999999999 99999999999996544 48999998875432 2222
Q ss_pred --ccccccccccccccCccccc-----CCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchh
Q 003254 675 --EANTKRVVGTYGYMSPEYAI-----DGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLE 747 (836)
Q Consensus 675 --~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (836)
....-..+|+..|||||+.. ...|+.+.|.||||||||-||+|.+||...-..+-. |.....-..--..
T Consensus 238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCG----WdrGe~Cr~CQ~~ 313 (463)
T KOG0607|consen 238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCG----WDRGEVCRVCQNK 313 (463)
T ss_pred CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCC----ccCCCccHHHHHH
Confidence 12223467889999999863 345889999999999999999999998643332211 1000000000011
Q ss_pred hccccccC--CCChHH----HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 748 LIDQSLDN--SCSFSE----ALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 748 ~~d~~l~~--~~~~~~----~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
+++.+..+ +++..+ ..+..+++...+..++.+|-++.+++.
T Consensus 314 LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 314 LFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 12222222 122222 234567888888899999999998876
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=292.74 Aligned_cols=269 Identities=23% Similarity=0.322 Sum_probs=200.7
Q ss_pred cccccCeecccCceeEEEEEeec-CcEEEEEEecCCC--chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCC-----eee
Q 003254 518 NFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD-----ERM 589 (836)
Q Consensus 518 ~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-----~~~ 589 (836)
+|.+.+.||.|++|.||+++... ++.||+|++.... ....+.+.+|+.+++.++|+||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 47778899999999999999865 8899999987653 345578899999999999999999999988775 789
Q ss_pred EEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCccccc
Q 003254 590 LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (836)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~ 669 (836)
+||||+++ +|..++.. ...+++..+..++.+|+.||+|||+.+ |+|+||||+|||+++++.++|+|||++...
T Consensus 81 lv~e~~~~-~l~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELMET-DLHKVIKS---PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchhh-hHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 99999984 78777742 347899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCccc-cccccccccccccCcccccCC-ccCccccccchhhhhhhhhhCCCCCCCCCCccccchhh--------hhHHh
Q 003254 670 GLDQTE-ANTKRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLG--------HAWRL 739 (836)
Q Consensus 670 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~--------~~~~~ 739 (836)
...... .......++..|+|||.+.+. .++.++||||||+++++|++|+.||...........+. ..+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 233 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF 233 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhh
Confidence 443210 112234678899999999887 78999999999999999999999975433211000000 00000
Q ss_pred hhccCchhhccc-cccCCC-----ChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hcCC
Q 003254 740 WIEERPLELIDQ-SLDNSC-----SFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM--LSGE 793 (836)
Q Consensus 740 ~~~~~~~~~~d~-~l~~~~-----~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~--L~~~ 793 (836)
.......+.+.. ...... .......+.+++.+||+.+|++||++.++++. +++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 295 (330)
T cd07834 234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL 295 (330)
T ss_pred ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhh
Confidence 000000000000 000000 01123457899999999999999999999974 5544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=298.05 Aligned_cols=201 Identities=29% Similarity=0.422 Sum_probs=174.6
Q ss_pred ccccCeecccCceeEEEEEee-cCcEEEEEEecCCC-chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCC------eeeE
Q 003254 519 FSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD------ERML 590 (836)
Q Consensus 519 f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------~~~l 590 (836)
+...+.||+|+||.||+|+.+ .|+.||||.++... ....+....|++++++++|+|||+++++-++.. ...+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 445678999999999999965 49999999987653 345677889999999999999999999866544 5789
Q ss_pred EEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEec--C--CCCceeeccCcc
Q 003254 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD--N--TMNPKISDFGLA 666 (836)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~--~--~~~~kl~DFgla 666 (836)
|||||.+|+|...|.+..+..-|++.+.+.+..+++.||.|||+++ |+||||||.||++- + .-.-||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 9999999999999988888888999999999999999999999998 99999999999993 3 335899999999
Q ss_pred cccCCCccccccccccccccccCcccccC-CccCccccccchhhhhhhhhhCCCCCCCCC
Q 003254 667 RSFGLDQTEANTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (836)
Q Consensus 667 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~elltG~~p~~~~~ 725 (836)
+.+..+. .....+||..|++||.... +.|+..+|.|||||++||.+||..||....
T Consensus 172 rel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~ 228 (732)
T KOG4250|consen 172 RELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFG 228 (732)
T ss_pred ccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCC
Confidence 9875333 4556899999999999995 789999999999999999999999986433
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-31 Score=291.21 Aligned_cols=265 Identities=21% Similarity=0.301 Sum_probs=193.0
Q ss_pred cccccccCeecccCceeEEEEEeec-CcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeC---------
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR--------- 585 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--------- 585 (836)
..+|...+.||.|+||.||+|.... |+.||+|++........+.+.+|++++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 3688899999999999999999754 889999998776666667889999999999999999999776543
Q ss_pred -----CeeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEec-CCCCce
Q 003254 586 -----DERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD-NTMNPK 659 (836)
Q Consensus 586 -----~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~-~~~~~k 659 (836)
...++||||++ ++|..++. ...+++..+..++.||++||.|||+.+ |+||||||+||+++ +++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLE----QGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence 35789999997 48877763 245889999999999999999999988 99999999999997 566799
Q ss_pred eeccCcccccCCCcccc-ccccccccccccCcccccC-CccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhh--
Q 003254 660 ISDFGLARSFGLDQTEA-NTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGH-- 735 (836)
Q Consensus 660 l~DFgla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~-- 735 (836)
|+|||+++.+....... ......++..|+|||.+.. ..++.++|||||||++|||++|+.||..............
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~ 235 (342)
T cd07854 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESV 235 (342)
T ss_pred ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 99999998653221111 1122357889999998754 4678899999999999999999999854322111000000
Q ss_pred ------hHHhhhccCchhhccccccCCCC-----hHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 736 ------AWRLWIEERPLELIDQSLDNSCS-----FSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 736 ------~~~~~~~~~~~~~~d~~l~~~~~-----~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
......................+ ......+.+++.+|++.+|++|||+.|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 236 PVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred CCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 00000000000000000000000 112245779999999999999999999984
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=309.87 Aligned_cols=254 Identities=26% Similarity=0.379 Sum_probs=186.2
Q ss_pred hcccccccCeecccCceeEEEEEee-cCcEEEEEEecCCC-chhHHHHHHHHHHHHhhcCCceeeEEeEEee--------
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQ-------- 584 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-------- 584 (836)
-..+|++.+.||+||||.|||++-+ ||+.||||++.... ......+.+|++.+++|+|||||+++..+.+
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 4467888999999999999999964 79999999987653 3445678899999999999999999741100
Q ss_pred ---------------------------------------------------------C----------------------
Q 003254 585 ---------------------------------------------------------R---------------------- 585 (836)
Q Consensus 585 ---------------------------------------------------------~---------------------- 585 (836)
+
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence 0
Q ss_pred --------------------------------CeeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhh
Q 003254 586 --------------------------------DERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLH 633 (836)
Q Consensus 586 --------------------------------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH 633 (836)
..+||=||||+..+|.+++....... .....++++.+|++||+|+|
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHHH
Confidence 11467789999888877774432211 36778899999999999999
Q ss_pred cCCCCcEEeccCCCCceEecCCCCceeeccCcccccC----------------CCccccccccccccccccCcccccCC-
Q 003254 634 QDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG----------------LDQTEANTKRVVGTYGYMSPEYAIDG- 696 (836)
Q Consensus 634 ~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~----------------~~~~~~~~~~~~gt~~y~aPE~~~~~- 696 (836)
+.+ ||||||||.||+||++..|||+|||+|.... ...........+||.-|+|||++.+.
T Consensus 715 ~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~ 791 (1351)
T KOG1035|consen 715 DQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS 791 (1351)
T ss_pred hCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence 999 9999999999999999999999999998721 01111123457899999999999764
Q ss_pred --ccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccccccCCCChHHHHHHHHHHHHccc
Q 003254 697 --LFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQ 774 (836)
Q Consensus 697 --~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~ 774 (836)
+|+.|+|+||+||||+||+.- |+.... . ......+......+- ..+..++...-..++.++++
T Consensus 792 ~~~Yn~KiDmYSLGIVlFEM~yP---F~TsME--R----a~iL~~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll~ 856 (1351)
T KOG1035|consen 792 SNKYNSKIDMYSLGIVLFEMLYP---FGTSME--R----ASILTNLRKGSIPEP------ADFFDPEHPEEASLIRWLLS 856 (1351)
T ss_pred cccccchhhhHHHHHHHHHHhcc---CCchHH--H----HHHHHhcccCCCCCC------cccccccchHHHHHHHHHhc
Confidence 499999999999999999763 322111 0 001111111111110 11222334445689999999
Q ss_pred CCCCCCCCHHHHHH
Q 003254 775 QRPEDRPNMSSVVL 788 (836)
Q Consensus 775 ~dP~~RPt~~eVl~ 788 (836)
.||.+|||+.|++.
T Consensus 857 hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 857 HDPSKRPTATELLN 870 (1351)
T ss_pred CCCccCCCHHHHhh
Confidence 99999999999874
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=280.42 Aligned_cols=249 Identities=27% Similarity=0.345 Sum_probs=192.7
Q ss_pred cccccCeecccCceeEEEEEeec-CcEEEEEEecCC-----CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEE
Q 003254 518 NFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG-----SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (836)
Q Consensus 518 ~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~-----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 591 (836)
+|.+.+.||+|+||.||+++... +..+++|.++.. ......++..|+.++++++||||+++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 47778899999999999998754 445556655432 122344577899999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhc-cCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccC
Q 003254 592 YEYLPNKSLDYFIFDT-TRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (836)
Q Consensus 592 ~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~ 670 (836)
|||+++++|..++... .....+++..+..++.|+++||.|||+.+ ++|+||||+||++++ +.+||+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999888643 23457899999999999999999999988 999999999999975 569999999988764
Q ss_pred CCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhcc
Q 003254 671 LDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELID 750 (836)
Q Consensus 671 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 750 (836)
.... ......++..|+|||.+.+..++.++||||||+++++|++|+.|+.... ..... .......
T Consensus 157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~------~~~~~-~~~~~~~------ 221 (260)
T cd08222 157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN------FLSVV-LRIVEGP------ 221 (260)
T ss_pred CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHH-HHHHcCC------
Confidence 3222 1223457889999999988889999999999999999999999864211 11100 1111110
Q ss_pred ccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 751 QSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 751 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
....+......+.+++.+|++.+|++||++.|+++
T Consensus 222 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 222 ---TPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred ---CCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 01112233456789999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=292.94 Aligned_cols=264 Identities=24% Similarity=0.321 Sum_probs=196.7
Q ss_pred HHHHHhhcccccccCeecccCceeEEEEEee-cCcEEEEEEecCCC--chhHHHHHHHHHHHHhhcCCceeeEEeEEeeC
Q 003254 509 LKIIANATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR 585 (836)
Q Consensus 509 ~~~l~~a~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~ 585 (836)
..++....++|...+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.++.+++|+||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 4556678899999999999999999999864 58899999987542 22346788899999999999999999988543
Q ss_pred ------CeeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCce
Q 003254 586 ------DERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPK 659 (836)
Q Consensus 586 ------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~k 659 (836)
...++++|++ +++|.+++. ...+++..+..++.||++||+|||+.+ |+||||||+||++++++.+|
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~k 160 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELK 160 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEE
Confidence 3367788876 778877763 235899999999999999999999998 99999999999999999999
Q ss_pred eeccCcccccCCCccccccccccccccccCcccccC-CccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHH
Q 003254 660 ISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWR 738 (836)
Q Consensus 660 l~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~ 738 (836)
|+|||+++.... ......++..|+|||.+.+ ..++.++||||||++++||++|+.|+....... ......+
T Consensus 161 l~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~---~~~~~~~ 232 (345)
T cd07877 161 ILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID---QLKLILR 232 (345)
T ss_pred Eecccccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHH
Confidence 999999876432 1223567889999999876 568899999999999999999999875322211 0000000
Q ss_pred hhhccCchhhc---------------cccccCCC---ChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 739 LWIEERPLELI---------------DQSLDNSC---SFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 739 ~~~~~~~~~~~---------------d~~l~~~~---~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
.. .....+.. ........ .......+.+++.+|++.+|.+||++.+++..
T Consensus 233 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 233 LV-GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred Hh-CCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 00 00000000 00000000 00123457899999999999999999998865
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=288.62 Aligned_cols=264 Identities=21% Similarity=0.311 Sum_probs=194.8
Q ss_pred HHhhcccccccCeecccCceeEEEEEee-cCcEEEEEEecCCC--chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCC--
Q 003254 512 IANATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD-- 586 (836)
Q Consensus 512 l~~a~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-- 586 (836)
+....++|+..+.||+|+||.||++... ++..||||++.... ....+.+.+|+.++++++||||+++++++....
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 3445688999999999999999999865 58899999986432 233456889999999999999999999987554
Q ss_pred ----eeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeec
Q 003254 587 ----ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISD 662 (836)
Q Consensus 587 ----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~D 662 (836)
..++||||+ +++|..++. ...+++..+..++.||++||+|||+.+ |+||||||+||++++++.+||+|
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~d 161 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMK----HEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILD 161 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEee
Confidence 358999998 678887773 246899999999999999999999988 99999999999999999999999
Q ss_pred cCcccccCCCccccccccccccccccCcccccC-CccCccccccchhhhhhhhhhCCCCCCCCCCcccc-ch-------h
Q 003254 663 FGLARSFGLDQTEANTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDH-NL-------L 733 (836)
Q Consensus 663 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~-~~-------~ 733 (836)
||++...... .....+++.|+|||.+.+ ..++.++||||||+++++|++|+.|+......... .. .
T Consensus 162 fg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 236 (343)
T cd07880 162 FGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPS 236 (343)
T ss_pred cccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 9999865321 223467889999999876 45889999999999999999999997533211000 00 0
Q ss_pred hhhHHhhhccCchhhccc--cccC----CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 734 GHAWRLWIEERPLELIDQ--SLDN----SCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 734 ~~~~~~~~~~~~~~~~d~--~l~~----~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
......+........... .... .........+.+++.+|++.+|++|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 237 KEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000000000000000 0000 000112234779999999999999999999983
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=282.77 Aligned_cols=259 Identities=26% Similarity=0.370 Sum_probs=196.2
Q ss_pred ccccCeecccCceeEEEEEeec-CcEEEEEEecCCC--chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEeec
Q 003254 519 FSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (836)
Q Consensus 519 f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 595 (836)
|+..+.||+|++|.||+|+... ++.+|+|.+.... ....+.+.+|+.++++++|+|++++++++...+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 4556789999999999999865 8999999987653 334567889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCccc
Q 003254 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE 675 (836)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 675 (836)
+ ++|.+++.... ..+++..+..++.++++||+|||+.+ |+||||+|+||++++++.+||+|||++........
T Consensus 81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 153 (282)
T cd07829 81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR- 153 (282)
T ss_pred C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence 8 58988885432 46899999999999999999999998 99999999999999999999999999987643221
Q ss_pred cccccccccccccCcccccCC-ccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCch------hh
Q 003254 676 ANTKRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPL------EL 748 (836)
Q Consensus 676 ~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------~~ 748 (836)
......++..|+|||.+.+. .++.++||||||++++||++|+.|+........ .....+........ .+
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
T cd07829 154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQ---LFKIFQILGTPTEESWPGVTKL 229 (282)
T ss_pred -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH---HHHHHHHhCCCcHHHHHhhccc
Confidence 12223457789999998776 789999999999999999999988754321110 00000000000000 00
Q ss_pred --ccccccC-------CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 749 --IDQSLDN-------SCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 749 --~d~~l~~-------~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
.+..... .........+.+++..||+.+|++||++.+|+.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 230 PDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0000000 000011346889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-31 Score=288.56 Aligned_cols=264 Identities=22% Similarity=0.257 Sum_probs=189.7
Q ss_pred cccccCeecccCceeEEEEEeec---CcEEEEEEecCCC--chhHHHHHHHHHHHHhh-cCCceeeEEeEEeeC----Ce
Q 003254 518 NFSEKNKLGEGGFGPVYKGMLIE---GQEIAVKRLSKGS--GQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQR----DE 587 (836)
Q Consensus 518 ~f~~~~~lG~G~fG~Vykg~~~~---g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~----~~ 587 (836)
+|+..+.||+|+||.||++.... +..||+|++.... ....+.+.+|+.+++++ +||||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 46778899999999999999753 6789999986532 22356788899999999 599999999975432 34
Q ss_pred eeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCccc
Q 003254 588 RMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667 (836)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~ 667 (836)
.++++||+. ++|...+. ....+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||+++
T Consensus 81 ~~~~~e~~~-~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIR---SGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 678888886 58888773 3456899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCccc--cccccccccccccCcccccC-CccCccccccchhhhhhhhhhCCCCCCCCCCccccc--------hhhhh
Q 003254 668 SFGLDQTE--ANTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHN--------LLGHA 736 (836)
Q Consensus 668 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~--------~~~~~ 736 (836)
.+...... .......|+..|+|||.+.+ ..++.++||||+|+++++|++|+.|+.......... .....
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET 233 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 76432211 11233578999999998765 468999999999999999999999875422110000 00000
Q ss_pred HHhhhccCchhhcc---cccc---CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 737 WRLWIEERPLELID---QSLD---NSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 737 ~~~~~~~~~~~~~d---~~l~---~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
.............. .... ..........+.+++.+|++.+|++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000000000 0000 0000112345789999999999999999999864
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=270.88 Aligned_cols=240 Identities=26% Similarity=0.349 Sum_probs=193.8
Q ss_pred ccccccCeecccCceeEEEEEeec-CcEEEEEEecCCC---chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEE
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 592 (836)
++|..+++||+|.||+|...+-+. ++-+|+|++++.. ......-..|-++|+..+||.+..+...+...+.+++||
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM 247 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM 247 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence 678888999999999999998755 8899999998763 344556678999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCC
Q 003254 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (836)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~ 672 (836)
||..+|.|..+| .+.+.+++....-+-..|..||.|||+++ ||.||||.+|.|||.+|++||+|||+++.-.
T Consensus 248 eyanGGeLf~HL---srer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I-- 319 (516)
T KOG0690|consen 248 EYANGGELFFHL---SRERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEI-- 319 (516)
T ss_pred EEccCceEeeeh---hhhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcc--
Confidence 999999998877 44567888888889999999999999988 9999999999999999999999999998632
Q ss_pred ccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhcccc
Q 003254 673 QTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQS 752 (836)
Q Consensus 673 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 752 (836)
.....++.++|||.|+|||++....|..++|-|.+||++|||++|+.||.....+..-.++ ... |
T Consensus 320 ~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLI-------l~e------d-- 384 (516)
T KOG0690|consen 320 KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELI-------LME------D-- 384 (516)
T ss_pred cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHH-------Hhh------h--
Confidence 2233456799999999999999999999999999999999999999997543222111100 000 0
Q ss_pred ccCCCChHHHHHHHHHHHHcccCCCCCCC
Q 003254 753 LDNSCSFSEALRCIQVGLLCVQQRPEDRP 781 (836)
Q Consensus 753 l~~~~~~~~~~~l~~li~~Cl~~dP~~RP 781 (836)
+ .++.....+...|....|..||.+|-
T Consensus 385 ~--kFPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 385 L--KFPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred c--cCCccCCHHHHHHHHHHhhcChHhhc
Confidence 0 11111123345677778899999995
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=293.53 Aligned_cols=262 Identities=23% Similarity=0.333 Sum_probs=195.0
Q ss_pred hhcccccccCeecccCceeEEEEEeec-CcEEEEEEecCC--CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCe---
Q 003254 514 NATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDE--- 587 (836)
Q Consensus 514 ~a~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~--- 587 (836)
...++|+..+.||+|++|.||+|+... ++.||+|++... .....+.+.+|+.++++++|+|++++++++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 346789999999999999999999864 788999998653 22344667889999999999999999998866554
Q ss_pred ---eeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccC
Q 003254 588 ---RMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFG 664 (836)
Q Consensus 588 ---~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFg 664 (836)
.++|+||+ +++|.+++.. ..+++..+..++.|+++||+|||+.+ |+|+||||+||++++++.+||+|||
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccc
Confidence 89999998 5688888742 46899999999999999999999988 9999999999999999999999999
Q ss_pred cccccCCCccccccccccccccccCcccccCC-ccCccccccchhhhhhhhhhCCCCCCCCCCccccchh--------hh
Q 003254 665 LARSFGLDQTEANTKRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLL--------GH 735 (836)
Q Consensus 665 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~--------~~ 735 (836)
++...... .....++..|+|||.+.+. .++.++||||||++++||++|+.|+............ ..
T Consensus 164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 238 (343)
T cd07851 164 LARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEE 238 (343)
T ss_pred cccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHH
Confidence 99865322 2234678899999998653 6789999999999999999999987532221100000 00
Q ss_pred hHHhhhccCchhhcccccc-CCCC-----hHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 736 AWRLWIEERPLELIDQSLD-NSCS-----FSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 736 ~~~~~~~~~~~~~~d~~l~-~~~~-----~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
.+..+........+..... .... ......+.+++.+|++.+|++|||+.||++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 239 LLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 0000000000000000000 0000 012356889999999999999999999975
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=308.76 Aligned_cols=145 Identities=28% Similarity=0.403 Sum_probs=130.6
Q ss_pred ccccccCeecccCceeEEEEEee-cCcEEEEEEecCCC---chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEE
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 592 (836)
++|.+.++||+|+||.||+|... .++.||||++.... ....+.+.+|+.++..++|+||+++++++......+|||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 67888999999999999999986 48899999986542 233467889999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCccc
Q 003254 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667 (836)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~ 667 (836)
||+++++|..++.. ...+++..++.++.||+.||+|||..+ |+||||||+||||+.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999843 345788999999999999999999987 9999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=271.84 Aligned_cols=236 Identities=26% Similarity=0.342 Sum_probs=190.7
Q ss_pred ecccCceeEEEEEeec-CcEEEEEEecCCCc---hhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEeecCCCCh
Q 003254 525 LGEGGFGPVYKGMLIE-GQEIAVKRLSKGSG---QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSL 600 (836)
Q Consensus 525 lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 600 (836)
||+|+||.||++...+ ++.+|+|.+..... .....+..|+.++++++|+||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 6999999999999864 88999999876532 2456889999999999999999999999999999999999999999
Q ss_pred hHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcccccccc
Q 003254 601 DYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKR 680 (836)
Q Consensus 601 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~ 680 (836)
.+++.. ...+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.++|+|||++....... .....
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~ 152 (250)
T cd05123 81 FSHLSK---EGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNT 152 (250)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccC
Confidence 999843 236899999999999999999999988 9999999999999999999999999998754321 12233
Q ss_pred ccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccccccCCCChH
Q 003254 681 VVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDNSCSFS 760 (836)
Q Consensus 681 ~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 760 (836)
..++..|+|||...+...+.++|+||||++++||++|+.|+..... ... ....... . ...+..
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~----~~~~~~~--------~--~~~~~~ 215 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KEI----YEKILKD--------P--LRFPEF 215 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHH----HHHHhcC--------C--CCCCCC
Confidence 5678899999999888899999999999999999999999743221 000 0111100 0 011112
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHH
Q 003254 761 EALRCIQVGLLCVQQRPEDRPNMSS 785 (836)
Q Consensus 761 ~~~~l~~li~~Cl~~dP~~RPt~~e 785 (836)
....+.+++.+|+..+|++||++.+
T Consensus 216 ~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 216 LSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCHHHHHHHHHHhcCCHhhCCCccc
Confidence 2356789999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=256.36 Aligned_cols=250 Identities=21% Similarity=0.343 Sum_probs=190.5
Q ss_pred ccccCeecccCceeEEEEEeec-CcEEEEEEecCCC-chhHHHHHHHHHHHHhhc-CCceeeEEeEEeeCCeeeEEEeec
Q 003254 519 FSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQRDERMLIYEYL 595 (836)
Q Consensus 519 f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~ 595 (836)
.+.+..||.|..|.|+|.+... |..+|||.+.... .+..++++..+.++.+-+ +|.||+.+|+|.......+-||.|
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM 173 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM 173 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH
Confidence 3445679999999999999866 8899999997763 445667788888877765 899999999999999999999988
Q ss_pred CCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCccc
Q 003254 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE 675 (836)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 675 (836)
.- .++.++.. ..+++++..+-++...+.+||.||.++. .|+|||+||+|||+|+.|.+|++|||++-.+-....
T Consensus 174 s~-C~ekLlkr--ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA- 247 (391)
T KOG0983|consen 174 ST-CAEKLLKR--IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA- 247 (391)
T ss_pred HH-HHHHHHHH--hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecccc-
Confidence 43 45555533 2356888888899999999999998764 599999999999999999999999999876532221
Q ss_pred cccccccccccccCccccc---CCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhcccc
Q 003254 676 ANTKRVVGTYGYMSPEYAI---DGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQS 752 (836)
Q Consensus 676 ~~~~~~~gt~~y~aPE~~~---~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 752 (836)
.....|-+.|||||.+. ...|+.++||||||+.|+||.||+.|+..-..+ .. .......+.+ +.
T Consensus 248 --htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td--Fe----~ltkvln~eP-----P~ 314 (391)
T KOG0983|consen 248 --HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD--FE----VLTKVLNEEP-----PL 314 (391)
T ss_pred --cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc--HH----HHHHHHhcCC-----CC
Confidence 23357889999999985 346899999999999999999999997532221 11 1111122222 22
Q ss_pred ccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 753 LDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 753 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
|.+..- -...+++++..||+.|+.+||...++++.
T Consensus 315 L~~~~g--FSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 315 LPGHMG--FSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred CCcccC--cCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 221111 12357789999999999999999998763
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-30 Score=260.18 Aligned_cols=254 Identities=22% Similarity=0.256 Sum_probs=195.8
Q ss_pred hccccccc-CeecccCceeEEEEEeec-CcEEEEEEecCCCchhHHHHHHHHHHHHhh-cCCceeeEEeEEee----CCe
Q 003254 515 ATDNFSEK-NKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQ----RDE 587 (836)
Q Consensus 515 a~~~f~~~-~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~----~~~ 587 (836)
.+++|++. ++||-|--|+|-....+. ++.+|+|++.. ....++|+++.-.. .|||||.++++++. ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 45666543 579999999999988765 88899999853 34567899887776 59999999999854 456
Q ss_pred eeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEec---CCCCceeeccC
Q 003254 588 RMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD---NTMNPKISDFG 664 (836)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~---~~~~~kl~DFg 664 (836)
+++|||.|++|.|...+.+ ...+.+++.++..|+.||+.|+.|||+.+ |.||||||+|+|.. .|-.+||+|||
T Consensus 134 LLiVmE~meGGeLfsriq~-~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQD-RGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eEeeeecccchHHHHHHHH-cccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence 8899999999999998855 34567999999999999999999999998 99999999999996 45679999999
Q ss_pred cccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccC
Q 003254 665 LARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEER 744 (836)
Q Consensus 665 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 744 (836)
+|+.-. ........+-|+.|.|||++-..+|+...|+||+||++|-|++|.+||...+..... .+ -.+....+
T Consensus 210 FAK~t~---~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ais--pg-Mk~rI~~g- 282 (400)
T KOG0604|consen 210 FAKETQ---EPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS--PG-MKRRIRTG- 282 (400)
T ss_pred cccccC---CCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCC--hh-HHhHhhcc-
Confidence 998643 334455678899999999999999999999999999999999999998644332110 00 00000000
Q ss_pred chhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 745 PLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 745 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
-.++.+ ..-....+...++++..|..+|.+|-|+.|++..
T Consensus 283 qy~FP~-----pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 283 QYEFPE-----PEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred CccCCC-----hhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 001111 1111223456789999999999999999999764
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-30 Score=275.70 Aligned_cols=242 Identities=25% Similarity=0.362 Sum_probs=188.9
Q ss_pred cCeecccCceeEEEEEeec-CcEEEEEEecCC--CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEeecCCC
Q 003254 522 KNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNK 598 (836)
Q Consensus 522 ~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 598 (836)
.+.||.|.||+||-|++.. |+.||||++.+. .......+++|+.||++++||.||.+.-.|+..+..+.|||-+.+.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 4789999999999999865 999999998765 3344578999999999999999999999999999999999999765
Q ss_pred ChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecC---CCCceeeccCcccccCCCccc
Q 003254 599 SLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---TMNPKISDFGLARSFGLDQTE 675 (836)
Q Consensus 599 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~---~~~~kl~DFgla~~~~~~~~~ 675 (836)
-|+-.| .. ..+.|++....-++.||+.||.|||.++ |+|+||||+||||.+ -..+||+|||+|+.++....+
T Consensus 649 MLEMIL-Ss-EkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR 723 (888)
T KOG4236|consen 649 MLEMIL-SS-EKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR 723 (888)
T ss_pred HHHHHH-Hh-hcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhhh
Confidence 554444 33 3456888888888999999999999999 999999999999954 357999999999998754433
Q ss_pred cccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccccccC
Q 003254 676 ANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDN 755 (836)
Q Consensus 676 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 755 (836)
...+||+.|+|||++.++.|...-|+||.|||+|--++|.-||..+. +..+-++.+.-++-....
T Consensus 724 ---rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE--dIndQIQNAaFMyPp~PW---------- 788 (888)
T KOG4236|consen 724 ---RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE--DINDQIQNAAFMYPPNPW---------- 788 (888)
T ss_pred ---hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc--chhHHhhccccccCCCch----------
Confidence 23789999999999999999999999999999999999999975322 112222222211111111
Q ss_pred CCChHHHHHHHHHHHHcccCCCCCCCCHHHH
Q 003254 756 SCSFSEALRCIQVGLLCVQQRPEDRPNMSSV 786 (836)
Q Consensus 756 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eV 786 (836)
.+.....+++|...||..-++|-+...-
T Consensus 789 ---~eis~~AidlIn~LLqVkm~kRysvdk~ 816 (888)
T KOG4236|consen 789 ---SEISPEAIDLINNLLQVKMRKRYSVDKS 816 (888)
T ss_pred ---hhcCHHHHHHHHHHHHHHHHHhcchHhh
Confidence 1122345677777777777777776553
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-30 Score=286.50 Aligned_cols=240 Identities=24% Similarity=0.276 Sum_probs=193.1
Q ss_pred hcccccccCeecccCceeEEEEEeec-CcEEEEEEecCCCchhHHHHHHHHHHHHhh-cCCceeeEEeEEeeCCeeeEEE
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDERMLIY 592 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 592 (836)
.++.|.....+|.|+|+.|-+..+.. ++..+||++.+... +-.+|+.++... +||||+++.+.+.+..+.++||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 46778888889999999999988754 88999999976632 234567666665 6999999999999999999999
Q ss_pred eecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEe-cCCCCceeeccCcccccCC
Q 003254 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLL-DNTMNPKISDFGLARSFGL 671 (836)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl-~~~~~~kl~DFgla~~~~~ 671 (836)
|.+.++-+.+.+... +....++..|+.+|+.|+.|||+++ ++||||||+|||+ ++.++++|+|||.++....
T Consensus 396 e~l~g~ell~ri~~~----~~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSK----PEFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELER 468 (612)
T ss_pred hhccccHHHHHHHhc----chhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence 999999887777432 2223778889999999999999998 9999999999999 5899999999999987653
Q ss_pred CccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccc
Q 003254 672 DQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQ 751 (836)
Q Consensus 672 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 751 (836)
. ....+-|..|.|||++....|++++|+||||++||+||+|+.|+.....+ .++...
T Consensus 469 ~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~------------------~ei~~~ 525 (612)
T KOG0603|consen 469 S-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG------------------IEIHTR 525 (612)
T ss_pred h-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch------------------HHHHHh
Confidence 3 33356788999999999999999999999999999999999997643332 011111
Q ss_pred cccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 752 SLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 752 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
...+.++......+.+|+.+||+.||.+||+|.++..
T Consensus 526 i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 526 IQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred hcCCccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 1122222333455779999999999999999999864
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-30 Score=270.21 Aligned_cols=256 Identities=29% Similarity=0.389 Sum_probs=194.7
Q ss_pred ccccccCeecccCceeEEEEEeec-CcEEEEEEecCC--Cc-----hhHHHHHHHHHHHHhhcCCceeeEEeEEeeC-Ce
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG--SG-----QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR-DE 587 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~--~~-----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-~~ 587 (836)
++|-.+++||+|||+.|||+.+-. .+-||||+-..+ .. ...+...+|..|.+.|+||.||++++++.-+ +.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 456678899999999999998654 677899975432 21 2234567899999999999999999998654 55
Q ss_pred eeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEec---CCCCceeeccC
Q 003254 588 RMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD---NTMNPKISDFG 664 (836)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~---~~~~~kl~DFg 664 (836)
.+-|.|||++.+|+.+|. ..+.++++++..|++||+.||.||.+.. ++|||-||||.||||- .-|.+||.|||
T Consensus 543 FCTVLEYceGNDLDFYLK---QhklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLK---QHKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred ceeeeeecCCCchhHHHH---hhhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeecc
Confidence 789999999999999994 4467999999999999999999999876 6799999999999994 45789999999
Q ss_pred cccccCCCccc-----cccccccccccccCcccccCC----ccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhh
Q 003254 665 LARSFGLDQTE-----ANTKRVVGTYGYMSPEYAIDG----LFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGH 735 (836)
Q Consensus 665 la~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~----~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~ 735 (836)
+++.+..+... ..+....||..|++||.+.-+ +++.|+||||+|||+|+.+-|++||+......+. +..
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdI--Lqe 696 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDI--LQE 696 (775)
T ss_pred hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHH--Hhh
Confidence 99998654433 223446899999999998633 4789999999999999999999999865443221 110
Q ss_pred hHHhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 003254 736 AWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVV 787 (836)
Q Consensus 736 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl 787 (836)
. .... ..++-- ..-+....+...+|++||+..-++|....++.
T Consensus 697 N--TIlk--AtEVqF-----P~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 697 N--TILK--ATEVQF-----PPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred h--chhc--ceeccC-----CCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 0 0000 001110 01111223456899999999999998877763
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-31 Score=263.21 Aligned_cols=257 Identities=24% Similarity=0.346 Sum_probs=193.5
Q ss_pred ccccccCeecccCceeEEEEEeec-CcEEEEEEecCCCc-hhHHHHHHHHHHHHhh-cCCceeeEEeEEeeCCeeeEEEe
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSG-QGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDERMLIYE 593 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 593 (836)
++.+.+..||.|.||+|+|-.++. |+..|||+++.... ...++++.|.+...+- ++||||+++|.+..++..++-||
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME 143 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME 143 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence 344556789999999999998865 99999999987644 6677888888877665 69999999999999999999999
Q ss_pred ecCCCChhHHHhh--ccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCC
Q 003254 594 YLPNKSLDYFIFD--TTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (836)
Q Consensus 594 y~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~ 671 (836)
.|+- +|+.+... ......+++...-+|...+.+||.||.++- .|||||+||+||||+..|.+||+|||++-.+..
T Consensus 144 LMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~ 220 (361)
T KOG1006|consen 144 LMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD 220 (361)
T ss_pred HHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHH
Confidence 9954 66554321 123456888888899999999999998764 599999999999999999999999999876532
Q ss_pred CccccccccccccccccCcccccC--CccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhc
Q 003254 672 DQTEANTKRVVGTYGYMSPEYAID--GLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELI 749 (836)
Q Consensus 672 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (836)
. .....-.|-..|||||.+.. ..|+.++||||||++|+|+.||+.|... .. .+.++.. +...+.+..+.
T Consensus 221 S---iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~----w~-svfeql~-~Vv~gdpp~l~ 291 (361)
T KOG1006|consen 221 S---IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRK----WD-SVFEQLC-QVVIGDPPILL 291 (361)
T ss_pred H---HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcch----HH-HHHHHHH-HHHcCCCCeec
Confidence 1 12223567889999999863 3589999999999999999999988531 11 1122222 22222222221
Q ss_pred cccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 750 DQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 750 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
.+ ....+....++.++-.|+.+|.++||...++.++
T Consensus 292 ~~----~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 292 FD----KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred Cc----ccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 11 1122344568899999999999999999998654
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=285.34 Aligned_cols=261 Identities=26% Similarity=0.391 Sum_probs=211.0
Q ss_pred ccHHHHHhhcccccccCeecccCceeEEEEEee-cCcEEEEEEecCCCchhHHHHHHHHHHHHhh-cCCceeeEEeEEee
Q 003254 507 FDLKIIANATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQ 584 (836)
Q Consensus 507 ~~~~~l~~a~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~ 584 (836)
..+..+..-++.|++.+.||+|.+|.|||++.. +++..|+|++.... ...+++..|.++++.. .|||++.++|++..
T Consensus 9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence 345556667788999999999999999999975 48889999986544 4457788999999988 59999999999864
Q ss_pred -----CCeeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCce
Q 003254 585 -----RDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPK 659 (836)
Q Consensus 585 -----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~k 659 (836)
++.++||||||.+|+..+++.... ...+.|..+..|+..++.||.|||.+. ++|||||-.|||+++++.||
T Consensus 88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VK 163 (953)
T KOG0587|consen 88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVK 163 (953)
T ss_pred ecCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEE
Confidence 457999999999999999997766 778999999999999999999999987 99999999999999999999
Q ss_pred eeccCcccccCCCccccccccccccccccCcccccCC-----ccCccccccchhhhhhhhhhCCCCCCCCCCccccchhh
Q 003254 660 ISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDG-----LFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLG 734 (836)
Q Consensus 660 l~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~ 734 (836)
|+|||++..+. ..........||+.|||||++... .|+..+|+||||++..||--|.+|+...++-.
T Consensus 164 LvDFGvSaQld--sT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr------ 235 (953)
T KOG0587|consen 164 LVDFGVSAQLD--STVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR------ 235 (953)
T ss_pred Eeeeeeeeeee--cccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh------
Confidence 99999988763 333344557899999999999643 47889999999999999999999965433321
Q ss_pred hhHHhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 735 HAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 735 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
+.-......+..+. .+..-...+.++|..||..|-++||++.++++
T Consensus 236 -aLF~IpRNPPPkLk-------rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 236 -ALFLIPRNPPPKLK-------RPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred -hhccCCCCCCcccc-------chhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 11111111121221 23344567889999999999999999998875
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-30 Score=269.26 Aligned_cols=264 Identities=23% Similarity=0.329 Sum_probs=210.6
Q ss_pred HHHHhhcccccccCeecccCceeEEEEEeec------CcEEEEEEecCCCc-hhHHHHHHHHHHHHhhcCCceeeEEeEE
Q 003254 510 KIIANATDNFSEKNKLGEGGFGPVYKGMLIE------GQEIAVKRLSKGSG-QGMEEFKNEVLLIAKLQHRNLVKLLGCC 582 (836)
Q Consensus 510 ~~l~~a~~~f~~~~~lG~G~fG~Vykg~~~~------g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~ 582 (836)
+++....+++.....+-+|.||.||+|.+.+ .+.|-||.++.... -....+..|-.++..+.|||+..+.+++
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence 4444555677777789999999999997643 45678888766543 3456788999999999999999999998
Q ss_pred eeC-CeeeEEEeecCCCChhHHHh-----hccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCC
Q 003254 583 TQR-DERMLIYEYLPNKSLDYFIF-----DTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTM 656 (836)
Q Consensus 583 ~~~-~~~~lV~Ey~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~ 656 (836)
.+. +..+.+|.++.-|+|..++. +....+.++..+...++.|++.|++|||.++ |||.||.++|++||+..
T Consensus 357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~L 433 (563)
T KOG1024|consen 357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQL 433 (563)
T ss_pred eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhhe
Confidence 765 45788899999999999998 4455567888899999999999999999998 99999999999999999
Q ss_pred CceeeccCcccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhh
Q 003254 657 NPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGH 735 (836)
Q Consensus 657 ~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~ 735 (836)
++||+|=.+++.+-..+........-.+..||+||.+.+..|+.++|||||||+||||+| |+.|...-++.+
T Consensus 434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE------- 506 (563)
T KOG1024|consen 434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE------- 506 (563)
T ss_pred eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH-------
Confidence 999999999998766655554444556789999999999999999999999999999988 666643211110
Q ss_pred hHHhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcC
Q 003254 736 AWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 792 (836)
Q Consensus 736 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~ 792 (836)
....+....+-.-+..++.++..++.-||...|++||+++|++.-|++
T Consensus 507 ---------m~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 507 ---------MEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred ---------HHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 001111111112345677788999999999999999999999998875
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=265.69 Aligned_cols=220 Identities=20% Similarity=0.164 Sum_probs=174.4
Q ss_pred cCceeEEEEEeec-CcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEeecCCCChhHHHhh
Q 003254 528 GGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFD 606 (836)
Q Consensus 528 G~fG~Vykg~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~ 606 (836)
|.+|.||++.... ++.+|+|++.... .+..|...+....|||++++++++...+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 8899999999864 8899999986543 234455555666799999999999999999999999999999998854
Q ss_pred ccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcccccccccccccc
Q 003254 607 TTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYG 686 (836)
Q Consensus 607 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~ 686 (836)
. ..+++..+..++.|+++||.|||+.+ ++||||||+||++++++.++++|||.+..+... .....++..
T Consensus 79 ~---~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~ 147 (237)
T cd05576 79 F---LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENM 147 (237)
T ss_pred h---cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCcc
Confidence 2 35899999999999999999999988 999999999999999999999999988765322 112345678
Q ss_pred ccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccccccCCCChHHHHHHH
Q 003254 687 YMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDNSCSFSEALRCI 766 (836)
Q Consensus 687 y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 766 (836)
|+|||.+.+..++.++||||+|++++||++|+.|+........ ..... ..+......+.
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~------------~~~~~---------~~~~~~~~~~~ 206 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN------------THTTL---------NIPEWVSEEAR 206 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc------------ccccc---------CCcccCCHHHH
Confidence 9999999888899999999999999999999977532111000 00000 01111234577
Q ss_pred HHHHHcccCCCCCCCCHH
Q 003254 767 QVGLLCVQQRPEDRPNMS 784 (836)
Q Consensus 767 ~li~~Cl~~dP~~RPt~~ 784 (836)
+++.+|++.||++||++.
T Consensus 207 ~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 207 SLLQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHHHccCCHHHhcCCC
Confidence 899999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-29 Score=260.12 Aligned_cols=238 Identities=27% Similarity=0.373 Sum_probs=191.3
Q ss_pred CceeEEEEEeec-CcEEEEEEecCCCchh-HHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEeecCCCChhHHHhh
Q 003254 529 GFGPVYKGMLIE-GQEIAVKRLSKGSGQG-MEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFD 606 (836)
Q Consensus 529 ~fG~Vykg~~~~-g~~vavK~l~~~~~~~-~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~ 606 (836)
+||.||+|+... ++.+|+|++....... .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999999875 8999999997665444 68899999999999999999999999999999999999999999998854
Q ss_pred ccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcccccccccccccc
Q 003254 607 TTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYG 686 (836)
Q Consensus 607 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~ 686 (836)
.. .+++..+..++.++++++.|||+.+ ++|+||+|+||++++++.++|+|||.+....... ......++..
T Consensus 81 ~~---~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~ 151 (244)
T smart00220 81 RG---RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPE 151 (244)
T ss_pred cc---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcC
Confidence 32 2889999999999999999999998 9999999999999999999999999998765332 2234567889
Q ss_pred ccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccccccCCCChHHHHHHH
Q 003254 687 YMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDNSCSFSEALRCI 766 (836)
Q Consensus 687 y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 766 (836)
|+|||.+.+..++.++|||+||+++++|++|..|+...... . ............ .. .........+.
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~--~----~~~~~~~~~~~~-~~------~~~~~~~~~~~ 218 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL--L----ELFKKIGKPKPP-FP------PPEWKISPEAK 218 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH--H----HHHHHHhccCCC-Cc------cccccCCHHHH
Confidence 99999999888999999999999999999999886432110 0 011111111000 00 00000235678
Q ss_pred HHHHHcccCCCCCCCCHHHHHH
Q 003254 767 QVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 767 ~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
+++.+|+..+|++||++.++++
T Consensus 219 ~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 219 DLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHccCCchhccCHHHHhh
Confidence 9999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.8e-29 Score=288.87 Aligned_cols=263 Identities=21% Similarity=0.265 Sum_probs=167.1
Q ss_pred hcccccccCeecccCceeEEEEEeec-----CcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeE------Ee
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-----GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGC------CT 583 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~~-----g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~------~~ 583 (836)
..++|+..+.||+|+||.||+|++.+ +..||||++...... +.+.+| .+....+.+++.++.. ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 56789999999999999999999854 588999997643221 111111 1111122222222111 34
Q ss_pred eCCeeeEEEeecCCCChhHHHhhccCC-----------------CcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCC
Q 003254 584 QRDERMLIYEYLPNKSLDYFIFDTTRS-----------------KLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLK 646 (836)
Q Consensus 584 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLk 646 (836)
.....++||||+++++|.+++...... .......+..++.||+.||+|||+.+ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 566789999999999999888543210 01122345679999999999999988 9999999
Q ss_pred CCceEecC-CCCceeeccCcccccCCCccccccccccccccccCcccccCC----------------------ccCcccc
Q 003254 647 ASNVLLDN-TMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDG----------------------LFSVKSD 703 (836)
Q Consensus 647 p~NILl~~-~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~t~ksD 703 (836)
|+|||+++ ++.+||+|||+++.+...... ......+++.|+|||.+... .++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCcccccccccc-CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999985 689999999999865432221 22346789999999965322 2345679
Q ss_pred ccchhhhhhhhhhCCCCCCCCCCccccch-----hhhhHHhhhccCchhhccccccC--CCChHHHHHHHHHHHHcccCC
Q 003254 704 VFSFGVLVLEIICGKKNRGFNHADHDHNL-----LGHAWRLWIEERPLELIDQSLDN--SCSFSEALRCIQVGLLCVQQR 776 (836)
Q Consensus 704 VwS~GvvL~elltG~~p~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~d~~l~~--~~~~~~~~~l~~li~~Cl~~d 776 (836)
||||||+||||+++..+...........+ ....|....... ..+.+.. ...........+|+.+||+.|
T Consensus 362 VwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~d~~~~~~~dLi~~mL~~d 437 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPR----ASPDLRRGFEVLDLDGGAGWELLKSMMRFK 437 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccc----cchhhhhhhhhccccchHHHHHHHHHccCC
Confidence 99999999999997655321000000000 000011100000 0000000 000011223558999999999
Q ss_pred CCCCCCHHHHHHH
Q 003254 777 PEDRPNMSSVVLM 789 (836)
Q Consensus 777 P~~RPt~~eVl~~ 789 (836)
|++|||+.|+++.
T Consensus 438 P~kR~ta~e~L~H 450 (566)
T PLN03225 438 GRQRISAKAALAH 450 (566)
T ss_pred cccCCCHHHHhCC
Confidence 9999999999874
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=261.88 Aligned_cols=259 Identities=20% Similarity=0.234 Sum_probs=197.2
Q ss_pred hcccccccCeecccCceeEEEEEeec-CcEEEEEEecCCCchhHHHHHHHHHHHHhhc-C-C----ceeeEEeEEeeCCe
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQ-H-R----NLVKLLGCCTQRDE 587 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H-~----niv~l~g~~~~~~~ 587 (836)
.+.+|.+..++|+|.||.|-+..... +..||||+++.. ....+..+-|+++++++. + | -+|.+.+++.-.++
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh 165 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH 165 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence 36789999999999999999988755 688999998543 344566778999999994 2 2 37888888999999
Q ss_pred eeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEec--------------
Q 003254 588 RMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD-------------- 653 (836)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~-------------- 653 (836)
.++|+|.+ +-++.+++.. .+-.+++...+..++.|+++++++||+.. ++|-||||+|||+.
T Consensus 166 iCivfell-G~S~~dFlk~-N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~ 240 (415)
T KOG0671|consen 166 ICIVFELL-GLSTFDFLKE-NNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKV 240 (415)
T ss_pred eEEEEecc-ChhHHHHhcc-CCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCcc
Confidence 99999987 4478888843 23457888999999999999999999998 99999999999992
Q ss_pred ------CCCCceeeccCcccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCc
Q 003254 654 ------NTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHAD 727 (836)
Q Consensus 654 ------~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~ 727 (836)
.+..+||.|||.|..-... ....+.|..|+|||++.+-.++.++||||+||||.|+++|...|..-...
T Consensus 241 ~~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~ 315 (415)
T KOG0671|consen 241 CFIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENL 315 (415)
T ss_pred ceeccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcH
Confidence 1345899999999864322 24578899999999999999999999999999999999999876533211
Q ss_pred cccchhhhhHHhhhccCchhhcccc-------------------------------c--cCCCChHHHHHHHHHHHHccc
Q 003254 728 HDHNLLGHAWRLWIEERPLELIDQS-------------------------------L--DNSCSFSEALRCIQVGLLCVQ 774 (836)
Q Consensus 728 ~~~~~~~~~~~~~~~~~~~~~~d~~-------------------------------l--~~~~~~~~~~~l~~li~~Cl~ 774 (836)
+... ..+......+..++... + .......+..++.+|+..||.
T Consensus 316 EHLa----MMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~ 391 (415)
T KOG0671|consen 316 EHLA----MMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLE 391 (415)
T ss_pred HHHH----HHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHc
Confidence 1100 01111111111111111 0 012344566789999999999
Q ss_pred CCCCCCCCHHHHHH
Q 003254 775 QRPEDRPNMSSVVL 788 (836)
Q Consensus 775 ~dP~~RPt~~eVl~ 788 (836)
.||.+|+|+.|++.
T Consensus 392 fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 392 FDPARRITLREALS 405 (415)
T ss_pred cCccccccHHHHhc
Confidence 99999999999975
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=280.91 Aligned_cols=262 Identities=19% Similarity=0.257 Sum_probs=179.9
Q ss_pred hcccccccCeecccCceeEEEEEe-----------------ecCcEEEEEEecCCCchhHHH--------------HHHH
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGML-----------------IEGQEIAVKRLSKGSGQGMEE--------------FKNE 563 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~-----------------~~g~~vavK~l~~~~~~~~~~--------------~~~E 563 (836)
..++|++.++||+|+||.||+|.+ .+++.||||++........++ +..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 457899999999999999999974 235679999986543222223 3447
Q ss_pred HHHHHhhcCCce-----eeEEeEEee--------CCeeeEEEeecCCCChhHHHhhccC---------------------
Q 003254 564 VLLIAKLQHRNL-----VKLLGCCTQ--------RDERMLIYEYLPNKSLDYFIFDTTR--------------------- 609 (836)
Q Consensus 564 i~~l~~l~H~ni-----v~l~g~~~~--------~~~~~lV~Ey~~~gsL~~~l~~~~~--------------------- 609 (836)
+.++.+++|.++ ++++++|.. .+..+|||||+++++|.++++....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777888877654 677787753 3568999999999999998864211
Q ss_pred CCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCccccccccccccccccC
Q 003254 610 SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMS 689 (836)
Q Consensus 610 ~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~a 689 (836)
...+++..+..++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||++..+...... ......+++.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeC
Confidence 123567788999999999999999988 999999999999999999999999999765432211 1112334789999
Q ss_pred cccccCCcc----------------------CccccccchhhhhhhhhhCCC-CCCCCCCccc----cchhhhhHHhhhc
Q 003254 690 PEYAIDGLF----------------------SVKSDVFSFGVLVLEIICGKK-NRGFNHADHD----HNLLGHAWRLWIE 742 (836)
Q Consensus 690 PE~~~~~~~----------------------t~ksDVwS~GvvL~elltG~~-p~~~~~~~~~----~~~~~~~~~~~~~ 742 (836)
||.+..... ..+.||||+||+|+||++|.. |+........ ..-....|+....
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~ 458 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG 458 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence 998754321 134799999999999999875 4421111000 0001111222111
Q ss_pred cCchhhccccccCCCChHHHHHHHHHHHHcccCCC---CCCCCHHHHHH
Q 003254 743 ERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRP---EDRPNMSSVVL 788 (836)
Q Consensus 743 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP---~~RPt~~eVl~ 788 (836)
... +- ...........+++.++|..+| .+|+|+.|+++
T Consensus 459 ~~~----~~----~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 459 QKY----DF----SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred cCC----Cc----ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 111 10 0011122456788999998765 68999999985
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-31 Score=258.40 Aligned_cols=266 Identities=22% Similarity=0.389 Sum_probs=193.3
Q ss_pred ccccccCeecccCceeEEEEEeec-CcEEEEEEecCCC--chhHHHHHHHHHHHHhhcCCceeeEEeEEeeC--------
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR-------- 585 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-------- 585 (836)
..|+...+||+|.||.|||++..+ |+.||+|+.-... ........+|++++..++|+|++.++..|...
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 456667899999999999999866 7889998754322 22234568899999999999999999888442
Q ss_pred CeeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCc
Q 003254 586 DERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGL 665 (836)
Q Consensus 586 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgl 665 (836)
...+|||.+|+. +|.-++.+ +...++..++.+++.++..||.|+|... |+|||+||.|+||+.++.+||+|||+
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn--~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSN--RKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcC--ccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccc
Confidence 237999999987 67666632 3356888999999999999999999987 99999999999999999999999999
Q ss_pred ccccCCCccc--cccccccccccccCcccccCC-ccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhH-----
Q 003254 666 ARSFGLDQTE--ANTKRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAW----- 737 (836)
Q Consensus 666 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~----- 737 (836)
++.+...... ......+-|..|++||.+.+. .|+++.|||+-|||+.||+++.+-+..........++....
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk 250 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK 250 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence 9877543322 222335669999999999875 68999999999999999999988765444333222222111
Q ss_pred HhhhccCchhhcc-----ccccCCC--------ChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 738 RLWIEERPLELID-----QSLDNSC--------SFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 738 ~~~~~~~~~~~~d-----~~l~~~~--------~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
+.|-.-...++.. |..++.. +.....+.++|+..++..||.+|+++.+++.
T Consensus 251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 0111111111111 1111110 1111235778999999999999999998764
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=234.33 Aligned_cols=261 Identities=24% Similarity=0.325 Sum_probs=191.1
Q ss_pred cccccCeecccCceeEEEEEeec-CcEEEEEEecCCC--chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEee
Q 003254 518 NFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (836)
Q Consensus 518 ~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 594 (836)
+|...++||+|.||+||||+..+ ++.||+|+.+-.+ +.-.....+|+-+++.++|+|||+++++...++.+.+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 46667899999999999999765 7889999986543 33345688999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcc
Q 003254 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (836)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~ 674 (836)
|.. +|..+..+ -.+.++.+....++.|+++||.+.|++. +.||||||.|.||+.+|++|++|||+++-++-...
T Consensus 83 cdq-dlkkyfds--lng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 83 CDQ-DLKKYFDS--LNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR 156 (292)
T ss_pred hhH-HHHHHHHh--cCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence 965 56555532 2456888999999999999999999998 99999999999999999999999999998864432
Q ss_pred ccccccccccccccCcccccCCc-cCccccccchhhhhhhhhhCCCC-CCCCCCccccchhhhhHHh--hhccC---chh
Q 003254 675 EANTKRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIICGKKN-RGFNHADHDHNLLGHAWRL--WIEER---PLE 747 (836)
Q Consensus 675 ~~~~~~~~gt~~y~aPE~~~~~~-~t~ksDVwS~GvvL~elltG~~p-~~~~~~~~~~~~~~~~~~~--~~~~~---~~~ 747 (836)
-.. ..+-|..|.+|.++.+.+ |+...|+||-||++.||....+| |..... ++.+....+.. ..++. ...
T Consensus 157 cys--aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dv--ddqlkrif~~lg~p~ed~wps~t~ 232 (292)
T KOG0662|consen 157 CYS--AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV--DDQLKRIFRLLGTPTEDQWPSMTK 232 (292)
T ss_pred eee--ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcH--HHHHHHHHHHhCCCccccCCcccc
Confidence 221 245689999999998765 88899999999999999875555 322111 11111111110 00110 112
Q ss_pred hccccccCCCC----hH-----HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 748 LIDQSLDNSCS----FS-----EALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 748 ~~d~~l~~~~~----~~-----~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
+.|...-..++ -. ...+-.++....+.-+|.+|.++++.++
T Consensus 233 lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 233 LPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 22222111111 11 1122356777778889999999998765
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=262.70 Aligned_cols=240 Identities=28% Similarity=0.363 Sum_probs=191.9
Q ss_pred ccccccCeecccCceeEEEEEeec-CcEEEEEEecCCC---chhHHHHHHHHHHHHhh-cCCceeeEEeEEeeCCeeeEE
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDERMLI 591 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV 591 (836)
.+|..+.+||+|+||.|..+..+. .+.+|||++++.. ....+--+.|-++|... +-|.++++..++..-+.+++|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 467888899999999999998765 5569999998762 23344456777777776 467899999999999999999
Q ss_pred EeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCC
Q 003254 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (836)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~ 671 (836)
|||+.+|+|-.++.+ -+.+.+..+.-+|..||-||-+||+++ |+.||||.+|||||.+|++||+|||+++.-.
T Consensus 429 MEyvnGGDLMyhiQQ---~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni- 501 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQ---VGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI- 501 (683)
T ss_pred EEEecCchhhhHHHH---hcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccc-
Confidence 999999999877743 455788889999999999999999999 9999999999999999999999999998632
Q ss_pred CccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccc
Q 003254 672 DQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQ 751 (836)
Q Consensus 672 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 751 (836)
.....+...+||+.|+|||++...+|...+|-|||||+||||+.|++||+....+ .+... +.+.
T Consensus 502 -~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~---elF~a------------I~eh 565 (683)
T KOG0696|consen 502 -FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED---ELFQA------------IMEH 565 (683)
T ss_pred -cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHH------------HHHc
Confidence 2334566789999999999999999999999999999999999999998643322 11111 1111
Q ss_pred cccCCCChHHHHHHHHHHHHcccCCCCCCC
Q 003254 752 SLDNSCSFSEALRCIQVGLLCVQQRPEDRP 781 (836)
Q Consensus 752 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP 781 (836)
. -.++.....+...++..-+...|.+|-
T Consensus 566 n--vsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 566 N--VSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred c--CcCcccccHHHHHHHHHHhhcCCcccc
Confidence 1 123334445667788888889998883
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=292.52 Aligned_cols=276 Identities=22% Similarity=0.251 Sum_probs=211.5
Q ss_pred HHHHHhhcccccccCeecccCceeEEEEEeec-CcEEEEEEecCC---CchhHHHHHHHHHHHHhhcCCceeeEEeEEee
Q 003254 509 LKIIANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQ 584 (836)
Q Consensus 509 ~~~l~~a~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~ 584 (836)
.+.+.-..++|.+++.||+|+||.|..++++. ++.||+|++.+- .......|.+|-.+|..-+.+=|+.+.-.|.+
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 44555566899999999999999999999976 788999999762 34456789999999999899999999999999
Q ss_pred CCeeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccC
Q 003254 585 RDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFG 664 (836)
Q Consensus 585 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFg 664 (836)
...+|||||||+||+|-.++... .++++..+.-++..|..||.-||+.| +|||||||+|||||..|++||+|||
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~---~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFG 220 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKF---DRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFG 220 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhc---CCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccch
Confidence 99999999999999999999543 36889999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCccccccccccccccccCccccc----C-CccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHh
Q 003254 665 LARSFGLDQTEANTKRVVGTYGYMSPEYAI----D-GLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRL 739 (836)
Q Consensus 665 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~ 739 (836)
.+..+..+.. ......+|||.|++||++. + +.|...+|-||+||++|||+.|..||.... ++......
T Consensus 221 sClkm~~dG~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads------lveTY~KI 293 (1317)
T KOG0612|consen 221 SCLKMDADGT-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS------LVETYGKI 293 (1317)
T ss_pred hHHhcCCCCc-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH------HHHHHHHH
Confidence 9988764432 3344579999999999985 3 579999999999999999999999985321 11111111
Q ss_pred hhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCC---HHHHHHHh-------cCCCCCCCCCCCCcc
Q 003254 740 WIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPN---MSSVVLML-------SGERSLPQPQQPGFF 805 (836)
Q Consensus 740 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt---~~eVl~~L-------~~~~~~~~p~~p~~~ 805 (836)
..-.....+.+ ...-...+.+||+..+ -+|+.|-. +.++-..- .+|++..+|-.|.+-
T Consensus 294 m~hk~~l~FP~-------~~~VSeeakdLI~~ll-~~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vPevs 361 (1317)
T KOG0612|consen 294 MNHKESLSFPD-------ETDVSEEAKDLIEALL-CDREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVPEVS 361 (1317)
T ss_pred hchhhhcCCCc-------ccccCHHHHHHHHHHh-cChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCCcCC
Confidence 11011111111 0112234556666655 47788877 77775432 345666666666654
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.7e-29 Score=279.87 Aligned_cols=246 Identities=26% Similarity=0.362 Sum_probs=187.8
Q ss_pred ccccCeecccCce-eEEEEEeecCcEEEEEEecCCCchhHHHHHHHHHHHHhh-cCCceeeEEeEEeeCCeeeEEEeecC
Q 003254 519 FSEKNKLGEGGFG-PVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDERMLIYEYLP 596 (836)
Q Consensus 519 f~~~~~lG~G~fG-~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~ 596 (836)
|...+.+|.|.-| .||+|.. +|++||||++-.. ......+|+..++.- +|||||++++.-.+...+||..|.|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 4445678999887 5799999 8899999998542 234567899999988 59999999999888999999999996
Q ss_pred CCChhHHHhhc-cCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecC-----CCCceeeccCcccccC
Q 003254 597 NKSLDYFIFDT-TRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-----TMNPKISDFGLARSFG 670 (836)
Q Consensus 597 ~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~-----~~~~kl~DFgla~~~~ 670 (836)
. +|++++... .............+..|+++||+|||+.+ ||||||||.||||+. ..+++|+|||+++.+.
T Consensus 587 ~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 587 C-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred h-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 5 899999653 11111222456788999999999999987 999999999999965 3579999999999987
Q ss_pred CCcccc-ccccccccccccCcccccCCccCccccccchhhhhhhhhhC-CCCCCCCCCccccchhhhhHHhhhccCchhh
Q 003254 671 LDQTEA-NTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICG-KKNRGFNHADHDHNLLGHAWRLWIEERPLEL 748 (836)
Q Consensus 671 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (836)
.+.... ......||.+|+|||++....-+.++||||+|||+|+.++| .+||+.....+...+. .......
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~--------~~~~L~~ 734 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILT--------GNYTLVH 734 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhc--------Cccceee
Confidence 654432 34557899999999999988888899999999999999997 7888743322111110 0000000
Q ss_pred ccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 749 IDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 749 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
+ ....++ ...+||.+|++.+|..||++.+|+.
T Consensus 735 L------~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 735 L------EPLPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred e------ccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 0 111111 6779999999999999999999973
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-29 Score=268.05 Aligned_cols=266 Identities=23% Similarity=0.298 Sum_probs=208.9
Q ss_pred ccccccCeecccCceeEEEEEeecCc-EEEEEEecCC---CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEE
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIEGQ-EIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~g~-~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 592 (836)
.+++....||-|+||.|=.+..+... .+|+|++++. .....+....|-.+|...+.|.||+++..|.+.+..||.|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 45666778999999999999886543 3888888665 3445567889999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCC
Q 003254 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (836)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~ 672 (836)
|-|-+|.|...|.+ ++.++.....-++..+.+|++|||.++ ||.|||||+|.+||.+|-+||.|||+|+.++..
T Consensus 500 EaClGGElWTiLrd---Rg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 500 EACLGGELWTILRD---RGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred HhhcCchhhhhhhh---cCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 99999999999954 456888888899999999999999999 999999999999999999999999999987643
Q ss_pred ccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhcccc
Q 003254 673 QTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQS 752 (836)
Q Consensus 673 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 752 (836)
..+.+++||+.|.|||++.++..+.++|.||||+++|||++|++||....+-...+++-.... ..
T Consensus 574 ---~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid------~i------ 638 (732)
T KOG0614|consen 574 ---RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGID------KI------ 638 (732)
T ss_pred ---CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhh------hh------
Confidence 346678999999999999999999999999999999999999999865443221111111100 00
Q ss_pred ccCCCChHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHHh-------cCC--CCCCCCCCCCccc
Q 003254 753 LDNSCSFSEALRCIQVGLLCVQQRPEDRPN-----MSSVVLML-------SGE--RSLPQPQQPGFFT 806 (836)
Q Consensus 753 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~eVl~~L-------~~~--~~~~~p~~p~~~~ 806 (836)
.++..-.....+++++....+|.+|-. +.+|-+.- +++ +.++.|-.|....
T Consensus 639 ---~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi~~~va~ 703 (732)
T KOG0614|consen 639 ---EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPIIPSVAN 703 (732)
T ss_pred ---hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCCccccCCC
Confidence 122222345668888888999999976 55555432 233 3456666666553
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8e-28 Score=243.78 Aligned_cols=280 Identities=23% Similarity=0.338 Sum_probs=211.0
Q ss_pred ccccccCeecccCceeEEEEEeec-CcEEEEEEecCC---CchhHHHHHHHHHHHHhh-cCCceeeEEeEEeeCCeeeEE
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDERMLI 591 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV 591 (836)
++|..+++||+|+|++|..+++.. .+.+|+|++++. ..+.+.-.+.|-.+..+. +||.+|.+..++..+..+++|
T Consensus 250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv 329 (593)
T KOG0695|consen 250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV 329 (593)
T ss_pred ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence 577788999999999999999866 677999998764 334455566777777665 699999999999999999999
Q ss_pred EeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCC
Q 003254 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (836)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~ 671 (836)
.||+++|+|-.++ .+...|+++.+.-+...|+.||.|||+.+ ||.||||.+|+|||..|.+||.|+|+++.-..
T Consensus 330 ieyv~ggdlmfhm---qrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l~ 403 (593)
T KOG0695|consen 330 IEYVNGGDLMFHM---QRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG 403 (593)
T ss_pred EEEecCcceeeeh---hhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCCC
Confidence 9999999885444 56677999999999999999999999999 99999999999999999999999999986322
Q ss_pred CccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCcccc-chhhhhHHhhhccCchhhcc
Q 003254 672 DQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDH-NLLGHAWRLWIEERPLELID 750 (836)
Q Consensus 672 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~d 750 (836)
....+..++||+.|.|||++.+..|...+|-|++||+++||+.|+.||.....+... +-.++..+...+.
T Consensus 404 --~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilek------- 474 (593)
T KOG0695|consen 404 --PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEK------- 474 (593)
T ss_pred --CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhh-------
Confidence 223456689999999999999999999999999999999999999998754433221 1112222211111
Q ss_pred ccccCCCChHHHHHHHHHHHHcccCCCCCCCC------HHHH----------HHHhcCCCCCCCCCCCCccccCCCCCCC
Q 003254 751 QSLDNSCSFSEALRCIQVGLLCVQQRPEDRPN------MSSV----------VLMLSGERSLPQPQQPGFFTGRNLPESE 814 (836)
Q Consensus 751 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt------~~eV----------l~~L~~~~~~~~p~~p~~~~~~~~~~~~ 814 (836)
.+ ..+-....+...+...-|.+||.+|.. ++++ .++|++ +.+.+|.+|+.-..+.+.+-.
T Consensus 475 -qi--riprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leq-k~v~ppf~p~i~~d~~l~~fd 550 (593)
T KOG0695|consen 475 -QI--RIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQ-KQVLPPFQPQITDDYGLDNFD 550 (593)
T ss_pred -cc--cccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhh-cccCCCCCCccccccCccccc
Confidence 11 111122234456777788889988832 2222 234444 445567888887766655543
Q ss_pred C
Q 003254 815 S 815 (836)
Q Consensus 815 ~ 815 (836)
+
T Consensus 551 ~ 551 (593)
T KOG0695|consen 551 T 551 (593)
T ss_pred c
Confidence 3
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.2e-29 Score=227.28 Aligned_cols=110 Identities=49% Similarity=0.784 Sum_probs=80.6
Q ss_pred CCcEEEeecCCCCCCCCc--ceEEEeeccCceEEEEcCCCCeEEee-cccCCC-CcceEEEecCCCeEEecCCCCCCCcc
Q 003254 91 EGTVTWVANRDAPLSDRS--GVLRINGERNGILVLLNSTNDTVWSS-NSSISA-QKPVAALMESGNLVVKDGKDNNPDNI 166 (836)
Q Consensus 91 ~~t~vW~Anr~~p~~~~~--~~l~~~~~~~g~l~l~~~~~~~~wst-~~~~~~-~~~~a~lld~GNlvl~~~~~~~~~~~ 166 (836)
++|+||+|||+.|+...+ ..|.|. .||+|+|+|..+.++|++ ++.... ....|+|+|+|||||++.. +.+
T Consensus 1 ~~tvvW~an~~~p~~~~s~~~~L~l~--~dGnLvl~~~~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d~~----~~~ 74 (114)
T PF01453_consen 1 PRTVVWVANRNSPLTSSSGNYTLILQ--SDGNLVLYDSNGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYDSS----GNV 74 (114)
T ss_dssp ---------TTEEEEECETTEEEEEE--TTSEEEEEETTTEEEEE--S-TTSS-SSEEEEEETTSEEEEEETT----SEE
T ss_pred CcccccccccccccccccccccceEC--CCCeEEEEcCCCCEEEEecccCCccccCeEEEEeCCCCEEEEeec----ceE
Confidence 379999999999996533 677777 999999999999999999 444333 5788999999999999863 799
Q ss_pred eeeeccCCCCCcCCCCeeeeeecCCCceEEEEccCCCCCC
Q 003254 167 LWQSFDYPCDTLLPGMKLGINLGTGLNRFLSSWKSTDDPA 206 (836)
Q Consensus 167 ~WqSFd~PTDtlLpgqkl~~~~~tg~~~~l~Sw~s~~dps 206 (836)
|||||||||||+||||+|+.+..+|.+..++||++.+|||
T Consensus 75 lW~Sf~~ptdt~L~~q~l~~~~~~~~~~~~~sw~s~~dps 114 (114)
T PF01453_consen 75 LWQSFDYPTDTLLPGQKLGDGNVTGKNDSLTSWSSNTDPS 114 (114)
T ss_dssp EEESTTSSS-EEEEEET--TSEEEEESTSSEEEESS----
T ss_pred EEeecCCCccEEEeccCcccCCCccccceEEeECCCCCCC
Confidence 9999999999999999999988888888899999999997
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.8e-28 Score=218.43 Aligned_cols=110 Identities=48% Similarity=1.075 Sum_probs=105.8
Q ss_pred EeeCCCCCccccCccccccCCceEEEEeeCCceeEEEEecCCCCccceEEEcccCcEEEEEEecCCceEEEeeccCCCCc
Q 003254 232 FRAGSWNGLHWTGVPQLQLNPVYTFEYVSNEKEAFYTYNLSNSSVPSRMVINPAGTVQRYTWMERTKTWTLFSRFSGVTL 311 (836)
Q Consensus 232 ~~~g~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~L~~~G~l~~y~w~~~~~~W~~~~~~~~~~~ 311 (836)
||+|+|||..|+|+|++..+..+.+.|+.+++|.||+|.+.+.++++|++||++|++++|.|++..+.|..+| .+|.
T Consensus 1 wrsG~WnG~~f~g~p~~~~~~~~~~~fv~~~~e~~~t~~~~~~s~~~r~~ld~~G~l~~~~w~~~~~~W~~~~---~~p~ 77 (110)
T PF00954_consen 1 WRSGPWNGQRFSGIPEMSSNSLYNYSFVSNNEEVYYTYSLSNSSVLSRLVLDSDGQLQRYIWNESTQSWSVFW---SAPK 77 (110)
T ss_pred CCccccCCeEECCcccccccceeEEEEEECCCeEEEEEecCCCceEEEEEEeeeeEEEEEEEecCCCcEEEEE---Eecc
Confidence 8999999999999999998899999999999999999999999999999999999999999999999999999 8999
Q ss_pred cCCCccCCCCCCcccccCCCCCcccccCCCccCC
Q 003254 312 DQCDSYALCGAYASCNINSNSPECECLQGFVPNS 345 (836)
Q Consensus 312 ~~Cd~~g~CG~~g~C~~~~~~~~C~Cl~Gf~~~~ 345 (836)
|+||+|+.||+||+|+.+ ..+.|+||+||+|++
T Consensus 78 d~Cd~y~~CG~~g~C~~~-~~~~C~Cl~GF~P~n 110 (110)
T PF00954_consen 78 DQCDVYGFCGPNGICNSN-NSPKCSCLPGFEPKN 110 (110)
T ss_pred cCCCCccccCCccEeCCC-CCCceECCCCcCCCc
Confidence 999999999999999876 678999999999975
|
This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-27 Score=258.45 Aligned_cols=206 Identities=23% Similarity=0.390 Sum_probs=174.9
Q ss_pred ccccccCeecccCceeEEEEEeec-CcEEEEEEecCCC---chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEE
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 592 (836)
.-|..++.||-|+||+|.++...+ ...+|+|.+++.+ .......++|-.||...+.+=||+|+-.|.+.+.+|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 457778899999999999998766 5668999998764 334556789999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccC--
Q 003254 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG-- 670 (836)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~-- 670 (836)
||+++|++-.+|. +.+.+.+..+.-++..+..|+++.|..| +|||||||+|||||.+|++||.||||+.-+.
T Consensus 709 dYIPGGDmMSLLI---rmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT 782 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLI---RMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 782 (1034)
T ss_pred eccCCccHHHHHH---HhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceec
Confidence 9999999988885 4467888888889999999999999998 9999999999999999999999999986441
Q ss_pred -------CCc-------------------------------cccccccccccccccCcccccCCccCccccccchhhhhh
Q 003254 671 -------LDQ-------------------------------TEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVL 712 (836)
Q Consensus 671 -------~~~-------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ 712 (836)
... .+......+||+.|+|||++....++..+|-||.|||||
T Consensus 783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~ 862 (1034)
T KOG0608|consen 783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY 862 (1034)
T ss_pred cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence 000 000111246999999999999999999999999999999
Q ss_pred hhhhCCCCCCCCCCcc
Q 003254 713 EIICGKKNRGFNHADH 728 (836)
Q Consensus 713 elltG~~p~~~~~~~~ 728 (836)
||+.|+.||-...+.+
T Consensus 863 em~~g~~pf~~~tp~~ 878 (1034)
T KOG0608|consen 863 EMLVGQPPFLADTPGE 878 (1034)
T ss_pred HHhhCCCCccCCCCCc
Confidence 9999999987655443
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-26 Score=233.08 Aligned_cols=211 Identities=36% Similarity=0.581 Sum_probs=183.4
Q ss_pred ecccCceeEEEEEeec-CcEEEEEEecCCCch-hHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEeecCCCChhH
Q 003254 525 LGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQ-GMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDY 602 (836)
Q Consensus 525 lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~ 602 (836)
||+|.+|.||++...+ ++.+++|++...... ..+.+.+|+..++.++|++++++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999865 899999998765432 35779999999999999999999999999999999999999999999
Q ss_pred HHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecC-CCCceeeccCcccccCCCccccccccc
Q 003254 603 FIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-TMNPKISDFGLARSFGLDQTEANTKRV 681 (836)
Q Consensus 603 ~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~-~~~~kl~DFgla~~~~~~~~~~~~~~~ 681 (836)
++.... ..+++..+..++.++++++++||+.+ ++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~ 153 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTI 153 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcc
Confidence 985432 46889999999999999999999998 999999999999999 89999999999987643221 12234
Q ss_pred cccccccCcccccCC-ccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccccccCCCChH
Q 003254 682 VGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDNSCSFS 760 (836)
Q Consensus 682 ~gt~~y~aPE~~~~~-~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 760 (836)
.+...|++||.+... ..+.+.|+|++|+++++|
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------- 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------- 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence 577899999999877 788999999999999999
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 003254 761 EALRCIQVGLLCVQQRPEDRPNMSSVVLML 790 (836)
Q Consensus 761 ~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L 790 (836)
..+.+++..|++.+|++||++.++++.|
T Consensus 188 --~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 --PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred --HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 3467899999999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-27 Score=227.97 Aligned_cols=201 Identities=26% Similarity=0.371 Sum_probs=165.7
Q ss_pred cccccccCeecccCceeEEEEEee-cCcEEEEEEecCC-CchhHHHHHHHHHHHHhh-cCCceeeEEeEEeeCCeeeEEE
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG-SGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDERMLIY 592 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 592 (836)
.++......||+|++|.|-|-++. +|+..|+|++... ..+..++..+|+.+..+. .+|.+|+++|........++.|
T Consensus 45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcM 124 (282)
T KOG0984|consen 45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICM 124 (282)
T ss_pred hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeH
Confidence 345555678999999999998875 4899999999765 445667788888887665 6999999999999999999999
Q ss_pred eecCCCChhHHHhhc-cCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCC
Q 003254 593 EYLPNKSLDYFIFDT-TRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (836)
Q Consensus 593 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~ 671 (836)
|.|.- +|+.+-.+. .+...+++..+-+|+..|.+||.|||++- .++|||+||+|||++.+|++||+|||.+-.+..
T Consensus 125 E~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d 201 (282)
T KOG0984|consen 125 ELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVD 201 (282)
T ss_pred HHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehh
Confidence 99954 777665442 34567889999999999999999999975 599999999999999999999999999876532
Q ss_pred CccccccccccccccccCcccccC----CccCccccccchhhhhhhhhhCCCCCC
Q 003254 672 DQTEANTKRVVGTYGYMSPEYAID----GLFSVKSDVFSFGVLVLEIICGKKNRG 722 (836)
Q Consensus 672 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~t~ksDVwS~GvvL~elltG~~p~~ 722 (836)
.- ......|-..|||||.+.. ..|+.|+||||||+.+.||.+++.|+.
T Consensus 202 Si---Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~ 253 (282)
T KOG0984|consen 202 SI---AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYE 253 (282)
T ss_pred hh---HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccc
Confidence 21 1222456778999999853 368999999999999999999999853
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.9e-28 Score=238.92 Aligned_cols=265 Identities=21% Similarity=0.308 Sum_probs=192.7
Q ss_pred ccccCeecccCceeEEEEEeec-CcEEEEEEecCC--CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeC-----CeeeE
Q 003254 519 FSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR-----DERML 590 (836)
Q Consensus 519 f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~~~l 590 (836)
.+..+.||-|+||.||..+++. |+.||+|++... +-...+.+.+|++++.-++|.|++..++...-. +++|.
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 3446789999999999999864 999999998543 223457888999999999999999888765332 34677
Q ss_pred EEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccC
Q 003254 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (836)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~ 670 (836)
|.|.|.. +|...+. ..+.++-..+.-+..||++||+|||+.+ |.||||||.|.|++.|-.+||+|||+++.-.
T Consensus 135 ~TELmQS-DLHKIIV---SPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee 207 (449)
T KOG0664|consen 135 LTELMQS-DLHKIIV---SPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWD 207 (449)
T ss_pred HHHHHHh-hhhheec---cCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccc
Confidence 8887754 6666663 3456888888889999999999999998 9999999999999999999999999999765
Q ss_pred CCccccccccccccccccCcccccCC-ccCccccccchhhhhhhhhhCCCCCCCCCCccccchhh--------hhHHhhh
Q 003254 671 LDQTEANTKRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLG--------HAWRLWI 741 (836)
Q Consensus 671 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~--------~~~~~~~ 741 (836)
.++....+ ..+-|..|+|||++++. .|+.+.||||.||++.||+-.+..|....+....+++- .+.+..-
T Consensus 208 ~d~~~hMT-qEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~AC 286 (449)
T KOG0664|consen 208 QRDRLNMT-HEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYAC 286 (449)
T ss_pred hhhhhhhH-HHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHh
Confidence 44443333 34668899999999986 59999999999999999998887665443333222211 1111111
Q ss_pred ccCchhhccccccC---------CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 003254 742 EERPLELIDQSLDN---------SCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLS 791 (836)
Q Consensus 742 ~~~~~~~~d~~l~~---------~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~ 791 (836)
++....++....+. ........+.+++.++++..||++|.+..+.+..+-
T Consensus 287 EGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 287 EGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred hhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 11111111111111 011122234567888899999999999999887664
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-26 Score=223.47 Aligned_cols=257 Identities=21% Similarity=0.321 Sum_probs=192.3
Q ss_pred hcccccccCeecccCceeEEEEEe-ecCcEEEEEEecCCCchhHHHHHHHHHHHHhhc-CCceeeEEeEEeeCC--eeeE
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGML-IEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQRD--ERML 590 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~--~~~l 590 (836)
..++|++.+++|+|.++.||.|.. .++++++||+++.. ..+.+.+|+++|..+. ||||+++++...+.. ...|
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 457899999999999999999985 45888999999643 3567899999999997 999999999987654 4679
Q ss_pred EEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecC-CCCceeeccCccccc
Q 003254 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-TMNPKISDFGLARSF 669 (836)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~-~~~~kl~DFgla~~~ 669 (836)
|+||+.+.+...+- ..|+..++..++.++++||.|+|+.| |.|||+||+|++||. .-.++|.|+|+|..+
T Consensus 113 iFE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
T ss_pred HhhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhc
Confidence 99999998875554 35778889999999999999999999 999999999999995 567999999999987
Q ss_pred CCCccccccccccccccccCcccccCC-ccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCch--
Q 003254 670 GLDQTEANTKRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPL-- 746 (836)
Q Consensus 670 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-- 746 (836)
....... ..+.+..|.-||.+.+- .|+..-|+|||||+|..|+..+.||-..... .+.++..+. .+..+...
T Consensus 184 Hp~~eYn---VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN-~DQLVkIak-VLGt~el~~Y 258 (338)
T KOG0668|consen 184 HPGKEYN---VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN-YDQLVKIAK-VLGTDELYAY 258 (338)
T ss_pred CCCceee---eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCC-HHHHHHHHH-HhChHHHHHH
Confidence 6554322 24567788899998765 4788899999999999999999997432222 122221111 00000000
Q ss_pred -----hhccccccC---------------CCChH-HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 747 -----ELIDQSLDN---------------SCSFS-EALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 747 -----~~~d~~l~~---------------~~~~~-~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
-.+|+.... ..+.. ...++++++...|..|-++|||++|.++
T Consensus 259 l~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 259 LNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 001111100 00001 1245778899999999999999999864
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.9e-26 Score=243.71 Aligned_cols=207 Identities=20% Similarity=0.255 Sum_probs=173.8
Q ss_pred ccHHHHHhhcccccccCeecccCceeEEEEEeec-CcEEEEEEecCCCchhHHHHHHHHHHHHhhcC------CceeeEE
Q 003254 507 FDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQH------RNLVKLL 579 (836)
Q Consensus 507 ~~~~~l~~a~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H------~niv~l~ 579 (836)
+.+..-+.....|.+....|+|-|+.|.+|.... |+.||||++..+. ...+.=+.|+++|++|+. -|+++++
T Consensus 422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~ 500 (752)
T KOG0670|consen 422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLF 500 (752)
T ss_pred EEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHH
Confidence 4445555666889998999999999999999765 8899999997653 334455789999999962 4789999
Q ss_pred eEEeeCCeeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecC-CCCc
Q 003254 580 GCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-TMNP 658 (836)
Q Consensus 580 g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~-~~~~ 658 (836)
..|...+++|||||-+. -+|.++|....+.--|....+..++.|+.-||..|...+ |+|.||||.|||+++ ...+
T Consensus 501 r~F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iL 576 (752)
T KOG0670|consen 501 RHFKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNIL 576 (752)
T ss_pred HHhhhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCccee
Confidence 99999999999999874 488899988777777888999999999999999999888 999999999999986 5679
Q ss_pred eeeccCcccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCC
Q 003254 659 KISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRG 722 (836)
Q Consensus 659 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~ 722 (836)
||||||.|........ ..+..+..|.|||++.|.+|+...|+||.||+||||+||+..|.
T Consensus 577 KLCDfGSA~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFp 636 (752)
T KOG0670|consen 577 KLCDFGSASFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFP 636 (752)
T ss_pred eeccCccccccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecC
Confidence 9999999987542221 12344668999999999999999999999999999999997654
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.5e-25 Score=203.19 Aligned_cols=115 Identities=44% Similarity=0.724 Sum_probs=100.5
Q ss_pred ccccCCCeEEeCCCeEEEeeecCCCCCceEEEEEEeecCCCcEEEeecCCCCCCCCcceEEEeeccCceEEEEcCCCCeE
Q 003254 52 QSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPLSDRSGVLRINGERNGILVLLNSTNDTV 131 (836)
Q Consensus 52 ~~l~~~~~l~S~~g~F~lgF~~~~~~~~~ylgiw~~~~~~~t~vW~Anr~~p~~~~~~~l~~~~~~~g~l~l~~~~~~~~ 131 (836)
++|.+|++|+|++|.|++|||.+......+.+|||.+++ +++||.||++.| ....+.|.|. .||+|+|+|.+|.++
T Consensus 2 ~~l~~~~~l~s~~~~f~~G~~~~~~q~~dgnlv~~~~~~-~~~vW~snt~~~-~~~~~~l~l~--~dGnLvl~~~~g~~v 77 (116)
T cd00028 2 NPLSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGSS-RTVVWVANRDNP-SGSSCTLTLQ--SDGNLVIYDGSGTVV 77 (116)
T ss_pred cCcCCCCEEEeCCCcEEEecccCCCCCCeEEEEEEeCCC-CeEEEECCCCCC-CCCCEEEEEe--cCCCeEEEcCCCcEE
Confidence 568889999999999999999997654589999999887 899999999999 4455778887 899999999999999
Q ss_pred EeecccCCCCcceEEEecCCCeEEecCCCCCCCcceeeeccCC
Q 003254 132 WSSNSSISAQKPVAALMESGNLVVKDGKDNNPDNILWQSFDYP 174 (836)
Q Consensus 132 wst~~~~~~~~~~a~lld~GNlvl~~~~~~~~~~~~WqSFd~P 174 (836)
|++++.......+|+|+|+|||||++.. +++||||||||
T Consensus 78 W~S~~~~~~~~~~~~L~ddGnlvl~~~~----~~~~W~Sf~~P 116 (116)
T cd00028 78 WSSNTTRVNGNYVLVLLDDGNLVLYDSD----GNFLWQSFDYP 116 (116)
T ss_pred EEecccCCCCceEEEEeCCCCEEEECCC----CCEEEcCCCCC
Confidence 9999764345668899999999999874 78899999999
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.7e-26 Score=245.51 Aligned_cols=195 Identities=27% Similarity=0.386 Sum_probs=165.1
Q ss_pred ccccccCeecccCceeEEEEEeec-CcEEEEEEecCCCc--------hhHHHHHHHHHHHHhhc---CCceeeEEeEEee
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSG--------QGMEEFKNEVLLIAKLQ---HRNLVKLLGCCTQ 584 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~--------~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~ 584 (836)
.+|+..+.+|+|+||.|+.++++. ..+|+||.+.+..- ...-..-.|+.||..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 357888999999999999999876 56799998865421 11123456999999997 9999999999999
Q ss_pred CCeeeEEEeec-CCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeecc
Q 003254 585 RDERMLIYEYL-PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDF 663 (836)
Q Consensus 585 ~~~~~lV~Ey~-~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DF 663 (836)
.+.++|++|-- ++-+|.+++ .....+++.++..|++||+.|+++||+++ |||||||-+|+.++.+|-+||.||
T Consensus 641 dd~yyl~te~hg~gIDLFd~I---E~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFI---EFKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred CCeeEEEecCCCCCcchhhhh---hccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeec
Confidence 99999999975 445777777 34456999999999999999999999999 999999999999999999999999
Q ss_pred CcccccCCCccccccccccccccccCcccccCCccCc-cccccchhhhhhhhhhCCCCC
Q 003254 664 GLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSV-KSDVFSFGVLVLEIICGKKNR 721 (836)
Q Consensus 664 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~-ksDVwS~GvvL~elltG~~p~ 721 (836)
|.+...... ....++||.+|.|||++.+.+|-- .-|||++|++||-++-...|+
T Consensus 715 gsaa~~ksg----pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy 769 (772)
T KOG1152|consen 715 GSAAYTKSG----PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY 769 (772)
T ss_pred cchhhhcCC----CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence 999875432 344589999999999999988754 479999999999998877775
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.9e-25 Score=226.78 Aligned_cols=198 Identities=34% Similarity=0.471 Sum_probs=171.4
Q ss_pred ccccCeecccCceeEEEEEeec-CcEEEEEEecCCCch-hHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEeecC
Q 003254 519 FSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQ-GMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLP 596 (836)
Q Consensus 519 f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 596 (836)
|...+.||.|++|.||++...+ ++.+++|.+...... ..+.+.+|++.+.+++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4556789999999999999876 889999999766544 67789999999999999999999999999999999999999
Q ss_pred CCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcccc
Q 003254 597 NKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEA 676 (836)
Q Consensus 597 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~~ 676 (836)
+++|.+++..... .+++..+..++.+++.++.+||+.+ ++|+||+|+||+++.++.++|+|||++..+......
T Consensus 81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~- 154 (225)
T smart00221 81 GGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA- 154 (225)
T ss_pred CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-
Confidence 9999998854321 1789999999999999999999987 999999999999999999999999999876543211
Q ss_pred ccccccccccccCcccc-cCCccCccccccchhhhhhhhhhCCCCCC
Q 003254 677 NTKRVVGTYGYMSPEYA-IDGLFSVKSDVFSFGVLVLEIICGKKNRG 722 (836)
Q Consensus 677 ~~~~~~gt~~y~aPE~~-~~~~~t~ksDVwS~GvvL~elltG~~p~~ 722 (836)
......++..|++||.+ ....++.++|||+||++++||++|+.|+.
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~ 201 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS 201 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence 22335677889999998 66778889999999999999999999973
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-26 Score=255.23 Aligned_cols=252 Identities=25% Similarity=0.361 Sum_probs=201.9
Q ss_pred hcccccccCeecccCceeEEEEEeec-CcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEe
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 593 (836)
-.++|+....+|.|.||.|||++... ++..|+|.++-.......-.++|+.+++..+||||+.++|.+......++.||
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 44678888999999999999999865 88899999988877778888999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCc
Q 003254 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (836)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~ 673 (836)
|+.+|+|.+.-+ -..++++.++..+.+..++||+|||+.+ -+|||||-.|||+++.+.+|++|||.+-.+..
T Consensus 93 ycgggslQdiy~---~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqita-- 164 (829)
T KOG0576|consen 93 YCGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITA-- 164 (829)
T ss_pred ecCCCcccceee---ecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhh--
Confidence 999999988763 3568999999999999999999999998 79999999999999999999999999876642
Q ss_pred cccccccccccccccCccccc---CCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhc--cCchhh
Q 003254 674 TEANTKRVVGTYGYMSPEYAI---DGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIE--ERPLEL 748 (836)
Q Consensus 674 ~~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 748 (836)
.-...+.+.||+.|||||+.. .+.|..++|||+.|+...|+---++|.-..++- .+.-...+ ..+..+
T Consensus 165 ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm-------r~l~LmTkS~~qpp~l 237 (829)
T KOG0576|consen 165 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM-------RALFLMTKSGFQPPTL 237 (829)
T ss_pred hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH-------HHHHHhhccCCCCCcc
Confidence 223344578999999999874 567999999999999999997766663211111 11111110 011111
Q ss_pred ccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 749 IDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 749 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
-|+. .-...+-++++.|+..+|++||++..++.
T Consensus 238 kDk~-------kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 238 KDKT-------KWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred cCCc-------cchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 1111 12234678999999999999999987553
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-25 Score=227.02 Aligned_cols=259 Identities=25% Similarity=0.314 Sum_probs=189.3
Q ss_pred ccccccCeecccCceeEEEEEe-ecCcEEEEEEecCC--CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeC------Ce
Q 003254 517 DNFSEKNKLGEGGFGPVYKGML-IEGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR------DE 587 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~-~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~~ 587 (836)
.+|..+..+|.|.- .|..+.+ -.++.||+|++... .....+...+|...+..++|+|+++++.++.-. .+
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 45666778888888 5555543 24889999987544 234556788999999999999999999998543 35
Q ss_pred eeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCccc
Q 003254 588 RMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667 (836)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~ 667 (836)
.++|||+|.. +|...+. -.++-..+..+..|++.|++|||+.+ |+||||||+||++..+..+||.|||+|+
T Consensus 96 ~y~v~e~m~~-nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 96 VYLVMELMDA-NLCQVIL-----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred HHHHHHhhhh-HHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhc
Confidence 7999999965 7777774 23677888899999999999999998 9999999999999999999999999998
Q ss_pred ccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccc----------------cc
Q 003254 668 SFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHD----------------HN 731 (836)
Q Consensus 668 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~----------------~~ 731 (836)
.-..+ -.....+.+..|.|||++.+..+.+.+||||+||++.||++|+.-|.....-++ ..
T Consensus 167 ~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~q 243 (369)
T KOG0665|consen 167 TEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQ 243 (369)
T ss_pred ccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHH
Confidence 64322 233446789999999999988899999999999999999999976542211111 01
Q ss_pred hhhhhHHhhhccCchhh--------ccccccC--CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 732 LLGHAWRLWIEERPLEL--------IDQSLDN--SCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 732 ~~~~~~~~~~~~~~~~~--------~d~~l~~--~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
+...+ +.+....+... .|..... ..+......+.+++.+||-.+|++|.++.+++..
T Consensus 244 L~~~~-r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 244 LQPTV-RNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred hhHHH-HHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 11111 11111221111 1111110 1111233456789999999999999999999875
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.6e-24 Score=227.26 Aligned_cols=131 Identities=27% Similarity=0.388 Sum_probs=108.5
Q ss_pred ccccccCeecccCceeEEEEEeec-CcEEEEEEecCCCchhHHHHHHHHHHHHhhc-----C---CceeeEEeEEee---
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQ-----H---RNLVKLLGCCTQ--- 584 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-----H---~niv~l~g~~~~--- 584 (836)
.+|.+.++||.|.|++||++.+.. .+-||+|+.+. .....+..+.||++|++++ | ..||+|++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS-AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS-AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh-hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 678889999999999999999866 56799998843 3345567789999999984 3 369999999965
Q ss_pred -CCeeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEe
Q 003254 585 -RDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLL 652 (836)
Q Consensus 585 -~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl 652 (836)
+.+.+||+|++.. +|..+|.... -+-++...+.+|++||+.||.|||.++ +|||-||||+|||+
T Consensus 157 NG~HVCMVfEvLGd-nLLklI~~s~-YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 157 NGQHVCMVFEVLGD-NLLKLIKYSN-YRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCcEEEEEehhhhh-HHHHHHHHhC-CCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 5579999999955 6666665433 234788899999999999999999998 69999999999999
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-24 Score=229.18 Aligned_cols=201 Identities=27% Similarity=0.436 Sum_probs=166.5
Q ss_pred HhhcccccccCeecccCceeEEEEEeec----CcEEEEEEecCCCchhHHHHHHHHHHHHhhc-CCceeeEEeEEeeCCe
Q 003254 513 ANATDNFSEKNKLGEGGFGPVYKGMLIE----GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQRDE 587 (836)
Q Consensus 513 ~~a~~~f~~~~~lG~G~fG~Vykg~~~~----g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~ 587 (836)
....+.|..+++||+|.|++||++++.. .+.||+|.+...+ ....+.+|+++|..+. +.||+++.+++...+.
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 3455678889999999999999998743 5679999986654 3466899999999995 9999999999999999
Q ss_pred eeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEec-CCCCceeeccCcc
Q 003254 588 RMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD-NTMNPKISDFGLA 666 (836)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~-~~~~~kl~DFgla 666 (836)
..+|+||+++....++.. .++..++..++..+.+||+++|.+| ||||||||+|+|.+ ..+.-.|.|||+|
T Consensus 110 v~ivlp~~~H~~f~~l~~------~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA 180 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYR------SLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLA 180 (418)
T ss_pred eEEEecccCccCHHHHHh------cCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhH
Confidence 999999999999888874 3668889999999999999999999 99999999999997 4577899999999
Q ss_pred cccCCCc-------------cc-----------------------------cccccccccccccCcccccC-CccCcccc
Q 003254 667 RSFGLDQ-------------TE-----------------------------ANTKRVVGTYGYMSPEYAID-GLFSVKSD 703 (836)
Q Consensus 667 ~~~~~~~-------------~~-----------------------------~~~~~~~gt~~y~aPE~~~~-~~~t~ksD 703 (836)
......+ .. .......||+||.|||++.. ...+.++|
T Consensus 181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD 260 (418)
T KOG1167|consen 181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID 260 (418)
T ss_pred HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence 8321000 00 00011358999999999875 45799999
Q ss_pred ccchhhhhhhhhhCCCCCCCC
Q 003254 704 VFSFGVLVLEIICGKKNRGFN 724 (836)
Q Consensus 704 VwS~GvvL~elltG~~p~~~~ 724 (836)
|||.|||++-+++++.||-..
T Consensus 261 iws~GVI~Lslls~~~PFf~a 281 (418)
T KOG1167|consen 261 IWSAGVILLSLLSRRYPFFKA 281 (418)
T ss_pred eeeccceeehhhccccccccC
Confidence 999999999999999997543
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-23 Score=192.64 Aligned_cols=113 Identities=45% Similarity=0.747 Sum_probs=98.7
Q ss_pred ccccCCCeEEeCCCeEEEeeecCCCCCceEEEEEEeecCCCcEEEeecCCCCCCCCcceEEEeeccCceEEEEcCCCCeE
Q 003254 52 QSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPLSDRSGVLRINGERNGILVLLNSTNDTV 131 (836)
Q Consensus 52 ~~l~~~~~l~S~~g~F~lgF~~~~~~~~~ylgiw~~~~~~~t~vW~Anr~~p~~~~~~~l~~~~~~~g~l~l~~~~~~~~ 131 (836)
+.|..+++|+|++|.|++|||.+... ..+.+|||++.+ +++||+|||+.|+.++ +.|.+. .||+|+|+|.+|.++
T Consensus 2 ~~l~~~~~l~s~~~~f~~G~~~~~~q-~dgnlV~~~~~~-~~~vW~snt~~~~~~~-~~l~l~--~dGnLvl~~~~g~~v 76 (114)
T smart00108 2 NTLSSGQTLVSGNSLFELGFFTLIMQ-NDYNLILYKSSS-RTVVWVANRDNPVSDS-CTLTLQ--SDGNLVLYDGDGRVV 76 (114)
T ss_pred cccCCCCEEecCCCcEeeeccccCCC-CCEEEEEEECCC-CcEEEECCCCCCCCCC-EEEEEe--CCCCEEEEeCCCCEE
Confidence 46788999999999999999998654 678999999887 8999999999998764 678887 899999999999999
Q ss_pred EeecccCCCCcceEEEecCCCeEEecCCCCCCCcceeeeccC
Q 003254 132 WSSNSSISAQKPVAALMESGNLVVKDGKDNNPDNILWQSFDY 173 (836)
Q Consensus 132 wst~~~~~~~~~~a~lld~GNlvl~~~~~~~~~~~~WqSFd~ 173 (836)
|+|++.......+|+|+|+|||||++.. ++++||||||
T Consensus 77 W~S~t~~~~~~~~~~L~ddGnlvl~~~~----~~~~W~Sf~~ 114 (114)
T smart00108 77 WSSNTTGANGNYVLVLLDDGNLVIYDSD----GNFLWQSFDY 114 (114)
T ss_pred EEecccCCCCceEEEEeCCCCEEEECCC----CCEEeCCCCC
Confidence 9999763445567999999999999864 6799999997
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.9e-24 Score=212.28 Aligned_cols=252 Identities=21% Similarity=0.343 Sum_probs=185.6
Q ss_pred ccccccCeecccCceeEEEEEeec-CcEEEEEEecCCCchhHHHHHHHHHHHHhh-cCCceeeEEeE-EeeCCeeeEEEe
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKL-QHRNLVKLLGC-CTQRDERMLIYE 593 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~-~~~~~~~~lV~E 593 (836)
+.|.+.+.||+|.||.+-.+.++. .+.+|+|-+...- ...++|.+|..---.| .|.||+.-+++ +...+.+.+++|
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 578888999999999999999876 6779999886543 3467888888765556 48999988765 455667889999
Q ss_pred ecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEec--CCCCceeeccCcccccCC
Q 003254 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD--NTMNPKISDFGLARSFGL 671 (836)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~--~~~~~kl~DFgla~~~~~ 671 (836)
|++.|+|..-+.. .-+.+....+++.|++.|+.|||+++ +||||||.+||||- +..++||+|||+.+..+.
T Consensus 103 ~aP~gdL~snv~~----~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 103 FAPRGDLRSNVEA----AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred cCccchhhhhcCc----ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 9999999877632 33667777899999999999999999 99999999999993 456899999999886542
Q ss_pred CccccccccccccccccCcccccCC-----ccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCch
Q 003254 672 DQTEANTKRVVGTYGYMSPEYAIDG-----LFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPL 746 (836)
Q Consensus 672 ~~~~~~~~~~~gt~~y~aPE~~~~~-----~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (836)
. .....-+..|.|||..... ...+.+|||+||++++.++||+.|..... ..+..-+.+..|......
T Consensus 176 t-----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~---~~d~~Y~~~~~w~~rk~~ 247 (378)
T KOG1345|consen 176 T-----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKAS---IMDKPYWEWEQWLKRKNP 247 (378)
T ss_pred e-----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhh---ccCchHHHHHHHhcccCc
Confidence 2 2223346689999987532 24677999999999999999999975222 222333455555554443
Q ss_pred hhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 003254 747 ELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLML 790 (836)
Q Consensus 747 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L 790 (836)
.+.+.. ..++ .++.++..+-+..+|++|--..++.++.
T Consensus 248 ~~P~~F--~~fs----~~a~r~Fkk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 248 ALPKKF--NPFS----EKALRLFKKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred cCchhh--cccC----HHHHHHHHHhcCCcccccchhHHHHHHH
Confidence 322211 1112 3455677788889999996666665554
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.5e-24 Score=262.19 Aligned_cols=196 Identities=19% Similarity=0.248 Sum_probs=138.0
Q ss_pred hhcC-CceeeEEeEE-------eeCCeeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcE
Q 003254 569 KLQH-RNLVKLLGCC-------TQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRI 640 (836)
Q Consensus 569 ~l~H-~niv~l~g~~-------~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i 640 (836)
.++| +||+++++++ .+.+..++++||+ +++|.+++... ...+++.+++.++.||++||+|||+++ |
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---I 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQG---I 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 4456 5788888877 2334567888987 55999998532 356899999999999999999999998 9
Q ss_pred EeccCCCCceEecC-------------------CCCceeeccCcccccCCCcc--------------ccccccccccccc
Q 003254 641 IHRDLKASNVLLDN-------------------TMNPKISDFGLARSFGLDQT--------------EANTKRVVGTYGY 687 (836)
Q Consensus 641 vH~DLkp~NILl~~-------------------~~~~kl~DFgla~~~~~~~~--------------~~~~~~~~gt~~y 687 (836)
+||||||+||||+. ++.+||+|||+++....... ........||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999954 45567777777764211000 0001113578899
Q ss_pred cCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccccccCCCChHHHHHHHH
Q 003254 688 MSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQ 767 (836)
Q Consensus 688 ~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~ 767 (836)
+|||++.+..++.++|||||||+||||++|..|+.... .... .... ....+. .........+
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~-----~~~~----~~~~----~~~~~~-----~~~~~~~~~~ 243 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS-----RTMS----SLRH----RVLPPQ-----ILLNWPKEAS 243 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH-----HHHH----HHHH----hhcChh-----hhhcCHHHHH
Confidence 99999999999999999999999999999887643110 0000 0000 000000 0111234567
Q ss_pred HHHHcccCCCCCCCCHHHHHH
Q 003254 768 VGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 768 li~~Cl~~dP~~RPt~~eVl~ 788 (836)
++.+||+.+|.+||+|.||++
T Consensus 244 ~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 244 FCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHhCCCChhhCcChHHHhh
Confidence 888999999999999999975
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.1e-22 Score=202.53 Aligned_cols=166 Identities=16% Similarity=0.165 Sum_probs=123.2
Q ss_pred CChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCccccc
Q 003254 598 KSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEAN 677 (836)
Q Consensus 598 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~ 677 (836)
|+|.+++.. +...+++.++..++.||++||+|||+++ ||+|||+++++.+|+ ||+++.....
T Consensus 1 GsL~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~----- 62 (176)
T smart00750 1 VSLADILEV--RGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE----- 62 (176)
T ss_pred CcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc-----
Confidence 688888853 2456999999999999999999999875 999999999999999 9998865321
Q ss_pred cccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccccccCCC
Q 003254 678 TKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDNSC 757 (836)
Q Consensus 678 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 757 (836)
...|++.|+|||++.+..++.++|||||||++|||++|+.|+...... .... ..+........ + ....
T Consensus 63 --~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~--~~~~----~~~~~~~~~~~--~--~~~~ 130 (176)
T smart00750 63 --QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL--SAIL----EILLNGMPADD--P--RDRS 130 (176)
T ss_pred --cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh--cHHH----HHHHHHhccCC--c--cccc
Confidence 125789999999999999999999999999999999999997432211 0011 11111000000 0 0001
Q ss_pred ChHHH---HHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 003254 758 SFSEA---LRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 793 (836)
Q Consensus 758 ~~~~~---~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 793 (836)
..... ..+.+++.+||+.+|++||++.|+++.+...
T Consensus 131 ~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 131 NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 11111 2588999999999999999999999988643
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-21 Score=214.15 Aligned_cols=176 Identities=19% Similarity=0.207 Sum_probs=134.0
Q ss_pred hhcccccccCeecccCceeEEEEEee--cCcEEEEEEecCC-----CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCC
Q 003254 514 NATDNFSEKNKLGEGGFGPVYKGMLI--EGQEIAVKRLSKG-----SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD 586 (836)
Q Consensus 514 ~a~~~f~~~~~lG~G~fG~Vykg~~~--~g~~vavK~l~~~-----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~ 586 (836)
...++|...+.||+|+||+||+|.+. +++.+|||++... .....+.|.+|++++++++|+|+++.+.. .+
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~ 91 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TG 91 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cC
Confidence 34578999999999999999999875 4777899987533 12235678999999999999999853322 24
Q ss_pred eeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccC-CCCceEecCCCCceeeccCc
Q 003254 587 ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDL-KASNVLLDNTMNPKISDFGL 665 (836)
Q Consensus 587 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DL-kp~NILl~~~~~~kl~DFgl 665 (836)
..+|||||+++++|.. + . . .. ...++.++++||.|||+.+ |+|||| ||+|||++.++.+||+|||+
T Consensus 92 ~~~LVmE~~~G~~L~~-~-~--~---~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGl 158 (365)
T PRK09188 92 KDGLVRGWTEGVPLHL-A-R--P---HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQL 158 (365)
T ss_pred CcEEEEEccCCCCHHH-h-C--c---cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECcc
Confidence 5799999999999962 2 1 1 01 1467889999999999998 999999 99999999999999999999
Q ss_pred ccccCCCccccc------cccccccccccCcccccCCc------cCcccccc
Q 003254 666 ARSFGLDQTEAN------TKRVVGTYGYMSPEYAIDGL------FSVKSDVF 705 (836)
Q Consensus 666 a~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~------~t~ksDVw 705 (836)
++.+........ .....+++.|+|||.+.... .+..+|-|
T Consensus 159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred ceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 998754322111 12456788899999986432 23346666
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.3e-22 Score=198.23 Aligned_cols=247 Identities=21% Similarity=0.313 Sum_probs=189.2
Q ss_pred cCeecccCceeEEEEEeecCcEEEEEEecCC--CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEeecCCCC
Q 003254 522 KNKLGEGGFGPVYKGMLIEGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKS 599 (836)
Q Consensus 522 ~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gs 599 (836)
..+|.+...|..|+|++ +|..+++|++... .....+.|.+|.-.++.+.||||++++|.|.......++..||+.|+
T Consensus 195 ~tkl~e~hsgelwrgrw-qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs 273 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRW-QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS 273 (448)
T ss_pred hhhhccCCCcccccccc-cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence 45788999999999999 6777888887644 33445789999999999999999999999999999999999999999
Q ss_pred hhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCccccccc
Q 003254 600 LDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTK 679 (836)
Q Consensus 600 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~ 679 (836)
|...+++. .+-.++..++.+++.+||+|++|||+..+ -|.---|.++.+++|++.+++|+-=. ++. + -...
T Consensus 274 lynvlhe~-t~vvvd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltarismad-~kf-----s-fqe~ 344 (448)
T KOG0195|consen 274 LYNVLHEQ-TSVVVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARISMAD-TKF-----S-FQEV 344 (448)
T ss_pred HHHHHhcC-ccEEEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhheeccc-cee-----e-eecc
Confidence 99999654 34467888999999999999999999873 24445689999999999998885211 110 0 0111
Q ss_pred cccccccccCcccccCCccC---ccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccccccCC
Q 003254 680 RVVGTYGYMSPEYAIDGLFS---VKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDNS 756 (836)
Q Consensus 680 ~~~gt~~y~aPE~~~~~~~t---~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 756 (836)
...-.+.||+||.+..++-+ .++|+|||.++||||.|...||....+-+. -.++.-..|+..
T Consensus 345 gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmec---------------gmkialeglrv~ 409 (448)
T KOG0195|consen 345 GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMEC---------------GMKIALEGLRVH 409 (448)
T ss_pred ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhh---------------hhhhhhcccccc
Confidence 23346889999999877643 578999999999999999999753222111 011222233334
Q ss_pred CChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 003254 757 CSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 793 (836)
Q Consensus 757 ~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 793 (836)
.++.....+.+|+.-|+..||.+||.+..|+-+||..
T Consensus 410 ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 410 IPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred CCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 4555556678999999999999999999999999864
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.9e-20 Score=201.13 Aligned_cols=260 Identities=22% Similarity=0.225 Sum_probs=191.0
Q ss_pred cccccCeecccCceeEEEEEeecC--cEEEEEEecCCCchhHHHHHHHHHHHHhhcC----CceeeEEeEE-eeCCeeeE
Q 003254 518 NFSEKNKLGEGGFGPVYKGMLIEG--QEIAVKRLSKGSGQGMEEFKNEVLLIAKLQH----RNLVKLLGCC-TQRDERML 590 (836)
Q Consensus 518 ~f~~~~~lG~G~fG~Vykg~~~~g--~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H----~niv~l~g~~-~~~~~~~l 590 (836)
+|.+.++||+|+||.||++..... ..+|+|............+..|+.++..+.+ +++.++++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999997664 4789998766543333378889999998873 5888899888 47778899
Q ss_pred EEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCC-----CCceeeccCc
Q 003254 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNT-----MNPKISDFGL 665 (836)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~-----~~~kl~DFgl 665 (836)
||+.+ +.+|.++..... .+.++....++|+.|++.+|++||+.+ ++||||||.|+++... ..+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99986 668888764433 567999999999999999999999999 9999999999999754 4699999999
Q ss_pred cc--ccCCCcc----cc-c-cccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhH
Q 003254 666 AR--SFGLDQT----EA-N-TKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAW 737 (836)
Q Consensus 666 a~--~~~~~~~----~~-~-~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~ 737 (836)
++ .+..... .. . .....||..|.++....+...+.+.|+||++.++.|++.|..|..........
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~------- 246 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLK------- 246 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchH-------
Confidence 99 3321211 11 1 22356999999999999999999999999999999999999885322221110
Q ss_pred HhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 003254 738 RLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 794 (836)
Q Consensus 738 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 794 (836)
..+........... ...... ..+.++...+-..+..++|....+...|++..
T Consensus 247 ~~~~~~~~~~~~~~--~~~~~~---~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~ 298 (322)
T KOG1164|consen 247 SKFEKDPRKLLTDR--FGDLKP---EEFAKILEYIDSLDYEDKPDYEKLAELLKDVF 298 (322)
T ss_pred HHHHHHhhhhcccc--ccCCCh---HHHHHHHHHhhccCCcCCCCHHHHHHHHHHHH
Confidence 00111111111111 111122 23444444555589999999999999987653
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.4e-19 Score=194.33 Aligned_cols=262 Identities=29% Similarity=0.385 Sum_probs=196.1
Q ss_pred ccccCeecccCceeEEEEEeecCcEEEEEEecCCCch---hHHHHHHHHHHHHhhcCC-ceeeEEeEEeeCCeeeEEEee
Q 003254 519 FSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQ---GMEEFKNEVLLIAKLQHR-NLVKLLGCCTQRDERMLIYEY 594 (836)
Q Consensus 519 f~~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~~---~~~~~~~Ei~~l~~l~H~-niv~l~g~~~~~~~~~lV~Ey 594 (836)
|...+.||.|+||.||++... ..+++|.+...... ....+.+|+.++..+.|+ +++++.+.+......++++||
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 566778999999999999986 78899998765432 467899999999999988 799999999777778999999
Q ss_pred cCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCC-CceeeccCcccccCCCc
Q 003254 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTM-NPKISDFGLARSFGLDQ 673 (836)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~-~~kl~DFgla~~~~~~~ 673 (836)
+.++++.+++........+.......++.+++.++.|+|+.+ ++|||+||+||+++... .+++.|||+++.+....
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999966633211126888999999999999999999998 99999999999999988 79999999998664433
Q ss_pred ccc----ccccccccccccCcccccC---CccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCch
Q 003254 674 TEA----NTKRVVGTYGYMSPEYAID---GLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPL 746 (836)
Q Consensus 674 ~~~----~~~~~~gt~~y~aPE~~~~---~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (836)
... ......|+..|+|||.+.+ .......|+|++|++++++++|..|+...... ................
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~ 233 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---SATSQTLKIILELPTP 233 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc---ccHHHHHHHHHhcCCc
Confidence 221 2345789999999999987 57889999999999999999999985433221 0011111111111100
Q ss_pred hhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 747 ELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 747 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
.................+.+++..|+..+|..|.++.+....
T Consensus 234 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 -SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred -ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000000000001223456789999999999999999987764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1e-20 Score=220.07 Aligned_cols=253 Identities=21% Similarity=0.239 Sum_probs=184.5
Q ss_pred ccCeecccCceeEEEEEeec-CcEEEEEEecC---C--Cc-hhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEe
Q 003254 521 EKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSK---G--SG-QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (836)
Q Consensus 521 ~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~---~--~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 593 (836)
..+.+|.|.+|.|+...... ....+.|.... . .. .....+..|+.+-..++|+|++..+..+.+.....-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 45789999999777766433 33344443321 1 11 111225567777788899999888888777776666699
Q ss_pred ecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCc
Q 003254 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (836)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~ 673 (836)
|++. +|..++.. ...+...++..+++|++.|++|||+.+ |.|||+|++|++++.++.+||+|||.+..+..+.
T Consensus 402 ~~~~-Dlf~~~~~---~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 402 YCPY-DLFSLVMS---NGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred cccH-HHHHHHhc---ccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 9999 99888843 246888999999999999999999999 9999999999999999999999999998876555
Q ss_pred cc--cccccccccccccCcccccCCccCcc-ccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhcc
Q 003254 674 TE--ANTKRVVGTYGYMSPEYAIDGLFSVK-SDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELID 750 (836)
Q Consensus 674 ~~--~~~~~~~gt~~y~aPE~~~~~~~t~k-sDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 750 (836)
+. ......+|+..|+|||.+.+..|.+. .||||.|+++..|++|+.|+......+..................
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~---- 550 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGP---- 550 (601)
T ss_pred chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccCh----
Confidence 44 44556889999999999999999765 799999999999999998865444333221000000000000000
Q ss_pred ccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 751 QSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 751 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
.........+...++.++|+.+|.+|-|+.+|++
T Consensus 551 ----~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 551 ----NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred ----HHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 0111223345678999999999999999999975
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.4e-20 Score=217.32 Aligned_cols=253 Identities=19% Similarity=0.229 Sum_probs=184.6
Q ss_pred cccccCeecccCceeEEEEEeecCcEEEEEEecCCC-chhHHHHHHHHHHHH--hhcCCceeeEEeEEeeCCeeeEEEee
Q 003254 518 NFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGS-GQGMEEFKNEVLLIA--KLQHRNLVKLLGCCTQRDERMLIYEY 594 (836)
Q Consensus 518 ~f~~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~--~l~H~niv~l~g~~~~~~~~~lV~Ey 594 (836)
++...+.||.+.|=+|.++++++|. |+||++-+.. .-..+.|.++++-++ .++|||.+++...-....-.|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5667789999999999999998887 9999986654 334555655554444 45899999999887777788999999
Q ss_pred cCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCC-c
Q 003254 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD-Q 673 (836)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~-~ 673 (836)
..+ +|.+.+ ..+..+...+...|+.|++.||..+|..+ |+|||||.+||||+.-+-+.|+||..-+...-. +
T Consensus 103 vkh-nLyDRl---STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 103 VKH-NLYDRL---STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred Hhh-hhhhhh---ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 876 666666 34556888899999999999999999999 999999999999999999999999887654322 2
Q ss_pred ccccccccc----ccccccCcccccCC----------c-cCccccccchhhhhhhhhhC-CCCCCCCCCccccchhhhhH
Q 003254 674 TEANTKRVV----GTYGYMSPEYAIDG----------L-FSVKSDVFSFGVLVLEIICG-KKNRGFNHADHDHNLLGHAW 737 (836)
Q Consensus 674 ~~~~~~~~~----gt~~y~aPE~~~~~----------~-~t~ksDVwS~GvvL~elltG-~~p~~~~~~~~~~~~~~~~~ 737 (836)
+......+. .-..|+|||.+... . .+++.||||+||++.||++. +++|... .+..+
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS------QL~aY-- 247 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS------QLLAY-- 247 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH------HHHhH--
Confidence 222222222 23479999998431 1 67899999999999999885 6665421 11110
Q ss_pred HhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 003254 738 RLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 794 (836)
Q Consensus 738 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 794 (836)
+.-....+..+++..- ...+..+++.|++.||++|-+++++++.-.|+.
T Consensus 248 r~~~~~~~e~~Le~Ie--------d~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~ 296 (1431)
T KOG1240|consen 248 RSGNADDPEQLLEKIE--------DVSLRNLILSMIQRDPSKRLSAEDYLQKYRGLV 296 (1431)
T ss_pred hccCccCHHHHHHhCc--------CccHHHHHHHHHccCchhccCHHHHHHhhhccc
Confidence 0000111111111111 114678999999999999999999999977653
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.7e-19 Score=182.18 Aligned_cols=172 Identities=13% Similarity=0.149 Sum_probs=133.6
Q ss_pred hcccccccCeecccCceeEEEEEeecCcEEEEEEecCCCchhHH---H------HHHHHHHHHhhcCCceeeEEeEEeeC
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGME---E------FKNEVLLIAKLQHRNLVKLLGCCTQR 585 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~---~------~~~Ei~~l~~l~H~niv~l~g~~~~~ 585 (836)
..++|...+.||.|+||.||.... ++..+|||.++.......+ . +.+|+..+.+++|++|..+..++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 457899999999999999999655 6778999999754332222 2 68999999999999999998886533
Q ss_pred --------CeeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCC
Q 003254 586 --------DERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMN 657 (836)
Q Consensus 586 --------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~ 657 (836)
...+|||||+++.+|.++.. ++. ....+++.+|..+|+.+ ++|||+||+||++++++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g- 172 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG- 172 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-
Confidence 35789999999999977631 222 34569999999999998 99999999999999888
Q ss_pred ceeeccCcccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhh
Q 003254 658 PKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC 716 (836)
Q Consensus 658 ~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt 716 (836)
++|.|||.......+... ..+.....+..++|+|+||+.+..+..
T Consensus 173 i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 173 LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHHH
Confidence 999999988754211110 013344456779999999999887643
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.7e-19 Score=178.95 Aligned_cols=139 Identities=16% Similarity=0.146 Sum_probs=108.4
Q ss_pred cCeecccCceeEEEEEeecCcEEEEEEecCCCch--h-------HHH-----------------HHHHHHHHHhhcCCce
Q 003254 522 KNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQ--G-------MEE-----------------FKNEVLLIAKLQHRNL 575 (836)
Q Consensus 522 ~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~~--~-------~~~-----------------~~~Ei~~l~~l~H~ni 575 (836)
...||+|+||.||+|...+|+.||||+++..... . ... ...|+..+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 3579999999999999888999999998654211 1 112 2349999999988776
Q ss_pred eeEEeEEeeCCeeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhh-hcCCCCcEEeccCCCCceEecC
Q 003254 576 VKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYL-HQDSRLRIIHRDLKASNVLLDN 654 (836)
Q Consensus 576 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivH~DLkp~NILl~~ 654 (836)
.....+.. ...+|||||++++++..... ....++......++.|++.+|.|| |+.+ |+||||||+|||++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-
Confidence 44333222 23489999999987765432 234688899999999999999999 6777 99999999999998
Q ss_pred CCCceeeccCccccc
Q 003254 655 TMNPKISDFGLARSF 669 (836)
Q Consensus 655 ~~~~kl~DFgla~~~ 669 (836)
++.++|+|||++...
T Consensus 153 ~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCcEEEEEccccccC
Confidence 478999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.3e-18 Score=168.83 Aligned_cols=203 Identities=23% Similarity=0.309 Sum_probs=167.5
Q ss_pred cccccccCeecccCceeEEEEEe-ecCcEEEEEEecCCCchhHHHHHHHHHHHHhhcC-CceeeEEeEEeeCCeeeEEEe
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGML-IEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQH-RNLVKLLGCCTQRDERMLIYE 593 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H-~niv~l~g~~~~~~~~~lV~E 593 (836)
..+|..+++||.|+||.+|.|.. .+|.+||||.-+.... ..++..|.++...++| ..|.++..+..+...-.|||+
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 36889999999999999999986 5699999998765433 2467789999999985 678888888899999999999
Q ss_pred ecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEec---CCCCceeeccCcccccC
Q 003254 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD---NTMNPKISDFGLARSFG 670 (836)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~---~~~~~kl~DFgla~~~~ 670 (836)
.+ +-+|+++..-. ...++.+.++-++-|++.-++|+|.++ .+||||||+|+|.. .-..+.+.|||+|+.+.
T Consensus 92 LL-GPsLEdLfnfC--~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFC--SRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred cc-CccHHHHHHHH--hhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhc
Confidence 87 56888776433 345888999999999999999999999 99999999999995 34579999999999875
Q ss_pred CCccc-----cccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCC
Q 003254 671 LDQTE-----ANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHA 726 (836)
Q Consensus 671 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~ 726 (836)
...+. .......||.+|.+-....+...+.+.|+-|+|.+|.++.-|..|+....+
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka 226 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKA 226 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccch
Confidence 32221 112336799999998888888889999999999999999999999764443
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=3e-18 Score=172.88 Aligned_cols=140 Identities=17% Similarity=0.194 Sum_probs=111.2
Q ss_pred cCeecccCceeEEEEEeecCcEEEEEEecCCCchh--------------------------HHHHHHHHHHHHhhcCCce
Q 003254 522 KNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQG--------------------------MEEFKNEVLLIAKLQHRNL 575 (836)
Q Consensus 522 ~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~--------------------------~~~~~~Ei~~l~~l~H~ni 575 (836)
.+.||+|++|.||+|+..+|+.||||+++...... ...+..|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46899999999999998789999999987542110 1123578999999999987
Q ss_pred eeEEeEEeeCCeeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhc-CCCCcEEeccCCCCceEecC
Q 003254 576 VKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQ-DSRLRIIHRDLKASNVLLDN 654 (836)
Q Consensus 576 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~DLkp~NILl~~ 654 (836)
.....+... ..+|||||++++++..... ....++......++.+++.++.+||+ .+ |+||||||+||+++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence 544443332 3489999999886544322 12357788899999999999999999 87 99999999999999
Q ss_pred CCCceeeccCcccccC
Q 003254 655 TMNPKISDFGLARSFG 670 (836)
Q Consensus 655 ~~~~kl~DFgla~~~~ 670 (836)
++.++|+|||++....
T Consensus 153 ~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 DGKPYIIDVSQAVELD 168 (190)
T ss_pred CCCEEEEEcccceecC
Confidence 8899999999998764
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.5e-18 Score=174.73 Aligned_cols=203 Identities=21% Similarity=0.310 Sum_probs=169.1
Q ss_pred ccccccCeecccCceeEEEEEe-ecCcEEEEEEecCCCchhHHHHHHHHHHHHhhc-CCceeeEEeEEeeCCeeeEEEee
Q 003254 517 DNFSEKNKLGEGGFGPVYKGML-IEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQRDERMLIYEY 594 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey 594 (836)
-+|.+.++||+|.||.++.|+. -+++.||||.-...++ .-+++.|...++.|. .++|...+-+..++.+-.||+|.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 3678889999999999999984 5699999998654432 356788999999885 68999999888888999999998
Q ss_pred cCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEec-----CCCCceeeccCccccc
Q 003254 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD-----NTMNPKISDFGLARSF 669 (836)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~-----~~~~~kl~DFgla~~~ 669 (836)
+ +-+|+++..- -...++.+.+..+|.|++.-++|+|++. +|.|||||+|+||. +...+.|+|||||+.+
T Consensus 106 L-GPSLEDLFD~--CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 106 L-GPSLEDLFDL--CGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred h-CcCHHHHHHH--hcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 7 5588777632 3456899999999999999999999998 99999999999995 3456899999999988
Q ss_pred CCCccc-----cccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCc
Q 003254 670 GLDQTE-----ANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHAD 727 (836)
Q Consensus 670 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~ 727 (836)
...... ...+...||.+||+-....+...+.+.|.-|+|-++++.|-|..|+....++
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~ 242 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAD 242 (449)
T ss_pred cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCc
Confidence 644332 1234467999999999999999999999999999999999999997654443
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.1e-18 Score=190.47 Aligned_cols=218 Identities=23% Similarity=0.331 Sum_probs=161.5
Q ss_pred HHhhcCCceeeEEeEEeeCCeeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCC
Q 003254 567 IAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLK 646 (836)
Q Consensus 567 l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLk 646 (836)
|+.+.|.|+.+++|.+..+...+.|.+|+..|+|.+.+.. ....++|.....++++|++||+|||... --.|+.++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeec
Confidence 3567899999999999999999999999999999999964 3457899999999999999999999876 23999999
Q ss_pred CCceEecCCCCceeeccCcccccCCCccccccccccccccccCcccccCC-------ccCccccccchhhhhhhhhhCCC
Q 003254 647 ASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDG-------LFSVKSDVFSFGVLVLEIICGKK 719 (836)
Q Consensus 647 p~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~t~ksDVwS~GvvL~elltG~~ 719 (836)
++|+++|....+||+|||+.................-..-|.|||.+.+. ..+.+.||||||++++|+++.+.
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 99999999999999999998765321111111112234579999998763 14677999999999999999999
Q ss_pred CCCCCCCcccc-chhhhhHHhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCCC
Q 003254 720 NRGFNHADHDH-NLLGHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS 795 (836)
Q Consensus 720 p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~ 795 (836)
|+......... .++.. ... .....+-|.+... .+....+..++..||..+|++||++.+|-..++.+..
T Consensus 157 ~~~~~~~~~~~~eii~~----~~~-~~~~~~rP~i~~~--~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 157 PFDLRNLVEDPDEIILR----VKK-GGSNPFRPSIELL--NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred ccccccccCChHHHHHH----HHh-cCCCCcCcchhhh--hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 97654333222 11111 111 0111111111100 0222368899999999999999999999999887643
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.73 E-value=9.7e-18 Score=175.84 Aligned_cols=234 Identities=21% Similarity=0.323 Sum_probs=150.8
Q ss_pred ccccccCeecccCceeEEEEEeec-CcEEEEEEecCCC---chhHHHHHHHHHHHHhhc----------CCceeeEEeEE
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQ----------HRNLVKLLGCC 582 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~----------H~niv~l~g~~ 582 (836)
..+...+.||.|+++.||.+++.+ |+++|||++.... ....+++++|...+..+. |-.++-.++..
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~ 91 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL 91 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence 345566789999999999999976 8999999875443 335667777776665532 22233222222
Q ss_pred e---------eCC--------eeeEEEeecCCCChhHHHhh---ccC-CCcCChhhhHHHHHHHHhhhHhhhcCCCCcEE
Q 003254 583 T---------QRD--------ERMLIYEYLPNKSLDYFIFD---TTR-SKLLDWSKRSHIIAGIARGLLYLHQDSRLRII 641 (836)
Q Consensus 583 ~---------~~~--------~~~lV~Ey~~~gsL~~~l~~---~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iv 641 (836)
. ... ..+++|+-+ .++|..++.- ... ...+....++.+..|+++.+++||+.+ ++
T Consensus 92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lV 167 (288)
T PF14531_consen 92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LV 167 (288)
T ss_dssp EETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred EEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eE
Confidence 1 111 235677776 4577776532 221 123445667788899999999999999 99
Q ss_pred eccCCCCceEecCCCCceeeccCcccccCCCccccccccccccccccCcccccC--------CccCccccccchhhhhhh
Q 003254 642 HRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAID--------GLFSVKSDVFSFGVLVLE 713 (836)
Q Consensus 642 H~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~t~ksDVwS~GvvL~e 713 (836)
|+||||+|++++.+|.++|+||+.....+..... ...+..|.+||.... -.++.+.|.|++|+++|.
T Consensus 168 Hgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~ 242 (288)
T PF14531_consen 168 HGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYS 242 (288)
T ss_dssp EST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHH
T ss_pred ecccceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHH
Confidence 9999999999999999999999988765422111 234578999997743 257899999999999999
Q ss_pred hhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCC
Q 003254 714 IICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDR 780 (836)
Q Consensus 714 lltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~R 780 (836)
|++++.|++.......... . -..+. +..+.+.+|+..+|+.+|++|
T Consensus 243 lWC~~lPf~~~~~~~~~~~-------------------~-f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 243 LWCGRLPFGLSSPEADPEW-------------------D-FSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHSS-STCCCGGGSTSGG-------------------G-GTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHHccCCCCCCCccccccc-------------------c-chhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9999999875433322111 1 11333 555667789999999999988
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.73 E-value=3e-18 Score=202.94 Aligned_cols=200 Identities=22% Similarity=0.276 Sum_probs=161.6
Q ss_pred HHhhcccccccCeecccCceeEEEEEeecCcEEEEEEecCCCchhHHHHHHHHHHHHhhc---CCceeeEEeEEeeCCee
Q 003254 512 IANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQ---HRNLVKLLGCCTQRDER 588 (836)
Q Consensus 512 l~~a~~~f~~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~~~~ 588 (836)
.+...+.|.+.+.||+|+||+||+|...+|+.||+|+-+....-. |.-=.+++.+|+ -+-|+++...+.-.+..
T Consensus 693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S 769 (974)
T KOG1166|consen 693 FEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNAS 769 (974)
T ss_pred eeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCcc
Confidence 344567899999999999999999999889999999876554321 111122333333 23455555556667778
Q ss_pred eEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEec-------CCCCceee
Q 003254 589 MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD-------NTMNPKIS 661 (836)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~-------~~~~~kl~ 661 (836)
+||+||.+.|+|.+++. ..+.++|.....++.|+++.+++||..+ |||+||||+|+||. +...++|+
T Consensus 770 ~lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lI 843 (974)
T KOG1166|consen 770 VLVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLI 843 (974)
T ss_pred eeeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEE
Confidence 99999999999999995 5677999999999999999999999998 99999999999993 45579999
Q ss_pred ccCcccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCC
Q 003254 662 DFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKN 720 (836)
Q Consensus 662 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p 720 (836)
|||.+..+..-.........++|-.+-.+|...|.+++.++|-|.++-+++-||.|+.-
T Consensus 844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred ecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 99999877533333455667889999999999999999999999999999999999854
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=6.6e-17 Score=164.27 Aligned_cols=137 Identities=20% Similarity=0.273 Sum_probs=106.9
Q ss_pred ccccCeecccCceeEEEEEeecCcEEEEEEecCCCchhHHHHHHHHHHHHhh-----cCCceeeEEeEEeeCC---e-ee
Q 003254 519 FSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKL-----QHRNLVKLLGCCTQRD---E-RM 589 (836)
Q Consensus 519 f~~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-----~H~niv~l~g~~~~~~---~-~~ 589 (836)
+...+.||+|+||.||. +++....+||++........+.+.+|+.+++.+ +||||++++|++++.. . ..
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 34457899999999996 544333479988765445567899999999999 5799999999998864 3 33
Q ss_pred EEEee--cCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhh-HhhhcCCCCcEEeccCCCCceEecC----CCCceeec
Q 003254 590 LIYEY--LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGL-LYLHQDSRLRIIHRDLKASNVLLDN----TMNPKISD 662 (836)
Q Consensus 590 lV~Ey--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL-~yLH~~~~~~ivH~DLkp~NILl~~----~~~~kl~D 662 (836)
+|+|| +++++|.+++.+ ..+++. ..++.+++.++ +|||+++ |+||||||+|||++. +..++|+|
T Consensus 82 ~I~e~~G~~~~tL~~~l~~----~~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiD 152 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQ----CRYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCD 152 (210)
T ss_pred EEecCCCCcchhHHHHHHc----ccccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEE
Confidence 78999 568999999943 224444 35677888777 9999998 999999999999973 34899999
Q ss_pred cCcc
Q 003254 663 FGLA 666 (836)
Q Consensus 663 Fgla 666 (836)
|+-+
T Consensus 153 g~G~ 156 (210)
T PRK10345 153 NIGE 156 (210)
T ss_pred CCCC
Confidence 5444
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=8.1e-17 Score=160.56 Aligned_cols=183 Identities=20% Similarity=0.140 Sum_probs=136.9
Q ss_pred ccCeecccCceeEEEEEeecCcEEEEEEecCCCch----hHHHHHHHHHHHHhhc-CCceeeEEeEEeeCCeeeEEEeec
Q 003254 521 EKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQ----GMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQRDERMLIYEYL 595 (836)
Q Consensus 521 ~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~~----~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~ 595 (836)
+...|++|+||+||.+.. .+.+++.+.+.....- ....|.+|+++|++++ |+++.+++++ ...+++|||+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 456899999999997765 6788888877654331 1225789999999995 5889999886 4469999999
Q ss_pred CCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccC-CCCceEecCCCCceeeccCcccccCCCcc
Q 003254 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDL-KASNVLLDNTMNPKISDFGLARSFGLDQT 674 (836)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DL-kp~NILl~~~~~~kl~DFgla~~~~~~~~ 674 (836)
.+.+|...+. . ....++.+++++|.++|.++ |+|||| ||+|||+++++.++|+|||++........
T Consensus 81 ~G~~L~~~~~----~------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 81 AGAAMYQRPP----R------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred cCccHHhhhh----h------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 9988864431 0 12357789999999999998 999999 79999999999999999999986543221
Q ss_pred c----c--c-----cccccccccccCcccccCC-ccC-ccccccchhhhhhhhhhCCCCC
Q 003254 675 E----A--N-----TKRVVGTYGYMSPEYAIDG-LFS-VKSDVFSFGVLVLEIICGKKNR 721 (836)
Q Consensus 675 ~----~--~-----~~~~~gt~~y~aPE~~~~~-~~t-~ksDVwS~GvvL~elltG~~p~ 721 (836)
. . . ......++.|++|+...-. ..+ ...+-++-|.-+|.++|++.+.
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~ 207 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH 207 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence 0 0 0 1112356777888754322 223 4568889999999999999874
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.65 E-value=8e-16 Score=157.89 Aligned_cols=134 Identities=21% Similarity=0.278 Sum_probs=113.3
Q ss_pred CeecccCceeEEEEEeecCcEEEEEEecCCCch--------hHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEee
Q 003254 523 NKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQ--------GMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (836)
Q Consensus 523 ~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~~--------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 594 (836)
+.||+|++|.||+|.. .|..+++|+....... ....+.+|+.++..++|+++.....++......++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 7788999986533211 124578899999999999998877777777888999999
Q ss_pred cCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccc
Q 003254 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (836)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~ 668 (836)
+++++|.+++... .. .+..++.+++.+|.+||+.+ ++|+|++|.|||++ ++.++|+|||.+..
T Consensus 81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999888432 12 78899999999999999998 99999999999999 78999999999874
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.65 E-value=9.5e-16 Score=159.56 Aligned_cols=146 Identities=16% Similarity=0.147 Sum_probs=112.5
Q ss_pred hcccccccCeecccCceeEEEEE--eecCcEEEEEEecCCCch------------------------hHHHHHHHHHHHH
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGM--LIEGQEIAVKRLSKGSGQ------------------------GMEEFKNEVLLIA 568 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~--~~~g~~vavK~l~~~~~~------------------------~~~~~~~Ei~~l~ 568 (836)
-...|.+.+.||+|+||.||+|. ..+|+.||+|+++..... ....+..|+..+.
T Consensus 26 ~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~ 105 (237)
T smart00090 26 RGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQ 105 (237)
T ss_pred cCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHH
Confidence 33457788999999999999998 567999999998643210 0123568999999
Q ss_pred hhcCCc--eeeEEeEEeeCCeeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCC
Q 003254 569 KLQHRN--LVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLK 646 (836)
Q Consensus 569 ~l~H~n--iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLk 646 (836)
++.+.. +.++++. ...++||||+++.+|...... ...+...+...++.||+.++.+||+.+ .++|||||
T Consensus 106 ~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dik 176 (237)
T smart00090 106 RLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK---DVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLS 176 (237)
T ss_pred HHHhcCCCCCeeeEe----cCceEEEEEecCCcccccccc---cCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCC
Confidence 997633 3444443 235899999999888665422 234555667899999999999999886 49999999
Q ss_pred CCceEecCCCCceeeccCcccccC
Q 003254 647 ASNVLLDNTMNPKISDFGLARSFG 670 (836)
Q Consensus 647 p~NILl~~~~~~kl~DFgla~~~~ 670 (836)
|+||+++ ++.++|+|||.+....
T Consensus 177 p~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 177 EYNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred hhhEEEE-CCCEEEEEChhhhccC
Confidence 9999999 8899999999988643
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.3e-15 Score=154.79 Aligned_cols=144 Identities=19% Similarity=0.226 Sum_probs=112.8
Q ss_pred HHHhhcccccccCeecccCceeEEEEEeecCcEEEEEEecCCCch----------------------hHHHHHHHHHHHH
Q 003254 511 IIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQ----------------------GMEEFKNEVLLIA 568 (836)
Q Consensus 511 ~l~~a~~~f~~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~~----------------------~~~~~~~Ei~~l~ 568 (836)
++......|...+.||+|+||.||++...+|+.||||++...... ....+..|+.++.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 344444457788999999999999999888999999987543210 1123567899999
Q ss_pred hhcCCc--eeeEEeEEeeCCeeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCC
Q 003254 569 KLQHRN--LVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLK 646 (836)
Q Consensus 569 ~l~H~n--iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLk 646 (836)
.+.|++ +.+.++. ...++||||+++++|..... ......++.+++.++.++|+.+ ++|||||
T Consensus 89 ~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~---------~~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~ 152 (198)
T cd05144 89 ALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRV---------LEDPEEVLDEILEEIVKAYKHG---IIHGDLS 152 (198)
T ss_pred HHHHcCCCCCceeec----CCceEEEEEeCCcchhhccc---------cccHHHHHHHHHHHHHHHHHCC---CCcCCCC
Confidence 998874 4444442 34589999999999866541 1345678899999999999988 9999999
Q ss_pred CCceEecCCCCceeeccCcccccC
Q 003254 647 ASNVLLDNTMNPKISDFGLARSFG 670 (836)
Q Consensus 647 p~NILl~~~~~~kl~DFgla~~~~ 670 (836)
|+||++++++.++|+|||++..+.
T Consensus 153 p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 153 EFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred cccEEEcCCCcEEEEECCccccCC
Confidence 999999999999999999997653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.64 E-value=4.2e-17 Score=181.07 Aligned_cols=230 Identities=26% Similarity=0.292 Sum_probs=174.2
Q ss_pred eecccCceeEEEEEe----ecCcEEEEEEecCCCch--hHHHHHHHHHHHHhhc-CCceeeEEeEEeeCCeeeEEEeecC
Q 003254 524 KLGEGGFGPVYKGML----IEGQEIAVKRLSKGSGQ--GMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQRDERMLIYEYLP 596 (836)
Q Consensus 524 ~lG~G~fG~Vykg~~----~~g~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~~ 596 (836)
.+|+|.||.|+.... ..|.-+|+|.+.+.... .......|..++..++ ||.+|++.-.+......+++.+|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 379999999987553 34677899988665321 1125567888899987 9999999999999999999999999
Q ss_pred CCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcccc
Q 003254 597 NKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEA 676 (836)
Q Consensus 597 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~~ 676 (836)
+|.|...+. .....+......+...++-+++++|+.+ |+|||+|++||+++.+|.+++.|||+++..-...
T Consensus 81 gg~lft~l~---~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~--- 151 (612)
T KOG0603|consen 81 GGDLFTRLS---KEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK--- 151 (612)
T ss_pred cchhhhccc---cCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhh---
Confidence 999877763 3344666677777888999999999998 9999999999999999999999999998653221
Q ss_pred ccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhcccccc--
Q 003254 677 NTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLD-- 754 (836)
Q Consensus 677 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~-- 754 (836)
..+||..|||||++. ....++|-||||++.+||++|..||.. + .+...++
T Consensus 152 ---~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-------~----------------~~~~Il~~~ 203 (612)
T KOG0603|consen 152 ---IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-------D----------------TMKRILKAE 203 (612)
T ss_pred ---hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-------H----------------HHHHHhhhc
Confidence 128999999999998 567789999999999999999999753 0 0001111
Q ss_pred CCCChHHHHHHHHHHHHcccCCCCCCCCH--HHHHHHh
Q 003254 755 NSCSFSEALRCIQVGLLCVQQRPEDRPNM--SSVVLML 790 (836)
Q Consensus 755 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~--~eVl~~L 790 (836)
...+.+....+.+++..+...+|..|--. ..+.+.+
T Consensus 204 ~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik 241 (612)
T KOG0603|consen 204 LEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIK 241 (612)
T ss_pred cCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHh
Confidence 12233334455667777777778777655 3444444
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.8e-15 Score=176.97 Aligned_cols=139 Identities=19% Similarity=0.322 Sum_probs=113.1
Q ss_pred hhcccccccCeecccCceeEEEEEeecCcEEEEEE-ecCCC-------chhHHHHHHHHHHHHhhcCCceeeEEeEEeeC
Q 003254 514 NATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKR-LSKGS-------GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR 585 (836)
Q Consensus 514 ~a~~~f~~~~~lG~G~fG~Vykg~~~~g~~vavK~-l~~~~-------~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~ 585 (836)
.....|...+.||+|+||.||+|.+.... +++|+ ..+.. ....+.+.+|++++..++|++++....++...
T Consensus 330 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~ 408 (535)
T PRK09605 330 EVKRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP 408 (535)
T ss_pred ccccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC
Confidence 34455567789999999999999875443 44443 22211 11235688999999999999999888888777
Q ss_pred CeeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCc
Q 003254 586 DERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGL 665 (836)
Q Consensus 586 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgl 665 (836)
...++||||+++++|.+++. ....++.+++++|.|||+.+ ++||||||+|||+ +++.++|+|||+
T Consensus 409 ~~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGl 473 (535)
T PRK09605 409 EEKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGL 473 (535)
T ss_pred CCCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCcc
Confidence 78899999999999988873 35678999999999999998 9999999999999 678999999999
Q ss_pred ccc
Q 003254 666 ARS 668 (836)
Q Consensus 666 a~~ 668 (836)
++.
T Consensus 474 a~~ 476 (535)
T PRK09605 474 GKY 476 (535)
T ss_pred ccc
Confidence 975
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.7e-15 Score=153.97 Aligned_cols=130 Identities=23% Similarity=0.334 Sum_probs=106.7
Q ss_pred eecccCceeEEEEEeecCcEEEEEEecCCCc--------hhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEeec
Q 003254 524 KLGEGGFGPVYKGMLIEGQEIAVKRLSKGSG--------QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (836)
Q Consensus 524 ~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~--------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 595 (836)
.||+|+||.||+|.+ ++..+++|+...... ...+++.+|++++..++|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 389999999999995 678899998654321 11356778999999999887665555566667789999999
Q ss_pred CCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccc
Q 003254 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (836)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~ 668 (836)
++++|.+++.... . .++.+++.+|.+||+.+ ++|+|++|.||+++ ++.+++.|||++..
T Consensus 80 ~g~~l~~~~~~~~---~-------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN---D-------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH---H-------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999988773211 0 78999999999999998 99999999999999 88999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.61 E-value=1.4e-16 Score=173.74 Aligned_cols=124 Identities=29% Similarity=0.438 Sum_probs=108.9
Q ss_pred eeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcc
Q 003254 587 ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLA 666 (836)
Q Consensus 587 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla 666 (836)
..++.|+++...+|.++|.........++...+.++.|++.|+.| ++ .+|+|+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 478999999999999999766666778899999999999999999 55 899999999999999999999999998
Q ss_pred cccCCCc----cccccccccccccccCcccccCCccCccccccchhhhhhhhhh
Q 003254 667 RSFGLDQ----TEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC 716 (836)
Q Consensus 667 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt 716 (836)
....... .........||..||+||.+.+..|+.|+||||||++|+||+.
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 7764333 1223345789999999999999999999999999999999988
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.58 E-value=5.3e-15 Score=154.74 Aligned_cols=198 Identities=20% Similarity=0.249 Sum_probs=133.2
Q ss_pred cCCceeeEEeEEee---------------------------CCeeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHH
Q 003254 571 QHRNLVKLLGCCTQ---------------------------RDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIA 623 (836)
Q Consensus 571 ~H~niv~l~g~~~~---------------------------~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~ 623 (836)
+|||||++.++|.+ ....|+||.-.+. +|..++.. ...+...+.-++.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~----~~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWT----RHRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhc----CCCchHHHHHHHH
Confidence 58888888876533 2246888887765 77777743 3456667778899
Q ss_pred HHHhhhHhhhcCCCCcEEeccCCCCceEe--cCCC--CceeeccCcccccCCC--ccc--cccccccccccccCcccccC
Q 003254 624 GIARGLLYLHQDSRLRIIHRDLKASNVLL--DNTM--NPKISDFGLARSFGLD--QTE--ANTKRVVGTYGYMSPEYAID 695 (836)
Q Consensus 624 ~ia~gL~yLH~~~~~~ivH~DLkp~NILl--~~~~--~~kl~DFgla~~~~~~--~~~--~~~~~~~gt~~y~aPE~~~~ 695 (836)
|+++|+.|||.++ |.|||+|++|||| |+|. .+.|+|||.+---... +-. ...-..-|...-||||+...
T Consensus 349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 9999999999999 9999999999999 4444 4678999987532210 000 01112346677899999864
Q ss_pred Cc------cCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccccccCCCChHHHHHHHHHH
Q 003254 696 GL------FSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVG 769 (836)
Q Consensus 696 ~~------~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li 769 (836)
.+ --.|+|.|+.|-+.||++....||.. ..+ ..+.... +.+.. -...+......+.+++
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~-rGe--m~L~~r~---Yqe~q---------LPalp~~vpp~~rqlV 490 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYK-RGE--MLLDTRT---YQESQ---------LPALPSRVPPVARQLV 490 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccc-cch--heechhh---hhhhh---------CCCCcccCChHHHHHH
Confidence 32 24689999999999999999999753 111 1110000 11111 1122233334567899
Q ss_pred HHcccCCCCCCCCHHHHHHHhc
Q 003254 770 LLCVQQRPEDRPNMSSVVLMLS 791 (836)
Q Consensus 770 ~~Cl~~dP~~RPt~~eVl~~L~ 791 (836)
...|+.||++||+..-....|.
T Consensus 491 ~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 491 FDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHhcCCccccCCccHHHhHHH
Confidence 9999999999999876665553
|
|
| >PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions [] | Back alignment and domain information |
|---|
Probab=99.56 E-value=2.5e-15 Score=122.74 Aligned_cols=66 Identities=50% Similarity=1.052 Sum_probs=59.1
Q ss_pred ccCCCceEEeeeecCCCCcccccccccCHHHHHHhhhccCceeeeecccccCCCCcccccccccccc
Q 003254 366 CKHGDGFLEHKAVKLPDTRFSWVDKNITLWECKELCSKNCSCTAYANADVRGRGSGCLLWFHDLIDI 432 (836)
Q Consensus 366 C~~~~~f~~~~~~~~p~~~~~~~~~~~s~~~C~~~Cl~~CsC~a~~~~~~~~~~~~C~~w~~~l~~~ 432 (836)
|+.+|+|+++++|++|++....++.+.++++|+..|++||||+||+|.++. ++++|++|+++|+++
T Consensus 1 C~~~d~F~~l~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~Ayay~~~~-~~~~C~lW~~~L~d~ 66 (66)
T PF08276_consen 1 CGSGDGFLKLPNMKLPDFDNAIVDSSVSLEECEKACLSNCSCTAYAYSNLS-GGGGCLLWYGDLVDL 66 (66)
T ss_pred CcCCCEEEEECCeeCCCCcceeeecCCCHHHHHhhcCCCCCEeeEEeeccC-CCCEEEEEcCEeecC
Confidence 556799999999999999877777789999999999999999999998665 678999999999874
|
These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.54 E-value=4.7e-14 Score=135.56 Aligned_cols=135 Identities=22% Similarity=0.219 Sum_probs=114.9
Q ss_pred ccCeecccCceeEEEEEeecCcEEEEEEecCCCchhHHHHHHHHHHHHhhcC--CceeeEEeEEeeCCeeeEEEeecCCC
Q 003254 521 EKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQH--RNLVKLLGCCTQRDERMLIYEYLPNK 598 (836)
Q Consensus 521 ~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H--~niv~l~g~~~~~~~~~lV~Ey~~~g 598 (836)
+.+.||+|.++.||++...+ ..+++|....... ...+.+|+.++..++| .++.+++++....+..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 35689999999999999844 7899999865543 5678999999999987 58999999888888899999999988
Q ss_pred ChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccc
Q 003254 599 SLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (836)
Q Consensus 599 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~ 668 (836)
.+..+ +......++.+++++|++||.....+++|+|++|+||++++.+.+++.|||.+..
T Consensus 79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77433 4556678899999999999987545699999999999999989999999999875
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.53 E-value=3.6e-14 Score=142.69 Aligned_cols=137 Identities=20% Similarity=0.259 Sum_probs=99.6
Q ss_pred cCeecccCceeEEEEEeecCcEEEEEEecCCCch--hHHH----------------------HHHHHHHHHhhcCCc--e
Q 003254 522 KNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQ--GMEE----------------------FKNEVLLIAKLQHRN--L 575 (836)
Q Consensus 522 ~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~~--~~~~----------------------~~~Ei~~l~~l~H~n--i 575 (836)
.+.||+|+||.||++...+|+.||||++...... .... ...|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999999888999999988653211 1111 135666666665433 4
Q ss_pred eeEEeEEeeCCeeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhc-CCCCcEEeccCCCCceEecC
Q 003254 576 VKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQ-DSRLRIIHRDLKASNVLLDN 654 (836)
Q Consensus 576 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~DLkp~NILl~~ 654 (836)
.+.+++ ...++||||++++.+......... .. .+...++.+++.++.++|. .+ |+|+||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence 445543 246899999999654322111100 11 6678899999999999999 77 99999999999999
Q ss_pred CCCceeeccCcccccC
Q 003254 655 TMNPKISDFGLARSFG 670 (836)
Q Consensus 655 ~~~~kl~DFgla~~~~ 670 (836)
++.++|+|||.+....
T Consensus 150 ~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 DGKVYIIDVPQAVEID 165 (187)
T ss_pred CCcEEEEECccccccc
Confidence 8999999999997653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.2e-14 Score=168.88 Aligned_cols=218 Identities=22% Similarity=0.282 Sum_probs=142.5
Q ss_pred hcccccccCeecccCceeEEEEEeec-CcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEe
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 593 (836)
...+|..++.|..|+||.||..+++. .+.+|+|+= +..-- .++ ++.....|.+|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~kiN-kq~li----lRn---ilt~a~npfvv----------------- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKIN-KQNLI----LRN---ILTFAGNPFVV----------------- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhccc-ccchh----hhc---cccccCCccee-----------------
Confidence 44688889999999999999999875 566888432 22110 000 12222233222
Q ss_pred ecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCc
Q 003254 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (836)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~ 673 (836)
|+-...+ ...+++... ++.+++|||+.+ |+|||+||+|.+|+.-|++|+.|||+.+......
T Consensus 136 ----gDc~tll---k~~g~lPvd--------mvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~ 197 (1205)
T KOG0606|consen 136 ----GDCATLL---KNIGPLPVD--------MVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSL 197 (1205)
T ss_pred ----chhhhhc---ccCCCCcch--------hhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhc
Confidence 2222233 122233322 278999999998 9999999999999999999999999987542100
Q ss_pred c-------------ccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhh
Q 003254 674 T-------------EANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLW 740 (836)
Q Consensus 674 ~-------------~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~ 740 (836)
. .-..+..+||+.|+|||++....|...+|-|++|+|+||.+-|..||..+.+++ +.+......
T Consensus 198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee---lfg~visd~ 274 (1205)
T KOG0606|consen 198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE---LFGQVISDD 274 (1205)
T ss_pred cchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH---HHhhhhhhh
Confidence 0 111234689999999999999999999999999999999999999986554432 111111110
Q ss_pred hccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 741 IEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 741 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
+ +.. +.+.....++.+++.+.|+.+|..|--....+++
T Consensus 275 i-----~wp------E~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~ev 312 (1205)
T KOG0606|consen 275 I-----EWP------EEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEV 312 (1205)
T ss_pred c-----ccc------ccCcCCCHHHHHHHHHHHHhChHhhcccchhhhh
Confidence 0 011 1111223456678888899999999644444433
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.49 E-value=2.3e-13 Score=141.94 Aligned_cols=134 Identities=20% Similarity=0.259 Sum_probs=105.0
Q ss_pred Ceec-ccCceeEEEEEeecCcEEEEEEecCCC-------------chhHHHHHHHHHHHHhhcCCce--eeEEeEEeeCC
Q 003254 523 NKLG-EGGFGPVYKGMLIEGQEIAVKRLSKGS-------------GQGMEEFKNEVLLIAKLQHRNL--VKLLGCCTQRD 586 (836)
Q Consensus 523 ~~lG-~G~fG~Vykg~~~~g~~vavK~l~~~~-------------~~~~~~~~~Ei~~l~~l~H~ni--v~l~g~~~~~~ 586 (836)
..|| .|+.|+||++.. .+..++||++.... ......+.+|+.++.+++|+++ ++.+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4688 899999999988 47889999885321 1223567889999999998875 67777654432
Q ss_pred e----eeEEEeecCC-CChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceee
Q 003254 587 E----RMLIYEYLPN-KSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKIS 661 (836)
Q Consensus 587 ~----~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~ 661 (836)
. .++|+||+++ .+|.+++.. ..++. ..+.+|+.+|.+||+.+ |+|+||||.|||++.++.++|+
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~----~~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQE----APLSE----EQWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhc----CCCCH----HHHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence 2 3599999997 688887732 23333 24678999999999998 9999999999999998999999
Q ss_pred ccCcccc
Q 003254 662 DFGLARS 668 (836)
Q Consensus 662 DFgla~~ 668 (836)
|||.+..
T Consensus 185 Dfg~~~~ 191 (239)
T PRK01723 185 DFDRGEL 191 (239)
T ss_pred ECCCccc
Confidence 9999875
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.48 E-value=9.2e-15 Score=170.54 Aligned_cols=255 Identities=23% Similarity=0.297 Sum_probs=186.9
Q ss_pred ccccccCeecccCceeEEEEEeec--CcEEEEEEecCCC--chhHHHHHHHHHHHHhhc-CCceeeEEeEEeeCCeeeEE
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE--GQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQRDERMLI 591 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~--g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV 591 (836)
..|...+.||+|.|+.|-...... ...+|+|.+.... ....+....|..+-..+. |+|++++++...+.+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 456667789999999998877644 3446777665443 333444556788877776 99999999999999999999
Q ss_pred EeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhh-cCCCCcEEeccCCCCceEecCCC-CceeeccCccccc
Q 003254 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLH-QDSRLRIIHRDLKASNVLLDNTM-NPKISDFGLARSF 669 (836)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~ivH~DLkp~NILl~~~~-~~kl~DFgla~~~ 669 (836)
.||..++++...+... .....+......++.|+..++.|+| +.+ +.|+||||+|.+++..+ ..+++|||+|..+
T Consensus 100 ~~~s~g~~~f~~i~~~-~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHP-DSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred cCcccccccccccccC-CccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccc
Confidence 9999999998777311 1113556677789999999999999 777 99999999999999999 9999999999988
Q ss_pred CC-Cccccccccccc-cccccCcccccCC-ccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCch
Q 003254 670 GL-DQTEANTKRVVG-TYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPL 746 (836)
Q Consensus 670 ~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (836)
.. ..........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|............ .+.+....
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~------~~~~~~~~ 249 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYS------SWKSNKGR 249 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccce------eecccccc
Confidence 76 444445556778 9999999999885 446779999999999999999998654333321110 01111100
Q ss_pred hhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 003254 747 ELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVV 787 (836)
Q Consensus 747 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl 787 (836)
........-.....++...++..+|+.|.+.+++.
T Consensus 250 ------~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 250 ------FTQLPWNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred ------cccCccccCChhhhhcccccccCCchhcccccccc
Confidence 00011111123355777788889999999888764
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.35 E-value=3.9e-12 Score=144.13 Aligned_cols=141 Identities=22% Similarity=0.306 Sum_probs=101.6
Q ss_pred cCeecccCceeEEEEEeecCcEEEEEEecCCCchhH----------------------------------------HHHH
Q 003254 522 KNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGM----------------------------------------EEFK 561 (836)
Q Consensus 522 ~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~----------------------------------------~~~~ 561 (836)
.+.||.|++|.||+|++.+|+.||||+.+....... -.|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 367999999999999999999999999865421110 0244
Q ss_pred HHHHHHHhhc----CCceeeEEeEE-eeCCeeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHh-hhHhhhcC
Q 003254 562 NEVLLIAKLQ----HRNLVKLLGCC-TQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIAR-GLLYLHQD 635 (836)
Q Consensus 562 ~Ei~~l~~l~----H~niv~l~g~~-~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~-gL~yLH~~ 635 (836)
+|...+.+++ |.+-+.+-.++ ......+|||||+++++|.+....... .. .+.+++..+++ .+..+|..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHHHHhC
Confidence 5666565553 33333333333 234567999999999999887642211 11 34567777766 47888988
Q ss_pred CCCcEEeccCCCCceEecCCCCceeeccCcccccC
Q 003254 636 SRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (836)
Q Consensus 636 ~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~ 670 (836)
+ ++|+|++|.||++++++.+++.|||++..+.
T Consensus 277 g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 277 G---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred C---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 8 9999999999999999999999999998764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.32 E-value=1.6e-12 Score=133.57 Aligned_cols=204 Identities=22% Similarity=0.286 Sum_probs=140.2
Q ss_pred HHHHHhhcCCceeeEEeEEeeC-----CeeeEEEeecCCCChhHHHhhccC-CCcCChhhhHHHHHHHHhhhHhhhcCCC
Q 003254 564 VLLIAKLQHRNLVKLLGCCTQR-----DERMLIYEYLPNKSLDYFIFDTTR-SKLLDWSKRSHIIAGIARGLLYLHQDSR 637 (836)
Q Consensus 564 i~~l~~l~H~niv~l~g~~~~~-----~~~~lV~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 637 (836)
..-|-.+.|.|||++..|+.+. .+..++.|||..|++..+|....+ ...+......+++-||..||.|||+..
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~- 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD- 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-
Confidence 3445566799999999887543 347889999999999999987543 345777778899999999999999975
Q ss_pred CcEEeccCCCCceEecCCCCceeeccCcccccCCCc---cccccccccccccccCcccccCCccCccccccchhhhhhhh
Q 003254 638 LRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ---TEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 714 (836)
Q Consensus 638 ~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~el 714 (836)
++|+|+++..+.|++..++-+||+--.- ..+.... .........+-++|.|||.-.....+.++|||+||+..+||
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap-~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem 275 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAP-DSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM 275 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCc-cccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence 7799999999999999999998853211 1111000 01112234567899999998888888999999999999999
Q ss_pred hhCCCCCCCCCCccccchhhhhHHhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 715 ICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 715 ltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
.-+..-......... .... . ....-.+...++ ..++..|++.+|..||+|++++.
T Consensus 276 ailEiq~tnseS~~~---~ee~----i-a~~i~~len~lq-----------r~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 276 AILEIQSTNSESKVE---VEEN----I-ANVIIGLENGLQ-----------RGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred HHheeccCCCcceee---hhhh----h-hhheeeccCccc-----------cCcCcccccCCCCCCcchhhhhc
Confidence 877643211111100 0000 0 000001111111 25677899999999999998764
|
|
| >cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Probab=99.29 E-value=2.3e-12 Score=108.64 Aligned_cols=71 Identities=28% Similarity=0.433 Sum_probs=61.8
Q ss_pred ccCCCceEEeeeecCCCCcccccccccCHHHHHHhhhc---cCceeeeecccccCCCCccccccccc-ccccccCCCCcc
Q 003254 366 CKHGDGFLEHKAVKLPDTRFSWVDKNITLWECKELCSK---NCSCTAYANADVRGRGSGCLLWFHDL-IDIKELPESGQD 441 (836)
Q Consensus 366 C~~~~~f~~~~~~~~p~~~~~~~~~~~s~~~C~~~Cl~---~CsC~a~~~~~~~~~~~~C~~w~~~l-~~~~~~~~~~~~ 441 (836)
|...++|+++.+|++|++.. .+++||++.|++ ||||+||+|.+. +.+|.+|++++ ++++.+.+.+.+
T Consensus 5 ~~~~g~fl~~~~~klpd~~~------~s~~eC~~~Cl~~~~nCsC~Aya~~~~---~~gC~~W~~~l~~d~~~~~~~g~~ 75 (80)
T cd00129 5 CKSAGTTLIKIALKIKTTKA------NTADECANRCEKNGLPFSCKAFVFAKA---RKQCLWFPFNSMSGVRKEFSHGFD 75 (80)
T ss_pred eecCCeEEEeecccCCcccc------cCHHHHHHHHhcCCCCCCceeeeccCC---CCCeEEecCcchhhHHhccCCCce
Confidence 44567899999999999754 689999999999 999999999743 36999999999 999888878889
Q ss_pred ceee
Q 003254 442 LFIR 445 (836)
Q Consensus 442 lylr 445 (836)
+|+|
T Consensus 76 Ly~r 79 (80)
T cd00129 76 LYEN 79 (80)
T ss_pred eEeE
Confidence 9987
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.22 E-value=6.2e-11 Score=116.94 Aligned_cols=131 Identities=21% Similarity=0.150 Sum_probs=98.5
Q ss_pred cCeecccCceeEEEEEeecCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCcee-eEEeEEeeCCeeeEEEeecCCCCh
Q 003254 522 KNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLV-KLLGCCTQRDERMLIYEYLPNKSL 600 (836)
Q Consensus 522 ~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv-~l~g~~~~~~~~~lV~Ey~~~gsL 600 (836)
.+.|+.|.++.||+++. .++.+++|....... ....+..|+.++..+.+.+++ +++.+. ....++||||+++.++
T Consensus 3 ~~~l~~G~~~~vy~~~~-~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV-ANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEE-CCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 35789999999999987 478899998754432 233567899999998765554 444443 3346899999999887
Q ss_pred hHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCC--CCcEEeccCCCCceEecCCCCceeeccCcccc
Q 003254 601 DYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDS--RLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (836)
Q Consensus 601 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~ 668 (836)
.... .....++.+++++|+.||..+ ...++|+|++|.||+++ ++.+++.||+.+..
T Consensus 79 ~~~~-----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 79 LTED-----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cccc-----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 5320 112345778999999999986 23469999999999999 66899999999864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Probab=99.13 E-value=5.8e-11 Score=102.62 Aligned_cols=80 Identities=46% Similarity=0.897 Sum_probs=63.8
Q ss_pred CccccCC---CceEEeeeecCCCCcccccccccCHHHHHHhhhccCceeeeecccccCCCCcccccccccccccccCCCC
Q 003254 363 PLDCKHG---DGFLEHKAVKLPDTRFSWVDKNITLWECKELCSKNCSCTAYANADVRGRGSGCLLWFHDLIDIKELPESG 439 (836)
Q Consensus 363 ~l~C~~~---~~f~~~~~~~~p~~~~~~~~~~~s~~~C~~~Cl~~CsC~a~~~~~~~~~~~~C~~w~~~l~~~~~~~~~~ 439 (836)
+++|..+ ++|..+.++++|+..... .+.++++|++.|++||+|+||+|.+ .+++|.+|...+.+.......+
T Consensus 2 ~~~C~~~~~~~~f~~~~~~~~~~~~~~~--~~~s~~~C~~~Cl~nCsC~a~~~~~---~~~~C~~~~~~~~~~~~~~~~~ 76 (84)
T cd01098 2 PLNCGGDGSTDGFLKLPDVKLPDNASAI--TAISLEECREACLSNCSCTAYAYNN---GSGGCLLWNGLLNNLRSLSSGG 76 (84)
T ss_pred CcccCCCCCCCEEEEeCCeeCCCchhhh--ccCCHHHHHHHHhcCCCcceeeecC---CCCeEEEEeceecceEeecCCC
Confidence 4567554 689999999999876543 7789999999999999999999973 3679999999988876544445
Q ss_pred ccceeehh
Q 003254 440 QDLFIRMA 447 (836)
Q Consensus 440 ~~lylr~a 447 (836)
..+|+|++
T Consensus 77 ~~~yiKv~ 84 (84)
T cd01098 77 GTLYLRLA 84 (84)
T ss_pred cEEEEEeC
Confidence 67888763
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.11 E-value=3e-10 Score=130.37 Aligned_cols=143 Identities=17% Similarity=0.228 Sum_probs=94.2
Q ss_pred ccccccCeecccCceeEEEEEeec-CcEEEEEEecCCCchh----------------------------------HH---
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQG----------------------------------ME--- 558 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~~----------------------------------~~--- 558 (836)
..|+. +.||.|++|.||+|++++ |++||||+.+...... .+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45665 689999999999999988 9999999987542110 01
Q ss_pred ---HHHHHHHHHHhhc----CCceeeEEeEEee-CCeeeEEEeecCCCChhHHHhhccCC---CcCChhhhHHHHHHHHh
Q 003254 559 ---EFKNEVLLIAKLQ----HRNLVKLLGCCTQ-RDERMLIYEYLPNKSLDYFIFDTTRS---KLLDWSKRSHIIAGIAR 627 (836)
Q Consensus 559 ---~~~~Ei~~l~~l~----H~niv~l~g~~~~-~~~~~lV~Ey~~~gsL~~~l~~~~~~---~~l~~~~~~~i~~~ia~ 627 (836)
+|.+|+..+.+++ +.+.+.+-.++.+ ....+|||||++|+.+.++..-.... ..+.......++.|
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q--- 275 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ--- 275 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH---
Confidence 2344554454443 4444444344432 45688999999999997643111111 11222222233333
Q ss_pred hhHhhhcCCCCcEEeccCCCCceEecCCC----CceeeccCcccccC
Q 003254 628 GLLYLHQDSRLRIIHRDLKASNVLLDNTM----NPKISDFGLARSFG 670 (836)
Q Consensus 628 gL~yLH~~~~~~ivH~DLkp~NILl~~~~----~~kl~DFgla~~~~ 670 (836)
++..+ ++|+|+||.||+++.++ .+++.|||+...+.
T Consensus 276 ----if~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 276 ----VFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred ----HHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 34455 99999999999999887 99999999998764
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.05 E-value=3.1e-10 Score=126.94 Aligned_cols=247 Identities=23% Similarity=0.284 Sum_probs=173.9
Q ss_pred cccccCeecc--cCceeEEEEEe--e-cCcEEEEEEecCCC--chhHHHHHHHHHHHHhhc-CCceeeEEeEEeeCCeee
Q 003254 518 NFSEKNKLGE--GGFGPVYKGML--I-EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQRDERM 589 (836)
Q Consensus 518 ~f~~~~~lG~--G~fG~Vykg~~--~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~ 589 (836)
.|.....+|. |.+|.||++.. . ++..+|+|+-+... +.....=.+|+....+++ |+|.++....++..+..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 3445567899 99999999987 3 47889999854332 233334456777777774 999999888899999999
Q ss_pred EEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHh----hhHhhhcCCCCcEEeccCCCCceEecCC-CCceeeccC
Q 003254 590 LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIAR----GLLYLHQDSRLRIIHRDLKASNVLLDNT-MNPKISDFG 664 (836)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~----gL~yLH~~~~~~ivH~DLkp~NILl~~~-~~~kl~DFg 664 (836)
+-.|++. .+|..+.+. ....++....+.+..+... ||.++|... ++|-|+||.||++.++ ...+++|||
T Consensus 195 iqtE~~~-~sl~~~~~~--~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 195 IQTELCG-ESLQSYCHT--PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred eeecccc-chhHHhhhc--ccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCcc
Confidence 9999886 566666643 2334666777777777777 999999998 9999999999999998 899999999
Q ss_pred cccccCCCccccc---cccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhh
Q 003254 665 LARSFGLDQTEAN---TKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWI 741 (836)
Q Consensus 665 la~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 741 (836)
+...++....... ..+..+...|++||... +.++.+.|+|++|.++++-.++......... ..|....
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~--------~~W~~~r 339 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKN--------SSWSQLR 339 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCC--------CCccccc
Confidence 9998865432111 12346778899999664 5678899999999999999888755321100 0111111
Q ss_pred cc-CchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 742 EE-RPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 742 ~~-~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
.. .+.+.++.. ..++..++.++++.+|..|++.+.+..
T Consensus 340 ~~~ip~e~~~~~---------s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 340 QGYIPLEFCEGG---------SSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred cccCchhhhcCc---------chhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 11 111222211 122334788899999999998776643
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.04 E-value=9.8e-10 Score=123.93 Aligned_cols=231 Identities=17% Similarity=0.194 Sum_probs=150.0
Q ss_pred ecCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEeecCCCChhHHHhhccCCCcCChhhh
Q 003254 539 IEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKR 618 (836)
Q Consensus 539 ~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~ 618 (836)
.++.+|.|...+...........+-++.++.++||||++++...++....|||.|-+. .|..++.. +.....
T Consensus 35 ~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~~~~v 106 (690)
T KOG1243|consen 35 ADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LGKEEV 106 (690)
T ss_pred ccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hHHHHH
Confidence 3588888888876665445567888999999999999999999999999999999864 45555532 335666
Q ss_pred HHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCccccccccccccccccCcccccCCcc
Q 003254 619 SHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLF 698 (836)
Q Consensus 619 ~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 698 (836)
..-+.||+.||.+||+.+ .++|++|....|+|++.|..||++|.++...... ........--..|..|+.+....
T Consensus 107 ~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~--~~~~~~~~~~~s~~~P~~~~~s~- 181 (690)
T KOG1243|consen 107 CLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGF--NAPAKSLYLIESFDDPEEIDPSE- 181 (690)
T ss_pred HHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccC--CcccccchhhhcccChhhcCccc-
Confidence 778899999999999776 5999999999999999999999999988653211 11111122223456666443221
Q ss_pred CccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCC
Q 003254 699 SVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPE 778 (836)
Q Consensus 699 t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~ 778 (836)
-..|.|.||++++|++.|..+............ . ...+..-+.+... ...... .++++..|....+-
T Consensus 182 -~s~D~~~Lg~li~el~ng~~~~~~~~~~~~~ip-k---------~~~~~~~k~~~~~-~~~r~n-~~~~~~~~~~~~gf 248 (690)
T KOG1243|consen 182 -WSIDSWGLGCLIEELFNGSLLTKTDLSNTGKIP-K---------ALIELYCKKLGAT-ELKRPN-KLRFILECRLLGGF 248 (690)
T ss_pred -cchhhhhHHHHHHHHhCcccCcchhhhccCccc-h---------hHHHHHHHHhccc-cccccc-hhhHHHHHHhcccc
Confidence 345999999999999999432111110000000 0 0001110001000 000011 44666667777777
Q ss_pred CCCCHHHHHHHhcCCCC
Q 003254 779 DRPNMSSVVLMLSGERS 795 (836)
Q Consensus 779 ~RPt~~eVl~~L~~~~~ 795 (836)
-|=..-+++..|+++.-
T Consensus 249 f~n~fvd~~~fLeel~l 265 (690)
T KOG1243|consen 249 FRNDFVDTLLFLEELRL 265 (690)
T ss_pred ccchHHHHHHHHHhccc
Confidence 77777777777776644
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.04 E-value=2.1e-09 Score=107.49 Aligned_cols=137 Identities=12% Similarity=0.095 Sum_probs=98.7
Q ss_pred CeecccCceeEEEEEeec-------CcEEEEEEecCCC------------c----------hhHHHH----HHHHHHHHh
Q 003254 523 NKLGEGGFGPVYKGMLIE-------GQEIAVKRLSKGS------------G----------QGMEEF----KNEVLLIAK 569 (836)
Q Consensus 523 ~~lG~G~fG~Vykg~~~~-------g~~vavK~l~~~~------------~----------~~~~~~----~~Ei~~l~~ 569 (836)
..||.|--+.||.|...+ +..+|||+.+... + ...+.+ ++|+..|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 479999999999998653 4789999864321 0 011223 379999999
Q ss_pred hcC--CceeeEEeEEeeCCeeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhh-hcCCCCcEEeccCC
Q 003254 570 LQH--RNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYL-HQDSRLRIIHRDLK 646 (836)
Q Consensus 570 l~H--~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivH~DLk 646 (836)
+.. -++.+++++ ...+|||||+.+..+..... +...++......+..+++.+|..| |..+ |+|+||+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L---kd~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDLs 152 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL---KDAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADLS 152 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh---hccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCCC
Confidence 863 456666654 56789999998754422111 112344456677889999999999 7777 9999999
Q ss_pred CCceEecCCCCceeeccCcccccC
Q 003254 647 ASNVLLDNTMNPKISDFGLARSFG 670 (836)
Q Consensus 647 p~NILl~~~~~~kl~DFgla~~~~ 670 (836)
+.||++++ +.+.|+|||.+....
T Consensus 153 ~~NIL~~~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 153 EYNMLWHD-GKVWFIDVSQSVEPT 175 (197)
T ss_pred HHHEEEEC-CcEEEEECCCceeCC
Confidence 99999974 679999999987653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.00 E-value=2.4e-09 Score=110.38 Aligned_cols=142 Identities=20% Similarity=0.265 Sum_probs=109.5
Q ss_pred CeecccCceeEEEEEeecCcEEEEEEecCCCc-hhHHHHHHHHHHHHhhcC--CceeeEEeEEeeCC---eeeEEEeecC
Q 003254 523 NKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSG-QGMEEFKNEVLLIAKLQH--RNLVKLLGCCTQRD---ERMLIYEYLP 596 (836)
Q Consensus 523 ~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H--~niv~l~g~~~~~~---~~~lV~Ey~~ 596 (836)
+.|+.|..+.||+++..+|+.+++|....... .....+..|++++..+.+ .++.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56899999999999987778999999755432 245678999999999976 34567777776543 5689999999
Q ss_pred CCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCC----------------------------------------
Q 003254 597 NKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDS---------------------------------------- 636 (836)
Q Consensus 597 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~---------------------------------------- 636 (836)
+.++...+.. ..++...+..++.+++++|.+||+..
T Consensus 84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9888665421 34566777788888888888888531
Q ss_pred -------------CCcEEeccCCCCceEecC--CCCceeeccCcccc
Q 003254 637 -------------RLRIIHRDLKASNVLLDN--TMNPKISDFGLARS 668 (836)
Q Consensus 637 -------------~~~ivH~DLkp~NILl~~--~~~~kl~DFgla~~ 668 (836)
...++|+|+.|.||++++ ++.+.|.||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245799999999999998 56789999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.92 E-value=1.2e-08 Score=98.62 Aligned_cols=131 Identities=22% Similarity=0.329 Sum_probs=100.4
Q ss_pred CeecccCceeEEEEEeecCcEEEEEE-ecCCC--ch-----hHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEee
Q 003254 523 NKLGEGGFGPVYKGMLIEGQEIAVKR-LSKGS--GQ-----GMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (836)
Q Consensus 523 ~~lG~G~fG~Vykg~~~~g~~vavK~-l~~~~--~~-----~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 594 (836)
..+++|+-+.+|.+.+ -|.++++|. +++.- +. ..+.-.+|+.++.+++--.|.-.+=+..+.....|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~-~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDF-LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeec-cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 3588999999999977 344466664 33321 11 123457899999999766665555566677788899999
Q ss_pred cCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccc
Q 003254 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (836)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~ 668 (836)
+++..|.+.+... +..++..|-.-+.-||..+ |+|+||.++||.+..+. +.+.||||+..
T Consensus 81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999998888432 3567778888889999999 99999999999998775 99999999874
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.91 E-value=1.6e-08 Score=97.10 Aligned_cols=143 Identities=23% Similarity=0.298 Sum_probs=106.2
Q ss_pred ccCeecccCceeEEEEEeecCcEEEEEE-ecCCCc-------hhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEE
Q 003254 521 EKNKLGEGGFGPVYKGMLIEGQEIAVKR-LSKGSG-------QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (836)
Q Consensus 521 ~~~~lG~G~fG~Vykg~~~~g~~vavK~-l~~~~~-------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 592 (836)
....|-+|+-+.|+++.. .|+...||. +.+... -..++.++|++++.+++--.|.-..-++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 456899999999999998 677766663 433321 12356788999999988666655555666677778999
Q ss_pred eecCC-CChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCC---CceeeccCcccc
Q 003254 593 EYLPN-KSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTM---NPKISDFGLARS 668 (836)
Q Consensus 593 Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~---~~kl~DFgla~~ 668 (836)
||+++ .++.+++...-... ........++..|-+.+.-||.++ |+|+||..+||+|..++ .+.+.|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 99977 47777776543322 222333678899999999999998 99999999999996443 358999999864
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.91 E-value=1.6e-09 Score=121.43 Aligned_cols=248 Identities=22% Similarity=0.195 Sum_probs=175.2
Q ss_pred cccccccCeecccCceeEEEEEee--cCcEEEEEEecCCCchhHHH--HHHHHHHHHhh-cCCceeeEEeEEeeCCeeeE
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLI--EGQEIAVKRLSKGSGQGMEE--FKNEVLLIAKL-QHRNLVKLLGCCTQRDERML 590 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~--~g~~vavK~l~~~~~~~~~~--~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~l 590 (836)
..+|..+..||.|.|+.|++.... ++..+++|.+.+.......+ -..|+.+...+ .|.++++....+......++
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i 343 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI 343 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC
Confidence 457888899999999999997754 47889999887654332222 24566666666 48999998888888888889
Q ss_pred EEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCC-CCceeeccCccccc
Q 003254 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNT-MNPKISDFGLARSF 669 (836)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~-~~~kl~DFgla~~~ 669 (836)
=-||++++++...+ .-...++...++++..+++.++.++|+.. ++|+|+||+||++..+ +.-++.|||.+..+
T Consensus 344 p~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~~ 417 (524)
T KOG0601|consen 344 PLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTRL 417 (524)
T ss_pred chhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccccccccc
Confidence 99999999887665 22345778889999999999999999888 9999999999999876 88999999998643
Q ss_pred CCCcccccccccccccccc--CcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchh
Q 003254 670 GLDQTEANTKRVVGTYGYM--SPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLE 747 (836)
Q Consensus 670 ~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (836)
..... ......+++ +++......+-.+.|+++||.-+.|.+++..-...... +.....+..
T Consensus 418 ~~~~~-----~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~----------~~~i~~~~~-- 480 (524)
T KOG0601|consen 418 AFSSG-----VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ----------SLTIRSGDT-- 480 (524)
T ss_pred ceecc-----cccccccccccchhhccccccccccccccccccccccccCcccCccccc----------ceeeecccc--
Confidence 21111 112233444 55555667788999999999999999998753211000 000000000
Q ss_pred hccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 003254 748 LIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 794 (836)
Q Consensus 748 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 794 (836)
+. .+ .....+..+...++..++..||.+.+.....+-+.
T Consensus 481 ---p~----~~-~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 481 ---PN----LP-GLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred ---cC----CC-chHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence 00 01 11134556777788999999999988877665443
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.84 E-value=2.9e-08 Score=108.74 Aligned_cols=169 Identities=22% Similarity=0.287 Sum_probs=130.2
Q ss_pred ceeEEEEEee-cCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEee----CCeeeEEEeecCC-CChhHH
Q 003254 530 FGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQ----RDERMLIYEYLPN-KSLDYF 603 (836)
Q Consensus 530 fG~Vykg~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~~lV~Ey~~~-gsL~~~ 603 (836)
-.+.||+... +|..|++||++....+.......-+++++++.|+|+|++..++.. +..+++||+|.++ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 3567898864 699999999965544444455667889999999999999998763 4468999999987 466666
Q ss_pred Hhhcc------------CCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCC
Q 003254 604 IFDTT------------RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (836)
Q Consensus 604 l~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~ 671 (836)
.+... .....++..++.++.|+..||.++|+.| +.-+-|.+++||++.+.+++|+..|....+..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 55322 1234667889999999999999999999 88899999999999999999999888776543
Q ss_pred CccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCC
Q 003254 672 DQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKN 720 (836)
Q Consensus 672 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p 720 (836)
+... -+. --.+-|.=.||.+++.|.||...
T Consensus 446 d~~~----------------~le---~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DPTE----------------PLE---SQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCCc----------------chh---HHhhhhHHHHHHHHHHHhhcccc
Confidence 3210 011 12356888999999999999755
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.73 E-value=5.5e-09 Score=122.67 Aligned_cols=251 Identities=17% Similarity=0.215 Sum_probs=164.8
Q ss_pred hhcccccccCeecccCceeEEEEEeec-CcEEEEEEecCC---CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeee
Q 003254 514 NATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERM 589 (836)
Q Consensus 514 ~a~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 589 (836)
...+.+.+.+-+-.|.++.++.++-.. |...+.|..... .....+..+.+-.++-..+||-+++..--+.......
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 345677777788899999998776432 322333322111 1112222333333333344566666655556677889
Q ss_pred EEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCccccc
Q 003254 590 LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (836)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~ 669 (836)
||++|+.+++|...++.. ...+..-....+..+..+++|||... +.|+|++|.|+|...++..+++||+.....
T Consensus 881 L~~~~~~~~~~~Skl~~~---~~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNS---GCLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred hhhHHhccCCchhhhhcC---CCcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccccc
Confidence 999999999998888543 34555556667777889999999976 899999999999999999999999844332
Q ss_pred CC---------------------Ccc----c----cccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCC
Q 003254 670 GL---------------------DQT----E----ANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKN 720 (836)
Q Consensus 670 ~~---------------------~~~----~----~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p 720 (836)
+. ... . .......+|+.|.+||.+.+......+|.|++|++++|.++|..|
T Consensus 955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen 955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence 10 000 0 112235689999999999999999999999999999999999999
Q ss_pred CCCCCCccccchhhhhHHhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHH
Q 003254 721 RGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMS 784 (836)
Q Consensus 721 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ 784 (836)
|.....+... +..... .... ...+.+...+..+++...+..+|.+|-.|.
T Consensus 1035 ~na~tpq~~f-------~ni~~~-~~~~------p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1035 FNAETPQQIF-------ENILNR-DIPW------PEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCcchhhhh-------hccccC-CCCC------CCCccccChhhhhhhhhhhccCchhccCcc
Confidence 7654433211 000000 0000 011222233455677777888999988776
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.71 E-value=1e-07 Score=95.13 Aligned_cols=126 Identities=26% Similarity=0.346 Sum_probs=84.2
Q ss_pred eEEEEEeecCcEEEEEEecCCC--------------c------------hhHHHHHHHHHHHHhhcCC--ceeeEEeEEe
Q 003254 532 PVYKGMLIEGQEIAVKRLSKGS--------------G------------QGMEEFKNEVLLIAKLQHR--NLVKLLGCCT 583 (836)
Q Consensus 532 ~Vykg~~~~g~~vavK~l~~~~--------------~------------~~~~~~~~Ei~~l~~l~H~--niv~l~g~~~ 583 (836)
.||.|...+|..+|||+.+... . ......++|.+.|.++... ++.+++.+.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4899999999999999875321 0 0122456799999999765 456666542
Q ss_pred eCCeeeEEEeecC--CCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHh-hhcCCCCcEEeccCCCCceEecCCCCcee
Q 003254 584 QRDERMLIYEYLP--NKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLY-LHQDSRLRIIHRDLKASNVLLDNTMNPKI 660 (836)
Q Consensus 584 ~~~~~~lV~Ey~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~y-LH~~~~~~ivH~DLkp~NILl~~~~~~kl 660 (836)
...|||||++ +..+..+. +. .++......++.+++..+.. +|..+ |+|+||.+.||+++++ .+.|
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~-~~----~~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLK-DV----DLSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHH-HC----GGGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred ---CCEEEEEecCCCccchhhHH-hc----cccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence 4579999998 55554433 11 12245567788888886666 46777 9999999999999988 9999
Q ss_pred eccCcccccC
Q 003254 661 SDFGLARSFG 670 (836)
Q Consensus 661 ~DFgla~~~~ 670 (836)
.|||.+....
T Consensus 148 IDf~qav~~~ 157 (188)
T PF01163_consen 148 IDFGQAVDSS 157 (188)
T ss_dssp --GTTEEETT
T ss_pred EecCcceecC
Confidence 9999987643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.69 E-value=2e-07 Score=98.62 Aligned_cols=140 Identities=18% Similarity=0.102 Sum_probs=100.8
Q ss_pred eecccCceeEEEEEeecCcEEEEEEecCCCch-hH----------HHHHHHHHHHHhhcCCc--eeeEEeEEee-----C
Q 003254 524 KLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQ-GM----------EEFKNEVLLIAKLQHRN--LVKLLGCCTQ-----R 585 (836)
Q Consensus 524 ~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~~-~~----------~~~~~Ei~~l~~l~H~n--iv~l~g~~~~-----~ 585 (836)
.+-.-....|++..+ +|+.+.||+....... .. ..+.+|...+.++...+ ..+++++.+. .
T Consensus 29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 344444445777665 7889999977433211 11 24788999999885433 3455566543 2
Q ss_pred CeeeEEEeecCCC-ChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecC-------CCC
Q 003254 586 DERMLIYEYLPNK-SLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-------TMN 657 (836)
Q Consensus 586 ~~~~lV~Ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~-------~~~ 657 (836)
...+||+|++++. +|.+++.+.. ..+.+...+..++.+++..+.-||..+ |+|+|++++|||++. +..
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCce
Confidence 3468999999986 7888874321 234456677899999999999999999 999999999999975 568
Q ss_pred ceeeccCcccc
Q 003254 658 PKISDFGLARS 668 (836)
Q Consensus 658 ~kl~DFgla~~ 668 (836)
+.++||+.++.
T Consensus 184 ~~LIDl~r~~~ 194 (268)
T PRK15123 184 LSVIDLHRAQI 194 (268)
T ss_pred EEEEECCcccc
Confidence 99999998864
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.54 E-value=5.8e-07 Score=96.22 Aligned_cols=261 Identities=15% Similarity=0.122 Sum_probs=154.5
Q ss_pred ccCeecccCceeEEEEEeecCcEEEEEEecCCCchhHHHHHHHHHHHHhh-cCCceeeEEeE------E-eeCCeeeEEE
Q 003254 521 EKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKL-QHRNLVKLLGC------C-TQRDERMLIY 592 (836)
Q Consensus 521 ~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~------~-~~~~~~~lV~ 592 (836)
....||+|+-+.+|-.- +-...+-|+.+........+ .+..|... .||-+-.-+.+ . ..+...-+.|
T Consensus 15 ~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecc--hhhchhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 35679999999999532 22234567776665443333 23333333 45543321111 1 1122255677
Q ss_pred eecCCCCh-hHHHhhcc---CCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccc
Q 003254 593 EYLPNKSL-DYFIFDTT---RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (836)
Q Consensus 593 Ey~~~gsL-~~~l~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~ 668 (836)
+.+++.-= ..++.... .-...+|.-.++++..+|.+.+-||+.| .+-+|+.++|+|+++++.+.|.|=..-..
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceee
Confidence 77665422 22221111 2235789999999999999999999999 88899999999999999999998655443
Q ss_pred cCCCccccccccccccccccCccccc-----CCccCccccccchhhhhhhhhhC-CCCCCCCCCccc-cchhh--hhHHh
Q 003254 669 FGLDQTEANTKRVVGTYGYMSPEYAI-----DGLFSVKSDVFSFGVLVLEIICG-KKNRGFNHADHD-HNLLG--HAWRL 739 (836)
Q Consensus 669 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDVwS~GvvL~elltG-~~p~~~~~~~~~-~~~~~--~~~~~ 739 (836)
. .+....-..+|...|.+||.-. +-.-+...|-|.+|+++++++.| ++|+..-..... ..... .+.-.
T Consensus 167 ~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~ 243 (637)
T COG4248 167 N---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGR 243 (637)
T ss_pred c---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcce
Confidence 2 2222333467889999999754 33456789999999999999987 888764322111 11111 11111
Q ss_pred hhccCchhhcccccc---CCCChHH-HHHHHHHHHHcccC--CCCCCCCHHHHHHHhcCCCC
Q 003254 740 WIEERPLELIDQSLD---NSCSFSE-ALRCIQVGLLCVQQ--RPEDRPNMSSVVLMLSGERS 795 (836)
Q Consensus 740 ~~~~~~~~~~d~~l~---~~~~~~~-~~~l~~li~~Cl~~--dP~~RPt~~eVl~~L~~~~~ 795 (836)
+..... -...++ ...+.+. ...+..+..+|+.. .+.-|||++..+..|..+.+
T Consensus 244 f~ya~~---~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~ 302 (637)
T COG4248 244 FAYASD---QRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQ 302 (637)
T ss_pred eeechh---ccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHH
Confidence 110000 000000 0111111 12334566677755 36789999999998876544
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.47 E-value=1.3e-06 Score=89.64 Aligned_cols=135 Identities=21% Similarity=0.252 Sum_probs=96.4
Q ss_pred cccCeecccCceeEEEEEeecCcEEEEEEecCCC----------------------chhHHHHHHHHHHHHhhcCC--ce
Q 003254 520 SEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGS----------------------GQGMEEFKNEVLLIAKLQHR--NL 575 (836)
Q Consensus 520 ~~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~----------------------~~~~~~~~~Ei~~l~~l~H~--ni 575 (836)
.+.++||.|--+.||.|..++|.++|||.=+... .......++|.++|.++.-. .+
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 4557899999999999999999999999532210 01123467899999998644 56
Q ss_pred eeEEeEEeeCCeeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCC
Q 003254 576 VKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNT 655 (836)
Q Consensus 576 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~ 655 (836)
.+.++. +...+||||+++-.|...- ++.+..-.++..|++-+.-+-..+ |||+|+.+-||+++++
T Consensus 174 P~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~d 238 (304)
T COG0478 174 PKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTED 238 (304)
T ss_pred CCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEecC
Confidence 666654 4568999999986653221 233344445555555554444555 9999999999999999
Q ss_pred CCceeeccCccccc
Q 003254 656 MNPKISDFGLARSF 669 (836)
Q Consensus 656 ~~~kl~DFgla~~~ 669 (836)
+.+.+.||-.+...
T Consensus 239 g~~~vIDwPQ~v~~ 252 (304)
T COG0478 239 GDIVVIDWPQAVPI 252 (304)
T ss_pred CCEEEEeCcccccC
Confidence 99999999776543
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.37 E-value=2.7e-07 Score=105.00 Aligned_cols=152 Identities=18% Similarity=0.267 Sum_probs=99.7
Q ss_pred HHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCccc----cccc---cccccccccCccccc
Q 003254 622 IAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE----ANTK---RVVGTYGYMSPEYAI 694 (836)
Q Consensus 622 ~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~----~~~~---~~~gt~~y~aPE~~~ 694 (836)
+.+++.||.|+|... .+||++|.|++|.++.++..||+.|+++......... .... ...-...|.|||++.
T Consensus 105 l~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 445669999999875 6999999999999999999999999988764321110 0000 012345799999999
Q ss_pred CCccCccccccchhhhhhhhhhCCCC-CCCCCCccccchhhhhHHhhhccCchhhccccccCCCChHHHHHHHHHHHHcc
Q 003254 695 DGLFSVKSDVFSFGVLVLEIICGKKN-RGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCV 773 (836)
Q Consensus 695 ~~~~t~ksDVwS~GvvL~elltG~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl 773 (836)
+...+.++|+||+|+++|-+..|..+ +...... .....+. ..+..-...++.+...++.+=+.+.+
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~-----~~~~~~~--------~~~~~~~~~~s~~~p~el~~~l~k~l 249 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGL-----LSYSFSR--------NLLNAGAFGYSNNLPSELRESLKKLL 249 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCc-----chhhhhh--------cccccccccccccCcHHHHHHHHHHh
Confidence 98899999999999999999955544 2211110 0000000 00000001122233445667777888
Q ss_pred cCCCCCCCCHHHHHH
Q 003254 774 QQRPEDRPNMSSVVL 788 (836)
Q Consensus 774 ~~dP~~RPt~~eVl~ 788 (836)
..++.-||++.++..
T Consensus 250 ~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 250 NGDSAVRPTLDLLLS 264 (700)
T ss_pred cCCcccCcchhhhhc
Confidence 999999997776643
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.35 E-value=2.5e-06 Score=87.12 Aligned_cols=122 Identities=26% Similarity=0.280 Sum_probs=91.1
Q ss_pred CcEEEEEEecCCC-------chhHHHHHHHHHHHHhhcC--CceeeEEeEEeeCC----eeeEEEeecCCC-ChhHHHhh
Q 003254 541 GQEIAVKRLSKGS-------GQGMEEFKNEVLLIAKLQH--RNLVKLLGCCTQRD----ERMLIYEYLPNK-SLDYFIFD 606 (836)
Q Consensus 541 g~~vavK~l~~~~-------~~~~~~~~~Ei~~l~~l~H--~niv~l~g~~~~~~----~~~lV~Ey~~~g-sL~~~l~~ 606 (836)
++.+.+|.+.... .-......+|...+..+.. -...+.+++.+... ..+||+|++++. +|.+++..
T Consensus 32 ~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~ 111 (206)
T PF06293_consen 32 GRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQ 111 (206)
T ss_pred ceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHh
Confidence 5566666543211 1234467889998888863 34566677765533 358999999984 78888854
Q ss_pred ccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCC---CceeeccCcccc
Q 003254 607 TTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTM---NPKISDFGLARS 668 (836)
Q Consensus 607 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~---~~kl~DFgla~~ 668 (836)
... ++......++.++++.++-||+.+ |+|+|+++.|||++.+. .+.++||+-++.
T Consensus 112 ~~~---~~~~~~~~ll~~l~~~i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 112 WEQ---LDPSQRRELLRALARLIAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred hcc---cchhhHHHHHHHHHHHHHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 222 566778899999999999999999 99999999999998877 899999998765
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.24 E-value=4.7e-06 Score=76.46 Aligned_cols=90 Identities=23% Similarity=0.388 Sum_probs=62.3
Q ss_pred ceEEEeeccCceEEEEcCC-CCeEEeecccCC-CCcceEEEecCCCeEEecCCCCCCCcceeeeccCCCCCcCCCCeeee
Q 003254 109 GVLRINGERNGILVLLNST-NDTVWSSNSSIS-AQKPVAALMESGNLVVKDGKDNNPDNILWQSFDYPCDTLLPGMKLGI 186 (836)
Q Consensus 109 ~~l~~~~~~~g~l~l~~~~-~~~~wst~~~~~-~~~~~a~lld~GNlvl~~~~~~~~~~~~WqSFd~PTDtlLpgqkl~~ 186 (836)
|..++..+.||++|+++.. +.+||++++... .....+.|.++|||||++.. +.++|+|= |
T Consensus 20 G~~~~~~q~dgnlV~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~----g~~vW~S~-----t--------- 81 (114)
T smart00108 20 GFFTLIMQNDYNLILYKSSSRTVVWVANRDNPVSDSCTLTLQSDGNLVLYDGD----GRVVWSSN-----T--------- 81 (114)
T ss_pred eccccCCCCCEEEEEEECCCCcEEEECCCCCCCCCCEEEEEeCCCCEEEEeCC----CCEEEEec-----c---------
Confidence 3334445589999999865 589999996433 22357889999999999864 56789871 1
Q ss_pred eecCCCceEEEEccCCCCCCCCCeeeccCCCCCceEEEEcCCeeEEee
Q 003254 187 NLGTGLNRFLSSWKSTDDPARGDFTYGLDPRGIPQLVLRKNSIITFRA 234 (836)
Q Consensus 187 ~~~tg~~~~l~Sw~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~ 234 (836)
....|.+.+.++++|...++-. ...+.|.+
T Consensus 82 -----------------~~~~~~~~~~L~ddGnlvl~~~-~~~~~W~S 111 (114)
T smart00108 82 -----------------TGANGNYVLVLLDDGNLVIYDS-DGNFLWQS 111 (114)
T ss_pred -----------------cCCCCceEEEEeCCCCEEEECC-CCCEEeCC
Confidence 0134567889999998765433 34567754
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.24 E-value=1.4e-05 Score=80.27 Aligned_cols=138 Identities=15% Similarity=0.158 Sum_probs=102.8
Q ss_pred ecccCceeEEEEEeecCcEEEEEEecCC------CchhHHHHHHHHHHHHhhcCC--ceeeEEeEEe-eC----CeeeEE
Q 003254 525 LGEGGFGPVYKGMLIEGQEIAVKRLSKG------SGQGMEEFKNEVLLIAKLQHR--NLVKLLGCCT-QR----DERMLI 591 (836)
Q Consensus 525 lG~G~fG~Vykg~~~~g~~vavK~l~~~------~~~~~~~~~~Ei~~l~~l~H~--niv~l~g~~~-~~----~~~~lV 591 (836)
-|+||-+.|++-.+ +|+.+-+|+-... .+.....|.+|+..|.++... .+.+++ ++. .. -..+||
T Consensus 26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 56789999999776 5557999986411 134567899999999999632 344555 332 21 236799
Q ss_pred EeecCC-CChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCC--ceeeccCcccc
Q 003254 592 YEYLPN-KSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMN--PKISDFGLARS 668 (836)
Q Consensus 592 ~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~--~kl~DFgla~~ 668 (836)
+|-+++ -+|.+++.+. ...+.+...+..++.+|++.++-||..+ +.|+|+.+.||+++.++. +++.||.-++.
T Consensus 104 Te~L~g~~~L~~~l~~~-~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQH-AVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcC-CcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 998764 4787777332 2235677778899999999999999999 999999999999986666 99999987664
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.18 E-value=2.2e-05 Score=81.27 Aligned_cols=140 Identities=17% Similarity=0.183 Sum_probs=86.0
Q ss_pred CeecccCceeEEEEEeecCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCc--eeeEEeEEeeCCeeeEEEeecCCCC-
Q 003254 523 NKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRN--LVKLLGCCTQRDERMLIYEYLPNKS- 599 (836)
Q Consensus 523 ~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~n--iv~l~g~~~~~~~~~lV~Ey~~~gs- 599 (836)
..||+|..+.||+. .|..+++|...... ......+|.+++..+..-. +.+.+++....+...+|||+++|..
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 57999999999983 35578888876533 3345688999999987443 4677788777777889999999963
Q ss_pred hhHHHh--------------h----ccC--CCcCChhhhH-HHHHH----------HHh-hhHhhhc-CCCCcEEeccCC
Q 003254 600 LDYFIF--------------D----TTR--SKLLDWSKRS-HIIAG----------IAR-GLLYLHQ-DSRLRIIHRDLK 646 (836)
Q Consensus 600 L~~~l~--------------~----~~~--~~~l~~~~~~-~i~~~----------ia~-gL~yLH~-~~~~~ivH~DLk 646 (836)
+...+. . ... .......... ++..+ +.+ ...+|.. .....++|+|+.
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 211110 0 000 0000100000 00000 000 1112211 123457999999
Q ss_pred CCceEecCCCCceeeccCcccc
Q 003254 647 ASNVLLDNTMNPKISDFGLARS 668 (836)
Q Consensus 647 p~NILl~~~~~~kl~DFgla~~ 668 (836)
|.||++++++ +.|.||+.+..
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCcEEEcCCC-cEEEechhcCc
Confidence 9999999888 99999998753
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.17 E-value=7.5e-06 Score=93.76 Aligned_cols=139 Identities=18% Similarity=0.317 Sum_probs=92.7
Q ss_pred CeecccCceeEEEEEeecCcEEEEEEecCCCchh------------------------------HH----------HHHH
Q 003254 523 NKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQG------------------------------ME----------EFKN 562 (836)
Q Consensus 523 ~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~------------------------------~~----------~~~~ 562 (836)
+-|+.++-|.||+|++++|+.||||+.+...... .+ .+..
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 5799999999999999999999999986432111 11 1334
Q ss_pred HHHHHHhhc-----CCceeeEEeEE-eeCCeeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhh-hHhhhcC
Q 003254 563 EVLLIAKLQ-----HRNLVKLLGCC-TQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARG-LLYLHQD 635 (836)
Q Consensus 563 Ei~~l~~l~-----H~niv~l~g~~-~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~g-L~yLH~~ 635 (836)
|..-+.+++ .+++ ++=.++ +-.....|+|||++|-.+.+...-.. ..++ +..++..++++ +..+-..
T Consensus 211 EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d---~k~ia~~~~~~f~~q~~~d 284 (517)
T COG0661 211 EAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGID---RKELAELLVRAFLRQLLRD 284 (517)
T ss_pred HHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCC---HHHHHHHHHHHHHHHHHhc
Confidence 555555442 2333 222333 33567899999999998888753222 2233 23334333333 2223234
Q ss_pred CCCcEEeccCCCCceEecCCCCceeeccCcccccC
Q 003254 636 SRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (836)
Q Consensus 636 ~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~ 670 (836)
+ +.|.|..|.||+++.++++.+.|||+...+.
T Consensus 285 g---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 285 G---FFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred C---ccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 4 9999999999999999999999999987764
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.15 E-value=9.2e-06 Score=74.72 Aligned_cols=88 Identities=22% Similarity=0.328 Sum_probs=61.9
Q ss_pred EEeecc-CceEEEEcCC-CCeEEeecccC-CCCcceEEEecCCCeEEecCCCCCCCcceeeeccCCCCCcCCCCeeeeee
Q 003254 112 RINGER-NGILVLLNST-NDTVWSSNSSI-SAQKPVAALMESGNLVVKDGKDNNPDNILWQSFDYPCDTLLPGMKLGINL 188 (836)
Q Consensus 112 ~~~~~~-~g~l~l~~~~-~~~~wst~~~~-~~~~~~a~lld~GNlvl~~~~~~~~~~~~WqSFd~PTDtlLpgqkl~~~~ 188 (836)
++..+. ||+||+++.. +.++|++|+.. ......+.|.++|||||.+.+ +.++|+|=-.
T Consensus 23 ~~~~q~~dgnlv~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~----g~~vW~S~~~--------------- 83 (116)
T cd00028 23 KLIMQSRDYNLILYKGSSRTVVWVANRDNPSGSSCTLTLQSDGNLVIYDGS----GTVVWSSNTT--------------- 83 (116)
T ss_pred cCCCCCCeEEEEEEeCCCCeEEEECCCCCCCCCCEEEEEecCCCeEEEcCC----CcEEEEeccc---------------
Confidence 334455 8999999765 58999999653 234556889999999999864 5778886421
Q ss_pred cCCCceEEEEccCCCCCCCCCeeeccCCCCCceEEEEcCCeeEEeeC
Q 003254 189 GTGLNRFLSSWKSTDDPARGDFTYGLDPRGIPQLVLRKNSIITFRAG 235 (836)
Q Consensus 189 ~tg~~~~l~Sw~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~g 235 (836)
.+.+.+.+.++++|...++-.+ ..+.|.+.
T Consensus 84 ----------------~~~~~~~~~L~ddGnlvl~~~~-~~~~W~Sf 113 (116)
T cd00028 84 ----------------RVNGNYVLVLLDDGNLVLYDSD-GNFLWQSF 113 (116)
T ss_pred ----------------CCCCceEEEEeCCCCEEEECCC-CCEEEcCC
Confidence 1246678889999987655433 45677654
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.09 E-value=1e-06 Score=99.00 Aligned_cols=191 Identities=17% Similarity=0.134 Sum_probs=137.5
Q ss_pred HhhcccccccCeecccCceeEEEEEeecCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCc-eeeEEeEEeeCCeeeEE
Q 003254 513 ANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRN-LVKLLGCCTQRDERMLI 591 (836)
Q Consensus 513 ~~a~~~f~~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~n-iv~l~g~~~~~~~~~lV 591 (836)
+.-++.+...+.+++|++++++|.+....+...++.+... ....-++++|.+++||| .++.++-+..+...+++
T Consensus 238 kDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~ 312 (829)
T KOG0576|consen 238 KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIP 312 (829)
T ss_pred cCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchh
Confidence 3344555556678999999999988655555556655433 44567899999999999 77777777777888999
Q ss_pred EeecCCC-ChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccC
Q 003254 592 YEYLPNK-SLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (836)
Q Consensus 592 ~Ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~ 670 (836)
++++..+ +-..... .....+..-+...+...-.++++|||+.. =+|+| ||+..+ ...|..||+.+..+.
T Consensus 313 ~~i~s~~rs~~~~~~--~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~ 382 (829)
T KOG0576|consen 313 MRICSTGRSSALEMT--VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLT 382 (829)
T ss_pred hhhhcCCccccccCC--hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccC
Confidence 9999877 2211110 00111223334455566678999999864 48888 777665 688999999988765
Q ss_pred CCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCC
Q 003254 671 LDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNR 721 (836)
Q Consensus 671 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~ 721 (836)
+.. ......+++.++|||+...+.+..+.|+|+.|+--.++--|-+|.
T Consensus 383 ~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 383 RTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred ccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 433 233467899999999999999999999999998777777776654
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.01 E-value=4.7e-05 Score=76.88 Aligned_cols=138 Identities=16% Similarity=0.164 Sum_probs=91.7
Q ss_pred hcccccccCeecccCceeEEEEEeecCcEEEEEEecCCCchhHHHH---------HHHHHHHHhhcC---CceeeEEeEE
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEF---------KNEVLLIAKLQH---RNLVKLLGCC 582 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~---------~~Ei~~l~~l~H---~niv~l~g~~ 582 (836)
...+|...+.+-......|.+-.. +|+.+++|..+.......+.| .+++..+.+++. ..+..++.+.
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 446777777777777667766665 688999998866543333322 234444444432 2333333332
Q ss_pred e-----eCCeeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCC
Q 003254 583 T-----QRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMN 657 (836)
Q Consensus 583 ~-----~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~ 657 (836)
+ .....+|+|||++|-.|.+.. .++. .++..+++++.-||+.| +.|+|..|.|+++++++
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~-------~i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~- 172 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIE-------DIDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG- 172 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccch-------hcCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc-
Confidence 2 223467999999998775543 1221 35567788899999999 99999999999998654
Q ss_pred ceeeccCcccc
Q 003254 658 PKISDFGLARS 668 (836)
Q Consensus 658 ~kl~DFgla~~ 668 (836)
+++.||+..+.
T Consensus 173 i~iID~~~k~~ 183 (229)
T PF06176_consen 173 IRIIDTQGKRM 183 (229)
T ss_pred EEEEECccccc
Confidence 99999987654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >smart00473 PAN_AP divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Probab=97.99 E-value=9e-06 Score=68.69 Aligned_cols=71 Identities=34% Similarity=0.625 Sum_probs=52.8
Q ss_pred CceEEeeeecCCCCcccccccccCHHHHHHhhhc-cCceeeeecccccCCCCcccccc-cccccccccCCCCcccee
Q 003254 370 DGFLEHKAVKLPDTRFSWVDKNITLWECKELCSK-NCSCTAYANADVRGRGSGCLLWF-HDLIDIKELPESGQDLFI 444 (836)
Q Consensus 370 ~~f~~~~~~~~p~~~~~~~~~~~s~~~C~~~Cl~-~CsC~a~~~~~~~~~~~~C~~w~-~~l~~~~~~~~~~~~lyl 444 (836)
..|.++.++++++..... ....++++|+..|++ +|+|.||.|.. .+.+|.+|. ..+.+....+..+.++|.
T Consensus 4 ~~f~~~~~~~l~~~~~~~-~~~~s~~~C~~~C~~~~~~C~s~~y~~---~~~~C~l~~~~~~~~~~~~~~~~~~~y~ 76 (78)
T smart00473 4 DCFVRLPNTKLPGFSRIV-ISVASLEECASKCLNSNCSCRSFTYNN---GTKGCLLWSESSLGDARLFPSGGVDLYE 76 (78)
T ss_pred ceeEEecCccCCCCccee-EcCCCHHHHHHHhCCCCCceEEEEEcC---CCCEEEEeeCCccccceecccCCceeEE
Confidence 568899999998654432 356799999999999 99999999974 457899999 666665533444444554
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.97 E-value=2.2e-05 Score=78.70 Aligned_cols=105 Identities=24% Similarity=0.235 Sum_probs=83.7
Q ss_pred HHHHHHHHhhcC-CceeeEEeEEeeCCeeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCc
Q 003254 561 KNEVLLIAKLQH-RNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLR 639 (836)
Q Consensus 561 ~~Ei~~l~~l~H-~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 639 (836)
.+|..+++.+++ +++.+++|+|- .++|.||...+++.........--..+|..|.+||.++++.+.+|++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 458889999986 69999999994 4789999987765321100011123689999999999999999999876566
Q ss_pred EEeccCCCCceEecCCCCceeeccCccccc
Q 003254 640 IIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (836)
Q Consensus 640 ivH~DLkp~NILl~~~~~~kl~DFgla~~~ 669 (836)
+...|++++|+-+++++++|+.|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 889999999999999999999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF11883 DUF3403: Domain of unknown function (DUF3403); InterPro: IPR021820 This functionally uncharacterised domain of around 50 amino acids is found in the C terminus of eukaryotic S-locus receptor kinase proteins | Back alignment and domain information |
|---|
Probab=97.92 E-value=9.5e-06 Score=60.79 Aligned_cols=45 Identities=60% Similarity=0.925 Sum_probs=40.8
Q ss_pred CCCCCCCCCCCCccccCCCCCCCCCCccC--CcCcccceeecccccC
Q 003254 792 GERSLPQPQQPGFFTGRNLPESESSSSRQ--YSASTNEITLSVLEAR 836 (836)
Q Consensus 792 ~~~~~~~p~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 836 (836)
+...+|.|++|+|+.+|...+.+++++.+ ...|.|.||+|.|+||
T Consensus 2 e~~~LP~PKqPgF~~~r~~~e~~sSss~~~~~~~SvNevTiT~l~~R 48 (48)
T PF11883_consen 2 ETATLPQPKQPGFFTGRSPSETDSSSSKQRDESCSVNEVTITMLEAR 48 (48)
T ss_pred CcccCCCCCCCCEEeEcCCCCcCCCcccccCCCCCeeeEEEEeEecC
Confidence 34678999999999999999999887777 8889999999999999
|
; GO: 0004674 protein serine/threonine kinase activity |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.92 E-value=6.5e-05 Score=77.76 Aligned_cols=143 Identities=20% Similarity=0.209 Sum_probs=84.6
Q ss_pred CeecccCceeEEEEEeecCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCC--ceeeEEeEEee---CCeeeEEEeecCC
Q 003254 523 NKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHR--NLVKLLGCCTQ---RDERMLIYEYLPN 597 (836)
Q Consensus 523 ~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~--niv~l~g~~~~---~~~~~lV~Ey~~~ 597 (836)
+.|+.|..+.||+....+ ..+++|..... .....+..|..++..+... .+.+++.+... ....+++||++++
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 578999999999999866 69999997544 4567788999999988633 34566664432 2346899999999
Q ss_pred CChhH----------------HHhh---c-cCCCcCChhh---------hHHH------------HHHHHh-hhHhhhc-
Q 003254 598 KSLDY----------------FIFD---T-TRSKLLDWSK---------RSHI------------IAGIAR-GLLYLHQ- 634 (836)
Q Consensus 598 gsL~~----------------~l~~---~-~~~~~l~~~~---------~~~i------------~~~ia~-gL~yLH~- 634 (836)
..+.. .+.. . .......+.. .... ...+.+ .+..++.
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL 159 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence 88876 1110 0 0001111100 0000 111222 2333332
Q ss_pred ---CCCCcEEeccCCCCceEec-CCCCceeeccCcccc
Q 003254 635 ---DSRLRIIHRDLKASNVLLD-NTMNPKISDFGLARS 668 (836)
Q Consensus 635 ---~~~~~ivH~DLkp~NILl~-~~~~~kl~DFgla~~ 668 (836)
.....++|+|+.|.||+++ +++.+.|.||+.+..
T Consensus 160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 2345699999999999999 666668999988753
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.90 E-value=8.8e-05 Score=75.68 Aligned_cols=136 Identities=16% Similarity=0.219 Sum_probs=91.7
Q ss_pred eecccCceeEEEEEeecCcEEEEEEecCCCchh-------------------HH-----HHHHHHHHHHhhc--CCceee
Q 003254 524 KLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQG-------------------ME-----EFKNEVLLIAKLQ--HRNLVK 577 (836)
Q Consensus 524 ~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~-------------------~~-----~~~~Ei~~l~~l~--H~niv~ 577 (836)
.|+.|--+.||+|...++..+|||+++...... .+ -...|+.-|.++. +-.+.+
T Consensus 55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~ 134 (268)
T COG1718 55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE 134 (268)
T ss_pred eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence 577888899999998889999999986432110 00 1234666666663 344455
Q ss_pred EEeEEeeCCeeeEEEeecCCCCh-hHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCC
Q 003254 578 LLGCCTQRDERMLIYEYLPNKSL-DYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTM 656 (836)
Q Consensus 578 l~g~~~~~~~~~lV~Ey~~~gsL-~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~ 656 (836)
.+++.. -.|||||+....+ .-.| ..-++...+...+..++++.+.-|-... .+||+||..-|||+. ++
T Consensus 135 Pi~~~~----nVLvMEfIg~~g~pAP~L----kDv~~e~~e~~~~~~~~v~~~~~l~~~a--~LVHgDLSEyNiL~~-~~ 203 (268)
T COG1718 135 PIAFRN----NVLVMEFIGDDGLPAPRL----KDVPLELEEAEGLYEDVVEYMRRLYKEA--GLVHGDLSEYNILVH-DG 203 (268)
T ss_pred ceeecC----CeEEEEeccCCCCCCCCc----ccCCcCchhHHHHHHHHHHHHHHHHHhc--CcccccchhhheEEE-CC
Confidence 555543 4799999966421 1111 1111222356777788888888887633 399999999999999 88
Q ss_pred CceeeccCcccccC
Q 003254 657 NPKISDFGLARSFG 670 (836)
Q Consensus 657 ~~kl~DFgla~~~~ 670 (836)
.+.|+|+|.|....
T Consensus 204 ~p~iID~~QaV~~~ 217 (268)
T COG1718 204 EPYIIDVSQAVTID 217 (268)
T ss_pred eEEEEECccccccC
Confidence 99999999887653
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.89 E-value=0.00012 Score=76.87 Aligned_cols=141 Identities=16% Similarity=0.135 Sum_probs=86.1
Q ss_pred eecccCc-eeEEEEEeecCcEEEEEEecCCCchhHHHHHHHHHHHHhhc-CCceeeEEeEEeeCCeeeEEEeecCCCChh
Q 003254 524 KLGEGGF-GPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQRDERMLIYEYLPNKSLD 601 (836)
Q Consensus 524 ~lG~G~f-G~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~ 601 (836)
.|..|.. ..||+.... +..++||+..... .....+|++++..+. +--+.+++++....+..++|||++++.++.
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 3555555 788998764 4788888875433 345678999998884 444567777777666789999999998876
Q ss_pred HHHh------------------hccC--CCcCCh--hhhHHHH-HH-------------------HHhhhHhhh----cC
Q 003254 602 YFIF------------------DTTR--SKLLDW--SKRSHII-AG-------------------IARGLLYLH----QD 635 (836)
Q Consensus 602 ~~l~------------------~~~~--~~~l~~--~~~~~i~-~~-------------------ia~gL~yLH----~~ 635 (836)
.... +... ..+... ....... .. +...+..|- ..
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 4321 0000 001110 0000000 00 011111111 11
Q ss_pred CCCcEEeccCCCCceEecCCCCceeeccCcccc
Q 003254 636 SRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (836)
Q Consensus 636 ~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~ 668 (836)
..+.++|+|+.|.|||++++..+.|.||+.+..
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 234589999999999999987788999998753
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00013 Score=83.46 Aligned_cols=140 Identities=17% Similarity=0.254 Sum_probs=89.0
Q ss_pred CeecccCceeEEEEEeecCcEEEEEEecCCCchh---------------------------HH----------HHHHHHH
Q 003254 523 NKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQG---------------------------ME----------EFKNEVL 565 (836)
Q Consensus 523 ~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~---------------------------~~----------~~~~Ei~ 565 (836)
+.||.-+.|.||+|++++|+.||||+-+..-... .+ +|.+|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 5799999999999999999999999876432111 00 1334444
Q ss_pred HHHhh----cCCce---eeEEeEE-eeCCeeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhh-hcCC
Q 003254 566 LIAKL----QHRNL---VKLLGCC-TQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYL-HQDS 636 (836)
Q Consensus 566 ~l~~l----~H~ni---v~l~g~~-~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~ 636 (836)
-..+. .|-++ |++=.++ .-...+.|+||||+|..+.+.-.-. ...++... ++..+.++...+ =..|
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~--~~gi~~~~---i~~~l~~~~~~qIf~~G 321 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAID--KRGISPHD---ILNKLVEAYLEQIFKTG 321 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHH--HcCCCHHH---HHHHHHHHHHHHHHhcC
Confidence 33333 35551 1122222 2235789999999999887664322 22244443 333343332222 1223
Q ss_pred CCcEEeccCCCCceEec----CCCCceeeccCcccccC
Q 003254 637 RLRIIHRDLKASNVLLD----NTMNPKISDFGLARSFG 670 (836)
Q Consensus 637 ~~~ivH~DLkp~NILl~----~~~~~kl~DFgla~~~~ 670 (836)
.+|+|=.|.||++. .++.+.+-|||+...+.
T Consensus 322 ---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 322 ---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred ---CccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 89999999999998 36789999999987653
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.00042 Score=69.81 Aligned_cols=129 Identities=16% Similarity=0.242 Sum_probs=90.3
Q ss_pred ccCeecccCceeEEEEEeecCcEEEEEEecCCC----------------chhHHHHHHHHHHHHhhc------CCceeeE
Q 003254 521 EKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGS----------------GQGMEEFKNEVLLIAKLQ------HRNLVKL 578 (836)
Q Consensus 521 ~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~----------------~~~~~~~~~Ei~~l~~l~------H~niv~l 578 (836)
....||+|+.-.||. ++++....||+..... ....++..+|+.-...+. +.+|.++
T Consensus 5 ~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 346799999999995 5667778888876554 123456677777777666 7899999
Q ss_pred EeEEeeCCeeeEEEeecCC--C----ChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEe
Q 003254 579 LGCCTQRDERMLIYEYLPN--K----SLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLL 652 (836)
Q Consensus 579 ~g~~~~~~~~~lV~Ey~~~--g----sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl 652 (836)
+|+.+.....-+|+|.+.+ | +|.+++. .+.++. ...+.+. +-..||-++. |+.+|++|+||++
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~----~~~~~~-~~~~~L~---~f~~~l~~~~---Iv~~dl~~~NIv~ 151 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLK----EGGLTE-ELRQALD---EFKRYLLDHH---IVIRDLNPHNIVV 151 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHH----cCCccH-HHHHHHH---HHHHHHHHcC---CeecCCCcccEEE
Confidence 9999999999999998743 3 4666662 233444 3333333 4445565555 9999999999999
Q ss_pred cCC--C--Cceeec
Q 003254 653 DNT--M--NPKISD 662 (836)
Q Consensus 653 ~~~--~--~~kl~D 662 (836)
..+ + .+.|+|
T Consensus 152 ~~~~~~~~~lvlID 165 (199)
T PF10707_consen 152 QRRDSGEFRLVLID 165 (199)
T ss_pred EecCCCceEEEEEe
Confidence 532 2 466666
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.00052 Score=62.76 Aligned_cols=100 Identities=25% Similarity=0.430 Sum_probs=64.2
Q ss_pred CeEEeCCCeEEEeeecCCCCCceEEEEEEeecCCCcEEEeec-CCCCCCCCcceEEEeeccCceEEEEcCCCCeEEeecc
Q 003254 58 ETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVAN-RDAPLSDRSGVLRINGERNGILVLLNSTNDTVWSSNS 136 (836)
Q Consensus 58 ~~l~S~~g~F~lgF~~~~~~~~~ylgiw~~~~~~~t~vW~An-r~~p~~~~~~~l~~~~~~~g~l~l~~~~~~~~wst~~ 136 (836)
+.+.+.+|.+.|-|-..|+ |-| |. ...+++|..+ ...... ....+.|. +||||||+|..+.++|++..
T Consensus 12 ~p~~~~s~~~~L~l~~dGn-----Lvl-~~--~~~~~iWss~~t~~~~~-~~~~~~L~--~~GNlvl~d~~~~~lW~Sf~ 80 (114)
T PF01453_consen 12 SPLTSSSGNYTLILQSDGN-----LVL-YD--SNGSVIWSSNNTSGRGN-SGCYLVLQ--DDGNLVLYDSSGNVLWQSFD 80 (114)
T ss_dssp EEEEECETTEEEEEETTSE-----EEE-EE--TTTEEEEE--S-TTSS--SSEEEEEE--TTSEEEEEETTSEEEEESTT
T ss_pred cccccccccccceECCCCe-----EEE-Ec--CCCCEEEEecccCCccc-cCeEEEEe--CCCCEEEEeecceEEEeecC
Confidence 4565655889999887664 444 33 2357799993 333322 34677887 89999999999999999952
Q ss_pred cCCCCcceEEEec--CCCeEEecCCCCCCCcceeeeccCCC
Q 003254 137 SISAQKPVAALME--SGNLVVKDGKDNNPDNILWQSFDYPC 175 (836)
Q Consensus 137 ~~~~~~~~a~lld--~GNlvl~~~~~~~~~~~~WqSFd~PT 175 (836)
....+.+...+ .||++ .... ..+.|.|=+.|+
T Consensus 81 --~ptdt~L~~q~l~~~~~~-~~~~----~~~sw~s~~dps 114 (114)
T PF01453_consen 81 --YPTDTLLPGQKLGDGNVT-GKND----SLTSWSSNTDPS 114 (114)
T ss_dssp --SSS-EEEEEET--TSEEE-EEST----SSEEEESS----
T ss_pred --CCccEEEeccCcccCCCc-cccc----eEEeECCCCCCC
Confidence 33455667777 89998 5432 467888876663
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.00079 Score=67.32 Aligned_cols=125 Identities=26% Similarity=0.377 Sum_probs=91.6
Q ss_pred ccccccCeecccCc-eeEEEEEeecCcEEEEEEecC---CCc------------------hhHHHHHHHHHHHHhhc---
Q 003254 517 DNFSEKNKLGEGGF-GPVYKGMLIEGQEIAVKRLSK---GSG------------------QGMEEFKNEVLLIAKLQ--- 571 (836)
Q Consensus 517 ~~f~~~~~lG~G~f-G~Vykg~~~~g~~vavK~l~~---~~~------------------~~~~~~~~Ei~~l~~l~--- 571 (836)
.+++..+.||.|.- |.|||++. +|+.+|+|.+.. ... .....|..|.+..++++
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 78889999999999 99999998 788999999321 100 11235788999999886
Q ss_pred CCce--eeEEeEEeeCC------------------eeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHh
Q 003254 572 HRNL--VKLLGCCTQRD------------------ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLY 631 (836)
Q Consensus 572 H~ni--v~l~g~~~~~~------------------~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~y 631 (836)
+.++ |+++|+..-.. .+.||.||++... .....-+.+|.+-|..
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------------~~~~~~~~~~~~dl~~ 179 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------------PLQIRDIPQMLRDLKI 179 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------------ccchhHHHHHHHHHHH
Confidence 3455 99999873321 1357888776532 1122345667777888
Q ss_pred hhcCCCCcEEeccCCCCceEecCCCCceeeccCcc
Q 003254 632 LHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLA 666 (836)
Q Consensus 632 LH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla 666 (836)
+|..+ |+-+|+++.|.. .-||+|||.+
T Consensus 180 ~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 99988 999999999975 4589999864
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.00048 Score=85.13 Aligned_cols=79 Identities=20% Similarity=0.377 Sum_probs=58.4
Q ss_pred cCeecccCceeEEEEEeecC---cEEEEEEecCCC-chhHHHHHHHHHHHHhhc-CCce--eeEEeEEeeC---CeeeEE
Q 003254 522 KNKLGEGGFGPVYKGMLIEG---QEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQ-HRNL--VKLLGCCTQR---DERMLI 591 (836)
Q Consensus 522 ~~~lG~G~fG~Vykg~~~~g---~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~-H~ni--v~l~g~~~~~---~~~~lV 591 (836)
.+.|+.|.+..+|+....++ ..+++|+..... ......+.+|+++++.+. |.++ .+++.+|.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 46789999999999887554 467888764432 123456889999999995 6665 7788887654 357899
Q ss_pred EeecCCCCh
Q 003254 592 YEYLPNKSL 600 (836)
Q Consensus 592 ~Ey~~~gsL 600 (836)
|||+++..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999998653
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.00061 Score=71.11 Aligned_cols=73 Identities=15% Similarity=0.274 Sum_probs=46.5
Q ss_pred CeecccCce-eEEEEEeecCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCC---ceeeEEeEEeeCC---eeeEEEeec
Q 003254 523 NKLGEGGFG-PVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHR---NLVKLLGCCTQRD---ERMLIYEYL 595 (836)
Q Consensus 523 ~~lG~G~fG-~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~---niv~l~g~~~~~~---~~~lV~Ey~ 595 (836)
+.|+.|+.. .||+. +..+++|..+.. .....+.+|.+++..+... -+.++++.....+ ..+++||++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 467777776 48875 345777865432 2345788999999888532 2344444433322 347899999
Q ss_pred CCCChh
Q 003254 596 PNKSLD 601 (836)
Q Consensus 596 ~~gsL~ 601 (836)
++.++.
T Consensus 77 ~G~~l~ 82 (235)
T cd05155 77 EGETAT 82 (235)
T ss_pred cCCCCC
Confidence 997764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.001 Score=69.30 Aligned_cols=74 Identities=20% Similarity=0.297 Sum_probs=49.8
Q ss_pred CeecccCceeEEEEEeec--CcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCce-eeEEeEEeeCCeeeEEEeecCCCC
Q 003254 523 NKLGEGGFGPVYKGMLIE--GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNL-VKLLGCCTQRDERMLIYEYLPNKS 599 (836)
Q Consensus 523 ~~lG~G~fG~Vykg~~~~--g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~Ey~~~gs 599 (836)
+.|..|-...+|+....+ ++.+++|+....... .....+|+.++..+...++ .++++... ..+||||+++.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 467888889999998764 678999977543222 1233578889988864444 34444332 248999999977
Q ss_pred hh
Q 003254 600 LD 601 (836)
Q Consensus 600 L~ 601 (836)
+.
T Consensus 79 l~ 80 (235)
T cd05157 79 LE 80 (235)
T ss_pred CC
Confidence 63
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.0018 Score=70.08 Aligned_cols=80 Identities=14% Similarity=0.122 Sum_probs=58.5
Q ss_pred cccccCeecccCceeEEEEEeecCcEEEEEEecCCCchhHHHHHHHHHHHHhhcC---CceeeEEeEEeeC---CeeeEE
Q 003254 518 NFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQH---RNLVKLLGCCTQR---DERMLI 591 (836)
Q Consensus 518 ~f~~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H---~niv~l~g~~~~~---~~~~lV 591 (836)
.....+.||.|..+.||+....++ .+++|..+.. .....+.+|...++.+.- ..+.++++++... +..+||
T Consensus 15 ~~~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV 91 (297)
T PRK10593 15 KLSRVECISEQPYAALWALYDSQG-NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL 91 (297)
T ss_pred hhheeeecCCccceeEEEEEcCCC-CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence 334456899999999999876555 4666764331 123578899999998853 3678888887543 568999
Q ss_pred EeecCCCCh
Q 003254 592 YEYLPNKSL 600 (836)
Q Consensus 592 ~Ey~~~gsL 600 (836)
||+++++++
T Consensus 92 mE~i~G~~~ 100 (297)
T PRK10593 92 LERLRGVSV 100 (297)
T ss_pred EeccCCEec
Confidence 999998765
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.00094 Score=70.63 Aligned_cols=139 Identities=17% Similarity=0.128 Sum_probs=80.0
Q ss_pred eecccCceeEEEEEeecCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCce-eeEEeEEeeCCeeeEEEeecCCCChhH
Q 003254 524 KLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNL-VKLLGCCTQRDERMLIYEYLPNKSLDY 602 (836)
Q Consensus 524 ~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~Ey~~~gsL~~ 602 (836)
.+..|-...+|+.. .+++.+++|+.........-...+|..+++.+....+ .++++... ..+||||+++..+..
T Consensus 3 ~~~~G~tn~~y~~~-~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIE-HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEE-eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence 45678888999887 3677889987654332221235789999998864433 33444332 368999999876542
Q ss_pred H-----------------Hhhcc-CCCcCChhhh-HHHHHHH---------HhhhHhhhcC-----CCCcEEeccCCCCc
Q 003254 603 F-----------------IFDTT-RSKLLDWSKR-SHIIAGI---------ARGLLYLHQD-----SRLRIIHRDLKASN 649 (836)
Q Consensus 603 ~-----------------l~~~~-~~~~l~~~~~-~~i~~~i---------a~gL~yLH~~-----~~~~ivH~DLkp~N 649 (836)
. ++... ...+++...+ ..+..++ ...+..+... ....++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1 11110 0111221111 1111111 1111112111 12358999999999
Q ss_pred eEecCCCCceeeccCcccc
Q 003254 650 VLLDNTMNPKISDFGLARS 668 (836)
Q Consensus 650 ILl~~~~~~kl~DFgla~~ 668 (836)
|++++++ +.|.||+.+..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999876 78999998764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.33 E-value=0.0013 Score=63.77 Aligned_cols=128 Identities=20% Similarity=0.249 Sum_probs=85.7
Q ss_pred ccCeecccCceeEEEEEeecCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceee-EEeEEeeCCeeeEEEeecCCCC
Q 003254 521 EKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVK-LLGCCTQRDERMLIYEYLPNKS 599 (836)
Q Consensus 521 ~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~-l~g~~~~~~~~~lV~Ey~~~gs 599 (836)
..+.|++|++|.||+|.+ .|..+|+|+-...+ ....+..|++++..++-.++-+ ++.|-. ..+.|||+.+-.
T Consensus 26 v~~~L~KG~~s~Vyl~~~-~~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G~~ 98 (201)
T COG2112 26 VEKELAKGTTSVVYLGEW-RGGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDGRP 98 (201)
T ss_pred hhhhhhcccccEEEEeec-cCceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcCcc
Confidence 456799999999999998 55688888765443 3567889999999998666644 333322 345599999988
Q ss_pred hhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCC-CCceEecCCCCceeeccCcccc
Q 003254 600 LDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLK-ASNVLLDNTMNPKISDFGLARS 668 (836)
Q Consensus 600 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLk-p~NILl~~~~~~kl~DFgla~~ 668 (836)
|...-... + .+-...+++.---|...+ |-|+.|. |..++|-.+..+.|.||..|..
T Consensus 99 L~~~~~~~------~----rk~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 99 LGKLEIGG------D----RKHLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhhhcc------c----HHHHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 76554211 1 123344555544444445 8888875 4444444455999999999874
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.24 E-value=0.004 Score=69.56 Aligned_cols=75 Identities=15% Similarity=0.198 Sum_probs=54.1
Q ss_pred CeecccCceeEEEEEeecC-cEEEEEEecCC-----C--chhHHHHHHHHHHHHhhc-C--CceeeEEeEEeeCCeeeEE
Q 003254 523 NKLGEGGFGPVYKGMLIEG-QEIAVKRLSKG-----S--GQGMEEFKNEVLLIAKLQ-H--RNLVKLLGCCTQRDERMLI 591 (836)
Q Consensus 523 ~~lG~G~fG~Vykg~~~~g-~~vavK~l~~~-----~--~~~~~~~~~Ei~~l~~l~-H--~niv~l~g~~~~~~~~~lV 591 (836)
+.||.|.+..||++...+| +.++||.-... . +...+++..|.+.|..+. + .++.+++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 5799999999999999877 58999984311 1 234566778888888763 2 346666666 33557899
Q ss_pred EeecCCCC
Q 003254 592 YEYLPNKS 599 (836)
Q Consensus 592 ~Ey~~~gs 599 (836)
|||+++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998743
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.19 E-value=0.001 Score=80.49 Aligned_cols=198 Identities=19% Similarity=0.175 Sum_probs=135.2
Q ss_pred HHHHHHHHHhhcCCceeeEEeEEeeCCeee----EEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcC
Q 003254 560 FKNEVLLIAKLQHRNLVKLLGCCTQRDERM----LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQD 635 (836)
Q Consensus 560 ~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~----lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~ 635 (836)
..-|+..+.++.|+|+++++.|..+....- +.-|++..-++...+. .-..++....+.+..+..+||+|+|+.
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q---~v~~i~~~~~r~~~~~~~~GL~~~h~~ 305 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ---SVGSIPLETLRILHQKLLEGLAYLHSL 305 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh---hccccCHHHHHHHHHHHhhhHHHHHHh
Confidence 345777788889999999999987655433 3346777777766663 335677888888999999999999998
Q ss_pred CCCcEEeccCCCC---ceEecCCCCceee--ccCcccccCCCccccccccccccccccCcccccCCccCc--cccccchh
Q 003254 636 SRLRIIHRDLKAS---NVLLDNTMNPKIS--DFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSV--KSDVFSFG 708 (836)
Q Consensus 636 ~~~~ivH~DLkp~---NILl~~~~~~kl~--DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~--ksDVwS~G 708 (836)
. ..|.-|..+ +--.+..+.+.++ ||+..+.+..... .....-+..+.+||......++. ..|+|.+|
T Consensus 306 ~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~---~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lg 379 (1351)
T KOG1035|consen 306 S---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK---SFSDLLAEIRNADEDLKENTAKKSRLTDLWCLG 379 (1351)
T ss_pred c---cceeEEecccccccccCccceeecchhhhcccccCCCccc---chhhcCccccccccccccccchhhhhhHHHHHH
Confidence 5 555555444 4455667777777 9988876542221 11133456788888887666554 47999999
Q ss_pred hhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 709 VLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 709 vvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
..+..+..|..+...... +..+++. . ... .+.+....|+..++++|++..+++.
T Consensus 380 ll~~~~~~~~~i~~~~~~------------------~~~~l~~----~-~~~---~~~d~~~~~~~~~~~~Rl~~~~ll~ 433 (1351)
T KOG1035|consen 380 LLLLQLSQGEDISEKSAV------------------PVSLLDV----L-STS---ELLDALPKCLDEDSEERLSALELLT 433 (1351)
T ss_pred HHHhhhhhcCcccccccc------------------hhhhhcc----c-cch---hhhhhhhhhcchhhhhccchhhhhh
Confidence 999999998765221100 0111110 0 000 3456778899999999999999988
Q ss_pred HhcC
Q 003254 789 MLSG 792 (836)
Q Consensus 789 ~L~~ 792 (836)
..-.
T Consensus 434 ~~f~ 437 (1351)
T KOG1035|consen 434 HPFL 437 (1351)
T ss_pred chhc
Confidence 7643
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.0023 Score=69.20 Aligned_cols=143 Identities=20% Similarity=0.198 Sum_probs=86.5
Q ss_pred cCeecccCceeEEEEEeecCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCc--eeeEEeE------EeeCCeeeEEEe
Q 003254 522 KNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRN--LVKLLGC------CTQRDERMLIYE 593 (836)
Q Consensus 522 ~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~n--iv~l~g~------~~~~~~~~lV~E 593 (836)
.+.|..|....+|+.... +..+++|+... ...+....|+.++..+.+.+ +.+++.. ....+..++|+|
T Consensus 19 i~~i~~G~~n~~y~v~~~-~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTD-SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeC-CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 456788888899998764 45788898754 23456677888888885433 4444432 123345689999
Q ss_pred ecCCCChhH----H----------HhhccCC--------CcCChhhhH----------HHHHHHHhhhHhhhc----CCC
Q 003254 594 YLPNKSLDY----F----------IFDTTRS--------KLLDWSKRS----------HIIAGIARGLLYLHQ----DSR 637 (836)
Q Consensus 594 y~~~gsL~~----~----------l~~~~~~--------~~l~~~~~~----------~i~~~ia~gL~yLH~----~~~ 637 (836)
|++|..+.. . ++..... ....|.... .....+.+++.++.. ...
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 999877532 0 1100000 111221111 011123334455443 122
Q ss_pred CcEEeccCCCCceEecCCCCceeeccCcccc
Q 003254 638 LRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (836)
Q Consensus 638 ~~ivH~DLkp~NILl~~~~~~kl~DFgla~~ 668 (836)
..++|+|+.|.||+++++..+.|.||+.+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 3599999999999999987788999988753
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.99 E-value=0.004 Score=67.60 Aligned_cols=74 Identities=26% Similarity=0.420 Sum_probs=50.0
Q ss_pred CeecccCceeEEEEEeec-------CcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCce-eeEEeEEeeCCeeeEEEee
Q 003254 523 NKLGEGGFGPVYKGMLIE-------GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNL-VKLLGCCTQRDERMLIYEY 594 (836)
Q Consensus 523 ~~lG~G~fG~Vykg~~~~-------g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~Ey 594 (836)
+.|..|-...+|+....+ ++.+++|+..... .......+|.+++..+....+ .++++++.. .+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 456777778999988755 5789999875543 223455788888888864333 345555432 358999
Q ss_pred cCCCChh
Q 003254 595 LPNKSLD 601 (836)
Q Consensus 595 ~~~gsL~ 601 (836)
++|..+.
T Consensus 79 i~G~~l~ 85 (302)
T cd05156 79 IPSRTLT 85 (302)
T ss_pred eCCCcCC
Confidence 9987764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.57 E-value=0.018 Score=63.69 Aligned_cols=141 Identities=18% Similarity=0.263 Sum_probs=83.3
Q ss_pred CeecccCceeEEEEEeec-----CcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCcee-eEEeEEeeCCeeeEEEeecC
Q 003254 523 NKLGEGGFGPVYKGMLIE-----GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLV-KLLGCCTQRDERMLIYEYLP 596 (836)
Q Consensus 523 ~~lG~G~fG~Vykg~~~~-----g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv-~l~g~~~~~~~~~lV~Ey~~ 596 (836)
..|..|-.-.+|+....+ ++.|++|+.......... -.+|..++..+...++. ++++.+..+ .|.||++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~ 116 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH 116 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence 356667788999987543 367899987655433333 37799999988654443 555655332 5899998
Q ss_pred CCChhHH-----------------Hhhcc-CC-C-cCChhhhHHHHHHH-----------------HhhhHh----hhc-
Q 003254 597 NKSLDYF-----------------IFDTT-RS-K-LLDWSKRSHIIAGI-----------------ARGLLY----LHQ- 634 (836)
Q Consensus 597 ~gsL~~~-----------------l~~~~-~~-~-~l~~~~~~~i~~~i-----------------a~gL~y----LH~- 634 (836)
+.+|... ++... .. . +.-+.++.++..++ ...+.. +..
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 8776421 11100 00 0 11122222322111 111111 221
Q ss_pred CCCCcEEeccCCCCceEecC-CCCceeeccCcccc
Q 003254 635 DSRLRIIHRDLKASNVLLDN-TMNPKISDFGLARS 668 (836)
Q Consensus 635 ~~~~~ivH~DLkp~NILl~~-~~~~kl~DFgla~~ 668 (836)
.....++|+|+++.||++++ ++.+.+.||..+..
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 22346899999999999986 57899999988764
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.54 E-value=0.024 Score=61.94 Aligned_cols=143 Identities=19% Similarity=0.209 Sum_probs=78.2
Q ss_pred cCeecccCceeEEEEEeecCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCc--eeeEEe------EEeeCCeeeEEEe
Q 003254 522 KNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRN--LVKLLG------CCTQRDERMLIYE 593 (836)
Q Consensus 522 ~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~n--iv~l~g------~~~~~~~~~lV~E 593 (836)
.+.|+.|....+|+....+| .+++|+.... ..+....|+.++..+...+ +.+.+. +....+..++++|
T Consensus 27 ~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~---~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~ 102 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTTQG-EYVLTLFERL---TAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT 102 (319)
T ss_pred cchhccccccceEEEEeCCC-cEEEEEeccC---ChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence 34577788889999887555 6889987521 2234445666666654222 233332 1123456789999
Q ss_pred ecCCCChhH-----H---------HhhccCC--------CcCCh-hhhHH------------HHHH-HHhhhHhhhcC--
Q 003254 594 YLPNKSLDY-----F---------IFDTTRS--------KLLDW-SKRSH------------IIAG-IARGLLYLHQD-- 635 (836)
Q Consensus 594 y~~~gsL~~-----~---------l~~~~~~--------~~l~~-~~~~~------------i~~~-ia~gL~yLH~~-- 635 (836)
|+++..+.. . ++..... ..+.| ..... .+.+ +...++.+...
T Consensus 103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 182 (319)
T PRK05231 103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAW 182 (319)
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccc
Confidence 999875421 0 1110000 01111 11111 1111 11122333211
Q ss_pred --CCCcEEeccCCCCceEecCCCCceeeccCcccc
Q 003254 636 --SRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (836)
Q Consensus 636 --~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~ 668 (836)
-+..++|+|+.|.||+++++...-|.||+.+..
T Consensus 183 ~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 183 PALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred ccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 233599999999999999776568999998753
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.49 E-value=0.029 Score=60.97 Aligned_cols=143 Identities=24% Similarity=0.247 Sum_probs=82.3
Q ss_pred cCeecccCceeEEEEEeecCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCc--eeeEEeEE------eeCCeeeEEEe
Q 003254 522 KNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRN--LVKLLGCC------TQRDERMLIYE 593 (836)
Q Consensus 522 ~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~n--iv~l~g~~------~~~~~~~lV~E 593 (836)
.+.++.|....+|+....+| .+++|+.+... ..++...|++++..+.... +.+++... ...+..++++|
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 45677777789999876444 67888775432 2345566777777774322 34444321 22345789999
Q ss_pred ecCCCChhH----H----------HhhccCC---------CcCChhhhH------------HHHHHHHhhhHhhhc----
Q 003254 594 YLPNKSLDY----F----------IFDTTRS---------KLLDWSKRS------------HIIAGIARGLLYLHQ---- 634 (836)
Q Consensus 594 y~~~gsL~~----~----------l~~~~~~---------~~l~~~~~~------------~i~~~ia~gL~yLH~---- 634 (836)
|++|..+.. . ++..... ..-.|.... .....+.+.++++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 998865421 0 1110000 001111110 011123334555532
Q ss_pred CCCCcEEeccCCCCceEecCCCCceeeccCccc
Q 003254 635 DSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667 (836)
Q Consensus 635 ~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~ 667 (836)
.....++|+|+.+.||++++++.+.|.||+.+.
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 223469999999999999988777899999875
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.24 E-value=0.04 Score=59.07 Aligned_cols=75 Identities=20% Similarity=0.272 Sum_probs=49.9
Q ss_pred cccCeecccCceeEEEEEeecCcEEEEEEecCCCchhHHHHHHHHHHHHhhc---CCceeeEEeEEeeCCeeeEEEeecC
Q 003254 520 SEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQ---HRNLVKLLGCCTQRDERMLIYEYLP 596 (836)
Q Consensus 520 ~~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~~~~~lV~Ey~~ 596 (836)
+..+.|+.|.-..+|+.. .+++.+.||.-. ......|..|.+-|+.|. --.+.+++++....+..+||+||++
T Consensus 20 ~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~ 95 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE 95 (288)
T ss_dssp -EEEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred eeeEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence 345678999999999987 578899999875 234467888999998883 3457788888877778899999998
Q ss_pred CC
Q 003254 597 NK 598 (836)
Q Consensus 597 ~g 598 (836)
.+
T Consensus 96 ~~ 97 (288)
T PF03881_consen 96 MG 97 (288)
T ss_dssp --
T ss_pred CC
Confidence 77
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.20 E-value=0.0063 Score=64.37 Aligned_cols=144 Identities=18% Similarity=0.194 Sum_probs=95.0
Q ss_pred HHHHHhhcccccccCeecccCceeEEEEEeecCcEEEEEEecCC---------Cc--------h-----hHHHHHHHHHH
Q 003254 509 LKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKG---------SG--------Q-----GMEEFKNEVLL 566 (836)
Q Consensus 509 ~~~l~~a~~~f~~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~---------~~--------~-----~~~~~~~Ei~~ 566 (836)
++.+..-.--++..++||-|--+.||.+-..+|++.++|.-+-. .. . ..-....|+..
T Consensus 84 lktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfaf 163 (465)
T KOG2268|consen 84 LKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAF 163 (465)
T ss_pred HHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHH
Confidence 33443333346778999999999999999999999999842211 00 0 01124568888
Q ss_pred HHhhc-CC-ceeeEEeEEeeCCeeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEecc
Q 003254 567 IAKLQ-HR-NLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRD 644 (836)
Q Consensus 567 l~~l~-H~-niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~D 644 (836)
|+.+. |. -+.+.+++ ...++|||++.+-.|-..- ...+...+ ...+..-+.-|-.+| +||+|
T Consensus 164 mkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~------~v~d~~~l---y~~lm~~Iv~la~~G---lIHgD 227 (465)
T KOG2268|consen 164 MKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVR------HVEDPPTL---YDDLMGLIVRLANHG---LIHGD 227 (465)
T ss_pred HHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeee------ecCChHHH---HHHHHHHHHHHHHcC---ceecc
Confidence 88885 32 23344443 3468899999887764332 11223333 333344445555666 99999
Q ss_pred CCCCceEecCCCCceeeccCcccc
Q 003254 645 LKASNVLLDNTMNPKISDFGLARS 668 (836)
Q Consensus 645 Lkp~NILl~~~~~~kl~DFgla~~ 668 (836)
..--||+++++..++++||--...
T Consensus 228 FNEFNimv~dd~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 228 FNEFNIMVKDDDKIVVIDFPQMVS 251 (465)
T ss_pred cchheeEEecCCCEEEeechHhhc
Confidence 999999999999999999976544
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.16 E-value=0.045 Score=58.50 Aligned_cols=31 Identities=23% Similarity=0.457 Sum_probs=25.8
Q ss_pred CcEEeccCCCCceEecCCCC-ceeeccCcccc
Q 003254 638 LRIIHRDLKASNVLLDNTMN-PKISDFGLARS 668 (836)
Q Consensus 638 ~~ivH~DLkp~NILl~~~~~-~kl~DFgla~~ 668 (836)
..++|+|+.+.||++++++. .-|.||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 35899999999999997555 46999998864
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=95.93 E-value=0.001 Score=82.01 Aligned_cols=160 Identities=13% Similarity=-0.058 Sum_probs=115.0
Q ss_pred HHHHHHHHHhhcCCceeeEEeEEee--CCeeeEEEeecCCCChhHHHhhccC-CCcCChhhhHHHHHHHHhhhHhhhcC-
Q 003254 560 FKNEVLLIAKLQHRNLVKLLGCCTQ--RDERMLIYEYLPNKSLDYFIFDTTR-SKLLDWSKRSHIIAGIARGLLYLHQD- 635 (836)
Q Consensus 560 ~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~lV~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~- 635 (836)
...|....++..|+++.+...-... ..+.+.+++|+..|.+...+.+... ..+++..-......+......-.|..
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 3445556666789988776655432 3456889999999999988876543 34454444444444435555555543
Q ss_pred -CCCcEEeccCCCCceEecCCCCceeeccCcccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhh
Q 003254 636 -SRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 714 (836)
Q Consensus 636 -~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~el 714 (836)
.....+|++||+-|.+|..+..+|++++|+.+.... .........+++.|++|+....-.++.++|+|..|+-+|++
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp--~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP--VLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred cCCccchhhhhhhhccceecCCcccccccccccccCc--hHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHH
Confidence 234579999999999999999999999999983221 12223345678899999998888899999999999999999
Q ss_pred hhCCCCC
Q 003254 715 ICGKKNR 721 (836)
Q Consensus 715 ltG~~p~ 721 (836)
--|..++
T Consensus 1434 s~~n~~f 1440 (2724)
T KOG1826|consen 1434 SDGNAYF 1440 (2724)
T ss_pred hcccHHH
Confidence 8877653
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.78 E-value=0.08 Score=57.22 Aligned_cols=145 Identities=15% Similarity=0.235 Sum_probs=79.7
Q ss_pred CeecccCceeEEEEEeecCcEEEEEEec-CCCchhHHHHHHHHHHHHhhcC--CceeeEEeEEeeCC--eeeEEEeecCC
Q 003254 523 NKLGEGGFGPVYKGMLIEGQEIAVKRLS-KGSGQGMEEFKNEVLLIAKLQH--RNLVKLLGCCTQRD--ERMLIYEYLPN 597 (836)
Q Consensus 523 ~~lG~G~fG~Vykg~~~~g~~vavK~l~-~~~~~~~~~~~~Ei~~l~~l~H--~niv~l~g~~~~~~--~~~lV~Ey~~~ 597 (836)
+.+..|..-.+|..... ++++++.+-. ...........+|..+|+.+.- .-+.+.+++|.++. ..+.||+|+++
T Consensus 31 ~~~~~G~sn~t~~~~~~-~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veG 109 (321)
T COG3173 31 EEISGGWSNDTFRLGDT-GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEG 109 (321)
T ss_pred eeccCCcccceEEEecC-CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecc
Confidence 34444444445554443 7788888221 1122334455678888877742 23445677776666 67999999988
Q ss_pred CChhHHHhhcc-----------------------------------CCCcCChhhhHHHHH--------HHHhhhHhhhc
Q 003254 598 KSLDYFIFDTT-----------------------------------RSKLLDWSKRSHIIA--------GIARGLLYLHQ 634 (836)
Q Consensus 598 gsL~~~l~~~~-----------------------------------~~~~l~~~~~~~i~~--------~ia~gL~yLH~ 634 (836)
..+...+.... .++.-.|...++.+. ....-..+|++
T Consensus 110 e~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~ 189 (321)
T COG3173 110 EVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEA 189 (321)
T ss_pred eeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHh
Confidence 43321111000 000011111111000 01112333332
Q ss_pred C-----CCCcEEeccCCCCceEecCCCCceeeccCcccc
Q 003254 635 D-----SRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (836)
Q Consensus 635 ~-----~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~ 668 (836)
+ +...++|+|+.+.||+++.+.-+-|.||+++..
T Consensus 190 ~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 190 NRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred cCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 2 235699999999999999888899999999875
|
|
| >cd01100 APPLE_Factor_XI_like Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins | Back alignment and domain information |
|---|
Probab=95.49 E-value=0.012 Score=48.97 Aligned_cols=47 Identities=19% Similarity=0.380 Sum_probs=32.7
Q ss_pred eecCCCCcccccccccCHHHHHHhhhccCceeeeecccccCCCCccccccc
Q 003254 377 AVKLPDTRFSWVDKNITLWECKELCSKNCSCTAYANADVRGRGSGCLLWFH 427 (836)
Q Consensus 377 ~~~~p~~~~~~~~~~~s~~~C~~~Cl~~CsC~a~~~~~~~~~~~~C~~w~~ 427 (836)
++.++..+.... ...+.++|+..|+.+|+|.||.|.. ....|+++..
T Consensus 11 ~~~~~g~d~~~~-~~~s~~~Cq~~C~~~~~C~afT~~~---~~~~C~lk~~ 57 (73)
T cd01100 11 NVDFRGGDLSTV-FASSAEQCQAACTADPGCLAFTYNT---KSKKCFLKSS 57 (73)
T ss_pred CCccccCCccee-ecCCHHHHHHHcCCCCCceEEEEEC---CCCeEEcccC
Confidence 444444433322 2568999999999999999999973 2457877655
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.45 E-value=0.082 Score=57.15 Aligned_cols=141 Identities=19% Similarity=0.181 Sum_probs=93.4
Q ss_pred ccCeecccCceeEEEEEeecCcEEEEEEecCCC-----c----hhHH-----------------HHHHHHHHHHhhcCCc
Q 003254 521 EKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGS-----G----QGME-----------------EFKNEVLLIAKLQHRN 574 (836)
Q Consensus 521 ~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~-----~----~~~~-----------------~~~~Ei~~l~~l~H~n 574 (836)
+...|..|--+.||.++-.+|..+|||+++... . .+.- -...|+.-|.+++...
T Consensus 148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 346789999999999999999999999875321 0 0000 1234666666665433
Q ss_pred eeeEEeEEeeCCeeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecC
Q 003254 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN 654 (836)
Q Consensus 575 iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~ 654 (836)
|.-.--.. -....|||+|+....- -....+...++...+..+-.+++.-|.-|.+.+ ++||.||.--|+|+-
T Consensus 228 IP~PePIl--Lk~hVLVM~FlGrdgw---~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyh- 299 (520)
T KOG2270|consen 228 IPCPEPIL--LKNHVLVMEFLGRDGW---AAPKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYH- 299 (520)
T ss_pred CCCCCcee--eecceEeeeeccCCCC---cCcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEE-
Confidence 21110000 1234799999864321 111122345677788888889999999998887 599999999999884
Q ss_pred CCCceeeccCccccc
Q 003254 655 TMNPKISDFGLARSF 669 (836)
Q Consensus 655 ~~~~kl~DFgla~~~ 669 (836)
+|.+.|+|-+-+...
T Consensus 300 dG~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 300 DGKLYIIDVSQSVEH 314 (520)
T ss_pred CCEEEEEEccccccC
Confidence 568899998876644
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.45 E-value=0.12 Score=56.86 Aligned_cols=74 Identities=16% Similarity=0.179 Sum_probs=48.3
Q ss_pred eecccCceeEEEEEeecC-cEEEEEEec----C---CCchhHHHHHHHHHHHHhhc--CCceeeEEeEEeeCCeeeEEEe
Q 003254 524 KLGEGGFGPVYKGMLIEG-QEIAVKRLS----K---GSGQGMEEFKNEVLLIAKLQ--HRNLVKLLGCCTQRDERMLIYE 593 (836)
Q Consensus 524 ~lG~G~fG~Vykg~~~~g-~~vavK~l~----~---~~~~~~~~~~~Ei~~l~~l~--H~niv~l~g~~~~~~~~~lV~E 593 (836)
.||.|...-||++..++| +.|+||.-. . ..+-..++..-|...|.... -|..++-+-++ +.+...+|||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~-D~e~~~~vME 80 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF-DTEMAVTVME 80 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE-ccccceehHh
Confidence 589999999999998665 689999742 1 12334455566777776653 35444433222 3455679999
Q ss_pred ecCCC
Q 003254 594 YLPNK 598 (836)
Q Consensus 594 y~~~g 598 (836)
+++..
T Consensus 81 dL~~~ 85 (370)
T TIGR01767 81 DLSHH 85 (370)
T ss_pred hCccc
Confidence 98653
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.33 E-value=0.12 Score=56.80 Aligned_cols=141 Identities=16% Similarity=0.199 Sum_probs=81.2
Q ss_pred CeecccCceeEEEEEeec----CcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCce-eeEEeEEeeCCeeeEEEeecCC
Q 003254 523 NKLGEGGFGPVYKGMLIE----GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNL-VKLLGCCTQRDERMLIYEYLPN 597 (836)
Q Consensus 523 ~~lG~G~fG~Vykg~~~~----g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~Ey~~~ 597 (836)
+.|..|-...+|+....+ +..|++|+....... .-.-.+|..+++.+..-++ .++++++..+ +|.+|+++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeCCc----EeehhhcC
Confidence 456667777889887543 237899987654432 2233678999998875555 3556655322 58999987
Q ss_pred CChhHH-------Hh-------hccCC------CcCChhhhHHHHHHH----------------------Hh---hhH-h
Q 003254 598 KSLDYF-------IF-------DTTRS------KLLDWSKRSHIIAGI----------------------AR---GLL-Y 631 (836)
Q Consensus 598 gsL~~~-------l~-------~~~~~------~~l~~~~~~~i~~~i----------------------a~---gL~-y 631 (836)
..|... +. ..... .+--|..+.++..++ .+ .+. .
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 765321 10 00000 011122222222221 11 111 1
Q ss_pred hhc-CCCCcEEeccCCCCceEecC-CCCceeeccCcccc
Q 003254 632 LHQ-DSRLRIIHRDLKASNVLLDN-TMNPKISDFGLARS 668 (836)
Q Consensus 632 LH~-~~~~~ivH~DLkp~NILl~~-~~~~kl~DFgla~~ 668 (836)
+.. .....++|+|+.+.|||+++ ++.+++.||..|-.
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 111 12235799999999999975 57899999998754
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.20 E-value=0.047 Score=55.81 Aligned_cols=30 Identities=30% Similarity=0.460 Sum_probs=21.5
Q ss_pred cEEeccCCCCceEe-cCCCCceeeccCcccc
Q 003254 639 RIIHRDLKASNVLL-DNTMNPKISDFGLARS 668 (836)
Q Consensus 639 ~ivH~DLkp~NILl-~~~~~~kl~DFgla~~ 668 (836)
.+.|+|+.+.|||+ +.++.++++||..|..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 48999999999999 8899999999998764
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 836 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 5e-55 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 8e-54 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 8e-41 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-40 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-38 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-38 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-38 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-36 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-24 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-24 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-24 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-24 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-24 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-24 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-24 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-24 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-24 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-24 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-24 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-24 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-24 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 6e-24 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 6e-24 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 6e-24 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-23 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-23 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 5e-23 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 5e-23 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 6e-23 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 6e-23 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 8e-23 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-22 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-22 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-22 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 5e-22 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-22 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 6e-22 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 8e-22 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-21 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-21 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-21 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-21 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-21 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-21 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-21 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-21 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-21 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-21 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-21 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-21 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-21 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-21 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-20 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-20 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-20 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-20 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 7e-20 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 8e-20 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 8e-20 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 9e-20 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-19 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-19 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-19 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-19 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-19 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-19 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-19 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-19 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-19 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-19 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-19 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-19 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-19 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-19 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-19 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-19 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-19 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-19 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-19 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-19 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 5e-19 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 7e-19 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 7e-19 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-19 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 8e-19 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-18 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-18 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-18 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-18 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-18 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-18 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-18 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-18 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-18 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-18 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-18 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-18 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-18 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-18 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-18 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-18 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-18 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-18 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-18 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-18 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-18 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-18 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-18 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-18 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-18 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-18 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-18 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-18 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-18 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 4e-18 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 4e-18 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 4e-18 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 5e-18 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 6e-18 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-18 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-18 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 6e-18 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 7e-18 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 7e-18 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 8e-18 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 8e-18 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 9e-18 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 9e-18 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-18 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 9e-18 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 9e-18 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-17 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-17 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-17 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-17 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-17 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-17 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-17 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-17 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-17 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-17 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-17 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-17 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-17 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-17 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-17 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-17 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-17 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-17 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-17 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-17 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-17 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-17 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-17 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-17 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-17 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-17 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-17 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-17 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-17 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-17 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-17 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-17 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-17 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-17 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-17 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-17 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-17 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-17 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-17 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-17 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-17 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-17 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-17 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-17 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-17 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-17 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-17 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-17 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-17 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-17 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-17 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-17 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-17 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-17 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-17 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-17 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-17 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-17 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-17 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-17 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-17 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 7e-17 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 7e-17 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 7e-17 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 8e-17 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 8e-17 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 8e-17 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 8e-17 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 8e-17 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-17 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 8e-17 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 9e-17 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 9e-17 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 9e-17 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-16 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-16 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-16 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-16 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-16 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-16 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-16 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-16 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-16 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-16 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-16 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-16 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-16 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-16 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-16 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-16 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-16 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-16 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-16 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 4e-16 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 5e-16 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 5e-16 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 5e-16 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 5e-16 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 5e-16 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-16 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 5e-16 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-16 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-16 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 5e-16 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 5e-16 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 5e-16 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 5e-16 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 6e-16 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 6e-16 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 6e-16 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 7e-16 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 7e-16 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 7e-16 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-16 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-16 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 8e-16 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 8e-16 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 9e-16 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 9e-16 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-15 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-15 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-15 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-15 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-15 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-15 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-15 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-15 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-15 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-15 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-15 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-15 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-15 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-15 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-15 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-15 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-15 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-15 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-15 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-15 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-15 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-15 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-15 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-15 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-15 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-15 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-15 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-15 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-15 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-15 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-15 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-15 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-15 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-15 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-15 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-15 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-15 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-15 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-15 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-15 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-15 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-15 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-15 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-15 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-15 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-15 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-15 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-15 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-15 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-15 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-15 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-15 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-15 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-15 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-15 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-15 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-15 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-15 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-15 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-15 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-15 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-15 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-15 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-15 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 3e-15 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-15 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-15 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-15 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-15 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-15 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-15 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-15 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-15 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-15 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-15 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-15 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-15 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-15 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-15 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-15 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-15 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-15 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 4e-15 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-15 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-15 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-15 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-15 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 4e-15 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-15 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-15 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 5e-15 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 5e-15 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-15 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 5e-15 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-15 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-15 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 6e-15 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 6e-15 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 6e-15 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-15 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 7e-15 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 7e-15 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-15 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 7e-15 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 7e-15 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 7e-15 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 8e-15 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 9e-15 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 9e-15 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 9e-15 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-14 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-14 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-14 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-14 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-14 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-14 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-14 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-14 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-14 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-14 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-14 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-14 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-14 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-14 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-14 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-14 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-14 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-14 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-14 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-14 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-14 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-14 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-14 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-14 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-14 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-14 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-14 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-14 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-14 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-14 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-14 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-14 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-14 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-14 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-14 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-14 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-14 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-14 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-14 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-14 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-14 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-14 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-14 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-14 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-14 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-14 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-14 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-14 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-14 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-14 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-14 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-14 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-14 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-14 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-14 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-14 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-14 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-14 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-14 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-14 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-14 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 5e-14 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 5e-14 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-14 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 6e-14 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-14 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-14 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 6e-14 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 7e-14 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 7e-14 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 7e-14 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 7e-14 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-14 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-14 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-14 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 8e-14 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 8e-14 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 8e-14 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 8e-14 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 8e-14 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-14 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 9e-14 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 9e-14 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 9e-14 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 9e-14 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 9e-14 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 9e-14 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 9e-14 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 9e-14 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 9e-14 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 9e-14 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 9e-14 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 9e-14 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-13 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-13 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-13 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-13 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-13 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-13 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-13 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-13 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-13 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-13 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-13 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-13 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-13 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-13 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-13 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-13 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-13 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-13 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-13 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-13 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-13 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-13 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-13 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-13 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-13 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-13 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-13 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-13 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 5e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 5e-13 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-13 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 5e-13 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-13 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 6e-13 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 6e-13 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-13 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-13 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 9e-13 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-12 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-12 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-12 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-12 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-12 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-12 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-12 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-12 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-12 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-12 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-12 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-12 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-12 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-12 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-12 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-12 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-12 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-12 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-12 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-12 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-12 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-12 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-12 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-12 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-12 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-12 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-12 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-12 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-12 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-12 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-12 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-12 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-12 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-12 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 5e-12 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 5e-12 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 5e-12 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 5e-12 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 5e-12 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-12 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 6e-12 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-12 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 6e-12 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 7e-12 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 7e-12 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-12 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 7e-12 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 8e-12 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-12 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 8e-12 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 8e-12 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 8e-12 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 8e-12 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 8e-12 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-12 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 8e-12 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 8e-12 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 8e-12 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 8e-12 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-12 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 8e-12 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 8e-12 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 8e-12 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 9e-12 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 9e-12 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 9e-12 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 9e-12 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 9e-12 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 9e-12 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 9e-12 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 9e-12 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-11 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-11 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-11 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-11 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-11 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-11 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-11 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-11 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-11 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-11 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-11 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-11 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-11 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-11 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-11 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-11 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-11 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-11 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-11 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-11 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-11 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-11 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-11 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-11 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-11 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-11 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-11 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-11 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-11 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-11 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-11 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-11 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-11 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-11 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-11 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-11 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-11 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-11 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-11 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-11 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-11 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-11 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-11 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-11 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-11 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-11 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-11 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-11 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-11 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-11 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-11 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-11 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 4e-11 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-11 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-11 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-11 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-11 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-11 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-11 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-11 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 4e-11 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-11 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-11 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-11 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 4e-11 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-11 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-11 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-11 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 4e-11 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-11 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 4e-11 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 4e-11 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-11 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 4e-11 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-11 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-11 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 4e-11 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 4e-11 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-11 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-11 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 5e-11 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 5e-11 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 5e-11 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 5e-11 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 5e-11 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 5e-11 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 5e-11 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 5e-11 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 5e-11 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 5e-11 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 5e-11 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 5e-11 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 5e-11 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-11 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 5e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 5e-11 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-11 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-11 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 5e-11 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-11 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 6e-11 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 6e-11 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 6e-11 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 6e-11 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 6e-11 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 6e-11 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 6e-11 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 6e-11 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 7e-11 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 7e-11 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 7e-11 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 7e-11 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 7e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 7e-11 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-11 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 7e-11 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 7e-11 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-11 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 7e-11 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 7e-11 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 7e-11 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 7e-11 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 7e-11 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 8e-11 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 8e-11 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 8e-11 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 8e-11 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 9e-11 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 9e-11 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 9e-11 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 9e-11 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 9e-11 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 9e-11 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 9e-11 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 9e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 9e-11 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 9e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 9e-11 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-11 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-10 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-10 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-10 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-10 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-10 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-10 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-10 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-10 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-10 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-10 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-10 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-10 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-10 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-10 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-10 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-10 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-10 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-10 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-10 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-10 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-10 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-10 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-10 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-10 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-10 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-10 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-10 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-10 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-10 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-10 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-10 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-10 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-10 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-10 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-10 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-10 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-10 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 4e-10 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-10 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-10 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-10 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-10 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-10 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-10 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 4e-10 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-10 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 5e-10 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 5e-10 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 5e-10 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 5e-10 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-10 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 5e-10 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-10 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 5e-10 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 5e-10 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 5e-10 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 5e-10 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-10 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 6e-10 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 6e-10 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 6e-10 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 6e-10 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 6e-10 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-10 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 6e-10 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 6e-10 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 6e-10 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-10 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 6e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 7e-10 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 7e-10 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 7e-10 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 7e-10 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 7e-10 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 7e-10 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 8e-10 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 8e-10 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 8e-10 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 8e-10 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 9e-10 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 9e-10 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 9e-10 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 9e-10 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 9e-10 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-09 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-09 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-09 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-09 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-09 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-09 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-09 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-09 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-09 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-09 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-09 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-09 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-09 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-09 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-09 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-09 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-09 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-09 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-09 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-09 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-09 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-09 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-09 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-09 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-09 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-09 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-09 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 3e-09 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-09 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-09 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 3e-09 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-09 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 3e-09 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-09 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-09 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 3e-09 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 4e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-09 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-09 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 4e-09 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 4e-09 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 4e-09 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 4e-09 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 4e-09 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 4e-09 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 4e-09 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-09 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 4e-09 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 4e-09 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 4e-09 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 4e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-09 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 4e-09 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 4e-09 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 4e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-09 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-09 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 5e-09 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 5e-09 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 5e-09 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 5e-09 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 5e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-09 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 5e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 5e-09 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-09 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-09 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 6e-09 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 6e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 6e-09 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 6e-09 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 6e-09 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 6e-09 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-09 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 7e-09 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-09 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 7e-09 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-09 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 7e-09 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 7e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 7e-09 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-09 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 7e-09 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 8e-09 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-09 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 8e-09 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 8e-09 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-09 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 8e-09 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 8e-09 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 9e-09 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 9e-09 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 9e-09 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-08 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-08 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-08 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-08 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-08 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-08 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-08 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-08 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-08 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-08 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-08 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-08 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-08 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-08 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-08 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-08 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-08 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-08 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 5e-08 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 5e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 6e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 6e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 6e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 6e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 6e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 7e-08 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 7e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 8e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 8e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 9e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 9e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 9e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 9e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 9e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 9e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 9e-08 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-07 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-07 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-07 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-07 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-07 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 3e-07 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 3e-07 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 3e-07 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 4e-07 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 4e-07 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 4e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-07 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 4e-07 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 6e-07 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 7e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 7e-07 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 8e-07 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-06 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-06 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-06 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 1e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-06 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-06 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-06 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-06 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-06 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 6e-06 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 6e-06 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 6e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 7e-06 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 7e-06 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-05 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 1e-05 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 1e-05 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 1e-05 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 1e-05 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 1e-05 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 433 bits (1115), Expect = e-147
Identities = 106/313 (33%), Positives = 163/313 (52%), Gaps = 19/313 (6%)
Query: 494 NQGNEKEEMELPIFDLKIIANATDNFSEK------NKLGEGGFGPVYKGMLIEGQEIAVK 547
N+ E + F + N T+NF E+ NK+GEGGFG VYKG + +AVK
Sbjct: 2 NKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVK 60
Query: 548 RLSKG----SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYF 603
+L+ + + ++F E+ ++AK QH NLV+LLG + D+ L+Y Y+PN SL
Sbjct: 61 KLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDR 120
Query: 604 IFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDF 663
+ + L W R I G A G+ +LH++ IHRD+K++N+LLD KISDF
Sbjct: 121 LSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDF 177
Query: 664 GLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGF 723
GLAR+ T R+VGT YM+PE + G + KSD++SFGV++LEII G
Sbjct: 178 GLARASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPA--V 234
Query: 724 NHADHDHNLLGHAWRLWIEERPLE-LIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPN 782
+ LL + EE+ +E ID+ +++ + V C+ ++ RP+
Sbjct: 235 DEHREPQLLLDIKEEIEDEEKTIEDYIDKKMND-ADSTSVEAMYSVASQCLHEKKNKRPD 293
Query: 783 MSSVVLMLSGERS 795
+ V +L +
Sbjct: 294 IKKVQQLLQEMTA 306
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 426 bits (1097), Expect = e-144
Identities = 126/292 (43%), Positives = 168/292 (57%), Gaps = 5/292 (1%)
Query: 506 IFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGME-EFKNEV 564
F L+ + A+DNFS KN LG GGFG VYKG L +G +AVKRL + QG E +F+ EV
Sbjct: 19 RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEV 78
Query: 565 LLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKL-LDWSKRSHIIA 623
+I+ HRNL++L G C ER+L+Y Y+ N S+ + + S+ LDW KR I
Sbjct: 79 EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIAL 138
Query: 624 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVG 683
G ARGL YLH +IIHRD+KA+N+LLD + DFGLA+ T T V G
Sbjct: 139 GSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT-AVRG 197
Query: 684 TYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHA--DHDHNLLGHAWRLWI 741
T G+++PEY G S K+DVF +GV++LE+I G++ D D LL L
Sbjct: 198 TIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 257
Query: 742 EERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 793
E++ L+D L + E + IQV LLC Q P +RP MS VV ML G+
Sbjct: 258 EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 375 bits (964), Expect = e-124
Identities = 106/295 (35%), Positives = 165/295 (55%), Gaps = 6/295 (2%)
Query: 507 FDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLL 566
L + AT+NF K +G G FG VYKG+L +G ++A+KR + S QG+EEF+ E+
Sbjct: 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88
Query: 567 IAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKL-LDWSKRSHIIAGI 625
++ +H +LV L+G C +R+E +LIY+Y+ N +L ++ + + + W +R I G
Sbjct: 89 LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148
Query: 626 ARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF-GLDQTEANTKRVVGT 684
ARGL YLH + IIHRD+K+ N+LLD PKI+DFG+++ LDQT +T V GT
Sbjct: 149 ARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLST-VVKGT 204
Query: 685 YGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEER 744
GY+ PEY I G + KSDV+SFGV++ E++C + + NL A +
Sbjct: 205 LGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ 264
Query: 745 PLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQP 799
+++D +L + + + C+ EDRP+M V+ L L +
Sbjct: 265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQES 319
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 293 bits (751), Expect = 1e-92
Identities = 65/307 (21%), Positives = 124/307 (40%), Gaps = 28/307 (9%)
Query: 507 FDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLL 566
+ + + G FG V+K + + +AVK Q + + EV
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQDKQSWQ-NEYEVYS 71
Query: 567 IAKLQHRNLVKLLGCCTQRD----ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHII 622
+ ++H N+++ +G + + LI + SL F+ ++ ++ W++ HI
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----KANVVSWNELCHIA 127
Query: 623 AGIARGLLYLHQD-------SRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE 675
+ARGL YLH+D + I HRD+K+ NVLL N + I+DFGLA F ++
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187
Query: 676 ANTKRVVGTYGYMSPEYAIDGL-----FSVKSDVFSFGVLVLEIICGKKNRGFNHADHDH 730
+T VGT YM+PE + ++ D+++ G+++ E+ ++
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247
Query: 731 NLLGHAWRLWIEERPLELIDQ-----SLDNSCSFSEALRCI-QVGLLCVQQRPEDRPNMS 784
+ E E++ L + + + + C E R +
Sbjct: 248 PFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAG 307
Query: 785 SVVLMLS 791
V ++
Sbjct: 308 CVGERIT 314
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 242 bits (619), Expect = 2e-73
Identities = 69/337 (20%), Positives = 123/337 (36%), Gaps = 47/337 (13%)
Query: 502 MELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFK 561
ME + + DN +G G +G VYKG L + + +AVK S + Q K
Sbjct: 1 MEAAASEPSL---DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEK 56
Query: 562 NEVLLIAKLQHRNLVKLLGCCT-----QRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWS 616
+ + ++H N+ + + R E +L+ EY PN SL ++ T DW
Sbjct: 57 -NIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----SDWV 111
Query: 617 KRSHIIAGIARGLLYLHQD------SRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF- 669
+ + RGL YLH + + I HRDL + NVL+ N ISDFGL+
Sbjct: 112 SSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLT 171
Query: 670 -----GLDQTEANTKRVVGTYGYMSPEYAIDGLFSV--------KSDVFSFGVLVLEIIC 716
+ + VGT YM+PE ++G ++ + D+++ G++ EI
Sbjct: 172 GNRLVRPGEEDNAAISEVGTIRYMAPEV-LEGAVNLRDXESALKQVDMYALGLIYWEIFM 230
Query: 717 GKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQ--------SLDNSCSFSEALRCIQV 768
+ + ++ + + ++ + +
Sbjct: 231 RCTDLFPGESVPEYQMA-FQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLK 289
Query: 769 GLL--CVQQRPEDRPNMSSVVLMLSG-ERSLPQPQQP 802
+ C Q E R ++ + +
Sbjct: 290 ETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSV 326
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 2e-62
Identities = 85/329 (25%), Positives = 149/329 (45%), Gaps = 42/329 (12%)
Query: 491 KHSNQGNEKEEMELPIFDLKIIANATD------NFSE---KNKLGEGGFGPVYKGMLIEG 541
KH + + + ++P + A D + + K K+G G FG V++ G
Sbjct: 2 KHHHHHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HG 60
Query: 542 QEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKS 599
++AVK L + + + EF EV ++ +L+H N+V +G TQ ++ EYL S
Sbjct: 61 SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGS 120
Query: 600 LDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPK 659
L + + + LD +R + +A+G+ YLH I+HR+LK+ N+L+D K
Sbjct: 121 LYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVK 179
Query: 660 ISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKK 719
+ DFGL+R T ++K GT +M+PE D + KSDV+SFGV++ E+ ++
Sbjct: 180 VCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQ 237
Query: 720 -NRGFNHADHDHNLLGHAWRLWIEE---RPL-ELIDQSLDNSCSFSEALRCIQVGLLCVQ 774
N A + RL I + +I+ C
Sbjct: 238 PWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEG--------------------CWT 277
Query: 775 QRPEDRPNMSSVVLMLSG--ERSLPQPQQ 801
P RP+ ++++ +L + ++P P +
Sbjct: 278 NEPWKRPSFATIMDLLRPLIKSAVPPPNR 306
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 4e-60
Identities = 69/289 (23%), Positives = 116/289 (40%), Gaps = 28/289 (9%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLV 576
+ +G G FG V K +++A+K++ S + F E+ ++++ H N+V
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIE--SESERKAFIVELRQLSRVNHPNIV 64
Query: 577 KLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDS 636
KL G C L+ EY SL + + ++G+ YLH
Sbjct: 65 KLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 637 RLRIIHRDLKASNVLLDNTMN-PKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAID 695
+IHRDLK N+LL KI DFG A + + G+ +M+PE
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEG 177
Query: 696 GLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDN 755
+S K DVFS+G+++ E+I +K + W + RP L
Sbjct: 178 SNYSEKCDVFSWGIILWEVITRRK----PFDEIGGPAFRIMWAVHNGTRP------PLIK 227
Query: 756 SCSFSEALRC-IQVGLLCVQQRPEDRPNMSSVVLML-SGERSLPQPQQP 802
+ + + + C + P RP+M +V ++ R P +P
Sbjct: 228 NL--PKPIESLMT---RCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEP 271
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 4e-60
Identities = 83/339 (24%), Positives = 126/339 (37%), Gaps = 49/339 (14%)
Query: 503 ELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFK 561
DL LG+G FG K E G+ + +K L + + F
Sbjct: 6 IFRPSDLIH----------GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFL 55
Query: 562 NEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHI 621
EV ++ L+H N++K +G + I EY+ +L I WS+R
Sbjct: 56 KEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKS--MDSQYPWSQRVSF 113
Query: 622 IAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKR- 680
IA G+ YLH + IIHRDL + N L+ N ++DFGLAR ++T+ R
Sbjct: 114 AKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRS 170
Query: 681 -----------VVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHD 729
VVG +M+PE + K DVFSFG+++ EII AD D
Sbjct: 171 LKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVN------ADPD 224
Query: 730 HNLLGHAWRLWIEE--RPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVV 787
+ + L + +C + + + C PE RP+ +
Sbjct: 225 YLPRTMDFGLNVRGFLDR------YCPPNC--PPSFF--PITVRCCDLDPEKRPSFVKLE 274
Query: 788 LMLSGERSLPQPQQPGFFTGRNLPESESSSSRQYSASTN 826
L R P G L + + Y +
Sbjct: 275 HWLETLRMHLAGHLP---LGPQLEQLDRGFWETYRRGES 310
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 4e-59
Identities = 70/216 (32%), Positives = 107/216 (49%), Gaps = 24/216 (11%)
Query: 518 NFSE---KNKLGEGGFGPVYKGMLIEGQEIAVKRLSKG----SGQGMEEFKNEVLLIAKL 570
+F+E + +G GGFG VY+ G E+AVK Q +E + E L A L
Sbjct: 5 DFAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAML 63
Query: 571 QHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLL 630
+H N++ L G C + L+ E+ L+ + K + + IARG+
Sbjct: 64 KHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL----SGKRIPPDILVNWAVQIARGMN 119
Query: 631 YLHQDSRLRIIHRDLKASNVLLDNTMNP--------KISDFGLARSFGLDQTEANTKRVV 682
YLH ++ + IIHRDLK+SN+L+ + KI+DFGLAR +
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR----EWHRTTKMSAA 175
Query: 683 GTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGK 718
G Y +M+PE +FS SDV+S+GVL+ E++ G+
Sbjct: 176 GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGE 211
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 201 bits (512), Expect = 9e-59
Identities = 75/309 (24%), Positives = 145/309 (46%), Gaps = 52/309 (16%)
Query: 503 ELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQG----- 556
E P L +A+ + + ++G+GGFG V+KG L++ +A+K L G +G
Sbjct: 7 EFPKSRLPTLAD--NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMI 64
Query: 557 --MEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLD 614
+EF+ EV +++ L H N+VKL G ++ E++P L + + D ++ +
Sbjct: 65 EKFQEFQREVFIMSNLNHPNIVKLYGLMHN--PPRMVMEFVPCGDLYHRLLD--KAHPIK 120
Query: 615 WSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-----TMNPKISDFGLARSF 669
WS + ++ IA G+ Y+ I+HRDL++ N+ L + + K++DFGL++
Sbjct: 121 WSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-- 177
Query: 670 GLDQTEANTKRVVGTYGYMSPE--YAIDGLFSVKSDVFSFGVLVLEIICGK---KNRGFN 724
Q+ + ++G + +M+PE A + ++ K+D +SF +++ I+ G+ +
Sbjct: 178 ---QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG 234
Query: 725 HADHDHNLLGHAWRLWI-EERPLELIDQSLDNSCSFSEALRCIQVGLL--CVQQRPEDRP 781
+ + R I E+ P L + ++ C P+ RP
Sbjct: 235 KIKFINMIREEGLRPTIPEDCPPRLRN-------------------VIELCWSGDPKKRP 275
Query: 782 NMSSVVLML 790
+ S +V L
Sbjct: 276 HFSYIVKEL 284
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 2e-57
Identities = 73/308 (23%), Positives = 140/308 (45%), Gaps = 36/308 (11%)
Query: 489 RKKHSNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKR 548
H + ++ E+P + + ++G G FG VYKG ++AVK
Sbjct: 6 HHHHHGSRDAADDWEIPDGQITV----------GQRIGSGSFGTVYKGKW--HGDVAVKM 53
Query: 549 LSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFD 606
L+ + Q ++ FKNEV ++ K +H N++ +G T + ++ ++ SL + +
Sbjct: 54 LNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHA 112
Query: 607 TTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLA 666
+ K I ARG+ YLH IIHRDLK++N+ L KI DFGLA
Sbjct: 113 --SETKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLA 167
Query: 667 RSFGLDQTEANTKRVVGTYGYMSPE---YAIDGLFSVKSDVFSFGVLVLEIICGKK-NRG 722
+++ G+ +M+PE +S +SDV++FG+++ E++ G+
Sbjct: 168 TEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSN 227
Query: 723 FNHADHDHNLLGHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPN 782
N+ D ++G P +S +C + ++ + C++++ ++RP+
Sbjct: 228 INNRDQIIEMVGRGSL-----SPDLSKVRS---NC--PKRMKRLM--AECLKKKRDERPS 275
Query: 783 MSSVVLML 790
++ +
Sbjct: 276 FPRILAEI 283
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 6e-57
Identities = 52/212 (24%), Positives = 92/212 (43%), Gaps = 22/212 (10%)
Query: 518 NFSE---KNKLGEGGFGPVYKGMLIEGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQH 572
+F + KL E G ++KG +G +I VK L S + +F E + H
Sbjct: 8 DFKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSH 66
Query: 573 RNLVKLLGCCTQRDER--MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLL 630
N++ +LG C LI ++P SL + + T + D S+ +ARG+
Sbjct: 67 PNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVV-DQSQAVKFALDMARGMA 125
Query: 631 YLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSP 690
+LH L I L + +V++D M +IS + SF + + +++P
Sbjct: 126 FLHTLEPL-IPRHALNSRSVMIDEDMTARISMADVKFSF-------QSPGRMYAPAWVAP 177
Query: 691 EYAIDG----LFSVKSDVFSFGVLVLEIICGK 718
E A+ +D++SF VL+ E++ +
Sbjct: 178 E-ALQKKPEDTNRRSADMWSFAVLLWELVTRE 208
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 1e-55
Identities = 79/337 (23%), Positives = 130/337 (38%), Gaps = 54/337 (16%)
Query: 488 RRKKHSNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVK 547
+K S +E ++P L+I +G+G FG VY G E+A++
Sbjct: 14 FPRKASQTSIFLQEWDIPFEQLEI----------GELIGKGRFGQVYHGRW--HGEVAIR 61
Query: 548 RLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIF 605
+ + ++ FK EV+ + +H N+V +G C +I ++L +
Sbjct: 62 LIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVR 121
Query: 606 DTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGL 665
D +LD +K I I +G+ YLH I+H+DLK+ NV DN I+DFGL
Sbjct: 122 D--AKIVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYDN-GKVVITDFGL 175
Query: 666 ARSFGLDQTEANTKR---VVGTYGYMSPE---------YAIDGLFSVKSDVFSFGVLVLE 713
G+ Q + G +++PE FS SDVF+ G + E
Sbjct: 176 FSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYE 235
Query: 714 IICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCV 773
+ + W++ +P L + + + I L C
Sbjct: 236 LHAREW------PFKTQPAEAIIWQMGTGMKP-NLSQIGMG------KEISDIL--LFCW 280
Query: 774 QQRPEDRPNMSSVVLMLSGERSLPQ----PQQPGFFT 806
E+RP + ++ ML LP+ PG F
Sbjct: 281 AFEQEERPTFTKLMDML---EKLPKRNRRLSHPGHFW 314
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 2e-49
Identities = 71/320 (22%), Positives = 121/320 (37%), Gaps = 51/320 (15%)
Query: 504 LPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNE 563
LP+ + IA ++G+G +G V+ G G+++AVK + E
Sbjct: 27 LPLLVQRTIA---KQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFT---TEEASWFRE 79
Query: 564 --VLLIAKLQHRNLVKLLGCCTQ----RDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSK 617
+ ++H N++ + + + LI +Y N SL ++ +S LD
Sbjct: 80 TEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKS 135
Query: 618 RSHIIAGIARGLLYLHQDSRLR-----IIHRDLKASNVLLDNTMNPKISDFGLARSF--G 670
+ GL +LH + I HRDLK+ N+L+ I+D GLA F
Sbjct: 136 MLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISD 195
Query: 671 LDQTEANTKRVVGTYGYMSPEYAIDGLFSV-------KSDVFSFGVLVLEIICGKKNRG- 722
++ + VGT YM PE +D + +D++SFG+++ E+ + G
Sbjct: 196 TNEVDIPPNTRVGTKRYMPPE-VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGI 254
Query: 723 -------FNHADHDHNLLGHAWRLWIEE--RPLELIDQSLDNSCSFSEALRCIQVGLL-- 771
++ + + RP S N S E LR + L+
Sbjct: 255 VEEYQLPYHDLVPSDPSYEDMREIVCIKKLRP------SFPNRWSSDECLRQM-GKLMTE 307
Query: 772 CVQQRPEDRPNMSSVVLMLS 791
C P R V L+
Sbjct: 308 CWAHNPASRLTALRVKKTLA 327
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 3e-49
Identities = 64/298 (21%), Positives = 115/298 (38%), Gaps = 42/298 (14%)
Query: 523 NKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNE--VLLIAKLQHRNLVKLLG 580
+G+G +G V++G +G+ +AVK S + + + E + L+H N++ +
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 581 CCT----QRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDS 636
+ LI Y SL ++ + LD I+ IA GL +LH +
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 637 RLR-----IIHRDLKASNVLLDNTMNPKISDFGLAR--SFGLDQTEANTKRVVGTYGYMS 689
I HRDLK+ N+L+ I+D GLA S +Q + VGT YM+
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 690 PE------YAIDGLFSVKSDVFSFGVLVLEIICGKKNRG--------FNHADHDHNLLGH 735
PE + D+++FG+++ E+ + G F +
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFED 245
Query: 736 AWRLWIEE--RPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLS 791
++ + RP I + + + + ++ C Q P R + L+
Sbjct: 246 MRKVVCVDQQRP--NIPNRWFSDPTLTSLAKLMK---ECWYQNPSARLTALRIKKTLT 298
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 171 bits (434), Expect = 1e-47
Identities = 82/326 (25%), Positives = 135/326 (41%), Gaps = 47/326 (14%)
Query: 486 MYRRKKHSNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLI-----E 540
+Y + + +++ + LK + +LG+G FG V
Sbjct: 20 LYFQGAMGSAFEDRDPTQFEERHLKFL----------QQLGKGNFGSVEMCRYDPLQDNT 69
Query: 541 GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDER--MLIYEYLPNK 598
G+ +AVK+L + + + +F+ E+ ++ LQH N+VK G C R LI EYLP
Sbjct: 70 GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 129
Query: 599 SLDYFIFD----TTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN 654
SL ++ KLL ++ + I +G+ YL R IHRDL N+L++N
Sbjct: 130 SLRDYLQKHKERIDHIKLLQYT------SQICKGMEYL---GTKRYIHRDLATRNILVEN 180
Query: 655 TMNPKISDFGLARSFGLDQTEANTKRVVGTYG-----YMSPEYAIDGLFSVKSDVFSFGV 709
KI DFGL + D+ V G + +PE + FSV SDV+SFGV
Sbjct: 181 ENRVKIGDFGLTKVLPQDKEYY----KVKEPGESPIFWYAPESLTESKFSVASDVWSFGV 236
Query: 710 LVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQS--LD--NSCSFSEALRC 765
++ E+ + A+ + I +EL+ + L + C + +
Sbjct: 237 VLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGC--PDEIYM 294
Query: 766 IQVGLLCVQQRPEDRPNMSSVVLMLS 791
I C RP+ + L +
Sbjct: 295 IM--TECWNNNVNQRPSFRDLALRVD 318
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 6e-47
Identities = 70/320 (21%), Positives = 124/320 (38%), Gaps = 51/320 (15%)
Query: 504 LPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNE 563
LP+ + IA + +G+G FG V++G G+E+AVK S + + E
Sbjct: 32 LPLLVQRTIA---RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFRE 84
Query: 564 --VLLIAKLQHRNLVKLLGCCTQRD----ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSK 617
+ L+H N++ + + + + L+ +Y + SL FD +
Sbjct: 85 AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEG 140
Query: 618 RSHIIAGIARGLLYLHQD-----SRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF--G 670
+ A GL +LH + + I HRDLK+ N+L+ I+D GLA
Sbjct: 141 MIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA 200
Query: 671 LDQTEANTKRVVGTYGYMSPEYAIDGLFSV-------KSDVFSFGVLVLEIICGKKNRG- 722
D + VGT YM+PE +D ++ ++D+++ G++ EI G
Sbjct: 201 TDTIDIAPNHRVGTKRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 259
Query: 723 -------FNHADHDHNLLGHAWRLWIEE--RPLELIDQSLDNSCSFSEALRCIQVGLL-- 771
+ + ++ E+ RP ++ N EALR + ++
Sbjct: 260 HEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRP------NIPNRWQSCEALRVM-AKIMRE 312
Query: 772 CVQQRPEDRPNMSSVVLMLS 791
C R + LS
Sbjct: 313 CWYANGAARLTALRIKKTLS 332
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 1e-46
Identities = 79/290 (27%), Positives = 124/290 (42%), Gaps = 37/290 (12%)
Query: 522 KNKLGEGGFGPVYKGMLI-----EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLV 576
+LG+G FG V G+ +AVK+L + + + +F+ E+ ++ LQH N+V
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 74
Query: 577 KLLGCCTQRDER--MLIYEYLPNKSLDYFIFD----TTRSKLLDWSKRSHIIAGIARGLL 630
K G C R LI EYLP SL ++ KLL ++ + I +G+
Sbjct: 75 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT------SQICKGME 128
Query: 631 YLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYG---- 686
YL R IHRDL N+L++N KI DFGL + D+ V G
Sbjct: 129 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFF----KVKEPGESPI 181
Query: 687 -YMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERP 745
+ +PE + FSV SDV+SFGV++ E+ + A+ + I
Sbjct: 182 FWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 241
Query: 746 LELIDQS--LD--NSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLS 791
+EL+ + L + C + + I C RP+ + L +
Sbjct: 242 IELLKNNGRLPRPDGC--PDEIYMIM--TECWNNNVNQRPSFRDLALRVD 287
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 2e-46
Identities = 86/362 (23%), Positives = 139/362 (38%), Gaps = 80/362 (22%)
Query: 492 HSNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLI-----EGQEIAV 546
H+ ++ LK I ++LG+G FG V G +AV
Sbjct: 8 HAQLYACQDPTIFEERHLKYI----------SQLGKGNFGSVELCRYDPLGDNTGALVAV 57
Query: 547 KRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDER--MLIYEYLPNKSLDYFI 604
K+L +F+ E+ ++ L +VK G + L+ EYLP+ L F+
Sbjct: 58 KQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL 117
Query: 605 FD----TTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKI 660
S+LL +S + I +G+ YL R +HRDL A N+L+++ + KI
Sbjct: 118 QRHRARLDASRLLLYS------SQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKI 168
Query: 661 SDFGLARSFGLDQTEANTKRVVGTYG-----YMSPEYAIDGLFSVKSDVFSFGVLVLEII 715
+DFGLA+ LD+ VV G + +PE D +FS +SDV+SFGV++ E+
Sbjct: 169 ADFGLAKLLPLDKDYY----VVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELF 224
Query: 716 -CGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVG----- 769
K+ + + + S L ++ G
Sbjct: 225 TYCDKS-------------------CSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPA 265
Query: 770 ------------LLCVQQRPEDRPNMSSVVL----MLSGERSLPQPQQPGFFTGRNLPES 813
LC P+DRP+ S++ + SG R G++ S
Sbjct: 266 PPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAFTAHPEGKHHSLS 325
Query: 814 ES 815
S
Sbjct: 326 FS 327
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 3e-46
Identities = 79/309 (25%), Positives = 117/309 (37%), Gaps = 55/309 (17%)
Query: 522 KNKLGEGGFGPVYKGMLI-----EGQEIAVKRLSKGSG-QGMEEFKNEVLLIAKLQHRNL 575
LGEG FG V G+ +AVK L +G Q +K E+ ++ L H ++
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 576 VKLLGCCTQRDER--MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLH 633
+K GCC L+ EY+P SL ++ + ++ I G+ YLH
Sbjct: 96 IKYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLH 151
Query: 634 QDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYG-----YM 688
IHRDL A NVLLDN KI DFGLA++ V G +
Sbjct: 152 A---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY----RVREDGDSPVFWY 204
Query: 689 SPEYAIDGLFSVKSDVFSFGVLVLEII-CGKKNRGFNHADHDH--------------NLL 733
+PE + F SDV+SFGV + E++ ++ + LL
Sbjct: 205 APECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL 264
Query: 734 GHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 793
RL RP + C + + C + RP +++ +L
Sbjct: 265 ERGERL---PRP---------DKC--PAEVYHLM--KNCWETEASFRPTFENLIPILKTV 308
Query: 794 RSLPQPQQP 802
Q Q P
Sbjct: 309 HEKYQGQAP 317
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 1e-45
Identities = 74/326 (22%), Positives = 121/326 (37%), Gaps = 48/326 (14%)
Query: 483 GGLMYRRKKHSNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGML-IEG 541
L + ++ K++ L DL + ++G G FG V+ G L +
Sbjct: 90 QPLTKKSGVVLHRAVPKDKWVLNHEDLVLG----------EQIGRGNFGEVFSGRLRADN 139
Query: 542 QEIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSL 600
+AVK + +F E ++ + H N+V+L+G CTQ+ ++ E +
Sbjct: 140 TLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 199
Query: 601 DYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKI 660
F+ T L ++ A G+ YL IHRDL A N L+ KI
Sbjct: 200 LTFL--RTEGARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKI 254
Query: 661 SDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEII----- 715
SDFG++R A+ + +PE G +S +SDV+SFG+L+ E
Sbjct: 255 SDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGAS 314
Query: 716 --CGKKNRG-FNHADHDHNLLGHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLC 772
N+ + RL P C +A+ + C
Sbjct: 315 PYPNLSNQQTREFVEKGG-------RL---PCP---------ELC--PDAVFRLM--EQC 351
Query: 773 VQQRPEDRPNMSSVVLMLSGERSLPQ 798
P RP+ S++ L R +
Sbjct: 352 WAYEPGQRPSFSTIYQELQSIRKRHR 377
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 1e-44
Identities = 78/341 (22%), Positives = 130/341 (38%), Gaps = 75/341 (21%)
Query: 483 GGLMYRRKKHSNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLI--- 539
G ++ +K + E + LK I LGEG FG V
Sbjct: 1 GDIVSEKKPAT----EVDPTHFEKRFLKRI----------RDLGEGHFGKVELCRYDPEG 46
Query: 540 --EGQEIAVKRLSKGSG-QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDER--MLIYEY 594
G+++AVK L SG + + K E+ ++ L H N+VK G CT+ LI E+
Sbjct: 47 DNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEF 106
Query: 595 LPNKSLDYFIFD----TTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNV 650
LP+ SL ++ + L ++ I +G+ YL + +HRDL A NV
Sbjct: 107 LPSGSLKEYLPKNKNKINLKQQLKYA------VQICKGMDYL---GSRQYVHRDLAARNV 157
Query: 651 LLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYG-----YMSPEYAIDGLFSVKSDVF 705
L+++ KI DFGL ++ D+ V + +PE + F + SDV+
Sbjct: 158 LVESEHQVKIGDFGLTKAIETDKEYY----TVKDDRDSPVFWYAPECLMQSKFYIASDVW 213
Query: 706 SFGVLVLEII-CGKKNRGFNHADHDH--------------NLLGHAWRLWIEERPLELID 750
SFGV + E++ + N L RL P
Sbjct: 214 SFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRL---PCP----- 265
Query: 751 QSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLS 791
+C + + + C + +P +R + +++
Sbjct: 266 ----PNC--PDEVYQLM--RKCWEFQPSNRTSFQNLIEGFE 298
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 2e-44
Identities = 62/208 (29%), Positives = 105/208 (50%), Gaps = 30/208 (14%)
Query: 523 NKLGEGGFGPVYKGMLIEGQE-----IAVKRLSKGSGQG-MEEFKNEVLLIAKLQHRNLV 576
LG G FG VYKG+ I E +A+K L + + +E +E ++A + + ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 577 KLLGCCTQRDERMLIYEYLPNKSLDYFIFD----TTRSKLLDWSKRSHIIAGIARGLLYL 632
+LLG C LI + +P L ++ + LL+W IA+G+ YL
Sbjct: 81 RLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIAKGMNYL 133
Query: 633 HQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYG-----Y 687
R++HRDL A NVL+ + KI+DFGLA+ G ++ E + + G +
Sbjct: 134 ---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----GKVPIKW 185
Query: 688 MSPEYAIDGLFSVKSDVFSFGVLVLEII 715
M+ E + +++ +SDV+S+GV V E++
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELM 213
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 2e-43
Identities = 62/245 (25%), Positives = 109/245 (44%), Gaps = 41/245 (16%)
Query: 494 NQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLI------EGQEIAVK 547
++ + D+ + +LGEG FG V+ + +AVK
Sbjct: 28 QYFSDACVHHIKRRDIVLK----------WELGEGAFGKVFLAECHNLLPEQDKMLVAVK 77
Query: 548 RLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYF---- 603
L + S ++F+ E L+ LQH+++V+ G CT+ ++++EY+ + L+ F
Sbjct: 78 ALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSH 137
Query: 604 --------IFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNT 655
+ L + + + +A G++YL + L +HRDL N L+
Sbjct: 138 GPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQG 194
Query: 656 MNPKISDFGLARSFGLDQTEANTKRVVGTYG-----YMSPEYAIDGLFSVKSDVFSFGVL 710
+ KI DFG++R D + R VG +M PE + F+ +SDV+SFGV+
Sbjct: 195 LVVKIGDFGMSR----DIYSTDYYR-VGGRTMLPIRWMPPESILYRKFTTESDVWSFGVV 249
Query: 711 VLEII 715
+ EI
Sbjct: 250 LWEIF 254
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 2e-43
Identities = 65/246 (26%), Positives = 106/246 (43%), Gaps = 42/246 (17%)
Query: 494 NQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLI------EGQEIAVK 547
+ + D+ + +LGEG FG V+ + +AVK
Sbjct: 2 AMHSGIHVQHIKRRDIVLK----------RELGEGAFGKVFLAECYNLSPTKDKMLVAVK 51
Query: 548 RLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYF---- 603
L + ++F+ E L+ LQH ++VK G C D ++++EY+ + L+ F
Sbjct: 52 ALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAH 111
Query: 604 ---------IFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN 654
L S+ HI + IA G++YL + +HRDL N L+
Sbjct: 112 GPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGA 168
Query: 655 TMNPKISDFGLARSFGLDQTEANTKRVVGTYG-----YMSPEYAIDGLFSVKSDVFSFGV 709
+ KI DFG++R D + R VG + +M PE + F+ +SDV+SFGV
Sbjct: 169 NLLVKIGDFGMSR----DVYSTDYYR-VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGV 223
Query: 710 LVLEII 715
++ EI
Sbjct: 224 ILWEIF 229
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 8e-43
Identities = 62/209 (29%), Positives = 97/209 (46%), Gaps = 30/209 (14%)
Query: 522 KNKLGEGGFGPVYKGMLI---EGQEI--AVKRLSKGSG-QGMEEFKNEVLLIAKLQHRNL 575
LG G FG V+KG+ I E +I +K + SG Q + + +L I L H ++
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 576 VKLLGCCTQRDERMLIYEYLPNKSLDYFIFD----TTRSKLLDWSKRSHIIAGIARGLLY 631
V+LLG C L+ +YLP SL + LL+W IA+G+ Y
Sbjct: 78 VRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWG------VQIAKGMYY 130
Query: 632 LHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYG----- 686
L ++HR+L A NVLL + +++DFG+A D +
Sbjct: 131 L---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSE-----AKTPIK 182
Query: 687 YMSPEYAIDGLFSVKSDVFSFGVLVLEII 715
+M+ E G ++ +SDV+S+GV V E++
Sbjct: 183 WMALESIHFGKYTHQSDVWSYGVTVWELM 211
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 1e-42
Identities = 58/225 (25%), Positives = 97/225 (43%), Gaps = 35/225 (15%)
Query: 498 EKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGM 557
+ L + +LK++ +G+G FG V G G ++AVK + +
Sbjct: 12 YRSGWALNMKELKLL----------QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA-- 58
Query: 558 EEFKNEVLLIAKLQHRNLVKLLGCCTQRDER-MLIYEYLPNKSLDYFIFDTTRSKLLDWS 616
+ F E ++ +L+H NLV+LLG + ++ EY+ SL ++ + +L
Sbjct: 59 QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGD 117
Query: 617 KRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEA 676
+ + YL +HRDL A NVL+ K+SDFGL + + +
Sbjct: 118 CLLKFSLDVCEAMEYL---EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASST 170
Query: 677 NTKRVVGTYG------YMSPEYAIDGLFSVKSDVFSFGVLVLEII 715
+ +PE + FS KSDV+SFG+L+ EI
Sbjct: 171 -------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIY 208
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 1e-42
Identities = 61/201 (30%), Positives = 96/201 (47%), Gaps = 21/201 (10%)
Query: 522 KNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGC 581
++G G FG V+ G + ++A+K + +G+ E+F E ++ KL H LV+L G
Sbjct: 13 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 582 CTQRDERMLIYEYLPNKSLDYFIFDT----TRSKLLDWSKRSHIIAGIARGLLYLHQDSR 637
C ++ L+ E++ + L ++ LL + G+ YL
Sbjct: 72 CLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMC------LDVCEGMAYL---EE 122
Query: 638 LRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT---YGYMSPEYAI 694
+IHRDL A N L+ K+SDFG+ R DQ ++T GT + SPE
Sbjct: 123 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST----GTKFPVKWASPEVFS 178
Query: 695 DGLFSVKSDVFSFGVLVLEII 715
+S KSDV+SFGVL+ E+
Sbjct: 179 FSRYSSKSDVWSFGVLMWEVF 199
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 2e-42
Identities = 71/219 (32%), Positives = 106/219 (48%), Gaps = 33/219 (15%)
Query: 522 KNKLGEGGFGPVYKGMLI------EGQEIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRN 574
+LGE FG VYKG L + Q +A+K L G EEF++E +L A+LQH N
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYF-------------IFDTTRSKLLDWSKRSHI 621
+V LLG T+ +I+ Y + L F D T L+ H+
Sbjct: 74 VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 622 IAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRV 681
+A IA G+ YL S ++H+DL NVL+ + +N KISD GL R + +
Sbjct: 134 VAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFRE--VYAADYYKL-- 186
Query: 682 VGTYG-----YMSPEYAIDGLFSVKSDVFSFGVLVLEII 715
+M+PE + G FS+ SD++S+GV++ E+
Sbjct: 187 -LGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVF 224
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 3e-42
Identities = 63/231 (27%), Positives = 103/231 (44%), Gaps = 23/231 (9%)
Query: 488 RRKKHSNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVK 547
+ S G E+ DL + +LG G FG V G ++A+K
Sbjct: 5 SKNAPSTAGLGYGSWEIDPKDLTFL----------KELGTGQFGVVKYGKWRGQYDVAIK 54
Query: 548 RLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDT 607
+ +GS +EF E ++ L H LV+L G CT++ +I EY+ N L ++
Sbjct: 55 MIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL--R 111
Query: 608 TRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
+ + + + YL + +HRDL A N L+++ K+SDFGL+R
Sbjct: 112 EMRHRFQTQQLLEMCKDVCEAMEYL---ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSR 168
Query: 668 SFGLDQTEANTKRVVGT---YGYMSPEYAIDGLFSVKSDVFSFGVLVLEII 715
D+ ++ G+ + PE + FS KSD+++FGVL+ EI
Sbjct: 169 YVLDDEYTSSV----GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIY 215
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 4e-42
Identities = 62/230 (26%), Positives = 100/230 (43%), Gaps = 23/230 (10%)
Query: 487 YRRKKHSNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAV 546
+ + L + +LK++ +G+G FG V G G ++AV
Sbjct: 173 MEGTVAAQDEFYRSGWALNMKELKLL----------QTIGKGEFGDVMLGDY-RGNKVAV 221
Query: 547 KRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDER-MLIYEYLPNKSLDYFIF 605
K + + + F E ++ +L+H NLV+LLG + ++ EY+ SL ++
Sbjct: 222 KCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR 279
Query: 606 DTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGL 665
R +L + + YL +HRDL A NVL+ K+SDFGL
Sbjct: 280 SRGR-SVLGGDCLLKFSLDVCEAMEYL---EGNNFVHRDLAARNVLVSEDNVAKVSDFGL 335
Query: 666 ARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEII 715
+ T+ K V + +PE + FS KSDV+SFG+L+ EI
Sbjct: 336 TKE--ASSTQDTGKLPV---KWTAPEALREKKFSTKSDVWSFGILLWEIY 380
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 6e-42
Identities = 63/214 (29%), Positives = 107/214 (50%), Gaps = 30/214 (14%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIEGQE-----IAVKRLSKGSGQG-MEEFKNEVLLIAKL 570
F + LG G FG VYKG+ I E +A+K L + + +E +E ++A +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 571 QHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFD----TTRSKLLDWSKRSHIIAGIA 626
+ ++ +LLG C LI + +P L ++ + LL+W IA
Sbjct: 75 DNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 127
Query: 627 RGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYG 686
+G+ YL R++HRDL A NVL+ + KI+DFGLA+ G ++ E + + G
Sbjct: 128 KGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----G 179
Query: 687 -----YMSPEYAIDGLFSVKSDVFSFGVLVLEII 715
+M+ E + +++ +SDV+S+GV V E++
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 213
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 7e-42
Identities = 62/197 (31%), Positives = 98/197 (49%), Gaps = 13/197 (6%)
Query: 522 KNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGC 581
+LG G FG V G ++AVK + +GS +EF E + KL H LVK G
Sbjct: 13 LKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGV 71
Query: 582 CTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRII 641
C++ ++ EY+ N L ++ + K L+ S+ + + G+ +L + I
Sbjct: 72 CSKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFL---ESHQFI 126
Query: 642 HRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT---YGYMSPEYAIDGLF 698
HRDL A N L+D + K+SDFG+ R DQ ++ GT + +PE +
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSV----GTKFPVKWSAPEVFHYFKY 182
Query: 699 SVKSDVFSFGVLVLEII 715
S KSDV++FG+L+ E+
Sbjct: 183 SSKSDVWAFGILMWEVF 199
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 7e-42
Identities = 62/200 (31%), Positives = 103/200 (51%), Gaps = 17/200 (8%)
Query: 522 KNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLG 580
K+KLG G +G VY+G+ +AVK L + + + +EEF E ++ +++H NLV+LLG
Sbjct: 18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 581 CCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRI 640
CT+ +I E++ +L ++ + + ++ I+ + YL +
Sbjct: 77 VCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYL---EKKNF 132
Query: 641 IHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTK-----RVVGTYGYMSPEYAID 695
IHRDL A N L+ K++DFGL+R D A+ + + +PE
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK------WTAPESLAY 186
Query: 696 GLFSVKSDVFSFGVLVLEII 715
FS+KSDV++FGVL+ EI
Sbjct: 187 NKFSIKSDVWAFGVLLWEIA 206
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 1e-41
Identities = 76/292 (26%), Positives = 122/292 (41%), Gaps = 58/292 (19%)
Query: 523 NKLGEGGFGPVYKGMLIEG----QEIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVK 577
+G G FG VY G L++ AVK L++ + +F E +++ H N++
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 578 LLGCCTQRDE-RMLIYEYLPNKSLDYFI----FDTTRSKLLDWSKRSHIIAGIARGLLYL 632
LLG C + + +++ Y+ + L FI + T L+ + +A+G+ YL
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG------LQVAKGMKYL 144
Query: 633 HQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYG------ 686
+ + +HRDL A N +LD K++DFGLAR D + V G
Sbjct: 145 ---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEYYSVHNKTGAKLPVK 197
Query: 687 YMSPEYAIDGLFSVKSDVFSFGVLVLEII-------CGKKNRGFNHADHDHNLLGHAWRL 739
+M+ E F+ KSDV+SFGVL+ E++ L RL
Sbjct: 198 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI------TVYLLQGRRL 251
Query: 740 WIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLS 791
+P C + L +V L C + E RP+ S +V +S
Sbjct: 252 ---LQP---------EYC--PDPLY--EVMLKCWHPKAEMRPSFSELVSRIS 287
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 1e-41
Identities = 76/301 (25%), Positives = 132/301 (43%), Gaps = 34/301 (11%)
Query: 493 SNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSK 551
++ E+ D+ + +KLG G +G VY+G+ +AVK L +
Sbjct: 206 YGVSPNYDKWEMERTDITMK----------HKLGGGQYGEVYEGVWKKYSLTVAVKTLKE 255
Query: 552 GSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSK 611
+ + +EEF E ++ +++H NLV+LLG CT+ +I E++ +L ++ +
Sbjct: 256 DTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQ 313
Query: 612 LLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671
+ ++ I+ + YL + IHR+L A N L+ K++DFGL+R
Sbjct: 314 EVSAVVLLYMATQISSAMEYL---EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG 370
Query: 672 DQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHD-H 730
D A+ + +PE FS+KSDV++FGVL+ EI + +
Sbjct: 371 DTYTAHAGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY 429
Query: 731 NLLGHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLML 790
LL +R+ ERP C E + ++ C Q P DRP+ + +
Sbjct: 430 ELLEKDYRM---ERP---------EGC--PEKVY--ELMRACWQWNPSDRPSFAEIHQAF 473
Query: 791 S 791
Sbjct: 474 E 474
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 1e-41
Identities = 62/231 (26%), Positives = 105/231 (45%), Gaps = 29/231 (12%)
Query: 497 NEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQE----IAVKRLSKG 552
E +++ +P + +G+G FG VY G I+ + A+K LS+
Sbjct: 9 AEVKDVLIPHERVVT--------HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI 60
Query: 553 SGQG-MEEFKNEVLLIAKLQHRNLVKLLGCCTQRDER-MLIYEYLPNKSLDYFIFDT--- 607
+ +E F E LL+ L H N++ L+G + ++ Y+ + L FI
Sbjct: 61 TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRN 120
Query: 608 -TRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLA 666
T L+ + +ARG+ YL + + +HRDL A N +LD + K++DFGLA
Sbjct: 121 PTVKDLISFG------LQVARGMEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLA 171
Query: 667 RSFGLDQTEANTKRVVGTY--GYMSPEYAIDGLFSVKSDVFSFGVLVLEII 715
R + + + + + E F+ KSDV+SFGVL+ E++
Sbjct: 172 RDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELL 222
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 1e-41
Identities = 68/215 (31%), Positives = 97/215 (45%), Gaps = 31/215 (14%)
Query: 522 KNKLGEGGFGPVYKGMLI------EGQEIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRN 574
LG G FG VY+G + ++AVK L + S Q +F E L+I+K H+N
Sbjct: 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYFI----FDTTRSKLLDWSKRSHIIAGIARGLL 630
+V+ +G Q R ++ E + L F+ ++ L H+ IA G
Sbjct: 95 IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154
Query: 631 YLHQDSRLRIIHRDLKASNVLL-----DNTMNPKISDFGLARSFGLDQTEANTKRVVGTY 685
YL IHRD+ A N LL KI DFG+AR D A+ R G
Sbjct: 155 YL---EENHFIHRDIAARNCLLTCPGPGRVA--KIGDFGMAR----DIYRASYYR-KGGC 204
Query: 686 GY-----MSPEYAIDGLFSVKSDVFSFGVLVLEII 715
M PE ++G+F+ K+D +SFGVL+ EI
Sbjct: 205 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 239
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 2e-41
Identities = 66/238 (27%), Positives = 110/238 (46%), Gaps = 40/238 (16%)
Query: 494 NQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQE-----IAVKR 548
NQ K E+ + +G G FG VYKGML +A+K
Sbjct: 31 NQAVLKFTTEIHPSCVTRQ----------KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKT 80
Query: 549 LSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFI--- 604
L G + + +F E ++ + H N+++L G ++ M+I EY+ N +LD F+
Sbjct: 81 LKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREK 140
Query: 605 -FDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDF 663
+ + +L+ GIA G+ YL + + +HRDL A N+L+++ + K+SDF
Sbjct: 141 DGEFSVLQLVGML------RGIAAGMKYL---ANMNYVHRDLAARNILVNSNLVCKVSDF 191
Query: 664 GLARSFGLDQTEANTKRVVGTYG------YMSPEYAIDGLFSVKSDVFSFGVLVLEII 715
GL+R D T G + +PE F+ SDV+SFG+++ E++
Sbjct: 192 GLSRVLEDDPEATYTTS-----GGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVM 244
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 2e-41
Identities = 80/321 (24%), Positives = 134/321 (41%), Gaps = 57/321 (17%)
Query: 522 KNKLGEGGFGPVYKGMLI------EGQEIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRN 574
+LG+G FG VY+G+ +A+K +++ S + EF NE ++ + +
Sbjct: 30 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 89
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYF-------IFDTTRSKLLDWSKRSHIIAGIAR 627
+V+LLG +Q ++I E + L + + + SK + IA
Sbjct: 90 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149
Query: 628 GLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGY 687
G+ YL + + +HRDL A N ++ KI DFG+ R D E + R G G
Sbjct: 150 GMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYR-KGGKGL 201
Query: 688 -----MSPEYAIDGLFSVKSDVFSFGVLVLEII-------CGKKNRGFNHADHDHNLLGH 735
MSPE DG+F+ SDV+SFGV++ EI G N +
Sbjct: 202 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV------LRFVME 255
Query: 736 AWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS 795
L ++P ++C + L + +C Q P+ RP+ ++ + E
Sbjct: 256 GGLL---DKP---------DNC--PDMLFELM--RMCWQYNPKMRPSFLEIISSIKEEME 299
Query: 796 LPQPQQPGFFTGRN-LPESES 815
+ +++ N LPE E
Sbjct: 300 PGFREVSFYYSEENKLPEPEE 320
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 2e-41
Identities = 76/221 (34%), Positives = 118/221 (53%), Gaps = 23/221 (10%)
Query: 498 EKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGM 557
++E E+P LK++ +LG G FG V+ G ++AVK L +GS
Sbjct: 4 WEDEWEVPRETLKLV----------ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-P 52
Query: 558 EEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSK 617
+ F E L+ +LQH+ LV+L TQ + +I EY+ N SL F+ T L +K
Sbjct: 53 DAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFL-KTPSGIKLTINK 110
Query: 618 RSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEAN 677
+ A IA G+ ++ IHRDL+A+N+L+ +T++ KI+DFGLAR ++ A
Sbjct: 111 LLDMAAQIAEGMAFI---EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR 167
Query: 678 TKRVVGT---YGYMSPEYAIDGLFSVKSDVFSFGVLVLEII 715
G + +PE G F++KSDV+SFG+L+ EI+
Sbjct: 168 E----GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIV 204
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 2e-41
Identities = 79/299 (26%), Positives = 131/299 (43%), Gaps = 63/299 (21%)
Query: 522 KNKLGEGGFGPVYKGMLIEGQE---IAVKRLSKG-SGQGMEEFKNEVLLIAKL-QHRNLV 576
++ +GEG FG V K + + A+KR+ + S +F E+ ++ KL H N++
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 577 KLLGCCTQRDERMLIYEYLPNKSLDYF-------------IFDTTRSKLLDWSKRSHIIA 623
LLG C R L EY P+ +L F + + L + H A
Sbjct: 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 624 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTK---- 679
+ARG+ YL S+ + IHRDL A N+L+ KI+DFGL+R + T
Sbjct: 150 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRG--QEVYVKKTMGRLP 204
Query: 680 -RVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEII-------CGKKNRGFNHADHDHN 731
R +M+ E +++ SDV+S+GVL+ EI+ CG +
Sbjct: 205 VR------WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL------YE 252
Query: 732 LLGHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLML 790
L +RL E+PL C + + + C +++P +RP+ + +++ L
Sbjct: 253 KLPQGYRL---EKPLN---------C--DDEVY--DLMRQCWREKPYERPSFAQILVSL 295
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 2e-41
Identities = 74/322 (22%), Positives = 127/322 (39%), Gaps = 59/322 (18%)
Query: 495 QGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLI--EGQEI--AVKRLS 550
G+ + E+ +++ +GEG FG V++G+ + E + A+K
Sbjct: 3 MGSSTRDYEIQRERIELG----------RCIGEGQFGDVHQGIYMSPENPALAVAIKTCK 52
Query: 551 KG-SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFI----F 605
S E+F E L + + H ++VKL+G T+ + +I E L F+ +
Sbjct: 53 NCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKY 111
Query: 606 DTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGL 665
+ L+ ++ ++ L YL R +HRD+ A NVL+ + K+ DFGL
Sbjct: 112 SLDLASLILYA------YQLSTALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGL 162
Query: 666 ARSFGLDQTEANTK-----RVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEII-CGKK 719
+R +K + +M+PE F+ SDV+ FGV + EI+ G K
Sbjct: 163 SRYMEDSTYYKASKGKLPIK------WMAPESINFRRFTSASDVWMFGVCMWEILMHGVK 216
Query: 720 N-RGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPE 778
+G + D + + RL P +C L + C P
Sbjct: 217 PFQGVKNNDV-IGRIENGERL---PMP---------PNC--PPTLY--SLMTKCWAYDPS 259
Query: 779 DRPNMSSVVLMLSGERSLPQPQ 800
RP + + LS + Q
Sbjct: 260 RRPRFTELKAQLSTILEEEKAQ 281
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 4e-41
Identities = 67/237 (28%), Positives = 105/237 (44%), Gaps = 39/237 (16%)
Query: 494 NQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLI----EGQEIAVKRL 549
+ E+ + I + +G G G V G L +A+K L
Sbjct: 36 GRAGRSFTREIEASRIHI----------EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKAL 85
Query: 550 SKGSGQGM-EEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDT- 607
G + +F +E ++ + H N+++L G T+ M++ EY+ N SLD F+
Sbjct: 86 KAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHD 145
Query: 608 ---TRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFG 664
T +L+ G+ G+ YL S L +HRDL A NVL+D+ + K+SDFG
Sbjct: 146 GQFTIMQLVGML------RGVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFG 196
Query: 665 LARSFGLDQTEANTKRVVGTYG------YMSPEYAIDGLFSVKSDVFSFGVLVLEII 715
L+R D A T G + +PE FS SDV+SFGV++ E++
Sbjct: 197 LSRVLEDDPDAAYTTT-----GGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVL 248
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 4e-41
Identities = 68/215 (31%), Positives = 96/215 (44%), Gaps = 31/215 (14%)
Query: 522 KNKLGEGGFGPVYKGMLI------EGQEIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRN 574
LG G FG VY+G + ++AVK L + S Q +F E L+I+K H+N
Sbjct: 76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYFI----FDTTRSKLLDWSKRSHIIAGIARGLL 630
+V+ +G Q R ++ E + L F+ ++ L H+ IA G
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195
Query: 631 YLHQDSRLRIIHRDLKASNVLL-----DNTMNPKISDFGLARSFGLDQTEANTKRVVGTY 685
YL IHRD+ A N LL KI DFG+AR D A R G
Sbjct: 196 YL---EENHFIHRDIAARNCLLTCPGPGRVA--KIGDFGMAR----DIYRAGYYR-KGGC 245
Query: 686 GY-----MSPEYAIDGLFSVKSDVFSFGVLVLEII 715
M PE ++G+F+ K+D +SFGVL+ EI
Sbjct: 246 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 280
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 5e-41
Identities = 74/287 (25%), Positives = 122/287 (42%), Gaps = 49/287 (17%)
Query: 517 DNFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNL 575
+F E +G GGFG V+K I+G+ +KR+ + E+ + EV +AKL H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNI 66
Query: 576 VKLLGCCTQRDERM----------------LIYEYLPNKSLDYFIFDTTRSKLLDWSKRS 619
V GC D + E+ +L+ +I + R + LD
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLAL 125
Query: 620 HIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTK 679
+ I +G+ Y+H ++I+RDLK SN+ L +T KI DFGL S + +
Sbjct: 126 ELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSL---KNDGKRT 179
Query: 680 RVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRL 739
R GT YMSPE + + D+++ G+++ E++ A
Sbjct: 180 RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD-----TAFETSKFFTD---- 230
Query: 740 WIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSV 786
+ + + S F + + + LL + PEDRPN S +
Sbjct: 231 -LRDGII---------SDIFDKKEKTLLQKLLSKK--PEDRPNTSEI 265
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 5e-41
Identities = 66/233 (28%), Positives = 108/233 (46%), Gaps = 25/233 (10%)
Query: 491 KHSNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQE----IAV 546
+ Q + EL ++ I +G G FG V G L + +A+
Sbjct: 29 EDPTQTVHEFAKELDATNISID----------KVVGAGEFGEVCSGRLKLPSKKEISVAI 78
Query: 547 KRLSKGSG-QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIF 605
K L G + +F E ++ + H N+++L G T+ M++ EY+ N SLD F+
Sbjct: 79 KTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL- 137
Query: 606 DTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGL 665
+ ++ GIA G+ YL S + +HRDL A N+L+++ + K+SDFGL
Sbjct: 138 -RKHDAQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGL 193
Query: 666 ARSFGLDQTEANTKRVVGT---YGYMSPEYAIDGLFSVKSDVFSFGVLVLEII 715
R D A T R G + SPE F+ SDV+S+G+++ E++
Sbjct: 194 GRVLEDDPEAAYTTR--GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 244
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 5e-41
Identities = 62/233 (26%), Positives = 94/233 (40%), Gaps = 36/233 (15%)
Query: 497 NEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGML--IEGQEI--AVKRLSKG 552
+ + DL+++ KLG+G FG V +G G+ + AVK L
Sbjct: 8 LQSLTCLIGEKDLRLL----------EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPD 57
Query: 553 ---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFI----F 605
+ M++F EV + L HRNL++L G ++ E P SL +
Sbjct: 58 VLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQG 116
Query: 606 DTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGL 665
L ++ +A G+ YL R IHRDL A N+LL KI DFGL
Sbjct: 117 HFLLGTLSRYA------VQVAEGMGYL---ESKRFIHRDLAARNLLLATRDLVKIGDFGL 167
Query: 666 ARSFGLDQTEANTKRVVGT---YGYMSPEYAIDGLFSVKSDVFSFGVLVLEII 715
R+ + + + + +PE FS SD + FGV + E+
Sbjct: 168 MRALPQNDDHYVMQE--HRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMF 218
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 6e-41
Identities = 74/234 (31%), Positives = 116/234 (49%), Gaps = 33/234 (14%)
Query: 490 KKHSNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRL 549
+ EK+ E+P LK+ KLG G FG V+ + ++AVK +
Sbjct: 171 SSKPQKPWEKDAWEIPRESLKLE----------KKLGAGQFGEVWMATYNKHTKVAVKTM 220
Query: 550 SKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFD--- 606
GS +E F E ++ LQH LVKL T+ + +I E++ SL F+
Sbjct: 221 KPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEG 278
Query: 607 --TTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFG 664
KL+D+S A IA G+ ++ + IHRDL+A+N+L+ ++ KI+DFG
Sbjct: 279 SKQPLPKLIDFS------AQIAEGMAFI---EQRNYIHRDLRAANILVSASLVCKIADFG 329
Query: 665 LARSFGLDQTEANTKRVVGT---YGYMSPEYAIDGLFSVKSDVFSFGVLVLEII 715
LAR ++ A G + +PE G F++KSDV+SFG+L++EI+
Sbjct: 330 LARVIEDNEYTARE----GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIV 379
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 9e-41
Identities = 58/214 (27%), Positives = 97/214 (45%), Gaps = 29/214 (13%)
Query: 522 KNKLGEGGFGPVYKGMLI----EGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNL 575
LGEG FG V +G L ++AVK + S + +EEF +E + H N+
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 576 VKLLGCCTQRD-----ERMLIYEYLPNKSLDYFI---FDTTRSKLLDWSKRSHIIAGIAR 627
++LLG C + + M+I ++ L ++ T K + + IA
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 628 GLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS-FGLDQTEANTK-----RV 681
G+ YL S +HRDL A N +L + M ++DFGL++ + D +
Sbjct: 159 GMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK- 214
Query: 682 VGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEII 715
+++ E D +++ KSDV++FGV + EI
Sbjct: 215 -----WIAIESLADRVYTSKSDVWAFGVTMWEIA 243
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 1e-40
Identities = 82/308 (26%), Positives = 140/308 (45%), Gaps = 34/308 (11%)
Query: 494 NQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGS 553
QG K+ E+P L++ KLG+G FG V+ G +A+K L G+
Sbjct: 171 TQGLAKDAWEIPRESLRLE----------VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT 220
Query: 554 GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLL 613
E F E ++ KL+H LV+L ++ + ++ EY+ SL F K L
Sbjct: 221 MS-PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDF-LKGETGKYL 277
Query: 614 DWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673
+ + A IA G+ Y+ R+ +HRDL+A+N+L+ + K++DFGLAR ++
Sbjct: 278 RLPQLVDMAAQIASGMAYV---ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 334
Query: 674 TEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHD-HNL 732
A + +PE A+ G F++KSDV+SFG+L+ E+ + + + +
Sbjct: 335 YTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ 393
Query: 733 LGHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 792
+ +R+ P C E+L + C ++ PE+RP + L
Sbjct: 394 VERGYRM---PCP---------PEC--PESLH--DLMCQCWRKEPEERPTFEYLQAFLED 437
Query: 793 ERSLPQPQ 800
+ +PQ
Sbjct: 438 YFTSTEPQ 445
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 1e-40
Identities = 59/306 (19%), Positives = 116/306 (37%), Gaps = 83/306 (27%)
Query: 522 KNKLGEGGFGPVYKGML--------IEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHR 573
LG+G F ++KG+ + E+ +K L K E F +++KL H+
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 574 NLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDT----TRSKLLDWSKRSHIIAGIARGL 629
+LV G C DE +L+ E++ SLD ++ L+ + +A +
Sbjct: 73 HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVA------KQLAAAM 126
Query: 630 LYLHQDSRLRIIHRDLKASNVLLDNTMNP--------KISDFGLARSFGLDQTEANTKRV 681
+L +IH ++ A N+LL + K+SD G++ + + + +R+
Sbjct: 127 HFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT--VLPKDILQERI 181
Query: 682 VGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLW 740
++ PE + ++ +D +SFG + EI G
Sbjct: 182 ----PWVPPECIENPKNLNLATDKWSFGTTLWEICS----------------GG------ 215
Query: 741 IEERPLELIDQSLDNSCSFSEALRCIQVG---------------LLCVQQRPEDRPNMSS 785
++PL +LD+ L+ + C+ P+ RP+ +
Sbjct: 216 --DKPL----SALDS----QRKLQFYEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRA 265
Query: 786 VVLMLS 791
++ L+
Sbjct: 266 IIRDLN 271
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 1e-40
Identities = 61/226 (26%), Positives = 106/226 (46%), Gaps = 30/226 (13%)
Query: 500 EEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQE---IAVKRLSKGSG-Q 555
+++ L +L I +LG G FG V +G+ ++ +A+K L +G+
Sbjct: 2 KKLFLKRDNLLIA---------DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA 52
Query: 556 GMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDW 615
EE E ++ +L + +V+L+G C + ML+ E L F+ + + +
Sbjct: 53 DTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFL--VGKREEIPV 109
Query: 616 SKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE 675
S + ++ ++ G+ YL +HRDL A NVLL N KISDFGL+++ G D +
Sbjct: 110 SNVAELLHQVSMGMKYL---EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY 166
Query: 676 ANTKRVVGTYG------YMSPEYAIDGLFSVKSDVFSFGVLVLEII 715
+ + +PE FS +SDV+S+GV + E +
Sbjct: 167 YTARS-----AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEAL 207
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 2e-40
Identities = 60/231 (25%), Positives = 96/231 (41%), Gaps = 38/231 (16%)
Query: 499 KEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGML-IEGQEI--AVKRLSKG--S 553
+E+ L L + E +LG G FG V KG ++ AVK L
Sbjct: 8 PKEVYLDRKLLTL---------EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND 58
Query: 554 GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFD---TTRS 610
+E E ++ +L + +V+++G C + ML+ E L+ ++
Sbjct: 59 PALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDK 117
Query: 611 KLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670
+++ ++ G+ YL +HRDL A NVLL KISDFGL+++
Sbjct: 118 NIIELV------HQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR 168
Query: 671 LDQTEANTKRVVGTYG------YMSPEYAIDGLFSVKSDVFSFGVLVLEII 715
D+ + + +PE FS KSDV+SFGVL+ E
Sbjct: 169 ADENYYKAQT-----HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAF 214
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 2e-40
Identities = 76/292 (26%), Positives = 124/292 (42%), Gaps = 58/292 (19%)
Query: 523 NKLGEGGFGPVYKGMLIEG----QEIAVKRLSKGSGQG-MEEFKNEVLLIAKLQHRNLVK 577
+G G FG VY G L++ AVK L++ + G + +F E +++ H N++
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 578 LLGCCTQRDE-RMLIYEYLPNKSLDYFI----FDTTRSKLLDWSKRSHIIAGIARGLLYL 632
LLG C + + +++ Y+ + L FI + T L+ + +A+G+ +L
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG------LQVAKGMKFL 208
Query: 633 HQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYG------ 686
+ + +HRDL A N +LD K++DFGLAR D + V G
Sbjct: 209 ---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEFDSVHNKTGAKLPVK 261
Query: 687 YMSPEYAIDGLFSVKSDVFSFGVLVLEII-------CGKKNRGFNHADHDHNLLGHAWRL 739
+M+ E F+ KSDV+SFGVL+ E++ L RL
Sbjct: 262 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI------TVYLLQGRRL 315
Query: 740 WIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLS 791
+P C + L +V L C + E RP+ S +V +S
Sbjct: 316 ---LQP---------EYC--PDPLY--EVMLKCWHPKAEMRPSFSELVSRIS 351
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 2e-40
Identities = 66/227 (29%), Positives = 106/227 (46%), Gaps = 36/227 (15%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLI--------EGQEIAVKRLSKG-SGQGMEEFKNEVLLI 567
D + LGEG FG V + E +AVK L + + + + +E+ ++
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 568 AKL-QHRNLVKLLGCCTQRDERMLIYEYLPNKSL-DY------------FIFDTTRSKLL 613
+ +H+N++ LLG CTQ +I EY +L +Y + + + +
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 614 DWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673
+ +ARG+ YL + + IHRDL A NVL+ KI+DFGLAR D
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR----DI 207
Query: 674 TEANTKRVVGTYG-----YMSPEYAIDGLFSVKSDVFSFGVLVLEII 715
+ + T G +M+PE D +++ +SDV+SFGVL+ EI
Sbjct: 208 NNIDYYK-KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 3e-40
Identities = 65/232 (28%), Positives = 107/232 (46%), Gaps = 41/232 (17%)
Query: 517 DNFSEKNKLGEGGFGPVYKGML--IEGQE----IAVKRLSKG-SGQGMEEFKNEVLLIAK 569
N LGEG FG V K ++G+ +AVK L + S + + +E ++ +
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 570 LQHRNLVKLLGCCTQRDERMLIYEYLPNKSL---------------------DYFIFDTT 608
+ H +++KL G C+Q +LI EY SL + D
Sbjct: 83 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 609 RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668
+ L I++G+ YL + ++++HRDL A N+L+ KISDFGL+R
Sbjct: 143 DERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSR- 198
Query: 669 FGLDQTEANTKRVVGTYG-----YMSPEYAIDGLFSVKSDVFSFGVLVLEII 715
D E ++ + G +M+ E D +++ +SDV+SFGVL+ EI+
Sbjct: 199 ---DVYEEDSYV-KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 246
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 4e-40
Identities = 58/214 (27%), Positives = 92/214 (42%), Gaps = 28/214 (13%)
Query: 522 KNKLGEGGFGPVYKGMLI----EGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNL 575
LG+G FG V + L ++AVK L + +EEF E + + H ++
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87
Query: 576 VKLLGCCTQRDER------MLIYEYLPNKSLDYFIFD---TTRSKLLDWSKRSHIIAGIA 626
KL+G + + M+I ++ + L F+ L + IA
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147
Query: 627 RGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYG 686
G+ YL S IHRDL A N +L M ++DFGL+R + R G
Sbjct: 148 CGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSR----KIYSGDYYR-QGCAS 199
Query: 687 -----YMSPEYAIDGLFSVKSDVFSFGVLVLEII 715
+++ E D L++V SDV++FGV + EI+
Sbjct: 200 KLPVKWLALESLADNLYTVHSDVWAFGVTMWEIM 233
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 6e-40
Identities = 59/227 (25%), Positives = 96/227 (42%), Gaps = 41/227 (18%)
Query: 522 KNKLGEGGFGPVYKGMLI------EGQEIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRN 574
+GEG FG V++ +AVK L + S +F+ E L+A+ + N
Sbjct: 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 111
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYF---------------------IFDTTRSKLL 613
+VKLLG C L++EY+ L+ F + L
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171
Query: 614 DWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673
+++ I +A G+ YL S + +HRDL N L+ M KI+DFGL+R +
Sbjct: 172 SCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR----NI 224
Query: 674 TEANTKRVVGTYGY-----MSPEYAIDGLFSVKSDVFSFGVLVLEII 715
A+ + M PE ++ +SDV+++GV++ EI
Sbjct: 225 YSADYYK-ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 270
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 7e-40
Identities = 66/227 (29%), Positives = 106/227 (46%), Gaps = 36/227 (15%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLI--------EGQEIAVKRLSKG-SGQGMEEFKNEVLLI 567
D + LGEG FG V + E +AVK L + + + + +E+ ++
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 568 AKL-QHRNLVKLLGCCTQRDERMLIYEYLPNKSL-DY------------FIFDTTRSKLL 613
+ +H+N++ LLG CTQ +I EY +L +Y + + + +
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 614 DWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673
+ +ARG+ YL + + IHRDL A NVL+ KI+DFGLAR D
Sbjct: 201 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR----DI 253
Query: 674 TEANTKRVVGTYG-----YMSPEYAIDGLFSVKSDVFSFGVLVLEII 715
+ + T G +M+PE D +++ +SDV+SFGVL+ EI
Sbjct: 254 NNIDYYK-KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 299
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 9e-40
Identities = 56/208 (26%), Positives = 96/208 (46%), Gaps = 30/208 (14%)
Query: 522 KNKLGEGGFGPVYKGMLI--EGQEI--AVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLV 576
LGEG FG VY+G+ +G++I AVK K + E+F +E +++ L H ++V
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 577 KLLGCCTQRDERMLIYEYLPNKSLDYFI----FDTTRSKLLDWSKRSHIIAGIARGLLYL 632
KL+G + + +I E P L +++ L+ +S I + + YL
Sbjct: 77 KLIGIIEE-EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYS------LQICKAMAYL 129
Query: 633 HQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTK-----RVVGTYGY 687
+ +HRD+ N+L+ + K+ DFGL+R + + + +
Sbjct: 130 ---ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIK------W 180
Query: 688 MSPEYAIDGLFSVKSDVFSFGVLVLEII 715
MSPE F+ SDV+ F V + EI+
Sbjct: 181 MSPESINFRRFTTASDVWMFAVCMWEIL 208
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 9e-40
Identities = 83/313 (26%), Positives = 141/313 (45%), Gaps = 34/313 (10%)
Query: 489 RKKHSNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKR 548
K QG K+ E+P L++ KLG+G FG V+ G +A+K
Sbjct: 249 TSKPQTQGLAKDAWEIPRESLRLE----------VKLGQGCFGEVWMGTWNGTTRVAIKT 298
Query: 549 LSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTT 608
L G+ E F E ++ KL+H LV+L ++ + ++ EY+ SL F
Sbjct: 299 LKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDF-LKGE 355
Query: 609 RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668
K L + + A IA G+ Y+ R+ +HRDL+A+N+L+ + K++DFGLAR
Sbjct: 356 TGKYLRLPQLVDMAAQIASGMAYV---ERMNYVHRDLRAANILVGENLVCKVADFGLARL 412
Query: 669 FGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADH 728
++ A + +PE A+ G F++KSDV+SFG+L+ E+ + +
Sbjct: 413 IEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR 471
Query: 729 D-HNLLGHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVV 787
+ + + +R+ P C E+L + C ++ PE+RP +
Sbjct: 472 EVLDQVERGYRM---PCP---------PEC--PESLH--DLMCQCWRKEPEERPTFEYLQ 515
Query: 788 LMLSGERSLPQPQ 800
L + +PQ
Sbjct: 516 AFLEDYFTSTEPQ 528
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 1e-39
Identities = 61/221 (27%), Positives = 94/221 (42%), Gaps = 35/221 (15%)
Query: 522 KNKLGEGGFGPVYKGMLI------EGQEIAVKRLSKG-SGQGMEEFKNEVLLIAKL-QHR 573
LG G FG V + + +AVK L +G + +E+ ++ + H
Sbjct: 32 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 574 NLVKLLGCCTQRDE-RMLIYEYLPNKSL-DY------------FIFDTTRSKLLDWSKRS 619
N+V LLG CT+ M+I E+ +L Y + L
Sbjct: 92 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 620 HIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTK 679
+A+G+ +L + + IHRDL A N+LL KI DFGLAR D +
Sbjct: 152 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR----DIYKDPDY 204
Query: 680 RVVGTYG-----YMSPEYAIDGLFSVKSDVFSFGVLVLEII 715
+M+PE D +++++SDV+SFGVL+ EI
Sbjct: 205 V-RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 244
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 1e-39
Identities = 82/334 (24%), Positives = 135/334 (40%), Gaps = 65/334 (19%)
Query: 522 KNKLGEGGFGPVYKGMLI--------EGQEIAVKRLSKG-SGQGMEEFKNEVLLIAKL-Q 571
LGEG FG V I ++AVK L + + + + +E+ ++ + +
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 572 HRNLVKLLGCCTQRDERMLIYEYLPNKSL-DY------------FIFDTTRSKLLDWSKR 618
H+N++ LLG CTQ +I EY +L +Y + + L
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 619 SHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANT 678
+ARG+ YL + + IHRDL A NVL+ KI+DFGLAR + +
Sbjct: 194 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR--DIHHIDYYK 248
Query: 679 KRVVGTYG-----YMSPEYAIDGLFSVKSDVFSFGVLVLEII-------CGKKNRGFNHA 726
K T G +M+PE D +++ +SDV+SFGVL+ EI G
Sbjct: 249 KT---TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL--- 302
Query: 727 DHDHNLLGHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSV 786
LL R+ ++P ++C + L + C P RP +
Sbjct: 303 ---FKLLKEGHRM---DKP---------SNC--TNELYMMM--RDCWHAVPSQRPTFKQL 343
Query: 787 VLMLSGERSLPQPQQPGFFTGRNLPESESSSSRQ 820
V L +L Q+ G++ + + + ++
Sbjct: 344 VEDLDRIVALTSNQEMGYYHHHHHHDYDIPTTEN 377
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 3e-39
Identities = 64/223 (28%), Positives = 98/223 (43%), Gaps = 32/223 (14%)
Query: 517 DNFSEKNKLGEGGFGPVYKGML--IEGQE----IAVKRLSKG-SGQGMEEFKNEVLLIAK 569
+N LG G FG V + + ++ +AVK L E +E+ +++
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 570 L-QHRNLVKLLGCCTQRDERMLIYEYLPNKSL-----------DYFIFDTTRSKLLDWSK 617
L QH N+V LLG CT ++I EY L + +
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165
Query: 618 RSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEAN 677
H + +A+G+ +L + IHRD+ A NVLL N KI DFGLAR D +
Sbjct: 166 LLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR----DIMNDS 218
Query: 678 TKRVVGTYG-----YMSPEYAIDGLFSVKSDVFSFGVLVLEII 715
V +M+PE D +++V+SDV+S+G+L+ EI
Sbjct: 219 NYIV-KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF 260
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 5e-39
Identities = 66/327 (20%), Positives = 114/327 (34%), Gaps = 58/327 (17%)
Query: 517 DNFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLS-KGSGQGMEEFKNEVLLIAKLQHRN 574
+F LG GGFG V++ ++ A+KR+ E+ EV +AKL+H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 575 LVKLLGC---------CTQRDERMLIY---EYLPNKSLDYFIFDTTRSKLLDWSKRSHII 622
+V+ ++ +Y + ++L ++ + + S HI
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 623 AGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRV- 681
IA + +LH ++HRDLK SN+ K+ DFGL + D+ E
Sbjct: 125 LQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 682 ---------VGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNL 732
VGT YMSPE +S K D+FS G+++ E++ F+
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY-----PFSTQMERVRT 236
Query: 733 LGHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 792
L + + + +L P +RP +++
Sbjct: 237 LTD-----VRNLKFPPL------FTQKYPCEYVMVQDMLSPS--PMERPEAINII----- 278
Query: 793 ERSLPQPQQPGFFTGRNLPESESSSSR 819
+ F + P R
Sbjct: 279 -------ENA-VFEDLDFPGKTVLRQR 297
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 9e-39
Identities = 62/266 (23%), Positives = 113/266 (42%), Gaps = 31/266 (11%)
Query: 524 KLGEGGFGPVYKGM-LIEGQEIAVK--RLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLG 580
++G G F VYKG+ E+A + K + + FK E ++ LQH N+V+
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 581 CC--TQRDERML--IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDS 636
T + ++ + + E + + +L ++ R K++ I +GL +LH +
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLHTRT 149
Query: 637 RLRIIHRDLKASNVLLDNTM-NPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAID 695
IIHRDLK N+ + + KI D GLA + + K V+GT +M+PE +
Sbjct: 150 P-PIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIGTPEFMAPEM-YE 203
Query: 696 GLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDN 755
+ DV++FG+ +LE+ + + + +R D+
Sbjct: 204 EKYDESVDVYAFGMCMLEMATSE------YPYSECQNAAQIYRRVTSGVKPASFDKVAI- 256
Query: 756 SCSFSEALRCIQVGLLCVQQRPEDRP 781
E I+ C++Q ++R
Sbjct: 257 ----PEVKEIIE---GCIRQNKDERY 275
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 1e-38
Identities = 58/227 (25%), Positives = 90/227 (39%), Gaps = 36/227 (15%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLI------EGQEIAVKRLSKG-SGQGMEEFKNEVLLIAK 569
+ S LG G FG V + +AVK L E +E+ +++
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 570 L-QHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYF---------------IFDTTRSKLL 613
L H N+V LLG CT ++I EY L F L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 614 DWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673
D +A+G+ +L + IHRDL A N+LL + KI DFGLAR +
Sbjct: 143 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARD--IKN 197
Query: 674 TEANTKRVVGTYG-----YMSPEYAIDGLFSVKSDVFSFGVLVLEII 715
+ +M+PE + +++ +SDV+S+G+ + E+
Sbjct: 198 DSNYVVK---GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 241
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 146 bits (369), Expect = 2e-38
Identities = 61/273 (22%), Positives = 118/273 (43%), Gaps = 25/273 (9%)
Query: 517 DNFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHR 573
+ + K+GEG FG +G++ +K ++ S + EE + EV ++A ++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 574 NLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLH 633
N+V+ + ++ +Y L I + + L + I L ++H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRI-NAQKGVLFQEDQILDWFVQICLALKHVH 142
Query: 634 QDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYA 693
+I+HRD+K+ N+ L ++ DFG+AR A +GT Y+SPE
Sbjct: 143 DR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGTPYYLSPEIC 197
Query: 694 IDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSL 753
+ ++ KSD+++ G ++ E+ K HA ++ + I +
Sbjct: 198 ENKPYNNKSDIWALGCVLYELCTLK------HAFEAGSMKNLVLK--IISGSFPPVSL-- 247
Query: 754 DNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSV 786
+S LR + L ++ P DRP+++S+
Sbjct: 248 ----HYSYDLRSLVSQLF--KRNPRDRPSVNSI 274
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 2e-38
Identities = 60/233 (25%), Positives = 108/233 (46%), Gaps = 17/233 (7%)
Query: 490 KKHSNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQE---IAV 546
+ + EL L + + + +LG G FG V +G+ ++ +A+
Sbjct: 311 DTSVFESPFSDPEELKDKKLFLKRD--NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAI 368
Query: 547 KRLSKGSGQGM-EEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIF 605
K L +G+ + EE E ++ +L + +V+L+G C + ML+ E L F+
Sbjct: 369 KVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFL- 426
Query: 606 DTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGL 665
+ + + S + ++ ++ G+ YL +HR+L A NVLL N KISDFGL
Sbjct: 427 -VGKREEIPVSNVAELLHQVSMGMKYL---EEKNFVHRNLAARNVLLVNRHYAKISDFGL 482
Query: 666 ARSFGLDQTEANTKRVVGT---YGYMSPEYAIDGLFSVKSDVFSFGVLVLEII 715
+++ G D + + + +PE FS +SDV+S+GV + E +
Sbjct: 483 SKALGADDSYYTAR--SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEAL 533
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-37
Identities = 69/298 (23%), Positives = 120/298 (40%), Gaps = 48/298 (16%)
Query: 516 TDNFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRN 574
+F E LG+G FG V K ++ + A+K++ + + +EV+L+A L H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63
Query: 575 LVKLLGC----------CTQRDERMLIY---EYLPNKSLDYFIFDTTRSKLLDWSKRSHI 621
+V+ T ++ ++ EY N +L I + + + +
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI--HSENLNQQRDEYWRL 121
Query: 622 IAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF------------ 669
I L Y+H IIHRDLK N+ +D + N KI DFGLA++
Sbjct: 122 FRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 670 GLDQTEANTKRVVGTYGYMSPE-YAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADH 728
L + N +GT Y++ E G ++ K D++S G++ E+I F+
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY-----PFSTGME 233
Query: 729 DHNLLGHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSV 786
N+L + +E DN + + I L+ P RP ++
Sbjct: 234 RVNILKK-----LRSVSIEFPPDFDDN---KMKVEKKIIRLLIDH--DPNKRPGARTL 281
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-37
Identities = 62/227 (27%), Positives = 97/227 (42%), Gaps = 41/227 (18%)
Query: 522 KNKLGEGGFGPVYKGMLI------EGQEIAVKRLSKG-SGQGMEEFKNEVLLIAKL-QHR 573
LG G FG V ++AVK L + E +E+ ++ +L H
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109
Query: 574 NLVKLLGCCTQRDERMLIYEYLPNKSL------------DYFIFDTTRSKLLDWSKRSHI 621
N+V LLG CT LI+EY L + I + +L + + +
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169
Query: 622 -------IAG-IARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673
A +A+G+ +L +HRDL A NVL+ + KI DFGLAR +
Sbjct: 170 TFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARD--IMS 224
Query: 674 TEANTKRVVGTYG-----YMSPEYAIDGLFSVKSDVFSFGVLVLEII 715
R +M+PE +G++++KSDV+S+G+L+ EI
Sbjct: 225 DSNYVVR---GNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIF 268
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 148 bits (374), Expect = 3e-37
Identities = 82/386 (21%), Positives = 149/386 (38%), Gaps = 54/386 (13%)
Query: 428 DLIDI--KELPESGQDLFIRMAASELDNVERRRQSKNKKQVMIIITSISLATAVIFIGGL 485
DLID + + + Q IR + + N ++ + ++S++ + +
Sbjct: 312 DLIDGYCRLVNGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEII 371
Query: 486 MYRRKKHSNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLI--EGQE 543
+ + + E+ +++ +GEG FG V++G+ + E
Sbjct: 372 DE---EDTYTMPSTRDYEIQRERIELG----------RCIGEGQFGDVHQGIYMSPENPA 418
Query: 544 I--AVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSL 600
+ A+K S E+F E L + + H ++VKL+G T+ + +I E L
Sbjct: 419 MAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGEL 477
Query: 601 DYFIFDT----TRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTM 656
F+ + L+ ++ ++ L YL R +HRD+ A NVL+ +
Sbjct: 478 RSFLQVRKFSLDLASLILYA------YQLSTALAYL---ESKRFVHRDIAARNVLVSSND 528
Query: 657 NPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEII- 715
K+ DFGL+R +K + +M+PE F+ SDV+ FGV + EI+
Sbjct: 529 CVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPESINFRRFTSASDVWMFGVCMWEILM 587
Query: 716 CGKKN-RGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQ 774
G K +G + D + + RL P +C L + C
Sbjct: 588 HGVKPFQGVKNNDV-IGRIENGERL---PMP---------PNC--PPTLY--SLMTKCWA 630
Query: 775 QRPEDRPNMSSVVLMLSGERSLPQPQ 800
P RP + + LS + Q
Sbjct: 631 YDPSRRPRFTELKAQLSTILEEEKLQ 656
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 4e-37
Identities = 54/242 (22%), Positives = 101/242 (41%), Gaps = 23/242 (9%)
Query: 492 HSNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSK 551
H + + ++ + ++ +S ++G GG V++ + + Q A+K ++
Sbjct: 3 HHHHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNL 62
Query: 552 G--SGQGMEEFKNEVLLIAKLQHRNL--VKLLGCCTQRDERMLIYEYLPNKSLDYFIFDT 607
Q ++ ++NE+ + KLQ + ++L ++ E N L+ ++
Sbjct: 63 EEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL--- 118
Query: 608 TRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
+ K +D +R + + +HQ I+H DLK +N L+ + K+ DFG+A
Sbjct: 119 KKKKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVD-GMLKLIDFGIAN 174
Query: 668 SFGLDQTEANTKRVVGTYGYMSPE-----------YAIDGLFSVKSDVFSFGVLVLEIIC 716
D T VGT YM PE S KSDV+S G ++ +
Sbjct: 175 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY 234
Query: 717 GK 718
GK
Sbjct: 235 GK 236
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 4e-37
Identities = 75/278 (26%), Positives = 117/278 (42%), Gaps = 26/278 (9%)
Query: 517 DNFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHR 573
+++ +G G +G K +G+ + K L G + + +EV L+ +L+H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 574 NLVKLLGCCTQRDERML--IYEYLPNKSLDYFIFDTTRSK-LLDWSKRSHIIAGIARGLL 630
N+V+ R L + EY L I T+ + LD ++ + L
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 631 YLHQ--DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYM 688
H+ D ++HRDLK +NV LD N K+ DFGLAR D + A T VGT YM
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTPYYM 183
Query: 689 SPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLEL 748
SPE ++ KSD++S G L+ E+ F A L G I E
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALM--PPFT-AFSQKELAGK-----IREGKFRR 235
Query: 749 IDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSV 786
I +S+ L I +L ++ RP++ +
Sbjct: 236 IPY------RYSDELNEIITRMLNLK--DYHRPSVEEI 265
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 5e-37
Identities = 72/275 (26%), Positives = 125/275 (45%), Gaps = 23/275 (8%)
Query: 517 DNFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQH 572
NF + K+G G F VY+ L++G +A+K++ + + E+ L+ +L H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 573 RNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRS-KLLDWSKRSHIIAGIARGLLY 631
N++K + +E ++ E L I + +L+ + L +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 632 LHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPE 691
+H R++HRD+K +NV + T K+ D GL R F T A++ +VGT YMSPE
Sbjct: 152 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPE 206
Query: 692 YAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQ 751
+ ++ KSD++S G L+ E+ + F NL + IE+ +
Sbjct: 207 RIHENGYNFKSDIWSLGCLLYEMAALQ--SPFY--GDKMNLYSLCKK--IEQCDYPPLPS 260
Query: 752 SLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSV 786
+SE LR Q+ +C+ PE RP+++ V
Sbjct: 261 D-----HYSEELR--QLVNMCINPDPEKRPDVTYV 288
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-36
Identities = 63/302 (20%), Positives = 114/302 (37%), Gaps = 35/302 (11%)
Query: 518 NFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLV 576
++ KLGEGGF V L +G A+KR+ Q EE + E + H N++
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89
Query: 577 KLLGCCTQRDERM----LIYEYLPNKSL-DYFIFDTTRSKLLDWSKRSHIIAGIARGLLY 631
+L+ C + L+ + +L + + L + ++ GI RGL
Sbjct: 90 RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149
Query: 632 LHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVV-------GT 684
+H HRDLK +N+LL + P + D G + + + T
Sbjct: 150 IHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 685 YGYMSPEYAIDG----LFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLW 740
Y +PE + ++DV+S G ++ ++ G+ G + L
Sbjct: 207 ISYRAPE-LFSVQSHCVIDERTDVWSLGCVLYAMMFGE------GPYDMVFQKGDSVALA 259
Query: 741 IEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPQ 800
++ + S+ S S AL + ++ V P RP++ ++ L + Q
Sbjct: 260 VQNQ------LSIPQSPRHSSALWQLLNSMMTVD--PHQRPHIPLLLSQLEALQPPAPGQ 311
Query: 801 QP 802
Sbjct: 312 HT 313
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-36
Identities = 52/211 (24%), Positives = 91/211 (43%), Gaps = 23/211 (10%)
Query: 523 NKLGEGGFGPVYKGMLIEGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNL--VKL 578
++G GG V++ + + Q A+K ++ Q ++ ++NE+ + KLQ + ++L
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 579 LGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRL 638
++ E N L+ ++ + K +D +R + + +HQ
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIHQ---H 127
Query: 639 RIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPE------- 691
I+H DLK +N L+ + K+ DFG+A D T VGT YM PE
Sbjct: 128 GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 186
Query: 692 ----YAIDGLFSVKSDVFSFGVLVLEIICGK 718
S KSDV+S G ++ + GK
Sbjct: 187 SRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 9e-36
Identities = 52/216 (24%), Positives = 92/216 (42%), Gaps = 23/216 (10%)
Query: 518 NFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNL 575
+S ++G GG V++ + + Q A+K ++ Q ++ ++NE+ + KLQ +
Sbjct: 57 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116
Query: 576 --VKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLH 633
++L ++ E N L+ ++ + K +D +R + + +H
Sbjct: 117 KIIRLYDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIH 172
Query: 634 QDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPE-- 691
Q I+H DLK +N L+ + K+ DFG+A D T VG YM PE
Sbjct: 173 Q---HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAI 228
Query: 692 ---------YAIDGLFSVKSDVFSFGVLVLEIICGK 718
S KSDV+S G ++ + GK
Sbjct: 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-35
Identities = 60/233 (25%), Positives = 107/233 (45%), Gaps = 18/233 (7%)
Query: 491 KHSNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRL 549
+ + +G+ + ++ ++ D ++ LG+G +G VY G + IA+K +
Sbjct: 3 RSTEEGDCESDLLEYDYEY-------DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEI 55
Query: 550 SKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTR 609
+ + + E+ L L+H+N+V+ LG ++ + E +P SL +
Sbjct: 56 PERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWG 115
Query: 610 SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTM-NPKISDFGLARS 668
+ I GL YLH + +I+HRD+K NVL++ KISDFG ++
Sbjct: 116 PLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKR 172
Query: 669 FGLDQTEANTKRVVGTYGYMSPEYAIDGL---FSVKSDVFSFGVLVLEIICGK 718
L T+ GT YM+PE ID + +D++S G ++E+ GK
Sbjct: 173 --LAGINPCTETFTGTLQYMAPE-IIDKGPRGYGKAADIWSLGCTIIEMATGK 222
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 6e-35
Identities = 66/300 (22%), Positives = 113/300 (37%), Gaps = 35/300 (11%)
Query: 488 RRKKHSNQGNEKEEMELPIFDLKIIANAT-DNFSEKNKLGEGGFGPVYKGM-LIEGQEIA 545
+ ++ S +G E ++ P +D + +F ++LG G +G V+K +G+ A
Sbjct: 27 QPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYA 86
Query: 546 VKRLSKG--SGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDERMLIY-EYLPNKSLD 601
VKR + EV K+ QH V+L + + + E SL
Sbjct: 87 VKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQA-WEEGGILYLQTELC-GPSLQ 144
Query: 602 YFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKIS 661
L ++ + L +LH ++H D+K +N+ L K+
Sbjct: 145 QHC--EAWGASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLG 199
Query: 662 DFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNR 721
DFGL G G YM+PE + G + +DVFS G+ +LE+ C +
Sbjct: 200 DFGLLVELG-TAGAGEV--QEGDPRYMAPE-LLQGSYGTAADVFSLGLTILEVACNME-- 253
Query: 722 GFNHADHDHNLLGHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRP 781
H G W + L + + S LR V ++ ++ P+ R
Sbjct: 254 ------LPHG--GEGW------QQLRQGYLPPEFTAGLSSELR--SVLVMMLEPDPKLRA 297
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-34
Identities = 58/235 (24%), Positives = 108/235 (45%), Gaps = 17/235 (7%)
Query: 488 RRKKHSNQGNEKEEMELPIFDLKIIANATD---NFSEKNKLGEGGFGPVYKGMLIE-GQE 543
S ++ L+++ + D K+GEG G V G++
Sbjct: 17 NLYFQSGVVTHEQFKA----ALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQ 72
Query: 544 IAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYF 603
+AVK + Q E NEV+++ QH N+V++ +E ++ E+L +L
Sbjct: 73 VAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALT-- 130
Query: 604 IFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDF 663
D L+ + + + + + L YLH +IHRD+K+ ++LL K+SDF
Sbjct: 131 --DIVSQVRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDF 185
Query: 664 GLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGK 718
G D + + +VGT +M+PE L++ + D++S G++V+E++ G+
Sbjct: 186 GFCAQISKDVPKRKS--LVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGE 238
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 4e-34
Identities = 62/226 (27%), Positives = 118/226 (52%), Gaps = 17/226 (7%)
Query: 497 NEKEEMELPIFDLKIIANATD---NFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG 552
+++E +E L+ I + D ++ K+G+G G VY M + GQE+A+++++
Sbjct: 1 SDEEILE----KLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ 56
Query: 553 SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKL 612
E NE+L++ + ++ N+V L DE ++ EYL SL D
Sbjct: 57 QQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETC 112
Query: 613 LDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672
+D + + + + L +LH + ++IHRD+K+ N+LL + K++DFG +
Sbjct: 113 MDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169
Query: 673 QTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGK 718
Q++ +T +VGT +M+PE + K D++S G++ +E+I G+
Sbjct: 170 QSKRST--MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-33
Identities = 59/244 (24%), Positives = 102/244 (41%), Gaps = 21/244 (8%)
Query: 483 GGLMYRRKKHSNQGNEKEEMELPIFDLKI-IANATDNFSEKNKLGEGGFGPVYKGMLIE- 540
G +R + NE + + + + + ++G G FG V++ +
Sbjct: 23 GSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQT 82
Query: 541 GQEIAVKRLSKGSGQGMEEFK-NEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKS 599
G + AVK++ +E F+ E++ A L +V L G + + E L S
Sbjct: 83 GFQCAVKKVR------LEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGS 136
Query: 600 LDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNP- 658
L I + L + + + GL YLH RI+H D+KA NVLL + +
Sbjct: 137 LGQLI---KQMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRA 190
Query: 659 KISDFGLAR---SFGLDQTEANTKRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEI 714
+ DFG A GL ++ + GT +M+PE + G K D++S ++L +
Sbjct: 191 ALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE-VVMGKPCDAKVDIWSSCCMMLHM 249
Query: 715 ICGK 718
+ G
Sbjct: 250 LNGC 253
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-33
Identities = 50/221 (22%), Positives = 92/221 (41%), Gaps = 22/221 (9%)
Query: 514 NATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEE-FKNEVLLIAKLQ 571
+ + + LG+G V++G + G A+K + S + E ++ KL
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65
Query: 572 HRNLVKLLGCCTQRDERM--LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGL 629
H+N+VKL + R LI E+ P SL + + + + L S+ ++ + G+
Sbjct: 66 HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125
Query: 630 LYLHQDSRLRIIHRDLKASNVLL----DNTMNPKISDFGLARSFGLDQTEANTKRVVGTY 685
+L + I+HR++K N++ D K++DFG AR D + + + GT
Sbjct: 126 NHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVS--LYGTE 179
Query: 686 GYMSPE--------YAIDGLFSVKSDVFSFGVLVLEIICGK 718
Y+ P+ + D++S GV G
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 4e-33
Identities = 49/210 (23%), Positives = 86/210 (40%), Gaps = 19/210 (9%)
Query: 518 NFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEV-LLIAKLQHRNLV 576
+F K+ LG G G + + + +++AVKR+ + EV LL +H N++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILP---ECFSFADREVQLLRESDEHPNVI 81
Query: 577 KLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDS 636
+ R + + E +Y + + ++ GL +LH
Sbjct: 82 RYFCTEKDRQFQYIAIELCAATLQEYVE---QKDFAHLGLEPITLLQQTTSGLAHLHS-- 136
Query: 637 RLRIIHRDLKASNVLLDNT-----MNPKISDFGLARSFGLDQTE-ANTKRVVGTYGYMSP 690
L I+HRDLK N+L+ + ISDFGL + + + + V GT G+++P
Sbjct: 137 -LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195
Query: 691 EY---AIDGLFSVKSDVFSFGVLVLEIICG 717
E + D+FS G + +I
Sbjct: 196 EMLSEDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 7e-33
Identities = 63/294 (21%), Positives = 107/294 (36%), Gaps = 57/294 (19%)
Query: 516 TDNFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKR--LSKGSGQGMEEFKNEVLLIAKL-Q 571
T F E K+G G FG V+K + ++G A+KR + EV A L Q
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 572 HRNLVKLLGCCTQRDERMLIY-EYLPNKSLDYFIFDTTRS-KLLDWSKRSHIIAGIARGL 629
H ++V+ + D MLI EY SL I + R ++ ++ + RGL
Sbjct: 70 HSHVVRYFSAWAEDD-HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128
Query: 630 LYLHQDSRLRIIHRDLKASNVLLDNTMNP-------------------KISDFGLARSFG 670
Y+H ++H D+K SN+ + T P KI D G
Sbjct: 129 RYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS 185
Query: 671 LDQTEANTKRVVGTYGYMSPEYAIDGLFS--VKSDVFSFGVLVLEIICGKKNRGFNHADH 728
Q E G +++ E + ++ K+D+F+ + V+ +
Sbjct: 186 SPQVE------EGDSRFLANE-VLQENYTHLPKADIFALALTVVCAAGAE------PLPR 232
Query: 729 DHNLLGHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPN 782
+ G W + R + S+ ++ + + PE RP+
Sbjct: 233 N----GDQWHEIRQGRLPRIPQV-------LSQEFT--ELLKVMIHPDPERRPS 273
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 61/208 (29%), Positives = 109/208 (52%), Gaps = 11/208 (5%)
Query: 513 ANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQG-MEEFKNEVLLIAKL 570
A+ + F++ K+G+G FG V+KG+ + +A+K + + +E+ + E+ ++++
Sbjct: 18 ADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC 77
Query: 571 QHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLL 630
+ K G + + +I EYL S D LD ++ + I+ I +GL
Sbjct: 78 DSPYVTKYYGSYLKDTKLWIIMEYLGGGSAL----DLLEPGPLDETQIATILREILKGLD 133
Query: 631 YLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSP 690
YLH + + IHRD+KA+NVLL K++DFG+A Q + NT VGT +M+P
Sbjct: 134 YLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAP 188
Query: 691 EYAIDGLFSVKSDVFSFGVLVLEIICGK 718
E + K+D++S G+ +E+ G+
Sbjct: 189 EVIKQSAYDSKADIWSLGITAIELARGE 216
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 3e-32
Identities = 66/327 (20%), Positives = 114/327 (34%), Gaps = 55/327 (16%)
Query: 524 KLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQ-HRNLVKLLGC 581
L EGGF VY+ + G+E A+KRL + EV + KL H N+V+
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 582 CTQRDERM-------LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQ 634
+ E L+ L L F+ L I R + ++H+
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR 154
Query: 635 DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKR----------VVGT 684
+ IIHRDLK N+LL N K+ DFG A + + + + T
Sbjct: 155 -QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213
Query: 685 YGYMSPEYAIDGLFSV--------KSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHA 736
Y +PE + + K D+++ G ++ + + H D L
Sbjct: 214 PMYRTPE-----IIDLYSNFPIGEKQDIWALGCILYLLCFRQ------HPFEDGAKLR-- 260
Query: 737 WRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSV---VLMLSGE 793
I + + + +L V PE+R +++ V + ++
Sbjct: 261 ----IVNGKYSIPPHD-----TQYTVFHSLIRAMLQVN--PEERLSIAEVVHQLQEIAAA 309
Query: 794 RSLPQPQQPGFFTGRNLPESESSSSRQ 820
R++ +N ++ SR
Sbjct: 310 RNVNPKSPITELLEQNGGYGSATLSRG 336
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 3e-32
Identities = 50/221 (22%), Positives = 92/221 (41%), Gaps = 22/221 (9%)
Query: 514 NATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEE-FKNEVLLIAKLQ 571
+ + + LG+G V++G + G A+K + S + E ++ KL
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65
Query: 572 HRNLVKLLGCCTQRDERM--LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGL 629
H+N+VKL + R LI E+ P SL + + + + L S+ ++ + G+
Sbjct: 66 HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125
Query: 630 LYLHQDSRLRIIHRDLKASNVLL----DNTMNPKISDFGLARSFGLDQTEANTKRVVGTY 685
+L + I+HR++K N++ D K++DFG AR D + + + GT
Sbjct: 126 NHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVS--LYGTE 179
Query: 686 GYMSPE--------YAIDGLFSVKSDVFSFGVLVLEIICGK 718
Y+ P+ + D++S GV G
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 5e-32
Identities = 35/222 (15%), Positives = 66/222 (29%), Gaps = 22/222 (9%)
Query: 516 TDNFSEKNKLGEGGFGPVYKGM------LIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAK 569
+ + LGEG F VY+ Q+ +K + + +
Sbjct: 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123
Query: 570 LQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFI--FDTTRSKLLDWSKRSHIIAGIAR 627
+K ++ +L+ E +L I + T K++ +
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLY 183
Query: 628 GLLYLHQDSRLRIIHRDLKASNVLLDNTMNP-----------KISDFGLARSFGLDQTEA 676
+ +H IIH D+K N +L N + D G + L
Sbjct: 184 MIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT 240
Query: 677 NTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGK 718
T G+ E + ++ + D F V ++ G
Sbjct: 241 IFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 5e-32
Identities = 62/204 (30%), Positives = 107/204 (52%), Gaps = 10/204 (4%)
Query: 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRN 574
+ F KLGEG +G VYK + E GQ +A+K++ ++E E+ ++ + +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP--VESDLQEIIKEISIMQQCDSPH 85
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQ 634
+VK G + + ++ EY S+ I R+K L + + I+ +GL YLH
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDII--RLRNKTLTEDEIATILQSTLKGLEYLHF 143
Query: 635 DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAI 694
R IHRD+KA N+LL+ + K++DFG+A + NT V+GT +M+PE
Sbjct: 144 M---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT--VIGTPFWMAPEVIQ 198
Query: 695 DGLFSVKSDVFSFGVLVLEIICGK 718
+ ++ +D++S G+ +E+ GK
Sbjct: 199 EIGYNCVADIWSLGITAIEMAEGK 222
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 5e-32
Identities = 55/200 (27%), Positives = 87/200 (43%), Gaps = 16/200 (8%)
Query: 525 LGEGGFGPVYKGMLIE-GQEIAVKRLSKGS--GQGMEE-FKNEVLLIAKLQHRNLVKLLG 580
LG+GGF ++ + + A K + K E E+ + L H+++V G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 581 CCTQRDERMLIYEYLPNKSLDYFIFD--TTRSKLLDWSKRSHIIAGIARGLLYLHQDSRL 638
D ++ E +SL + R L + R + + I G YLH+
Sbjct: 109 FFEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEAR-YYLRQIVLGCQYLHR---N 160
Query: 639 RIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLF 698
R+IHRDLK N+ L+ + KI DFGLA D + GT Y++PE
Sbjct: 161 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKGH 218
Query: 699 SVKSDVFSFGVLVLEIICGK 718
S + DV+S G ++ ++ GK
Sbjct: 219 SFEVDVWSIGCIMYTLLVGK 238
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 7e-32
Identities = 55/209 (26%), Positives = 102/209 (48%), Gaps = 13/209 (6%)
Query: 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRN 574
+ + +LG+G FG VYK E G A K + S + +E++ E+ ++A H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQ 634
+VKLLG + ++ E+ P ++D + + L + + + L +LH
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDAIM--LELDRGLTEPQIQVVCRQMLEALNFLHS 135
Query: 635 DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPE--- 691
RIIHRDLKA NVL+ + +++DFG++ + ++ +GT +M+PE
Sbjct: 136 K---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPEVVM 190
Query: 692 --YAIDGLFSVKSDVFSFGVLVLEIICGK 718
D + K+D++S G+ ++E+ +
Sbjct: 191 CETMKDTPYDYKADIWSLGITLIEMAQIE 219
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 8e-32
Identities = 56/200 (28%), Positives = 87/200 (43%), Gaps = 16/200 (8%)
Query: 525 LGEGGFGPVYKGMLIE-GQEIAVKRLSKGS--GQGMEE-FKNEVLLIAKLQHRNLVKLLG 580
LG+GGF ++ + + A K + K E E+ + L H+++V G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 581 CCTQRDERMLIYEYLPNKSLDYFIFD--TTRSKLLDWSKRSHIIAGIARGLLYLHQDSRL 638
D ++ E +SL + R L + R + + I G YLH R
Sbjct: 83 FFEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEAR-YYLRQIVLGCQYLH---RN 134
Query: 639 RIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLF 698
R+IHRDLK N+ L+ + KI DFGLA D + GT Y++PE
Sbjct: 135 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKGH 192
Query: 699 SVKSDVFSFGVLVLEIICGK 718
S + DV+S G ++ ++ GK
Sbjct: 193 SFEVDVWSIGCIMYTLLVGK 212
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 129 bits (324), Expect = 5e-31
Identities = 59/214 (27%), Positives = 92/214 (42%), Gaps = 17/214 (7%)
Query: 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEE-FKNEVLLIAKLQHR 573
+ K +LG GGFG V + + + G+++A+K+ + E + E+ ++ KL H
Sbjct: 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHP 72
Query: 574 NLVKLL------GCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIAR 627
N+V D +L EY L ++ L +++ I+
Sbjct: 73 NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 132
Query: 628 GLLYLHQDSRLRIIHRDLKASNVLLD---NTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
L YLH+ RIIHRDLK N++L + KI D G A+ VGT
Sbjct: 133 ALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-QGELCTE--FVGT 186
Query: 685 YGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGK 718
Y++PE ++V D +SFG L E I G
Sbjct: 187 LQYLAPELLEQKKYTVTVDYWSFGTLAFECITGF 220
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 6e-31
Identities = 64/200 (32%), Positives = 100/200 (50%), Gaps = 15/200 (7%)
Query: 525 LGEGGFGPVYKGMLIE-GQEIAVKRLSKGS--GQGMEE-FKNEVLLIAKLQHRNLVKLLG 580
LG+G F VY+ I G E+A+K + K + GM + +NEV + +L+H ++++L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 581 CCTQRDERMLIYEYLPNKSLDYFIFD--TTRSKLLDWSKRSHIIAGIARGLLYLHQDSRL 638
+ L+ E N + R K ++ H + I G+LYLH
Sbjct: 79 YFEDSNYVYLVLEMCHNGEM----NRYLKNRVKPFSENEARHFMHQIITGMLYLH---SH 131
Query: 639 RIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLF 698
I+HRDL SN+LL MN KI+DFGLA + + T + GT Y+SPE A
Sbjct: 132 GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNYISPEIATRSAH 189
Query: 699 SVKSDVFSFGVLVLEIICGK 718
++SDV+S G + ++ G+
Sbjct: 190 GLESDVWSLGCMFYTLLIGR 209
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 9e-31
Identities = 60/272 (22%), Positives = 89/272 (32%), Gaps = 72/272 (26%)
Query: 517 DNFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLS-KGSGQGMEEFKNEVLLIAKLQHRN 574
+F +G GGFG V++ ++ A+KR+ E+ EV +AKL+H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSK----------------------- 611
+V+ + E D S
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 612 ----------------------LLDWSKRS------------HIIAGIARGLLYLHQDSR 637
L DW R HI IA + +LH
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS--- 182
Query: 638 LRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTK----------RVVGTYGY 687
++HRDLK SN+ K+ DFGL + D+ E VGT Y
Sbjct: 183 KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242
Query: 688 MSPEYAIDGLFSVKSDVFSFGVLVLEIICGKK 719
MSPE +S K D+FS G+++ E++
Sbjct: 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFS 274
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 9e-31
Identities = 55/204 (26%), Positives = 100/204 (49%), Gaps = 11/204 (5%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLS-KGSGQGMEEFKNEVLLIAKLQHRN 574
D+F + ++LG G G V+K G +A K + + + E+ ++ +
Sbjct: 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQ 634
+V G E + E++ SLD + ++ + + + +GL YL
Sbjct: 93 IVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLTYLR- 148
Query: 635 DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAI 694
+ +I+HRD+K SN+L+++ K+ DFG+ S L + AN+ VGT YMSPE
Sbjct: 149 -EKHKIMHRDVKPSNILVNSRGEIKLCDFGV--SGQLIDSMANS--FVGTRSYMSPERLQ 203
Query: 695 DGLFSVKSDVFSFGVLVLEIICGK 718
+SV+SD++S G+ ++E+ G+
Sbjct: 204 GTHYSVQSDIWSMGLSLVEMAVGR 227
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-30
Identities = 56/242 (23%), Positives = 89/242 (36%), Gaps = 38/242 (15%)
Query: 503 ELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKN 562
+P F+ + + + LG G G V +G+ +AVKR+ +
Sbjct: 5 NIPNFEQSL----KNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALM 57
Query: 563 EV-LLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFI----FDTTRSKLLDWSK 617
E+ LL H N+++ T + E N +L + KL
Sbjct: 58 EIKLLTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYN 116
Query: 618 RSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNP-------------KISDFG 664
++ IA G+ +LH L+IIHRDLK N+L+ + ISDFG
Sbjct: 117 PISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG 173
Query: 665 LARSFGLDQT--EANTKRVVGTYGYMSPEYAIDGLFSV-------KSDVFSFGVLVLEII 715
L + Q+ N GT G+ +PE + D+FS G + I+
Sbjct: 174 LCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYIL 233
Query: 716 CG 717
Sbjct: 234 SK 235
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 56/199 (28%), Positives = 100/199 (50%), Gaps = 11/199 (5%)
Query: 524 KLGEGGFGPVYKGM-LIEGQEIAVKRLS---KGSGQGMEEFKNEVLLIAKLQHRNLVKLL 579
KLG GG VY I ++A+K + + + ++ F+ EV ++L H+N+V ++
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 580 GCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLR 639
+ D L+ EY+ +L +I L + I G+ + H +R
Sbjct: 78 DVDEEDDCYYLVMEYIEGPTLSEYIESHGP---LSVDTAINFTNQILDGIKHAH---DMR 131
Query: 640 IIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFS 699
I+HRD+K N+L+D+ KI DFG+A++ + + T V+GT Y SPE A
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALS-ETSLTQTNHVLGTVQYFSPEQAKGEATD 190
Query: 700 VKSDVFSFGVLVLEIICGK 718
+D++S G+++ E++ G+
Sbjct: 191 ECTDIYSIGIVLYEMLVGE 209
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 4e-30
Identities = 69/236 (29%), Positives = 109/236 (46%), Gaps = 22/236 (9%)
Query: 497 NEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQ 555
++ L DL + + F +G G +G VYKG ++ GQ A+K + +G
Sbjct: 4 SDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM-DVTGD 62
Query: 556 GMEEFKNEVLLIAKL-QHRNLVKLLGC------CTQRDERMLIYEYLPNKSL-DYFIFDT 607
EE K E+ ++ K HRN+ G D+ L+ E+ S+ D +
Sbjct: 63 EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD--LIKN 120
Query: 608 TRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
T+ L ++I I RGL +LHQ ++IHRD+K NVLL K+ DFG++
Sbjct: 121 TKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSA 177
Query: 668 SFGLDQTEANTKRVVGTYGYMSPE-----YAIDGLFSVKSDVFSFGVLVLEIICGK 718
LD+T +GT +M+PE D + KSD++S G+ +E+ G
Sbjct: 178 Q--LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-29
Identities = 64/220 (29%), Positives = 103/220 (46%), Gaps = 19/220 (8%)
Query: 506 IFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLS---KGSGQGMEEFK 561
+ +L + FS+ ++G G FG VY + + +A+K++S K S + ++
Sbjct: 43 VAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDII 102
Query: 562 NEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHI 621
EV + KL+H N ++ GC + L+ EY + D K L + + +
Sbjct: 103 KEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASD---LLEVHKKPLQEVEIAAV 159
Query: 622 IAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRV 681
G +GL YLH +IHRD+KA N+LL K+ DFG A AN+
Sbjct: 160 THGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM----APANS--F 210
Query: 682 VGTYGYMSPE---YAIDGLFSVKSDVFSFGVLVLEIICGK 718
VGT +M+PE +G + K DV+S G+ +E+ K
Sbjct: 211 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 250
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-29
Identities = 66/248 (26%), Positives = 105/248 (42%), Gaps = 28/248 (11%)
Query: 485 LMYRRKKHSNQGNEKEEMELPIFDLKIIANATDNFSEK----NKLGEGGFGPVYKGMLIE 540
+ + S + N + +L I + + SE KLG G +G V
Sbjct: 1 MHHHHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKV 60
Query: 541 -GQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPN 597
E A+K + K S + EV ++ L H N++KL + L+ E
Sbjct: 61 THVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKG 120
Query: 598 KSLDYFIFD--TTRSKLLDWSKR--SHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD 653
L FD R K ++ + II + G+ YLH+ I+HRDLK N+LL+
Sbjct: 121 GEL----FDEIIHRMKF---NEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLE 170
Query: 654 NTM---NPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVL 710
+ KI DFGL+ F + K +GT Y++PE + + K DV+S GV+
Sbjct: 171 SKEKDALIKIVDFGLSAVFENQKK---MKERLGTAYYIAPE-VLRKKYDEKCDVWSIGVI 226
Query: 711 VLEIICGK 718
+ ++ G
Sbjct: 227 LFILLAGY 234
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 65/284 (22%), Positives = 114/284 (40%), Gaps = 48/284 (16%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKN-----EVLLIAKL 570
D+ +LG G +G V K + GQ +AVKR+ +E K ++ + +
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNS--QEQKRLLMDLDISM-RTV 63
Query: 571 QHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTT-RSKLLDWSKRSHIIAGIARGL 629
V G + + + E + + SLD F + + + I I + L
Sbjct: 64 DCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKAL 122
Query: 630 LYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMS 689
+LH S+L +IHRD+K SNVL++ K+ DFG++ L A G YM+
Sbjct: 123 EHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGY--LVDDVAKD-IDAGCKPYMA 177
Query: 690 PE----YAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERP 745
PE +SVKSD++S G+ ++E+ + F + P
Sbjct: 178 PERINPELNQKGYSVKSDIWSLGITMIELAILR----FPYDSWGT--------------P 219
Query: 746 LELIDQSLDN------SCSFSEALR-CIQVGLLCVQQRPEDRPN 782
+ + Q ++ + FS C+++ ++RP
Sbjct: 220 FQQLKQVVEEPSPQLPADKFSAEFVDFTS---QCLKKNSKERPT 260
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 2e-29
Identities = 48/268 (17%), Positives = 92/268 (34%), Gaps = 51/268 (19%)
Query: 524 KLGEGGFGPVYKG--MLIEGQEIAVKRL-SKGSGQGMEEFKNEVLLIAKLQHRNLVKLL- 579
+ GG G +Y + G+ + +K L G + E +A++ H ++V++
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 580 -GCCTQRDERMLIY---EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQD 635
T R + Y EY+ +SL L ++ + I L YLH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-----LPVAEAIAYLLEILPALSYLH-- 199
Query: 636 SRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAID 695
+ +++ DLK N++L K+ D G ++ + GT G+ +PE
Sbjct: 200 -SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSR--INSFGY----LYGTPGFQAPEIV-R 250
Query: 696 GLFSVKSDVFSFGVLVLEIICGKKNRGFN--HADHDHNLLGHAWRLWIEERPLELIDQSL 753
+V +D+++ G + + N + D E+ P+ S
Sbjct: 251 TGPTVATDIYTVGRTLAALTLDL--PTRNGRYVDGLP-----------EDDPVLKTYDSY 297
Query: 754 DNSCSFSEALRCIQVGLLCVQQRPEDRP 781
+ + P R
Sbjct: 298 GR------------LLRRAIDPDPRQRF 313
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 61/207 (29%), Positives = 94/207 (45%), Gaps = 16/207 (7%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG--SGQGMEE-FKNEVLLIAKLQH 572
++F LG+G FG VY + +A+K L K G+E + EV + + L+H
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 573 RNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDT-TRSKLLDWSKRSHIIAGIARGLLY 631
N+++L G LI EY P ++ + + D + + I +A L Y
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSY 124
Query: 632 LHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPE 691
H R+IHRD+K N+LL + KI+DFG S + + GT Y+ PE
Sbjct: 125 CH---SKRVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRTD--LCGTLDYLPPE 177
Query: 692 YAIDGLFSVKSDVFSFGVLVLEIICGK 718
+ K D++S GVL E + GK
Sbjct: 178 MIEGRMHDEKVDLWSLGVLCYEFLVGK 204
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 5e-29
Identities = 30/298 (10%), Positives = 66/298 (22%), Gaps = 51/298 (17%)
Query: 525 LGEGGFGPVYKGMLIE-GQEIAVKRLSK---GSGQGMEEFKNEVLLIAKLQHRNLVKLLG 580
L G V+ +E ++ A+K + S +E A+L + +
Sbjct: 70 LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARD 129
Query: 581 CC--------------------------TQRDERMLIYEYLP---NKSLDYFIFDTTRSK 611
+L+ F
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRG 189
Query: 612 LLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671
+ A + R L ++H N+ + + D G
Sbjct: 190 DEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG- 245
Query: 672 DQTEANTKRVVGTYGYMSPEY--AIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHD 729
Y E+ A F+ + + G+ + + C F
Sbjct: 246 ----TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF--LPF---GLV 296
Query: 730 HNLLGHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVV 787
+ +W+ R + + + ++ + L R +
Sbjct: 297 TPGIKGSWKR-PSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFD--RRRRLLPLEAM 351
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 7e-29
Identities = 58/214 (27%), Positives = 100/214 (46%), Gaps = 21/214 (9%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVL-----LIAKL 570
++ + ++G G +G V K + GQ +AVKR+ E+ + ++L ++
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD---EKEQKQLLMDLDVVMRSS 78
Query: 571 QHRNLVKLLGCCTQRDERMLIYEYLPNKSLD--YFIFDTTRSKLLDWSKRSHIIAGIARG 628
+V+ G + + + E + + S D Y + ++ I +
Sbjct: 79 DCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKA 137
Query: 629 LLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYM 688
L +L L+IIHRD+K SN+LLD + N K+ DFG+ S L + A T R G YM
Sbjct: 138 LNHLK--ENLKIIHRDIKPSNILLDRSGNIKLCDFGI--SGQLVDSIAKT-RDAGCRPYM 192
Query: 689 SPE----YAIDGLFSVKSDVFSFGVLVLEIICGK 718
+PE A + V+SDV+S G+ + E+ G+
Sbjct: 193 APERIDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 119 bits (298), Expect = 8e-29
Identities = 51/349 (14%), Positives = 98/349 (28%), Gaps = 74/349 (21%)
Query: 525 LGEGGFGPVYKGM-LIEGQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQH-------- 572
LG+ + G+ V +++ K EVL + L+
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 573 --------RNLVKLLGCCT-----QRDERMLIYEY-----LPNKSL----DYFIFDTTRS 610
+LVK + M + +L + + ++
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 611 KLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670
K L R + + R L LH ++H L+ +++LD ++ F G
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262
Query: 671 LDQTEANTKRVVGTYGYMSPEYAI-----DGLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725
+ R + L + D ++ G+ + I C
Sbjct: 263 -ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCA-------- 313
Query: 726 ADHDHNLLGHAWRL-WIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMS 784
L ++ L + + + + +R + G L + EDR
Sbjct: 314 ------------DLPNTDDAALGGSEWIFRSCKNIPQPVRALLEGFL--RYPKEDRLLPL 359
Query: 785 SVV-------LMLSGERSLPQPQQPGFFTGR-NLPESESSSSRQYSAST 825
+ L +LP Q G T P S +S + A+
Sbjct: 360 QAMETPEYEQLRTELSAALPLYQTDGEPTREGGAPPSGTSQPDEAGAAE 408
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 114 bits (289), Expect = 2e-28
Identities = 54/186 (29%), Positives = 89/186 (47%), Gaps = 26/186 (13%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKN--------EVLLI 567
+NF + K+GEG +G VYK G+ +A+K++ ++ E+ L+
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR------LDTETEGVPSTAIREISLL 56
Query: 568 AKLQHRNLVKLLGCCTQRDERMLIYEYLPN--KSLDYFIFDTTRSKLLDWSKRSHIIAGI 625
+L H N+VKLL ++ L++E+L K D + + + +
Sbjct: 57 KELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKF----MDASALTGIPLPLIKSYLFQL 112
Query: 626 ARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTY 685
+GL + H R++HRDLK N+L++ K++DFGLAR+FG T VV T
Sbjct: 113 LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYTHEVV-TL 167
Query: 686 GYMSPE 691
Y +PE
Sbjct: 168 WYRAPE 173
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 62/303 (20%), Positives = 117/303 (38%), Gaps = 40/303 (13%)
Query: 493 SNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRL-S 550
S+ + K+ L I + A D ++G G G V+K + G IAVK++
Sbjct: 2 SSGSSGKQTGYLTIGGQRYQAEIND-LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRR 60
Query: 551 KGSGQGMEEFKNEV-LLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTR 609
G+ + + ++ +++ +V+ G + + E + +
Sbjct: 61 SGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAE--KLKKRM 117
Query: 610 SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669
+ + I + L YL + +IHRD+K SN+LLD K+ DFG+ S
Sbjct: 118 QGPIPERILGKMTVAIVKALYYLK--EKHGVIHRDVKPSNILLDERGQIKLCDFGI--SG 173
Query: 670 GLDQTEANTKRVVGTYGYMSPE-----YAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFN 724
L +A R G YM+PE + +++DV+S G+ ++E+ G+ F
Sbjct: 174 RLVDDKAKD-RSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ----FP 228
Query: 725 HADHDHNLLGHAWRLWIEERPLELIDQ----SLDNSCSFSEALR-CIQVGLLCVQQRPED 779
+ + + + L + Q L FS + ++ C+ +
Sbjct: 229 YKN-CKTD----FEV------LTKVLQEEPPLLPGHMGFSGDFQSFVK---DCLTKDHRK 274
Query: 780 RPN 782
RP
Sbjct: 275 RPK 277
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 71/288 (24%), Positives = 124/288 (43%), Gaps = 39/288 (13%)
Query: 514 NATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLS-KGSGQGMEEFKNEVLLIAKLQ 571
D++ + +G G V +++A+KR++ + M+E E+ +++
Sbjct: 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCH 71
Query: 572 HRNLVKLLGCCTQRDERMLIYEYLPNKSL-----DYFIFDTTRSKLLDWSKRSHIIAGIA 626
H N+V +DE L+ + L S+ +S +LD S + I+ +
Sbjct: 72 HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131
Query: 627 RGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS-FGLDQTEANTKR--VVG 683
GL YLH++ IHRD+KA N+LL + +I+DFG++ N R VG
Sbjct: 132 EGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVG 188
Query: 684 TYGYMSPE-------YAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHA 736
T +M+PE Y K+D++SFG+ +E+ G + +
Sbjct: 189 TPCWMAPEVMEQVRGY------DFKADIWSFGITAIELATGAA----PYHKYPPM---KV 235
Query: 737 WRLWIEERP--LELIDQSLDNSCSFSEALR-CIQVGLLCVQQRPEDRP 781
L ++ P LE Q + + ++ R I LC+Q+ PE RP
Sbjct: 236 LMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMIS---LCLQKDPEKRP 280
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 5e-28
Identities = 56/205 (27%), Positives = 92/205 (44%), Gaps = 17/205 (8%)
Query: 524 KLGEGGFGPVYKGM-LIEGQEIAVKRLS---KGSGQGMEEFKNEVLLIAKLQHRNLVKLL 579
LG GG V+ L + +++AVK L F+ E A L H +V +
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 580 --GCCTQRDERMLIY---EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQ 634
G + L Y EY+ +L + + + +IA + L + H
Sbjct: 79 DTGE-AETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSH- 133
Query: 635 DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD-QTEANTKRVVGTYGYMSPEYA 693
+ IIHRD+K +N+++ T K+ DFG+AR+ + T V+GT Y+SPE A
Sbjct: 134 --QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 694 IDGLFSVKSDVFSFGVLVLEIICGK 718
+SDV+S G ++ E++ G+
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGE 216
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 6e-28
Identities = 57/211 (27%), Positives = 91/211 (43%), Gaps = 13/211 (6%)
Query: 513 ANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEE-FKNEVLLIAKL 570
D F K KLG G FG V+ G E +K ++K Q E + E+ ++ L
Sbjct: 18 GTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSL 77
Query: 571 QHRNLVKLLGCCTQRDERMLIYEYLPNKSL-DYFIFDTTRSKLLDWSKRSHIIAGIARGL 629
H N++K+ ++ E L + + R K L + ++ + L
Sbjct: 78 DHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNAL 137
Query: 630 LYLHQDSRLRIIHRDLKASNVLLDNT---MNPKISDFGLARSFGLDQTEANTKRVVGTYG 686
Y H ++H+DLK N+L +T KI DFGLA F D+ + GT
Sbjct: 138 AYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH---STNAAGTAL 191
Query: 687 YMSPEYAIDGLFSVKSDVFSFGVLVLEIICG 717
YM+PE + K D++S GV++ ++ G
Sbjct: 192 YMAPE-VFKRDVTFKCDIWSAGVVMYFLLTG 221
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 8e-28
Identities = 54/228 (23%), Positives = 95/228 (41%), Gaps = 35/228 (15%)
Query: 517 DNFSEKNKLGEGGFGPVY---------------KGMLIEGQEIAVKRLSKGSGQGMEE-F 560
+++ L +G F + K +L + ++ K S + + F
Sbjct: 31 NDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDF 90
Query: 561 KNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSL-DY----FIFDTTRSKLLDW 615
KNE+ +I +++ + G T DE +IYEY+ N S+ + F+ D + +
Sbjct: 91 KNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPI 150
Query: 616 SKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE 675
II + Y+H + I HRD+K SN+L+D K+SDFG + +
Sbjct: 151 QVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYM----VD 204
Query: 676 ANTKRVVGTYGYMSPE-----YAIDGLFSVKSDVFSFGVLVLEIICGK 718
K GTY +M PE + +G K D++S G+ + +
Sbjct: 205 KKIKGSRGTYEFMPPEFFSNESSYNGA---KVDIWSLGICLYVMFYNV 249
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 53/185 (28%), Positives = 93/185 (50%), Gaps = 26/185 (14%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKN--------EVLLIA 568
+ + + K+GEG +G VYK +G+ +A+KR+ ++ E+ L+
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIR------LDAEDEGIPSTAIREISLLK 74
Query: 569 KLQHRNLVKLLGCCTQRDERMLIYEYLPN--KSLDYFIFDTTRSKLLDWSKRSHIIAGIA 626
+L H N+V L+ L++E++ K + D ++ L D + + +
Sbjct: 75 ELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKV----LDENKTGLQDSQIKI-YLYQLL 129
Query: 627 RGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYG 686
RG+ + HQ RI+HRDLK N+L+++ K++DFGLAR+FG + T VV T
Sbjct: 130 RGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFG-IPVRSYTHEVV-TLW 184
Query: 687 YMSPE 691
Y +P+
Sbjct: 185 YRAPD 189
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-27
Identities = 66/213 (30%), Positives = 103/213 (48%), Gaps = 25/213 (11%)
Query: 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSK---GSGQGMEEFKNEVLLIAKLQ 571
+D + + LG+G FG V GQE AVK +SK E EV L+ +L
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 572 HRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFD--TTRSKLLDWSKR--SHIIAGIAR 627
H N++KL + L+ E L FD +R + S+ + II +
Sbjct: 85 HPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRF---SEVDAARIIRQVLS 137
Query: 628 GLLYLHQDSRLRIIHRDLKASNVLLDNTM---NPKISDFGLARSFGLDQTEANTKRVVGT 684
G+ Y+H+ +I+HRDLK N+LL++ N +I DFGL+ F + K +GT
Sbjct: 138 GITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK---MKDKIGT 191
Query: 685 YGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICG 717
Y++PE + G + K DV+S GV++ ++ G
Sbjct: 192 AYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 2e-27
Identities = 43/311 (13%), Positives = 90/311 (28%), Gaps = 81/311 (26%)
Query: 525 LGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQ--------- 571
LG+ + E G+ V +++ K EVL + L+
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 572 ----------------HRNLVKLLGCCTQRDERMLIY---EYLPNKSL----DYFIFDTT 608
+ ++++ +RD +L +L + + ++
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRL--DERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198
Query: 609 RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668
K L R + + R L LH ++H L+ +++LD ++ F
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 255
Query: 669 FGLDQTEANTKRVVGTYGYMSPEYAID-----------GLFSVKSDVFSFGVLVLEIICG 717
G + G+ PE L + D ++ G+++ I C
Sbjct: 256 DGARVV------SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA 309
Query: 718 KKNRGFNHADHDHNLLGHAWRL-WIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQR 776
L ++ L + + + + +R + G L
Sbjct: 310 --------------------DLPITKDAALGGSEWIFRSCKNIPQPVRALLEGFLRY--P 347
Query: 777 PEDRPNMSSVV 787
EDR +
Sbjct: 348 KEDRLLPLQAM 358
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-27
Identities = 64/220 (29%), Positives = 101/220 (45%), Gaps = 24/220 (10%)
Query: 508 DLKIIANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG--SGQGMEEFKNEV 564
+L + ++ LG+G FG V K QE AVK ++K + EV
Sbjct: 13 NLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREV 72
Query: 565 LLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFD--TTRSKLLDWSKR--SH 620
L+ KL H N++KL ++ E L FD R + S+ +
Sbjct: 73 ELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL----FDEIIKRKRF---SEHDAAR 125
Query: 621 IIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNT---MNPKISDFGLARSFGLDQTEAN 677
II + G+ Y+H+ I+HRDLK N+LL++ + KI DFGL+ F +
Sbjct: 126 IIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK--- 179
Query: 678 TKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICG 717
K +GT Y++PE + G + K DV+S GV++ ++ G
Sbjct: 180 MKDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-27
Identities = 41/216 (18%), Positives = 80/216 (37%), Gaps = 18/216 (8%)
Query: 516 TDNFSEKNKLGEG--GFGPVYKGMLIE-GQEIAVKR--LSKGSGQGMEEFKNEVLLIAKL 570
+ +G+G V G+ + V+R L S + + + E+ +
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 571 QHRNLVKLLGCCTQRDERMLIYEYLPNKSL-DYFIFDTTRSKLLDWSKRSHIIAGIARGL 629
H N+V +E ++ ++ S D + T ++ ++I+ G+ + L
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKD--LICTHFMDGMNELAIAYILQGVLKAL 141
Query: 630 LYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANT-----KRVVGT 684
Y+H +HR +KAS++L+ +S S K V
Sbjct: 142 DYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKV 198
Query: 685 YGYMSPE--YAIDGLFSVKSDVFSFGVLVLEIICGK 718
++SPE + KSD++S G+ E+ G
Sbjct: 199 LPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 4e-27
Identities = 53/185 (28%), Positives = 89/185 (48%), Gaps = 26/185 (14%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKN--------EVLLIA 568
+ + K+GEG +G VYK G+ A+K++ +E+ E+ ++
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIR------LEKEDEGIPSTTIREISILK 55
Query: 569 KLQHRNLVKLLGCCTQRDERMLIYEYLPN--KSLDYFIFDTTRSKLLDWSKRSHIIAGIA 626
+L+H N+VKL + +L++E+L K L D L + +S + +
Sbjct: 56 ELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKL----LDVCEGGLESVTAKS-FLLQLL 110
Query: 627 RGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYG 686
G+ Y H R++HRDLK N+L++ KI+DFGLAR+FG T +V T
Sbjct: 111 NGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFG-IPVRKYTHEIV-TLW 165
Query: 687 YMSPE 691
Y +P+
Sbjct: 166 YRAPD 170
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 5e-27
Identities = 51/214 (23%), Positives = 93/214 (43%), Gaps = 26/214 (12%)
Query: 516 TDNFSEK----NKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKL 570
+ ++ N +G G +G V + A K++ K + ++ FK E+ ++ L
Sbjct: 4 KGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSL 63
Query: 571 QHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFD--TTRSKLLDWSKR--SHIIAGIA 626
H N+++L + L+ E L F+ + + + I+ +
Sbjct: 64 DHPNIIRLYETFEDNTDIYLVMELCTGGEL----FERVVHKRVF---RESDAARIMKDVL 116
Query: 627 RGLLYLHQDSRLRIIHRDLKASNVLLDNT---MNPKISDFGLARSFGLDQTEANTKRVVG 683
+ Y H+ L + HRDLK N L K+ DFGLA F + + VG
Sbjct: 117 SAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM---MRTKVG 170
Query: 684 TYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICG 717
T Y+SP+ ++GL+ + D +S GV++ ++CG
Sbjct: 171 TPYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCG 203
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 6e-27
Identities = 48/186 (25%), Positives = 88/186 (47%), Gaps = 27/186 (14%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKN--------EVLLI 567
+ + K+GEG +G V+K E + +A+KR+ +++ E+ L+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR------LDDDDEGVPSSALREICLL 55
Query: 568 AKLQHRNLVKLLGCCTQRDERMLIYEYLPN--KSLDYFIFDTTRSKLLDWSKRSHIIAGI 625
+L+H+N+V+L + L++E+ K FD+ L +S + +
Sbjct: 56 KELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKY----FDSCNGDLDPEIVKS-FLFQL 110
Query: 626 ARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTY 685
+GL + H ++HRDLK N+L++ K+++FGLAR+FG + VV T
Sbjct: 111 LKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFG-IPVRCYSAEVV-TL 165
Query: 686 GYMSPE 691
Y P+
Sbjct: 166 WYRPPD 171
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 6e-27
Identities = 42/202 (20%), Positives = 80/202 (39%), Gaps = 17/202 (8%)
Query: 524 KLGEGGFGPVYKGM-LIEGQEIAVKRLS---KGSGQGMEEFKNEVLLIAKLQHRNLVKL- 578
+G GG G VY+ + + +A+K +S + E +LQ ++V +
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100
Query: 579 -LGCCTQRDERM-LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDS 636
G + D ++ + + L + L + I+ I L H
Sbjct: 101 DFG---EIDGQLYVDMRLINGVDLAAMLRRQGP---LAPPRAVAIVRQIGSALDAAHAA- 153
Query: 637 RLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDG 696
HRD+K N+L+ + DFG+A + D+ VGT YM+PE +
Sbjct: 154 --GATHRDVKPENILVSADDFAYLVDFGIASATT-DEKLTQLGNTVGTLYYMAPERFSES 210
Query: 697 LFSVKSDVFSFGVLVLEIICGK 718
+ ++D+++ ++ E + G
Sbjct: 211 HATYRADIYALTCVLYECLTGS 232
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 7e-27
Identities = 63/212 (29%), Positives = 98/212 (46%), Gaps = 24/212 (11%)
Query: 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQH 572
+ ++ LG+G FG V K QE AVK ++K + EV L+ KL H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 573 RNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFD--TTRSKLLDWSKR--SHIIAGIARG 628
N++KL ++ E L FD R + S+ + II + G
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGEL----FDEIIKRKRF---SEHDAARIIKQVFSG 133
Query: 629 LLYLHQDSRLRIIHRDLKASNVLL---DNTMNPKISDFGLARSFGLDQTEANTKRVVGTY 685
+ Y+H+ I+HRDLK N+LL + + KI DFGL+ F + K +GT
Sbjct: 134 ITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTA 187
Query: 686 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIICG 717
Y++PE + G + K DV+S GV++ ++ G
Sbjct: 188 YYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 8e-27
Identities = 50/237 (21%), Positives = 94/237 (39%), Gaps = 19/237 (8%)
Query: 490 KKHSNQGNEKEEMELPIFDLKIIANATDNFSEK----NKLGEGGFGPVYKGMLIE-GQEI 544
N ++ E + + + + + +LG G FG V++ + G+
Sbjct: 20 GPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVF 79
Query: 545 AVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFI 604
K ++ KNE+ ++ +L H L+ L + E +LI E+L L
Sbjct: 80 VAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGEL---- 135
Query: 605 FD--TTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNP--KI 660
FD + ++ + + GL ++H+ I+H D+K N++ + KI
Sbjct: 136 FDRIAAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKI 192
Query: 661 SDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICG 717
DFGLA D+ K T + +PE +D+++ GVL ++ G
Sbjct: 193 IDFGLATKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 1e-26
Identities = 55/207 (26%), Positives = 90/207 (43%), Gaps = 16/207 (7%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG--SGQGMEE-FKNEVLLIAKLQH 572
D+F LG+G FG VY + +A+K L K +G+E + E+ + + L+H
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 573 RNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDT-TRSKLLDWSKRSHIIAGIARGLLY 631
N++++ R L+ E+ P L + + D + + + +A L Y
Sbjct: 74 PNILRMYNYFHDRKRIYLMLEFAPRGEL----YKELQKHGRFDEQRSATFMEELADALHY 129
Query: 632 LHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPE 691
H ++IHRD+K N+L+ KI+DFG S T + GT Y+ PE
Sbjct: 130 CH---ERKVIHRDIKPENLLMGYKGELKIADFGW--SVHAPSLRRRT--MCGTLDYLPPE 182
Query: 692 YAIDGLFSVKSDVFSFGVLVLEIICGK 718
K D++ GVL E + G
Sbjct: 183 MIEGKTHDEKVDLWCAGVLCYEFLVGM 209
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-26
Identities = 62/233 (26%), Positives = 101/233 (43%), Gaps = 21/233 (9%)
Query: 489 RKKHSNQGNEKEEMELPIFDLKIIANATDNFSE------KNKLGEGGFGPVYKGMLIE-G 541
+ K ++ FD +I+ + LG G FG V+K G
Sbjct: 55 KSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATG 114
Query: 542 QEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLD 601
++A K + + EE KNE+ ++ +L H NL++L +++ +L+ EY+ L
Sbjct: 115 LKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL- 173
Query: 602 YFIFD--TTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNP- 658
FD S L + I G+ ++HQ + I+H DLK N+L N
Sbjct: 174 ---FDRIIDESYNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQ 227
Query: 659 -KISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVL 710
KI DFGLAR + + K GT +++PE S +D++S GV+
Sbjct: 228 IKIIDFGLARRYKPRE---KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVI 277
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 59/189 (31%), Positives = 90/189 (47%), Gaps = 30/189 (15%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKN--------EVLLI 567
+ + + LGEG F VYK Q +A+K++ G E K+ E+ L+
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGH---RSEAKDGINRTALREIKLL 66
Query: 568 AKLQHRNLVKLLGCCTQRDERMLIYEYLPN--KSLDYFIFDTTRSKLLDWSKRSHI---I 622
+L H N++ LL + L+++++ + + L SHI +
Sbjct: 67 QELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVI----IKDNSLVLTP----SHIKAYM 118
Query: 623 AGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVV 682
+GL YLHQ I+HRDLK +N+LLD K++DFGLA+SFG A T +VV
Sbjct: 119 LMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFG-SPNRAYTHQVV 174
Query: 683 GTYGYMSPE 691
T Y +PE
Sbjct: 175 -TRWYRAPE 182
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-26
Identities = 65/249 (26%), Positives = 109/249 (43%), Gaps = 35/249 (14%)
Query: 490 KKHSNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKR 548
N + + ++ K +++ + KLG G +G V E A+K
Sbjct: 9 SGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKV 68
Query: 549 LSK-------------GSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595
+ K + EE NE+ L+ L H N++KL + L+ E+
Sbjct: 69 IKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFY 128
Query: 596 PNKSLDYFIFD--TTRSKLLDWSKR--SHIIAGIARGLLYLHQDSRLRIIHRDLKASNVL 651
L F+ R K + ++I+ I G+ YLH+ I+HRD+K N+L
Sbjct: 129 EGGEL----FEQIINRHKF---DECDAANIMKQILSGICYLHK---HNIVHRDIKPENIL 178
Query: 652 LDNT---MNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFG 708
L+N +N KI DFGL+ F D + +GT Y++PE + ++ K DV+S G
Sbjct: 179 LENKNSLLNIKIVDFGLSSFFSKDYK---LRDRLGTAYYIAPE-VLKKKYNEKCDVWSCG 234
Query: 709 VLVLEIICG 717
V++ ++CG
Sbjct: 235 VIMYILLCG 243
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 3e-26
Identities = 51/239 (21%), Positives = 95/239 (39%), Gaps = 19/239 (7%)
Query: 488 RRKKHSNQGNEKEEMELPIFDLKIIANATDNFSEK----NKLGEGGFGPVYKGMLIE-GQ 542
+ S+ + + + + D+ + +LG G FG V++ G
Sbjct: 124 GKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGN 183
Query: 543 EIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDY 602
A K + E + E+ ++ L+H LV L +E ++IYE++ L
Sbjct: 184 NFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGEL-- 241
Query: 603 FIFDTTRSKLLDWSKR--SHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNP-- 658
F+ + S+ + + +GL ++H+ +H DLK N++ +
Sbjct: 242 --FEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNEL 296
Query: 659 KISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICG 717
K+ DFGL Q + K GT + +PE A +D++S GVL ++ G
Sbjct: 297 KLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 4e-26
Identities = 51/186 (27%), Positives = 92/186 (49%), Gaps = 17/186 (9%)
Query: 514 NATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKN-----EVLLI 567
+++ F + KLG G + VYKG+ G +A+K + S +G E+ L+
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGT----PSTAIREISLM 57
Query: 568 AKLQHRNLVKLLGCCTQRDERMLIYEYLPN--KSLDYFIFDTTRSKLLDWSKRSHIIAGI 625
+L+H N+V+L ++ L++E++ N K + L+ + + +
Sbjct: 58 KELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQL 117
Query: 626 ARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTY 685
+GL + H++ +I+HRDLK N+L++ K+ DFGLAR+FG + VV T
Sbjct: 118 LQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG-IPVNTFSSEVV-TL 172
Query: 686 GYMSPE 691
Y +P+
Sbjct: 173 WYRAPD 178
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 6e-26
Identities = 56/216 (25%), Positives = 91/216 (42%), Gaps = 23/216 (10%)
Query: 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVK-----RLSKGSGQGMEEFKNEVLLIAK 569
D + +G+G F V + + E GQ+ AVK + + G E+ K E +
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 570 LQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFD--TTRSKLLDW---SKRSHIIAG 624
L+H ++V+LL + +++E++ L R+ + SH +
Sbjct: 83 LKHPHIVELLETYSSDGMLYMVFEFMDGADL----CFEIVKRADAGFVYSEAVASHYMRQ 138
Query: 625 IARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNP---KISDFGLARSFGLDQTEANTKRV 681
I L Y H IIHRD+K VLL + N K+ FG+A G A
Sbjct: 139 ILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG--R 193
Query: 682 VGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICG 717
VGT +M+PE + DV+ GV++ ++ G
Sbjct: 194 VGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 8e-26
Identities = 53/274 (19%), Positives = 92/274 (33%), Gaps = 52/274 (18%)
Query: 494 NQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVK----- 547
+ + E F + + K +G+G +G V + + A+K
Sbjct: 3 HHHHHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKN 62
Query: 548 RLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDT 607
++ + + + +E K EV L+ KL H N+ +L L+ E L +
Sbjct: 63 KIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVF 122
Query: 608 TRSKLLDWSKR-------------------------------------SHIIAGIARGLL 630
+ S+I+ I L
Sbjct: 123 IDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH 182
Query: 631 YLHQDSRLRIIHRDLKASNVLL--DNTMNPKISDFGLARSFGLDQTEANT--KRVVGTYG 686
YLH I HRD+K N L + + K+ DFGL++ F GT
Sbjct: 183 YLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPY 239
Query: 687 YMSPE--YAIDGLFSVKSDVFSFGVLVLEIICGK 718
+++PE + + K D +S GVL+ ++ G
Sbjct: 240 FVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGA 273
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 9e-26
Identities = 58/212 (27%), Positives = 97/212 (45%), Gaps = 23/212 (10%)
Query: 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSK--GSGQGMEEFKNEVLLIAKLQH 572
+DN+ K +LG+G F V + + G E A K ++ S + ++ + E + KLQH
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 573 RNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFD--TTRSKLLDWSKR--SHIIAGIARG 628
N+V+L + L+++ + L F+ R S+ SH I I
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVAREFY---SEADASHCIQQILES 117
Query: 629 LLYLHQDSRLRIIHRDLKASNVLLDNTMNP---KISDFGLARSFGLDQTEANTKRVVGTY 685
+ Y H I+HR+LK N+LL + K++DFGLA + GT
Sbjct: 118 IAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTP 171
Query: 686 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIICG 717
GY+SPE +S D+++ GV++ ++ G
Sbjct: 172 GYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 45/184 (24%), Positives = 77/184 (41%), Gaps = 23/184 (12%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKN--------EVLLI 567
+ + + K+GEG +G V+K + GQ +A+K+ E E+ ++
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF------LESEDDPVIKKIALREIRML 56
Query: 568 AKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIAR 627
+L+H NLV LL ++ L++EY + L + + I +
Sbjct: 57 KQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELD---RYQRGVPEHLVKSITWQTLQ 113
Query: 628 GLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGY 687
+ + H+ IHRD+K N+L+ K+ DFG AR ++ V T Y
Sbjct: 114 AVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLT-GPSDYYDDEVA-TRWY 168
Query: 688 MSPE 691
SPE
Sbjct: 169 RSPE 172
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-25
Identities = 54/226 (23%), Positives = 99/226 (43%), Gaps = 48/226 (21%)
Query: 516 TDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKN-EVLLIAKLQHRN 574
++ +G G FG V++ L+E E+A+K++ + + FKN E+ ++ ++H N
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD-----KRFKNRELQIMRIVKHPN 93
Query: 575 LVKLLGCCTQRDERM------LIYEYLPNKSLDYFIFDTTRSKLLD-WSKRSHIIAG--- 624
+V L ++ L+ EY+P T + ++K +
Sbjct: 94 VVDLKAFFYSNGDKKDEVFLNLVLEYVP----------ETVYRASRHYAKLKQTMPMLLI 143
Query: 625 ------IARGLLYLHQDSRLRIIHRDLKASNVLLD-NTMNPKISDFGLARSFGLDQTEAN 677
+ R L Y+H + I HRD+K N+LLD + K+ DFG A+ E N
Sbjct: 144 KLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL--IAGEPN 198
Query: 678 TKRVVGTYGYMSPEYAIDGLF-----SVKSDVFSFGVLVLEIICGK 718
+ Y Y +PE +F + D++S G ++ E++ G+
Sbjct: 199 VSYICSRY-YRAPEL----IFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 51/184 (27%), Positives = 83/184 (45%), Gaps = 24/184 (13%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKN-----EVLLIAKL 570
+ + + +KLGEG + VYKG +A+K + +G EV L+ L
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGA----PCTAIREVSLLKDL 57
Query: 571 QHRNLVKLLGCCTQRDERMLIYEYLPN---KSLDYFIFDTTRSKLLDWSKRSHIIAGIAR 627
+H N+V L L++EYL + LD +++ + + R
Sbjct: 58 KHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLD------DCGNIINMHNVKLFLFQLLR 111
Query: 628 GLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGY 687
GL Y H+ +++HRDLK N+L++ K++DFGLAR+ T+ VV T Y
Sbjct: 112 GLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKS-IPTKTYDNEVV-TLWY 166
Query: 688 MSPE 691
P+
Sbjct: 167 RPPD 170
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 4e-25
Identities = 58/214 (27%), Positives = 95/214 (44%), Gaps = 27/214 (12%)
Query: 510 KIIANATDNFSEK----NKLGEGGFGPVYKGMLIE-GQEIAVKRLSK--GSGQGMEEFKN 562
+ + NA+ FS+ +LG+G F V + + G E A K ++ S + ++ +
Sbjct: 18 EFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLER 77
Query: 563 EVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFD--TTRSKLLDWSKR-- 618
E + KLQH N+V+L + L+++ + L F+ R S+
Sbjct: 78 EARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVAREFY---SEADA 130
Query: 619 SHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNP---KISDFGLARSFGLDQTE 675
SH I I + Y H I+HR+LK N+LL + K++DFGLA +
Sbjct: 131 SHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA- 186
Query: 676 ANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGV 709
GT GY+SPE +S D+++ GV
Sbjct: 187 --WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGV 218
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 6e-25
Identities = 53/197 (26%), Positives = 91/197 (46%), Gaps = 37/197 (18%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQGMEEFKN--------EVLLI 567
+ + K+G+G FG V+K + + A+K++ ME K E+ ++
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL------MENEKEGFPITALREIKIL 70
Query: 568 AKLQHRNLVKLLGCCTQRDERM--------LIYEYLPN--KSLDYFIFDTTRSKLLDWSK 617
L+H N+V L+ C + L++++ + L K S+
Sbjct: 71 QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGL----LSNVLVKFTL-SE 125
Query: 618 RSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEAN 677
++ + GL Y+H++ +I+HRD+KA+NVL+ K++DFGLAR+F L +
Sbjct: 126 IKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP 182
Query: 678 ---TKRVVGTYGYMSPE 691
T RVV T Y PE
Sbjct: 183 NRYTNRVV-TLWYRPPE 198
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 7e-25
Identities = 48/184 (26%), Positives = 80/184 (43%), Gaps = 23/184 (12%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKN--------EVLLI 567
+ + +GEG +G V K + G+ +A+K+ + E+ L+
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFL------ESDDDKMVKKIAMREIKLL 78
Query: 568 AKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIAR 627
+L+H NLV LL C ++ L++E++ + LD LD+ + I
Sbjct: 79 KQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDL---ELFPNGLDYQVVQKYLFQIIN 135
Query: 628 GLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGY 687
G+ + H IIHRD+K N+L+ + K+ DFG AR+ E V T Y
Sbjct: 136 GIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLA-APGEVYDDEVA-TRWY 190
Query: 688 MSPE 691
+PE
Sbjct: 191 RAPE 194
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 8e-25
Identities = 53/210 (25%), Positives = 87/210 (41%), Gaps = 22/210 (10%)
Query: 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRN 574
F LG G F V+ G+ A+K + K +NE+ ++ K++H N
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYFIFD--TTRSKLLDWSKR--SHIIAGIARGLL 630
+V L L+ + + L FD R +++ S +I + +
Sbjct: 68 IVTLEDIYESTTHYYLVMQLVSGGEL----FDRILERGVY---TEKDASLVIQQVLSAVK 120
Query: 631 YLHQDSRLRIIHRDLKASNVLL---DNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGY 687
YLH+ I+HRDLK N+L + I+DFGL++ GT GY
Sbjct: 121 YLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ----NGIMSTACGTPGY 173
Query: 688 MSPEYAIDGLFSVKSDVFSFGVLVLEIICG 717
++PE +S D +S GV+ ++CG
Sbjct: 174 VAPEVLAQKPYSKAVDCWSIGVITYILLCG 203
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 8e-25
Identities = 56/195 (28%), Positives = 84/195 (43%), Gaps = 41/195 (21%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKN--------EVLLI 567
D + KLGEG +G VYK + + +A+KR+ +E + EV L+
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR------LEHEEEGVPGTAIREVSLL 87
Query: 568 AKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKR---SHI--- 621
+LQHRN+++L LI+EY + K +D + I
Sbjct: 88 KELQHRNIIELKSVIHHNHRLHLIFEYA----------ENDLKKYMDKNPDVSMRVIKSF 137
Query: 622 IAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNP-----KISDFGLARSFGLDQTEA 676
+ + G+ + H R +HRDLK N+LL + KI DFGLAR+FG
Sbjct: 138 LYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG-IPIRQ 193
Query: 677 NTKRVVGTYGYMSPE 691
T ++ T Y PE
Sbjct: 194 FTHEII-TLWYRPPE 207
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 8e-25
Identities = 40/202 (19%), Positives = 81/202 (40%), Gaps = 16/202 (7%)
Query: 514 NATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQH 572
+ + LG G FG V++ + + K + G K E+ ++ +H
Sbjct: 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARH 60
Query: 573 RNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKR--SHIIAGIARGLL 630
RN++ L +E ++I+E++ + F+ + + ++R + + L
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDI----FERINTSAFELNEREIVSYVHQVCEALQ 116
Query: 631 YLHQDSRLRIIHRDLKASNVLLDNTMNP--KISDFGLARSFGLDQTEANTKRVVGTYGYM 688
+LH I H D++ N++ + KI +FG AR + + Y
Sbjct: 117 FLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN---FRLLFTAPEYY 170
Query: 689 SPEYAIDGLFSVKSDVFSFGVL 710
+PE + S +D++S G L
Sbjct: 171 APEVHQHDVVSTATDMWSLGTL 192
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 9e-25
Identities = 55/213 (25%), Positives = 94/213 (44%), Gaps = 28/213 (13%)
Query: 513 ANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSK------GSGQGMEEFKNEVL 565
+ D++ +LG G F V K G+E A K + K G EE + EV
Sbjct: 1 SMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVN 60
Query: 566 LIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFD--TTRSKLLDWSKR--SHI 621
++ +++H N++ L + + +LI E + L FD + L ++ +
Sbjct: 61 ILREIRHPNIITLHDIFENKTDVVLILELVSGGEL----FDFLAEKESL---TEDEATQF 113
Query: 622 IAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNP----KISDFGLARSFGLDQTEAN 677
+ I G+ YLH RI H DLK N++L + P K+ DFG+A
Sbjct: 114 LKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE--- 167
Query: 678 TKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVL 710
K + GT +++PE +++D++S GV+
Sbjct: 168 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 200
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 58/205 (28%), Positives = 91/205 (44%), Gaps = 27/205 (13%)
Query: 525 LGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEE-FKNEVLLIAKLQHRNLVKLLGCC 582
LGEG +G V + + + +AVK + E K E+ + L H N+VK G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 583 TQRDERMLIYEYLPNKSL-DYFIFDTTRSKLLDWSKRSH---IIAGIARGLLYLHQDSRL 638
+ + + L EY L D + + + ++AG+ YLH +
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVV----YLH---GI 124
Query: 639 RIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPE------Y 692
I HRD+K N+LLD N KISDFGLA F + E ++ GT Y++PE +
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 693 AIDGLFSVKSDVFSFGVLVLEIICG 717
DV+S G+++ ++ G
Sbjct: 185 --HAE---PVDVWSCGIVLTAMLAG 204
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 58/213 (27%), Positives = 90/213 (42%), Gaps = 28/213 (13%)
Query: 513 ANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSK------GSGQGMEEFKNEVL 565
D + +LG G F V K G E A K + K G EE + EV
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVS 67
Query: 566 LIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFD--TTRSKLLDWSKR--SHI 621
++ ++ H N++ L R + +LI E + L FD + L S+ +
Sbjct: 68 ILRQVLHPNIITLHDVYENRTDVVLILELVSGGEL----FDFLAQKESL---SEEEATSF 120
Query: 622 IAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNP----KISDFGLARSFGLDQTEAN 677
I I G+ YLH +I H DLK N++L + P K+ DFGLA
Sbjct: 121 IKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE--- 174
Query: 678 TKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVL 710
K + GT +++PE +++D++S GV+
Sbjct: 175 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 207
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 57/210 (27%), Positives = 90/210 (42%), Gaps = 22/210 (10%)
Query: 513 ANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSK------GSGQGMEEFKNEVL 565
D + +LG G F V K G E A K + K G EE + EV
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 566 LIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDT-TRSKLLDWSKRSHIIAG 624
++ ++ H N++ L R + +LI E + L FD + + L + + I
Sbjct: 68 ILRQVLHHNVITLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFIKQ 123
Query: 625 IARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNP----KISDFGLARSFGLDQTEANTKR 680
I G+ YLH +I H DLK N++L + P K+ DFGLA K
Sbjct: 124 ILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKN 177
Query: 681 VVGTYGYMSPEYAIDGLFSVKSDVFSFGVL 710
+ GT +++PE +++D++S GV+
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVI 207
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 4e-24
Identities = 51/242 (21%), Positives = 98/242 (40%), Gaps = 33/242 (13%)
Query: 488 RRKKHSNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAV 546
+ K N + E + D + K+ +G G V + + G E AV
Sbjct: 65 QPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAV 124
Query: 547 KRLSKGSGQG--------MEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDERMLIYEYLPN 597
K + + + E + E ++ ++ H +++ L+ L+++ +
Sbjct: 125 KIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRK 184
Query: 598 KSLDYFIFD--TTRSKLLDWSKR--SHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD 653
L FD T + L S++ I+ + + +LH I+HRDLK N+LLD
Sbjct: 185 GEL----FDYLTEKVAL---SEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLD 234
Query: 654 NTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPE------YAIDGLFSVKSDVFSF 707
+ M ++SDFG + + + + GT GY++PE + + D+++
Sbjct: 235 DNMQIRLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWAC 291
Query: 708 GV 709
GV
Sbjct: 292 GV 293
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 4e-24
Identities = 59/229 (25%), Positives = 105/229 (45%), Gaps = 53/229 (23%)
Query: 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKN-EVLLIAKLQHR 573
++++ +G G FG VY+ L + G+ +A+K++ + + FKN E+ ++ KL H
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHC 107
Query: 574 NLVKLLGCCTQRDERM------LIYEYLPNKSLDYFIFDTTRSKLLDWSKRS-------H 620
N+V+L E+ L+ +Y+P T ++ R+ +
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVP----------ETVYRVARHYSRAKQTLPVIY 157
Query: 621 I---IAGIARGLLYLHQDSRLRIIHRDLKASNVLLD-NTMNPKISDFGLARSFGLDQTEA 676
+ + + R L Y+H I HRD+K N+LLD +T K+ DFG A+ L + E
Sbjct: 158 VKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ--LVRGEP 212
Query: 677 NTKRVVGTYGYMSPE-------YAIDGLFSVKSDVFSFGVLVLEIICGK 718
N + Y Y +PE Y + DV+S G ++ E++ G+
Sbjct: 213 NVSYICSRY-YRAPELIFGATDY------TSSIDVWSAGCVLAELLLGQ 254
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-24
Identities = 58/205 (28%), Positives = 91/205 (44%), Gaps = 27/205 (13%)
Query: 525 LGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEE-FKNEVLLIAKLQHRNLVKLLGCC 582
LGEG +G V + + + +AVK + E K E+ + L H N+VK G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 583 TQRDERMLIYEYLPNKSL-DYFIFDTTRSKLLDWSKRSH---IIAGIARGLLYLHQDSRL 638
+ + + L EY L D + + + ++AG+ YLH +
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVV----YLH---GI 124
Query: 639 RIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPE------Y 692
I HRD+K N+LLD N KISDFGLA F + E ++ GT Y++PE +
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 693 AIDGLFSVKSDVFSFGVLVLEIICG 717
DV+S G+++ ++ G
Sbjct: 185 --HAE---PVDVWSCGIVLTAMLAG 204
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 57/229 (24%), Positives = 98/229 (42%), Gaps = 38/229 (16%)
Query: 514 NATDNFSEK----NKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGM---------EE 559
++T F E LG G V + + +E AVK + G E
Sbjct: 10 HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 560 FKNEVLLIAKL-QHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFD--TTRSKLLDWS 616
EV ++ K+ H N+++L L+++ + L FD T + L S
Sbjct: 70 TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL----FDYLTEKVTL---S 122
Query: 617 KR--SHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674
++ I+ + + LH+ L I+HRDLK N+LLD+ MN K++DFG + +
Sbjct: 123 EKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK 179
Query: 675 EANTKRVVGTYGYMSPE------YAIDGLFSVKSDVFSFGVLVLEIICG 717
+ V GT Y++PE + + D++S GV++ ++ G
Sbjct: 180 ---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-24
Identities = 50/193 (25%), Positives = 91/193 (47%), Gaps = 32/193 (16%)
Query: 517 DNFSEKNKLGEGGFGPVYKG--MLIEGQEIAVKRLSKGSGQGMEEFKN--------EVLL 566
+ ++GEG +G V+K + G+ +A+KR+ ++ + EV +
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR------VQTGEEGMPLSTIREVAV 64
Query: 567 IAKLQ---HRNLVKLLGCCTQRDER-----MLIYEYLPNKSLDYFIFDTTRSKLLDWSKR 618
+ L+ H N+V+L CT L++E++ ++ L ++ D +
Sbjct: 65 LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETI 122
Query: 619 SHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANT 678
++ + RGL +LH R++HRDLK N+L+ ++ K++DFGLAR + T
Sbjct: 123 KDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--T 177
Query: 679 KRVVGTYGYMSPE 691
VV T Y +PE
Sbjct: 178 SVVV-TLWYRAPE 189
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 7e-24
Identities = 57/212 (26%), Positives = 93/212 (43%), Gaps = 28/212 (13%)
Query: 514 NATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSK------GSGQGMEEFKNEVLL 566
N D + +LG G F V K G + A K + K G E+ + EV +
Sbjct: 8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 567 IAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFD--TTRSKLLDWSKR--SHII 622
+ ++QH N++ L + + +LI E + L FD + L ++ + +
Sbjct: 68 LKEIQHPNVITLHEVYENKTDVILILELVAGGEL----FDFLAEKESL---TEEEATEFL 120
Query: 623 AGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNP----KISDFGLARSFGLDQTEANT 678
I G+ YLH L+I H DLK N++L + P KI DFGLA
Sbjct: 121 KQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---F 174
Query: 679 KRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVL 710
K + GT +++PE +++D++S GV+
Sbjct: 175 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 206
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 54/191 (28%), Positives = 88/191 (46%), Gaps = 22/191 (11%)
Query: 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQ-GMEEFKN----EVLLIA 568
AT + ++G G +G VYK G +A+K + +G G EV L+
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 569 KLQ---HRNLVKLLGCCTQRDER-----MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSH 620
+L+ H N+V+L+ C L++E++ ++ L ++ D L
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKD 124
Query: 621 IIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKR 680
++ RGL +LH + I+HRDLK N+L+ + K++DFGLAR + T
Sbjct: 125 LMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA--LTPV 179
Query: 681 VVGTYGYMSPE 691
VV T Y +PE
Sbjct: 180 VV-TLWYRAPE 189
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 53/215 (24%), Positives = 92/215 (42%), Gaps = 29/215 (13%)
Query: 522 KNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQ-HRNLVKLL 579
++ LGEG V + + QE AVK + K G EV ++ + Q HRN+++L+
Sbjct: 18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 580 GCCTQRDERMLIYEYLPNKSLDYFIFD--TTRSKLLDWSKR--SHIIAGIARGLLYLHQD 635
+ D L++E + S+ R ++ S ++ +A L +LH
Sbjct: 78 EFFEEEDRFYLVFEKMRGGSI----LSHIHKRRHF---NELEASVVVQDVASALDFLHN- 129
Query: 636 SRLRIIHRDLKASNVLLDNTMNP---KISDFGLARSFGLDQTEANTKR-----VVGTYGY 687
I HRDLK N+L ++ KI DF L L+ + G+ Y
Sbjct: 130 --KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEY 187
Query: 688 MSPE-----YAIDGLFSVKSDVFSFGVLVLEIICG 717
M+PE ++ + D++S GV++ ++ G
Sbjct: 188 MAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-23
Identities = 54/207 (26%), Positives = 95/207 (45%), Gaps = 22/207 (10%)
Query: 513 ANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSK--GSGQGMEEFKNEVLLIAK 569
T+ + +LG+G F V + + + GQE A ++ S + ++ + E +
Sbjct: 7 TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRL 66
Query: 570 LQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFD--TTRSKLLDWSKR--SHIIAGI 625
L+H N+V+L ++ LI++ + L F+ R S+ SH I I
Sbjct: 67 LKHPNIVRLHDSISEEGHHYLIFDLVTGGEL----FEDIVAREYY---SEADASHCIQQI 119
Query: 626 ARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNP---KISDFGLARSFGLDQTEANTKRVV 682
+L+ HQ + ++HR+LK N+LL + + K++DFGLA +Q
Sbjct: 120 LEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG--FA 174
Query: 683 GTYGYMSPEYAIDGLFSVKSDVFSFGV 709
GT GY+SPE + D+++ GV
Sbjct: 175 GTPGYLSPEVLRKDPYGKPVDLWACGV 201
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 5e-23
Identities = 50/186 (26%), Positives = 88/186 (47%), Gaps = 20/186 (10%)
Query: 521 EKNKLGEGGFGPVYKGMLIE---GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVK 577
E K+G G +G VYK + ++ A+K++ +G+G M + E+ L+ +L+H N++
Sbjct: 25 EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQI-EGTGISMSACR-EIALLRELKHPNVIS 82
Query: 578 LLGCCTQRDER--MLIYEYLPN---KSLDYFIFDTTRSKL--LDWSKRSHIIAGIARGLL 630
L +R L+++Y + + + K L ++ I G+
Sbjct: 83 LQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 142
Query: 631 YLHQDSRLRIIHRDLKASNVLLDNTMNP----KISDFGLARSFGL-DQTEANTKRVVGTY 685
YLH + ++HRDLK +N+L+ KI+D G AR F + A+ VV T+
Sbjct: 143 YLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 199
Query: 686 GYMSPE 691
Y +PE
Sbjct: 200 WYRAPE 205
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 7e-23
Identities = 61/207 (29%), Positives = 97/207 (46%), Gaps = 31/207 (14%)
Query: 525 LGEGGFGPVYKGM-LIEGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGC 581
+G+G F V ++ G+E+A+K + K + +++ EV ++ L H N+VKL
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 582 CTQRDERMLIYEYLPNKSL-DYFIFDTTRSKLLDWSKRSH---IIAGIARGLLYLHQDSR 637
LI EY + DY + ++ + RS I++ + Y H +
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYLV---AHGRMKEKEARSKFRQIVSAVQ----YCH---Q 132
Query: 638 LRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPE------ 691
RI+HRDLKA N+LLD MN KI+DFG + F + G Y +PE
Sbjct: 133 KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL---DAFCGAPPYAAPELFQGKK 189
Query: 692 YAIDGLFSVKSDVFSFGVLVLEIICGK 718
Y DG + DV+S GV++ ++ G
Sbjct: 190 Y--DGP---EVDVWSLGVILYTLVSGS 211
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 1e-22
Identities = 52/216 (24%), Positives = 86/216 (39%), Gaps = 40/216 (18%)
Query: 525 LGEGGFGPVYKGM-LIEGQEIAVKRLSKGS----GQGMEEFKNEVLLIAKLQHRNLVKL- 578
LGEG +G V + + AVK L K G K E+ L+ +L+H+N+++L
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 579 --LGCCTQRDERMLIY---EYLPNKSLDYFIFD-TTRSKLLDWSKRSH---IIAGIARGL 629
L ++ +Y EY + + D + + +I G+
Sbjct: 73 DVLYNEEKQK----MYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQLIDGLE--- 123
Query: 630 LYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMS 689
YLH I+H+D+K N+LL KIS G+A + + + G+ +
Sbjct: 124 -YLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQP 179
Query: 690 PE-------YAIDGLFSVKSDVFSFGVLVLEIICGK 718
PE + G K D++S GV + I G
Sbjct: 180 PEIANGLDTF--SGF---KVDIWSAGVTLYNITTGL 210
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 1e-22
Identities = 52/217 (23%), Positives = 86/217 (39%), Gaps = 36/217 (16%)
Query: 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRN 574
TD + K +G G + + + E AVK + K EE +L+ QH N
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE---IEILLRYGQHPN 77
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYFIFD--TTRSKLLDWSKR--SHIIAGIARGLL 630
++ L ++ E + L D + S+R S ++ I + +
Sbjct: 78 IITLKDVYDDGKYVYVVTELMKGGEL----LDKILRQKFF---SEREASAVLFTITKTVE 130
Query: 631 YLHQDSRLRIIHRDLKASNVLL----DNTMNPKISDFGLARSFGLDQTEANTKRVVGTYG 686
YLH ++HRDLK SN+L N + +I DFG A+ + T T
Sbjct: 131 YLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT--PCYTAN 185
Query: 687 YMSPE------YAIDGLFSVKSDVFSFGVLVLEIICG 717
+++PE Y D++S GVL+ ++ G
Sbjct: 186 FVAPEVLERQGY------DAACDIWSLGVLLYTMLTG 216
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-22
Identities = 66/217 (30%), Positives = 98/217 (45%), Gaps = 33/217 (15%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEI-AVKRLSKG---SGQGMEEFKNEVLLIAKLQH 572
+ F + LG+GGFG V + ++ A K+L K +G NE ++ K+
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 573 RNLVKLLGCCTQRDERM-LIYEYLPNKSLDYFI-------FDTTRSKLLDWSKRSHIIAG 624
R +V L + + + L+ + L + I F R+ A
Sbjct: 244 RFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFY--------AAE 294
Query: 625 IARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
I GL LH R RI++RDLK N+LLD+ + +ISD GLA QT K VGT
Sbjct: 295 ICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGT 348
Query: 685 YGYMSPEYAIDGL---FSVKSDVFSFGVLVLEIICGK 718
GYM+PE + FS D ++ G L+ E+I G+
Sbjct: 349 VGYMAPE-VVKNERYTFSP--DWWALGCLLYEMIAGQ 382
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-22
Identities = 61/212 (28%), Positives = 93/212 (43%), Gaps = 22/212 (10%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQGMEEF---KNEVLLIAKLQH 572
++F LGEG F V + A+K L K + E ++++L H
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 573 RNLVKLLGCCTQRDERM-LIYEYLPNKSLDYFI-----FDTTRSKLLDWSKRSHIIAGIA 626
VKL Q DE++ Y N L +I FD T ++ A I
Sbjct: 90 PFFVKLYFTF-QDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY--------TAEIV 140
Query: 627 RGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYG 686
L YLH IIHRDLK N+LL+ M+ +I+DFG A+ + +A VGT
Sbjct: 141 SALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 197
Query: 687 YMSPEYAIDGLFSVKSDVFSFGVLVLEIICGK 718
Y+SPE + SD+++ G ++ +++ G
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVAGL 229
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 2e-22
Identities = 58/236 (24%), Positives = 97/236 (41%), Gaps = 27/236 (11%)
Query: 486 MYRRKKHSNQGNEKEEMELPIFDLKIIANATDNFSEK----NKLGEGGFGPVYKGMLIE- 540
+Y + S + + D I + D S+ ++LG G VY+
Sbjct: 18 LYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGT 77
Query: 541 GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSL 600
+ A+K L K + + + E+ ++ +L H N++KL E L+ E + L
Sbjct: 78 QKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGEL 135
Query: 601 DYFIFD--TTRSKLLDWSKR--SHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLL---D 653
FD + S+R + + I + YLH+ I+HRDLK N+L
Sbjct: 136 ----FDRIVEKGYY---SERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPA 185
Query: 654 NTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGV 709
KI+DFGL++ K V GT GY +PE + + D++S G+
Sbjct: 186 PDAPLKIADFGLSKIVEHQVL---MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGI 238
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 2e-22
Identities = 51/218 (23%), Positives = 88/218 (40%), Gaps = 27/218 (12%)
Query: 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSK--------GSGQGMEEFKNEVLL 566
D + LG G G V + +++A++ +SK + E+ +
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 567 IAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFD-TTRSKLLDWSKRSHIIAGI 625
+ KL H ++K+ D ++ E + L FD +K L + +
Sbjct: 194 LKKLNHPCIIKIKNFFDAED-YYIVLELMEGGEL----FDKVVGNKRLKEATCKLYFYQM 248
Query: 626 ARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNP---KISDFGLARSFGLDQTEANTKRVV 682
+ YLH+ IIHRDLK NVLL + KI+DFG ++ G + +
Sbjct: 249 LLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLC 302
Query: 683 GTYGYMSPE---YAIDGLFSVKSDVFSFGVLVLEIICG 717
GT Y++PE ++ D +S GV++ + G
Sbjct: 303 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 3e-22
Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 12/208 (5%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEI-AVKRLSKG---SGQGMEEFKNEVLLIAKLQH 572
D F + LG GGFG V+ + ++ A K+L+K +G + E ++AK+
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 573 RNLVKLLGCCTQRDERM-LIYEYLPNKSLDYFIFDTT-RSKLLDWSKRSHIIAGIARGLL 630
R +V L + + L+ + + Y I++ + + A I GL
Sbjct: 245 RFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303
Query: 631 YLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSP 690
+LHQ II+RDLK NVLLD+ N +ISD GLA QT+ GT G+M+P
Sbjct: 304 HLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG--YAGTPGFMAP 358
Query: 691 EYAIDGLFSVKSDVFSFGVLVLEIICGK 718
E + + D F+ GV + E+I +
Sbjct: 359 ELLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-22
Identities = 60/218 (27%), Positives = 97/218 (44%), Gaps = 34/218 (15%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEI-AVKRLSKG---SGQGMEEFKNE--VL-LIAK 569
++FS +G GGFG VY + ++ A+K L K QG NE +L L++
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 570 LQHRNLVKLLGCCTQRDERM-LIYEYLPNKSLDYFI-----FDTTRSKLLDWSKRSHIIA 623
+V + +++ I + + L Y + F + A
Sbjct: 249 GDCPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFY--------AA 299
Query: 624 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVG 683
I GL ++H +++RDLK +N+LLD + +ISD GLA F + A VG
Sbjct: 300 EIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVG 352
Query: 684 TYGYMSPEYAIDGL---FSVKSDVFSFGVLVLEIICGK 718
T+GYM+PE G+ S D FS G ++ +++ G
Sbjct: 353 THGYMAPEVLQKGVAYDSSA--DWFSLGCMLFKLLRGH 388
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 6e-22
Identities = 53/229 (23%), Positives = 95/229 (41%), Gaps = 25/229 (10%)
Query: 497 NEKEEMELPIFDLKIIANATDNFSEK-----NKLGEGGFGPVYKGMLIE-GQEIAVKRLS 550
+ + + + + +NF+ +LG G F V + + GQE A K L
Sbjct: 4 HHHHSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLK 63
Query: 551 K--GSGQGMEEFKNEVLLIAKLQHR-NLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDT 607
K E +E+ ++ + ++ L E +LI EY + F
Sbjct: 64 KRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEI----FSL 119
Query: 608 TRSKLLDW---SKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---TMNPKIS 661
+L + + +I I G+ YLHQ I+H DLK N+LL + + KI
Sbjct: 120 CLPELAEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIV 176
Query: 662 DFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVL 710
DFG++R G + ++GT Y++PE + +D+++ G++
Sbjct: 177 DFGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGII 222
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 7e-22
Identities = 52/224 (23%), Positives = 85/224 (37%), Gaps = 39/224 (17%)
Query: 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEE--------FKNEVLL 566
D + LG G G V + +++A+K +SK + E+ +
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 567 IAKLQHRNLVKLLGCCTQRDERMLIY---EYLPNKSLDYFIFD--TTRSKLLDWSKR--S 619
+ KL H ++K+ D Y E + L FD +L +
Sbjct: 69 LKKLNHPCIIKIKNFFDAED----YYIVLELMEGGEL----FDKVVGNKRL---KEATCK 117
Query: 620 HIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNT---MNPKISDFGLARSFGLDQTEA 676
+ + YLH IIHRDLK NVLL + KI+DFG ++ G
Sbjct: 118 LYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-- 172
Query: 677 NTKRVVGTYGYMSPE---YAIDGLFSVKSDVFSFGVLVLEIICG 717
+ + GT Y++PE ++ D +S GV++ + G
Sbjct: 173 -MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 1e-21
Identities = 57/210 (27%), Positives = 89/210 (42%), Gaps = 30/210 (14%)
Query: 525 LGEGGFGPVYKGM-LIEGQEIAVKRLSK------GSGQGMEEFKNEVLLIAKLQHR--NL 575
LG GGFG VY G+ + + +A+K + K G EV+L+ K+ +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 576 VKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQD 635
++LL + D +LI E P D F F T R L + R + + + H
Sbjct: 111 IRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCH-- 166
Query: 636 SRLRIIHRDLKASNVLLD-NTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPE--- 691
++HRD+K N+L+D N K+ DFG + GT Y PE
Sbjct: 167 -NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIR 221
Query: 692 ---YAIDGLFSVKSDVFSFGVLVLEIICGK 718
Y G + V+S G+L+ +++CG
Sbjct: 222 YHRY--HGR---SAAVWSLGILLYDMVCGD 246
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 1e-21
Identities = 45/219 (20%), Positives = 83/219 (37%), Gaps = 50/219 (22%)
Query: 525 LGEGGFGPVYKGM-LIEGQEIAVKRLSK--------GSGQGMEEFKNEVLLIAKLQHRNL 575
LG G FG V+ + + +E+ VK + K + + E+ ++++++H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 576 VKLLGCCTQRDERMLIYEYLPNKSLDYFI----------FD-TTRSKLLDWSKRSHIIAG 624
+K+ + N+ + F R LD S+I
Sbjct: 92 IKV-------------LDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQ 138
Query: 625 IARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
+ + YL IIHRD+K N+++ K+ DFG A + GT
Sbjct: 139 LVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL---FYTFCGT 192
Query: 685 YGYMSPE------YAIDGLFSVKSDVFSFGVLVLEIICG 717
Y +PE Y G + +++S GV + ++
Sbjct: 193 IEYCAPEVLMGNPY--RGP---ELEMWSLGVTLYTLVFE 226
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 5e-21
Identities = 52/205 (25%), Positives = 87/205 (42%), Gaps = 24/205 (11%)
Query: 522 KNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQ-HRNLVKLL 579
LGEG F K + + Q AVK +SK + + E+ + + H N+VKL
Sbjct: 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLH 72
Query: 580 GCCTQRDERMLIYEYLPNKSLDYFIFD--TTRSKLLDWSKR--SHIIAGIARGLLYLHQD 635
+ L+ E L L F+ + S+ S+I+ + + ++H
Sbjct: 73 EVFHDQLHTFLVMELLNGGEL----FERIKKKKHF---SETEASYIMRKLVSAVSHMHD- 124
Query: 636 SRLRIIHRDLKASNVLL---DNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEY 692
+ ++HRDLK N+L ++ + KI DFG AR D T T Y +PE
Sbjct: 125 --VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT--PCFTLHYAAPEL 180
Query: 693 AIDGLFSVKSDVFSFGVLVLEIICG 717
+ D++S GV++ ++ G
Sbjct: 181 LNQNGYDESCDLWSLGVILYTMLSG 205
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 6e-21
Identities = 58/232 (25%), Positives = 97/232 (41%), Gaps = 53/232 (22%)
Query: 525 LGEGGFGPVYKGM-LIEGQEIAVKRLSK-------------------------GSGQGME 558
+G+G +G V + A+K LSK +G
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 559 EF-KNEVLLIAKLQHRNLVKL---LGCCTQRDERMLIYEYLPNKSLDYFIFDT-TRSKLL 613
E E+ ++ KL H N+VKL L D +++E + + + T L
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPN-EDHLYMVFELVNQGPV----MEVPTLKPLS 135
Query: 614 DWSKRSH---IIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670
+ R + +I GI YLH +IIHRD+K SN+L+ + KI+DFG++ F
Sbjct: 136 EDQARFYFQDLIKGIE----YLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEF- 187
Query: 671 LDQTEANTKRVVGTYGYMSPEYAIDGLFSV----KSDVFSFGVLVLEIICGK 718
++A VGT +M+PE ++ + DV++ GV + + G+
Sbjct: 188 -KGSDALLSNTVGTPAFMAPE-SLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 7e-21
Identities = 56/235 (23%), Positives = 92/235 (39%), Gaps = 55/235 (23%)
Query: 514 NATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKN----EVLLIA 568
D F + G+G FG V G G +A+K++ + F+N + +A
Sbjct: 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-----RFRNRELQIMQDLA 74
Query: 569 KLQHRNLVKLLGCCTQRDER-------MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRS-- 619
L H N+V+L ER ++ EY+P T + R
Sbjct: 75 VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP----------DTLHRCCRNYYRRQV 124
Query: 620 -----HI---IAGIARGLLYLHQDSRLRIIHRDLKASNVLLD-NTMNPKISDFGLARSFG 670
I + + R + LH S + + HRD+K NVL++ K+ DFG A+
Sbjct: 125 APPPILIKVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKK-- 181
Query: 671 LDQTEANTKRVVGTYGYMSPE-------YAIDGLFSVKSDVFSFGVLVLEIICGK 718
L +E N + Y Y +PE Y + D++S G + E++ G+
Sbjct: 182 LSPSEPNVAYICSRY-YRAPELIFGNQHY------TTAVDIWSVGCIFAEMMLGE 229
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 1e-20
Identities = 49/206 (23%), Positives = 88/206 (42%), Gaps = 22/206 (10%)
Query: 525 LGEGGFGPVYKGM-LIEGQEIAVKRLSK------GSGQGMEEFKNEV----LLIAKLQHR 573
LG+GGFG V+ G L + ++A+K + + EV + A H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 574 NLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLH 633
+++LL ++ ML+ E P + D F + T + L + R + + + H
Sbjct: 99 GVIRLLDWFETQEGFMLVLER-PLPAQDLFDYITEKGPLGEGPSR-CFFGQVVAAIQHCH 156
Query: 634 QDSRLRIIHRDLKASNVLLD-NTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEY 692
++HRD+K N+L+D K+ DFG + GT Y PE+
Sbjct: 157 ---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALL----HDEPYTDFDGTRVYSPPEW 209
Query: 693 AIDGLFS-VKSDVFSFGVLVLEIICG 717
+ + + V+S G+L+ +++CG
Sbjct: 210 ISRHQYHALPATVWSLGILLYDMVCG 235
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 1e-19
Identities = 47/214 (21%), Positives = 83/214 (38%), Gaps = 40/214 (18%)
Query: 522 KNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEV-LLIAKLQHRNLVKLL 579
K LG G G V + GQ+ A+K L + + EV ++V +L
Sbjct: 34 KQVLGLGVNGKVLECFHRRTGQKCALKLLYD-----SPKARQEVDHHWQASGGPHIVCIL 88
Query: 580 GCCTQRDERMLIYEYLPNKSLDYFI----------FDTTRSKLLDW-SKR--SHIIAGIA 626
+YE + + I F + + ++R + I+ I
Sbjct: 89 D----------VYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIG 138
Query: 627 RGLLYLHQDSRLRIIHRDLKASNVLL---DNTMNPKISDFGLARSFGLDQTEANTKRVVG 683
+ +LH I HRD+K N+L + K++DFG A+ T+ +
Sbjct: 139 TAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET----TQNALQTPCY 191
Query: 684 TYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICG 717
T Y++PE + D++S GV++ ++CG
Sbjct: 192 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 225
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 1e-19
Identities = 59/211 (27%), Positives = 97/211 (45%), Gaps = 38/211 (18%)
Query: 525 LGEGGFGPVYKGM-LIEGQEIAVKRLSK---GSGQGMEEFKNEVLLIAKLQHRNLVKLLG 580
LG G FG V G + G ++AVK L++ S + + K E+ + +H +++KL
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 581 CCTQRDERMLIYEYLPNKSL-DYFIFDTTRSKLLDWSKRSH---IIAGIARGLLYLHQDS 636
+ + ++ EY+ L DY ++ + R I++ + Y H
Sbjct: 79 VISTPTDFFMVMEYVSGGELFDYIC---KHGRVEEMEARRLFQQILSAVD----YCH--- 128
Query: 637 RLRIIHRDLKASNVLLDNTMNPKISDFGLARSF---GLDQTEANTKRVVGTYGYMSPE-- 691
R ++HRDLK NVLLD MN KI+DFGL+ +T G+ Y +PE
Sbjct: 129 RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT------SCGSPNYAAPEVI 182
Query: 692 ----YAIDGLFSVKSDVFSFGVLVLEIICGK 718
Y G + D++S GV++ ++CG
Sbjct: 183 SGRLY--AGP---EVDIWSCGVILYALLCGT 208
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 3e-19
Identities = 57/253 (22%), Positives = 96/253 (37%), Gaps = 65/253 (25%)
Query: 514 NATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKN-EVLLIAKLQ 571
++ +S LG G FG V + IE G+ A+K++ + +KN E+ ++ L
Sbjct: 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP-----RYKNRELDIMKVLD 58
Query: 572 HRNLVKLLGCCTQRDERMLIYEYLPNKSLD-------------------------YFIF- 605
H N++KL+ + P+ I
Sbjct: 59 HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIME 118
Query: 606 --DTTRSKLLDWSKRS-------HI---IAGIARGLLYLHQDSRLRIIHRDLKASNVLLD 653
T K+L RS I I + R + ++H L I HRD+K N+L++
Sbjct: 119 YVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVN 175
Query: 654 -NTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPE-------YAIDGLFSVKSDVF 705
K+ DFG A+ L +E + + + Y +PE Y + D++
Sbjct: 176 SKDNTLKLCDFGSAK--KLIPSEPSVAYICSRF-YRAPELMLGATEY------TPSIDLW 226
Query: 706 SFGVLVLEIICGK 718
S G + E+I GK
Sbjct: 227 SIGCVFGELILGK 239
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 6e-19
Identities = 55/208 (26%), Positives = 90/208 (43%), Gaps = 36/208 (17%)
Query: 525 LGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEE-FKNEVLLIAKLQHRNLVKLLGCC 582
+G G FG + + +AVK + +G ++E + E++ L+H N+V+
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERG--AAIDENVQREIINHRSLRHPNIVRFKEVI 85
Query: 583 TQRDERMLIYEYLPNKSLDYFIFD--TTRSKLLDWSKRS---HIIAGIARGLLYLHQDSR 637
+I EY L ++ + + R +++G++ Y H
Sbjct: 86 LTPTHLAIIMEYASGGEL----YERICNAGRFSEDEARFFFQQLLSGVS----YCH---S 134
Query: 638 LRIIHRDLKASNVLLD--NTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPE---- 691
++I HRDLK N LLD KI DFG ++S L K VGT Y++PE
Sbjct: 135 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLR 191
Query: 692 --YAIDGLFSVKSDVFSFGVLVLEIICG 717
Y DG +DV+S GV + ++ G
Sbjct: 192 QEY--DGK---IADVWSCGVTLYVMLVG 214
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 9e-19
Identities = 63/217 (29%), Positives = 99/217 (45%), Gaps = 32/217 (14%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQGMEEFKN---EVLLIAKLQH 572
D+F +G+G FG V + +++ A+K ++K E +N E+ ++ L+H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 573 RNLVKLLGCCTQRDERM-LIYEYLPNKSLDYFI-----FDTTRSKLLDWSKRSHIIAGIA 626
LV L Q +E M ++ + L L Y + F KL I +
Sbjct: 75 PFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLF--------ICELV 125
Query: 627 RGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYG 686
L YL RIIHRD+K N+LLD + I+DF +A +T+ T + GT
Sbjct: 126 MALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAML-PRETQITT--MAGTKP 179
Query: 687 YMSPE--YAIDGL---FSVKSDVFSFGVLVLEIICGK 718
YM+PE + G F+V D +S GV E++ G+
Sbjct: 180 YMAPEMFSSRKGAGYSFAV--DWWSLGVTAYELLRGR 214
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 1e-18
Identities = 56/217 (25%), Positives = 93/217 (42%), Gaps = 51/217 (23%)
Query: 525 LGEGGFGPVYKGM-LIEGQEIAVKRLSKG--SGQGMEE-FKNEVLLIAKLQHRNLVKLLG 580
LGEG FG V Q++A+K +S+ M + E+ + L+H +++KL
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL-- 74
Query: 581 CCTQRDERMLIYEYLPNKSLDYFI--------FD--TTRSKLLDWSKRSH---IIAGIAR 627
Y+ + + + FD + ++ + R II I
Sbjct: 75 -----------YDVITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIE- 122
Query: 628 GLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGY 687
Y H R +I+HRDLK N+LLD+ +N KI+DFGL+ T G+ Y
Sbjct: 123 ---YCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF-LKT--SCGSPNY 173
Query: 688 MSPE------YAIDGLFSVKSDVFSFGVLVLEIICGK 718
+PE Y G + DV+S G+++ ++ G+
Sbjct: 174 AAPEVINGKLY--AGP---EVDVWSCGIVLYVMLVGR 205
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 1e-18
Identities = 51/243 (20%), Positives = 89/243 (36%), Gaps = 29/243 (11%)
Query: 488 RRKKHSNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAV 546
+ + +K A D LG G G V + ++ A+
Sbjct: 33 AQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFAL 92
Query: 547 KRLSKGSGQGMEEFKNEV-LLIAKLQHRNLVKLLGCC-TQRDERMLIY---EYLPNKSLD 601
K L + + EV L Q ++V+++ R + E L L
Sbjct: 93 KMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGEL- 146
Query: 602 YFIFDTTRSKLLDW-SKR--SHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNP 658
F + + ++R S I+ I + YLH + I HRD+K N+L + P
Sbjct: 147 ---FSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSK-RP 199
Query: 659 ----KISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 714
K++DFG A+ + T Y++PE + D++S GV++ +
Sbjct: 200 NAILKLTDFGFAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYIL 256
Query: 715 ICG 717
+CG
Sbjct: 257 LCG 259
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 2e-18
Identities = 51/217 (23%), Positives = 93/217 (42%), Gaps = 21/217 (9%)
Query: 509 LKIIANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLI 567
+ D++ KLG G + V++ + I +++ VK L ++ K E+ ++
Sbjct: 28 HVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKIL 84
Query: 568 AKLQ-HRNLVKLLGCCTQRDERM--LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAG 624
L+ N++ L R L++E++ N L D+ R +
Sbjct: 85 ENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRF-YMYE 138
Query: 625 IARGLLYLHQDSRLRIIHRDLKASNVLLD-NTMNPKISDFGLARSFGLDQTEANTKRVVG 683
I + L Y H S I+HRD+K NV++D ++ D+GLA + + RV
Sbjct: 139 ILKALDYCH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY--HPGQEYNVRVAS 193
Query: 684 TYGYMSPEYAIDGLFSVKS-DVFSFGVLVLEIICGKK 719
Y + PE +D S D++S G ++ +I K+
Sbjct: 194 RY-FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 229
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 2e-18
Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 32/208 (15%)
Query: 525 LGEGGFGPVYKGM-LIEGQEIAVKRLSK---GSGQGMEEFKNEVLLIAKLQHRNLVKLLG 580
LG G FG V G + G ++AVK L++ S + + + E+ + +H +++KL
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 581 CCTQRDERMLIYEYLPNKSL-DYFIFDTTRSKLLDWSKRSH---IIAGIARGLLYLHQDS 636
+ + ++ EY+ L DY +L + R I++G+ Y H
Sbjct: 84 VISTPSDIFMVMEYVSGGELFDYIC---KNGRLDEKESRRLFQQILSGVD----YCH--- 133
Query: 637 RLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPE----- 691
R ++HRDLK NVLLD MN KI+DFGL+ + + G+ Y +PE
Sbjct: 134 RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---LRTSCGSPNYAAPEVISGR 190
Query: 692 -YAIDGLFSVKSDVFSFGVLVLEIICGK 718
Y G + D++S GV++ ++CG
Sbjct: 191 LY--AGP---EVDIWSSGVILYALLCGT 213
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 85.8 bits (212), Expect = 4e-18
Identities = 35/91 (38%), Positives = 51/91 (56%), Gaps = 3/91 (3%)
Query: 625 IARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
+A+G+ +L + + IHRDL A N+LL KI DFGLAR D
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 685 YGYMSPEYAIDGLFSVKSDVFSFGVLVLEII 715
+M+PE D +++++SDV+SFGVL+ EI
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 289
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 68.8 bits (168), Expect = 2e-12
Identities = 36/162 (22%), Positives = 63/162 (38%), Gaps = 19/162 (11%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLI------EGQEIAVKRLSKGSGQG-MEEFKNEVLLIAK 569
D LG G FG V + + +AVK L +G+ +E+ ++
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81
Query: 570 L-QHRNLVKLLGCCTQRDER-MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIAR 627
+ H N+V LLG CT+ M+I E+ +L ++ SKR+ + +
Sbjct: 82 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----------RSKRNEFVPYKTK 131
Query: 628 GLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669
G + + I DLK + ++ + S F +S
Sbjct: 132 GARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSL 173
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 2e-17
Identities = 48/219 (21%), Positives = 87/219 (39%), Gaps = 31/219 (14%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEI-AVKRLSKG---SGQGMEEFKNEVLLIAKLQH 572
D+F +G G F V + + ++ A+K ++K + F+ E ++
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120
Query: 573 RNLVKLLGCCTQRDERM-LIYEYLPNKSLDYFI------FDTTRSKLLDWSKRSHIIAGI 625
R + +L Q + + L+ EY L + ++ +A I
Sbjct: 121 RWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFY--------LAEI 171
Query: 626 ARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTY 685
+ +H+ L +HRD+K N+LLD + +++DFG D T + VGT
Sbjct: 172 VMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT-VRSLVAVGTP 227
Query: 686 GYMSPE-------YAIDGLFSVKSDVFSFGVLVLEIICG 717
Y+SPE G + + D ++ GV E+ G
Sbjct: 228 DYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYG 266
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 3e-17
Identities = 50/217 (23%), Positives = 88/217 (40%), Gaps = 29/217 (13%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQGMEE---FKNEVLLIAKLQH 572
++F +G G FG V L ++ A+K L+K E F+ E ++
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 573 RNLVKLLGCCTQRDERM-LIYEYLPNKSLDYFI------FDTTRSKLLDWSKRSHIIAGI 625
+ + L Q D + L+ +Y L + ++ +A +
Sbjct: 134 KWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFY--------LAEM 184
Query: 626 ARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTY 685
+ +HQ L +HRD+K N+L+D + +++DFG D T + VGT
Sbjct: 185 VIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-VQSSVAVGTP 240
Query: 686 GYMSPE-----YAIDGLFSVKSDVFSFGVLVLEIICG 717
Y+SPE G + + D +S GV + E++ G
Sbjct: 241 DYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYG 277
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 50/231 (21%), Positives = 91/231 (39%), Gaps = 46/231 (19%)
Query: 516 TDNFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKN---------EVL 565
+ + LG GG G V+ + + +A+K++ + E+
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIV---------LTDPQSVKHALREIK 60
Query: 566 LIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLD-YFIFD--------TTRSKLLDWS 616
+I +L H N+VK+ ++ + Y + + L
Sbjct: 61 IIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEE 120
Query: 617 KRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMN--PKISDFGLARSFGLDQT 674
+ + RGL Y+H + ++HRDLK +N+ + NT + KI DFGLAR +
Sbjct: 121 HARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFI-NTEDLVLKIGDFGLARIMDPHYS 176
Query: 675 EAN--TKRVVGTYGYMSPEYAIDGLFSVKS-----DVFSFGVLVLEIICGK 718
++ +V T Y SP L S + D+++ G + E++ GK
Sbjct: 177 HKGHLSEGLV-TKWYRSPRL----LLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 2e-16
Identities = 56/204 (27%), Positives = 86/204 (42%), Gaps = 23/204 (11%)
Query: 525 LGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQGMEEF---KNEVLLIAKLQHRNLVKLLG 580
LG+G FG V A+K L K +E E ++ +H L L
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK- 214
Query: 581 CCTQRDERM-LIYEYLPNKSLDYFI-----FDTTRSKLLDWSKRSHIIAGIARGLLYLHQ 634
Q +R+ + EY L + + F R++ A I L YLH
Sbjct: 215 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFY--------GAEIVSALDYLH- 265
Query: 635 DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAI 694
S +++RDLK N++LD + KI+DFGL + D T GT Y++PE
Sbjct: 266 -SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYLAPEVLE 322
Query: 695 DGLFSVKSDVFSFGVLVLEIICGK 718
D + D + GV++ E++CG+
Sbjct: 323 DNDYGRAVDWWGLGVVMYEMMCGR 346
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 81.4 bits (201), Expect = 3e-16
Identities = 42/222 (18%), Positives = 92/222 (41%), Gaps = 35/222 (15%)
Query: 487 YRRKKHSNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGM-LIEGQEIA 545
R++ HS++ + + D + ++ +G G +G V + +E + +A
Sbjct: 29 QRKQHHSSKPTASMPRPHSDWQI------PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVA 82
Query: 546 VKRLSKGSGQGMEEFKN---------EVLLIAKLQHRNLVKLLGCCTQRDERM-----LI 591
+K++ + F++ E+ ++ +L H ++VK+L +D ++
Sbjct: 83 IKKILR-------VFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVV 135
Query: 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVL 651
E T L + ++ ++ + G+ Y+H S I+HRDLK +N L
Sbjct: 136 LEIAD-SDFKKLF--RTPVYLTELHIKT-LLYNLLVGVKYVH--SA-GILHRDLKPANCL 188
Query: 652 LDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYA 693
++ + K+ DFGLAR+ + + + M+
Sbjct: 189 VNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTF 230
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 4e-16
Identities = 55/241 (22%), Positives = 99/241 (41%), Gaps = 26/241 (10%)
Query: 490 KKHSNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEI-AVKR 548
+K+ N N + I ++ + +++ +G G FG V +++ A+K
Sbjct: 42 RKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKL 101
Query: 549 LSKGSGQGMEE---FKNEVLLIAKLQHRNLVKLLGCCTQRDERM-LIYEYLPN----KSL 600
LSK + F E ++A +V+L Q D + ++ EY+P +
Sbjct: 102 LSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLM 160
Query: 601 DYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKI 660
+ ++ A + L +H + IHRD+K N+LLD + + K+
Sbjct: 161 SNYDVPEKWARFY--------TAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKL 209
Query: 661 SDFGLARSFGLDQTEANTKRVVGTYGYMSPE----YAIDGLFSVKSDVFSFGVLVLEIIC 716
+DFG + VGT Y+SPE DG + + D +S GV + E++
Sbjct: 210 ADFGTCMKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV 268
Query: 717 G 717
G
Sbjct: 269 G 269
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 4e-16
Identities = 57/226 (25%), Positives = 99/226 (43%), Gaps = 49/226 (21%)
Query: 516 TDNFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKN---------EVL 565
+ +G G G V I + +A+K+LS+ F+N E++
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-------PFQNQTHAKRAYRELV 76
Query: 566 LIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLD-----YFIFD--------TTRSKL 612
L+ + H+N++ LL + P KSL+ Y + + + +L
Sbjct: 77 LMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMEL 124
Query: 613 LDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672
+ S+++ + G+ +LH IIHRDLK SN+++ + KI DFGLAR+
Sbjct: 125 DH-ERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AG 178
Query: 673 QTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGK 718
+ T VV T Y +PE + + D++S G ++ E+I G
Sbjct: 179 TSFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 9e-16
Identities = 54/227 (23%), Positives = 96/227 (42%), Gaps = 52/227 (22%)
Query: 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKN---------EVL 565
+ +G G +G V + G+++A+K+LS+ F++ E+L
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR-------PFQSEIFAKRAYRELL 75
Query: 566 LIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLD-----YFIFD--------TTRSKL 612
L+ +QH N++ LL + P SL Y + K
Sbjct: 76 LLKHMQHENVIGLLDV------------FTPASSLRNFYDFYLVMPFMQTDLQKIMGLKF 123
Query: 613 LDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672
+ K +++ + +GL Y+H ++HRDLK N+ ++ KI DFGLAR +
Sbjct: 124 SE-EKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAE 179
Query: 673 QTEANTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGK 718
T V T Y +PE + ++ D++S G ++ E++ GK
Sbjct: 180 MTG-----YVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 1e-15
Identities = 56/225 (24%), Positives = 100/225 (44%), Gaps = 47/225 (20%)
Query: 516 TDNFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKN---------EVL 565
+ +G G G V + + +A+K+LS+ F+N E++
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-------PFQNQTHAKRAYRELV 113
Query: 566 LIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLD-----YFIFDTTRSKL-------L 613
L+ + H+N++ LL + P K+L+ Y + + + L L
Sbjct: 114 LMKCVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMEL 161
Query: 614 DWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673
D + S+++ + G+ +LH IIHRDLK SN+++ + KI DFGLAR+
Sbjct: 162 DHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART--AGT 216
Query: 674 TEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGK 718
+ T VV T Y +PE + + D++S G ++ E++ K
Sbjct: 217 SFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 54/204 (26%), Positives = 85/204 (41%), Gaps = 24/204 (11%)
Query: 525 LGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQGMEEF---KNEVLLIAKLQHRNLVKLLG 580
LG+G FG V A+K L K +E E ++ +H L L
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK- 71
Query: 581 CCTQRDERM-LIYEYLPNKSLDYFI-----FDTTRSKLLDWSKRSHIIAGIARGLLYLHQ 634
Q +R+ + EY L + + F R++ A I L YLH
Sbjct: 72 YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFY--------GAEIVSALEYLHS 123
Query: 635 DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAI 694
+++RD+K N++LD + KI+DFGL + D T GT Y++PE
Sbjct: 124 ---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAPEVLE 178
Query: 695 DGLFSVKSDVFSFGVLVLEIICGK 718
D + D + GV++ E++CG+
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 3e-15
Identities = 53/231 (22%), Positives = 96/231 (41%), Gaps = 59/231 (25%)
Query: 516 TDNFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKN---------EVL 565
+ + +G G +G V + G ++A+K+L + F++ E+
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR-------PFQSELFAKRAYRELR 76
Query: 566 LIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLD-----YFIFD--------TTRSKL 612
L+ ++H N++ LL + P+++LD Y + + +
Sbjct: 77 LLKHMRHENVIGLLDV------------FTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK 124
Query: 613 LDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672
L + ++ + +GL Y+H IIHRDLK N+ ++ KI DFGLAR +
Sbjct: 125 LGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSE 181
Query: 673 QTEANTKRVVGTYGYMSPEYAIDGLFSVKS-----DVFSFGVLVLEIICGK 718
T V T Y +PE + + D++S G ++ E+I GK
Sbjct: 182 MTGY-----VVTRWYRAPEV----ILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 3e-15
Identities = 50/226 (22%), Positives = 85/226 (37%), Gaps = 38/226 (16%)
Query: 516 TDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEE--FKN---------EV 564
++ + + G +G V G+ EG +A+KR+ G + E+
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 565 LLIAKLQHRNLVKLLGCCTQRDERM-----LIYEYLPNKSLDYFIFDTTRSKLLDWSKRS 619
L+ H N++ L +E L+ E + L I + ++
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVI--HDQRIVISPQHIQ 137
Query: 620 HIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ--TEAN 677
+ + I GL LH+ ++HRDL N+LL + + I DF LAR D T
Sbjct: 138 YFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADANKTH-- 192
Query: 678 TKRVVGTYGYMSPEYAIDGLFSVKS-----DVFSFGVLVLEIICGK 718
V Y +PE + K D++S G ++ E+ K
Sbjct: 193 ---YVTHRWYRAPEL----VMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 76.4 bits (189), Expect = 4e-15
Identities = 61/209 (29%), Positives = 101/209 (48%), Gaps = 32/209 (15%)
Query: 525 LGEGGFGPVY---KGMLIEGQEI-AVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKL 578
LG+G FG V+ K + +++ A+K L K + + K E ++ ++ H +VKL
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 579 LGCCTQRDERM-LIYEYLPNKSLDYFI-----FDTTRSKLLDWSKRSHIIAGIARGLLYL 632
Q + ++ LI ++L L + F K +A +A L +L
Sbjct: 92 H-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFY--------LAELALALDHL 142
Query: 633 HQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEY 692
H L II+RDLK N+LLD + K++DFGL++ + +A + GT YM+PE
Sbjct: 143 HS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMAPE- 196
Query: 693 AIDGL---FSVKSDVFSFGVLVLEIICGK 718
++ S D +SFGVL+ E++ G
Sbjct: 197 VVNRRGHTQSA--DWWSFGVLMFEMLTGT 223
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 5e-15
Identities = 51/225 (22%), Positives = 98/225 (43%), Gaps = 43/225 (19%)
Query: 516 TDNFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKN---------EVL 565
++ + +GEG +G V + +A+K++S F++ E+
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--------FEHQTYCQRTLREIK 77
Query: 566 LIAKLQHRNLVKLLGCCTQRDERM-----LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSH 620
++ + +H N++ + ++ + + L + +++ L +
Sbjct: 78 ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLL----KTQHLSNDHICY 132
Query: 621 IIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEAN--T 678
+ I RGL Y+H S ++HRDLK SN+LL+ T + KI DFGLAR D T
Sbjct: 133 FLYQILRGLKYIH--SA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 189
Query: 679 KRVVGTYGYMSPEYAIDGLFSVKS-----DVFSFGVLVLEIICGK 718
+ V T Y +PE + + K D++S G ++ E++ +
Sbjct: 190 EYVA-TRWYRAPEI----MLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 6e-15
Identities = 57/227 (25%), Positives = 98/227 (43%), Gaps = 51/227 (22%)
Query: 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKN---------EVL 565
+ + + +G G +G V + G +AVK+LS+ F++ E+
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-------PFQSIIHAKRTYRELR 80
Query: 566 LIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLD-----YFIFD--------TTRSKL 612
L+ ++H N++ LL + P +SL+ Y + + +
Sbjct: 81 LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 128
Query: 613 LDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672
L +I I RGL Y+H IIHRDLK SN+ ++ KI DFGLAR +
Sbjct: 129 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADE 185
Query: 673 QTEANTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGK 718
T V T Y +PE ++ ++ D++S G ++ E++ G+
Sbjct: 186 MTGY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 7e-15
Identities = 51/211 (24%), Positives = 88/211 (41%), Gaps = 27/211 (12%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQGMEEF---KNEVLLIAKLQH 572
D F LG G FG V E A+K L K +++ NE ++ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 573 RNLVKLLGCCTQRDERM-LIYEYLPNKSLDYFI-----FDTTRSKLLDWSKRSHIIAGIA 626
LVKL + + + ++ EY+ + + F ++ A I
Sbjct: 101 PFLVKLEFSF-KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF--------YAAQIV 151
Query: 627 RGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYG 686
YLH L +I+RDLK N+L+D +++DFG A+ + + T + GT
Sbjct: 152 LTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPE 203
Query: 687 YMSPEYAIDGLFSVKSDVFSFGVLVLEIICG 717
++PE + ++ D ++ GVL+ E+ G
Sbjct: 204 ALAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 8e-15
Identities = 63/205 (30%), Positives = 96/205 (46%), Gaps = 27/205 (13%)
Query: 525 LGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQGMEEFK-----NEVLLIAKLQHRNLVKL 578
LG+G FG V+ + + A+K L K ++ + VL +A +H L +
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA-WEHPFLTHM 83
Query: 579 LGCCTQRDERM-LIYEYLPNKSLDYFI-----FDTTRSKLLDWSKRSHIIAGIARGLLYL 632
C Q E + + EYL L Y I FD +R+ A I GL +L
Sbjct: 84 F-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATF--------YAAEIILGLQFL 134
Query: 633 HQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEY 692
H I++RDLK N+LLD + KI+DFG+ + L + NT GT Y++PE
Sbjct: 135 HS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPEI 189
Query: 693 AIDGLFSVKSDVFSFGVLVLEIICG 717
+ ++ D +SFGVL+ E++ G
Sbjct: 190 LLGQKYNHSVDWWSFGVLLYEMLIG 214
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 9e-15
Identities = 58/209 (27%), Positives = 93/209 (44%), Gaps = 33/209 (15%)
Query: 525 LGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQGMEEF---KNE--VLLIAKLQHRNLVKL 578
+G G + V L + I A+K + K E+ + E V A H LV L
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQA-SNHPFLVGL 75
Query: 579 LGCCTQRDERM-LIYEYLPNKSLDYFI-----FDTTRSKLLDWSKRSHIIAGIARGLLYL 632
C Q + R+ + EY+ L + + ++ A I+ L YL
Sbjct: 76 H-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFY--------SAEISLALNYL 126
Query: 633 HQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEY 692
H+ II+RDLK NVLLD+ + K++D+G+ + +T GT Y++PE
Sbjct: 127 HE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGTPNYIAPE- 180
Query: 693 AIDGL---FSVKSDVFSFGVLVLEIICGK 718
+ G FSV D ++ GVL+ E++ G+
Sbjct: 181 ILRGEDYGFSV--DWWALGVLMFEMMAGR 207
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 1e-14
Identities = 53/206 (25%), Positives = 89/206 (43%), Gaps = 27/206 (13%)
Query: 525 LGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQGMEEF---KNE--VLLIAKLQHRNLVKL 578
+G G + V L + I A++ + K E+ + E V A H LV L
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQA-SNHPFLVGL 118
Query: 579 LGCCTQRDERM-LIYEYLPNKSLDYFI-----FDTTRSKLLDWSKRSHIIAGIARGLLYL 632
C Q + R+ + EY+ L + + ++ A I+ L YL
Sbjct: 119 H-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFY--------SAEISLALNYL 169
Query: 633 HQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEY 692
H+ II+RDLK NVLLD+ + K++D+G+ + +T GT Y++PE
Sbjct: 170 HE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGTPNYIAPEI 224
Query: 693 AIDGLFSVKSDVFSFGVLVLEIICGK 718
+ D ++ GVL+ E++ G+
Sbjct: 225 LRGEDYGFSVDWWALGVLMFEMMAGR 250
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 1e-14
Identities = 61/206 (29%), Positives = 99/206 (48%), Gaps = 27/206 (13%)
Query: 525 LGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQGMEEFK-----NEVLLIAKLQHRNLVKL 578
LG+G FG V + E ++ AVK L K ++ + +L +A+ H L +L
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-NHPFLTQL 89
Query: 579 LGCCTQRDERM-LIYEYLPNKSLDYFI-----FDTTRSKLLDWSKRSHIIAGIARGLLYL 632
CC Q +R+ + E++ L + I FD R++ A I L++L
Sbjct: 90 F-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF--------YAAEIISALMFL 140
Query: 633 HQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEY 692
H II+RDLK NVLLD+ + K++DFG+ + + T GT Y++PE
Sbjct: 141 HD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT--FCGTPDYIAPEI 195
Query: 693 AIDGLFSVKSDVFSFGVLVLEIICGK 718
+ L+ D ++ GVL+ E++CG
Sbjct: 196 LQEMLYGPAVDWWAMGVLLYEMLCGH 221
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 1e-14
Identities = 61/206 (29%), Positives = 90/206 (43%), Gaps = 27/206 (13%)
Query: 525 LGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQGMEEF---KNE--VLLIAKLQHRNLVKL 578
LG+G FG V E+ AVK L K ++ E VL + + L +L
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG-KPPFLTQL 86
Query: 579 LGCCTQRDERM-LIYEYLPNKSLDYFI-----FDTTRSKLLDWSKRSHIIAGIARGLLYL 632
C Q +R+ + EY+ L Y I F + A IA GL +L
Sbjct: 87 H-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVF--------YAAEIAIGLFFL 137
Query: 633 HQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEY 692
II+RDLK NV+LD+ + KI+DFG+ + D T GT Y++PE
Sbjct: 138 QS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT--FCGTPDYIAPEI 192
Query: 693 AIDGLFSVKSDVFSFGVLVLEIICGK 718
+ D ++FGVL+ E++ G+
Sbjct: 193 IAYQPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 1e-14
Identities = 29/285 (10%), Positives = 76/285 (26%), Gaps = 51/285 (17%)
Query: 524 KLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSG---QGMEEFKNEVLLIAKLQHRNLVKLL 579
G ++ + +++A+ + ++E + L ++++ + ++L
Sbjct: 38 FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97
Query: 580 GCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLR 639
R +++ E++ SL + + + +A H R
Sbjct: 98 DVVHTRAGGLVVAEWIRGGSLQ----EVADTSP-SPVGAIRAMQSLAAAADAAH---RAG 149
Query: 640 IIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFS 699
+ S V +S G V+ M +
Sbjct: 150 VALSIDHPSRVR--------VSIDGDV--------------VLAYPATMPDA-------N 180
Query: 700 VKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDNSCSF 759
+ D+ G + ++ + A L + ID+ +
Sbjct: 181 PQDDIRGIGASLYALLVNR--WPLPEAGVRSGLAPAERDTAGQPIEPADIDRDI------ 232
Query: 760 SEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPQQPGF 804
+ + + Q R + + LM + + G
Sbjct: 233 PFQISAVAARSV--QGDGGIRSASTLLNLMQQATAVADRTEVLGP 275
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 2e-14
Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 28/208 (13%)
Query: 525 LGEGGFGPVY---KGMLIEGQEI-AVKRLSKGS----GQGMEEFKNEVLLIAKLQHRNLV 576
LG+GG+G V+ K +I A+K L K + K E ++ +++H +V
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 577 KLLGCCTQRDERM-LIYEYLPNKSLDYFI-----FDTTRSKLLDWSKRSHIIAGIARGLL 630
L+ Q ++ LI EYL L + F + +A I+ L
Sbjct: 85 DLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFY--------LAEISMALG 135
Query: 631 YLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSP 690
+LHQ II+RDLK N++L++ + K++DFGL + D T +T GT YM+P
Sbjct: 136 HLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT--FCGTIEYMAP 190
Query: 691 EYAIDGLFSVKSDVFSFGVLVLEIICGK 718
E + + D +S G L+ +++ G
Sbjct: 191 EILMRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 76.2 bits (187), Expect = 2e-14
Identities = 65/217 (29%), Positives = 95/217 (43%), Gaps = 33/217 (15%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE----GQEIAVKRLSKG---SGQGMEEFKNE--VLLI 567
+F+ LG+G FG V ML E + AVK L K +E E VL +
Sbjct: 341 TDFNFLMVLGKGSFGKV---MLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLAL 397
Query: 568 AKLQHRNLVKLLGCCTQRDERM-LIYEYLPNKSLDYFI-----FDTTRSKLLDWSKRSHI 621
+ L +L C Q +R+ + EY+ L Y I F +
Sbjct: 398 P-GKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFY-------- 447
Query: 622 IAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRV 681
A IA GL +L II+RDLK NV+LD+ + KI+DFG+ + D T
Sbjct: 448 AAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT--F 502
Query: 682 VGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGK 718
GT Y++PE + D ++FGVL+ E++ G+
Sbjct: 503 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 74.1 bits (183), Expect = 2e-14
Identities = 56/214 (26%), Positives = 95/214 (44%), Gaps = 33/214 (15%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQGMEEF---KNEVLLIAKLQH 572
+F LG G FG V+ A+K L K +++ +E L+++ + H
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 573 RNLVKLLGCCTQRDERM-LIYEYLPNKSLDYFI-----FDTTRSKLLDWSKRSHIIAGIA 626
++++ G Q +++ +I +Y+ L + F +K A +
Sbjct: 66 PFIIRMWGTF-QDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFY--------AAEVC 116
Query: 627 RGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYG 686
L YLH II+RDLK N+LLD + KI+DFG A+ T + GT
Sbjct: 117 LALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTPD 168
Query: 687 YMSPEYAIDGL---FSVKSDVFSFGVLVLEIICG 717
Y++PE + S+ D +SFG+L+ E++ G
Sbjct: 169 YIAPE-VVSTKPYNKSI--DWWSFGILIYEMLAG 199
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 40/180 (22%), Positives = 65/180 (36%), Gaps = 36/180 (20%)
Query: 505 PIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNE 563
+K A D LG G G V + ++ A+K L + + E
Sbjct: 6 SGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARRE 60
Query: 564 V-LLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFI----------FDTTRSKL 612
V L Q ++V+++ +YE L I F + +
Sbjct: 61 VELHWRASQCPHIVRIVD----------VYENLYAGRKCLLIVMECLDGGELFSRIQDRG 110
Query: 613 LDW-SKR--SHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNT---MNPKISDFGLA 666
++R S I+ I + YLH + I HRD+K N+L + K++DFG A
Sbjct: 111 DQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 4e-14
Identities = 57/209 (27%), Positives = 93/209 (44%), Gaps = 33/209 (15%)
Query: 525 LGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQGMEEF---KNE--VLLIAKLQHRNLVKL 578
+G+G FG V + AVK L K + +E +E VLL ++H LV L
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKN-VKHPFLVGL 104
Query: 579 LGCCTQRDERM-LIYEYLPNKSLDYFI-----FDTTRSKLLDWSKRSHIIAGIARGLLYL 632
Q +++ + +Y+ L Y + F R++ A IA L YL
Sbjct: 105 H-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFY--------AAEIASALGYL 155
Query: 633 HQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEY 692
H L I++RDLK N+LLD+ + ++DFGL + + +T GT Y++PE
Sbjct: 156 HS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST--FCGTPEYLAPE- 209
Query: 693 AIDGL---FSVKSDVFSFGVLVLEIICGK 718
+ +V D + G ++ E++ G
Sbjct: 210 VLHKQPYDRTV--DWWCLGAVLYEMLYGL 236
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 73.0 bits (178), Expect = 6e-14
Identities = 48/301 (15%), Positives = 91/301 (30%), Gaps = 63/301 (20%)
Query: 515 ATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRL--------SKGSGQGMEEFKNEVLL 566
T+ K+GEG FG V++ + + +A+K + + + EE E+++
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 567 IAKLQ---------HRNLVKLLGCC-------------------TQRDERMLIYEYLPNK 598
+L + L T+ + ++
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 599 SLDYFIF-------DTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVL 651
F + R+KL + I+ + L LR HRDL NVL
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNVL 194
Query: 652 LDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLV 711
L T K+ +S + + V Y DG VF +
Sbjct: 195 LKKTSLKKLHYTLNGKSSTIP----SCGLQVSIIDYTLSRLERDG-----IVVFCDVSMD 245
Query: 712 LEIICGKKNRGFNHADHDHNLLGHAWR--------LWIEERPLELIDQSLDNSCSFSEAL 763
++ G + F+ + W LW+ +++ Q + + A+
Sbjct: 246 EDLFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAM 305
Query: 764 R 764
+
Sbjct: 306 K 306
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 7e-14
Identities = 39/240 (16%), Positives = 81/240 (33%), Gaps = 63/240 (26%)
Query: 486 MYRRKKHSNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGM-LIEGQEI 544
M+ HS+ + + DN+ K+ +G G +G VY + +
Sbjct: 1 MHHHHHHSSGRENLYFQGIKNVHV------PDNYIIKHLIGRGSYGYVYLAYDKNTEKNV 54
Query: 545 AVKRLSKGSGQGMEEFKN---------EVLLIAKLQHRNLVKLLGCCTQRDERM-----L 590
A+K++++ F++ E+ ++ +L+ +++L D +
Sbjct: 55 AIKKVNR-------MFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYI 107
Query: 591 IYEYLP---------NKSLD-----YFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDS 636
+ E L +++ + G ++H
Sbjct: 108 VLEIADSDLKKLFKTPIFLTEEHIKTILYN------------------LLLGENFIH--E 147
Query: 637 RLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDG 696
IIHRDLK +N LL+ + K+ DFGLAR+ ++ + +
Sbjct: 148 S-GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKK 206
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 5e-13
Identities = 47/198 (23%), Positives = 84/198 (42%), Gaps = 34/198 (17%)
Query: 510 KIIANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKN------ 562
+I+ N + +F K+ LGEG +G V G+ +A+K++ F
Sbjct: 4 RIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP--------FDKPLFALR 55
Query: 563 ---EVLLIAKLQHRNLVKLLGCCTQRDERM-----LIYEYLPNKSLDYFIFDTTRSKLLD 614
E+ ++ +H N++ + +I E + L I +++L
Sbjct: 56 TLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVI----STQMLS 110
Query: 615 WSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674
+ I R + LH + +IHRDLK SN+L+++ + K+ DFGLAR D++
Sbjct: 111 DDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARII--DES 165
Query: 675 EANTKRVVGTYGYMSPEY 692
A+ G M E+
Sbjct: 166 AADNSEPTGQQSGMV-EF 182
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 8e-13
Identities = 56/215 (26%), Positives = 95/215 (44%), Gaps = 38/215 (17%)
Query: 525 LGEGGFGPVY---KGMLIEGQEI-AVKRLSKGS----GQGMEEFKNE--VLLIAKLQHRN 574
LG G +G V+ K + ++ A+K L K + + E + E VL + Q
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR-QSPF 120
Query: 575 LVKLLGCCTQRDERM-LIYEYLPNKSLDYFI-----FDTTRSKLLDWSKRSHIIAGIARG 628
LV L Q + ++ LI +Y+ L + F ++ + I
Sbjct: 121 LVTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQI--------YVGEIVLA 171
Query: 629 LLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYM 688
L +LH+ L II+RD+K N+LLD+ + ++DFGL++ + GT YM
Sbjct: 172 LEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKE-FVADETERAYDFCGTIEYM 227
Query: 689 SPEYAIDGL-----FSVKSDVFSFGVLVLEIICGK 718
+P+ + G +V D +S GVL+ E++ G
Sbjct: 228 APD-IVRGGDSGHDKAV--DWWSLGVLMYELLTGA 259
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 3e-12
Identities = 48/201 (23%), Positives = 95/201 (47%), Gaps = 28/201 (13%)
Query: 510 KIIANATDNFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKN------ 562
++ + + KLG+G +G V+K + G+ +AVK++ F+N
Sbjct: 2 RVDRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-------FQNSTDAQR 54
Query: 563 ---EVLLIAKLQ-HRNLVKLLGCCT--QRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWS 616
E++++ +L H N+V LL + L+++Y+ L I R+ +L+
Sbjct: 55 TFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVI----RANILEPV 109
Query: 617 KRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEA 676
+ +++ + + + YLH S ++HRD+K SN+LL+ + K++DFGL+RSF +
Sbjct: 110 HKQYVVYQLIKVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVT 166
Query: 677 NTKRVVGTYGYMSPEYAIDGL 697
N + + + L
Sbjct: 167 NNIPLSINENTENFDDDQPIL 187
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 56/248 (22%), Positives = 86/248 (34%), Gaps = 65/248 (26%)
Query: 524 KLGEGGFGPVYKGM-LIEGQEIAVKRL---SKGSGQGMEEFKNEVLLIAKLQHRNLVKLL 579
KLG G F V+ ++ +A+K + + +E +KLL
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDE----------------IKLL 69
Query: 580 GCCTQRDERMLIYEYLPN--KSLDYFIFDTTRSK------------LLDWSKRSH----- 620
D + K LD+F LL K+
Sbjct: 70 QRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIP 129
Query: 621 --IIAGIAR----GLLYLHQDSRLRIIHRDLKASNVLLDNTMNP------KISDFGLARS 668
+ I++ GL Y+H R IIH D+K NVL++ +P KI+D G A
Sbjct: 130 LIYVKQISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW 187
Query: 669 FGLDQTEANTKRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIICGK-----KNRG 722
+ T + T Y SPE + G + +D++S L+ E+I G
Sbjct: 188 YDEHYTN-----SIQTREYRSPE-VLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGH 241
Query: 723 FNHADHDH 730
D DH
Sbjct: 242 SYTKDDDH 249
|
| >1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 1e-11
Identities = 22/128 (17%), Positives = 47/128 (36%), Gaps = 21/128 (16%)
Query: 46 DTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPLS 105
+ ++ G+ + G++L E + N + Y T W +N
Sbjct: 2 NLLTNGEGLYAGQSLDV--EPYHFIMQEDCNL------VLYDH---STSVWASNTGIL-- 48
Query: 106 DRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDN 165
+ + +G V+ ++ ++W+S+S V L E GN+V+ +
Sbjct: 49 -GKKGCKAVLQSDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIY-------GS 100
Query: 166 ILWQSFDY 173
+W + Y
Sbjct: 101 DIWSTGTY 108
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* Length = 110 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 4e-11
Identities = 24/126 (19%), Positives = 46/126 (36%), Gaps = 21/126 (16%)
Query: 45 LDTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPL 104
++++S S+ G +L S+ L N + Y G W +N
Sbjct: 1 VNSLSSPNSLFTGHSL-EVGPSYRLIMQGDCNF------VLYDS---GKPVWASNTGGLG 50
Query: 105 SDRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPD 164
S L NG LV+ + +N +W + ++ V L + N+V+
Sbjct: 51 SGCRLTLHNNGN----LVIYDQSNRVIWQTKTNGKEDHYVLVLQQDRNVVIY-------G 99
Query: 165 NILWQS 170
++W +
Sbjct: 100 PVVWAT 105
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 2e-09
Identities = 20/130 (15%), Positives = 45/130 (34%), Gaps = 20/130 (15%)
Query: 46 DTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPLS 105
D ++ G + G +L + + N L ++ W + + S
Sbjct: 2 DRLNSGHQLDTGGSLAE--GGYLFIIQNDCN-----LVLYDN----NRAVWASGTNGKAS 50
Query: 106 DRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDN 165
++ +G LV+ + + +W+SN++ L N+V+ D +N
Sbjct: 51 GCVLKMQNDGN----LVIYSGSR-AIWASNTNRQNGNYYLILQRDRNVVIYDNS----NN 101
Query: 166 ILWQSFDYPC 175
+W +
Sbjct: 102 AIWATHTNVG 111
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 4e-09
Identities = 44/183 (24%), Positives = 73/183 (39%), Gaps = 32/183 (17%)
Query: 524 KLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQH-RNLVKLLGC 581
K+G G FG +Y G I G+E+A+K + E + +Q + + C
Sbjct: 16 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ--LHIESKIYKMMQGGVGIPTIRWC 73
Query: 582 CTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRS---HIIAGIARGLL----YLHQ 634
+ D +++ E L SL+ L ++ R + +A ++ Y+H
Sbjct: 74 GAEGDYNVMVMELL-GPSLED---------LFNFCSRKFSLKTVLLLADQMISRIEYIHS 123
Query: 635 DSRLRIIHRDLKASNVLLDNTMNPK---ISDFGLARSFGLDQTEA-----NTKRVVGTYG 686
+ IHRD+K N L+ I DFGLA+ + +T K + GT
Sbjct: 124 KN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 180
Query: 687 YMS 689
Y S
Sbjct: 181 YAS 183
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* Length = 115 | Back alignment and structure |
|---|
Score = 54.1 bits (130), Expect = 5e-09
Identities = 25/125 (20%), Positives = 44/125 (35%), Gaps = 22/125 (17%)
Query: 46 DTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPLS 105
+ + GQ++ +L + ++ L + N + Y+ G W +N D S
Sbjct: 3 NVLLSGQTLHADHSLQAG--AYTLTIQNKCNL------VKYQN---GRQIWASNTDRRGS 51
Query: 106 DRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDN 165
L +G LV+ + N+ VW S K L + G V+
Sbjct: 52 GCRLTLLSDGN----LVIYDHNNNDVWGSACWGDNGKYALVLQKDGRFVIY-------GP 100
Query: 166 ILWQS 170
+LW
Sbjct: 101 VLWSL 105
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 57.9 bits (140), Expect = 5e-09
Identities = 38/201 (18%), Positives = 71/201 (35%), Gaps = 48/201 (23%)
Query: 524 KLGEGGFGPVYKGMLIEGQEI------AVKRLSKGSGQGMEEFK-----NEVLLIAKLQH 572
+G+GGFG +Y + + + VK +G E K + I K
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 573 RNLVKLLG----------CCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRS--- 619
+K LG + R +I + L K+ + + +
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQ---------KIYEANAKRFSR 151
Query: 620 HIIAGIARGLL----YLHQDSRLRIIHRDLKASNVLLDNTMNPKI--SDFGLARSFGLDQ 673
+ ++ +L Y+H+ +H D+KASN+LL+ ++ D+GLA + +
Sbjct: 152 KTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEG 208
Query: 674 T-----EANTKRVVGTYGYMS 689
+ GT + S
Sbjct: 209 VHKAYAADPKRCHDGTIEFTS 229
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 43/197 (21%), Positives = 71/197 (36%), Gaps = 35/197 (17%)
Query: 511 IIANATDNFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAK 569
++ NF K+G G FG + G L + +A+K S +
Sbjct: 6 MVGP---NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLG 62
Query: 570 LQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRS---HIIAGIA 626
+ ++ ++ E L SL+ L D R+ + IA
Sbjct: 63 -SGDGIPQVYYFGPCGKYNAMVLELL-GPSLED---------LFDLCDRTFSLKTVLMIA 111
Query: 627 RGLL----YLHQDSRLRIIHRDLKASNVLLDNTMNPK-----ISDFGLARSFGLDQTEA- 676
L+ Y+H + +I+RD+K N L+ N I DF LA+ + +T+
Sbjct: 112 IQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKH 168
Query: 677 ----NTKRVVGTYGYMS 689
K + GT YMS
Sbjct: 169 IPYREHKSLTGTARYMS 185
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 36/199 (18%), Positives = 67/199 (33%), Gaps = 42/199 (21%)
Query: 523 NKLGEGGFGPVYKGM---------LIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHR 573
+ G +Y+ + Q+ ++K L G+ E LQ
Sbjct: 48 SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAAKPLQVN 106
Query: 574 NLVKLLGC------------CTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHI 621
KL Q R L+ L +SL D + +L S+RS
Sbjct: 107 KWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQS-ALDVSPKHVL--SERS-- 160
Query: 622 IAGIARGLL----YLHQDSRLRIIHRDLKASNVLLDNTMNPKI--SDFGLARSFGLDQT- 674
+ +A LL +LH++ +H ++ A N+ +D ++ + +G A +
Sbjct: 161 VLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKH 217
Query: 675 ----EANTKRVVGTYGYMS 689
E + G ++S
Sbjct: 218 VAYVEGSRSPHEGDLEFIS 236
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 57.6 bits (138), Expect = 2e-08
Identities = 62/432 (14%), Positives = 123/432 (28%), Gaps = 105/432 (24%)
Query: 426 FHDLIDIKELPESGQDLFIRMAASELDNVERRRQSKNKKQVMIIITSISLATAV-IFIGG 484
F D D K++ + + + + E+D++ + + + + V F+
Sbjct: 29 FVDNFDCKDVQDMPKSIL---SKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEE 85
Query: 485 --------LMYRRKKHSNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKG 536
LM K Q + I + N F++ N V +
Sbjct: 86 VLRINYKFLMSPIKTEQRQ--PSMMTRMYIEQRDRLYNDNQVFAKYN---------VSRL 134
Query: 537 MLIEGQEIAVKRLSKGSG---QGMEEF-K----NEVLLIAKLQHRNLVKL----LGCCTQ 584
A+ L G+ K +V L K+Q + K+ L C
Sbjct: 135 QPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNS 194
Query: 585 RDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRD 644
+ + + + L + D +W+ RS + I + + + R + +
Sbjct: 195 PETVLEMLQKL------LYQIDP------NWTSRSDHSSNIKLRIHSIQAELRRLLKSKP 242
Query: 645 LKASNVLLDNTMNPKISDFGLARSFGL---------DQTEANTKRVVGTYGYMSPEYAID 695
+ ++L N N K +F L + + T ++S ++
Sbjct: 243 YENCLLVLLNVQNAKA-----WNAFNLSCKILLTTRFKQVTD-FLSAATTTHISLDHHSM 296
Query: 696 GLFSVKS-DVFS--FGV--------------LVLEIICGKKNRGFNHADHDHNLLGHAWR 738
L + + L II G D+ W+
Sbjct: 297 TLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDN--------WK 348
Query: 739 LWIEERPLELIDQSLDN-----------SCS-FSEALRCIQVGLLCV--QQRPEDRPNMS 784
++ +I+ SL+ S F + I LL + + M
Sbjct: 349 HVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAH-IPTILLSLIWFDVIKSDV-MV 406
Query: 785 SVVLMLSGERSL 796
V + SL
Sbjct: 407 VVNKLHK--YSL 416
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 42.5 bits (99), Expect = 7e-04
Identities = 64/386 (16%), Positives = 115/386 (29%), Gaps = 116/386 (30%)
Query: 95 TWVAN---RDAPLSDR--SGVLRIN-GERNG------ILVLLNSTNDTVWSSNSSISAQK 142
TWVA + + + +N N +L L D W+S S S+
Sbjct: 164 TWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNI 223
Query: 143 PVAA---------LMESGN-----LVVKDGKDNNPDNILWQSFDYPCDTLLPGMKLGINL 188
+ L++S LV+ + ++ W +F+ C LL
Sbjct: 224 KLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAK----AWNAFNLSCKILL------TTR 273
Query: 189 GTGLNRFLSSWKSTD---DPARGDFT-----------YGLDPRGIPQLVLRKN----SII 230
+ FLS+ +T D T P+ +P+ VL N SII
Sbjct: 274 FKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSII 333
Query: 231 --TFRAGSWNGLHWTGVPQLQLNPVYTFEYVS------NEKEAFYTYNLS--NSSVPSRM 280
+ R G W + + + T S E + LS S
Sbjct: 334 AESIRDGL---ATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMF-DRLSVFPPSAH--- 386
Query: 281 VINPAGTVQRYTWMERTKT-----WTLFSRFSGVTLDQCDS-YALCGAY----ASCN--- 327
I P + W + K+ ++S V +S ++ Y
Sbjct: 387 -I-PTILLSLI-WFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEY 443
Query: 328 ------INS-NSPECECLQGFVPNSQREWDMQYKSGGCVRRTPL-----DCKHGDGFLEH 375
++ N P+ +P ++ + + + +H +
Sbjct: 444 ALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSH----------IGHHLKNIEHPERMTLF 493
Query: 376 KAVKLPDTRFSWVDKNI----TLWEC 397
+ V L D F ++++ I T W
Sbjct: 494 RMVFL-D--FRFLEQKIRHDSTAWNA 516
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 55.7 bits (134), Expect = 3e-08
Identities = 70/363 (19%), Positives = 111/363 (30%), Gaps = 127/363 (34%)
Query: 524 KLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCC 582
KLG G F V+ + + +A+K + K + E +E+ +LL
Sbjct: 44 KLGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETALDEI------------RLLKSV 90
Query: 583 TQRDERMLIYEYLPNKSLDYF------------IFDTTRSKLLDWSKRS----------- 619
D E + + LD F +F+ LL W +S
Sbjct: 91 RNSDPNDPNREMVV-QLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVK 149
Query: 620 HIIAGIARGLLYLHQDSRLRIIHRDLKASNVLL--------------------------- 652
II + +GL YLH ++ RIIH D+K N+LL
Sbjct: 150 KIIQQVLQGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSG 207
Query: 653 ----------------------DNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSP 690
+ KI+D G A TE + T Y S
Sbjct: 208 SAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTE-----DIQTRQYRSL 262
Query: 691 EYAIDGLFSVKSDVFSFGVLVLEIICGK-----KNRGFNHADHDH-----NLLGH----- 735
E I ++ +D++S + E+ G + D DH LLG
Sbjct: 263 EVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKL 322
Query: 736 ---------------AWRLWIEERPLELIDQSLDNSCSFS--EALRCIQVGLLCVQQRPE 778
+ + +P L + ++ +S EA L ++ PE
Sbjct: 323 IVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEK-YEWSQEEAAGFTDFLLPMLELIPE 381
Query: 779 DRP 781
R
Sbjct: 382 KRA 384
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 3e-08
Identities = 39/198 (19%), Positives = 79/198 (39%), Gaps = 35/198 (17%)
Query: 510 KIIANATDNFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKNEVLLIA 568
++ ++ ++GEG FG +++G L+ Q++A+K + S + +
Sbjct: 6 NVVGV---HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLL 62
Query: 569 KLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRS---HIIAGI 625
+ + + +L+ + L SL+ LLD R +A
Sbjct: 63 A-GCTGIPNVYYFGQEGLHNVLVIDLLG-PSLED---------LLDLCGRKFSVKTVAMA 111
Query: 626 ARGLL----YLHQDSRLRIIHRDLKASNVLLDNTMNPK-----ISDFGLARSFGLDQTEA 676
A+ +L +H+ S +++RD+K N L+ + + DFG+ + + T+
Sbjct: 112 AKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQ 168
Query: 677 -----NTKRVVGTYGYMS 689
K + GT YMS
Sbjct: 169 HIPYREKKNLSGTARYMS 186
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 5e-08
Identities = 42/198 (21%), Positives = 73/198 (36%), Gaps = 45/198 (22%)
Query: 524 KLGEGGFGPVYKGM-LIEGQEIA---VKRLSKGSGQGMEEFK-----NEVLLIAKLQHRN 574
K+G GGFG +Y + ++ A VK + +G E K + I K R
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 575 LVKLLG----------CCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKR--SHII 622
+ LG R R ++ E L L K+ + +
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQ---------KISGQNGTFKKSTV 153
Query: 623 AGIARGLL----YLHQDSRLRIIHRDLKASNVLLDNTMNPKI--SDFGLARSFGLDQT-- 674
+ +L Y+H++ +H D+KA+N+LL ++ +D+GL+ + +
Sbjct: 154 LQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHK 210
Query: 675 ---EANTKRVVGTYGYMS 689
E K GT + S
Sbjct: 211 QYQENPRKGHNGTIEFTS 228
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 55.0 bits (132), Expect = 6e-08
Identities = 41/183 (22%), Positives = 71/183 (38%), Gaps = 32/183 (17%)
Query: 524 KLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLV-KLLGC 581
K+G G FG +Y G + +E+A+K + + E + LQ + +
Sbjct: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ--LLYESKIYRILQGGTGIPNVRWF 71
Query: 582 CTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRS---HIIAGIARGLL----YLHQ 634
+ D +L+ + L SL+ L ++ R + +A ++ ++H
Sbjct: 72 GVEGDYNVLVMDLL-GPSLED---------LFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
Query: 635 DSRLRIIHRDLKASNVLLDNTMNPK---ISDFGLARSFGLDQTEA-----NTKRVVGTYG 686
S +HRD+K N L+ I DFGLA+ + T K + GT
Sbjct: 122 KS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTAR 178
Query: 687 YMS 689
Y S
Sbjct: 179 YAS 181
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* Length = 109 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 9e-08
Identities = 20/125 (16%), Positives = 41/125 (32%), Gaps = 22/125 (17%)
Query: 46 DTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPLS 105
+ + G+++ GE L + + N + Y W N
Sbjct: 2 NILYSGETLSPGEFLNN--GRYVFIMQEDCNL------VLYDV---DKPIWATNTGGLDR 50
Query: 106 DRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDN 165
++ +G LV+ + N+ +W+SN+ V L + N+V+
Sbjct: 51 RCHLSMQSDGN----LVVYSPRNNPIWASNTGGENGNYVCVLQKDRNVVIY-------GT 99
Query: 166 ILWQS 170
W +
Sbjct: 100 ARWAT 104
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 54/252 (21%), Positives = 98/252 (38%), Gaps = 45/252 (17%)
Query: 488 RRKKHSNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGM-LIEGQEIAV 546
+ +K N G + + + + + + + + + +G+G FG V K +E + +A+
Sbjct: 28 KERKVYNDGYDDDNYDYIVKNGEKWMD---RYEIDSLIGKGSFGQVVKAYDRVEQEWVAI 84
Query: 547 K---RLSKGSGQGMEEFKNEVLLIAKLQHR------NLVKLLGCCTQRD------ERMLI 591
K Q EV L+ + +V L R+ E +
Sbjct: 85 KIIKNKKAFLNQAQ----IEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSY 140
Query: 592 --YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASN 649
Y+ L N + + TR + LL+L L IIH DLK N
Sbjct: 141 NLYDLLRNTNFRGVSLNLTR----------KFAQQMCTALLFLA-TPELSIIHCDLKPEN 189
Query: 650 VLLDNTMNP--KISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGL-FSVKSDVFS 706
+LL N KI DFG + + + + + Y SPE + G+ + + D++S
Sbjct: 190 ILLCNPKRSAIKIVDFGSS----CQLGQRIYQYIQSRF-YRSPE-VLLGMPYDLAIDMWS 243
Query: 707 FGVLVLEIICGK 718
G +++E+ G+
Sbjct: 244 LGCILVEMHTGE 255
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 4e-07
Identities = 52/218 (23%), Positives = 86/218 (39%), Gaps = 50/218 (22%)
Query: 525 LGEGGFGPVYKGM-LIEGQEIAVKRL---SKGSGQGMEEFKNEVLLIAKLQHR------N 574
+G+G FG V K Q +A+K + + Q EE + ++ L+ + N
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIR----ILEHLRKQDKDNTMN 160
Query: 575 LVKLLGCCTQRD------ERMLI--YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIA 626
++ +L T R+ E + + YE + F R I
Sbjct: 161 VIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVR----------KFAHSIL 210
Query: 627 RGLLYLHQDSRLRIIHRDLKASNVLLDNTMNP--KISDFGLARSFGLDQTEANTKRVVGT 684
+ L LH + RIIH DLK N+LL K+ DFG + + Q V T
Sbjct: 211 QCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS-CY-EHQR-------VYT 258
Query: 685 Y----GYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGK 718
Y Y +PE + + + D++S G ++ E++ G
Sbjct: 259 YIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 109 | Back alignment and structure |
|---|
Score = 45.2 bits (107), Expect = 5e-06
Identities = 28/136 (20%), Positives = 43/136 (31%), Gaps = 30/136 (22%)
Query: 46 DTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPLS 105
+ + GQ++ L + F+L N Y G W + T RD
Sbjct: 4 NYLLSGQTLDTEGHLKN--GDFDLVMQDDCNL-VLYNGNWQ------SNTANNGRDC--- 51
Query: 106 DRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDN 165
L + G LV+ N TVW S + A + G LVV
Sbjct: 52 ----KLTLTD--YGELVIKNGDGSTVWKSGAQSVKGNYAAVVHPDGRLVVF-------GP 98
Query: 166 ILWQSFDYPCDTLLPG 181
+++ D + G
Sbjct: 99 SVFKI-----DPWVRG 109
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 1e-05
Identities = 24/116 (20%), Positives = 43/116 (37%), Gaps = 16/116 (13%)
Query: 40 SAARTLDTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVAN 99
+ T + + GQ + L + ++ +L N L ++ K + T
Sbjct: 1 NIPFTNNLLFSGQVLYGDGRLTA--KNHQLVMQGDCN-----LVLYGGKYGWQSNTHGNG 53
Query: 100 RDAPLSDRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAALMESGNLVV 155
LR+N G L++ + T+WSS SS + V L + G V+
Sbjct: 54 EHC-------FLRLNH--KGELIIKDDDFKTIWSSRSSSKQGEYVLILQDDGFGVI 100
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 2e-05
Identities = 23/138 (16%), Positives = 44/138 (31%), Gaps = 24/138 (17%)
Query: 33 SFLFYIISAARTLDTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEG 92
+ +F + +S+ ++ + + N + Y
Sbjct: 2 NIIFSKQPDDNHPQILHATESL----EILFGTHVYRFIMQTDCNL------VLYDN---N 48
Query: 93 TVTWVANRDAPLSDRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAALMESGN 152
W N + VL+ +G LV++ + N TVW S + A V L N
Sbjct: 49 NPIWATNTGGLGNGCRAVLQPDGV----LVVITNENVTVWQSPVAGKAGHYVLVLQPDRN 104
Query: 153 LVVKDGKDNNPDNILWQS 170
+V+ + LW +
Sbjct: 105 VVIY-------GDALWAT 115
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 44.3 bits (103), Expect = 1e-04
Identities = 29/168 (17%), Positives = 53/168 (31%), Gaps = 14/168 (8%)
Query: 40 SAARTLDTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVAN 99
+ Q++ G+ L+S + F+L GN L I
Sbjct: 9 FNGVGTSVLPAYQTLSAGQYLLSPNQRFKLLLQGDGN-----LVIQDNGATVWVANEQQP 63
Query: 100 RDAPLSDRSGVLRINGERNGILVLLNSTNDTVWSS-----NSSISAQKPVAALMESGNLV 154
+ + R+ + L + + VW + S+ + L + GN+V
Sbjct: 64 FSSTIPLRNKKAPLAFYVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIV 123
Query: 155 VKDGKD--NNPDNILWQSFDYPCDTLLPGMKL--GINLGTGLNRFLSS 198
+ D N I L PG +L G+ G G ++ +
Sbjct: 124 LVDSLALWNGTPAIPLVPGAIDSLLLAPGSELVQGVVYGAGASKLVFQ 171
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 113 | Back alignment and structure |
|---|
Score = 41.0 bits (96), Expect = 2e-04
Identities = 21/113 (18%), Positives = 38/113 (33%), Gaps = 13/113 (11%)
Query: 43 RTLDTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDA 102
R + + Q + D L + + L N + K ++ + W +
Sbjct: 4 RVRNVLFSSQVMYDNAQLAT--RDYSLVMRDDCNL------VLTKG-SKTNIVWESGTSG 54
Query: 103 PLSDRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAALMESGNLVV 155
L +GE L + + +TV+ SN+ V L +G VV
Sbjct: 55 RGQHCFMRLGHSGE----LDITDDRLNTVFVSNTVGQEGDYVLILQINGQAVV 103
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 5e-04
Identities = 57/276 (20%), Positives = 95/276 (34%), Gaps = 63/276 (22%)
Query: 486 MYRRKKHSNQ-GNEKEEMELPIFDLKIIANATDNFSEK----NKLGEGGFGPVYKGM-LI 539
M+ HS+ N + + I + K+G+G FG V +
Sbjct: 1 MHHHHHHSSGRENLYFQGDDEIVHFSWKKG--MLLNNAFLVIRKMGDGTFGRVLLCQHID 58
Query: 540 EGQEIAVK---RLSKGSGQGMEEFKNEVLLIAKLQHR-----NLVKLLGCCTQRD----- 586
+ AVK + K + E ++ K+Q+ N+VK G D
Sbjct: 59 NKKYYAVKVVRNIKKYTRSAKIEAD----ILKKIQNDDINNNNIVKYHGKFMYYDHMCLI 114
Query: 587 -ERMLI--YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHR 643
E + YE + + + F + + I + L YL ++ + H
Sbjct: 115 FEPLGPSLYEIITRNNYNGFHIEDIK----------LYCIEILKALNYLR---KMSLTHT 161
Query: 644 DLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKR--------------------VVG 683
DLK N+LLD+ K + G TK ++
Sbjct: 162 DLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIIN 221
Query: 684 TYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIICGK 718
T Y +PE I L + V SD++SFG ++ E+ G
Sbjct: 222 TRQYRAPE-VILNLGWDVSSDMWSFGCVLAELYTGS 256
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 836 | |||
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.98 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.97 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.9 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.84 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.82 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 99.81 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.8 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.78 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.76 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.73 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.72 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.66 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.63 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.61 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.59 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.58 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.56 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.54 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.5 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.4 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.19 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 99.16 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.13 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.08 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.07 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 98.92 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 98.91 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.87 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 98.86 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 98.77 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.66 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 98.56 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.43 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.37 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.17 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.14 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.08 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.06 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.73 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.7 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.66 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.5 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.28 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.03 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.95 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.9 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.84 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.82 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.62 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.57 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.5 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.05 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.9 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.37 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 93.88 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 91.84 | |
| 3no2_A | 276 | Uncharacterized protein; six-bladed beta-propeller | 86.72 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 82.31 |
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-51 Score=448.59 Aligned_cols=261 Identities=26% Similarity=0.396 Sum_probs=207.8
Q ss_pred ccccccCeecccCceeEEEEEee------cCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeE
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLI------EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~------~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 590 (836)
++|...++||+|+||.||+|++. +++.||||+++.......++|.+|++++++++|||||+++|+|.+.+..+|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 56777889999999999999864 378899999988777778899999999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhcc------------CCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCc
Q 003254 591 IYEYLPNKSLDYFIFDTT------------RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNP 658 (836)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~ 658 (836)
|||||++|+|.+++.... ...+++|.+++.|+.|||+||+|||+.+ |+||||||+||||++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 999999999999997532 1246999999999999999999999988 9999999999999999999
Q ss_pred eeeccCcccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhH
Q 003254 659 KISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAW 737 (836)
Q Consensus 659 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~ 737 (836)
||+|||+++.+.............||+.|||||++.+..++.++|||||||+||||+| |+.||...... . ..
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~---~----~~ 270 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT---E----AI 270 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH---H----HH
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH---H----HH
Confidence 9999999997654443333445689999999999999999999999999999999999 89997532211 1 11
Q ss_pred HhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCCCC
Q 003254 738 RLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSL 796 (836)
Q Consensus 738 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~~ 796 (836)
........ ...+......+.+|+.+||+.||++||||.||++.|+.+...
T Consensus 271 ~~i~~g~~---------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 271 DCITQGRE---------LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp HHHHHTCC---------CCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHHHcCCC---------CCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 11111111 111222345678999999999999999999999999987543
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=443.78 Aligned_cols=259 Identities=28% Similarity=0.430 Sum_probs=214.0
Q ss_pred ccccccCeecccCceeEEEEEee------cCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeE
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLI------EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~------~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 590 (836)
++|...++||+|+||.||+|++. +++.||||+++.......++|.+|++++++++|||||+++|+|.+.+..+|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 57888899999999999999864 367899999988777778899999999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhcc----------CCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCcee
Q 003254 591 IYEYLPNKSLDYFIFDTT----------RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKI 660 (836)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl 660 (836)
|||||++|+|.++|.... ....++|.++++++.|||+||+|||+++ |+||||||+||||++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence 999999999999997532 2357999999999999999999999988 999999999999999999999
Q ss_pred eccCcccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHh
Q 003254 661 SDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRL 739 (836)
Q Consensus 661 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 739 (836)
+|||+|+...............||+.|||||++.++.|+.++|||||||+||||+| |+.||...... .+ ...
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~---~~----~~~ 242 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN---EV----IEC 242 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH---HH----HHH
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---HH----HHH
Confidence 99999987654433333444679999999999999999999999999999999999 89997532211 11 111
Q ss_pred hhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 003254 740 WIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 794 (836)
Q Consensus 740 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 794 (836)
...... ...+......+.+|+.+||+.||++||||+||++.|+.+.
T Consensus 243 i~~~~~---------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~ 288 (299)
T 4asz_A 243 ITQGRV---------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLA 288 (299)
T ss_dssp HHHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHcCCC---------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 111111 1112233456789999999999999999999999998764
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-51 Score=442.22 Aligned_cols=260 Identities=29% Similarity=0.442 Sum_probs=211.9
Q ss_pred ccccccCeecccCceeEEEEEee------cCcEEEEEEecCCC-chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeee
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLI------EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERM 589 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~------~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 589 (836)
.+++..++||+|+||+||+|++. +++.||||+++... ....++|++|+.++++++|||||+++|+|.+.+..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 34566789999999999999963 46789999997553 345678999999999999999999999999999999
Q ss_pred EEEeecCCCChhHHHhhccC-------------CCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCC
Q 003254 590 LIYEYLPNKSLDYFIFDTTR-------------SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTM 656 (836)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~ 656 (836)
||||||++|+|.++|..... ...++|.++++++.|||+||+|||+++ ||||||||+||||++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence 99999999999999964321 246899999999999999999999998 99999999999999999
Q ss_pred CceeeccCcccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhh
Q 003254 657 NPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGH 735 (836)
Q Consensus 657 ~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~ 735 (836)
.+||+|||+++.+.............||+.|||||++.++.|+.++|||||||+||||+| |+.||...... .+
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~---~~--- 256 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ---DV--- 256 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH---HH---
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH---HH---
Confidence 999999999987654443334445689999999999999999999999999999999999 88887532211 11
Q ss_pred hHHhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCCC
Q 003254 736 AWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS 795 (836)
Q Consensus 736 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~ 795 (836)
......... ...+......+.+|+.+||+.||++||||.||++.|+....
T Consensus 257 -~~~i~~~~~---------~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~n 306 (308)
T 4gt4_A 257 -VEMIRNRQV---------LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWGN 306 (308)
T ss_dssp -HHHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCC
T ss_pred -HHHHHcCCC---------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhccC
Confidence 111111111 11223344568899999999999999999999999987654
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-50 Score=432.79 Aligned_cols=259 Identities=25% Similarity=0.379 Sum_probs=201.7
Q ss_pred ccccccCeecccCceeEEEEEeecCcEEEEEEecCC--CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEee
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 594 (836)
+++...++||+|+||+||+|++.+ .||||+++.. ..+..++|.+|+.++++++|||||+++|++.+ +..+|||||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy 112 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW 112 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence 567778899999999999998743 6999998644 34456789999999999999999999999865 568999999
Q ss_pred cCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcc
Q 003254 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (836)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~ 674 (836)
|++|+|.++|... ...++|.++..|+.|||+||+|||+++ ||||||||+||||++++.+||+|||+|+.......
T Consensus 113 ~~gGsL~~~l~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~ 187 (307)
T 3omv_A 113 CEGSSLYKHLHVQ--ETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG 187 (307)
T ss_dssp CSSCBHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred CCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence 9999999999542 356999999999999999999999988 99999999999999999999999999987654333
Q ss_pred ccccccccccccccCcccccC---CccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccc
Q 003254 675 EANTKRVVGTYGYMSPEYAID---GLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQ 751 (836)
Q Consensus 675 ~~~~~~~~gt~~y~aPE~~~~---~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 751 (836)
.......+||+.|||||++.+ ++|+.++|||||||+||||+||+.||....... .......... ..+
T Consensus 188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~------~~~~~~~~~~----~~p 257 (307)
T 3omv_A 188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD------QIIFMVGRGY----ASP 257 (307)
T ss_dssp ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH------HHHHHHHTTC----CCC
T ss_pred ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH------HHHHHHhcCC----CCC
Confidence 334455789999999999863 469999999999999999999999975322211 1111111110 011
Q ss_pred cccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 003254 752 SLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 794 (836)
Q Consensus 752 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 794 (836)
.+. .........+.+|+.+||+.||++||||.||++.|+.++
T Consensus 258 ~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~ 299 (307)
T 3omv_A 258 DLS-KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ 299 (307)
T ss_dssp CST-TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH
T ss_pred Ccc-cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 110 112233456789999999999999999999999998764
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=428.69 Aligned_cols=269 Identities=28% Similarity=0.393 Sum_probs=216.6
Q ss_pred ccHHHHHhhcccccccCeecccCceeEEEEEeec------CcEEEEEEecCCCc-hhHHHHHHHHHHHHhhcC-CceeeE
Q 003254 507 FDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIE------GQEIAVKRLSKGSG-QGMEEFKNEVLLIAKLQH-RNLVKL 578 (836)
Q Consensus 507 ~~~~~l~~a~~~f~~~~~lG~G~fG~Vykg~~~~------g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H-~niv~l 578 (836)
++....+...++|+..++||+|+||.||+|++.. ++.||||++..... ...++|.+|+.++.+++| ||||++
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 3444445556889999999999999999999753 36799999976543 345779999999999965 899999
Q ss_pred EeEEeeC-CeeeEEEeecCCCChhHHHhhccC-------------CCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEecc
Q 003254 579 LGCCTQR-DERMLIYEYLPNKSLDYFIFDTTR-------------SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRD 644 (836)
Q Consensus 579 ~g~~~~~-~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~D 644 (836)
+|+|.+. +..+||||||++|+|.++|..... ...+++.++..++.|||+||+|||+++ |||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCc
Confidence 9999764 568999999999999999975322 345899999999999999999999998 99999
Q ss_pred CCCCceEecCCCCceeeccCcccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCC
Q 003254 645 LKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGF 723 (836)
Q Consensus 645 Lkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~ 723 (836)
|||+||||++++.+||+|||+|+.+..+..........||+.|||||++.++.|+.++|||||||+||||+| |+.||..
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999998765544444455789999999999999999999999999999999998 8999754
Q ss_pred CCCccccchhhhhHHhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 003254 724 NHADHDHNLLGHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 793 (836)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 793 (836)
..... ........+.. ...+.....++.+++.+||+.||++|||+.||++.|+.+
T Consensus 291 ~~~~~------~~~~~i~~g~~---------~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~l 345 (353)
T 4ase_A 291 VKIDE------EFCRRLKEGTR---------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 345 (353)
T ss_dssp CCCSH------HHHHHHHHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCHHH------HHHHHHHcCCC---------CCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 32211 11111111111 111222335678999999999999999999999999875
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=422.54 Aligned_cols=272 Identities=21% Similarity=0.238 Sum_probs=200.7
Q ss_pred ccccccCeecccCceeEEEEEeecCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCC----eeeEEE
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD----ERMLIY 592 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----~~~lV~ 592 (836)
++|...++||+|+||.||+|++ +|+.||||+++.... ....+..|+..+.+++|||||+++|++.+.+ ..+|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 4677888999999999999998 689999999965432 2223345666677889999999999998754 579999
Q ss_pred eecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCC-----CCcEEeccCCCCceEecCCCCceeeccCccc
Q 003254 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDS-----RLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667 (836)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivH~DLkp~NILl~~~~~~kl~DFgla~ 667 (836)
|||++|+|.+++.. ..++|..+.+++.|+++||+|||++. .++|+||||||+||||++++.+||+|||+|+
T Consensus 81 Ey~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cCCCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 99999999999953 35899999999999999999999872 2359999999999999999999999999998
Q ss_pred ccCCCccc--cccccccccccccCcccccCC------ccCccccccchhhhhhhhhhCCCCCCCCCCccccch----hhh
Q 003254 668 SFGLDQTE--ANTKRVVGTYGYMSPEYAIDG------LFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNL----LGH 735 (836)
Q Consensus 668 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~----~~~ 735 (836)
........ ......+||+.|||||++.+. .++.++|||||||+||||+||++|+........... ...
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~ 236 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence 76433222 122346899999999998754 478899999999999999999987653322111100 000
Q ss_pred hHHhhhccCchhhccccccC-CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 003254 736 AWRLWIEERPLELIDQSLDN-SCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 794 (836)
Q Consensus 736 ~~~~~~~~~~~~~~d~~l~~-~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 794 (836)
...........+.+++.+.. ..+.+....+.+|+.+||+.||++||||.||++.|+++.
T Consensus 237 ~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~ 296 (303)
T 3hmm_A 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred hHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 00000000000111111111 122345667889999999999999999999999998763
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-48 Score=421.94 Aligned_cols=249 Identities=23% Similarity=0.338 Sum_probs=207.4
Q ss_pred ccccccCeecccCceeEEEEEeec-CcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEeec
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 595 (836)
+.|+..++||+|+||.||+|+... |+.||||++........+.+.+|+.++++++|||||++++++.+.+..+||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 568889999999999999999864 8999999997666566678999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCccc
Q 003254 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE 675 (836)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 675 (836)
++|+|.+++.. ..+++.++..++.||+.||+|||+++ |+||||||+||||++++.+||+|||+|+.+.....
T Consensus 154 ~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~- 225 (346)
T 4fih_A 154 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP- 225 (346)
T ss_dssp TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-
T ss_pred CCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCC-
Confidence 99999998853 35899999999999999999999998 99999999999999999999999999997653322
Q ss_pred cccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccccccC
Q 003254 676 ANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDN 755 (836)
Q Consensus 676 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 755 (836)
.....+||+.|||||++.+..|+.++|||||||+||||++|+.||...... . ............ +.
T Consensus 226 -~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~---~----~~~~i~~~~~~~-----~~- 291 (346)
T 4fih_A 226 -RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL---K----AMKMIRDNLPPR-----LK- 291 (346)
T ss_dssp -CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---H----HHHHHHHSSCCC-----CS-
T ss_pred -cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH---H----HHHHHHcCCCCC-----CC-
Confidence 234578999999999999999999999999999999999999998532211 1 111111111110 10
Q ss_pred CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 756 SCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 756 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
........+.+|+.+||+.||++|||+.|+++
T Consensus 292 -~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 292 -NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp -CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11122345779999999999999999999976
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=423.83 Aligned_cols=250 Identities=23% Similarity=0.356 Sum_probs=201.0
Q ss_pred ccccccCeecccCceeEEEEEeec-CcEEEEEEecCC--CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEe
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 593 (836)
++|++.++||+|+||.||+|+... |+.||||++... .....+.+.+|+.++++++|||||++++++.+.+..+||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 689999999999999999999754 899999999755 33456789999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCc
Q 003254 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (836)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~ 673 (836)
||++|+|.+++... +...+++.++..++.||+.||+|||+++ |+||||||+||||++++.+||+|||+|+.+...
T Consensus 104 y~~gg~L~~~i~~~-~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~- 178 (350)
T 4b9d_A 104 YCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST- 178 (350)
T ss_dssp CCTTCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHH-
T ss_pred CCCCCcHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCC-
Confidence 99999999999543 3456788999999999999999999998 999999999999999999999999999876422
Q ss_pred cccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccccc
Q 003254 674 TEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSL 753 (836)
Q Consensus 674 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 753 (836)
.......+||+.|||||++.+..|+.++|||||||+||||++|+.||...... .+ . .........
T Consensus 179 -~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~---~~---~-~~i~~~~~~------- 243 (350)
T 4b9d_A 179 -VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK---NL---V-LKIISGSFP------- 243 (350)
T ss_dssp -HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HH---H-HHHHHTCCC-------
T ss_pred -cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH---HH---H-HHHHcCCCC-------
Confidence 12233468999999999999999999999999999999999999998532211 11 1 111111110
Q ss_pred cCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 754 DNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 754 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
..+......+.+|+.+||+.||++|||+.|+++
T Consensus 244 --~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 244 --PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111122345789999999999999999999986
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-48 Score=418.55 Aligned_cols=253 Identities=23% Similarity=0.238 Sum_probs=203.1
Q ss_pred cccccccCeecccCceeEEEEEeec-CcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEee
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 594 (836)
.+.|+..++||+|+||.||+|+... |+.||||+++.... ..+|+.++++++|||||++++++.+.+..+|||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 3568888899999999999999865 89999999975432 24799999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCC-CceeeccCcccccCCCc
Q 003254 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTM-NPKISDFGLARSFGLDQ 673 (836)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~-~~kl~DFgla~~~~~~~ 673 (836)
|++|+|.+++.. .+.+++.++..++.||+.||+|||+++ |+||||||+||||+.++ .+||+|||+|+.+....
T Consensus 132 ~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 132 LEGGSLGQLIKQ---MGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp CTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred cCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 999999999954 346999999999999999999999998 99999999999999887 69999999999875432
Q ss_pred cc---cccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhcc
Q 003254 674 TE---ANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELID 750 (836)
Q Consensus 674 ~~---~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 750 (836)
.. ......+||+.|||||++.+..|+.++|||||||+||||++|+.||....... +.... .....+..
T Consensus 206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~~~~i---~~~~~~~~--- 276 (336)
T 4g3f_A 206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP---LCLKI---ASEPPPIR--- 276 (336)
T ss_dssp --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC---CHHHH---HHSCCGGG---
T ss_pred cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH---HHHHH---HcCCCCch---
Confidence 21 12234689999999999999999999999999999999999999986433221 11111 11111100
Q ss_pred ccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 003254 751 QSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 793 (836)
Q Consensus 751 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 793 (836)
..+......+.+++.+||+.||++|||+.|+++.|...
T Consensus 277 -----~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~ 314 (336)
T 4g3f_A 277 -----EIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKA 314 (336)
T ss_dssp -----GSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----hcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 11122234577999999999999999999999887653
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-48 Score=415.45 Aligned_cols=248 Identities=24% Similarity=0.306 Sum_probs=207.5
Q ss_pred ccccccCeecccCceeEEEEEeec-CcEEEEEEecCC---CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEE
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 592 (836)
++|++.+.||+|+||+||+++... |+.||||++.+. .....+.+.+|++++++++|||||++++++.+.+..+|||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 679999999999999999999854 899999999753 2344578999999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCC
Q 003254 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (836)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~ 672 (836)
||+++|+|.+++.. .+.+++.++..++.||+.||+|||+++ |+||||||+||||++++.+||+|||+|+.+...
T Consensus 112 Ey~~gG~L~~~i~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 112 SYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 99999999999954 356999999999999999999999998 999999999999999999999999999987654
Q ss_pred ccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhcccc
Q 003254 673 QTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQS 752 (836)
Q Consensus 673 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 752 (836)
.........+||+.|||||++.+..|+.++||||+||+||||++|+.||..... ..+. ........
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~---~~~~----~~i~~~~~------- 251 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE---GLIF----AKIIKLEY------- 251 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHH----HHHHHTCC-------
T ss_pred CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHH----HHHHcCCC-------
Confidence 444445567999999999999999999999999999999999999999853221 1111 11111111
Q ss_pred ccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 003254 753 LDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVV 787 (836)
Q Consensus 753 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl 787 (836)
..+......+.+|+.+||+.||++|||+.|++
T Consensus 252 ---~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 252 ---DFPEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp ---CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred ---CCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 01111224577999999999999999999863
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-47 Score=403.49 Aligned_cols=246 Identities=25% Similarity=0.372 Sum_probs=195.7
Q ss_pred cccCeecccCceeEEEEEeec-CcEEEEEEecCC--CchhHHHHHHHHHHHHhhcCCceeeEEeEEee----CCeeeEEE
Q 003254 520 SEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQ----RDERMLIY 592 (836)
Q Consensus 520 ~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~~lV~ 592 (836)
...++||+|+||.||+|++.. ++.||+|++... .....+.|.+|+.++++++|||||++++++.. ....+|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 566789999999999999865 889999998654 33456789999999999999999999999865 34579999
Q ss_pred eecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEec-CCCCceeeccCcccccCC
Q 003254 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD-NTMNPKISDFGLARSFGL 671 (836)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~-~~~~~kl~DFgla~~~~~ 671 (836)
|||++|+|.+++.. ...+++..+..++.||+.||+|||+++ ++|+||||||+||||+ +++.+||+|||+|+....
T Consensus 109 Ey~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 99999999999954 356899999999999999999999875 3599999999999998 489999999999986432
Q ss_pred CccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccc
Q 003254 672 DQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQ 751 (836)
Q Consensus 672 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 751 (836)
......+||+.|||||++.+ .|+.++|||||||+||||+||+.||...... ................+
T Consensus 185 ----~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~------~~~~~~i~~~~~~~~~~- 252 (290)
T 3fpq_A 185 ----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA------AQIYRRVTSGVKPASFD- 252 (290)
T ss_dssp ----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH------HHHHHHHTTTCCCGGGG-
T ss_pred ----CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH------HHHHHHHHcCCCCCCCC-
Confidence 22345789999999998865 6999999999999999999999998532211 11111111111111111
Q ss_pred cccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 752 SLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 752 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
.. ....+.+|+.+||+.||++|||+.|+++
T Consensus 253 ---~~----~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 253 ---KV----AIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp ---GC----CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---cc----CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11 1234778999999999999999999986
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-47 Score=422.79 Aligned_cols=250 Identities=23% Similarity=0.338 Sum_probs=208.3
Q ss_pred cccccccCeecccCceeEEEEEeec-CcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEee
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 594 (836)
.+.|+..++||+|+||.||+|+... |+.||||++........+.+.+|+.+|++++|||||++++++.+.+..+|||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 3579999999999999999999864 899999999877666677899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcc
Q 003254 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (836)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~ 674 (836)
|++|+|.+++.. ..+++.++..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.+.....
T Consensus 230 ~~gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~ 302 (423)
T 4fie_A 230 LEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 302 (423)
T ss_dssp CTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC
T ss_pred CCCCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCc
Confidence 999999998843 35899999999999999999999998 99999999999999999999999999987643322
Q ss_pred ccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhcccccc
Q 003254 675 EANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLD 754 (836)
Q Consensus 675 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 754 (836)
.....+||+.|||||++.+..|+.++|||||||+||||++|+.||...... . .......... +.+.
T Consensus 303 --~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~---~----~~~~i~~~~~-----~~~~ 368 (423)
T 4fie_A 303 --RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL---K----AMKMIRDNLP-----PRLK 368 (423)
T ss_dssp --CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---H----HHHHHHHSCC-----CCCS
T ss_pred --cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH---H----HHHHHHcCCC-----CCCc
Confidence 234578999999999999999999999999999999999999998532211 1 1111111111 1111
Q ss_pred CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 755 NSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 755 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
........+.+|+.+||+.||++|||+.|+++
T Consensus 369 --~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 369 --NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp --CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 01112245779999999999999999999976
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=396.67 Aligned_cols=245 Identities=24% Similarity=0.367 Sum_probs=189.0
Q ss_pred ccccccCeecccCceeEEEEEee-cCcEEEEEEecCCC---chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEE
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 592 (836)
++|++.+.||+|+||.||+++.. +|+.||||++.+.. ....+.+.+|+.++++++|||||++++++.+.+..++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 68999999999999999999975 48999999997542 334567999999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCC
Q 003254 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (836)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~ 672 (836)
||+ +|+|.+++.+ .+.+++.++..++.||+.||+|||+++ |+||||||+||||++++.+||+|||+|+.....
T Consensus 93 Ey~-~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 93 EYA-GNELFDYIVQ---RDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp ECC-CEEHHHHHHH---SCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred eCC-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 999 6789888854 456999999999999999999999998 999999999999999999999999999875422
Q ss_pred ccccccccccccccccCcccccCCcc-CccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccc
Q 003254 673 QTEANTKRVVGTYGYMSPEYAIDGLF-SVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQ 751 (836)
Q Consensus 673 ~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 751 (836)
. .....+||+.|||||++.+..+ +.++||||+||+||||++|+.||..... ..+ .+.......
T Consensus 166 ~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~---~~~----~~~i~~~~~------ 229 (275)
T 3hyh_A 166 N---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI---PVL----FKNISNGVY------ 229 (275)
T ss_dssp ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHH----HHHHHHTCC------
T ss_pred C---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH---HHH----HHHHHcCCC------
Confidence 1 2334789999999999998876 5799999999999999999999853211 111 111111111
Q ss_pred cccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 752 SLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 752 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
..+......+.+++.+||+.||++|||+.|+++
T Consensus 230 ----~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 230 ----TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp ----CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ----CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 011112245779999999999999999999987
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-47 Score=404.80 Aligned_cols=247 Identities=24% Similarity=0.288 Sum_probs=195.1
Q ss_pred ccccccCeecccCceeEEEEEee----cCcEEEEEEecCCC--chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeE
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLI----EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~----~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 590 (836)
++|++.+.||+|+||+||+++.. .++.||||++++.. ......+.+|+.++++++|||||++++++.+.+..+|
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999863 36789999997542 2234578899999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccC
Q 003254 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (836)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~ 670 (836)
||||+++|+|.+++.. .+.+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+...
T Consensus 104 vmEy~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EECCCTTCEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEcCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 9999999999999954 346999999999999999999999998 9999999999999999999999999998653
Q ss_pred CCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhcc
Q 003254 671 LDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELID 750 (836)
Q Consensus 671 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 750 (836)
... ......+||+.|||||++.+..|+.++||||+||+||||++|+.||...... .+ .........
T Consensus 178 ~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~---~~----~~~i~~~~~----- 243 (304)
T 3ubd_A 178 DHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK---ET----MTMILKAKL----- 243 (304)
T ss_dssp -----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH----HHHHHHCCC-----
T ss_pred CCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHH---HH----HHHHHcCCC-----
Confidence 322 2233478999999999999999999999999999999999999998532211 11 111111111
Q ss_pred ccccCCCChHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 003254 751 QSLDNSCSFSEALRCIQVGLLCVQQRPEDRPN-----MSSVVL 788 (836)
Q Consensus 751 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~eVl~ 788 (836)
..+......+.+|+.+||+.||++||| ++|+++
T Consensus 244 -----~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 244 -----GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred -----CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 111112345779999999999999998 467764
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=394.06 Aligned_cols=251 Identities=24% Similarity=0.339 Sum_probs=187.9
Q ss_pred ccccccCeecccCceeEEEEEee-cCcEEEEEEecCCCc-hhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCe-------
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSG-QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDE------- 587 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~------- 587 (836)
++|+..+.||+|+||.||+|+.. +|+.||||+++.... ...+.+.+|+.++++++|||||++++++.+.+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 46899999999999999999975 489999999976543 345679999999999999999999999876543
Q ss_pred -----eeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeec
Q 003254 588 -----RMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISD 662 (836)
Q Consensus 588 -----~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~D 662 (836)
.++||||+++|+|.+++.........++..+..++.||++||+|||+++ |+||||||+||||+.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence 6899999999999999965544445666778899999999999999998 99999999999999999999999
Q ss_pred cCcccccCCCcccc----------ccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccch
Q 003254 663 FGLARSFGLDQTEA----------NTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNL 732 (836)
Q Consensus 663 Fgla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~ 732 (836)
||+|+.+....... .....+||+.|||||++.+..|+.++|||||||+||||++ ||... ...
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~-----~~~ 233 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ-----MER 233 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH-----HHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc-----cHH
Confidence 99999875432211 1223579999999999999999999999999999999996 54210 000
Q ss_pred hhhhHHhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 733 LGHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 733 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
. .............. .......+.+++.+||+.||++|||+.|+++
T Consensus 234 ~-~~~~~~~~~~~p~~---------~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 234 V-RTLTDVRNLKFPPL---------FTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp H-HHHHHHHTTCCCHH---------HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred H-HHHHHHhcCCCCCC---------CcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0 00111111110000 0112234568999999999999999999987
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=385.82 Aligned_cols=285 Identities=35% Similarity=0.598 Sum_probs=241.4
Q ss_pred HHHHHhhcccccccCeecccCceeEEEEEeecCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCee
Q 003254 509 LKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDER 588 (836)
Q Consensus 509 ~~~l~~a~~~f~~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 588 (836)
+.++..++++|+..+.||+|+||.||+|++.+++.||||++........+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 31 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 110 (321)
T 2qkw_B 31 LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEM 110 (321)
T ss_dssp CSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCC
T ss_pred HHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeE
Confidence 33455678999999999999999999999888999999999877667778899999999999999999999999999999
Q ss_pred eEEEeecCCCChhHHHhhccC-CCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCccc
Q 003254 589 MLIYEYLPNKSLDYFIFDTTR-SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667 (836)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~ 667 (836)
++||||+++|+|.+++..... ...+++..+..++.||++||+|||+++ |+||||||+|||+++++.+||+|||+++
T Consensus 111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 187 (321)
T 2qkw_B 111 ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISK 187 (321)
T ss_dssp EEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCE
T ss_pred EEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccccc
Confidence 999999999999999864322 235899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchh
Q 003254 668 SFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLE 747 (836)
Q Consensus 668 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (836)
...............||+.|+|||++.+..++.++||||||+++|||++|+.|+.............+............
T Consensus 188 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (321)
T 2qkw_B 188 KGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQ 267 (321)
T ss_dssp ECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCS
T ss_pred ccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHH
Confidence 75433332223345689999999999999999999999999999999999999876555544444444444444444556
Q ss_pred hccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCCCC
Q 003254 748 LIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSL 796 (836)
Q Consensus 748 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~~ 796 (836)
.+++.+...........+.+++.+||+.||++|||+.||++.|+.+...
T Consensus 268 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 268 IVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp SSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred hcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 6666666667778888999999999999999999999999999876443
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=373.95 Aligned_cols=229 Identities=18% Similarity=0.231 Sum_probs=182.7
Q ss_pred ccccccccCCCccccCCCeEEeCCCeEEEeeecCCCCCceEEEEEEeecCCCcEEEeecCCCCCCCC----cceEEEeec
Q 003254 41 AARTLDTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPLSDR----SGVLRINGE 116 (836)
Q Consensus 41 ~~~~~~~i~~~~~l~~~~~l~S~~g~F~lgF~~~~~~~~~ylgiw~~~~~~~t~vW~Anr~~p~~~~----~~~l~~~~~ 116 (836)
++++.|+|++||+|++|++|+|++|+|+||||+++ ++|| |+ +.+ +||+||||+|+.++ +++|+|+
T Consensus 10 ~~~~~~~l~~g~~l~~~~~l~S~~g~F~lgf~~~~---~~~l---y~--~~~-vvW~Anr~~p~~~~~~~~~~~l~l~-- 78 (276)
T 3m7h_A 10 NGVGTSVLPAYQTLSAGQYLLSPNQRFKLLLQGDG---NLVI---QD--NGA-TVWVANEQQPFSSTIPLRNKKAPLA-- 78 (276)
T ss_dssp CCTTSSEECTTEEBCTTCEEECTTSSEEEEECTTS---CEEE---EE--TTE-EEEECSTTSTTEEEEECCCTTCCSE--
T ss_pred ccccCCEecCCCEecCCCEEEcCCCcEEEEEECCC---CeEE---EC--CCC-eEEECCCCCCcCCcccccceEEEEe--
Confidence 46678999999999999999999999999999543 6787 76 777 99999999999885 7889998
Q ss_pred cCceEEE--EcCCCCeEEeecccCC-----CCcceEEEecCCCeEEecCCCCCCCcceeeeccCCCCCcCCCCeeeeeec
Q 003254 117 RNGILVL--LNSTNDTVWSSNSSIS-----AQKPVAALMESGNLVVKDGKDNNPDNILWQSFDYPCDTLLPGMKLGINLG 189 (836)
Q Consensus 117 ~~g~l~l--~~~~~~~~wst~~~~~-----~~~~~a~lld~GNlvl~~~~~~~~~~~~WqSFd~PTDtlLpgqkl~~~~~ 189 (836)
.||+||| .|++|.+||+|+++.. ..+.+|+|+|+|||||++ +.+|||| |||||||||||||.+.+
T Consensus 79 ~~G~Lvl~~~~~~~~~vWst~~~~~~~~~~~~~~~a~L~d~GNlVl~~------~~~lWqS--~ptdtlLpg~~~~~~l~ 150 (276)
T 3m7h_A 79 FYVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLVD------SLALWNG--TPAIPLVPGAIDSLLLA 150 (276)
T ss_dssp EEESSSEEEEEGGGTEEEEECCCCCCCTTHHHHEEEEECTTSCEEEEE------EEEEEES--CTTSCCCCSCTTCEEEC
T ss_pred CCCcEEEEEeCCCCCEEEEeCCCcccccccCCceEEEEeCCCCEEecC------CceeeCc--ccccccccccccccccc
Confidence 8899999 7888999999996532 345789999999999997 4789999 99999999999999999
Q ss_pred CCCceEEEEccCCCCCCCCCeeeccCCCCCceEEEEc-CCeeEEeeCCCCCccccCccccccCCceEEEEeeCCc-eeEE
Q 003254 190 TGLNRFLSSWKSTDDPARGDFTYGLDPRGIPQLVLRK-NSIITFRAGSWNGLHWTGVPQLQLNPVYTFEYVSNEK-EAFY 267 (836)
Q Consensus 190 tg~~~~l~Sw~s~~dps~G~~~~~~~~~g~~~~~~~~-~~~~~~~~g~w~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 267 (836)
+|.. | ++.+||++|.|+++++++|. +++++ +..+||++|.|++.. ..+..+....+.+.++++ ...+
T Consensus 151 ~g~~--L---~S~~dps~G~fsl~l~~dGn--lvLy~~~~~~yW~Sgt~~~~~----~~l~l~~dGnLvl~d~~~~~vWs 219 (276)
T 3m7h_A 151 PGSE--L---VQGVVYGAGASKLVFQGDGN--LVAYGPNGAATWNAGTQGKGA----VRAVFQGDGNLVVYGAGNAVLWH 219 (276)
T ss_dssp SSEE--E---CTTCEEEETTEEEEECTTSC--EEEECTTSSEEEECCCTTTTC----CEEEECTTSCEEEECTTSCEEEE
T ss_pred cCcc--c---ccCCCCCCceEEEeecCCce--EEEEeCCCeEEEECCCCCCcc----EEEEEcCCCeEEEEeCCCcEEEE
Confidence 8865 5 67899999999999999995 44554 468999999997632 122222333344444433 3333
Q ss_pred EEecCCCCccceEEEcccCcEEEEEEecCCceEEEee
Q 003254 268 TYNLSNSSVPSRMVINPAGTVQRYTWMERTKTWTLFS 304 (836)
Q Consensus 268 ~~~~~~~~~~~r~~L~~~G~l~~y~w~~~~~~W~~~~ 304 (836)
+++. ....+|++|+.||++++|.| ...|..++
T Consensus 220 S~t~--~~~~~rl~Ld~dGnLvly~~---~~~Wqsf~ 251 (276)
T 3m7h_A 220 SHTG--GHASAVLRLQANGSIAILDE---KPVWARFG 251 (276)
T ss_dssp CSCT--TCTTCEEEECTTSCEEEEEE---EEEEESSS
T ss_pred ecCC--CCCCEEEEEcCCccEEEEcC---CCeEEccC
Confidence 3322 23458999999999999999 46788766
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=392.34 Aligned_cols=262 Identities=21% Similarity=0.322 Sum_probs=199.7
Q ss_pred cccccccCeecccCceeEEEEEee-cCcEEEEEEecCCC--chhHHHHHHHHHHHHhhcCCceeeEEeEEee------CC
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQ------RD 586 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~------~~ 586 (836)
.++|++.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.+|+.++|||||++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 467999999999999999999985 49999999997543 3345678899999999999999999998754 35
Q ss_pred eeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcc
Q 003254 587 ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLA 666 (836)
Q Consensus 587 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla 666 (836)
..+||||||+ |+|.+++. ..+.+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|
T Consensus 133 ~~~ivmE~~~-g~L~~~i~---~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIH---SSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp CEEEEEECCS-EEHHHHHT---SSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEeCCC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeeccee
Confidence 6899999996 67888884 3467999999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCc--cccccccccccccccCcccccCC-ccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhcc
Q 003254 667 RSFGLDQ--TEANTKRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEE 743 (836)
Q Consensus 667 ~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 743 (836)
+.+.... ........+||+.|+|||++.+. .++.++||||+||+||||++|+.||......+. ..........
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~---l~~I~~~~g~- 281 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQ---LQLIMMVLGT- 281 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH---HHHHHHHHCC-
T ss_pred eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHH---HHHHHHhcCC-
Confidence 8764322 12233457899999999998875 569999999999999999999999854322111 1111000000
Q ss_pred Cchhhcc-----------cccc--CCCCh-----HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 744 RPLELID-----------QSLD--NSCSF-----SEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 744 ~~~~~~d-----------~~l~--~~~~~-----~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
...+... ..+. ...+. .....+.+|+.+||+.||++|||+.|+++
T Consensus 282 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 282 PSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp CCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0000000 0000 00011 11245789999999999999999999986
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=378.01 Aligned_cols=291 Identities=43% Similarity=0.680 Sum_probs=240.6
Q ss_pred cCcccHHHHHhhcccccccCeecccCceeEEEEEeecCcEEEEEEecCCCc-hhHHHHHHHHHHHHhhcCCceeeEEeEE
Q 003254 504 LPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSG-QGMEEFKNEVLLIAKLQHRNLVKLLGCC 582 (836)
Q Consensus 504 ~~~~~~~~l~~a~~~f~~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~ 582 (836)
+..+++.++..+.++|+..+.||+|+||.||+|+..+|+.||||++..... .....+.+|+.+++.++||||+++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 456888999999999999999999999999999988899999999876532 2334789999999999999999999999
Q ss_pred eeCCeeeEEEeecCCCChhHHHhhcc-CCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceee
Q 003254 583 TQRDERMLIYEYLPNKSLDYFIFDTT-RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKIS 661 (836)
Q Consensus 583 ~~~~~~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~ 661 (836)
...+..++||||+++|+|.+++.... ....+++..+..++.|++.||+|||+....+|+||||||+|||+++++.+||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~ 176 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence 99999999999999999999996543 23459999999999999999999999922239999999999999999999999
Q ss_pred ccCcccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCC--CccccchhhhhHHh
Q 003254 662 DFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNH--ADHDHNLLGHAWRL 739 (836)
Q Consensus 662 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~--~~~~~~~~~~~~~~ 739 (836)
|||+++........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.|+.... .........+....
T Consensus 177 Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 255 (326)
T 3uim_A 177 DFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255 (326)
T ss_dssp CCSSCEECCSSSSC-EECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred cCccccccCccccc-ccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence 99999876433222 2233569999999999999999999999999999999999999985221 11222233333333
Q ss_pred hhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCCC
Q 003254 740 WIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS 795 (836)
Q Consensus 740 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~ 795 (836)
..........+..+...........+.+++.+||+.+|++|||+.||+++|++...
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~ 311 (326)
T 3uim_A 256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL 311 (326)
T ss_dssp TSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSC
T ss_pred hhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcch
Confidence 44445556677777777888888999999999999999999999999999997533
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=380.27 Aligned_cols=201 Identities=24% Similarity=0.358 Sum_probs=171.7
Q ss_pred HHhhcccccccCeecccCceeEEEEEee----cCcEEEEEEecCCCchhHHHHHHHHHHHHhh-cCCceeeEEeEEeeCC
Q 003254 512 IANATDNFSEKNKLGEGGFGPVYKGMLI----EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRD 586 (836)
Q Consensus 512 l~~a~~~f~~~~~lG~G~fG~Vykg~~~----~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~ 586 (836)
+....+.|++.++||+|+||+||+|+.+ .++.||||++.... ...++.+|++++..+ +|||||++++++.+.+
T Consensus 16 ~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~ 93 (361)
T 4f9c_A 16 VPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKND 93 (361)
T ss_dssp SGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETT
T ss_pred cCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECC
Confidence 3445688999999999999999999864 36789999986543 345688999999998 6999999999999999
Q ss_pred eeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCC-CCceeeccCc
Q 003254 587 ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNT-MNPKISDFGL 665 (836)
Q Consensus 587 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~-~~~kl~DFgl 665 (836)
..+|||||+++|+|.+++. .+++.++..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+
T Consensus 94 ~~~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGl 164 (361)
T 4f9c_A 94 HVVIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGL 164 (361)
T ss_dssp EEEEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCC
Confidence 9999999999999999882 4889999999999999999999998 9999999999999876 7999999999
Q ss_pred ccccCCCccc--------------------------cccccccccccccCcccccCC-ccCccccccchhhhhhhhhhCC
Q 003254 666 ARSFGLDQTE--------------------------ANTKRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIICGK 718 (836)
Q Consensus 666 a~~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~GvvL~elltG~ 718 (836)
|+........ ......+||+.|+|||++.+. .++.++||||+||++|||++|+
T Consensus 165 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~ 244 (361)
T 4f9c_A 165 AQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGR 244 (361)
T ss_dssp CEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTC
T ss_pred CcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCC
Confidence 9865422110 112235799999999999876 4899999999999999999999
Q ss_pred CCCCC
Q 003254 719 KNRGF 723 (836)
Q Consensus 719 ~p~~~ 723 (836)
.||..
T Consensus 245 ~Pf~~ 249 (361)
T 4f9c_A 245 YPFYK 249 (361)
T ss_dssp SSSSC
T ss_pred CCCCC
Confidence 99843
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=398.27 Aligned_cols=251 Identities=22% Similarity=0.307 Sum_probs=206.8
Q ss_pred ccccccCeecccCceeEEEEEeec-CcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEeec
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 595 (836)
++|++.+.||+|+||.||+++... |+.||+|++........+.+.+|+.+|+.++|||||++++++.+....+||||||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~ 236 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence 689999999999999999999864 8999999998776666778999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCC--CCceeeccCcccccCCCc
Q 003254 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNT--MNPKISDFGLARSFGLDQ 673 (836)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~--~~~kl~DFgla~~~~~~~ 673 (836)
++|+|.+++.. +...+++.++..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+|+.+....
T Consensus 237 ~gg~L~~~i~~--~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~ 311 (573)
T 3uto_A 237 SGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311 (573)
T ss_dssp CCCBHHHHHTC--TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred CCCcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence 99999998843 3356899999999999999999999998 9999999999999854 899999999999874332
Q ss_pred cccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccccc
Q 003254 674 TEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSL 753 (836)
Q Consensus 674 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 753 (836)
.....+||+.|||||++.+..|+.++||||+||+||||++|+.||...... .. ......... ...++ .
T Consensus 312 ---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~---~~----~~~i~~~~~-~~~~~-~ 379 (573)
T 3uto_A 312 ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD---ET----LRNVKSCDW-NMDDS-A 379 (573)
T ss_dssp ---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH---HH----HHHHHTTCC-CCCSG-G
T ss_pred ---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH---HH----HHHHHhCCC-CCCcc-c
Confidence 233468999999999999999999999999999999999999998532211 11 111111100 00000 0
Q ss_pred cCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 754 DNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 754 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
.. .....+.+|+.+||+.||++|||+.|+++
T Consensus 380 ~~----~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 380 FS----GISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp GT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cc----CCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 01 11245779999999999999999999987
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=359.21 Aligned_cols=285 Identities=35% Similarity=0.562 Sum_probs=230.9
Q ss_pred cccCcccHHHHHhhccccccc------CeecccCceeEEEEEeecCcEEEEEEecCC----CchhHHHHHHHHHHHHhhc
Q 003254 502 MELPIFDLKIIANATDNFSEK------NKLGEGGFGPVYKGMLIEGQEIAVKRLSKG----SGQGMEEFKNEVLLIAKLQ 571 (836)
Q Consensus 502 ~~~~~~~~~~l~~a~~~f~~~------~~lG~G~fG~Vykg~~~~g~~vavK~l~~~----~~~~~~~~~~Ei~~l~~l~ 571 (836)
.....|++.++..++++|... +.||+|+||.||+|+. +++.||||++... .....+.+.+|+.++++++
T Consensus 10 ~~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 88 (307)
T 2nru_A 10 TRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ 88 (307)
T ss_dssp -CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC
T ss_pred CCCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC
Confidence 345678999999999999877 8999999999999997 6889999998653 2344678999999999999
Q ss_pred CCceeeEEeEEeeCCeeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceE
Q 003254 572 HRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVL 651 (836)
Q Consensus 572 H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NIL 651 (836)
||||+++++++...+..++||||+++++|.+++........+++..+..++.||+.||+|||+.+ |+||||||+||+
T Consensus 89 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil 165 (307)
T 2nru_A 89 HENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANIL 165 (307)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEE
T ss_pred CCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEE
Confidence 99999999999999999999999999999999976555667999999999999999999999998 999999999999
Q ss_pred ecCCCCceeeccCcccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccc
Q 003254 652 LDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHN 731 (836)
Q Consensus 652 l~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~ 731 (836)
+++++.+||+|||+++...............|++.|+|||.+.+ .++.++||||||+++|||++|+.|+........
T Consensus 166 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-- 242 (307)
T 2nru_A 166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL-- 242 (307)
T ss_dssp ECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB--
T ss_pred EcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH--
Confidence 99999999999999987654333333344678999999998765 589999999999999999999999764333221
Q ss_pred hhhhhHHhhhc--cCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCCC
Q 003254 732 LLGHAWRLWIE--ERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS 795 (836)
Q Consensus 732 ~~~~~~~~~~~--~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~ 795 (836)
... ....... ....+.+++.+. .........+.+++.+||+.+|++|||+.+|++.|+++.+
T Consensus 243 ~~~-~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 243 LLD-IKEEIEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp TTH-HHHHHHTTSCCHHHHSCSSCS-CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HHH-HHHHhhhhhhhhhhhcccccc-ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 111 1111111 112233333332 3455667789999999999999999999999999987643
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=392.79 Aligned_cols=249 Identities=25% Similarity=0.321 Sum_probs=197.7
Q ss_pred cccccccCeecccCceeEEEEEeec-CcEEEEEEecCCC---chhHHHHHH---HHHHHHhhcCCceeeEEeEEeeCCee
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKN---EVLLIAKLQHRNLVKLLGCCTQRDER 588 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~---~~~~~~~~~---Ei~~l~~l~H~niv~l~g~~~~~~~~ 588 (836)
.++|++.+.||+|+||.||+++... |+.||||++.+.. ......+.+ ++.+++.++|||||++++++.+.+..
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 3789999999999999999999865 8999999996431 122233334 45666677899999999999999999
Q ss_pred eEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccc
Q 003254 589 MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (836)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~ 668 (836)
+|||||+++|+|..+|.. .+.+++..+..++.||+.||+|||+++ ||||||||+||||++++.+||+|||+|+.
T Consensus 268 ylVmEy~~GGdL~~~l~~---~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp EEEECCCCSCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeee
Confidence 999999999999999954 356999999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCccccccccccccccccCcccccC-CccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchh
Q 003254 669 FGLDQTEANTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLE 747 (836)
Q Consensus 669 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (836)
+... .....+||+.|||||++.+ ..|+.++|+||+||+||||++|+.||..........+ .+.......
T Consensus 342 ~~~~----~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i----~~~i~~~~~-- 411 (689)
T 3v5w_A 342 FSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----DRMTLTMAV-- 411 (689)
T ss_dssp CSSC----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHH----HHHHHHCCC--
T ss_pred cCCC----CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH----HHhhcCCCC--
Confidence 6432 2344789999999999975 5799999999999999999999999853222211111 111111100
Q ss_pred hccccccCCCChHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 003254 748 LIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPN-----MSSVVL 788 (836)
Q Consensus 748 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~eVl~ 788 (836)
..+......+.+|+.+||+.||++|++ +.||++
T Consensus 412 --------~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 412 --------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp --------CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred --------CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 111122345779999999999999998 678764
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=366.65 Aligned_cols=270 Identities=27% Similarity=0.409 Sum_probs=205.6
Q ss_pred HHhhcccccccCeecccCceeEEEEEeecCcEEEEEEecCCC--chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeee
Q 003254 512 IANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERM 589 (836)
Q Consensus 512 l~~a~~~f~~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 589 (836)
+....++|++.+.||+|+||.||+|+. .|+.||||++.... ....+++.+|+.++++++||||+++++++......+
T Consensus 32 ~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 110 (309)
T 3p86_A 32 MDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLS 110 (309)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCE
T ss_pred ccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceE
Confidence 334557899999999999999999987 68899999987653 344568999999999999999999999999999999
Q ss_pred EEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCccccc
Q 003254 590 LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (836)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~ 669 (836)
+||||+++|+|.+++........+++..++.++.||+.||+|||+.+ .+|+||||||+|||+++++.+||+|||+++..
T Consensus 111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 189 (309)
T 3p86_A 111 IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK 189 (309)
T ss_dssp EEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred EEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence 99999999999999965433345899999999999999999999875 34999999999999999999999999999864
Q ss_pred CCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhc
Q 003254 670 GLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELI 749 (836)
Q Consensus 670 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (836)
.... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||....... . ..........
T Consensus 190 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~---~---~~~~~~~~~~---- 257 (309)
T 3p86_A 190 ASTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ---V---VAAVGFKCKR---- 257 (309)
T ss_dssp --------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH---H---HHHHHHSCCC----
T ss_pred cccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---H---HHHHHhcCCC----
Confidence 3221 12234678999999999999999999999999999999999999975322110 0 0000000000
Q ss_pred cccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCCCCCCCC
Q 003254 750 DQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPQ 800 (836)
Q Consensus 750 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~~~~p~ 800 (836)
...+......+.+++.+||+.+|++|||+.||++.|+.+.....|+
T Consensus 258 -----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~ 303 (309)
T 3p86_A 258 -----LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPP 303 (309)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-----
T ss_pred -----CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCC
Confidence 1111222345789999999999999999999999999875544443
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=364.30 Aligned_cols=261 Identities=28% Similarity=0.398 Sum_probs=212.4
Q ss_pred cccccccCeecccCceeEEEEEeec-CcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEee
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 594 (836)
.++|...+.||+|+||.||+++... ++.||+|++........+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 3678889999999999999999864 889999999777777788999999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcc
Q 003254 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (836)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~ 674 (836)
+++++|.+++... ...+++.++..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.....
T Consensus 89 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 89 IKGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp CTTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred cCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 9999999999643 356899999999999999999999998 99999999999999999999999999987643322
Q ss_pred cc------------ccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhc
Q 003254 675 EA------------NTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIE 742 (836)
Q Consensus 675 ~~------------~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 742 (836)
.. ......||+.|+|||.+.+..++.++||||||+++|||++|..|+.............
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~-------- 235 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN-------- 235 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBC--------
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhh--------
Confidence 11 1113579999999999999999999999999999999999998875433322111100
Q ss_pred cCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCCC
Q 003254 743 ERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS 795 (836)
Q Consensus 743 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~ 795 (836)
.....+... +......+.+++.+||+.||++|||+.|+++.|+.+..
T Consensus 236 --~~~~~~~~~----~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~ 282 (310)
T 3s95_A 236 --VRGFLDRYC----PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM 282 (310)
T ss_dssp --HHHHHHHTC----CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --hhccccccC----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 001111111 11122346789999999999999999999999998753
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=368.67 Aligned_cols=260 Identities=28% Similarity=0.406 Sum_probs=211.4
Q ss_pred cccccccCeecccCceeEEEEEee--------cCcEEEEEEecCCC-chhHHHHHHHHHHHHhh-cCCceeeEEeEEeeC
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLI--------EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQR 585 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~--------~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~ 585 (836)
.++|+..+.||+|+||.||+|+.. .+..||||+++... ....+++.+|+.+++++ +||||+++++++...
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 478889999999999999999863 35679999997653 34567899999999999 899999999999999
Q ss_pred CeeeEEEeecCCCChhHHHhhccC-------------CCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEe
Q 003254 586 DERMLIYEYLPNKSLDYFIFDTTR-------------SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLL 652 (836)
Q Consensus 586 ~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl 652 (836)
+..++||||+++|+|.+++..... ...+++.++..++.||+.||+|||+++ |+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 999999999999999999975431 245889999999999999999999998 9999999999999
Q ss_pred cCCCCceeeccCcccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccc
Q 003254 653 DNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHN 731 (836)
Q Consensus 653 ~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~ 731 (836)
++++.+||+|||+++.+.............+|+.|+|||++.+..++.++|||||||++|||++ |+.|+.......
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~--- 313 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--- 313 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---
Confidence 9999999999999987654433333334567889999999999999999999999999999999 888875322111
Q ss_pred hhhhhHHhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 003254 732 LLGHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 794 (836)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 794 (836)
+ ........ ....+......+.+++.+||+.+|++|||+.|+++.|+.+.
T Consensus 314 ~----~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il 363 (370)
T 2psq_A 314 L----FKLLKEGH---------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 363 (370)
T ss_dssp H----HHHHHTTC---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred H----HHHHhcCC---------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1 11111111 11112223356789999999999999999999999998753
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=364.74 Aligned_cols=266 Identities=24% Similarity=0.337 Sum_probs=208.0
Q ss_pred cccccccCeecccCceeEEEEEeecCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCe----eeEE
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDE----RMLI 591 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~----~~lV 591 (836)
.++|+..++||+|+||.||+|+. .++.||||++.... .....+..|+.++++++||||+++++++..... .++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEE-TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEE-CCCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 46899999999999999999987 48999999996543 334456679999999999999999999987543 6999
Q ss_pred EeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcC----------CCCcEEeccCCCCceEecCCCCceee
Q 003254 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQD----------SRLRIIHRDLKASNVLLDNTMNPKIS 661 (836)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~----------~~~~ivH~DLkp~NILl~~~~~~kl~ 661 (836)
|||+++|+|.+++.. ..+++..+..++.||+.||+|||+. + |+||||||+|||+++++.+||+
T Consensus 101 ~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~ 173 (322)
T 3soc_A 101 TAFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIA 173 (322)
T ss_dssp EECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEEC
T ss_pred EecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEc
Confidence 999999999999953 3589999999999999999999998 6 9999999999999999999999
Q ss_pred ccCcccccCCCccccccccccccccccCcccccC-----CccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhh-
Q 003254 662 DFGLARSFGLDQTEANTKRVVGTYGYMSPEYAID-----GLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGH- 735 (836)
Q Consensus 662 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~- 735 (836)
|||+++.+.............||+.|+|||++.+ ..++.++|||||||++|||++|+.||..............
T Consensus 174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~ 253 (322)
T 3soc_A 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI 253 (322)
T ss_dssp CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH
T ss_pred cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh
Confidence 9999987754444333444679999999999986 4577899999999999999999999864333221111100
Q ss_pred --------hHHhhhccCchhhccccccCC-CChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 003254 736 --------AWRLWIEERPLELIDQSLDNS-CSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 794 (836)
Q Consensus 736 --------~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 794 (836)
......... ..+.+... ........+.+++.+||+.||++|||+.||++.|+.+.
T Consensus 254 ~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~ 317 (322)
T 3soc_A 254 GQHPSLEDMQEVVVHKK----KRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQ 317 (322)
T ss_dssp CSSCCHHHHHHHHTTSC----CCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccCCchhhhhhhhhccc----CCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 000000000 01111100 12244566899999999999999999999999998763
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=350.70 Aligned_cols=251 Identities=24% Similarity=0.396 Sum_probs=206.8
Q ss_pred hcccccccCeecccCceeEEEEEee-cCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEe
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 593 (836)
..++|+..+.||+|+||.||++... +++.||||++........+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 4468999999999999999999964 589999999976655567789999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCc
Q 003254 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (836)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~ 673 (836)
|+++|+|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 98 ~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 98 YLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp CCTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 9999999999853 35889999999999999999999998 9999999999999999999999999998764332
Q ss_pred cccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccccc
Q 003254 674 TEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSL 753 (836)
Q Consensus 674 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 753 (836)
. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... ...........+ ..
T Consensus 171 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~~~~~~~~-~~----- 236 (297)
T 3fxz_A 171 S--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL------RALYLIATNGTP-EL----- 236 (297)
T ss_dssp C--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHHCSC-CC-----
T ss_pred c--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCCC-CC-----
Confidence 2 223467999999999999999999999999999999999999997532211 111111111110 00
Q ss_pred cCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 754 DNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 754 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
..+......+.+++.+||+.||++|||+.|+++
T Consensus 237 --~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 237 --QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp --SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --CCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 111122345779999999999999999999986
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=360.09 Aligned_cols=262 Identities=27% Similarity=0.400 Sum_probs=209.0
Q ss_pred cccccccCeecccCceeEEEEEee----cCcEEEEEEecCC-CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeE
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLI----EGQEIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~----~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 590 (836)
.++|++.+.||+|+||.||+|++. .+..||||++... .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 367888999999999999999985 3456999999765 34456789999999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccC
Q 003254 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (836)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~ 670 (836)
||||+++++|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 128 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 128 VTEYMENGSLDTFLRT--HDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeeCCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 9999999999999853 2356899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCcccc-ccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhccCchhh
Q 003254 671 LDQTEA-NTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEERPLEL 748 (836)
Q Consensus 671 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (836)
...... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.|+...... .. .......
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---~~----~~~~~~~----- 270 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR---DV----ISSVEEG----- 270 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH---HH----HHHHHTT-----
T ss_pred cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH---HH----HHHHHcC-----
Confidence 432211 2223456788999999999999999999999999999999 99987432211 01 1111111
Q ss_pred ccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCCCCCC
Q 003254 749 IDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQ 798 (836)
Q Consensus 749 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~~~~ 798 (836)
.....+......+.+++.+||+.||++|||+.||++.|+.+...++
T Consensus 271 ----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~ 316 (325)
T 3kul_A 271 ----YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE 316 (325)
T ss_dssp ----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred ----CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence 1111122334567899999999999999999999999998755433
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=370.48 Aligned_cols=259 Identities=25% Similarity=0.356 Sum_probs=209.0
Q ss_pred hcccccccCeecccCceeEEEEEee-cCcEEEEEEecCCC-chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEE
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 592 (836)
..++|...+.||+|+||.||+|++. +++.||||+++... ....++|.+|+.++++++||||+++++++...+..++||
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 191 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence 3467888999999999999999986 58999999987553 334567899999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCC
Q 003254 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (836)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~ 672 (836)
||+++|+|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 192 e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 192 ELVQGGDFLTFLRTE--GARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp ECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred EcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 999999999999642 346899999999999999999999998 999999999999999999999999999865433
Q ss_pred ccccccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhccCchhhccc
Q 003254 673 QTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQ 751 (836)
Q Consensus 673 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 751 (836)
..........+++.|+|||.+.++.++.++||||||+++|||++ |+.|+...... .........
T Consensus 267 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~-------~~~~~~~~~-------- 331 (377)
T 3cbl_A 267 VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ-------QTREFVEKG-------- 331 (377)
T ss_dssp EEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH-------HHHHHHHTT--------
T ss_pred ceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHcC--------
Confidence 22222222345778999999999999999999999999999998 88886532211 011111111
Q ss_pred cccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 003254 752 SLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 794 (836)
Q Consensus 752 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 794 (836)
.....+......+.+++.+||+.||++|||+.+|++.|+.+.
T Consensus 332 -~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~ 373 (377)
T 3cbl_A 332 -GRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373 (377)
T ss_dssp -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 111112223346789999999999999999999999998753
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=365.00 Aligned_cols=270 Identities=28% Similarity=0.391 Sum_probs=215.3
Q ss_pred cccHHHHHhhcccccccCeecccCceeEEEEEee------cCcEEEEEEecCCC-chhHHHHHHHHHHHHhh-cCCceee
Q 003254 506 IFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLI------EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKL-QHRNLVK 577 (836)
Q Consensus 506 ~~~~~~l~~a~~~f~~~~~lG~G~fG~Vykg~~~------~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~ 577 (836)
.++....+...++|+..+.||+|+||.||+|++. +++.||||++.... ....+.+.+|+.++.++ +||||++
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence 4566667777899999999999999999999842 35789999997653 33456799999999999 7999999
Q ss_pred EEeEEeeCCe-eeEEEeecCCCChhHHHhhccC-----------------------------------------------
Q 003254 578 LLGCCTQRDE-RMLIYEYLPNKSLDYFIFDTTR----------------------------------------------- 609 (836)
Q Consensus 578 l~g~~~~~~~-~~lV~Ey~~~gsL~~~l~~~~~----------------------------------------------- 609 (836)
+++++.+.+. .++||||+++|+|.+++.....
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 9999987654 8999999999999999975432
Q ss_pred ----------------CCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCc
Q 003254 610 ----------------SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (836)
Q Consensus 610 ----------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~ 673 (836)
...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 122889999999999999999999998 9999999999999999999999999998765443
Q ss_pred cccccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhccCchhhcccc
Q 003254 674 TEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQS 752 (836)
Q Consensus 674 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 752 (836)
.........||+.|+|||++.+..++.++||||||+++|||++ |+.|+....... ...........
T Consensus 248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~~~~~~~~~~~------- 314 (359)
T 3vhe_A 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------EFCRRLKEGTR------- 314 (359)
T ss_dssp TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH------HHHHHHHHTCC-------
T ss_pred cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH------HHHHHHHcCCC-------
Confidence 3333444678999999999999999999999999999999998 999975332211 11111111111
Q ss_pred ccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 003254 753 LDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 793 (836)
Q Consensus 753 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 793 (836)
...+......+.+++.+||+.+|++|||+.||++.|+.+
T Consensus 315 --~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 353 (359)
T 3vhe_A 315 --MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353 (359)
T ss_dssp --CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 011112234578999999999999999999999999875
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=366.32 Aligned_cols=273 Identities=28% Similarity=0.396 Sum_probs=216.2
Q ss_pred hcccccccCeecccCceeEEEEEee--------cCcEEEEEEecCCC-chhHHHHHHHHHHHHhh-cCCceeeEEeEEee
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLI--------EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQ 584 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~--------~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~ 584 (836)
..++|...+.||+|+||.||+|+.. .+..||||++.... ....+++.+|+++++++ +||||+++++++..
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 3478899999999999999999863 24579999997653 34457899999999999 89999999999999
Q ss_pred CCeeeEEEeecCCCChhHHHhhccC-------------CCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceE
Q 003254 585 RDERMLIYEYLPNKSLDYFIFDTTR-------------SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVL 651 (836)
Q Consensus 585 ~~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NIL 651 (836)
.+..++||||+++|+|.+++..... ...+++..+..++.||+.||+|||+.+ |+||||||+|||
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL 223 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEE
Confidence 9999999999999999999975432 245899999999999999999999998 999999999999
Q ss_pred ecCCCCceeeccCcccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCcccc
Q 003254 652 LDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDH 730 (836)
Q Consensus 652 l~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~ 730 (836)
|++++.+||+|||+++...............+|+.|+|||++.+..++.++||||||++++||++ |+.|+......
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~--- 300 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--- 300 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---
T ss_pred EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---
Confidence 99999999999999987654433333444567889999999999999999999999999999999 88886432211
Q ss_pred chhhhhHHhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCCCCCCCCCCCccc
Q 003254 731 NLLGHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPQQPGFFT 806 (836)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~~~~p~~p~~~~ 806 (836)
........... ...+......+.+++.+||+.+|++|||+.||++.|+.+.............
T Consensus 301 ----~~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~~~ 363 (382)
T 3tt0_A 301 ----ELFKLLKEGHR---------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEMGYYH 363 (382)
T ss_dssp ----HHHHHHHTTCC---------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC-----
T ss_pred ----HHHHHHHcCCC---------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCCCCCCC
Confidence 11111111111 1111223346789999999999999999999999999886554444444443
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=359.03 Aligned_cols=274 Identities=26% Similarity=0.372 Sum_probs=206.0
Q ss_pred cccccccCeecccCceeEEEEEe-----ecCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeC--Cee
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGML-----IEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR--DER 588 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~-----~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~ 588 (836)
.++|+..+.||+|+||.||++++ .+++.||||++........+.+.+|+.++++++||||+++++++... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 46889999999999999999984 24889999999877767778899999999999999999999998654 458
Q ss_pred eEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccc
Q 003254 589 MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (836)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~ 668 (836)
++||||+++++|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 89 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp EEEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred EEEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 9999999999999999543 345899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCccc-cccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchh
Q 003254 669 FGLDQTE-ANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLE 747 (836)
Q Consensus 669 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (836)
....... .......++..|+|||.+.+..++.++||||||+++|||++|..|+.........................+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (295)
T 3ugc_A 164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 243 (295)
T ss_dssp ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHH
Confidence 6433221 112234577789999999999999999999999999999999988643211000000000000000000001
Q ss_pred hccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 003254 748 LIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 794 (836)
Q Consensus 748 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 794 (836)
.+........+......+.+++.+||+.+|++|||+.||++.|+.+.
T Consensus 244 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~ 290 (295)
T 3ugc_A 244 LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 290 (295)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 11111111222333456889999999999999999999999998763
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=352.13 Aligned_cols=262 Identities=24% Similarity=0.342 Sum_probs=211.8
Q ss_pred CcccHHHHHhhccc----------ccccCeecccCceeEEEEEee-cCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCC
Q 003254 505 PIFDLKIIANATDN----------FSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHR 573 (836)
Q Consensus 505 ~~~~~~~l~~a~~~----------f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~ 573 (836)
+.++.+++..+++. |...+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 34666666665543 667789999999999999986 5999999999877666778899999999999999
Q ss_pred ceeeEEeEEeeCCeeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEec
Q 003254 574 NLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD 653 (836)
Q Consensus 574 niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~ 653 (836)
||+++++++...+..++||||+++++|.+++. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~ 175 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVS----QVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLT 175 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEC
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEC
Confidence 99999999999999999999999999999884 246899999999999999999999998 99999999999999
Q ss_pred CCCCceeeccCcccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchh
Q 003254 654 NTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLL 733 (836)
Q Consensus 654 ~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~ 733 (836)
.++.+||+|||++........ ......||+.|+|||++.+..++.++||||||+++|||++|+.|+......
T Consensus 176 ~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~------ 247 (321)
T 2c30_A 176 LDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV------ 247 (321)
T ss_dssp TTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------
T ss_pred CCCcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------
Confidence 999999999999987643322 223467999999999999999999999999999999999999997532211
Q ss_pred hhhHHhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 734 GHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 734 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
............. +. ........+.+++.+||+.||++|||+.|+++.
T Consensus 248 -~~~~~~~~~~~~~-----~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 248 -QAMKRLRDSPPPK-----LK--NSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp -HHHHHHHHSSCCC-----CT--TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred -HHHHHHhcCCCCC-----cC--ccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111111111110 00 011123457799999999999999999999873
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=343.97 Aligned_cols=259 Identities=27% Similarity=0.367 Sum_probs=210.7
Q ss_pred hcccccccCeecccCceeEEEEEeecCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEee
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 594 (836)
..++|+..+.||+|+||.||++...++..||||++..... ..+++.+|+.++.+++||||+++++++......++||||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence 3478899999999999999999998888999999975543 357799999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcc
Q 003254 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (836)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~ 674 (836)
+++++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 85 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 159 (268)
T 3sxs_A 85 ISNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY 159 (268)
T ss_dssp CTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred cCCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence 9999999998543 346899999999999999999999998 99999999999999999999999999987643322
Q ss_pred ccccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhccCchhhccccc
Q 003254 675 EANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSL 753 (836)
Q Consensus 675 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 753 (836)
. ......+++.|+|||.+.+..++.++||||||++++||++ |+.|+....... ..........
T Consensus 160 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~-------- 223 (268)
T 3sxs_A 160 V-SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE-------VVLKVSQGHR-------- 223 (268)
T ss_dssp E-ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH-------HHHHHHTTCC--------
T ss_pred h-cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH-------HHHHHHcCCC--------
Confidence 2 2223456778999999999899999999999999999999 898874322110 0011111100
Q ss_pred cCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCCCC
Q 003254 754 DNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSL 796 (836)
Q Consensus 754 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~~ 796 (836)
...+......+.+++.+||+.+|++|||+.|+++.|+.+...
T Consensus 224 -~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 224 -LYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp -CCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred -CCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 001111224578999999999999999999999999987653
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=358.85 Aligned_cols=257 Identities=26% Similarity=0.436 Sum_probs=201.1
Q ss_pred cccccccCeecccCceeEEEEEeec-Cc----EEEEEEecCC-CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeee
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQ----EIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERM 589 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~~-g~----~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 589 (836)
.++|+..+.||+|+||.||+|++.. ++ +||+|.+... .....+++.+|+.++++++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 3678899999999999999999643 44 3688887544 3345678999999999999999999999998754 78
Q ss_pred EEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCccccc
Q 003254 590 LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (836)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~ 669 (836)
+|+||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 93 ~v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEEECCTTCBHHHHHHHS--TTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred EEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 999999999999998643 356899999999999999999999998 999999999999999999999999999987
Q ss_pred CCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhccCchhh
Q 003254 670 GLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEERPLEL 748 (836)
Q Consensus 670 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (836)
.............+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+....... . ...
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~----~~~--------- 231 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---I----SSI--------- 231 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---H----HHH---------
T ss_pred cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH---H----HHH---------
Confidence 54444333344567889999999999999999999999999999999 999975432211 1 011
Q ss_pred ccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 003254 749 IDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 794 (836)
Q Consensus 749 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 794 (836)
+........+......+.+++.+||+.+|++||++.||++.|+.+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 277 (327)
T 3poz_A 232 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp HHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHH
T ss_pred HHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 1111111122223456789999999999999999999999997653
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=346.58 Aligned_cols=256 Identities=27% Similarity=0.409 Sum_probs=209.4
Q ss_pred cccccccCeecccCceeEEEEEeecCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEeec
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 595 (836)
.++|+..+.||+|+||.||+++..+++.||+|++.... ...+++.+|+.++++++||||+++++++.+....++||||+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 36788899999999999999999889999999997554 33577999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCccc
Q 003254 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE 675 (836)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 675 (836)
++++|.+++.. ....+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 88 ~~~~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 161 (269)
T 4hcu_A 88 EHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY- 161 (269)
T ss_dssp TTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH-
T ss_pred CCCcHHHHHHh--cCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccccccc-
Confidence 99999999853 3356899999999999999999999998 99999999999999999999999999987643322
Q ss_pred cccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhccCchhhcccccc
Q 003254 676 ANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLD 754 (836)
Q Consensus 676 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 754 (836)
.......+++.|+|||.+.+..++.++||||||++++||++ |+.|+...... . ........ ..
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~---~----~~~~~~~~---------~~ 225 (269)
T 4hcu_A 162 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS---E----VVEDISTG---------FR 225 (269)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---H----HHHHHHTT---------CC
T ss_pred ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH---H----HHHHHhcC---------cc
Confidence 12233556788999999998999999999999999999999 88887532211 0 11111111 00
Q ss_pred CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 003254 755 NSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 794 (836)
Q Consensus 755 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 794 (836)
...+......+.+++.+||+.+|++|||+.|+++.|+++.
T Consensus 226 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~ 265 (269)
T 4hcu_A 226 LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 265 (269)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHH
Confidence 0111112345789999999999999999999999998754
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=365.11 Aligned_cols=258 Identities=28% Similarity=0.440 Sum_probs=197.6
Q ss_pred cccccccCeecccCceeEEEEEee----cCcEEEEEEecCCC-chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeE
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLI----EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~----~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 590 (836)
.++|+..+.||+|+||.||+|++. .+..||||+++... ....++|.+|+.++++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 368899999999999999999975 47789999997653 3456789999999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccC
Q 003254 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (836)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~ 670 (836)
||||+++|+|.+++.. ....+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 124 v~e~~~~~sL~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 124 VTEYMENGSLDSFLRK--HDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 9999999999999953 2346899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCcccc-ccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhccCchhh
Q 003254 671 LDQTEA-NTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEERPLEL 748 (836)
Q Consensus 671 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (836)
...... ......+++.|+|||++.+..++.++||||||+++|||++ |+.|+...... .. ...
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~---~~----~~~--------- 262 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ---DV----IKA--------- 262 (373)
T ss_dssp ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH---HH----HHH---------
T ss_pred cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH---HH----HHH---------
Confidence 332211 1222345778999999999999999999999999999998 99987432211 01 111
Q ss_pred ccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 003254 749 IDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 794 (836)
Q Consensus 749 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 794 (836)
+........+......+.+++.+||+.+|++||++.||++.|+.+.
T Consensus 263 i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 308 (373)
T 2qol_A 263 VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308 (373)
T ss_dssp HHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHH
Confidence 1111111122233456889999999999999999999999998763
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=351.98 Aligned_cols=254 Identities=24% Similarity=0.346 Sum_probs=202.8
Q ss_pred cccccccCeecccCceeEEEEEee-cCcEEEEEEecCCC-chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEe
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 593 (836)
.++|+..+.||+|+||.||+++.. +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 478999999999999999999986 58899999986543 2334678999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCc
Q 003254 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (836)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~ 673 (836)
|+++++|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 86 ~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 86 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 999999999883 3456899999999999999999999998 9999999999999999999999999998764333
Q ss_pred cccccccccccccccCcccccCCcc-CccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhcccc
Q 003254 674 TEANTKRVVGTYGYMSPEYAIDGLF-SVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQS 752 (836)
Q Consensus 674 ~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 752 (836)
.........||+.|+|||++.+..+ +.++||||||+++|||++|+.||........ ....+...... .
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~------~~~~~~~~~~~--~--- 228 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ------EYSDWKEKKTY--L--- 228 (323)
T ss_dssp EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH------HHHHHHTTCTT--S---
T ss_pred cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH------HHHHHhccccc--C---
Confidence 3333345689999999999988775 7899999999999999999999854322111 01111111000 0
Q ss_pred ccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 753 LDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 753 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
.........+.+++.+||+.||++|||+.|+++.
T Consensus 229 ---~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 229 ---NPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp ---TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ---CccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 0001123456789999999999999999999764
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=358.33 Aligned_cols=268 Identities=26% Similarity=0.401 Sum_probs=214.8
Q ss_pred HHHHhhcccccccCeecccCceeEEEEEeec------CcEEEEEEecCCC-chhHHHHHHHHHHHHhhcCCceeeEEeEE
Q 003254 510 KIIANATDNFSEKNKLGEGGFGPVYKGMLIE------GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCC 582 (836)
Q Consensus 510 ~~l~~a~~~f~~~~~lG~G~fG~Vykg~~~~------g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~ 582 (836)
..+....++|+..+.||+|+||.||+|+... ++.||||+++... ....+.+.+|+.++++++||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 119 (343)
T 1luf_A 40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 119 (343)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 3344566899999999999999999999853 4789999997653 34467899999999999999999999999
Q ss_pred eeCCeeeEEEeecCCCChhHHHhhccC---------------------CCcCChhhhHHHHHHHHhhhHhhhcCCCCcEE
Q 003254 583 TQRDERMLIYEYLPNKSLDYFIFDTTR---------------------SKLLDWSKRSHIIAGIARGLLYLHQDSRLRII 641 (836)
Q Consensus 583 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iv 641 (836)
...+..++||||+++++|.+++..... ...+++.+++.++.||++||.|||+++ |+
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---iv 196 (343)
T 1luf_A 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FV 196 (343)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 999999999999999999999975321 256899999999999999999999998 99
Q ss_pred eccCCCCceEecCCCCceeeccCcccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCC
Q 003254 642 HRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKN 720 (836)
Q Consensus 642 H~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p 720 (836)
||||||+|||+++++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.|
T Consensus 197 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 276 (343)
T 1luf_A 197 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276 (343)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred cCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCc
Confidence 999999999999999999999999987654333233334567899999999998899999999999999999999 8888
Q ss_pred CCCCCCccccchhhhhHHhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCCCC
Q 003254 721 RGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSL 796 (836)
Q Consensus 721 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~~ 796 (836)
+...... ............ ..+......+.+++.+||+.+|++|||+.||++.|+.+...
T Consensus 277 ~~~~~~~-------~~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 277 YYGMAHE-------EVIYYVRDGNIL---------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336 (343)
T ss_dssp TTTSCHH-------HHHHHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred CCCCChH-------HHHHHHhCCCcC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence 7532111 111111111110 11122234678999999999999999999999999987653
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=353.40 Aligned_cols=260 Identities=27% Similarity=0.402 Sum_probs=211.8
Q ss_pred hcccccccCeecccCceeEEEEEee------cCcEEEEEEecCCC-chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCe
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLI------EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDE 587 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~------~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 587 (836)
..++|...+.||+|+||.||+++.. +++.||||++.... ....+.+.+|+.++++++||||+++++++...+.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 4578999999999999999999863 35789999997653 3456789999999999999999999999999999
Q ss_pred eeEEEeecCCCChhHHHhhccC---------------------CCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCC
Q 003254 588 RMLIYEYLPNKSLDYFIFDTTR---------------------SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLK 646 (836)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLk 646 (836)
.++||||+++++|.+++..... ...+++..+..++.||++||+|||+++ |+|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccc
Confidence 9999999999999999975432 234889999999999999999999998 9999999
Q ss_pred CCceEecCCCCceeeccCcccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCC
Q 003254 647 ASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNH 725 (836)
Q Consensus 647 p~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~ 725 (836)
|+|||+++++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.|+....
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999987654433333334567889999999999999999999999999999999 998875332
Q ss_pred CccccchhhhhHHhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 003254 726 ADHDHNLLGHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 793 (836)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 793 (836)
... .......... ...+......+.+++.+||+.||++|||+.||++.|+.+
T Consensus 258 ~~~-------~~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~ 309 (314)
T 2ivs_A 258 PER-------LFNLLKTGHR---------MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309 (314)
T ss_dssp GGG-------HHHHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHH-------HHHHhhcCCc---------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 211 1111111110 111122335678999999999999999999999999875
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=353.66 Aligned_cols=249 Identities=24% Similarity=0.370 Sum_probs=205.0
Q ss_pred hcccccccCeecccCceeEEEEEe-ecCcEEEEEEecCC--CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEE
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGML-IEGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~-~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 591 (836)
..++|+..+.||+|+||.||+|++ .+|+.||||++... .....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 457899999999999999999998 45899999998654 334567789999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCC
Q 003254 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (836)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~ 671 (836)
|||+++|+|.+++... +.+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+..
T Consensus 93 ~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAH---GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp ECCCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred EECCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 9999999999998543 45899999999999999999999998 99999999999999999999999999987643
Q ss_pred CccccccccccccccccCcccccCCccC-ccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhcc
Q 003254 672 DQTEANTKRVVGTYGYMSPEYAIDGLFS-VKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELID 750 (836)
Q Consensus 672 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t-~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 750 (836)
.. ......||+.|+|||++.+..++ .++|||||||++|||++|+.||...... . ..........
T Consensus 167 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~-~~~~i~~~~~----- 231 (328)
T 3fe3_A 167 GG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK------E-LRERVLRGKY----- 231 (328)
T ss_dssp SC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH------H-HHHHHHHCCC-----
T ss_pred CC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH------H-HHHHHHhCCC-----
Confidence 32 23346799999999999988765 8999999999999999999997532211 0 1111111100
Q ss_pred ccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 751 QSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 751 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
..+......+.+++.+||+.||++|||+.|+++.
T Consensus 232 -----~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 232 -----RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp -----CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred -----CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1111223457799999999999999999999864
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=371.66 Aligned_cols=261 Identities=28% Similarity=0.417 Sum_probs=211.1
Q ss_pred HhhcccccccCeecccCceeEEEEEeecCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEE
Q 003254 513 ANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (836)
Q Consensus 513 ~~a~~~f~~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 592 (836)
+...++|...+.||+|+||.||+|++.++..||||+++... ...++|.+|+.++++++||||+++++++. .+..++||
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~ 261 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIIT 261 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred eechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEE
Confidence 34457888899999999999999999888999999997644 45688999999999999999999999986 66789999
Q ss_pred eecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCC
Q 003254 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (836)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~ 672 (836)
||+++|+|.+++... ....+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 262 e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~ 337 (454)
T 1qcf_A 262 EFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDN 337 (454)
T ss_dssp CCCTTCBHHHHHHSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH
T ss_pred eecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC
Confidence 999999999999543 2235788999999999999999999998 999999999999999999999999999876432
Q ss_pred ccccccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhccCchhhccc
Q 003254 673 QTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQ 751 (836)
Q Consensus 673 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 751 (836)
.. .......++..|+|||++..+.++.++||||||++||||++ |+.|+...... ... ......
T Consensus 338 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~---~~~----~~i~~~-------- 401 (454)
T 1qcf_A 338 EY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVI----RALERG-------- 401 (454)
T ss_dssp HH-HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHH----HHHHHT--------
T ss_pred ce-eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH---HHH----HHHHcC--------
Confidence 21 11223456789999999998999999999999999999999 99887532211 111 111111
Q ss_pred cccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCCCC
Q 003254 752 SLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSL 796 (836)
Q Consensus 752 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~~ 796 (836)
.....+......+.+++.+||+.||++|||+.+|++.|+.+...
T Consensus 402 -~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 402 -YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp -CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred -CCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 01111222345678999999999999999999999999998653
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=345.42 Aligned_cols=262 Identities=23% Similarity=0.287 Sum_probs=201.2
Q ss_pred hcccccccCeecccCceeEEEEEeecCcEEEEEEecCCCchhHHHHHHHHHHHHh--hcCCceeeEEeEEeeC----Cee
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAK--LQHRNLVKLLGCCTQR----DER 588 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~--l~H~niv~l~g~~~~~----~~~ 588 (836)
..++|+..+.||+|+||.||+|+. +++.||||++... ..+.+..|.+++.. ++||||+++++++... ...
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 457899999999999999999988 7899999998643 34556677777776 7899999999997543 457
Q ss_pred eEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhh--------cCCCCcEEeccCCCCceEecCCCCcee
Q 003254 589 MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLH--------QDSRLRIIHRDLKASNVLLDNTMNPKI 660 (836)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~ivH~DLkp~NILl~~~~~~kl 660 (836)
++||||+++|+|.+++. ...+++..+.+++.||+.||+||| +.+ |+||||||+|||++.++.+||
T Consensus 82 ~lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp EEEECCCTTCBHHHHHT----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEE
T ss_pred EEehhhccCCCHHHHHh----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEE
Confidence 89999999999999993 346899999999999999999999 666 999999999999999999999
Q ss_pred eccCcccccCCCcccc--ccccccccccccCcccccCC------ccCccccccchhhhhhhhhhC----------CCCCC
Q 003254 661 SDFGLARSFGLDQTEA--NTKRVVGTYGYMSPEYAIDG------LFSVKSDVFSFGVLVLEIICG----------KKNRG 722 (836)
Q Consensus 661 ~DFgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~t~ksDVwS~GvvL~elltG----------~~p~~ 722 (836)
+|||+++......... ......||+.|+|||.+.+. .++.++||||||+++|||++| +.|+.
T Consensus 155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~ 234 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234 (301)
T ss_dssp CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence 9999998754332211 12335799999999999876 567899999999999999999 66654
Q ss_pred CCCCccccchhhhhHHhhhcc-CchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 003254 723 FNHADHDHNLLGHAWRLWIEE-RPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 793 (836)
Q Consensus 723 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 793 (836)
......... .......... ...... ...........+.+++.+||+.||++|||+.||++.|+.+
T Consensus 235 ~~~~~~~~~--~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 235 DVVPNDPSF--EDMRKVVCVDQQRPNIP----NRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TTSCSSCCH--HHHHHHHTTSCCCCCCC----GGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCCCCcch--hhhhHHHhccCCCCCCC----hhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 322221111 1111111100 000000 0112234567789999999999999999999999999864
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=364.98 Aligned_cols=260 Identities=29% Similarity=0.415 Sum_probs=208.2
Q ss_pred cccccccCeecccCceeEEEEEee------cCcEEEEEEecCC-CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCee
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLI------EGQEIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDER 588 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~------~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 588 (836)
.++|+..+.||+|+||.||+|++. .++.||||++... ......++.+|+.++++++||||+++++++......
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 367889999999999999999953 3678999999654 344556789999999999999999999999999999
Q ss_pred eEEEeecCCCChhHHHhhccC----CCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCC---Cceee
Q 003254 589 MLIYEYLPNKSLDYFIFDTTR----SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTM---NPKIS 661 (836)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~---~~kl~ 661 (836)
++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence 999999999999999975432 245889999999999999999999998 99999999999999544 59999
Q ss_pred ccCcccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhh
Q 003254 662 DFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLW 740 (836)
Q Consensus 662 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 740 (836)
|||+++.+.............+|+.|+|||++.+..++.++|||||||++|||++ |+.|+...... . .....
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~---~----~~~~i 299 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ---E----VLEFV 299 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---H----HHHHH
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH---H----HHHHH
Confidence 9999986533322233334567899999999999999999999999999999998 88887532211 0 11111
Q ss_pred hccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 003254 741 IEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 794 (836)
Q Consensus 741 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 794 (836)
.... ....+......+.+++.+||+.+|++|||+.||++.|+.+.
T Consensus 300 ~~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 300 TSGG---------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp HTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HcCC---------CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 1111 01111222345789999999999999999999999998763
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=356.24 Aligned_cols=263 Identities=27% Similarity=0.417 Sum_probs=209.0
Q ss_pred hcccccccCeecccCceeEEEEEee------cCcEEEEEEecCCC-chhHHHHHHHHHHHHhh-cCCceeeEEeEEeeCC
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLI------EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRD 586 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~------~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~ 586 (836)
..++|...+.||+|+||.||+|+.. .+..||||++.... ....+.+.+|+.++.++ +||||+++++++...+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 4578999999999999999999962 35689999997542 34557899999999999 8999999999999999
Q ss_pred eeeEEEeecCCCChhHHHhhccCC--------------------CcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCC
Q 003254 587 ERMLIYEYLPNKSLDYFIFDTTRS--------------------KLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLK 646 (836)
Q Consensus 587 ~~~lV~Ey~~~gsL~~~l~~~~~~--------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLk 646 (836)
..++||||+++|+|.+++...... ..+++..++.++.||+.||+|||+.+ |+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCC
Confidence 999999999999999999654321 34889999999999999999999998 9999999
Q ss_pred CCceEecCCCCceeeccCcccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCC
Q 003254 647 ASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNH 725 (836)
Q Consensus 647 p~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~ 725 (836)
|+|||++.++.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+....
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 9999999999999999999987654333333334567889999999999999999999999999999998 998875432
Q ss_pred CccccchhhhhHHhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCCC
Q 003254 726 ADHDHNLLGHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS 795 (836)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~ 795 (836)
... . ........ .....+......+.+++.+||+.||++|||+.||++.|+.+..
T Consensus 280 ~~~--~----~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 334 (344)
T 1rjb_A 280 VDA--N----FYKLIQNG---------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA 334 (344)
T ss_dssp CSH--H----HHHHHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred cHH--H----HHHHHhcC---------CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 211 0 11111111 1111112223567899999999999999999999999988644
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=371.88 Aligned_cols=259 Identities=26% Similarity=0.398 Sum_probs=212.1
Q ss_pred hcccccccCeecccCceeEEEEEeec-CcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEe
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 593 (836)
..++|+..++||+|+||.||+|++.. +..||||++.... ...++|.+|+.++++++||||+++++++...+..++|||
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E 296 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 296 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence 34678888999999999999999876 8899999997543 346789999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCc
Q 003254 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (836)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~ 673 (836)
|+++|+|.+++... ....+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++......
T Consensus 297 ~~~~g~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 372 (495)
T 1opk_A 297 FMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372 (495)
T ss_dssp CCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred ccCCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence 99999999999653 3356899999999999999999999998 9999999999999999999999999998764322
Q ss_pred cccccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhccCchhhcccc
Q 003254 674 TEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQS 752 (836)
Q Consensus 674 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 752 (836)
. .......++..|+|||++.+..++.++|||||||+||||++ |+.|+...... .+ ..... ..
T Consensus 373 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~---~~----~~~~~---------~~ 435 (495)
T 1opk_A 373 Y-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QV----YELLE---------KD 435 (495)
T ss_dssp E-ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GH----HHHHH---------TT
T ss_pred e-eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH---HH----HHHHH---------cC
Confidence 2 12223456789999999999999999999999999999999 88886532211 11 11111 11
Q ss_pred ccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCCC
Q 003254 753 LDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS 795 (836)
Q Consensus 753 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~ 795 (836)
.....+......+.+|+.+||+.+|++|||+.||++.|+.+..
T Consensus 436 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 436 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred CCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 1111222334567899999999999999999999999998743
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=342.10 Aligned_cols=254 Identities=30% Similarity=0.461 Sum_probs=196.1
Q ss_pred cccccccCeecccCceeEEEEEeecCcEEEEEEecCCC----chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEE
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGS----GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 591 (836)
.++|+..+.||+|+||.||+|.. .++.||||++.... ....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 46888999999999999999997 58899999986543 23357789999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecC--------CCCceeecc
Q 003254 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN--------TMNPKISDF 663 (836)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~--------~~~~kl~DF 663 (836)
|||+++++|.+++. ...+++..+..++.|++.||+|||+++..+|+||||||+|||++. ++.+||+||
T Consensus 85 ~e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 85 MEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 99999999998883 356899999999999999999999987556899999999999986 778999999
Q ss_pred CcccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhcc
Q 003254 664 GLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEE 743 (836)
Q Consensus 664 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 743 (836)
|++....... .....|++.|+|||.+.+..++.++||||||++++||++|+.|+...... ..........
T Consensus 161 g~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~ 230 (271)
T 3dtc_A 161 GLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL------AVAYGVAMNK 230 (271)
T ss_dssp CC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH------HHHHHHHTSC
T ss_pred Cccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHhhhcCC
Confidence 9998654322 22357899999999999999999999999999999999999997532211 0011111110
Q ss_pred CchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 003254 744 RPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 793 (836)
Q Consensus 744 ~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 793 (836)
.....+......+.+++.+||+.+|++|||+.|+++.|+.+
T Consensus 231 ---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 231 ---------LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp ---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred ---------CCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 01111222335678999999999999999999999999864
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=344.40 Aligned_cols=270 Identities=21% Similarity=0.257 Sum_probs=213.5
Q ss_pred cccccccCeecccCceeEEEEEeec-CcEEEEEEecCCC-chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCC--eeeEE
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD--ERMLI 591 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~--~~~lV 591 (836)
.++|...+.||+|+||.||+|+... ++.||||++.... ....+.+.+|+.++++++||||+++++++.... ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 4679999999999999999999865 8999999987543 334577889999999999999999999998765 67999
Q ss_pred EeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEe----cCCCCceeeccCccc
Q 003254 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLL----DNTMNPKISDFGLAR 667 (836)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl----~~~~~~kl~DFgla~ 667 (836)
|||+++++|.+++........+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 999999999999976555555999999999999999999999998 9999999999999 788889999999998
Q ss_pred ccCCCccccccccccccccccCccccc--------CCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHh
Q 003254 668 SFGLDQTEANTKRVVGTYGYMSPEYAI--------DGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRL 739 (836)
Q Consensus 668 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~ 739 (836)
.+..... .....||+.|+|||++. +..++.++|||||||++|||++|+.||.......... . ....
T Consensus 165 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~--~-~~~~ 238 (319)
T 4euu_A 165 ELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK--E-VMYK 238 (319)
T ss_dssp ECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCH--H-HHHH
T ss_pred ecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhH--H-HHHH
Confidence 7643322 22357899999999986 5778999999999999999999999975432221111 1 1111
Q ss_pred hhccCchhhccc-------------c--ccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 003254 740 WIEERPLELIDQ-------------S--LDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 794 (836)
Q Consensus 740 ~~~~~~~~~~d~-------------~--l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 794 (836)
.....+...+.. . .....+......+.+++.+||+.||++|||+.|+++..+...
T Consensus 239 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp HHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred HhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 111111111100 0 111344556677889999999999999999999999987643
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=348.70 Aligned_cols=261 Identities=26% Similarity=0.391 Sum_probs=211.1
Q ss_pred hcccccccCeecccCceeEEEEEe------ecCcEEEEEEecCCCc-hhHHHHHHHHHHHHhh-cCCceeeEEeEEeeCC
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGML------IEGQEIAVKRLSKGSG-QGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRD 586 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~------~~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~ 586 (836)
..++|+..+.||+|+||.||+|+. ..++.||||++..... ...+.+.+|+.+++++ +||||+++++++...+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 346889999999999999999985 2367899999976543 3457899999999999 8999999999999999
Q ss_pred eeeEEEeecCCCChhHHHhhccC---------------CCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceE
Q 003254 587 ERMLIYEYLPNKSLDYFIFDTTR---------------SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVL 651 (836)
Q Consensus 587 ~~~lV~Ey~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NIL 651 (836)
..++||||+++|+|.+++..... ...+++..+..++.||+.||+|||+++ |+||||||+||+
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil 177 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNIL 177 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEE
Confidence 99999999999999999965432 125899999999999999999999998 999999999999
Q ss_pred ecCCCCceeeccCcccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCcccc
Q 003254 652 LDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDH 730 (836)
Q Consensus 652 l~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~ 730 (836)
+++++.+||+|||+++...............+++.|+|||.+.+..++.++||||||++++||++ |+.|+.......
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-- 255 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS-- 255 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH--
T ss_pred EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh--
Confidence 99999999999999987754443333334567889999999999999999999999999999999 888875432211
Q ss_pred chhhhhHHhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 003254 731 NLLGHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 793 (836)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 793 (836)
. ........ .....+......+.+++.+||+.||++|||+.||++.|+.+
T Consensus 256 ~----~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 305 (313)
T 1t46_A 256 K----FYKMIKEG---------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (313)
T ss_dssp H----HHHHHHHT---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred H----HHHHhccC---------CCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 0 11111111 01111112234678999999999999999999999999875
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=344.64 Aligned_cols=256 Identities=25% Similarity=0.380 Sum_probs=206.3
Q ss_pred hcccccccCeecccCceeEEEEEeecCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEee
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 594 (836)
..++|+..+.||+|+||.||++...++..||||++.... ...+++.+|+.++.+++||||+++++++.+.+..++||||
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 100 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 100 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence 457889999999999999999999888899999997554 3357799999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcc
Q 003254 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (836)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~ 674 (836)
+++++|.+++... ...+++..+..++.|++.||+|||+++ |+||||||+||++++++.+||+|||++........
T Consensus 101 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 175 (283)
T 3gen_A 101 MANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 175 (283)
T ss_dssp CTTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH
T ss_pred cCCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccccccccc
Confidence 9999999999542 346899999999999999999999998 99999999999999999999999999987643221
Q ss_pred ccccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhccCchhhccccc
Q 003254 675 EANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSL 753 (836)
Q Consensus 675 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 753 (836)
.......+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+....... ........ .
T Consensus 176 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~-------~~~~~~~~---------~ 238 (283)
T 3gen_A 176 -TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE-------TAEHIAQG---------L 238 (283)
T ss_dssp -HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-------HHHHHHTT---------C
T ss_pred -ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH-------HHHHHhcc---------c
Confidence 12223456788999999998899999999999999999998 998875322110 11111111 0
Q ss_pred cCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 003254 754 DNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 793 (836)
Q Consensus 754 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 793 (836)
....+......+.+++.+||+.+|++|||+.|+++.|+.+
T Consensus 239 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 278 (283)
T 3gen_A 239 RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 278 (283)
T ss_dssp CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 0111111234578999999999999999999999999865
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=353.25 Aligned_cols=264 Identities=24% Similarity=0.373 Sum_probs=195.4
Q ss_pred HhhcccccccCeecccCceeEEEEEeecCc----EEEEEEecCC--CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCC
Q 003254 513 ANATDNFSEKNKLGEGGFGPVYKGMLIEGQ----EIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD 586 (836)
Q Consensus 513 ~~a~~~f~~~~~lG~G~fG~Vykg~~~~g~----~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~ 586 (836)
....++|+..+.||+|+||.||+|+..... .||||++... .....+.+.+|+.++++++||||+++++++....
T Consensus 19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 98 (323)
T 3qup_A 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR 98 (323)
T ss_dssp BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence 345578999999999999999999976532 7999998754 3455678999999999999999999999998776
Q ss_pred ee------eEEEeecCCCChhHHHhhccC---CCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCC
Q 003254 587 ER------MLIYEYLPNKSLDYFIFDTTR---SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMN 657 (836)
Q Consensus 587 ~~------~lV~Ey~~~gsL~~~l~~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~ 657 (836)
.. ++||||+++|+|.+++..... ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.
T Consensus 99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~ 175 (323)
T 3qup_A 99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMT 175 (323)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSC
T ss_pred cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCC
Confidence 65 999999999999999865432 225899999999999999999999998 999999999999999999
Q ss_pred ceeeccCcccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhh
Q 003254 658 PKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHA 736 (836)
Q Consensus 658 ~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~ 736 (836)
+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.|+....... .
T Consensus 176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~---- 248 (323)
T 3qup_A 176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE---I---- 248 (323)
T ss_dssp EEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---H----
T ss_pred EEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH---H----
Confidence 99999999987654333233333556889999999999999999999999999999999 888875322211 1
Q ss_pred HHhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCCC
Q 003254 737 WRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS 795 (836)
Q Consensus 737 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~ 795 (836)
......... ..........+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 249 ~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~ 298 (323)
T 3qup_A 249 YNYLIGGNR---------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILG 298 (323)
T ss_dssp HHHHHTTCC---------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHhcCCC---------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 111111110 01112233467899999999999999999999999998643
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=354.19 Aligned_cols=257 Identities=25% Similarity=0.358 Sum_probs=202.8
Q ss_pred ccccccCeecccCceeEEEEEeec-Cc----EEEEEEecCCC-chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeE
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQ----EIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-g~----~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 590 (836)
++|+..+.||+|+||.||+|++.. ++ +||+|.+.... ....+.+.+|+.++++++||||+++++++. .+..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 578889999999999999999754 44 38888875443 344567889999999999999999999986 567899
Q ss_pred EEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccC
Q 003254 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (836)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~ 670 (836)
||||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 92 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp EEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred EEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccC
Confidence 99999999999998542 357899999999999999999999998 9999999999999999999999999999875
Q ss_pred CCccccccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhccCchhhc
Q 003254 671 LDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEERPLELI 749 (836)
Q Consensus 671 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (836)
............++..|+|||.+.+..++.++||||||+++|||++ |+.|+........ ..........
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-------~~~~~~~~~~--- 236 (325)
T 3kex_A 167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEV-------PDLLEKGERL--- 236 (325)
T ss_dssp CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHH-------HHHHHTTCBC---
T ss_pred cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHH-------HHHHHcCCCC---
Confidence 5444333445678889999999999999999999999999999999 9999764322211 1111111000
Q ss_pred cccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCCC
Q 003254 750 DQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS 795 (836)
Q Consensus 750 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~ 795 (836)
..+......+.+++.+||+.+|++|||+.||++.|+.+..
T Consensus 237 ------~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 237 ------AQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp ------CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred ------CCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 0111112246689999999999999999999999987643
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=342.03 Aligned_cols=263 Identities=24% Similarity=0.336 Sum_probs=206.7
Q ss_pred cccccccCeecccCceeEEEEEee-cCcEEEEEEecCCC---chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEE
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 591 (836)
.++|+..+.||+|+||.||+++.. .++.||+|++.... ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 468999999999999999999975 48899999986542 34457889999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCC
Q 003254 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (836)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~ 671 (836)
|||+++++|.+++... .++++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 90 ~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESH---GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 9999999999998543 46899999999999999999999998 99999999999999999999999999987643
Q ss_pred CccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccc
Q 003254 672 DQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQ 751 (836)
Q Consensus 672 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 751 (836)
... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... ...........+ .. ..
T Consensus 164 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~------~~~~~~~~~~~~-~~-~~ 234 (294)
T 4eqm_A 164 TSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV------SIAIKHIQDSVP-NV-TT 234 (294)
T ss_dssp ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH------HHHHHHHSSCCC-CH-HH
T ss_pred ccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHhhccCC-Cc-ch
Confidence 221 2233457899999999999999999999999999999999999997532211 111111111111 00 00
Q ss_pred cccCCCChHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHhcCCCCCC
Q 003254 752 SLDNSCSFSEALRCIQVGLLCVQQRPEDRP-NMSSVVLMLSGERSLP 797 (836)
Q Consensus 752 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-t~~eVl~~L~~~~~~~ 797 (836)
.........+.+++.+|++.||++|| ++.++.+.|+......
T Consensus 235 ----~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~ 277 (294)
T 4eqm_A 235 ----DVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN 277 (294)
T ss_dssp ----HSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred ----hcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence 01112234577999999999999999 9999999999875433
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=368.80 Aligned_cols=260 Identities=27% Similarity=0.418 Sum_probs=205.6
Q ss_pred hcccccccCeecccCceeEEEEEeecCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEee
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 594 (836)
..++|+..++||+|+||.||+|++.++..||||+++... ...++|.+|+.++++++||||+++++++.+ +..++||||
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~ 259 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 259 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence 456788899999999999999999888889999997544 345789999999999999999999999876 778999999
Q ss_pred cCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcc
Q 003254 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (836)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~ 674 (836)
+++|+|.+++... ....+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.......
T Consensus 260 ~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 335 (452)
T 1fmk_A 260 MSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 335 (452)
T ss_dssp CTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred hcCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCce
Confidence 9999999999542 2345899999999999999999999998 99999999999999999999999999987643221
Q ss_pred ccccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhccCchhhccccc
Q 003254 675 EANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSL 753 (836)
Q Consensus 675 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 753 (836)
.......++..|+|||.+.++.++.++||||||++||||++ |+.|+...... . ........ .
T Consensus 336 -~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~---~----~~~~i~~~---------~ 398 (452)
T 1fmk_A 336 -TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---E----VLDQVERG---------Y 398 (452)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---H----HHHHHHTT---------C
T ss_pred -ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH---H----HHHHHHcC---------C
Confidence 11223456789999999999999999999999999999999 88886432211 1 11111111 1
Q ss_pred cCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCCCCC
Q 003254 754 DNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLP 797 (836)
Q Consensus 754 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~~~ 797 (836)
....+......+.+++.+||+.+|++|||+.+|++.|+.+....
T Consensus 399 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~ 442 (452)
T 1fmk_A 399 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442 (452)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence 11122233456789999999999999999999999999986543
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=350.06 Aligned_cols=249 Identities=24% Similarity=0.322 Sum_probs=204.0
Q ss_pred cccccccCeecccCceeEEEEEeec-CcEEEEEEecCC---CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEE
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 591 (836)
.++|+..+.||+|+||.||+++... |+.||+|++++. .....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 3689999999999999999999864 899999999654 233456789999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCC
Q 003254 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (836)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~ 671 (836)
|||+++|+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 84 MEYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 999999999988853 346899999999999999999999998 99999999999999999999999999986432
Q ss_pred CccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccc
Q 003254 672 DQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQ 751 (836)
Q Consensus 672 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 751 (836)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...... .. .........
T Consensus 158 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~----~~~i~~~~~------ 222 (337)
T 1o6l_A 158 DG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---RL----FELILMEEI------ 222 (337)
T ss_dssp TT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HH----HHHHHHCCC------
T ss_pred CC--CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH---HH----HHHHHcCCC------
Confidence 21 2234468999999999999999999999999999999999999997532211 11 111111100
Q ss_pred cccCCCChHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 003254 752 SLDNSCSFSEALRCIQVGLLCVQQRPEDRP-----NMSSVVLM 789 (836)
Q Consensus 752 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~eVl~~ 789 (836)
..+......+.+++.+||+.||++|| ++.||++.
T Consensus 223 ----~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 223 ----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ----CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 11112234577999999999999999 89999763
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=346.56 Aligned_cols=264 Identities=25% Similarity=0.349 Sum_probs=202.0
Q ss_pred hhcccccccCeecccCceeEEEEEeecCcEEEEEEecCCC--chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEE
Q 003254 514 NATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (836)
Q Consensus 514 ~a~~~f~~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 591 (836)
...++|+..++||+|+||.||+++..+|+.||+|++.... ....+.+.+|+.++++++||||+++++++......++|
T Consensus 18 ~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 97 (311)
T 3niz_A 18 GLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLV 97 (311)
T ss_dssp CSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEE
T ss_pred chHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEE
Confidence 3457899999999999999999999889999999986543 23356788999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCC
Q 003254 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (836)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~ 671 (836)
|||+++ +|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 98 ~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 171 (311)
T 3niz_A 98 FEFMEK-DLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGI 171 (311)
T ss_dssp EECCSE-EHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred EcCCCC-CHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence 999985 77777643 3346899999999999999999999998 99999999999999999999999999987643
Q ss_pred CccccccccccccccccCcccccC-CccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchh---
Q 003254 672 DQTEANTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLE--- 747 (836)
Q Consensus 672 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 747 (836)
... ......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ............+.+
T Consensus 172 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~ 246 (311)
T 3niz_A 172 PVR--SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ---LPKIFSILGTPNPREWPQ 246 (311)
T ss_dssp CCC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH---HHHHHHHHCCCCTTTSGG
T ss_pred Ccc--cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHHCCCChHHhhh
Confidence 222 2233578999999999876 5689999999999999999999999864333221 111111111111100
Q ss_pred -------------hccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 748 -------------LIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 748 -------------~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
..+.............++.+++.+||+.||++|||+.|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 247 VQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp GTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00000000000112245789999999999999999999987
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=350.51 Aligned_cols=252 Identities=23% Similarity=0.305 Sum_probs=203.8
Q ss_pred hcccccccCeecccCceeEEEEEeec-CcEEEEEEecCCCch------hHHHHHHHHHHHHhhcCCceeeEEeEEeeCCe
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQ------GMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDE 587 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 587 (836)
..+.|++.+.||+|+||.||+++... |+.||+|++...... ..+.+.+|+.++++++||||+++++++.....
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 45789999999999999999999864 899999999765322 35789999999999999999999999999999
Q ss_pred eeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCC----Cceeecc
Q 003254 588 RMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTM----NPKISDF 663 (836)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~----~~kl~DF 663 (836)
.++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++ .+||+||
T Consensus 90 ~~lv~e~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEEECCCSCBHHHHHTT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 9999999999999999843 456899999999999999999999998 99999999999998776 7999999
Q ss_pred CcccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhcc
Q 003254 664 GLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEE 743 (836)
Q Consensus 664 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 743 (836)
|++..+.... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ... ......
T Consensus 164 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~---~~~----~~i~~~ 233 (361)
T 2yab_A 164 GLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---ETL----ANITAV 233 (361)
T ss_dssp SSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHH----HHHHTT
T ss_pred CCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH---HHH----HHHHhc
Confidence 9998764322 223467999999999999999999999999999999999999997532211 110 111110
Q ss_pred CchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 744 RPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 744 ~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
.. . .++.... .....+.+++.+||+.||++|||+.|+++
T Consensus 234 ~~-~-~~~~~~~----~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 234 SY-D-FDEEFFS----QTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp CC-C-CCHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CC-C-CCchhcc----CCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00 0 0000000 11245779999999999999999999985
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=346.77 Aligned_cols=260 Identities=19% Similarity=0.202 Sum_probs=207.2
Q ss_pred cccccccCeecccCceeEEEEEee-cCcEEEEEEecCCCchhHHHHHHHHHHHHhh-cCCceeeEEeEEeeCCeeeEEEe
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDERMLIYE 593 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 593 (836)
.++|+..+.||+|+||.||+|+.. +|+.||||++..... .+.+.+|+.+++++ +||||+++++++...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 468999999999999999999974 588999999875432 35688999999999 89999999999999999999999
Q ss_pred ecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCC-----ceeeccCcccc
Q 003254 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMN-----PKISDFGLARS 668 (836)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~-----~kl~DFgla~~ 668 (836)
|+ +++|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||+++.
T Consensus 86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 86 LL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred eC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 99 99999998643 457999999999999999999999998 999999999999998887 99999999987
Q ss_pred cCCCcccc-----ccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhcc
Q 003254 669 FGLDQTEA-----NTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEE 743 (836)
Q Consensus 669 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 743 (836)
+....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.....................
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~- 238 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRA- 238 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHH-
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhcc-
Confidence 64332211 123467999999999999999999999999999999999999998654332211111111110000
Q ss_pred CchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 003254 744 RPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 793 (836)
Q Consensus 744 ~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 793 (836)
.+.+. +... .. .+.+++..|++.+|.+||++.+|++.|+.+
T Consensus 239 ~~~~~----~~~~----~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~ 279 (330)
T 2izr_A 239 TPIEV----LCEN----FP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDL 279 (330)
T ss_dssp SCHHH----HTTT----CH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred CCHHH----Hhcc----Ch-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence 00000 0000 11 688999999999999999999999999754
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=363.82 Aligned_cols=252 Identities=25% Similarity=0.346 Sum_probs=205.4
Q ss_pred hcccccccCeecccCceeEEEEEeecCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCC-eeeEEEe
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD-ERMLIYE 593 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-~~~lV~E 593 (836)
..++|+..+.||+|+||.||+|.. .|+.||||+++... ..+.|.+|+.++++++||||+++++++.+.+ ..++|||
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e 267 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 267 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEe-cCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence 446788899999999999999998 57899999997653 4578999999999999999999999987765 7899999
Q ss_pred ecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCc
Q 003254 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (836)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~ 673 (836)
|+++|+|.+++... ....+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 268 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~- 342 (450)
T 1k9a_A 268 YMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 342 (450)
T ss_dssp CCTTCBHHHHHHHH-CTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred ecCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc-
Confidence 99999999999653 2345789999999999999999999998 999999999999999999999999999864321
Q ss_pred cccccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhccCchhhcccc
Q 003254 674 TEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQS 752 (836)
Q Consensus 674 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 752 (836)
.....+++.|+|||.+.+..++.++||||||++||||++ |+.|+....... .. ......
T Consensus 343 ----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---~~----~~i~~~--------- 402 (450)
T 1k9a_A 343 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VV----PRVEKG--------- 402 (450)
T ss_dssp --------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT---HH----HHHHTT---------
T ss_pred ----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HH----HHHHcC---------
Confidence 112356889999999999999999999999999999998 999875332211 11 111111
Q ss_pred ccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 003254 753 LDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 794 (836)
Q Consensus 753 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 794 (836)
.....+......+.+++.+||+.||++|||+.+|++.|+.+.
T Consensus 403 ~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~ 444 (450)
T 1k9a_A 403 YKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR 444 (450)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 111122233456789999999999999999999999998764
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=348.70 Aligned_cols=252 Identities=23% Similarity=0.322 Sum_probs=198.7
Q ss_pred cccccccCeecccCceeEEEEEee-cCcEEEEEEecCCC-chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCe------
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDE------ 587 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~------ 587 (836)
.++|+..+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.++++++||||+++++++.+...
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 467899999999999999999986 58999999997543 3456789999999999999999999999866442
Q ss_pred ---------------------------------------------------eeEEEeecCCCChhHHHhhccCCCcCChh
Q 003254 588 ---------------------------------------------------RMLIYEYLPNKSLDYFIFDTTRSKLLDWS 616 (836)
Q Consensus 588 ---------------------------------------------------~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~ 616 (836)
.++||||+++++|.+++.........++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 78999999999999999765555566777
Q ss_pred hhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCccc----------ccccccccccc
Q 003254 617 KRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE----------ANTKRVVGTYG 686 (836)
Q Consensus 617 ~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~----------~~~~~~~gt~~ 686 (836)
.+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++........ .......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 88999999999999999998 999999999999999999999999999887543211 11233579999
Q ss_pred ccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccccccCCCChHHHHHHH
Q 003254 687 YMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDNSCSFSEALRCI 766 (836)
Q Consensus 687 y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 766 (836)
|+|||.+.+..++.++||||||+++|||++|..|+. . . ............. .........+.
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~------~--~-~~~~~~~~~~~~~---------~~~~~~~~~~~ 303 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM------E--R-VRIITDVRNLKFP---------LLFTQKYPQEH 303 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH------H--H-HHHHHHHHTTCCC---------HHHHHHCHHHH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh------H--H-HHHHHHhhccCCC---------cccccCChhHH
Confidence 999999999999999999999999999999876521 0 0 0000000000000 00112234567
Q ss_pred HHHHHcccCCCCCCCCHHHHHH
Q 003254 767 QVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 767 ~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
+++.+||+.||++|||+.|+++
T Consensus 304 ~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 304 MMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHHCSSGGGSCCHHHHHH
T ss_pred HHHHHHccCCCCcCCCHHHHhh
Confidence 8999999999999999999986
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=345.97 Aligned_cols=252 Identities=18% Similarity=0.266 Sum_probs=204.1
Q ss_pred hcccccccCeecccCceeEEEEEeec-CcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEe
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 593 (836)
..++|...+.||+|+||.||+++... ++.+|+|.+.... ...+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 81 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence 35789999999999999999999865 7889999986543 445678999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecC--CCCceeeccCcccccCC
Q 003254 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN--TMNPKISDFGLARSFGL 671 (836)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~--~~~~kl~DFgla~~~~~ 671 (836)
|+++++|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++.+..
T Consensus 82 ~~~g~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~ 156 (321)
T 1tki_A 82 FISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred eCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence 9999999999843 2346899999999999999999999998 999999999999987 78999999999987643
Q ss_pred CccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccc
Q 003254 672 DQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQ 751 (836)
Q Consensus 672 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 751 (836)
.. ......||+.|+|||++.+..++.++||||||+++|||++|+.||...... ... ......... . ..
T Consensus 157 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~----~~i~~~~~~-~-~~ 224 (321)
T 1tki_A 157 GD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ---QII----ENIMNAEYT-F-DE 224 (321)
T ss_dssp TC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHH----HHHHHTCCC-C-CH
T ss_pred CC---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH---HHH----HHHHcCCCC-C-Ch
Confidence 22 223467899999999999999999999999999999999999997532211 111 111111000 0 00
Q ss_pred cccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 752 SLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 752 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
.... .....+.+++.+||+.||++|||+.|+++
T Consensus 225 ~~~~----~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 225 EAFK----EISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHHT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hhhc----cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0000 11245789999999999999999999987
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=339.89 Aligned_cols=263 Identities=16% Similarity=0.186 Sum_probs=209.6
Q ss_pred hcccccccCeecccCceeEEEEEe-ecCcEEEEEEecCCCchhHHHHHHHHHHHHhh-cCCceeeEEeEEeeCCeeeEEE
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGML-IEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDERMLIY 592 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 592 (836)
..++|+..+.||+|+||.||+|+. .+++.||||++.... ..+.+.+|+.++..+ +|+|++++++++......++||
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 85 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 85 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence 346799999999999999999997 458999999986543 335688999999999 7999999999999999999999
Q ss_pred eecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCC-----ceeeccCccc
Q 003254 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMN-----PKISDFGLAR 667 (836)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~-----~kl~DFgla~ 667 (836)
||+ +++|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||+++
T Consensus 86 e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~ 159 (298)
T 1csn_A 86 DLL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159 (298)
T ss_dssp ECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred Eec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence 999 99999999543 346899999999999999999999998 999999999999987765 9999999998
Q ss_pred ccCCCccc-----cccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhc
Q 003254 668 SFGLDQTE-----ANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIE 742 (836)
Q Consensus 668 ~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 742 (836)
........ .......||+.|+|||.+.+..++.++||||||+++|||++|+.|+.....................
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (298)
T 1csn_A 160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 239 (298)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred ccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccC
Confidence 76543221 1223467999999999999999999999999999999999999998654332222111111111111
Q ss_pred cCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 003254 743 ERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 794 (836)
Q Consensus 743 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 794 (836)
....+. .. .....+.+++.+||+.+|++||++.+|++.|+.+.
T Consensus 240 ~~~~~~-----~~----~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~ 282 (298)
T 1csn_A 240 TPLREL-----CA----GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 282 (298)
T ss_dssp SCHHHH-----TT----TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred ccHHHH-----Hh----hCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHH
Confidence 111111 01 12245789999999999999999999999998763
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=343.09 Aligned_cols=249 Identities=24% Similarity=0.308 Sum_probs=194.5
Q ss_pred cccccccCeecccCceeEEEEEeec-CcEEEEEEecCCCc--------------------------hhHHHHHHHHHHHH
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSG--------------------------QGMEEFKNEVLLIA 568 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~--------------------------~~~~~~~~Ei~~l~ 568 (836)
.++|+..+.||+|+||.||+|+... ++.||||++..... ...+.+.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 4689999999999999999999754 88999999865421 12356899999999
Q ss_pred hhcCCceeeEEeEEee--CCeeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCC
Q 003254 569 KLQHRNLVKLLGCCTQ--RDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLK 646 (836)
Q Consensus 569 ~l~H~niv~l~g~~~~--~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLk 646 (836)
+++||||+++++++.. ....++||||+++++|.+++ ....+++..+..++.||+.||+|||+++ |+|||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk 164 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK 164 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence 9999999999999986 56789999999999997764 3457999999999999999999999998 9999999
Q ss_pred CCceEecCCCCceeeccCcccccCCCccccccccccccccccCcccccCCc---cCccccccchhhhhhhhhhCCCCCCC
Q 003254 647 ASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGL---FSVKSDVFSFGVLVLEIICGKKNRGF 723 (836)
Q Consensus 647 p~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~t~ksDVwS~GvvL~elltG~~p~~~ 723 (836)
|+|||++.++.+||+|||+++.+..... ......||+.|+|||.+.+.. ++.++||||||+++|||++|+.||..
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 242 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred HHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 9999999999999999999987643322 123357899999999998765 47889999999999999999999753
Q ss_pred CCCccccchhhhhHHhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 724 NHADHDHNLLGHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
.... . .......... .. .........+.+++.+||+.||++|||+.|+++
T Consensus 243 ~~~~------~-~~~~~~~~~~-~~-------~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 243 ERIM------C-LHSKIKSQAL-EF-------PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp SSHH------H-HHHHHHHCCC-CC-------CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ccHH------H-HHHHHhcccC-CC-------CCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 2110 0 0111111100 00 001112345789999999999999999999874
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=353.59 Aligned_cols=251 Identities=22% Similarity=0.332 Sum_probs=199.2
Q ss_pred hcccccccCeecccCceeEEEEEeec-CcEEEEEEecCCC---chhHHHHHHHHHHHHhh-cCCceeeEEeEEeeCCeee
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDERM 589 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~ 589 (836)
..++|+..+.||+|+||.||+++... ++.||||++++.. ....+.+.+|..++.++ +||||+++++++...+..+
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 129 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 129 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence 34789999999999999999999865 7889999997542 33445688999999887 8999999999999999999
Q ss_pred EEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCccccc
Q 003254 590 LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (836)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~ 669 (836)
+||||+++|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++..
T Consensus 130 lV~E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 203 (396)
T ss_dssp EEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEEcCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeec
Confidence 99999999999998854 346899999999999999999999998 999999999999999999999999999863
Q ss_pred CCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCcccc--chhhhhHHhhhccCchh
Q 003254 670 GLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDH--NLLGHAWRLWIEERPLE 747 (836)
Q Consensus 670 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 747 (836)
... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||......... ...............
T Consensus 204 ~~~--~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~-- 279 (396)
T 4dc2_A 204 LRP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-- 279 (396)
T ss_dssp CCT--TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC--
T ss_pred ccC--CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc--
Confidence 222 12234578999999999999999999999999999999999999998643222111 011111111111110
Q ss_pred hccccccCCCChHHHHHHHHHHHHcccCCCCCCCCH
Q 003254 748 LIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNM 783 (836)
Q Consensus 748 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~ 783 (836)
..+......+.+|+.+||+.||++||++
T Consensus 280 --------~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 280 --------RIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp --------CCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred --------CCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 1112223457899999999999999995
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=343.84 Aligned_cols=255 Identities=24% Similarity=0.367 Sum_probs=197.5
Q ss_pred cccccccCeecccCceeEEEEEeecCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEeec
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 595 (836)
.++|+..+.||+|+||.||+++. .++.||||++... ...+.|.+|+.++++++||||+++++++. +..++||||+
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~ 81 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYA 81 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECC
T ss_pred HhHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcC
Confidence 36788899999999999999987 5788999998643 34578999999999999999999999887 4589999999
Q ss_pred CCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCC-ceeeccCcccccCCCcc
Q 003254 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMN-PKISDFGLARSFGLDQT 674 (836)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~-~kl~DFgla~~~~~~~~ 674 (836)
++++|.+++........+++..++.++.||++||+|||+....+|+||||||+|||++.++. +||+|||++......
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-- 159 (307)
T 2eva_A 82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-- 159 (307)
T ss_dssp TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------
T ss_pred CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc--
Confidence 99999999965544445788999999999999999999943233999999999999998886 799999999765321
Q ss_pred ccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhcccccc
Q 003254 675 EANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLD 754 (836)
Q Consensus 675 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 754 (836)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.|+....... ....+.. ......
T Consensus 160 ---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----~~~~~~~-~~~~~~-------- 223 (307)
T 2eva_A 160 ---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA----FRIMWAV-HNGTRP-------- 223 (307)
T ss_dssp --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH----HHHHHHH-HTTCCC--------
T ss_pred ---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH----HHHHHHH-hcCCCC--------
Confidence 123468999999999999999999999999999999999999975322211 0111111 111110
Q ss_pred CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 003254 755 NSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 794 (836)
Q Consensus 755 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 794 (836)
.........+.+++.+||+.+|++|||+.||++.|+.+.
T Consensus 224 -~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 262 (307)
T 2eva_A 224 -PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLM 262 (307)
T ss_dssp -CCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHG
T ss_pred -CcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 011112245779999999999999999999999998764
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=349.20 Aligned_cols=262 Identities=27% Similarity=0.402 Sum_probs=210.2
Q ss_pred hcccccccCeecccCceeEEEEEee--------cCcEEEEEEecCCC-chhHHHHHHHHHHHHhh-cCCceeeEEeEEee
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLI--------EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQ 584 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~--------~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~ 584 (836)
..++|...+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.+++++ +||||+++++++..
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 4578999999999999999999863 46789999997653 34567899999999999 89999999999999
Q ss_pred CCeeeEEEeecCCCChhHHHhhccC-------------CCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceE
Q 003254 585 RDERMLIYEYLPNKSLDYFIFDTTR-------------SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVL 651 (836)
Q Consensus 585 ~~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NIL 651 (836)
.+..++||||+++|+|.+++..... ...+++..++.++.||++||+|||+.+ |+||||||+|||
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEE
Confidence 9999999999999999999965432 234889999999999999999999998 999999999999
Q ss_pred ecCCCCceeeccCcccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCcccc
Q 003254 652 LDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDH 730 (836)
Q Consensus 652 l~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~ 730 (836)
++.++.+||+|||+++...............+++.|+|||++.+..++.++||||||+++|||++ |+.|+......
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--- 266 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE--- 266 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---
T ss_pred EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH---
Confidence 99999999999999987654433233334567889999999998899999999999999999999 88886532211
Q ss_pred chhhhhHHhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCCC
Q 003254 731 NLLGHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS 795 (836)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~ 795 (836)
. .......... ...+......+.+++.+||+.+|++|||+.||++.|+.+..
T Consensus 267 ~----~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~ 318 (334)
T 2pvf_A 267 E----LFKLLKEGHR---------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318 (334)
T ss_dssp H----HHHHHHHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred H----HHHHHhcCCC---------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 0 1111111110 11112233467899999999999999999999999987643
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=349.71 Aligned_cols=268 Identities=25% Similarity=0.389 Sum_probs=214.2
Q ss_pred HHHHHhhcccccccCeecccCceeEEEEEee------cCcEEEEEEecCCCc-hhHHHHHHHHHHHHhhcCCceeeEEeE
Q 003254 509 LKIIANATDNFSEKNKLGEGGFGPVYKGMLI------EGQEIAVKRLSKGSG-QGMEEFKNEVLLIAKLQHRNLVKLLGC 581 (836)
Q Consensus 509 ~~~l~~a~~~f~~~~~lG~G~fG~Vykg~~~------~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~ 581 (836)
..+.....++|+..+.||+|+||.||+|+.. .++.||||++..... .....+.+|+.++++++||||++++++
T Consensus 17 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 96 (322)
T 1p4o_A 17 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGV 96 (322)
T ss_dssp CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred hhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEE
Confidence 3344556788999999999999999999875 367899999975533 345678999999999999999999999
Q ss_pred EeeCCeeeEEEeecCCCChhHHHhhccC-------CCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecC
Q 003254 582 CTQRDERMLIYEYLPNKSLDYFIFDTTR-------SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN 654 (836)
Q Consensus 582 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~ 654 (836)
+...+..++||||+++|+|.+++..... ...+++..+..++.||+.||.|||+++ |+||||||+|||++.
T Consensus 97 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~ 173 (322)
T 1p4o_A 97 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAE 173 (322)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECT
T ss_pred EccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcC
Confidence 9999999999999999999999865321 245789999999999999999999998 999999999999999
Q ss_pred CCCceeeccCcccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchh
Q 003254 655 TMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLL 733 (836)
Q Consensus 655 ~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~ 733 (836)
++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.|+......
T Consensus 174 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------ 247 (322)
T 1p4o_A 174 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE------ 247 (322)
T ss_dssp TCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH------
T ss_pred CCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH------
Confidence 99999999999987643332223333567889999999999999999999999999999999 78876432111
Q ss_pred hhhHHhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCCC
Q 003254 734 GHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS 795 (836)
Q Consensus 734 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~ 795 (836)
............ .........+.+++.+||+.+|++|||+.|+++.|+.+..
T Consensus 248 -~~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 248 -QVLRFVMEGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp -HHHHHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred -HHHHHHHcCCcC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 111111111110 1112223457899999999999999999999999998754
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=348.53 Aligned_cols=254 Identities=23% Similarity=0.316 Sum_probs=202.3
Q ss_pred cccccccCeecccCceeEEEEEeec-CcEEEEEEecCC-----CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeee
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG-----SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERM 589 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~-----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 589 (836)
.+.|+..+.||+|+||.||+++... |+.||||++... .....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 3678999999999999999999754 899999998532 1224678999999999999999999999999999999
Q ss_pred EEEeecCCCChhHHHhhcc-CCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCC---ceeeccCc
Q 003254 590 LIYEYLPNKSLDYFIFDTT-RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMN---PKISDFGL 665 (836)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~---~kl~DFgl 665 (836)
+||||+++++|.+.+.... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 9999999999988876533 2345899999999999999999999998 999999999999986554 99999999
Q ss_pred ccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCc
Q 003254 666 ARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERP 745 (836)
Q Consensus 666 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (836)
++.+..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... .. ..........
T Consensus 180 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~----~~~~i~~~~~ 249 (351)
T 3c0i_A 180 AIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK----ER----LFEGIIKGKY 249 (351)
T ss_dssp CEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH----HH----HHHHHHHTCC
T ss_pred eeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH----HH----HHHHHHcCCC
Confidence 987653221 2234579999999999999999999999999999999999999975321 11 1111111100
Q ss_pred hhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 746 LELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 746 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
. ..+.... .....+.+++.+||+.||++|||+.|+++
T Consensus 250 ~--~~~~~~~----~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 250 K--MNPRQWS----HISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp C--CCHHHHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred C--CCccccc----cCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 0000000 11245779999999999999999999986
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=350.68 Aligned_cols=264 Identities=28% Similarity=0.413 Sum_probs=210.6
Q ss_pred HHhhcccccccCeecccCceeEEEEEeec-C-----cEEEEEEecCCC-chhHHHHHHHHHHHHhh-cCCceeeEEeEEe
Q 003254 512 IANATDNFSEKNKLGEGGFGPVYKGMLIE-G-----QEIAVKRLSKGS-GQGMEEFKNEVLLIAKL-QHRNLVKLLGCCT 583 (836)
Q Consensus 512 l~~a~~~f~~~~~lG~G~fG~Vykg~~~~-g-----~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~ 583 (836)
.+...++|...+.||+|+||.||+|.... + ..||+|.+.... ....+.+.+|+.+++++ +||||+++++++.
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 34456789999999999999999999743 2 479999997653 34567799999999999 8999999999999
Q ss_pred eCCeeeEEEeecCCCChhHHHhhccC-----------CCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEe
Q 003254 584 QRDERMLIYEYLPNKSLDYFIFDTTR-----------SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLL 652 (836)
Q Consensus 584 ~~~~~~lV~Ey~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl 652 (836)
..+..++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+.+ |+||||||+|||+
T Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLL 197 (333)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEE
T ss_pred cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEE
Confidence 99999999999999999999865321 345789999999999999999999998 9999999999999
Q ss_pred cCCCCceeeccCcccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccc
Q 003254 653 DNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHN 731 (836)
Q Consensus 653 ~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~ 731 (836)
++++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+....... .
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~ 275 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS--K 275 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH--H
T ss_pred CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH--H
Confidence 9999999999999987644333222334567889999999999999999999999999999999 888865322211 0
Q ss_pred hhhhhHHhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 003254 732 LLGHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 793 (836)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 793 (836)
........ .....+......+.+++.+||+.+|++|||+.||++.|+.+
T Consensus 276 ----~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 276 ----FYKLVKDG---------YQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp ----HHHHHHHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----HHHHHhcC---------CCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence 11111111 00011111234678999999999999999999999999864
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=337.94 Aligned_cols=262 Identities=22% Similarity=0.302 Sum_probs=199.4
Q ss_pred ccccccCeecccCceeEEEEEeec-CcEEEEEEecCCC--chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEe
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 593 (836)
++|+..++||+|+||.||+|+... ++.||||++.... ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 578899999999999999999864 8899999997543 3345778899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCc
Q 003254 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (836)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~ 673 (836)
|++++ |...+.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~-l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 82 FCDQD-LKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEE-HHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred cCCCC-HHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence 99864 4444432 2456999999999999999999999998 9999999999999999999999999998764322
Q ss_pred cccccccccccccccCcccccCCc-cCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchh-----
Q 003254 674 TEANTKRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLE----- 747 (836)
Q Consensus 674 ~~~~~~~~~gt~~y~aPE~~~~~~-~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 747 (836)
. ......||+.|+|||++.+.. ++.++||||||++++||++|+.|+...... ........+.........
T Consensus 156 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~--~~~~~~i~~~~~~~~~~~~~~~~ 231 (292)
T 3o0g_A 156 R--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV--DDQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp S--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH--HHHHHHHHHHHCCCCTTTCTTGG
T ss_pred c--cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCH--HHHHHHHHHHhCCCChhhhhhhc
Confidence 2 223357899999999998766 899999999999999999998885322111 111111111111100000
Q ss_pred -hccc---------cccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 748 -LIDQ---------SLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 748 -~~d~---------~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
..+. .............+.+++.+||+.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 0000 0000111123356779999999999999999999986
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=352.06 Aligned_cols=274 Identities=28% Similarity=0.378 Sum_probs=211.0
Q ss_pred ccccccCeecccCceeEEEEEe-----ecCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEe--eCCeee
Q 003254 517 DNFSEKNKLGEGGFGPVYKGML-----IEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCT--QRDERM 589 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~-----~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~--~~~~~~ 589 (836)
++|+..+.||+|+||.||++++ ..++.||||++........+.+.+|+.++++++||||+++++++. .....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 6788999999999999999984 358899999998777677788999999999999999999999986 455688
Q ss_pred EEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCccccc
Q 003254 590 LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (836)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~ 669 (836)
+||||+++++|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 103 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRH--RARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp EEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred EEEeecCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceec
Confidence 999999999999998543 235899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCccc-cccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhh
Q 003254 670 GLDQTE-ANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLEL 748 (836)
Q Consensus 670 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (836)
...... .......+++.|+|||.+.+..++.++||||||++++||++|+.|+........... .............+.
T Consensus 178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 256 (327)
T 3lxl_A 178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMM-GCERDVPALSRLLEL 256 (327)
T ss_dssp CTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHC-C----CCHHHHHHHH
T ss_pred ccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhc-ccccccccHHHHHHH
Confidence 533221 122335678889999999999999999999999999999999988642111000000 000000000000111
Q ss_pred ccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCCCC
Q 003254 749 IDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSL 796 (836)
Q Consensus 749 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~~ 796 (836)
+........+......+.+++.+||+.||++|||+.||++.|+.+...
T Consensus 257 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 304 (327)
T 3lxl_A 257 LEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG 304 (327)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---
T ss_pred hhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 111112222333445688999999999999999999999999987553
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=345.58 Aligned_cols=253 Identities=23% Similarity=0.323 Sum_probs=203.8
Q ss_pred hcccccccCeecccCceeEEEEEeec-CcEEEEEEecCCCc------hhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCe
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSG------QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDE 587 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 587 (836)
..+.|...+.||+|+||.||+++... |+.||+|++..... ...+.+.+|+.++++++||||+++++++.....
T Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 88 (326)
T 2y0a_A 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 88 (326)
T ss_dssp HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 34678999999999999999999864 89999999875432 135789999999999999999999999999999
Q ss_pred eeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCC----Cceeecc
Q 003254 588 RMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTM----NPKISDF 663 (836)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~----~~kl~DF 663 (836)
.++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++ .+||+||
T Consensus 89 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Df 162 (326)
T 2y0a_A 89 VILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDF 162 (326)
T ss_dssp EEEEEECCCSCBHHHHHTT---SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEEcCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence 9999999999999999843 456899999999999999999999998 99999999999999887 8999999
Q ss_pred CcccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhcc
Q 003254 664 GLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEE 743 (836)
Q Consensus 664 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 743 (836)
|+++.+.... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...... ... ......
T Consensus 163 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~----~~~~~~ 232 (326)
T 2y0a_A 163 GLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---ETL----ANVSAV 232 (326)
T ss_dssp TTCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHH----HHHHHT
T ss_pred CCCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH---HHH----HHHHhc
Confidence 9998764322 223467999999999999999999999999999999999999997532211 010 000000
Q ss_pred CchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 744 RPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 744 ~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
.. ..... ... .....+.+++.+||+.||++|||+.|+++.
T Consensus 233 ~~-~~~~~-~~~----~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 233 NY-EFEDE-YFS----NTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp CC-CCCHH-HHT----TSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CC-CcCcc-ccc----cCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00 00000 000 112457799999999999999999999873
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=341.48 Aligned_cols=253 Identities=22% Similarity=0.368 Sum_probs=203.7
Q ss_pred cccccccCeecccCceeEEEEEeec-C-------cEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCe
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLIE-G-------QEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDE 587 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~~-g-------~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 587 (836)
.++|...+.||+|+||.||+|+... + ..||+|++........+.+.+|+.++++++||||+++++++...+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 4688899999999999999999754 3 4799999977666677889999999999999999999999999999
Q ss_pred eeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCC--------ce
Q 003254 588 RMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMN--------PK 659 (836)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~--------~k 659 (836)
.++||||+++++|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++. +|
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CEEEEECCCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence 99999999999999999643 334899999999999999999999998 999999999999998887 99
Q ss_pred eeccCcccccCCCccccccccccccccccCcccccC-CccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHH
Q 003254 660 ISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWR 738 (836)
Q Consensus 660 l~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~ 738 (836)
|+|||++...... ....+++.|+|||.+.+ ..++.++||||||+++|||++|..|+....... ....
T Consensus 162 l~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~------~~~~ 229 (289)
T 4fvq_A 162 LSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ------RKLQ 229 (289)
T ss_dssp ECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH------HHHH
T ss_pred eccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchH------HHHH
Confidence 9999998754321 22457889999999987 679999999999999999999765532211110 0000
Q ss_pred hhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCCCC
Q 003254 739 LWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSL 796 (836)
Q Consensus 739 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~~ 796 (836)
...... ..+......+.+++.+||+.||++|||+.|+++.|+.+...
T Consensus 230 ~~~~~~-----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p 276 (289)
T 4fvq_A 230 FYEDRH-----------QLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276 (289)
T ss_dssp HHHTTC-----------CCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred HhhccC-----------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 000000 00011123467899999999999999999999999998663
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=345.93 Aligned_cols=270 Identities=28% Similarity=0.398 Sum_probs=214.2
Q ss_pred ccHHHHHhhcccccccCeecccCceeEEEEEee------cCcEEEEEEecCCCc-hhHHHHHHHHHHHHhh-cCCceeeE
Q 003254 507 FDLKIIANATDNFSEKNKLGEGGFGPVYKGMLI------EGQEIAVKRLSKGSG-QGMEEFKNEVLLIAKL-QHRNLVKL 578 (836)
Q Consensus 507 ~~~~~l~~a~~~f~~~~~lG~G~fG~Vykg~~~------~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l-~H~niv~l 578 (836)
++........++|+..+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+.++.++ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 445555667789999999999999999999852 367899999976543 3456789999999999 79999999
Q ss_pred EeEEeeCC-eeeEEEeecCCCChhHHHhhccC-------------CCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEecc
Q 003254 579 LGCCTQRD-ERMLIYEYLPNKSLDYFIFDTTR-------------SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRD 644 (836)
Q Consensus 579 ~g~~~~~~-~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~D 644 (836)
++++...+ ..++||||+++++|.+++..... ...+++..+..++.||++||.|||+.+ |+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---ccccc
Confidence 99987755 48999999999999999965432 123889999999999999999999998 99999
Q ss_pred CCCCceEecCCCCceeeccCcccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCC
Q 003254 645 LKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGF 723 (836)
Q Consensus 645 Lkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~ 723 (836)
|||+||+++.++.+||+|||+++.+.............+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+..
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 999999999999999999999987654433333344567899999999999999999999999999999998 9988753
Q ss_pred CCCccccchhhhhHHhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 003254 724 NHADHDHNLLGHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 794 (836)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 794 (836)
..... ............ ..+......+.+++.+||+.+|++|||+.||++.|+.+.
T Consensus 254 ~~~~~------~~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 309 (316)
T 2xir_A 254 VKIDE------EFCRRLKEGTRM---------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 309 (316)
T ss_dssp CCCSH------HHHHHHHHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cchhH------HHHHHhccCccC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 32211 111111111110 111122345789999999999999999999999998753
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=350.91 Aligned_cols=248 Identities=26% Similarity=0.398 Sum_probs=198.4
Q ss_pred cccccccCeecccCceeEEEEEeec-CcEEEEEEecCC---CchhHHHHHHHHHHHHhh-cCCceeeEEeEEeeCCeeeE
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDERML 590 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~l 590 (836)
.++|+..+.||+|+||.||+++... |+.||||++.+. .....+.+.+|..++..+ +||||+++++++...+..++
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 4789999999999999999999865 899999999754 223456788999999988 69999999999999999999
Q ss_pred EEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccC
Q 003254 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (836)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~ 670 (836)
||||+++|+|..++... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 102 v~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKS---RRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 175 (353)
T ss_dssp EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeecc
Confidence 99999999999998543 46899999999999999999999998 9999999999999999999999999998643
Q ss_pred CCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhcc
Q 003254 671 LDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELID 750 (836)
Q Consensus 671 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 750 (836)
.. .......+||+.|+|||++.+..++.++|||||||++|||++|+.||...... .. .........
T Consensus 176 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~---~~----~~~i~~~~~----- 241 (353)
T 3txo_A 176 CN--GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED---DL----FEAILNDEV----- 241 (353)
T ss_dssp C-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH----HHHHHHCCC-----
T ss_pred cC--CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH---HH----HHHHHcCCC-----
Confidence 22 22234468999999999999989999999999999999999999997532211 11 111111110
Q ss_pred ccccCCCChHHHHHHHHHHHHcccCCCCCCCCH------HHHHH
Q 003254 751 QSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNM------SSVVL 788 (836)
Q Consensus 751 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~------~eVl~ 788 (836)
..+......+.+++.+||+.+|++||++ .||++
T Consensus 242 -----~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 242 -----VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred -----CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 1111223457799999999999999998 77765
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=337.43 Aligned_cols=256 Identities=27% Similarity=0.388 Sum_probs=208.9
Q ss_pred cccccccCeecccCceeEEEEEeecCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEeec
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 595 (836)
.++|+..+.||+|+||.||++...+++.||+|++..... ..+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 367888999999999999999998889999999976543 3478999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCccc
Q 003254 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE 675 (836)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 675 (836)
++++|.+++... ...+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||++........
T Consensus 86 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~- 159 (267)
T 3t9t_A 86 EHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY- 159 (267)
T ss_dssp TTCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH-
T ss_pred CCCcHHHHHhhC--cccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccccc-
Confidence 999999998543 346899999999999999999999998 99999999999999999999999999987643221
Q ss_pred cccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhccCchhhcccccc
Q 003254 676 ANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLD 754 (836)
Q Consensus 676 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 754 (836)
.......++..|+|||.+.+..++.++||||||+++|||++ |+.|+...... . ......... .
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~----~~~~i~~~~---------~ 223 (267)
T 3t9t_A 160 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS---E----VVEDISTGF---------R 223 (267)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---H----HHHHHHTTC---------C
T ss_pred cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH---H----HHHHHhcCC---------c
Confidence 12223457789999999998899999999999999999999 88886532211 0 111111110 0
Q ss_pred CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 003254 755 NSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 794 (836)
Q Consensus 755 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 794 (836)
...+......+.+++.+||+.+|++|||+.|+++.|+++.
T Consensus 224 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (267)
T 3t9t_A 224 LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 263 (267)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0111122345789999999999999999999999998764
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=359.10 Aligned_cols=265 Identities=19% Similarity=0.227 Sum_probs=208.7
Q ss_pred ccHHHHHhhcccccccCeecccCceeEEEEEeec-CcEEEEEEecCCC---chhHHHHHHHHHHHHhhcCCceeeEEeEE
Q 003254 507 FDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCC 582 (836)
Q Consensus 507 ~~~~~l~~a~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~ 582 (836)
+.++.+....++|+..++||+|+||.||+++... ++.||||++.+.. ....+.+.+|+.++..++||||+++++++
T Consensus 64 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 143 (437)
T 4aw2_A 64 SKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF 143 (437)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred chhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 3455666778999999999999999999999876 7889999986532 22234588999999999999999999999
Q ss_pred eeCCeeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeec
Q 003254 583 TQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISD 662 (836)
Q Consensus 583 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~D 662 (836)
.+.+..+|||||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|
T Consensus 144 ~~~~~~~lV~Ey~~gg~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~D 218 (437)
T 4aw2_A 144 QDDNNLYLVMDYYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLAD 218 (437)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECC
T ss_pred eeCCEEEEEEecCCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcc
Confidence 9999999999999999999999542 356899999999999999999999998 99999999999999999999999
Q ss_pred cCcccccCCCccccccccccccccccCccccc-----CCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhH
Q 003254 663 FGLARSFGLDQTEANTKRVVGTYGYMSPEYAI-----DGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAW 737 (836)
Q Consensus 663 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~ 737 (836)
||+++....... ......+||+.|+|||++. .+.++.++|||||||++|||++|+.||....... ....
T Consensus 219 FGla~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~---~~~~-- 292 (437)
T 4aw2_A 219 FGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE---TYGK-- 292 (437)
T ss_dssp CTTCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHH--
T ss_pred hhhhhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhH---HHHh--
Confidence 999987643322 1223368999999999997 5679999999999999999999999985322111 1110
Q ss_pred HhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 003254 738 RLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPED--RPNMSSVVLM 789 (836)
Q Consensus 738 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~--RPt~~eVl~~ 789 (836)
..... ....-+ .........+.+++.+||+.+|++ ||++.|+++.
T Consensus 293 --i~~~~-~~~~~p----~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 293 --IMNHK-ERFQFP----TQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp --HHTHH-HHCCCC----SSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred --hhhcc-ccccCC----cccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 00000 000000 000112345678999999888888 9999999873
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=336.58 Aligned_cols=256 Identities=28% Similarity=0.511 Sum_probs=202.2
Q ss_pred hcccccccCeecccCceeEEEEEee-cCcEEEEEEecCCCchh-------HHHHHHHHHHHHhhcCCceeeEEeEEeeCC
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQG-------MEEFKNEVLLIAKLQHRNLVKLLGCCTQRD 586 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~~~~-------~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~ 586 (836)
..++|+..+.||+|+||.||+|+.. +++.||||++....... .+.+.+|+.++++++||||+++++++.+..
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP 96 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT
T ss_pred hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC
Confidence 3478999999999999999999985 58899999986543221 267899999999999999999999986554
Q ss_pred eeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCC-----ceee
Q 003254 587 ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMN-----PKIS 661 (836)
Q Consensus 587 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~-----~kl~ 661 (836)
++||||+++++|.+++.. ....+++..+..++.|++.||+|||+.+ .+|+||||||+|||++.++. +||+
T Consensus 97 --~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 97 --RMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp --EEEEECCTTCBHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred --eEEEEecCCCCHHHHHhc--ccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 799999999999888854 3457999999999999999999999975 34999999999999987776 9999
Q ss_pred ccCcccccCCCccccccccccccccccCcccc--cCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHh
Q 003254 662 DFGLARSFGLDQTEANTKRVVGTYGYMSPEYA--IDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRL 739 (836)
Q Consensus 662 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~ 739 (836)
|||+++.... ......||+.|+|||.+ ....++.++||||||+++|||++|+.||......... . ...
T Consensus 172 Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~----~~~ 241 (287)
T 4f0f_A 172 DFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK-F----INM 241 (287)
T ss_dssp CCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHH-H----HHH
T ss_pred CCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHH-H----HHH
Confidence 9999985432 22336789999999998 4556899999999999999999999997543222110 0 001
Q ss_pred hhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 003254 740 WIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 793 (836)
Q Consensus 740 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 793 (836)
.... ......+......+.+++.+||+.||++|||+.||++.|+++
T Consensus 242 ~~~~--------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 242 IREE--------GLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HHHS--------CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred Hhcc--------CCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 1111 011112222335678999999999999999999999999864
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=340.43 Aligned_cols=258 Identities=27% Similarity=0.407 Sum_probs=211.2
Q ss_pred hhcccccccCeecccCceeEEEEEeec-CcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEE
Q 003254 514 NATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (836)
Q Consensus 514 ~a~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 592 (836)
...++|+..+.||+|+||.||+|.... ++.||+|++.... ...+.+.+|+.++++++||||+++++++...+..++||
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 88 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 88 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence 355789999999999999999999876 8889999996543 45678999999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCC
Q 003254 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (836)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~ 672 (836)
||+++++|.+++... ....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 89 e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 164 (288)
T 3kfa_A 89 EFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164 (288)
T ss_dssp ECCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred EcCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence 999999999999653 3456899999999999999999999998 999999999999999999999999999876533
Q ss_pred ccccccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhccCchhhccc
Q 003254 673 QTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQ 751 (836)
Q Consensus 673 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 751 (836)
.. .......+++.|+|||.+.+..++.++||||||+++|+|++ |+.|+....... . .......
T Consensus 165 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~---~----~~~~~~~-------- 228 (288)
T 3kfa_A 165 TY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---V----YELLEKD-------- 228 (288)
T ss_dssp SS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---H----HHHHHTT--------
T ss_pred cc-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---H----HHHHhcc--------
Confidence 22 22233567889999999999999999999999999999999 888865322211 1 1111111
Q ss_pred cccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 003254 752 SLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 793 (836)
Q Consensus 752 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 793 (836)
.....+......+.+++.+||+.||++|||+.||++.|+.+
T Consensus 229 -~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~ 269 (288)
T 3kfa_A 229 -YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269 (288)
T ss_dssp -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence 11111122235678999999999999999999999999864
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=338.18 Aligned_cols=257 Identities=30% Similarity=0.434 Sum_probs=206.9
Q ss_pred hcccccccCeecccCceeEEEEEeecCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEee
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 594 (836)
..++|+..+.||+|+||.||+|...+++.||||++.... ...+.+.+|++++++++||||+++++++. .+..++||||
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 88 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEY 88 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEEC
T ss_pred CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEec
Confidence 346888999999999999999998888899999996543 34678999999999999999999999986 4568999999
Q ss_pred cCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcc
Q 003254 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (836)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~ 674 (836)
+++++|.+++... ....+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||++........
T Consensus 89 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T 1qpc_A 89 MENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (279)
T ss_dssp CTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred CCCCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCccc
Confidence 9999999998532 1236899999999999999999999998 99999999999999999999999999987653322
Q ss_pred ccccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhccCchhhccccc
Q 003254 675 EANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSL 753 (836)
Q Consensus 675 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 753 (836)
.......++..|+|||.+.++.++.++||||||++++||++ |+.|+...... .. ........
T Consensus 165 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~----~~~~~~~~--------- 227 (279)
T 1qpc_A 165 -TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP---EV----IQNLERGY--------- 227 (279)
T ss_dssp -ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HH----HHHHHTTC---------
T ss_pred -ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH---HH----HHHHhccc---------
Confidence 12223456789999999998899999999999999999999 88886432211 11 11111110
Q ss_pred cCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 003254 754 DNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 794 (836)
Q Consensus 754 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 794 (836)
....+......+.+++.+|++.+|++|||+.++++.|+.+.
T Consensus 228 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 268 (279)
T 1qpc_A 228 RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (279)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 00111122346789999999999999999999999998763
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=351.70 Aligned_cols=253 Identities=24% Similarity=0.337 Sum_probs=197.1
Q ss_pred hcccccccCeecccCceeEEEEEeecCcEEEEEEecCC--CchhHHHHHHHHHHHHhhcC--CceeeEEeEEeeCCeeeE
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQH--RNLVKLLGCCTQRDERML 590 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H--~niv~l~g~~~~~~~~~l 590 (836)
..++|++.+.||+|+||.||++...+++.||||++... .....+.+.+|+.++.+++| +||+++++++......++
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 45779999999999999999999988999999998754 33455789999999999986 999999999999999999
Q ss_pred EEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccC
Q 003254 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (836)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~ 670 (836)
||| +.+++|.+++.. ...+++.++..++.||+.||+|||+.+ |+||||||+|||++ ++.+||+|||+++.+.
T Consensus 87 v~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 87 VME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp EEC-CCSEEHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred EEe-CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccC
Confidence 999 568899999854 356899999999999999999999998 99999999999997 5789999999998765
Q ss_pred CCccccccccccccccccCcccccC-----------CccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHh
Q 003254 671 LDQTEANTKRVVGTYGYMSPEYAID-----------GLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRL 739 (836)
Q Consensus 671 ~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~ 739 (836)
............||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .....
T Consensus 159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~~~~~-- 231 (343)
T 3dbq_A 159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----ISKLH-- 231 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHHHH--
T ss_pred cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH-----HHHHH--
Confidence 4433333345679999999999864 67899999999999999999999997532111 01010
Q ss_pred hhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 740 WIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 740 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
..+++......+......+.+++.+||+.||++|||+.|+++.
T Consensus 232 -------~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 232 -------AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp -------HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -------HHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 1111111111122223457799999999999999999999864
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=349.69 Aligned_cols=270 Identities=27% Similarity=0.356 Sum_probs=207.1
Q ss_pred ccccCeecccCceeEEEEEee-----cCcEEEEEEecCCC-chhHHHHHHHHHHHHhhcCCceeeEEeEEeeC--CeeeE
Q 003254 519 FSEKNKLGEGGFGPVYKGMLI-----EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR--DERML 590 (836)
Q Consensus 519 f~~~~~lG~G~fG~Vykg~~~-----~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~l 590 (836)
|+..+.||+|+||.||++.+. +++.||||++.... ....+.+.+|+.++++++||||+++++++... ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 488899999999999888642 47889999997653 34467799999999999999999999999874 56899
Q ss_pred EEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccC
Q 003254 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (836)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~ 670 (836)
||||+++++|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 113 v~e~~~~~~L~~~l~~----~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp EECCCTTCBHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred EEecccCCcHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 9999999999999843 34899999999999999999999998 9999999999999999999999999998875
Q ss_pred CCccc-cccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhc
Q 003254 671 LDQTE-ANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELI 749 (836)
Q Consensus 671 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (836)
..... .......++..|+|||.+.+..++.++||||||++++||++|+.|+........ ................+.+
T Consensus 186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 264 (318)
T 3lxp_A 186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFL-ELIGIAQGQMTVLRLTELL 264 (318)
T ss_dssp TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-HHHCSCCHHHHHHHHHHHH
T ss_pred ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhh-hhhcccccchhHHHHHHHH
Confidence 43221 122335678889999999999999999999999999999999988642111000 0000000000000111122
Q ss_pred cccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCCCC
Q 003254 750 DQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSL 796 (836)
Q Consensus 750 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~~ 796 (836)
+.......+......+.+++.+||+.||++|||+.|+++.|+.+...
T Consensus 265 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 311 (318)
T 3lxp_A 265 ERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEK 311 (318)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHh
Confidence 22222222333446788999999999999999999999999987543
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=337.98 Aligned_cols=261 Identities=23% Similarity=0.337 Sum_probs=198.4
Q ss_pred ccccccCeecccCceeEEEEEeecCcEEEEEEecCCCc--hhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEee
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSG--QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 594 (836)
++|+..+.||+|+||.||+++...|+.||+|++..... ...+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 57889999999999999999997799999999865432 2346788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcc
Q 003254 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (836)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~ 674 (836)
+++ +|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (288)
T 1ob3_A 82 LDQ-DLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (288)
T ss_dssp CSE-EHHHHHHT--STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred cCC-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence 986 88888743 2356899999999999999999999998 99999999999999999999999999987643221
Q ss_pred ccccccccccccccCcccccCC-ccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCch-------
Q 003254 675 EANTKRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPL------- 746 (836)
Q Consensus 675 ~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------- 746 (836)
......+|+.|+|||++.+. .++.++||||||+++|||++|+.||....... ......+........
T Consensus 156 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T 1ob3_A 156 --KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD---QLMRIFRILGTPNSKNWPNVTE 230 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTTTSTTGGG
T ss_pred --ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHHCCCChhhchhhhc
Confidence 12235789999999999764 58999999999999999999999975432111 111111111000000
Q ss_pred -hhcccccc-------CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 747 -ELIDQSLD-------NSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 747 -~~~d~~l~-------~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
...++... ..........+.+++.+||+.||++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00111000 0011122345789999999999999999999986
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=349.83 Aligned_cols=253 Identities=23% Similarity=0.337 Sum_probs=203.4
Q ss_pred hcccccccCeecccCceeEEEEEeec-CcEEEEEEecCCC--chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEE
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 591 (836)
..++|+..+.||+|+||.||+++... |+.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 45789999999999999999999854 8999999997543 34456789999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCC---CCceeeccCcccc
Q 003254 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNT---MNPKISDFGLARS 668 (836)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~---~~~kl~DFgla~~ 668 (836)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.+ +.+||+|||++..
T Consensus 107 ~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 107 FDLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp ECCCCSCBHHHHHTT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred EecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 999999999988843 456899999999999999999999998 9999999999999765 4599999999987
Q ss_pred cCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhh
Q 003254 669 FGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLEL 748 (836)
Q Consensus 669 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (836)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+ ......... ..
T Consensus 181 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~---~~~----~~~i~~~~~-~~ 249 (362)
T 2bdw_A 181 VNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ---HRL----YAQIKAGAY-DY 249 (362)
T ss_dssp CTTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHH----HHHHHHTCC-CC
T ss_pred ecCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHH----HHHHHhCCC-CC
Confidence 64322 22346799999999999999999999999999999999999999753221 111 111111100 00
Q ss_pred ccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 749 IDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 749 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
.. .........+.+++.+||+.||++|||+.|+++.
T Consensus 250 ~~-----~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 250 PS-----PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp CT-----TGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred Cc-----ccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 0001123457799999999999999999998764
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=371.52 Aligned_cols=262 Identities=26% Similarity=0.413 Sum_probs=211.1
Q ss_pred hhcccccccCeecccCceeEEEEEeecCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEe
Q 003254 514 NATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (836)
Q Consensus 514 ~a~~~f~~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 593 (836)
...++|+..++||+|+||.||+|++.++..||||+++... ...++|.+|+.++++++|+||+++++++.+ +..+||||
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e 341 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 341 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred cchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeee
Confidence 3456788899999999999999999888889999997644 345789999999999999999999999876 77899999
Q ss_pred ecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCc
Q 003254 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (836)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~ 673 (836)
|+++|+|.+++... ....+++.+++.++.||++||+|||+++ |+||||||+||||++++.+||+|||+++.+....
T Consensus 342 ~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 417 (535)
T 2h8h_A 342 YMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 417 (535)
T ss_dssp CCTTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH
T ss_pred hhcCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCc
Confidence 99999999999542 2345899999999999999999999998 9999999999999999999999999998764321
Q ss_pred cccccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhccCchhhcccc
Q 003254 674 TEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQS 752 (836)
Q Consensus 674 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 752 (836)
. .......++..|+|||.+.++.++.++|||||||+||||++ |+.|+...... . ........
T Consensus 418 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~---~----~~~~i~~~--------- 480 (535)
T 2h8h_A 418 Y-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---E----VLDQVERG--------- 480 (535)
T ss_dssp H-HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH---H----HHHHHHTT---------
T ss_pred e-ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---H----HHHHHHcC---------
Confidence 1 11223456789999999999999999999999999999999 88886432211 1 11111111
Q ss_pred ccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCCCCCC
Q 003254 753 LDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQ 798 (836)
Q Consensus 753 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~~~~ 798 (836)
.....+......+.+|+.+||+.||++|||+.+|+++|+.+.....
T Consensus 481 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~ 526 (535)
T 2h8h_A 481 YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 526 (535)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCS
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccC
Confidence 1111122334567899999999999999999999999998765433
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=347.36 Aligned_cols=273 Identities=24% Similarity=0.329 Sum_probs=201.5
Q ss_pred hcccccccCeecccCceeEEEEEee-cCcEEEEEEecCCC---chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCee--
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDER-- 588 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~-- 588 (836)
..++|+..+.||+|+||.||+++.. +++.||||++.... ....+.+.+|+.++++++||||+++++++......
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 4578999999999999999999974 58899999997653 23456789999999999999999999998776544
Q ss_pred --eEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcc
Q 003254 589 --MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLA 666 (836)
Q Consensus 589 --~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla 666 (836)
++||||+++++|.+++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred ccEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 999999999999999854 346899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCccc-cccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCc
Q 003254 667 RSFGLDQTE-ANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERP 745 (836)
Q Consensus 667 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (836)
+.+...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... ............
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~------~~~~~~~~~~~~ 237 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV------SVAYQHVREDPI 237 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHCCCC
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHhcCCCC
Confidence 876433221 2233457899999999999999999999999999999999999997532211 111111111110
Q ss_pred hhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHH-HHHHhcCCCCCCCCCCCCccc
Q 003254 746 LELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSS-VVLMLSGERSLPQPQQPGFFT 806 (836)
Q Consensus 746 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~e-Vl~~L~~~~~~~~p~~p~~~~ 806 (836)
.. ... .......+.+++.+||+.||++||++.+ +...|........|..|....
T Consensus 238 ~~---~~~----~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~~~~~~~~~~ 292 (311)
T 3ork_A 238 PP---SAR----HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAPKVLT 292 (311)
T ss_dssp CH---HHH----STTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTTCCCSSCCCCC
T ss_pred Cc---ccc----cCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcCCCCCCCcccc
Confidence 00 000 0112245779999999999999996555 545665554444444444443
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=358.02 Aligned_cols=255 Identities=22% Similarity=0.291 Sum_probs=203.4
Q ss_pred hhcccccccCeecccCceeEEEEEee-cCcEEEEEEecCCC--chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeE
Q 003254 514 NATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (836)
Q Consensus 514 ~a~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 590 (836)
...++|+..+.||+|+||.||++... +|+.+|+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 34578999999999999999999875 48899999987653 2345678999999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEec---CCCCceeeccCccc
Q 003254 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD---NTMNPKISDFGLAR 667 (836)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~---~~~~~kl~DFgla~ 667 (836)
||||+++|+|.+.+.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++ +++.+||+|||++.
T Consensus 88 v~E~~~gg~L~~~i~~---~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 88 IFDLVTGGELFEDIVA---REYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp EECCCBCCBHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred EEEeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 9999999999998854 356899999999999999999999998 99999999999998 56889999999998
Q ss_pred ccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchh
Q 003254 668 SFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLE 747 (836)
Q Consensus 668 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (836)
....... ......||+.|+|||++.+..++.++||||+||++|+|++|+.||...... .. ......... .
T Consensus 162 ~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~---~~----~~~i~~~~~-~ 231 (444)
T 3soa_A 162 EVEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH---RL----YQQIKAGAY-D 231 (444)
T ss_dssp CCCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HH----HHHHHHTCC-C
T ss_pred EecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH---HH----HHHHHhCCC-C
Confidence 7643222 223467999999999999999999999999999999999999997532211 11 111111100 0
Q ss_pred hccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 748 LIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 748 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
... .........+.+++.+||+.||++|||+.|+++.
T Consensus 232 ~~~-----~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 232 FPS-----PEWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp CCT-----TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCc-----cccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 000 0001123457799999999999999999999873
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=335.80 Aligned_cols=255 Identities=22% Similarity=0.330 Sum_probs=204.1
Q ss_pred cccccccCeecccCceeEEEEEeecCcEEEEEEecCCC--chhHHHHHHHHHHHHhhcCCceeeEEeEEeeC--CeeeEE
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR--DERMLI 591 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV 591 (836)
.++|...+.||+|+||.||+|+. +++.||||++.... ....+.+.+|+.++++++||||+++++++... ...++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 36788899999999999999998 58899999987653 34556899999999999999999999999877 778999
Q ss_pred EeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCC
Q 003254 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (836)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~ 671 (836)
|||+++|+|.+++... ....+++..+..++.||+.||+|||+.+ .+|+||||||+||++++++.++|.|||++....
T Consensus 88 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~- 164 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQ- 164 (271)
T ss_dssp EECCTTCBHHHHHHSC-SSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS-
T ss_pred ecccCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeec-
Confidence 9999999999999542 2336899999999999999999999875 359999999999999999999999998876432
Q ss_pred CccccccccccccccccCcccccCCccCc---cccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhh
Q 003254 672 DQTEANTKRVVGTYGYMSPEYAIDGLFSV---KSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLEL 748 (836)
Q Consensus 672 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~---ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (836)
.....+|+.|+|||.+.+..++. ++||||||+++|||++|+.|+...... ..........
T Consensus 165 ------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~----- 227 (271)
T 3kmu_A 165 ------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM------EIGMKVALEG----- 227 (271)
T ss_dssp ------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH------HHHHHHHHSC-----
T ss_pred ------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH------HHHHHHHhcC-----
Confidence 12346799999999998765544 899999999999999999997532211 1111111111
Q ss_pred ccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCCC
Q 003254 749 IDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS 795 (836)
Q Consensus 749 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~ 795 (836)
.....+......+.+++..||+.||++|||+.|+++.|+.+..
T Consensus 228 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 228 ----LRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp ----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred ----CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 1111122233457899999999999999999999999987643
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=339.10 Aligned_cols=256 Identities=24% Similarity=0.310 Sum_probs=195.0
Q ss_pred hcccccccCeecccCceeEEEEEeec----CcEEEEEEecCCC-chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeee
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLIE----GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERM 589 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~~----g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 589 (836)
..++|+..+.||+|+||.||+|.... +..||+|++.... ....+.+.+|+.++++++||||+++++++. .+..+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 91 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 91 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence 45788999999999999999999743 4569999987643 344577999999999999999999999984 56789
Q ss_pred EEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCccccc
Q 003254 590 LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (836)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~ 669 (836)
+||||+++++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 92 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp EEEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECcccccccc
Confidence 999999999999998542 346899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhccCchhh
Q 003254 670 GLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEERPLEL 748 (836)
Q Consensus 670 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (836)
..... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.|+....... .. ........
T Consensus 167 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~---~~----~~i~~~~~--- 235 (281)
T 1mp8_A 167 EDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VI----GRIENGER--- 235 (281)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HH----HHHHTTCC---
T ss_pred Ccccc-cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH---HH----HHHHcCCC---
Confidence 43221 11223456789999999998899999999999999999997 888875432211 11 11111110
Q ss_pred ccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 003254 749 IDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 793 (836)
Q Consensus 749 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 793 (836)
...+......+.+++.+||+.+|++|||+.|+++.|+.+
T Consensus 236 ------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 274 (281)
T 1mp8_A 236 ------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274 (281)
T ss_dssp ------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 011122335678999999999999999999999999865
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-38 Score=344.52 Aligned_cols=254 Identities=22% Similarity=0.331 Sum_probs=201.9
Q ss_pred ccccccCeecccCceeEEEEEeec-CcEEEEEEecCC---CchhHHHHHHHHHHHHhh-cCCceeeEEeEEeeCCeeeEE
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDERMLI 591 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV 591 (836)
++|+..+.||+|+||.||+++... ++.||+|++.+. .....+.+.+|+.++.++ +||||+++++++...+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 678999999999999999999865 889999999754 233456788999999988 899999999999999999999
Q ss_pred EeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCC
Q 003254 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (836)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~ 671 (836)
|||+++|+|..++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 89 ~e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred EeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 9999999999988542 46899999999999999999999998 99999999999999999999999999986432
Q ss_pred CccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCcccc--chhhhhHHhhhccCchhhc
Q 003254 672 DQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDH--NLLGHAWRLWIEERPLELI 749 (836)
Q Consensus 672 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 749 (836)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......... ...............
T Consensus 163 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~---- 236 (345)
T 3a8x_A 163 PG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI---- 236 (345)
T ss_dssp TT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC----
T ss_pred CC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC----
Confidence 21 2234468999999999999999999999999999999999999998542221110 001111111111110
Q ss_pred cccccCCCChHHHHHHHHHHHHcccCCCCCCCCH------HHHHH
Q 003254 750 DQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNM------SSVVL 788 (836)
Q Consensus 750 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~------~eVl~ 788 (836)
..+......+.+++.+||+.||++||++ .|+++
T Consensus 237 ------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~ 275 (345)
T 3a8x_A 237 ------RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 275 (345)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred ------CCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence 1112223457899999999999999995 56654
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=355.30 Aligned_cols=260 Identities=20% Similarity=0.224 Sum_probs=206.4
Q ss_pred HHHHHhhcccccccCeecccCceeEEEEEeec-CcEEEEEEecCCC---chhHHHHHHHHHHHHhhcCCceeeEEeEEee
Q 003254 509 LKIIANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQ 584 (836)
Q Consensus 509 ~~~l~~a~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~ 584 (836)
+..+....++|+..+.||+|+||.||+++... ++.||+|++.+.. ....+.+.+|+.+++.++||||+++++++.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 44555677899999999999999999999865 8899999986531 2234568899999999999999999999999
Q ss_pred CCeeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccC
Q 003254 585 RDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFG 664 (836)
Q Consensus 585 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFg 664 (836)
.+..++||||+++|+|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG 213 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFG 213 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccc
Confidence 9999999999999999998843 35889999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCccccccccccccccccCcccccCCc----cCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhh
Q 003254 665 LARSFGLDQTEANTKRVVGTYGYMSPEYAIDGL----FSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLW 740 (836)
Q Consensus 665 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~ 740 (836)
+++.+..... ......+||+.|+|||++.+.. ++.++|||||||+||||++|+.||...... ... ...
T Consensus 214 ~a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~---~~~----~~i 285 (410)
T 3v8s_A 214 TCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV---GTY----SKI 285 (410)
T ss_dssp TCEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHH----HHH
T ss_pred eeEeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh---hHH----HHH
Confidence 9987643321 1233468999999999998655 889999999999999999999998532211 111 111
Q ss_pred hccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 003254 741 IEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPED--RPNMSSVVLM 789 (836)
Q Consensus 741 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~--RPt~~eVl~~ 789 (836)
..... . +...........+.+|+.+||+.+|++ ||++.||++.
T Consensus 286 ~~~~~-~-----~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 286 MNHKN-S-----LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp HTHHH-H-----CCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred Hhccc-c-----ccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 00000 0 000000112245778999999999988 9999999974
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=342.42 Aligned_cols=244 Identities=23% Similarity=0.274 Sum_probs=192.4
Q ss_pred ccccccCeecccCceeEEEEEee-cCcEEEEEEecCCC--chhHHHHHHHHHHHHhh-cCCceeeEEeEEeeCCeeeEEE
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDERMLIY 592 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 592 (836)
++|+..++||+|+||.||+|+.. +|+.||||++.... .....++..|+..+.++ +||||+++++++.+.+..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 67999999999999999999986 58999999986543 23344556666666666 8999999999999999999999
Q ss_pred eecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCC
Q 003254 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (836)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~ 672 (836)
||+ +++|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 137 e~~-~~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~ 210 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAW--GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA 210 (311)
T ss_dssp ECC-CCBHHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred ecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence 999 66888887543 346999999999999999999999998 999999999999999999999999999876432
Q ss_pred ccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhcccc
Q 003254 673 QTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQS 752 (836)
Q Consensus 673 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 752 (836)
. ......||+.|+|||++.+ .++.++|||||||++|||++|..++... ..+......... +.
T Consensus 211 ~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~----------~~~~~~~~~~~~----~~ 272 (311)
T 3p1a_A 211 G---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG----------EGWQQLRQGYLP----PE 272 (311)
T ss_dssp -------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH----------HHHHHHTTTCCC----HH
T ss_pred C---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc----------cHHHHHhccCCC----cc
Confidence 2 2233568999999998876 7899999999999999999997664210 011111111110 00
Q ss_pred ccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 753 LDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 753 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
+. ......+.+++.+||+.||++|||+.|+++
T Consensus 273 ~~----~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 273 FT----AGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp HH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cc----cCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 11 112345789999999999999999999986
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=348.30 Aligned_cols=260 Identities=23% Similarity=0.266 Sum_probs=192.3
Q ss_pred hhcccccccCeecccCceeEEEEEee-cCcEEEEEEecCCCchhHHHHHHHHHHHHhhc-CCceeeEEeEEe--------
Q 003254 514 NATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQ-HRNLVKLLGCCT-------- 583 (836)
Q Consensus 514 ~a~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~-------- 583 (836)
....+|+..+.||+|+||.||+++.. +++.||||++........+.+.+|+.++.++. ||||+++++++.
T Consensus 25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 104 (337)
T 3ll6_A 25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104 (337)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred ccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence 34568999999999999999999975 58999999997776667788999999999996 999999999994
Q ss_pred eCCeeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeecc
Q 003254 584 QRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDF 663 (836)
Q Consensus 584 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DF 663 (836)
.....++||||+. |+|.+++........+++..++.++.||+.||+|||+.+ .+|+||||||+|||+++++.+||+||
T Consensus 105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Df 182 (337)
T 3ll6_A 105 GQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDF 182 (337)
T ss_dssp SSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred CCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecC
Confidence 3344789999996 789888876555667999999999999999999999875 34999999999999999999999999
Q ss_pred CcccccCCCcccc----------ccccccccccccCcccc---cCCccCccccccchhhhhhhhhhCCCCCCCCCCcccc
Q 003254 664 GLARSFGLDQTEA----------NTKRVVGTYGYMSPEYA---IDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDH 730 (836)
Q Consensus 664 gla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~ 730 (836)
|+++......... ......||+.|+|||++ .+..++.++||||||+++|||++|+.|+.......
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-- 260 (337)
T 3ll6_A 183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR-- 260 (337)
T ss_dssp TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH--
Confidence 9998765322211 11134689999999998 56778999999999999999999999975321110
Q ss_pred chhhhhHHhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 003254 731 NLLGHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 794 (836)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 794 (836)
.+...............+.+++.+||+.+|++|||+.|+++.|+.+.
T Consensus 261 -----------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~ 307 (337)
T 3ll6_A 261 -----------------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIA 307 (337)
T ss_dssp ----------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----------------hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 00000000111111123678999999999999999999999998874
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=343.29 Aligned_cols=261 Identities=22% Similarity=0.304 Sum_probs=197.8
Q ss_pred ccccccc-CeecccCceeEEEEEee-cCcEEEEEEecCCCchhHHHHHHHHHHHHhh-cCCceeeEEeEEeeCCeeeEEE
Q 003254 516 TDNFSEK-NKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDERMLIY 592 (836)
Q Consensus 516 ~~~f~~~-~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 592 (836)
.+.|.+. +.||+|+||.||+++.. +++.||||++........+.+.+|+.++.++ +||||+++++++.+.+..++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 3567764 68999999999999975 5899999999877666678899999999995 7999999999999999999999
Q ss_pred eecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCC---ceeeccCccccc
Q 003254 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMN---PKISDFGLARSF 669 (836)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~---~kl~DFgla~~~ 669 (836)
||+++++|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++. +||+|||++...
T Consensus 91 e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 91 EKMRGGSILSHIHKR---RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp ECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred EcCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 999999999998543 46899999999999999999999998 999999999999988766 999999999865
Q ss_pred CCCcc-----ccccccccccccccCcccccC-----CccCccccccchhhhhhhhhhCCCCCCCCCCccccchh------
Q 003254 670 GLDQT-----EANTKRVVGTYGYMSPEYAID-----GLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLL------ 733 (836)
Q Consensus 670 ~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~------ 733 (836)
..... ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||............
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 244 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence 42211 111223568999999999875 56899999999999999999999998654332211000
Q ss_pred --hhhHHhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 734 --GHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 734 --~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
............ ....... ......+.+++.+||+.||++|||+.|+++
T Consensus 245 ~~~~~~~~i~~~~~-~~~~~~~-----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 245 CQNMLFESIQEGKY-EFPDKDW-----AHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHHHHHCCC-CCCHHHH-----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHhccCc-ccCchhc-----ccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 000011111100 0000000 011245789999999999999999999998
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=341.19 Aligned_cols=265 Identities=22% Similarity=0.290 Sum_probs=207.0
Q ss_pred hcccccccCeecccCceeEEEEEe-ecCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEee----CCeee
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGML-IEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQ----RDERM 589 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~~ 589 (836)
..++|+..+.||+|+||.||+++. .+++.||||++........+.+.+|+.+++.++||||+++++++.. ....+
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 457899999999999999999997 4589999999977666677889999999999999999999999873 34689
Q ss_pred EEEeecCCCChhHHHhhcc-CCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccc
Q 003254 590 LIYEYLPNKSLDYFIFDTT-RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (836)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~ 668 (836)
+||||+++++|.+++.... ....+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 9999999999999986532 3457899999999999999999999998 99999999999999999999999999876
Q ss_pred cCCCcccc-------ccccccccccccCcccccCCc---cCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHH
Q 003254 669 FGLDQTEA-------NTKRVVGTYGYMSPEYAIDGL---FSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWR 738 (836)
Q Consensus 669 ~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~ 738 (836)
........ ......||+.|+|||.+.+.. ++.++||||||+++|||++|+.|+......... . . .
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~-~---~ 258 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS-V-A---L 258 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC-H-H---H
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch-h-h---H
Confidence 53211110 112245799999999987554 789999999999999999999996421110000 0 0 0
Q ss_pred hhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCCCC
Q 003254 739 LWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSL 796 (836)
Q Consensus 739 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~~ 796 (836)
.... .............+.+++.+||+.||++|||+.||++.|+.+...
T Consensus 259 ~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 307 (317)
T 2buj_A 259 AVQN---------QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP 307 (317)
T ss_dssp HHHC---------C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCC
T ss_pred Hhhc---------cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCC
Confidence 0000 000011112234678999999999999999999999999987653
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=343.39 Aligned_cols=270 Identities=23% Similarity=0.289 Sum_probs=199.9
Q ss_pred HhhcccccccCeecccCceeEEEEEeecCcEEEEEEecCCCchhHHHHHHHHHHHHhh--cCCceeeEEeEEeeC----C
Q 003254 513 ANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKL--QHRNLVKLLGCCTQR----D 586 (836)
Q Consensus 513 ~~a~~~f~~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l--~H~niv~l~g~~~~~----~ 586 (836)
....++|+..+.||+|+||.||+|+. .++.||||++.... ...+..|.+++..+ +||||+++++++... .
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 108 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT 108 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred cccccceEEEeEeecCCCeEEEEEEE-CCceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence 34557899999999999999999988 48999999985432 34455566666554 899999999999887 6
Q ss_pred eeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCC-----CCcEEeccCCCCceEecCCCCceee
Q 003254 587 ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDS-----RLRIIHRDLKASNVLLDNTMNPKIS 661 (836)
Q Consensus 587 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivH~DLkp~NILl~~~~~~kl~ 661 (836)
..++||||+++|+|.+++.. ..+++..+..++.|++.||+|||++. ..+|+||||||+|||++.++.+||+
T Consensus 109 ~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~ 184 (337)
T 3mdy_A 109 QLYLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA 184 (337)
T ss_dssp EEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred ceEEEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEE
Confidence 78999999999999999943 35899999999999999999999881 1129999999999999999999999
Q ss_pred ccCcccccCCCcccc--ccccccccccccCcccccCCccCcc------ccccchhhhhhhhhhCCCC----------CCC
Q 003254 662 DFGLARSFGLDQTEA--NTKRVVGTYGYMSPEYAIDGLFSVK------SDVFSFGVLVLEIICGKKN----------RGF 723 (836)
Q Consensus 662 DFgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~k------sDVwS~GvvL~elltG~~p----------~~~ 723 (836)
|||+++.+....... ......||+.|+|||++.+...+.+ +|||||||++|||++|..| +..
T Consensus 185 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~ 264 (337)
T 3mdy_A 185 DLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD 264 (337)
T ss_dssp CCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhh
Confidence 999998764332221 1224579999999999987766554 9999999999999999544 322
Q ss_pred CCCccccchhhhhHHhhhccCchhhccccccCC-CChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCCCC
Q 003254 724 NHADHDHNLLGHAWRLWIEERPLELIDQSLDNS-CSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSL 796 (836)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~~ 796 (836)
....... .......... ....+..... ........+.+++.+||+.||++|||+.||++.|+.+...
T Consensus 265 ~~~~~~~--~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 332 (337)
T 3mdy_A 265 LVPSDPS--YEDMREIVCI----KKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES 332 (337)
T ss_dssp TSCSSCC--HHHHHHHHTT----SCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred hcCCCCc--hhhhHHHHhh----hccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhh
Confidence 1111110 0000000000 0011111101 1225567789999999999999999999999999886543
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=338.24 Aligned_cols=261 Identities=25% Similarity=0.406 Sum_probs=194.7
Q ss_pred hcccccccCeecccCceeEEEEEeecCcEEEEEEecCCC--chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEE
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 592 (836)
..++|+..++||+|+||.||+|+.. ..||||++.... ....+.+.+|+.++++++||||+++++++ .....++||
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~ 98 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT 98 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred CccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence 4578999999999999999999864 359999986543 34557899999999999999999999965 456789999
Q ss_pred eecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCC
Q 003254 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (836)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~ 672 (836)
||+++++|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 99 e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 173 (289)
T 3og7_A 99 QWCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW 173 (289)
T ss_dssp ECCCEEEHHHHHTT--C---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred EecCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccccc
Confidence 99999999998853 3456899999999999999999999998 999999999999999999999999999876433
Q ss_pred ccccccccccccccccCccccc---CCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhc
Q 003254 673 QTEANTKRVVGTYGYMSPEYAI---DGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELI 749 (836)
Q Consensus 673 ~~~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (836)
..........||+.|+|||.+. +..++.++||||||+++|||++|+.|+...... .. .............
T Consensus 174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~----~~~~~~~~~~~~~- 246 (289)
T 3og7_A 174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR--DQ----IIEMVGRGSLSPD- 246 (289)
T ss_dssp ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH--HH----HHHHHHHTSCCCC-
T ss_pred cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH--HH----HHHHhcccccCcc-
Confidence 3333334467899999999986 667899999999999999999999997532221 11 1111111111000
Q ss_pred cccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 003254 750 DQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 794 (836)
Q Consensus 750 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 794 (836)
+ ..........+.+++.+||+.+|++|||+.|+++.|+.+.
T Consensus 247 ---~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 247 ---L-SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp ---T-TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred ---h-hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 0 0111223356889999999999999999999999999864
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=343.63 Aligned_cols=264 Identities=24% Similarity=0.376 Sum_probs=188.9
Q ss_pred cccccccCeecccCceeEEEEEeec-CcEEEEEEecCCC-chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEe
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 593 (836)
.++|+..+.||+|+||.||+|.... |+.||+|++.... ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 4678999999999999999999754 8999999987553 2345678999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhccC---CCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccC
Q 003254 594 YLPNKSLDYFIFDTTR---SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (836)
Q Consensus 594 y~~~gsL~~~l~~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~ 670 (836)
|++ ++|.+++..... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 589888864321 245889999999999999999999998 9999999999999999999999999998764
Q ss_pred CCccccccccccccccccCcccccCC-ccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccC-----
Q 003254 671 LDQTEANTKRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEER----- 744 (836)
Q Consensus 671 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~----- 744 (836)
.... ......+|+.|+|||++.+. .++.++|||||||++|||++|+.||........ ............
T Consensus 160 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~ 234 (317)
T 2pmi_A 160 IPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQ---LKLIFDIMGTPNESLWP 234 (317)
T ss_dssp SCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCSCCTTTCG
T ss_pred CCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCChhHhh
Confidence 3222 22335789999999999764 689999999999999999999999864332111 111100000000
Q ss_pred ---------------chhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 745 ---------------PLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 745 ---------------~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
....+...+...........+.+++.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 235 SVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 00000000000011112346789999999999999999999975
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=350.00 Aligned_cols=253 Identities=22% Similarity=0.262 Sum_probs=205.5
Q ss_pred cccccccCeecccCceeEEEEEeec-CcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEee
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 594 (836)
.++|++.+.||+|+||.||+|+... |+.||+|++..........+.+|+.+++.++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 4679999999999999999999864 889999999877666667899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecC--CCCceeeccCcccccCCC
Q 003254 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN--TMNPKISDFGLARSFGLD 672 (836)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~--~~~~kl~DFgla~~~~~~ 672 (836)
+++|+|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+++.....
T Consensus 130 ~~gg~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 130 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 999999998843 2346899999999999999999999998 999999999999974 578999999999876432
Q ss_pred ccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhcccc
Q 003254 673 QTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQS 752 (836)
Q Consensus 673 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 752 (836)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .... ....... .
T Consensus 205 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~---~~~~----~i~~~~~------~ 268 (387)
T 1kob_A 205 E---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL---ETLQ----NVKRCDW------E 268 (387)
T ss_dssp S---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHH----HHHHCCC------C
T ss_pred c---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH---HHHH----HHHhCCC------C
Confidence 2 123357899999999999999999999999999999999999997532211 1111 1110000 0
Q ss_pred ccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 753 LDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 753 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
............+.+++.+||+.||++|||+.|+++.
T Consensus 269 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 269 FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 0001111223457899999999999999999999874
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=352.91 Aligned_cols=252 Identities=23% Similarity=0.336 Sum_probs=197.0
Q ss_pred cccccccCeecccCceeEEEEEeecCcEEEEEEecCC--CchhHHHHHHHHHHHHhhc--CCceeeEEeEEeeCCeeeEE
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQ--HRNLVKLLGCCTQRDERMLI 591 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~--H~niv~l~g~~~~~~~~~lV 591 (836)
.++|++.+.||+|+||.||++....++.||||++... .....+.+.+|+.++.+++ ||||+++++++...+..++|
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 3569999999999999999999888999999998654 3345678999999999996 59999999999999999999
Q ss_pred EeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCC
Q 003254 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (836)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~ 671 (836)
|| +.+++|.+++.. ...+++.++..++.||+.||.|||+.+ |+||||||+|||++ ++.+||+|||+++.+..
T Consensus 135 ~E-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp EE-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred Ee-cCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 99 678899999854 346888999999999999999999998 99999999999995 57999999999987654
Q ss_pred CccccccccccccccccCcccccC-----------CccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhh
Q 003254 672 DQTEANTKRVVGTYGYMSPEYAID-----------GLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLW 740 (836)
Q Consensus 672 ~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~ 740 (836)
...........||+.|+|||++.+ ..++.++|||||||+||||++|+.||...... .... .
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-----~~~~-~-- 278 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----ISKL-H-- 278 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-----HHHH-H--
T ss_pred CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH-----HHHH-H--
Confidence 333333345679999999999865 46899999999999999999999997532211 0111 1
Q ss_pred hccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 741 IEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 741 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
.++++......+......+.+++.+||+.||++|||+.||++.
T Consensus 279 ------~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 279 ------AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp ------HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ------HHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 1111111111111123457899999999999999999999864
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=342.62 Aligned_cols=267 Identities=24% Similarity=0.371 Sum_probs=199.8
Q ss_pred HHHHHhhcccccccCeecccCceeEEEEEeec----CcEEEEEEecCC--CchhHHHHHHHHHHHHhhcCCceeeEEeEE
Q 003254 509 LKIIANATDNFSEKNKLGEGGFGPVYKGMLIE----GQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCC 582 (836)
Q Consensus 509 ~~~l~~a~~~f~~~~~lG~G~fG~Vykg~~~~----g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~ 582 (836)
++.+....++|...+.||+|+||.||+|+... ++.||||++... .....+.+.+|+.++++++||||+++++++
T Consensus 26 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 105 (313)
T 3brb_A 26 LEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVC 105 (313)
T ss_dssp TTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred HHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence 34444566889999999999999999998753 457999998754 334457799999999999999999999999
Q ss_pred eeCCe-----eeEEEeecCCCChhHHHhhcc---CCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecC
Q 003254 583 TQRDE-----RMLIYEYLPNKSLDYFIFDTT---RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN 654 (836)
Q Consensus 583 ~~~~~-----~~lV~Ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~ 654 (836)
.+... .++||||+++++|.+++.... ....+++..++.++.||++||.|||+.+ |+||||||+|||+++
T Consensus 106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~ 182 (313)
T 3brb_A 106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRD 182 (313)
T ss_dssp EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECT
T ss_pred eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcC
Confidence 87653 499999999999999985432 3356999999999999999999999998 999999999999999
Q ss_pred CCCceeeccCcccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchh
Q 003254 655 TMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLL 733 (836)
Q Consensus 655 ~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~ 733 (836)
++.+||+|||++................+++.|+|||.+.+..++.++||||||+++|||++ |+.|+....... ..
T Consensus 183 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~ 259 (313)
T 3brb_A 183 DMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE---MY 259 (313)
T ss_dssp TSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HH
T ss_pred CCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH---HH
Confidence 99999999999987654332222333567889999999999999999999999999999999 788865322211 11
Q ss_pred hhhHHhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 003254 734 GHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 794 (836)
Q Consensus 734 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 794 (836)
........ ...+......+.+++.+||+.+|++|||+.++++.|+.+.
T Consensus 260 ----~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~ 307 (313)
T 3brb_A 260 ----DYLLHGHR---------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL 307 (313)
T ss_dssp ----HHHHTTCC---------CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----HHHHcCCC---------CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11111110 0111122346789999999999999999999999998753
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=349.35 Aligned_cols=267 Identities=19% Similarity=0.209 Sum_probs=204.3
Q ss_pred hcccccccCeecccCceeEEEEEeec------CcEEEEEEecCCCchhH-----------HHHHHHHHHHHhhcCCceee
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLIE------GQEIAVKRLSKGSGQGM-----------EEFKNEVLLIAKLQHRNLVK 577 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~~------g~~vavK~l~~~~~~~~-----------~~~~~Ei~~l~~l~H~niv~ 577 (836)
..++|.+.+.||+|+||.||+|.+.. ++.||||++........ ..+..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 45689999999999999999999865 36799999876542211 12344566677778999999
Q ss_pred EEeEEeeC----CeeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEec
Q 003254 578 LLGCCTQR----DERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD 653 (836)
Q Consensus 578 l~g~~~~~----~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~ 653 (836)
+++++... ...+|||||+ +++|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~ 186 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA--NAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEe
Confidence 99998775 4489999999 9999999854 3457999999999999999999999998 99999999999999
Q ss_pred --CCCCceeeccCcccccCCCcccc-----ccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCC
Q 003254 654 --NTMNPKISDFGLARSFGLDQTEA-----NTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHA 726 (836)
Q Consensus 654 --~~~~~kl~DFgla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~ 726 (836)
.++.+||+|||+++.+....... ......||+.|+|||++.+..++.++|||||||+||||++|+.||.....
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~ 266 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK 266 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 88999999999998764332211 11235599999999999999999999999999999999999999763222
Q ss_pred ccccchhhhhHHhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 003254 727 DHDHNLLGHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 793 (836)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 793 (836)
. ........ ........+++++.+... .....+.+++..||+.+|++||++.+|++.|+.+
T Consensus 267 ~--~~~~~~~~-~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~ 327 (364)
T 3op5_A 267 D--PKYVRDSK-IRYRENIASLMDKCFPAA---NAPGEIAKYMETVKLLDYTEKPLYENLRDILLQG 327 (364)
T ss_dssp C--HHHHHHHH-HHHHHCHHHHHHHHSCTT---CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred C--HHHHHHHH-HHhhhhHHHHHHHhcccc---cCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Confidence 1 11111111 111122334444333211 1234577899999999999999999999999875
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-38 Score=350.35 Aligned_cols=276 Identities=18% Similarity=0.223 Sum_probs=206.5
Q ss_pred hhcccccccCeeccc--CceeEEEEEee-cCcEEEEEEecCCC--chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCee
Q 003254 514 NATDNFSEKNKLGEG--GFGPVYKGMLI-EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDER 588 (836)
Q Consensus 514 ~a~~~f~~~~~lG~G--~fG~Vykg~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 588 (836)
...++|++.++||+| +||.||+++.. +|+.||||++.... ....+.+.+|+.+++.++||||+++++++...+..
T Consensus 22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 101 (389)
T 3gni_B 22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL 101 (389)
T ss_dssp CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEE
Confidence 345789999999999 99999999986 48999999997543 34456788999999999999999999999999999
Q ss_pred eEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccc
Q 003254 589 MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (836)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~ 668 (836)
++||||+++|+|.+++... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 102 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~ 177 (389)
T 3gni_B 102 WVVTSFMAYGSAKDLICTH-FMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLS 177 (389)
T ss_dssp EEEEECCTTCBHHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEEEccCCCCHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEccccccee
Confidence 9999999999999998643 2356899999999999999999999998 99999999999999999999999999876
Q ss_pred cCCCcc-----ccccccccccccccCcccccC--CccCccccccchhhhhhhhhhCCCCCCCCCCccccch-hhhhHHhh
Q 003254 669 FGLDQT-----EANTKRVVGTYGYMSPEYAID--GLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNL-LGHAWRLW 740 (836)
Q Consensus 669 ~~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~-~~~~~~~~ 740 (836)
...... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||........... ........
T Consensus 178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 257 (389)
T 3gni_B 178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCL 257 (389)
T ss_dssp CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--------
T ss_pred eccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcc
Confidence 432111 111223478999999999987 5799999999999999999999999854322211000 00000000
Q ss_pred hccC--chhh-------------ccccc-------------cCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--h
Q 003254 741 IEER--PLEL-------------IDQSL-------------DNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM--L 790 (836)
Q Consensus 741 ~~~~--~~~~-------------~d~~l-------------~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~--L 790 (836)
.... ..+. ....+ ...........+.+|+.+||+.||++|||+.|+++. +
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f 337 (389)
T 3gni_B 258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFF 337 (389)
T ss_dssp ------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGG
T ss_pred ccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHH
Confidence 0000 0000 00000 000111123458899999999999999999999864 5
Q ss_pred cCC
Q 003254 791 SGE 793 (836)
Q Consensus 791 ~~~ 793 (836)
+++
T Consensus 338 ~~~ 340 (389)
T 3gni_B 338 KQI 340 (389)
T ss_dssp GGC
T ss_pred HHH
Confidence 554
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=348.93 Aligned_cols=259 Identities=25% Similarity=0.411 Sum_probs=199.9
Q ss_pred cccccccCeecccCceeEEEEEeec-Cc----EEEEEEecCC-CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeee
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQ----EIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERM 589 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~~-g~----~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 589 (836)
.++|+..+.||+|+||.||+|+... ++ +||+|.+... .....+++.+|+.++++++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 3679999999999999999999754 44 3588877544 3445678999999999999999999999998754 78
Q ss_pred EEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCccccc
Q 003254 590 LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (836)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~ 669 (836)
+|+||+++|+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 93 ~v~~~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEECCCSSCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred EEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 999999999999998643 346899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhccCchhh
Q 003254 670 GLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEERPLEL 748 (836)
Q Consensus 670 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (836)
.............+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+....... .. ......
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~----~~~~~~----- 235 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---IS----SILEKG----- 235 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HH----HHHHTT-----
T ss_pred cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HH----HHHHcC-----
Confidence 54433333334567889999999999999999999999999999999 999975432221 10 111111
Q ss_pred ccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCCCC
Q 003254 749 IDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSL 796 (836)
Q Consensus 749 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~~ 796 (836)
.....+......+.+++.+||+.+|++|||+.|+++.|+.+...
T Consensus 236 ----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 236 ----ERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp ----CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred ----CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 11111222334578999999999999999999999999987543
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-38 Score=348.27 Aligned_cols=250 Identities=22% Similarity=0.332 Sum_probs=203.0
Q ss_pred cccccccCeecccCceeEEEEEeec-CcEEEEEEecCCC---chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEE
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 591 (836)
.++|++.+.||+|+||.||++.... ++.||+|++.... ....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 3679999999999999999999865 8899999986532 23456788999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCC
Q 003254 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (836)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~ 671 (836)
|||+++|+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++..+..
T Consensus 94 ~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQ---NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp ECCCTTEEHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 999999999999843 456899999999999999999999998 99999999999999999999999999987643
Q ss_pred CccccccccccccccccCcccccC---CccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhh
Q 003254 672 DQTEANTKRVVGTYGYMSPEYAID---GLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLEL 748 (836)
Q Consensus 672 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (836)
. .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||............. ......
T Consensus 168 ~---~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~----~~~~~~---- 236 (384)
T 4fr4_A 168 E---TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVH----TFETTV---- 236 (384)
T ss_dssp T---CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHH----HHHHCC----
T ss_pred C---CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHH----HHhhcc----
Confidence 2 22334689999999999974 458999999999999999999999986433322111111 111000
Q ss_pred ccccccCCCChHHHHHHHHHHHHcccCCCCCCCC-HHHHHH
Q 003254 749 IDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPN-MSSVVL 788 (836)
Q Consensus 749 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-~~eVl~ 788 (836)
...+......+.+++.+||+.+|++||+ +.+|++
T Consensus 237 ------~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 237 ------VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp ------CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ------cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 0111222346789999999999999998 777764
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=343.92 Aligned_cols=263 Identities=26% Similarity=0.404 Sum_probs=204.8
Q ss_pred ccccccCeecccCceeEEEEEe-----ecCcEEEEEEecCCC-chhHHHHHHHHHHHHhhcCCceeeEEeEEeeC--Cee
Q 003254 517 DNFSEKNKLGEGGFGPVYKGML-----IEGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR--DER 588 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~-----~~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~ 588 (836)
+.|+..+.||+|+||.||++++ ..++.||||++.... ....+.+.+|+.++++++||||+++++++... ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 5688889999999999999983 358899999997543 34557899999999999999999999999876 568
Q ss_pred eEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccc
Q 003254 589 MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (836)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~ 668 (836)
++||||+++++|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 101 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp EEEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccccc
Confidence 9999999999999998543 346899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCccc-cccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCc--------cccchhhhhHHh
Q 003254 669 FGLDQTE-ANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHAD--------HDHNLLGHAWRL 739 (836)
Q Consensus 669 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~--------~~~~~~~~~~~~ 739 (836)
....... .......+|..|+|||.+.+..++.++||||||+++|||++|+.|+...... ..........
T Consensus 176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-- 253 (302)
T 4e5w_A 176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV-- 253 (302)
T ss_dssp CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHH--
T ss_pred ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHH--
Confidence 7543321 2233456788899999999999999999999999999999999874311000 0000000000
Q ss_pred hhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 003254 740 WIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 793 (836)
Q Consensus 740 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 793 (836)
..+........+......+.+++.+||+.||++|||+.|+++.|+.+
T Consensus 254 -------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 300 (302)
T 4e5w_A 254 -------NTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300 (302)
T ss_dssp -------HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------HHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 01111111122223345688999999999999999999999999864
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=349.61 Aligned_cols=213 Identities=28% Similarity=0.313 Sum_probs=183.8
Q ss_pred cccccCcccHHHHHhhcccccccCeecccCceeEEEEEee-cCcEEEEEEecCCCchhHHHHHHHHHHHHhhc-----CC
Q 003254 500 EEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQ-----HR 573 (836)
Q Consensus 500 ~~~~~~~~~~~~l~~a~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-----H~ 573 (836)
++.+...++++......++|.+.++||+|+||.||+++.. +++.||||++... ....+.+..|+.++..++ ||
T Consensus 18 ~~~~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~ 96 (360)
T 3llt_A 18 GDDEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNN 96 (360)
T ss_dssp --CGGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGG
T ss_pred cCccceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCC
Confidence 3445556777777778899999999999999999999985 4889999999643 344567788999999996 99
Q ss_pred ceeeEEeEEeeCCeeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEec
Q 003254 574 NLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD 653 (836)
Q Consensus 574 niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~ 653 (836)
||+++++++...+..++||||+ +++|.+++... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++
T Consensus 97 ~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~ 171 (360)
T 3llt_A 97 NIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRN-NYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLD 171 (360)
T ss_dssp GBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEES
T ss_pred CeecccceeeECCeeEEEEcCC-CCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEc
Confidence 9999999999999999999999 89999998643 2345899999999999999999999998 99999999999997
Q ss_pred C-------------------------CCCceeeccCcccccCCCccccccccccccccccCcccccCCccCccccccchh
Q 003254 654 N-------------------------TMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFG 708 (836)
Q Consensus 654 ~-------------------------~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~G 708 (836)
+ ++.+||+|||++...... .....||+.|+|||++.+..++.++||||||
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG 246 (360)
T 3llt_A 172 DPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFG 246 (360)
T ss_dssp CTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHH
T ss_pred cccccccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHH
Confidence 5 789999999999864321 2235789999999999999999999999999
Q ss_pred hhhhhhhhCCCCCCC
Q 003254 709 VLVLEIICGKKNRGF 723 (836)
Q Consensus 709 vvL~elltG~~p~~~ 723 (836)
|++|||++|+.||..
T Consensus 247 ~il~ell~g~~pf~~ 261 (360)
T 3llt_A 247 CVLAELYTGSLLFRT 261 (360)
T ss_dssp HHHHHHHHSSCSCCC
T ss_pred HHHHHHHHCCCCCCC
Confidence 999999999999864
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=339.77 Aligned_cols=265 Identities=20% Similarity=0.288 Sum_probs=197.9
Q ss_pred ccccccCeecccCceeEEEEEeec-CcEEEEEEecCCCc--hhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEe
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSG--QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 593 (836)
++|+..+.||+|+||.||+++... |+.||||++..... ...+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 678999999999999999999865 89999999865532 335678899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCc
Q 003254 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (836)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~ 673 (836)
|+++++|..++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 83 ~~~~~~l~~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 83 YCDHTVLHELDRY---QRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp CCSEEHHHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred eCCCchHHHHHhh---hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 9999999888743 356899999999999999999999998 9999999999999999999999999998764322
Q ss_pred cccccccccccccccCcccccC-CccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhh--------HHhhhccC
Q 003254 674 TEANTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHA--------WRLWIEER 744 (836)
Q Consensus 674 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~--------~~~~~~~~ 744 (836)
. ......||+.|+|||.+.+ ..++.++||||||++++||++|+.|+......+........ ...+....
T Consensus 157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
T 4agu_A 157 D--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQ 234 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCG
T ss_pred c--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccc
Confidence 2 1233578999999999976 67899999999999999999999997543322111110000 00000000
Q ss_pred ch---hhccccccCC---CChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 745 PL---ELIDQSLDNS---CSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 745 ~~---~~~d~~l~~~---~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
.. ...++..... ........+.+++.+||+.||++|||++|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 235 YFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp GGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred ccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00 0000000000 001123457899999999999999999999863
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=342.75 Aligned_cols=267 Identities=21% Similarity=0.252 Sum_probs=200.3
Q ss_pred cccccccCeecccCceeEEEEEee----cCcEEEEEEecCCCch-----------hHHHHHHHHHHHHhhcCCceeeEEe
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLI----EGQEIAVKRLSKGSGQ-----------GMEEFKNEVLLIAKLQHRNLVKLLG 580 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~----~g~~vavK~l~~~~~~-----------~~~~~~~Ei~~l~~l~H~niv~l~g 580 (836)
.++|...+.||+|+||.||+|+.. .+..+|||++...... ..+.+.+|+.++..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 468999999999999999999986 5778999998765432 1234667888999999999999999
Q ss_pred EEee----CCeeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCC
Q 003254 581 CCTQ----RDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTM 656 (836)
Q Consensus 581 ~~~~----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~ 656 (836)
++.. ....++||||+ +++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQN---GTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGG---GBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence 9988 67899999999 99999998532 37999999999999999999999998 99999999999998877
Q ss_pred --CceeeccCcccccCCCccc-----cccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccc
Q 003254 657 --NPKISDFGLARSFGLDQTE-----ANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHD 729 (836)
Q Consensus 657 --~~kl~DFgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~ 729 (836)
.+||+|||+++.+...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.......
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~- 267 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP- 267 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH-
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc-
Confidence 9999999999876432211 11134578999999999999999999999999999999999999974321111
Q ss_pred cchhhhhHHhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCCC
Q 003254 730 HNLLGHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS 795 (836)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~ 795 (836)
..............+..+.. ... .......+.+++..||+.+|++|||+.+|++.|+....
T Consensus 268 -~~~~~~~~~~~~~~~~~~~~-~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 268 -VAVQTAKTNLLDELPQSVLK-WAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp -HHHHHHHHHHHHTTTHHHHH-HSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred -HHHHHHHHhhcccccHHHHh-hcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 11111111111111111111 000 01223467899999999999999999999999998654
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=348.36 Aligned_cols=266 Identities=27% Similarity=0.402 Sum_probs=208.4
Q ss_pred cccccccCeecccCceeEEEEEe-----ecCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCC--ee
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGML-----IEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD--ER 588 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~-----~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~--~~ 588 (836)
.++|+..+.||+|+||.||+++. .+++.||||++........+.+.+|+.++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 36788899999999999999984 358899999998777677788999999999999999999999987654 68
Q ss_pred eEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccc
Q 003254 589 MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (836)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~ 668 (836)
++||||+++++|.+++... ...+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||++..
T Consensus 120 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp EEEECCCTTCBHHHHHHHS--TTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEECCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 9999999999999999543 346899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCcccc-ccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhcc----
Q 003254 669 FGLDQTEA-NTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEE---- 743 (836)
Q Consensus 669 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---- 743 (836)
........ ......++..|+|||.+.+..++.++||||||++++||++|+.|+...... ..+.....
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~--------~~~~~~~~~~~~ 266 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE--------FMRMIGNDKQGQ 266 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHH--------HHHHHCTTCCTH
T ss_pred ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHH--------HHHhhccccchh
Confidence 65433221 122345677899999999989999999999999999999999875421100 00000000
Q ss_pred ----CchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 003254 744 ----RPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 794 (836)
Q Consensus 744 ----~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 794 (836)
...+.+........+......+.+++.+||+.+|++|||+.||++.|+.+.
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~ 321 (326)
T 2w1i_A 267 MIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321 (326)
T ss_dssp HHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 000111111111122233456889999999999999999999999998753
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-38 Score=340.33 Aligned_cols=245 Identities=23% Similarity=0.297 Sum_probs=202.3
Q ss_pred cccccccCeecccCceeEEEEEee-cCcEEEEEEecCCC---chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEE
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 591 (836)
.++|+..+.||+|+||.||+++.. +|+.||+|++.+.. ....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 367899999999999999999986 48999999986542 23456788999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCC
Q 003254 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (836)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~ 671 (836)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 85 ~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 85 MDYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp ECCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred EeCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 999999999999854 346899999999999999999999998 99999999999999999999999999987532
Q ss_pred CccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccc
Q 003254 672 DQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQ 751 (836)
Q Consensus 672 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 751 (836)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... . ..........
T Consensus 159 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~-~~~~i~~~~~------ 220 (318)
T 1fot_A 159 -----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM------K-TYEKILNAEL------ 220 (318)
T ss_dssp -----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------H-HHHHHHHCCC------
T ss_pred -----ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH------H-HHHHHHhCCC------
Confidence 123467999999999999999999999999999999999999997532211 0 1111111110
Q ss_pred cccCCCChHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 003254 752 SLDNSCSFSEALRCIQVGLLCVQQRPEDRP-----NMSSVVL 788 (836)
Q Consensus 752 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~eVl~ 788 (836)
..+......+.+++.+||+.||++|| ++.||++
T Consensus 221 ----~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 221 ----RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred ----CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 11112234577999999999999999 8999884
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=335.61 Aligned_cols=255 Identities=27% Similarity=0.432 Sum_probs=205.6
Q ss_pred ccccccC-eecccCceeEEEEEee---cCcEEEEEEecCCC-chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEE
Q 003254 517 DNFSEKN-KLGEGGFGPVYKGMLI---EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (836)
Q Consensus 517 ~~f~~~~-~lG~G~fG~Vykg~~~---~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 591 (836)
++|...+ .||+|+||.||+|+.. .++.||||++.... ....+++.+|+.++++++||||+++++++ +.+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 5566665 8999999999999864 47789999997653 34567899999999999999999999999 55678999
Q ss_pred EeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCC
Q 003254 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (836)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~ 671 (836)
|||+++++|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+||++++++.+||+|||++.....
T Consensus 88 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 88 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp EECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 999999999999853 3456899999999999999999999998 99999999999999999999999999987753
Q ss_pred Cccc-cccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhccCchhhc
Q 003254 672 DQTE-ANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEERPLELI 749 (836)
Q Consensus 672 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (836)
.... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+....... . ........
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~----~~~i~~~~----- 230 (287)
T 1u59_A 163 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---V----MAFIEQGK----- 230 (287)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH---H----HHHHHTTC-----
T ss_pred CcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH---H----HHHHhcCC-----
Confidence 3222 12223456889999999998899999999999999999998 999975432211 1 11111111
Q ss_pred cccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 003254 750 DQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 793 (836)
Q Consensus 750 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 793 (836)
....+......+.+++..||+.+|++||++.||++.|+.+
T Consensus 231 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 270 (287)
T 1u59_A 231 ----RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 270 (287)
T ss_dssp ----CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0111223345688999999999999999999999999875
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=344.42 Aligned_cols=247 Identities=22% Similarity=0.324 Sum_probs=200.4
Q ss_pred hcccccccCeecccCceeEEEEEee-cCcEEEEEEecCCC---chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeE
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 590 (836)
..++|.+.+.||+|+||.||+|+.. .++.||||++.... ....+.+.+|+.+++.++||||+++++++...+..++
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 86 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM 86 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 3468999999999999999999974 58999999986431 2234578999999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccC
Q 003254 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (836)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~ 670 (836)
||||+ +|+|.+++... ..+++.++..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||++....
T Consensus 87 v~E~~-~g~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~ 159 (336)
T 3h4j_B 87 VIEYA-GGELFDYIVEK---KRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMT 159 (336)
T ss_dssp EECCC-CEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred EEECC-CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence 99999 67888887543 46899999999999999999999998 9999999999999999999999999998754
Q ss_pred CCccccccccccccccccCcccccCCcc-CccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhc
Q 003254 671 LDQTEANTKRVVGTYGYMSPEYAIDGLF-SVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELI 749 (836)
Q Consensus 671 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (836)
... ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||.......... .+
T Consensus 160 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~----------------~i 220 (336)
T 3h4j_B 160 DGN---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK----------------KV 220 (336)
T ss_dssp TSB---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC----------------CC
T ss_pred CCc---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH----------------HH
Confidence 322 2234679999999999998876 789999999999999999999975322211100 00
Q ss_pred cccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 750 DQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 750 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
... ....+......+.+++.+||+.||.+|||+.|+++
T Consensus 221 ~~~-~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 221 NSC-VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp CSS-CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred HcC-CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 000 00111122345779999999999999999999976
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-38 Score=341.58 Aligned_cols=250 Identities=22% Similarity=0.246 Sum_probs=178.1
Q ss_pred cCeecccCceeEEEEEeec-CcEEEEEEecCCCchhHHHHHHHHHHHHhhc-CCceeeEEeEEeeCCeeeEEEeecCCCC
Q 003254 522 KNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQRDERMLIYEYLPNKS 599 (836)
Q Consensus 522 ~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~~~gs 599 (836)
.+.||+|+||.||+++... ++.||||++... ....+.+|+.++..++ ||||+++++++.+....++||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 3789999999999999864 899999999643 3467789999999997 9999999999999999999999999999
Q ss_pred hhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCC---CceeeccCcccccCCCcccc
Q 003254 600 LDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTM---NPKISDFGLARSFGLDQTEA 676 (836)
Q Consensus 600 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~---~~kl~DFgla~~~~~~~~~~ 676 (836)
|.+++.. ...+++.++..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||+++.......
T Consensus 93 L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~-- 164 (325)
T 3kn6_A 93 LFERIKK---KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-- 164 (325)
T ss_dssp HHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred HHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC--
Confidence 9999954 356999999999999999999999998 99999999999997665 899999999986543222
Q ss_pred ccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccccccCC
Q 003254 677 NTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDNS 756 (836)
Q Consensus 677 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 756 (836)
......||+.|+|||++.+..++.++||||||+++|||++|+.||......................... . ...
T Consensus 165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~-~-----~~~ 238 (325)
T 3kn6_A 165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS-F-----EGE 238 (325)
T ss_dssp -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC-C-----CSH
T ss_pred cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC-C-----Ccc
Confidence 2234578999999999999999999999999999999999999986433221111111111111111100 0 000
Q ss_pred CChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 757 CSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 757 ~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
........+.+++.+||+.||++|||+.|+++
T Consensus 239 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 239 AWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp HHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred cccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 00112345789999999999999999999874
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=335.98 Aligned_cols=254 Identities=28% Similarity=0.416 Sum_probs=204.2
Q ss_pred hcccccccCeecccCceeEEEEEee-cCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEee---------
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQ--------- 584 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--------- 584 (836)
..++|+..+.||+|+||.||+++.. +++.||+|++.... +.+.+|+.++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 3467899999999999999999986 58999999997653 457789999999999999999998854
Q ss_pred -------CCeeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCC
Q 003254 585 -------RDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMN 657 (836)
Q Consensus 585 -------~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~ 657 (836)
....++||||+++++|.+++... ....+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHG-GGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCC
Confidence 44579999999999999999643 2356899999999999999999999998 999999999999999999
Q ss_pred ceeeccCcccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhH
Q 003254 658 PKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAW 737 (836)
Q Consensus 658 ~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~ 737 (836)
+||+|||++........ .....+++.|+|||.+.+..++.++||||||+++|||++|..|+.. .....
T Consensus 161 ~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~---------~~~~~ 228 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE---------TSKFF 228 (284)
T ss_dssp EEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH---------HHHHH
T ss_pred EEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh---------HHHHH
Confidence 99999999987643321 2235689999999999999999999999999999999999877320 00011
Q ss_pred HhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCCCCCCCC
Q 003254 738 RLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPQ 800 (836)
Q Consensus 738 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~~~~p~ 800 (836)
...... .+ +......+.+++.+||+.||++|||+.|+++.|+.+...++..
T Consensus 229 ~~~~~~--------~~----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~~ 279 (284)
T 2a19_B 229 TDLRDG--------II----SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKN 279 (284)
T ss_dssp HHHHTT--------CC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-----
T ss_pred HHhhcc--------cc----cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCcc
Confidence 111111 11 1112234678999999999999999999999999876655443
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-38 Score=348.28 Aligned_cols=248 Identities=26% Similarity=0.316 Sum_probs=196.0
Q ss_pred cccCeecccCceeEEEEEee-cCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEeecCCC
Q 003254 520 SEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNK 598 (836)
Q Consensus 520 ~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 598 (836)
...+.||+|+||.||+|+.. +|+.||+|++........+++.+|+.++++++||||+++++++...+..++||||++++
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~ 171 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence 33568999999999999975 48999999998776667788999999999999999999999999999999999999999
Q ss_pred ChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEe--cCCCCceeeccCcccccCCCcccc
Q 003254 599 SLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLL--DNTMNPKISDFGLARSFGLDQTEA 676 (836)
Q Consensus 599 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl--~~~~~~kl~DFgla~~~~~~~~~~ 676 (836)
+|.+++... ...+++..+..++.||++||+|||+.+ |+||||||+|||+ ++++.+||+|||+++.+.....
T Consensus 172 ~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~-- 244 (373)
T 2x4f_A 172 ELFDRIIDE--SYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK-- 244 (373)
T ss_dssp EEHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--
T ss_pred cHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--
Confidence 999888542 346899999999999999999999998 9999999999999 5678999999999987643322
Q ss_pred ccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccccccCC
Q 003254 677 NTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDNS 756 (836)
Q Consensus 677 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 756 (836)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ... ........ ......
T Consensus 245 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~---~~~----~~i~~~~~-~~~~~~---- 311 (373)
T 2x4f_A 245 -LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA---ETL----NNILACRW-DLEDEE---- 311 (373)
T ss_dssp -CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHH----HHHHHTCC-CSCSGG----
T ss_pred -cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH---HHH----HHHHhccC-CCChhh----
Confidence 22356999999999999999999999999999999999999997532211 111 11111100 000000
Q ss_pred CChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 757 CSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 757 ~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
.......+.+++.+||+.||++|||+.|+++
T Consensus 312 -~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 312 -FQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp -GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -hccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0112245789999999999999999999987
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=332.66 Aligned_cols=262 Identities=21% Similarity=0.271 Sum_probs=202.0
Q ss_pred hcccccccCeecccCceeEEEEEee-cCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEE-eeCCeeeEEE
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCC-TQRDERMLIY 592 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~-~~~~~~~lV~ 592 (836)
..++|+..+.||+|+||.||+|+.. +++.||||++..... .+++.+|+.++..++|++++..+..+ ......++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 4578999999999999999999974 588999998755432 34688999999999988877766655 6667789999
Q ss_pred eecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEe---cCCCCceeeccCccccc
Q 003254 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLL---DNTMNPKISDFGLARSF 669 (836)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl---~~~~~~kl~DFgla~~~ 669 (836)
||+ +++|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||+ ++++.+||+|||+++..
T Consensus 85 e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Ecc-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 999 99999998532 346899999999999999999999998 9999999999999 78999999999999876
Q ss_pred CCCccc-----cccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccC
Q 003254 670 GLDQTE-----ANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEER 744 (836)
Q Consensus 670 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 744 (836)
...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......................
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence 543221 122346789999999999999999999999999999999999999865443322222221111111111
Q ss_pred chhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 003254 745 PLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 793 (836)
Q Consensus 745 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 793 (836)
. +. +... ....+.+++.+||+.+|++|||+.+|++.|+.+
T Consensus 239 ~-~~----~~~~----~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 278 (296)
T 4hgt_A 239 I-EV----LCKG----YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp H-HH----HTTT----SCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred h-hh----hhcc----CCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHH
Confidence 0 00 0011 124578999999999999999999999999875
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=329.96 Aligned_cols=253 Identities=25% Similarity=0.351 Sum_probs=203.8
Q ss_pred cccccccCeecccCceeEEEEEee-cCcEEEEEEecCCC-chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEe
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 593 (836)
.++|+..+.||+|+||.||+++.. +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 467899999999999999999986 48999999986443 3445788999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCc
Q 003254 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (836)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~ 673 (836)
|+++++|.+++. ....+++..+..++.||+.||+|||+.+ |+|+||||+||+++.++.+||+|||++..+....
T Consensus 86 ~~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 86 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (276)
T ss_dssp CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ecCCCcHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence 999999998883 3456899999999999999999999998 9999999999999999999999999998764332
Q ss_pred cccccccccccccccCcccccCCcc-CccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhcccc
Q 003254 674 TEANTKRVVGTYGYMSPEYAIDGLF-SVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQS 752 (836)
Q Consensus 674 ~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 752 (836)
.........|++.|+|||.+.+..+ +.++||||||++++||++|+.|+........ ....+...... .
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~~~~~~--~--- 228 (276)
T 2yex_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ------EYSDWKEKKTY--L--- 228 (276)
T ss_dssp EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH------HHHHHHTTCTT--S---
T ss_pred chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH------HHHHhhhcccc--c---
Confidence 2222344678999999999987765 7899999999999999999999754322111 01111111000 0
Q ss_pred ccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 753 LDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 753 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
.........+.+++.+||+.||++|||+.|+++
T Consensus 229 ---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 229 ---NPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp ---TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 000112345778999999999999999999976
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=347.31 Aligned_cols=249 Identities=26% Similarity=0.390 Sum_probs=201.8
Q ss_pred hhcccccccCeecccCceeEEEEEeec-CcEEEEEEecCCC---chhHHHHHHHHHHHHhh-cCCceeeEEeEEeeCCee
Q 003254 514 NATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDER 588 (836)
Q Consensus 514 ~a~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~ 588 (836)
...++|...+.||+|+||.||+++... |+.||||++++.. ....+.+..|..++..+ +||||+++++++...+..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 345789999999999999999999864 8899999997542 23456788899999987 899999999999999999
Q ss_pred eEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccc
Q 003254 589 MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (836)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~ 668 (836)
++||||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 94 ~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp EEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 9999999999999998542 45899999999999999999999998 99999999999999999999999999986
Q ss_pred cCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhh
Q 003254 669 FGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLEL 748 (836)
Q Consensus 669 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (836)
..... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...... .. .........
T Consensus 168 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~----~~~i~~~~~--- 235 (345)
T 1xjd_A 168 NMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE---EL----FHSIRMDNP--- 235 (345)
T ss_dssp CCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH----HHHHHHCCC---
T ss_pred cccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH---HH----HHHHHhCCC---
Confidence 43221 2234578999999999999999999999999999999999999997532211 11 111111110
Q ss_pred ccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHH-HHH
Q 003254 749 IDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMS-SVV 787 (836)
Q Consensus 749 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~-eVl 787 (836)
..+......+.+++.+||+.||++||++. ||+
T Consensus 236 -------~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 236 -------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp -------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred -------CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 11111234577999999999999999997 665
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=337.62 Aligned_cols=257 Identities=26% Similarity=0.378 Sum_probs=203.4
Q ss_pred hhcccccccC-eecccCceeEEEEEee---cCcEEEEEEecCCC--chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCe
Q 003254 514 NATDNFSEKN-KLGEGGFGPVYKGMLI---EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDE 587 (836)
Q Consensus 514 ~a~~~f~~~~-~lG~G~fG~Vykg~~~---~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 587 (836)
...++|...+ .||+|+||.||+|... .++.||||++.... ....+++.+|+.+++.++||||+++++++ +.+.
T Consensus 13 ~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~ 91 (291)
T 1xbb_A 13 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAES 91 (291)
T ss_dssp CCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSS
T ss_pred ecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCC
Confidence 3446788777 9999999999999653 36889999997543 33467899999999999999999999999 5677
Q ss_pred eeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCccc
Q 003254 588 RMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667 (836)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~ 667 (836)
.++||||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++.
T Consensus 92 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 165 (291)
T 1xbb_A 92 WMLVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSK 165 (291)
T ss_dssp EEEEEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred cEEEEEeCCCCCHHHHHHh---CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcce
Confidence 8999999999999999954 345899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCcccc-ccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhccCc
Q 003254 668 SFGLDQTEA-NTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEERP 745 (836)
Q Consensus 668 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (836)
......... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.|+....... ..........
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~ 238 (291)
T 1xbb_A 166 ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTAMLEKGER 238 (291)
T ss_dssp ECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTTCC
T ss_pred eeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCC
Confidence 765433221 1222446789999999998899999999999999999999 999875322110 1111111110
Q ss_pred hhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 003254 746 LELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 793 (836)
Q Consensus 746 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 793 (836)
...+......+.+++.+||+.||++||++.||++.|+.+
T Consensus 239 ---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 277 (291)
T 1xbb_A 239 ---------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 277 (291)
T ss_dssp ---------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred ---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111222345678999999999999999999999999875
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-38 Score=344.97 Aligned_cols=251 Identities=24% Similarity=0.323 Sum_probs=188.5
Q ss_pred hcccccccCeecccCceeEEEEEeec-CcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEe
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 593 (836)
..++|+..+.||+|+||.||+|+... ++.||||++.... ..+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 45789999999999999999999865 7889999997543 34678899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecC---CCCceeeccCcccccC
Q 003254 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---TMNPKISDFGLARSFG 670 (836)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~---~~~~kl~DFgla~~~~ 670 (836)
|+++++|.+++.. ...+++.++..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++...
T Consensus 129 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 129 LVTGGELFDRIVE---KGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp CCCSCBHHHHHTT---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred eCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 9999999998843 456899999999999999999999998 999999999999975 8899999999998754
Q ss_pred CCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhcc
Q 003254 671 LDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELID 750 (836)
Q Consensus 671 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 750 (836)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.|+....... ........... ....
T Consensus 203 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~~i~~~~~-~~~~ 272 (349)
T 2w4o_A 203 HQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ------FMFRRILNCEY-YFIS 272 (349)
T ss_dssp -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH------HHHHHHHTTCC-CCCT
T ss_pred ccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH------HHHHHHHhCCC-ccCC
Confidence 221 2234678999999999999999999999999999999999999975322211 01111111110 0000
Q ss_pred ccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 751 QSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 751 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
.........+.+++.+||+.||++|||+.|+++
T Consensus 273 -----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 273 -----PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp -----TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -----chhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111122345789999999999999999999987
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=353.31 Aligned_cols=264 Identities=21% Similarity=0.249 Sum_probs=206.9
Q ss_pred ccHHHHHhhcccccccCeecccCceeEEEEEee-cCcEEEEEEecCCC---chhHHHHHHHHHHHHhhcCCceeeEEeEE
Q 003254 507 FDLKIIANATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCC 582 (836)
Q Consensus 507 ~~~~~l~~a~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~ 582 (836)
+.+++.....++|+..+.||+|+||.||+++.. +|+.||||++.+.. ....+.+.+|..++..++||||+++++++
T Consensus 51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 130 (412)
T 2vd5_A 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF 130 (412)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 345556667789999999999999999999986 48999999996532 22345688999999999999999999999
Q ss_pred eeCCeeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeec
Q 003254 583 TQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISD 662 (836)
Q Consensus 583 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~D 662 (836)
.+.+..+|||||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|
T Consensus 131 ~~~~~~~lVmE~~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~D 205 (412)
T 2vd5_A 131 QDENYLYLVMEYYVGGDLLTLLSKF--GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLAD 205 (412)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHH--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECC
T ss_pred eeCCEEEEEEcCCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEee
Confidence 9999999999999999999999543 246899999999999999999999998 99999999999999999999999
Q ss_pred cCcccccCCCccccccccccccccccCccccc-------CCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhh
Q 003254 663 FGLARSFGLDQTEANTKRVVGTYGYMSPEYAI-------DGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGH 735 (836)
Q Consensus 663 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~ 735 (836)
||+++....... ......+||+.|+|||++. +..++.++|||||||++|||++|+.||....... ...
T Consensus 206 FGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~---~~~- 280 (412)
T 2vd5_A 206 FGSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE---TYG- 280 (412)
T ss_dssp CTTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHH-
T ss_pred chhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHH---HHH-
Confidence 999987643322 1223468999999999997 4678999999999999999999999985422111 100
Q ss_pred hHHhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCC---CCHHHHHHH
Q 003254 736 AWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDR---PNMSSVVLM 789 (836)
Q Consensus 736 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~R---Pt~~eVl~~ 789 (836)
...... ....-+.. .......+.+++.+||+ +|++| |+++||++.
T Consensus 281 ---~i~~~~-~~~~~p~~----~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 281 ---KIVHYK-EHLSLPLV----DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp ---HHHTHH-HHCCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred ---HHHhcc-cCcCCCcc----ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 000000 00000000 11122457799999999 99998 689999763
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-38 Score=343.98 Aligned_cols=261 Identities=20% Similarity=0.219 Sum_probs=199.9
Q ss_pred HHhhcccccccCeecccCceeEEEEEeec-CcEEEEEEecCC-----CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeC
Q 003254 512 IANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG-----SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR 585 (836)
Q Consensus 512 l~~a~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~-----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~ 585 (836)
+....++|+..+.||+|+||.||+++... ++.||+|++... .....+.+.+|+.++++++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 45567889999999999999999999854 788999998643 334567899999999999999999999999999
Q ss_pred CeeeEEEeecCCCChhHHHhhcc-------------------------------------CCCcCChhhhHHHHHHHHhh
Q 003254 586 DERMLIYEYLPNKSLDYFIFDTT-------------------------------------RSKLLDWSKRSHIIAGIARG 628 (836)
Q Consensus 586 ~~~~lV~Ey~~~gsL~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~~ia~g 628 (836)
+..++||||+++|+|.+++.... ....+++..+..++.||+.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 99999999999999999884211 01234567788999999999
Q ss_pred hHhhhcCCCCcEEeccCCCCceEecCCC--CceeeccCcccccCCCcc--ccccccccccccccCcccccC--CccCccc
Q 003254 629 LLYLHQDSRLRIIHRDLKASNVLLDNTM--NPKISDFGLARSFGLDQT--EANTKRVVGTYGYMSPEYAID--GLFSVKS 702 (836)
Q Consensus 629 L~yLH~~~~~~ivH~DLkp~NILl~~~~--~~kl~DFgla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~--~~~t~ks 702 (836)
|+|||+.+ |+||||||+|||++.++ .+||+|||+++.+..... ........||+.|+|||.+.+ ..++.++
T Consensus 181 l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 99999998 99999999999998766 899999999987643221 112334678999999999975 6789999
Q ss_pred cccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCC
Q 003254 703 DVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPN 782 (836)
Q Consensus 703 DVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt 782 (836)
||||||+++|||++|+.||...... ............ ...+ ........+.+++.+||+.+|++|||
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~------~~~~~~~~~~~~--~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rps 324 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDA------DTISQVLNKKLC--FENP-----NYNVLSPLARDLLSNLLNRNVDERFD 324 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCCC--TTSG-----GGGGSCHHHHHHHHHHSCSCTTTSCC
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChH------HHHHHHHhcccc--cCCc-----ccccCCHHHHHHHHHHcCCChhHCCC
Confidence 9999999999999999997532211 111111111100 0000 00112345779999999999999999
Q ss_pred HHHHHH
Q 003254 783 MSSVVL 788 (836)
Q Consensus 783 ~~eVl~ 788 (836)
+.|+++
T Consensus 325 ~~~~l~ 330 (345)
T 3hko_A 325 AMRALQ 330 (345)
T ss_dssp HHHHHH
T ss_pred HHHHhc
Confidence 999987
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-38 Score=334.31 Aligned_cols=256 Identities=25% Similarity=0.355 Sum_probs=202.5
Q ss_pred hcccccccCeecccCceeEEEEEeec----CcEEEEEEecCCC-chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeee
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLIE----GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERM 589 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~~----g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 589 (836)
..++|...+.||+|+||.||+|+... +..||+|++.... ....+.+.+|+.++++++||||+++++++.+ +..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 45789999999999999999998754 3469999987653 3456789999999999999999999999865 5578
Q ss_pred EEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCccccc
Q 003254 590 LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (836)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~ 669 (836)
+||||+++++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 89 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERN--KNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp EEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred EEEecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccc
Confidence 999999999999999543 345899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhccCchhh
Q 003254 670 GLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEERPLEL 748 (836)
Q Consensus 670 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (836)
..... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.|+....... ... .......
T Consensus 164 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~---~~~----~~~~~~~--- 232 (281)
T 3cc6_A 164 EDEDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD---VIG----VLEKGDR--- 232 (281)
T ss_dssp ----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG---HHH----HHHHTCC---
T ss_pred ccccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH---HHH----HHhcCCC---
Confidence 43222 11223456889999999998899999999999999999998 999975322211 111 1111100
Q ss_pred ccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 003254 749 IDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 793 (836)
Q Consensus 749 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 793 (836)
...+......+.+++.+||+.+|++|||+.|+++.|+.+
T Consensus 233 ------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 271 (281)
T 3cc6_A 233 ------LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271 (281)
T ss_dssp ------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence 011112234578999999999999999999999999865
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=331.11 Aligned_cols=263 Identities=20% Similarity=0.248 Sum_probs=206.1
Q ss_pred hcccccccCeecccCceeEEEEEe-ecCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEE-eeCCeeeEEE
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGML-IEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCC-TQRDERMLIY 592 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~-~~~~~~~lV~ 592 (836)
..++|+..+.||+|+||.||+|+. .+++.||||++..... .+++.+|+.++..++|++++..+..+ ......++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 457899999999999999999997 4589999999865532 35689999999999988876666655 5667789999
Q ss_pred eecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEe---cCCCCceeeccCccccc
Q 003254 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLL---DNTMNPKISDFGLARSF 669 (836)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl---~~~~~~kl~DFgla~~~ 669 (836)
||+ +++|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||+ ++++.+||+|||+++..
T Consensus 85 e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 85 ELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Eec-CCCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 999 89999998532 346899999999999999999999998 9999999999999 48899999999999876
Q ss_pred CCCcccc-----ccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccC
Q 003254 670 GLDQTEA-----NTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEER 744 (836)
Q Consensus 670 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 744 (836)
....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......................
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence 5432211 12346789999999999999999999999999999999999999865433322222221111111111
Q ss_pred chhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 003254 745 PLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 794 (836)
Q Consensus 745 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 794 (836)
... +... ....+.+++.+||+.||++|||+.+|++.|+.+.
T Consensus 239 ~~~-----~~~~----~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 279 (296)
T 3uzp_A 239 IEV-----LCKG----YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 279 (296)
T ss_dssp HHH-----HTTT----SCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred hHH-----HHhh----CCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHH
Confidence 000 0111 1245789999999999999999999999998763
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=335.15 Aligned_cols=256 Identities=27% Similarity=0.335 Sum_probs=202.0
Q ss_pred cccccCeecccCceeEEEEEeec----CcEEEEEEecCCCc-hhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCee-eEE
Q 003254 518 NFSEKNKLGEGGFGPVYKGMLIE----GQEIAVKRLSKGSG-QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDER-MLI 591 (836)
Q Consensus 518 ~f~~~~~lG~G~fG~Vykg~~~~----g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~-~lV 591 (836)
.|...+.||+|+||.||+|+..+ +..+|+|++..... ...+.+.+|+.++++++||||+++++++...+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 45556899999999999998643 23699999876433 4567899999999999999999999999876665 999
Q ss_pred EeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCC
Q 003254 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (836)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~ 671 (836)
|||+.+++|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 102 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 102 LPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp ECCCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred EecccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 999999999999954 3456889999999999999999999998 99999999999999999999999999987643
Q ss_pred Ccc--ccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhc
Q 003254 672 DQT--EANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELI 749 (836)
Q Consensus 672 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (836)
... ........+++.|+|||.+.+..++.++||||||+++|||++|..|+...... ..... ......
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~--~~~~~----~~~~~~----- 245 (298)
T 3pls_A 177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP--FDLTH----FLAQGR----- 245 (298)
T ss_dssp GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG--GGHHH----HHHTTC-----
T ss_pred CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH--HHHHH----HhhcCC-----
Confidence 321 12223456789999999999999999999999999999999976654221111 11111 111110
Q ss_pred cccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 003254 750 DQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 793 (836)
Q Consensus 750 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 793 (836)
....+......+.+++.+||+.+|++|||+.|+++.|+++
T Consensus 246 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~ 285 (298)
T 3pls_A 246 ----RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI 285 (298)
T ss_dssp ----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0011112234578999999999999999999999999876
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=330.93 Aligned_cols=251 Identities=20% Similarity=0.302 Sum_probs=203.1
Q ss_pred hcccccccCeecccCceeEEEEEeec-CcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEe
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 593 (836)
..++|+..+.||+|+||.||+|+... +..+|+|++........+.+.+|+.++++++||||+++++++......++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 45689999999999999999999865 77899999977655667889999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEe---cCCCCceeeccCcccccC
Q 003254 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLL---DNTMNPKISDFGLARSFG 670 (836)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl---~~~~~~kl~DFgla~~~~ 670 (836)
|+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||++ +.++.+||+|||++..+.
T Consensus 87 ~~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 87 LCTGGELFERVVH---KRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp CCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred ccCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 9999999988854 345899999999999999999999998 9999999999999 788999999999998764
Q ss_pred CCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhcc
Q 003254 671 LDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELID 750 (836)
Q Consensus 671 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 750 (836)
... ......||+.|+|||.+.+. ++.++||||||++++||++|+.|+...... . .......... ....
T Consensus 161 ~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~----~~~~~~~~~~-~~~~ 228 (277)
T 3f3z_A 161 PGK---MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDS---E----VMLKIREGTF-TFPE 228 (277)
T ss_dssp TTS---CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---H----HHHHHHHCCC-CCCH
T ss_pred Ccc---chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHH---H----HHHHHHhCCC-CCCc
Confidence 322 22335789999999988654 899999999999999999999997532211 0 1111111100 0000
Q ss_pred ccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 751 QSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 751 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
... ......+.+++.+||+.||++|||+.|+++
T Consensus 229 ~~~-----~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 229 KDW-----LNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp HHH-----TTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred hhh-----hcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 011245779999999999999999999975
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=342.23 Aligned_cols=257 Identities=27% Similarity=0.421 Sum_probs=200.2
Q ss_pred ccccccCeecccCceeEEEEEeec-----CcEEEEEEecCCC-chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeE
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-----GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-----g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 590 (836)
++|...+.||+|+||.||+|.... +..||||++.... ......+.+|+.++++++||||+++++++...+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 567778999999999999998754 2459999997653 3345678999999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccC
Q 003254 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (836)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~ 670 (836)
||||+++++|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 124 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 198 (333)
T 1mqb_A 124 ITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 198 (333)
T ss_dssp EEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence 9999999999999854 2356899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCccc-cccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhccCchhh
Q 003254 671 LDQTE-ANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEERPLEL 748 (836)
Q Consensus 671 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (836)
..... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.|+...... . .........
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~---~----~~~~~~~~~---- 267 (333)
T 1mqb_A 199 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH---E----VMKAINDGF---- 267 (333)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---H----HHHHHHTTC----
T ss_pred cccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH---H----HHHHHHCCC----
Confidence 33221 11222356788999999999999999999999999999999 99987432211 1 111111110
Q ss_pred ccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 003254 749 IDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 794 (836)
Q Consensus 749 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 794 (836)
....+......+.+++.+||+.+|++||++.||++.|+.+.
T Consensus 268 -----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 308 (333)
T 1mqb_A 268 -----RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 308 (333)
T ss_dssp -----CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred -----cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 01111223356789999999999999999999999998764
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=341.21 Aligned_cols=248 Identities=23% Similarity=0.291 Sum_probs=192.7
Q ss_pred cccccccCeecccCceeEEEEEe----ecCcEEEEEEecCCC----chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCe
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGML----IEGQEIAVKRLSKGS----GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDE 587 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~----~~g~~vavK~l~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 587 (836)
.++|+..+.||+|+||.||+++. ..|+.||+|++.+.. ......+.+|+.++++++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46899999999999999999997 368999999997642 2344568899999999999999999999999999
Q ss_pred eeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCccc
Q 003254 588 RMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667 (836)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~ 667 (836)
.++||||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLER---EGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEEECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEEeCCCCCcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 9999999999999999854 345889999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchh
Q 003254 668 SFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLE 747 (836)
Q Consensus 668 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (836)
...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...... .. .........
T Consensus 170 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~----~~~i~~~~~-- 238 (327)
T 3a62_A 170 ESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK---KT----IDKILKCKL-- 238 (327)
T ss_dssp -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HH----HHHHHHTCC--
T ss_pred ccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH---HH----HHHHHhCCC--
Confidence 643222 1223467999999999999999999999999999999999999997532211 11 111111100
Q ss_pred hccccccCCCChHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 003254 748 LIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRP-----NMSSVVL 788 (836)
Q Consensus 748 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~eVl~ 788 (836)
..+......+.+++.+||+.+|++|| ++.|+++
T Consensus 239 --------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 239 --------NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp --------CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred --------CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 11112234577999999999999999 7788876
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=344.07 Aligned_cols=245 Identities=21% Similarity=0.237 Sum_probs=202.9
Q ss_pred cccccccCeecccCceeEEEEEee-cCcEEEEEEecCCC---chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEE
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 591 (836)
.++|+..+.||+|+||.||+++.. +|+.||||++.+.. ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 368899999999999999999986 48999999986542 23456788999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCC
Q 003254 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (836)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~ 671 (836)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 120 ~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp EECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccC
Confidence 9999999999998543 45899999999999999999999998 99999999999999999999999999987542
Q ss_pred CccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccc
Q 003254 672 DQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQ 751 (836)
Q Consensus 672 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 751 (836)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...........
T Consensus 194 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-------~~~~~i~~~~~------ 255 (350)
T 1rdq_E 194 R-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-------QIYEKIVSGKV------ 255 (350)
T ss_dssp C-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCCC------
T ss_pred C-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH-------HHHHHHHcCCC------
Confidence 2 23467999999999999999999999999999999999999997532211 11111111110
Q ss_pred cccCCCChHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 003254 752 SLDNSCSFSEALRCIQVGLLCVQQRPEDRPN-----MSSVVL 788 (836)
Q Consensus 752 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~eVl~ 788 (836)
..+......+.+++.+||+.||++||+ +.||++
T Consensus 256 ----~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 256 ----RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ----CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ----CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 111122345789999999999999998 888875
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=345.39 Aligned_cols=254 Identities=23% Similarity=0.305 Sum_probs=193.5
Q ss_pred hcccccccCeecccCceeEEEEEee-cCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEe
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 593 (836)
..++|...+.||+|+||.||+++.. .++.||||++.... ...+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence 4578999999999999999999986 48899999997543 234678899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCC--ceeeccCcccccCC
Q 003254 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMN--PKISDFGLARSFGL 671 (836)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~--~kl~DFgla~~~~~ 671 (836)
|+++|+|.+++.. .+.+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||+++....
T Consensus 97 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~ 170 (361)
T 3uc3_A 97 YASGGELYERICN---AGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170 (361)
T ss_dssp CCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred eCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence 9999999999854 345899999999999999999999998 999999999999987765 99999999975322
Q ss_pred CccccccccccccccccCcccccCCccCcc-ccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhcc
Q 003254 672 DQTEANTKRVVGTYGYMSPEYAIDGLFSVK-SDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELID 750 (836)
Q Consensus 672 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k-sDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 750 (836)
. .......||+.|+|||++.+..++.+ +|||||||++|||++|+.||........ ... .........
T Consensus 171 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~~-~~~~~~~~~------ 238 (361)
T 3uc3_A 171 H---SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD--YRK-TIQRILSVK------ 238 (361)
T ss_dssp -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC--HHH-HHHHHHTTC------
T ss_pred c---CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH--HHH-HHHHHhcCC------
Confidence 1 12234579999999999988887665 8999999999999999999864322211 111 111111000
Q ss_pred ccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 751 QSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 751 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
............+.+++.+||+.+|++|||+.|+++.
T Consensus 239 --~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 239 --YSIPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp --CCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred --CCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 0000011122457799999999999999999999874
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=348.78 Aligned_cols=271 Identities=21% Similarity=0.257 Sum_probs=213.3
Q ss_pred cccccccCeecccCceeEEEEEeec-CcEEEEEEecCCC-chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCC--eeeEE
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD--ERMLI 591 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~--~~~lV 591 (836)
.++|...+.||+|+||.||+|+... |+.||||++.... ....+.+.+|++++++++||||+++++++.... ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 4689999999999999999999865 8999999997543 234577889999999999999999999998765 67999
Q ss_pred EeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEe----cCCCCceeeccCccc
Q 003254 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLL----DNTMNPKISDFGLAR 667 (836)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl----~~~~~~kl~DFgla~ 667 (836)
|||+++|+|.+++........+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 999999999999966544455999999999999999999999998 9999999999999 778889999999998
Q ss_pred ccCCCccccccccccccccccCcccccC--------CccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHh
Q 003254 668 SFGLDQTEANTKRVVGTYGYMSPEYAID--------GLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRL 739 (836)
Q Consensus 668 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~ 739 (836)
...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......... . ....
T Consensus 165 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~--~-~~~~ 238 (396)
T 4eut_A 165 ELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK--E-VMYK 238 (396)
T ss_dssp ECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCH--H-HHHH
T ss_pred EccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchH--H-HHHH
Confidence 764332 2233578999999999865 568899999999999999999999975432211111 1 1111
Q ss_pred hhccCchhhccc-------------cc--cCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCCC
Q 003254 740 WIEERPLELIDQ-------------SL--DNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS 795 (836)
Q Consensus 740 ~~~~~~~~~~d~-------------~l--~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~ 795 (836)
.....+...+.. .+ ....+......+.+++.+||+.||++||++.|+++.|+.+..
T Consensus 239 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~ 309 (396)
T 4eut_A 239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (396)
T ss_dssp HHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred HhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence 111221111100 01 112345566778899999999999999999999999887533
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=335.57 Aligned_cols=260 Identities=26% Similarity=0.354 Sum_probs=201.6
Q ss_pred hcccccccCeecccCceeEEEEEeec----CcEEEEEEecCCC-chhHHHHHHHHHHHHhhcCCceeeEEeEEe-eCCee
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLIE----GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCT-QRDER 588 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~~----g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~-~~~~~ 588 (836)
....|...+.||+|+||.||+|+..+ ...+|+|.+.... ....+.+.+|+.++++++||||+++++++. ..+..
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (298)
T 3f66_A 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 102 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence 34578888999999999999999643 2358999987643 345678999999999999999999999865 45578
Q ss_pred eEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccc
Q 003254 589 MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (836)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~ 668 (836)
++||||+++++|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.
T Consensus 103 ~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~ 177 (298)
T 3f66_A 103 LVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARD 177 (298)
T ss_dssp EEEEECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred EEEEeCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccccc
Confidence 999999999999999953 3456889999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCccc--cccccccccccccCcccccCCccCccccccchhhhhhhhhhCCC-CCCCCCCccccchhhhhHHhhhccCc
Q 003254 669 FGLDQTE--ANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKK-NRGFNHADHDHNLLGHAWRLWIEERP 745 (836)
Q Consensus 669 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~-p~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (836)
....... .......+|+.|+|||.+.+..++.++||||||++++||++|.. |+....... ... .......
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~---~~~----~~~~~~~ 250 (298)
T 3f66_A 178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITV----YLLQGRR 250 (298)
T ss_dssp CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT---HHH----HHHTTCC
T ss_pred ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH---HHH----HHhcCCC
Confidence 6433221 12233567889999999999999999999999999999999554 433221111 110 0111100
Q ss_pred hhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCCC
Q 003254 746 LELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS 795 (836)
Q Consensus 746 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~ 795 (836)
...+......+.+++.+||+.+|++|||+.|+++.|+.+..
T Consensus 251 ---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 291 (298)
T 3f66_A 251 ---------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 291 (298)
T ss_dssp ---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 00111122457899999999999999999999999988643
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=330.59 Aligned_cols=252 Identities=23% Similarity=0.329 Sum_probs=202.7
Q ss_pred hcccccccCeecccCceeEEEEEeec-CcEEEEEEecCC--CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEE
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 591 (836)
..++|+..+.||+|+||.||++.... ++.||+|++... .....+.+.+|+.++++++||||+++++++......++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 45789999999999999999999864 889999998654 334457788999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCC---ceeeccCcccc
Q 003254 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMN---PKISDFGLARS 668 (836)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~---~kl~DFgla~~ 668 (836)
|||+++++|.+.+... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++. +||+|||++..
T Consensus 84 ~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 9999999998888543 46899999999999999999999998 999999999999986655 99999999987
Q ss_pred cCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhh
Q 003254 669 FGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLEL 748 (836)
Q Consensus 669 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (836)
...... .....|++.|+|||.+.+..++.++||||||+++++|++|+.|+...... ... ........ ..
T Consensus 158 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~---~~~----~~~~~~~~-~~ 226 (284)
T 3kk8_A 158 VNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLY----AQIKAGAY-DY 226 (284)
T ss_dssp CCSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH----HHHHHTCC-CC
T ss_pred cccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh---HHH----HHHHhccc-cC
Confidence 643222 23367899999999999999999999999999999999999997432211 111 11111100 00
Q ss_pred ccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 749 IDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 749 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
.. .........+.+++.+||+.+|++|||+.|+++
T Consensus 227 ~~-----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 227 PS-----PEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp CT-----TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred Cc-----hhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 00 000112245779999999999999999999987
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-38 Score=339.08 Aligned_cols=264 Identities=23% Similarity=0.338 Sum_probs=200.0
Q ss_pred hcccccccCeecccCceeEEEEEee-cCcEEEEEEecCC---CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeE
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 590 (836)
..++|++.+.||+|+||.||+|... +|+.||||++... .....+.+.+|+.++++++||||+++++++...+..++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 3467999999999999999999974 5899999998753 23456778999999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhcc-CCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCccccc
Q 003254 591 IYEYLPNKSLDYFIFDTT-RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (836)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~ 669 (836)
||||+++++|.+++.... ....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFF 186 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence 999999999999986432 3456899999999999999999999998 999999999999999999999999999875
Q ss_pred CCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhc
Q 003254 670 GLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELI 749 (836)
Q Consensus 670 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (836)
..... ......+++.|+|||.+.+..++.++||||||+++|||++|+.|+...... .... ...........
T Consensus 187 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~-~~~~~~~~~~~-- 257 (310)
T 2wqm_A 187 SSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSL-CKKIEQCDYPP-- 257 (310)
T ss_dssp --------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC----HHHH-HHHHHTTCSCC--
T ss_pred cCCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh----HHHH-HHHhhcccCCC--
Confidence 43221 222356899999999999999999999999999999999999997532211 1010 11111110000
Q ss_pred cccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCCCC
Q 003254 750 DQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSL 796 (836)
Q Consensus 750 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~~ 796 (836)
.........+.+++.+||+.||++|||+.||++.|+.+.+.
T Consensus 258 ------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~ 298 (310)
T 2wqm_A 258 ------LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHAC 298 (310)
T ss_dssp ------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ------CcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 00112234578999999999999999999999999987553
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=344.01 Aligned_cols=248 Identities=27% Similarity=0.344 Sum_probs=201.8
Q ss_pred cccccccCeecccCceeEEEEEeec-CcEEEEEEecCCC---chhHHHHHHHHHHHHhh-cCCceeeEEeEEeeCCeeeE
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDERML 590 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~l 590 (836)
.++|+..+.||+|+||.||+++... ++.||||++.+.. ....+.+..|..++..+ +||||+++++++...+..++
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 4789999999999999999999865 7889999987542 23456788999999988 79999999999999999999
Q ss_pred EEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccC
Q 003254 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (836)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~ 670 (836)
||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 99 v~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 172 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 172 (353)
T ss_dssp EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence 99999999999998543 45899999999999999999999998 9999999999999999999999999998643
Q ss_pred CCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhcc
Q 003254 671 LDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELID 750 (836)
Q Consensus 671 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 750 (836)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...... .. .........
T Consensus 173 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~---~~----~~~i~~~~~----- 238 (353)
T 2i0e_A 173 WDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---EL----FQSIMEHNV----- 238 (353)
T ss_dssp CTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH----HHHHHHCCC-----
T ss_pred cCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH---HH----HHHHHhCCC-----
Confidence 221 2234468999999999999999999999999999999999999997532211 11 111111110
Q ss_pred ccccCCCChHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 003254 751 QSLDNSCSFSEALRCIQVGLLCVQQRPEDRPN-----MSSVVL 788 (836)
Q Consensus 751 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~eVl~ 788 (836)
..+......+.+++.+||+.||++||+ +.||++
T Consensus 239 -----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 239 -----AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred -----CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 111122345789999999999999995 577764
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=336.05 Aligned_cols=263 Identities=25% Similarity=0.344 Sum_probs=197.2
Q ss_pred hcccccccCeecccCceeEEEEEee-cCcEEEEEEecCCC-----chhHHHHHHHHHHHHhhc---CCceeeEEeEEeeC
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS-----GQGMEEFKNEVLLIAKLQ---HRNLVKLLGCCTQR 585 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~-----~~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~ 585 (836)
..++|+..+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.++++++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 4578999999999999999999974 48999999986432 122356778888887775 99999999999876
Q ss_pred C-----eeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCcee
Q 003254 586 D-----ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKI 660 (836)
Q Consensus 586 ~-----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl 660 (836)
. ..++||||+. ++|.+++... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKA-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTC-CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEE
Confidence 5 4799999997 5998888543 2344899999999999999999999998 999999999999999999999
Q ss_pred eccCcccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhh
Q 003254 661 SDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLW 740 (836)
Q Consensus 661 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~ 740 (836)
+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .........
T Consensus 162 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~ 235 (308)
T 3g33_A 162 ADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD---QLGKIFDLI 235 (308)
T ss_dssp CSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH---HHHHHHHHH
T ss_pred eeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHh
Confidence 9999998754222 2234678999999999999999999999999999999999999975432211 111111111
Q ss_pred hccCchh------hccccccC--C-----CChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 741 IEERPLE------LIDQSLDN--S-----CSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 741 ~~~~~~~------~~d~~l~~--~-----~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
....... ........ . ........+.+++.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 236 GLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp CCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 0000000 00000000 0 01122345789999999999999999999986
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-38 Score=341.34 Aligned_cols=262 Identities=29% Similarity=0.415 Sum_probs=204.4
Q ss_pred hcccccccCeecccCceeEEEEEee------cCcEEEEEEecCC-CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCe
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLI------EGQEIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDE 587 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~------~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 587 (836)
..++|+..+.||+|+||.||+|+.. .++.||||++... ......++.+|+.++++++||||+++++++.....
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 3478999999999999999999842 3678999999754 34456689999999999999999999999999999
Q ss_pred eeEEEeecCCCChhHHHhhccC----CCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEec---CCCCcee
Q 003254 588 RMLIYEYLPNKSLDYFIFDTTR----SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD---NTMNPKI 660 (836)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~---~~~~~kl 660 (836)
.++||||+++++|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++ ++..+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEE
Confidence 9999999999999999975432 145889999999999999999999998 99999999999998 4556999
Q ss_pred eccCcccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHh
Q 003254 661 SDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRL 739 (836)
Q Consensus 661 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 739 (836)
+|||++................+++.|+|||.+.+..++.++||||||+++|||++ |+.|+...... . ....
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~----~~~~ 257 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ---E----VLEF 257 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---H----HHHH
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH---H----HHHH
Confidence 99999986543333233334567899999999998999999999999999999998 88886532211 0 1111
Q ss_pred hhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCCC
Q 003254 740 WIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS 795 (836)
Q Consensus 740 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~ 795 (836)
...... ..........+.+++.+||+.+|++||++.||++.|+.+..
T Consensus 258 ~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 258 VTSGGR---------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp HHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HhcCCC---------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 111100 01111223467899999999999999999999999987643
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=331.97 Aligned_cols=248 Identities=25% Similarity=0.363 Sum_probs=199.9
Q ss_pred hcccccccCeecccCceeEEEEEeec-CcEEEEEEecCCC---chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeE
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 590 (836)
+.++|+..+.||+|+||.||++.... ++.||||++.... ....+.+.+|+.++++++||||+++++++.+....++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 45789999999999999999999865 7789999986432 2235678999999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccC
Q 003254 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (836)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~ 670 (836)
||||+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 87 v~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp EECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 99999999999998543 45899999999999999999999988 9999999999999999999999999986543
Q ss_pred CCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhcc
Q 003254 671 LDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELID 750 (836)
Q Consensus 671 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 750 (836)
.. ......|++.|+|||.+.+..++.++||||||+++|||++|+.|+....... ........
T Consensus 161 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~------- 222 (279)
T 3fdn_A 161 SS----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE-------TYKRISRV------- 222 (279)
T ss_dssp -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHHT-------
T ss_pred cc----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH-------HHHHHHhC-------
Confidence 22 1233578999999999999999999999999999999999999975322110 01111000
Q ss_pred ccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 751 QSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 751 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
....+......+.+++.+||+.+|++|||+.||++.
T Consensus 223 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 223 ---EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp ---CCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred ---CCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 001111223457799999999999999999999974
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=367.37 Aligned_cols=254 Identities=26% Similarity=0.418 Sum_probs=200.1
Q ss_pred cccccC-eecccCceeEEEEEee---cCcEEEEEEecCCC-chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEE
Q 003254 518 NFSEKN-KLGEGGFGPVYKGMLI---EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (836)
Q Consensus 518 ~f~~~~-~lG~G~fG~Vykg~~~---~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 592 (836)
++...+ +||+|+||.||+|.+. ++..||||+++... ....++|.+|+.++++++||||+++++++.. +..++||
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~ 414 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM 414 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence 344444 7999999999999875 36679999997653 3456889999999999999999999999976 6689999
Q ss_pred eecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCC
Q 003254 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (836)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~ 672 (836)
||+++|+|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+||||++++.+||+|||+++.+...
T Consensus 415 E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~ 489 (613)
T 2ozo_A 415 EMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGAD 489 (613)
T ss_dssp ECCTTCBHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC--
T ss_pred EeCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCC
Confidence 99999999999853 3456899999999999999999999998 999999999999999999999999999876433
Q ss_pred cccc-ccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhccCchhhcc
Q 003254 673 QTEA-NTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEERPLELID 750 (836)
Q Consensus 673 ~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 750 (836)
.... ......+++.|+|||++.++.++.++|||||||+||||++ |+.|+....... + ........
T Consensus 490 ~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~---~----~~~i~~~~------ 556 (613)
T 2ozo_A 490 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---V----MAFIEQGK------ 556 (613)
T ss_dssp ------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH---H----HHHHHTTC------
T ss_pred CceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---H----HHHHHcCC------
Confidence 2211 1122345689999999999999999999999999999998 999975432211 1 11111111
Q ss_pred ccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 003254 751 QSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 793 (836)
Q Consensus 751 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 793 (836)
....+......+.+|+..||+.+|++||++.+|++.|+.+
T Consensus 557 ---~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 596 (613)
T 2ozo_A 557 ---RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 596 (613)
T ss_dssp ---CCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred ---CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1112223345688999999999999999999999999875
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=339.46 Aligned_cols=265 Identities=22% Similarity=0.276 Sum_probs=205.4
Q ss_pred HhhcccccccCeecccCceeEEEEEeecCcEEEEEEecCCCchhHHHHHHHHHHHHh--hcCCceeeEEeEEeeCC----
Q 003254 513 ANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAK--LQHRNLVKLLGCCTQRD---- 586 (836)
Q Consensus 513 ~~a~~~f~~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~--l~H~niv~l~g~~~~~~---- 586 (836)
....++|...+.||+|+||.||+|+. +|+.||||++... ..+.+.+|++++.. ++||||+++++++....
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~ 113 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 113 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred ccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence 44567899999999999999999998 6899999998643 34677889999888 78999999999998876
Q ss_pred eeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhh--------cCCCCcEEeccCCCCceEecCCCCc
Q 003254 587 ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLH--------QDSRLRIIHRDLKASNVLLDNTMNP 658 (836)
Q Consensus 587 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~ivH~DLkp~NILl~~~~~~ 658 (836)
..++||||+++|+|.+++.. ..+++..++.++.||+.||+||| +.+ |+||||||+|||++.++.+
T Consensus 114 ~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~ 186 (342)
T 1b6c_B 114 QLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTC 186 (342)
T ss_dssp CEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCE
T ss_pred eeEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCE
Confidence 78999999999999999953 35899999999999999999999 666 9999999999999999999
Q ss_pred eeeccCcccccCCCcccc--ccccccccccccCcccccCC------ccCccccccchhhhhhhhhhC----------CCC
Q 003254 659 KISDFGLARSFGLDQTEA--NTKRVVGTYGYMSPEYAIDG------LFSVKSDVFSFGVLVLEIICG----------KKN 720 (836)
Q Consensus 659 kl~DFgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~t~ksDVwS~GvvL~elltG----------~~p 720 (836)
||+|||++.......... ......||+.|+|||++.+. .++.++||||||+++|||++| +.|
T Consensus 187 kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p 266 (342)
T 1b6c_B 187 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 266 (342)
T ss_dssp EECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccC
Confidence 999999998764332211 22345789999999999765 345789999999999999999 445
Q ss_pred CCCCCCccccchhhhhHHhhhccCchhhccccccC-CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 003254 721 RGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDN-SCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 794 (836)
Q Consensus 721 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~-~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 794 (836)
+......... ........... ...+.+.. ..+.+....+.+++.+||+.||++|||+.||++.|+.+.
T Consensus 267 ~~~~~~~~~~--~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~ 335 (342)
T 1b6c_B 267 YYDLVPSDPS--VEEMRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 335 (342)
T ss_dssp TTTTSCSSCC--HHHHHHHHTTS----CCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccccCcCccc--HHHHHHHHHHH----HhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 4322211110 01111111111 01111111 122355677899999999999999999999999998764
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=335.20 Aligned_cols=252 Identities=23% Similarity=0.302 Sum_probs=203.5
Q ss_pred hcccccccCeecccCceeEEEEEeec-CcEEEEEEecCCCch------hHHHHHHHHHHHHhhcCCceeeEEeEEeeCCe
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQ------GMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDE 587 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 587 (836)
..++|+..+.||+|+||.||+++... |+.||||++...... ..+++.+|+.++++++||||+++++++.....
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 34679999999999999999999864 899999998764321 35789999999999999999999999999999
Q ss_pred eeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCC----Cceeecc
Q 003254 588 RMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTM----NPKISDF 663 (836)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~----~~kl~DF 663 (836)
.++||||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++ .+||+||
T Consensus 90 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (321)
T ss_dssp EEEEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccC
Confidence 9999999999999999853 356899999999999999999999998 99999999999999887 7999999
Q ss_pred CcccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhcc
Q 003254 664 GLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEE 743 (836)
Q Consensus 664 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 743 (836)
|++....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.|+...... .. .......
T Consensus 164 g~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~----~~~i~~~ 233 (321)
T 2a2a_A 164 GLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---ET----LANITSV 233 (321)
T ss_dssp TTCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH---HH----HHHHHTT
T ss_pred ccceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH---HH----HHHHHhc
Confidence 9998764322 223457899999999999999999999999999999999999997532211 00 0111100
Q ss_pred CchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 744 RPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 744 ~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
.. . ..+.... .....+.+++.+||+.||++|||+.|+++
T Consensus 234 ~~-~-~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 234 SY-D-FDEEFFS----HTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp CC-C-CCHHHHT----TCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred cc-c-cChhhhc----ccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00 0 0000000 11245779999999999999999999987
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=343.23 Aligned_cols=254 Identities=16% Similarity=0.135 Sum_probs=204.8
Q ss_pred HhhcccccccCeecccCceeEEEEE------eecCcEEEEEEecCCCchhHHHHHHHHHHHHhhc---CCceeeEEeEEe
Q 003254 513 ANATDNFSEKNKLGEGGFGPVYKGM------LIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQ---HRNLVKLLGCCT 583 (836)
Q Consensus 513 ~~a~~~f~~~~~lG~G~fG~Vykg~------~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~ 583 (836)
....++|.+.+.||+|+||.||+|+ ...++.||||++.... ..++..|+.++..++ |+||+++++++.
T Consensus 61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~ 137 (365)
T 3e7e_A 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHL 137 (365)
T ss_dssp ECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred EECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence 3456789999999999999999994 3458899999997543 456788888888886 999999999999
Q ss_pred eCCeeeEEEeecCCCChhHHHhhcc--CCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecC-------
Q 003254 584 QRDERMLIYEYLPNKSLDYFIFDTT--RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN------- 654 (836)
Q Consensus 584 ~~~~~~lV~Ey~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~------- 654 (836)
..+..++||||+++|+|.+++.... ....+++..+..++.||+.||+|||+.+ |+||||||+||||+.
T Consensus 138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~ 214 (365)
T 3e7e_A 138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDD 214 (365)
T ss_dssp CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC--
T ss_pred cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccc
Confidence 9999999999999999999996532 3457999999999999999999999998 999999999999998
Q ss_pred ----CCCceeeccCcccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCcccc
Q 003254 655 ----TMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDH 730 (836)
Q Consensus 655 ----~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~ 730 (836)
++.+||+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 215 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-- 292 (365)
T 3e7e_A 215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE-- 292 (365)
T ss_dssp ----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE--
T ss_pred cccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc--
Confidence 89999999999986543333333445679999999999999999999999999999999999999864211110
Q ss_pred chhhhhHHhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCC-CCHHHHHHHhcCC
Q 003254 731 NLLGHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDR-PNMSSVVLMLSGE 793 (836)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~R-Pt~~eVl~~L~~~ 793 (836)
..+...+.... ....+.+++..|++.+|.+| |++.++.+.|+..
T Consensus 293 ----------------~~~~~~~~~~~---~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~ 337 (365)
T 3e7e_A 293 ----------------CKPEGLFRRLP---HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKV 337 (365)
T ss_dssp ----------------EEECSCCTTCS---SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred ----------------eeechhccccC---cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHH
Confidence 00111111111 13345688899999999999 6888888888765
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-38 Score=348.13 Aligned_cols=258 Identities=27% Similarity=0.380 Sum_probs=193.0
Q ss_pred ccccccCeecccCceeEEEEEeec----CcEEEEEEecCCC-chhHHHHHHHHHHHHhhcCCceeeEEeEEee-CCeeeE
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE----GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQ-RDERML 590 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~----g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~~~l 590 (836)
..|...+.||+|+||.||+|++.+ +..||||.+.... ....++|.+|+.++++++||||+++++++.+ .+..++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 356677899999999999999753 2358999986543 3456789999999999999999999998754 457899
Q ss_pred EEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccC
Q 003254 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (836)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~ 670 (836)
||||+++|+|.+++.. ....+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 169 v~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EEECCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEECCCCCCHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccc
Confidence 9999999999999953 3346889999999999999999999998 9999999999999999999999999998764
Q ss_pred CCcccc--ccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhccCchh
Q 003254 671 LDQTEA--NTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEERPLE 747 (836)
Q Consensus 671 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (836)
...... ......+++.|+|||.+.+..++.++||||||+++|||++ |.+|+....... ... .......
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~---~~~----~~~~~~~-- 314 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITV----YLLQGRR-- 314 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC---HHH----HHHTTCC--
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH---HHH----HHHcCCC--
Confidence 322111 1223457889999999999999999999999999999999 556654322211 111 1111110
Q ss_pred hccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCCC
Q 003254 748 LIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS 795 (836)
Q Consensus 748 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~ 795 (836)
. ..+......+.+++.+||+.+|++|||+.||++.|+.+..
T Consensus 315 ~-------~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~ 355 (373)
T 3c1x_A 315 L-------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 355 (373)
T ss_dssp C-------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred C-------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 0 0111223457899999999999999999999999987643
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=341.74 Aligned_cols=243 Identities=21% Similarity=0.318 Sum_probs=201.1
Q ss_pred hcccccccCeecccCceeEEEEEee-cCcEEEEEEecCCCc--------hhHHHHHHHHHHHHhhcCCceeeEEeEEeeC
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSG--------QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR 585 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~~--------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~ 585 (836)
..++|+..+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+.++++++||||+++++++...
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 4578999999999999999999975 488999999876531 2345678899999999999999999999999
Q ss_pred CeeeEEEeecCCC-ChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccC
Q 003254 586 DERMLIYEYLPNK-SLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFG 664 (836)
Q Consensus 586 ~~~~lV~Ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFg 664 (836)
+..++||||+..| +|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDR---HPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHT---CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEEeCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecc
Confidence 9999999999877 99888843 346899999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCccccccccccccccccCcccccCCcc-CccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhcc
Q 003254 665 LARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLF-SVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEE 743 (836)
Q Consensus 665 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 743 (836)
++....... ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||.....
T Consensus 176 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----------------- 235 (335)
T 3dls_A 176 SAAYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE----------------- 235 (335)
T ss_dssp TCEECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG-----------------
T ss_pred cceECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH-----------------
Confidence 998764332 2233678999999999998876 8899999999999999999999742110
Q ss_pred CchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 744 RPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 744 ~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
....... .+......+.+++.+||+.||++|||+.|+++.
T Consensus 236 ----~~~~~~~--~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 236 ----TVEAAIH--PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ----GTTTCCC--CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ----HHhhccC--CCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000 011122457799999999999999999999985
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=329.71 Aligned_cols=250 Identities=28% Similarity=0.461 Sum_probs=183.1
Q ss_pred hcccccccCeecccCceeEEEEEee-cCcEEEEEEecCCC---chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeE
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 590 (836)
..++|...+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.++++++||||+++++++...+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 3467999999999999999999974 58999999986432 2234678999999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccC
Q 003254 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (836)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~ 670 (836)
||||+++++|.+++.. ....+++..+..++.||++||+|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 89 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKN--RVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163 (278)
T ss_dssp EEECCTTEEHHHHHHT--CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence 9999999999999853 2356899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhcc
Q 003254 671 LDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELID 750 (836)
Q Consensus 671 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 750 (836)
.... ......|++.|+|||.+.+..++.++||||||++++||++|+.|+.......... ..... +
T Consensus 164 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-------~~~~~------~ 228 (278)
T 3cok_A 164 MPHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN-------KVVLA------D 228 (278)
T ss_dssp ------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------------CCSS------C
T ss_pred CCCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH-------HHhhc------c
Confidence 3222 1223578999999999999999999999999999999999999976433211100 00000 0
Q ss_pred ccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 751 QSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 751 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
. ..+......+.+++.+||+.||++|||+.|+++
T Consensus 229 ~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 229 Y----EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp C----CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred c----CCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 0 011112345779999999999999999999975
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=330.34 Aligned_cols=253 Identities=25% Similarity=0.388 Sum_probs=199.1
Q ss_pred ccccccCeecccCceeEEEEEee-cCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEeec
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 595 (836)
++|.....||+|+||.||+|+.. +++.||||.+........+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 34555568999999999999975 48899999998776666788999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecC-CCCceeeccCcccccCCCcc
Q 003254 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-TMNPKISDFGLARSFGLDQT 674 (836)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~-~~~~kl~DFgla~~~~~~~~ 674 (836)
++++|.+++........+++..+..++.||+.||+|||+.+ |+|+||||+||+++. ++.+||+|||++.......
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~- 177 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN- 177 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCC-
Confidence 99999999976544456778899999999999999999998 999999999999987 8999999999998764321
Q ss_pred ccccccccccccccCcccccCCc--cCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhcccc
Q 003254 675 EANTKRVVGTYGYMSPEYAIDGL--FSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQS 752 (836)
Q Consensus 675 ~~~~~~~~gt~~y~aPE~~~~~~--~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 752 (836)
.......|++.|+|||++.+.. ++.++||||||+++|||++|+.|+....... ..........
T Consensus 178 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~~~~~~~--------- 242 (295)
T 2clq_A 178 -PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ-----AAMFKVGMFK--------- 242 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH-----HHHHHHHHHC---------
T ss_pred -CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh-----HHHHhhcccc---------
Confidence 1223457899999999997654 8899999999999999999999974211110 0000000000
Q ss_pred ccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 753 LDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 753 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
.....+......+.+++.+||+.||++||++.|+++
T Consensus 243 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 243 VHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp CCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred ccccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 011112223346779999999999999999999985
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=340.99 Aligned_cols=266 Identities=25% Similarity=0.344 Sum_probs=195.0
Q ss_pred cccccccCeecccCceeEEEEEeecCcEEEEEEecCCCchhHHHHHHHHHH--HHhhcCCceeeEEeEEee-----CCee
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLL--IAKLQHRNLVKLLGCCTQ-----RDER 588 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~--l~~l~H~niv~l~g~~~~-----~~~~ 588 (836)
.++|+..+.||+|+||.||+|+. +++.||||++.... ...+..|.++ +..++||||+++++.+.. ....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 47899999999999999999987 78999999986432 3344444444 445899999999986543 2356
Q ss_pred eEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcC---------CCCcEEeccCCCCceEecCCCCce
Q 003254 589 MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQD---------SRLRIIHRDLKASNVLLDNTMNPK 659 (836)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~---------~~~~ivH~DLkp~NILl~~~~~~k 659 (836)
++||||+++|+|.+++.. ...++..+..++.||++||+|||+. + |+||||||+|||++.++.+|
T Consensus 88 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~k 160 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSL----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCV 160 (336)
T ss_dssp EEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEE
T ss_pred EEEEecCCCCcHHHHHhh----cccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEE
Confidence 899999999999999943 2358899999999999999999998 6 99999999999999999999
Q ss_pred eeccCcccccCCCcc------ccccccccccccccCcccccC-------CccCccccccchhhhhhhhhhCCCCCCCCCC
Q 003254 660 ISDFGLARSFGLDQT------EANTKRVVGTYGYMSPEYAID-------GLFSVKSDVFSFGVLVLEIICGKKNRGFNHA 726 (836)
Q Consensus 660 l~DFgla~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~t~ksDVwS~GvvL~elltG~~p~~~~~~ 726 (836)
|+|||+++.+..... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.|+.....
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 999999987643221 111223579999999999987 4677899999999999999999876532222
Q ss_pred ccccchhhhhHHhhhccCch---------hhccccccC--CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 003254 727 DHDHNLLGHAWRLWIEERPL---------ELIDQSLDN--SCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 794 (836)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~~~---------~~~d~~l~~--~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 794 (836)
....... ........... ....+.+.. .........+.+++.+||+.||++|||+.||++.|+++.
T Consensus 241 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll 317 (336)
T 3g2f_A 241 VPEYQMA--FQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM 317 (336)
T ss_dssp CCCCCCT--THHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhHHHHh--hhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence 1110000 00000000000 000011111 112235567899999999999999999999999998764
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=343.86 Aligned_cols=247 Identities=28% Similarity=0.424 Sum_probs=198.1
Q ss_pred cccccccCeecccCceeEEEEEee-cCcEEEEEEecCCC---chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEE
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 591 (836)
.+.|+..+.||+|+||.||+|+.. +|+.||||++.... ....+++.+|+.++++++||||+++++++...+..++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 356888899999999999999974 58899999997543 23346789999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCC
Q 003254 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (836)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~ 671 (836)
|||+. |+|.+++... ...+++..+..++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||++.....
T Consensus 133 ~e~~~-g~l~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp EECCS-EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 99998 5777776432 356899999999999999999999998 99999999999999999999999999986532
Q ss_pred CccccccccccccccccCccccc---CCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhh
Q 003254 672 DQTEANTKRVVGTYGYMSPEYAI---DGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLEL 748 (836)
Q Consensus 672 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (836)
. ....||+.|+|||++. ++.++.++|||||||++|||++|+.|+...... ...........+
T Consensus 207 ~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~------~~~~~~~~~~~~--- 271 (348)
T 1u5q_A 207 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQNESP--- 271 (348)
T ss_dssp B------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHSCCC---
T ss_pred C------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHHhcCCC---
Confidence 1 2357899999999984 567899999999999999999999997432111 111111111110
Q ss_pred ccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 749 IDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 749 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
.+. .......+.+++.+||+.+|++|||+.|+++.
T Consensus 272 ---~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 272 ---ALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp ---CCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred ---CCC---CCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 010 11122457789999999999999999999864
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-37 Score=332.01 Aligned_cols=262 Identities=18% Similarity=0.199 Sum_probs=198.5
Q ss_pred cccccccCeecccCceeEEEEEee-cCcEEEEEEecCCC---chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEE
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 591 (836)
.++|...+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 478999999999999999999986 48899999987542 23347789999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCC
Q 003254 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (836)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~ 671 (836)
|||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 113 ~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQ---GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp EECCCCEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred EEecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 9999999999998543 46899999999999999999999998 99999999999999999999999999987543
Q ss_pred CccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccc
Q 003254 672 DQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQ 751 (836)
Q Consensus 672 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 751 (836)
... .......|++.|+|||.+.+..++.++||||||+++|||++|+.||...... ............ +
T Consensus 187 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~~~~----~ 254 (309)
T 2h34_A 187 EKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-------VMGAHINQAIPR----P 254 (309)
T ss_dssp -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-------HHHHHHHSCCCC----G
T ss_pred ccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-------HHHHHhccCCCC----c
Confidence 221 1223357899999999999999999999999999999999999997532111 011111111000 0
Q ss_pred cccCCCChHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHhcCCCCCCC
Q 003254 752 SLDNSCSFSEALRCIQVGLLCVQQRPEDRP-NMSSVVLMLSGERSLPQ 798 (836)
Q Consensus 752 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-t~~eVl~~L~~~~~~~~ 798 (836)
. .........+.+++.+||+.||++|| ++.++++.|+.......
T Consensus 255 ~---~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~ 299 (309)
T 2h34_A 255 S---TVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD 299 (309)
T ss_dssp G---GTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred c---ccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence 0 01111223577899999999999999 99999999998755443
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=340.45 Aligned_cols=252 Identities=21% Similarity=0.296 Sum_probs=199.1
Q ss_pred hcccccccCeecccCceeEEEEEeec-CcEEEEEEecCCCchhHHHHHHHHHHHHhh-cCCceeeEEeEEeeCCeeeEEE
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDERMLIY 592 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 592 (836)
..++|+..+.||+|+||.||+++... |+.||||++.+... ...+|++++.++ +||||+++++++.+.+..++||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 45789999999999999999999864 88999999976542 345688888888 7999999999999999999999
Q ss_pred eecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCC----CCceeeccCcccc
Q 003254 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNT----MNPKISDFGLARS 668 (836)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~----~~~kl~DFgla~~ 668 (836)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+.++ +.+||+|||+++.
T Consensus 96 E~~~gg~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 96 ELMKGGELLDKILR---QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp CCCCSCBHHHHHHT---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred eCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 99999999998853 356899999999999999999999998 9999999999998543 3499999999987
Q ss_pred cCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhh
Q 003254 669 FGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLEL 748 (836)
Q Consensus 669 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (836)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..........+. ........ .
T Consensus 170 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~----~~i~~~~~-~- 241 (342)
T 2qr7_A 170 LRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEIL----ARIGSGKF-S- 241 (342)
T ss_dssp CBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHH----HHHHHCCC-C-
T ss_pred CcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHH----HHHccCCc-c-
Confidence 643322 223467899999999999888999999999999999999999998643222111111 11111110 0
Q ss_pred ccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 749 IDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 749 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
+...........+.+++.+||+.||++|||+.|+++
T Consensus 242 ----~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 242 ----LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp ----CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ----cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 000111122345779999999999999999999986
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=339.06 Aligned_cols=257 Identities=27% Similarity=0.436 Sum_probs=202.6
Q ss_pred ccccccCeecccCceeEEEEEeec-CcE--EEEEEecCC-CchhHHHHHHHHHHHHhh-cCCceeeEEeEEeeCCeeeEE
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQE--IAVKRLSKG-SGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDERMLI 591 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-g~~--vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV 591 (836)
++|+..+.||+|+||.||+++... +.. +|+|++... .....+.+.+|+.++.++ +||||+++++++...+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 678889999999999999999765 554 499998754 334556789999999999 899999999999999999999
Q ss_pred EeecCCCChhHHHhhcc-------------CCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCc
Q 003254 592 YEYLPNKSLDYFIFDTT-------------RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNP 658 (836)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~ 658 (836)
|||+++++|.+++.... ....+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999986532 2346899999999999999999999998 9999999999999999999
Q ss_pred eeeccCcccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhH
Q 003254 659 KISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAW 737 (836)
Q Consensus 659 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~ 737 (836)
||+|||+++.... ........+++.|+|||.+.+..++.++||||||+++|||++ |+.|+....... ..
T Consensus 182 kL~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~-------~~ 251 (327)
T 1fvr_A 182 KIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-------LY 251 (327)
T ss_dssp EECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HH
T ss_pred EEcccCcCccccc---cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH-------HH
Confidence 9999999975321 111223456889999999998899999999999999999998 999875322110 11
Q ss_pred HhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCCC
Q 003254 738 RLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS 795 (836)
Q Consensus 738 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~ 795 (836)
...... .....+......+.+++.+||+.+|++|||+.|+++.|+.+..
T Consensus 252 ~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 300 (327)
T 1fvr_A 252 EKLPQG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 300 (327)
T ss_dssp HHGGGT---------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHhhcC---------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 111111 0011112223567899999999999999999999999987644
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=340.94 Aligned_cols=265 Identities=23% Similarity=0.340 Sum_probs=195.3
Q ss_pred ccccccCeecccCceeEEEEEee-cCcEEEEEEecCCCch-hHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEee
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQ-GMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 594 (836)
++|...+.||+|+||.||+|+.. +++.||||++...... ....+.+|+.++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57889999999999999999986 5889999998654322 223456799999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcc
Q 003254 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (836)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~ 674 (836)
++ |+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~- 154 (324)
T 3mtl_A 82 LD-KDLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT- 154 (324)
T ss_dssp CS-EEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCc-
Confidence 98 4888887543 346899999999999999999999998 9999999999999999999999999998653221
Q ss_pred ccccccccccccccCcccccC-CccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccccc
Q 003254 675 EANTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSL 753 (836)
Q Consensus 675 ~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 753 (836)
.......+|+.|+|||++.+ ..++.++||||||+++|||++|+.||........ .....+..... ..+.....+
T Consensus 155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~i~~~~~~~-~~~~~~~~~ 229 (324)
T 3mtl_A 155 -KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQ---LHFIFRILGTP-TEETWPGIL 229 (324)
T ss_dssp ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCC-CTTTSTTGG
T ss_pred -cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCC-ChHhchhhh
Confidence 12233578999999999876 5689999999999999999999999864332211 11111111100 000000000
Q ss_pred -------------cC----CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HhcCC
Q 003254 754 -------------DN----SCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL--MLSGE 793 (836)
Q Consensus 754 -------------~~----~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~--~L~~~ 793 (836)
.. .........+.+++.+||+.||++|||+.|+++ .+.+.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 288 (324)
T 3mtl_A 230 SNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSL 288 (324)
T ss_dssp GCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGG
T ss_pred cchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhc
Confidence 00 000112245789999999999999999999987 44444
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=329.98 Aligned_cols=246 Identities=24% Similarity=0.337 Sum_probs=199.1
Q ss_pred hcccccccCeecccCceeEEEEEee-cCcEEEEEEecCC--CchhHHHHHHHHHHHHhh-cCCceeeEEeEEeeCCeeeE
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDERML 590 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~l 590 (836)
..++|+..+.||+|+||.||+++.. +++.||||++... ......++.+|+.++..+ +||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 4578999999999999999999986 5899999998764 334567788999999999 89999999999999999999
Q ss_pred EEeecCCCChhHHHhhccC-CCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecC---------------
Q 003254 591 IYEYLPNKSLDYFIFDTTR-SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN--------------- 654 (836)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~--------------- 654 (836)
||||+++++|.+++..... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccc
Confidence 9999999999999965422 256899999999999999999999998 999999999999984
Q ss_pred ----CCCceeeccCcccccCCCccccccccccccccccCcccccCC-ccCccccccchhhhhhhhhhCCCCCCCCCCccc
Q 003254 655 ----TMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIICGKKNRGFNHADHD 729 (836)
Q Consensus 655 ----~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~ 729 (836)
...+||+|||++....... ...||+.|+|||.+.+. .++.++||||||++++||++|.+++...
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----- 234 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG----- 234 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS-----
T ss_pred ccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch-----
Confidence 4479999999998764321 24589999999999876 6778999999999999999998764211
Q ss_pred cchhhhhHHhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 730 HNLLGHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
. ........... ..+......+.+++.+||+.||++|||+.|+++
T Consensus 235 -~----~~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 235 -D----QWHEIRQGRLP---------RIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp -H----HHHHHHTTCCC---------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -h----HHHHHHcCCCC---------CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 0 11111111110 111122345789999999999999999999976
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=338.13 Aligned_cols=249 Identities=24% Similarity=0.329 Sum_probs=204.1
Q ss_pred hcccccccCeecccCceeEEEEEeec-CcEEEEEEecCC---CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeE
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 590 (836)
..++|...+.||+|+||.||+++..+ ++.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 34688999999999999999999865 788999998654 23456778999999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccC
Q 003254 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (836)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~ 670 (836)
||||+++++|.+++.. ...+++.++..++.||++||+|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 119 v~e~~~~~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 119 VLELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp EECCCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 9999999999998854 346899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhcc
Q 003254 671 LDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELID 750 (836)
Q Consensus 671 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 750 (836)
.... ......|++.|+|||++.+..++.++||||||+++|||++|+.|+....... ..........
T Consensus 193 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~~~~~~~~~----- 258 (335)
T 2owb_A 193 YDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE-------TYLRIKKNEY----- 258 (335)
T ss_dssp STTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHHTCC-----
T ss_pred cCcc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH-------HHHHHhcCCC-----
Confidence 3222 2234678999999999999999999999999999999999999975322110 0111111100
Q ss_pred ccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 751 QSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 751 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
..+......+.+++.+||+.||++|||+.|+++
T Consensus 259 -----~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 259 -----SIPKHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred -----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 011112245778999999999999999999987
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=357.47 Aligned_cols=248 Identities=24% Similarity=0.323 Sum_probs=193.0
Q ss_pred cccccccCeecccCceeEEEEEeec-CcEEEEEEecCC---CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEE
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 591 (836)
.++|+..+.||+|+||.||+++... |+.||||++... .......+.+|+.+++.++||||+++++++...+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 4679999999999999999999754 889999998653 334456788999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhc-CCCCcEEeccCCCCceEecCCCCceeeccCcccccC
Q 003254 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQ-DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (836)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~ 670 (836)
|||+++|+|..++.. ...+++..+..++.||+.||+|||+ .+ |+||||||+||||+.++.+||+|||+++...
T Consensus 227 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 227 MEYANGGELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp ECCCSSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EeeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 999999999998854 3468999999999999999999998 77 9999999999999999999999999998643
Q ss_pred CCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhcc
Q 003254 671 LDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELID 750 (836)
Q Consensus 671 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 750 (836)
... .......||+.|+|||++.+..++.++|||||||+||||++|+.||...... .. .........
T Consensus 301 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~----~~~i~~~~~----- 366 (446)
T 4ejn_A 301 KDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KL----FELILMEEI----- 366 (446)
T ss_dssp C-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH----HHHHHHCCC-----
T ss_pred CCC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH---HH----HHHHHhCCC-----
Confidence 222 2233468999999999999999999999999999999999999997532211 11 111111100
Q ss_pred ccccCCCChHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 003254 751 QSLDNSCSFSEALRCIQVGLLCVQQRPEDRP-----NMSSVVL 788 (836)
Q Consensus 751 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~eVl~ 788 (836)
..+......+.+++.+||+.||++|| ++.|+++
T Consensus 367 -----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 367 -----RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -----CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 11112234578999999999999999 9999986
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-37 Score=331.37 Aligned_cols=250 Identities=26% Similarity=0.412 Sum_probs=204.8
Q ss_pred hcccccccCeecccCceeEEEEEee-cCcEEEEEEecCCC-chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEE
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 592 (836)
..+.|+..+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.+++.++||||+++++++......++||
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 99 (303)
T 3a7i_A 20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 99 (303)
T ss_dssp GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence 3467889999999999999999875 48899999987553 345678999999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCC
Q 003254 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (836)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~ 672 (836)
||+++++|.+++. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 100 e~~~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 172 (303)
T 3a7i_A 100 EYLGGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 172 (303)
T ss_dssp ECCTTEEHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred EeCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCcc
Confidence 9999999999883 356899999999999999999999998 999999999999999999999999999876433
Q ss_pred ccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhcccc
Q 003254 673 QTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQS 752 (836)
Q Consensus 673 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 752 (836)
.. ......|++.|+|||.+.+..++.++||||||++++||++|+.|+....... .......... +.
T Consensus 173 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~-----~~ 238 (303)
T 3a7i_A 173 QI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK-------VLFLIPKNNP-----PT 238 (303)
T ss_dssp BC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-------HHHHHHHSCC-----CC
T ss_pred cc--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH-------HHHHhhcCCC-----CC
Confidence 21 2234578999999999999999999999999999999999999975322110 0011111111 11
Q ss_pred ccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 753 LDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 753 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
+ .......+.+++.+||+.+|++|||+.|+++.
T Consensus 239 ~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 239 L----EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp C----CSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred C----ccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 1 11223457899999999999999999999864
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=352.56 Aligned_cols=247 Identities=24% Similarity=0.390 Sum_probs=203.1
Q ss_pred cccccccCeecccCceeEEEEEee-cCcEEEEEEecCCC---chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEE
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 591 (836)
.++|...+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 367889999999999999999986 58999999986532 23356789999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCC
Q 003254 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (836)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~ 671 (836)
|||+++|+|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 95 ~E~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 95 MEYVSGGELFDYIC---KNGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp EECCSSEEHHHHTT---SSSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred EeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 99999999999984 3456999999999999999999999998 99999999999999999999999999987643
Q ss_pred CccccccccccccccccCcccccCCcc-CccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhcc
Q 003254 672 DQTEANTKRVVGTYGYMSPEYAIDGLF-SVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELID 750 (836)
Q Consensus 672 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 750 (836)
.. ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||...... . ..........
T Consensus 169 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~---~----~~~~i~~~~~----- 233 (476)
T 2y94_A 169 GE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP---T----LFKKICDGIF----- 233 (476)
T ss_dssp TC---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH---H----HHHHHHTTCC-----
T ss_pred cc---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH---H----HHHHHhcCCc-----
Confidence 22 2234679999999999998775 78999999999999999999997532211 1 1111111110
Q ss_pred ccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 751 QSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 751 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
..+......+.+++.+||+.||++|||+.||++
T Consensus 234 -----~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 234 -----YTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp -----CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -----CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 011112245779999999999999999999997
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=342.77 Aligned_cols=252 Identities=21% Similarity=0.234 Sum_probs=189.9
Q ss_pred cccccc-CeecccCceeEEEEEeec-CcEEEEEEecCCCchhHHHHHHHHHHHHh-hcCCceeeEEeEEee----CCeee
Q 003254 517 DNFSEK-NKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAK-LQHRNLVKLLGCCTQ----RDERM 589 (836)
Q Consensus 517 ~~f~~~-~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~-l~H~niv~l~g~~~~----~~~~~ 589 (836)
++|... +.||+|+||.||++.... |+.||||++.. ...+.+|+.++.+ .+||||+++++++.. ....+
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 556665 689999999999999864 88999999963 2457788888755 489999999999875 56789
Q ss_pred EEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecC---CCCceeeccCcc
Q 003254 590 LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---TMNPKISDFGLA 666 (836)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~---~~~~kl~DFgla 666 (836)
|||||+++|+|.+++... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||++
T Consensus 136 lv~E~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEeCCCCcHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccc
Confidence 999999999999999542 2346899999999999999999999998 999999999999987 789999999999
Q ss_pred cccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCch
Q 003254 667 RSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPL 746 (836)
Q Consensus 667 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (836)
+...... ......||+.|+|||++.+..++.++|||||||+||||++|+.||............ .........
T Consensus 212 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~---~~~i~~~~~- 284 (400)
T 1nxk_A 212 KETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM---KTRIRMGQY- 284 (400)
T ss_dssp EECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSH---HHHHHHTCC-
T ss_pred cccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHH---HHHHHcCcc-
Confidence 8754221 223467899999999999999999999999999999999999998644332211000 000110000
Q ss_pred hhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 747 ELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 747 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
.... .........+.+|+.+||+.||++|||+.||++.
T Consensus 285 ~~~~-----~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 285 EFPN-----PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp CCCT-----TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cCCC-----cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0000 0001123457899999999999999999999974
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=347.58 Aligned_cols=202 Identities=27% Similarity=0.497 Sum_probs=163.0
Q ss_pred hhcccccccCeecccCceeEEEEEee-cCcEEEEEEecCC--CchhHHHHHHHHHHHHhhc-CCceeeEEeEEeeCC--e
Q 003254 514 NATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQRD--E 587 (836)
Q Consensus 514 ~a~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~--~ 587 (836)
...++|+..+.||+|+||.||+|... +|+.||||++... .....+.+.+|+.++.++. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 34578999999999999999999975 4899999998654 3345567889999999997 999999999997544 6
Q ss_pred eeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCccc
Q 003254 588 RMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667 (836)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~ 667 (836)
.++||||++ ++|..++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 86 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp EEEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 899999998 588888843 46889999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCc-------------------cccccccccccccccCcccccC-CccCccccccchhhhhhhhhhCCCCCCC
Q 003254 668 SFGLDQ-------------------TEANTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGKKNRGF 723 (836)
Q Consensus 668 ~~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~elltG~~p~~~ 723 (836)
.+.... ........+||+.|+|||++.+ ..++.++|||||||+++||++|+.||..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 233 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPG 233 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCC
Confidence 763211 1111233579999999999986 6789999999999999999999999854
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=332.03 Aligned_cols=251 Identities=24% Similarity=0.337 Sum_probs=196.9
Q ss_pred cccccccCeecccCceeEEEEEeecCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeC-CeeeEEEee
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR-DERMLIYEY 594 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-~~~~lV~Ey 594 (836)
.++|+..+.||+|+||.||+++. .|+.||||++.... ..+.+.+|+.++++++||||+++++++.+. +..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 46889999999999999999987 58899999986543 457899999999999999999999997654 468999999
Q ss_pred cCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcc
Q 003254 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (836)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~ 674 (836)
+++++|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++......
T Consensus 97 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-- 170 (278)
T 1byg_A 97 MAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 170 (278)
T ss_dssp CTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred CCCCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc--
Confidence 99999999985432 234789999999999999999999998 999999999999999999999999999864322
Q ss_pred ccccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhccCchhhccccc
Q 003254 675 EANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSL 753 (836)
Q Consensus 675 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 753 (836)
.....+++.|+|||.+.+..++.++||||||++++||++ |+.|+....... . ....... .
T Consensus 171 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~----~~~~~~~---------~ 231 (278)
T 1byg_A 171 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---V----VPRVEKG---------Y 231 (278)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---H----HHHHTTT---------C
T ss_pred ---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH---H----HHHHhcC---------C
Confidence 122457889999999998899999999999999999998 998875322111 1 1111111 0
Q ss_pred cCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 003254 754 DNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 794 (836)
Q Consensus 754 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 794 (836)
....+......+.+++.+||+.||++|||+.|+++.|+.+.
T Consensus 232 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~ 272 (278)
T 1byg_A 232 KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 272 (278)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHH
Confidence 11112223356789999999999999999999999998763
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=331.93 Aligned_cols=259 Identities=25% Similarity=0.301 Sum_probs=203.4
Q ss_pred cccccccCeecccCceeEEEEEee-cCcEEEEEEecCCC--chhHHHHHHHHHHHHhhcCCceeeEEeEEee--CCeeeE
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQ--RDERML 590 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~l 590 (836)
.++|+..+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.. ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 468999999999999999999986 48999999997543 3456779999999999999999999998854 567899
Q ss_pred EEeecCCCChhHHHhhcc-CCCcCChhhhHHHHHHHHhhhHhhhcCC--CCcEEeccCCCCceEecCCCCceeeccCccc
Q 003254 591 IYEYLPNKSLDYFIFDTT-RSKLLDWSKRSHIIAGIARGLLYLHQDS--RLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667 (836)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivH~DLkp~NILl~~~~~~kl~DFgla~ 667 (836)
||||+++++|.+++.... ....+++..++.++.||+.||+|||+.+ ..+|+||||||+||++++++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 999999999999986543 2345899999999999999999999976 2349999999999999999999999999998
Q ss_pred ccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchh
Q 003254 668 SFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLE 747 (836)
Q Consensus 668 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (836)
....... ......|++.|+|||.+.+..++.++||||||+++|||++|+.|+...... .. ..........
T Consensus 165 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~----~~~i~~~~~~- 234 (279)
T 2w5a_A 165 ILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK---EL----AGKIREGKFR- 234 (279)
T ss_dssp HC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH----HHHHHHTCCC-
T ss_pred eeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH---HH----HHHHhhcccc-
Confidence 7643221 122356899999999999999999999999999999999999997533211 11 1111111110
Q ss_pred hccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcC
Q 003254 748 LIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 792 (836)
Q Consensus 748 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~ 792 (836)
..+......+.+++.+||+.+|++|||+.||++.+..
T Consensus 235 --------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 235 --------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp --------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred --------cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 1111223467899999999999999999999987654
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-37 Score=354.94 Aligned_cols=254 Identities=27% Similarity=0.369 Sum_probs=205.7
Q ss_pred hcccccccCeecccCceeEEEEEee-cCcEEEEEEecCCC---chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeE
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 590 (836)
..++|+..+.||+|+||.||+++.. +|+.||||++.+.. ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 4577999999999999999999986 48999999986532 2345678899999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccC
Q 003254 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (836)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~ 670 (836)
||||+++|+|..++.... ...+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.+.
T Consensus 262 VmEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp EECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecc
Confidence 999999999999885432 345899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhcc
Q 003254 671 LDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELID 750 (836)
Q Consensus 671 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 750 (836)
... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||........... ........ .
T Consensus 338 ~~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~---i~~~i~~~-~----- 405 (576)
T 2acx_A 338 EGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE---VERLVKEV-P----- 405 (576)
T ss_dssp TTC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHH---HHHHHHHC-C-----
T ss_pred cCc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHH---HHHHhhcc-c-----
Confidence 322 12335899999999999999999999999999999999999999864332211111 11111110 0
Q ss_pred ccccCCCChHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 003254 751 QSLDNSCSFSEALRCIQVGLLCVQQRPEDRP-----NMSSVVL 788 (836)
Q Consensus 751 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~eVl~ 788 (836)
...+......+.+|+.+||+.||++|| ++.||++
T Consensus 406 ----~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 406 ----EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred ----ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 011112234578999999999999999 7888875
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=325.90 Aligned_cols=252 Identities=25% Similarity=0.353 Sum_probs=197.1
Q ss_pred cccccccCeecccCceeEEEEEeec-CcEEEEEEecCCC-chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEe
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 593 (836)
.++|...++||+|+||.||++.... ++.+|+|++.... ....+.+.+|+.++++++||||+++++++......++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 3678999999999999999999854 8899999987553 3356789999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcc-CCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEe---cCCCCceeeccCccccc
Q 003254 594 YLPNKSLDYFIFDTT-RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLL---DNTMNPKISDFGLARSF 669 (836)
Q Consensus 594 y~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl---~~~~~~kl~DFgla~~~ 669 (836)
|+++++|.+++.... ....+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||++..+
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 999999999886532 3467999999999999999999999998 9999999999999 45688999999999875
Q ss_pred CCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhc
Q 003254 670 GLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELI 749 (836)
Q Consensus 670 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (836)
.... ......|++.|+|||.+. +.++.++||||||++++||++|+.||....... . . ............
T Consensus 178 ~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~---~---~-~~~~~~~~~~~~ 246 (285)
T 3is5_A 178 KSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE---V---Q-QKATYKEPNYAV 246 (285)
T ss_dssp ------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---H---H-HHHHHCCCCCCC
T ss_pred CCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHH---H---H-hhhccCCccccc
Confidence 4322 223457899999999875 568999999999999999999999975322110 0 0 000000000000
Q ss_pred cccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 750 DQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 750 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
. .......+.+++.+||+.||++|||+.||++
T Consensus 247 ~-------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 247 E-------CRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp ---------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred c-------cCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 0011245678999999999999999999985
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=343.52 Aligned_cols=263 Identities=23% Similarity=0.315 Sum_probs=202.9
Q ss_pred cccccccCeecccCceeEEEEEee-cCcEEEEEEecCCC-chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEe
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 593 (836)
.++|+..+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 468999999999999999999986 48899999997653 3445778999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcC-CCCcEEeccCCCCceEecCCCCceeeccCcccccCCC
Q 003254 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (836)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~ 672 (836)
|+++++|.+++... ..+++..+..++.+++.||+|||+. + |+||||||+|||++.++.+||+|||++.....
T Consensus 112 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~- 184 (360)
T 3eqc_A 112 HMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID- 184 (360)
T ss_dssp CCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH-
T ss_pred CCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCccccc-
Confidence 99999999999543 4588999999999999999999985 7 99999999999999999999999999976421
Q ss_pred ccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhh---------H------
Q 003254 673 QTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHA---------W------ 737 (836)
Q Consensus 673 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~---------~------ 737 (836)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||............... .
T Consensus 185 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (360)
T 3eqc_A 185 ---SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 261 (360)
T ss_dssp ---HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------
T ss_pred ---ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCC
Confidence 1223357899999999999999999999999999999999999997643221110000000 0
Q ss_pred --------HhhhccCchhhccccccC----CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 738 --------RLWIEERPLELIDQSLDN----SCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 738 --------~~~~~~~~~~~~d~~l~~----~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
.........+.++..... .........+.+++.+||+.||++|||+.|+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp ------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 000000000111111110 011112345789999999999999999999986
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=340.57 Aligned_cols=266 Identities=23% Similarity=0.362 Sum_probs=199.1
Q ss_pred hcccccccCeecccCceeEEEEEeec-CcEEEEEEecCCCc--hhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEE
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSG--QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 591 (836)
..++|+..+.||+|+||.||+++... |+.||||++..... ...+.+.+|+.++++++||||+++++++...+..++|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 102 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLV 102 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEE
Confidence 34689999999999999999999865 89999999865532 3356688999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCC
Q 003254 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (836)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~ 671 (836)
|||+++++|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 103 ~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 103 FEFVDHTILDDLEL---FPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp EECCSEEHHHHHHH---STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred EecCCcchHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 99999999988763 2346899999999999999999999998 99999999999999999999999999987543
Q ss_pred CccccccccccccccccCcccccCC-ccCccccccchhhhhhhhhhCCCCCCCCCCccccchhh--------hhHHhhhc
Q 003254 672 DQTEANTKRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLG--------HAWRLWIE 742 (836)
Q Consensus 672 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~--------~~~~~~~~ 742 (836)
... ......|++.|+|||.+.+. .++.++||||||+++|||++|+.||............. .....+..
T Consensus 177 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (331)
T 4aaa_A 177 PGE--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNK 254 (331)
T ss_dssp ---------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHH
T ss_pred Ccc--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhh
Confidence 222 22335789999999999875 78999999999999999999999975433211100000 00000000
Q ss_pred cCc-hhhccccccCCCC-----hHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 743 ERP-LELIDQSLDNSCS-----FSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 743 ~~~-~~~~d~~l~~~~~-----~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
... .....+.+..... ......+.+++.+||+.||++|||+.|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 255 NPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp CGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000 0000011111111 122356889999999999999999999875
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=340.74 Aligned_cols=255 Identities=24% Similarity=0.317 Sum_probs=202.5
Q ss_pred cccccccCeecccCceeEEEEEee----cCcEEEEEEecCCC----chhHHHHHHHHHHHHhh-cCCceeeEEeEEeeCC
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLI----EGQEIAVKRLSKGS----GQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRD 586 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~----~g~~vavK~l~~~~----~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~ 586 (836)
.++|+..+.||+|+||.||+++.. .++.||||+++... ....+.+.+|+.++.++ +||||+++++++....
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 368999999999999999999973 58999999986532 23456678899999999 5999999999999999
Q ss_pred eeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcc
Q 003254 587 ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLA 666 (836)
Q Consensus 587 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla 666 (836)
..++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eEEEEeecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 999999999999999998543 46899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCcccccCC--ccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccC
Q 003254 667 RSFGLDQTEANTKRVVGTYGYMSPEYAIDG--LFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEER 744 (836)
Q Consensus 667 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 744 (836)
+.+..... .......||+.|+|||++.+. .++.++|||||||+||||++|+.||.......... . .........
T Consensus 207 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~--~-~~~~~~~~~ 282 (355)
T 1vzo_A 207 KEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA--E-ISRRILKSE 282 (355)
T ss_dssp EECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHH--H-HHHHHHHCC
T ss_pred eecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHH--H-HHHHHhccC
Confidence 87643222 223346799999999999863 47899999999999999999999986433221111 1 111111110
Q ss_pred chhhccccccCCCChHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHHh
Q 003254 745 PLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRP-----NMSSVVLML 790 (836)
Q Consensus 745 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~eVl~~L 790 (836)
...+......+.+++.+||+.||++|| ++.|+++..
T Consensus 283 ----------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 283 ----------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp ----------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred ----------CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 111222234577999999999999999 999998754
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=344.80 Aligned_cols=245 Identities=22% Similarity=0.264 Sum_probs=190.0
Q ss_pred cccccccCeecccCceeEEEEEeec-CcEEEEEEecCCC---chhHHHHHHHHHH-HHhhcCCceeeEEeEEeeCCeeeE
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLL-IAKLQHRNLVKLLGCCTQRDERML 590 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~~-l~~l~H~niv~l~g~~~~~~~~~l 590 (836)
.++|+..+.||+|+||.||+++... ++.||||++.+.. ....+.+.+|..+ ++.++||||+++++++...+..++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 3689999999999999999999865 7889999997543 2234456677776 567899999999999999999999
Q ss_pred EEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccC
Q 003254 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (836)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~ 670 (836)
||||+++|+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 117 v~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 117 VLDYINGGELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 9999999999998854 346889999999999999999999998 9999999999999999999999999998643
Q ss_pred CCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhcc
Q 003254 671 LDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELID 750 (836)
Q Consensus 671 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 750 (836)
.. .......+||+.|+|||++.+..++.++|||||||++|||++|+.||...... . .........
T Consensus 191 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~---~----~~~~i~~~~------ 255 (373)
T 2r5t_A 191 EH--NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA---E----MYDNILNKP------ 255 (373)
T ss_dssp CC--CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH---H----HHHHHHHSC------
T ss_pred cC--CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH---H----HHHHHHhcc------
Confidence 22 12234578999999999999999999999999999999999999997532211 1 111111110
Q ss_pred ccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHH
Q 003254 751 QSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSS 785 (836)
Q Consensus 751 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~e 785 (836)
+ ..+......+.+++.+||+.||++||++.+
T Consensus 256 --~--~~~~~~~~~~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 256 --L--QLKPNITNSARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp --C--CCCSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred --c--CCCCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence 0 011112245779999999999999999853
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-37 Score=350.19 Aligned_cols=259 Identities=24% Similarity=0.308 Sum_probs=193.7
Q ss_pred cccccccCeecccCceeEEEEEeec-CcEEEEEEecCC--CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeC------C
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR------D 586 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~ 586 (836)
.++|+..+.||+|+||.||++.... ++.||||++... .....+++.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 4789999999999999999999754 889999999754 334567789999999999999999999999654 3
Q ss_pred eeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcc
Q 003254 587 ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLA 666 (836)
Q Consensus 587 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla 666 (836)
..++||||++++ |...+. ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 141 ~~~lv~E~~~~~-l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp EEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred eEEEEEeCCCCC-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEee
Confidence 569999999875 555552 24889999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHh-------
Q 003254 667 RSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRL------- 739 (836)
Q Consensus 667 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~------- 739 (836)
+..... ......+||+.|+|||++.+..++.++|||||||+|+||++|+.||......+. .....+.
T Consensus 212 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~---~~~i~~~lg~p~~~ 285 (464)
T 3ttj_A 212 RTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ---WNKVIEQLGTPCPE 285 (464)
T ss_dssp -----C---CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCSCCHH
T ss_pred eecCCC---cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCCCCHH
Confidence 875432 123346899999999999999999999999999999999999999854321111 0000000
Q ss_pred -----------hhccCc-------hhhccccccCCC---ChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 740 -----------WIEERP-------LELIDQSLDNSC---SFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 740 -----------~~~~~~-------~~~~d~~l~~~~---~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
+....+ .......+.... .......+.+|+.+||+.||++|||+.|+++.
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 286 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000 000000000000 01124568899999999999999999999874
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=330.31 Aligned_cols=250 Identities=24% Similarity=0.324 Sum_probs=204.3
Q ss_pred hcccccccCeecccCceeEEEEEeec-CcEEEEEEecCC---CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeE
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 590 (836)
..++|...+.||+|+||.||++...+ ++.||+|++... .....+.+.+|+.+++.++||||+++++++...+..++
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 92 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence 34688999999999999999999865 788999998654 23455778999999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccC
Q 003254 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (836)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~ 670 (836)
||||+++++|.+++.. ...+++.++..++.||++||+|||+.+ |+||||||+||++++++.+||+|||++....
T Consensus 93 v~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 93 VLELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166 (294)
T ss_dssp EEECCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence 9999999999998853 346899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhcc
Q 003254 671 LDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELID 750 (836)
Q Consensus 671 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 750 (836)
.... ......|++.|+|||.+.+..++.++||||||++++||++|+.|+....... ..........
T Consensus 167 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------~~~~~~~~~~----- 232 (294)
T 2rku_A 167 YDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE-------TYLRIKKNEY----- 232 (294)
T ss_dssp STTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHTTCC-----
T ss_pred cCcc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHhhccC-----
Confidence 3222 2233578999999999999999999999999999999999999975322110 1111111100
Q ss_pred ccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 751 QSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 751 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
..+......+.+++.+||+.||++|||+.|+++.
T Consensus 233 -----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 233 -----SIPKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred -----CCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0111122457789999999999999999999873
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-37 Score=327.28 Aligned_cols=250 Identities=22% Similarity=0.313 Sum_probs=199.5
Q ss_pred ccccccCeecccCceeEEEEEee-cCcEEEEEEecCCCc------hhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeee
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSG------QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERM 589 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~~------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 589 (836)
++|+..+.||+|+||.||+++.. +++.||+|.+..... ...+.+.+|+.++++++||||+++++++......+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 57889999999999999999986 489999999875422 23678999999999999999999999999999999
Q ss_pred EEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCC----CceeeccCc
Q 003254 590 LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTM----NPKISDFGL 665 (836)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~----~~kl~DFgl 665 (836)
+||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||++++++ .+||+|||+
T Consensus 85 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 85 LILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEeecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 99999999999999854 346899999999999999999999998 99999999999998877 899999999
Q ss_pred ccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCc
Q 003254 666 ARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERP 745 (836)
Q Consensus 666 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (836)
+....... ......+++.|+|||.+.+..++.++||||||++++||++|+.|+....... ..........
T Consensus 159 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~ 228 (283)
T 3bhy_A 159 AHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE-------TLTNISAVNY 228 (283)
T ss_dssp CEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHTTCC
T ss_pred ceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH-------HHHHhHhccc
Confidence 98764322 1233568999999999999999999999999999999999999975322110 1111110000
Q ss_pred hhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 746 LELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 746 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
. ...... ......+.+++.+||+.||++|||+.|+++
T Consensus 229 -~-~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 229 -D-FDEEYF----SNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp -C-CCHHHH----TTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -C-Ccchhc----ccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 0 000000 011245779999999999999999999987
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-37 Score=337.24 Aligned_cols=263 Identities=22% Similarity=0.345 Sum_probs=198.5
Q ss_pred cccccccCeecccCceeEEEEEee-cCcEEEEEEecCCC--chhHHHHHHHHHHHHhhcCCceeeEEeEEeeC-------
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR------- 585 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------- 585 (836)
.++|+..+.||+|+||.||+++.. +|+.||||++.... ......+.+|+.+++.++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 368999999999999999999984 58999999986543 23356788999999999999999999999773
Q ss_pred -CeeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccC
Q 003254 586 -DERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFG 664 (836)
Q Consensus 586 -~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFg 664 (836)
+..++||||+++ +|...+.. ....+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCC-CHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccch
Confidence 468999999986 66666643 2346899999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCcc--ccccccccccccccCcccccC-CccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhh
Q 003254 665 LARSFGLDQT--EANTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWI 741 (836)
Q Consensus 665 la~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 741 (836)
+++.+..... ........||+.|+|||++.+ ..++.++|||||||+++||++|+.|+........... .... .
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~---i~~~-~ 245 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLAL---ISQL-C 245 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHH-H
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHHH-h
Confidence 9987653222 122234578999999999876 4589999999999999999999999764332211111 1000 0
Q ss_pred ccCchhh---------ccc---cccCCCChH-H------HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 742 EERPLEL---------IDQ---SLDNSCSFS-E------ALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 742 ~~~~~~~---------~d~---~l~~~~~~~-~------~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
.....+. .+. ......... . ...+.+|+.+||+.||++|||+.|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 246 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp CCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 0000000 000 000001111 1 234789999999999999999999987
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-37 Score=331.08 Aligned_cols=257 Identities=22% Similarity=0.324 Sum_probs=203.7
Q ss_pred hcccccccCeecccCceeEEEEEee-cCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEe
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 593 (836)
..++|...+.||+|+||.||+++.. +|+.||+|++........+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 3468899999999999999999986 589999999987655556778999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEe---cCCCCceeeccCcccccC
Q 003254 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLL---DNTMNPKISDFGLARSFG 670 (836)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl---~~~~~~kl~DFgla~~~~ 670 (836)
|+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||++ ++++.+||+|||++....
T Consensus 87 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 87 LVSGGELFDRILER---GVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp CCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred cCCCccHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 99999999988543 46899999999999999999999998 9999999999999 788999999999997643
Q ss_pred CCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhcc
Q 003254 671 LDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELID 750 (836)
Q Consensus 671 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 750 (836)
.. ......|++.|+|||.+.+..++.++||||||+++|||++|+.|+...... .. ......... ..
T Consensus 161 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~----~~~i~~~~~-~~-- 226 (304)
T 2jam_A 161 NG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES---KL----FEKIKEGYY-EF-- 226 (304)
T ss_dssp CB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH---HH----HHHHHHCCC-CC--
T ss_pred CC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HH----HHHHHcCCC-CC--
Confidence 21 223356899999999999999999999999999999999999997532211 11 111111100 00
Q ss_pred ccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HhcCCC
Q 003254 751 QSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL--MLSGER 794 (836)
Q Consensus 751 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~--~L~~~~ 794 (836)
...........+.+++.+||+.||++|||+.|+++ .+++..
T Consensus 227 ---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (304)
T 2jam_A 227 ---ESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNT 269 (304)
T ss_dssp ---CTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred ---CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence 00111122346789999999999999999999987 455443
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=366.88 Aligned_cols=248 Identities=27% Similarity=0.391 Sum_probs=196.2
Q ss_pred CeecccCceeEEEEEee---cCcEEEEEEecCCC--chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEeecCC
Q 003254 523 NKLGEGGFGPVYKGMLI---EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPN 597 (836)
Q Consensus 523 ~~lG~G~fG~Vykg~~~---~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 597 (836)
++||+|+||.||+|.+. .++.||||+++... ....+++.+|+.++++++|||||++++++. .+..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence 47999999999999764 36789999997543 334678999999999999999999999996 4568899999999
Q ss_pred CChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCccc-c
Q 003254 598 KSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE-A 676 (836)
Q Consensus 598 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~-~ 676 (836)
|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+||||++++.+||+|||+++.+...... .
T Consensus 454 g~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 454 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred CCHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 999999953 356899999999999999999999998 999999999999999999999999999877543321 1
Q ss_pred ccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhccCchhhccccccC
Q 003254 677 NTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDN 755 (836)
Q Consensus 677 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 755 (836)
......+|+.|+|||++.+..++.++|||||||+||||++ |+.|+....... ........ ...
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-------~~~~i~~~---------~~~ 591 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTAMLEKG---------ERM 591 (635)
T ss_dssp -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTT---------CCC
T ss_pred cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcC---------CCC
Confidence 1223456789999999999999999999999999999998 999975322211 11111111 111
Q ss_pred CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 003254 756 SCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 793 (836)
Q Consensus 756 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 793 (836)
..+......+.+++.+||+.||++||++.+|++.|+.+
T Consensus 592 ~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 629 (635)
T 4fl3_A 592 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 629 (635)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 12223345688999999999999999999999999864
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=340.63 Aligned_cols=263 Identities=14% Similarity=0.164 Sum_probs=204.2
Q ss_pred cccccccCeecccCceeEEEEEeec---------CcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceee---------
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLIE---------GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVK--------- 577 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~~---------g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~--------- 577 (836)
.++|...+.||+|+||.||+|+... ++.||||++... +.+.+|+.++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 4789999999999999999999864 788999998654 46889999999999999988
Q ss_pred ------EEeEEee-CCeeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCce
Q 003254 578 ------LLGCCTQ-RDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNV 650 (836)
Q Consensus 578 ------l~g~~~~-~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NI 650 (836)
+++++.. ....++||||+ +++|.+++... ....+++..+..++.||+.||+|||+++ |+||||||+||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI 190 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI 190 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence 6777766 67889999999 99999999643 2357999999999999999999999998 99999999999
Q ss_pred EecCCC--CceeeccCcccccCCCcccc-----ccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCC
Q 003254 651 LLDNTM--NPKISDFGLARSFGLDQTEA-----NTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGF 723 (836)
Q Consensus 651 Ll~~~~--~~kl~DFgla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~ 723 (836)
|++.++ .+||+|||+++.+....... ......||+.|+|||.+.+..++.++||||||++||||++|+.||..
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999998 99999999998765332211 11335789999999999999999999999999999999999999754
Q ss_pred CCCccccchhhhhHHhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 003254 724 NHADHDHNLLGHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 794 (836)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 794 (836)
...... ........+. .....+.+.... .......+.+++.+||+.||++|||+.||++.|+++.
T Consensus 271 ~~~~~~--~~~~~~~~~~-~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 335 (352)
T 2jii_A 271 CLPNTE--DIMKQKQKFV-DKPGPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALL 335 (352)
T ss_dssp GTTCHH--HHHHHHHHHH-HSCCCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred CCcCHH--HHHHHHHhcc-CChhhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHH
Confidence 321111 1111111111 111111111110 0011245789999999999999999999999998763
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-37 Score=334.88 Aligned_cols=262 Identities=21% Similarity=0.301 Sum_probs=203.4
Q ss_pred cHHHHHhhccccccc-CeecccCceeEEEEEeec-CcEEEEEEecCCC--chhHHHHHHHHHHHHhhc-CCceeeEEeEE
Q 003254 508 DLKIIANATDNFSEK-NKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQ-HRNLVKLLGCC 582 (836)
Q Consensus 508 ~~~~l~~a~~~f~~~-~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~ 582 (836)
.+...+...+.|... +.||+|+||.||+++... ++.||+|++.... .....++.+|+.++..++ ||||+++++++
T Consensus 19 ~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~ 98 (327)
T 3lm5_A 19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY 98 (327)
T ss_dssp CSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred HHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 334445556677776 789999999999999864 8999999987542 334678999999999995 69999999999
Q ss_pred eeCCeeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecC---CCCce
Q 003254 583 TQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---TMNPK 659 (836)
Q Consensus 583 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~---~~~~k 659 (836)
...+..++||||+++|+|.+++... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++. ++.+|
T Consensus 99 ~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~k 174 (327)
T 3lm5_A 99 ENTSEIILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIK 174 (327)
T ss_dssp ECSSEEEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEE
T ss_pred EeCCeEEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEE
Confidence 9999999999999999999988432 2456899999999999999999999998 999999999999987 78999
Q ss_pred eeccCcccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHh
Q 003254 660 ISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRL 739 (836)
Q Consensus 660 l~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~ 739 (836)
|+|||+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.|+....... .. ..
T Consensus 175 L~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~----~~ 244 (327)
T 3lm5_A 175 IVDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE---TY----LN 244 (327)
T ss_dssp ECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH----HH
T ss_pred EeeCccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH---HH----HH
Confidence 99999998764322 1233578999999999999999999999999999999999999975322110 00 00
Q ss_pred hhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 740 WIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 740 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
...... . ............+.+++.+||+.||++|||+.|+++.
T Consensus 245 i~~~~~-~-----~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 245 ISQVNV-D-----YSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp HHHTCC-C-----CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred HHhccc-c-----cCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 000000 0 0001111223457799999999999999999999864
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=338.82 Aligned_cols=263 Identities=23% Similarity=0.319 Sum_probs=191.9
Q ss_pred hhcccccccCeecccCceeEEEEEee-cCcEEEEEEecCCCc--hhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeE
Q 003254 514 NATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSG--QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (836)
Q Consensus 514 ~a~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 590 (836)
...++|+..++||+|+||.||+++.. +++.||||++..... ...+.+.+|+.++++++||||+++++++...+..++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 44578999999999999999999975 488999999965432 234567899999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEec-----CCCCceeeccCc
Q 003254 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD-----NTMNPKISDFGL 665 (836)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~-----~~~~~kl~DFgl 665 (836)
||||+++ +|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++ +++.+||+|||+
T Consensus 111 v~e~~~~-~L~~~~~~---~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 111 IFEYAEN-DLKKYMDK---NPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp EEECCSE-EHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred EEecCCC-CHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 9999985 89888854 345899999999999999999999998 99999999999994 555699999999
Q ss_pred ccccCCCccccccccccccccccCcccccCC-ccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccC
Q 003254 666 ARSFGLDQTEANTKRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEER 744 (836)
Q Consensus 666 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 744 (836)
++.+..... ......+|+.|+|||++.+. .++.++|||||||++|||++|+.||....... .............
T Consensus 184 a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~~~~~~~~~~ 258 (329)
T 3gbz_A 184 ARAFGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID---QLFKIFEVLGLPD 258 (329)
T ss_dssp HHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCC
T ss_pred ccccCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH---HHHHHHHHhCCCc
Confidence 987643222 22335689999999999875 48999999999999999999999975432211 1111111000000
Q ss_pred chh----------------hccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 745 PLE----------------LIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 745 ~~~----------------~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
... .....+...........+.+++.+||+.||++|||+.|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 259 DTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 000 00000000000112245789999999999999999999986
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-37 Score=346.29 Aligned_cols=253 Identities=21% Similarity=0.311 Sum_probs=190.5
Q ss_pred hhcccccccCeecccCceeEEEEEeec-CcEEEEEEecCCC--------chhHHHHHHHHHHHHhhcCCceeeEEeEEee
Q 003254 514 NATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS--------GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQ 584 (836)
Q Consensus 514 ~a~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~--------~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~ 584 (836)
...++|...+.||+|+||.||+|.... ++.||||++.... ......+.+|+.++++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 345789999999999999999999865 7899999986532 122345889999999999999999999975
Q ss_pred CCeeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCC---CCceee
Q 003254 585 RDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNT---MNPKIS 661 (836)
Q Consensus 585 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~---~~~kl~ 661 (836)
.+..++||||+++|+|.+++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.+ ..+||+
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred cCceEEEEEcCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEe
Confidence 456899999999999988884 3456999999999999999999999998 9999999999999654 459999
Q ss_pred ccCcccccCCCccccccccccccccccCcccccC---CccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHH
Q 003254 662 DFGLARSFGLDQTEANTKRVVGTYGYMSPEYAID---GLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWR 738 (836)
Q Consensus 662 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~ 738 (836)
|||+++..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .+...
T Consensus 285 DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~--~~~~~--- 356 (419)
T 3i6u_A 285 DFGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQ--- 356 (419)
T ss_dssp CSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC--CHHHH---
T ss_pred ecccceecCCC---ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH--HHHHH---
Confidence 99999876432 22234679999999999863 678899999999999999999999986432211 11110
Q ss_pred hhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 739 LWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 739 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
...... .... ... ......+.+++.+||+.||++|||+.|+++
T Consensus 357 -i~~~~~-~~~~-~~~----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 357 -ITSGKY-NFIP-EVW----AEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp -HHTTCC-CCCH-HHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -HhcCCC-CCCc-hhh----cccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 010100 0000 000 011245789999999999999999999987
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=341.87 Aligned_cols=254 Identities=11% Similarity=0.070 Sum_probs=183.1
Q ss_pred cccccccCeecccCceeEEEEEee-cCcEEEEEEecCCCc---hhHHHHHHHHHHHHhh--cCCceeeEE-------eEE
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSG---QGMEEFKNEVLLIAKL--QHRNLVKLL-------GCC 582 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l--~H~niv~l~-------g~~ 582 (836)
..+|...+.||+|+||.||+|+.. +|+.||||++..... ...+.+++|+.++..+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 456888999999999999999975 589999999987543 3456778886666666 599988755 444
Q ss_pred eeC-----------------CeeeEEEeecCCCChhHHHhhccCCCcCChhhh------HHHHHHHHhhhHhhhcCCCCc
Q 003254 583 TQR-----------------DERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKR------SHIIAGIARGLLYLHQDSRLR 639 (836)
Q Consensus 583 ~~~-----------------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~~ia~gL~yLH~~~~~~ 639 (836)
... ...++||||++ |+|.+++.... ..+.+..+ ..++.||+.||+|||+++
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--- 214 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD--FVYVFRGDEGILALHILTAQLIRLAANLQSKG--- 214 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH--HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc--cccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---
Confidence 332 33799999999 89999996542 24566666 788899999999999998
Q ss_pred EEeccCCCCceEecCCCCceeeccCcccccCCCccccccccccccccccCcccccC--CccCccccccchhhhhhhhhhC
Q 003254 640 IIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAID--GLFSVKSDVFSFGVLVLEIICG 717 (836)
Q Consensus 640 ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~ksDVwS~GvvL~elltG 717 (836)
|+||||||+||||+.++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++|||||||+||||++|
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg 289 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence 999999999999999999999999999875321 113456799999999987 6799999999999999999999
Q ss_pred CCCCCCCCCccccchhhhhHHhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 718 KKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 718 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
+.||............ .......................+.+++.+||+.||++|||+.|+++
T Consensus 290 ~~Pf~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 290 FLPFGLVTPGIKGSWK--------RPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp SCSTTBCCTTCTTCCC--------BCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCCcCcccccchh--------hhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 9998654322111100 00000000001111111122356789999999999999999999974
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=351.23 Aligned_cols=256 Identities=27% Similarity=0.376 Sum_probs=205.5
Q ss_pred hcccccccCeecccCceeEEEEEeec-CcEEEEEEecCCC---chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeE
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 590 (836)
..++|...+.||+|+||.||+++... |+.||||++.+.. ....+.+.+|+.++++++||||+++++++......++
T Consensus 183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 262 (543)
T 3c4z_A 183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCL 262 (543)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEE
Confidence 34789999999999999999999864 8999999996542 2345678899999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhccC-CCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCccccc
Q 003254 591 IYEYLPNKSLDYFIFDTTR-SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (836)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~ 669 (836)
||||+++|+|..++..... ...+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.+
T Consensus 263 VmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~ 339 (543)
T 3c4z_A 263 VMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVEL 339 (543)
T ss_dssp EECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeec
Confidence 9999999999999865432 346899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhc
Q 003254 670 GLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELI 749 (836)
Q Consensus 670 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (836)
..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||......... ............
T Consensus 340 ~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~---~~~~~~i~~~~~---- 410 (543)
T 3c4z_A 340 KAGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN---KELKQRVLEQAV---- 410 (543)
T ss_dssp CTTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCH---HHHHHHHHHCCC----
T ss_pred cCCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhH---HHHHHHHhhccc----
Confidence 43322 223458999999999999999999999999999999999999998643221111 011111111100
Q ss_pred cccccCCCChHHHHHHHHHHHHcccCCCCCCCCH-----HHHHH
Q 003254 750 DQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNM-----SSVVL 788 (836)
Q Consensus 750 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~-----~eVl~ 788 (836)
..+......+.+++.+||+.||++||++ .+|++
T Consensus 411 ------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 411 ------TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp ------CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred ------CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 1112223457799999999999999975 56653
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=347.61 Aligned_cols=196 Identities=23% Similarity=0.402 Sum_probs=155.3
Q ss_pred cccccccCeecccCceeEEEEEee-cCcEEEEEEecCC--CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeC-----Ce
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR-----DE 587 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~ 587 (836)
.++|++.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+.++++++||||+++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 478999999999999999999976 4899999998654 334557889999999999999999999998443 56
Q ss_pred eeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCccc
Q 003254 588 RMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667 (836)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~ 667 (836)
.++||||+. ++|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 132 ~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFR---TPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEEECCCS-EEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEeccc-cchhhhcc---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccch
Confidence 899999985 68888874 3456999999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCccc-------------------------cccccccccccccCcccc-cCCccCccccccchhhhhhhhhhCC
Q 003254 668 SFGLDQTE-------------------------ANTKRVVGTYGYMSPEYA-IDGLFSVKSDVFSFGVLVLEIICGK 718 (836)
Q Consensus 668 ~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~t~ksDVwS~GvvL~elltG~ 718 (836)
........ ......+||+.|+|||++ .+..++.++|||||||+||||++|.
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~ 281 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMI 281 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTS
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhc
Confidence 76432111 112345789999999986 4567999999999999999999953
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=314.15 Aligned_cols=217 Identities=17% Similarity=0.177 Sum_probs=170.8
Q ss_pred ccccccCCCccccCCCeEEeCCCeEEEeeecCCCCCceEEEEEEeecCCCcEEEeecCCCCCCCCcceEEEeeccCceEE
Q 003254 43 RTLDTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPLSDRSGVLRINGERNGILV 122 (836)
Q Consensus 43 ~~~~~i~~~~~l~~~~~l~S~~g~F~lgF~~~~~~~~~ylgiw~~~~~~~t~vW~Anr~~p~~~~~~~l~~~~~~~g~l~ 122 (836)
++.|+|++||+|.+|++| ++|.|+|||+.+++ +. +|.. +|+||+|||+.| ..+.|+|. .||+||
T Consensus 6 ~~~~~i~~g~~L~~g~~l--~~g~f~l~f~~~gn-----l~-ly~~---~~~vW~an~~~~---~~~~l~l~--~dGnLv 69 (236)
T 1dlp_A 6 GLSHEGSHPQTLHAAQSL--ELSSFRFTMQSDCN-----LV-LFDS---DVRVWASNTAGA---TGCRAVLQ--SDGLLV 69 (236)
T ss_dssp CSSSSSCSCSCCCTTCEE--CSTTEEEEECTTSC-----EE-EEES---SSEEECCCCCSC---SCCBCCBC--SSSCBC
T ss_pred eccceeCCCCEECCCCEE--EcCCEEEEECCCCc-----EE-EEEC---CEEEEECCCCCC---CCeEEEEc--CCCcEE
Confidence 567999999999999999 59999999987665 23 3442 799999999998 45788887 899999
Q ss_pred EEcCCCCeEEeecccCCCCcceEEEecCCCeEEecCCCCCCCcceeeeccCCCCCc-CCCCeeeeee-cCCC-----ceE
Q 003254 123 LLNSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDNILWQSFDYPCDTL-LPGMKLGINL-GTGL-----NRF 195 (836)
Q Consensus 123 l~~~~~~~~wst~~~~~~~~~~a~lld~GNlvl~~~~~~~~~~~~WqSFd~PTDtl-Lpgqkl~~~~-~tg~-----~~~ 195 (836)
|+|++|.+||+|++........|+|+|+|||||++ .++||||||||||+ |||| |.|. .+|+ ++.
T Consensus 70 l~d~~~~~vW~s~~~~~~~~~~~~l~d~Gnlvl~~-------~~~W~S~~~p~~t~~lp~~--g~d~L~~gq~~~~~~~~ 140 (236)
T 1dlp_A 70 ILTAQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYG-------PGLWDSGTSNKGSVVVANN--GNSILYSTQGNDNHPQT 140 (236)
T ss_dssp CBCTTTCCSCCCCCCCCSSCCEEEECSSSCEEEEC-------SEEEECSCCCSSCCCCSSC--CCEECCCC--CCCCCCE
T ss_pred EEcCCCcEEEeCCccccCCcEEEEEeCCCCEEEec-------CCEEECCCCCCcccccCCc--cceEEecCCcCCCccce
Confidence 99999999999997544445689999999999984 27999999999887 6665 5555 5555 667
Q ss_pred EEEccCCCCCCCCCeeeccCCCCCceEEEEcCCeeEEeeCCCCCccccCccccccCCceEEEEeeCCceeEEEEecCCCC
Q 003254 196 LSSWKSTDDPARGDFTYGLDPRGIPQLVLRKNSIITFRAGSWNGLHWTGVPQLQLNPVYTFEYVSNEKEAFYTYNLSNSS 275 (836)
Q Consensus 196 l~Sw~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~g~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (836)
|+| .+||++|.|+++++++| +++++++..+||++|+|++. +...+++..+..+ +.|..++++.+++|.....
T Consensus 141 L~s---~~d~s~G~~~l~l~~dG--~LvL~~~~~~~W~s~~~~~~-~~~~~~L~~~Gnl-~ly~~~~~~vw~s~~~~~~- 212 (236)
T 1dlp_A 141 LHA---TQSLQLSPYRLSMETDC--NLVLFDRDDRVWSTNTAGKG-TGCRAVLQPNGRM-DVLTNQNIAVWTSGNSRSA- 212 (236)
T ss_dssp ECS---SCCCBCSSCEEEEETTT--EEEEEBTTBCCSCCCCCSSC-SSCEEEEETTTEE-EEEETTTEEEEECCCCCSS-
T ss_pred EEc---CcEeecCcEEEEECCCC--cEEEEcCCEeEEeCCCcCCC-CceEEEECCCCcE-EEEeCCCcEEEEeCCCCCC-
Confidence 874 78999999999999999 68888888899999999754 5566666544432 3344455555555554433
Q ss_pred ccceEEEcccCcEEEEE
Q 003254 276 VPSRMVINPAGTVQRYT 292 (836)
Q Consensus 276 ~~~r~~L~~~G~l~~y~ 292 (836)
...|++|++||++++|.
T Consensus 213 ~~~rl~Ld~dG~l~ly~ 229 (236)
T 1dlp_A 213 GRYVFVLQPDRNLAIYG 229 (236)
T ss_dssp SCCEEEECSSSCEEEEC
T ss_pred CCEEEEEcCCCcEEEeC
Confidence 46899999999999994
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-38 Score=348.55 Aligned_cols=243 Identities=16% Similarity=0.170 Sum_probs=188.7
Q ss_pred hcccccccCeecccCceeEEEEEee-cCcEEEEEEecCC---CchhHHHHHHHH---HHHHhhcCCceeeEE-------e
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG---SGQGMEEFKNEV---LLIAKLQHRNLVKLL-------G 580 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei---~~l~~l~H~niv~l~-------g 580 (836)
..++|...+.||+|+||.||+|+.. +|+.||||++... .....+.+.+|+ .++++++||||++++ +
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 3578888999999999999999974 5899999999743 334567899999 455556899999998 6
Q ss_pred EEeeCC-----------------eeeEEEeecCCCChhHHHhhccC----CCcCChhhhHHHHHHHHhhhHhhhcCCCCc
Q 003254 581 CCTQRD-----------------ERMLIYEYLPNKSLDYFIFDTTR----SKLLDWSKRSHIIAGIARGLLYLHQDSRLR 639 (836)
Q Consensus 581 ~~~~~~-----------------~~~lV~Ey~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 639 (836)
++...+ ..+|||||+ +|+|.+++..... ...+++..+..++.||+.||+|||+++
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--- 226 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--- 226 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence 655443 278999999 6899999965321 123446888899999999999999998
Q ss_pred EEeccCCCCceEecCCCCceeeccCcccccCCCccccccccccccccccCcccccCC-----------ccCccccccchh
Q 003254 640 IIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDG-----------LFSVKSDVFSFG 708 (836)
Q Consensus 640 ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~t~ksDVwS~G 708 (836)
|+||||||+||||+.++.+||+|||+++.... ......| +.|+|||++.+. .++.++||||||
T Consensus 227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG 300 (377)
T 3byv_A 227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALG 300 (377)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHH
T ss_pred eecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHH
Confidence 99999999999999999999999999986432 2233567 999999999887 899999999999
Q ss_pred hhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 709 VLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 709 vvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
|+||||++|+.||.......... ...... ......+.+++.+||+.||++|||+.|+++
T Consensus 301 ~il~elltg~~Pf~~~~~~~~~~-------------------~~~~~~--~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 301 LVIYWIWCADLPITKDAALGGSE-------------------WIFRSC--KNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHHHSSCCC------CCSG-------------------GGGSSC--CCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHHHCCCCCcccccccchh-------------------hhhhhc--cCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 99999999999975322211100 000000 011245778999999999999999999986
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=331.53 Aligned_cols=259 Identities=27% Similarity=0.360 Sum_probs=196.9
Q ss_pred cccccccCeecccCceeEEEEEeec--Cc--EEEEEEecCC---CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCee
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLIE--GQ--EIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDER 588 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~~--g~--~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 588 (836)
.++|+..+.||+|+||.||+|++.. ++ .||||+++.. .....+.+.+|+.++++++||||+++++++.... .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 4689999999999999999998643 33 6899998654 2345678999999999999999999999998754 8
Q ss_pred eEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccc
Q 003254 589 MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (836)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~ 668 (836)
++|+||+++++|.+++... ...+++..+..++.||++||.|||+++ |+|+||||+||+++.++.+||+|||++..
T Consensus 96 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp EEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccc
Confidence 8999999999999998643 346899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCccc-cccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhccCch
Q 003254 669 FGLDQTE-ANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEERPL 746 (836)
Q Consensus 669 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (836)
....... .......++..|+|||.+.+..++.++||||||+++|||++ |+.|+...... .. .........
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~----~~~~~~~~~- 242 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS---QI----LHKIDKEGE- 242 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HH----HHHHHTSCC-
T ss_pred ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH---HH----HHHHHccCC-
Confidence 6533221 12233467889999999998899999999999999999999 99987532211 11 111111100
Q ss_pred hhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCCC
Q 003254 747 ELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS 795 (836)
Q Consensus 747 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~ 795 (836)
...........+.+++.+||+.+|++|||+.++++.|+++..
T Consensus 243 -------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 243 -------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp -------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred -------CCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 001112233567899999999999999999999999988654
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=346.19 Aligned_cols=201 Identities=23% Similarity=0.390 Sum_probs=168.1
Q ss_pred hcccccccCeecccCceeEEEEEeec-CcEEEEEEecCC--CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeC-----C
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR-----D 586 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~ 586 (836)
..++|...+.||+|+||.||+|+... ++.||||++... .....+.+.+|+.++++++||||+++++++... .
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 35789999999999999999999865 788999999754 334457889999999999999999999999776 5
Q ss_pred eeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcc
Q 003254 587 ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLA 666 (836)
Q Consensus 587 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla 666 (836)
..++||||++ ++|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 104 ~~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 104 ELYIVLEIAD-SDLKKLFK---TPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp CEEEEEECCS-EEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecCC-cCHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 6899999987 58988884 3456999999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCccc--------------------cccccccccccccCcccc-cCCccCccccccchhhhhhhhhhCCCCCC
Q 003254 667 RSFGLDQTE--------------------ANTKRVVGTYGYMSPEYA-IDGLFSVKSDVFSFGVLVLEIICGKKNRG 722 (836)
Q Consensus 667 ~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~t~ksDVwS~GvvL~elltG~~p~~ 722 (836)
+........ ......+||+.|+|||++ ....++.++|||||||+||||++|..|+.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 976433211 112446889999999986 56679999999999999999998765543
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=334.93 Aligned_cols=257 Identities=19% Similarity=0.344 Sum_probs=203.7
Q ss_pred HHHHhhcccccccCeecccCceeEEEEEee-cCcEEEEEEecCCCc--------hhHHHHHHHHHHHHhh-cCCceeeEE
Q 003254 510 KIIANATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSG--------QGMEEFKNEVLLIAKL-QHRNLVKLL 579 (836)
Q Consensus 510 ~~l~~a~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~~--------~~~~~~~~Ei~~l~~l-~H~niv~l~ 579 (836)
.......++|...+.||+|+||.||++++. +|+.||||++..... ...+.+.+|+.++.++ +||||++++
T Consensus 87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 166 (365)
T 2y7j_A 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI 166 (365)
T ss_dssp HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 334455678999999999999999999986 599999999875532 1245678999999999 799999999
Q ss_pred eEEeeCCeeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCce
Q 003254 580 GCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPK 659 (836)
Q Consensus 580 g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~k 659 (836)
+++......++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+|+||||+|||+++++.+|
T Consensus 167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ik 240 (365)
T 2y7j_A 167 DSYESSSFMFLVFDLMRKGELFDYLTE---KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIR 240 (365)
T ss_dssp EEEEBSSEEEEEECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEE
T ss_pred EEEeeCCEEEEEEEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEE
Confidence 999999999999999999999999854 346899999999999999999999998 99999999999999999999
Q ss_pred eeccCcccccCCCccccccccccccccccCcccccC------CccCccccccchhhhhhhhhhCCCCCCCCCCccccchh
Q 003254 660 ISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAID------GLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLL 733 (836)
Q Consensus 660 l~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~ 733 (836)
|+|||++..+.... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||...... ..
T Consensus 241 l~DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~---~~- 313 (365)
T 2y7j_A 241 LSDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI---LM- 313 (365)
T ss_dssp ECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HH-
T ss_pred EEecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH---HH-
Confidence 99999998764322 2234679999999999863 35889999999999999999999997532111 00
Q ss_pred hhhHHhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 734 GHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 734 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
......... ....+.. . .....+.+++.+||+.||++|||+.|+++
T Consensus 314 ---~~~i~~~~~-~~~~~~~-~----~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 314 ---LRMIMEGQY-QFSSPEW-D----DRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp ---HHHHHHTCC-CCCHHHH-S----SSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ---HHHHHhCCC-CCCCccc-c----cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111111100 0000000 0 11235779999999999999999999986
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=326.50 Aligned_cols=256 Identities=21% Similarity=0.262 Sum_probs=199.7
Q ss_pred cccccccCeecccCceeEEEEEeec-CcEEEEEEecCCC----chhHHHHHHHHHHHHhhcCCceeeEEeEE--eeCCee
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS----GQGMEEFKNEVLLIAKLQHRNLVKLLGCC--TQRDER 588 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~--~~~~~~ 588 (836)
.++|.+.+.||+|+||.||++.... ++.||+|++.... ....+.+.+|+.++++++||||+++++++ .+....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 4789999999999999999999854 8899999986532 23457899999999999999999999998 445678
Q ss_pred eEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccc
Q 003254 589 MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (836)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~ 668 (836)
++||||++++ |.+++... ....+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccc
Confidence 9999999987 66666443 3457899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCccccccccccccccccCcccccCCc--cCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCch
Q 003254 669 FGLDQTEANTKRVVGTYGYMSPEYAIDGL--FSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPL 746 (836)
Q Consensus 669 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (836)
..............|++.|+|||++.+.. ++.++||||||+++|||++|+.|+...... ...........
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~i~~~~~- 230 (305)
T 2wtk_C 159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY-------KLFENIGKGSY- 230 (305)
T ss_dssp CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHHHHHCCC-
T ss_pred cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH-------HHHHHHhcCCC-
Confidence 65333333334467899999999997643 478999999999999999999997532211 01111111110
Q ss_pred hhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hcCC
Q 003254 747 ELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM--LSGE 793 (836)
Q Consensus 747 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~--L~~~ 793 (836)
..+......+.+++.+||+.||++|||+.|+++. +...
T Consensus 231 ---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 270 (305)
T 2wtk_C 231 ---------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKK 270 (305)
T ss_dssp ---------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSC
T ss_pred ---------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccC
Confidence 1111223457799999999999999999999964 4444
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-37 Score=326.44 Aligned_cols=246 Identities=22% Similarity=0.311 Sum_probs=201.8
Q ss_pred cccccccCeecccCceeEEEEEeec-CcEEEEEEecCCC---chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEE
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 591 (836)
.++|...+.||+|+||.||+++... ++.||+|++.... ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 3678999999999999999999864 7889999986432 22346789999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCC
Q 003254 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (836)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~ 671 (836)
|||+++++|.+++... ..+++..+..++.||++||.|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 93 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 93 LEFAPRGELYKELQKH---GRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp ECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 9999999999998543 45899999999999999999999998 99999999999999999999999999876532
Q ss_pred CccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccc
Q 003254 672 DQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQ 751 (836)
Q Consensus 672 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 751 (836)
. ......|++.|+|||.+.+..++.++||||||++++||++|+.|+....... ......... .
T Consensus 167 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~~~~~~~~------~ 229 (284)
T 2vgo_A 167 L----RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE-------THRRIVNVD------L 229 (284)
T ss_dssp S----CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHTTC------C
T ss_pred c----ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH-------HHHHHhccc------c
Confidence 2 1233578999999999999999999999999999999999999975322110 011111110 0
Q ss_pred cccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 752 SLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 752 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
..+......+.+++.+||+.+|++|||+.|+++
T Consensus 230 ----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 230 ----KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp ----CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ----CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 111122345779999999999999999999986
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=335.89 Aligned_cols=265 Identities=25% Similarity=0.328 Sum_probs=196.2
Q ss_pred hhcccccccCeecccCceeEEEEEeec-CcEEEEEEecCCCc-----hhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCe
Q 003254 514 NATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSG-----QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDE 587 (836)
Q Consensus 514 ~a~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~-----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 587 (836)
...++|+..+.||+|+||.||+++... |+.||||++..... ...+.+.+|+.++++++||||+++++++...+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 345789999999999999999999864 89999999865322 123568899999999999999999999999999
Q ss_pred eeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCccc
Q 003254 588 RMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667 (836)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~ 667 (836)
.++||||+++ +|..++.. ....+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 87 ~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp CEEEEECCSE-EHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred eEEEEEcCCC-CHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccce
Confidence 9999999986 78777743 3356899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCccccccccccccccccCcccccCC-ccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCch
Q 003254 668 SFGLDQTEANTKRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPL 746 (836)
Q Consensus 668 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (836)
.+..... ......+|+.|+|||.+.+. .++.++|||||||++|||++|.+|+...... ................
T Consensus 161 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~---~~~~~i~~~~~~~~~~ 235 (346)
T 1ua2_A 161 SFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL---DQLTRIFETLGTPTEE 235 (346)
T ss_dssp TTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCCCCTT
T ss_pred eccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHH---HHHHHHHHHcCCCChh
Confidence 7643222 22345789999999999764 5899999999999999999999886533211 1111111111110000
Q ss_pred h------hccccc---cCCCC-----hHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 747 E------LIDQSL---DNSCS-----FSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 747 ~------~~d~~l---~~~~~-----~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
. ..+... ....+ ......+.+++.+||+.||++|||+.|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 236 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp TSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0 000000 00001 1123568899999999999999999999875
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=333.05 Aligned_cols=265 Identities=25% Similarity=0.385 Sum_probs=186.2
Q ss_pred hhcccccccCeecccCceeEEEEEee-cCcEEEEEEecCCC-chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEE
Q 003254 514 NATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (836)
Q Consensus 514 ~a~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 591 (836)
...++|+..+.||+|+||.||++... +++.||||++.... ....+++.+|+.++++++||||+++++++...+..++|
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 34578999999999999999999975 58899999986543 33456788999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhc-----cCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcc
Q 003254 592 YEYLPNKSLDYFIFDT-----TRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLA 666 (836)
Q Consensus 592 ~Ey~~~gsL~~~l~~~-----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla 666 (836)
|||+++++|.+++... .....+++..+..++.||+.||.|||+.+ |+||||||+||++++++.+||+|||++
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccch
Confidence 9999999999998642 12456899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCcc---ccccccccccccccCcccccC-CccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhc
Q 003254 667 RSFGLDQT---EANTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIE 742 (836)
Q Consensus 667 ~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 742 (836)
........ ........||+.|+|||.+.+ ..++.++||||||+++|||++|+.|+....... .. ... ..
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~---~~~-~~ 241 (303)
T 2vwi_A 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK---VL---MLT-LQ 241 (303)
T ss_dssp HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG---HH---HHH-HT
T ss_pred heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh---HH---HHH-hc
Confidence 87643221 111233578999999999876 568999999999999999999999975432211 00 011 11
Q ss_pred cCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 743 ERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 743 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
......................+.+++.+||+.||++|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 242 NDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp SSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 1111110000000111122345789999999999999999999986
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=346.26 Aligned_cols=261 Identities=21% Similarity=0.257 Sum_probs=205.4
Q ss_pred cccccccCeecccCceeEEEEEee-cCcEEEEEEecCCCchhHHHHHHHHHHHHhhcC-CceeeEEeEEeeCCeeeEEEe
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQH-RNLVKLLGCCTQRDERMLIYE 593 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H-~niv~l~g~~~~~~~~~lV~E 593 (836)
.++|++.++||+|+||.||+|+.. +++.||||++..... .+++..|++++..++| +++..+..++.+.+..+||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 478999999999999999999974 489999998865432 3468899999999987 566666777778888999999
Q ss_pred ecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEe---cCCCCceeeccCcccccC
Q 003254 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLL---DNTMNPKISDFGLARSFG 670 (836)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl---~~~~~~kl~DFgla~~~~ 670 (836)
|+ +++|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||| ++++.+||+|||+++.+.
T Consensus 84 ~~-g~sL~~ll~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 84 LL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred CC-CCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 99 99999998542 346999999999999999999999998 9999999999999 688999999999998765
Q ss_pred CCcccc-----ccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCc
Q 003254 671 LDQTEA-----NTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERP 745 (836)
Q Consensus 671 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (836)
...... ......||+.|+|||.+.+..++.++|||||||+||||++|+.||........................
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI 237 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH
Confidence 432211 122467999999999999999999999999999999999999998654333222221111111111111
Q ss_pred hhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 003254 746 LELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 793 (836)
Q Consensus 746 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 793 (836)
..+. .. ....+.+++..||+.+|++||++.+|+++|+.+
T Consensus 238 ~~l~-----~~----~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 238 EALC-----RG----YPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp HHHH-----TT----SCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred HHHh-----cC----CcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 1111 11 124678999999999999999999999998764
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=325.53 Aligned_cols=249 Identities=24% Similarity=0.350 Sum_probs=196.6
Q ss_pred ccccccCeecccCceeEEEEEeec-CcEEEEEEecCC--CchhHHHHHHHHHHHHhhcCCceeeEEeEEee----CCeee
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQ----RDERM 589 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~~ 589 (836)
+.|...+.||+|+||.||+|.... +..||+|++... .....+.+.+|+.++++++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 457788899999999999999854 788999998654 33456778999999999999999999999865 34589
Q ss_pred EEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEec-CCCCceeeccCcccc
Q 003254 590 LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD-NTMNPKISDFGLARS 668 (836)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~-~~~~~kl~DFgla~~ 668 (836)
+||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ .+|+||||||+|||++ +++.+||+|||++..
T Consensus 106 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEEecCCCCHHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 999999999999999542 46899999999999999999999875 3599999999999998 789999999999976
Q ss_pred cCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhh
Q 003254 669 FGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLEL 748 (836)
Q Consensus 669 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (836)
.... ......|++.|+|||.+. +.++.++||||||+++|||++|+.|+...... ...............
T Consensus 182 ~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~------~~~~~~~~~~~~~~~ 250 (290)
T 1t4h_A 182 KRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNA------AQIYRRVTSGVKPAS 250 (290)
T ss_dssp CCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH------HHHHHHHTTTCCCGG
T ss_pred cccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcH------HHHHHHHhccCCccc
Confidence 4322 223357899999999886 45899999999999999999999997532211 111111111111111
Q ss_pred ccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 749 IDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 749 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
. +......+.+++.+||+.+|++|||+.||++
T Consensus 251 ~--------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 251 F--------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp G--------GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred c--------CCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 1 1111235789999999999999999999986
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=328.88 Aligned_cols=256 Identities=19% Similarity=0.296 Sum_probs=198.4
Q ss_pred cccccccCeecccCceeEEEEEee-cCcEEEEEEecCCCchhHHHHHHHHHHHHhhc-CCceeeEEeEEee--CCeeeEE
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQ--RDERMLI 591 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~--~~~~~lV 591 (836)
.++|+..+.||+|+||.||+|+.. +++.||||++... ..+.+.+|+.++++++ ||||+++++++.. ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 478999999999999999999874 5899999998643 3467899999999997 9999999999987 5678999
Q ss_pred EeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCC-CceeeccCcccccC
Q 003254 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTM-NPKISDFGLARSFG 670 (836)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~-~~kl~DFgla~~~~ 670 (836)
|||+++++|.+++. .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||+++.+.
T Consensus 112 ~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp EECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 99999999988872 3788999999999999999999998 99999999999999766 89999999998764
Q ss_pred CCccccccccccccccccCcccccC-CccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhc-------
Q 003254 671 LDQTEANTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIE------- 742 (836)
Q Consensus 671 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~------- 742 (836)
.... .....++..|+|||.+.+ ..++.++|||||||+++||++|+.|+......... ..........
T Consensus 183 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~--l~~~~~~~~~~~~~~~~ 257 (330)
T 3nsz_A 183 PGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ--LVRIAKVLGTEDLYDYI 257 (330)
T ss_dssp TTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHH--HHHHHHHHCHHHHHHHH
T ss_pred CCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHH--HHHHHHhcCCchhhhHH
Confidence 3322 233578999999999987 67899999999999999999999997433221110 0000000000
Q ss_pred ----------------cCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 743 ----------------ERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 743 ----------------~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
.......+..............+.+++.+||+.||++|||+.|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 258 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000000111111111123456789999999999999999999987
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=326.20 Aligned_cols=253 Identities=24% Similarity=0.379 Sum_probs=198.3
Q ss_pred hcccccccCeecccCceeEEEEEeec-CcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEe
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 593 (836)
..++|++.+.||+|+||.||+|+... ++.||+|++........+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 45789999999999999999999865 88999999977766677889999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCc
Q 003254 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (836)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~ 673 (836)
|+++++|.+++... ...+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 97 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 170 (302)
T 2j7t_A 97 FCPGGAVDAIMLEL--DRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT- 170 (302)
T ss_dssp CCTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH-
T ss_pred eCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcccccc-
Confidence 99999999988543 346899999999999999999999998 999999999999999999999999997643211
Q ss_pred cccccccccccccccCcccc-----cCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhh
Q 003254 674 TEANTKRVVGTYGYMSPEYA-----IDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLEL 748 (836)
Q Consensus 674 ~~~~~~~~~gt~~y~aPE~~-----~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (836)
........|++.|+|||++ .+..++.++||||||+++|||++|+.|+...... ..... .........
T Consensus 171 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~-~~~~~~~~~ 242 (302)
T 2j7t_A 171 -LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RVLLK-IAKSDPPTL 242 (302)
T ss_dssp -HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHH-HHHSCCCCC
T ss_pred -ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH------HHHHH-HhccCCccc
Confidence 1112235789999999998 3667899999999999999999999997532211 11111 111111100
Q ss_pred ccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 749 IDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 749 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
. .+......+.+++.+||+.||++|||+.|+++
T Consensus 243 ~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 243 L-------TPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp S-------SGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred C-------CccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0 11122345789999999999999999999975
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-37 Score=333.59 Aligned_cols=261 Identities=27% Similarity=0.387 Sum_probs=199.2
Q ss_pred cccHHHHHhhcccccccCeecccCceeEEEEEee-cCcEEEEEEecCCCchhHHHHHHHHHHHHhh-cCCceeeEEeEEe
Q 003254 506 IFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCT 583 (836)
Q Consensus 506 ~~~~~~l~~a~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~ 583 (836)
.+++..+....++|+..+.||+|+||.||+|+.. +++.||||++.... ...+.+.+|+.++.++ +||||+++++++.
T Consensus 13 ~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 91 (326)
T 2x7f_A 13 EIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFI 91 (326)
T ss_dssp ---CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred hccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEe
Confidence 3455556667889999999999999999999985 58999999986543 3457889999999999 7999999999997
Q ss_pred e------CCeeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCC
Q 003254 584 Q------RDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMN 657 (836)
Q Consensus 584 ~------~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~ 657 (836)
. ....++||||+++++|.+++... ....+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.
T Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~ 167 (326)
T 2x7f_A 92 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAE 167 (326)
T ss_dssp ECC--CCCCEEEEEEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCC
T ss_pred eccCccccceEEEEEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCC
Confidence 7 46789999999999999998643 2356899999999999999999999998 999999999999999999
Q ss_pred ceeeccCcccccCCCccccccccccccccccCccccc-----CCccCccccccchhhhhhhhhhCCCCCCCCCCccccch
Q 003254 658 PKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAI-----DGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNL 732 (836)
Q Consensus 658 ~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~ 732 (836)
+||+|||++........ ......|++.|+|||++. +..++.++||||||+++|||++|+.|+......
T Consensus 168 ~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----- 240 (326)
T 2x7f_A 168 VKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM----- 240 (326)
T ss_dssp EEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH-----
T ss_pred EEEeeCcCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH-----
Confidence 99999999987542211 223357899999999987 567899999999999999999999997432211
Q ss_pred hhhhHHhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 733 LGHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 733 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
..... ......... ........+.+++.+||+.||++|||+.|+++
T Consensus 241 -~~~~~-~~~~~~~~~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 241 -RALFL-IPRNPAPRL--------KSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp -HHHHH-HHHSCCCCC--------SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred -HHHHH-hhcCccccC--------CccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 00111 111111000 01112245779999999999999999999987
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-36 Score=336.65 Aligned_cols=262 Identities=23% Similarity=0.268 Sum_probs=200.7
Q ss_pred cccccccCeecccCceeEEEEEeec-CcEEEEEEecCCCchhHHHHHHHHHHHHhhc--------CCceeeEEeEEe---
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQ--------HRNLVKLLGCCT--- 583 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~--------H~niv~l~g~~~--- 583 (836)
.++|++.++||+|+||.||+++... ++.||||++... ....+.+.+|+.+++.++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 4789999999999999999998754 889999999643 345677899999999996 788999999987
Q ss_pred -eCCeeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcC-CCCcEEeccCCCCceEecCCC-----
Q 003254 584 -QRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNTM----- 656 (836)
Q Consensus 584 -~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~DLkp~NILl~~~~----- 656 (836)
.....++||||+. ++|.+.+... ....+++..+..++.||+.||+|||++ + |+||||||+||||+.++
T Consensus 115 ~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 115 VNGTHICMVFEVLG-HHLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp TTEEEEEEEECCCC-CBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHH
T ss_pred CCCceEEEEEeccC-ccHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhh
Confidence 5567899999995 5555555432 235689999999999999999999998 7 99999999999998775
Q ss_pred --------------------------------------------CceeeccCcccccCCCccccccccccccccccCccc
Q 003254 657 --------------------------------------------NPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEY 692 (836)
Q Consensus 657 --------------------------------------------~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~ 692 (836)
.+||+|||++...... .....||+.|+|||+
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHH
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChh
Confidence 8999999999875422 223578999999999
Q ss_pred ccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhH--HhhhccCchhh----------cccc--------
Q 003254 693 AIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAW--RLWIEERPLEL----------IDQS-------- 752 (836)
Q Consensus 693 ~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~----------~d~~-------- 752 (836)
+.+..++.++|||||||+||||++|+.||................ .......+.+. ....
T Consensus 265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (397)
T 1wak_A 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK 344 (397)
T ss_dssp HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence 999999999999999999999999999986543322111110000 00011111100 0000
Q ss_pred ---------c--cCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 753 ---------L--DNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 753 ---------l--~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
+ ....+......+.+|+.+||+.||++|||+.||++
T Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 0 01234556677899999999999999999999985
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=337.28 Aligned_cols=263 Identities=22% Similarity=0.345 Sum_probs=196.8
Q ss_pred hcccccccCeecccCceeEEEEEee-cCcEEEEEEecCC--CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCC-----
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD----- 586 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----- 586 (836)
..++|+..+.||+|+||.||+|+.. +|+.||||++... .....+.+.+|+.+++.++||||+++++++...+
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 3478999999999999999999985 4899999998654 2334567899999999999999999999997653
Q ss_pred -eeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCc
Q 003254 587 -ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGL 665 (836)
Q Consensus 587 -~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgl 665 (836)
..++||||+ +++|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeec
Confidence 459999999 7899988853 45899999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCccccccccccccccccCcccccC-CccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccC
Q 003254 666 ARSFGLDQTEANTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEER 744 (836)
Q Consensus 666 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 744 (836)
++..... .....+|+.|+|||++.+ ..++.++||||+||+++||++|+.||......+. ....... ....
T Consensus 175 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---l~~i~~~-~g~~ 245 (367)
T 1cm8_A 175 ARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ---LKEIMKV-TGTP 245 (367)
T ss_dssp CEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHH-HCCC
T ss_pred ccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHh-cCCC
Confidence 9875422 233578999999999987 6799999999999999999999999764322111 0000000 0000
Q ss_pred chhhccc-----------cc----c---CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HhcCCC
Q 003254 745 PLELIDQ-----------SL----D---NSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL--MLSGER 794 (836)
Q Consensus 745 ~~~~~d~-----------~l----~---~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~--~L~~~~ 794 (836)
+.+.+.. .+ . ..........+.+|+.+||+.||++|||+.|+++ .++...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 246 PAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 315 (367)
T ss_dssp CHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred CHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence 1000000 00 0 0011122345789999999999999999999998 455543
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-37 Score=331.84 Aligned_cols=259 Identities=23% Similarity=0.335 Sum_probs=198.8
Q ss_pred HHHHHhhcccccccCeecccCceeEEEEEeecCcEEEEEEecCC--CchhHHHHHHHHHHHHhhc--CCceeeEEeEEee
Q 003254 509 LKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQ--HRNLVKLLGCCTQ 584 (836)
Q Consensus 509 ~~~l~~a~~~f~~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~--H~niv~l~g~~~~ 584 (836)
+..+....++|+..+.||+|+||.||++...+++.||||++... .....+.+.+|+.++.+++ |+||+++++++..
T Consensus 20 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~ 99 (313)
T 3cek_A 20 FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT 99 (313)
T ss_dssp CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC
T ss_pred eeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec
Confidence 33444566889999999999999999999988999999998654 3345678999999999997 5999999999999
Q ss_pred CCeeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccC
Q 003254 585 RDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFG 664 (836)
Q Consensus 585 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFg 664 (836)
.+..++||| +.+++|.+++.. ...+++..+..++.||++||.|||+.+ |+||||||+|||+++ +.+||+|||
T Consensus 100 ~~~~~lv~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg 171 (313)
T 3cek_A 100 DQYIYMVME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFG 171 (313)
T ss_dssp SSEEEEEEC-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCS
T ss_pred CCEEEEEEe-cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeecc
Confidence 999999999 678899999854 346899999999999999999999998 999999999999965 899999999
Q ss_pred cccccCCCccccccccccccccccCcccccC-----------CccCccccccchhhhhhhhhhCCCCCCCCCCccccchh
Q 003254 665 LARSFGLDQTEANTKRVVGTYGYMSPEYAID-----------GLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLL 733 (836)
Q Consensus 665 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~ 733 (836)
++..+.............|++.|+|||.+.+ ..++.++||||||+++|||++|+.|+...... .
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-----~ 246 (313)
T 3cek_A 172 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----I 246 (313)
T ss_dssp SSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-----H
T ss_pred ccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH-----H
Confidence 9987654333223334578999999999875 46889999999999999999999997532211 0
Q ss_pred hhhHHhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 734 GHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 734 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
.. ... .+++......+......+.+++.+||+.||++||++.|+++.
T Consensus 247 ~~-~~~--------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 247 SK-LHA--------IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp HH-HHH--------HHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HH-HHH--------HHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 00 011 111111111111123457899999999999999999999863
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-37 Score=339.04 Aligned_cols=269 Identities=20% Similarity=0.264 Sum_probs=197.6
Q ss_pred cHHHHHhhcccccccCeecccCceeEEEEEeecCcEEEEEEecCCCc-----------hhHHHHHHHHHHHHhhcCCcee
Q 003254 508 DLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSG-----------QGMEEFKNEVLLIAKLQHRNLV 576 (836)
Q Consensus 508 ~~~~l~~a~~~f~~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~-----------~~~~~~~~Ei~~l~~l~H~niv 576 (836)
...++....++|...+.||+|+||.||+|...+|+.||||++..... ...+.+.+|+.++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 35667788899999999999999999999988899999999854321 1237789999999999999999
Q ss_pred eEEeEEeeC-----CeeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceE
Q 003254 577 KLLGCCTQR-----DERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVL 651 (836)
Q Consensus 577 ~l~g~~~~~-----~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NIL 651 (836)
++++++... ...++||||++ |+|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl 166 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNIL 166 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEE
Confidence 999998543 35799999998 577777753 3456899999999999999999999998 999999999999
Q ss_pred ecCCCCceeeccCcccccCCCccccccccccccccccCcccccC-CccCccccccchhhhhhhhhhCCCCCCCCCCcccc
Q 003254 652 LDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDH 730 (836)
Q Consensus 652 l~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~ 730 (836)
++.++.+||+|||+++...... ......+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||.......
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-- 241 (362)
T 3pg1_A 167 LADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN-- 241 (362)
T ss_dssp ECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--
T ss_pred EcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHH--
Confidence 9999999999999998543222 2233578999999999887 678999999999999999999999975432111
Q ss_pred chhhhhHHhhhccCc-----------hhhccccccC-------CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 731 NLLGHAWRLWIEERP-----------LELIDQSLDN-------SCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 731 ~~~~~~~~~~~~~~~-----------~~~~d~~l~~-------~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
.............. .+.+...+.. .........+.+++.+||+.||++|||+.|+++
T Consensus 242 -~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 242 -QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp -HHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -HHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 11111110000000 0000000000 001112345789999999999999999999986
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-37 Score=327.42 Aligned_cols=253 Identities=23% Similarity=0.317 Sum_probs=185.9
Q ss_pred hcccccccCeecccCceeEEEEEee-cCcEEEEEEecCCCc-h-hHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEE
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSG-Q-GMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~~-~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 591 (836)
..++|+..+.||+|+||.||+++.. +|+.||||++..... . ..+.+.++...++.++||||+++++++...+..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 4578999999999999999999975 588999999976532 2 233445555667888999999999999999999999
Q ss_pred EeecCCCChhHHHhhc-cCCCcCChhhhHHHHHHHHhhhHhhhcC-CCCcEEeccCCCCceEecCCCCceeeccCccccc
Q 003254 592 YEYLPNKSLDYFIFDT-TRSKLLDWSKRSHIIAGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (836)
Q Consensus 592 ~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~ 669 (836)
|||+++ +|.+++... .....+++..+..++.||+.||+|||++ + |+||||||+||+++.++.+||+|||++...
T Consensus 85 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 85 MELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred Eehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 999985 887776542 2346799999999999999999999998 7 999999999999999999999999999876
Q ss_pred CCCccccccccccccccccCcccc----cCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCc
Q 003254 670 GLDQTEANTKRVVGTYGYMSPEYA----IDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERP 745 (836)
Q Consensus 670 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (836)
..... .....||+.|+|||.+ .+..++.++||||||++++||++|+.|+...... ........... .
T Consensus 161 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~~-~ 231 (290)
T 3fme_A 161 VDDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP-----FQQLKQVVEEP-S 231 (290)
T ss_dssp ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH-----HHHHHHHHHSC-C
T ss_pred ccccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch-----HHHHHHHhccC-C
Confidence 43221 2234689999999996 5667899999999999999999999997532111 01111111111 1
Q ss_pred hhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 746 LELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 746 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
... ........+.+++.+||+.+|++|||+.|+++
T Consensus 232 ~~~--------~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 232 PQL--------PADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp CCC--------CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCc--------ccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 000 11122345789999999999999999999976
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-36 Score=326.28 Aligned_cols=252 Identities=26% Similarity=0.400 Sum_probs=198.9
Q ss_pred hhcccccccCeecccCceeEEEEEeec-CcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEE
Q 003254 514 NATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (836)
Q Consensus 514 ~a~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 592 (836)
...++|+..+.||+|+||.||+|+... |+.||||++.... ..+++.+|+.++.+++||||+++++++...+..++||
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 345789999999999999999999865 8999999997643 3577899999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCC
Q 003254 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (836)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~ 672 (836)
||+++++|.+++.. ....+++..+..++.+|+.||.|||+.+ ++|+||||+||+++.++.+||+|||++......
T Consensus 104 e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 104 EYCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178 (314)
T ss_dssp ECCTTEEHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred ecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence 99999999999853 2456899999999999999999999998 999999999999999999999999999876432
Q ss_pred ccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhcccc
Q 003254 673 QTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQS 752 (836)
Q Consensus 673 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 752 (836)
.. ......|++.|+|||.+.+..++.++||||||+++|||++|+.|+...... .... ..........
T Consensus 179 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~-~~~~~~~~~~---- 245 (314)
T 3com_A 179 MA--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM------RAIF-MIPTNPPPTF---- 245 (314)
T ss_dssp BS--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHH-HHHHSCCCCC----
T ss_pred cc--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH------HHHH-HHhcCCCccc----
Confidence 21 223357899999999999999999999999999999999999997532211 0000 0111111000
Q ss_pred ccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 753 LDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 753 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
..+......+.+++.+||+.||++|||+.++++
T Consensus 246 ---~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 246 ---RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp ---SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ---CCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 011112345789999999999999999999986
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=322.16 Aligned_cols=248 Identities=23% Similarity=0.356 Sum_probs=194.6
Q ss_pred cccccccCeecccCceeEEEEEee-cCcEEEEEEecCCC---chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEE
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 591 (836)
.++|.+.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 468899999999999999999986 58999999986432 23456789999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCC
Q 003254 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (836)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~ 671 (836)
|||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 90 MEYVSGGELFDYICKH---GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp EECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred EeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 9999999999998543 45899999999999999999999998 99999999999999999999999999987643
Q ss_pred CccccccccccccccccCcccccCCcc-CccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhcc
Q 003254 672 DQTEANTKRVVGTYGYMSPEYAIDGLF-SVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELID 750 (836)
Q Consensus 672 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 750 (836)
.. ......+++.|+|||.+.+..+ +.++||||||++++||++|+.|+...... ...........
T Consensus 164 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~~~~~~~~~~~----- 228 (276)
T 2h6d_A 164 GE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP-------TLFKKIRGGVF----- 228 (276)
T ss_dssp ----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCCC-----
T ss_pred Cc---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH-------HHHHHhhcCcc-----
Confidence 22 1223568999999999988765 68999999999999999999997532111 01111111100
Q ss_pred ccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 751 QSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 751 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
..+......+.+++.+||+.||++|||+.||++.
T Consensus 229 -----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 229 -----YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred -----cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0111122457789999999999999999999974
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=339.01 Aligned_cols=265 Identities=18% Similarity=0.263 Sum_probs=197.5
Q ss_pred cccccccCeecccCceeEEEEEeecCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCe------ee
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDE------RM 589 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~------~~ 589 (836)
..+|+..+.||+|+||.||+++...+..+|+|++..... ...+|+.+++.++||||+++++++..... .+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 457899999999999999999998877799998865432 22469999999999999999999965443 78
Q ss_pred EEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEec-CCCCceeeccCcccc
Q 003254 590 LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD-NTMNPKISDFGLARS 668 (836)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~-~~~~~kl~DFgla~~ 668 (836)
+||||++++.+............+++..+..++.||+.||+|||+.+ |+||||||+||||+ .++.+||+|||+++.
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 99999998655544433334567999999999999999999999998 99999999999999 799999999999987
Q ss_pred cCCCccccccccccccccccCcccccCC-ccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCch-
Q 003254 669 FGLDQTEANTKRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPL- 746 (836)
Q Consensus 669 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~- 746 (836)
+..... .....+|+.|+|||++.+. .++.++|||||||++|||++|+.||......+. ..............
T Consensus 192 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~---l~~i~~~~g~p~~~~ 265 (394)
T 4e7w_A 192 LIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQ---LVEIIKVLGTPSREQ 265 (394)
T ss_dssp CCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCCCCHHH
T ss_pred ccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCCHHH
Confidence 643322 2235789999999998765 589999999999999999999999764322111 00010100000000
Q ss_pred ------hhccccc---c-----CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hcCC
Q 003254 747 ------ELIDQSL---D-----NSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM--LSGE 793 (836)
Q Consensus 747 ------~~~d~~l---~-----~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~--L~~~ 793 (836)
...+..+ . ..........+.+|+.+||+.||++|||+.|+++. ++++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 328 (394)
T 4e7w_A 266 IKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDEL 328 (394)
T ss_dssp HHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTT
T ss_pred HHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhh
Confidence 0000000 0 00111123468899999999999999999999974 5554
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-36 Score=322.61 Aligned_cols=253 Identities=21% Similarity=0.285 Sum_probs=201.8
Q ss_pred hhcccccccCeecccCceeEEEEEeec-CcEEEEEEecCCC---------chhHHHHHHHHHHHHhhc-CCceeeEEeEE
Q 003254 514 NATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---------GQGMEEFKNEVLLIAKLQ-HRNLVKLLGCC 582 (836)
Q Consensus 514 ~a~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~---------~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~ 582 (836)
...++|+..+.||+|+||.||+++... |+.||||++.... ....+.+.+|+.+++++. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 345789999999999999999999864 8899999986543 123456889999999996 99999999999
Q ss_pred eeCCeeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeec
Q 003254 583 TQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISD 662 (836)
Q Consensus 583 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~D 662 (836)
......++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~d 167 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTD 167 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECC
T ss_pred ccCCeEEEEEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEec
Confidence 999999999999999999999854 346899999999999999999999998 99999999999999999999999
Q ss_pred cCcccccCCCccccccccccccccccCccccc------CCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhh
Q 003254 663 FGLARSFGLDQTEANTKRVVGTYGYMSPEYAI------DGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHA 736 (836)
Q Consensus 663 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~ 736 (836)
||++..+.... ......+++.|+|||++. ...++.++||||||++++||++|+.|+...... . .
T Consensus 168 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~----~ 237 (298)
T 1phk_A 168 FGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM---L----M 237 (298)
T ss_dssp CTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---H----H
T ss_pred ccchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH---H----H
Confidence 99998764322 223357899999999985 456889999999999999999999997532211 0 1
Q ss_pred HHhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 737 WRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 737 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
.......... . ...........+.+++.+||+.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~-~-----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 238 LRMIMSGNYQ-F-----GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHHHHHTCCC-C-----CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHhcCCcc-c-----CcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 1111111100 0 00001122346789999999999999999999975
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=348.30 Aligned_cols=251 Identities=24% Similarity=0.320 Sum_probs=196.3
Q ss_pred hcccccccCeecccCceeEEEEEee-cCcEEEEEEecCCC--chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEE
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 591 (836)
..+.|...+.||+|+||.||+++.. .+..||+|++.... ....+.+.+|+.+++.++||||+++++++......++|
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3467999999999999999999986 48899999987653 33467889999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecC---CCCceeeccCcccc
Q 003254 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---TMNPKISDFGLARS 668 (836)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~---~~~~kl~DFgla~~ 668 (836)
|||+++|+|.+.+... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||++..
T Consensus 115 ~e~~~~g~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 115 MECYKGGELFDEIIHR---MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp EECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 9999999998888543 45899999999999999999999998 999999999999976 45599999999987
Q ss_pred cCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhh
Q 003254 669 FGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLEL 748 (836)
Q Consensus 669 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (836)
+.... ......||+.|+|||++. +.++.++||||+||++|+|++|+.||...... .. ......... ..
T Consensus 189 ~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~----~~~i~~~~~-~~ 256 (494)
T 3lij_A 189 FENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ---EI----LRKVEKGKY-TF 256 (494)
T ss_dssp CBTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH----HHHHHHTCC-CC
T ss_pred CCCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---HH----HHHHHhCCC-CC
Confidence 64322 223467999999999876 56999999999999999999999997542221 11 111111100 00
Q ss_pred ccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 749 IDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 749 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
..+.. ......+.+++.+||+.+|++|||+.|+++
T Consensus 257 ~~~~~-----~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 257 DSPEW-----KNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp CSGGG-----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred Cchhc-----ccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 00000 012245779999999999999999999985
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=334.14 Aligned_cols=258 Identities=22% Similarity=0.326 Sum_probs=202.4
Q ss_pred cccccccCeecccCceeEEEEEeecCcEEEEEEecCCCch-----------------hHHHHHHHHHHHHhhcCCceeeE
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQ-----------------GMEEFKNEVLLIAKLQHRNLVKL 578 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~~-----------------~~~~~~~Ei~~l~~l~H~niv~l 578 (836)
.++|...+.||+|+||.||+++. +|+.||||++...... ..+.+.+|+.++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999999999 9999999998643211 11789999999999999999999
Q ss_pred EeEEeeCCeeeEEEeecCCCChhHH------HhhccCCCcCChhhhHHHHHHHHhhhHhhhc-CCCCcEEeccCCCCceE
Q 003254 579 LGCCTQRDERMLIYEYLPNKSLDYF------IFDTTRSKLLDWSKRSHIIAGIARGLLYLHQ-DSRLRIIHRDLKASNVL 651 (836)
Q Consensus 579 ~g~~~~~~~~~lV~Ey~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~DLkp~NIL 651 (836)
++++.+.+..++||||+++++|.++ +.. .....+++..+..++.||+.||.|||+ .+ |+||||||+||+
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil 184 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNIL 184 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEE
Confidence 9999999999999999999999988 422 224679999999999999999999998 77 999999999999
Q ss_pred ecCCCCceeeccCcccccCCCccccccccccccccccCcccccCC-ccCc-cccccchhhhhhhhhhCCCCCCCCCCccc
Q 003254 652 LDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDG-LFSV-KSDVFSFGVLVLEIICGKKNRGFNHADHD 729 (836)
Q Consensus 652 l~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~-ksDVwS~GvvL~elltG~~p~~~~~~~~~ 729 (836)
++.++.+||+|||++...... ......|++.|+|||.+.+. .++. ++||||||++++||++|+.|+......
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-- 258 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL-- 258 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS--
T ss_pred EcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH--
Confidence 999999999999999876432 23346789999999999887 6766 999999999999999999997643321
Q ss_pred cchhhhhHHhhhccCch------hhcccccc---CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 730 HNLLGHAWRLWIEERPL------ELIDQSLD---NSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 730 ~~~~~~~~~~~~~~~~~------~~~d~~l~---~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
... .......... ....+... ..........+.+++.+||+.||++|||+.|+++
T Consensus 259 ~~~----~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 259 VEL----FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp HHH----HHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHH----HHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111 1111111000 00000000 0001122346789999999999999999999987
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=347.46 Aligned_cols=252 Identities=25% Similarity=0.314 Sum_probs=200.1
Q ss_pred hcccccccCeecccCceeEEEEEee-cCcEEEEEEecCC--CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEE
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 591 (836)
..++|.+.+.||+|+||.||+++.. +++.||||++... .....+.+.+|+.++++++||||+++++++......++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 3468999999999999999999986 4899999998643 223457889999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEec---CCCCceeeccCcccc
Q 003254 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD---NTMNPKISDFGLARS 668 (836)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~---~~~~~kl~DFgla~~ 668 (836)
|||+++++|.+.+... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||+++.
T Consensus 100 ~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 100 GELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 9999999999888543 46899999999999999999999998 99999999999995 566899999999987
Q ss_pred cCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhh
Q 003254 669 FGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLEL 748 (836)
Q Consensus 669 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (836)
+.... ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||...... ... ......... .
T Consensus 174 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~----~~i~~~~~~-~ 241 (486)
T 3mwu_A 174 FQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY---DIL----KRVETGKYA-F 241 (486)
T ss_dssp BCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH----HHHHHTCCC-S
T ss_pred CCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHH----HHHHhCCCC-C
Confidence 64322 2234579999999999875 5899999999999999999999997532211 111 111111000 0
Q ss_pred ccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 749 IDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 749 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
.. .........+.+++.+||+.+|++|||+.|+++.
T Consensus 242 ~~-----~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 242 DL-----PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp CS-----GGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred CC-----cccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 0001122457799999999999999999999974
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-36 Score=333.44 Aligned_cols=262 Identities=24% Similarity=0.298 Sum_probs=191.0
Q ss_pred cccccccCeecccCceeEEEEEee-cCcEEEEEEecCC--CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCC------
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD------ 586 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------ 586 (836)
.++|+..+.||+|+||.||++... .++.||||++... .....+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 468999999999999999999975 4889999999754 2344567889999999999999999999997655
Q ss_pred eeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcc
Q 003254 587 ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLA 666 (836)
Q Consensus 587 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla 666 (836)
..++||||+++ +|.+.+. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred ceEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence 67999999985 6777763 34889999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchh-------------
Q 003254 667 RSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLL------------- 733 (836)
Q Consensus 667 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~------------- 733 (836)
+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||............
T Consensus 175 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 251 (371)
T 2xrw_A 175 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK 251 (371)
T ss_dssp ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHT
T ss_pred ccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 8754221 223357899999999999999999999999999999999999997543221100000
Q ss_pred --hhhHHhhhccCc-------hhhccccccCCC---ChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 734 --GHAWRLWIEERP-------LELIDQSLDNSC---SFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 734 --~~~~~~~~~~~~-------~~~~d~~l~~~~---~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
......+....+ .+.......... .......+.+|+.+||+.||++|||+.|+++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 252 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp TSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 000000000000 000000000000 11224568899999999999999999999873
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=360.53 Aligned_cols=249 Identities=26% Similarity=0.338 Sum_probs=203.1
Q ss_pred hcccccccCeecccCceeEEEEEeec-CcEEEEEEecCC---CchhHHHHHHHHHHHHhh-cCCceeeEEeEEeeCCeee
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDERM 589 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~ 589 (836)
..++|+..+.||+|+||.||+++... ++.||||++.+. .....+.+..|..++..+ +||+|+++++++...+..+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 34689999999999999999999865 788999998753 233456788899999987 7999999999999999999
Q ss_pred EEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCccccc
Q 003254 590 LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (836)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~ 669 (836)
|||||+++|+|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++..
T Consensus 419 lV~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEEeCcCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 999999999999998543 46899999999999999999999998 999999999999999999999999999864
Q ss_pred CCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhc
Q 003254 670 GLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELI 749 (836)
Q Consensus 670 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (836)
.... .......||+.|+|||++.+..++.++|||||||+||||++|+.||...... . ..........
T Consensus 493 ~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~---~----~~~~i~~~~~---- 559 (674)
T 3pfq_A 493 IWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---E----LFQSIMEHNV---- 559 (674)
T ss_dssp CCTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH---H----HHHHHHSSCC----
T ss_pred ccCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH---H----HHHHHHhCCC----
Confidence 3222 2234578999999999999999999999999999999999999997532211 1 1111111110
Q ss_pred cccccCCCChHHHHHHHHHHHHcccCCCCCCCCH-----HHHHH
Q 003254 750 DQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNM-----SSVVL 788 (836)
Q Consensus 750 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~-----~eVl~ 788 (836)
.++......+.+|+.+||+.||++||++ .||++
T Consensus 560 ------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 560 ------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp ------CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred ------CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 1112233467899999999999999997 77764
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-36 Score=325.24 Aligned_cols=264 Identities=21% Similarity=0.318 Sum_probs=193.7
Q ss_pred cccccccCeecccCceeEEEEEeec-CcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEe-----------
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCT----------- 583 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~----------- 583 (836)
.++|...+.||+|+||.||+|+... ++.||||++........+++.+|+.++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 4689999999999999999999865 8999999998777677788999999999999999999999873
Q ss_pred ---eCCeeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEec-CCCCce
Q 003254 584 ---QRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD-NTMNPK 659 (836)
Q Consensus 584 ---~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~-~~~~~k 659 (836)
+....++||||++ |+|.+++. ...+++..+..++.||++||+|||+.+ |+||||||+|||++ +++.+|
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLE----QGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhh----cCCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence 3467899999998 68988883 356899999999999999999999998 99999999999997 577999
Q ss_pred eeccCcccccCCCcc-ccccccccccccccCcccccC-CccCccccccchhhhhhhhhhCCCCCCCCCCccccchhh---
Q 003254 660 ISDFGLARSFGLDQT-EANTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLG--- 734 (836)
Q Consensus 660 l~DFgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~--- 734 (836)
|+|||+++....... ........++..|+|||.+.+ ..++.++||||||+++|||++|+.||.............
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 241 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESI 241 (320)
T ss_dssp ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHS
T ss_pred EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 999999987643221 112233567899999998875 678999999999999999999999976432211000000
Q ss_pred -----hhHHhhhccCchhhcccccc-CCCC-----hHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 735 -----HAWRLWIEERPLELIDQSLD-NSCS-----FSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 735 -----~~~~~~~~~~~~~~~d~~l~-~~~~-----~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
..+.......+ ..+..... ...+ ......+.+++.+||+.||++|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 242 PVVHEEDRQELLSVIP-VYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp CCCCHHHHHHHHTTSC-HHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CCCchhhhhhhhhcCc-ccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 00000000000 00000000 0000 112345789999999999999999999986
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-36 Score=327.55 Aligned_cols=252 Identities=21% Similarity=0.318 Sum_probs=194.3
Q ss_pred hcccccccCeecccCceeEEEEEeec-CcEEEEEEecCCC--------chhHHHHHHHHHHHHhhcCCceeeEEeEEeeC
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS--------GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR 585 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~--------~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~ 585 (836)
..++|.+.+.||+|+||.||+++... ++.||||++.... ......+.+|+.++++++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 34689999999999999999999865 7899999986532 12234688999999999999999999998765
Q ss_pred CeeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCC---ceeec
Q 003254 586 DERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMN---PKISD 662 (836)
Q Consensus 586 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~---~kl~D 662 (836)
. .++||||+++++|.+++. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++. +||+|
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp S-EEEEEECCTTEETHHHHS---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECC
T ss_pred c-eEEEEecCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEcc
Confidence 4 899999999999999884 3456899999999999999999999998 999999999999987654 99999
Q ss_pred cCcccccCCCccccccccccccccccCccccc---CCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHh
Q 003254 663 FGLARSFGLDQTEANTKRVVGTYGYMSPEYAI---DGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRL 739 (836)
Q Consensus 663 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~ 739 (836)
||+++...... ......||+.|+|||++. ...++.++||||||+++|||++|+.|+....... .+...
T Consensus 161 fg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~---- 231 (322)
T 2ycf_A 161 FGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQ---- 231 (322)
T ss_dssp CTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS--CHHHH----
T ss_pred Cccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH--HHHHH----
Confidence 99998764321 122356899999999974 5678999999999999999999999975432221 11111
Q ss_pred hhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 740 WIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 740 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
...... ... +.... .....+.+++.+||+.||++|||+.|+++
T Consensus 232 ~~~~~~-~~~-~~~~~----~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 232 ITSGKY-NFI-PEVWA----EVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HHHTCC-CCC-HHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHhCcc-ccC-chhhh----hcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 010100 000 00000 11245789999999999999999999884
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-36 Score=346.57 Aligned_cols=251 Identities=26% Similarity=0.371 Sum_probs=198.3
Q ss_pred hcccccccCeecccCceeEEEEEeec-CcEEEEEEecCCCc-------------hhHHHHHHHHHHHHhhcCCceeeEEe
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSG-------------QGMEEFKNEVLLIAKLQHRNLVKLLG 580 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~-------------~~~~~~~~Ei~~l~~l~H~niv~l~g 580 (836)
..++|.+.++||+|+||.||+++... ++.||||++..... ...+.+.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 45789999999999999999999865 78999999865421 33567899999999999999999999
Q ss_pred EEeeCCeeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCC---C
Q 003254 581 CCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTM---N 657 (836)
Q Consensus 581 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~---~ 657 (836)
++......++||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINR---HKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCcc
Confidence 999999999999999999999888543 46899999999999999999999998 99999999999998765 6
Q ss_pred ceeeccCcccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhH
Q 003254 658 PKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAW 737 (836)
Q Consensus 658 ~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~ 737 (836)
+||+|||++..+.... ......||+.|+|||++. +.++.++||||+||++|+|++|+.||...... .. .
T Consensus 188 ~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~----~ 256 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ---DI----I 256 (504)
T ss_dssp EEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH----H
T ss_pred EEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH---HH----H
Confidence 9999999998764332 223457999999999986 56899999999999999999999997542221 11 1
Q ss_pred HhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 738 RLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 738 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
......... ....... .....+.+++.+||+.||++|||+.|+++
T Consensus 257 ~~i~~~~~~--~~~~~~~----~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 257 KKVEKGKYY--FDFNDWK----NISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp HHHHHCCCC--CCHHHHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHcCCCC--CCccccC----CCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 111111100 0000000 11245789999999999999999999986
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-37 Score=333.37 Aligned_cols=262 Identities=25% Similarity=0.356 Sum_probs=199.8
Q ss_pred HHhhcccccccCeecccCceeEEEEEeecCcEEEEEEecCCC--chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeee
Q 003254 512 IANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERM 589 (836)
Q Consensus 512 l~~a~~~f~~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 589 (836)
.....++|+..+.||+|+||.||+|+... .+|+|++.... ....+.+.+|+.++++++||||+++++++...+..+
T Consensus 28 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 105 (319)
T 2y4i_B 28 WDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLA 105 (319)
T ss_dssp SSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEE
T ss_pred ccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceE
Confidence 33445789999999999999999998743 59999986542 334467889999999999999999999999999999
Q ss_pred EEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCccccc
Q 003254 590 LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (836)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~ 669 (836)
+||||+++++|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++ ++.+||+|||++...
T Consensus 106 iv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~ 179 (319)
T 2y4i_B 106 IITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSIS 179 (319)
T ss_dssp EECBCCCSEEHHHHTTS--SCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC--
T ss_pred EEeecccCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCcccc
Confidence 99999999999999843 2346899999999999999999999998 99999999999998 679999999998765
Q ss_pred CCCc---cccccccccccccccCcccccC---------CccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhH
Q 003254 670 GLDQ---TEANTKRVVGTYGYMSPEYAID---------GLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAW 737 (836)
Q Consensus 670 ~~~~---~~~~~~~~~gt~~y~aPE~~~~---------~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~ 737 (836)
.... .........|++.|+|||.+.+ ..++.++||||||+++|||++|+.|+...... . ..
T Consensus 180 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~-~~ 252 (319)
T 2y4i_B 180 GVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE------A-II 252 (319)
T ss_dssp --------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH------H-HH
T ss_pred ccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------H-HH
Confidence 3221 1122233568999999999874 45789999999999999999999997532211 0 11
Q ss_pred HhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCCCC
Q 003254 738 RLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSL 796 (836)
Q Consensus 738 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~~ 796 (836)
............. ......+.+++.+||+.+|++|||+.+|+++|+.+...
T Consensus 253 ~~~~~~~~~~~~~--------~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~ 303 (319)
T 2y4i_B 253 WQMGTGMKPNLSQ--------IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303 (319)
T ss_dssp HHHHTTCCCCCCC--------SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred HHhccCCCCCCCc--------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 1111111111100 01123477999999999999999999999999998543
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-36 Score=329.84 Aligned_cols=268 Identities=20% Similarity=0.248 Sum_probs=190.1
Q ss_pred HHHhhcccccccCeecccCceeEEEEEee-cCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCe--
Q 003254 511 IIANATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDE-- 587 (836)
Q Consensus 511 ~l~~a~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~-- 587 (836)
......++|++.+.||+|+||.||+|+.. +|+.||||++.... .....+.+|+..+..++||||+++++++.....
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 34556689999999999999999999985 48999999986543 334566788889999999999999999976443
Q ss_pred -----eeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhh--cCCCCcEEeccCCCCceEecC-CCCce
Q 003254 588 -----RMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLH--QDSRLRIIHRDLKASNVLLDN-TMNPK 659 (836)
Q Consensus 588 -----~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH--~~~~~~ivH~DLkp~NILl~~-~~~~k 659 (836)
.++||||++++.+..+.........+++..+..++.|++.||.||| +.+ |+||||||+|||++. ++.+|
T Consensus 96 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~k 172 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTLK 172 (360)
T ss_dssp TTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEEE
T ss_pred ccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcEE
Confidence 7899999987543333322344567889999999999999999999 777 999999999999996 89999
Q ss_pred eeccCcccccCCCccccccccccccccccCcccccCCc-cCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHH
Q 003254 660 ISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWR 738 (836)
Q Consensus 660 l~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~ 738 (836)
|+|||+++.+..... .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||....... ......+
T Consensus 173 l~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~---~~~~~~~ 246 (360)
T 3e3p_A 173 LCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAG---QLHEIVR 246 (360)
T ss_dssp ECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHH
T ss_pred EeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHH---HHHHHHH
Confidence 999999987643222 22357899999999987654 8999999999999999999999976432211 1111111
Q ss_pred hhhccCchhhccc-------------------cccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 739 LWIEERPLELIDQ-------------------SLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 739 ~~~~~~~~~~~d~-------------------~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
.. .....+.+.. .............+.+|+.+||+.||++|||+.|+++.
T Consensus 247 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 247 VL-GCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HH-CCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred Hc-CCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00 0000000000 00011122245678899999999999999999999863
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=348.12 Aligned_cols=251 Identities=26% Similarity=0.323 Sum_probs=202.3
Q ss_pred hcccccccCeecccCceeEEEEEee-cCcEEEEEEecCCC---chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeE
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 590 (836)
..++|+..+.||+|+||.||+++.. .|+.||||++.... ....+.+.+|+.++++++||||+++++++......++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 3467999999999999999999986 58999999986542 3456789999999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEe---cCCCCceeeccCccc
Q 003254 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLL---DNTMNPKISDFGLAR 667 (836)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl---~~~~~~kl~DFgla~ 667 (836)
||||+.+|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||++.
T Consensus 104 v~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 104 VGEVYTGGELFDEIIS---RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp EECCCCSCBHHHHHHT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred EEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 9999999999988853 356899999999999999999999998 9999999999999 567899999999998
Q ss_pred ccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchh
Q 003254 668 SFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLE 747 (836)
Q Consensus 668 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (836)
.+.... ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||...... .. ..........
T Consensus 178 ~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~----~~~i~~~~~~- 245 (484)
T 3nyv_A 178 HFEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY---DI----LKKVEKGKYT- 245 (484)
T ss_dssp HBCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH----HHHHHHCCCC-
T ss_pred Eccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH---HH----HHHHHcCCCC-
Confidence 764322 2233579999999999876 6899999999999999999999997532211 11 1111111100
Q ss_pred hccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 748 LIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 748 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
... .........+.+++.+||+.+|++|||+.|+++
T Consensus 246 ~~~-----~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 246 FEL-----PQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp CCS-----GGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCC-----cccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 000 000112345779999999999999999999986
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=334.12 Aligned_cols=262 Identities=21% Similarity=0.314 Sum_probs=199.8
Q ss_pred hcccccccCeecccCceeEEEEEee-cCcEEEEEEecCCC-chhHHHHHHHHHHHHhhcCCceeeEEeEEeeC-----Ce
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR-----DE 587 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~ 587 (836)
..++|+..+.||+|+||.||++... +++.||||++.... ....+.+.+|+.++.+++||||+++++++... ..
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 3568999999999999999999975 47889999997543 33457789999999999999999999999655 35
Q ss_pred eeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCccc
Q 003254 588 RMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667 (836)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~ 667 (836)
.++||||+++ +|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 105 ~~iv~e~~~~-~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 176 (364)
T 3qyz_A 105 VYIVQDLMET-DLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLAR 176 (364)
T ss_dssp EEEEEECCSE-EHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEcccCc-CHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceE
Confidence 8999999984 88888743 35899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCcccc-ccccccccccccCcccccCC-ccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCc
Q 003254 668 SFGLDQTEA-NTKRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERP 745 (836)
Q Consensus 668 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (836)
......... ......||+.|+|||++.+. .++.++||||||+++|||++|+.||......+. ......... ...
T Consensus 177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~~i~~~~~-~~~ 252 (364)
T 3qyz_A 177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ---LNHILGILG-SPS 252 (364)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGH---HHHHHHHHC-SCC
T ss_pred ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHH---HHHHHHHhC-CCC
Confidence 765332221 12345799999999987654 589999999999999999999999854332211 111111000 000
Q ss_pred hhhcc------------ccc-cCCCC-----hHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 746 LELID------------QSL-DNSCS-----FSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 746 ~~~~d------------~~l-~~~~~-----~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
.+.+. ... ..... ......+.+++.+||+.||++|||+.|+++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 253 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000 000 00000 112245789999999999999999999987
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=336.96 Aligned_cols=199 Identities=22% Similarity=0.302 Sum_probs=171.9
Q ss_pred hcccccccCeecccCceeEEEEEeec-CcEEEEEEecCCCchhHHHHHHHHHHHHhh------cCCceeeEEeEEeeCCe
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKL------QHRNLVKLLGCCTQRDE 587 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l------~H~niv~l~g~~~~~~~ 587 (836)
...+|++.+.||+|+||.||+|.... ++.||||++... ....+++.+|+.++..+ +|+||+++++++.....
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 34679999999999999999998765 889999999653 34456788899999888 46799999999999999
Q ss_pred eeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCC--ceeeccCc
Q 003254 588 RMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMN--PKISDFGL 665 (836)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~--~kl~DFgl 665 (836)
.++||||+. ++|.+++... ....+++..+..++.||+.||+|||+.+ |+||||||+||||+.++. +||+|||+
T Consensus 174 ~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 174 ICMTFELLS-MNLYELIKKN-KFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp EEEEECCCC-CBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred EEEEEeccC-CCHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeeccc
Confidence 999999996 5888888543 2345899999999999999999999998 999999999999999887 99999999
Q ss_pred ccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCC
Q 003254 666 ARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (836)
Q Consensus 666 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~ 724 (836)
+..... ......||+.|+|||++.+..++.++|||||||+||||++|+.||...
T Consensus 249 a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 249 SCYEHQ-----RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp CEETTC-----CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ceecCC-----cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 976432 122357899999999999999999999999999999999999997543
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=341.33 Aligned_cols=258 Identities=21% Similarity=0.279 Sum_probs=191.3
Q ss_pred ccccccCeecccCceeEEEEEeec-CcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCC------eee
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD------ERM 589 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------~~~ 589 (836)
.+|+..+.||+|+||.||+|++.. |+.||||++.... +.+.+|++++++++||||+++++++.... ..+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 468888999999999999999864 8999999986543 22347999999999999999999985422 267
Q ss_pred EEEeecCCCChhHHHhhc-cCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCC-CCceeeccCccc
Q 003254 590 LIYEYLPNKSLDYFIFDT-TRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNT-MNPKISDFGLAR 667 (836)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~-~~~kl~DFgla~ 667 (836)
+||||+++ +|...+... .....+++..+..++.||++||+|||+.+ |+||||||+||||+.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 99999986 555555332 33467999999999999999999999998 9999999999999955 568999999998
Q ss_pred ccCCCccccccccccccccccCcccccCC-ccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhcc---
Q 003254 668 SFGLDQTEANTKRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEE--- 743 (836)
Q Consensus 668 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~--- 743 (836)
.+..... .....||+.|+|||++.+. .++.++|||||||+||||++|+.||......+ .+ ..........
T Consensus 206 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~--~l-~~i~~~lg~p~~~ 279 (420)
T 1j1b_A 206 QLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QL-VEIIKVLGTPTRE 279 (420)
T ss_dssp ECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HH-HHHHHHHCSCCHH
T ss_pred hcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HH-HHHHHHhCCCCHH
Confidence 7643222 2235789999999999765 79999999999999999999999976432211 11 1111100000
Q ss_pred -------CchhhccccccC-----CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 744 -------RPLELIDQSLDN-----SCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 744 -------~~~~~~d~~l~~-----~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
...+...+.+.. .+.......+.+|+.+||+.||++|||+.|+++
T Consensus 280 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 280 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 000000000000 011122356889999999999999999999985
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=322.72 Aligned_cols=259 Identities=20% Similarity=0.269 Sum_probs=202.2
Q ss_pred hcccccccCeecccCceeEEEEEe-e-cCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCc------eeeEEeEEeeCC
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGML-I-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRN------LVKLLGCCTQRD 586 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~-~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~n------iv~l~g~~~~~~ 586 (836)
..++|++.+.||+|+||.||++.. . +++.||||++... ....+.+.+|+.++..++|++ ++++++++...+
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~ 90 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG 90 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence 346899999999999999999987 3 5889999999643 344577899999999997665 999999999999
Q ss_pred eeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecC------------
Q 003254 587 ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN------------ 654 (836)
Q Consensus 587 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~------------ 654 (836)
..++||||+ +++|.+++... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.
T Consensus 91 ~~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~ 165 (339)
T 1z57_A 91 HICIVFELL-GLSTYDFIKEN-GFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIK 165 (339)
T ss_dssp EEEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----
T ss_pred cEEEEEcCC-CCCHHHHHHhc-CCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCccc
Confidence 999999999 88998888543 2346889999999999999999999998 999999999999987
Q ss_pred -------CCCceeeccCcccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCc
Q 003254 655 -------TMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHAD 727 (836)
Q Consensus 655 -------~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~ 727 (836)
++.+||+|||++...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||......
T Consensus 166 ~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 240 (339)
T 1z57_A 166 RDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK 240 (339)
T ss_dssp CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred cccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence 678999999999864321 23357899999999999999999999999999999999999998643321
Q ss_pred cccchhhhhHHhhhccCchhhc------------------------------cccc-cCCCChHHHHHHHHHHHHcccCC
Q 003254 728 HDHNLLGHAWRLWIEERPLELI------------------------------DQSL-DNSCSFSEALRCIQVGLLCVQQR 776 (836)
Q Consensus 728 ~~~~~~~~~~~~~~~~~~~~~~------------------------------d~~l-~~~~~~~~~~~l~~li~~Cl~~d 776 (836)
..... ........+..+. .+.. ...........+.+++.+||+.|
T Consensus 241 ~~~~~----~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 316 (339)
T 1z57_A 241 EHLAM----MERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYD 316 (339)
T ss_dssp HHHHH----HHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSS
T ss_pred HHHHH----HHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcC
Confidence 11100 0000111010000 0000 01123345667899999999999
Q ss_pred CCCCCCHHHHHH
Q 003254 777 PEDRPNMSSVVL 788 (836)
Q Consensus 777 P~~RPt~~eVl~ 788 (836)
|++|||+.||++
T Consensus 317 P~~Rpt~~ell~ 328 (339)
T 1z57_A 317 PAKRITLREALK 328 (339)
T ss_dssp TTTSCCHHHHTT
T ss_pred cccccCHHHHhc
Confidence 999999999975
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-36 Score=321.24 Aligned_cols=252 Identities=23% Similarity=0.368 Sum_probs=191.7
Q ss_pred cccccccCeecccCceeEEEEEee-cCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEee----------
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQ---------- 584 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~---------- 584 (836)
.++|+..+.||+|+||.||+|+.. +++.||||++... ....+.+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 468999999999999999999975 5899999998643 3445788999999999999999999998865
Q ss_pred ---CCeeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceee
Q 003254 585 ---RDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKIS 661 (836)
Q Consensus 585 ---~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~ 661 (836)
....++||||+++++|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHS--ENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHH--SCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEEC
T ss_pred cccCCceEEEEecCCCCCHHHhhhc--cccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEe
Confidence 3567999999999999999964 2346788899999999999999999998 9999999999999999999999
Q ss_pred ccCcccccCCCcc------------ccccccccccccccCcccccCC-ccCccccccchhhhhhhhhhCCCCCCCCCCcc
Q 003254 662 DFGLARSFGLDQT------------EANTKRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIICGKKNRGFNHADH 728 (836)
Q Consensus 662 DFgla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~ 728 (836)
|||++........ ........|++.|+|||.+.+. .++.++||||||+++|||++ |+.. ...
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~--~~~ 233 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFST--GME 233 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSS--HHH
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCC--chh
Confidence 9999987643211 1122345689999999999864 68999999999999999998 3211 000
Q ss_pred ccchhhhhHHhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 729 DHNLLGHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
.. ......... ...+....+......+.+++.+||+.||++|||+.|+++
T Consensus 234 ~~----~~~~~~~~~------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 234 RV----NILKKLRSV------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HH----HHHHHHHST------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HH----HHHHhcccc------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 00 011111110 011111223334456789999999999999999999987
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=336.37 Aligned_cols=262 Identities=21% Similarity=0.271 Sum_probs=194.4
Q ss_pred HhhcccccccCeecccCceeEEEEEee-cCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeC------
Q 003254 513 ANATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR------ 585 (836)
Q Consensus 513 ~~a~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------ 585 (836)
+...++|+..+.||+|+||.||+|+.. +|+.||||++..... ...+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 445678999999999999999999974 589999999865432 234799999999999999999998443
Q ss_pred --------------------------------CeeeEEEeecCCCChhHHHhhc-cCCCcCChhhhHHHHHHHHhhhHhh
Q 003254 586 --------------------------------DERMLIYEYLPNKSLDYFIFDT-TRSKLLDWSKRSHIIAGIARGLLYL 632 (836)
Q Consensus 586 --------------------------------~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yL 632 (836)
...++||||++ ++|.+.+... .....+++..+..++.||++||+||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 33789999998 4777777542 3346799999999999999999999
Q ss_pred hcCCCCcEEeccCCCCceEec-CCCCceeeccCcccccCCCccccccccccccccccCcccccCC-ccCccccccchhhh
Q 003254 633 HQDSRLRIIHRDLKASNVLLD-NTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVL 710 (836)
Q Consensus 633 H~~~~~~ivH~DLkp~NILl~-~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~Gvv 710 (836)
|+.+ |+||||||+|||++ +++.+||+|||+++.+..... .....+|+.|+|||.+.+. .++.++||||+||+
T Consensus 158 H~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 158 HSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp HTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred HHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 9998 99999999999998 688999999999987643322 2235789999999998875 48999999999999
Q ss_pred hhhhhhCCCCCCCCCCccccchhhhhHHhhhccCch----------hhccccc-----cCCCChHHHHHHHHHHHHcccC
Q 003254 711 VLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPL----------ELIDQSL-----DNSCSFSEALRCIQVGLLCVQQ 775 (836)
Q Consensus 711 L~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~d~~l-----~~~~~~~~~~~l~~li~~Cl~~ 775 (836)
+|||++|+.||......+. .............. +..-+.. ....+......+.+|+.+||+.
T Consensus 232 l~ell~g~~pf~~~~~~~~---~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 308 (383)
T 3eb0_A 232 FGELILGKPLFSGETSIDQ---LVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRY 308 (383)
T ss_dssp HHHHHHSSCSSCCSSHHHH---HHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCS
T ss_pred HHHHHhCCCCCCCCChHHH---HHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccC
Confidence 9999999999764322111 11111100000000 0000000 0001122334578999999999
Q ss_pred CCCCCCCHHHHHH
Q 003254 776 RPEDRPNMSSVVL 788 (836)
Q Consensus 776 dP~~RPt~~eVl~ 788 (836)
||++|||+.|+++
T Consensus 309 dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 309 EPDLRINPYEAMA 321 (383)
T ss_dssp SGGGSCCHHHHHT
T ss_pred ChhhCCCHHHHhc
Confidence 9999999999984
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-36 Score=324.98 Aligned_cols=264 Identities=23% Similarity=0.335 Sum_probs=199.8
Q ss_pred hhcccccccCeecccCceeEEEEEee--cCcEEEEEEecCCC--chhHHHHHHHHHHHHhh---cCCceeeEEeEEe---
Q 003254 514 NATDNFSEKNKLGEGGFGPVYKGMLI--EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKL---QHRNLVKLLGCCT--- 583 (836)
Q Consensus 514 ~a~~~f~~~~~lG~G~fG~Vykg~~~--~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~--- 583 (836)
.+.++|+..+.||+|+||.||+++.. +|+.||||++.... ......+.+|+.+++.+ +||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 45688999999999999999999983 57899999986432 22234677888888777 7999999999987
Q ss_pred --eCCeeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceee
Q 003254 584 --QRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKIS 661 (836)
Q Consensus 584 --~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~ 661 (836)
.....++||||++ |+|.+++... ....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHS-CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEe
Confidence 5567899999998 6998888543 2345899999999999999999999998 9999999999999999999999
Q ss_pred ccCcccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhh
Q 003254 662 DFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWI 741 (836)
Q Consensus 662 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 741 (836)
|||+++...... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||....... ..........
T Consensus 163 Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~ 236 (326)
T 1blx_A 163 DFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGKILDVIG 236 (326)
T ss_dssp SCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHC
T ss_pred cCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH---HHHHHHHHcC
Confidence 999998754222 2234678999999999999999999999999999999999999976432211 1111111000
Q ss_pred ccCc----------hhhccccc---cCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 742 EERP----------LELIDQSL---DNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 742 ~~~~----------~~~~d~~l---~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
.... ........ ...........+.+++.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 237 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp CCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000 00000000 00111122345779999999999999999999985
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-36 Score=332.95 Aligned_cols=258 Identities=25% Similarity=0.367 Sum_probs=183.0
Q ss_pred hcccccccCeecccCceeEEEEEee-cCcEEEEEEecCC--CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeC------
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR------ 585 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------ 585 (836)
..++|+..+.||+|+||.||+|... +|+.||||++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 3478999999999999999999975 4889999998654 234556788999999999999999999998654
Q ss_pred CeeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCc
Q 003254 586 DERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGL 665 (836)
Q Consensus 586 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgl 665 (836)
...++|+||+ +++|.+++.. ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CCCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC---
T ss_pred CeEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeeccc
Confidence 5579999998 6789888732 46899999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCccccccccccccccccCcccccC-CccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccC
Q 003254 666 ARSFGLDQTEANTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEER 744 (836)
Q Consensus 666 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 744 (836)
++..... .....||+.|+|||++.+ ..++.++|||||||+++||++|+.||........ .....+. ....
T Consensus 179 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---l~~i~~~-~g~p 249 (367)
T 2fst_X 179 ARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ---LKLILRL-VGTP 249 (367)
T ss_dssp -----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHH-HCSC
T ss_pred ccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHH-hCCC
Confidence 9865321 233678999999999987 6789999999999999999999999754322111 1111110 0000
Q ss_pred chhhccc-----------ccc--CCCCh-----HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 745 PLELIDQ-----------SLD--NSCSF-----SEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 745 ~~~~~d~-----------~l~--~~~~~-----~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
..+.+.. .+. ..... .....+.+|+.+||+.||++|||+.|+++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 250 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp CHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 0010000 000 00111 112457899999999999999999999874
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=326.99 Aligned_cols=263 Identities=22% Similarity=0.276 Sum_probs=197.6
Q ss_pred hcccccccCeecccCceeEEEEEee-cCcEEEEEEecCCC-chhHHHHHHHHHHHHhhcCCceeeEEeEEeeC-----Ce
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR-----DE 587 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~ 587 (836)
..++|...+.||+|+||.||+|+.. +|+.||||++.... ......+.+|+.++++++||||+++++++... ..
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 4578999999999999999999986 48899999996543 33456788999999999999999999998664 66
Q ss_pred eeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCccc
Q 003254 588 RMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667 (836)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~ 667 (836)
.++||||+. ++|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 89 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp EEEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 899999997 588888743 46899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCcccc--------ccccccccccccCcccccC-CccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHH
Q 003254 668 SFGLDQTEA--------NTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWR 738 (836)
Q Consensus 668 ~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~ 738 (836)
.+....... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||......... .....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~~~~~ 237 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQL---LLIFG 237 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHH
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH---HHHHH
Confidence 764322111 1223578999999998765 67899999999999999999999997643211100 00000
Q ss_pred hhhccC------------chhhcccccc-CCC-----ChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 739 LWIEER------------PLELIDQSLD-NSC-----SFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 739 ~~~~~~------------~~~~~d~~l~-~~~-----~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
...... ..+.+..... ... .......+.+++.+||+.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp HHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000000 0000000000 000 0112345789999999999999999999987
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-36 Score=356.61 Aligned_cols=258 Identities=24% Similarity=0.306 Sum_probs=202.9
Q ss_pred HhhcccccccCeecccCceeEEEEEeec----CcEEEEEEecCCC-chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCe
Q 003254 513 ANATDNFSEKNKLGEGGFGPVYKGMLIE----GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDE 587 (836)
Q Consensus 513 ~~a~~~f~~~~~lG~G~fG~Vykg~~~~----g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 587 (836)
....++|+..+.||+|+||.||+|++.. +..||||++.... ....+.+.+|+.++++++||||+++++++. .+.
T Consensus 386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~ 464 (656)
T 2j0j_A 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP 464 (656)
T ss_dssp BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSS
T ss_pred ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCc
Confidence 3445789999999999999999999743 4579999987543 344578999999999999999999999985 466
Q ss_pred eeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCccc
Q 003254 588 RMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667 (836)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~ 667 (836)
.++||||+++|+|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 465 ~~lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~ 539 (656)
T 2j0j_A 465 VWIIMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSR 539 (656)
T ss_dssp CEEEEECCTTCBHHHHHHHT--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred eEEEEEcCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCe
Confidence 89999999999999998542 346899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhccCch
Q 003254 668 SFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEERPL 746 (836)
Q Consensus 668 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (836)
....... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... ... ........
T Consensus 540 ~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~---~~~----~~i~~~~~- 610 (656)
T 2j0j_A 540 YMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVI----GRIENGER- 610 (656)
T ss_dssp SCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHH----HHHHHTCC-
T ss_pred ecCCCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH---HHH----HHHHcCCC-
Confidence 7643222 12223456789999999998899999999999999999997 88887532211 111 11111110
Q ss_pred hhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 003254 747 ELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 793 (836)
Q Consensus 747 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 793 (836)
...+......+.+++.+||+.||++|||+.||++.|+.+
T Consensus 611 --------~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i 649 (656)
T 2j0j_A 611 --------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649 (656)
T ss_dssp --------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --------CCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 011222335678999999999999999999999999865
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-35 Score=326.03 Aligned_cols=266 Identities=23% Similarity=0.322 Sum_probs=201.2
Q ss_pred cccccccCeecccCceeEEEEEee-cCcEEEEEEecCCCchhHHHHHHHHHHHHhhc-----------CCceeeEEeEEe
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQ-----------HRNLVKLLGCCT 583 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-----------H~niv~l~g~~~ 583 (836)
.++|...+.||+|+||.||+|+.. +++.||||++... ....+.+.+|+.++.+++ |+||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 368999999999999999999974 5889999999643 334567889999999886 899999999997
Q ss_pred eCC----eeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcC-CCCcEEeccCCCCceEec-----
Q 003254 584 QRD----ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQD-SRLRIIHRDLKASNVLLD----- 653 (836)
Q Consensus 584 ~~~----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~DLkp~NILl~----- 653 (836)
..+ ..++||||+ +++|.+++... ....+++..+..++.||+.||+|||++ + |+||||||+|||++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKY-EHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHh-hccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence 654 689999999 88999988653 234589999999999999999999998 7 99999999999994
Q ss_pred -CCCCceeeccCcccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCcccc--
Q 003254 654 -NTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDH-- 730 (836)
Q Consensus 654 -~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~-- 730 (836)
..+.+||+|||++...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||.........
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 246 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246 (373)
T ss_dssp TTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred cCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence 4458999999999875422 22357899999999999999999999999999999999999998643322111
Q ss_pred -chhhhhHHhhhccCchhhc----------c-----------------ccc--cCCCChHHHHHHHHHHHHcccCCCCCC
Q 003254 731 -NLLGHAWRLWIEERPLELI----------D-----------------QSL--DNSCSFSEALRCIQVGLLCVQQRPEDR 780 (836)
Q Consensus 731 -~~~~~~~~~~~~~~~~~~~----------d-----------------~~l--~~~~~~~~~~~l~~li~~Cl~~dP~~R 780 (836)
......... ....+..+. . ..+ ....+......+.+|+.+||+.||++|
T Consensus 247 ~~~~~~~~~~-~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 325 (373)
T 1q8y_A 247 DDHIAQIIEL-LGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR 325 (373)
T ss_dssp HHHHHHHHHH-HCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred HHHHHHHHHh-cCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcccc
Confidence 001111000 000000000 0 000 112345566788999999999999999
Q ss_pred CCHHHHHH--HhcCC
Q 003254 781 PNMSSVVL--MLSGE 793 (836)
Q Consensus 781 Pt~~eVl~--~L~~~ 793 (836)
||+.||++ .+.+.
T Consensus 326 pt~~ell~hp~f~~~ 340 (373)
T 1q8y_A 326 ADAGGLVNHPWLKDT 340 (373)
T ss_dssp BCHHHHHTCGGGTTC
T ss_pred CCHHHHhhChhhhcc
Confidence 99999987 44443
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=335.36 Aligned_cols=203 Identities=25% Similarity=0.392 Sum_probs=155.0
Q ss_pred cccccc-cCeecccCceeEEEEEee---cCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEee--CCeee
Q 003254 516 TDNFSE-KNKLGEGGFGPVYKGMLI---EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQ--RDERM 589 (836)
Q Consensus 516 ~~~f~~-~~~lG~G~fG~Vykg~~~---~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~ 589 (836)
.+.|++ .++||+|+||.||+|+.. +++.||||++.... ..+.+.+|+.++++++||||+++++++.. ....+
T Consensus 19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (405)
T 3rgf_A 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVW 96 (405)
T ss_dssp HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence 345665 457999999999999975 47889999996543 23578899999999999999999999954 66789
Q ss_pred EEEeecCCCChhHHHhhcc------CCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEe----cCCCCce
Q 003254 590 LIYEYLPNKSLDYFIFDTT------RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLL----DNTMNPK 659 (836)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl----~~~~~~k 659 (836)
+||||+++ +|.+++.... ....+++..+..++.||+.||+|||+.+ |+||||||+|||| ++++.+|
T Consensus 97 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~k 172 (405)
T 3rgf_A 97 LLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVK 172 (405)
T ss_dssp EEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEE
T ss_pred EEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEE
Confidence 99999975 6766664321 1235899999999999999999999998 9999999999999 7789999
Q ss_pred eeccCcccccCCCcc-ccccccccccccccCcccccCC-ccCccccccchhhhhhhhhhCCCCCCCC
Q 003254 660 ISDFGLARSFGLDQT-EANTKRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (836)
Q Consensus 660 l~DFgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~GvvL~elltG~~p~~~~ 724 (836)
|+|||+++.+..... ........||+.|+|||++.+. .++.++|||||||+||||++|+.||...
T Consensus 173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 239 (405)
T 3rgf_A 173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 239 (405)
T ss_dssp ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence 999999987653221 1223346789999999999874 5899999999999999999999998643
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=327.89 Aligned_cols=257 Identities=21% Similarity=0.314 Sum_probs=195.0
Q ss_pred hcccccccCeecccCceeEEEEEeec-CcEEEEEEecCCC--chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCee---
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDER--- 588 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~--- 588 (836)
..++|...+.||+|+||.||+|.... |+.||||++.... ....+.+.+|+.+++.++||||+++++++...+..
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 34688899999999999999999754 8899999997643 33457889999999999999999999999877665
Q ss_pred ---eEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCc
Q 003254 589 ---MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGL 665 (836)
Q Consensus 589 ---~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgl 665 (836)
++||||+. ++|.+.+ ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 120 ~~~~lv~e~~~-~~l~~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIM-----GMEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCCEEEEECCC-EEHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eeEEEEEcccc-ccHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCc
Confidence 99999998 5777766 234899999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCccccccccccccccccCcccccC-CccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccC
Q 003254 666 ARSFGLDQTEANTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEER 744 (836)
Q Consensus 666 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 744 (836)
++..... .....||+.|+|||++.+ ..++.++||||||++++||++|+.||......+ ........ ....
T Consensus 191 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~~~-~~~~ 261 (371)
T 4exu_A 191 ARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD---QLTQILKV-TGVP 261 (371)
T ss_dssp C-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHH-HCCC
T ss_pred ccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHH-hCCC
Confidence 9865322 233578999999999987 679999999999999999999999975432111 11100000 0000
Q ss_pred chhhcc------------ccccC-CC-----ChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 745 PLELID------------QSLDN-SC-----SFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 745 ~~~~~d------------~~l~~-~~-----~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
..+... ..... .. .......+.+|+.+||+.||++|||+.|+++.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 262 GTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp CHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred cHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 000000 00000 00 01123567899999999999999999999864
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-35 Score=325.58 Aligned_cols=205 Identities=24% Similarity=0.318 Sum_probs=172.6
Q ss_pred HHHhhcccccccCeecccCceeEEEEEeec-CcEEEEEEecCCCchhHHHHHHHHHHHHhhc-CC-----ceeeEEeEEe
Q 003254 511 IIANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQ-HR-----NLVKLLGCCT 583 (836)
Q Consensus 511 ~l~~a~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~-----niv~l~g~~~ 583 (836)
......++|+..+.||+|+||.||+|+... ++.||||++... ....+++..|+.++..++ |+ +++++++++.
T Consensus 48 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~ 126 (382)
T 2vx3_A 48 NGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM 126 (382)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE
T ss_pred cCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec
Confidence 334556899999999999999999999764 788999999643 344567888999999885 55 4999999999
Q ss_pred eCCeeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEec--CCCCceee
Q 003254 584 QRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD--NTMNPKIS 661 (836)
Q Consensus 584 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~--~~~~~kl~ 661 (836)
..+..++||||++ ++|.+++.... ...+++..+..++.||+.||.|||.+. .+|+||||||+||||+ .++.+||+
T Consensus 127 ~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll~~~~~~~~kL~ 203 (382)
T 2vx3_A 127 FRNHLCLVFEMLS-YNLYDLLRNTN-FRGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNPKRSAIKIV 203 (382)
T ss_dssp ETTEEEEEEECCC-CBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEESSTTSCCEEEC
T ss_pred cCCceEEEEecCC-CCHHHHHhhcC-cCCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEEecCCCCcEEEE
Confidence 9999999999996 49988886432 345899999999999999999999531 2399999999999994 57889999
Q ss_pred ccCcccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCC
Q 003254 662 DFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (836)
Q Consensus 662 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~ 724 (836)
|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 204 DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 204 DFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp CCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999876422 22367899999999999999999999999999999999999998643
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=323.63 Aligned_cols=255 Identities=24% Similarity=0.353 Sum_probs=177.8
Q ss_pred cccccccCeecccCceeEEEEEee-cCcEEEEEEecCCC-chhHHHHHHHHH-HHHhhcCCceeeEEeEEeeCCeeeEEE
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS-GQGMEEFKNEVL-LIAKLQHRNLVKLLGCCTQRDERMLIY 592 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~-~l~~l~H~niv~l~g~~~~~~~~~lV~ 592 (836)
.++|+..+.||+|+||.||++... +|+.||||++.... .....++..|+. +++.++||||+++++++...+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 368888999999999999999985 48899999997653 233445666666 677789999999999999999999999
Q ss_pred eecCCCChhHHHhhc--cCCCcCChhhhHHHHHHHHhhhHhhhcC-CCCcEEeccCCCCceEecCCCCceeeccCccccc
Q 003254 593 EYLPNKSLDYFIFDT--TRSKLLDWSKRSHIIAGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (836)
Q Consensus 593 Ey~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~ 669 (836)
||+++ +|.+++... .....+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||+++..
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99986 777776431 1246789999999999999999999998 7 999999999999999999999999999876
Q ss_pred CCCccccccccccccccccCcccc----cCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCc
Q 003254 670 GLDQTEANTKRVVGTYGYMSPEYA----IDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERP 745 (836)
Q Consensus 670 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (836)
.... ......|++.|+|||.+ .+..++.++||||||+++|||++|+.|+......... .........
T Consensus 177 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~------~~~~~~~~~ 247 (327)
T 3aln_A 177 VDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ------LTQVVKGDP 247 (327)
T ss_dssp --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------CCCCCSCC
T ss_pred cccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH------HHHHhcCCC
Confidence 4322 12234689999999998 4567899999999999999999999997532211000 000000100
Q ss_pred hhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 746 LELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 746 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
. .+...........+.+++.+||+.||++|||+.||++
T Consensus 248 ~-----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 248 P-----QLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp C-----CCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred C-----CCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 0 0111111122346789999999999999999999865
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-35 Score=322.03 Aligned_cols=258 Identities=20% Similarity=0.225 Sum_probs=174.4
Q ss_pred hcccccccC-eecccCceeEEEEEee-cCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEee----CCee
Q 003254 515 ATDNFSEKN-KLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQ----RDER 588 (836)
Q Consensus 515 a~~~f~~~~-~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~ 588 (836)
..++|.+.+ .||+|+||.||+++.. +|+.||||++.... ....+....+..++||||+++++++.. ....
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 346788854 6999999999999986 48999999986532 222223334566789999999999876 4458
Q ss_pred eEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecC---CCCceeeccCc
Q 003254 589 MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---TMNPKISDFGL 665 (836)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~---~~~~kl~DFgl 665 (836)
++||||+++|+|.+++... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 102 ~lv~e~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQER-GDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecccc
Confidence 9999999999999999643 2346899999999999999999999998 999999999999976 45599999999
Q ss_pred ccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCc
Q 003254 666 ARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERP 745 (836)
Q Consensus 666 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (836)
++..... ......+|+.|+|||++.+..++.++||||||+++|||++|+.|+........... ........
T Consensus 178 ~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~---~~~~~~~~-- 248 (336)
T 3fhr_A 178 AKETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG---MKRRIRLG-- 248 (336)
T ss_dssp CEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------
T ss_pred ceecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh---HHHhhhcc--
Confidence 9865322 22335789999999999999999999999999999999999999754332211000 00000000
Q ss_pred hhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HhcCC
Q 003254 746 LELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL--MLSGE 793 (836)
Q Consensus 746 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~--~L~~~ 793 (836)
...............+.+++.+||+.||++|||+.|+++ .+.+.
T Consensus 249 ----~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 249 ----QYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp ------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred ----ccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 000000111122345789999999999999999999998 44443
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=316.20 Aligned_cols=252 Identities=25% Similarity=0.311 Sum_probs=200.1
Q ss_pred hhcccccccCeecccCceeEEEEEee-cCcEEEEEEecCCC--chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeE
Q 003254 514 NATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (836)
Q Consensus 514 ~a~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 590 (836)
...++|++.+.||+|+||.||+++.. +++.||||++.... ....+.+.+|+.++++++||||+++++++......++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 34578999999999999999999986 58999999986542 3456789999999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCC---CCceeeccCccc
Q 003254 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNT---MNPKISDFGLAR 667 (836)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~---~~~kl~DFgla~ 667 (836)
|+||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.+ +.+||+|||++.
T Consensus 99 v~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~ 172 (287)
T 2wei_A 99 VGELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (287)
T ss_dssp EECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred EEEccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcce
Confidence 99999999998888543 45899999999999999999999998 9999999999999754 479999999998
Q ss_pred ccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchh
Q 003254 668 SFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLE 747 (836)
Q Consensus 668 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (836)
...... ......+++.|+|||.+.+ .++.++||||||+++++|++|+.|+...... . ...........
T Consensus 173 ~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~----~~~~~~~~~~~- 240 (287)
T 2wei_A 173 CFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY---D----ILKRVETGKYA- 240 (287)
T ss_dssp TBCCCS---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---H----HHHHHHHCCCC-
T ss_pred eecCCC---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH---H----HHHHHHcCCCC-
Confidence 764322 1223468899999998875 4899999999999999999999997532211 1 11111111100
Q ss_pred hccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 748 LIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 748 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
...+. .......+.+++.+||+.+|++|||+.|+++
T Consensus 241 ~~~~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 241 FDLPQ-----WRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp CCSGG-----GTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCchh-----hhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 00000 0111245779999999999999999999987
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=326.21 Aligned_cols=255 Identities=22% Similarity=0.317 Sum_probs=194.1
Q ss_pred cccccccCeecccCceeEEEEEeec-CcEEEEEEecCCC--chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCe-----
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDE----- 587 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~----- 587 (836)
.++|...+.||+|+||.||+|+... |+.||||++.... ....+.+.+|+.+++.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 4678999999999999999999854 8999999996542 3345678999999999999999999999987654
Q ss_pred -eeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcc
Q 003254 588 -RMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLA 666 (836)
Q Consensus 588 -~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla 666 (836)
.++||||++ ++|.+++. ..+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred eEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccc
Confidence 499999998 58877662 34899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCcccccC-CccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCc
Q 003254 667 RSFGLDQTEANTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERP 745 (836)
Q Consensus 667 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (836)
+..... .....+|+.|+|||.+.+ ..++.++||||||++++||++|+.||....... ......... ....
T Consensus 174 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~---~~~~i~~~~-~~~~ 244 (353)
T 3coi_A 174 RHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD---QLTQILKVT-GVPG 244 (353)
T ss_dssp TC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH---HHHHHHHHH-CBCC
T ss_pred cCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHh-CCCC
Confidence 864321 223578999999999887 678999999999999999999999975432111 111110000 0000
Q ss_pred hhh------------cc---cccc---CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 746 LEL------------ID---QSLD---NSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 746 ~~~------------~d---~~l~---~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
.+. +. .... ..........+.+++.+||+.||++|||+.|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 245 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp HHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000 00 0000 0111223456789999999999999999999986
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-35 Score=332.72 Aligned_cols=253 Identities=24% Similarity=0.292 Sum_probs=185.9
Q ss_pred ccccccCeecccCceeEEEEEeecCcEEEEEEecCCCchhHHHHHHHHHHHHhh-cCCceeeEEeEEeeCCeeeEEEeec
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDERMLIYEYL 595 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~ 595 (836)
+.|...+.||+|+||+||.+...+|+.||||++... ..+.+.+|+.++.++ +||||+++++++...+..++||||+
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 344556789999999998766667999999998653 345678999999987 8999999999999999999999999
Q ss_pred CCCChhHHHhhccCCC----cCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCC-------------CCc
Q 003254 596 PNKSLDYFIFDTTRSK----LLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNT-------------MNP 658 (836)
Q Consensus 596 ~~gsL~~~l~~~~~~~----~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~-------------~~~ 658 (836)
. |+|.+++....... ..++..+..++.||+.||+|||+.+ |+||||||+|||++.+ +.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEE
Confidence 6 69999986532211 1244567889999999999999998 9999999999999654 489
Q ss_pred eeeccCcccccCCCcccc--ccccccccccccCcccccC-------CccCccccccchhhhhhhhhh-CCCCCCCCCCcc
Q 003254 659 KISDFGLARSFGLDQTEA--NTKRVVGTYGYMSPEYAID-------GLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADH 728 (836)
Q Consensus 659 kl~DFgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~ 728 (836)
||+|||+++.+....... ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.|+.......
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~ 247 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence 999999999875432211 1234579999999999975 668999999999999999999 898875322211
Q ss_pred ccchhhhhHHhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 729 DHNLLGHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
. . ...... .. +.+...........+.+++.+||+.||++|||+.||++
T Consensus 248 -----~---~-i~~~~~-~~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 248 -----S---N-IIRGIF-SL--DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp -----H---H-HHHTCC-CC--CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----H---H-HhcCCC-Cc--ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 0 0 000000 00 00111123344567889999999999999999999985
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=318.62 Aligned_cols=259 Identities=19% Similarity=0.272 Sum_probs=199.0
Q ss_pred hcccccccCeecccCceeEEEEEeec-C-cEEEEEEecCCCchhHHHHHHHHHHHHhhcCCc------eeeEEeEEeeCC
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-G-QEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRN------LVKLLGCCTQRD 586 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~~-g-~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~n------iv~l~g~~~~~~ 586 (836)
..++|++.+.||+|+||.||++.... + +.||||++... ....+.+.+|+.++++++|++ ++.+++++...+
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 95 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG 95 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence 34789999999999999999999753 4 68999999643 344577889999999998766 999999999999
Q ss_pred eeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEe--------------
Q 003254 587 ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLL-------------- 652 (836)
Q Consensus 587 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl-------------- 652 (836)
..++||||+ +++|.+++... ....+++..+..++.||+.||+|||+.+ |+||||||+|||+
T Consensus 96 ~~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~ 170 (355)
T 2eu9_A 96 HMCIAFELL-GKNTFEFLKEN-NFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKS 170 (355)
T ss_dssp EEEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred eEEEEEecc-CCChHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccccccccccc
Confidence 999999999 55666666432 2346899999999999999999999998 9999999999999
Q ss_pred -----cCCCCceeeccCcccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCc
Q 003254 653 -----DNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHAD 727 (836)
Q Consensus 653 -----~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~ 727 (836)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||......
T Consensus 171 ~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 245 (355)
T 2eu9_A 171 CEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR 245 (355)
T ss_dssp CCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred ccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence 56889999999999864321 22357899999999999999999999999999999999999998643321
Q ss_pred cccchhhhhHHhhhccCchhhccc------------------------------c-ccCCCChHHHHHHHHHHHHcccCC
Q 003254 728 HDHNLLGHAWRLWIEERPLELIDQ------------------------------S-LDNSCSFSEALRCIQVGLLCVQQR 776 (836)
Q Consensus 728 ~~~~~~~~~~~~~~~~~~~~~~d~------------------------------~-l~~~~~~~~~~~l~~li~~Cl~~d 776 (836)
... ... .......+..+... . ........+...+.+|+.+||+.|
T Consensus 246 ~~~---~~~-~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 321 (355)
T 2eu9_A 246 EHL---VMM-EKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFD 321 (355)
T ss_dssp HHH---HHH-HHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSS
T ss_pred HHH---HHH-HHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCC
Confidence 110 000 00011111100000 0 000112234557889999999999
Q ss_pred CCCCCCHHHHHH
Q 003254 777 PEDRPNMSSVVL 788 (836)
Q Consensus 777 P~~RPt~~eVl~ 788 (836)
|++|||+.|+++
T Consensus 322 P~~Rpt~~e~l~ 333 (355)
T 2eu9_A 322 PAQRITLAEALL 333 (355)
T ss_dssp TTTSCCHHHHTT
T ss_pred hhhCcCHHHHhc
Confidence 999999999974
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=322.52 Aligned_cols=244 Identities=23% Similarity=0.419 Sum_probs=189.7
Q ss_pred HHhhcccccccCeecccCceeEEEEEee-cCcEEEEEEecCCCc------hhHHHHHHHHHHHHhh----cCCceeeEEe
Q 003254 512 IANATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSG------QGMEEFKNEVLLIAKL----QHRNLVKLLG 580 (836)
Q Consensus 512 l~~a~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~~------~~~~~~~~Ei~~l~~l----~H~niv~l~g 580 (836)
.....++|...+.||+|+||.||+|+.. +++.||||++..... .....+.+|+.++.++ +|+||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 3445678999999999999999999875 488999999965532 1234567799999999 8999999999
Q ss_pred EEeeCCeeeEEEee-cCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEec-CCCCc
Q 003254 581 CCTQRDERMLIYEY-LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD-NTMNP 658 (836)
Q Consensus 581 ~~~~~~~~~lV~Ey-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~-~~~~~ 658 (836)
++...+..++|+|| +.+++|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+||+++ +++.+
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~ 179 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITE---KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCA 179 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEE
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeE
Confidence 99999999999999 789999999854 345899999999999999999999998 99999999999999 88999
Q ss_pred eeeccCcccccCCCccccccccccccccccCcccccCCcc-CccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhH
Q 003254 659 KISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLF-SVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAW 737 (836)
Q Consensus 659 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~ 737 (836)
||+|||++....... .....|+..|+|||++.+..+ +.++||||||+++|||++|+.|+.... .
T Consensus 180 kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----~------ 244 (312)
T 2iwi_A 180 KLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-----E------ 244 (312)
T ss_dssp EECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----H------
T ss_pred EEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-----H------
Confidence 999999998764322 233568999999999987666 458999999999999999999974210 0
Q ss_pred HhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 738 RLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 738 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
.... .. .........+.+++.+||+.+|++|||+.|+++
T Consensus 245 --~~~~--------~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 245 --ILEA--------EL--HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp --HHHT--------CC--CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred --Hhhh--------cc--CCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 00 011122345779999999999999999999987
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-36 Score=324.74 Aligned_cols=243 Identities=24% Similarity=0.391 Sum_probs=197.5
Q ss_pred HhhcccccccCeecccCceeEEEEEee-cCcEEEEEEecCCCc------hhHHHHHHHHHHHHhhc--CCceeeEEeEEe
Q 003254 513 ANATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSG------QGMEEFKNEVLLIAKLQ--HRNLVKLLGCCT 583 (836)
Q Consensus 513 ~~a~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~~------~~~~~~~~Ei~~l~~l~--H~niv~l~g~~~ 583 (836)
....++|+..+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+.++++++ |+||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 445678999999999999999999874 488999999865422 12356778999999996 599999999999
Q ss_pred eCCeeeEEEeecCC-CChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEec-CCCCceee
Q 003254 584 QRDERMLIYEYLPN-KSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD-NTMNPKIS 661 (836)
Q Consensus 584 ~~~~~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~-~~~~~kl~ 661 (836)
..+..++|+||+.+ ++|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||++ +++.+||+
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~ 192 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLI 192 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEEC
T ss_pred cCCcEEEEEEcCCCCccHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEe
Confidence 99999999999986 899999854 346899999999999999999999998 99999999999999 78999999
Q ss_pred ccCcccccCCCccccccccccccccccCcccccCCcc-CccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhh
Q 003254 662 DFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLF-SVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLW 740 (836)
Q Consensus 662 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~ 740 (836)
|||+++..... ......||+.|+|||++.+..+ +.++||||||+++|||++|+.|+.... . .
T Consensus 193 Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-----~--------~ 255 (320)
T 3a99_A 193 DFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----E--------I 255 (320)
T ss_dssp CCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----H--------H
T ss_pred eCccccccccc----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-----h--------h
Confidence 99999876432 1223568999999999987665 788999999999999999999974210 0 0
Q ss_pred hccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 741 IEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 741 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
..... .... .....+.+++.+||+.||++|||+.||++
T Consensus 256 ~~~~~------~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 256 IRGQV------FFRQ----RVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp HHCCC------CCSS----CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hcccc------cccc----cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000 0011 12245779999999999999999999987
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-35 Score=315.59 Aligned_cols=252 Identities=20% Similarity=0.341 Sum_probs=178.5
Q ss_pred hcccccccCeecccCceeEEEEEee-cCcEEEEEEecCCCch--hHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEE
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQ--GMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 591 (836)
..++|+..+.||+|+||.||+++.. +|+.||||++...... ..+.+.++..+++.++||||+++++++...+..++|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv 102 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA 102 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence 3467888999999999999999986 5899999999765322 233445555678888999999999999999999999
Q ss_pred EeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcC-CCCcEEeccCCCCceEecCCCCceeeccCcccccC
Q 003254 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (836)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~ 670 (836)
|||+ ++.+..+... ....+++..+..++.||++||.|||+. + |+||||||+||+++.++.+||+|||++..+.
T Consensus 103 ~e~~-~~~~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 103 MELM-GTCAEKLKKR--MQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp ECCC-SEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred Eecc-CCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 9999 4455444422 245689999999999999999999985 7 9999999999999999999999999997654
Q ss_pred CCccccccccccccccccCccccc-----CCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCc
Q 003254 671 LDQTEANTKRVVGTYGYMSPEYAI-----DGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERP 745 (836)
Q Consensus 671 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (836)
... ......+++.|+|||++. ...++.++||||||+++|||++|+.|+...... .. ..........
T Consensus 177 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~----~~~~~~~~~~ 247 (318)
T 2dyl_A 177 DDK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD--FE----VLTKVLQEEP 247 (318)
T ss_dssp -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH--HH----HHHHHHHSCC
T ss_pred CCc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc--HH----HHHHHhccCC
Confidence 322 122356899999999984 556889999999999999999999997532211 01 1111111111
Q ss_pred hhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 746 LELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 746 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
... .. .......+.+++.+||+.||++||++.|+++
T Consensus 248 ~~~-----~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 248 PLL-----PG--HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp CCC-----CS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCC-----Cc--cCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 100 00 0112245779999999999999999999976
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=328.01 Aligned_cols=252 Identities=22% Similarity=0.324 Sum_probs=187.4
Q ss_pred hhcccccccCeecccCceeEEEEEeecCcEEEEEEecCCCchhHHHHHHHHHHHHhh-cCCceeeEEeEEeeCCeeeEEE
Q 003254 514 NATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDERMLIY 592 (836)
Q Consensus 514 ~a~~~f~~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 592 (836)
....+|...+.||+|+||.|+.....+|+.||||++.... ...+.+|+.+++++ +||||+++++++.+....++||
T Consensus 21 i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 97 (432)
T 3p23_A 21 VGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI 97 (432)
T ss_dssp ETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT---EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred EccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence 3446788899999999999665555579999999996543 23467899999999 7999999999999999999999
Q ss_pred eecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecC-----CCCceeeccCccc
Q 003254 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-----TMNPKISDFGLAR 667 (836)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~-----~~~~kl~DFgla~ 667 (836)
||+. |+|.+++... ...+....+..++.||+.||+|||+.+ |+||||||+|||++. ...+||+|||+++
T Consensus 98 E~~~-g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~ 171 (432)
T 3p23_A 98 ELCA-ATLQEYVEQK--DFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171 (432)
T ss_dssp ECCS-EEHHHHHHSS--SCCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEE
T ss_pred ECCC-CCHHHHHHhc--CCCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEeccccee
Confidence 9997 5898888543 234556677899999999999999998 999999999999943 3468899999998
Q ss_pred ccCCCcc-ccccccccccccccCccccc---CCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhc
Q 003254 668 SFGLDQT-EANTKRVVGTYGYMSPEYAI---DGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIE 742 (836)
Q Consensus 668 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 742 (836)
.+..... ........||+.|+|||++. ...++.++|||||||++|||++ |+.|++...... ......
T Consensus 172 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~--------~~~~~~ 243 (432)
T 3p23_A 172 KLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ--------ANILLG 243 (432)
T ss_dssp CC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH--------HHHHTT
T ss_pred eccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH--------HHHHhc
Confidence 7653322 12233467999999999997 4567889999999999999999 888874322110 011111
Q ss_pred cCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 743 ERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 743 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
....... .........+.+++.+||+.||++|||+.||++
T Consensus 244 ~~~~~~~------~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 244 ACSLDCL------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp CCCCTTS------CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cCCcccc------CccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 1111111 111233445789999999999999999999984
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=340.13 Aligned_cols=264 Identities=25% Similarity=0.319 Sum_probs=197.9
Q ss_pred cccccccCeecccCceeEEEEEeec-CcEEEEEEecCC-CchhHHHHHHHHHHHHhhcCCceeeEEeEEee------CCe
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQ------RDE 587 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~------~~~ 587 (836)
.++|++.+.||+|+||.||+|.... |+.||||++... .....+.+.+|+.++++++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 3789999999999999999999854 889999998764 34456779999999999999999999999765 667
Q ss_pred eeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCC---ceeeccC
Q 003254 588 RMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMN---PKISDFG 664 (836)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~---~kl~DFg 664 (836)
.++||||+++|+|.+++........+++..+..++.+|+.||+|||+.+ |+||||||+||+++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccc
Confidence 8999999999999999976555557999999999999999999999998 999999999999997665 9999999
Q ss_pred cccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCcccc--chhhhhHH-hhh
Q 003254 665 LARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDH--NLLGHAWR-LWI 741 (836)
Q Consensus 665 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~--~~~~~~~~-~~~ 741 (836)
++....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......... ........ ...
T Consensus 170 ~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~ 246 (676)
T 3qa8_A 170 YAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVV 246 (676)
T ss_dssp CCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCS
T ss_pred ccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhh
Confidence 998764332 223467899999999999999999999999999999999999997532110000 00000000 000
Q ss_pred ccCchh--hccccc--cCCCChHHHHHHHHHHHHcccCCCCCCCCHHH
Q 003254 742 EERPLE--LIDQSL--DNSCSFSEALRCIQVGLLCVQQRPEDRPNMSS 785 (836)
Q Consensus 742 ~~~~~~--~~d~~l--~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~e 785 (836)
...... .....+ ...........+.+++.+||+.||++|||+.|
T Consensus 247 ~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e 294 (676)
T 3qa8_A 247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ 294 (676)
T ss_dssp CCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred hhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence 000000 000000 11233445677899999999999999999966
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-34 Score=340.86 Aligned_cols=238 Identities=20% Similarity=0.307 Sum_probs=191.2
Q ss_pred cccccccCeecccCceeEEEEEee--cCcEEEEEEecCCC-chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCe-----
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLI--EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDE----- 587 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~--~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~----- 587 (836)
.++|++.+.||+|+||.||++.+. +|+.||||++.... ....+.+.+|+.++++++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 368999999999999999999986 48899999986543 3455678999999999999999999999987665
Q ss_pred eeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCccc
Q 003254 588 RMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667 (836)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~ 667 (836)
.+|||||+++++|.+++. ..+++.++..++.||+.||.|||+++ |+||||||+|||++++ .+||+|||+++
T Consensus 159 ~~lv~E~~~g~~L~~~~~-----~~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKG-----QKLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp EEEEEECCCCEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred eEEEEEeCCCCcHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccch
Confidence 699999999999988763 26899999999999999999999998 9999999999999986 99999999998
Q ss_pred ccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchh
Q 003254 668 SFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLE 747 (836)
Q Consensus 668 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (836)
..... ....||+.|+|||++.++. +.++|||||||+|+||++|..|+........ +
T Consensus 230 ~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~---------------~-- 285 (681)
T 2pzi_A 230 RINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL---------------P-- 285 (681)
T ss_dssp ETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC---------------C--
T ss_pred hcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc---------------c--
Confidence 75422 3357999999999987654 8999999999999999999877542111000 0
Q ss_pred hccccccCCCChHHHHHHHHHHHHcccCCCCCCCC-HHHHHHHhcC
Q 003254 748 LIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPN-MSSVVLMLSG 792 (836)
Q Consensus 748 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-~~eVl~~L~~ 792 (836)
...........+.+++.+||+.||++||+ +.++...|.+
T Consensus 286 ------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 286 ------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp ------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 00000112245779999999999999994 6666666654
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-33 Score=300.55 Aligned_cols=232 Identities=11% Similarity=0.077 Sum_probs=182.3
Q ss_pred cccccccCeecccCceeEEEEEeec-CcEEEEEEecCCC---chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEE
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 591 (836)
.++|++.+.||+|+||.||+|+... ++.||||++.... ....+.+.+|+.++.+++||||+++++++...+..++|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 3679999999999999999999865 8999999997653 23457899999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCC
Q 003254 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (836)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~ 671 (836)
|||+++++|.+++.. + ....++.+++.||+.||+|||+++ |+||||||+|||+++++.+||++++
T Consensus 110 ~e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~------- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA------- 174 (286)
T ss_dssp EECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred EEecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc-------
Confidence 999999999999832 2 345578899999999999999998 9999999999999999999998543
Q ss_pred CccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccc
Q 003254 672 DQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQ 751 (836)
Q Consensus 672 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 751 (836)
|++| ++.++||||||++||||++|+.||............. .... ...... .
T Consensus 175 ---------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~---~~~~-~~~~~~--~ 226 (286)
T 3uqc_A 175 ---------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE---RDTA-GQPIEP--A 226 (286)
T ss_dssp ---------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC---BCTT-SCBCCH--H
T ss_pred ---------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH---HHhc-cCCCCh--h
Confidence 3333 5889999999999999999999986543322110000 0000 000000 0
Q ss_pred cccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCCC
Q 003254 752 SLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS 795 (836)
Q Consensus 752 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~ 795 (836)
.+. ......+.+++.+||+.||++| |+.|+++.|+....
T Consensus 227 ~~~----~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~ 265 (286)
T 3uqc_A 227 DID----RDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA 265 (286)
T ss_dssp HHC----TTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred hcc----cCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence 000 1122457899999999999999 99999999987643
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-33 Score=298.49 Aligned_cols=227 Identities=21% Similarity=0.262 Sum_probs=176.6
Q ss_pred ccccccc-CeecccCceeEEEEEee-cCcEEEEEEecCCCchhHHHHHHHHHHH-HhhcCCceeeEEeEEee----CCee
Q 003254 516 TDNFSEK-NKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLI-AKLQHRNLVKLLGCCTQ----RDER 588 (836)
Q Consensus 516 ~~~f~~~-~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l-~~l~H~niv~l~g~~~~----~~~~ 588 (836)
.++|... +.||+|+||.||++... +++.||+|++.. ...+.+|+.++ +..+||||+++++++.. ....
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 3567666 67999999999999985 488999999854 24677888888 55589999999999977 6778
Q ss_pred eEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecC---CCCceeeccCc
Q 003254 589 MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---TMNPKISDFGL 665 (836)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~---~~~~kl~DFgl 665 (836)
++||||+++++|.+++... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 91 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEEECCCCSCBHHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 9999999999999999653 2346899999999999999999999998 999999999999997 78999999999
Q ss_pred ccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCc
Q 003254 666 ARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERP 745 (836)
Q Consensus 666 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (836)
+.... +..++.++||||||+++|||++|+.||........... ..
T Consensus 167 a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~-----------~~ 211 (299)
T 3m2w_A 167 AKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG-----------MK 211 (299)
T ss_dssp CEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CC-----------SC
T ss_pred ccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHH-----------HH
Confidence 87532 23468899999999999999999999754322110000 00
Q ss_pred hhhccccccCCCC----hHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 746 LELIDQSLDNSCS----FSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 746 ~~~~d~~l~~~~~----~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
....... ...+ ......+.+++.+||+.||++|||+.|+++
T Consensus 212 ~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 212 TRIRMGQ--YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp CSSCTTC--CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHhhcc--ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0000000 0011 112345789999999999999999999997
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.98 E-value=3.1e-33 Score=315.75 Aligned_cols=242 Identities=17% Similarity=0.169 Sum_probs=178.5
Q ss_pred hcccccccCeecccCceeEEEEEee-cCcEEEEEEecCCC---chhHHHHHHHHHHHHhhcC-Ccee---------e---
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQH-RNLV---------K--- 577 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H-~niv---------~--- 577 (836)
..++|...+.||+|+||.||+|++. +|+.||||++.... ....+.+++|+.+++.++| +|.. .
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 4456778889999999999999965 48999999987432 2336789999999999987 2211 1
Q ss_pred ---------EEeEEee-----CCeeeEEEeecCCCChhHHHhhc----cCCCcCChhhhHHHHHHHHhhhHhhhcCCCCc
Q 003254 578 ---------LLGCCTQ-----RDERMLIYEYLPNKSLDYFIFDT----TRSKLLDWSKRSHIIAGIARGLLYLHQDSRLR 639 (836)
Q Consensus 578 ---------l~g~~~~-----~~~~~lV~Ey~~~gsL~~~l~~~----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 639 (836)
+..+... ....+++|+++ +++|.+++... .....+++..++.++.||++||+|||+++
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--- 231 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--- 231 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 1111111 12346666654 67898888421 23456888999999999999999999998
Q ss_pred EEeccCCCCceEecCCCCceeeccCcccccCCCccccccccccccccccCcccc----------cCCccCccccccchhh
Q 003254 640 IIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYA----------IDGLFSVKSDVFSFGV 709 (836)
Q Consensus 640 ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~t~ksDVwS~Gv 709 (836)
|+||||||+||||+.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||||
T Consensus 232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGv 305 (413)
T 3dzo_A 232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGL 305 (413)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHH
T ss_pred cccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHH
Confidence 999999999999999999999999999865322 333567 999999999 5667899999999999
Q ss_pred hhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 003254 710 LVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVV 787 (836)
Q Consensus 710 vL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl 787 (836)
++|||++|+.||........ .+..+.... .....+.+|+.+||+.||++||++.|++
T Consensus 306 il~elltg~~Pf~~~~~~~~-------------------~~~~~~~~~--~~~~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 306 AIYWIWCADLPNTDDAALGG-------------------SEWIFRSCK--NIPQPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp HHHHHHHSSCCCCTTGGGSC-------------------SGGGGSSCC--CCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred HHHHHHHCCCCCCCcchhhh-------------------HHHHHhhcc--cCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 99999999999754322111 111111110 1124578999999999999999976664
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.97 E-value=6e-33 Score=304.59 Aligned_cols=242 Identities=16% Similarity=0.142 Sum_probs=182.3
Q ss_pred cccccccCeecccCceeEEEEEeecCcEEEEEEecCCC--------chhHHHHHHHHHHHHhhc---------CCceeeE
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGS--------GQGMEEFKNEVLLIAKLQ---------HRNLVKL 578 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~--------~~~~~~~~~Ei~~l~~l~---------H~niv~l 578 (836)
.++|+..+.||+|+||.||+|+. +|+.||||++.... ....+.+.+|+.++++++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 46788999999999999999998 78999999997542 223478899999999986 7777777
Q ss_pred EeEEe------------------------------eCCeeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhh
Q 003254 579 LGCCT------------------------------QRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARG 628 (836)
Q Consensus 579 ~g~~~------------------------------~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~g 628 (836)
.+++. .....+|||||+++|++.+.+. ...+++..+..++.||+.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~----~~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR----TKLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT----TTCCCHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH----hcCCCHHHHHHHHHHHHHH
Confidence 77643 2678999999999997666652 2568999999999999999
Q ss_pred hHhhh-cCCCCcEEeccCCCCceEecCCC--------------------CceeeccCcccccCCCccccccccccccccc
Q 003254 629 LLYLH-QDSRLRIIHRDLKASNVLLDNTM--------------------NPKISDFGLARSFGLDQTEANTKRVVGTYGY 687 (836)
Q Consensus 629 L~yLH-~~~~~~ivH~DLkp~NILl~~~~--------------------~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y 687 (836)
|+||| +.+ |+||||||+||||+.++ .+||+|||+++.... ....||+.|
T Consensus 174 L~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y 243 (336)
T 2vuw_A 174 LAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVS 243 (336)
T ss_dssp HHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCT
T ss_pred HHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeecc
Confidence 99999 888 99999999999999887 899999999987532 135799999
Q ss_pred cCcccccCCccCccccccchhhh-hhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccccccCCCChHHHHHHH
Q 003254 688 MSPEYAIDGLFSVKSDVFSFGVL-VLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDNSCSFSEALRCI 766 (836)
Q Consensus 688 ~aPE~~~~~~~t~ksDVwS~Gvv-L~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 766 (836)
+|||++.+.. +.++||||++++ .+++++|..|+.. ................ ................+.
T Consensus 244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~------~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~s~~~~ 313 (336)
T 2vuw_A 244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN------VLWLHYLTDKMLKQMT---FKTKCNTPAMKQIKRKIQ 313 (336)
T ss_dssp TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH------HHHHHHHHHHHHHTCC---CSSCCCSHHHHHHHHHHH
T ss_pred cChhhhcCCC-ccceehhhhhCCCCcccccccCCCcc------hhhhhHHHHhhhhhhc---cCcccchhhhhhcCHHHH
Confidence 9999998776 899999998777 8889999888521 0000000001110000 000000011223456789
Q ss_pred HHHHHcccCCCCCCCCHHHHH
Q 003254 767 QVGLLCVQQRPEDRPNMSSVV 787 (836)
Q Consensus 767 ~li~~Cl~~dP~~RPt~~eVl 787 (836)
+|+.+||+.| |+.|++
T Consensus 314 dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 314 EFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHhccC-----CHHHHH
Confidence 9999999966 999988
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.7e-28 Score=282.61 Aligned_cols=184 Identities=17% Similarity=0.150 Sum_probs=130.8
Q ss_pred eecccCceeEEEEEee-cCcEEEEEEecCCC----------chhHHHHHHHHHHHHhh-cCCceeeEEeEEeeCCeeeEE
Q 003254 524 KLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS----------GQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDERMLI 591 (836)
Q Consensus 524 ~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~----------~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV 591 (836)
..+.|+.|.+.+++.. -|+.++||.+.+.. ....++|.+|+++|+++ .|+||+++++++++++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 4567777776665543 38899999986542 22346799999999999 699999999999999999999
Q ss_pred EeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCC
Q 003254 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (836)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~ 671 (836)
|||++|++|.++|.. .++++.. +|+.||+.||+|||+++ ||||||||+||||++++.+||+|||+|+....
T Consensus 321 MEyv~G~~L~d~i~~---~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 321 MEKLPGRLLSDMLAA---GEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp EECCCSEEHHHHHHT---TCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred EecCCCCcHHHHHHh---CCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 999999999999953 3455543 58999999999999999 99999999999999999999999999987643
Q ss_pred CccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCC
Q 003254 672 DQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKK 719 (836)
Q Consensus 672 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~ 719 (836)
... .....+||+.|+|||++.+ .+..++|+|++|++++++.++..
T Consensus 392 ~~~--~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 392 DCS--WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp --C--CSHHHHHHHHHHHHHHC------------------CCCCTTHH
T ss_pred CCc--cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccc
Confidence 322 2344789999999999875 46778999999999999977653
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=2.1e-24 Score=250.96 Aligned_cols=184 Identities=19% Similarity=0.192 Sum_probs=144.9
Q ss_pred cccCeecccCceeEEEEEeecCcEEEEEEecCCCc--------hhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEE
Q 003254 520 SEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSG--------QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (836)
Q Consensus 520 ~~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~--------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 591 (836)
...+.||+|+||.||++.. .++.+++|+...... ...+.+.+|++++++++||||+++..++...+..+||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 3456899999999999954 678899998644321 1234589999999999999999776666677888999
Q ss_pred EeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCC
Q 003254 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (836)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~ 671 (836)
|||+++++|.+++.. +..++.||++||+|||+++ |+||||||+|||+++ .+||+|||+++....
T Consensus 418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 999999999999843 5689999999999999998 999999999999999 999999999998754
Q ss_pred Ccccc-----ccccccccccccCcccccC--CccCccccccchhhhhhhhhhCCCC
Q 003254 672 DQTEA-----NTKRVVGTYGYMSPEYAID--GLFSVKSDVFSFGVLVLEIICGKKN 720 (836)
Q Consensus 672 ~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~t~ksDVwS~GvvL~elltG~~p 720 (836)
..... ......||+.|+|||++.. ..|+..+|+|+..+-.++-+.++.+
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~r 537 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRAR 537 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccc
Confidence 32211 1234689999999999987 5688899999999888888776654
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=1.4e-21 Score=208.47 Aligned_cols=153 Identities=19% Similarity=0.154 Sum_probs=122.6
Q ss_pred HHHHHhhcccccccCeecccCceeEEEEEeecCcEEEEEEecCCCc------------------hhHHHHHHHHHHHHhh
Q 003254 509 LKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSG------------------QGMEEFKNEVLLIAKL 570 (836)
Q Consensus 509 ~~~l~~a~~~f~~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~------------------~~~~~~~~Ei~~l~~l 570 (836)
+..+......|+..+.||+|+||.||+|...+|+.||||.++.... .....+.+|+.+++++
T Consensus 82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l 161 (282)
T 1zar_A 82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL 161 (282)
T ss_dssp HHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence 3444555667777899999999999999996699999999864321 1346789999999999
Q ss_pred cCCceeeEEeEEeeCCeeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCce
Q 003254 571 QHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNV 650 (836)
Q Consensus 571 ~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NI 650 (836)
+ | +++.+++.. +..++||||+++++|.+ + .......++.||+.||.|||+.+ |+||||||+||
T Consensus 162 ~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l---------~~~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NI 224 (282)
T 1zar_A 162 Q--G-LAVPKVYAW-EGNAVLMELIDAKELYR-V---------RVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNV 224 (282)
T ss_dssp T--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-C---------CCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSE
T ss_pred c--C-CCcCeEEec-cceEEEEEecCCCcHHH-c---------chhhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHE
Confidence 9 4 566665433 56799999999999977 4 12345579999999999999998 99999999999
Q ss_pred EecCCCCceeeccCcccccCCCccccccccccccccccCccccc
Q 003254 651 LLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAI 694 (836)
Q Consensus 651 Ll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 694 (836)
|++ ++.+||+|||+++. +..++|||++.
T Consensus 225 Ll~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~ 252 (282)
T 1zar_A 225 LVS-EEGIWIIDFPQSVE---------------VGEEGWREILE 252 (282)
T ss_dssp EEE-TTEEEECCCTTCEE---------------TTSTTHHHHHH
T ss_pred EEE-CCcEEEEECCCCeE---------------CCCCCHHHHHH
Confidence 999 99999999999874 23468888774
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.82 E-value=8.2e-20 Score=167.16 Aligned_cols=109 Identities=21% Similarity=0.323 Sum_probs=93.1
Q ss_pred ccccccCCCccccCCCeEE--eCCCeEEEeeecCCCCCceEEEEEEeecCCCcEEEeecCCCCCCCCcceEEEeeccCce
Q 003254 43 RTLDTISLGQSIKDGETLV--SAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPLSDRSGVLRINGERNGI 120 (836)
Q Consensus 43 ~~~~~i~~~~~l~~~~~l~--S~~g~F~lgF~~~~~~~~~ylgiw~~~~~~~t~vW~Anr~~p~~~~~~~l~~~~~~~g~ 120 (836)
++.|+|++||+|.+|++|+ |++|.|+|+|+.+|+ + +||++ +++||+||++.| +..+.|+|. +|||
T Consensus 6 ~~~~~l~~g~~L~~g~~l~~~S~~g~~~L~~~~dgn-----l-vly~~---~~~vW~sn~~~~--~~~~~l~l~--~dGN 72 (119)
T 1b2p_A 6 SKQPDDNHPQILHATESLEILFGTHVYRFIMQTDCN-----L-VLYDN---NNPIWATNTGGL--GNGCRAVLQ--PDGV 72 (119)
T ss_dssp CSCSSSCCCCEEETTCEEEEEETTEEEEEEECTTSC-----E-EEEET---TEEEEECCCTTS--CSSCEEEEC--TTSC
T ss_pred ecCcccCCCCEEcCCCEEEEeCCCCCEEEEEecCCC-----E-EEEEC---CEEEEeCCCccC--CCceEEEEc--cCCE
Confidence 4679999999999999999 999999999998775 2 57875 799999999877 334788887 8999
Q ss_pred EEEEcCCCCeEEeecccCCCCcceEEEecCCCeEEecCCCCCCCcceeeec
Q 003254 121 LVLLNSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDNILWQSF 171 (836)
Q Consensus 121 l~l~~~~~~~~wst~~~~~~~~~~a~lld~GNlvl~~~~~~~~~~~~WqSF 171 (836)
|||+|.++.++|+|++........++|+|+|||||++ .++|||=
T Consensus 73 LVl~d~~~~~lW~S~~~~~~g~~~l~l~~~Gnlvl~~-------~~~W~Sg 116 (119)
T 1b2p_A 73 LVVITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYG-------DALWATQ 116 (119)
T ss_dssp EEEECTTCCEEEECSCCCCSSCEEEEECTTSCEEEEE-------SEEEECC
T ss_pred EEEEeCCCcEEEcCCCCCCCCCEEEEEECCCcEEEEC-------ccEeCCC
Confidence 9999999999999996544455679999999999986 2699983
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=99.81 E-value=1.4e-19 Score=161.65 Aligned_cols=104 Identities=18% Similarity=0.396 Sum_probs=89.3
Q ss_pred cccCCCccccCCCeEEeCCCeEEEeeecCCCCCceEEEEEEeecCCCcEEEeecCCCCCCCCcceEEEeeccCceEEEEc
Q 003254 46 DTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPLSDRSGVLRINGERNGILVLLN 125 (836)
Q Consensus 46 ~~i~~~~~l~~~~~l~S~~g~F~lgF~~~~~~~~~ylgiw~~~~~~~t~vW~Anr~~p~~~~~~~l~~~~~~~g~l~l~~ 125 (836)
|+|.+||.|.+|++|+| |.|.|.|...++ |.++. ..++||+|||+.|..+. +.|++. .||+|||+|
T Consensus 2 n~L~~g~~L~~g~~L~s--g~y~l~~q~DgN-----Lvly~----~~~~vW~ant~~~~~~~-~~L~l~--~dGnLvL~d 67 (105)
T 4h3o_A 2 NILDNNEGLYAGQSLDV--EPYHFIMQDDCN-----LVLYD----HSTSTWASNTEIGGKSG-CSAVLQ--SDGNFVVYD 67 (105)
T ss_dssp CEECTTEEECTTCEEEE--TTEEEEECTTSC-----EEEEE----TTEEEEECCCCCTTCCS-CEEEEC--TTSCEEEEC
T ss_pred CCcCCCCEEcCCCEEEE--CCEEEEECCCCe-----EEEEE----CCEEEEEecCCCCCCcc-EEEEEe--CCccEEEEC
Confidence 78999999999999998 889999987765 66654 46899999999997653 578887 899999999
Q ss_pred CCCCeEEeecccCCCCcceEEEecCCCeEEecCCCCCCCcceeee
Q 003254 126 STNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDNILWQS 170 (836)
Q Consensus 126 ~~~~~~wst~~~~~~~~~~a~lld~GNlvl~~~~~~~~~~~~WqS 170 (836)
+++.+||+|+++......+|+|+|+|||||++. .||||
T Consensus 68 ~~~~~vWss~t~~~~~~~~l~L~ddGNlVly~~-------~~W~S 105 (105)
T 4h3o_A 68 SSGRSLWASHSTRGSGNYILILQDDGNVIIYGS-------DIWST 105 (105)
T ss_dssp TTCCEEEECCCCCCSSCEEEEECTTSCEEEEES-------EEEEC
T ss_pred CCcEEEEEecCCCCCCCEEEEEeCCCeEEEECC-------cEecC
Confidence 999999999976555667899999999999953 49998
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=2.4e-19 Score=161.94 Aligned_cols=110 Identities=22% Similarity=0.417 Sum_probs=93.1
Q ss_pred ccccCCCccccCCCeEEeCCCeEEEeeecCCCCCceEEEEEEeecCCCcEEEeecCCCCCCCCcceEEEeeccCceEEEE
Q 003254 45 LDTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPLSDRSGVLRINGERNGILVLL 124 (836)
Q Consensus 45 ~~~i~~~~~l~~~~~l~S~~g~F~lgF~~~~~~~~~ylgiw~~~~~~~t~vW~Anr~~p~~~~~~~l~~~~~~~g~l~l~ 124 (836)
.|+|.+||+|.+|++|+ ++|.|+|+|+..|+ | |+|+ .+++||.||++.|- ..+.++|. .||||||+
T Consensus 1 ~d~l~~g~~L~~g~~l~-~~~~~~l~~~~dGn-----l-vl~~---~~~~vW~sn~~~~~--~~~~l~l~--~dGNLVl~ 66 (110)
T 3a0c_A 1 VNSLSSPNSLFTGHSLE-VGPSYRLIMQGDCN-----F-VLYD---SGKPVWASNTGGLG--SGCRLTLH--NNGNLVIY 66 (110)
T ss_dssp CCEEETTCEECTTCEEE-ETTTEEEEECTTSC-----E-EEEE---TTEEEEECCCTTSC--SSCEEEEC--TTSCEEEE
T ss_pred CCEeCCCCEECCCCEEE-ECCCEEEEEcCCCc-----E-EEEE---CCEEEEECCCCCCC--CcEEEEEe--CCCCEEEE
Confidence 38999999999999999 99999999988775 2 6676 47999999998763 34678887 89999999
Q ss_pred cCCCCeEEeecccCCCCcceEEEecCCCeEEecCCCCCCCcceeeeccCCC
Q 003254 125 NSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDNILWQSFDYPC 175 (836)
Q Consensus 125 ~~~~~~~wst~~~~~~~~~~a~lld~GNlvl~~~~~~~~~~~~WqSFd~PT 175 (836)
|.++.++|+|++........++|+|+|||||++. ++||||+||.
T Consensus 67 ~~~~~~~W~S~t~~~~g~~~l~l~~dGnlvl~~~-------~~W~S~~~~~ 110 (110)
T 3a0c_A 67 DQSNRVIWQTKTNGKEDHYVLVLQQDRNVVIYGP-------VVWATGSGPA 110 (110)
T ss_dssp CTTCCEEEECCCCCSSSCCEEEECTTSCEEEECS-------EEEECSCCC-
T ss_pred CCCCcEEEecCCCCCCCCEEEEEeCCccEEEECC-------CEecCCCcCC
Confidence 9999999999976544455799999999999852 6999999983
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=1e-18 Score=159.39 Aligned_cols=110 Identities=24% Similarity=0.402 Sum_probs=91.8
Q ss_pred ccccCCCccccCCCeEEeCCCeEEEeeecCCCCCceEEEEEEeecCCCcEEEeecCCCCCCCCcceEEEeeccCceEEEE
Q 003254 45 LDTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPLSDRSGVLRINGERNGILVLL 124 (836)
Q Consensus 45 ~~~i~~~~~l~~~~~l~S~~g~F~lgF~~~~~~~~~ylgiw~~~~~~~t~vW~Anr~~p~~~~~~~l~~~~~~~g~l~l~ 124 (836)
.|||.+||+|.+|++|+ +|.|+|+|+.+++ + ++|+ ..++||+||++.|. ..+.|+|. ++|+|||+
T Consensus 2 ~dtl~~gq~L~~g~~L~--~g~~~L~~~~dgn-----l-vly~---~~~~vW~sn~~~~~--~~~~l~l~--~~GnLvl~ 66 (115)
T 2dpf_A 2 DNVLLSGQTLHADHSLQ--AGAYTLTIQNKCN-----L-VKYQ---NGRQIWASNTDRRG--SGCRLTLL--SDGNLVIY 66 (115)
T ss_dssp CCEEETTCEEETTEEEE--ETTEEEEECTTSC-----E-EEEE---TTEEEEECSCTTSC--SSCEEEEC--TTSCEEEE
T ss_pred CCEeCCCCEECCCCEEE--CCCEEEEEcCCCc-----E-EEEe---CCEEEEeCCCCCCC--CceEEEEC--CCCcEEEE
Confidence 58999999999999998 7999999987664 2 2365 47999999999883 35678887 89999999
Q ss_pred cCCCCeEEeecccCCCCcceEEEecCCCeEEecCCCCCCCcceeeeccCCCC
Q 003254 125 NSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDNILWQSFDYPCD 176 (836)
Q Consensus 125 ~~~~~~~wst~~~~~~~~~~a~lld~GNlvl~~~~~~~~~~~~WqSFd~PTD 176 (836)
|.++.++|++++........++|+|+|||||++. ++||||.+++.
T Consensus 67 d~~~~~vW~S~~~~~~g~~~l~l~~dGnlvl~~~-------~~W~S~~~~~~ 111 (115)
T 2dpf_A 67 DHNNNDVWGSACWGDNGKYALVLQKDGRFVIYGP-------VLWSLGPNGCR 111 (115)
T ss_dssp CTTCCEEEECCCCCSSSCCEEEECTTSCEEEECS-------EEECSSTTCBC
T ss_pred CCCceEEEEcCCCCCCCCEEEEEeCCCeEEEECC-------CEEECCCCCCc
Confidence 9989999999865444456799999999999842 69999998764
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.76 E-value=2.3e-18 Score=156.34 Aligned_cols=110 Identities=21% Similarity=0.451 Sum_probs=91.2
Q ss_pred ccccCCCccccCCCeEEeCCCeEEEeeecCCCCCceEEEEEEeecCCCcEEEeecCCCCCCCCcceEEEeeccCceEEEE
Q 003254 45 LDTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPLSDRSGVLRINGERNGILVLL 124 (836)
Q Consensus 45 ~~~i~~~~~l~~~~~l~S~~g~F~lgF~~~~~~~~~ylgiw~~~~~~~t~vW~Anr~~p~~~~~~~l~~~~~~~g~l~l~ 124 (836)
+|||.+||+|.+|++| ++|.|+|+|+.+|+ | +||++ +++||+||++.+ +..+.|+|. ++|||||+
T Consensus 1 tdtl~~gq~L~~g~~L--~~~~~~L~~~~dgn-----l-vl~~~---~~~vW~sn~~~~--~~~~~l~l~--~~GNLvl~ 65 (112)
T 1xd5_A 1 SDRLNSGHQLDTGGSL--AEGGYLFIIQNDCN-----L-VLYDN---NRAVWASGTNGK--ASGCVLKMQ--NDGNLVIY 65 (112)
T ss_dssp CCEEETTEEECTTCEE--EETTEEEEECTTSC-----E-EEEET---TEEEEECCCTTS--CSSEEEEEC--TTSCEEEE
T ss_pred CCCCCCCCEECCCCEE--eCCCEEEEEcCCCc-----E-EEEEC---CEEEEeCCCcCC--CCCEEEEEe--CCCCEEEE
Confidence 4899999999999999 58999999998876 2 35764 689999999753 344678887 89999999
Q ss_pred cCCCCeEEeecccCCCCcceEEEecCCCeEEecCCCCCCCcceeeeccCC
Q 003254 125 NSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDNILWQSFDYP 174 (836)
Q Consensus 125 ~~~~~~~wst~~~~~~~~~~a~lld~GNlvl~~~~~~~~~~~~WqSFd~P 174 (836)
| ++.++|+|++........++|+++|||||++.. +.++||||+|.
T Consensus 66 d-~~~~~W~S~~~~~~g~~~l~l~~dGnlvl~~~~----~~~~W~S~~~~ 110 (112)
T 1xd5_A 66 S-GSRAIWASNTNRQNGNYYLILQRDRNVVIYDNS----NNAIWATHTNV 110 (112)
T ss_dssp E-TTEEEEECCCCCSCCCCEEEECTTSCEEEECTT----SCEEEECCCCC
T ss_pred c-CCEEEEECCccCCCCCEEEEEeCCCcEEEECCC----CceEEECCCcc
Confidence 9 888999998654444567999999999999743 57899999984
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=1.2e-17 Score=175.55 Aligned_cols=137 Identities=15% Similarity=0.168 Sum_probs=107.4
Q ss_pred cccccCeecccCceeEEEEEe-ecCcE--EEEEEecCCCch------------------------hHHHHHHHHHHHHhh
Q 003254 518 NFSEKNKLGEGGFGPVYKGML-IEGQE--IAVKRLSKGSGQ------------------------GMEEFKNEVLLIAKL 570 (836)
Q Consensus 518 ~f~~~~~lG~G~fG~Vykg~~-~~g~~--vavK~l~~~~~~------------------------~~~~~~~Ei~~l~~l 570 (836)
-|+..+.||+|+||.||+|.. .+|+. ||||+++..... ....+.+|+.++.++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 466778999999999999998 67888 999987543111 113678999999999
Q ss_pred cCCce--eeEEeEEeeCCeeeEEEeecCC-C----ChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhh-cCCCCcEEe
Q 003254 571 QHRNL--VKLLGCCTQRDERMLIYEYLPN-K----SLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLH-QDSRLRIIH 642 (836)
Q Consensus 571 ~H~ni--v~l~g~~~~~~~~~lV~Ey~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~ivH 642 (836)
+|+++ ..+++. ...+|||||+.+ | +|.+.... .++..+..++.||+.||.||| +.+ |+|
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---ivH 194 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LVH 194 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EEC
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EEe
Confidence 98764 344432 367899999942 4 55554421 235677899999999999999 887 999
Q ss_pred ccCCCCceEecCCCCceeeccCccccc
Q 003254 643 RDLKASNVLLDNTMNPKISDFGLARSF 669 (836)
Q Consensus 643 ~DLkp~NILl~~~~~~kl~DFgla~~~ 669 (836)
|||||+|||+++ .++|+|||+|...
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCCHHHEEEcC--cEEEEECcccccC
Confidence 999999999998 9999999999764
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=1.9e-17 Score=149.31 Aligned_cols=105 Identities=23% Similarity=0.384 Sum_probs=86.4
Q ss_pred ccccCCCccccCCCeEEeCCCeEEEeeecCCCCCceEEEEEEeecCCCcEEEeecCCCCCCCCcceEEEeeccCceEEEE
Q 003254 45 LDTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPLSDRSGVLRINGERNGILVLL 124 (836)
Q Consensus 45 ~~~i~~~~~l~~~~~l~S~~g~F~lgF~~~~~~~~~ylgiw~~~~~~~t~vW~Anr~~p~~~~~~~l~~~~~~~g~l~l~ 124 (836)
.+||.+||+|.+|++|+ +|.|.|+|+..|+ |.+ |.. .++||++|++.+ +..+.|.|. .||+|||+
T Consensus 1 ~ntL~~gq~L~~g~~L~--~g~~~L~~q~dGn-----Lvl-y~~---~~~vW~snt~~~--~~~~~l~l~--~dGNLvl~ 65 (109)
T 3dzw_A 1 DNILYSGETLSPGEFLN--NGRYVFIMQEDCN-----LVL-YDV---DKPIWATNTGGL--DRRCHLSMQ--SDGNLVVY 65 (109)
T ss_dssp CCEEETTEEECTTCEEE--ETTEEEEECTTSC-----EEE-EET---TEEEEECCCTTS--SSSCEEEEC--TTSCEEEE
T ss_pred CCCcCCCCEeCCCCEEE--CCCEEEEEcCCCc-----EEE-EeC---CEEEEECCcccC--CCCEEEEEe--CCCCEEEE
Confidence 37899999999999996 7999999988765 323 654 689999999876 334678887 89999999
Q ss_pred cCCCCeEEeecccCCCCcceEEEecCCCeEEecCCCCCCCcceeeec
Q 003254 125 NSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDNILWQSF 171 (836)
Q Consensus 125 ~~~~~~~wst~~~~~~~~~~a~lld~GNlvl~~~~~~~~~~~~WqSF 171 (836)
|.++.++|++++.......+|+|+|+|||||++. ++|||=
T Consensus 66 ~~~~~~~W~S~t~~~~~~~~~~L~ddGNlvly~~-------~~W~s~ 105 (109)
T 3dzw_A 66 SPRNNPIWASNTGGENGNYVCVLQKDRNVVIYGT-------ARWATG 105 (109)
T ss_dssp CTTSCEEEECCCCCSSSCEEEEECTTSCEEEEES-------CCCCCC
T ss_pred CCCCCEEEECCCCCCCCCEEEEEeCCCEEEEECC-------CEEeCC
Confidence 9999999999975444456799999999999963 599984
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.66 E-value=2.6e-16 Score=141.81 Aligned_cols=105 Identities=24% Similarity=0.344 Sum_probs=84.1
Q ss_pred ccccccCCCccccCCCeEEeCCCeEEEeeecCCCCCceEEEEEEeecCCCcEEEeecCCCCCCCCcceEEEeeccCceEE
Q 003254 43 RTLDTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPLSDRSGVLRINGERNGILV 122 (836)
Q Consensus 43 ~~~~~i~~~~~l~~~~~l~S~~g~F~lgF~~~~~~~~~ylgiw~~~~~~~t~vW~Anr~~p~~~~~~~l~~~~~~~g~l~ 122 (836)
.+.|||.+||+|..|++|+| |.|.|-|...|+ |.+ |.. ++||.+|++.. +..+.|.|. +||+||
T Consensus 4 ~~~dtL~~gq~L~~g~~L~s--g~~~L~~q~dGn-----Lvl-~~~----~~vW~snt~~~--~~~~~l~l~--~dGNLv 67 (110)
T 3r0e_B 4 FTNNLLFSGQVLYGDGRLTA--KNHQLVMQGDCN-----LVL-YGG----KYGWQSNTHGN--GEHCFLRLN--HKGELI 67 (110)
T ss_dssp CBTTEEETTCEEETTEEEEC--SSCEEEECTTSC-----EEE-ECS----SSCEECCCTTS--SSSCEEEEC--TTSCEE
T ss_pred cccCEECCCCEecCCCEEEe--CCEEEEEcCCCe-----EEE-ECC----eEEEECCCcCC--CcCEEEEEe--CCCcEE
Confidence 57799999999999999998 459997755544 555 643 58999999862 334678887 899999
Q ss_pred EEcCCCCeEEeecccCCCCcceEEEecCCCeEEecCCCCCCCcceeee
Q 003254 123 LLNSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDNILWQS 170 (836)
Q Consensus 123 l~~~~~~~~wst~~~~~~~~~~a~lld~GNlvl~~~~~~~~~~~~WqS 170 (836)
|+|.++.++|++++.......+|+|+|+|||||++ ..+|+|
T Consensus 68 l~d~~~~~iW~S~t~~~~~~~~~~L~~dGNlvly~-------~~~W~t 108 (110)
T 3r0e_B 68 IKDDDFKTIWSSRSSSKQGEYVLILQDDGFGVIYG-------PAIFET 108 (110)
T ss_dssp EECTTCCEEEECCCCCSSSCCEEEECTTSCEEEEC-------SEEEES
T ss_pred EEeCCCCEEEEcCCcCCCCCEEEEEcCCccEEEec-------CCEecC
Confidence 99999999999997543444689999999999996 359987
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.63 E-value=2e-15 Score=136.78 Aligned_cols=108 Identities=19% Similarity=0.279 Sum_probs=87.2
Q ss_pred ccccccCCCccccCCCeEEeCCCeEEEeeecCCCCCceEEEEEEeecCCCcEEEeecCCCCCCCCcceEEEeeccCceEE
Q 003254 43 RTLDTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPLSDRSGVLRINGERNGILV 122 (836)
Q Consensus 43 ~~~~~i~~~~~l~~~~~l~S~~g~F~lgF~~~~~~~~~ylgiw~~~~~~~t~vW~Anr~~p~~~~~~~l~~~~~~~g~l~ 122 (836)
.+.|+|.+||.|..|+.|.+ |.|.|-|...|+ |.++.. ...++||.+|++.+- ....|.|. +||+||
T Consensus 4 ~~~~tL~~gq~L~~g~~L~~--g~~~L~~q~dGN-----LvL~~~--~~~~~vWssnt~~~~--~~~~l~l~--~dGNLV 70 (113)
T 3mez_B 4 RVRNVLFSSQVMYDNAQLAT--RDYSLVMRDDCN-----LVLTKG--SKTNIVWESGTSGRG--QHCFMRLG--HSGELD 70 (113)
T ss_dssp CCSSEEETTCEEETTCEEEE--TTEEEEECTTSC-----EEEEET--TTTEEEEECCCTTSC--SSCEEEEC--TTSCEE
T ss_pred ccCCEeCCCCEECCCCEeEc--CCEEEEEcCCCE-----EEEEEC--CCCEEEEECCcccCC--cCEEEEEe--CCCcEE
Confidence 46799999999999999975 889999977665 666432 146899999998652 34678887 899999
Q ss_pred EEcCCCCeEEeecccCCCCcceEEEecCCCeEEecCCCCCCCcceeee
Q 003254 123 LLNSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDNILWQS 170 (836)
Q Consensus 123 l~~~~~~~~wst~~~~~~~~~~a~lld~GNlvl~~~~~~~~~~~~WqS 170 (836)
|+|.++.++|++++.......+|+|+|+|||||++ ..+|+|
T Consensus 71 l~d~~~~~iW~S~t~~~~~~~~~~L~~dGnlvly~-------~~~W~s 111 (113)
T 3mez_B 71 ITDDRLNTVFVSNTVGQEGDYVLILQINGQAVVYG-------PAVWST 111 (113)
T ss_dssp EECTTSCEEEECSCCCSSSCCEEEECTTSCEEEEC-------SEEEES
T ss_pred EECCCCCEEEECCCcCCCCCEEEEEcCCceEEEec-------CCEecC
Confidence 99999999999997544444689999999999995 359997
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.61 E-value=1.7e-15 Score=137.37 Aligned_cols=97 Identities=22% Similarity=0.348 Sum_probs=77.5
Q ss_pred CCCCCCcceEEEeeccCceEEEEcCCCCeEEeecccCCCCcceEEEecCCCeEEecCCCCCCCcceeeeccCCCCCcCCC
Q 003254 102 APLSDRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDNILWQSFDYPCDTLLPG 181 (836)
Q Consensus 102 ~p~~~~~~~l~~~~~~~g~l~l~~~~~~~~wst~~~~~~~~~~a~lld~GNlvl~~~~~~~~~~~~WqSFd~PTDtlLpg 181 (836)
.|+.+....|.+. .||+|||++. +.+||++++.......+|+|+|+|||||++ . +.++||||+
T Consensus 14 ~~L~~~~~~L~~~--~dgnlvl~~~-~~~vW~sn~~~~~~~~~l~l~~~GNLvl~d-~----~~~~W~S~~--------- 76 (112)
T 1xd5_A 14 GSLAEGGYLFIIQ--NDCNLVLYDN-NRAVWASGTNGKASGCVLKMQNDGNLVIYS-G----SRAIWASNT--------- 76 (112)
T ss_dssp CEEEETTEEEEEC--TTSCEEEEET-TEEEEECCCTTSCSSEEEEECTTSCEEEEE-T----TEEEEECCC---------
T ss_pred CEEeCCCEEEEEc--CCCcEEEEEC-CEEEEeCCCcCCCCCEEEEEeCCCCEEEEc-C----CEEEEECCc---------
Confidence 3443445667776 8999999987 789999997543345689999999999998 3 579999993
Q ss_pred CeeeeeecCCCceEEEEccCCCCCCCCCeeeccCCCCCceEEEEc-CCeeEEeeCCCCC
Q 003254 182 MKLGINLGTGLNRFLSSWKSTDDPARGDFTYGLDPRGIPQLVLRK-NSIITFRAGSWNG 239 (836)
Q Consensus 182 qkl~~~~~tg~~~~l~Sw~s~~dps~G~~~~~~~~~g~~~~~~~~-~~~~~~~~g~w~~ 239 (836)
||++|.|++.++++|. ++++. ...+||++++|+|
T Consensus 77 ----------------------~~~~g~~~l~l~~dGn--lvl~~~~~~~~W~S~~~~g 111 (112)
T 1xd5_A 77 ----------------------NRQNGNYYLILQRDRN--VVIYDNSNNAIWATHTNVG 111 (112)
T ss_dssp ----------------------CCSCCCCEEEECTTSC--EEEECTTSCEEEECCCCCC
T ss_pred ----------------------cCCCCCEEEEEeCCCc--EEEECCCCceEEECCCccC
Confidence 4567899999999998 45554 5789999999987
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.59 E-value=6.8e-16 Score=169.15 Aligned_cols=144 Identities=15% Similarity=0.213 Sum_probs=102.9
Q ss_pred HHHHhhcccccccCeecccCceeEEEEEeecCcEEEEEEecCCCc--------------hhHHHH--------HHHHHHH
Q 003254 510 KIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSG--------------QGMEEF--------KNEVLLI 567 (836)
Q Consensus 510 ~~l~~a~~~f~~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~--------------~~~~~~--------~~Ei~~l 567 (836)
..+.....-|++.+.||+|+||.||+|...+|+.||||+++.... ...... ..|...|
T Consensus 88 ~~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL 167 (397)
T 4gyi_A 88 HTHAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFM 167 (397)
T ss_dssp HHHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHH
Confidence 334444445889999999999999999998999999998753210 011112 2355555
Q ss_pred HhhcCCcee--eEEeEEeeCCeeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccC
Q 003254 568 AKLQHRNLV--KLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDL 645 (836)
Q Consensus 568 ~~l~H~niv--~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DL 645 (836)
.++.+.++. ..++. ...+|||||++++.|..+. +......++.||+.+|.|||+.+ ||||||
T Consensus 168 ~rL~~~gv~vp~p~~~----~~~~LVME~i~G~~L~~l~---------~~~~~~~l~~qll~~l~~lH~~g---IVHrDL 231 (397)
T 4gyi_A 168 KALYEEGFPVPEPIAQ----SRHTIVMSLVDALPMRQVS---------SVPDPASLYADLIALILRLAKHG---LIHGDF 231 (397)
T ss_dssp HHHHHTTCSCCCEEEE----ETTEEEEECCSCEEGGGCC---------CCSCHHHHHHHHHHHHHHHHHTT---EECSCC
T ss_pred HHHHhcCCCCCeeeec----cCceEEEEecCCccHhhhc---------ccHHHHHHHHHHHHHHHHHHHCC---CcCCCC
Confidence 555443331 22221 2347999999998875443 22345678999999999999998 999999
Q ss_pred CCCceEecCCCC----------ceeeccCccccc
Q 003254 646 KASNVLLDNTMN----------PKISDFGLARSF 669 (836)
Q Consensus 646 kp~NILl~~~~~----------~kl~DFgla~~~ 669 (836)
||.|||+++++. +.|+||+-+...
T Consensus 232 Kp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 232 NEFNILIREEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp STTSEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred CHHHEEEeCCCCcccccccccceEEEEeCCcccC
Confidence 999999987763 889999987654
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.58 E-value=4.2e-15 Score=134.03 Aligned_cols=88 Identities=23% Similarity=0.362 Sum_probs=71.6
Q ss_pred cceEEEeeccCceEEEEcCCCCeEEeecccCCCCcceEEEecCCCeEEecCCCCCCCcceeeeccCCCCCcCCCCeeeee
Q 003254 108 SGVLRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDNILWQSFDYPCDTLLPGMKLGIN 187 (836)
Q Consensus 108 ~~~l~~~~~~~g~l~l~~~~~~~~wst~~~~~~~~~~a~lld~GNlvl~~~~~~~~~~~~WqSFd~PTDtlLpgqkl~~~ 187 (836)
..+|.+. .||+|||++ .+.+||++++.......+++|+|+|||||++.+ +.++||||
T Consensus 21 ~~~l~~~--~dGnlvl~~-~~~~vW~sn~~~~~~~~~l~l~~dGNLVl~~~~----~~~~W~S~---------------- 77 (110)
T 3a0c_A 21 SYRLIMQ--GDCNFVLYD-SGKPVWASNTGGLGSGCRLTLHNNGNLVIYDQS----NRVIWQTK---------------- 77 (110)
T ss_dssp TEEEEEC--TTSCEEEEE-TTEEEEECCCTTSCSSCEEEECTTSCEEEECTT----CCEEEECC----------------
T ss_pred CEEEEEc--CCCcEEEEE-CCEEEEECCCCCCCCcEEEEEeCCCCEEEECCC----CcEEEecC----------------
Confidence 4567775 899999998 579999999754444568999999999999864 67999999
Q ss_pred ecCCCceEEEEccCCCCCCCCCeeeccCCCCCceEEEEcCCeeEEeeCCC
Q 003254 188 LGTGLNRFLSSWKSTDDPARGDFTYGLDPRGIPQLVLRKNSIITFRAGSW 237 (836)
Q Consensus 188 ~~tg~~~~l~Sw~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~g~w 237 (836)
+++++|.|++.++++|. +++++. .||+++.+
T Consensus 78 ---------------t~~~~g~~~l~l~~dGn--lvl~~~--~~W~S~~~ 108 (110)
T 3a0c_A 78 ---------------TNGKEDHYVLVLQQDRN--VVIYGP--VVWATGSG 108 (110)
T ss_dssp ---------------CCCSSSCCEEEECTTSC--EEEECS--EEEECSCC
T ss_pred ---------------CCCCCCCEEEEEeCCcc--EEEECC--CEecCCCc
Confidence 35677999999999997 556664 79999865
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.56 E-value=1.2e-14 Score=130.74 Aligned_cols=108 Identities=25% Similarity=0.386 Sum_probs=85.7
Q ss_pred cccccCCCccccCCCeEEeCCCeEEEeeecCCCCCceEEEEEEeecCCCcEEEeecCCCCCCCCcceEEEeeccCceEEE
Q 003254 44 TLDTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPLSDRSGVLRINGERNGILVL 123 (836)
Q Consensus 44 ~~~~i~~~~~l~~~~~l~S~~g~F~lgF~~~~~~~~~ylgiw~~~~~~~t~vW~Anr~~p~~~~~~~l~~~~~~~g~l~l 123 (836)
+.|||.+||.|..|+.| .+|.|.|.|...|+ |-+ |.. +|.+|+..+ .....|++. +||+|||
T Consensus 2 ~~dtL~~gq~L~~g~~L--~~g~~~L~~q~dGN-----Lvl-~~~------~Wssnt~~~--~~~~~l~l~--~dGnLvl 63 (109)
T 3r0e_A 2 GTNYLLSGQTLDTEGHL--KNGDFDLVMQDDCN-----LVL-YNG------NWQSNTANN--GRDCKLTLT--DYGELVI 63 (109)
T ss_dssp CCSEEETTCEECTTCEE--EETTEEEEECTTSC-----EEE-ETT------TEECCCTTS--CSSCEEEEC--TTSCEEE
T ss_pred ccCCcCCCCCcCCCCEe--ECCCEEEEEecCCe-----EEE-EeC------eEEcCCCCC--CCcEEEEEc--CCCeEEE
Confidence 67999999999999999 57999999977665 323 431 699998764 234678887 8999999
Q ss_pred EcCCCCeEEeecccCCCCcceEEEecCCCeEEecCCCCCCCcceeeeccCCCCCcCCC
Q 003254 124 LNSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDNILWQSFDYPCDTLLPG 181 (836)
Q Consensus 124 ~~~~~~~~wst~~~~~~~~~~a~lld~GNlvl~~~~~~~~~~~~WqSFd~PTDtlLpg 181 (836)
+|.++.++|++++.......+|+|+|+|||||++ ..+|+| +|.+||
T Consensus 64 ~d~~~~~vWss~t~~~~~~~~~~L~~dGNlvly~-------~~~W~s-----~t~~~~ 109 (109)
T 3r0e_A 64 KNGDGSTVWKSGAQSVKGNYAAVVHPDGRLVVFG-------PSVFKI-----DPWVRG 109 (109)
T ss_dssp ECTTSCEEEECCCCCSSSCCEEEEETTTEEEEEC-------SEEEEE-----CTTSCC
T ss_pred EeCCCCEEEcCCCcCCCcCEEEEEcCCCeEEEEe-------cCEECC-----CCccCC
Confidence 9999999999987544445689999999999995 359998 555554
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.54 E-value=2.9e-14 Score=130.26 Aligned_cols=88 Identities=24% Similarity=0.328 Sum_probs=70.6
Q ss_pred ceEEEeeccCceEEEEcCCCCeEEeecccCCCCcceEEEecCCCeEEecCCCCCCCcceeeeccCCCCCcCCCCeeeeee
Q 003254 109 GVLRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDNILWQSFDYPCDTLLPGMKLGINL 188 (836)
Q Consensus 109 ~~l~~~~~~~g~l~l~~~~~~~~wst~~~~~~~~~~a~lld~GNlvl~~~~~~~~~~~~WqSFd~PTDtlLpgqkl~~~~ 188 (836)
+..++.++.||+|||++. +.+||++++........|+|+|+|||||+|.+ +.++||||
T Consensus 30 g~~~L~~~~dgnlvly~~-~~~vW~sn~~~~~~~~~l~l~~dGNLVl~d~~----~~~lW~S~----------------- 87 (119)
T 1b2p_A 30 HVYRFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITNE----NVTVWQSP----------------- 87 (119)
T ss_dssp EEEEEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECTT----CCEEEECS-----------------
T ss_pred CCEEEEEecCCCEEEEEC-CEEEEeCCCccCCCceEEEEccCCEEEEEeCC----CcEEEcCC-----------------
Confidence 444444458999999987 89999999754444578999999999999864 67999999
Q ss_pred cCCCceEEEEccCCCCCCCCCeeeccCCCCCceEEEEcCCeeEEeeCC
Q 003254 189 GTGLNRFLSSWKSTDDPARGDFTYGLDPRGIPQLVLRKNSIITFRAGS 236 (836)
Q Consensus 189 ~tg~~~~l~Sw~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~g~ 236 (836)
+||++|.|++.++++|. +++++ .+||++|+
T Consensus 88 --------------~~~~~g~~~l~l~~~Gn--lvl~~--~~~W~Sg~ 117 (119)
T 1b2p_A 88 --------------VAGKAGHYVLVLQPDRN--VVIYG--DALWATQT 117 (119)
T ss_dssp --------------CCCCSSCEEEEECTTSC--EEEEE--SEEEECCC
T ss_pred --------------CCCCCCCEEEEEECCCc--EEEEC--ccEeCCCC
Confidence 35678999999999998 55555 38999885
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.50 E-value=8.2e-14 Score=126.77 Aligned_cols=90 Identities=23% Similarity=0.363 Sum_probs=72.3
Q ss_pred ceEEEeeccCceEEEEcCCCCeEEeecccCCCCcceEEEecCCCeEEecCCCCCCCcceeeeccCCCCCcCCCCeeeeee
Q 003254 109 GVLRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDNILWQSFDYPCDTLLPGMKLGINL 188 (836)
Q Consensus 109 ~~l~~~~~~~g~l~l~~~~~~~~wst~~~~~~~~~~a~lld~GNlvl~~~~~~~~~~~~WqSFd~PTDtlLpgqkl~~~~ 188 (836)
..|.+. .||+|+|++ .+.+||++++........++|+++|||||+|.+ +.++||||++
T Consensus 22 ~~L~~~--~dgnlvly~-~~~~vW~sn~~~~~~~~~l~l~~~GnLvl~d~~----~~~vW~S~~~--------------- 79 (115)
T 2dpf_A 22 YTLTIQ--NKCNLVKYQ-NGRQIWASNTDRRGSGCRLTLLSDGNLVIYDHN----NNDVWGSACW--------------- 79 (115)
T ss_dssp EEEEEC--TTSCEEEEE-TTEEEEECSCTTSCSSCEEEECTTSCEEEECTT----CCEEEECCCC---------------
T ss_pred EEEEEc--CCCcEEEEe-CCEEEEeCCCCCCCCceEEEECCCCcEEEECCC----ceEEEEcCCC---------------
Confidence 455554 899999998 578999999654334568999999999999853 6799999997
Q ss_pred cCCCceEEEEccCCCCCCCCCeeeccCCCCCceEEEEcCCeeEEeeCCCCCc
Q 003254 189 GTGLNRFLSSWKSTDDPARGDFTYGLDPRGIPQLVLRKNSIITFRAGSWNGL 240 (836)
Q Consensus 189 ~tg~~~~l~Sw~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~g~w~~~ 240 (836)
+++|.|++.++++|. +++++. +||++++|...
T Consensus 80 ----------------~~~g~~~l~l~~dGn--lvl~~~--~~W~S~~~~~~ 111 (115)
T 2dpf_A 80 ----------------GDNGKYALVLQKDGR--FVIYGP--VLWSLGPNGCR 111 (115)
T ss_dssp ----------------CSSSCCEEEECTTSC--EEEECS--EEECSSTTCBC
T ss_pred ----------------CCCCCEEEEEeCCCe--EEEECC--CEEECCCCCCc
Confidence 356789999999997 556654 89999999753
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.40 E-value=7.6e-13 Score=119.29 Aligned_cols=103 Identities=19% Similarity=0.320 Sum_probs=80.3
Q ss_pred ccccCCCccccCCCeEEeCCCeEEEeeecCCCCCceEEEEEEeecCCCcEEEeecCCCCCCCCcceEEEeeccCceEEEE
Q 003254 45 LDTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPLSDRSGVLRINGERNGILVLL 124 (836)
Q Consensus 45 ~~~i~~~~~l~~~~~l~S~~g~F~lgF~~~~~~~~~ylgiw~~~~~~~t~vW~Anr~~p~~~~~~~l~~~~~~~g~l~l~ 124 (836)
+|+|.+||.|.+|+.| .+|.|.|-|...|+ |.+ |.. .. ||.+|+..+ .....|.+. .||||||+
T Consensus 2 ~~~l~~gq~L~~g~~L--~~g~~~L~~q~dGn-----Lvl-~~~---~~-vW~snt~~~--~~~~~l~l~--~dGNLVl~ 65 (111)
T 3mez_A 2 NNVLLTGDVIHTDNQL--SYESAAFVMQGDCN-----LVL-YNE---AG-GFQSNTHGR--GVDCTLRLN--NRGQLEIH 65 (111)
T ss_dssp TTEEETTCEECTTCEE--EETTEEEEECTTSC-----EEE-ECS---SC-CEECCCTTS--CSSCEEEEC--TTSCEEEE
T ss_pred cCEeCCCCEeCCCCEE--ecCCEEEEEccCCe-----EEE-ECC---CC-EEECCcccC--CcCEEEEEc--CCCcEEEE
Confidence 5899999999999999 47899999976665 434 543 23 999999876 234677876 89999999
Q ss_pred cCCCC-eEEeecccC--CCCcceEEEecCCCeEEecCCCCCCCcceeee
Q 003254 125 NSTND-TVWSSNSSI--SAQKPVAALMESGNLVVKDGKDNNPDNILWQS 170 (836)
Q Consensus 125 ~~~~~-~~wst~~~~--~~~~~~a~lld~GNlvl~~~~~~~~~~~~WqS 170 (836)
|.++. ++|++++.. .....+++|+|+|||||++ ..+|+|
T Consensus 66 ~~~~~~~vW~S~t~~~~~~~~~~l~Lq~dGNlvly~-------~~~W~s 107 (111)
T 3mez_A 66 SANSNTPVWVYPRSVNTVRGNYAATLGPDQHVTIYG-------PAIWST 107 (111)
T ss_dssp CSSCSSCSEEESSSCCCCSSCCEEEECTTSCEEEEC-------SEEEEC
T ss_pred eCCCCEEEEEeccccCCCCcCEEEEECCCCeEEEec-------cCEEcc
Confidence 98876 599999532 2234678999999999995 459987
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.19 E-value=5.6e-11 Score=124.65 Aligned_cols=145 Identities=16% Similarity=0.083 Sum_probs=114.2
Q ss_pred hcccccccCeecccCceeEEEEEeecCcEEEEEEecCCCchhHHHHHHHHHHHHhhc-CCceeeEEeEEeeCCeeeEEEe
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQRDERMLIYE 593 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~E 593 (836)
..+.|.....++.|+.+.||+... .++.+++|+...........+.+|+.+++.+. |..+.++++++...+..++|||
T Consensus 12 ~l~~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e 90 (263)
T 3tm0_A 12 LIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS 90 (263)
T ss_dssp HHTTSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred HhccceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEE
Confidence 345687777888888999999976 47899999986532223456889999999995 6778899999988889999999
Q ss_pred ecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcC--------------------------------------
Q 003254 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQD-------------------------------------- 635 (836)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-------------------------------------- 635 (836)
|+++.+|.+.+. +......++.+++++|+.||+.
T Consensus 91 ~i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (263)
T 3tm0_A 91 EADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT 162 (263)
T ss_dssp CCSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred ecCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence 999999876531 2233457889999999999981
Q ss_pred ------------------CCCcEEeccCCCCceEecCCCCceeeccCcccc
Q 003254 636 ------------------SRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (836)
Q Consensus 636 ------------------~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~ 668 (836)
....++|+|++|.||+++++..+.|.||+.+..
T Consensus 163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 114599999999999998766677999988753
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=99.16 E-value=6.8e-11 Score=124.24 Aligned_cols=113 Identities=19% Similarity=0.327 Sum_probs=86.8
Q ss_pred ccccccCCCcc----ccCCCeEEeCCCeEEEeeecCC--CCCceEEEEEEeecCCCcEEEeecCCCCCCCCcceEEEeec
Q 003254 43 RTLDTISLGQS----IKDGETLVSAKESFELGFFSPG--NSKSRYLGIWYKKIAEGTVTWVANRDAPLSDRSGVLRINGE 116 (836)
Q Consensus 43 ~~~~~i~~~~~----l~~~~~l~S~~g~F~lgF~~~~--~~~~~ylgiw~~~~~~~t~vW~Anr~~p~~~~~~~l~~~~~ 116 (836)
...||+.|||. |..|+.|+|+ ..++.|+|... ...+.+ + |.+ ..+++|.+++..+- . ..|++.
T Consensus 134 ~ptdtlLpg~~~~~~l~~g~~L~S~-~dps~G~fsl~l~~dGnlv--L-y~~--~~~~yW~Sgt~~~~--~-~~l~l~-- 202 (276)
T 3m7h_A 134 TPAIPLVPGAIDSLLLAPGSELVQG-VVYGAGASKLVFQGDGNLV--A-YGP--NGAATWNAGTQGKG--A-VRAVFQ-- 202 (276)
T ss_dssp CTTSCCCCSCTTCEEECSSEEECTT-CEEEETTEEEEECTTSCEE--E-ECT--TSSEEEECCCTTTT--C-CEEEEC--
T ss_pred ccccccccccccccccccCcccccC-CCCCCceEEEeecCCceEE--E-EeC--CCeEEEECCCCCCc--c-EEEEEc--
Confidence 67899999999 8899998664 56777776542 223333 3 332 36899999998762 2 577776
Q ss_pred cCceEEEEcCCCCeEEeecccCCCCcceEEEecCCCeEEecCCCCCCCcceeeeccC
Q 003254 117 RNGILVLLNSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDNILWQSFDY 173 (836)
Q Consensus 117 ~~g~l~l~~~~~~~~wst~~~~~~~~~~a~lld~GNlvl~~~~~~~~~~~~WqSFd~ 173 (836)
.+|+|+++|.++.++|++++... ...+|+|+++|||||++. +++||||||
T Consensus 203 ~dGnLvl~d~~~~~vWsS~t~~~-~~~rl~Ld~dGnLvly~~------~~~Wqsf~~ 252 (276)
T 3m7h_A 203 GDGNLVVYGAGNAVLWHSHTGGH-ASAVLRLQANGSIAILDE------KPVWARFGF 252 (276)
T ss_dssp TTSCEEEECTTSCEEEECSCTTC-TTCEEEECTTSCEEEEEE------EEEEESSSC
T ss_pred CCCeEEEEeCCCcEEEEecCCCC-CCEEEEEcCCccEEEEcC------CCeEEccCc
Confidence 89999999998899999996533 357899999999999963 579999997
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.13 E-value=1.3e-10 Score=105.02 Aligned_cols=95 Identities=24% Similarity=0.303 Sum_probs=70.3
Q ss_pred CCCCCCCcceEEEeeccCceEEEEcC-CCCeEEeecccCCCCcceEEEecCCCeEEecCCCCCCCcceeeeccCCCCCcC
Q 003254 101 DAPLSDRSGVLRINGERNGILVLLNS-TNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDNILWQSFDYPCDTLL 179 (836)
Q Consensus 101 ~~p~~~~~~~l~~~~~~~g~l~l~~~-~~~~~wst~~~~~~~~~~a~lld~GNlvl~~~~~~~~~~~~WqSFd~PTDtlL 179 (836)
+.|+.+....|.+. .||+|||++. .+.++|++++........++|+|+|||||++.+ +.++|||=.+
T Consensus 18 g~~L~~g~~~L~~q--~dGNLvL~~~~~~~~vWssnt~~~~~~~~l~l~~dGNLVl~d~~----~~~iW~S~t~------ 85 (113)
T 3mez_B 18 NAQLATRDYSLVMR--DDCNLVLTKGSKTNIVWESGTSGRGQHCFMRLGHSGELDITDDR----LNTVFVSNTV------ 85 (113)
T ss_dssp TCEEEETTEEEEEC--TTSCEEEEETTTTEEEEECCCTTSCSSCEEEECTTSCEEEECTT----SCEEEECSCC------
T ss_pred CCEeEcCCEEEEEc--CCCEEEEEECCCCEEEEECCcccCCcCEEEEEeCCCcEEEECCC----CCEEEECCCc------
Confidence 45555545667775 9999999998 489999999754334568999999999999864 5789997421
Q ss_pred CCCeeeeeecCCCceEEEEccCCCCCCCCCeeeccCCCCCceEEEEcCCeeEEeeCC
Q 003254 180 PGMKLGINLGTGLNRFLSSWKSTDDPARGDFTYGLDPRGIPQLVLRKNSIITFRAGS 236 (836)
Q Consensus 180 pgqkl~~~~~tg~~~~l~Sw~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~g~ 236 (836)
-..|.|.+.++.+|...++ + .+.|.+|+
T Consensus 86 -------------------------~~~~~~~~~L~~dGnlvly--~--~~~W~s~~ 113 (113)
T 3mez_B 86 -------------------------GQEGDYVLILQINGQAVVY--G--PAVWSTAA 113 (113)
T ss_dssp -------------------------CSSSCCEEEECTTSCEEEE--C--SEEEESCC
T ss_pred -------------------------CCCCCEEEEEcCCceEEEe--c--CCEecCCC
Confidence 0124588999999987655 3 57888774
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.08 E-value=2.5e-10 Score=119.13 Aligned_cols=139 Identities=16% Similarity=0.148 Sum_probs=102.1
Q ss_pred cccccccCeecccCceeEEEEEeecCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCc--eeeEEeEEeeCCeeeEEEe
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRN--LVKLLGCCTQRDERMLIYE 593 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~n--iv~l~g~~~~~~~~~lV~E 593 (836)
..++......+.|..+.||+....+|+.+++|+.... ....+..|+.+++.+.+.+ +.+++++....+..++|||
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e 95 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLG 95 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEE
T ss_pred cCCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEE
Confidence 3445443233455669999998777888999997543 2356789999999997555 4568888887778899999
Q ss_pred ecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCC-------------------------------------
Q 003254 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDS------------------------------------- 636 (836)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------------------------------------- 636 (836)
|+++.+|. . .. .....++.++++.|..||+..
T Consensus 96 ~i~G~~l~--~-~~--------~~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (264)
T 1nd4_A 96 EVPGQDLL--S-SH--------LAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG 164 (264)
T ss_dssp CCSSEETT--T-SC--------CCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred ecCCcccC--c-Cc--------CCHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence 99998874 2 10 112356777777788887643
Q ss_pred ------------------CCcEEeccCCCCceEecCCCCceeeccCcccc
Q 003254 637 ------------------RLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (836)
Q Consensus 637 ------------------~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~ 668 (836)
...++|+|++|.||+++++..+.|.||+.+..
T Consensus 165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12399999999999998876677999998753
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.07 E-value=3.5e-10 Score=101.74 Aligned_cols=94 Identities=18% Similarity=0.233 Sum_probs=67.3
Q ss_pred CCCCCCcceEEEeeccCceEEEEcCCCCeEEeecccCCCCcceEEEecCCCeEEecCCCCCCCcceeeeccCCCCCcCCC
Q 003254 102 APLSDRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDNILWQSFDYPCDTLLPG 181 (836)
Q Consensus 102 ~p~~~~~~~l~~~~~~~g~l~l~~~~~~~~wst~~~~~~~~~~a~lld~GNlvl~~~~~~~~~~~~WqSFd~PTDtlLpg 181 (836)
.++.+....|.+. .||+|||++.++ +|++++........++|+|+|||||++... +.++|||..+
T Consensus 15 ~~L~~g~~~L~~q--~dGnLvl~~~~~--vW~snt~~~~~~~~l~l~~dGNLVl~~~~~---~~~vW~S~t~-------- 79 (111)
T 3mez_A 15 NQLSYESAAFVMQ--GDCNLVLYNEAG--GFQSNTHGRGVDCTLRLNNRGQLEIHSANS---NTPVWVYPRS-------- 79 (111)
T ss_dssp CEEEETTEEEEEC--TTSCEEEECSSC--CEECCCTTSCSSCEEEECTTSCEEEECSSC---SSCSEEESSS--------
T ss_pred CEEecCCEEEEEc--cCCeEEEECCCC--EEECCcccCCcCEEEEEcCCCcEEEEeCCC---CEEEEEeccc--------
Confidence 3333334556665 999999999877 999997544344689999999999998641 2359999731
Q ss_pred CeeeeeecCCCceEEEEccCCCCCCCCCeeeccCCCCCceEEEEcCCeeEEeeC
Q 003254 182 MKLGINLGTGLNRFLSSWKSTDDPARGDFTYGLDPRGIPQLVLRKNSIITFRAG 235 (836)
Q Consensus 182 qkl~~~~~tg~~~~l~Sw~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~g 235 (836)
.....|.|.+.++.+|...++ . .++|.++
T Consensus 80 ---------------------~~~~~~~~~l~Lq~dGNlvly--~--~~~W~s~ 108 (111)
T 3mez_A 80 ---------------------VNTVRGNYAATLGPDQHVTIY--G--PAIWSTP 108 (111)
T ss_dssp ---------------------CCCCSSCCEEEECTTSCEEEE--C--SEEEECC
T ss_pred ---------------------cCCCCcCEEEEECCCCeEEEe--c--cCEEccC
Confidence 011347899999999987655 3 6788776
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=98.92 E-value=3.2e-09 Score=95.28 Aligned_cols=85 Identities=20% Similarity=0.349 Sum_probs=62.0
Q ss_pred ceEEEeeccCceEEEEcCCCCeEEeecccCCCCcceEEEecCCCeEEecCCCCCCCcceeeeccCCCCCcCCCCeeeeee
Q 003254 109 GVLRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDNILWQSFDYPCDTLLPGMKLGINL 188 (836)
Q Consensus 109 ~~l~~~~~~~g~l~l~~~~~~~~wst~~~~~~~~~~a~lld~GNlvl~~~~~~~~~~~~WqSFd~PTDtlLpgqkl~~~~ 188 (836)
..|.+ +.||+|||++. +.++|++++........++|+|+|||||++.+ +.++|||....
T Consensus 21 ~~L~~--q~dGnLvly~~-~~~vW~snt~~~~~~~~l~l~~dGNLvl~~~~----~~~~W~S~t~~-------------- 79 (109)
T 3dzw_A 21 YVFIM--QEDCNLVLYDV-DKPIWATNTGGLDRRCHLSMQSDGNLVVYSPR----NNPIWASNTGG-------------- 79 (109)
T ss_dssp EEEEE--CTTSCEEEEET-TEEEEECCCTTSSSSCEEEECTTSCEEEECTT----SCEEEECCCCC--------------
T ss_pred EEEEE--cCCCcEEEEeC-CEEEEECCcccCCCCEEEEEeCCCCEEEECCC----CCEEEECCCCC--------------
Confidence 34555 49999999987 68999999754334567899999999999864 57899986311
Q ss_pred cCCCceEEEEccCCCCCCCCCeeeccCCCCCceEEEEcCCeeEEeeC
Q 003254 189 GTGLNRFLSSWKSTDDPARGDFTYGLDPRGIPQLVLRKNSIITFRAG 235 (836)
Q Consensus 189 ~tg~~~~l~Sw~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~g 235 (836)
..+.|.+.++.+|...++ +. ..|.+|
T Consensus 80 -----------------~~~~~~~~L~ddGNlvly--~~--~~W~s~ 105 (109)
T 3dzw_A 80 -----------------ENGNYVCVLQKDRNVVIY--GT--ARWATG 105 (109)
T ss_dssp -----------------SSSCEEEEECTTSCEEEE--ES--CCCCCC
T ss_pred -----------------CCCCEEEEEeCCCEEEEE--CC--CEEeCC
Confidence 124678899999987654 32 556554
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=98.91 E-value=3e-09 Score=95.47 Aligned_cols=84 Identities=21% Similarity=0.343 Sum_probs=62.4
Q ss_pred ceEEEeeccCceEEEEcCCCCeEEeecccCCCCcceEEEecCCCeEEecCCCCCCCcceeeeccCCCCCcCCCCeeeeee
Q 003254 109 GVLRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDNILWQSFDYPCDTLLPGMKLGINL 188 (836)
Q Consensus 109 ~~l~~~~~~~g~l~l~~~~~~~~wst~~~~~~~~~~a~lld~GNlvl~~~~~~~~~~~~WqSFd~PTDtlLpgqkl~~~~ 188 (836)
..|.+. .||+|||++. .++|++++........++|+|+|||||++.+ +.++|||-.+-
T Consensus 26 ~~L~~q--~dGnLvl~~~--~~vW~snt~~~~~~~~l~l~~dGNLvl~d~~----~~~iW~S~t~~-------------- 83 (110)
T 3r0e_B 26 HQLVMQ--GDCNLVLYGG--KYGWQSNTHGNGEHCFLRLNHKGELIIKDDD----FKTIWSSRSSS-------------- 83 (110)
T ss_dssp CEEEEC--TTSCEEEECS--SSCEECCCTTSSSSCEEEECTTSCEEEECTT----CCEEEECCCCC--------------
T ss_pred EEEEEc--CCCeEEEECC--eEEEECCCcCCCcCEEEEEeCCCcEEEEeCC----CCEEEEcCCcC--------------
Confidence 456665 8999999986 5899999754434467899999999999864 57899986310
Q ss_pred cCCCceEEEEccCCCCCCCCCeeeccCCCCCceEEEEcCCeeEEeeC
Q 003254 189 GTGLNRFLSSWKSTDDPARGDFTYGLDPRGIPQLVLRKNSIITFRAG 235 (836)
Q Consensus 189 ~tg~~~~l~Sw~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~g 235 (836)
..|.|.+.++.+|...++ + ...|.+|
T Consensus 84 -----------------~~~~~~~~L~~dGNlvly--~--~~~W~t~ 109 (110)
T 3r0e_B 84 -----------------KQGEYVLILQDDGFGVIY--G--PAIFETS 109 (110)
T ss_dssp -----------------SSSCCEEEECTTSCEEEE--C--SEEEESC
T ss_pred -----------------CCCCEEEEEcCCccEEEe--c--CCEecCC
Confidence 124578899999987654 3 3678776
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.87 E-value=6.4e-09 Score=114.26 Aligned_cols=142 Identities=17% Similarity=0.246 Sum_probs=106.7
Q ss_pred ccCeecccCceeEEEEEeecCcEEEEEEec--CCC-chhHHHHHHHHHHHHhhc--CCceeeEEeEEeeC---CeeeEEE
Q 003254 521 EKNKLGEGGFGPVYKGMLIEGQEIAVKRLS--KGS-GQGMEEFKNEVLLIAKLQ--HRNLVKLLGCCTQR---DERMLIY 592 (836)
Q Consensus 521 ~~~~lG~G~fG~Vykg~~~~g~~vavK~l~--~~~-~~~~~~~~~Ei~~l~~l~--H~niv~l~g~~~~~---~~~~lV~ 592 (836)
..+.|+.|.++.||+.... +..+++|+.. ... ......+.+|+.+++.+. +..+.+++.++.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 3567999999999998874 5688888875 322 123457888999999997 45678899988776 3489999
Q ss_pred eecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCC------------------------------------
Q 003254 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDS------------------------------------ 636 (836)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------------------------------------ 636 (836)
||+++..+.+.. ...++..++..++.++++.|+.||...
T Consensus 121 e~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 121 EFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp ECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 999998874322 123677888899999999999999731
Q ss_pred -------------------CCcEEeccCCCCceEecCCCC--ceeeccCcccc
Q 003254 637 -------------------RLRIIHRDLKASNVLLDNTMN--PKISDFGLARS 668 (836)
Q Consensus 637 -------------------~~~ivH~DLkp~NILl~~~~~--~kl~DFgla~~ 668 (836)
...++|+|+++.|||+++++. +.|.||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 246999999999999987653 68999998864
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=98.86 E-value=4.6e-09 Score=94.10 Aligned_cols=92 Identities=24% Similarity=0.461 Sum_probs=66.2
Q ss_pred CCCCCCCcceEEEeeccCceEEEEcCCCCeEEeecccCCCCcceEEEecCCCeEEecCCCCCCCcceeeeccCCCCCcCC
Q 003254 101 DAPLSDRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDNILWQSFDYPCDTLLP 180 (836)
Q Consensus 101 ~~p~~~~~~~l~~~~~~~g~l~l~~~~~~~~wst~~~~~~~~~~a~lld~GNlvl~~~~~~~~~~~~WqSFd~PTDtlLp 180 (836)
+.|+.+....|.+. .||||||+++ +|++++........++|.++|||||++.+ +.++|+|- |
T Consensus 15 g~~L~~g~~~L~~q--~dGNLvl~~~----~Wssnt~~~~~~~~l~l~~dGnLvl~d~~----~~~vWss~-----t--- 76 (109)
T 3r0e_A 15 EGHLKNGDFDLVMQ--DDCNLVLYNG----NWQSNTANNGRDCKLTLTDYGELVIKNGD----GSTVWKSG-----A--- 76 (109)
T ss_dssp TCEEEETTEEEEEC--TTSCEEEETT----TEECCCTTSCSSCEEEECTTSCEEEECTT----SCEEEECC-----C---
T ss_pred CCEeECCCEEEEEe--cCCeEEEEeC----eEEcCCCCCCCcEEEEEcCCCeEEEEeCC----CCEEEcCC-----C---
Confidence 34444344566665 9999999984 79999764444567899999999999863 57889752 1
Q ss_pred CCeeeeeecCCCceEEEEccCCCCCCCCCeeeccCCCCCceEEEEcCCeeEEeeCCC
Q 003254 181 GMKLGINLGTGLNRFLSSWKSTDDPARGDFTYGLDPRGIPQLVLRKNSIITFRAGSW 237 (836)
Q Consensus 181 gqkl~~~~~tg~~~~l~Sw~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~g~w 237 (836)
....+.|.+.++++|...++ . .+.|.++.|
T Consensus 77 -----------------------~~~~~~~~~~L~~dGNlvly--~--~~~W~s~t~ 106 (109)
T 3r0e_A 77 -----------------------QSVKGNYAAVVHPDGRLVVF--G--PSVFKIDPW 106 (109)
T ss_dssp -----------------------CCSSSCCEEEEETTTEEEEE--C--SEEEEECTT
T ss_pred -----------------------cCCCcCEEEEEcCCCeEEEE--e--cCEECCCCc
Confidence 00235678999999976654 3 578999887
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=98.77 E-value=3.8e-08 Score=101.30 Aligned_cols=89 Identities=25% Similarity=0.357 Sum_probs=65.3
Q ss_pred ceEEEeeccCceEEEEcCCCCeEEeecccCCCCcceEEEecCCCeEEecCCCCCCCcceeeeccCCCCCcCCCCeeeeee
Q 003254 109 GVLRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDNILWQSFDYPCDTLLPGMKLGINL 188 (836)
Q Consensus 109 ~~l~~~~~~~g~l~l~~~~~~~~wst~~~~~~~~~~a~lld~GNlvl~~~~~~~~~~~~WqSFd~PTDtlLpgqkl~~~~ 188 (836)
+..++.++.+|+|+|+++ +.+||++|+... ....++|.++|||||+|.+ +.++|+|+++.
T Consensus 26 g~f~l~f~~~gnl~ly~~-~~~vW~an~~~~-~~~~l~l~~dGnLvl~d~~----~~~vW~s~~~~-------------- 85 (236)
T 1dlp_A 26 SSFRFTMQSDCNLVLFDS-DVRVWASNTAGA-TGCRAVLQSDGLLVILTAQ----NTIRWSSGTKG-------------- 85 (236)
T ss_dssp TTEEEEECTTSCEEEEES-SSEEECCCCCSC-SCCBCCBCSSSCBCCBCTT----TCCSCCCCCCC--------------
T ss_pred CCEEEEECCCCcEEEEEC-CEEEEECCCCCC-CCeEEEEcCCCcEEEEcCC----CcEEEeCCccc--------------
Confidence 334444458999999986 789999996533 4567899999999999864 67899998741
Q ss_pred cCCCceEEEEccCCCCCCCCCeeeccCCCCCceEEEEcCCeeEEeeCCCC
Q 003254 189 GTGLNRFLSSWKSTDDPARGDFTYGLDPRGIPQLVLRKNSIITFRAGSWN 238 (836)
Q Consensus 189 ~tg~~~~l~Sw~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~g~w~ 238 (836)
+.|.|.+.++.+|...++ .. .+|.+..+.
T Consensus 86 -----------------~~~~~~~~l~d~Gnlvl~--~~--~~W~S~~~p 114 (236)
T 1dlp_A 86 -----------------SIGNYVLVLQPDRTVTIY--GP--GLWDSGTSN 114 (236)
T ss_dssp -----------------CSSCCEEEECSSSCEEEE--CS--EEEECSCCC
T ss_pred -----------------cCCcEEEEEeCCCCEEEe--cC--CEEECCCCC
Confidence 235677888888876553 22 788887664
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.66 E-value=9e-09 Score=110.34 Aligned_cols=186 Identities=18% Similarity=0.209 Sum_probs=120.3
Q ss_pred cCeecccCceeEEEEEeecCcEEEEEEecCCCchhHHHHHHHHHHHHhhc-CCc--eeeEEeEEeeCC---eeeEEEeec
Q 003254 522 KNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQ-HRN--LVKLLGCCTQRD---ERMLIYEYL 595 (836)
Q Consensus 522 ~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~n--iv~l~g~~~~~~---~~~lV~Ey~ 595 (836)
.+.++.|....||+.. ..+++|+.... .....+.+|+.+++.+. +.. +.+++......+ ..++|||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4568999999999863 56889986432 34567899999999884 333 344555443333 348899999
Q ss_pred CCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcC----------------------------------------
Q 003254 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQD---------------------------------------- 635 (836)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~---------------------------------------- 635 (836)
++.+|..... ..++..++..++.++++.|+.||..
T Consensus 99 ~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 99 KGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred CCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 9988865432 2356667777788888888888751
Q ss_pred ---------------CCCcEEeccCCCCceEecC--CCCceeeccCcccccCCCcccccccc------------cccccc
Q 003254 636 ---------------SRLRIIHRDLKASNVLLDN--TMNPKISDFGLARSFGLDQTEANTKR------------VVGTYG 686 (836)
Q Consensus 636 ---------------~~~~ivH~DLkp~NILl~~--~~~~kl~DFgla~~~~~~~~~~~~~~------------~~gt~~ 686 (836)
....++|+|++|.||++++ +..+.|.||+.+..-........... .....+
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~ 253 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYK 253 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence 1235899999999999998 55688999998865321111000000 000011
Q ss_pred ccC-cccccCCccCccccccchhhhhhhhhhCCCC
Q 003254 687 YMS-PEYAIDGLFSVKSDVFSFGVLVLEIICGKKN 720 (836)
Q Consensus 687 y~a-PE~~~~~~~t~ksDVwS~GvvL~elltG~~p 720 (836)
... |+.... .....+.|+++.+++++.+|..+
T Consensus 254 ~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~ 286 (304)
T 3sg8_A 254 HKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMD 286 (304)
T ss_dssp CSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHH
T ss_pred CCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHH
Confidence 111 222111 12236899999999999999865
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=98.56 E-value=3e-07 Score=81.57 Aligned_cols=76 Identities=26% Similarity=0.411 Sum_probs=56.1
Q ss_pred EEeeccCceEEEEcCCCCeEEeecccCC-CCcceEEEecCCCeEEecCCCCCCCcceeeeccCCCCCcCCCCeeeeeecC
Q 003254 112 RINGERNGILVLLNSTNDTVWSSNSSIS-AQKPVAALMESGNLVVKDGKDNNPDNILWQSFDYPCDTLLPGMKLGINLGT 190 (836)
Q Consensus 112 ~~~~~~~g~l~l~~~~~~~~wst~~~~~-~~~~~a~lld~GNlvl~~~~~~~~~~~~WqSFd~PTDtlLpgqkl~~~~~t 190 (836)
+|..+.||||||++. +.+||++++... .....+.|.++|||||+|.+ +.++|.|=.
T Consensus 22 ~l~~q~DgNLvly~~-~~~vW~ant~~~~~~~~~L~l~~dGnLvL~d~~----~~~vWss~t------------------ 78 (105)
T 4h3o_A 22 HFIMQDDCNLVLYDH-STSTWASNTEIGGKSGCSAVLQSDGNFVVYDSS----GRSLWASHS------------------ 78 (105)
T ss_dssp EEEECTTSCEEEEET-TEEEEECCCCCTTCCSCEEEECTTSCEEEECTT----CCEEEECCC------------------
T ss_pred EEEECCCCeEEEEEC-CEEEEEecCCCCCCccEEEEEeCCccEEEECCC----cEEEEEecC------------------
Confidence 444459999999984 578999996433 23457899999999999874 678898621
Q ss_pred CCceEEEEccCCCCCCCCCeeeccCCCCCceEE
Q 003254 191 GLNRFLSSWKSTDDPARGDFTYGLDPRGIPQLV 223 (836)
Q Consensus 191 g~~~~l~Sw~s~~dps~G~~~~~~~~~g~~~~~ 223 (836)
....+.|.+.++++|...++
T Consensus 79 -------------~~~~~~~~l~L~ddGNlVly 98 (105)
T 4h3o_A 79 -------------TRGSGNYILILQDDGNVIIY 98 (105)
T ss_dssp -------------CCCSSCEEEEECTTSCEEEE
T ss_pred -------------CCCCCCEEEEEeCCCeEEEE
Confidence 11346688999999987654
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.17 E-value=8.1e-06 Score=87.31 Aligned_cols=136 Identities=21% Similarity=0.168 Sum_probs=92.6
Q ss_pred cCeecccCceeEEEEEeecCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCC---ceeeEEeEEe-eCCeeeEEEeecCC
Q 003254 522 KNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHR---NLVKLLGCCT-QRDERMLIYEYLPN 597 (836)
Q Consensus 522 ~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~---niv~l~g~~~-~~~~~~lV~Ey~~~ 597 (836)
.+.++.|....||+. |..+++|+.. .......+..|+.++..+.+. .+.+.+.+.. ..+..++||||+++
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 356888888899987 6778888853 223456789999999999752 3556666664 34557899999999
Q ss_pred CChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcC------------------------------------------
Q 003254 598 KSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQD------------------------------------------ 635 (836)
Q Consensus 598 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------------------------------------------ 635 (836)
..+...... .++..++..++.++++.|+.||..
T Consensus 98 ~~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 98 QILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp EECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred eECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 888653211 123333444444444444444432
Q ss_pred ---------------CCCcEEeccCCCCceEecC---CCCc-eeeccCcccc
Q 003254 636 ---------------SRLRIIHRDLKASNVLLDN---TMNP-KISDFGLARS 668 (836)
Q Consensus 636 ---------------~~~~ivH~DLkp~NILl~~---~~~~-kl~DFgla~~ 668 (836)
....++|+|+++.||++++ ++.+ .|.||+.+..
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2235799999999999987 4554 8999998764
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.14 E-value=1.4e-05 Score=83.54 Aligned_cols=135 Identities=17% Similarity=0.156 Sum_probs=95.9
Q ss_pred eecccCce-eEEEEEeec-CcEEEEEEecCCCchhHHHHHHHHHHHHhhc-CCceeeEEeEEeeCCeeeEEEeecCCCCh
Q 003254 524 KLGEGGFG-PVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQRDERMLIYEYLPNKSL 600 (836)
Q Consensus 524 ~lG~G~fG-~Vykg~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 600 (836)
.+..|..| .||+..... +..+++|+-.. .....+.+|...++.+. +--+.++++++...+..++|||++++.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 45666666 589887654 66799998643 23456888999999885 33467888999888999999999999887
Q ss_pred hHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcC---------------------------------------------
Q 003254 601 DYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQD--------------------------------------------- 635 (836)
Q Consensus 601 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~--------------------------------------------- 635 (836)
.+.... .......+..++++.|+-||..
T Consensus 108 ~~~~~~-------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 108 FQVLEE-------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp HHHHHH-------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred cccccC-------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 665421 1122334555555555555532
Q ss_pred ----------CCCcEEeccCCCCceEecCCCCceeeccCcccc
Q 003254 636 ----------SRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (836)
Q Consensus 636 ----------~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~ 668 (836)
....++|+|+.+.||++++++.+-|.||+.+..
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 112379999999999999887778999998753
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.08 E-value=8.2e-06 Score=89.15 Aligned_cols=80 Identities=6% Similarity=-0.022 Sum_probs=57.2
Q ss_pred cCee-cccCceeEEEEEee-------cCcEEEEEEecCCC---chhHHHHHHHHHHHHhhc-C--CceeeEEeEEeeC--
Q 003254 522 KNKL-GEGGFGPVYKGMLI-------EGQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQ-H--RNLVKLLGCCTQR-- 585 (836)
Q Consensus 522 ~~~l-G~G~fG~Vykg~~~-------~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~-H--~niv~l~g~~~~~-- 585 (836)
.+.| +.|....+|+.... +++.+++|+..... ......+.+|+.+++.+. + ..+.+++.++...
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3567 88999999998765 26789999864322 111256788999998885 3 3567788887655
Q ss_pred -CeeeEEEeecCCCChh
Q 003254 586 -DERMLIYEYLPNKSLD 601 (836)
Q Consensus 586 -~~~~lV~Ey~~~gsL~ 601 (836)
+..++||||+++..+.
T Consensus 105 ~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TSSCEEEEECCCCBCCC
T ss_pred cCCceEEEEecCCCChh
Confidence 3468999999987764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.73 E-value=0.00011 Score=81.45 Aligned_cols=75 Identities=12% Similarity=0.188 Sum_probs=50.6
Q ss_pred cCeecccCceeEEEEEee-cCcEEEEEEecCCCc-------hhHHHHHHHHHHHHhhcC--Ccee-eEEeEEeeCCeeeE
Q 003254 522 KNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSG-------QGMEEFKNEVLLIAKLQH--RNLV-KLLGCCTQRDERML 590 (836)
Q Consensus 522 ~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~~-------~~~~~~~~Ei~~l~~l~H--~niv-~l~g~~~~~~~~~l 590 (836)
.+.||.|..+.||+++.. +++.++||....... ...+.+..|.++++.+.. +..+ +++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 357999999999999764 468899998643211 234567889999988853 4433 55544 3455789
Q ss_pred EEeecCCC
Q 003254 591 IYEYLPNK 598 (836)
Q Consensus 591 V~Ey~~~g 598 (836)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999864
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.70 E-value=0.0002 Score=75.62 Aligned_cols=80 Identities=19% Similarity=0.228 Sum_probs=59.8
Q ss_pred ccccccCeecccCceeEEEEEeecCcEEEEEEecCCCchhHHHHHHHHHHHHhhcC---CceeeEEeEEeeCCeeeEEEe
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQH---RNLVKLLGCCTQRDERMLIYE 593 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H---~niv~l~g~~~~~~~~~lV~E 593 (836)
......+.+|.|..+.||+.++.+|+.++||+...........|..|+..|+.+.- --+.++++.. ..++|||
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e 90 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAME 90 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEE
Confidence 34555678999999999999999999999998765544444568899999998842 1244555442 3478999
Q ss_pred ecCCCCh
Q 003254 594 YLPNKSL 600 (836)
Q Consensus 594 y~~~gsL 600 (836)
|++.+..
T Consensus 91 ~l~~~~~ 97 (288)
T 3f7w_A 91 WVDERPP 97 (288)
T ss_dssp CCCCCCC
T ss_pred eecccCC
Confidence 9987754
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.66 E-value=0.00017 Score=77.78 Aligned_cols=141 Identities=16% Similarity=0.198 Sum_probs=80.5
Q ss_pred CeecccCceeEEEEEeecCcEEEEEEecCCCchhHHHHHHHHHHHHhhcC--CceeeEEe------EEeeCCeeeEEEee
Q 003254 523 NKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQH--RNLVKLLG------CCTQRDERMLIYEY 594 (836)
Q Consensus 523 ~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H--~niv~l~g------~~~~~~~~~lV~Ey 594 (836)
+.|+.|..+.||+....+| .+++|+.... ..++..|+.++..+.. -.+.+++. +....+..++||||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4566677899999887554 5899998652 2334456666665531 12333332 12345667899999
Q ss_pred cCCCChh--------------HHHhhccCC-----------CcCChhhhH------------------------------
Q 003254 595 LPNKSLD--------------YFIFDTTRS-----------KLLDWSKRS------------------------------ 619 (836)
Q Consensus 595 ~~~gsL~--------------~~l~~~~~~-----------~~l~~~~~~------------------------------ 619 (836)
+++..+. ..++..... ..-.|...+
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9987653 111111100 011222110
Q ss_pred -HHHHHHHhhhHhhhc----------CCCCcEEeccCCCCceEecCCCCceeeccCcccc
Q 003254 620 -HIIAGIARGLLYLHQ----------DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (836)
Q Consensus 620 -~i~~~ia~gL~yLH~----------~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~ 668 (836)
.+...+.+++.+|+. .....++|+|+++.|||++.++.+.|.||+.+..
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 111123345666653 1234699999999999998888999999998753
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.50 E-value=0.00057 Score=72.92 Aligned_cols=76 Identities=22% Similarity=0.188 Sum_probs=61.4
Q ss_pred ccCeecccCceeEEEEEeecCcEEEEEEecCCCchhHHHHHHHHHHHHhhc---CCceeeEEeEEeeCCeeeEEEeecCC
Q 003254 521 EKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQ---HRNLVKLLGCCTQRDERMLIYEYLPN 597 (836)
Q Consensus 521 ~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~~~~~lV~Ey~~~ 597 (836)
..+.|+.|....+|+... ++..+++|+.... ....+..|...|+.+. ...+.+++.+....+..++||||+++
T Consensus 40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 346799999999999886 5778999987532 3567889999999884 25678888888877889999999999
Q ss_pred CCh
Q 003254 598 KSL 600 (836)
Q Consensus 598 gsL 600 (836)
..+
T Consensus 116 ~~~ 118 (312)
T 3jr1_A 116 SKN 118 (312)
T ss_dssp CCC
T ss_pred CCC
Confidence 865
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.28 E-value=0.00095 Score=74.47 Aligned_cols=77 Identities=9% Similarity=0.048 Sum_probs=47.0
Q ss_pred CcEEeccCCCCceEecCCCCceeeccCcccccCCCcccccccccc--ccccccCcccccCC---ccCccccccchhhhhh
Q 003254 638 LRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVV--GTYGYMSPEYAIDG---LFSVKSDVFSFGVLVL 712 (836)
Q Consensus 638 ~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~---~~t~ksDVwS~GvvL~ 712 (836)
..++|+|++|.|||+++++ ++|.||+.+..-..... ..... -...|.+|+..... .-....++......+|
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~D---la~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFD---IGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW 307 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHH---HHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHH---HHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence 4599999999999998776 99999998875321110 00011 11345666544311 1123355567777888
Q ss_pred hhhhCC
Q 003254 713 EIICGK 718 (836)
Q Consensus 713 elltG~ 718 (836)
+.++++
T Consensus 308 ~~y~~~ 313 (420)
T 2pyw_A 308 NLFNKR 313 (420)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 777653
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.03 E-value=0.0019 Score=72.18 Aligned_cols=73 Identities=19% Similarity=0.286 Sum_probs=51.0
Q ss_pred cCeecccCceeEEEEEeec--------CcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCce-eeEEeEEeeCCeeeEEE
Q 003254 522 KNKLGEGGFGPVYKGMLIE--------GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNL-VKLLGCCTQRDERMLIY 592 (836)
Q Consensus 522 ~~~lG~G~fG~Vykg~~~~--------g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~ 592 (836)
.+.|+.|....+|+....+ ++.+++|+..... ..+.+..|..++..+...++ .++++.+.. .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 3578889999999998753 4789999884321 12455679999998853333 567766543 3899
Q ss_pred eecCCCCh
Q 003254 593 EYLPNKSL 600 (836)
Q Consensus 593 Ey~~~gsL 600 (836)
||+++.+|
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99987554
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.95 E-value=0.0025 Score=67.98 Aligned_cols=144 Identities=15% Similarity=0.101 Sum_probs=79.7
Q ss_pred cCeecccCceeEEEEEeecCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCc--eeeEEeE------EeeCCeeeEEEe
Q 003254 522 KNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRN--LVKLLGC------CTQRDERMLIYE 593 (836)
Q Consensus 522 ~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~n--iv~l~g~------~~~~~~~~lV~E 593 (836)
.+.|+.|....+|+....+| .+++|+.... ...+++..|+.++..+...+ +.+++.. ....+..++++|
T Consensus 27 ~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~ 103 (322)
T 2ppq_A 27 YKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALIS 103 (322)
T ss_dssp EEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEE
T ss_pred eeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEE
Confidence 34577788899999987555 6889988652 12345667888887774222 2333321 122355789999
Q ss_pred ecCCCChhH--------------HHhhccCC---C------cCChhhhHHH------------HHHHHhhhHhhhcC---
Q 003254 594 YLPNKSLDY--------------FIFDTTRS---K------LLDWSKRSHI------------IAGIARGLLYLHQD--- 635 (836)
Q Consensus 594 y~~~gsL~~--------------~l~~~~~~---~------~l~~~~~~~i------------~~~ia~gL~yLH~~--- 635 (836)
|+++..+.. .++..... . ...|.....- ...+.+.++.+++.
T Consensus 104 ~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~ 183 (322)
T 2ppq_A 104 FLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPK 183 (322)
T ss_dssp CCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCC
T ss_pred eCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcc
Confidence 999875421 01111000 0 0112211100 01123334444321
Q ss_pred -CCCcEEeccCCCCceEecCCCCceeeccCcccc
Q 003254 636 -SRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (836)
Q Consensus 636 -~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~ 668 (836)
....++|+|+.+.|||++++..+.|.||+.+..
T Consensus 184 ~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 184 DLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp SSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 234699999999999999876668999987753
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.90 E-value=0.0015 Score=69.22 Aligned_cols=72 Identities=11% Similarity=0.186 Sum_probs=46.6
Q ss_pred cCeecccCceeEEEEEeecCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCce-eeEEeEEeeCCeeeEEEeec-CCCC
Q 003254 522 KNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNL-VKLLGCCTQRDERMLIYEYL-PNKS 599 (836)
Q Consensus 522 ~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~Ey~-~~gs 599 (836)
.+.|+.|....+|+. +.+++|+....... .....+|+.+++.+...++ .+++++. .+.-++|+||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCcc
Confidence 568999999999998 56888887643221 1233568888887753333 4555543 34457899999 6655
Q ss_pred hh
Q 003254 600 LD 601 (836)
Q Consensus 600 L~ 601 (836)
+.
T Consensus 95 l~ 96 (301)
T 3dxq_A 95 MS 96 (301)
T ss_dssp CC
T ss_pred CC
Confidence 53
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.84 E-value=0.0049 Score=69.33 Aligned_cols=74 Identities=14% Similarity=0.071 Sum_probs=49.1
Q ss_pred cCeecccCceeEEEEEeec-CcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCce-eeEEeEEeeCCeeeEEEeecCCCC
Q 003254 522 KNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNL-VKLLGCCTQRDERMLIYEYLPNKS 599 (836)
Q Consensus 522 ~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~Ey~~~gs 599 (836)
.+.|+.|-...+|+....+ +..+++|+........ -.-.+|..++..+...++ .++++.+. + .+||||+++.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 3578889999999998765 4788899874432221 122589999999875445 56777663 2 25999998765
Q ss_pred h
Q 003254 600 L 600 (836)
Q Consensus 600 L 600 (836)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.82 E-value=0.0042 Score=68.02 Aligned_cols=141 Identities=17% Similarity=0.218 Sum_probs=83.4
Q ss_pred CeecccCceeEEEEEeec--------CcEEEEEEecCCCchhHHHHHHHHHHHHhhc-CCceeeEEeEEeeCCeeeEEEe
Q 003254 523 NKLGEGGFGPVYKGMLIE--------GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQRDERMLIYE 593 (836)
Q Consensus 523 ~~lG~G~fG~Vykg~~~~--------g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~E 593 (836)
+.|..|-...+|+....+ ++.+++|+.... ........+|..+++.+. +.-..++++++.. .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 568888889999988752 478999986332 223456678999998885 3333566766654 29999
Q ss_pred ecCCCChhHH-----------------Hhhcc--CCCcCC--hhhhHHHHHHHHh-------------------hhHhh-
Q 003254 594 YLPNKSLDYF-----------------IFDTT--RSKLLD--WSKRSHIIAGIAR-------------------GLLYL- 632 (836)
Q Consensus 594 y~~~gsL~~~-----------------l~~~~--~~~~l~--~~~~~~i~~~ia~-------------------gL~yL- 632 (836)
|+++..|... ++... -.+... |.++.++..++.. .+..|
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9998765421 01100 011122 3344444444322 12222
Q ss_pred ---hcC-CCCcEEeccCCCCceEecCC----CCceeeccCcccc
Q 003254 633 ---HQD-SRLRIIHRDLKASNVLLDNT----MNPKISDFGLARS 668 (836)
Q Consensus 633 ---H~~-~~~~ivH~DLkp~NILl~~~----~~~kl~DFgla~~ 668 (836)
... ....++|+|+.+.||+++++ +.+.|.||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 221 23469999999999999876 7899999998753
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.62 E-value=0.0093 Score=63.98 Aligned_cols=141 Identities=16% Similarity=0.107 Sum_probs=72.6
Q ss_pred CeecccCcee-EEEEEeecCcEEEEEEecCCCchhHHHHHHHHHHHHhhcC--CceeeEEeEEeeCCeeeEEEeecCCCC
Q 003254 523 NKLGEGGFGP-VYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQH--RNLVKLLGCCTQRDERMLIYEYLPNKS 599 (836)
Q Consensus 523 ~~lG~G~fG~-Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H--~niv~l~g~~~~~~~~~lV~Ey~~~gs 599 (836)
+.|+.|.... +|+....+|+.+++|...... .+.+..|+.++..+.. -.+.+++.+.... -++|||++.+..
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~---~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEE---GGDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTT---TCCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCC---CccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCcc
Confidence 4566665554 667765447778887654322 1344567777777742 2345666664332 378999998766
Q ss_pred hhHHHhhcc---------------------CC--CcCChhhhH-------H-H------------HHHHHhhhHhhh---
Q 003254 600 LDYFIFDTT---------------------RS--KLLDWSKRS-------H-I------------IAGIARGLLYLH--- 633 (836)
Q Consensus 600 L~~~l~~~~---------------------~~--~~l~~~~~~-------~-i------------~~~ia~gL~yLH--- 633 (836)
+.+.+.... .. ..++..... . + ...+.+.+..+.
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 644332100 00 011110000 0 0 001111122221
Q ss_pred cCCCCcEEeccCCCCceEecCC----CCceeeccCcccc
Q 003254 634 QDSRLRIIHRDLKASNVLLDNT----MNPKISDFGLARS 668 (836)
Q Consensus 634 ~~~~~~ivH~DLkp~NILl~~~----~~~kl~DFgla~~ 668 (836)
......++|+|+.+.||+++.+ ..+.|.||+.+..
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 1123469999999999999874 6789999998864
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.57 E-value=0.011 Score=63.26 Aligned_cols=76 Identities=9% Similarity=0.074 Sum_probs=50.7
Q ss_pred CeecccCceeEEEEEeecCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCc--eeeEEeE-----EeeCCeeeEEEeec
Q 003254 523 NKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRN--LVKLLGC-----CTQRDERMLIYEYL 595 (836)
Q Consensus 523 ~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~n--iv~l~g~-----~~~~~~~~lV~Ey~ 595 (836)
..++ |....||+....+|+.+++|+..... ...+.+..|..++..+.... +.+++.. ....+..++||||+
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 3566 88889999887678789999986332 23456777888888875222 3444443 12244567899999
Q ss_pred CCCCh
Q 003254 596 PNKSL 600 (836)
Q Consensus 596 ~~gsL 600 (836)
++..+
T Consensus 110 ~G~~~ 114 (328)
T 1zyl_A 110 GGRQF 114 (328)
T ss_dssp CCEEC
T ss_pred CCCCC
Confidence 88654
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.50 E-value=0.006 Score=66.60 Aligned_cols=73 Identities=15% Similarity=0.126 Sum_probs=45.4
Q ss_pred CeecccCceeEEEEEeecC---------cEEEEEEecCCCchhHHHHHHHHHHHHhhcCCc-eeeEEeEEeeCCeeeEEE
Q 003254 523 NKLGEGGFGPVYKGMLIEG---------QEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRN-LVKLLGCCTQRDERMLIY 592 (836)
Q Consensus 523 ~~lG~G~fG~Vykg~~~~g---------~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~n-iv~l~g~~~~~~~~~lV~ 592 (836)
+.|+.|....+|+....++ +.+++|+...... .......|..++..+...+ ..++++.. .-.+||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF----NGGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec----CCcEEE
Confidence 4678888899999987542 6888888754322 1223467888888885333 34666544 136899
Q ss_pred eecCCCCh
Q 003254 593 EYLPNKSL 600 (836)
Q Consensus 593 Ey~~~gsL 600 (836)
||+++..+
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99988654
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.05 E-value=0.022 Score=61.40 Aligned_cols=67 Identities=7% Similarity=0.060 Sum_probs=43.4
Q ss_pred ccCceeEEEEEeecCcEEEEEEecCCCchhHHHHHHHHHHHHhhcC---CceeeEEeE------EeeCCeeeEEEeecCC
Q 003254 527 EGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQH---RNLVKLLGC------CTQRDERMLIYEYLPN 597 (836)
Q Consensus 527 ~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H---~niv~l~g~------~~~~~~~~lV~Ey~~~ 597 (836)
.|....||+....+| .+++|+...... ..|+.++..+.. +.+.+++.. ....+..++||||+++
T Consensus 33 ~g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G 105 (339)
T 3i1a_A 33 ADTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHA 105 (339)
T ss_dssp SCSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCC
T ss_pred CccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCC
Confidence 333679999987667 899998765431 356666666531 224444432 2334667899999998
Q ss_pred CCh
Q 003254 598 KSL 600 (836)
Q Consensus 598 gsL 600 (836)
..+
T Consensus 106 ~~~ 108 (339)
T 3i1a_A 106 PNG 108 (339)
T ss_dssp CBT
T ss_pred CcC
Confidence 765
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.37 E-value=0.021 Score=56.59 Aligned_cols=102 Identities=9% Similarity=0.002 Sum_probs=66.0
Q ss_pred ChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcccccc
Q 003254 599 SLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANT 678 (836)
Q Consensus 599 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~ 678 (836)
+|.+.|.. ...++++++++.++.|.+++|.-+-... .+ ..+=+.|..|+|..+|.|.+.+ ..+.
T Consensus 34 SL~eIL~~--~~~PlsEEqaWALc~Qc~~~L~~~~~~~-~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 34 SLEEILRL--YNQPINEEQAWAVCYQCCGSLRAAARRR-QP-RHRVRSAAQIRVWRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT-CC-CCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred cHHHHHHH--cCCCcCHHHHHHHHHHHHHHHHhhhhcc-cC-CceecCCcceEEecCCceeccc-cccc-----------
Confidence 78888843 4678999999999999999987762111 01 1233457899999999988764 1110
Q ss_pred ccccccccccCcccccCCccCccccccchhhhhhhhhhCCCC
Q 003254 679 KRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKN 720 (836)
Q Consensus 679 ~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p 720 (836)
.....+.|||... ...+.+.-|||+|+++|.-+--..|
T Consensus 98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp ------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 1123456888763 3457889999999999998775443
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=93.88 E-value=0.19 Score=55.57 Aligned_cols=74 Identities=14% Similarity=0.141 Sum_probs=49.4
Q ss_pred cCeecccCceeEEEEEeec--------CcEEEEEEecCCCchhHHHHHHHHHHHHhhc-CCceeeEEeEEeeCCeeeEEE
Q 003254 522 KNKLGEGGFGPVYKGMLIE--------GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQRDERMLIY 592 (836)
Q Consensus 522 ~~~lG~G~fG~Vykg~~~~--------g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~ 592 (836)
.+.|..|-...+|+....+ ++.+++|+....... .-.-.+|..+++.+. +.-..++++.+. -++||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADFP----EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence 3567888889999998753 578999986543222 223467888888885 332345555332 37899
Q ss_pred eecCCCCh
Q 003254 593 EYLPNKSL 600 (836)
Q Consensus 593 Ey~~~gsL 600 (836)
||+++..|
T Consensus 150 efI~G~~l 157 (424)
T 3mes_A 150 EFIDGEPL 157 (424)
T ss_dssp ECCCSEEC
T ss_pred EEeCCccC
Confidence 99998764
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=91.84 E-value=0.58 Score=51.37 Aligned_cols=30 Identities=23% Similarity=0.365 Sum_probs=25.3
Q ss_pred cEEeccCCCCceEe------cCCCCceeeccCcccc
Q 003254 639 RIIHRDLKASNVLL------DNTMNPKISDFGLARS 668 (836)
Q Consensus 639 ~ivH~DLkp~NILl------~~~~~~kl~DFgla~~ 668 (836)
.++|+|+.+.|||+ +++..+++.||.+|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 36799999999999 4567899999998754
|
| >3no2_A Uncharacterized protein; six-bladed beta-propeller, structural genomics, joint center structural genomics, JCSG, protein structure initiative; HET: MSE CIT PEG; 1.35A {Bacteroides caccae} | Back alignment and structure |
|---|
Probab=86.72 E-value=18 Score=36.82 Aligned_cols=74 Identities=11% Similarity=0.212 Sum_probs=46.5
Q ss_pred EEEEEEeecCCCcEEEeecCCCC--CC----CCcceEEEeeccCceEEEEcCCCCeEEeecccCCCCcceEEEecCCCeE
Q 003254 81 YLGIWYKKIAEGTVTWVANRDAP--LS----DRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAALMESGNLV 154 (836)
Q Consensus 81 ylgiw~~~~~~~t~vW~Anr~~p--~~----~~~~~l~~~~~~~g~l~l~~~~~~~~wst~~~~~~~~~~a~lld~GNlv 154 (836)
.+.||= ....+++|...+..+ +. .+.+.+-++ .++.+..+|.+|..+|.-..........+..+.+||++
T Consensus 16 ~v~~~d--~~tG~~~w~~~~~~~~~~~~~~~~pdG~ilvs--~~~~V~~~d~~G~~~W~~~~~~~~~~~~~~~~~dG~~l 91 (276)
T 3no2_A 16 KIAIIN--KDTKEIVWEYPLEKGWECNSVAATKAGEILFS--YSKGAKMITRDGRELWNIAAPAGCEMQTARILPDGNAL 91 (276)
T ss_dssp EEEEEE--TTTTEEEEEEECCTTCCCCEEEECTTSCEEEE--CBSEEEEECTTSCEEEEEECCTTCEEEEEEECTTSCEE
T ss_pred EEEEEE--CCCCeEEEEeCCCccCCCcCeEECCCCCEEEe--CCCCEEEECCCCCEEEEEcCCCCccccccEECCCCCEE
Confidence 355652 336788899887542 21 123555554 45667777889999999875322223346778888888
Q ss_pred EecC
Q 003254 155 VKDG 158 (836)
Q Consensus 155 l~~~ 158 (836)
+.+.
T Consensus 92 v~~~ 95 (276)
T 3no2_A 92 VAWC 95 (276)
T ss_dssp EEEE
T ss_pred EEec
Confidence 8754
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=82.31 E-value=3.2 Score=40.93 Aligned_cols=84 Identities=13% Similarity=0.055 Sum_probs=60.5
Q ss_pred cCCceeeEEeEEeeCCeeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCce
Q 003254 571 QHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNV 650 (836)
Q Consensus 571 ~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NI 650 (836)
.||++++. .+-.+.+...+.|+.-++ ...+- .-+.++...+++++.+|+....+++. -+|--|.|+||
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~--~~~f~----~ik~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL 110 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDN--HTPFD----NIKSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDEL 110 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTT--SEEGG----GGGGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcc--cCCHH----HHHhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceE
Confidence 58888877 455556665555554332 21111 12347789999999999999877764 47889999999
Q ss_pred EecCCCCceeeccCcc
Q 003254 651 LLDNTMNPKISDFGLA 666 (836)
Q Consensus 651 Ll~~~~~~kl~DFgla 666 (836)
+++.++.+++.-.|+-
T Consensus 111 ~f~~~~~p~i~~RGik 126 (215)
T 4ann_A 111 FFTRDGLPIAKTRGLQ 126 (215)
T ss_dssp EECTTSCEEESCCEET
T ss_pred EEcCCCCEEEEEccCc
Confidence 9999999999876653
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 836 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-73 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-67 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-65 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-65 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-64 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 6e-64 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-62 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-62 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-61 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-61 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-60 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-60 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-60 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 5e-60 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-59 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-59 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-59 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-59 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-59 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-59 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 5e-59 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-58 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-57 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-57 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-57 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 5e-57 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-56 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-55 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-53 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-53 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-50 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-50 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 9e-50 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-48 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-46 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 6e-46 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-45 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-45 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-45 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 9e-45 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-44 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-44 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-43 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-42 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 4e-42 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-41 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-41 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-41 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-40 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-40 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-38 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-38 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-38 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-37 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-36 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 7e-36 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-35 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-33 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 6e-33 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-31 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-31 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-27 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-24 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 1e-18 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 3e-14 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 8e-14 | |
| d1xd5a_ | 112 | b.78.1.1 (A:) Gastrodianin (antifungal protein) {G | 2e-13 | |
| d1b2pa_ | 119 | b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill | 3e-10 | |
| d1dlpa1 | 115 | b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p | 2e-08 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 238 bits (609), Expect = 4e-73
Identities = 66/286 (23%), Positives = 139/286 (48%), Gaps = 21/286 (7%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLV 576
+ ++G G FG VYKG + + ++ + Q ++ FKNEV ++ K +H N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 577 KLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDS 636
+G T + ++ ++ SL + + + K I A+G+ YLH S
Sbjct: 68 LFMGYSTA-PQLAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHAKS 124
Query: 637 RLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYA--- 693
IIHRDLK++N+ L + KI DFGLA +++ G+ +M+PE
Sbjct: 125 ---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 694 IDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSL 753
+S +SDV++FG+++ E++ G+ +++ ++ ++ R ++ ++
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLP--YSNINNRDQIIFMVGRGYLSPDLSKVRS--- 236
Query: 754 DNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSG-ERSLPQ 798
+ +A++ ++ C++++ ++RP ++ + RSLP+
Sbjct: 237 ----NCPKAMK--RLMAECLKKKRDERPLFPQILASIELLARSLPK 276
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (568), Expect = 2e-67
Identities = 88/292 (30%), Positives = 146/292 (50%), Gaps = 32/292 (10%)
Query: 499 KEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGME 558
++E E+P LK++ +LG G FG V+ G ++AVK L +GS +
Sbjct: 5 EDEWEVPRETLKLV----------ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPD 53
Query: 559 EFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKR 618
F E L+ +LQH+ LV+L TQ + +I EY+ N SL F+ + KL +K
Sbjct: 54 AFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKL-TINKL 111
Query: 619 SHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANT 678
+ A IA G+ ++ + + IHRDL+A+N+L+ +T++ KI+DFGLAR ++ A
Sbjct: 112 LDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE 168
Query: 679 KRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWR 738
+ +PE G F++KSDV+SFG+L+ EI+ + + ++ + R
Sbjct: 169 -GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRI--PYPGMTNPEVIQNLER 225
Query: 739 LWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLML 790
+ RP ++ Q+ LC ++RPEDRP + +L
Sbjct: 226 GYRMVRPDNCPEE-------------LYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (556), Expect = 2e-65
Identities = 82/314 (26%), Positives = 141/314 (44%), Gaps = 33/314 (10%)
Query: 491 KHSNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLS 550
K QG K+ E+P L++ KLG+G FG V+ G +A+K L
Sbjct: 1 KPQTQGLAKDAWEIPRESLRLE----------VKLGQGCFGEVWMGTWNGTTRVAIKTLK 50
Query: 551 KGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRS 610
G+ E F E ++ KL+H LV+L ++ + ++ EY+ SL F+
Sbjct: 51 PGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE-TG 107
Query: 611 KLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670
K L + + A IA G+ Y+ + + +HRDL+A+N+L+ + K++DFGLAR
Sbjct: 108 KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIE 164
Query: 671 LDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDH 730
++ A + +PE A+ G F++KSDV+SFG+L+ E+ +
Sbjct: 165 DNEYTARQ-GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR----------- 212
Query: 731 NLLGHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLML 790
+ + L+ +++ C + C ++ PE+RP + L
Sbjct: 213 ----VPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 268
Query: 791 SGERSLPQPQ-QPG 803
+ +PQ QPG
Sbjct: 269 EDYFTSTEPQYQPG 282
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (551), Expect = 4e-65
Identities = 70/275 (25%), Positives = 121/275 (44%), Gaps = 22/275 (8%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLV 576
+ ++G G FG V+ G + ++A+K + +G+ E+F E ++ KL H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLV 63
Query: 577 KLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDS 636
+L G C ++ L++E++ + L ++ + L + + G+ YL +
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEE-- 119
Query: 637 RLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDG 696
+IHRDL A N L+ K+SDFG+ R F LD ++ + SPE
Sbjct: 120 -ACVIHRDLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFS 177
Query: 697 LFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDNS 756
+S KSDV+SFGVL+ E+ K + ++ + +P
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKI--PYENRSNSEVVEDISTGFRLYKPRLAST------ 229
Query: 757 CSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLS 791
Q+ C ++RPEDRP S ++ L+
Sbjct: 230 -------HVYQIMNHCWKERPEDRPAFSRLLRQLA 257
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (551), Expect = 1e-64
Identities = 62/292 (21%), Positives = 115/292 (39%), Gaps = 28/292 (9%)
Query: 522 KNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGC 581
+ +G+G FG V++G G+E+AVK S + + E+ L+H N++ +
Sbjct: 8 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAA 65
Query: 582 CTQRD----ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQD-- 635
+ + + L+ +Y + SL ++ + + A GL +LH +
Sbjct: 66 DNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIV 121
Query: 636 ---SRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF--GLDQTEANTKRVVGTYGYMSP 690
+ I HRDLK+ N+L+ I+D GLA D + VGT YM+P
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181
Query: 691 EYAIDGL------FSVKSDVFSFGVLVLEIICGKKNRGFNHAD----HDHNLLGHAWRLW 740
E D + ++D+++ G++ EI G + +D +
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241
Query: 741 IEERPLELIDQSLDNSCSFSEALRCI-QVGLLCVQQRPEDRPNMSSVVLMLS 791
+ + + ++ N EALR + ++ C R + LS
Sbjct: 242 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (542), Expect = 6e-64
Identities = 65/274 (23%), Positives = 115/274 (41%), Gaps = 22/274 (8%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLV 576
+ + +LG G FG V G ++A+K + +GS +EF E ++ L H LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 62
Query: 577 KLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDS 636
+L G CT++ +I EY+ N L ++ + + + + + YL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESK- 119
Query: 637 RLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDG 696
+ +HRDL A N L+++ K+SDFGL+R D ++ + PE +
Sbjct: 120 --QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYS 176
Query: 697 LFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDNS 756
FS KSD+++FGVL+ EI K + + E I Q L
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGK---------------MPYERFTNSETAEHIAQGLRLY 221
Query: 757 CSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLML 790
+ + + C ++ ++RP ++ +
Sbjct: 222 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNI 255
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (539), Expect = 1e-62
Identities = 61/276 (22%), Positives = 113/276 (40%), Gaps = 11/276 (3%)
Query: 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGM-EEFKNEVLLIAKLQH 572
D+F + ++LG G G V+K G +A K + + + E+ ++ +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 573 RNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYL 632
+V G E + E++ SLD + ++ + + + +GL YL
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYL 120
Query: 633 HQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEY 692
+ +I+HRD+K SN+L+++ K+ DFG++ ++ VGT YMSPE
Sbjct: 121 R--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMSPER 174
Query: 693 AIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQS 752
+SV+SD++S G+ ++E+ G+ A + G E P
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234
Query: 753 LDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788
S ++ + + L E P + S V
Sbjct: 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVF 270
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 210 bits (536), Expect = 2e-62
Identities = 70/301 (23%), Positives = 125/301 (41%), Gaps = 37/301 (12%)
Query: 507 FDLKIIANATDNFSEK---------NKLGEGGFGPVYKGMLI----EGQEIAVKRLSKG- 552
F + A F+++ +G G FG V G L +A+K L G
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 553 SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKL 612
+ + +F +E ++ + H N++ L G T+ M+I E++ N SLD F+
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ--NDGQ 124
Query: 613 LDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672
+ ++ GIA G+ YL + +HRDL A N+L+++ + K+SDFGL+R D
Sbjct: 125 FTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 673 QTEANTKRVVG---TYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHD 729
++ +G + +PE F+ SDV+S+G+++ E++ +
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE---------- 231
Query: 730 HNLLGHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789
+ + + I+Q Q+ L C Q+ RP +V
Sbjct: 232 -----RPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286
Query: 790 L 790
L
Sbjct: 287 L 287
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 207 bits (527), Expect = 2e-61
Identities = 71/275 (25%), Positives = 127/275 (46%), Gaps = 22/275 (8%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNL 575
+ + K+KLG G +G VY+G+ + +AVK L + + + +EEF E ++ +++H NL
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 75
Query: 576 VKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQD 635
V+LLG CT+ +I E++ +L ++ + R + + ++ I+ + YL
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYLE-- 132
Query: 636 SRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAID 695
+ IHRDL A N L+ K++DFGL+R D A+ + +PE
Sbjct: 133 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA-GAKFPIKWTAPESLAY 190
Query: 696 GLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDN 755
FS+KSDV++FGVL+ EI + + + EL+++
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATYGMSP---------------YPGIDLSQVYELLEKDYRM 235
Query: 756 SCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLML 790
+ ++ C Q P DRP+ + +
Sbjct: 236 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 270
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 207 bits (526), Expect = 4e-61
Identities = 71/319 (22%), Positives = 124/319 (38%), Gaps = 56/319 (17%)
Query: 500 EEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIE------GQEIAVKRLSKGS 553
+E P +N +GEG FG V++ +AVK L + +
Sbjct: 6 LSLEYP----------RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA 55
Query: 554 GQGME-EFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKL 612
M+ +F+ E L+A+ + N+VKLLG C L++EY+ L+ F+ + +
Sbjct: 56 SADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTV 115
Query: 613 ---------------------LDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVL 651
L +++ I +A G+ YL + + +HRDL N L
Sbjct: 116 CSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCL 172
Query: 652 LDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLV 711
+ M KI+DFGL+R+ +M PE ++ +SDV+++GV++
Sbjct: 173 VGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVL 232
Query: 712 LEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLL 771
EI + A + + L + + L + L
Sbjct: 233 WEIFSYGLQPYYGMAHEE------VIYYVRDGNILACPE---------NCPLELYNLMRL 277
Query: 772 CVQQRPEDRPNMSSVVLML 790
C + P DRP+ S+ +L
Sbjct: 278 CWSKLPADRPSFCSIHRIL 296
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (521), Expect = 1e-60
Identities = 71/288 (24%), Positives = 127/288 (44%), Gaps = 27/288 (9%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIEGQE-----IAVKRLSKGSGQGM-EEFKNEVLLIAKL 570
+ + +G G FG VYKGML +A+K L G + +F E ++ +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 571 QHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLL 630
H N+++L G ++ M+I EY+ N +LD F+ + + + ++ GIA G+
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMK 124
Query: 631 YLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANT-KRVVGTYGYMS 689
YL + +HRDL A N+L+++ + K+SDFGL+R D T + +
Sbjct: 125 YLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181
Query: 690 PEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELI 749
PE F+ SDV+SFG+++ E++ + + ++H+ ++ I
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV---------------MKAI 226
Query: 750 DQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLP 797
+ Q+ + C QQ RP + +V +L P
Sbjct: 227 NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 274
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 2e-60
Identities = 70/282 (24%), Positives = 123/282 (43%), Gaps = 27/282 (9%)
Query: 515 ATDNFS-EKNKLGEGGFGPVYKGMLI---EGQEIAVKRLSKGSGQG-MEEFKNEVLLIAK 569
DN +LG G FG V +G+ + ++A+K L +G+ + EE E ++ +
Sbjct: 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 65
Query: 570 LQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGL 629
L + +V+L+G C Q + ML+ E L F+ + + + S + ++ ++ G+
Sbjct: 66 LDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGM 122
Query: 630 LYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKR-VVGTYGYM 688
YL + +HRDL A NVLL N KISDFGL+++ G D + + +
Sbjct: 123 KYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 179
Query: 689 SPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLEL 748
+PE FS +SDV+S+GV + E + + ++ +
Sbjct: 180 APECINFRKFSSRSDVWSYGVTMWEALSYGQ---------------KPYKKMKGPEVMAF 224
Query: 749 IDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLML 790
I+Q C + C + EDRP+ +V +
Sbjct: 225 IEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 266
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 3e-60
Identities = 67/276 (24%), Positives = 113/276 (40%), Gaps = 28/276 (10%)
Query: 521 EKNKLGEGGFGPVYKGMLIE---GQEIAVKRLSKGSGQG--MEEFKNEVLLIAKLQHRNL 575
E +LG G FG V KG + +AVK L + +E E ++ +L + +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 576 VKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQD 635
V+++G C + + ML+ E L+ ++ + ++ ++ G+ YL +
Sbjct: 71 VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEES 126
Query: 636 SRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTK-RVVGTYGYMSPEYAI 694
+HRDL A NVLL KISDFGL+++ D+ + + +PE
Sbjct: 127 ---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 183
Query: 695 DGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLD 754
FS KSDV+SFGVL+ E + +R ++++
Sbjct: 184 YYKFSSKSDVWSFGVLMWEAFSYGQ---------------KPYRGMKGSEVTAMLEKGER 228
Query: 755 NSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLML 790
C + LC E+RP ++V L L
Sbjct: 229 MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 264
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 5e-60
Identities = 79/325 (24%), Positives = 138/325 (42%), Gaps = 44/325 (13%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIEG---QEIAVKRLSK-GSGQGMEEFKNEVLLIAKL-Q 571
++ ++ +GEG FG V K + + + A+KR+ + S +F E+ ++ KL
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 572 HRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFI-------------FDTTRSKLLDWSKR 618
H N++ LLG C R L EY P+ +L F+ + + L +
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 619 SHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANT 678
H A +ARG+ YL Q + IHRDL A N+L+ KI+DFGL+R +
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQ---EVYVKK 183
Query: 679 KRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWR 738
+M+ E +++ SDV+S+GVL+ EI+ L +
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT--PYCGMTCAELYEKLPQ 241
Query: 739 LWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQ 798
+ E+PL D+ + C +++P +RP+ + +++ L R L +
Sbjct: 242 GYRLEKPLNCDDE-------------VYDLMRQCWREKPYERPSFAQILVSL--NRMLEE 286
Query: 799 PQQPGFFTGRNLPESESSSSRQYSA 823
+ + L E + + SA
Sbjct: 287 RKT---YVNTTLYEKFTYAGIDCSA 308
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 202 bits (516), Expect = 1e-59
Identities = 77/320 (24%), Positives = 127/320 (39%), Gaps = 47/320 (14%)
Query: 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQG---MEEFKNEVLLIAKLQ 571
FS+ ++G G FG VY + + +A+K++S Q ++ EV + KL+
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 572 HRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLY 631
H N ++ GC + L+ EY + D K L + + + G +GL Y
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAY 130
Query: 632 LHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPE 691
LH +IHRD+KA N+LL K+ DFG A A VGT +M+PE
Sbjct: 131 LHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANSFVGTPYWMAPE 181
Query: 692 YAI---DGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLEL 748
+ +G + K DV+S G+ +E+ K + N + + + E P
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERK------PPLFNMNAMSALYHIAQNESPAL- 234
Query: 749 IDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPQQPGFFTGR 808
S +SE R C+Q+ P+DRP ++ + F
Sbjct: 235 ------QSGHWSEYFR--NFVDSCLQKIPQDRPTSEVLL------------KHR-FVLRE 273
Query: 809 NLPESESSSSRQYSASTNEI 828
P ++ + E+
Sbjct: 274 RPPTVIMDLIQRTKDAVREL 293
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 1e-59
Identities = 66/273 (24%), Positives = 110/273 (40%), Gaps = 23/273 (8%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGM-EEFKNEVLLIAKLQHRN 574
+++ LGEG +G V + + +AVK + E K E+ + L H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQ 634
+VK G + + + L EY L I + + G++YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVVYLHG 121
Query: 635 DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAI 694
+ I HRD+K N+LLD N KISDFGLA F + E ++ GT Y++PE
Sbjct: 122 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 695 DGLF-SVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSL 753
F + DV+S G+++ ++ G+ D + W E++ + +
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGEL---PWDQPSDSCQE---YSDWKEKKTYLNPWKKI 232
Query: 754 DNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSV 786
D S L + + + P R + +
Sbjct: 233 D-----SAPLALLH---KILVENPSARITIPDI 257
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 2e-59
Identities = 73/326 (22%), Positives = 138/326 (42%), Gaps = 32/326 (9%)
Query: 509 LKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQE-----IAVKRLSKG-SGQGMEEFKN 562
L+I+ T+ F + LG G FG VYKG+ I E +A+K L + S + +E +
Sbjct: 3 LRIL-KETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD 60
Query: 563 EVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHII 622
E ++A + + ++ +LLG C LI + +P L ++ + + +
Sbjct: 61 EAYVMASVDNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWC 117
Query: 623 AGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVV 682
IA+G+ YL R++HRDL A NVL+ + KI+DFGLA+ G ++ E + +
Sbjct: 118 VQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 174
Query: 683 GTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIE 742
+M+ E + +++ +SDV+S+GV V E++ +
Sbjct: 175 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS---------------KPYDGIPA 219
Query: 743 ERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPQQP 802
++++ + + + C + RP +++ + PQ+
Sbjct: 220 SEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF--SKMARDPQRY 277
Query: 803 GFFTG-RNLPESESSSSRQYSASTNE 827
G + + S Y A +E
Sbjct: 278 LVIQGDERMHLPSPTDSNFYRALMDE 303
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 3e-59
Identities = 64/275 (23%), Positives = 107/275 (38%), Gaps = 28/275 (10%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLV 576
+G+G FG V G G ++AVK + + + F E ++ +L+H NLV
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 63
Query: 577 KLLGCCTQRDERM-LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQD 635
+LLG + + ++ EY+ SL ++ R +L + + YL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLE-- 120
Query: 636 SRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAID 695
+HRDL A NVL+ K+SDFGL + Q + +PE +
Sbjct: 121 -GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-----TGKLPVKWTAPEALRE 174
Query: 696 GLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDN 755
FS KSDV+SFG+L+ EI + +++ + + + P +
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGRV--PYPRIPLKDVVPRVEKGYKMDAP---------D 223
Query: 756 SCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLML 790
C +V C RP+ + L
Sbjct: 224 GCP----PAVYEVMKNCWHLDAAMRPSFLQLREQL 254
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 3e-59
Identities = 67/302 (22%), Positives = 112/302 (37%), Gaps = 40/302 (13%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE------GQEIAVKRLSKGSGQG-MEEFKNEVLLIAK 569
+ S LG G FG V + +AVK L + E +E+ +++
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 570 L-QHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKL---------------L 613
L H N+V LLG CT ++I EY L F+ S + L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 614 DWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673
D +A+G+ +L IHRDL A N+LL + KI DFGLAR D
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 674 TEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLL 733
+M+PE + +++ +SDV+S+G+ + E+ +
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS------------- 246
Query: 734 GHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 793
+ ++ + ++I + + C P RP +V ++ +
Sbjct: 247 -PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
Query: 794 RS 795
S
Sbjct: 306 IS 307
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (511), Expect = 4e-59
Identities = 66/279 (23%), Positives = 123/279 (44%), Gaps = 27/279 (9%)
Query: 514 NATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQH 572
N D + +LG+G FG VYK E A K + S + +E++ E+ ++A H
Sbjct: 9 NPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDH 68
Query: 573 RNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYL 632
N+VKLL + ++ E+ ++D + + + L S+ + L YL
Sbjct: 69 PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYL 126
Query: 633 HQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEY 692
H +IIHRDLKA N+L + K++DFG++ ++ +GT +M+PE
Sbjct: 127 HD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEV 181
Query: 693 AI-----DGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLE 747
+ D + K+DV+S G+ ++E+ + +H + +L + P
Sbjct: 182 VMCETSKDRPYDYKADVWSLGITLIEMAEIEP---PHHELNPMRVL----LKIAKSEPPT 234
Query: 748 LIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSV 786
L + + S S ++ C+++ + R S +
Sbjct: 235 L---AQPSRWS-SNFKDFLK---KCLEKNVDARWTTSQL 266
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 5e-59
Identities = 73/302 (24%), Positives = 126/302 (41%), Gaps = 36/302 (11%)
Query: 498 EKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIE----GQEIAVKRLSKGS 553
+ + + L + +F+E +G G FG VY G L++ AVK L++ +
Sbjct: 16 AVQHVVIGPSSLIV------HFNEV--IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT 67
Query: 554 GQG-MEEFKNEVLLIAKLQHRNLVKLLGCCTQRDER-MLIYEYLPNKSLDYFIFDTTRSK 611
G + +F E +++ H N++ LLG C + + +++ Y+ + L FI + +
Sbjct: 68 DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETH 125
Query: 612 LLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671
+A+G+ + + +HRDL A N +LD K++DFGLAR
Sbjct: 126 NPTVKDLIGFGLQVAKGM---KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 182
Query: 672 DQTEANTKR--VVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHD 729
+ ++ + +M+ E F+ KSDV+SFGVL+ E++ D
Sbjct: 183 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA-----PPYPD 237
Query: 730 HNLLGHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789
N L R L C +V L C + E RP+ S +V
Sbjct: 238 VNTFDITVYLLQGRRLL------QPEYCP----DPLYEVMLKCWHPKAEMRPSFSELVSR 287
Query: 790 LS 791
+S
Sbjct: 288 IS 289
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 2e-58
Identities = 68/280 (24%), Positives = 112/280 (40%), Gaps = 28/280 (10%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHR 573
+++ +G G +G K G+ + K L GS + +EV L+ +L+H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 574 NLVKLLGCCTQRDERML--IYEYLPNKSLDYFIFDTTRSK-LLDWSKRSHIIAGIARGLL 630
N+V+ R L + EY L I T+ + LD ++ + L
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 631 YLHQ--DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYM 688
H+ D ++HRDLK +NV LD N K+ DFGLAR D + A VGT YM
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA--FVGTPYYM 181
Query: 689 SPEYAIDGLFSVKSDVFSFGVLVLEIICGKK-NRGFNHADHDHNLLGHAWRLWIEERPLE 747
SPE ++ KSD++S G L+ E+ F+ + + +R E
Sbjct: 182 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDE 241
Query: 748 LIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVV 787
L + + + + RP++ ++
Sbjct: 242 LNE-----------------IITRMLNLKDYHRPSVEEIL 264
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 1e-57
Identities = 70/305 (22%), Positives = 111/305 (36%), Gaps = 45/305 (14%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE------GQEIAVKRLSKGSGQG-MEEFKNEVLLIAK 569
+N LG G FG V ++AVK L + + E +E+ ++ +
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 570 L-QHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFD--------------------TT 608
L H N+V LLG CT LI+EY L ++
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 609 RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668
+L + +A+G+ +L +HRDL A NVL+ + KI DFGLAR
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 669 FGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADH 728
D +M+PE +G++++KSDV+S+G+L+ EI +
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV-NPYPGIPV 272
Query: 729 DHNLLGHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788
D N +LI F + C RP+ ++
Sbjct: 273 DANF-------------YKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 319
Query: 789 MLSGE 793
L +
Sbjct: 320 FLGCQ 324
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 1e-57
Identities = 71/303 (23%), Positives = 131/303 (43%), Gaps = 33/303 (10%)
Query: 517 DNFSEKNKLGEGGFGPVYKGML------IEGQEIAVKRLSKG-SGQGMEEFKNEVLLIAK 569
+ + +LG+G FG VY+G+ +A+K +++ S + EF NE ++ +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 570 LQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIF-------DTTRSKLLDWSKRSHII 622
++V+LLG +Q ++I E + L ++ + SK +
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 623 AGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVV 682
IA G+ YL+ + + +HRDL A N ++ KI DFG+ R + +
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 683 GTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIE 742
+MSPE DG+F+ SDV+SFGV++ EI + + + ++ R +E
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE-QPYQGLSNE-----QVLRFVME 250
Query: 743 ERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPQQP 802
L+ D D ++ +C Q P+ RP+ ++ + E P ++
Sbjct: 251 GGLLDKPDNCPD---------MLFELMRMCWQYNPKMRPSFLEIISSIKEEME-PGFREV 300
Query: 803 GFF 805
F+
Sbjct: 301 SFY 303
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 2e-57
Identities = 64/274 (23%), Positives = 115/274 (41%), Gaps = 31/274 (11%)
Query: 522 KNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKL 578
++G G F VYKG+ E E+A L + + FK E ++ LQH N+V+
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 579 LGCC----TQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQ 634
+ +L+ E + + +L ++ R K++ I +GL +LH
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHT 130
Query: 635 DSRLRIIHRDLKASNVLL-DNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYA 693
+ IIHRDLK N+ + T + KI D GLA K V+GT +M+PE
Sbjct: 131 RTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF----AKAVIGTPEFMAPEM- 184
Query: 694 IDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSL 753
+ + DV++FG+ +LE+ + + I R + +
Sbjct: 185 YEEKYDESVDVYAFGMCMLEMATSE-----------YPYSECQNAAQIYRRVTSGVKPAS 233
Query: 754 DNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVV 787
+ + E I+ C++Q ++R ++ ++
Sbjct: 234 FDKVAIPEVKEIIE---GCIRQNKDERYSIKDLL 264
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 5e-57
Identities = 67/276 (24%), Positives = 124/276 (44%), Gaps = 24/276 (8%)
Query: 512 IANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKL 570
+ + ++ K+G+G G VY M + GQE+A+++++ E NE+L++ +
Sbjct: 15 VGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN 74
Query: 571 QHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLL 630
++ N+V L DE ++ EYL SL + +T D + + + + L
Sbjct: 75 KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM----DEGQIAAVCRECLQALE 130
Query: 631 YLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSP 690
+LH ++IHRD+K+ N+LL + K++DFG +Q++ +T +VGT +M+P
Sbjct: 131 FLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAP 185
Query: 691 EYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELID 750
E + K D++S G++ +E+I G+ + N L + + P
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGE------PPYLNENPLRALYLIATNGTP----- 234
Query: 751 QSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSV 786
L N S R L E R + +
Sbjct: 235 -ELQNPEKLSAIFRDFLNRCL--DMDVEKRGSAKEL 267
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (490), Expect = 2e-56
Identities = 71/282 (25%), Positives = 107/282 (37%), Gaps = 28/282 (9%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLI----EGQEIAVKRLSK---GSGQGMEEFKNEVLLIAK 569
+ KLG+G FG V +G + +AVK L + M++F EV +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 570 LQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGL 629
L HRNL++L G +M + E P SL + S +A G+
Sbjct: 68 LDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGM 124
Query: 630 LYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE-ANTKRVVGTYGYM 688
YL R IHRDL A N+LL KI DFGL R+ + + + +
Sbjct: 125 GYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 689 SPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLEL 748
+PE FS SD + FGV + E+ + N ++ E L
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQ-----EPWIGLNGSQILHKIDKEGERLPR 236
Query: 749 IDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLML 790
+ + + V + C +PEDRP ++ L
Sbjct: 237 PE-------DCPQDIY--NVMVQCWAHKPEDRPTFVALRDFL 269
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 1e-55
Identities = 64/277 (23%), Positives = 109/277 (39%), Gaps = 35/277 (12%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQH 572
++F LG+G FG VY + +A+K L K + + EV + + L+H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 573 RNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYL 632
N+++L G LI EY P ++ + ++ D + + I +A L Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYC 122
Query: 633 HQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEY 692
H R+IHRD+K N+LL + KI+DFG + + + GT Y+ PE
Sbjct: 123 HS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEM 175
Query: 693 AIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQS 752
+ K D++S GVL E + GK + E +
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGK-------------------PPFEANTYQETYKRI 216
Query: 753 LDNSCSFSEAL--RCIQVGLLCVQQRPEDRPNMSSVV 787
+F + + + ++ P RP + V+
Sbjct: 217 SRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 253
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (472), Expect = 1e-53
Identities = 74/297 (24%), Positives = 107/297 (36%), Gaps = 39/297 (13%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE------GQEIAVKRLSKGSGQG--MEEFKNEVLLIA 568
D LG G FG V + + +AVK L +G+ +LI
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 569 KLQHRNLVKLLGCCTQRDER-MLIYEYLPNKSLDYFIF-------------DTTRSKLLD 614
H N+V LLG CT+ M+I E+ +L ++ + L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 615 WSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674
+A+G+ +L + IHRDL A N+LL KI DFGLAR D
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 675 EANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLG 734
+M+PE D +++++SDV+SFGVL+ EI +
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA-----SPYPGVKIDE 244
Query: 735 HAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLS 791
R E + D + Q L C P RP S +V L
Sbjct: 245 EFCRRLKEGTRMRAPDYTTP---------EMYQTMLDCWHGEPSQRPTFSELVEHLG 292
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 1e-53
Identities = 66/280 (23%), Positives = 111/280 (39%), Gaps = 27/280 (9%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLI----EGQEIAVKRLSKGSGQGM-EEFKNEVLLIAKLQ 571
+ +GEG FG V++G+ + +A+K + + E+F E L + +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 572 HRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLY 631
H ++VKL+G T+ + +I E L F+ S LD + ++ L Y
Sbjct: 67 HPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTALAY 123
Query: 632 LHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPE 691
L R +HRD+ A NVL+ + K+ DFGL+R D T + +M+PE
Sbjct: 124 LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPE 179
Query: 692 YAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQ 751
F+ SDV+ FGV + EI+ +++++G P
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGVK--PFQGVKNNDVIGRIENGERLPMP------ 231
Query: 752 SLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLS 791
+ L + C P RP + + LS
Sbjct: 232 -----PNCPPTLY--SLMTKCWAYDPSRRPRFTELKAQLS 264
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 1e-50
Identities = 73/298 (24%), Positives = 115/298 (38%), Gaps = 41/298 (13%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE--------GQEIAVKRLSKG-SGQGMEEFKNEVLLI 567
D LGEG FG V I ++AVK L + + + + +E+ ++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 568 AKL-QHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKL-------------L 613
+ +H+N++ LLG CTQ +I EY +L ++ L L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 614 DWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673
+ARG+ YL + IHRDL A NVL+ KI+DFGLAR
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 674 TEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLL 733
T +M+PE D +++ +SDV+SFGVL+ EI + + +
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG------SPYPGVPV 243
Query: 734 GHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLS 791
++L E ++ + + C P RP +V L
Sbjct: 244 EELFKLLKEGHRMDKPSNCTN---------ELYMMMRDCWHAVPSQRPTFKQLVEDLD 292
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 3e-50
Identities = 60/274 (21%), Positives = 100/274 (36%), Gaps = 31/274 (11%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQH 572
++F LGEG F V + +E A+K L K + E ++++L H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 573 RNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYL 632
VKL ++ Y N L +I + D + A I L YL
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYL 124
Query: 633 HQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEY 692
H IIHRDLK N+LL+ M+ +I+DFG A+ + +A VGT Y+SPE
Sbjct: 125 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181
Query: 693 AIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQS 752
+ SD+++ G ++ +++ G + + +
Sbjct: 182 LTEKSACKSSDLWALGCIIYQLVAGL-------------------PPFRAGNEYLIFQKI 222
Query: 753 LDNSCSFSEAL--RCIQVGLLCVQQRPEDRPNMS 784
+ F E + + + R
Sbjct: 223 IKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCE 256
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 177 bits (449), Expect = 9e-50
Identities = 63/304 (20%), Positives = 113/304 (37%), Gaps = 39/304 (12%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNL 575
D++ +LG G FG V++ G A K + E + E+ ++ L+H L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 576 VKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQD 635
V L +E ++IYE++ L + D + + + + +GL ++H
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMH-- 141
Query: 636 SRLRIIHRDLKASNVLLDNTMNP--KISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYA 693
+H DLK N++ + K+ DFGL + + K GT + +PE A
Sbjct: 142 -ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL---DPKQSVKVTTGTAEFAAPEVA 197
Query: 694 IDGLFSVKSDVFSFGVLVLEIICGKK-NRGFNHADHDHNLLGHAWRLWIEERPLELIDQS 752
+D++S GVL ++ G G N + N+ W + D S
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNM----------DDS 247
Query: 753 LDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPQQPGFFTGRNLPE 812
+ S + I+ + P R + + + P + T N P
Sbjct: 248 AFSGIS-EDGKDFIR---KLLLADPNTRMTIHQAL------------EHP-WLTPGNAPG 290
Query: 813 SESS 816
+S
Sbjct: 291 RDSQ 294
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 173 bits (440), Expect = 1e-48
Identities = 57/274 (20%), Positives = 101/274 (36%), Gaps = 26/274 (9%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNL 575
D + +LG G FG V++ + G+ K ++ KNE+ ++ +L H L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 576 VKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQD 635
+ L + E +LI E+L L I + ++ + + GL ++H
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRI--AAEDYKMSEAEVINYMRQACEGLKHMH-- 144
Query: 636 SRLRIIHRDLKASNVLLDNTMNP--KISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYA 693
I+H D+K N++ + KI DFGLA D+ K T + +PE
Sbjct: 145 -EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIV 200
Query: 694 IDGLFSVKSDVFSFGVLVLEIICGKKN-RGFNHADHDHNLLGHAWRLWIEERPLELIDQS 752
+D+++ GVL ++ G G + + N+ W +
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFS------- 253
Query: 753 LDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSV 786
S S + LL + P R +
Sbjct: 254 -----SVSPEAKDFIKNLLQKE--PRKRLTVHDA 280
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 167 bits (424), Expect = 3e-46
Identities = 68/275 (24%), Positives = 113/275 (41%), Gaps = 32/275 (11%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQ- 571
++FS +G GGFG VY + G+ A+K L K QG NE ++++ +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 572 --HRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGL 629
+V + D+ I + + L Y + + + + A I GL
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGL 120
Query: 630 LYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMS 689
++H +++RDLK +N+LLD + +ISD GLA F + VGT+GYM+
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMA 173
Query: 690 PEYAIDGL-FSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLEL 748
PE G+ + +D FS G ++ +++ G + H + + +E
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD--- 230
Query: 749 IDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNM 783
SFS LR + GLL R
Sbjct: 231 ---------SFSPELRSLLEGLLQRD--VNRRLGC 254
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 6e-46
Identities = 62/294 (21%), Positives = 120/294 (40%), Gaps = 27/294 (9%)
Query: 514 NATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGM-EEFKNEVLLIAKLQ 571
+ ++ + +GEG +G V +A+K++S Q + E+ ++ + +
Sbjct: 5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR 64
Query: 572 HRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLY 631
H N++ + + YL + ++ +++ L + + I RGL Y
Sbjct: 65 HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKY 124
Query: 632 LHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANT-KRVVGTYGYMSP 690
+H ++HRDLK SN+LL+ T + KI DFGLAR D V T Y +P
Sbjct: 125 IHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 181
Query: 691 EYAIDGLFSVKS-DVFSFGVLVLEIICGKK-NRGFNHADHDHNLLGHAWRLWIEERPLEL 748
E ++ KS D++S G ++ E++ + G ++ D +++LG E+ +
Sbjct: 182 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 241
Query: 749 IDQSLDNSCSF----------------SEALRCIQVGLLCVQQRPEDRPNMSSV 786
++ + S S+AL + + P R +
Sbjct: 242 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLD---KMLTFNPHKRIEVEQA 292
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 162 bits (412), Expect = 1e-45
Identities = 61/288 (21%), Positives = 111/288 (38%), Gaps = 40/288 (13%)
Query: 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQG---MEEFKNEVLLIAKLQ 571
+D + LG GG V+ + +++AVK L + F+ E A L
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 572 HRNLVKLLGCCTQRDER----MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIAR 627
H +V + ++ EY+ +L + + + +IA +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 122
Query: 628 GLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE-ANTKRVVGTYG 686
L + H + IIHRD+K +N+++ T K+ DFG+AR+ T V+GT
Sbjct: 123 ALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 687 YMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPL 746
Y+SPE A +SDV+S G ++ E++ G+ + + P+
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGE-------------------PPFTGDSPV 220
Query: 747 ELIDQSLDNSCSFSEALR------CIQVGLLCVQQRPEDRPNMSSVVL 788
+ Q + A V L + + PE+R ++ +
Sbjct: 221 SVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMR 268
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 162 bits (410), Expect = 4e-45
Identities = 53/292 (18%), Positives = 97/292 (33%), Gaps = 29/292 (9%)
Query: 508 DLKIIANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLL 566
+L++ + + K+G G FG +Y G I G+E+A+K + + E +
Sbjct: 2 ELRV----GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKI 55
Query: 567 IAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIA 626
+Q + + C + ++ L SL+ S+ + +
Sbjct: 56 YKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNF--CSRKFSLKTVLLLADQMI 113
Query: 627 RGLLYLHQDSRLRIIHRDLKASNVL---LDNTMNPKISDFGLARSFGLDQTEAN-----T 678
+ Y+H IHRD+K N L I DFGLA+ + +T +
Sbjct: 114 SRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYREN 170
Query: 679 KRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWR 738
K + GT Y S + S + D+ S G +++ G A
Sbjct: 171 KNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE 230
Query: 739 LWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLML 790
+ L + C R +D+P+ S + +
Sbjct: 231 KKMSTPIEVLCK-------GYPSEFA--TYLNFCRSLRFDDKPDYSYLRQLF 273
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 162 bits (410), Expect = 5e-45
Identities = 58/294 (19%), Positives = 106/294 (36%), Gaps = 25/294 (8%)
Query: 514 NATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEE-FKNEVLLIAKLQ 571
+ D + ++ LG G F V + +A+K ++K + +G E +NE+ ++ K++
Sbjct: 6 DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIK 65
Query: 572 HRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLY 631
H N+V L LI + + L I S +I + + Y
Sbjct: 66 HPNIVALDDIYESGGHLYLIMQLVSGGELFDRI---VEKGFYTERDASRLIFQVLDAVKY 122
Query: 632 LHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPE 691
LH + + LD ISDFGL++ GT GY++PE
Sbjct: 123 LHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACGTPGYVAPE 179
Query: 692 YAIDGLFSVKSDVFSFGVLVLEIICGKKN-RGFNHADHDHNLLGHAWRLWIEERPLELID 750
+S D +S GV+ ++CG N A +L +
Sbjct: 180 VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWD----- 234
Query: 751 QSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM--LSGERSLPQPQQP 802
S++ + L+ ++ PE R + ++G+ +L +
Sbjct: 235 -------DISDSAKDFIRHLM--EKDPEKRFTCEQALQHPWIAGDTALDKNIHQ 279
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 9e-45
Identities = 67/279 (24%), Positives = 112/279 (40%), Gaps = 34/279 (12%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSG---QGMEEFKNEV-LLIAKLQ 571
++F LG+G FG V+ + Q A+K L K +E E +L +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 572 HRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLY 631
H L + ++ + EYL L Y I + D S+ + A I GL +
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQF 118
Query: 632 LHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPE 691
LH I++RDLK N+LLD + KI+DFG+ + L + NT GT Y++PE
Sbjct: 119 LH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPE 173
Query: 692 YAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQ 751
+ ++ D +SFGVL+ E++ G+ + + EL
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQ-------------------SPFHGQDEEELFHS 214
Query: 752 SLDNSCSFSEAL--RCIQVGLLCVQQRPEDRPNMSSVVL 788
++ + L + + + PE R + +
Sbjct: 215 IRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 253
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 159 bits (404), Expect = 2e-44
Identities = 60/288 (20%), Positives = 112/288 (38%), Gaps = 41/288 (14%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGM---------EEFKNEVLL 566
+N+ K LG G V + + +E AVK + G E EV +
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 567 IAKLQ-HRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGI 625
+ K+ H N+++L L+++ + L ++ T L + I+ +
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRAL 119
Query: 626 ARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTY 685
+ LH +L I+HRDLK N+LLD+ MN K++DFG + + + V GT
Sbjct: 120 LEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTP 173
Query: 686 GYMSPEYAIDGL------FSVKSDVFSFGVLVLEIICGKK-NRGFNHADHDHNLLGHAWR 738
Y++PE + + + D++S GV++ ++ G ++ ++
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ 233
Query: 739 LWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSV 786
E +S+ ++ + L VQ P+ R
Sbjct: 234 FGSPEWD------------DYSDTVKDLVSRFLVVQ--PQKRYTAEEA 267
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 4e-44
Identities = 50/279 (17%), Positives = 103/279 (36%), Gaps = 37/279 (13%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNL 575
+ + LG G FG V++ + + K + G K E+ ++ +HRN+
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARHRNI 63
Query: 576 VKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQD 635
+ L +E ++I+E++ + I T + L+ + + + L +LH
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERI--NTSAFELNEREIVSYVHQVCEALQFLHS- 120
Query: 636 SRLRIIHRDLKASNVLLDNTMNP--KISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYA 693
I H D++ N++ + KI +FG AR N + + Y +PE
Sbjct: 121 --HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVH 175
Query: 694 IDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSL 753
+ S +D++S G LV ++ G ++ E ++I+ +
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGI-------------------NPFLAETNQQIIENIM 216
Query: 754 DNSCSFSEALR------CIQVGLLCVQQRPEDRPNMSSV 786
+ +F E + + + + R S
Sbjct: 217 NAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEA 255
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 158 bits (401), Expect = 1e-43
Identities = 60/245 (24%), Positives = 103/245 (42%), Gaps = 18/245 (7%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQH 572
+F LG G FG V+ G+ A+K L K + +E +E L+++ + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 573 RNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYL 632
++++ G + +I +Y+ L + + R A + L YL
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF---PNPVAKFYAAEVCLALEYL 120
Query: 633 HQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEY 692
H II+RDLK N+LLD + KI+DFG A+ T + GT Y++PE
Sbjct: 121 H---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYV-----PDVTYTLCGTPDYIAPEV 172
Query: 693 AIDGLFSVKSDVFSFGVLVLEIICGKK-NRGFNHADHDHNLLGHAWRL--WIEERPLELI 749
++ D +SFG+L+ E++ G N +L R + E +L+
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLL 232
Query: 750 DQSLD 754
+ +
Sbjct: 233 SRLIT 237
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 153 bits (387), Expect = 4e-42
Identities = 63/285 (22%), Positives = 115/285 (40%), Gaps = 23/285 (8%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEIAVK--RLSKGSGQGMEEFKNEVLLIAKLQHRN 574
+ + K+GEG +G VYK G+ A+K RL K E+ ++ +L+H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQ 634
+VKL + +L++E+L L+ + + G+ Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 635 DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAI 694
R++HRDLK N+L++ KI+DFGLAR+FG+ + + T Y +P+ +
Sbjct: 119 ---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH--EIVTLWYRAPDVLM 173
Query: 695 -DGLFSVKSDVFSFGVLVLEIICGKK-NRGFNHADHDHNLL------GHAWRLWIEERPL 746
+S D++S G + E++ G G + AD + + E P
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233
Query: 747 ELIDQSLDNSCSFSEALRCIQVGLL-----CVQQRPEDRPNMSSV 786
+ ++ + L+ + + ++ P R
Sbjct: 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 153 bits (387), Expect = 4e-42
Identities = 43/292 (14%), Positives = 101/292 (34%), Gaps = 30/292 (10%)
Query: 511 IIANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAK 569
++ ++ ++GEG FG +++G + Q++A+K + S + ++E
Sbjct: 2 VVGV---HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKL 56
Query: 570 LQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGL 629
L + + Q ++ L SL+ + + + + +
Sbjct: 57 LAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDL--CGRKFSVKTVAMAAKQMLARV 114
Query: 630 LYLHQDSRLRIIHRDLKASNVLLDNTMNP-----KISDFGLARSFGLDQTEAN-----TK 679
+H+ +++RD+K N L+ + + DFG+ + + T+ + K
Sbjct: 115 QSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKK 171
Query: 680 RVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRL 739
+ GT YMS + S + D+ + G + + + G A +
Sbjct: 172 NLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY-----E 226
Query: 740 WIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLS 791
I E+ + L E + + + P+ + + S
Sbjct: 227 RIGEKKQSTPLRELCAGFP-EEFYKYMH---YARNLAFDATPDYDYLQGLFS 274
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 1e-41
Identities = 66/292 (22%), Positives = 119/292 (40%), Gaps = 26/292 (8%)
Query: 515 ATDNFSEKNKLGEGGFGPVYKGMLIE--GQEIAVKRLSKGSGQGM--EEFKNEVLLIAKL 570
A + ++GEG +G V+K ++ G+ +A+KR+ +G+ EV ++ L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 571 ---QHRNLVKLLGCCTQRDERMLIYEYLPNKSLD---YFIFDTTRSKLLDWSKRSHIIAG 624
+H N+V+L CT L + +D D + ++
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 625 IARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
+ RGL +LH R++HRDLK N+L+ ++ K++DFGLAR + VV T
Sbjct: 125 LLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA---LTSVVVT 178
Query: 685 YGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKN-RGFNHADHDHNLLGHAWRLWIEE 743
Y +PE + ++ D++S G + E+ K RG + D +L E+
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238
Query: 744 RPLELIDQSLDNSCSFSEALR---------CIQVGLLCVQQRPEDRPNMSSV 786
P ++ ++ + + L C+ P R + S
Sbjct: 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (386), Expect = 2e-41
Identities = 68/337 (20%), Positives = 127/337 (37%), Gaps = 37/337 (10%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNL 575
++++ +G G FG VY+ L + G+ +A+K++ + E+ ++ KL H N+
Sbjct: 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNI 75
Query: 576 VKLLGCCTQRDERM------LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGL 629
V+L E+ L+ +Y+P + + L + + R L
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 630 LYLHQDSRLRIIHRDLKASNVLLD-NTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYM 688
Y+H I HRD+K N+LLD +T K+ DFG A+ + E N + Y
Sbjct: 136 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICSRYYRA 190
Query: 689 SPEYAIDGLFSVKSDVFSFGVLVLEIICGKK----NRGFNHADHDHNLLGHAWRLWIEER 744
++ DV+S G ++ E++ G+ + G + +LG R I E
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250
Query: 745 PLELIDQSLDNSCSFS-----------EALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 793
+ + EA+ ++ P R S
Sbjct: 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCS---RLLEYTPTARLTPLE-ACAHSFF 306
Query: 794 RSLPQPQQPGFFTGRNLPESESSSSRQYSASTNEITL 830
L P GR+ P + ++++ S++ T+
Sbjct: 307 DELRDPNVK-LPNGRDTPALFNFTTQELSSNPPLATI 342
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 3e-41
Identities = 71/321 (22%), Positives = 120/321 (37%), Gaps = 46/321 (14%)
Query: 521 EK-NKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEE-----FKNEVLLIAKLQHR 573
EK + LGEG F VYK Q +A+K++ G ++ E+ L+ +L H
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60
Query: 574 NLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLH 633
N++ LL + L+++++ S +L S + +GL YLH
Sbjct: 61 NIIGLLDAFGHKSNISLVFDFMETDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLH 117
Query: 634 QDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYA 693
Q I+HRDLK +N+LLD K++DFGLA+SFG V T Y +PE
Sbjct: 118 QH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--AYTHQVVTRWYRAPELL 172
Query: 694 ID-GLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQS 752
++ V D+++ G ++ E++ F D D + L + + D
Sbjct: 173 FGARMYGVGVDMWAVGCILAELLLR---VPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC 229
Query: 753 LDNSCSFSEALRCIQVGLL--------------CVQQRPEDRPNMSSVVLMLSGERSLPQ 798
++ I + + P R + +
Sbjct: 230 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL----------- 278
Query: 799 PQQPGFFTGRNLPESESSSSR 819
+ +F+ R P R
Sbjct: 279 -KMK-YFSNRPGPTPGCQLPR 297
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 1e-40
Identities = 64/286 (22%), Positives = 115/286 (40%), Gaps = 23/286 (8%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHR 573
+NF + K+GEG +G VYK G+ +A+K++ + E+ L+ +L H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 574 NLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLH 633
N+VKLL ++ L++E+L + D + + + + +GL + H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 634 QDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPE-Y 692
R++HRDLK N+L++ K++DFGLAR+FG+ V T Y +PE
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH--EVVTLWYRAPEIL 174
Query: 693 AIDGLFSVKSDVFSFGVLVLEIICGKKN-RGFNHADHDHNLLGHAWRLWIEERPLELIDQ 751
+S D++S G + E++ + G + D + P
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234
Query: 752 SLDNSC------SFSEALRCIQVGLL-----CVQQRPEDRPNMSSV 786
S FS+ + + + P R + +
Sbjct: 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 5e-40
Identities = 67/284 (23%), Positives = 112/284 (39%), Gaps = 33/284 (11%)
Query: 514 NATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS------GQGMEEFKNEVLL 566
N D + +LG G F V K G + A K + K G E+ + EV +
Sbjct: 7 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 66
Query: 567 IAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIA 626
+ ++QH N++ L + + +LI E + L F+ + L + + + I
Sbjct: 67 LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLA---EKESLTEEEATEFLKQIL 123
Query: 627 RGLLYLHQDSRLRIIHRDLKASNVLLDNTMNP----KISDFGLARSFGLDQTEANTKRVV 682
G+ YLH L+I H DLK N++L + P KI DFGLA K +
Sbjct: 124 NGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIF 177
Query: 683 GTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIE 742
GT +++PE +++D++S GV+ ++ G D L + +
Sbjct: 178 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS---PFLGDTKQETLAN-----VS 229
Query: 743 ERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSV 786
E D+ N S + LL + P+ R +
Sbjct: 230 AVNYEFEDEYFSN---TSALAKDFIRRLL--VKDPKKRMTIQDS 268
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 1e-38
Identities = 60/274 (21%), Positives = 99/274 (36%), Gaps = 43/274 (15%)
Query: 524 KLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEE------FKNEVLLIAKLQ--HRN 574
LG GGFG VY G+ + +A+K + K E EV+L+ K+
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQ 634
+++LL + D +LI E + T L + + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLEAVRHCHN 128
Query: 635 DSRLRIIHRDLKASNVLLD-NTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEY- 692
++HRD+K N+L+D N K+ DFG + GT Y PE+
Sbjct: 129 ---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 181
Query: 693 AIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQS 752
+ V+S G+L+ +++CG F H + E+I
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGD--IPFEHDE-------------------EIIRGQ 220
Query: 753 LDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSV 786
+ S + + C+ RP DRP +
Sbjct: 221 VFFRQRVSSECQ--HLIRWCLALRPSDRPTFEEI 252
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 1e-38
Identities = 68/319 (21%), Positives = 122/319 (38%), Gaps = 33/319 (10%)
Query: 509 LKIIANA-TDNFSEKNK-LGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVL 565
L+I NA D++ ++ LG G G V + ++ A+K L + + EV
Sbjct: 2 LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVE 56
Query: 566 LIAKL-QHRNLVKLLGCC----TQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSH 620
L + Q ++V+++ R +++ E L L I D + + S
Sbjct: 57 LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDR-GDQAFTEREASE 115
Query: 621 IIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNP---KISDFGLARSFGLDQTEAN 677
I+ I + YLH + I HRD+K N+L + K++DFG A+ +
Sbjct: 116 IMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT 172
Query: 678 TKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAW 737
T Y++PE + D++S GV++ ++CG + +
Sbjct: 173 PCY---TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGY----PPFYSNHGLAISPGM 225
Query: 738 RLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLP 797
+ I E + SE ++ + LL + P R ++ + +S
Sbjct: 226 KTRIRMGQYEFPNPEWSE---VSEEVKMLIRNLL--KTEPTQRMTITEFMNHPWIMQSTK 280
Query: 798 QPQQPGFFTGRNLPESESS 816
PQ P T R L E +
Sbjct: 281 VPQTP-LHTSRVLKEDKER 298
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 3e-38
Identities = 53/206 (25%), Positives = 88/206 (42%), Gaps = 12/206 (5%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQH 572
++F LG+G FG V G+ A+K L K + + E ++ +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 573 RNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYL 632
L L D + EY L + + +R ++ + A I L YL
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSALEYL 121
Query: 633 HQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEY 692
H +++RD+K N++LD + KI+DFGL + A K GT Y++PE
Sbjct: 122 H---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKE--GISDGATMKTFCGTPEYLAPEV 176
Query: 693 AIDGLFSVKSDVFSFGVLVLEIICGK 718
D + D + GV++ E++CG+
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 1e-37
Identities = 58/299 (19%), Positives = 116/299 (38%), Gaps = 35/299 (11%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQG--MEEFKNEVLLIAKLQHR 573
+ + K+G+G FG V+K + GQ++A+K++ + + E+ ++ L+H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 574 NLVKLLGCCTQRDERM--------LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGI 625
N+V L+ C + L++++ + + S+ ++ +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQML 126
Query: 626 ARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKR--VVG 683
GL Y+H++ +I+HRD+KA+NVL+ K++DFGLAR+F L + + V
Sbjct: 127 LNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183
Query: 684 TYGYMSPEYAI-DGLFSVKSDVFSFGVLVLEIICGKK----NRGFNHADHDHNLLG---- 734
T Y PE + + + D++ G ++ E+ N + L G
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243
Query: 735 HAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLL-------CVQQRPEDRPNMSSV 786
W E ++ + L+ + P R +
Sbjct: 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 1e-36
Identities = 59/286 (20%), Positives = 110/286 (38%), Gaps = 23/286 (8%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHR 573
+ + K+GEG +G V+K E + +A+KR+ E+ L+ +L+H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 574 NLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLH 633
N+V+L + L++E+ YF + LD + + +GL + H
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 634 QDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYA 693
++HRDLK N+L++ K+++FGLAR+FG+ + VV +
Sbjct: 119 S---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY-SAEVVTLWYRPPDVLF 174
Query: 694 IDGLFSVKSDVFSFGVLVLEIICGKK--NRGFNHADHDHNLLGHAWRLWIEERPLELIDQ 751
L+S D++S G + E+ + G + D + E+ P
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234
Query: 752 SLDNSCSFSEALRCIQVG---------LL--CVQQRPEDRPNMSSV 786
+ + V LL ++ P R +
Sbjct: 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 137 bits (345), Expect = 7e-36
Identities = 62/270 (22%), Positives = 97/270 (35%), Gaps = 32/270 (11%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQH 572
D F LG G FG V E G A+K L K + +E NE ++ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 573 RNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYL 632
LVKL ++ EY+ + + R A I YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYL 157
Query: 633 HQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEY 692
H L +I+RDLK N+L+D +++DFG A+ + + T + GT ++PE
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEALAPEI 209
Query: 693 AIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQS 752
+ ++ D ++ GVL+ E+ G AD + +
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYP---PFFADQPIQIYEKIVSGKVRFPS------- 259
Query: 753 LDNSCSFSEALRCIQVGLLCVQQRPEDRPN 782
FS L+ + LL V R
Sbjct: 260 -----HFSSDLKDLLRNLLQVD--LTKRFG 282
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 4e-35
Identities = 69/346 (19%), Positives = 135/346 (39%), Gaps = 41/346 (11%)
Query: 510 KIIANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG--SGQGMEEFKNEVLL 566
K + + +G G +G V + G ++A+K+L + S + E+ L
Sbjct: 11 KTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRL 70
Query: 567 IAKLQHRNLVKLLGCCTQRDERMLIYE-YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGI 625
+ ++H N++ LL T + + YL + + + + L + ++ +
Sbjct: 71 LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQM 130
Query: 626 ARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTY 685
+GL Y+H IIHRDLK N+ ++ KI DFGLAR Q ++ V T
Sbjct: 131 LKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMTGYVVTR 182
Query: 686 GYMSPEYAIDGL-FSVKSDVFSFGVLVLEIICGKK-NRGFNHADHDHNLLGHAWRLWIEE 743
Y +PE ++ + ++ D++S G ++ E+I GK +G +H D ++ E
Sbjct: 183 WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF 242
Query: 744 RPLELIDQSLDNSCSFSEALRCIQVGLL-------------CVQQRPEDRPNMSSVVLML 790
D++ + E + +L + E R +
Sbjct: 243 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEAL--- 299
Query: 791 SGERSLPQPQQPGFFTGRNLPESESSSSRQYSASTNEITLSVLEAR 836
P +F + E E ++Y S +++ ++ E +
Sbjct: 300 ---------AHP-YFESLHDTEDE-PQVQKYDDSFDDVDRTLDEWK 334
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 129 bits (325), Expect = 2e-33
Identities = 59/315 (18%), Positives = 126/315 (40%), Gaps = 24/315 (7%)
Query: 483 GGLMYRRKKHSNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIE-G 541
G + R + +++ + + D++ KLG G + V++ + I
Sbjct: 1 GPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNN 60
Query: 542 QEIAVKRLSKGSGQGMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQRDERM--LIYEYLPNK 598
+++ VK L ++ K E+ ++ L+ N++ L R L++E++ N
Sbjct: 61 EKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNT 117
Query: 599 SLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-TMN 657
+ L + I + L Y H + I+HRD+K NV++D+
Sbjct: 118 DFKQLY------QTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRK 168
Query: 658 PKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIIC 716
++ D+GLA + Q V + + PE +D ++ D++S G ++ +I
Sbjct: 169 LRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIF 225
Query: 717 GKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQ-SLDNSCSFSEALRCIQVGLLCVQQ 775
K+ F H +++ L ++ E + ID+ +++ F++ L
Sbjct: 226 RKEP--FFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFV 283
Query: 776 RPEDRPNMSSVVLML 790
E++ +S L
Sbjct: 284 HSENQHLVSPEALDF 298
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 6e-33
Identities = 69/276 (25%), Positives = 112/276 (40%), Gaps = 31/276 (11%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE----GQEIAVKRLSKGS----GQGMEEFKNEVLLIA 568
+NF LG G +G V+ I G+ A+K L K + + E + E ++
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 569 KLQHR-NLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIAR 627
++ LV L + LI +Y+ L + R + + I
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER---FTEHEVQIYVGEIVL 140
Query: 628 GLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGY 687
L +LH +L II+RD+K N+LLD+ + ++DFGL++ F D+TE GT Y
Sbjct: 141 ALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEY 196
Query: 688 MSPEYAIDGL--FSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERP 745
M+P+ G D +S GVL+ E++ G F D + N R ++ P
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA--SPF-TVDGEKNSQAEISRRILKSEP 253
Query: 746 LELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRP 781
S + A IQ + + P+ R
Sbjct: 254 ------PYPQEMS-ALAKDLIQ---RLLMKDPKKRL 279
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (313), Expect = 1e-31
Identities = 72/346 (20%), Positives = 130/346 (37%), Gaps = 41/346 (11%)
Query: 510 KIIANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG--SGQGMEEFKNEVLL 566
K I + + + +G G +G V + G +AVK+LS+ S + E+ L
Sbjct: 11 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 70
Query: 567 IAKLQHRNLVKLLGCCTQRDERMLI-YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGI 625
+ ++H N++ LL T YL + + + + + L +I I
Sbjct: 71 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 130
Query: 626 ARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTY 685
RGL Y+H IIHRDLK SN+ ++ KI DFGLAR + T T
Sbjct: 131 LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA-----TR 182
Query: 686 GYMSPEYAIDGL-FSVKSDVFSFGVLVLEIICGKKN-RGFNHADHDHNLLGHAWRLWIEE 743
Y +PE ++ + ++ D++S G ++ E++ G+ G +H D +L E
Sbjct: 183 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 242
Query: 744 RPLELIDQSLDNSCSFSEALRCIQVGLL-------------CVQQRPEDRPNMSSVVLML 790
+ + + S ++ + + + + R +
Sbjct: 243 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA---- 298
Query: 791 SGERSLPQPQQPGFFTGRNLPESESSSSRQYSASTNEITLSVLEAR 836
L +F + P+ E + Y S L + E +
Sbjct: 299 -----LAHA----YFAQYHDPDDEPVAD-PYDQSFESRDLLIDEWK 334
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 2e-31
Identities = 50/211 (23%), Positives = 92/211 (43%), Gaps = 21/211 (9%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHR 573
+ +G G G V + +A+K+LS+ + + E++L+ + H+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 574 NLVKLLGCCTQRD------ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIAR 627
N++ LL T + + L+ E + + D + S+++ +
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL------DHERMSYLLYQMLC 130
Query: 628 GLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGY 687
G+ +LH IIHRDLK SN+++ + KI DFGLAR+ G V T Y
Sbjct: 131 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYY 184
Query: 688 MSPEYAIDGLFSVKSDVFSFGVLVLEIICGK 718
+PE + + D++S G ++ E++ K
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 112 bits (280), Expect = 2e-27
Identities = 39/210 (18%), Positives = 78/210 (37%), Gaps = 18/210 (8%)
Query: 524 KLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCC 582
KLG G F V+ ++ +A+K + E ++E+ L+ ++ + K
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 583 TQRDERMLIYEYLPNKSLDYF-------------IFDTTRSKLLDWSKRSHIIAGIARGL 629
++L + + + + + + I + GL
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 630 LYLHQDSRLRIIHRDLKASNVLLD-NTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYM 688
Y+H+ R IIH D+K NVL++ + +A + + + T Y
Sbjct: 139 DYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 689 SPEYAIDGLFSVKSDVFSFGVLVLEIICGK 718
SPE + + +D++S L+ E+I G
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 98.7 bits (245), Expect = 3e-24
Identities = 40/202 (19%), Positives = 64/202 (31%), Gaps = 27/202 (13%)
Query: 523 NKLGEGGFGPVYKGMLIEGQEIAVKRLSKGS----------GQGMEEFKNEVLLIAKLQH 572
+GEG V+ + E VK G G F + A+ +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 573 RNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYL 632
R L KL G + Y + N L I ++ + ++ I +
Sbjct: 66 RALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPD-EVLDMILEEVAKF 119
Query: 633 HQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKR-VVGTYGYMSPE 691
+ I+H DL NVL+ I DF + G + +R V Y S
Sbjct: 120 YHR---GIVHGDLSQYNVLVSE-EGIWIIDFPQSVEVGEEGWREILERDVRNIITYFSRT 175
Query: 692 YAIDGLFSVKSDVFSFGVLVLE 713
Y + D+ S +L+
Sbjct: 176 Y------RTEKDINSAIDRILQ 191
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 80.0 bits (197), Expect = 1e-18
Identities = 20/128 (15%), Positives = 47/128 (36%), Gaps = 21/128 (16%)
Query: 46 DTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPLS 105
+ ++ G+ + G++L + + L ++ T W +N
Sbjct: 2 NLLTNGEGLYAGQSLDV-------EPYHFIMQEDCNLVLYDH----STSVWASNTGILGK 50
Query: 106 DRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDN 165
+ + +G V+ ++ ++W+S+S V L E GN+V+ +
Sbjct: 51 KGCKAVLQS---DGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIY-------GS 100
Query: 166 ILWQSFDY 173
+W + Y
Sbjct: 101 DIWSTGTY 108
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 67.0 bits (163), Expect = 3e-14
Identities = 26/128 (20%), Positives = 45/128 (35%), Gaps = 22/128 (17%)
Query: 46 DTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPLS 105
+ + G+++ GE L SF N L ++ W N
Sbjct: 2 NILYSGETLSTGEFLNYG--SFVFIMQEDCN-----LVLYD----VDKPIWATNTGGL-- 48
Query: 106 DRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDN 165
RS L + + N LV+ N +N +W+SN+ V L + N+V+
Sbjct: 49 SRSCFLSMQTDGN--LVVYNPSNKPIWASNTGGQNGNYVCILQKDRNVVIY-------GT 99
Query: 166 ILWQSFDY 173
W + +
Sbjct: 100 DRWATGTH 107
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 66.5 bits (162), Expect = 8e-14
Identities = 18/89 (20%), Positives = 32/89 (35%), Gaps = 7/89 (7%)
Query: 84 IWYKKIAEGTVTWVANRDAPLSDRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQKP 143
I Y + L L + + LVL + +D VWS+N++
Sbjct: 12 ILYSTQGNDNHPQTLHATQSLQLSPYRLSMET--DCNLVLFDR-DDRVWSTNTAGKGTGC 68
Query: 144 VAALMESGNLVVKDGKDNNPDNILWQSFD 172
A L +G + V + + +W S +
Sbjct: 69 RAVLQPNGRMDVLTNQ----NIAVWTSGN 93
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Score = 64.8 bits (157), Expect = 2e-13
Identities = 20/131 (15%), Positives = 44/131 (33%), Gaps = 20/131 (15%)
Query: 46 DTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPLS 105
D ++ G + G +L + + N + Y W + + S
Sbjct: 2 DRLNSGHQLDTGGSLAEGG--YLFIIQNDCNL------VLYDN---NRAVWASGTNGKAS 50
Query: 106 DRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDN 165
++ +G + S + +W+SN++ L N+V+ D N +N
Sbjct: 51 GCVLKMQNDGNLV-----IYSGSRAIWASNTNRQNGNYYLILQRDRNVVIYD----NSNN 101
Query: 166 ILWQSFDYPCD 176
+W + +
Sbjct: 102 AIWATHTNVGN 112
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 56.2 bits (135), Expect = 3e-10
Identities = 22/139 (15%), Positives = 44/139 (31%), Gaps = 24/139 (17%)
Query: 35 LFYIISAARTLDTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTV 94
+F + +S+ ++ + + N L ++
Sbjct: 4 IFSKQPDDNHPQILHATESL----EILFGTHVYRFIMQTDCN-----LVLY----DNNNP 50
Query: 95 TWVANRDAPLSDRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAALMESGNLV 154
W N + R + +G+LV++ + N TVW S + A V L N+V
Sbjct: 51 IWATNTGGLGNG----CRAVLQPDGVLVVITNENVTVWQSPVAGKAGHYVLVLQPDRNVV 106
Query: 155 VKDGKDNNPDNILWQSFDY 173
+ + LW +
Sbjct: 107 IY-------GDALWATQTV 118
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 50.7 bits (121), Expect = 2e-08
Identities = 20/115 (17%), Positives = 31/115 (26%), Gaps = 35/115 (30%)
Query: 84 IWYKKIAEGTVTWVANRDAPLSDRSGVLRINGERN------------------------- 118
I + EG+ + L S + + N
Sbjct: 3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFDSDVRVWASNTAGATGCRAVL 62
Query: 119 ---GILVLLNSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDNILWQS 170
G+LV+L + N WSS + S V L + + LW S
Sbjct: 63 QSDGLLVILTAQNTIRWSSGTKGSIGNYVLVLQPDRTVTIY-------GPGLWDS 110
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 836 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.83 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 99.81 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.79 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 99.78 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.64 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 99.49 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.48 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.26 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 98.94 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 98.85 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 98.78 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 98.65 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 98.44 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.33 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.62 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.32 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.37 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.35 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.67 | |
| d1emoa2 | 39 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 93.5 | |
| d2vj3a1 | 42 | Neurogenic locus notch homolog protein 1, Notch1 { | 87.85 | |
| d1xkba1 | 39 | Factor X, N-terminal module {Human (Homo sapiens) | 84.37 | |
| d1emoa1 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 80.19 | |
| d1i0ua2 | 41 | Low density lipoprotein (LDL) receptor, different | 80.03 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-48 Score=411.15 Aligned_cols=256 Identities=27% Similarity=0.412 Sum_probs=199.5
Q ss_pred ccccccCeecccCceeEEEEEeecCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEeecC
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLP 596 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 596 (836)
++|+..++||+|+||.||+|++.+++.||||+++... ...++|.+|+.++++++|||||+++|++.+.+..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 5788899999999999999999888999999997543 445789999999999999999999999999999999999999
Q ss_pred CCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcccc
Q 003254 597 NKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEA 676 (836)
Q Consensus 597 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~~ 676 (836)
+|+|.+++.. ....+++..+..++.|||+||+|||+++ |+||||||+||||++++.+||+|||+++.+..... .
T Consensus 84 ~g~L~~~l~~--~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-~ 157 (263)
T d1sm2a_ 84 HGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-T 157 (263)
T ss_dssp TCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred CCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCc-e
Confidence 9999998854 3456899999999999999999999998 99999999999999999999999999987643322 2
Q ss_pred ccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccccccCC
Q 003254 677 NTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDNS 756 (836)
Q Consensus 677 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 756 (836)
......||+.|+|||++.+..++.++|||||||+||||+|+..|+...... .... ...... ....
T Consensus 158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~--~~~~----~~i~~~---------~~~~ 222 (263)
T d1sm2a_ 158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--SEVV----EDISTG---------FRLY 222 (263)
T ss_dssp -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH--HHHH----HHHHHT---------CCCC
T ss_pred eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH--HHHH----HHHHhc---------CCCC
Confidence 223467899999999999999999999999999999999965443211111 1111 111111 0111
Q ss_pred CChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 003254 757 CSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 794 (836)
Q Consensus 757 ~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 794 (836)
.+.....++.+++.+||+.||++||||+||++.|+++.
T Consensus 223 ~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~ 260 (263)
T d1sm2a_ 223 KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260 (263)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 11222356789999999999999999999999998753
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-48 Score=405.67 Aligned_cols=253 Identities=25% Similarity=0.340 Sum_probs=203.4
Q ss_pred cccccccCeecccCceeEEEEEee-cCcEEEEEEecCCC-chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEe
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 593 (836)
.++|++.++||+|+||+||+|+.. +|+.||||++.... .+..+.+.+|+.++++++|||||++++++.+.+..+||||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 468999999999999999999985 48999999987653 3345679999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCc
Q 003254 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (836)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~ 673 (836)
|+++|+|.+++. ....+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+.+....
T Consensus 84 y~~gg~L~~~l~---~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 84 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ccCCCcHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 999999999884 3457999999999999999999999998 9999999999999999999999999999875443
Q ss_pred cccccccccccccccCcccccCCcc-CccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhcccc
Q 003254 674 TEANTKRVVGTYGYMSPEYAIDGLF-SVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQS 752 (836)
Q Consensus 674 ~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 752 (836)
........+||+.|+|||++.+..+ +.++||||+||+||||++|+.||........ . ...........
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~--~----~~~~~~~~~~~----- 226 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--E----YSDWKEKKTYL----- 226 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH--H----HHHHHTTCTTS-----
T ss_pred ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH--H----HHHHhcCCCCC-----
Confidence 3333445789999999999988876 6789999999999999999999854322111 0 01111111100
Q ss_pred ccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 753 LDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 753 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
.........+.+|+.+||+.||++|||++|+++
T Consensus 227 ---~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 227 ---NPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp ---TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 000111245678999999999999999999865
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-48 Score=407.70 Aligned_cols=260 Identities=25% Similarity=0.388 Sum_probs=202.0
Q ss_pred cccccccCeecccCceeEEEEEeecCcEEEEEEecCC--CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEe
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 593 (836)
.++|+..+.||+|+||.||+|++. ..||||+++.. .....+.|++|+.++++++|||||++++++.+ +..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 367888999999999999999864 36999998654 34567889999999999999999999998764 56899999
Q ss_pred ecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCc
Q 003254 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (836)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~ 673 (836)
|+++|+|.+++... ...+++..+..++.||++||+|||+++ |+||||||+||||++++.+||+|||+|+......
T Consensus 84 y~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 84 WCEGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp CCCEEEHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred cCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 99999999998542 346999999999999999999999988 9999999999999999999999999998765444
Q ss_pred cccccccccccccccCcccccC---CccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhcc
Q 003254 674 TEANTKRVVGTYGYMSPEYAID---GLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELID 750 (836)
Q Consensus 674 ~~~~~~~~~gt~~y~aPE~~~~---~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 750 (836)
.........||+.|+|||++.+ +.++.++|||||||+||||+||+.||....... . .......... .
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~--~----~~~~~~~~~~----~ 228 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--Q----IIFMVGRGYL----S 228 (276)
T ss_dssp -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH--H----HHHHHHHTSC----C
T ss_pred CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH--H----HHHHHhcCCC----C
Confidence 4344455789999999999864 358999999999999999999999975322211 1 1111111110 0
Q ss_pred ccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 003254 751 QSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 794 (836)
Q Consensus 751 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 794 (836)
+.+ ..........+.+|+.+||+.||++||||+||++.|+.+.
T Consensus 229 p~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~ 271 (276)
T d1uwha_ 229 PDL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLA 271 (276)
T ss_dssp CCG-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred Ccc-hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 000 0112223356789999999999999999999999998764
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-48 Score=407.63 Aligned_cols=256 Identities=30% Similarity=0.432 Sum_probs=206.1
Q ss_pred cccccccCeecccCceeEEEEEeecCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEeec
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 595 (836)
.++|+..++||+|+||.||+|++++++.||||+++... ...++|.+|+.++++++|||||+++|++.+ +..++||||+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~ 89 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence 36788889999999999999999888899999997543 445789999999999999999999998854 5679999999
Q ss_pred CCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCccc
Q 003254 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE 675 (836)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 675 (836)
++|+|.+++... ....+++..+++++.||++||+|||+++ |+||||||+||||++++.+||+|||+|+.+......
T Consensus 90 ~~g~L~~~~~~~-~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~ 165 (272)
T d1qpca_ 90 ENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (272)
T ss_dssp TTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred CCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCccc
Confidence 999999887443 2345899999999999999999999988 999999999999999999999999999987543222
Q ss_pred cccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccccccC
Q 003254 676 ANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDN 755 (836)
Q Consensus 676 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 755 (836)
......||+.|+|||++.++.++.++|||||||+||||+||..|+...... .. ......... ..
T Consensus 166 -~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~--~~----~~~~i~~~~---------~~ 229 (272)
T d1qpca_ 166 -AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN--PE----VIQNLERGY---------RM 229 (272)
T ss_dssp -CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HH----HHHHHHTTC---------CC
T ss_pred -cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH--HH----HHHHHHhcC---------CC
Confidence 223467899999999999999999999999999999999976654321111 11 111111110 11
Q ss_pred CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 003254 756 SCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 793 (836)
Q Consensus 756 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 793 (836)
..+......+.+|+.+||+.||++||||+||+++|+..
T Consensus 230 ~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ 267 (272)
T d1qpca_ 230 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (272)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence 11122334678999999999999999999999999853
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.7e-48 Score=411.32 Aligned_cols=259 Identities=26% Similarity=0.385 Sum_probs=211.8
Q ss_pred hcccccccCeecccCceeEEEEEeec-CcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEe
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 593 (836)
..++|+..++||+|+||+||+|++.. |+.||||+++... ...++|.+|+.++++++|||||++++++.+.+..++|||
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E 93 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 93 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEee
Confidence 34678889999999999999999865 8899999986543 446789999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCc
Q 003254 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (836)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~ 673 (836)
|+++|+|.+++... ....+++..+..++.||++||+|||+++ |+||||||+||||++++.+||+|||+++......
T Consensus 94 ~~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~ 169 (287)
T d1opja_ 94 FMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 169 (287)
T ss_dssp CCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred cccCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCC
Confidence 99999999998653 3457899999999999999999999998 9999999999999999999999999998765332
Q ss_pred cccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccccc
Q 003254 674 TEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSL 753 (836)
Q Consensus 674 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 753 (836)
.. ......|++.|+|||++.++.++.++|||||||+||||++|+.|+...... .......... .
T Consensus 170 ~~-~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~------~~~~~~i~~~---------~ 233 (287)
T d1opja_ 170 YT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL------SQVYELLEKD---------Y 233 (287)
T ss_dssp SE-EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH------HHHHHHHHTT---------C
T ss_pred ce-eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH------HHHHHHHhcC---------C
Confidence 22 223356889999999999999999999999999999999987765321111 1111111111 1
Q ss_pred cCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 003254 754 DNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 794 (836)
Q Consensus 754 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 794 (836)
....+......+.+|+.+||+.||++||||.||++.|+.+.
T Consensus 234 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 234 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 11222233456889999999999999999999999998764
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-47 Score=398.20 Aligned_cols=254 Identities=24% Similarity=0.376 Sum_probs=210.8
Q ss_pred ccccccCeecccCceeEEEEEeecCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEeecC
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLP 596 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 596 (836)
++|+..++||+|+||+||+|++++++.||||+++... ...++|++|+.++++++||||++++|++.+.+..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 6889999999999999999999888899999997654 345789999999999999999999999999999999999999
Q ss_pred CCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcccc
Q 003254 597 NKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEA 676 (836)
Q Consensus 597 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~~ 676 (836)
+|+|..++... ...+++..+.+++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.+......
T Consensus 83 ~g~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~- 156 (258)
T d1k2pa_ 83 NGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT- 156 (258)
T ss_dssp TEEHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-
T ss_pred CCcHHHhhhcc--ccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCce-
Confidence 99999987543 456889999999999999999999998 999999999999999999999999999876543222
Q ss_pred ccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhccCchhhccccccC
Q 003254 677 NTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDN 755 (836)
Q Consensus 677 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 755 (836)
......+|+.|+|||.+.++.++.++|||||||++|||+| |+.|+...... .+. ....... +.
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~---~~~----~~i~~~~---------~~ 220 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS---ETA----EHIAQGL---------RL 220 (258)
T ss_dssp CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH---HHH----HHHHTTC---------CC
T ss_pred eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH---HHH----HHHHhCC---------CC
Confidence 2334678999999999999999999999999999999998 78887533221 111 1111111 11
Q ss_pred CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 003254 756 SCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 793 (836)
Q Consensus 756 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 793 (836)
..+......+.+++.+||+.||++|||++||++.|..+
T Consensus 221 ~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 221 YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 11222335678999999999999999999999998654
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-47 Score=410.73 Aligned_cols=257 Identities=26% Similarity=0.399 Sum_probs=197.5
Q ss_pred ccccccCeecccCceeEEEEEeec-C---cEEEEEEecCC-CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEE
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-G---QEIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-g---~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 591 (836)
++|+..++||+|+||.||+|++.. + ..||||++... .....++|.+|+.++++++|||||+++|++.+.+..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 456777899999999999999753 3 25899998654 344567899999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCC
Q 003254 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (836)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~ 671 (836)
|||+++|+|.+++.. ....+++.++..++.||++||+|||+++ |+||||||+||||++++.+||+|||+++.+..
T Consensus 106 ~Ey~~~g~L~~~~~~--~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp EECCTTEEHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEecCCCcceeeecc--ccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccC
Confidence 999999999998853 3456999999999999999999999988 99999999999999999999999999987754
Q ss_pred Cccccc---cccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhccCchh
Q 003254 672 DQTEAN---TKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEERPLE 747 (836)
Q Consensus 672 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (836)
...... .....||+.|+|||.+.++.++.++|||||||+||||+| |+.|+...... .+. ......
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~---~~~----~~i~~~---- 249 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ---DVI----NAIEQD---- 249 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHH----HHHHTT----
T ss_pred CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH---HHH----HHHHcC----
Confidence 332221 222457899999999999999999999999999999998 88887532211 111 111111
Q ss_pred hccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 003254 748 LIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 794 (836)
Q Consensus 748 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 794 (836)
.....+......+.+|+.+||+.||++||||.||++.|+.+.
T Consensus 250 -----~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l 291 (299)
T d1jpaa_ 250 -----YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMI 291 (299)
T ss_dssp -----CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred -----CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 111222334456789999999999999999999999998753
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-47 Score=403.81 Aligned_cols=262 Identities=27% Similarity=0.434 Sum_probs=205.7
Q ss_pred ccccccCeecccCceeEEEEEeecCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEeecC
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLP 596 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 596 (836)
++|++.+.||+|+||.||+|+++++++||||+++... ...+.|.+|+.++++++|||||+++|++. .+..++||||++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~ 94 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 94 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecC
Confidence 6789999999999999999999888899999996543 44578999999999999999999999985 466899999999
Q ss_pred CCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcccc
Q 003254 597 NKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEA 676 (836)
Q Consensus 597 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~~ 676 (836)
+|+|..++... ..+.++|.+++.++.||++||+|||+++ |+||||||+||||++++.+||+|||+++.+..... .
T Consensus 95 ~g~l~~~~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~-~ 169 (285)
T d1fmka3 95 KGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-T 169 (285)
T ss_dssp TCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred CCchhhhhhhc-ccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCc-e
Confidence 99999888653 2346999999999999999999999998 99999999999999999999999999987643322 2
Q ss_pred ccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccccccCC
Q 003254 677 NTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDNS 756 (836)
Q Consensus 677 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 756 (836)
......||+.|+|||++.++.++.++|||||||+||||++|..|+...... .... ...... ....
T Consensus 170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~--~~~~----~~i~~~---------~~~~ 234 (285)
T d1fmka3 170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVL----DQVERG---------YRMP 234 (285)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHH----HHHHTT---------CCCC
T ss_pred eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH--HHHH----HHHHhc---------CCCC
Confidence 223367899999999999999999999999999999999977664322211 1111 111111 1111
Q ss_pred CChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCCCCCCCC
Q 003254 757 CSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPQ 800 (836)
Q Consensus 757 ~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~~~~p~ 800 (836)
.+......+.+++.+||+.||++||||.+|+++|+.......|+
T Consensus 235 ~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~ 278 (285)
T d1fmka3 235 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278 (285)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCC
T ss_pred CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCCC
Confidence 22233356789999999999999999999999999876544443
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-46 Score=397.71 Aligned_cols=249 Identities=24% Similarity=0.397 Sum_probs=206.3
Q ss_pred ccccccCeecccCceeEEEEEee-cCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEeec
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 595 (836)
++|+..++||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++|||||++++++.+.+..+|||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 57999999999999999999975 49999999997665556678999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCccc
Q 003254 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE 675 (836)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 675 (836)
++|+|.+++.+ ..+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 100 ~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~- 171 (293)
T d1yhwa1 100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (293)
T ss_dssp TTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred CCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccccc-
Confidence 99999988743 35899999999999999999999998 99999999999999999999999999997643322
Q ss_pred cccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccccccC
Q 003254 676 ANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDN 755 (836)
Q Consensus 676 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 755 (836)
......||+.|+|||++.++.++.++|||||||++|||++|+.||...... ...........+ ..
T Consensus 172 -~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~------~~~~~~~~~~~~-~~------- 236 (293)
T d1yhwa1 172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL------RALYLIATNGTP-EL------- 236 (293)
T ss_dssp -CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHHCSC-CC-------
T ss_pred -cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH------HHHHHHHhCCCC-CC-------
Confidence 233468999999999999999999999999999999999999997532211 111111111111 00
Q ss_pred CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 756 SCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 756 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
..+......+.+++.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111122345789999999999999999999975
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-47 Score=404.50 Aligned_cols=259 Identities=27% Similarity=0.436 Sum_probs=201.8
Q ss_pred ccccccCeecccCceeEEEEEeecC-----cEEEEEEecCCC-chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeE
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIEG-----QEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~g-----~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 590 (836)
+.|+..+.||+|+||.||+|++... ..||||++.... ....++|.+|+.++++++|||||+++|++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4678889999999999999998652 369999997653 3345679999999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccC
Q 003254 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (836)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~ 670 (836)
||||+.++++.+++.. ....+++.++..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.+.
T Consensus 87 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 87 ITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp EEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEecccCcchhhhhc--ccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhccc
Confidence 9999999999888754 3357999999999999999999999998 9999999999999999999999999998764
Q ss_pred CCccc-cccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhc
Q 003254 671 LDQTE-ANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELI 749 (836)
Q Consensus 671 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (836)
..... .......||+.|+|||++.++.++.++|||||||+||||++|..|+...... .. .......
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~--~~----~~~~i~~------- 228 (283)
T d1mqba_ 162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--HE----VMKAIND------- 228 (283)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HH----HHHHHHT-------
T ss_pred CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH--HH----HHHHHhc-------
Confidence 33222 2233456899999999999999999999999999999999976664322211 11 1111111
Q ss_pred cccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCCC
Q 003254 750 DQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS 795 (836)
Q Consensus 750 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~ 795 (836)
..+...+......+.+|+.+||+.+|++||||.||+++|+.+..
T Consensus 229 --~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 229 --GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp --TCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred --cCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 11112223344568899999999999999999999999987644
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-47 Score=409.75 Aligned_cols=257 Identities=28% Similarity=0.432 Sum_probs=205.6
Q ss_pred ccccccCeecccCceeEEEEEeec-C-----cEEEEEEecCC-CchhHHHHHHHHHHHHhh-cCCceeeEEeEEeeCCee
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-G-----QEIAVKRLSKG-SGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDER 588 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-g-----~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~ 588 (836)
++|+..++||+|+||+||+|+... + ..||||++... .....+.+.+|+.++.++ +|||||++++++.+.+..
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 678889999999999999999754 2 36999998654 334556799999999998 899999999999999999
Q ss_pred eEEEeecCCCChhHHHhhccC--------------------CCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCC
Q 003254 589 MLIYEYLPNKSLDYFIFDTTR--------------------SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKAS 648 (836)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~ 648 (836)
++||||+++|+|.+++..... ...+++..++.++.||++||+|||+++ |+||||||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp~ 193 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAAR 193 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGG
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCchh
Confidence 999999999999999965321 245899999999999999999999998 999999999
Q ss_pred ceEecCCCCceeeccCcccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCc
Q 003254 649 NVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHAD 727 (836)
Q Consensus 649 NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~ 727 (836)
|||++.++.+||+|||+|+...............||+.|+|||++.++.++.++|||||||+||||+| |+.||......
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999987654433333345678999999999999999999999999999999998 89887532221
Q ss_pred cccchhhhhHHhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 003254 728 HDHNLLGHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLS 791 (836)
Q Consensus 728 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~ 791 (836)
. .+ ....... .+...+......+.+|+.+||+.||++||||+||+++|.
T Consensus 274 ~--~~----~~~~~~~---------~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 274 A--NF----YKLIQNG---------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp H--HH----HHHHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred H--HH----HHHHhcC---------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 1 11 1111111 111122223356889999999999999999999999985
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=399.44 Aligned_cols=255 Identities=27% Similarity=0.425 Sum_probs=205.2
Q ss_pred ccccccC-eecccCceeEEEEEeec---CcEEEEEEecCCC-chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEE
Q 003254 517 DNFSEKN-KLGEGGFGPVYKGMLIE---GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (836)
Q Consensus 517 ~~f~~~~-~lG~G~fG~Vykg~~~~---g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 591 (836)
++|...+ +||+|+||.||+|++.. +..||||+++... ....++|.+|++++++++|||||+++|++.. +..+||
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 5666666 49999999999998643 5579999997653 3456789999999999999999999999864 568999
Q ss_pred EeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCC
Q 003254 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (836)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~ 671 (836)
|||+++|+|.+++.. ....+++..+..++.||++||+|||+++ |+||||||+||||++++.+||+|||+++.+..
T Consensus 87 mE~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccc
Confidence 999999999998743 3457999999999999999999999998 99999999999999999999999999998754
Q ss_pred Cccc-cccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhccCchhhc
Q 003254 672 DQTE-ANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEERPLELI 749 (836)
Q Consensus 672 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (836)
.... .......||+.|+|||++.++.++.++|||||||++|||+| |+.||...... .+ ......+..
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~---~~----~~~i~~~~~---- 230 (285)
T d1u59a_ 162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EV----MAFIEQGKR---- 230 (285)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HH----HHHHHTTCC----
T ss_pred cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH---HH----HHHHHcCCC----
Confidence 3322 22234568999999999999999999999999999999998 89997543221 11 111111111
Q ss_pred cccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 003254 750 DQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 793 (836)
Q Consensus 750 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 793 (836)
...+......+.+|+.+||+.+|++||||.+|++.|+..
T Consensus 231 -----~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 231 -----MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp -----CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 112223335678999999999999999999999999753
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=395.66 Aligned_cols=245 Identities=25% Similarity=0.363 Sum_probs=203.8
Q ss_pred ccccccCeecccCceeEEEEEeec-CcEEEEEEecCC---CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEE
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 592 (836)
++|++.+.||+|+||.||+|+... ++.||+|++.+. .....+.+.+|+.++++++|||||++++++.+.+..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 579999999999999999999864 889999998643 2334567899999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCC
Q 003254 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (836)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~ 672 (836)
||+++|+|.+++.. ...+++..+..++.||++||+|||+++ |+||||||+|||+++++.+||+|||+|+.....
T Consensus 86 Ey~~~g~L~~~l~~---~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred eecCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 99999999999854 346899999999999999999999998 999999999999999999999999999865322
Q ss_pred ccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhcccc
Q 003254 673 QTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQS 752 (836)
Q Consensus 673 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 752 (836)
......||+.|+|||++.+..++.++|||||||+||||++|+.||...... . ..........
T Consensus 160 ----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~---~----~~~~i~~~~~------- 221 (263)
T d2j4za1 160 ----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ---E----TYKRISRVEF------- 221 (263)
T ss_dssp ----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH---H----HHHHHHTTCC-------
T ss_pred ----cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH---H----HHHHHHcCCC-------
Confidence 233467999999999999999999999999999999999999997532211 1 1111111110
Q ss_pred ccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 753 LDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 753 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
..+......+.+++.+||+.||++|||++||++
T Consensus 222 ---~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 222 ---TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 111112345778999999999999999999986
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-46 Score=398.89 Aligned_cols=247 Identities=27% Similarity=0.399 Sum_probs=197.6
Q ss_pred CeecccCceeEEEEEeec---CcEEEEEEecCC--CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEeecCC
Q 003254 523 NKLGEGGFGPVYKGMLIE---GQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPN 597 (836)
Q Consensus 523 ~~lG~G~fG~Vykg~~~~---g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 597 (836)
++||+|+||.||+|.+.+ ++.||||+++.. .....++|.+|+.++++++|||||+++|+|.. +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 479999999999998754 467999998654 33445789999999999999999999999864 567899999999
Q ss_pred CChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcccc-
Q 003254 598 KSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEA- 676 (836)
Q Consensus 598 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~~- 676 (836)
|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.+.......
T Consensus 92 g~L~~~l~~---~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 92 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CcHHHHHhh---ccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 999999853 456999999999999999999999988 9999999999999999999999999999875433322
Q ss_pred ccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhccCchhhccccccC
Q 003254 677 NTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDN 755 (836)
Q Consensus 677 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 755 (836)
......||+.|+|||.+.+..++.++|||||||++|||+| |+.||...... . ......... ..
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~---~----~~~~i~~~~---------~~ 229 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---E----VTAMLEKGE---------RM 229 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---H----HHHHHHTTC---------CC
T ss_pred cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH---H----HHHHHHcCC---------CC
Confidence 2334578999999999999999999999999999999998 89997532211 1 111111111 11
Q ss_pred CCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcC
Q 003254 756 SCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 792 (836)
Q Consensus 756 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~ 792 (836)
..+......+.+|+.+||+.||++||||+||+++|+.
T Consensus 230 ~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 230 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 1222234567899999999999999999999999875
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-47 Score=399.86 Aligned_cols=254 Identities=25% Similarity=0.320 Sum_probs=193.9
Q ss_pred ccccccCeecccCceeEEEEEee-cCcEEEEEEecCCC--chhHHHHHHHHHHHHhhcCCceeeEEeEEee--CCeeeEE
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQ--RDERMLI 591 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~lV 591 (836)
++|++.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++|||||++++++.+ ....++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 68999999999999999999975 48999999987653 3445678999999999999999999999865 4557999
Q ss_pred EeecCCCChhHHHhhcc-CCCcCChhhhHHHHHHHHhhhHhhhcCC--CCcEEeccCCCCceEecCCCCceeeccCcccc
Q 003254 592 YEYLPNKSLDYFIFDTT-RSKLLDWSKRSHIIAGIARGLLYLHQDS--RLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (836)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~ 668 (836)
|||+++|+|.+++.... ....+++..++.++.||+.||+|||+++ ..+|+||||||+||||++++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 99999999999986532 3457999999999999999999999865 23599999999999999999999999999998
Q ss_pred cCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhh
Q 003254 669 FGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLEL 748 (836)
Q Consensus 669 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (836)
+..... ......||+.|+|||++.+..++.++|||||||+||||++|+.||...... .+ ..........
T Consensus 164 ~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~---~~----~~~i~~~~~~-- 232 (269)
T d2java1 164 LNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK---EL----AGKIREGKFR-- 232 (269)
T ss_dssp C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HH----HHHHHHTCCC--
T ss_pred cccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH---HH----HHHHHcCCCC--
Confidence 643222 233468999999999999999999999999999999999999997532211 11 1111111111
Q ss_pred ccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 749 IDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 749 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
..+......+.+|+.+||+.||++|||+.|+++
T Consensus 233 -------~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 233 -------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 111122345789999999999999999999975
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-46 Score=398.69 Aligned_cols=251 Identities=24% Similarity=0.347 Sum_probs=206.0
Q ss_pred ccccccCeecccCceeEEEEEeec-CcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEeec
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 595 (836)
+.|++.++||+|+||.||+|+... |+.||||++........+.+.+|++++++++|||||++++++.+.+..+|||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 568889999999999999999854 8899999998777777889999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCccc
Q 003254 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE 675 (836)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 675 (836)
++|+|.+++.+. .+.+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+..... .
T Consensus 92 ~~g~L~~~~~~~--~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~--~ 164 (288)
T d2jfla1 92 AGGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--I 164 (288)
T ss_dssp TTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHH--H
T ss_pred CCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCC--c
Confidence 999999987543 356999999999999999999999998 999999999999999999999999999765322 1
Q ss_pred cccccccccccccCccccc-----CCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhcc
Q 003254 676 ANTKRVVGTYGYMSPEYAI-----DGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELID 750 (836)
Q Consensus 676 ~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 750 (836)
.......||+.|+|||++. +..|+.++|||||||+||||++|+.||....... . ............
T Consensus 165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~---~----~~~i~~~~~~~~-- 235 (288)
T d2jfla1 165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR---V----LLKIAKSEPPTL-- 235 (288)
T ss_dssp HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG---H----HHHHHHSCCCCC--
T ss_pred ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH---H----HHHHHcCCCCCC--
Confidence 1233468999999999984 4568999999999999999999999975432211 1 111111111111
Q ss_pred ccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 751 QSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 751 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
..+......+.+|+.+||+.||++|||+.|+++
T Consensus 236 -----~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 236 -----AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp -----SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -----CccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 011122346789999999999999999999976
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-47 Score=401.41 Aligned_cols=248 Identities=24% Similarity=0.309 Sum_probs=201.4
Q ss_pred ccccccCeecccCceeEEEEEee-cCcEEEEEEecCC---CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEE
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 592 (836)
++|++.+.||+|+||.||+|+.. +|+.||||++.+. .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 67999999999999999999985 4899999998643 2334567999999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCC
Q 003254 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (836)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~ 672 (836)
||+++|+|.+++.. .+.+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+|+.+...
T Consensus 88 Ey~~gg~L~~~~~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhhc---cCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence 99999999998854 356999999999999999999999998 999999999999999999999999999987644
Q ss_pred ccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhcccc
Q 003254 673 QTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQS 752 (836)
Q Consensus 673 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 752 (836)
..........||+.|+|||++.+..++.++|||||||+||||++|+.||...... .+ .........
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~---~~----~~~i~~~~~------- 227 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY---LI----FQKIIKLEY------- 227 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH----HHHHHTTCC-------
T ss_pred CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH---HH----HHHHHcCCC-------
Confidence 4444444578999999999999999999999999999999999999998532211 11 111111110
Q ss_pred ccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 003254 753 LDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVV 787 (836)
Q Consensus 753 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl 787 (836)
..+......+.+|+.+||+.||++|||++|++
T Consensus 228 ---~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~ 259 (288)
T d1uu3a_ 228 ---DFPEKFFPKARDLVEKLLVLDATKRLGCEEME 259 (288)
T ss_dssp ---CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred ---CCCccCCHHHHHHHHHHccCCHhHCcCHHHHc
Confidence 11112234578999999999999999999864
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3e-46 Score=401.29 Aligned_cols=266 Identities=26% Similarity=0.392 Sum_probs=213.3
Q ss_pred HHHHhhcccccccCeecccCceeEEEEEee------cCcEEEEEEecCCCc-hhHHHHHHHHHHHHhhcCCceeeEEeEE
Q 003254 510 KIIANATDNFSEKNKLGEGGFGPVYKGMLI------EGQEIAVKRLSKGSG-QGMEEFKNEVLLIAKLQHRNLVKLLGCC 582 (836)
Q Consensus 510 ~~l~~a~~~f~~~~~lG~G~fG~Vykg~~~------~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~ 582 (836)
.+++...++|+..+.||+|+||+||+|+.. +++.||||+++.... ...++|.+|+.++++++||||+++++++
T Consensus 6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 345556688999999999999999999974 357899999976543 3456799999999999999999999999
Q ss_pred eeCCeeeEEEeecCCCChhHHHhhcc---------------------CCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEE
Q 003254 583 TQRDERMLIYEYLPNKSLDYFIFDTT---------------------RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRII 641 (836)
Q Consensus 583 ~~~~~~~lV~Ey~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iv 641 (836)
...+..++||||+++|+|.+++.... ....+++..++.++.||+.||+|||+++ |+
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iv 162 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FV 162 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eE
Confidence 99999999999999999999986432 1234889999999999999999999998 99
Q ss_pred eccCCCCceEecCCCCceeeccCcccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCC-C
Q 003254 642 HRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKK-N 720 (836)
Q Consensus 642 H~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~-p 720 (836)
||||||+||||+.++.+||+|||+++.+.............+++.|+|||.+.+..++.++|||||||+||||++|.. |
T Consensus 163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p 242 (301)
T d1lufa_ 163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 242 (301)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred eeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCC
Confidence 999999999999999999999999987654443344445678999999999999999999999999999999999964 5
Q ss_pred CCCCCCccccchhhhhHHhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 003254 721 RGFNHADHDHNLLGHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 794 (836)
Q Consensus 721 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 794 (836)
+...... .. .......... ..+.....++.+|+.+||+.+|++||||.||+++|+++.
T Consensus 243 ~~~~~~~---e~----~~~v~~~~~~---------~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 243 YYGMAHE---EV----IYYVRDGNIL---------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTTSCHH---HH----HHHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCCHH---HH----HHHHHcCCCC---------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 4322111 11 1111111111 112223346789999999999999999999999999874
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-46 Score=406.44 Aligned_cols=264 Identities=23% Similarity=0.333 Sum_probs=204.4
Q ss_pred hcccccccCeecccCceeEEEEEee-cCcEEEEEEecCCC-chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEE
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 592 (836)
..++|+..++||+|+||.||+|+.. +|+.||+|+++... ....+++.+|+.++++++|||||++++++.+.+..++||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 4578999999999999999999975 48899999997653 344578899999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcC-CCCcEEeccCCCCceEecCCCCceeeccCcccccCC
Q 003254 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (836)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~ 671 (836)
||+++|+|.+++.+. +.+++..+..++.||+.||.|||++ + |+||||||+||||++++.+||+|||+|+.+..
T Consensus 84 Ey~~gg~L~~~l~~~---~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp ECCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EcCCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 999999999999543 4689999999999999999999974 6 99999999999999999999999999987532
Q ss_pred CccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhH--------------
Q 003254 672 DQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAW-------------- 737 (836)
Q Consensus 672 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~-------------- 737 (836)
......+||+.|+|||++.+..|+.++||||+||++|||++|+.||................
T Consensus 158 ----~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (322)
T d1s9ja_ 158 ----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233 (322)
T ss_dssp ----HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------
T ss_pred ----CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccc
Confidence 12234689999999999999999999999999999999999999986433221100000000
Q ss_pred -----Hhhhcc----CchhhccccccCC----CChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 738 -----RLWIEE----RPLELIDQSLDNS----CSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 738 -----~~~~~~----~~~~~~d~~l~~~----~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
...... ...+..+...... ........+.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp ------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 000000 0000000000000 00011245789999999999999999999987
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-45 Score=383.11 Aligned_cols=247 Identities=25% Similarity=0.367 Sum_probs=195.1
Q ss_pred ccccCeecccCceeEEEEEeec-CcEEEEEEecCC--CchhHHHHHHHHHHHHhhcCCceeeEEeEEee----CCeeeEE
Q 003254 519 FSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQ----RDERMLI 591 (836)
Q Consensus 519 f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~~lV 591 (836)
|+..++||+|+||+||+|+... ++.||+|++... .....+.|.+|++++++++|||||++++++.. ....++|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 3556689999999999999864 889999998654 33456679999999999999999999999865 3457999
Q ss_pred EeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEec-CCCCceeeccCcccccC
Q 003254 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD-NTMNPKISDFGLARSFG 670 (836)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~-~~~~~kl~DFgla~~~~ 670 (836)
|||+++|+|.+++.. ...+++..+..++.||++||+|||+++ .+|+||||||+||||+ +++.+||+|||+++...
T Consensus 91 mE~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp EECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EeCCCCCcHHHHHhc---cccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 999999999999854 346899999999999999999999875 4599999999999996 58899999999998643
Q ss_pred CCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhcc
Q 003254 671 LDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELID 750 (836)
Q Consensus 671 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 750 (836)
.. ......||+.|+|||++.+ .++.++|||||||+||||++|+.||...... ....+..........++
T Consensus 167 ~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~------~~~~~~i~~~~~~~~~~ 235 (270)
T d1t4ha_ 167 AS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA------AQIYRRVTSGVKPASFD 235 (270)
T ss_dssp TT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH------HHHHHHHTTTCCCGGGG
T ss_pred CC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH------HHHHHHHHcCCCCcccC
Confidence 22 2234689999999998865 5999999999999999999999997532211 11111111111111111
Q ss_pred ccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 751 QSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 751 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
......+.+|+.+||+.||++|||+.|+++
T Consensus 236 --------~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 236 --------KVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp --------GCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --------ccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 111234778999999999999999999976
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.3e-45 Score=394.74 Aligned_cols=245 Identities=28% Similarity=0.417 Sum_probs=199.5
Q ss_pred ccccccCeecccCceeEEEEEee-cCcEEEEEEecCCCc---hhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEE
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSG---QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 592 (836)
+.|+..++||+|+||.||+|+.. +|+.||||++..... ...+.+.+|+.++++++|||||++++++.+.+..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 45899999999999999999975 488899999976532 34467899999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCC
Q 003254 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (836)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~ 672 (836)
||+++|+|+.++.. .+.+++.++..++.||+.||.|||+++ |+||||||+||||++++.+||+|||+|+....
T Consensus 95 E~~~~g~l~~~~~~---~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~- 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 167 (309)
T ss_dssp ECCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred EecCCCchHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC-
Confidence 99999999766632 457999999999999999999999998 99999999999999999999999999986532
Q ss_pred ccccccccccccccccCcccccC---CccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhc
Q 003254 673 QTEANTKRVVGTYGYMSPEYAID---GLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELI 749 (836)
Q Consensus 673 ~~~~~~~~~~gt~~y~aPE~~~~---~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (836)
.....||+.|+|||++.+ +.|+.++|||||||++|||++|+.||...... ..... ..........
T Consensus 168 -----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~------~~~~~-i~~~~~~~~~ 235 (309)
T d1u5ra_ 168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYH-IAQNESPALQ 235 (309)
T ss_dssp -----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHH-HHHSCCCCCS
T ss_pred -----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH------HHHHH-HHhCCCCCCC
Confidence 233679999999999864 46899999999999999999999997532111 11111 1111111111
Q ss_pred cccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 750 DQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 750 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
+......+.+|+.+||+.||++|||+.|+++
T Consensus 236 --------~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 236 --------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp --------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred --------CCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 1112345789999999999999999999986
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.1e-45 Score=394.84 Aligned_cols=256 Identities=23% Similarity=0.311 Sum_probs=191.2
Q ss_pred hcccccccCeecccCceeEEEEEeec-CcEEEEEEecCCC-chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEE
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 592 (836)
..+.|++.+.||+|+||+||+|+... |+.||||++.... ....+.+.+|+.++++++|||||++++++.+.+..+|||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 44679999999999999999999864 8899999997653 233456889999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEec---CCCCceeeccCccccc
Q 003254 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD---NTMNPKISDFGLARSF 669 (836)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~---~~~~~kl~DFgla~~~ 669 (836)
||+++|+|.+++.. .+.+++.++..++.||+.||+|||+++ |+||||||+|||+. +++.+||+|||+++..
T Consensus 87 E~~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 87 QLVSGGELFDRIVE---KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CCCCSCBHHHHHHT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred eccCCCcHHHhhhc---ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 99999999999943 457999999999999999999999998 99999999999994 5789999999999865
Q ss_pred CCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhc
Q 003254 670 GLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELI 749 (836)
Q Consensus 670 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (836)
.... .....+||+.|+|||++.+..++.++|||||||+||||++|+.||...... .. ......... .
T Consensus 161 ~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~---~~----~~~i~~~~~-~-- 227 (307)
T d1a06a_ 161 DPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA---KL----FEQILKAEY-E-- 227 (307)
T ss_dssp ---------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HH----HHHHHTTCC-C--
T ss_pred cCCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH---HH----HHHHhccCC-C--
Confidence 4222 233467999999999999999999999999999999999999997532211 11 111111110 0
Q ss_pred cccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hcC
Q 003254 750 DQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM--LSG 792 (836)
Q Consensus 750 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~--L~~ 792 (836)
............+.+++.+||+.||++|||+.|+++. +.+
T Consensus 228 ---~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 269 (307)
T d1a06a_ 228 ---FDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG 269 (307)
T ss_dssp ---CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred ---CCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence 0001111223457899999999999999999999883 544
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-45 Score=394.99 Aligned_cols=256 Identities=26% Similarity=0.427 Sum_probs=201.7
Q ss_pred ccccccCeecccCceeEEEEEeec-Cc----EEEEEEecCC-CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeE
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQ----EIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-g~----~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 590 (836)
++|+..++||+|+||+||+|++.. |+ +||+|+++.. .....++|.+|+.++++++|||||+++|+|.+. ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 469999999999999999999753 43 5899988654 345678899999999999999999999999864 5678
Q ss_pred EEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccC
Q 003254 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (836)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~ 670 (836)
++||+.+|+|.+++.. ....+++..+++++.|||.||+|||+++ |+||||||+||||+.++.+||+|||+++.+.
T Consensus 88 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEECCTTCBHHHHHHH--TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred EEEeccCCcccccccc--cccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence 8999999999888754 3457999999999999999999999998 9999999999999999999999999999876
Q ss_pred CCccccccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhccCchhhc
Q 003254 671 LDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEERPLELI 749 (836)
Q Consensus 671 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (836)
............||+.|+|||++.++.++.++|||||||+||||+| |+.|+....... +. .....+
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~---~~----~~i~~~------ 229 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---IS----SILEKG------ 229 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG---HH----HHHHHT------
T ss_pred cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH---HH----HHHHcC------
Confidence 5444444445678999999999999999999999999999999999 677765322211 11 111111
Q ss_pred cccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 003254 750 DQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 794 (836)
Q Consensus 750 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 794 (836)
.+...+......+.+|+.+||+.||++|||+.||++.|+.+.
T Consensus 230 ---~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~ 271 (317)
T d1xkka_ 230 ---ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271 (317)
T ss_dssp ---CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---CCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence 111122233456789999999999999999999999987653
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-45 Score=391.68 Aligned_cols=266 Identities=27% Similarity=0.380 Sum_probs=201.2
Q ss_pred HHHHhhcccccccCeecccCceeEEEEEeec------CcEEEEEEecCCC-chhHHHHHHHHHHHHhh-cCCceeeEEeE
Q 003254 510 KIIANATDNFSEKNKLGEGGFGPVYKGMLIE------GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKL-QHRNLVKLLGC 581 (836)
Q Consensus 510 ~~l~~a~~~f~~~~~lG~G~fG~Vykg~~~~------g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~ 581 (836)
...+...++|+..++||+|+||.||+|+... ++.||||+++... ....+++.+|..++.++ +|+||++++++
T Consensus 6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~ 85 (299)
T d1ywna1 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 85 (299)
T ss_dssp HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence 3333344789999999999999999999643 4689999997543 34456788888888887 68999999999
Q ss_pred EeeC-CeeeEEEeecCCCChhHHHhhccC-------------CCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCC
Q 003254 582 CTQR-DERMLIYEYLPNKSLDYFIFDTTR-------------SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKA 647 (836)
Q Consensus 582 ~~~~-~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp 647 (836)
+.+. ...++||||+++|+|.+++..... ...+++.++..++.||++||+|||+++ |+||||||
T Consensus 86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp 162 (299)
T d1ywna1 86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAA 162 (299)
T ss_dssp ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCG
T ss_pred eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCc
Confidence 8765 468999999999999999965321 345899999999999999999999998 99999999
Q ss_pred CceEecCCCCceeeccCcccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCC-CCCCCCC
Q 003254 648 SNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKK-NRGFNHA 726 (836)
Q Consensus 648 ~NILl~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~-p~~~~~~ 726 (836)
+||||++++.+||+|||+|+...............||+.|+|||++.++.++.++|||||||++|||++|.. |+.....
T Consensus 163 ~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~ 242 (299)
T d1ywna1 163 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 242 (299)
T ss_dssp GGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred cceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987655444444455789999999999999999999999999999999999754 5432221
Q ss_pred ccccchhhhhHHhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 003254 727 DHDHNLLGHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 793 (836)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 793 (836)
.. ............ ..+.....++.+++.+||+.||++|||+.||++.|+.+
T Consensus 243 ~~------~~~~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i 294 (299)
T d1ywna1 243 DE------EFCRRLKEGTRM---------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294 (299)
T ss_dssp SH------HHHHHHHHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HH------HHHHHHhcCCCC---------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 11 111111111111 11122234578999999999999999999999999865
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.3e-44 Score=395.42 Aligned_cols=252 Identities=23% Similarity=0.321 Sum_probs=206.9
Q ss_pred ccccccCeecccCceeEEEEEee-cCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEeec
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 595 (836)
++|++.+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++|||||++++++.+.+..+|||||+
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 58999999999999999999975 48999999998777666788999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEec--CCCCceeeccCcccccCCCc
Q 003254 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD--NTMNPKISDFGLARSFGLDQ 673 (836)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~--~~~~~kl~DFgla~~~~~~~ 673 (836)
++|+|.+++.. ....+++.++..++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||+++.+....
T Consensus 106 ~gg~L~~~l~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 106 SGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp CSCBHHHHHTC--TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred CCCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence 99999998843 2356999999999999999999999998 99999999999995 46889999999998764332
Q ss_pred cccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccccc
Q 003254 674 TEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSL 753 (836)
Q Consensus 674 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 753 (836)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ... ........ . .
T Consensus 181 ---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~---~~~----~~i~~~~~-~-----~ 244 (350)
T d1koaa2 181 ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD---ETL----RNVKSCDW-N-----M 244 (350)
T ss_dssp ---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH----HHHHHTCC-C-----S
T ss_pred ---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH---HHH----HHHHhCCC-C-----C
Confidence 223468999999999999999999999999999999999999997532211 111 11111100 0 0
Q ss_pred cCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 754 DNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 754 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
...........+.+|+.+||+.||++|||+.|+++.
T Consensus 245 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 245 DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp CCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000001122457799999999999999999999984
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-45 Score=385.04 Aligned_cols=251 Identities=24% Similarity=0.342 Sum_probs=197.2
Q ss_pred cccccccCeecccCceeEEEEEeecCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeC-CeeeEEEee
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR-DERMLIYEY 594 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-~~~~lV~Ey 594 (836)
-++|+..++||+|+||.||+|++ .|++||||+++.. ...++|.+|++++++++||||++++|++.+. +..++||||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred HHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence 35788889999999999999998 6889999999654 3457899999999999999999999998654 568999999
Q ss_pred cCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcc
Q 003254 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (836)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~ 674 (836)
+++|+|.+++... ....+++..+++++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-- 156 (262)
T d1byga_ 83 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 156 (262)
T ss_dssp CTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred cCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC--
Confidence 9999999999643 2346899999999999999999999988 999999999999999999999999999865322
Q ss_pred ccccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhccCchhhccccc
Q 003254 675 EANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSL 753 (836)
Q Consensus 675 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 753 (836)
.....++..|+|||++.++.++.++|||||||++|||+| |+.|+...... .+.. ..... .
T Consensus 157 ---~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~---~~~~----~i~~~---------~ 217 (262)
T d1byga_ 157 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVP----RVEKG---------Y 217 (262)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHHH----HHTTT---------C
T ss_pred ---CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH---HHHH----HHHcC---------C
Confidence 223467899999999999999999999999999999998 56665432221 1111 11111 1
Q ss_pred cCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 003254 754 DNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 794 (836)
Q Consensus 754 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 794 (836)
+...+.....++.+|+.+||+.||++||||.||+++|+.++
T Consensus 218 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~ 258 (262)
T d1byga_ 218 KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258 (262)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 11222233356789999999999999999999999998753
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.8e-44 Score=393.08 Aligned_cols=257 Identities=22% Similarity=0.278 Sum_probs=209.3
Q ss_pred cccccccCeecccCceeEEEEEee-cCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEee
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 594 (836)
.++|++.+.||+|+||.||+|+.. +|+.||||+++.......+.+.+|+.++++++|||||++++++.+.+..+|||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 367999999999999999999975 4999999999877666667889999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEec--CCCCceeeccCcccccCCC
Q 003254 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD--NTMNPKISDFGLARSFGLD 672 (836)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~--~~~~~kl~DFgla~~~~~~ 672 (836)
+++|+|.+++.. ....+++.++..++.||+.||+|||+++ |+||||||+||||+ +++.+||+|||+|..+...
T Consensus 108 ~~gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 108 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCChHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCC
Confidence 999999887742 3446999999999999999999999998 99999999999997 6789999999999986533
Q ss_pred ccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhcccc
Q 003254 673 QTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQS 752 (836)
Q Consensus 673 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 752 (836)
. ......||+.|+|||++.+..++.++|||||||+||||++|+.||...... ... ........ .
T Consensus 183 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~---~~~----~~i~~~~~------~ 246 (352)
T d1koba_ 183 E---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL---ETL----QNVKRCDW------E 246 (352)
T ss_dssp S---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHH----HHHHHCCC------C
T ss_pred C---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH---HHH----HHHHhCCC------C
Confidence 2 233467899999999999999999999999999999999999997532211 111 11111100 0
Q ss_pred ccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hcCC
Q 003254 753 LDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM--LSGE 793 (836)
Q Consensus 753 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~--L~~~ 793 (836)
............+.+|+.+||+.||++|||+.|+++. +++.
T Consensus 247 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 247 FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 0011111223457799999999999999999999884 6554
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-45 Score=385.45 Aligned_cols=256 Identities=27% Similarity=0.367 Sum_probs=196.1
Q ss_pred ccccccCeecccCceeEEEEEeec--C--cEEEEEEecCC---CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeee
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE--G--QEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERM 589 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~--g--~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 589 (836)
++|+..+.||+|+||.||+|++.. + ..||||++... .....++|.+|+.++++++|||||+++|++.+ ...+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 678999999999999999998743 2 36899998654 34456789999999999999999999999965 5678
Q ss_pred EEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCccccc
Q 003254 590 LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (836)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~ 669 (836)
+||||+++|++.+.+... ...+++..+..++.|||+||.|||+++ |+||||||+||||+.++.+||+|||+++.+
T Consensus 87 lv~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp EEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeeeecCcchhhhhhcc--cCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhc
Confidence 999999999999887543 456999999999999999999999988 999999999999999999999999999987
Q ss_pred CCCcccc-ccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhccCchh
Q 003254 670 GLDQTEA-NTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEERPLE 747 (836)
Q Consensus 670 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (836)
....... ......|+..|+|||.+.+..++.++|||||||++|||+| |+.||...... ... ........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~---~~~---~~i~~~~~--- 232 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS---QIL---HKIDKEGE--- 232 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHH---HHHHTSCC---
T ss_pred ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH---HHH---HHHHhCCC---
Confidence 5443322 2334567889999999999999999999999999999998 89887532111 111 11111110
Q ss_pred hccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 003254 748 LIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 793 (836)
Q Consensus 748 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 793 (836)
....+......+.+|+.+||+.||++||||.||++.|++.
T Consensus 233 ------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 233 ------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 0111122234678999999999999999999999999763
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-44 Score=388.19 Aligned_cols=257 Identities=27% Similarity=0.430 Sum_probs=203.4
Q ss_pred ccccccCeecccCceeEEEEEeec-Cc--EEEEEEecCC-CchhHHHHHHHHHHHHhh-cCCceeeEEeEEeeCCeeeEE
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQ--EIAVKRLSKG-SGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDERMLI 591 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-g~--~vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV 591 (836)
++|+..++||+|+||.||+|++.+ |. .||||++... .....++|.+|+++++++ +|||||+++|++.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 678888999999999999999865 43 4788888654 334567899999999998 799999999999999999999
Q ss_pred EeecCCCChhHHHhhc-------------cCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCc
Q 003254 592 YEYLPNKSLDYFIFDT-------------TRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNP 658 (836)
Q Consensus 592 ~Ey~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~ 658 (836)
|||+++|+|.+++... .....+++..+.+++.|||+||.|||+.+ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 9999999999998643 23467999999999999999999999998 9999999999999999999
Q ss_pred eeeccCcccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCC-CCCCCCCccccchhhhhH
Q 003254 659 KISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKK-NRGFNHADHDHNLLGHAW 737 (836)
Q Consensus 659 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~-p~~~~~~~~~~~~~~~~~ 737 (836)
||+|||+++..... .......||..|+|||.+.++.++.++|||||||++|||++|.. |+..... ..+ .
T Consensus 167 kl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~---~~~----~ 236 (309)
T d1fvra_ 167 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AEL----Y 236 (309)
T ss_dssp EECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHH----H
T ss_pred EEcccccccccccc---ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH---HHH----H
Confidence 99999999865322 22234568999999999999999999999999999999999765 4432111 111 1
Q ss_pred HhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCCC
Q 003254 738 RLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS 795 (836)
Q Consensus 738 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~ 795 (836)
....... +...+......+.+|+.+||+.||++||||+||++.|+.+..
T Consensus 237 ~~i~~~~---------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 285 (309)
T d1fvra_ 237 EKLPQGY---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285 (309)
T ss_dssp HHGGGTC---------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHhcC---------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 1111111 111222233568899999999999999999999999988743
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=383.62 Aligned_cols=255 Identities=25% Similarity=0.330 Sum_probs=195.2
Q ss_pred cccccccCeecccCceeEEEEEeec----CcEEEEEEecCCC-chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeE
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLIE----GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~~----g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 590 (836)
.++|+..+.||+|+||.||+|++.. +..||||+++... ....+.|.+|+.++++++|||||++++++. .+..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 3678899999999999999998753 3568999986543 344577999999999999999999999996 467899
Q ss_pred EEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccC
Q 003254 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (836)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~ 670 (836)
||||+++|+|.+++.. ....+++..++.++.||++||.|||+++ |+||||||+||++++++.+||+|||+++.+.
T Consensus 85 v~E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp EEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEEeccCCcHHhhhhc--cCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheecc
Confidence 9999999999988753 3456899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCccccccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccchhhhhHHhhhccCchhhc
Q 003254 671 LDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLGHAWRLWIEERPLELI 749 (836)
Q Consensus 671 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (836)
.... .......||+.|+|||++.++.++.++|||||||+||||++ |++|+...... .+. .........
T Consensus 160 ~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~---~~~----~~i~~~~~~--- 228 (273)
T d1mp8a_ 160 DSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVI----GRIENGERL--- 228 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHH----HHHHTTCCC---
T ss_pred CCcc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH---HHH----HHHHcCCCC---
Confidence 3322 22334678999999999999999999999999999999998 78886543221 111 111111111
Q ss_pred cccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 003254 750 DQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 793 (836)
Q Consensus 750 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 793 (836)
..+......+.+|+.+||+.||++|||+.||++.|+.+
T Consensus 229 ------~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i 266 (273)
T d1mp8a_ 229 ------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266 (273)
T ss_dssp ------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11222335678999999999999999999999999764
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-44 Score=387.69 Aligned_cols=260 Identities=28% Similarity=0.391 Sum_probs=207.7
Q ss_pred cccccccCeecccCceeEEEEEeec--------CcEEEEEEecCCCc-hhHHHHHHHHHHHHhh-cCCceeeEEeEEeeC
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLIE--------GQEIAVKRLSKGSG-QGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQR 585 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~~--------g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~ 585 (836)
.++|+..+.||+|+||.||+|+... +..||||+++.... ....++.+|+..+.++ +|||||+++++|.+.
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 3678888999999999999998643 24799999976543 4557889999999998 799999999999999
Q ss_pred CeeeEEEeecCCCChhHHHhhccC-------------CCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEe
Q 003254 586 DERMLIYEYLPNKSLDYFIFDTTR-------------SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLL 652 (836)
Q Consensus 586 ~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl 652 (836)
...++||||+++|+|.+++..... ...+++.++++++.||+.||+|||+.+ |+||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence 999999999999999999965431 246899999999999999999999998 9999999999999
Q ss_pred cCCCCceeeccCcccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhh-CCCCCCCCCCccccc
Q 003254 653 DNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHN 731 (836)
Q Consensus 653 ~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~ellt-G~~p~~~~~~~~~~~ 731 (836)
+.++.+||+|||+++...............+++.|+|||.+.++.++.++||||||+++|||++ |+.|+......
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~---- 244 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---- 244 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH----
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH----
Confidence 9999999999999998765544444555788999999999999999999999999999999998 57776432211
Q ss_pred hhhhhHHhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 003254 732 LLGHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 794 (836)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 794 (836)
.....+...... ..+......+.+|+.+||+.||++|||+.||++.|+++.
T Consensus 245 ---~~~~~i~~~~~~---------~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 245 ---ELFKLLKEGHRM---------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp ---HHHHHHHTTCCC---------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---HHHHHHHcCCCC---------CCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence 111222111111 111222346789999999999999999999999998763
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-44 Score=388.73 Aligned_cols=260 Identities=25% Similarity=0.378 Sum_probs=210.0
Q ss_pred cccccccCeecccCceeEEEEEee------cCcEEEEEEecCCC-chhHHHHHHHHHHHHhh-cCCceeeEEeEEeeCCe
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLI------EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDE 587 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~------~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~ 587 (836)
.++|+..++||+|+||.||+|++. .++.||||+++... .....+|.+|+.+++++ +|||||++++++.+...
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 368888899999999999999863 35789999997654 34556799999999999 69999999999999999
Q ss_pred eeEEEeecCCCChhHHHhhcc---------------CCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEe
Q 003254 588 RMLIYEYLPNKSLDYFIFDTT---------------RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLL 652 (836)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl 652 (836)
.++||||+++|+|.+++.... ....+++..+..++.||++||+|||+++ ++||||||+|||+
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccc
Confidence 999999999999999987542 1235899999999999999999999998 9999999999999
Q ss_pred cCCCCceeeccCcccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCC-CCCCCCccccc
Q 003254 653 DNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKN-RGFNHADHDHN 731 (836)
Q Consensus 653 ~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p-~~~~~~~~~~~ 731 (836)
+.++.+||+|||+++...............||+.|+|||.+.++.++.++|||||||++|||+|++.| +.......
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~--- 255 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS--- 255 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH---
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHH---
Confidence 99999999999999987654444444457889999999999999999999999999999999995544 33222110
Q ss_pred hhhhhHHhhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 003254 732 LLGHAWRLWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 793 (836)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 793 (836)
....... .......+......+.+|+.+||+.||++||||.||+++|+++
T Consensus 256 ---~~~~~i~---------~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 256 ---KFYKMIK---------EGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp ---HHHHHHH---------HTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---HHHHHHh---------cCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 0111111 1111112222335688999999999999999999999999864
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-44 Score=381.04 Aligned_cols=252 Identities=23% Similarity=0.323 Sum_probs=203.6
Q ss_pred hcccccccCeecccCceeEEEEEee-cCcEEEEEEecCCC------chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCe
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS------GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDE 587 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~------~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 587 (836)
..+.|++.+.||+|+||.||+|+.. +|+.||||++.+.. ....+.+.+|+.++++++|||||++++++.+.+.
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 87 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 3467999999999999999999985 58999999986542 1235789999999999999999999999999999
Q ss_pred eeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCC----Cceeecc
Q 003254 588 RMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTM----NPKISDF 663 (836)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~----~~kl~DF 663 (836)
.+|||||+++|+|.+++.. .+.+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 88 ~~iv~E~~~gg~L~~~i~~---~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~Df 161 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDF 161 (293)
T ss_dssp EEEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEEcCCCccccchhcc---ccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecch
Confidence 9999999999999999854 346999999999999999999999998 99999999999998776 5999999
Q ss_pred CcccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhcc
Q 003254 664 GLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEE 743 (836)
Q Consensus 664 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 743 (836)
|++........ .....||+.|+|||++.+..++.++|||||||+||||++|+.||....... . .......
T Consensus 162 G~a~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~---~----~~~i~~~ 231 (293)
T d1jksa_ 162 GLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---T----LANVSAV 231 (293)
T ss_dssp TTCEECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---H----HHHHHTT
T ss_pred hhhhhcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH---H----HHHHHhc
Confidence 99987643322 234678999999999999999999999999999999999999975322111 1 1111111
Q ss_pred CchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 744 RPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 744 ~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
.. ....+ .. ......+.+|+.+||+.||++|||++|+++
T Consensus 232 ~~-~~~~~-~~----~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 232 NY-EFEDE-YF----SNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp CC-CCCHH-HH----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CC-CCCch-hc----CCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 00000 00 011245779999999999999999999986
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-44 Score=388.13 Aligned_cols=268 Identities=22% Similarity=0.277 Sum_probs=198.9
Q ss_pred ccccccCeecccCceeEEEEEeecCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCC----eeeEEE
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD----ERMLIY 592 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----~~~lV~ 592 (836)
++|...+.||+|+||.||+|++ +|+.||||+++... .....+..|+..+.+++|||||++++++.+.+ ..++||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~-~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc-hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 5677788999999999999997 78999999986432 11222334555556789999999999997654 578999
Q ss_pred eecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCC-----CCcEEeccCCCCceEecCCCCceeeccCccc
Q 003254 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDS-----RLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667 (836)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivH~DLkp~NILl~~~~~~kl~DFgla~ 667 (836)
||+++|+|.+++.. ..++|..+.+++.++|.||+|||+.. ..+|+||||||+||||++++.+||+|||+++
T Consensus 81 Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred ecccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 99999999999953 35899999999999999999999741 2359999999999999999999999999998
Q ss_pred ccCCCccc--cccccccccccccCcccccCC------ccCccccccchhhhhhhhhhCCCCCCCCCCccccch-------
Q 003254 668 SFGLDQTE--ANTKRVVGTYGYMSPEYAIDG------LFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNL------- 732 (836)
Q Consensus 668 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~------- 732 (836)
........ .......||+.|+|||++.+. .++.++|||||||+||||+||..|++..........
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence 77443222 223446899999999998754 368899999999999999999987653222211100
Q ss_pred -hhhhHHhhhccCchhhccccccCC-CChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCC
Q 003254 733 -LGHAWRLWIEERPLELIDQSLDNS-CSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 794 (836)
Q Consensus 733 -~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~ 794 (836)
.......... +...+.+... .+.+....+.+|+.+||+.||++||||.||++.|+++.
T Consensus 237 ~~~~~~~~~~~----~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 296 (303)
T d1vjya_ 237 SVEEMRKVVCE----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp CHHHHHHHHTT----SCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred hHHHHHHHHhc----cccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 0001111111 1111111111 12345566889999999999999999999999998753
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-44 Score=385.58 Aligned_cols=261 Identities=25% Similarity=0.392 Sum_probs=211.0
Q ss_pred cccccccCeecccCceeEEEEEee------cCcEEEEEEecCCC-chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCee
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLI------EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDER 588 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~------~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 588 (836)
.++|+..++||+|+||.||+|.+. .++.||||+++... ......|.+|+.++++++|||||++++++...+..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 367888899999999999999874 25789999997553 34456789999999999999999999999999999
Q ss_pred eEEEeecCCCChhHHHhhcc-------CCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceee
Q 003254 589 MLIYEYLPNKSLDYFIFDTT-------RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKIS 661 (836)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~ 661 (836)
++||||+++|+|.+++.... ....+++..+.+++.|+|+||.|||+++ |+||||||+||||++++++||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEe
Confidence 99999999999999886432 2235788999999999999999999988 9999999999999999999999
Q ss_pred ccCcccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCC-CCCCCCCCccccchhhhhHHhh
Q 003254 662 DFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGK-KNRGFNHADHDHNLLGHAWRLW 740 (836)
Q Consensus 662 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~-~p~~~~~~~~~~~~~~~~~~~~ 740 (836)
|||+++.+.............+|+.|+|||.+.++.++.++||||||++||||+||+ .|+...... ......
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~-------~~~~~i 248 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE-------QVLRFV 248 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH-------HHHHHH
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHH-------HHHHHH
Confidence 999998775544444444567899999999999999999999999999999999996 444321110 111111
Q ss_pred hccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCCC
Q 003254 741 IEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS 795 (836)
Q Consensus 741 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~ 795 (836)
...... ..+......+.+++.+||+.+|++||||+||+++|++..+
T Consensus 249 ~~~~~~---------~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 249 MEGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp HTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HhCCCC---------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 111111 1111223468899999999999999999999999988644
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-44 Score=383.18 Aligned_cols=254 Identities=27% Similarity=0.396 Sum_probs=201.4
Q ss_pred cCeecccCceeEEEEEeecC----cEEEEEEecCC-CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeC-CeeeEEEeec
Q 003254 522 KNKLGEGGFGPVYKGMLIEG----QEIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR-DERMLIYEYL 595 (836)
Q Consensus 522 ~~~lG~G~fG~Vykg~~~~g----~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-~~~~lV~Ey~ 595 (836)
.++||+|+||+||+|++.++ ..||||+++.. .....++|.+|++++++++||||++++|++.+. ...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 46899999999999998542 25899999754 445568899999999999999999999998764 5789999999
Q ss_pred CCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCccc
Q 003254 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE 675 (836)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 675 (836)
++|+|.+++.. ....+++..+++++.|+++||.|||+.+ |+||||||+||||++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~--~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 112 KHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp TTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred ecCchhhhhcc--ccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 99999998853 3446778899999999999999999998 999999999999999999999999999976543322
Q ss_pred c--ccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccccc
Q 003254 676 A--NTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQSL 753 (836)
Q Consensus 676 ~--~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 753 (836)
. ......||+.|+|||.+.++.++.++||||||++||||++|+.|+....... .... ....+...
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~--~~~~----~i~~g~~~------- 253 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITV----YLLQGRRL------- 253 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHH----HHHTTCCC-------
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH--HHHH----HHHcCCCC-------
Confidence 2 2233578999999999999999999999999999999999888764322111 1111 11111110
Q ss_pred cCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCCCC
Q 003254 754 DNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS 795 (836)
Q Consensus 754 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~~~ 795 (836)
..+......+.+|+.+||+.||++||+|.||++.|+.+..
T Consensus 254 --~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~ 293 (311)
T d1r0pa_ 254 --LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293 (311)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 0111223457899999999999999999999999998743
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-43 Score=385.13 Aligned_cols=248 Identities=24% Similarity=0.323 Sum_probs=204.6
Q ss_pred cccccccCeecccCceeEEEEEee-cCcEEEEEEecCC---CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEE
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 591 (836)
-++|++.+.||+|+||.||+++.. +|+.||||++++. .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 367999999999999999999975 4899999999754 233467789999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCC
Q 003254 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (836)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~ 671 (836)
|||+++|+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+....
T Consensus 84 ~ey~~gg~L~~~~~~---~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 84 MEYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eeccCCCchhhhhhc---ccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeeccccccccc
Confidence 999999999998854 346889999999999999999999998 99999999999999999999999999987543
Q ss_pred CccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccc
Q 003254 672 DQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQ 751 (836)
Q Consensus 672 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 751 (836)
.. ......+||+.|+|||++.+..|+.++||||+||+||||++|++||...... .+ .........
T Consensus 158 ~~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~---~~----~~~i~~~~~------ 222 (337)
T d1o6la_ 158 DG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---RL----FELILMEEI------ 222 (337)
T ss_dssp TT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HH----HHHHHHCCC------
T ss_pred CC--cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH---HH----HHHHhcCCC------
Confidence 22 2234478999999999999999999999999999999999999997543211 11 111111110
Q ss_pred cccCCCChHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 003254 752 SLDNSCSFSEALRCIQVGLLCVQQRPEDRPN-----MSSVVL 788 (836)
Q Consensus 752 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~eVl~ 788 (836)
..+......+.+|+.+||+.||++||+ +.|+++
T Consensus 223 ----~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 223 ----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ----CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 111122345779999999999999995 888876
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.9e-43 Score=381.13 Aligned_cols=244 Identities=23% Similarity=0.301 Sum_probs=202.3
Q ss_pred ccccccCeecccCceeEEEEEeec-CcEEEEEEecCC---CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEE
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 592 (836)
++|++.+.||+|+||+||+|+... |+.||||++++. .....+.+.+|+.++++++|||||++++++.+.+..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 579999999999999999999854 899999998643 2334678999999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCC
Q 003254 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (836)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~ 672 (836)
||+++|+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.....
T Consensus 84 E~~~gg~l~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eecCCccccccccc---cccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 99999999888843 446788899999999999999999998 999999999999999999999999999876422
Q ss_pred ccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhcccc
Q 003254 673 QTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQS 752 (836)
Q Consensus 673 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 752 (836)
....+||+.|+|||++.+..++.++|||||||+||||++|+.||...... .. .........
T Consensus 158 -----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~---~~----~~~i~~~~~------- 218 (316)
T d1fota_ 158 -----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM---KT----YEKILNAEL------- 218 (316)
T ss_dssp -----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH---HH----HHHHHHCCC-------
T ss_pred -----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH---HH----HHHHHcCCC-------
Confidence 23468999999999999999999999999999999999999998532211 11 111111110
Q ss_pred ccCCCChHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 003254 753 LDNSCSFSEALRCIQVGLLCVQQRPEDRP-----NMSSVVL 788 (836)
Q Consensus 753 l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~eVl~ 788 (836)
..+......+.+++.+||+.||++|| |++|+++
T Consensus 219 ---~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 219 ---RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred ---CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 11111224577999999999999996 8999986
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-43 Score=376.47 Aligned_cols=260 Identities=24% Similarity=0.308 Sum_probs=195.4
Q ss_pred cCeecccCceeEEEEEeec-CcEEEEEEecCCCc-----hhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEeec
Q 003254 522 KNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSG-----QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (836)
Q Consensus 522 ~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~-----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 595 (836)
.++||+|+||+||+|+... |+.||||+++.... ...+.+.+|+.++++++|||||++++++...+..+|||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 5689999999999999854 89999999865422 12356889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCccc
Q 003254 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE 675 (836)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~~ 675 (836)
.++++..+. .....+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.+.....
T Consensus 83 ~~~~~~~~~---~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~- 155 (299)
T d1ua2a_ 83 ETDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR- 155 (299)
T ss_dssp SEEHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-
T ss_pred cchHHhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCcc-
Confidence 998776555 34567899999999999999999999998 99999999999999999999999999987643322
Q ss_pred cccccccccccccCcccccCC-ccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhh------
Q 003254 676 ANTKRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLEL------ 748 (836)
Q Consensus 676 ~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 748 (836)
.....+||+.|+|||++.+. .++.++|||||||++|||++|+.||......+ ......+..........
T Consensus 156 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~---~l~~i~~~~~~~~~~~~~~~~~~ 231 (299)
T d1ua2a_ 156 -AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD---QLTRIFETLGTPTEEQWPDMCSL 231 (299)
T ss_dssp -CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCTTTSSSTTSS
T ss_pred -cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH---HHHHHHHhcCCCChhhccchhcc
Confidence 22346799999999998754 57999999999999999999999975432211 11111111000000000
Q ss_pred ccc-ccc--CCCCh-----HHHHHHHHHHHHcccCCCCCCCCHHHHHH--HhcC
Q 003254 749 IDQ-SLD--NSCSF-----SEALRCIQVGLLCVQQRPEDRPNMSSVVL--MLSG 792 (836)
Q Consensus 749 ~d~-~l~--~~~~~-----~~~~~l~~li~~Cl~~dP~~RPt~~eVl~--~L~~ 792 (836)
... ... ...+. .....+.+|+.+||+.||++|||++|+++ .+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~ 285 (299)
T d1ua2a_ 232 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 285 (299)
T ss_dssp TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred chhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCC
Confidence 000 000 00111 11245789999999999999999999987 3543
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-43 Score=382.01 Aligned_cols=247 Identities=26% Similarity=0.391 Sum_probs=200.5
Q ss_pred ccccccCeecccCceeEEEEEeec-CcEEEEEEecCCC---chhHHHHHHHHHHHH-hhcCCceeeEEeEEeeCCeeeEE
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIA-KLQHRNLVKLLGCCTQRDERMLI 591 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~~l~-~l~H~niv~l~g~~~~~~~~~lV 591 (836)
++|++.+.||+|+||+||+|+... |+.||||++++.. ....+.+..|..++. .++|||||++++++.+.+..+||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 679999999999999999999864 8999999996532 234456677777765 68999999999999999999999
Q ss_pred EeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCC
Q 003254 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (836)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~ 671 (836)
|||+++|+|.+++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++....
T Consensus 82 mEy~~~g~L~~~i~~---~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence 999999999999854 345889999999999999999999998 99999999999999999999999999987543
Q ss_pred CccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccc
Q 003254 672 DQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQ 751 (836)
Q Consensus 672 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 751 (836)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... . .........+
T Consensus 156 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~---~----~~~~i~~~~~------ 220 (320)
T d1xjda_ 156 GDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE---E----LFHSIRMDNP------ 220 (320)
T ss_dssp TTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---H----HHHHHHHCCC------
T ss_pred ccc--cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH---H----HHHHHHcCCC------
Confidence 322 233468999999999999999999999999999999999999998532211 1 1111111111
Q ss_pred cccCCCChHHHHHHHHHHHHcccCCCCCCCCHH-HHHH
Q 003254 752 SLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMS-SVVL 788 (836)
Q Consensus 752 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~-eVl~ 788 (836)
..+......+.+|+.+||+.||++|||+. |+++
T Consensus 221 ----~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 221 ----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp ----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ----CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 11111234578999999999999999996 6753
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1e-42 Score=380.67 Aligned_cols=244 Identities=21% Similarity=0.248 Sum_probs=202.8
Q ss_pred ccccccCeecccCceeEEEEEee-cCcEEEEEEecCC---CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEE
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 592 (836)
++|++.+.||+|+||.||+++.. +|+.||||++.+. .....+.+.+|+.+++.++|||||++++++......++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 67999999999999999999985 4999999998643 2234567899999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCC
Q 003254 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (836)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~ 672 (836)
||+.+|+|..++... +.+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+|+.+...
T Consensus 121 e~~~~g~l~~~l~~~---~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred ccccccchhhhHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 999999999998543 46899999999999999999999998 999999999999999999999999999876422
Q ss_pred ccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhcccc
Q 003254 673 QTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQS 752 (836)
Q Consensus 673 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 752 (836)
.....||+.|+|||++.+..++.++|||||||+||||++|+.||...... .. .........
T Consensus 195 -----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~---~~----~~~i~~~~~------- 255 (350)
T d1rdqe_ 195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI---QI----YEKIVSGKV------- 255 (350)
T ss_dssp -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH----HHHHHHCCC-------
T ss_pred -----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHH---HH----HHHHhcCCC-------
Confidence 23467999999999999999999999999999999999999998532111 11 111111110
Q ss_pred ccCCCChHHHHHHHHHHHHcccCCCCCC-----CCHHHHHH
Q 003254 753 LDNSCSFSEALRCIQVGLLCVQQRPEDR-----PNMSSVVL 788 (836)
Q Consensus 753 l~~~~~~~~~~~l~~li~~Cl~~dP~~R-----Pt~~eVl~ 788 (836)
..+......+.+++.+||+.||.+| ||++|+++
T Consensus 256 ---~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 256 ---RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ---CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ---CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 1111223457799999999999999 49999986
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3.9e-43 Score=372.46 Aligned_cols=259 Identities=24% Similarity=0.316 Sum_probs=199.4
Q ss_pred cccccccCeecccCceeEEEEEee-cCcEEEEEEecCCC---chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCe----
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDE---- 587 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~---- 587 (836)
.++|++.+.||+|+||.||+|+.. +|+.||||+++... ....+.|.+|+.+++.++||||+++++++.....
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 467999999999999999999975 58999999997543 3345679999999999999999999999876543
Q ss_pred eeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCccc
Q 003254 588 RMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667 (836)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~ 667 (836)
.+|||||+++++|..++.. .+.+++.++..++.||++||+|||+++ |+||||||+|||++.++.++|+|||.+.
T Consensus 86 ~~lvmE~~~g~~L~~~~~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEehhhhcc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence 7899999999999988854 346899999999999999999999998 9999999999999999999999999987
Q ss_pred ccCCCcc-ccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCch
Q 003254 668 SFGLDQT-EANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPL 746 (836)
Q Consensus 668 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (836)
....... ........||+.|+|||++.+..++.++|||||||+||||++|+.||...... .............
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~~~~~~~~~ 233 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV------SVAYQHVREDPIP 233 (277)
T ss_dssp ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHCCCCC
T ss_pred hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH------HHHHHHHhcCCCC
Confidence 6543322 22334467999999999999999999999999999999999999997532211 1111111111110
Q ss_pred hhccccccCCCChHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHhcCC
Q 003254 747 ELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRP-NMSSVVLMLSGE 793 (836)
Q Consensus 747 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-t~~eVl~~L~~~ 793 (836)
. .. ........+.+++.+||+.||++|| |++++++.|..+
T Consensus 234 ~---~~----~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 234 P---SA----RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp G---GG----TSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred C---ch----hccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 0 00 0111224577999999999999999 899998888653
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=6.8e-43 Score=369.61 Aligned_cols=251 Identities=22% Similarity=0.297 Sum_probs=202.3
Q ss_pred cccccccCeecccCceeEEEEEee-cCcEEEEEEecCCCc---------hhHHHHHHHHHHHHhhc-CCceeeEEeEEee
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSG---------QGMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQ 584 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~~---------~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~ 584 (836)
.++|+..+.||+|+||+||+++.. +|+.||||++++... ...+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 368999999999999999999975 588999999876532 12346889999999997 9999999999999
Q ss_pred CCeeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccC
Q 003254 585 RDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFG 664 (836)
Q Consensus 585 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFg 664 (836)
.+..+|||||+++|+|.+++.. ...+++.++..++.||++||+|||+++ |+||||||+||||+.++.+||+|||
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred CcceEEEEEcCCCchHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccch
Confidence 9999999999999999999954 346999999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCccccccccccccccccCcccccC------CccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHH
Q 003254 665 LARSFGLDQTEANTKRVVGTYGYMSPEYAID------GLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWR 738 (836)
Q Consensus 665 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~ 738 (836)
+++.+..... .....||+.|+|||++.+ ..++.++||||+||+||||++|+.||...... ....
T Consensus 156 ~a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~-------~~~~ 225 (277)
T d1phka_ 156 FSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM-------LMLR 225 (277)
T ss_dssp TCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHH
T ss_pred heeEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHH-------HHHH
Confidence 9998653322 234679999999999853 34788999999999999999999998643211 1111
Q ss_pred hhhccCchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 739 LWIEERPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 739 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
........ . ...........+.+++.+||+.+|++|||+.||++
T Consensus 226 ~i~~~~~~-~-----~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 226 MIMSGNYQ-F-----GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HHHHTCCC-C-----CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHhCCCC-C-----CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 11111110 0 00011122246789999999999999999999975
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-42 Score=374.71 Aligned_cols=252 Identities=17% Similarity=0.254 Sum_probs=203.2
Q ss_pred hcccccccCeecccCceeEEEEEeec-CcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEe
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 593 (836)
..++|++.+.||+|+||+||+|+... |+.||||+++... .....+.+|+++++.++|||||++++++.+.+..+||||
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 34789999999999999999999864 8899999997654 334568899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecC--CCCceeeccCcccccCC
Q 003254 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN--TMNPKISDFGLARSFGL 671 (836)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~--~~~~kl~DFgla~~~~~ 671 (836)
|+++|+|.+++.. ....+++.++..++.||+.||+|||+++ |+||||||+|||++. ...+||+|||+++....
T Consensus 82 ~~~gg~L~~~i~~--~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~ 156 (321)
T d1tkia_ 82 FISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred cCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhcccc
Confidence 9999999999843 2346899999999999999999999998 999999999999984 45899999999987643
Q ss_pred CccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhhccc
Q 003254 672 DQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLELIDQ 751 (836)
Q Consensus 672 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 751 (836)
.. ......+|+.|+|||.+.+..++.++||||+||++|||++|+.||...... .. ......... ....+
T Consensus 157 ~~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~---~~----~~~i~~~~~-~~~~~ 225 (321)
T d1tkia_ 157 GD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ---QI----IENIMNAEY-TFDEE 225 (321)
T ss_dssp TC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH---HH----HHHHHHTCC-CCCHH
T ss_pred CC---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH---HH----HHHHHhCCC-CCChh
Confidence 22 223367899999999999999999999999999999999999997543221 11 111111100 00000
Q ss_pred cccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 752 SLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 752 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
.... ...++.+++.+||+.||++|||+.|+++
T Consensus 226 -~~~~----~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 226 -AFKE----ISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp -HHTT----SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -hccC----CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0001 1235779999999999999999999987
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1e-42 Score=382.57 Aligned_cols=248 Identities=25% Similarity=0.337 Sum_probs=196.3
Q ss_pred ccccccCeecccCceeEEEEEeec-CcEEEEEEecCCC---chhHHHHHHH---HHHHHhhcCCceeeEEeEEeeCCeee
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNE---VLLIAKLQHRNLVKLLGCCTQRDERM 589 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~---~~~~~~~~~E---i~~l~~l~H~niv~l~g~~~~~~~~~ 589 (836)
++|++.+.||+|+||.||+|+... |+.||||++.+.. ......+.+| +.+++.++|||||++++++.+.+..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 679999999999999999999864 8999999986431 1222334444 66666778999999999999999999
Q ss_pred EEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCccccc
Q 003254 590 LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (836)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~ 669 (836)
+||||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+||||++++.+||+|||+|+.+
T Consensus 84 ivmE~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEECCCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHHh---cccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 99999999999999854 346889999999999999999999998 999999999999999999999999999876
Q ss_pred CCCccccccccccccccccCcccccC-CccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCchhh
Q 003254 670 GLDQTEANTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPLEL 748 (836)
Q Consensus 670 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (836)
... ......||+.|+|||++.+ ..++.++|||||||+||||++|+.||..........+ .+... ....
T Consensus 158 ~~~----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~----~~~~~-~~~~-- 226 (364)
T d1omwa3 158 SKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----DRMTL-TMAV-- 226 (364)
T ss_dssp SSS----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHH----HHHSS-SCCC--
T ss_pred CCC----cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHH----HHhcc-cCCC--
Confidence 433 2334679999999999975 4689999999999999999999999864332211110 00000 0000
Q ss_pred ccccccCCCChHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 003254 749 IDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPN-----MSSVVL 788 (836)
Q Consensus 749 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~eVl~ 788 (836)
..+......+.+|+.+||+.||++||| ++|+++
T Consensus 227 -------~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 227 -------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp -------CCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred -------CCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 011112245789999999999999999 688875
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-42 Score=371.26 Aligned_cols=267 Identities=22% Similarity=0.330 Sum_probs=200.9
Q ss_pred ccccccCeecccCceeEEEEEee-cCcEEEEEEecCCC--chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEe
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 593 (836)
++|++.++||+|+||+||+|+.. +|+.||||+++... ....+++.+|+.++++++|||||++++++.+....++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 68999999999999999999974 58999999996542 2346789999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCc
Q 003254 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (836)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~ 673 (836)
|+.++.+.... . .....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+......
T Consensus 82 ~~~~~~~~~~~-~-~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQDLKKFMD-A-SALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSEEHHHHHH-H-TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ecCCchhhhhh-h-hcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc
Confidence 99865554333 2 23456999999999999999999999998 9999999999999999999999999998764322
Q ss_pred cccccccccccccccCcccccCCc-cCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCc------h
Q 003254 674 TEANTKRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERP------L 746 (836)
Q Consensus 674 ~~~~~~~~~gt~~y~aPE~~~~~~-~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~------~ 746 (836)
.......||+.|+|||.+.... ++.++||||+||++|||++|+.||....... .............. .
T Consensus 157 --~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~ 231 (298)
T d1gz8a_ 157 --RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID---QLFRIFRTLGTPDEVVWPGVT 231 (298)
T ss_dssp --BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTTTSTTGG
T ss_pred --ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH---HHHHHHHhcCCCchhhccccc
Confidence 2233467999999999987665 5889999999999999999999985432111 11111110000000 0
Q ss_pred hhcc--cccc--CCCC-----hHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hcCC
Q 003254 747 ELID--QSLD--NSCS-----FSEALRCIQVGLLCVQQRPEDRPNMSSVVLM--LSGE 793 (836)
Q Consensus 747 ~~~d--~~l~--~~~~-----~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~--L~~~ 793 (836)
...+ .... .... ......+.+++.+||+.||++|||+.|+++. ++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp GSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 0000 0000 0000 1112457899999999999999999999984 6554
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-42 Score=374.33 Aligned_cols=252 Identities=21% Similarity=0.237 Sum_probs=195.6
Q ss_pred cccccccC-eecccCceeEEEEEee-cCcEEEEEEecCCCchhHHHHHHHHHHHHhh-cCCceeeEEeEEee----CCee
Q 003254 516 TDNFSEKN-KLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQ----RDER 588 (836)
Q Consensus 516 ~~~f~~~~-~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~----~~~~ 588 (836)
.++|.+.+ .||+|+||.||+|+.. +++.||||+++. ...+.+|+.++.++ +|||||++++++.. ....
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 36788765 5999999999999974 489999999864 25677899987665 89999999999865 4568
Q ss_pred eEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecC---CCCceeeccCc
Q 003254 589 MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---TMNPKISDFGL 665 (836)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~---~~~~kl~DFgl 665 (836)
+||||||++|+|.+++... ....+++.++..++.||+.||+|||+.+ |+||||||+|||+++ ++.+||+|||+
T Consensus 85 ~ivmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEECCCCCcHHHHHHhc-CCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccce
Confidence 9999999999999999542 2356999999999999999999999998 999999999999975 56799999999
Q ss_pred ccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCc
Q 003254 666 ARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERP 745 (836)
Q Consensus 666 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (836)
|+...... ......||+.|+|||++.+..|+.++|||||||+||||++|+.||........... ........ .
T Consensus 161 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~---~~~~i~~~-~ 233 (335)
T d2ozaa1 161 AKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG---MKTRIRMG-Q 233 (335)
T ss_dssp CEECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSC-S
T ss_pred eeeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHH---HHHHHhcC-C
Confidence 98764332 23346799999999999999999999999999999999999999853322111000 00000000 0
Q ss_pred hhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 746 LELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 746 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
... ..........++.+|+.+||+.||++|||+.|+++
T Consensus 234 ~~~-----~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 234 YEF-----PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp SSC-----CTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCC-----CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 000 00000112346789999999999999999999988
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=4.2e-42 Score=366.30 Aligned_cols=261 Identities=23% Similarity=0.337 Sum_probs=199.7
Q ss_pred ccccccCeecccCceeEEEEEeecCcEEEEEEecCCC--chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEee
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 594 (836)
++|+..++||+|+||+||+|+.++|+.||||++.... ....+.+.+|+.++++++|||||++++++...+..++++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 6899999999999999999999889999999996553 33457899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCcc
Q 003254 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (836)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~~ 674 (836)
+.++.+..+. ...+.+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~~~~~~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 82 LDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp CSEEHHHHHH---TSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred ehhhhHHHHH---hhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence 9988776665 33467999999999999999999999988 99999999999999999999999999987643322
Q ss_pred ccccccccccccccCcccccCC-ccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCc------hh
Q 003254 675 EANTKRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERP------LE 747 (836)
Q Consensus 675 ~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~------~~ 747 (836)
......+++.|+|||.+.+. .++.++|||||||+++||++|+.||......+ .............. .+
T Consensus 156 --~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~ 230 (286)
T d1ob3a_ 156 --KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD---QLMRIFRILGTPNSKNWPNVTE 230 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTTTSTTGGG
T ss_pred --ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH---HHHHHHHhhCCCChhhccchhh
Confidence 22335689999999998754 57999999999999999999999985432111 11111110000000 00
Q ss_pred h--ccccc-------cCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 748 L--IDQSL-------DNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 748 ~--~d~~l-------~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
. .+... ...........+.+++.+||+.||++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 00000 00111112346789999999999999999999974
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-41 Score=364.63 Aligned_cols=263 Identities=23% Similarity=0.325 Sum_probs=196.6
Q ss_pred hcccccccCeecccCceeEEEEEee-c-CcEEEEEEecCCC--chhHHHHHHHHHHHHhh---cCCceeeEEeEEee---
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLI-E-GQEIAVKRLSKGS--GQGMEEFKNEVLLIAKL---QHRNLVKLLGCCTQ--- 584 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~-~-g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~~--- 584 (836)
..++|++.++||+|+||+||+|++. . ++.||||+++... ......+.+|+.+++.+ +||||+++++++..
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 4578999999999999999999974 3 5679999986432 22344567788887776 79999999999853
Q ss_pred --CCeeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeec
Q 003254 585 --RDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISD 662 (836)
Q Consensus 585 --~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~D 662 (836)
....+++|||++++.+..... .....+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred ccCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecc
Confidence 346799999999987754442 34456899999999999999999999998 99999999999999999999999
Q ss_pred cCcccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhc
Q 003254 663 FGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIE 742 (836)
Q Consensus 663 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 742 (836)
||+++..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||......+ ...........
T Consensus 160 fg~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~---~~~~i~~~~~~ 233 (305)
T d1blxa_ 160 FGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGKILDVIGL 233 (305)
T ss_dssp CCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCC
T ss_pred hhhhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHH---HHHHHHHhhCC
Confidence 9999865322 22345789999999999999999999999999999999999999986432211 11111110000
Q ss_pred cCc----------hhhccccc---cCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 743 ERP----------LELIDQSL---DNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 743 ~~~----------~~~~d~~l---~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
... ........ ...........+.+|+.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 234 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000 00000000 00011112245778999999999999999999986
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-42 Score=363.20 Aligned_cols=240 Identities=24% Similarity=0.393 Sum_probs=193.8
Q ss_pred cccccccCeecccCceeEEEEEee-cCcEEEEEEecCCCc------hhHHHHHHHHHHHHhhc--CCceeeEEeEEeeCC
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSG------QGMEEFKNEVLLIAKLQ--HRNLVKLLGCCTQRD 586 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~~------~~~~~~~~Ei~~l~~l~--H~niv~l~g~~~~~~ 586 (836)
.++|++.+.||+|+||.||+|+.. +|+.||||++.+... ....++.+|+.++++++ |||||++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 367999999999999999999975 589999999865321 12345778999999997 899999999999999
Q ss_pred eeeEEEeecCC-CChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecC-CCCceeeccC
Q 003254 587 ERMLIYEYLPN-KSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-TMNPKISDFG 664 (836)
Q Consensus 587 ~~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~-~~~~kl~DFg 664 (836)
..++||||+.+ +++.+++.. ...+++.++..++.||++||+|||+++ |+||||||+|||++. ++.+||+|||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred eEEEEEEeccCcchHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccc
Confidence 99999999976 566666643 356899999999999999999999998 999999999999985 5799999999
Q ss_pred cccccCCCccccccccccccccccCcccccCCcc-CccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhcc
Q 003254 665 LARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLF-SVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEE 743 (836)
Q Consensus 665 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 743 (836)
+++..... ......||+.|+|||++.+..+ +.++||||+||+||||++|+.||.... . ....
T Consensus 157 ~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~--------i~~~ 219 (273)
T d1xwsa_ 157 SGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----E--------IIRG 219 (273)
T ss_dssp TCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----H--------HHHC
T ss_pred cceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-----H--------Hhhc
Confidence 99875322 2234679999999999987765 677999999999999999999975210 0 0000
Q ss_pred CchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 744 RPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 744 ~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
. ....... ..++.+++.+||+.||++|||++|+++
T Consensus 220 ~------~~~~~~~----s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 220 Q------VFFRQRV----SSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp C------CCCSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred c------cCCCCCC----CHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 0 0011112 245779999999999999999999986
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-40 Score=359.04 Aligned_cols=265 Identities=22% Similarity=0.327 Sum_probs=195.9
Q ss_pred cccccccCeecccCceeEEEEEee-cCcEEEEEEecCC--CchhHHHHHHHHHHHHhhcCCceeeEEeEEee--------
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQ-------- 584 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-------- 584 (836)
.++|++.++||+|+||+||+|+.. +|+.||||++... .....+.+.+|+.++++++|||++++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 478999999999999999999975 5899999998644 33445778999999999999999999999855
Q ss_pred CCeeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccC
Q 003254 585 RDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFG 664 (836)
Q Consensus 585 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFg 664 (836)
....++||||+.++.+.... .....++...+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp --CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecc
Confidence 34578999999988776544 33456888999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCccc--cccccccccccccCcccccCC-ccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhh
Q 003254 665 LARSFGLDQTE--ANTKRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWI 741 (836)
Q Consensus 665 la~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 741 (836)
+++.+...... .......||+.|+|||.+.+. .++.++||||+||++|||++|+.||........ .....+...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~---~~~i~~~~~ 239 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ---LALISQLCG 239 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHC
T ss_pred eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHH---HHHHHHhcC
Confidence 99876533221 122335799999999998765 689999999999999999999999854322111 111111110
Q ss_pred ccC-----------chhhccccccCCCChHH-------HHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 742 EER-----------PLELIDQSLDNSCSFSE-------ALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 742 ~~~-----------~~~~~d~~l~~~~~~~~-------~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
... ..+.+............ ...+++|+.+||+.||++|||++|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 240 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp CCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 000 00000000011111111 2346789999999999999999999863
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-40 Score=362.19 Aligned_cols=266 Identities=20% Similarity=0.261 Sum_probs=195.3
Q ss_pred cccccCeecccCceeEEEEEeec-CcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCceeeEEeEEeeC------CeeeE
Q 003254 518 NFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR------DERML 590 (836)
Q Consensus 518 ~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~~~~l 590 (836)
+|+..++||+|+||+||+|++.. |+.||||++..... .+.+|+.++++++||||+++++++... ...+|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 68888999999999999999864 89999999976532 234799999999999999999998543 23689
Q ss_pred EEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCC-CceeeccCccccc
Q 003254 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTM-NPKISDFGLARSF 669 (836)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~-~~kl~DFgla~~~ 669 (836)
||||++++.+..+.........+++.++..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+++.+
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999987765554433345567999999999999999999999998 99999999999999765 8999999999876
Q ss_pred CCCccccccccccccccccCcccccC-CccCccccccchhhhhhhhhhCCCCCCCCCCccccchh--------hhhHHhh
Q 003254 670 GLDQTEANTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLL--------GHAWRLW 740 (836)
Q Consensus 670 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~--------~~~~~~~ 740 (836)
..... .....|++.|+|||.+.+ ..++.++||||+||++|||++|+.||......+..... ...+...
T Consensus 174 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~ 250 (350)
T d1q5ka_ 174 VRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250 (350)
T ss_dssp CTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred cCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhh
Confidence 43322 233679999999998875 46899999999999999999999998543321110000 0000000
Q ss_pred hccCch----hhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HhcCC
Q 003254 741 IEERPL----ELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL--MLSGE 793 (836)
Q Consensus 741 ~~~~~~----~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~--~L~~~ 793 (836)
...... ..................+.+|+.+||+.||++|||+.|+++ .++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred ccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 000000 000000000011122345789999999999999999999996 35544
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.8e-40 Score=351.45 Aligned_cols=260 Identities=21% Similarity=0.251 Sum_probs=196.3
Q ss_pred ccccccCeecccCceeEEEEEee-cCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCcee-eEEeEEeeCCeeeEEEee
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLV-KLLGCCTQRDERMLIYEY 594 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv-~l~g~~~~~~~~~lV~Ey 594 (836)
++|++.+.||+|+||.||+|++. +|+.||||++..... .+++..|+++++.++|+|++ .+.++..+.+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 57999999999999999999975 488999999876532 35688999999999877655 555566777889999999
Q ss_pred cCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEec---CCCCceeeccCcccccCC
Q 003254 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD---NTMNPKISDFGLARSFGL 671 (836)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~---~~~~~kl~DFgla~~~~~ 671 (836)
+.+ +|...+.. ....+++..+..++.|++.||+|||+++ |+||||||+|||++ .+..+||+|||+|+.+..
T Consensus 85 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 85 LGP-SLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp CCC-BHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred cCC-chhhhhhh--ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 954 55555532 3456999999999999999999999998 99999999999985 456799999999998753
Q ss_pred Cccc-----cccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCch
Q 003254 672 DQTE-----ANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPL 746 (836)
Q Consensus 672 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (836)
.... .......||+.|+|||.+.+..++.++|||||||++|||++|+.|+.........................
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 238 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHH
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChh
Confidence 3221 12334679999999999999999999999999999999999999986544332222111111111111111
Q ss_pred hhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 003254 747 ELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 793 (836)
Q Consensus 747 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 793 (836)
+. ... ....+.+++..|++.+|++||+++++.+.|+.+
T Consensus 239 ~~-----~~~----~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 239 VL-----CKG----YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp HH-----TTT----SCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred Hh-----ccC----CCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 11 111 124577899999999999999999999888754
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.7e-39 Score=345.37 Aligned_cols=261 Identities=16% Similarity=0.189 Sum_probs=204.6
Q ss_pred cccccccCeecccCceeEEEEEee-cCcEEEEEEecCCCchhHHHHHHHHHHHHhhcC-CceeeEEeEEeeCCeeeEEEe
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQH-RNLVKLLGCCTQRDERMLIYE 593 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H-~niv~l~g~~~~~~~~~lV~E 593 (836)
.++|++.++||+|+||.||+|+.. +|+.||||++.... ....+++|+++++.++| +|++.+++++.+....++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 468999999999999999999975 48899999986543 23467889999999975 899999999999999999999
Q ss_pred ecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecC-----CCCceeeccCcccc
Q 003254 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-----TMNPKISDFGLARS 668 (836)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~-----~~~~kl~DFgla~~ 668 (836)
|+ +++|.+++.. ....++...+..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+|+.
T Consensus 82 ~~-~~~l~~~~~~--~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 82 LL-GPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHh--hccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 98 6788888754 3346899999999999999999999998 999999999999964 57899999999998
Q ss_pred cCCCccc-----cccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhcc
Q 003254 669 FGLDQTE-----ANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEE 743 (836)
Q Consensus 669 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 743 (836)
+...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.|+......................
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence 6432221 12334679999999999999999999999999999999999999986443332221111111110111
Q ss_pred CchhhccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcCC
Q 003254 744 RPLELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 793 (836)
Q Consensus 744 ~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~L~~~ 793 (836)
...++ .... ..++.+++..|++.+|++||+++.+.+.|+.+
T Consensus 236 ~~~~l-----~~~~----p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~ 276 (293)
T d1csna_ 236 PLREL-----CAGF----PEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276 (293)
T ss_dssp CHHHH-----TTTS----CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred ChHHh-----cCCC----CHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 11111 1112 23577899999999999999999998888764
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-39 Score=346.75 Aligned_cols=262 Identities=21% Similarity=0.297 Sum_probs=201.7
Q ss_pred ccccccCeecccCceeEEEEEee-cCcEEEEEEecCCC--chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCCeeeEEEe
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~E 593 (836)
++|++.++||+|+||+||+|+.. +|+.||||+++... ....+.+++|+.+++.++||||+++++++......++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 57999999999999999999975 48899999986543 3456789999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccccCCCc
Q 003254 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (836)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~~~~~~ 673 (836)
++.+++|..++. ..+.+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.++......
T Consensus 82 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred eccccccccccc---cccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 999999887773 3456889999999999999999999998 9999999999999999999999999998865332
Q ss_pred cccccccccccccccCcccccCCc-cCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCc------h
Q 003254 674 TEANTKRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERP------L 746 (836)
Q Consensus 674 ~~~~~~~~~gt~~y~aPE~~~~~~-~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~------~ 746 (836)
. ......+++.|+|||.+.+.. ++.++||||+||+++||++|+.|+...... ................ .
T Consensus 156 ~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 231 (292)
T d1unla_ 156 R--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV--DDQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp S--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH--HHHHHHHHHHHCCCCTTTCTTGG
T ss_pred c--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCH--HHHHHHHHhhcCCCChhhhhhhh
Confidence 2 222346788999999987665 689999999999999999999986422211 1111111111100000 0
Q ss_pred hh--------ccccc-cCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 747 EL--------IDQSL-DNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 747 ~~--------~d~~l-~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
.. ..... ...........+.+|+.+||+.||++|||++||++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 00000 00111122345778999999999999999999986
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-40 Score=359.40 Aligned_cols=269 Identities=20% Similarity=0.288 Sum_probs=198.6
Q ss_pred hcccccccCeecccCceeEEEEEee-cCcEEEEEEecCCC-chhHHHHHHHHHHHHhhcCCceeeEEeEEeeCC----ee
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD----ER 588 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----~~ 588 (836)
.+++|++.++||+|+||+||+|+.. +|+.||||++.... ....+.+++|+.+|++++||||+++++++.... ..
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 3467999999999999999999974 59999999997543 344678899999999999999999999997653 24
Q ss_pred eEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcccc
Q 003254 589 MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (836)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~ 668 (836)
+++++|+.+|+|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+||||++++.+||+|||++..
T Consensus 86 ~~l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~ 158 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 158 (345)
T ss_dssp EEEEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceee
Confidence 566677889999999843 35899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCccc-cccccccccccccCcccccC-CccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCch
Q 003254 669 FGLDQTE-ANTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERPL 746 (836)
Q Consensus 669 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (836)
....... .......||+.|+|||++.. ..++.++||||+||+++||++|+.||......+.. .............
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~---~~~~~~~~~~~~~ 235 (345)
T d1pmea_ 159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL---NHILGILGSPSQE 235 (345)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCSCCHH
T ss_pred ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHH---HHHhhhccCCChh
Confidence 6443222 22344679999999999854 46789999999999999999999997543221110 0000000000000
Q ss_pred -----------hhccccc-cCCCCh-----HHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hcCC
Q 003254 747 -----------ELIDQSL-DNSCSF-----SEALRCIQVGLLCVQQRPEDRPNMSSVVLM--LSGE 793 (836)
Q Consensus 747 -----------~~~d~~l-~~~~~~-----~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~--L~~~ 793 (836)
....... ....+. ....++.+++.+||+.||++|||+.|+++. |+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~ 301 (345)
T d1pmea_ 236 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301 (345)
T ss_dssp HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred hhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 0000000 000011 112357899999999999999999999974 5543
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-40 Score=358.07 Aligned_cols=263 Identities=22% Similarity=0.330 Sum_probs=194.1
Q ss_pred cccccccCeecccCceeEEEEEeec-CcEEEEEEecCC--CchhHHHHHHHHHHHHhhcCCceeeEEeEEeeCC------
Q 003254 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD------ 586 (836)
Q Consensus 516 ~~~f~~~~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------ 586 (836)
.++|++.++||+|+||+||+|+... |+.||||+++.. .....+.+.+|+.+|++++|||||++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 4789999999999999999999754 999999999754 3344567899999999999999999999997655
Q ss_pred eeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcc
Q 003254 587 ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLA 666 (836)
Q Consensus 587 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla 666 (836)
..++||||+ +.+|..++. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 97 ~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMK----HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCEEEEECC-SEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecc-cccHHHHHH----hccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccce
Confidence 469999999 456766653 246999999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCcccccCC-ccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCc
Q 003254 667 RSFGLDQTEANTKRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERP 745 (836)
Q Consensus 667 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (836)
+..... .....||+.|+|||.+.+. .++.++||||+||+++||++|+.|+......... ..... .....+
T Consensus 169 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~---~~~~~-~~~~~~ 239 (346)
T d1cm8a_ 169 RQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQL---KEIMK-VTGTPP 239 (346)
T ss_dssp EECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHH-HHCCCC
T ss_pred eccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHH---HHHHh-ccCCCc
Confidence 875432 2346789999999998764 5789999999999999999999997543211110 00000 000000
Q ss_pred hhhcc-----------ccc----c---CCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hcCCCC
Q 003254 746 LELID-----------QSL----D---NSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM--LSGERS 795 (836)
Q Consensus 746 ~~~~d-----------~~l----~---~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~--L~~~~~ 795 (836)
.+... ..+ . ..........+.+|+.+||+.||++|||+.|+++. ++++..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~ 309 (346)
T d1cm8a_ 240 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 309 (346)
T ss_dssp HHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred HHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCC
Confidence 00000 000 0 00111122456799999999999999999999984 666543
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-39 Score=351.17 Aligned_cols=252 Identities=24% Similarity=0.330 Sum_probs=200.4
Q ss_pred ccccccCeecccCceeEEEEEee----cCcEEEEEEecCC----CchhHHHHHHHHHHHHhhcC-CceeeEEeEEeeCCe
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLI----EGQEIAVKRLSKG----SGQGMEEFKNEVLLIAKLQH-RNLVKLLGCCTQRDE 587 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~----~g~~vavK~l~~~----~~~~~~~~~~Ei~~l~~l~H-~niv~l~g~~~~~~~ 587 (836)
++|++.+.||+|+||+||+|+.. +|+.||||++... .....+.+.+|++++++++| |||+++++++.....
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 67999999999999999999862 3789999998643 22345678899999999977 899999999999999
Q ss_pred eeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCccc
Q 003254 588 RMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667 (836)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~ 667 (836)
.++||||+.+|+|.+++... ..+....+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~---~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHHhc---ccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence 99999999999999998543 35678889999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCccccccccccccccccCcccccCC--ccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCc
Q 003254 668 SFGLDQTEANTKRVVGTYGYMSPEYAIDG--LFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERP 745 (836)
Q Consensus 668 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (836)
.+...... ......|++.|+|||.+.+. .++.++|||||||+||||++|+.||........... ..+......+
T Consensus 178 ~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~---i~~~~~~~~~ 253 (322)
T d1vzoa_ 178 EFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE---ISRRILKSEP 253 (322)
T ss_dssp ECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHH---HHHHHHHCCC
T ss_pred hhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHhcccCCC
Confidence 76433222 23346799999999999764 478899999999999999999999864433322111 1111111110
Q ss_pred hhhccccccCCCChHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 003254 746 LELIDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRP-----NMSSVVL 788 (836)
Q Consensus 746 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~eVl~ 788 (836)
..+......+.+++.+||+.||++|| |++|+++
T Consensus 254 ----------~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 254 ----------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp ----------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ----------CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 11122345678999999999999999 5889986
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.9e-39 Score=350.14 Aligned_cols=257 Identities=19% Similarity=0.309 Sum_probs=195.0
Q ss_pred ccccccCeecccCceeEEEEEee-cCcEEEEEEecCCCchhHHHHHHHHHHHHhhc-CCceeeEEeEEeeC--CeeeEEE
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQR--DERMLIY 592 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~--~~~~lV~ 592 (836)
++|++.++||+|+||+||+|+.. +|+.||||+++... .+++.+|+.++++++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 68999999999999999999985 48899999986533 467889999999995 99999999998744 4589999
Q ss_pred eecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCC-CceeeccCcccccCC
Q 003254 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTM-NPKISDFGLARSFGL 671 (836)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~-~~kl~DFgla~~~~~ 671 (836)
||+++++|..+. +.+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+++....
T Consensus 112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred eecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence 999999987654 35899999999999999999999998 99999999999998654 699999999987643
Q ss_pred CccccccccccccccccCcccccCC-ccCccccccchhhhhhhhhhCCCCCCCCCCccccch-hhh--------hH-Hhh
Q 003254 672 DQTEANTKRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNL-LGH--------AW-RLW 740 (836)
Q Consensus 672 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~-~~~--------~~-~~~ 740 (836)
... .....+|+.|+|||.+.+. .++.++||||+||+++||++|+.|+........... ... .+ ...
T Consensus 183 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 259 (328)
T d3bqca1 183 GQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 259 (328)
T ss_dssp TCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred CCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhc
Confidence 322 2346789999999998865 479999999999999999999999764433211000 000 00 000
Q ss_pred hccCchhh-----------ccccccCCCChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003254 741 IEERPLEL-----------IDQSLDNSCSFSEALRCIQVGLLCVQQRPEDRPNMSSVVL 788 (836)
Q Consensus 741 ~~~~~~~~-----------~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~ 788 (836)
........ ...............++.+|+.+||+.||++|||++|+++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp TCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000000 0000000111122345789999999999999999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-38 Score=348.23 Aligned_cols=261 Identities=24% Similarity=0.300 Sum_probs=188.7
Q ss_pred ccccccCeecccCceeEEEEEee-cCcEEEEEEecCCC--chhHHHHHHHHHHHHhhcCCceeeEEeEEee------CCe
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQ------RDE 587 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~------~~~ 587 (836)
++|++.++||+|+||+||+|.+. +|+.||||++.... ....+++.+|+.++++++||||+++++++.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 67999999999999999999986 49999999997543 3445678999999999999999999999964 357
Q ss_pred eeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCccc
Q 003254 588 RMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667 (836)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~ 667 (836)
.++||||+.++.+. .+ ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+|++|||+++
T Consensus 97 ~~iv~Ey~~~~l~~-~~-----~~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 97 VYLVMELMDANLCQ-VI-----QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEECCSEEHHH-HH-----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eEEEEeccchHHHH-hh-----hcCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhh
Confidence 89999999876554 33 235789999999999999999999998 9999999999999999999999999988
Q ss_pred ccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchh--------------
Q 003254 668 SFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLL-------------- 733 (836)
Q Consensus 668 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~-------------- 733 (836)
...... ......+|+.|+|||++.+..++.++||||+||+++||++|+.||............
T Consensus 168 ~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 244 (355)
T d2b1pa1 168 TAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred cccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHH
Confidence 754322 233457899999999999999999999999999999999999998533211100000
Q ss_pred -hhhHHhhhccCc-------hhhccccccCCC---ChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003254 734 -GHAWRLWIEERP-------LELIDQSLDNSC---SFSEALRCIQVGLLCVQQRPEDRPNMSSVVLM 789 (836)
Q Consensus 734 -~~~~~~~~~~~~-------~~~~d~~l~~~~---~~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~~ 789 (836)
............ ............ .......+.+|+.+||+.||++|||++||++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000000000000 011111111111 11234568899999999999999999999853
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-38 Score=348.51 Aligned_cols=264 Identities=22% Similarity=0.297 Sum_probs=197.0
Q ss_pred hcccccccCeecccCceeEEEEEee-cCcEEEEEEecCCC--chhHHHHHHHHHHHHhhcCCceeeEEeEEeeC-----C
Q 003254 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR-----D 586 (836)
Q Consensus 515 a~~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~ 586 (836)
..++|++.++||+|+||+||+|+.. +|+.||||+++... ....+++.+|+.++++++|||+|++++++... .
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 3578999999999999999999975 59999999997553 33456788999999999999999999998643 3
Q ss_pred eeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceeeccCcc
Q 003254 587 ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLA 666 (836)
Q Consensus 587 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~DFgla 666 (836)
..++++||+.+|+|.+++. .+.+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||++
T Consensus 96 ~~~~i~~~~~gg~L~~~~~----~~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp CCCEEEEECCSEEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC---
T ss_pred ceEEEEEeecCCchhhhcc----cccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchh
Confidence 4577888899999999883 346999999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCccccccccccccccccCcccccCC-ccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhhhHHhhhccCc
Q 003254 667 RSFGLDQTEANTKRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHAWRLWIEERP 745 (836)
Q Consensus 667 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (836)
..... ......|++.|+|||.+.+. .++.++||||+||++|+|++|+.||......... ........ ...
T Consensus 169 ~~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~---~~i~~~~~-~~~ 239 (348)
T d2gfsa1 169 RHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL---KLILRLVG-TPG 239 (348)
T ss_dssp -CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHC-CCC
T ss_pred cccCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHH---HHHHHhcC-CCC
Confidence 76432 22346789999999987765 4689999999999999999999997543221110 00000000 000
Q ss_pred hh------------hcccccc-CCCC-----hHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HhcCCC
Q 003254 746 LE------------LIDQSLD-NSCS-----FSEALRCIQVGLLCVQQRPEDRPNMSSVVL--MLSGER 794 (836)
Q Consensus 746 ~~------------~~d~~l~-~~~~-----~~~~~~l~~li~~Cl~~dP~~RPt~~eVl~--~L~~~~ 794 (836)
.+ ....... .... ......+.+|+.+||+.||++|||+.|+++ .+.+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~ 308 (348)
T d2gfsa1 240 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308 (348)
T ss_dssp HHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred hHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence 00 0000000 0000 011245779999999999999999999997 466543
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.8e-34 Score=317.50 Aligned_cols=263 Identities=21% Similarity=0.251 Sum_probs=192.8
Q ss_pred ccccccCeecccCceeEEEEEee-cCcEEEEEEecCCCchhHHHHHHHHHHHHhhc-----------CCceeeEEeEEee
Q 003254 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQ-----------HRNLVKLLGCCTQ 584 (836)
Q Consensus 517 ~~f~~~~~lG~G~fG~Vykg~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-----------H~niv~l~g~~~~ 584 (836)
++|++.++||+|+||+||+|+.. +|+.||||+++... ...+.+.+|+.++++++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 35999999999999999999975 58999999997543 33467788999988875 5789999988865
Q ss_pred C--CeeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhc-CCCCcEEeccCCCCceEecCCCC----
Q 003254 585 R--DERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQ-DSRLRIIHRDLKASNVLLDNTMN---- 657 (836)
Q Consensus 585 ~--~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~DLkp~NILl~~~~~---- 657 (836)
. ...+++++++..+..............+++..+..++.||+.||+|||+ .+ |+||||||+||||+.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence 3 4567777777666554444444556678899999999999999999997 66 999999999999986553
Q ss_pred --ceeeccCcccccCCCccccccccccccccccCcccccCCccCccccccchhhhhhhhhhCCCCCCCCCCccccchhhh
Q 003254 658 --PKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGH 735 (836)
Q Consensus 658 --~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL~elltG~~p~~~~~~~~~~~~~~~ 735 (836)
+|++|||.+..... ......||+.|+|||++.+..++.++||||+||+++||++|+.||..............
T Consensus 169 ~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~ 243 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243 (362)
T ss_dssp EEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred ceeeEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence 99999999986432 12346799999999999999999999999999999999999999864332211111000
Q ss_pred ---hHHhhhccCchhhc----------cc-------------------cccCCCChHHHHHHHHHHHHcccCCCCCCCCH
Q 003254 736 ---AWRLWIEERPLELI----------DQ-------------------SLDNSCSFSEALRCIQVGLLCVQQRPEDRPNM 783 (836)
Q Consensus 736 ---~~~~~~~~~~~~~~----------d~-------------------~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~ 783 (836)
....+ ...+.+.. +. .............+.+|+.+||+.||++|||+
T Consensus 244 ~~~~~~~l-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta 322 (362)
T d1q8ya_ 244 IAQIIELL-GELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 322 (362)
T ss_dssp HHHHHHHH-CSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHh-CCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCH
Confidence 00000 00000000 00 00112344566778999999999999999999
Q ss_pred HHHHHH
Q 003254 784 SSVVLM 789 (836)
Q Consensus 784 ~eVl~~ 789 (836)
+|+++.
T Consensus 323 ~e~L~H 328 (362)
T d1q8ya_ 323 GGLVNH 328 (362)
T ss_dssp HHHHTC
T ss_pred HHHhcC
Confidence 999874
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.83 E-value=1.6e-21 Score=193.17 Aligned_cols=169 Identities=20% Similarity=0.181 Sum_probs=121.4
Q ss_pred cccCeecccCceeEEEEEeecCcEEEEEEecCCCc------------------hhHHHHHHHHHHHHhhcCCceeeEEeE
Q 003254 520 SEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSG------------------QGMEEFKNEVLLIAKLQHRNLVKLLGC 581 (836)
Q Consensus 520 ~~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~------------------~~~~~~~~Ei~~l~~l~H~niv~l~g~ 581 (836)
.+.++||+|+||.||+|+..+|++||||+++.... .....+..|+..+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 35679999999999999998899999998753210 012234568889999999999988866
Q ss_pred EeeCCeeeEEEeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcCCCCcEEeccCCCCceEecCCCCceee
Q 003254 582 CTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKIS 661 (836)
Q Consensus 582 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~~kl~ 661 (836)
. ..+++|||+++..+. .++......++.|++++|+|||+.+ |+||||||+|||+++++ ++|+
T Consensus 83 ~----~~~lvme~~~~~~~~----------~l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~~-~~li 144 (191)
T d1zara2 83 E----GNAVLMELIDAKELY----------RVRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEEG-IWII 144 (191)
T ss_dssp E----TTEEEEECCCCEEGG----------GCCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETTE-EEEC
T ss_pred c----CCEEEEEeecccccc----------chhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCCC-EEEE
Confidence 3 247999999886542 2455667789999999999999998 99999999999999764 8999
Q ss_pred ccCcccccCCCccccccccccccccccCcccccCCccCccccccchhhhh
Q 003254 662 DFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLV 711 (836)
Q Consensus 662 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~GvvL 711 (836)
|||+|..........-..+.+ .. -.|. ....|..++|+||..--+
T Consensus 145 DFG~a~~~~~~~~~~~l~rd~---~~-~~~~-f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 145 DFPQSVEVGEEGWREILERDV---RN-IITY-FSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CCTTCEETTSTTHHHHHHHHH---HH-HHHH-HHHHHCCCCCHHHHHHHH
T ss_pred ECCCcccCCCCCcHHHHHHHH---HH-HHHH-HcCCCCCcccHHHHHHHH
Confidence 999998754222111000000 00 0111 135678899999975433
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=99.81 E-value=8.6e-20 Score=163.40 Aligned_cols=112 Identities=20% Similarity=0.412 Sum_probs=93.1
Q ss_pred ccccCCCccccCCCeEEeCCCeEEEeeecCCCCCceEEEEEEeecCCCcEEEeecCCCCCCCCcceEEEeeccCceEEEE
Q 003254 45 LDTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPLSDRSGVLRINGERNGILVLL 124 (836)
Q Consensus 45 ~~~i~~~~~l~~~~~l~S~~g~F~lgF~~~~~~~~~ylgiw~~~~~~~t~vW~Anr~~p~~~~~~~l~~~~~~~g~l~l~ 124 (836)
+|||.+||.|..|++|+| |.|+|.|...|+ |.|+. ..++||.||++.|..+ ..|.+. .||+|||+
T Consensus 1 tDtL~~gq~L~~g~~l~~--g~~~l~~q~DGN-----Lvly~----~~~~vW~s~~~~~~~~--~~l~l~--~dGnLvl~ 65 (112)
T d1xd5a_ 1 SDRLNSGHQLDTGGSLAE--GGYLFIIQNDCN-----LVLYD----NNRAVWASGTNGKASG--CVLKMQ--NDGNLVIY 65 (112)
T ss_dssp CCEEETTEEECTTCEEEE--TTEEEEECTTSC-----EEEEE----TTEEEEECCCTTSCSS--EEEEEC--TTSCEEEE
T ss_pred CCEecCCCEecCCCEEEE--CCEEEEEcCCCC-----EEEEc----CCcEEEEccCccCCCC--cEEEEe--ccccEEEE
Confidence 489999999999999975 999999998776 56654 4689999999988543 457776 99999999
Q ss_pred cCCCCeEEeecccCCCCcceEEEecCCCeEEecCCCCCCCcceeeeccCCCC
Q 003254 125 NSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDNILWQSFDYPCD 176 (836)
Q Consensus 125 ~~~~~~~wst~~~~~~~~~~a~lld~GNlvl~~~~~~~~~~~~WqSFd~PTD 176 (836)
|. +..+|+++++......+|+|+|+|||||++.. +.++|||+.+|+|
T Consensus 66 ~~-~~~~w~s~t~~~~~~~~l~L~ddGNlvly~~~----~~~~W~S~t~~~n 112 (112)
T d1xd5a_ 66 SG-SRAIWASNTNRQNGNYYLILQRDRNVVIYDNS----NNAIWATHTNVGN 112 (112)
T ss_dssp ET-TEEEEECCCCCSCCCCEEEECTTSCEEEECTT----SCEEEECCCCCCC
T ss_pred ec-CCeEEEEeeccCCCceEEEEcCCCCEEEECCC----CcEEecCCCccCC
Confidence 96 56788887665555678999999999999864 6789999999986
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.79 E-value=2.1e-19 Score=159.27 Aligned_cols=107 Identities=23% Similarity=0.329 Sum_probs=90.6
Q ss_pred ccccCCCccccCCCeEEeCCCeEEEeeecCCCCCceEEEEEEeecCCCcEEEeecCCCCCCCCcceEEEeeccCceEEEE
Q 003254 45 LDTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPLSDRSGVLRINGERNGILVLL 124 (836)
Q Consensus 45 ~~~i~~~~~l~~~~~l~S~~g~F~lgF~~~~~~~~~ylgiw~~~~~~~t~vW~Anr~~p~~~~~~~l~~~~~~~g~l~l~ 124 (836)
+|+|.+||.|.+|++|. +|.|+|.|+.+|+ |.|+. ..++||.||++.|-. ...|.+. .+|+|+|+
T Consensus 1 ~~~L~~g~~L~~G~~l~--ng~~~l~~q~DGN-----Lvly~----~~~~vW~s~~~~~~~--~~~l~l~--~~Gnlvl~ 65 (108)
T d1jpca_ 1 DNILYSGETLSTGEFLN--YGSFVFIMQEDCN-----LVLYD----VDKPIWATNTGGLSR--SCFLSMQ--TDGNLVVY 65 (108)
T ss_dssp CCEEETTEEECTTCEEE--ETTEEEEECTTSC-----EEEEE----TTEEEEECCCTTSCS--SCEEEEC--TTSCEEEE
T ss_pred CCCccCCCEecCCCEEE--cCCEEEEECCCCe-----EEEEe----CCceeeEeCCCCCCC--ccEEEEe--ccceEEEE
Confidence 47899999999999995 6999999998886 67765 468999999998843 3567776 89999999
Q ss_pred cCCCCeEEeecccCCCCcceEEEecCCCeEEecCCCCCCCcceeeeccC
Q 003254 125 NSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDNILWQSFDY 173 (836)
Q Consensus 125 ~~~~~~~wst~~~~~~~~~~a~lld~GNlvl~~~~~~~~~~~~WqSFd~ 173 (836)
|++|.+||++++.......+|+|+|+|||||++. .+||||+|
T Consensus 66 ~~~g~~vWsS~t~~~~~~~~l~L~ddGNlVly~~-------~~W~S~t~ 107 (108)
T d1jpca_ 66 NPSNKPIWASNTGGQNGNYVCILQKDRNVVIYGT-------DRWATGTH 107 (108)
T ss_dssp CTTCCEEEECCCCCSCSCEEEEECTTSCEEEEEC-------CCCCCCCC
T ss_pred CCCccceEEccccCCCCcEEEEEcCCCCEEEeCC-------CcccCCCC
Confidence 9999999999976555566789999999999953 38999987
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=99.78 E-value=6.3e-19 Score=156.25 Aligned_cols=107 Identities=21% Similarity=0.379 Sum_probs=89.7
Q ss_pred cccCCCccccCCCeEEeCCCeEEEeeecCCCCCceEEEEEEeecCCCcEEEeecCCCCCCCCcceEEEeeccCceEEEEc
Q 003254 46 DTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPLSDRSGVLRINGERNGILVLLN 125 (836)
Q Consensus 46 ~~i~~~~~l~~~~~l~S~~g~F~lgF~~~~~~~~~ylgiw~~~~~~~t~vW~Anr~~p~~~~~~~l~~~~~~~g~l~l~~ 125 (836)
|+|.+||.|.+|++|.+ |.|.|+|...++ |.++. ..++||+||++.|.... +.|.+. +||+|||+|
T Consensus 2 ~~L~~g~~L~~g~~l~~--g~~~l~~q~dgn-----Lvl~~----~~~~vW~ant~~~~~~~-~~l~l~--~dGnLvl~~ 67 (109)
T d1kj1a_ 2 NLLTNGEGLYAGQSLDV--EPYHFIMQEDCN-----LVLYD----HSTSVWASNTGILGKKG-CKAVLQ--SDGNFVVYD 67 (109)
T ss_dssp CEEETTCEEETTCEEEE--TTEEEEECTTSC-----EEEEE----TTEEEEECCCCCTTCCC-CEEEEC--TTSCEEEEC
T ss_pred CCccCCCEEeCCCEEEe--CCEEEEecCCCe-----EEEEe----CCEEEEEeCCCCCCcee-EEEEEc--CCceEEEEe
Confidence 78999999999999974 889999987765 55543 46899999999998653 567776 899999999
Q ss_pred CCCCeEEeecccCCCCcceEEEecCCCeEEecCCCCCCCcceeeeccC
Q 003254 126 STNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDNILWQSFDY 173 (836)
Q Consensus 126 ~~~~~~wst~~~~~~~~~~a~lld~GNlvl~~~~~~~~~~~~WqSFd~ 173 (836)
++|.+||+|+++......+|+|+|+|||||++. .+|||+-|
T Consensus 68 ~~g~~vW~s~t~~~~~~~~l~L~ddGNlvly~~-------~~W~S~t~ 108 (109)
T d1kj1a_ 68 AEGRSLWASHSVRGNGNYVLVLQEDGNVVIYGS-------DIWSTGTY 108 (109)
T ss_dssp SSSCEEEECCCCCCSSCCEEEECTTSCEEEECC-------EEEECCCC
T ss_pred CCCcEEEEEeeECCCCCEEEEEeCCCcEEEECC-------CEecCCCc
Confidence 999999999976555567899999999999953 39999865
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.64 E-value=9.9e-17 Score=144.27 Aligned_cols=103 Identities=20% Similarity=0.312 Sum_probs=86.0
Q ss_pred EEEEeecCCCcEEEeecCCCCCCCCcceEEEeeccCceEEEEcCCCCeEEeecccCCCCcceEEEecCCCeEEecCCCCC
Q 003254 83 GIWYKKIAEGTVTWVANRDAPLSDRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNN 162 (836)
Q Consensus 83 giw~~~~~~~t~vW~Anr~~p~~~~~~~l~~~~~~~g~l~l~~~~~~~~wst~~~~~~~~~~a~lld~GNlvl~~~~~~~ 162 (836)
-|||.++++++++|++|++.|+....-.|.+. .||+|||++. +.++|++++........|.|+|+|||||++.+
T Consensus 11 ~il~~~~~~~~~~~~l~~~q~l~~g~y~L~~q--~DGNLvL~~~-~~~vW~s~t~~~~~~~~~~l~~~GnLvl~d~~--- 84 (120)
T d1dlpa2 11 SILYSTQGNDNHPQTLHATQSLQLSPYRLSME--TDCNLVLFDR-DDRVWSTNTAGKGTGCRAVLQPNGRMDVLTNQ--- 84 (120)
T ss_dssp EECCCC--CCCCCCEECSSCCCBCSSCEEEEE--TTTEEEEEBT-TBCCSCCCCCSSCSSCEEEEETTTEEEEEETT---
T ss_pred eEEEcCCCCCCcccEEcCCCeeEcCCEEEEEc--CCCcEEEecC-CcEEEEEccccCCCcEEEEEeCCeeEEEEcCC---
Confidence 58999999999999999999998776778887 9999999986 67899999766556678999999999999864
Q ss_pred CCcceeeeccCCCCCcCCCCeeeeeecCCCceEEEEccCCCCCCCCCeeeccCCCCCceEE
Q 003254 163 PDNILWQSFDYPCDTLLPGMKLGINLGTGLNRFLSSWKSTDDPARGDFTYGLDPRGIPQLV 223 (836)
Q Consensus 163 ~~~~~WqSFd~PTDtlLpgqkl~~~~~tg~~~~l~Sw~s~~dps~G~~~~~~~~~g~~~~~ 223 (836)
++++||||. +.++|.|.+.++++|...++
T Consensus 85 -~~~lW~S~t-------------------------------~~~~~~~~l~Lq~DGnlvlY 113 (120)
T d1dlpa2 85 -NIAVWTSGN-------------------------------SRSAGRYVFVLQPDRNLAIY 113 (120)
T ss_dssp -TEEEEECCC-------------------------------CCSSSCCEEEECSSSCEEEE
T ss_pred -CCEEEEeCC-------------------------------CCCCCcEEEEECCCCcEEEe
Confidence 688999983 24668899999999987654
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.49 E-value=8.2e-14 Score=124.49 Aligned_cols=101 Identities=22% Similarity=0.363 Sum_probs=78.8
Q ss_pred ccccCCCe--EEeCCCeEEEeeecCCCCCceEEEEEEeecCCCcEEEeecCCCCCCCCcceEEEeeccCceEEEEcCCCC
Q 003254 52 QSIKDGET--LVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPLSDRSGVLRINGERNGILVLLNSTND 129 (836)
Q Consensus 52 ~~l~~~~~--l~S~~g~F~lgF~~~~~~~~~ylgiw~~~~~~~t~vW~Anr~~p~~~~~~~l~~~~~~~g~l~l~~~~~~ 129 (836)
|.|.++|+ +.+..|.|.|.|...|+ |.+ |. ..++||.||+..|.. ...|.+. .||+|+|.|++|.
T Consensus 15 ~~l~~~q~l~~~~~~~~y~l~mQ~DGN-----LVL-y~---~~~~vWssnt~~~~~--~~~l~l~--~dGnLvL~d~~g~ 81 (119)
T d1b2pa_ 15 QILHATESLEILFGTHVYRFIMQTDCN-----LVL-YD---NNNPIWATNTGGLGN--GCRAVLQ--PDGVLVVITNENV 81 (119)
T ss_dssp CEEETTCEEEEEETTEEEEEEECTTSC-----EEE-EE---TTEEEEECCCTTSCS--SCEEEEC--TTSCEEEECTTCC
T ss_pred CEEeCCCeEEEecCCceEEEEECCCCc-----EEE-EE---CCeEEEEecCCCCCc--ceEEEEE--eCCCEEEECCCCc
Confidence 44444444 46679999999998877 555 43 468999999987643 3567776 8999999999999
Q ss_pred eEEeecccCCCCcceEEEecCCCeEEecCCCCCCCcceeeecc
Q 003254 130 TVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDNILWQSFD 172 (836)
Q Consensus 130 ~~wst~~~~~~~~~~a~lld~GNlvl~~~~~~~~~~~~WqSFd 172 (836)
+||++++.......+|+|+|+|||||++ ..+|||-.
T Consensus 82 ~vWsS~t~~~~~~~~l~Lq~DGNlvlYg-------~~~W~S~T 117 (119)
T d1b2pa_ 82 TVWQSPVAGKAGHYVLVLQPDRNVVIYG-------DALWATQT 117 (119)
T ss_dssp EEEECSCCCCSSCEEEEECTTSCEEEEE-------SEEEECCC
T ss_pred EEEECCCcCCCCceEEEEcCCCCEEEEC-------CCEeccCC
Confidence 9999997655555678999999999984 35999964
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.48 E-value=9.7e-15 Score=129.66 Aligned_cols=110 Identities=23% Similarity=0.307 Sum_probs=89.0
Q ss_pred EEEeecCCCcEEEeecCCCCCCCCcceEEEeeccCceEEEEcCCCCeEEeecccCCCCcceEEEecCCCeEEecCCCCCC
Q 003254 84 IWYKKIAEGTVTWVANRDAPLSDRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNP 163 (836)
Q Consensus 84 iw~~~~~~~t~vW~Anr~~p~~~~~~~l~~~~~~~g~l~l~~~~~~~~wst~~~~~~~~~~a~lld~GNlvl~~~~~~~~ 163 (836)
|||.-.+..+..|..+.+.++.+...+|.+. .||||||++ .+.++|++++.. ..+..+.|+|+|||||++..
T Consensus 3 ~~~~~~~~~~~~~tl~~~~~l~~g~~~l~~q--~DGNLvL~~-~~~~vW~s~t~~-~~~~~l~l~~dGNLvl~d~~---- 74 (115)
T d1dlpa1 3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQ--SDCNLVLFD-SDVRVWASNTAG-ATGCRAVLQSDGLLVILTAQ---- 74 (115)
T ss_dssp CCBCSSSSSCSCSCCCTTCEECSTTEEEEEC--TTSCEEEEE-SSSEEECCCCCS-CSCCBCCBCSSSCBCCBCTT----
T ss_pred EEEecCCCCCCcceecCCCcEEcCCEEEEEC--CCCeEEEEc-CCeeEEEcccCC-CCceEEEEeccCCEEEEccC----
Confidence 6777667788889999999998766777776 999999998 468899999653 45678999999999999864
Q ss_pred CcceeeeccCCCCCcCCCCeeeeeecCCCceEEEEccCCCCCCCCCeeeccCCCCCceEEEEcCCeeEEeeCC
Q 003254 164 DNILWQSFDYPCDTLLPGMKLGINLGTGLNRFLSSWKSTDDPARGDFTYGLDPRGIPQLVLRKNSIITFRAGS 236 (836)
Q Consensus 164 ~~~~WqSFd~PTDtlLpgqkl~~~~~tg~~~~l~Sw~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~g~ 236 (836)
+.+||||+. +.+.|.|.+.++++|...++ +.++|.+|.
T Consensus 75 ~~~vWsS~t-------------------------------~~~~g~y~l~Lq~DGNlvlY----~~~~Wssgt 112 (115)
T d1dlpa1 75 NTIRWSSGT-------------------------------KGSIGNYVLVLQPDRTVTIY----GPGLWDSGT 112 (115)
T ss_dssp TCCSCCCCC-------------------------------CCCSSCCEEEECSSSCEEEE----CSEEEECSC
T ss_pred CCEEEEcCC-------------------------------CCCCCCEEEEECCCCcEEEe----CCCeecCCC
Confidence 678999863 34689999999999986544 347888774
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.26 E-value=1.7e-12 Score=114.90 Aligned_cols=99 Identities=23% Similarity=0.351 Sum_probs=75.4
Q ss_pred CccccCCCeEEeCCCeEEEeeecCCCCCceEEEEEEeecCCCcEEEeecCCCCCCCCcceEEEeeccCceEEEEcCCCCe
Q 003254 51 GQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPLSDRSGVLRINGERNGILVLLNSTNDT 130 (836)
Q Consensus 51 ~~~l~~~~~l~S~~g~F~lgF~~~~~~~~~ylgiw~~~~~~~t~vW~Anr~~p~~~~~~~l~~~~~~~g~l~l~~~~~~~ 130 (836)
.|+|.+++.| .+|.|.|.|...|+ |.++. ..++||.+|...+ ....+.+. .||+|||.|.++.+
T Consensus 14 ~~tl~~~~~l--~~g~~~l~~q~DGN-----LvL~~----~~~~vW~s~t~~~---~~~~l~l~--~dGNLvl~d~~~~~ 77 (115)
T d1dlpa1 14 PQTLHAAQSL--ELSSFRFTMQSDCN-----LVLFD----SDVRVWASNTAGA---TGCRAVLQ--SDGLLVILTAQNTI 77 (115)
T ss_dssp CSCCCTTCEE--CSTTEEEEECTTSC-----EEEEE----SSSEEECCCCCSC---SCCBCCBC--SSSCBCCBCTTTCC
T ss_pred cceecCCCcE--EcCCEEEEECCCCe-----EEEEc----CCeeEEEcccCCC---CceEEEEe--ccCCEEEEccCCCE
Confidence 3455555555 46779999998877 66753 4678999986532 23566766 89999999999999
Q ss_pred EEeecccCCCCcceEEEecCCCeEEecCCCCCCCcceeeecc
Q 003254 131 VWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDNILWQSFD 172 (836)
Q Consensus 131 ~wst~~~~~~~~~~a~lld~GNlvl~~~~~~~~~~~~WqSFd 172 (836)
||++.+.......+++|.++|||||++ ..+|+|-.
T Consensus 78 vWsS~t~~~~g~y~l~Lq~DGNlvlY~-------~~~Wssgt 112 (115)
T d1dlpa1 78 RWSSGTKGSIGNYVLVLQPDRTVTIYG-------PGLWDSGT 112 (115)
T ss_dssp SCCCCCCCCSSCCEEEECSSSCEEEEC-------SEEEECSC
T ss_pred EEEcCCCCCCCCEEEEECCCCcEEEeC-------CCeecCCC
Confidence 999997655566679999999999994 35999853
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.94 E-value=1.2e-09 Score=97.18 Aligned_cols=99 Identities=24% Similarity=0.369 Sum_probs=71.8
Q ss_pred CCccccCCCeEEeCCCeEEEeeecCCCCCceEEEEEEeecCCCcEEEeecCCCCCCCCcceEEEeeccCceEEEEcCCCC
Q 003254 50 LGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPLSDRSGVLRINGERNGILVLLNSTND 129 (836)
Q Consensus 50 ~~~~l~~~~~l~S~~g~F~lgF~~~~~~~~~ylgiw~~~~~~~t~vW~Anr~~p~~~~~~~l~~~~~~~g~l~l~~~~~~ 129 (836)
+.+.|..++.| ..|.|.|.|-..|+ |.|+. ...+||.+|- +-......+.|. .+|+|||.|.++.
T Consensus 22 ~~~~l~~~q~l--~~g~y~L~~q~DGN-----LvL~~----~~~~vW~s~t--~~~~~~~~~~l~--~~GnLvl~d~~~~ 86 (120)
T d1dlpa2 22 HPQTLHATQSL--QLSPYRLSMETDCN-----LVLFD----RDDRVWSTNT--AGKGTGCRAVLQ--PNGRMDVLTNQNI 86 (120)
T ss_dssp CCCEECSSCCC--BCSSCEEEEETTTE-----EEEEB----TTBCCSCCCC--CSSCSSCEEEEE--TTTEEEEEETTTE
T ss_pred cccEEcCCCee--EcCCEEEEEcCCCc-----EEEec----CCcEEEEEcc--ccCCCcEEEEEe--CCeeEEEEcCCCC
Confidence 34455555555 35668888876654 55542 3577899874 333344567776 8999999999999
Q ss_pred eEEeecccCCCCcceEEEecCCCeEEecCCCCCCCcceeee
Q 003254 130 TVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDNILWQS 170 (836)
Q Consensus 130 ~~wst~~~~~~~~~~a~lld~GNlvl~~~~~~~~~~~~WqS 170 (836)
++|++++.......++.|.++|||||++. .+|.|
T Consensus 87 ~lW~S~t~~~~~~~~l~Lq~DGnlvlY~~-------~~W~t 120 (120)
T d1dlpa2 87 AVWTSGNSRSAGRYVFVLQPDRNLAIYGG-------ALWTT 120 (120)
T ss_dssp EEEECCCCCSSSCCEEEECSSSCEEEECC-------CCCBC
T ss_pred EEEEeCCCCCCCcEEEEECCCCcEEEeCC-------CcccC
Confidence 99999976555666789999999999943 48875
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.85 E-value=6e-09 Score=92.35 Aligned_cols=88 Identities=23% Similarity=0.305 Sum_probs=67.2
Q ss_pred cceEEEeeccCceEEEEcCCCCeEEeecccCCCCcceEEEecCCCeEEecCCCCCCCcceeeeccCCCCCcCCCCeeeee
Q 003254 108 SGVLRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDNILWQSFDYPCDTLLPGMKLGIN 187 (836)
Q Consensus 108 ~~~l~~~~~~~g~l~l~~~~~~~~wst~~~~~~~~~~a~lld~GNlvl~~~~~~~~~~~~WqSFd~PTDtlLpgqkl~~~ 187 (836)
++..+|..+.||||||+++ +.++|++++........+.|.++|||||++.. +.++|+|.-
T Consensus 29 ~~~y~l~mQ~DGNLVLy~~-~~~vWssnt~~~~~~~~l~l~~dGnLvL~d~~----g~~vWsS~t--------------- 88 (119)
T d1b2pa_ 29 THVYRFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITNE----NVTVWQSPV--------------- 88 (119)
T ss_dssp TEEEEEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECTT----CCEEEECSC---------------
T ss_pred CceEEEEECCCCcEEEEEC-CeEEEEecCCCCCcceEEEEEeCCCEEEECCC----CcEEEECCC---------------
Confidence 4666666779999999975 56899999765555678999999999999864 678897631
Q ss_pred ecCCCceEEEEccCCCCCCCCCeeeccCCCCCceEEEEcCCeeEEeeC
Q 003254 188 LGTGLNRFLSSWKSTDDPARGDFTYGLDPRGIPQLVLRKNSIITFRAG 235 (836)
Q Consensus 188 ~~tg~~~~l~Sw~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~g 235 (836)
.-+.|.|.+.++++|...++ +.+.|.++
T Consensus 89 ----------------~~~~~~~~l~Lq~DGNlvlY----g~~~W~S~ 116 (119)
T d1b2pa_ 89 ----------------AGKAGHYVLVLQPDRNVVIY----GDALWATQ 116 (119)
T ss_dssp ----------------CCCSSCEEEEECTTSCEEEE----ESEEEECC
T ss_pred ----------------cCCCCceEEEEcCCCCEEEE----CCCEeccC
Confidence 12456788999999987664 24678776
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=98.78 E-value=8.5e-09 Score=89.98 Aligned_cols=77 Identities=18% Similarity=0.336 Sum_probs=58.6
Q ss_pred EEEeeccCceEEEEcCCCCeEEeecccCCCCcceEEEecCCCeEEecCCCCCCCcceeeeccCCCCCcCCCCeeeeeecC
Q 003254 111 LRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDNILWQSFDYPCDTLLPGMKLGINLGT 190 (836)
Q Consensus 111 l~~~~~~~g~l~l~~~~~~~~wst~~~~~~~~~~a~lld~GNlvl~~~~~~~~~~~~WqSFd~PTDtlLpgqkl~~~~~t 190 (836)
.++..+.||||||++ .+.+||++++........+.|.++|||||++.. +.++|.|
T Consensus 21 ~~l~~q~DGNLvly~-~~~~vW~s~~~~~~~~~~l~l~~~Gnlvl~~~~----g~~vWsS-------------------- 75 (108)
T d1jpca_ 21 FVFIMQEDCNLVLYD-VDKPIWATNTGGLSRSCFLSMQTDGNLVVYNPS----NKPIWAS-------------------- 75 (108)
T ss_dssp EEEEECTTSCEEEEE-TTEEEEECCCTTSCSSCEEEECTTSCEEEECTT----CCEEEEC--------------------
T ss_pred EEEEECCCCeEEEEe-CCceeeEeCCCCCCCccEEEEeccceEEEECCC----ccceEEc--------------------
Confidence 344455999999997 457899999765555667999999999999864 6788976
Q ss_pred CCceEEEEccCCCCCCCCCeeeccCCCCCceEE
Q 003254 191 GLNRFLSSWKSTDDPARGDFTYGLDPRGIPQLV 223 (836)
Q Consensus 191 g~~~~l~Sw~s~~dps~G~~~~~~~~~g~~~~~ 223 (836)
.+..+.+.|.+.++++|...++
T Consensus 76 -----------~t~~~~~~~~l~L~ddGNlVly 97 (108)
T d1jpca_ 76 -----------NTGGQNGNYVCILQKDRNVVIY 97 (108)
T ss_dssp -----------CCCCSCSCEEEEECTTSCEEEE
T ss_pred -----------cccCCCCcEEEEEcCCCCEEEe
Confidence 1122456788999999987654
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=98.65 E-value=7.2e-08 Score=84.00 Aligned_cols=85 Identities=26% Similarity=0.400 Sum_probs=61.3
Q ss_pred EEeeccCceEEEEcCCCCeEEeecccCC-CCcceEEEecCCCeEEecCCCCCCCcceeeeccCCCCCcCCCCeeeeeecC
Q 003254 112 RINGERNGILVLLNSTNDTVWSSNSSIS-AQKPVAALMESGNLVVKDGKDNNPDNILWQSFDYPCDTLLPGMKLGINLGT 190 (836)
Q Consensus 112 ~~~~~~~g~l~l~~~~~~~~wst~~~~~-~~~~~a~lld~GNlvl~~~~~~~~~~~~WqSFd~PTDtlLpgqkl~~~~~t 190 (836)
++.++.||+|||++ .+.+||++++... .....+.|.++|||||++.+ +.++|+|=
T Consensus 22 ~l~~q~dgnLvl~~-~~~~vW~ant~~~~~~~~~l~l~~dGnLvl~~~~----g~~vW~s~------------------- 77 (109)
T d1kj1a_ 22 HFIMQEDCNLVLYD-HSTSVWASNTGILGKKGCKAVLQSDGNFVVYDAE----GRSLWASH------------------- 77 (109)
T ss_dssp EEEECTTSCEEEEE-TTEEEEECCCCCTTCCCCEEEECTTSCEEEECSS----SCEEEECC-------------------
T ss_pred EEEecCCCeEEEEe-CCEEEEEeCCCCCCceeEEEEEcCCceEEEEeCC----CcEEEEEe-------------------
Confidence 44445999999987 5678999986532 23456899999999999864 67889861
Q ss_pred CCceEEEEccCCCCCCCCCeeeccCCCCCceEEEEcCCeeEEeeCC
Q 003254 191 GLNRFLSSWKSTDDPARGDFTYGLDPRGIPQLVLRKNSIITFRAGS 236 (836)
Q Consensus 191 g~~~~l~Sw~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~g~ 236 (836)
+..+.|.|.+.++++|...++ + ...|.++.
T Consensus 78 ------------t~~~~~~~~l~L~ddGNlvly--~--~~~W~S~t 107 (109)
T d1kj1a_ 78 ------------SVRGNGNYVLVLQEDGNVVIY--G--SDIWSTGT 107 (109)
T ss_dssp ------------CCCCSSCCEEEECTTSCEEEE--C--CEEEECCC
T ss_pred ------------eECCCCCEEEEEeCCCcEEEE--C--CCEecCCC
Confidence 112356788999999987654 3 35787654
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=98.44 E-value=4.6e-07 Score=79.35 Aligned_cols=88 Identities=20% Similarity=0.328 Sum_probs=63.0
Q ss_pred EEEeeccCceEEEEcCCCCeEEeecccCCCCcceEEEecCCCeEEecCCCCCCCcceeeeccCCCCCcCCCCeeeeeecC
Q 003254 111 LRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDNILWQSFDYPCDTLLPGMKLGINLGT 190 (836)
Q Consensus 111 l~~~~~~~g~l~l~~~~~~~~wst~~~~~~~~~~a~lld~GNlvl~~~~~~~~~~~~WqSFd~PTDtlLpgqkl~~~~~t 190 (836)
.+|.++.||||||++ .+.+||++++........+.|..+|||||++. ++.+|-|
T Consensus 21 ~~l~~q~DGNLvly~-~~~~vW~s~~~~~~~~~~l~l~~dGnLvl~~~-----~~~~w~s-------------------- 74 (112)
T d1xd5a_ 21 YLFIIQNDCNLVLYD-NNRAVWASGTNGKASGCVLKMQNDGNLVIYSG-----SRAIWAS-------------------- 74 (112)
T ss_dssp EEEEECTTSCEEEEE-TTEEEEECCCTTSCSSEEEEECTTSCEEEEET-----TEEEEEC--------------------
T ss_pred EEEEEcCCCCEEEEc-CCcEEEEccCccCCCCcEEEEeccccEEEEec-----CCeEEEE--------------------
Confidence 344455999999987 56899999966545567799999999999985 3455643
Q ss_pred CCceEEEEccCCCCCCCCCeeeccCCCCCceEEEEcCCeeEEeeCC
Q 003254 191 GLNRFLSSWKSTDDPARGDFTYGLDPRGIPQLVLRKNSIITFRAGS 236 (836)
Q Consensus 191 g~~~~l~Sw~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~g~ 236 (836)
.+.-..|.|.+.++.+|...++ .....+.|.++.
T Consensus 75 -----------~t~~~~~~~~l~L~ddGNlvly-~~~~~~~W~S~t 108 (112)
T d1xd5a_ 75 -----------NTNRQNGNYYLILQRDRNVVIY-DNSNNAIWATHT 108 (112)
T ss_dssp -----------CCCCSCCCCEEEECTTSCEEEE-CTTSCEEEECCC
T ss_pred -----------eeccCCCceEEEEcCCCCEEEE-CCCCcEEecCCC
Confidence 2222456789999999987654 233567888764
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.33 E-value=1.2e-06 Score=88.65 Aligned_cols=147 Identities=16% Similarity=0.083 Sum_probs=99.1
Q ss_pred HhhcccccccCeecccCceeEEEEEeecCcEEEEEEecCCCchhHHHHHHHHHHHHhhc-CCceeeEEeEEeeCCeeeEE
Q 003254 513 ANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQRDERMLI 591 (836)
Q Consensus 513 ~~a~~~f~~~~~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV 591 (836)
...-+.|...+..+.+.-..||+... +++.++||+...........+.+|...+..+. +--+.+++.+....+..++|
T Consensus 10 ~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv 88 (263)
T d1j7la_ 10 KKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp HHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred HHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEE
Confidence 33345565554444444568998864 67778899886655445556788999988874 44467788888888889999
Q ss_pred EeecCCCChhHHHhhccCCCcCChhhhHHHHHHHHhhhHhhhcC------------------------------------
Q 003254 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQD------------------------------------ 635 (836)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------------------------------------ 635 (836)
||++++.++...... ......++.++++.++.||+.
T Consensus 89 ~~~l~G~~~~~~~~~--------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T d1j7la_ 89 MSEADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EECCSSEEHHHHTTT--------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGST
T ss_pred EEecccccccccccc--------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccc
Confidence 999999877544311 112223444444555555432
Q ss_pred --------------------CCCcEEeccCCCCceEecCCCCceeeccCcccc
Q 003254 636 --------------------SRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (836)
Q Consensus 636 --------------------~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~ 668 (836)
....++|+|+.|.||+++++..+-|.||+.+..
T Consensus 161 ~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 112379999999999999877677999988753
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.62 E-value=9.7e-05 Score=73.72 Aligned_cols=74 Identities=18% Similarity=0.209 Sum_probs=54.3
Q ss_pred eecccCc-eeEEEEEeecCcEEEEEEecCCCchhHHHHHHHHHHHHhhcC--CceeeEEeEEeeCCeeeEEEeecCCCCh
Q 003254 524 KLGEGGF-GPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQH--RNLVKLLGCCTQRDERMLIYEYLPNKSL 600 (836)
Q Consensus 524 ~lG~G~f-G~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H--~niv~l~g~~~~~~~~~lV~Ey~~~gsL 600 (836)
.+..|.. +.||+....++..+++|...... ...+..|...++.+.. -.+.+++.+..+.+..++|||++++.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 4555553 67899988778889999865433 2356778888887753 3356778888888889999999988765
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.32 E-value=0.00044 Score=73.78 Aligned_cols=75 Identities=12% Similarity=0.167 Sum_probs=49.1
Q ss_pred CeecccCceeEEEEEeec-CcEEEEEEecCC-------CchhHHHHHHHHHHHHhhc-C-C-ceeeEEeEEeeCCeeeEE
Q 003254 523 NKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG-------SGQGMEEFKNEVLLIAKLQ-H-R-NLVKLLGCCTQRDERMLI 591 (836)
Q Consensus 523 ~~lG~G~fG~Vykg~~~~-g~~vavK~l~~~-------~~~~~~~~~~Ei~~l~~l~-H-~-niv~l~g~~~~~~~~~lV 591 (836)
+.||.|....||+....+ ++.++||.-... .+....+...|.+.++.+. + | .+.+++.+ +.+..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 468999999999998765 678999974321 1223345567888887763 3 3 34555544 44567899
Q ss_pred EeecCCCC
Q 003254 592 YEYLPNKS 599 (836)
Q Consensus 592 ~Ey~~~gs 599 (836)
||++++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99998754
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.37 E-value=0.0055 Score=63.08 Aligned_cols=136 Identities=13% Similarity=0.144 Sum_probs=78.8
Q ss_pred ceeEEEEEeecCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCce--eeEE-----eEEeeCCeeeEEEeecCCCChhH
Q 003254 530 FGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNL--VKLL-----GCCTQRDERMLIYEYLPNKSLDY 602 (836)
Q Consensus 530 fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~ni--v~l~-----g~~~~~~~~~lV~Ey~~~gsL~~ 602 (836)
.-.||+.+..+|+.+++|+.+.. ....+++..|...+..|...++ +..+ ......+..+.+++++++..++.
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred cceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence 45899999989999999987543 2345778889999888853322 1111 12234556788999988754321
Q ss_pred ----H----------Hhhc------cCCCcCC-------------------hhhhHHHHHHHHhhhHhhh----cCCCCc
Q 003254 603 ----F----------IFDT------TRSKLLD-------------------WSKRSHIIAGIARGLLYLH----QDSRLR 639 (836)
Q Consensus 603 ----~----------l~~~------~~~~~l~-------------------~~~~~~i~~~ia~gL~yLH----~~~~~~ 639 (836)
. ++.. .....++ ...+..+...+.+.++.+. +..+..
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence 0 0000 0011111 1111112222222222322 223446
Q ss_pred EEeccCCCCceEecCCCCceeeccCcccc
Q 003254 640 IIHRDLKASNVLLDNTMNPKISDFGLARS 668 (836)
Q Consensus 640 ivH~DLkp~NILl~~~~~~kl~DFgla~~ 668 (836)
++|+|+.+.|||++++ ..+.||+-+..
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eecCCCCcccEEEeCC--ceEEechhccc
Confidence 8999999999999754 45889998763
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.35 E-value=0.0083 Score=63.52 Aligned_cols=72 Identities=17% Similarity=0.232 Sum_probs=49.7
Q ss_pred CeecccCceeEEEEEeecC--------cEEEEEEecCCCchhHHHHHHHHHHHHhhc-CCceeeEEeEEeeCCeeeEEEe
Q 003254 523 NKLGEGGFGPVYKGMLIEG--------QEIAVKRLSKGSGQGMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQRDERMLIYE 593 (836)
Q Consensus 523 ~~lG~G~fG~Vykg~~~~g--------~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~E 593 (836)
+.|+.|-.-.+|+...+++ +.|++++... . .......+|..+++.+. +.-..++++++.. .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-P-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-C-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-c-chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 5788899999999987543 4566666542 2 22344568999999885 4334577777653 68999
Q ss_pred ecCCCCh
Q 003254 594 YLPNKSL 600 (836)
Q Consensus 594 y~~~gsL 600 (836)
|+++..+
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9987554
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.67 E-value=0.032 Score=56.63 Aligned_cols=158 Identities=13% Similarity=0.018 Sum_probs=82.5
Q ss_pred cHHHHHhhcccccccC-----eecccCceeEEEEEeecCcEEEEEEecCCCchhHHHHHHHHHHHHhhcCCce--eeEEe
Q 003254 508 DLKIIANATDNFSEKN-----KLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNL--VKLLG 580 (836)
Q Consensus 508 ~~~~l~~a~~~f~~~~-----~lG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~ni--v~l~g 580 (836)
+.++++....+|...+ .|..|---+.|+.+..+| .+++|+..... ..++...|+.++..+.+.++ ...+.
T Consensus 4 s~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi~ 80 (316)
T d2ppqa1 4 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLP 80 (316)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccce
Confidence 3445555556665433 345666678899887655 58999885432 23455667777777753222 11111
Q ss_pred ------EEeeCCeeeEEEeecCCCChhHH--------------HhhccC------------------------CCcCChh
Q 003254 581 ------CCTQRDERMLIYEYLPNKSLDYF--------------IFDTTR------------------------SKLLDWS 616 (836)
Q Consensus 581 ------~~~~~~~~~lV~Ey~~~gsL~~~--------------l~~~~~------------------------~~~l~~~ 616 (836)
+.........++.++.+...... ++.... .......
T Consensus 81 ~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (316)
T d2ppqa1 81 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 160 (316)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred ecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcch
Confidence 12223455667777665433110 000000 0001111
Q ss_pred hhHHHHHHHHhhhHhhhcC-CCCcEEeccCCCCceEecCCCCceeeccCcccc
Q 003254 617 KRSHIIAGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (836)
Q Consensus 617 ~~~~i~~~ia~gL~yLH~~-~~~~ivH~DLkp~NILl~~~~~~kl~DFgla~~ 668 (836)
.....+..+...+.-.+.. -+.++||+|+.++||+++++...-|.||+.+..
T Consensus 161 ~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 161 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 1222233333333333322 234599999999999999887778999998753
|
| >d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=93.50 E-value=0.014 Score=37.24 Aligned_cols=33 Identities=33% Similarity=0.783 Sum_probs=26.5
Q ss_pred cCCCccCCCCCCcccccCCCCCcccccCCCccCC
Q 003254 312 DQCDSYALCGAYASCNINSNSPECECLQGFVPNS 345 (836)
Q Consensus 312 ~~Cd~~g~CG~~g~C~~~~~~~~C~Cl~Gf~~~~ 345 (836)
|+|.+-..|| ||.|+.--..-.|.|-.||+|..
T Consensus 2 dECsignpCG-nGTCtNviGgFec~C~~GFepgp 34 (39)
T d1emoa2 2 DECSVGNPCG-NGTCKNVIGGFECTCEEGFEPGP 34 (39)
T ss_dssp CGGGTTCSSS-SSCEEECSSSEEECCSSSSCCCS
T ss_pred CccccCCccC-CceeeecccceEEeecCCcCCCc
Confidence 7899999998 89997542345799999999854
|
| >d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=87.85 E-value=0.088 Score=35.81 Aligned_cols=33 Identities=33% Similarity=0.705 Sum_probs=25.8
Q ss_pred ccCCCc-cCCCCCCcccccCCCCCcccccCCCcc
Q 003254 311 LDQCDS-YALCGAYASCNINSNSPECECLQGFVP 343 (836)
Q Consensus 311 ~~~Cd~-~g~CG~~g~C~~~~~~~~C~Cl~Gf~~ 343 (836)
.|+|.. ...|..+|.|.....+-.|.|++||+-
T Consensus 3 ideC~~~~~pC~n~g~C~n~~g~y~C~C~~G~~G 36 (42)
T d2vj3a1 3 VDECSLGANPCEHAGKCINTLGSFECQCLQGYTG 36 (42)
T ss_dssp CCTTTSSSCSSSTTCEEEECSSSEEEECCTTEES
T ss_pred CccccCCCCCCCCCcEeECCCCCEEeECCCCCcC
Confidence 367875 578999999976545568999999963
|
| >d1xkba1 g.3.11.1 (A:48-86) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor X, N-terminal module species: Human (Homo sapiens) [TaxId: 9606]
Probab=84.37 E-value=0.24 Score=32.95 Aligned_cols=31 Identities=32% Similarity=0.758 Sum_probs=23.3
Q ss_pred cCCCccCCCCCCcccccCCCCCcccccCCCcc
Q 003254 312 DQCDSYALCGAYASCNINSNSPECECLQGFVP 343 (836)
Q Consensus 312 ~~Cd~~g~CG~~g~C~~~~~~~~C~Cl~Gf~~ 343 (836)
|+|. ...|...|.|......-.|.|++||.-
T Consensus 1 D~C~-~~PC~ngg~C~~~~~~y~C~C~~G~~G 31 (39)
T d1xkba1 1 DQCE-TSPCQNQGKCKDGLGEYTCTCLEGFEG 31 (39)
T ss_dssp CTTT-TCCCCSSCEECCCSSSCCEECCTTEET
T ss_pred CcCC-CCCCCCCcEEECCCCCEEEECCCCCCc
Confidence 4565 477888899975545678999999964
|
| >d1emoa1 g.3.11.1 (A:2124-2166) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=80.19 E-value=0.5 Score=32.03 Aligned_cols=32 Identities=25% Similarity=0.574 Sum_probs=25.0
Q ss_pred ccCCCccCCCCCCcccccCCCCCcccccCCCcc
Q 003254 311 LDQCDSYALCGAYASCNINSNSPECECLQGFVP 343 (836)
Q Consensus 311 ~~~Cd~~g~CG~~g~C~~~~~~~~C~Cl~Gf~~ 343 (836)
.|+|.... |+.++.|.....+=.|.|++||..
T Consensus 5 idEC~~~~-~~~~~~C~Nt~Gsy~C~C~~Gy~~ 36 (43)
T d1emoa1 5 MDECKEPD-VCKHGQCINTDGSYRCECPFGYIL 36 (43)
T ss_dssp CCSSSSTT-SCSSSCCCCCSSCCCCCCCTTEEE
T ss_pred eeccCCcC-CCCCCEeECCCCCeEeECCCCccc
Confidence 58897654 567899986656678999999975
|
| >d1i0ua2 g.3.11.1 (A:42-82) Low density lipoprotein (LDL) receptor, different EGF domains {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Low density lipoprotein (LDL) receptor, different EGF domains species: Human (Homo sapiens) [TaxId: 9606]
Probab=80.03 E-value=0.43 Score=31.98 Aligned_cols=31 Identities=26% Similarity=0.647 Sum_probs=24.1
Q ss_pred cCCCccCCCCCCcccccCCCCCcccccCCCccC
Q 003254 312 DQCDSYALCGAYASCNINSNSPECECLQGFVPN 344 (836)
Q Consensus 312 ~~Cd~~g~CG~~g~C~~~~~~~~C~Cl~Gf~~~ 344 (836)
|+|...+.| ..+|.....+-.|+|++||...
T Consensus 2 dEC~~~~~C--~~~C~n~~Gsy~C~C~~Gy~L~ 32 (41)
T d1i0ua2 2 DECQDPDTC--SQLCVNLEGGYKCQCEEGFQLD 32 (41)
T ss_dssp CTTTTTTSC--SSCEECSSSCCEECCCTTEEEC
T ss_pred ccCCCCCCC--CCEeECCCCCEEeECCCCCeEC
Confidence 678877777 4689766556789999999764
|